Citrus Sinensis ID: 037197
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1009 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FRS6 | 1029 | Leucine-rich repeat recep | yes | no | 0.991 | 0.971 | 0.655 | 0.0 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.988 | 0.984 | 0.621 | 0.0 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.940 | 0.911 | 0.448 | 0.0 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.921 | 0.927 | 0.415 | 0.0 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.943 | 0.950 | 0.411 | 0.0 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.915 | 0.942 | 0.413 | 0.0 | |
| O65440 | 992 | Leucine-rich repeat recep | no | no | 0.931 | 0.947 | 0.406 | 0.0 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.912 | 0.924 | 0.388 | 1e-178 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.903 | 0.799 | 0.373 | 1e-177 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.950 | 0.844 | 0.377 | 1e-169 |
| >sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1322 bits (3421), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 676/1031 (65%), Positives = 820/1031 (79%), Gaps = 31/1031 (3%)
Query: 4 HLLFLYCYI---------VESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAE-NGLL 53
L FL+ YI E+ + E LL+ K+ L DP N L+DWK P NA + L+
Sbjct: 5 RLFFLFYYIGFALFPFVSSETFQNSEQEILLAFKSDLFDPSNNLQDWKRPENATTFSELV 64
Query: 54 HCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANL 113
HC+WTGV C++ G+V KL LSNM+L+G+VS+ I+ SL +L++ N F SSLPKSL+NL
Sbjct: 65 HCHWTGVHCDANGYVAKLLLSNMNLSGNVSDQIQSFPSLQALDLSNNAFESSLPKSLSNL 124
Query: 114 TALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSF 173
T+LK +DVS N+F G+FP GLG A+GLT VNASSNNFSGFLPEDLGNAT+LE LDFRG +
Sbjct: 125 TSLKVIDVSVNSFFGTFPYGLGMATGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRGGY 184
Query: 174 FEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNL 233
FEGSVP+SF+NL+ LKFLGLSGNN GK+P +G+LSSLETIILGYN F GEIP EFG L
Sbjct: 185 FEGSVPSSFKNLKNLKFLGLSGNNFGGKVPKVIGELSSLETIILGYNGFMGEIPEEFGKL 244
Query: 234 TNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQ 293
T L+YLDLAVG+L+GQIP +LG+LK+LTTVYLY+N TGK+P ELG +TSL FLDLSDNQ
Sbjct: 245 TRLQYLDLAVGNLTGQIPSSLGQLKQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSDNQ 304
Query: 294 ISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQS 353
I+GEIP+++ ELKNLQLLNLM NQLTG+IP K+ EL LEVLELW+NSL+GSLP+ LG++
Sbjct: 305 ITGEIPMEVGELKNLQLLNLMRNQLTGIIPSKIAELPNLEVLELWQNSLMGSLPVHLGKN 364
Query: 354 SPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNL 413
SPL+ LD SSN LSG+IP+GLC S NLTKLILFNNSFSG P + +C +LVRVR+Q N
Sbjct: 365 SPLKWLDVSSNKLSGDIPSGLCYSRNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQKNH 424
Query: 414 ISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSI 473
ISG+IP G G+LP LQ LE+A NNLTG+IPDDI+LSTSLSF+DIS + S L SSI S
Sbjct: 425 ISGSIPAGSGDLPMLQHLELAKNNLTGKIPDDIALSTSLSFIDIS-FNHLSSLSSSIFSS 483
Query: 474 PSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNR 533
P+LQTF+ASHNN KIPN++Q PSLSVLDLS N SG IP IAS EKLVSLNL++N+
Sbjct: 484 PNLQTFIASHNNFAGKIPNQIQDRPSLSVLDLSFNHFSGGIPERIASFEKLVSLNLKSNQ 543
Query: 534 FSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILM 593
GEIPKA+A M LA+LD+SNNSL G IP + GASP LEMLN+S+NKL+GP+PSN +
Sbjct: 544 LVGEIPKALAGMHMLAVLDLSNNSLTGNIPADLGASPTLEMLNVSFNKLDGPIPSNMLFA 603
Query: 594 NINPNELIGNAGLCGSVLPPCSQN--LTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVF 651
I+P +L+GN GLCG VLPPCS++ L+AK ++H+NH +FGFI+GT VIV++G++F
Sbjct: 604 AIDPKDLVGNNGLCGGVLPPCSKSLALSAKGRNPGRIHVNHAVFGFIVGTSVIVAMGMMF 663
Query: 652 FAGKWAYRRWYLYNSFFDDLF--KKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMG 709
AG+W Y RW LY++F + KK +EWPWRL+AFQRL FT+ +IL+ +KESNIIGMG
Sbjct: 664 LAGRWIYTRWDLYSNFAREYIFCKKPREEWPWRLVAFQRLCFTAGDILSHIKESNIIGMG 723
Query: 710 GNGIVYKAE-FHRPHMVVAVKKLWRS---DNDI-------ESGDDLFREVSLLGRLRHRN 758
GIVYKAE RP + VAVKKLWRS NDI + DD+ REV+LLG LRHRN
Sbjct: 724 AIGIVYKAEVMRRPLLTVAVKKLWRSPSPQNDIEDHHQEEDEEDDILREVNLLGGLRHRN 783
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
IV++LGY+HNE VMMVY+YMPN +LG ALH K+ LL DW+SRYN+AVG+ QGLNYLH
Sbjct: 784 IVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNVAVGVVQGLNYLH 843
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYT 878
+DC PP+IHRDIKSNNILLD+NLEARIADFGLA+MMLHKNETVSMVAGSYGYIAPEYGYT
Sbjct: 844 NDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMMLHKNETVSMVAGSYGYIAPEYGYT 903
Query: 879 LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938
LK+DEKSDIYS GVVLLEL+TGKMP+DP+F S D+VEW+ +K N++ +E +D SIAG
Sbjct: 904 LKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDSIDVVEWIRRKVKKNESLEEVIDASIAG 963
Query: 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNGGHNLSKERP 998
CKHV EEMLL LRIA+LCTAKLPK RP++RDVITML EAKPRRKS+CQ G + P
Sbjct: 964 DCKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITMLAEAKPRRKSVCQVAG-----DLP 1018
Query: 999 IFGNSPVLGLL 1009
IF NSPV+GL+
Sbjct: 1019 IFRNSPVVGLI 1029
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 1217 bits (3148), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 636/1023 (62%), Positives = 785/1023 (76%), Gaps = 26/1023 (2%)
Query: 1 MQTHLLFLY-CYI-----VESNADD--ELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGL 52
M+ +LFLY CYI V ++ D+ ELS LLS+K+ L+DPLN L+DWK+ +
Sbjct: 3 MKIIVLFLYYCYIGSTSSVLASIDNVNELSVLLSVKSTLVDPLNFLKDWKLSDTSD---- 58
Query: 53 LHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLAN 112
HCNWTGV CNS G VEKLDL+ M+L G +S++I L SL S NI CN F S LPKS+
Sbjct: 59 -HCNWTGVRCNSNGNVEKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFESLLPKSIP- 116
Query: 113 LTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGS 172
LKS+D+SQN+F GS ++ GL +NAS NN SG L EDLGN SLE LD RG+
Sbjct: 117 --PLKSIDISQNSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGN 174
Query: 173 FFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGN 232
FF+GS+P+SF+NLQKL+FLGLSGNNLTG++P LGQL SLET ILGYN F+G IP EFGN
Sbjct: 175 FFQGSLPSSFKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEFGN 234
Query: 233 LTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDN 292
+ +L+YLDLA+G LSG+IP LG+LK L T+ LY+NNFTG IP E+GSIT+L LD SDN
Sbjct: 235 INSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDN 294
Query: 293 QISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQ 352
++GEIP+++ +LKNLQLLNLM N+L+G IP + L +L+VLELW N+L G LP LG+
Sbjct: 295 ALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGK 354
Query: 353 SSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNN 412
+SPL+ LD SSN SGEIP+ LC+ GNLTKLILFNN+F+G P +LSTC+SLVRVR+QNN
Sbjct: 355 NSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNN 414
Query: 413 LISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILS 472
L++G+IP+G G L LQRLE+A N L+G IP DIS S SLSF+D S N + S LPS+ILS
Sbjct: 415 LLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILS 474
Query: 473 IPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNN 532
I +LQ F+ + N + ++P++ Q CPSLS LDLSSN+L+G IP+SIASCEKLVSLNLRNN
Sbjct: 475 IHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNN 534
Query: 533 RFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGIL 592
+GEIP+ + TM LA+LD+SNNSL G +PE+ G SPALE+LN+SYNKL GPVP NG L
Sbjct: 535 NLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFL 594
Query: 593 MNINPNELIGNAGLCGSVLPPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVFF 652
INP++L GN+GLCG VLPPCS+ A + +H I+ G++IG +++LGI+
Sbjct: 595 KTINPDDLRGNSGLCGGVLPPCSKFQRATSSHS-SLHGKRIVAGWLIGIASVLALGILTI 653
Query: 653 AGKWAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNG 712
+ Y++WY N F D S EWPWRL+AF RL FT+S+ILAC+KESN+IGMG G
Sbjct: 654 VTRTLYKKWY-SNGFCGD-ETASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGATG 711
Query: 713 IVYKAEFHRPHMVVAVKKLWRSDNDIESGD--DLFREVSLLGRLRHRNIVRLLGYLHNET 770
IVYKAE R V+AVKKLWRS DIE G D EV+LLG+LRHRNIVRLLG+L+N+
Sbjct: 712 IVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDK 771
Query: 771 NVMMVYDYMPNDSLGEALHGKE-AGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRD 829
N+M+VY++M N +LG+A+HGK AG+LLVDWVSRYNIA+G+A GL YLHHDC PPVIHRD
Sbjct: 772 NMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRD 831
Query: 830 IKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYS 889
IKSNNILLDANL+ARIADFGLARMM K ETVSMVAGSYGYIAPEYGYTLKVDEK DIYS
Sbjct: 832 IKSNNILLDANLDARIADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYS 891
Query: 890 FGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLL 949
+GVVLLELLTG+ PL+P FG S DIVEWV I+ N + +EALDP++ G C++VQEEMLL
Sbjct: 892 YGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEALDPNV-GNCRYVQEEMLL 950
Query: 950 VLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSIC--QNGGHNLS-KERPIFGNSPVL 1006
VL+IA+LCT KLPK RP+MRDVI+MLGEAKPRRKS +N +L+ K +F SPV
Sbjct: 951 VLQIALLCTTKLPKDRPSMRDVISMLGEAKPRRKSNSNEENTSRSLAEKHSSVFSTSPVN 1010
Query: 1007 GLL 1009
GLL
Sbjct: 1011 GLL 1013
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 806 bits (2082), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/968 (44%), Positives = 614/968 (63%), Gaps = 19/968 (1%)
Query: 34 PLNMLEDWKMPSNAAENGLLHCNWTGVWC-NSRGFVEKLDLSNMSLNGSVSENIRGLRSL 92
P + +DWK+P N +N + C+W+GV C N V LDLS+ +L+G + IR L SL
Sbjct: 49 PPSAFQDWKVPVNG-QNDAVWCSWSGVVCDNVTAQVISLDLSHRNLSGRIPIQIRYLSSL 107
Query: 93 SSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSG 152
LN+ N S P S+ +LT L ++D+S+N+F SFP G+ K L NA SNNF G
Sbjct: 108 LYLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKLKFLKVFNAFSNNFEG 167
Query: 153 FLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSL 212
LP D+ LE L+F GS+FEG +P ++ LQ+LKF+ L+GN L GK+PP LG L+ L
Sbjct: 168 LLPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNVLGGKLPPRLGLLTEL 227
Query: 213 ETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTG 272
+ + +GYN F G IP+EF L+NL+Y D++ SLSG +P LG L L T++L++N FTG
Sbjct: 228 QHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGFTG 287
Query: 273 KIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKL 332
+IP ++ SL LD S NQ+SG IP + LKNL L+L+ N L+G +P+ +GEL +L
Sbjct: 288 EIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELPEL 347
Query: 333 EVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSG 392
L LW N+ G LP +LG + L +D S+N +G IP+ LC L KLILF+N F G
Sbjct: 348 TTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEG 407
Query: 393 TFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSL 452
P SL+ C+SL R R QNN ++GTIP+G G+L +L ++++NN T QIP D + + L
Sbjct: 408 ELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAPVL 467
Query: 453 SFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSG 512
++++S N LP +I P+LQ F AS +NL +IPN + C S ++L NSL+G
Sbjct: 468 QYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIPNYV-GCKSFYRIELQGNSLNG 526
Query: 513 EIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPAL 572
IP I CEKL+ LNL N +G IP ++T+P++A +D+S+N L G IP +FG+S +
Sbjct: 527 TIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKTI 586
Query: 573 EMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSVL-PPC-SQNLTAKPGQTRKMHI 630
N+SYN+L GP+PS G ++NP+ N GLCG ++ PC S A H
Sbjct: 587 TTFNVSYNQLIGPIPS-GSFAHLNPSFFSSNEGLCGDLVGKPCNSDRFNAGNADIDGHHK 645
Query: 631 NH---IIFGFIIGTLVIVSLGIVFFAGKWAYRRWYL-YNSFFDDLFKKSCKEWPWRLIAF 686
G I+ L ++G+ FF A R + Y + D + PW+L AF
Sbjct: 646 EERPKKTAGAIVWILA-AAIGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPWKLTAF 704
Query: 687 QRLNFTSSEILACV-KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND----IESG 741
QRLNFT+ +++ C+ K NI+GMG G VYKAE ++AVKKLW + +
Sbjct: 705 QRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGE-IIAVKKLWGKNKENGKIRRRK 763
Query: 742 DDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAG-KLLVDW 800
+ EV +LG +RHRNIVRLLG N M++Y+YMPN SL + LHG + +W
Sbjct: 764 SGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEW 823
Query: 801 VSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860
+ Y IA+G+AQG+ YLHHDC P ++HRD+K +NILLDA+ EAR+ADFG+A+ ++ +E+
Sbjct: 824 TALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAK-LIQTDES 882
Query: 861 VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLS 920
+S+VAGSYGYIAPEY YTL+VD+KSDIYS+GV+LLE++TGK ++P FG IV+WV S
Sbjct: 883 MSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGNSIVDWVRS 942
Query: 921 MIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980
+K+ + +E LD S+ C ++EEM +LRIA+LCT++ P RP MRDV+ +L EAKP
Sbjct: 943 KLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQEAKP 1002
Query: 981 RRKSICQN 988
+RK++ N
Sbjct: 1003 KRKTVGDN 1010
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 696 bits (1797), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/971 (41%), Positives = 575/971 (59%), Gaps = 41/971 (4%)
Query: 20 ELSTLLSIKAGLI----DPLNMLEDWKMPSNAAENGLLHCNWTGVWCN-SRGFVEKLDLS 74
E LLS+K L D + L WK+ ++ C W GV C+ SR V LDLS
Sbjct: 25 EFRALLSLKTSLTGAGDDKNSPLSSWKVSTS-------FCTWIGVTCDVSRRHVTSLDLS 77
Query: 75 NMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGL 134
++L+G++S ++ LR L +L++ N + +P +++L+ L+ +++S N F GSFP +
Sbjct: 78 GLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEI 137
Query: 135 GKASGLTSV---NASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFL 191
+SGL ++ + +NN +G LP + N T L L G++F G +P S+ + +++L
Sbjct: 138 --SSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYL 195
Query: 192 GLSGNNLTGKIPPELGQLSSLETIILGY-NAFEGEIPAEFGNLTNLRYLDLAVGSLSGQI 250
+SGN L GKIPPE+G L++L + +GY NAFE +P E GNL+ L D A L+G+I
Sbjct: 196 AVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEI 255
Query: 251 PPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQL 310
PP +G+L+KL T++L N F+G + ELG+++SL +DLS+N +GEIP AELKNL L
Sbjct: 256 PPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTL 315
Query: 311 LNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEI 370
LNL N+L G IP+ +G+L +LEVL+LW+N+ GS+P +LG++ L +D SSN L+G +
Sbjct: 316 LNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTL 375
Query: 371 PTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQR 430
P +C L LI N G+ P SL C+SL R+R+ N ++G+IP GL LP L +
Sbjct: 376 PPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQ 435
Query: 431 LEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKI 490
+E+ +N L+G++P +S +L + +S N L LP +I + +Q + N Q I
Sbjct: 436 VELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPI 495
Query: 491 PNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAI 550
P+E+ LS +D S N SG I I+ C+ L ++L N SGEIP + M L
Sbjct: 496 PSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNY 555
Query: 551 LDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSV 610
L++S N L G IP + + +L L+ SYN L G VP G N +GN LCG
Sbjct: 556 LNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPY 615
Query: 611 LPPCSQNLTAKPGQTR-KMHINHIIFGFIIGTLVIVSLGIVFFAGKWAYRRWYLYNSFFD 669
L PC + Q+ K ++ + ++ L++ S+ A A
Sbjct: 616 LGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARS---------- 665
Query: 670 DLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVK 729
KK+ + WRL AFQRL+FT ++L +KE NIIG GG GIVYK + VAVK
Sbjct: 666 --LKKASESRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDL-VAVK 722
Query: 730 KLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALH 789
+L E+ LGR+RHR+IVRLLG+ N ++VY+YMPN SLGE LH
Sbjct: 723 RLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLH 782
Query: 790 GKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFG 849
GK+ G L W +RY IA+ A+GL YLHHDC P ++HRD+KSNNILLD+N EA +ADFG
Sbjct: 783 GKKGGHL--HWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFG 840
Query: 850 LARMMLHK--NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPA 907
LA+ + +E +S +AGSYGYIAPEY YTLKVDEKSD+YSFGVVLLEL+TG+ P+
Sbjct: 841 LAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVG-E 899
Query: 908 FGGSKDIVEWVLSMIKSNKAQD-EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP 966
FG DIV+WV M SNK + LDP ++ H E+ V +A+LC + RP
Sbjct: 900 FGDGVDIVQWVRKMTDSNKDSVLKVLDPRLSSIPIH---EVTHVFYVAMLCVEEQAVERP 956
Query: 967 TMRDVITMLGE 977
TMR+V+ +L E
Sbjct: 957 TMREVVQILTE 967
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 696 bits (1796), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/995 (41%), Positives = 582/995 (58%), Gaps = 43/995 (4%)
Query: 20 ELSTLLSIKAGL-IDPLN-MLEDWKMPSNAAENGLLHCNWTGVWCN-SRGFVEKLDLSNM 76
EL LLS+K+ ID + +L W + + C+WTGV C+ S V LDLS +
Sbjct: 27 ELHALLSLKSSFTIDEHSPLLTSWNLSTT-------FCSWTGVTCDVSLRHVTSLDLSGL 79
Query: 77 SLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGK 136
+L+G++S ++ L L +L++ N+ + +P ++NL L+ +++S N F GSFP L
Sbjct: 80 NLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDEL-- 137
Query: 137 ASGLTSVNA---SSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGL 193
+SGL ++ +NN +G LP L N T L L G++F G +P ++ L++L +
Sbjct: 138 SSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAV 197
Query: 194 SGNNLTGKIPPELGQLSSLETIILGY-NAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPP 252
SGN LTGKIPPE+G L++L + +GY NAFE +P E GNL+ L D A L+G+IPP
Sbjct: 198 SGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPP 257
Query: 253 ALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLN 312
+G+L+KL T++L N FTG I ELG I+SL +DLS+N +GEIP ++LKNL LLN
Sbjct: 258 EIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLN 317
Query: 313 LMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPT 372
L N+L G IP+ +GE+ +LEVL+LW+N+ GS+P +LG++ L LD SSN L+G +P
Sbjct: 318 LFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPP 377
Query: 373 GLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLE 432
+C L LI N G+ P SL C+SL R+R+ N ++G+IP L LP L ++E
Sbjct: 378 NMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVE 437
Query: 433 MANNNLTGQIP-DDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIP 491
+ +N LTG++P +S L + +S N L LP++I ++ +Q + N IP
Sbjct: 438 LQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIP 497
Query: 492 NELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAIL 551
E+ LS LD S N SG I I+ C+ L ++L N SG+IP + M L L
Sbjct: 498 PEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYL 557
Query: 552 DMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSVL 611
++S N L G IP + +L ++ SYN L G VPS G N +GN+ LCG L
Sbjct: 558 NLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYL 617
Query: 612 PPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVFFAGKWAYRRWYLYNSFFDDL 671
PC + T + H+ + + ++ + + FA + L N
Sbjct: 618 GPCGKG-------THQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRN------ 664
Query: 672 FKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKL 731
+ + WRL AFQRL+FT ++L +KE NIIG GG GIVYK + + VAVK+L
Sbjct: 665 ---ASEAKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDL-VAVKRL 720
Query: 732 WRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGK 791
+ E+ LGR+RHR+IVRLLG+ N ++VY+YMPN SLGE LHGK
Sbjct: 721 ATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK 780
Query: 792 EAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851
+ G L W +RY IA+ A+GL YLHHDC P ++HRD+KSNNILLD+N EA +ADFGLA
Sbjct: 781 KGGHL--HWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLA 838
Query: 852 RMMLHK--NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFG 909
+ + +E +S +AGSYGYIAPEY YTLKVDEKSD+YSFGVVLLEL+TGK P+ FG
Sbjct: 839 KFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVG-EFG 897
Query: 910 GSKDIVEWVLSMIKSNK-AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTM 968
DIV+WV SM SNK + +D ++ H E+ V +A+LC + RPTM
Sbjct: 898 DGVDIVQWVRSMTDSNKDCVLKVIDLRLSSVPVH---EVTHVFYVALLCVEEQAVERPTM 954
Query: 969 RDVITMLGEAKPRRKSICQNGGHNLSKERPIFGNS 1003
R+V+ +L E S Q +++++ P S
Sbjct: 955 REVVQILTEIPKIPLSKQQAAESDVTEKAPAINES 989
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 691 bits (1782), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/979 (41%), Positives = 583/979 (59%), Gaps = 55/979 (5%)
Query: 17 ADDELSTLLSIKAGLIDPLNM-LEDWKMPSNAAENGLLHCNWTGVWCNSRGFVEKLDLSN 75
A ++ LL++K+ +I P L DW S+ HC+++GV C+ V L++S
Sbjct: 24 AYTDMEVLLNLKSSMIGPKGHGLHDWIHSSSPDA----HCSFSGVSCDDDARVISLNVSF 79
Query: 76 MSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQN-NFIGSFPTGL 134
L G++S I L L +L + N F LP + +LT+LK +++S N N G+FP +
Sbjct: 80 TPLFGTISPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEI 139
Query: 135 GKA-SGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGL 193
KA L ++ +NNF+G LP ++ L+ L F G+FF G +P S+ ++Q L++LGL
Sbjct: 140 LKAMVDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEYLGL 199
Query: 194 SGNNLTGKIPPELGQLSSLETIILGY-NAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPP 252
+G L+GK P L +L +L + +GY N++ G +P EFG LT L LD+A +L+G+IP
Sbjct: 200 NGAGLSGKSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPT 259
Query: 253 ALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLN 312
+L LK L T++L+ NN TG IPPEL + SL LDLS NQ++GEIP L N+ L+N
Sbjct: 260 SLSNLKHLHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLIN 319
Query: 313 LMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPT 372
L N L G IP+ +GEL KLEV E+W+N+ LP LG++ L +LD S N L+G IP
Sbjct: 320 LFRNNLYGQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPK 379
Query: 373 GLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLE 432
LC L LIL NN F G P L CKSL ++R+ NL++GT+P GL NLP + +E
Sbjct: 380 DLCRGEKLEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIE 439
Query: 433 MANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPN 492
+ +N +G++P +S L + +S N +P +I + P+LQT N + IP
Sbjct: 440 LTDNFFSGELPVTMS-GDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPR 498
Query: 493 ELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILD 552
E+ LS ++ S+N+++G IP SI+ C L+S++L NR +GEIPK + + L L+
Sbjct: 499 EIFELKHLSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLN 558
Query: 553 MSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSVLP 612
+S N L G IP G +L L+LS+N L G VP G + N GN LC
Sbjct: 559 ISGNQLTGSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLC----L 614
Query: 613 PCSQNLTAKPGQTRKMHINHIIF--GFIIGTLVIVSLGIVFFAGKWAYRRWYLYNSFFDD 670
P + +PGQT H + +F I+ T++ G++ + A R+
Sbjct: 615 PHRVSCPTRPGQTSD-HNHTALFSPSRIVITVIAAITGLILIS--VAIRQMNK------- 664
Query: 671 LFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMV-VAVK 729
KK+ K W+L AFQ+L+F S ++L C+KE NIIG GG GIVY+ P+ V VA+K
Sbjct: 665 --KKNQKSLAWKLTAFQKLDFKSEDVLECLKEENIIGKGGAGIVYRGSM--PNNVDVAIK 720
Query: 730 KL-----WRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSL 784
+L RSD+ + E+ LGR+RHR+IVRLLGY+ N+ +++Y+YMPN SL
Sbjct: 721 RLVGRGTGRSDHGFTA------EIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSL 774
Query: 785 GEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEAR 844
GE LHG + G L W +R+ +AV A+GL YLHHDC P ++HRD+KSNNILLD++ EA
Sbjct: 775 GELLHGSKGGHL--QWETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAH 832
Query: 845 IADFGLARMMLH--KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKM 902
+ADFGLA+ ++ +E +S +AGSYGYIAPEY YTLKVDEKSD+YSFGVVLLEL+ GK
Sbjct: 833 VADFGLAKFLVDGAASECMSSIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKK 892
Query: 903 PLDPAFGGSKDIVEWVLSMIKS-NKAQDEAL-----DPSIAGQCKHVQEEMLLVLRIAVL 956
P+ FG DIV WV + + + D A+ DP + G + ++ V +IA++
Sbjct: 893 PVG-EFGEGVDIVRWVRNTEEEITQPSDAAIVVAIVDPRLTG---YPLTSVIHVFKIAMM 948
Query: 957 CTAKLPKGRPTMRDVITML 975
C + RPTMR+V+ ML
Sbjct: 949 CVEEEAAARPTMREVVHML 967
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 656 bits (1692), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/974 (40%), Positives = 569/974 (58%), Gaps = 34/974 (3%)
Query: 20 ELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWC-NSRGFVEKLDLSNMSL 78
+ + L+S+K L+ W +P+ N L C+WTGV C N + +LDLSN+++
Sbjct: 34 QANVLISLKQSFDSYDPSLDSWNIPN---FNSL--CSWTGVSCDNLNQSITRLDLSNLNI 88
Query: 79 NGSVSENIRGLR-SLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPT-GLGK 136
+G++S I L SL L+I N F+ LPK + L+ L+ +++S N F G T G +
Sbjct: 89 SGTISPEISRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEGELETRGFSQ 148
Query: 137 ASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGN 196
+ L +++A N+F+G LP L T LE LD G++F+G +P S+ + LKFL LSGN
Sbjct: 149 MTQLVTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSGN 208
Query: 197 NLTGKIPPELGQLSSLETIILGY-NAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALG 255
+L G+IP EL +++L + LGY N + G IPA+FG L NL +LDLA SL G IP LG
Sbjct: 209 DLRGRIPNELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAELG 268
Query: 256 RLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMC 315
LK L ++L N TG +P ELG++TSL LDLS+N + GEIP++L+ L+ LQL NL
Sbjct: 269 NLKNLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLFF 328
Query: 316 NQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLC 375
N+L G IP+ + EL L++L+LW N+ G +P +LG + L +D S+N L+G IP LC
Sbjct: 329 NRLHGEIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPESLC 388
Query: 376 DSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMAN 435
L LILFNN G P L C+ L R R+ N ++ +P GL LP+L LE+ N
Sbjct: 389 FGRRLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQN 448
Query: 436 NNLTGQIPDDISLS---TSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPN 492
N LTG+IP++ + + +SL+ +++S N L +P SI ++ SLQ + N L +IP
Sbjct: 449 NFLTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQIPG 508
Query: 493 ELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILD 552
E+ + SL +D+S N+ SG+ P C L L+L +N+ SG+IP ++ + L L+
Sbjct: 509 EIGSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLN 568
Query: 553 MSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSVLP 612
+S NS +P G +L + S+N G VP++G N +GN LCG
Sbjct: 569 VSWNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSN 628
Query: 613 PCSQNLTAKPGQTRKMHINHI-IFGFIIGTLVIVSLGIVFFAGKWAYRRWYLYNSFFDDL 671
PC N + Q++ ++ N+ G I + + + N
Sbjct: 629 PC--NGSQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKN------ 680
Query: 672 FKKSCKEWP--WRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVK 729
++ K P W+LI FQ+L F S IL CVKE+++IG GG GIVYK VAVK
Sbjct: 681 -RRMRKNNPNLWKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYKGVMPNGEE-VAVK 738
Query: 730 KLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALH 789
KL + L E+ LGR+RHRNIVRLL + N+ ++VY+YMPN SLGE LH
Sbjct: 739 KLLTITKGSSHDNGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLH 798
Query: 790 GKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFG 849
GK + + W +R IA+ A+GL YLHHDC P +IHRD+KSNNILL EA +ADFG
Sbjct: 799 GKAG--VFLKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFG 856
Query: 850 LARMMLHKN---ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
LA+ M+ N E +S +AGSYGYIAPEY YTL++DEKSD+YSFGVVLLEL+TG+ P+D
Sbjct: 857 LAKFMMQDNGASECMSSIAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDN 916
Query: 907 AFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQ-EEMLLVLRIAVLCTAKLPKGR 965
DIV+W S I++N + + I + ++ E + + +A+LC + R
Sbjct: 917 FGEEGIDIVQW--SKIQTN-CNRQGVVKIIDQRLSNIPLAEAMELFFVAMLCVQEHSVER 973
Query: 966 PTMRDVITMLGEAK 979
PTMR+V+ M+ +AK
Sbjct: 974 PTMREVVQMISQAK 987
|
Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 626 bits (1615), Expect = e-178, Method: Compositional matrix adjust.
Identities = 378/972 (38%), Positives = 556/972 (57%), Gaps = 51/972 (5%)
Query: 24 LLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWCNSR-GFVEKLDLSNMSLNGSV 82
L +K L DP + L W SN A C W+GV C V +DLS+ +L G
Sbjct: 23 LQQVKLSLDDPDSYLSSWN--SNDAS----PCRWSGVSCAGDFSSVTSVDLSSANLAGPF 76
Query: 83 SENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTS 142
I L +L+ L++ N S+LP ++A +L+++D+SQN G P L L
Sbjct: 77 PSVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADIPTLVH 136
Query: 143 VNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLT-GK 201
++ + NNFSG +P G +LE L + +G++P N+ LK L LS N + +
Sbjct: 137 LDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNPFSPSR 196
Query: 202 IPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLT 261
IPPE G L++LE + L G+IP G L+ L LDLA+ L G IPP+LG L +
Sbjct: 197 IPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTNVV 256
Query: 262 TVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGL 321
+ LY N+ TG+IPPELG++ SL LD S NQ++G+IP +L + L+ LNL N L G
Sbjct: 257 QIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVP-LESLNLYENNLEGE 315
Query: 322 IPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLT 381
+P + L + ++ N L G LP LG +SPLR LD S N SG++P LC G L
Sbjct: 316 LPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGELE 375
Query: 382 KLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQ 441
+L++ +NSFSG P SL+ C+SL R+R+ N SG++P G LP + LE+ NN+ +G+
Sbjct: 376 ELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGE 435
Query: 442 IPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLS 501
I I +++LS + +S N LP I S+ +L AS N +P+ L + L
Sbjct: 436 ISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGELG 495
Query: 502 VLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGR 561
LDL N SGE+ + I S +KL LNL +N F+G+IP + ++ L LD+S N G+
Sbjct: 496 TLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGK 555
Query: 562 IPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSVLPPCSQNLTAK 621
IP + S L LNLSYN+L G +P + + ++ N IGN GLCG + C AK
Sbjct: 556 IPVSL-QSLKLNQLNLSYNRLSGDLPPS-LAKDMYKNSFIGNPGLCGDIKGLCGSENEAK 613
Query: 622 PGQTRKMHINHIIFGFIIGTLVIVSLGIVFFAGKWAYRRWYLYNSFFDDLFKKSCKEWPW 681
++ ++ + F++ +V+++ G+ +F ++ Y +F ++ + W
Sbjct: 614 ----KRGYVWLLRSIFVLAAMVLLA-GVAWF--------YFKYRTFKK---ARAMERSKW 657
Query: 682 RLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLW------RSD 735
L++F +L F+ EIL + E N+IG G +G VYK VAVK+LW D
Sbjct: 658 TLMSFHKLGFSEHEILESLDEDNVIGAGASGKVYKVVLTNGE-TVAVKRLWTGSVKETGD 716
Query: 736 NDIESG------DDLFR-EVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEAL 788
D E G D+ F EV LG++RH+NIV+L ++VY+YMPN SLG+ L
Sbjct: 717 CDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLL 776
Query: 789 HGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848
H + G ++ W +R+ I + A+GL+YLHHD PP++HRDIKSNNIL+D + AR+ADF
Sbjct: 777 HSSKGG--MLGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADF 834
Query: 849 GLAR---MMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
G+A+ + +++S++AGS GYIAPEY YTL+V+EKSDIYSFGVV+LE++T K P+D
Sbjct: 835 GVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVD 894
Query: 906 PAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGR 965
P G KD+V+WV S + K + +DP + C +EE+ +L + +LCT+ LP R
Sbjct: 895 PEL-GEKDLVKWVCSTL-DQKGIEHVIDPKL-DSC--FKEEISKILNVGLLCTSPLPINR 949
Query: 966 PTMRDVITMLGE 977
P+MR V+ ML E
Sbjct: 950 PSMRRVVKMLQE 961
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 623 bits (1607), Expect = e-177, Method: Compositional matrix adjust.
Identities = 383/1025 (37%), Positives = 553/1025 (53%), Gaps = 113/1025 (11%)
Query: 56 NWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTA 115
NWT + C+S+GF+ +D+ ++ L S+ +N+ RSL L I +LP+SL +
Sbjct: 71 NWTFITCSSQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLG 130
Query: 116 LKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFE 175
LK +D+S N +G P L K L ++ +SN +G +P D+ + L+SL +
Sbjct: 131 LKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLT 190
Query: 176 GSVPTSFRNLQKLKFLGLSGN---------------NLT----------GKIPPELGQLS 210
GS+PT L L+ + + GN NLT G +P LG+L
Sbjct: 191 GSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLK 250
Query: 211 SLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNF 270
LET+ + GEIP++ GN + L L L SLSG IP +G+L KL ++L++N+
Sbjct: 251 KLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSL 310
Query: 271 TGKIPPELGSITSLAFLDLS------------------------DNQISGEIPVKLAELK 306
G IP E+G+ ++L +DLS DN+ SG IP ++
Sbjct: 311 VGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCS 370
Query: 307 NLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLL 366
+L L L NQ++GLIP +LG LTKL + W N L GS+P L + L+ LD S N L
Sbjct: 371 SLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSL 430
Query: 367 SGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLP 426
+G IP+GL NLTKL+L +NS SG P + C SLVR+R+ N I+G IP G+G+L
Sbjct: 431 TGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLK 490
Query: 427 SLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNL 486
+ L+ ++N L G++PD+I + L +D+S N LE LP+ + S+ LQ S N
Sbjct: 491 KINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQF 550
Query: 487 QAK------------------------IPNELQACPSLSVLDLSSNSLSGEIPASIASCE 522
K IP L C L +LDL SN LSGEIP+ + E
Sbjct: 551 SGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIE 610
Query: 523 KL-VSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNK 581
L ++LNL +NR +G+IP +A++ L+ILD+S+N L G + L LN+SYN
Sbjct: 611 NLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAP-LANIENLVSLNISYNS 669
Query: 582 LEGPVPSNGILMNINPNELIGNAGLCGSVLPPCSQNLTAKPG----------QTRKMHIN 631
G +P N + ++P +L GN LC S C LT + G +TRK+ +
Sbjct: 670 FSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDSCF--LTYRKGNGLGDDGDASRTRKLRLT 727
Query: 632 HIIFGFIIGTLVIVSLGIVFFAGKWAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNF 691
+ + L+I+ V A R + N +L + + W+ FQ+LNF
Sbjct: 728 LALLITLTVVLMILGAVAVIRA------RRNIDNERDSELGET----YKWQFTPFQKLNF 777
Query: 692 TSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRS------DNDIESGDDLF 745
+ +I+ C+ E N+IG G +G+VY+A+ V+AVKKLW + D ++ D F
Sbjct: 778 SVDQIIRCLVEPNVIGKGCSGVVYRADVDNGE-VIAVKKLWPAMVNGGHDEKTKNVRDSF 836
Query: 746 R-EVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRY 804
EV LG +RH+NIVR LG N +++YDYMPN SLG LH + L DW RY
Sbjct: 837 SAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSSL--DWDLRY 894
Query: 805 NIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN--ETVS 862
I +G AQGL YLHHDC PP++HRDIK+NNIL+ + E IADFGLA+++ + +
Sbjct: 895 RILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSN 954
Query: 863 MVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922
VAGSYGYIAPEYGY++K+ EKSD+YS+GVV+LE+LTGK P+DP +V+WV
Sbjct: 955 TVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWV---- 1010
Query: 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982
+ N+ E LD ++ + + +EM+ VL A+LC P RPTM+DV ML E K R
Sbjct: 1011 RQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEIKQER 1070
Query: 983 KSICQ 987
+ +
Sbjct: 1071 EEYAK 1075
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 598 bits (1541), Expect = e-169, Method: Compositional matrix adjust.
Identities = 387/1026 (37%), Positives = 567/1026 (55%), Gaps = 67/1026 (6%)
Query: 11 YIVESNADDELST---LLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWCNSRGF 67
YI S++D++L T ++S++ L P N+ + N N TG + G
Sbjct: 73 YITCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVISN----TNLTGAISSEIGD 128
Query: 68 VEKL---DLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQN 124
+L DLS+ SL G + ++ L++L L + N +P L + +LK++++ N
Sbjct: 129 CSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDN 188
Query: 125 NFIGSFPTGLGKASGLTSVNASSNN-FSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFR 183
+ P LGK S L S+ A N+ SG +PE++GN +L+ L + GS+P S
Sbjct: 189 YLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLG 248
Query: 184 NLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAV 243
L KL+ L + L+G+IP ELG S L + L N G +P E G L NL + L
Sbjct: 249 QLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQ 308
Query: 244 GSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLA 303
+L G IP +G +K L + L N F+G IP G++++L L LS N I+G IP L+
Sbjct: 309 NNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILS 368
Query: 304 ELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASS 363
L + NQ++GLIP ++G L +L + W+N L G++P L L+ LD S
Sbjct: 369 NCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQ 428
Query: 364 NLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLG 423
N L+G +P GL NLTKL+L +N+ SG P+ + C SLVR+R+ NN I+G IP G+G
Sbjct: 429 NYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIG 488
Query: 424 NLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASH 483
L +L L+++ NNL+G +P +IS L +++S N L+ YLP S+ S+ LQ S
Sbjct: 489 FLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSS 548
Query: 484 NNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVA 543
N+L KIP+ L SL+ L LS NS +GEIP+S+ C L L+L +N SG IP+ +
Sbjct: 549 NDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELF 608
Query: 544 TMPTLAI-LDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPS-----NGILMNINP 597
+ L I L++S NSL G IPE A L +L++S+N L G + + N + +NI+
Sbjct: 609 DIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSALSGLENLVSLNISH 668
Query: 598 N------------------ELIGNAGLCGSVLPPCSQNLTAKPGQTRKMHIN--HIIFGF 637
N E+ GN GLC C + +++ R +H + I G
Sbjct: 669 NRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQRGVHSHRLRIAIGL 728
Query: 638 IIG-TLVIVSLGIV-FFAGKWAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSE 695
+I T V+ LG++ K R D+ + W W+ FQ+LNFT
Sbjct: 729 LISVTAVLAVLGVLAVIRAKQMIRD--------DNDSETGENLWTWQFTPFQKLNFTVEH 780
Query: 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWR------SDNDIESG--DDLFRE 747
+L C+ E N+IG G +GIVYKAE V+AVKKLW ++ SG D E
Sbjct: 781 VLKCLVEGNVIGKGCSGIVYKAEMPN-REVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAE 839
Query: 748 VSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIA 807
V LG +RH+NIVR LG N+ +++YDYM N SLG LH + +G + W RY I
Sbjct: 840 VKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLH-ERSGVCSLGWEVRYKII 898
Query: 808 VGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN--ETVSMVA 865
+G AQGL YLHHDC PP++HRDIK+NNIL+ + E I DFGLA+++ + + + +A
Sbjct: 899 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIA 958
Query: 866 GSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN 925
GSYGYIAPEYGY++K+ EKSD+YS+GVV+LE+LTGK P+DP IV+WV
Sbjct: 959 GSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWV------K 1012
Query: 926 KAQD-EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE-AKPRRK 983
K +D + +D + + + EEM+ L +A+LC +P+ RPTM+DV ML E + R +
Sbjct: 1013 KIRDIQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAMLSEICQEREE 1072
Query: 984 SICQNG 989
S+ +G
Sbjct: 1073 SMKVDG 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1009 | ||||||
| 224145839 | 1018 | predicted protein [Populus trichocarpa] | 0.999 | 0.990 | 0.772 | 0.0 | |
| 224125742 | 1017 | predicted protein [Populus trichocarpa] | 0.999 | 0.991 | 0.779 | 0.0 | |
| 255561989 | 966 | protein with unknown function [Ricinus c | 0.957 | 1.0 | 0.790 | 0.0 | |
| 357441421 | 1018 | Receptor-like protein kinase [Medicago t | 0.998 | 0.989 | 0.717 | 0.0 | |
| 356533648 | 1034 | PREDICTED: leucine-rich repeat receptor- | 0.998 | 0.973 | 0.731 | 0.0 | |
| 356574888 | 1032 | PREDICTED: leucine-rich repeat receptor- | 0.997 | 0.974 | 0.730 | 0.0 | |
| 359480057 | 1022 | PREDICTED: leucine-rich repeat receptor- | 0.994 | 0.981 | 0.698 | 0.0 | |
| 255590183 | 1017 | Receptor protein kinase CLAVATA1 precurs | 0.984 | 0.976 | 0.685 | 0.0 | |
| 224065541 | 1019 | predicted protein [Populus trichocarpa] | 0.993 | 0.983 | 0.680 | 0.0 | |
| 356570674 | 1018 | PREDICTED: leucine-rich repeat receptor- | 0.986 | 0.977 | 0.668 | 0.0 |
| >gi|224145839|ref|XP_002325782.1| predicted protein [Populus trichocarpa] gi|222862657|gb|EEF00164.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1599 bits (4141), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 787/1019 (77%), Positives = 886/1019 (86%), Gaps = 11/1019 (1%)
Query: 1 MQTHLLFLYC------YIVES----NADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAEN 50
MQT LLF +C VE +ELSTLL I++ L+DP N LE W+MP N++EN
Sbjct: 1 MQTLLLFFFCCFGLSLVFVEGVQSVQQHEELSTLLLIRSSLVDPSNQLEGWRMPRNSSEN 60
Query: 51 GLLHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSL 110
HCNWTG+WCNS+GFVE+LDLSNM+L G+VS++I+ L SLS LN CN F SSLP+ L
Sbjct: 61 QSPHCNWTGIWCNSKGFVERLDLSNMNLTGNVSDHIQDLHSLSFLNFSCNGFDSSLPREL 120
Query: 111 ANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFR 170
LT+LK++DVSQNNF+GSFPTGLG ASGLTSVNASSNNFSG+LPEDLGNATSLESLDFR
Sbjct: 121 GTLTSLKTIDVSQNNFVGSFPTGLGMASGLTSVNASSNNFSGYLPEDLGNATSLESLDFR 180
Query: 171 GSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEF 230
GSFFEGS+P SF+NLQKLKFLGLSGNNLTG+IP E+GQL+SLETIILGYN FEGEIP E
Sbjct: 181 GSFFEGSIPGSFKNLQKLKFLGLSGNNLTGRIPREIGQLASLETIILGYNEFEGEIPEEI 240
Query: 231 GNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLS 290
GNLTNLRYLDLAVGSLSGQIP LGRLK+LTTVYLYKNNFTG+IPPELG TSL FLDLS
Sbjct: 241 GNLTNLRYLDLAVGSLSGQIPAELGRLKQLTTVYLYKNNFTGQIPPELGDATSLVFLDLS 300
Query: 291 DNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRL 350
DNQISGEIPV+LAELKNLQLLNLM NQL G IP KLGELTKLEVLELWKN L G LP L
Sbjct: 301 DNQISGEIPVELAELKNLQLLNLMRNQLKGTIPTKLGELTKLEVLELWKNFLTGPLPENL 360
Query: 351 GQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQ 410
GQ+SPL+ LD SSN LSGEIP GLC SGNLTKLILFNNSFSG P+SLSTC+SLVRVR+Q
Sbjct: 361 GQNSPLQWLDVSSNSLSGEIPPGLCHSGNLTKLILFNNSFSGPIPMSLSTCESLVRVRMQ 420
Query: 411 NNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSI 470
NNLISGTIPVGLG+LP LQRLE+ANNNLTGQIPDDI LSTSLSF+D+S NHL+S LP SI
Sbjct: 421 NNLISGTIPVGLGSLPMLQRLELANNNLTGQIPDDIGLSTSLSFIDVSGNHLQSSLPYSI 480
Query: 471 LSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLR 530
LSIPSLQ FMAS+NNL+ +IP++ Q CPSL++LDLSSN LSG+IP SIASCEKLV+LNL+
Sbjct: 481 LSIPSLQIFMASNNNLEGQIPDQFQDCPSLTLLDLSSNHLSGKIPESIASCEKLVNLNLK 540
Query: 531 NNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNG 590
NN+F+GEIPKA++TMPTLAILD+SNNSL GRIPENFG SPALE LNLS+NKLEGPVPSNG
Sbjct: 541 NNQFTGEIPKAISTMPTLAILDLSNNSLVGRIPENFGNSPALETLNLSFNKLEGPVPSNG 600
Query: 591 ILMNINPNELIGNAGLCGSVLPPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIV 650
+L INPN+L+GNAGLCG +LPPCS ++ Q + + + H+I GFI+G +++SLGI
Sbjct: 601 MLTTINPNDLVGNAGLCGGILPPCSP-ASSVSKQQQNLRVKHVIIGFIVGISIVLSLGIA 659
Query: 651 FFAGKWAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGG 710
FF G+ Y+RWYLYNSFF D F S K WPW L+AFQR++FTSS+I+AC+ ESNIIGMGG
Sbjct: 660 FFTGRLIYKRWYLYNSFFYDWFNNSNKAWPWTLVAFQRISFTSSDIIACIMESNIIGMGG 719
Query: 711 NGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET 770
GIVYKAE +RPH VAVKKLWR++ DIE+GDDLFREV+LLGRLRHRNIVRLLGY+HNET
Sbjct: 720 TGIVYKAEAYRPHATVAVKKLWRTERDIENGDDLFREVNLLGRLRHRNIVRLLGYIHNET 779
Query: 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDI 830
+V+MVY+YMPN +LG ALHGKEAG LLVDWVSRYN+AVG+AQGLNYLHHDC PPVIHRDI
Sbjct: 780 DVLMVYEYMPNGNLGTALHGKEAGNLLVDWVSRYNVAVGVAQGLNYLHHDCHPPVIHRDI 839
Query: 831 KSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSF 890
KSNNILLD+NLEARIADFGLARMM +KNETVSMVAGSYGYIAPEYGYTLKV EKSDIYSF
Sbjct: 840 KSNNILLDSNLEARIADFGLARMMSYKNETVSMVAGSYGYIAPEYGYTLKVGEKSDIYSF 899
Query: 891 GVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLV 950
GVVLLELLTGKMPLDPAFG S DIVEWV I++N+A +EALD SIAG CK VQEEMLLV
Sbjct: 900 GVVLLELLTGKMPLDPAFGESVDIVEWVRRKIRNNRALEEALDHSIAGHCKDVQEEMLLV 959
Query: 951 LRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNGGHNLSKERPIFGNSPVLGLL 1009
LRIA+LCTAKLPK RP+MRDVITMLGEAKPRRKSIC NG N SKERPIF NSPV+GLL
Sbjct: 960 LRIAILCTAKLPKDRPSMRDVITMLGEAKPRRKSICHNGVQNPSKERPIFSNSPVIGLL 1018
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224125742|ref|XP_002319664.1| predicted protein [Populus trichocarpa] gi|222858040|gb|EEE95587.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1583 bits (4100), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 794/1018 (77%), Positives = 880/1018 (86%), Gaps = 10/1018 (0%)
Query: 1 MQTHLLFLYCYI---------VESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENG 51
MQT LLF I V+S DELSTLL IK+ LIDP N L WKMP NAA N
Sbjct: 1 MQTLLLFFDICIAFSLVFVEGVQSVQYDELSTLLLIKSSLIDPSNKLMGWKMPGNAAGNR 60
Query: 52 LLHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLA 111
HCNWTGV C+++GFVE+LDLSNM+L+G VS +I+ LRSLS LNI CN F SSLPKSL
Sbjct: 61 SPHCNWTGVRCSTKGFVERLDLSNMNLSGIVSYHIQELRSLSFLNISCNGFDSSLPKSLG 120
Query: 112 NLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRG 171
LT+LK++DVSQNNFIGSFPTGLG ASGLTSVNASSNNFSG+LPEDLGNATSLESLDFRG
Sbjct: 121 TLTSLKTIDVSQNNFIGSFPTGLGMASGLTSVNASSNNFSGYLPEDLGNATSLESLDFRG 180
Query: 172 SFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFG 231
SFF GS+P+SF+ LQKLKFLGLSGNNLTG+IP E+GQL+SLETIILGYN FEGEIPAE G
Sbjct: 181 SFFVGSIPSSFKYLQKLKFLGLSGNNLTGRIPREIGQLASLETIILGYNEFEGEIPAEIG 240
Query: 232 NLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSD 291
NLT+L+YLDLAVG LSGQIP LGRLK+L TVYLYKNNFTGKIPPELG+ TSL FLDLSD
Sbjct: 241 NLTSLQYLDLAVGRLSGQIPAELGRLKQLATVYLYKNNFTGKIPPELGNATSLVFLDLSD 300
Query: 292 NQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLG 351
NQISGEIPV++AELKNLQLLNLM NQL G IP KLGELTKLEVLELWKN L G LP LG
Sbjct: 301 NQISGEIPVEVAELKNLQLLNLMSNQLKGTIPTKLGELTKLEVLELWKNFLTGPLPENLG 360
Query: 352 QSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQN 411
Q+SPL+ LD SSN LSGEIP GLC SGNLTKLILFNNSFSG P SLSTCKSLVRVR+QN
Sbjct: 361 QNSPLQWLDVSSNSLSGEIPPGLCHSGNLTKLILFNNSFSGPIPTSLSTCKSLVRVRMQN 420
Query: 412 NLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSIL 471
NLISGTIPVGLG+LP LQRLE+ANNNLTGQIPDDI+LSTSLSF+D+S NHLES LP IL
Sbjct: 421 NLISGTIPVGLGSLPLLQRLELANNNLTGQIPDDIALSTSLSFIDVSGNHLESSLPYGIL 480
Query: 472 SIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRN 531
S+P+LQ FMAS+NN + +IP++ Q CPSLS+L+LSSN SG+IP SIASCEKLV+LNL+N
Sbjct: 481 SVPNLQIFMASNNNFEGQIPDQFQDCPSLSLLELSSNHFSGKIPESIASCEKLVNLNLQN 540
Query: 532 NRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGI 591
N+F+GEIPKA++TMPTLAILD+SNNSL GRIP NFG SPALEM+NLS+NKLEGPVPSNG+
Sbjct: 541 NQFTGEIPKAISTMPTLAILDLSNNSLVGRIPANFGTSPALEMVNLSFNKLEGPVPSNGM 600
Query: 592 LMNINPNELIGNAGLCGSVLPPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVF 651
L INPN+LIGNAGLCG VLPPCS +A Q + + H+I GFIIG +I++LGI F
Sbjct: 601 LTTINPNDLIGNAGLCGGVLPPCSTTSSASK-QQENLRVKHVITGFIIGVSIILTLGIAF 659
Query: 652 FAGKWAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGN 711
F G+W Y+RWYLYNSFFDD KS KEWPW L+AFQR++FTSS+ILA +KESNIIGMGG
Sbjct: 660 FTGRWLYKRWYLYNSFFDDWHNKSNKEWPWTLVAFQRISFTSSDILASIKESNIIGMGGT 719
Query: 712 GIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771
GIVYKAE HRPH +VAVKKLWR++ D+E+GDDLFREVSLLGRLRHRNIVRLLGYLHNET+
Sbjct: 720 GIVYKAEAHRPHAIVAVKKLWRTETDLENGDDLFREVSLLGRLRHRNIVRLLGYLHNETD 779
Query: 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIK 831
VMMVY+YMPN +LG ALHGKEAG LLVDWVSRYNIAVG+AQGLNYLHHDC PPVIHRDIK
Sbjct: 780 VMMVYEYMPNGNLGTALHGKEAGNLLVDWVSRYNIAVGVAQGLNYLHHDCHPPVIHRDIK 839
Query: 832 SNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFG 891
SNNILLDANLEARIADFGLARMM HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFG
Sbjct: 840 SNNILLDANLEARIADFGLARMMSHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFG 899
Query: 892 VVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVL 951
VVLLELLTGKMPLDPAF S DIVEW I++N+A +EALD SIAGQ KHVQEEMLLVL
Sbjct: 900 VVLLELLTGKMPLDPAFEESVDIVEWARRKIRNNRALEEALDHSIAGQYKHVQEEMLLVL 959
Query: 952 RIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNGGHNLSKERPIFGNSPVLGLL 1009
RIA+LCTAKLPK RP+MRDVITMLGEAKPRRKS C N N +ERPIF SPV+GLL
Sbjct: 960 RIAILCTAKLPKDRPSMRDVITMLGEAKPRRKSTCHNNVQNPREERPIFSTSPVIGLL 1017
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561989|ref|XP_002522003.1| protein with unknown function [Ricinus communis] gi|223538807|gb|EEF40407.1| protein with unknown function [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1569 bits (4063), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 764/967 (79%), Positives = 860/967 (88%), Gaps = 1/967 (0%)
Query: 43 MPSNAAENGLLHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEF 102
MP N +N HCNWTG+WCNS+G VEKL L NMSL+G+VS++I+GLR LS L+I CNEF
Sbjct: 1 MPRNLDDNHSPHCNWTGIWCNSKGLVEKLVLFNMSLSGNVSDHIQGLRDLSVLDISCNEF 60
Query: 103 ASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNAT 162
ASSLPKSL NLT+L+S+DVSQNNFIGSFPTGLG+ASGLTSVNASSNNFSG LPEDLGNAT
Sbjct: 61 ASSLPKSLGNLTSLESIDVSQNNFIGSFPTGLGRASGLTSVNASSNNFSGLLPEDLGNAT 120
Query: 163 SLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAF 222
SLESLDFRGSFFEGS+P SF+NLQKLKFLGLSGNNLTGKIP E+GQLSSLETIILGYN F
Sbjct: 121 SLESLDFRGSFFEGSIPISFKNLQKLKFLGLSGNNLTGKIPIEIGQLSSLETIILGYNDF 180
Query: 223 EGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSIT 282
EGEIPAE GNLTNL+YLDLAVG+LSGQIP LGRLKKLTT+YLYKNNFTGKIPPELG+I
Sbjct: 181 EGEIPAEIGNLTNLQYLDLAVGTLSGQIPVELGRLKKLTTIYLYKNNFTGKIPPELGNIA 240
Query: 283 SLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSL 342
SL FLDLSDNQISGEIPV++AELKNLQLLNLMCN+LTG IP K+GEL KLEVLELWKNSL
Sbjct: 241 SLQFLDLSDNQISGEIPVEIAELKNLQLLNLMCNKLTGPIPSKIGELAKLEVLELWKNSL 300
Query: 343 IGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCK 402
G LP LG++SPL LD SSN LSG+IP GLC GNLTKLILFNNSFSG PV LSTCK
Sbjct: 301 TGPLPKNLGENSPLVWLDVSSNSLSGDIPPGLCQFGNLTKLILFNNSFSGPIPVGLSTCK 360
Query: 403 SLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHL 462
SLVRVRVQNNLISGTIPVG G+LP L+RLE+ANNNLTG+I DDI++STSLSF+DIS N L
Sbjct: 361 SLVRVRVQNNLISGTIPVGFGSLPMLERLELANNNLTGEISDDIAISTSLSFIDISRNRL 420
Query: 463 ESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCE 522
+S LP +ILSIP LQ FMAS+NNL KIP++ Q CPSL +LDLS N SG +P SIASCE
Sbjct: 421 DSSLPYNILSIPKLQIFMASNNNLVGKIPDQFQDCPSLILLDLSRNYFSGTLPGSIASCE 480
Query: 523 KLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKL 582
KLV+LNL+NN+ +GEIPKA++TMPTLAILD+SNNSL G+IP+NFG+SPALEM++LS+N+L
Sbjct: 481 KLVNLNLQNNQLTGEIPKAISTMPTLAILDLSNNSLIGQIPKNFGSSPALEMVDLSFNRL 540
Query: 583 EGPVPSNGILMNINPNELIGNAGLCGSVLPPCSQNLTAKPGQTRKMHINHIIFGFIIGTL 642
EGPVP+NGILM INPN+LIGNAGLCG +LPPC+ + + P + + I+H+I GFIIG
Sbjct: 541 EGPVPANGILMTINPNDLIGNAGLCGGILPPCAAS-ASTPKRRENLRIHHVIVGFIIGIS 599
Query: 643 VIVSLGIVFFAGKWAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKE 702
VI+SLGI F G+W Y+RWYLYNSFF D FKKS KEWPW L+AFQR++FTSS+IL+C+KE
Sbjct: 600 VILSLGIAFVTGRWLYKRWYLYNSFFYDWFKKSSKEWPWILVAFQRISFTSSDILSCIKE 659
Query: 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRL 762
SN++GMGG GIVYKAE +RPH+VVAVKKLWR+D DIE+GDDLF EVSLLGRLRHRNIVRL
Sbjct: 660 SNVVGMGGTGIVYKAEVNRPHVVVAVKKLWRTDTDIENGDDLFAEVSLLGRLRHRNIVRL 719
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
LGYLHNETNVMM+Y+YMPN +L ALHGKEAGK+LVDWVSRYNIA G+AQGLNYLHHDC
Sbjct: 720 LGYLHNETNVMMIYEYMPNGNLWSALHGKEAGKILVDWVSRYNIAAGVAQGLNYLHHDCN 779
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD 882
PPVIHRDIKSNNILLDA LEARIADFGLARMM+HKNETVSMVAGSYGYIAPEYGYTLKVD
Sbjct: 780 PPVIHRDIKSNNILLDAKLEARIADFGLARMMVHKNETVSMVAGSYGYIAPEYGYTLKVD 839
Query: 883 EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942
EKSDIYSFGVVLLELLTGK PLDPAFG S DIVEW+ I+SN+ +EALDPSIAGQCKH
Sbjct: 840 EKSDIYSFGVVLLELLTGKKPLDPAFGESTDIVEWMQRKIRSNRPLEEALDPSIAGQCKH 899
Query: 943 VQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNGGHNLSKERPIFGN 1002
VQEEMLLVLR+A+LCTAK PK RP+MRDVITMLGEAKPRRKSIC NG HN SKE+ +F N
Sbjct: 900 VQEEMLLVLRVAILCTAKNPKDRPSMRDVITMLGEAKPRRKSICHNGVHNPSKEKQVFSN 959
Query: 1003 SPVLGLL 1009
SPV+GLL
Sbjct: 960 SPVIGLL 966
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357441421|ref|XP_003590988.1| Receptor-like protein kinase [Medicago truncatula] gi|355480036|gb|AES61239.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1503 bits (3892), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 732/1020 (71%), Positives = 853/1020 (83%), Gaps = 13/1020 (1%)
Query: 1 MQTHLLFLYCYIV---------ESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAE-N 50
MQTHL YCYI+ +S +DELSTLLSIK+ LID +N L+DW+ PSNA
Sbjct: 1 MQTHLFLFYCYIIVSLIFTERAQSATNDELSTLLSIKSSLIDSMNHLKDWQPPSNATRWQ 60
Query: 51 GLLHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSL 110
LHCNWTG+ CN++GFVE L+L NM+L+G VS +I+ L SLS NI CN FAS+LPKSL
Sbjct: 61 SRLHCNWTGIGCNTKGFVESLELYNMNLSGIVSNHIQSLSSLSYFNISCNNFASTLPKSL 120
Query: 111 ANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFR 170
+NLT+LKS DVSQN F G+FPTG G+A+ L S+NASSN FSG LPED+ NAT LES DFR
Sbjct: 121 SNLTSLKSFDVSQNYFTGTFPTGFGRAAELKSINASSNEFSGLLPEDIENATLLESFDFR 180
Query: 171 GSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEF 230
G++F +P SF+NLQKLKFLGLSGNN TGKIP LG+LSSLET+I+GYNAFEGEIPAEF
Sbjct: 181 GNYFASPIPKSFKNLQKLKFLGLSGNNFTGKIPEYLGELSSLETLIMGYNAFEGEIPAEF 240
Query: 231 GNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLS 290
GN+TNL+YLDLAVG+LSG+IPP LG+LK LTT+YLY+N FT KIPP+LG+I SLAFLDLS
Sbjct: 241 GNMTNLQYLDLAVGTLSGRIPPELGKLKNLTTIYLYRNKFTAKIPPQLGNIMSLAFLDLS 300
Query: 291 DNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRL 350
DNQI+GEIP +LA+L+NLQLLNLM N+LTG +P KLGEL KL+VLELWKNSL GSLPM L
Sbjct: 301 DNQITGEIPEELAKLENLQLLNLMSNKLTGPVPKKLGELKKLQVLELWKNSLEGSLPMNL 360
Query: 351 GQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQ 410
G++SPL+ LD SSN LSGEIP GLC +GNLTKLILFNNSFSG P LS C SLVRVR+Q
Sbjct: 361 GRNSPLQWLDVSSNSLSGEIPPGLCTTGNLTKLILFNNSFSGPIPSGLSNCSSLVRVRIQ 420
Query: 411 NNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSI 470
NNLISGTIPVG G+L SLQRLE+A NN TGQIP DI+ STSLSF+D+SWNHLES LPS I
Sbjct: 421 NNLISGTIPVGFGSLLSLQRLELAKNNFTGQIPIDITSSTSLSFIDVSWNHLESSLPSEI 480
Query: 471 LSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLR 530
LSIP+LQTF+ASHNNL IP+E Q CPSLSVLDLS+ +S IP IASC+KLV+LNLR
Sbjct: 481 LSIPTLQTFIASHNNLGGTIPDEFQGCPSLSVLDLSNAYISSPIPKGIASCQKLVNLNLR 540
Query: 531 NNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNG 590
NN +GEIPK++ MPTL++LD+SNNSL GRIPENFG+SPALE +NLSYNKLEGPVPSNG
Sbjct: 541 NNHLTGEIPKSITNMPTLSVLDLSNNSLTGRIPENFGSSPALETMNLSYNKLEGPVPSNG 600
Query: 591 ILMNINPNELIGNAGLCGSVLPPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIV 650
IL+ +NPN+ +GNAGLCGS+LPPCSQ+ T Q R HI+HI+ GF+ G VI+SL V
Sbjct: 601 ILLTMNPNDFVGNAGLCGSILPPCSQSSTVT-SQKRSSHISHIVIGFVTGISVILSLAAV 659
Query: 651 FFAGKWAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGG 710
+F GKW Y + Y+YNSF D FK + ++WPWRL+AFQR++FTSSEIL C+KESN+IGMGG
Sbjct: 660 YFGGKWLYNKCYMYNSFIYDWFKHNNEDWPWRLVAFQRISFTSSEILTCIKESNVIGMGG 719
Query: 711 NGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET 770
GIVYKAE H+P + VAVKKLWRS DIE+G+D+ REV LLGRLRHRNIVRLLGY+HNE
Sbjct: 720 AGIVYKAEIHKPQITVAVKKLWRSSPDIENGNDVLREVELLGRLRHRNIVRLLGYVHNER 779
Query: 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDI 830
+V+MVY+YM N +LG ALHG+++ +LLVDWVSRYNIA+G+AQG+NYLHHDC PPVIHRDI
Sbjct: 780 DVIMVYEYMINGNLGTALHGEQSARLLVDWVSRYNIALGVAQGMNYLHHDCHPPVIHRDI 839
Query: 831 KSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSF 890
KSNNILLDANLEARIADFGLARMM+ KNETV+MVAGSYGYIAPEYGYTLKVDEK DIYS+
Sbjct: 840 KSNNILLDANLEARIADFGLARMMIQKNETVTMVAGSYGYIAPEYGYTLKVDEKIDIYSY 899
Query: 891 GVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLV 950
GVVLLELLTGKMPLD F + DIVEW+ ++NKA EALDP+IAGQCKHVQEEMLLV
Sbjct: 900 GVVLLELLTGKMPLDHTFEEAVDIVEWIQKK-RNNKAMLEALDPTIAGQCKHVQEEMLLV 958
Query: 951 LRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNGGHNLSKER-PIFGNSPVLGLL 1009
LRIA+LCTAKLPK RP+MRD+ITMLGEAKPRRKSIC NG S E+ IF SPV LL
Sbjct: 959 LRIALLCTAKLPKERPSMRDIITMLGEAKPRRKSICGNGRQESSIEKGTIFTTSPVASLL 1018
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356533648|ref|XP_003535373.1| PREDICTED: leucine-rich repeat receptor-like protein kinase PXL1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1502 bits (3889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 745/1018 (73%), Positives = 860/1018 (84%), Gaps = 11/1018 (1%)
Query: 1 MQTHLLFL-YCYI------VESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLL 53
MQ+HLLF YCYI ++ ADDELSTLLSIK+ LIDP+ L+DW++PSN + G
Sbjct: 19 MQSHLLFFFYCYIGLSLIFTKAAADDELSTLLSIKSTLIDPMKHLKDWQLPSNVTQPGSP 78
Query: 54 HCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANL 113
HCNWTGV CNS+GFVE L+LSNM+L+G VS+ I+ L SLSS NI CN F+SSLPKSL+NL
Sbjct: 79 HCNWTGVGCNSKGFVESLELSNMNLSGHVSDRIQSLSSLSSFNISCNRFSSSLPKSLSNL 138
Query: 114 TALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSF 173
T+LKS DVSQN F GSFPTGLG+A+GL S+NASSN F GFLPED+GNAT LESLDFRGS+
Sbjct: 139 TSLKSFDVSQNYFTGSFPTGLGRAAGLRSINASSNEFLGFLPEDIGNATLLESLDFRGSY 198
Query: 174 FEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNL 233
F +P SF+NLQKLKFLGLSGNN TGKIP LG+L+ LET+I+GYN FEGEIPAEFGNL
Sbjct: 199 FVSPIPRSFKNLQKLKFLGLSGNNFTGKIPGYLGELAFLETLIIGYNLFEGEIPAEFGNL 258
Query: 234 TNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQ 293
T+L+YLDLAVGSLSGQIP LG+L KLTT+Y+Y NNFTGKIPP+LG+ITSLAFLDLSDNQ
Sbjct: 259 TSLQYLDLAVGSLSGQIPAELGKLTKLTTIYMYHNNFTGKIPPQLGNITSLAFLDLSDNQ 318
Query: 294 ISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQS 353
ISGEIP +LA+L+NL+LLNLM N+LTG +P+KLGE L+VLELWKNS G LP LGQ+
Sbjct: 319 ISGEIPEELAKLENLKLLNLMTNKLTGPVPEKLGEWKNLQVLELWKNSFHGPLPHNLGQN 378
Query: 354 SPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNL 413
SPL+ LD SSN LSGEIP GLC +GNLTKLILFNNSF+G P L+ C SLVRVR+QNNL
Sbjct: 379 SPLQWLDVSSNSLSGEIPPGLCTTGNLTKLILFNNSFTGFIPSGLANCSSLVRVRIQNNL 438
Query: 414 ISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSI 473
ISGTIPVG G+L LQRLE+A NNLTG+IP DI+ STSLSF+D+SWNHL+S LPS ILSI
Sbjct: 439 ISGTIPVGFGSLLGLQRLELAKNNLTGKIPTDITSSTSLSFIDVSWNHLQSSLPSDILSI 498
Query: 474 PSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNR 533
PSLQTF+ASHNN IP+E Q CPSLSVLDLS+ +SG IP SIAS +KLV+LNLRNNR
Sbjct: 499 PSLQTFIASHNNFGGNIPDEFQDCPSLSVLDLSNTHISGTIPESIASSKKLVNLNLRNNR 558
Query: 534 FSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILM 593
+GEIPK++ MPTL++LD+SNNSL GRIPENFG SPALEMLNLSYNKLEGPVPSNG+L+
Sbjct: 559 LTGEIPKSITNMPTLSVLDLSNNSLTGRIPENFGNSPALEMLNLSYNKLEGPVPSNGMLV 618
Query: 594 NINPNELIGNAGLCGSVLPPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVFFA 653
INPN+LIGN GLCG +L PCS + A R HI HII GF+ G VI++LG V+F
Sbjct: 619 TINPNDLIGNEGLCGGILHPCSPSF-AVTSHRRSSHIRHIIIGFVTGISVILALGAVYFG 677
Query: 654 GKWAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGI 713
G+ Y+RW+LYN+FF D F++S ++WPWRL+AFQR+ TSS+ILAC+KESN+IGMGG GI
Sbjct: 678 GRCLYKRWHLYNNFFHDRFQQSNEDWPWRLVAFQRITITSSDILACIKESNVIGMGGTGI 737
Query: 714 VYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773
VYKAE HRPH+ VAVKKLWRS DIE G+D+ REV LLGRLRHRNIVRLLGY+HNE NVM
Sbjct: 738 VYKAEIHRPHITVAVKKLWRSRTDIEDGNDVLREVELLGRLRHRNIVRLLGYVHNERNVM 797
Query: 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSN 833
MVY+YMPN +LG ALHG+++ +LLVDWVSRYNIA+G+AQGLNYLHHDC PPVIHRDIKSN
Sbjct: 798 MVYEYMPNGNLGTALHGEQSARLLVDWVSRYNIALGVAQGLNYLHHDCHPPVIHRDIKSN 857
Query: 834 NILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVV 893
NILLDANLEARIADFGLARMM+ KNETVSMVAGSYGYIAPEYGYTLKVDEK DIYS+GVV
Sbjct: 858 NILLDANLEARIADFGLARMMIQKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVV 917
Query: 894 LLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRI 953
LLELLTGK PLDP+F S DIVEW+ KS+KA EALDP+IA QCKHVQEEMLLVLRI
Sbjct: 918 LLELLTGKTPLDPSFEESIDIVEWIRKK-KSSKALVEALDPAIASQCKHVQEEMLLVLRI 976
Query: 954 AVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNGGHNLSK-ERP-IFGNSPVLGLL 1009
A+LCTAKLPK RP MRD+ITMLGEAKPRRKS+C NGG + S E+P IF SPV+ LL
Sbjct: 977 ALLCTAKLPKERPPMRDIITMLGEAKPRRKSVCHNGGQDTSSVEKPTIFTTSPVISLL 1034
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574888|ref|XP_003555575.1| PREDICTED: leucine-rich repeat receptor-like protein kinase PXL1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1492 bits (3863), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 743/1017 (73%), Positives = 858/1017 (84%), Gaps = 11/1017 (1%)
Query: 1 MQTHLLFLYCYI------VESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLH 54
MQ+HLLF Y YI +++ADDELSTLLSIK+ LIDP+ L+DW+ PSN + G H
Sbjct: 19 MQSHLLFFYYYIGLSLIFTKASADDELSTLLSIKSILIDPMKHLKDWQTPSNVTQPGSPH 78
Query: 55 CNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLT 114
CNWTGV CNS+GFVE LDLSNM+L+G VS I+ L SLSS NI CN FASSLPKSL+NLT
Sbjct: 79 CNWTGVGCNSKGFVESLDLSNMNLSGRVSNRIQSLSSLSSFNIRCNNFASSLPKSLSNLT 138
Query: 115 ALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFF 174
+LKS DVSQN F GSFPTGLG+A+GL +NASSN FSGFLPED+GNAT LESLDFRGS+F
Sbjct: 139 SLKSFDVSQNYFTGSFPTGLGRATGLRLINASSNEFSGFLPEDIGNATLLESLDFRGSYF 198
Query: 175 EGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLT 234
+P SF+NLQKLKFLGLSGNN TG+IP LG+L SLET+I+GYN FEG IPAEFGNLT
Sbjct: 199 MSPIPMSFKNLQKLKFLGLSGNNFTGRIPGYLGELISLETLIIGYNLFEGGIPAEFGNLT 258
Query: 235 NLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQI 294
+L+YLDLAVGSL GQIP LG+L KLTT+YLY NNFTGKIPP+LG ITSLAFLDLSDNQI
Sbjct: 259 SLQYLDLAVGSLGGQIPAELGKLTKLTTIYLYHNNFTGKIPPQLGDITSLAFLDLSDNQI 318
Query: 295 SGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSS 354
SG+IP +LA+L+NL+LLNLM N+L+G +P+KLGEL L+VLELWKNSL G LP LGQ+S
Sbjct: 319 SGKIPEELAKLENLKLLNLMANKLSGPVPEKLGELKNLQVLELWKNSLHGPLPHNLGQNS 378
Query: 355 PLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLI 414
PL+ LD SSN LSGEIP GLC +GNLTKLILFNNSF+G P L+ C SLVRVR+QNNLI
Sbjct: 379 PLQWLDVSSNSLSGEIPPGLCTTGNLTKLILFNNSFTGFIPSGLANCLSLVRVRIQNNLI 438
Query: 415 SGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIP 474
SGTIP+G G+L LQRLE+A NNLT +IP DI+LSTSLSF+D+SWNHLES LPS ILSIP
Sbjct: 439 SGTIPIGFGSLLGLQRLELATNNLTEKIPTDITLSTSLSFIDVSWNHLESSLPSDILSIP 498
Query: 475 SLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRF 534
SLQTF+ASHNN IP+E Q CPSLSVLDLS+ +SG IP SIASC+KLV+LNLRNN
Sbjct: 499 SLQTFIASHNNFGGNIPDEFQDCPSLSVLDLSNTHISGTIPESIASCQKLVNLNLRNNCL 558
Query: 535 SGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMN 594
+GEIPK++ MPTL++LD+SNNSL GR+PENFG SPALEMLNLSYNKLEGPVPSNG+L+
Sbjct: 559 TGEIPKSITKMPTLSVLDLSNNSLTGRMPENFGNSPALEMLNLSYNKLEGPVPSNGMLVT 618
Query: 595 INPNELIGNAGLCGSVLPPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVFFAG 654
INPN+LIGN GLCG +LPPCS +L A R HI H+I GF+ G VI++LG V+F G
Sbjct: 619 INPNDLIGNEGLCGGILPPCSPSL-AVTSHRRSSHIRHVIIGFVTGVSVILALGAVYFGG 677
Query: 655 KWAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIV 714
+ Y+RW+LYN+FF D F +S ++WPWRL+AFQR++ TSS+ILAC+KESN+IGMGG GIV
Sbjct: 678 RCLYKRWHLYNNFFHDWF-QSNEDWPWRLVAFQRISITSSDILACIKESNVIGMGGTGIV 736
Query: 715 YKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774
YKAE HRPH+ +AVKKLWRS DIE G+D REV LLGRLRHRNIVRLLGY+HNE NVMM
Sbjct: 737 YKAEIHRPHVTLAVKKLWRSRTDIEDGNDALREVELLGRLRHRNIVRLLGYVHNERNVMM 796
Query: 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNN 834
VY+YMPN +LG ALHG+++ +LLVDWVSRYNIA+G+AQGLNYLHHDC P VIHRDIKSNN
Sbjct: 797 VYEYMPNGNLGTALHGEQSARLLVDWVSRYNIALGVAQGLNYLHHDCHPLVIHRDIKSNN 856
Query: 835 ILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVL 894
ILLD+NLEARIADFGLARMM+ KNETVSMVAGSYGYIAPEYGYTLKVDEK DIYS+GVVL
Sbjct: 857 ILLDSNLEARIADFGLARMMIQKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVL 916
Query: 895 LELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIA 954
LELLTGKMPLDP+F S DIVEW+ KSNKA EALDP+IA QCKHVQEEMLLVLRIA
Sbjct: 917 LELLTGKMPLDPSFEESIDIVEWIRKK-KSNKALLEALDPAIASQCKHVQEEMLLVLRIA 975
Query: 955 VLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNGGHN-LSKERP-IFGNSPVLGLL 1009
+LCTAKLPK RP MRD++TMLGEAKPRRKSIC NGG + S E+P IF SP++ LL
Sbjct: 976 LLCTAKLPKERPPMRDIVTMLGEAKPRRKSICHNGGQDSRSVEKPTIFTTSPIISLL 1032
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480057|ref|XP_003632392.1| PREDICTED: leucine-rich repeat receptor-like protein kinase PXL2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1390 bits (3598), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 705/1010 (69%), Positives = 828/1010 (81%), Gaps = 7/1010 (0%)
Query: 5 LLFLYCYIV---ESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVW 61
L F YC I DE+S LLSIK GL+DPLN L DWK+ N NG +HCNWTGVW
Sbjct: 15 LFFFYCCIGCYGRGVEKDEVSVLLSIKRGLVDPLNQLGDWKVEENGVGNGSVHCNWTGVW 74
Query: 62 CNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDV 121
CNS+G VE+LDLS+M+L+G V + I LRSL+ LN+CCN F+SSLPK+++NL AL+S DV
Sbjct: 75 CNSKGGVERLDLSHMNLSGRVLDEIERLRSLAHLNLCCNGFSSSLPKTMSNLLALRSFDV 134
Query: 122 SQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTS 181
SQN F G FP G G+A GLT +NASSNNFSGFLPEDLGN T+LE LD RGSFF+GS+P S
Sbjct: 135 SQNFFEGGFPVGFGRAPGLTILNASSNNFSGFLPEDLGNLTALEILDLRGSFFQGSIPKS 194
Query: 182 FRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDL 241
F+NLQKLKFLGLSGNNLTG+IP E+GQLSSLETIILGYN FEGEIP E GNLTNL+YLDL
Sbjct: 195 FKNLQKLKFLGLSGNNLTGQIPREIGQLSSLETIILGYNEFEGEIPVELGNLTNLKYLDL 254
Query: 242 AVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVK 301
AVG+ G+IP ALGRLK L TV+LYKNNF G+IPPE+G+ITSL LDLSDN +SGEIP +
Sbjct: 255 AVGNHGGKIPAALGRLKLLNTVFLYKNNFEGEIPPEIGNITSLQLLDLSDNLLSGEIPAE 314
Query: 302 LAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDA 361
+A+LKNLQLLNLMCNQL+G +P L L +LEVLELW NSL G LP LG++SPL+ LD
Sbjct: 315 IAKLKNLQLLNLMCNQLSGSVPSGLEWLPELEVLELWNNSLTGPLPNDLGKNSPLQWLDV 374
Query: 362 SSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVG 421
SSN +G IP LC+ GNLTKLILFNN FSG P+ LSTC SLVRVR+ NNLISGT+PVG
Sbjct: 375 SSNSFTGGIPPSLCNGGNLTKLILFNNGFSGPIPIGLSTCASLVRVRMHNNLISGTVPVG 434
Query: 422 LGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMA 481
G L LQRLE+ANN+LTGQIP DI+ STSLSF+D+S N L+S LPS+ILSIP LQ FMA
Sbjct: 435 FGKLEKLQRLELANNSLTGQIPGDIASSTSLSFIDLSRNRLQSSLPSTILSIPQLQNFMA 494
Query: 482 SHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKA 541
SHNNL+ +IP++ Q PSLSVLDLSSN L+G IPASIASCEK+V+LNL+NNR +G+IPK
Sbjct: 495 SHNNLEGEIPDQFQDSPSLSVLDLSSNQLTGSIPASIASCEKMVNLNLQNNRLTGQIPKT 554
Query: 542 VATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELI 601
VATMPTLAILD+SNNSL G IPENFG SPALE LN+SYN+LEGPVP+NG+L INP++L+
Sbjct: 555 VATMPTLAILDLSNNSLTGTIPENFGTSPALESLNVSYNRLEGPVPTNGVLRTINPDDLV 614
Query: 602 GNAGLCGSVLPPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVFFAGKWAYRRW 661
GNAGLCG VLPPCS + R +H HI+ G++IG ++++G+ F + Y+RW
Sbjct: 615 GNAGLCGGVLPPCSWG-AETASRHRGVHAKHIVAGWVIGISTVLAVGVAVFGARSLYKRW 673
Query: 662 YLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHR 721
Y S F + F+ EWPWRL+AFQRL FTS++ILAC+KESN+IGMG GIVYKAE R
Sbjct: 674 YSNGSCFTERFEVGNGEWPWRLMAFQRLGFTSADILACIKESNVIGMGATGIVYKAEMPR 733
Query: 722 PHMVVAVKKLWRSDNDIESG--DDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779
+ VVAVKKLWRS+ DIE+G +DL EV+LLGRLRHRNIVRLLG+LHN+++VM+VY++M
Sbjct: 734 LNTVVAVKKLWRSETDIETGSSEDLVGEVNLLGRLRHRNIVRLLGFLHNDSDVMIVYEFM 793
Query: 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA 839
N SLGEALHGK+ G+LLVDWVSRYNIA+G+AQGL YLHHDC PPVIHRD+KSNNILLDA
Sbjct: 794 HNGSLGEALHGKQGGRLLVDWVSRYNIAIGVAQGLAYLHHDCHPPVIHRDVKSNNILLDA 853
Query: 840 NLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT 899
NLEARIADFGLARMM+ KNETVSMVAGSYGYIAPEYGYTLKVDEK DIYSFGVVLLELLT
Sbjct: 854 NLEARIADFGLARMMVRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSFGVVLLELLT 913
Query: 900 GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTA 959
GK PLD FG DIVEWV I+ N+A +EALDP++ G CK+VQEEMLLVLRIA+LCTA
Sbjct: 914 GKRPLDAEFGELVDIVEWVRWKIRDNRALEEALDPNV-GNCKYVQEEMLLVLRIALLCTA 972
Query: 960 KLPKGRPTMRDVITMLGEAKPRRKSICQNGGHNLSKERPIFGNSPVLGLL 1009
KLPK RP+MRDVITMLGEAKPRRKS G++++K RP+F SPV GL+
Sbjct: 973 KLPKDRPSMRDVITMLGEAKPRRKSSSNINGYDINKARPVFSTSPVNGLM 1022
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255590183|ref|XP_002535195.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223523778|gb|EEF27188.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1387 bits (3590), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 690/1006 (68%), Positives = 829/1006 (82%), Gaps = 13/1006 (1%)
Query: 8 LYCYIVESNA-DDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWCNSRG 66
++C S A ++E+S LLSIKA L+DPLN L+DWK+ + +A HCNWTGV CNS G
Sbjct: 21 VFCAFSSSAALNEEVSVLLSIKASLLDPLNKLQDWKLSNTSA-----HCNWTGVRCNSHG 75
Query: 67 FVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNF 126
VEKLDLS+M+L+GSV ++I L+SL+SLN+CCN F+SSL K+++NLT+LKS DVSQN F
Sbjct: 76 AVEKLDLSHMNLSGSVPDDIHELQSLTSLNLCCNGFSSSLTKAISNLTSLKSFDVSQNFF 135
Query: 127 IGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQ 186
IG FP G G+A+GLT +NASSNNFSGF+PED+G+A LE+LD RGSFFEGS+P SF+NL
Sbjct: 136 IGKFPIGFGRAAGLTLLNASSNNFSGFIPEDIGDAILLETLDLRGSFFEGSIPKSFKNLH 195
Query: 187 KLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSL 246
KLKFLGLSGNNLTG+IP ELGQLSSLE II+GYN FEG IPAEFGNL+NL+YLDLAVG+L
Sbjct: 196 KLKFLGLSGNNLTGQIPAELGQLSSLERIIIGYNEFEGGIPAEFGNLSNLKYLDLAVGNL 255
Query: 247 SGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELK 306
G+IP LGRLK L TV+LY+NNF GKIP +G++TSL LDLSDN +SGEIP + AELK
Sbjct: 256 GGEIPAELGRLKLLETVFLYQNNFEGKIPAAIGNMTSLKLLDLSDNVLSGEIPAEFAELK 315
Query: 307 NLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLL 366
NLQLLNLMCNQL+G +P +G LT+L+VLELW NSL G LP LG++S L+ LD SSN
Sbjct: 316 NLQLLNLMCNQLSGSVPAGVGGLTQLQVLELWNNSLSGPLPSDLGKNSALQWLDLSSNSF 375
Query: 367 SGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLP 426
SGEIP LC GNLTKLILFNN+FSG P+SLSTC SLVRVR+QNN + GTIP+GLG LP
Sbjct: 376 SGEIPAFLCTGGNLTKLILFNNAFSGPIPLSLSTCHSLVRVRMQNNFLDGTIPLGLGKLP 435
Query: 427 SLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNL 486
L+RLE+ANN+LTGQIP+D++ S+SLSF+D+S NHL S LPS+IL+IP+LQ FMAS NNL
Sbjct: 436 KLERLEVANNSLTGQIPNDLATSSSLSFIDLSKNHLTSSLPSTILAIPNLQNFMASSNNL 495
Query: 487 QAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMP 546
+ +IP++ Q CPSLSVLDLSSN S IP SIASCEKLV LNL+NN+ SGEIPKA+A MP
Sbjct: 496 EGEIPDQFQDCPSLSVLDLSSNHFSSTIPTSIASCEKLVYLNLKNNQLSGEIPKAIAKMP 555
Query: 547 TLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGL 606
TLAILD+SNNSL G IPENFG+SPALE+LN+S+N+LEGPVP+NG+L INP++LIGNAGL
Sbjct: 556 TLAILDLSNNSLTGGIPENFGSSPALEVLNVSHNRLEGPVPANGVLRTINPDDLIGNAGL 615
Query: 607 CGSVLPPCSQN-LTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVFFAGKWAYRRWYLYN 665
CG VLPPCS LTA + + +H HII +II ++++L I + Y+RWY
Sbjct: 616 CGGVLPPCSHEALTAS--EQKGLHRKHIIAEWIISVSLVLALVIGLIGVRSLYKRWYSNG 673
Query: 666 SFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMV 725
S F++ F+ EWPWRL+AFQRL FTS++ILACVKES +IGMG G VY+AE R + V
Sbjct: 674 SCFEESFETGKGEWPWRLMAFQRLGFTSADILACVKESTVIGMGATGTVYRAEIPRLNTV 733
Query: 726 VAVKKLWRSDNDIESG--DDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDS 783
VAVKKLWRS DIE+G +D EV+LLG+LRHRNIVRLLG+LHN+T++M++Y+YM N +
Sbjct: 734 VAVKKLWRSGTDIETGSNNDFVGEVNLLGKLRHRNIVRLLGFLHNDTDMMILYEYMHNGN 793
Query: 784 LGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEA 843
LGEALHG +AG+LLVDWVSRYNIAVG+AQGL Y+HHDC PPVIHRD+KSNNILLDANLEA
Sbjct: 794 LGEALHGNQAGRLLVDWVSRYNIAVGVAQGLAYMHHDCHPPVIHRDVKSNNILLDANLEA 853
Query: 844 RIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
RIADFGLARMM+ KNETVSMVAGSYGYIAPEYGYTLKVDEK D YS+GVVLLELLTGK P
Sbjct: 854 RIADFGLARMMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDTYSYGVVLLELLTGKRP 913
Query: 904 LDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPK 963
LDP FG S DIVEW+ I+ N+ +EALD ++ G CKHVQEEMLLVLRIA+LCTAKLPK
Sbjct: 914 LDPEFGESVDIVEWIRRKIRDNRPLEEALDNNV-GNCKHVQEEMLLVLRIALLCTAKLPK 972
Query: 964 GRPTMRDVITMLGEAKPRRKSICQNGGHNLSKERPIFGNSPVLGLL 1009
RP+MRDVITMLGEAKPRRKSI + G + +KE+P+F SPV GL+
Sbjct: 973 DRPSMRDVITMLGEAKPRRKSITSS-GFDSNKEKPVFSTSPVNGLV 1017
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065541|ref|XP_002301848.1| predicted protein [Populus trichocarpa] gi|222843574|gb|EEE81121.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1377 bits (3563), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 693/1019 (68%), Positives = 832/1019 (81%), Gaps = 17/1019 (1%)
Query: 1 MQTHLLFLYC-------YIVESNA-DDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGL 52
+Q +L YC +VE N DE+S LLS+KAGL+DP N L DWK+ +++A
Sbjct: 8 LQVLVLLFYCCVGIGSAVVVEKNVFGDEVSALLSLKAGLLDPSNSLRDWKLSNSSA---- 63
Query: 53 LHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLAN 112
HCNW GVWCNS G VEKLDLS+M+L G VS++I+ L SL+SLN+CCN F+SSL K+++N
Sbjct: 64 -HCNWAGVWCNSNGAVEKLDLSHMNLTGHVSDDIQRLESLTSLNLCCNGFSSSLTKAISN 122
Query: 113 LTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGS 172
LT+LK +DVSQN FIGSFP GLG+A+GLT +NASSNNFSG +PEDLGNATSLE+LD RGS
Sbjct: 123 LTSLKDIDVSQNLFIGSFPVGLGRAAGLTLLNASSNNFSGIIPEDLGNATSLETLDLRGS 182
Query: 173 FFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGN 232
FFEGS+P SFRNL+KLKFLGLSGN+LTG++P ELG LSSLE II+GYN FEG IPAEFGN
Sbjct: 183 FFEGSIPKSFRNLRKLKFLGLSGNSLTGQLPAELGLLSSLEKIIIGYNEFEGGIPAEFGN 242
Query: 233 LTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDN 292
LTNL+YLDLA+G+LSG+IP LGRLK L TV+LY+NN GK+P +G+ITSL LDLSDN
Sbjct: 243 LTNLKYLDLAIGNLSGEIPAELGRLKALETVFLYQNNLEGKLPAAIGNITSLQLLDLSDN 302
Query: 293 QISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQ 352
+SGEIP ++ LKNLQLLNLM NQL+G IP +G LT+L VLELW NSL G LP LG+
Sbjct: 303 NLSGEIPAEIVNLKNLQLLNLMSNQLSGSIPAGVGGLTQLSVLELWSNSLSGPLPRDLGK 362
Query: 353 SSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNN 412
+SPL+ LD SSN LSGEIP LC+ GNLTKLILFNNSFSG P SLSTC SLVRVR+QNN
Sbjct: 363 NSPLQWLDVSSNSLSGEIPASLCNGGNLTKLILFNNSFSGPIPDSLSTCFSLVRVRMQNN 422
Query: 413 LISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILS 472
+SG IPVGLG L LQRLE+ANN+LTGQIP D++ S+SLSF+DIS N L S LPS++LS
Sbjct: 423 FLSGAIPVGLGKLGKLQRLELANNSLTGQIPIDLAFSSSLSFIDISRNRLRSSLPSTVLS 482
Query: 473 IPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNN 532
I +LQTFMAS+NNL+ +IP++ Q PSLS LDLSSN SG IPASIASCEKLV+LNL+NN
Sbjct: 483 IQNLQTFMASNNNLEGEIPDQFQDRPSLSALDLSSNHFSGSIPASIASCEKLVNLNLKNN 542
Query: 533 RFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGIL 592
R +GEIPKAVA MP LA+LD+SNNSL G +PENFG+SPALEMLN+SYNKL+GPVP+NG+L
Sbjct: 543 RLTGEIPKAVAMMPALAVLDLSNNSLTGGLPENFGSSPALEMLNVSYNKLQGPVPANGVL 602
Query: 593 MNINPNELIGNAGLCGSVLPPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVFF 652
INP++L+GN GLCG VLPPCS +L GQ R +H I+ G++IG + ++GI
Sbjct: 603 RAINPDDLVGNVGLCGGVLPPCSHSLLNASGQ-RNVHTKRIVAGWLIGISSVFAVGIALV 661
Query: 653 AGKWAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNG 712
+ Y+RWY S F+ ++ EWPWRL+A+QRL FTSS+ILAC+KESN+IGMG G
Sbjct: 662 GAQLLYKRWYSNGSCFEKSYEMGSGEWPWRLMAYQRLGFTSSDILACLKESNVIGMGATG 721
Query: 713 IVYKAEFHRPHMVVAVKKLWRSDNDIESG--DDLFREVSLLGRLRHRNIVRLLGYLHNET 770
VYKAE R + VVAVKKLWRS DIE+G D EV+LLG+LRHRNIVRLLG+LHN++
Sbjct: 722 TVYKAEVPRSNTVVAVKKLWRSGADIETGSSSDFVGEVNLLGKLRHRNIVRLLGFLHNDS 781
Query: 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDI 830
++M++Y+YM N SLGE LHGK+AG+LLVDWVSRYNIA+G+AQGL YLHHDC+PPVIHRDI
Sbjct: 782 DMMILYEYMHNGSLGEVLHGKQAGRLLVDWVSRYNIALGVAQGLAYLHHDCRPPVIHRDI 841
Query: 831 KSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSF 890
KSNNILLD +LEARIADFGLAR+M+ KNETVSMVAGSYGYIAPEYGYTLKVDEK DIYS+
Sbjct: 842 KSNNILLDTDLEARIADFGLARVMIRKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSY 901
Query: 891 GVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLV 950
GVVLLELLTGK PLDP FG S DIVEW+ I+ N++ +EALD ++ G CKHVQEEMLLV
Sbjct: 902 GVVLLELLTGKRPLDPEFGESVDIVEWIRRKIRDNRSLEEALDQNV-GNCKHVQEEMLLV 960
Query: 951 LRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNGGHNLSKERPIFGNSPVLGLL 1009
LRIA+LCTAKLPK RP+MRDVITMLGEAKPRRKS + G++ +K++P+F SPV GL+
Sbjct: 961 LRIALLCTAKLPKDRPSMRDVITMLGEAKPRRKSSSNSSGYDSNKDKPVFNTSPVNGLV 1019
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356570674|ref|XP_003553510.1| PREDICTED: leucine-rich repeat receptor-like protein kinase PXL2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1340 bits (3469), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 668/999 (66%), Positives = 795/999 (79%), Gaps = 4/999 (0%)
Query: 9 YCYIVESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWCNSRGFV 68
+ Y + +E+S LLSIKAGL+DPLN L+DWK+ HCNWTG+ CNS G V
Sbjct: 16 FSYGFAAAVTNEVSALLSIKAGLVDPLNALQDWKLHGKEPGQDASHCNWTGIKCNSAGAV 75
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
EKLDLS+ +L+G VS +I+ L SL+SLN+CCN F++ LPKS+ANLT L S+DVSQN FIG
Sbjct: 76 EKLDLSHKNLSGRVSNDIQRLESLTSLNLCCNAFSTPLPKSIANLTTLNSLDVSQNLFIG 135
Query: 129 SFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKL 188
FP GLG+A L ++NASSN FSG LPEDL NA+ LE LD RGSFF GSVP SF NL KL
Sbjct: 136 DFPLGLGRALRLVALNASSNEFSGSLPEDLANASCLEMLDLRGSFFVGSVPKSFSNLHKL 195
Query: 189 KFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSG 248
KFLGLSGNNLTGKIP ELGQLSSLE +ILGYN FEG IP EFGNLTNL+YLDLAV +L G
Sbjct: 196 KFLGLSGNNLTGKIPGELGQLSSLEHMILGYNEFEGGIPDEFGNLTNLKYLDLAVANLGG 255
Query: 249 QIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNL 308
+IP LG LK L TV+LY NNF G+IPP +G++TSL LDLSDN +SG+IP ++++LKNL
Sbjct: 256 EIPGGLGELKLLNTVFLYNNNFDGRIPPAIGNMTSLQLLDLSDNMLSGKIPSEISQLKNL 315
Query: 309 QLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSG 368
+LLN M N+L+G +P G+L +LEVLELW NSL G LP LG++SPL+ LD SSN LSG
Sbjct: 316 KLLNFMGNKLSGPVPSGFGDLQQLEVLELWNNSLSGPLPSNLGKNSPLQWLDVSSNSLSG 375
Query: 369 EIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSL 428
EIP LC GNLTKLILFNN+F+G P SLS C SLVRVR+QNN +SGT+PVGLG L L
Sbjct: 376 EIPETLCSQGNLTKLILFNNAFTGPIPSSLSMCPSLVRVRIQNNFLSGTVPVGLGKLGKL 435
Query: 429 QRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQA 488
QRLE+ANN+L+G IPDDIS STSLSF+D+S N L S LPS++LSIP LQ FM S+NNL+
Sbjct: 436 QRLELANNSLSGGIPDDISSSTSLSFIDLSRNKLHSSLPSTVLSIPDLQAFMVSNNNLEG 495
Query: 489 KIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTL 548
+IP++ Q CPSL+VLDLSSN LSG IPASIASC+KLV+LNL+NN+ + EIPKA+A MPTL
Sbjct: 496 EIPDQFQDCPSLAVLDLSSNHLSGSIPASIASCQKLVNLNLQNNQLTSEIPKALAKMPTL 555
Query: 549 AILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCG 608
A+LD+SNNSL G+IPE+FG SPALE LN+SYNKLEGPVP+NGIL INPN+L+GNAGLCG
Sbjct: 556 AMLDLSNNSLTGQIPESFGVSPALEALNVSYNKLEGPVPANGILRTINPNDLLGNAGLCG 615
Query: 609 SVLPPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVFFAGKWAYRRWYLYNSFF 668
+LPPC QN +A + + HII +I G I+ +GI + Y RWY F
Sbjct: 616 GILPPCDQN-SAYSSRHGSLRAKHIITAWITGISSILVIGIAILVARSLYIRWYTDGFCF 674
Query: 669 DDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAV 728
+ F K K WPWRL+AFQRL FTS++ILACVKE+N+IGMG G+VYKAE + + VVAV
Sbjct: 675 QERFYKGSKGWPWRLMAFQRLGFTSTDILACVKETNVIGMGATGVVYKAEVPQSNTVVAV 734
Query: 729 KKLWRSDNDIESG--DDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGE 786
KKLWR+ DIE G DDL EV++LGRLRHRNIVRLLG+LHN+ +VM+VY++M N +LGE
Sbjct: 735 KKLWRTGTDIEVGSSDDLVGEVNVLGRLRHRNIVRLLGFLHNDIDVMIVYEFMHNGNLGE 794
Query: 787 ALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIA 846
ALHG++A +LLVDWVSRYNIA+G+AQGL YLHHDC PPVIHRDIK+NNILLDANLEARIA
Sbjct: 795 ALHGRQATRLLVDWVSRYNIALGVAQGLAYLHHDCHPPVIHRDIKTNNILLDANLEARIA 854
Query: 847 DFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
DFGLA+MM+ KNETVSMVAGSYGYIAPEYGY LKVDEK D+YS+GVVLLELLTGK PLD
Sbjct: 855 DFGLAKMMIRKNETVSMVAGSYGYIAPEYGYALKVDEKIDVYSYGVVLLELLTGKRPLDS 914
Query: 907 AFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP 966
FG S DIVEW+ I+ NK+ +EALDPS+ G +HV EEMLLVLRIA+LCTAKLPK RP
Sbjct: 915 DFGESIDIVEWIRMKIRDNKSLEEALDPSV-GNNRHVLEEMLLVLRIAILCTAKLPKDRP 973
Query: 967 TMRDVITMLGEAKPRRKSICQNGGHNLSKERPIFGNSPV 1005
TMRDV+ MLGEAKPRRKS + +KE P+F SPV
Sbjct: 974 TMRDVVMMLGEAKPRRKSSGNSNDVANNKETPVFSTSPV 1012
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1009 | ||||||
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.977 | 0.958 | 0.630 | 0.0 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.988 | 0.984 | 0.588 | 1.2e-310 | |
| TAIR|locus:2161158 | 1041 | PXY "PHLOEM INTERCALATED WITH | 0.953 | 0.924 | 0.427 | 7.2e-210 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.935 | 0.941 | 0.400 | 2.5e-177 | |
| TAIR|locus:2120412 | 992 | BAM3 "BARELY ANY MERISTEM 3" [ | 0.931 | 0.947 | 0.390 | 2.2e-169 | |
| UNIPROTKB|Q5Z9N5 | 994 | P0481E08.42 "Os06g0717200 prot | 0.942 | 0.956 | 0.371 | 1.5e-163 | |
| TAIR|locus:2032553 | 996 | HSL1 "HAESA-like 1" [Arabidops | 0.928 | 0.940 | 0.373 | 6.8e-159 | |
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.901 | 0.916 | 0.368 | 4.4e-154 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.895 | 0.792 | 0.359 | 7.1e-148 | |
| TAIR|locus:2180617 | 1005 | AT5G25930 [Arabidopsis thalian | 0.918 | 0.922 | 0.356 | 9e-148 |
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3223 (1139.6 bits), Expect = 0., P = 0.
Identities = 637/1010 (63%), Positives = 776/1010 (76%)
Query: 16 NADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAE-NGLLHCNWTGVWCNSRGFVEKLDLS 74
N++ E+ LL+ K+ L DP N L+DWK P NA + L+HC+WTGV C++ G+V KL LS
Sbjct: 28 NSEQEI--LLAFKSDLFDPSNNLQDWKRPENATTFSELVHCHWTGVHCDANGYVAKLLLS 85
Query: 75 NMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGL 134
NM+L+G+VS+ I+ SL +L++ N F SSLPKSL+NLT+LK +DVS N+F G+FP GL
Sbjct: 86 NMNLSGNVSDQIQSFPSLQALDLSNNAFESSLPKSLSNLTSLKVIDVSVNSFFGTFPYGL 145
Query: 135 GKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLS 194
G A+GLT VNASSNNFSGFLPEDLGNAT+LE LDFRG +FEGSVP+SF+NL+ LKFLGLS
Sbjct: 146 GMATGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRGGYFEGSVPSSFKNLKNLKFLGLS 205
Query: 195 GNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPAL 254
GNN GK+P +G+LSSLETIILGYN F GEIP EFG LT L+YLDLAVG+L+GQIP +L
Sbjct: 206 GNNFGGKVPKVIGELSSLETIILGYNGFMGEIPEEFGKLTRLQYLDLAVGNLTGQIPSSL 265
Query: 255 GRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKXXXXXXXXXXXXX 314
G+LK+LTTVYLY+N TGK+P ELG +TSL FLDLSDNQI+GEIP++
Sbjct: 266 GQLKQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSDNQITGEIPMEVGELKNLQLLNLM 325
Query: 315 XXXXTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGL 374
TG+IP K+ EL LEVLELW+NSL+GSLP+ LG++SPL+ LD SSN LSG+IP+GL
Sbjct: 326 RNQLTGIIPSKIAELPNLEVLELWQNSLMGSLPVHLGKNSPLKWLDVSSNKLSGDIPSGL 385
Query: 375 CDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMA 434
C S NLTKLILFNNSFSG P + +C +LVRVR+Q N ISG+IP G G+LP LQ LE+A
Sbjct: 386 CYSRNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQKNHISGSIPAGSGDLPMLQHLELA 445
Query: 435 NNNLTGQIPDDISLSTSLSFVDISWNHLESYXXXXXXXXXXXQTFMASHNNLQAKIPNEL 494
NNLTG+IPDDI+LSTSLSF+DIS+NHL S QTF+ASHNN KIPN++
Sbjct: 446 KNNLTGKIPDDIALSTSLSFIDISFNHLSSLSSSIFSSPNL-QTFIASHNNFAGKIPNQI 504
Query: 495 QACPXXXXXXXXXXXXXGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMS 554
Q P G IP IAS EKLVSLNL++N+ GEIPKA+A M LA+LD+S
Sbjct: 505 QDRPSLSVLDLSFNHFSGGIPERIASFEKLVSLNLKSNQLVGEIPKALAGMHMLAVLDLS 564
Query: 555 NNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSVLPPC 614
NNSL G IP + GASP LEMLN+S+NKL+GP+PSN + I+P +L+GN GLCG VLPPC
Sbjct: 565 NNSLTGNIPADLGASPTLEMLNVSFNKLDGPIPSNMLFAAIDPKDLVGNNGLCGGVLPPC 624
Query: 615 SQNL--TAKPGQTRKMXXXXXXXXXXXXTLVIVSLGIVFFAGKWAYRRWYLYNSFFDD-L 671
S++L +AK ++ T VIV++G++F AG+W Y RW LY++F + +
Sbjct: 625 SKSLALSAKGRNPGRIHVNHAVFGFIVGTSVIVAMGMMFLAGRWIYTRWDLYSNFAREYI 684
Query: 672 F-KKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAE-FHRPHMVVAVK 729
F KK +EWPWRL+AFQRL FT+ +IL+ +KESNIIGMG GIVYKAE RP + VAVK
Sbjct: 685 FCKKPREEWPWRLVAFQRLCFTAGDILSHIKESNIIGMGAIGIVYKAEVMRRPLLTVAVK 744
Query: 730 KLWRS---DNDIESG-------DDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779
KLWRS NDIE DD+ REV+LLG LRHRNIV++LGY+HNE VMMVY+YM
Sbjct: 745 KLWRSPSPQNDIEDHHQEEDEEDDILREVNLLGGLRHRNIVKILGYVHNEREVMMVYEYM 804
Query: 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA 839
PN +LG ALH K+ LL DW+SRYN+AVG+ QGLNYLH+DC PP+IHRDIKSNNILLD+
Sbjct: 805 PNGNLGTALHSKDEKFLLRDWLSRYNVAVGVVQGLNYLHNDCYPPIIHRDIKSNNILLDS 864
Query: 840 NLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT 899
NLEARIADFGLA+MMLHKNETVSMVAGSYGYIAPEYGYTLK+DEKSDIYS GVVLLEL+T
Sbjct: 865 NLEARIADFGLAKMMLHKNETVSMVAGSYGYIAPEYGYTLKIDEKSDIYSLGVVLLELVT 924
Query: 900 GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTA 959
GKMP+DP+F S D+VEW+ +K N++ +E +D SIAG CKHV EEMLL LRIA+LCTA
Sbjct: 925 GKMPIDPSFEDSIDVVEWIRRKVKKNESLEEVIDASIAGDCKHVIEEMLLALRIALLCTA 984
Query: 960 KLPKGRPTMRDVITMLGEAKPRRKSICQNGGHNLSKERPIFGNSPVLGLL 1009
KLPK RP++RDVITML EAKPRRKS+CQ G + PIF NSPV+GL+
Sbjct: 985 KLPKDRPSIRDVITMLAEAKPRRKSVCQVAG-----DLPIFRNSPVVGLI 1029
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2980 (1054.1 bits), Expect = 1.2e-310, P = 1.2e-310
Identities = 602/1023 (58%), Positives = 743/1023 (72%)
Query: 1 MQTHLLFLY-CYI-----VESNADD--ELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGL 52
M+ +LFLY CYI V ++ D+ ELS LLS+K+ L+DPLN L+DWK+ S+ ++
Sbjct: 3 MKIIVLFLYYCYIGSTSSVLASIDNVNELSVLLSVKSTLVDPLNFLKDWKL-SDTSD--- 58
Query: 53 LHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLAN 112
HCNWTGV CNS G VEKLDL+ M+L G +S++I L SL S NI CN F S LPKS+
Sbjct: 59 -HCNWTGVRCNSNGNVEKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFESLLPKSIP- 116
Query: 113 LTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGS 172
LKS+D+SQN+F GS ++ GL +NAS NN SG L EDLGN SLE LD RG+
Sbjct: 117 --PLKSIDISQNSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGN 174
Query: 173 FFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGN 232
FF+GS+P+SF+NLQKL+FLGLSGNNLTG++P LGQL SLET ILGYN F+G IP EFGN
Sbjct: 175 FFQGSLPSSFKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEFGN 234
Query: 233 LTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDN 292
+ +L+YLDLA+G LSG+IP LG+LK L T+ LY+NNFTG IP E+GSIT+L LD SDN
Sbjct: 235 INSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDN 294
Query: 293 QISGEIPVKXXXXXXXXXXXXXXXXXTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQ 352
++GEIP++ +G IP + L +L+VLELW N+L G LP LG+
Sbjct: 295 ALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGK 354
Query: 353 SSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNN 412
+SPL+ LD SSN SGEIP+ LC+ GNLTKLILFNN+F+G P +LSTC+SLVRVR+QNN
Sbjct: 355 NSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNN 414
Query: 413 LISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYXXXXXXX 472
L++G+IP+G G L LQRLE+A N L+G IP DIS S SLSF+D S N + S
Sbjct: 415 LLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILS 474
Query: 473 XXXXQTFMASHNNLQAKIPNELQACPXXXXXXXXXXXXXGEIPASIASCEKLVSLNLRNN 532
Q F+ + N + ++P++ Q CP G IP+SIASCEKLVSLNLRNN
Sbjct: 475 IHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNN 534
Query: 533 RFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGIL 592
+GEIP+ + TM LA+LD+SNNSL G +PE+ G SPALE+LN+SYNKL GPVP NG L
Sbjct: 535 NLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFL 594
Query: 593 MNINPNELIGNAGLCGSVLPPCSQNLTAKPGQTRKMXXXXXXXXXXXXTLVIVSLGIVFF 652
INP++L GN+GLCG VLPPCS+ A + + +++LGI+
Sbjct: 595 KTINPDDLRGNSGLCGGVLPPCSKFQRATSSHS-SLHGKRIVAGWLIGIASVLALGILTI 653
Query: 653 AGKWAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNG 712
+ Y++WY N F D S EWPWRL+AF RL FT+S+ILAC+KESN+IGMG G
Sbjct: 654 VTRTLYKKWYS-NGFCGDE-TASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGATG 711
Query: 713 IVYKAEFHRPHMVVAVKKLWRSDNDIESGD--DLFREVSLLGRLRHRNIVRLLGYLHNET 770
IVYKAE R V+AVKKLWRS DIE G D EV+LLG+LRHRNIVRLLG+L+N+
Sbjct: 712 IVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDK 771
Query: 771 NVMMVYDYMPNDSLGEALHGKEA-GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRD 829
N+M+VY++M N +LG+A+HGK A G+LLVDWVSRYNIA+G+A GL YLHHDC PPVIHRD
Sbjct: 772 NMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRD 831
Query: 830 IKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYS 889
IKSNNILLDANL+ARIADFGLARMM K ETVSMVAGSYGYIAPEYGYTLKVDEK DIYS
Sbjct: 832 IKSNNILLDANLDARIADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYS 891
Query: 890 FGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLL 949
+GVVLLELLTG+ PL+P FG S DIVEWV I+ N + +EALDP++ G C++VQEEMLL
Sbjct: 892 YGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEALDPNV-GNCRYVQEEMLL 950
Query: 950 VLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSIC--QNGGHNLS-KERPIFGNSPVL 1006
VL+IA+LCT KLPK RP+MRDVI+MLGEAKPRRKS +N +L+ K +F SPV
Sbjct: 951 VLQIALLCTTKLPKDRPSMRDVISMLGEAKPRRKSNSNEENTSRSLAEKHSSVFSTSPVN 1010
Query: 1007 GLL 1009
GLL
Sbjct: 1011 GLL 1013
|
|
| TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2029 (719.3 bits), Expect = 7.2e-210, P = 7.2e-210
Identities = 420/983 (42%), Positives = 596/983 (60%)
Query: 20 ELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWC-NSRGFVEKLDLSNMSL 78
+L +LLS+K L P + +DWK+P N +N + C+W+GV C N V LDLS+ +L
Sbjct: 35 QLLSLLSLKTSLSGPPSAFQDWKVPVNG-QNDAVWCSWSGVVCDNVTAQVISLDLSHRNL 93
Query: 79 NGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKAS 138
+G + IR L SL LN+ N S P S+ +LT L ++D+S+N+F SFP G+ K
Sbjct: 94 SGRIPIQIRYLSSLLYLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKLK 153
Query: 139 GLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNL 198
L NA SNNF G LP D+ LE L+F GS+FEG +P ++ LQ+LKF+ L+GN L
Sbjct: 154 FLKVFNAFSNNFEGLLPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNVL 213
Query: 199 TGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLK 258
GK+PP LG L+ L+ + +GYN F G IP+EF L+NL+Y D++ SLSG +P LG L
Sbjct: 214 GGKLPPRLGLLTELQHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLS 273
Query: 259 KLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKXXXXXXXXXXXXXXXXX 318
L T++L++N FTG+IP ++ SL LD S NQ+SG IP
Sbjct: 274 NLETLFLFQNGFTGEIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNL 333
Query: 319 TGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSG 378
+G +P+ +GEL +L L LW N+ G LP +LG + L +D S+N +G IP+ LC
Sbjct: 334 SGEVPEGIGELPELTTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGN 393
Query: 379 NLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNL 438
L KLILF+N F G P SL+ C+SL R R QNN ++GTIP+G G+L +L ++++NN
Sbjct: 394 KLYKLILFSNMFEGELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRF 453
Query: 439 TGQIPDDISLSTSLSFVDISWNHLESYXXXXXXXXXXXQTFMASHNNLQAKIPNELQACP 498
T QIP D + + L ++++S N Q F AS +NL +IPN + C
Sbjct: 454 TDQIPADFATAPVLQYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIPNYV-GCK 512
Query: 499 XXXXXXXXXXXXXGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSL 558
G IP I CEKL+ LNL N +G IP ++T+P++A +D+S+N L
Sbjct: 513 SFYRIELQGNSLNGTIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLL 572
Query: 559 FGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSVL-PPC-SQ 616
G IP +FG+S + N+SYN+L GP+PS G ++NP+ N GLCG ++ PC S
Sbjct: 573 TGTIPSDFGSSKTITTFNVSYNQLIGPIPS-GSFAHLNPSFFSSNEGLCGDLVGKPCNSD 631
Query: 617 NLTAKPGQT--RKMXXXXXXXXXXXXTLVIVSLGIVFFAGKWAYRRWYL-YNSFFDDLFK 673
A ++ ++G+ FF A R + Y + D +
Sbjct: 632 RFNAGNADIDGHHKEERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVDGGGR 691
Query: 674 KSCKEWPWRLIAFQRLNFTSSEILACV-KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLW 732
PW+L AFQRLNFT+ +++ C+ K NI+GMG G VYKAE ++AVKKLW
Sbjct: 692 NGGDIGPWKLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGE-IIAVKKLW 750
Query: 733 RSDNDIESG------DDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGE 786
+ E+G + EV +LG +RHRNIVRLLG N M++Y+YMPN SL +
Sbjct: 751 GKNK--ENGKIRRRKSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDD 808
Query: 787 ALHGKEAGKLLV-DWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARI 845
LHG + +W + Y IA+G+AQG+ YLHHDC P ++HRD+K +NILLDA+ EAR+
Sbjct: 809 LLHGGDKTMTAAAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARV 868
Query: 846 ADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
ADFG+A++ + +E++S+VAGSYGYIAPEY YTL+VD+KSDIYS+GV+LLE++TGK ++
Sbjct: 869 ADFGVAKL-IQTDESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVE 927
Query: 906 PAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGR 965
P FG IV+WV S +K+ + +E LD S+ C ++EEM +LRIA+LCT++ P R
Sbjct: 928 PEFGEGNSIVDWVRSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDR 987
Query: 966 PTMRDVITMLGEAKPRRKSICQN 988
P MRDV+ +L EAKP+RK++ N
Sbjct: 988 PPMRDVLLILQEAKPKRKTVGDN 1010
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1722 (611.2 bits), Expect = 2.5e-177, P = 2.5e-177
Identities = 395/987 (40%), Positives = 559/987 (56%)
Query: 5 LLFLYCYIVESNADDELSTLLSIKAGLI---DPLNM-LEDWKMPSNAAENGLLHCNWTGV 60
LL + S E LLS+K L D N L WK+ ++ C W GV
Sbjct: 10 LLHISHTFTASRPISEFRALLSLKTSLTGAGDDKNSPLSSWKVSTS-------FCTWIGV 62
Query: 61 WCN-SRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSM 119
C+ SR V LDLS ++L+G++S ++ LR L +L++ N + +P +++L+ L+ +
Sbjct: 63 TCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHL 122
Query: 120 DVSQNNFIGSFPTGLGKASGLTSV---NASSNNFSGFLPEDLGNATSLESLDFRGSFFEG 176
++S N F GSFP + +SGL ++ + +NN +G LP + N T L L G++F G
Sbjct: 123 NLSNNVFNGSFPDEI--SSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAG 180
Query: 177 SVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGY-NAFEGEIPAEFGNLTN 235
+P S+ + +++L +SGN L GKIPPE+G L++L + +GY NAFE +P E GNL+
Sbjct: 181 KIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSE 240
Query: 236 LRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQIS 295
L D A L+G+IPP +G+L+KL T++L N F+G + ELG+++SL +DLS+N +
Sbjct: 241 LVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFT 300
Query: 296 GEIPVKXXXXXXXXXXXXXXXXXTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP 355
GEIP G IP+ +G+L +LEVL+LW+N+ GS+P +LG++
Sbjct: 301 GEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGK 360
Query: 356 LRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLIS 415
L +D SSN L+G +P +C L LI N G+ P SL C+SL R+R+ N ++
Sbjct: 361 LNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLN 420
Query: 416 GTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYXXXXXXXXXX 475
G+IP GL LP L ++E+ +N L+G++P +S +L + +S N L
Sbjct: 421 GSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTG 480
Query: 476 XQTFMASHNNLQAKIPNELQACPXXXXXXXXXXXXXGEIPASIASCEKLVSLNLRNNRFS 535
Q + N Q IP+E+ G I I+ C+ L ++L N S
Sbjct: 481 VQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELS 540
Query: 536 GEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNI 595
GEIP + M L L++S N L G IP + + +L L+ SYN L G VP G
Sbjct: 541 GEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYF 600
Query: 596 NPNELIGNAGLCGSVLPPCSQNLTAKPGQTRKMXXXXXXXXXXXXTLVIVSLGIVFFAGK 655
N +GN LCG L PC + AK G L++V LG++ +
Sbjct: 601 NYTSFLGNPDLCGPYLGPCKDGV-AKGGHQ----SHSKGPLSASMKLLLV-LGLLVCSIA 654
Query: 656 WAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVY 715
+A S KK+ + WRL AFQRL+FT ++L +KE NIIG GG GIVY
Sbjct: 655 FAVVAIIKARSL-----KKASESRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVY 709
Query: 716 KAEFHRPHMVVAVKKLWRSDNDIESGDDLFR-EVSLLGRLRHRNIVRLLGYLHN-ETNVM 773
K +V AVK+L S D F E+ LGR+RHR+IVRLLG+ N ETN +
Sbjct: 710 KGVMPNGDLV-AVKRLAAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN-L 766
Query: 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSN 833
+VY+YMPN SLGE LHGK+ G L W +RY IA+ A+GL YLHHDC P ++HRD+KSN
Sbjct: 767 LVYEYMPNGSLGEVLHGKKGGHL--HWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSN 824
Query: 834 NILLDANLEARIADFGLARMMLHK--NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFG 891
NILLD+N EA +ADFGLA+ + +E +S +AGSYGYIAPEY YTLKVDEKSD+YSFG
Sbjct: 825 NILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFG 884
Query: 892 VVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD-EALDPSIAGQCKHVQEEMLLV 950
VVLLEL+TG+ P+ FG DIV+WV M SNK + LDP ++ H E+ V
Sbjct: 885 VVLLELVTGRKPVGE-FGDGVDIVQWVRKMTDSNKDSVLKVLDPRLSSIPIH---EVTHV 940
Query: 951 LRIAVLCTAKLPKGRPTMRDVITMLGE 977
+A+LC + RPTMR+V+ +L E
Sbjct: 941 FYVAMLCVEEQAVERPTMREVVQILTE 967
|
|
| TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1647 (584.8 bits), Expect = 2.2e-169, P = 2.2e-169
Identities = 380/974 (39%), Positives = 542/974 (55%)
Query: 20 ELSTLLSIKAGL--IDPLNMLEDWKMPSNAAENGLLHCNWTGVWC-NSRGFVEKLDLSNM 76
+ + L+S+K DP L+ W +P+ N L C+WTGV C N + +LDLSN+
Sbjct: 34 QANVLISLKQSFDSYDP--SLDSWNIPNF---NSL--CSWTGVSCDNLNQSITRLDLSNL 86
Query: 77 SLNGSVSENIRGLR-SLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPT-GL 134
+++G++S I L SL L+I N F+ LPK + L+ L+ +++S N F G T G
Sbjct: 87 NISGTISPEISRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEGELETRGF 146
Query: 135 GKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLS 194
+ + L +++A N+F+G LP L T LE LD G++F+G +P S+ + LKFL LS
Sbjct: 147 SQMTQLVTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLS 206
Query: 195 GNNLTGKIPPELGQLSSLETIILGY-NAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPA 253
GN+L G+IP EL +++L + LGY N + G IPA+FG L NL +LDLA SL G IP
Sbjct: 207 GNDLRGRIPNELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAE 266
Query: 254 LGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKXXXXXXXXXXXX 313
LG LK L ++L N TG +P ELG++TSL LDLS+N + GEIP++
Sbjct: 267 LGNLKNLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNL 326
Query: 314 XXXXXTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTG 373
G IP+ + EL L++L+LW N+ G +P +LG + L +D S+N L+G IP
Sbjct: 327 FFNRLHGEIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPES 386
Query: 374 LCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEM 433
LC L LILFNN G P L C+ L R R+ N ++ +P GL LP+L LE+
Sbjct: 387 LCFGRRLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLEL 446
Query: 434 ANNNLTGQIPDDISLS---TSLSFVDISWNHLESYXXXXXXXXXXXQTFMASHNNLQAKI 490
NN LTG+IP++ + + +SL+ +++S N L Q + N L +I
Sbjct: 447 QNNFLTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQI 506
Query: 491 PNELQACPXXXXXXXXXXXXXGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAI 550
P E+ + G+ P C L L+L +N+ SG+IP ++ + L
Sbjct: 507 PGEIGSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNY 566
Query: 551 LDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSV 610
L++S NS +P G +L + S+N G VP++G N +GN LCG
Sbjct: 567 LNVSWNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFS 626
Query: 611 LPPCSQNLTAKPGQTRKMXXXXXXXXXXXXTLVIVSLGIVFFAGKWAYRRWYLYNSFFDD 670
PC+ + Q + LG++ F + + + +
Sbjct: 627 SNPCNGSQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGF-----FLVFVVLAVVKNR 681
Query: 671 LFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKK 730
+K+ W+LI FQ+L F S IL CVKE+++IG GG GIVYK V AVKK
Sbjct: 682 RMRKNNPNL-WKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYKGVMPNGEEV-AVKK 739
Query: 731 LWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHG 790
L + L E+ LGR+RHRNIVRLL + N+ ++VY+YMPN SLGE LHG
Sbjct: 740 LLTITKGSSHDNGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHG 799
Query: 791 KEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850
K AG L W +R IA+ A+GL YLHHDC P +IHRD+KSNNILL EA +ADFGL
Sbjct: 800 K-AGVFL-KWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGL 857
Query: 851 ARMMLHKN---ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPA 907
A+ M+ N E +S +AGSYGYIAPEY YTL++DEKSD+YSFGVVLLEL+TG+ P+D
Sbjct: 858 AKFMMQDNGASECMSSIAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDN- 916
Query: 908 FGGSK-DIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQ-EEMLLVLRIAVLCTAKLPKGR 965
FG DIV+W S I++N + + I + ++ E + + +A+LC + R
Sbjct: 917 FGEEGIDIVQW--SKIQTN-CNRQGVVKIIDQRLSNIPLAEAMELFFVAMLCVQEHSVER 973
Query: 966 PTMRDVITMLGEAK 979
PTMR+V+ M+ +AK
Sbjct: 974 PTMREVVQMISQAK 987
|
|
| UNIPROTKB|Q5Z9N5 P0481E08.42 "Os06g0717200 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1592 (565.5 bits), Expect = 1.5e-163, P = 1.5e-163
Identities = 372/1001 (37%), Positives = 541/1001 (54%)
Query: 1 MQTHLLFLYCYIVESNA--DDELSTLLSIKAGLIDPLNM-----LEDWKMPSNAAENGLL 53
M LL L + S A D ++ L +KA L+ + L DW + A
Sbjct: 1 MPPTLLLLLLLLPPSLASPDRDIYALAKLKAALVPSPSATAPPPLADW----DPAATSPA 56
Query: 54 HCNWTGVWCNSRGFVEKLDLSNMSLN-GSVSENIRGLRSLSSLNI--CCNEFASSLPKSL 110
HC ++GV C+ R V ++L+ + L+ G + I L SL++L I CC +P L
Sbjct: 57 HCTFSGVTCDGRSRVVAINLTALPLHSGYLPPEIALLDSLANLTIAACC--LPGHVPLEL 114
Query: 111 ANLTALKSMDVSQNNFIGSFPT--GLGKAS----GLTSVNASSNNFSGFLPEDLGNATSL 164
L +L+ +++S NN G FP G AS L ++A +NN SG LP + L
Sbjct: 115 PTLPSLRHLNLSNNNLSGHFPVPDSGGGASPYFPSLELIDAYNNNLSGLLPPFSASHARL 174
Query: 165 ESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGY-NAFE 223
L G++F G++P S+ +L L++LGL+GN L+G +P L +L+ L + +GY N ++
Sbjct: 175 RYLHLGGNYFTGAIPDSYGDLAALEYLGLNGNTLSGHVPVSLSRLTRLREMYIGYYNQYD 234
Query: 224 GEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITS 283
G +P EFG+L L LD++ +L+G +PP LGRL++L T++L N +G+IPP+LG ++S
Sbjct: 235 GGVPPEFGDLGALLRLDMSSCNLTGPVPPELGRLQRLDTLFLQWNRLSGEIPPQLGDLSS 294
Query: 284 LAFLDLSDNQISGEIPVKXXXXXXXXXXXXXXXXXTGLIPDKLGELTKLEVLELWKNSLI 343
LA LDLS N ++GEIP G IPD + +LEVL+LW N+L
Sbjct: 295 LASLDLSVNDLAGEIPPSLANLSNLKLLNLFRNHLRGSIPDFVAGFAQLEVLQLWDNNLT 354
Query: 344 GSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKS 403
G++P LG++ L+ LD ++N L+G IP LC L L+L N G P SL CK+
Sbjct: 355 GNIPAGLGKNGRLKTLDLATNHLTGPIPADLCAGRRLEMLVLMENGLFGPIPDSLGDCKT 414
Query: 404 LVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLE 463
L RVR+ N ++G +P GL NLP +E+ +N LTG++PD I + + + N +
Sbjct: 415 LTRVRLAKNFLTGPVPAGLFNLPQANMVELTDNLLTGELPDVIG-GDKIGMLLLGNNGIG 473
Query: 464 SYXXXXXXXXXXXQTFMASHNNLQAKIPNELQACPXXXXXXXXXXXXXGEIPASIASCEK 523
QT NN +P E+ G IP + C
Sbjct: 474 GRIPPAIGNLPALQTLSLESNNFSGALPPEIGNLKNLSRLNVSGNALTGAIPDELIRCAS 533
Query: 524 LVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
L +++L N FSGEIP+++ ++ L L++S N L G +P +L L++SYN L
Sbjct: 534 LAAVDLSRNGFSGEIPESITSLKILCTLNVSRNRLTGELPPEMSNMTSLTTLDVSYNSLS 593
Query: 584 GPVPSNGILMNINPNELIGNAGLCGS-VLPPCSQNLTAKPGQTRKMXXXXXXXXXXXXTL 642
GPVP G + N + +GN GLCG V C ++ G L
Sbjct: 594 GPVPMQGQFLVFNESSFVGNPGLCGGPVADACPPSMAGGGGGAGSQLRLRWDSKKMLVAL 653
Query: 643 V--IVSLGIVFFAGKWAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACV 700
V ++ + F + W ++ + W++ AFQ+L F++ +++ CV
Sbjct: 654 VAAFAAVAVAFLGARKGCSAWR-------SAARR--RSGAWKMTAFQKLEFSAEDVVECV 704
Query: 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDNDIESGDDLFREVSLLGRLRHRNI 759
KE NIIG GG GIVY + A+K+L R + + G EV+ LGR+RHRNI
Sbjct: 705 KEDNIIGKGGAGIVYHGVTRGAEL--AIKRLVGRGGGEHDRG--FSAEVTTLGRIRHRNI 760
Query: 760 VRLLGYLHN-ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
VRLLG++ N ETN+++ Y+YMPN SLGE LHG + G L W +R +A A GL YLH
Sbjct: 761 VRLLGFVSNRETNLLL-YEYMPNGSLGEMLHGGKGGHL--GWEARARVAAEAACGLCYLH 817
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK-NETVSMVAGSYGYIAPEYGY 877
HDC P +IHRD+KSNNILLD+ EA +ADFGLA+ + +E +S +AGSYGYIAPEY Y
Sbjct: 818 HDCAPRIIHRDVKSNNILLDSAFEAHVADFGLAKFLGGATSECMSAIAGSYGYIAPEYAY 877
Query: 878 TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS-NKAQDEALDPSI 936
TL+VDEKSD+YSFGVVLLEL+TG+ P+ FG DIV WV + D A ++
Sbjct: 878 TLRVDEKSDVYSFGVVLLELITGRRPVG-GFGDGVDIVHWVRKVTAELPDNSDTAAVLAV 936
Query: 937 AGQCKHVQEEMLLV--LRIAVLCTAKLPKGRPTMRDVITML 975
A + + L+V ++A+ C + RPTMR+V+ ML
Sbjct: 937 ADRRLTPEPVALMVNLYKVAMACVEEASTARPTMREVVHML 977
|
|
| TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1548 (550.0 bits), Expect = 6.8e-159, P = 6.8e-159
Identities = 372/997 (37%), Positives = 538/997 (53%)
Query: 4 HLLFLYCY---IVESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGV 60
+LLFL+ + N D + L +K L DP + L W SN A C W+GV
Sbjct: 2 YLLFLFLLFPTVFSLNQDGFI--LQQVKLSLDDPDSYLSSWN--SNDASP----CRWSGV 53
Query: 61 WC-NSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSM 119
C V +DLS+ +L G I L +L+ L++ N S+LP ++A +L+++
Sbjct: 54 SCAGDFSSVTSVDLSSANLAGPFPSVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTL 113
Query: 120 DVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVP 179
D+SQN G P L L ++ + NNFSG +P G +LE L + +G++P
Sbjct: 114 DLSQNLLTGELPQTLADIPTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIP 173
Query: 180 TSFRNLQKLKFLGLSGNNLT-GKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRY 238
N+ LK L LS N + +IPPE G L++LE + L G+IP G L+ L
Sbjct: 174 PFLGNISTLKMLNLSYNPFSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVD 233
Query: 239 LDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEI 298
LDLA+ L G IPP+LG L + + LY N+ TG+IPPELG++ SL LD S NQ++G+I
Sbjct: 234 LDLALNDLVGHIPPSLGGLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKI 293
Query: 299 PVKXXXXXXXXXXXXXXXXXTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRR 358
P + G +P + L + ++ N L G LP LG +SPLR
Sbjct: 294 PDELCRVPLESLNLYENNLE-GELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRW 352
Query: 359 LDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTI 418
LD S N SG++P LC G L +L++ +NSFSG P SL+ C+SL R+R+ N SG++
Sbjct: 353 LDVSENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSV 412
Query: 419 PVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYXXXXXXXXXXXQT 478
P G LP + LE+ NN+ +G+I I +++LS + +S N
Sbjct: 413 PTGFWGLPHVNLLELVNNSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQ 472
Query: 479 FMASHNNLQAKIPNELQACPXXXXXXXXXXXXXGEIPASIASCEKLVSLNLRNNRFSGEI 538
AS N +P+ L + GE+ + I S +KL LNL +N F+G+I
Sbjct: 473 LSASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKI 532
Query: 539 PKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPN 598
P + ++ L LD+S N G+IP + S L LNLSYN+L G +P + + ++ N
Sbjct: 533 PDEIGSLSVLNYLDLSGNMFSGKIPVSL-QSLKLNQLNLSYNRLSGDLPPS-LAKDMYKN 590
Query: 599 ELIGNAGLCGSVLPPC-SQNLTAKPGQTRKMXXXXXXXXXXXXTLVIVSLGIVFFAG-KW 656
IGN GLCG + C S+N K G + + V +V AG W
Sbjct: 591 SFIGNPGLCGDIKGLCGSENEAKKRGYVWLLRS------------IFVLAAMVLLAGVAW 638
Query: 657 AYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYK 716
Y + Y +F ++ + W L++F +L F+ EIL + E N+IG G +G VYK
Sbjct: 639 FY---FKYRTFKK---ARAMERSKWTLMSFHKLGFSEHEILESLDEDNVIGAGASGKVYK 692
Query: 717 AEFHRPHMVVAVKKLWRS------DNDIESG------DDLFR-EVSLLGRLRHRNIVRLL 763
VAVK+LW D D E G D+ F EV LG++RH+NIV+L
Sbjct: 693 VVLTNGE-TVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLW 751
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
++VY+YMPN SLG+ LH + G L W +R+ I + A+GL+YLHHD P
Sbjct: 752 CCCSTRDCKLLVYEYMPNGSLGDLLHSSKGGML--GWQTRFKIILDAAEGLSYLHHDSVP 809
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARM--MLHKN-ETVSMVAGSYGYIAPEYGYTLK 880
P++HRDIKSNNIL+D + AR+ADFG+A+ + K +++S++AGS GYIAPEY YTL+
Sbjct: 810 PIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLR 869
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQC 940
V+EKSDIYSFGVV+LE++T K P+DP G KD+V+WV S + K + +DP + C
Sbjct: 870 VNEKSDIYSFGVVILEIVTRKRPVDPELG-EKDLVKWVCSTL-DQKGIEHVIDPKL-DSC 926
Query: 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977
+EE+ +L + +LCT+ LP RP+MR V+ ML E
Sbjct: 927 --FKEEISKILNVGLLCTSPLPINRPSMRRVVKMLQE 961
|
|
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1435 (510.2 bits), Expect = 4.4e-154, Sum P(2) = 4.4e-154
Identities = 354/961 (36%), Positives = 513/961 (53%)
Query: 5 LLFLYCYI-VESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWCN 63
LL L C++ V SN D E+ + + K L DP L+DW + + CNWTG+ C+
Sbjct: 13 LLLLSCFLQVSSNGDAEILSRVK-KTRLFDPDGNLQDWVITGDNRSP----CNWTGITCH 67
Query: 64 SR-GF---VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTA-LKS 118
R G V +DLS +++G +R+L ++ + N ++ + +L + L++
Sbjct: 68 IRKGSSLAVTTIDLSGYNISGGFPYGFCRIRTLINITLSQNNLNGTIDSAPLSLCSKLQN 127
Query: 119 MDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSV 178
+ ++QNNF G P + L + SN F+G +P+ G T+L+ L+ G+ G V
Sbjct: 128 LILNQNNFSGKLPEFSPEFRKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIV 187
Query: 179 PTSFRNLQKLKFLGLSGNNLT-GKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLR 237
P L +L L L+ + IP LG LS+L + L ++ GEIP NL L
Sbjct: 188 PAFLGYLTELTRLDLAYISFDPSPIPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLE 247
Query: 238 YLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGE 297
LDLA+ SL+G+IP ++GRL+ + + LY N +GK+P +G++T L D+S N ++GE
Sbjct: 248 NLDLAMNSLTGEIPESIGRLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGE 307
Query: 298 IPVKXXXXXXXXXXXXXXXXXTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLR 357
+P K TG +PD + L +++ NS G+LP LG+ S +
Sbjct: 308 LPEKIAALQLISFNLNDNFF-TGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEIS 366
Query: 358 RLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGT 417
D S+N SGE+P LC L K+I F+N SG P S C SL +R+ +N +SG
Sbjct: 367 EFDVSTNRFSGELPPYLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGE 426
Query: 418 IPVGLGNLPSLQRLEMANNN-LTGQIPDDISLSTSLSFVDISWNHLESYXXXXXXXXXXX 476
+P LP L RLE+ANNN L G IP IS + LS ++IS N+
Sbjct: 427 VPARFWELP-LTRLELANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDL 485
Query: 477 QTFMASHNNLQAKIPNELQACPXXXXXXXXXXXXXGEIPASIASCEKLVSLNLRNNRFSG 536
+ S N+ IP+ + GEIP+S++SC +L LNL NNR G
Sbjct: 486 RVIDLSRNSFLGSIPSCINKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRG 545
Query: 537 EIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNIN 596
IP + +P L LD+SNN L G IP L N+S NKL G +PS G +I
Sbjct: 546 GIPPELGDLPVLNYLDLSNNQLTGEIPAEL-LRLKLNQFNVSDNKLYGKIPS-GFQQDIF 603
Query: 597 PNELIGNAGLCGSVLPPCSQNLTAKPGQTRKMXXXXXXXXXXXXTLVIVSLGIVFFAGKW 656
+GN LC L P +P ++++ L I L IV G
Sbjct: 604 RPSFLGNPNLCAPNLDPI------RPCRSKR---------ETRYILPISILCIVALTGAL 648
Query: 657 AYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYK 716
W + LFK+ K ++ FQR+ FT +I + E NIIG GG+G+VY+
Sbjct: 649 V---WLFIKT--KPLFKRKPKRTN-KITIFQRVGFTEEDIYPQLTEDNIIGSGGSGLVYR 702
Query: 717 AEFHRPHMVVAVKKLWRSDNDIESGDDLFR-EVSLLGRLRHRNIVRLLGYLHNETNVMMV 775
+ + +AVKKLW + +FR EV LGR+RH NIV+LL + E +V
Sbjct: 703 VKL-KSGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGNIVKLLMCCNGEEFRFLV 761
Query: 776 YDYMPNDSLGEALHGKEAGKLL--VDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSN 833
Y++M N SLG+ LH ++ + + +DW +R++IAVG AQGL+YLHHD PP++HRD+KSN
Sbjct: 762 YEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDVKSN 821
Query: 834 NILLDANLEARIADFGLARMMLHKNET----VSM--VAGSYGYIAPEYGYTLKVDEKSDI 887
NILLD ++ R+ADFGLA+ + ++ VSM VAGSYGYIAPEYGYT KV+EKSD+
Sbjct: 822 NILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNEKSDV 881
Query: 888 YSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI---KSNKAQDEALDPSIAGQCKHVQ 944
YSFGVVLLEL+TGK P D +FG +KDIV++ + S A+D A++ G + +
Sbjct: 882 YSFGVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYPSPSAEDGAMNQDSLGNYRDLS 941
Query: 945 E 945
+
Sbjct: 942 K 942
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1444 (513.4 bits), Expect = 7.1e-148, P = 7.1e-148
Identities = 334/929 (35%), Positives = 492/929 (52%)
Query: 68 VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
+E L L++ L G + +I L SL + N S+P L L+ L+ + + N I
Sbjct: 155 LETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEI 214
Query: 128 -GSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQ 186
G P+ +G S LT + + + SG LP LG LE+L + G +P+ N
Sbjct: 215 SGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCS 274
Query: 187 KLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSL 246
+L L L N+L+G IP E+GQL+ LE + L N+ G IP E GN +NL+ +DL++ L
Sbjct: 275 ELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLL 334
Query: 247 SGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKXXXXX 306
SG IP ++GRL L + N F+G IP + + +SL L L NQISG IP +
Sbjct: 335 SGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLT 394
Query: 307 XXXXXXXXXXXXTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLL 366
G IP L + T L+ L+L +NSL G++P L L +L SN L
Sbjct: 395 KLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSL 454
Query: 367 SGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLP 426
SG IP + + +L +L L N +G P + + K + + +N + G +P +G+
Sbjct: 455 SGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCS 514
Query: 427 SLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYXXXXXXXXXXXQTFMASHNNL 486
LQ ++++NN+L G +P+ +S + L +D+S N + S N
Sbjct: 515 ELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLF 574
Query: 487 QAKIPNELQACPXXXXXXXXXXXXXGEIPASIASCEKL-VSLNLRNNRFSGEIPKAVATM 545
IP L C GEIP+ + E L ++LNL +NR +G+IP +A++
Sbjct: 575 SGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASL 634
Query: 546 PTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAG 605
L+ILD+S+N L G + L LN+SYN G +P N + ++P +L GN
Sbjct: 635 NKLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKK 693
Query: 606 LCGSVLPPCSQNLTAKPGQTRKMXXXXXXXXXXXXTL-VIVSLGIVFFA-GKWAYRRWYL 663
LC S C LT + G TL ++++L +V G A R
Sbjct: 694 LCSSTQDSCF--LTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIR--A 749
Query: 664 YNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPH 723
+ ++ + + + W+ FQ+LNF+ +I+ C+ E N+IG G +G+VY+A+
Sbjct: 750 RRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGE 809
Query: 724 MVVAVKKLWRS------DNDIESGDDLFR-EVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776
V+AVKKLW + D ++ D F EV LG +RH+NIVR LG N +++Y
Sbjct: 810 -VIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMY 868
Query: 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNIL 836
DYMPN SLG LH + L DW RY I +G AQGL YLHHDC PP++HRDIK+NNIL
Sbjct: 869 DYMPNGSLGSLLHERRGSSL--DWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNIL 926
Query: 837 LDANLEARIADFGLARMMLHKN--ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVL 894
+ + E IADFGLA+++ + + VAGSYGYIAPEYGY++K+ EKSD+YS+GVV+
Sbjct: 927 IGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVV 986
Query: 895 LELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIA 954
LE+LTGK P+DP +V+WV + N+ E LD ++ + + +EM+ VL A
Sbjct: 987 LEVLTGKQPIDPTVPEGIHLVDWV----RQNRGSLEVLDSTLRSRTEAEADEMMQVLGTA 1042
Query: 955 VLCTAKLPKGRPTMRDVITMLGEAKPRRK 983
+LC P RPTM+DV ML E K R+
Sbjct: 1043 LLCVNSSPDERPTMKDVAAMLKEIKQERE 1071
|
|
| TAIR|locus:2180617 AT5G25930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1443 (513.0 bits), Expect = 9.0e-148, P = 9.0e-148
Identities = 350/981 (35%), Positives = 532/981 (54%)
Query: 13 VESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWCNSRGFVEKLD 72
V S +D+ STLL++K L DP + L W S+ CNW+ + C + G V ++
Sbjct: 20 VFSQFNDQ-STLLNLKRDLGDPPS-LRLWNNTSSP-------CNWSEITCTA-GNVTGIN 69
Query: 73 LSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPT 132
N + G+V I L +L+ L++ N FA P L N T L+ +D+SQN GS P
Sbjct: 70 FKNQNFTGTVPTTICDLSNLNFLDLSFNYFAGEFPTVLYNCTKLQYLDLSQNLLNGSLPV 129
Query: 133 GLGKASG-LTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFL 191
+ + S L ++ ++N FSG +P+ LG + L+ L+ S ++G+ P+ +L +L+ L
Sbjct: 130 DIDRLSPELDYLDLAANGFSGDIPKSLGRISKLKVLNLYQSEYDGTFPSEIGDLSELEEL 189
Query: 192 GLSGNN-LT-GKIPPELGQLSSLETIILGYNAFEGEI-PAEFGNLTNLRYLDLAVGSLSG 248
L+ N+ T KIP E G+L L+ + L GEI P F N+T+L ++DL+V +L+G
Sbjct: 190 RLALNDKFTPAKIPIEFGKLKKLKYMWLEEMNLIGEISPVVFENMTDLEHVDLSVNNLTG 249
Query: 249 QIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKXXXXXXX 308
+IP L LK LT YL+ N TG+IP + S T+L FLDLS N ++G IPV
Sbjct: 250 RIPDVLFGLKNLTEFYLFANGLTGEIPKSI-SATNLVFLDLSANNLTGSIPVSIGNLTKL 308
Query: 309 XXXXXXXXXXTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSG 368
TG IP +G+L L+ +++ N L G +P +G S L R + S N L+G
Sbjct: 309 QVLNLFNNKLTGEIPPVIGKLPGLKEFKIFNNKLTGEIPAEIGVHSKLERFEVSENQLTG 368
Query: 369 EIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSL 428
++P LC G L +++++N+ +G P SL C +L+ V++QNN SG P + N S+
Sbjct: 369 KLPENLCKGGKLQGVVVYSNNLTGEIPESLGDCGTLLTVQLQNNDFSGKFPSRIWNASSM 428
Query: 429 QRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYXXXXXXXXXXXQTFMASHNNLQA 488
L+++NN+ TG++P++++ + +S ++I N F A +N
Sbjct: 429 YSLQVSNNSFTGELPENVAWN--MSRIEIDNNRFSGEIPKKIGTWSSLVEFKAGNNQFSG 486
Query: 489 KIPNELQACPXXXXXXXXXXXXXGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTL 548
+ P EL + GE+P I S + L++L+L N+ SGEIP+A+ +P L
Sbjct: 487 EFPKELTSLSNLISIFLDENDLTGELPDEIISWKSLITLSLSKNKLSGEIPRALGLLPRL 546
Query: 549 AILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNIN-PNELIGNAGLC 607
LD+S N G IP G S L N+S N+L G +P L N+ + N+ LC
Sbjct: 547 LNLDLSENQFSGGIPPEIG-SLKLTTFNVSSNRLTGGIPEQ--LDNLAYERSFLNNSNLC 603
Query: 608 GS----VLPPCSQNLTAKPGQTRKMXXXXXXXXXXXXTLVIVSLGIVFFAGKWAYRRWYL 663
LP C + G K+ L+ ++L + FF + Y R
Sbjct: 604 ADNPVLSLPDCRKQRRGSRGFPGKILAMILVIAVL---LLTITLFVTFFVVR-DYTRKQ- 658
Query: 664 YNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPH 723
++ E W+L +F R++F S+I++ + E +IG GG+G VYK
Sbjct: 659 ---------RRRGLE-TWKLTSFHRVDFAESDIVSNLMEHYVIGSGGSGKVYKIFVESSG 708
Query: 724 MVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPND 782
VAVK++W S D + + EV +LG +RH NIV+LL + E + ++VY+Y+
Sbjct: 709 QCVAVKRIWDSKKLDQKLEKEFIAEVEILGTIRHSNIVKLLCCISREDSKLLVYEYLEKR 768
Query: 783 SLGEALHGKEAGKLL----VDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD 838
SL + LHGK+ G + + W R NIAVG AQGL Y+HHDC P +IHRD+KS+NILLD
Sbjct: 769 SLDQWLHGKKKGGTVEANNLTWSQRLNIAVGAAQGLCYMHHDCTPAIIHRDVKSSNILLD 828
Query: 839 ANLEARIADFGLARMMLHKNE---TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLL 895
+ A+IADFGLA++++ +N+ T+S VAGS+GYIAPEY YT KVDEK D+YSFGVVLL
Sbjct: 829 SEFNAKIADFGLAKLLIKQNQEPHTMSAVAGSFGYIAPEYAYTSKVDEKIDVYSFGVVLL 888
Query: 896 ELLTGKMPLDPAFGGSK-DIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIA 954
EL+TG+ + G ++ +W +S K EA D I E M V ++
Sbjct: 889 ELVTGR---EGNNGDEHTNLADWSWKHYQSGKPTAEAFDEDIKEAS--TTEAMTTVFKLG 943
Query: 955 VLCTAKLPKGRPTMRDVITML 975
++CT LP RP+M++V+ +L
Sbjct: 944 LMCTNTLPSHRPSMKEVLYVL 964
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FRS6 | PXL1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6556 | 0.9910 | 0.9718 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1009 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.0 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-33 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-29 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-27 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-25 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-23 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-22 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-19 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-19 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-16 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-07 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 5e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 9e-06 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 9e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 634 bits (1638), Expect = 0.0
Identities = 375/1003 (37%), Positives = 543/1003 (54%), Gaps = 67/1003 (6%)
Query: 1 MQTHLLFLYCYIVESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGV 60
+ L FL+ +A+ EL LLS K+ + DPL L +W S C W G+
Sbjct: 12 LIFMLFFLFLNFSMLHAE-ELELLLSFKSSINDPLKYLSNWN-SSADV------CLWQGI 63
Query: 61 WCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLT-ALKSM 119
CN+ V +DLS +++G +S I L + ++N+ N+ + +P + + +L+ +
Sbjct: 64 TCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL 123
Query: 120 DVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVP 179
++S NNF GS P G L +++ S+N SG +P D+G+ +SL+ LD G+ G +P
Sbjct: 124 NLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
Query: 180 TSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYL 239
S NL L+FL L+ N L G+IP ELGQ+ SL+ I LGYN GEIP E G LT+L +L
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHL 241
Query: 240 DLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIP 299
DL +L+G IP +LG LK L ++LY+N +G IPP + S+ L LDLSDN +SGEIP
Sbjct: 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
Query: 300 VKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRL 359
+ +L+NL++L+L N TG IP L L +L+VL+LW N G +P LG+ + L L
Sbjct: 302 ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361
Query: 360 DASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIP 419
D S+N L+GEIP GLC SGNL KLILF+NS G P SL C+SL RVR+Q+N SG +P
Sbjct: 362 DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421
Query: 420 VGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTF 479
LP + L+++NNNL G+I SL + ++ N LP S S L+
Sbjct: 422 SEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENL 480
Query: 480 MASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIP 539
S N +P +L + L L LS N LSGEIP ++SC+KLVSL+L +N+ SG+IP
Sbjct: 481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540
Query: 540 KAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNE 599
+ + MP L+ LD+S N L G IP+N G +L +N+S+N L G +PS G + IN +
Sbjct: 541 ASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASA 600
Query: 600 LIGNAGLCG----SVLPPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVFFAGK 655
+ GN LCG S LPPC + + +I + F++ L +V+ G VF G+
Sbjct: 601 VAGNIDLCGGDTTSGLPPCKRVRKTP---SWWFYITCTLGAFLV--LALVAFGFVFIRGR 655
Query: 656 WAYR---------RWYLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNII 706
W L FFD KS T ++IL+ +KE N+I
Sbjct: 656 NNLELKRVENEDGTWEL--QFFDSKVSKS---------------ITINDILSSLKEENVI 698
Query: 707 GMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYL 766
G G YK + + M VK++ ++ S E++ +G+L+H NIV+L+G
Sbjct: 699 SRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS------EIADMGKLQHPNIVKLIGLC 752
Query: 767 HNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVI 826
+E ++++Y+ +L E L + W R IA+GIA+ L +LH C P V+
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 827 HRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSD 886
++ I++D E + L ++ + A Y+APE T + EKSD
Sbjct: 806 VGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA----YVAPETRETKDITEKSD 860
Query: 887 IYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEE 946
IY FG++L+ELLTGK P D FG IVEW S+ D +DPSI G Q E
Sbjct: 861 IYGFGLILIELLTGKSPADAEFGVHGSIVEWA-RYCYSDCHLDMWIDPSIRGDVSVNQNE 919
Query: 947 MLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNG 989
++ V+ +A+ CTA P RP DV+ L E+ R S C G
Sbjct: 920 IVEVMNLALHCTATDPTARPCANDVLKTL-ESASRSSSSCVTG 961
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 1e-48
Identities = 89/273 (32%), Positives = 135/273 (49%), Gaps = 30/273 (10%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G G G VYKA+ +VAVK L + + RE+ +L RL H NIVRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
++ ++ +V +Y L + L G L + ++ IA+ I +GL YLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAK-KIALQILRGLEYLHSN---G 118
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE-----YGYTL 879
+IHRD+K NILLD N +IADFGLA+ +L + +++ G+ Y+APE GY
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 880 KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQ-DEALDPSIAG 938
KV D++S GV+L ELLTGK P G + ++ I + DE S +
Sbjct: 179 KV----DVWSLGVILYELLTGKPPF---SGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
+ K + ++ L K P RPT ++
Sbjct: 232 EAKDLIKKCL----------NKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 2e-48
Identities = 81/271 (29%), Positives = 126/271 (46%), Gaps = 24/271 (8%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G VY A + +VA+K + + + + + RE+ +L +L+H NIVRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
+E + +V +Y L + L K+ G+L D Y I L YLH
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFY--LRQILSALEYLHSKG-- 117
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
++HRD+K NILLD + ++ADFGLAR + + + V G+ Y+APE +
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 884 KSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHV 943
DI+S GV+L ELLTGK P F G ++E + I K + I+ + K
Sbjct: 176 AVDIWSLGVILYELLTGKPP----FPGDDQLLE-LFKKIGKPKPPFPPPEWDISPEAKD- 229
Query: 944 QEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974
L+ + K P+ R T + +
Sbjct: 230 -----LIRK----LLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 68/194 (35%), Positives = 105/194 (54%), Gaps = 9/194 (4%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G GG G VY A + VA+K + + D+ ++L RE+ +L +L H NIV+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL-EELLREIEILKKLNHPNIVKLYGV 59
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+E ++ +V +Y SL + L E + I + I +GL YLH +
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLH---SNGI 113
Query: 826 IHRDIKSNNILLDA-NLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE-YGYTLKVDE 883
IHRD+K NILLD+ N + ++ADFGL++++ + + G+ Y+APE E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 884 KSDIYSFGVVLLEL 897
KSDI+S GV+L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 80/294 (27%), Positives = 133/294 (45%), Gaps = 54/294 (18%)
Query: 700 VKESNIIGMGGNGIVYKAEF----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
+ +G G G VYK + VAVK L + D + ++ RE ++ +L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLD 59
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
H NIV+LLG E +M+V +YMP L + L ++ + + A+ IA+G+
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGME 117
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI---A 872
YL IHRD+ + N L+ NL +I+DFGL+R ++ V G I A
Sbjct: 118 YLESK---NFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYKVKGGKLPIRWMA 172
Query: 873 PE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP---LDPAFGGSKDIVEWVLS---M 921
PE G +T KSD++SFGV+L E+ T G+ P + +++E++ +
Sbjct: 173 PESLKEGKFT----SKSDVWSFGVLLWEIFTLGEEPYPGMSN-----AEVLEYLKKGYRL 223
Query: 922 IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
K E + ++ + C A+ P+ RPT +++ +L
Sbjct: 224 PKPPNCPPE-------------------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 9e-41
Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 49/291 (16%)
Query: 700 VKESNIIGMGGNGIVYKAEF----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
+ +G G G VYK + + + VAVK L + D + ++ RE ++ +L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLD 59
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
H N+V+LLG E + +V +YM L L K KL + + A+ IA+G+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLS--DLLSFALQIARGME 116
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS---YGYIA 872
YL IHRD+ + N L+ NL +I+DFGL+R ++ G ++A
Sbjct: 117 YLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMA 171
Query: 873 PE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP---LDPAFGGSKDIVEWVLSMIKS 924
PE G +T KSD++SFGV+L E+ T G+ P + ++++E++
Sbjct: 172 PESLKEGKFT----SKSDVWSFGVLLWEIFTLGEQPYPGMSN-----EEVLEYL------ 216
Query: 925 NKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
L + E+ + + C A+ P+ RPT +++ +L
Sbjct: 217 --KNGYRLPQP-----PNCPPEL---YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 82/290 (28%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 700 VKESNIIGMGGNGIVYKA----EFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
++ +G G G VYK + VAVK L + E ++ E S++ +L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLS 59
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
H NIVRLLG + +V +YMP L + L K KL + +A+ IA+G+
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKD--LLQMALQIAKGME 116
Query: 816 YLH-HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG--SYGYIA 872
YL + +HRD+ + N L+ NL +I+DFGL+R + + G ++A
Sbjct: 117 YLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA 172
Query: 873 PE----YGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNK- 926
PE +T KSD++SFGV+L E+ T G+ P P + VL +++
Sbjct: 173 PESLKDGKFT----SKSDVWSFGVLLWEIFTLGEQPY-PGMSNEE-----VLELLEDGYR 222
Query: 927 -AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
+ P + E ML C A P+ RPT +++ L
Sbjct: 223 LPR-----PENC--PDELYELML-------QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 33/283 (11%)
Query: 704 NIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
+G G G VYK + VAVK L + D E D +E ++ +L H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 761 RLLGYLHNETNVMMVYDYMPNDSL-----GEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
RLLG E + +V +YM L K + + A+ IA+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG--SYGYIAP 873
YL +HRD+ + N L+ +L +I+DFGL+R + + G ++AP
Sbjct: 120 YLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 874 EYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932
E KSD++SFGV+L E+ T G P + G + E VL ++
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP----YPGLSN--EEVLEYLRKGYRLP--- 227
Query: 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
+ ++ +E+ + + C P+ RPT +++ L
Sbjct: 228 ------KPEYCPDEL---YELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG- 764
IG GG G VYKA R VA+K + E + + E+ +L + +H NIV+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH--HDCQ 822
YL + + +V ++ SL + L L ++ Y + + +GL YLH
Sbjct: 66 YLKKD-ELWIVMEFCSGGSLKDLLKSTN-QTLTESQIA-Y-VCKELLKGLEYLHSNG--- 118
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE------YG 876
+IHRDIK+ NILL ++ E ++ DFGL+ + +MV G+ ++APE Y
Sbjct: 119 --IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV-GTPYWMAPEVINGKPYD 175
Query: 877 YTLKVDEKSDIYSFGVVLLELLTGKMPL 904
Y K+DI+S G+ +EL GK P
Sbjct: 176 Y------KADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 72/212 (33%), Positives = 108/212 (50%), Gaps = 27/212 (12%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
++G G G VY A ++AVK + S + E + L RE+ +L L+H NIVR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 764 G-YLHNETNVMMVY-DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-HD 820
G E N + ++ +Y+ SL L K+ GKL + +Y I +GL YLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKY--TRQILEGLAYLHSNG 121
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM---VAGSYGYIAPE--- 874
++HRDIK NIL+D++ ++ADFG A+ L ET V G+ ++APE
Sbjct: 122 ----IVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 875 ---YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
YG +DI+S G ++E+ TGK P
Sbjct: 177 GEEYGR------AADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRL 762
++IG G G+VYK VA+K++ E+ + +E+ LL L+H NIV+
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
+G + ++ ++ +Y N SL + + K+ G V+ Y + QGL YLH +
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVY--VYQVLQGLAYLH---E 117
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMM--LHKNETVSMVAGSYGYIAPEYGYTLK 880
VIHRDIK+ NIL + ++ADFG+A + + K++ V G+ ++APE
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSG 175
Query: 881 VDEKSDIYSFGVVLLELLTGKMP---LDPA 907
SDI+S G ++ELLTG P L+P
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPM 205
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 69/222 (31%), Positives = 103/222 (46%), Gaps = 45/222 (20%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-----REVSLLGRLRHRN 758
IG G G VYKA + +VA+KK+ +E+ + F RE+ LL +LRH N
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI-----RMENEKEGFPITAIREIKLLQKLRHPN 59
Query: 759 IVRLLGYLHNE--TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNY 816
IVRL + ++ ++ MV++YM +D G L K + Y + +GL Y
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDSPEVKFTESQIKCY--MKQLLEGLQY 115
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG------- 869
LH + ++HRDIK +NIL++ + ++ADFGLAR + Y
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPY------TKRNSADYTNRVITLW 166
Query: 870 YIAPE-------YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
Y PE YG + D++S G +L EL GK
Sbjct: 167 YRPPELLLGATRYGP------EVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 14/205 (6%)
Query: 706 IGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRL 762
+G G G+V + E+ + VAVK L +SD + DD +E +++ L H N++RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
G + +MMV + P SL + L G L+ + Y AV IA G+ YL
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDY--AVQIANGMRYLE---S 115
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG---SYGYIAPEYGYTL 879
IHRD+ + NILL ++ + +I DFGL R + + M + + APE T
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 880 KVDEKSDIYSFGVVLLELLT-GKMP 903
SD++ FGV L E+ T G+ P
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 7e-29
Identities = 80/279 (28%), Positives = 120/279 (43%), Gaps = 25/279 (8%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-REVSLLGRLRH-RNIVRLL 763
+G G G VY A + VA+K L + + F RE+ +L L H NIV+L
Sbjct: 8 LGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
+ +E ++ +V +Y+ SL + L L + + + I I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF-ILAQILSALEYLH---SK 120
Query: 824 PVIHRDIKSNNILLDANL-EARIADFGLARMMLHKNETVSMVA------GSYGYIAPEY- 875
+IHRDIK NILLD + ++ DFGLA+++ T S+ A G+ GY+APE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 876 --GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933
SDI+S G+ L ELLTG P + + L +I A
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFE--GEKNSSATSQTLKIILELPTPSLASP 238
Query: 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
S + + L+ + AK PK R + +
Sbjct: 239 LSPSNPELISKAASDLLKK----LLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 56/165 (33%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 745 FREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEAL-HGKEAGKLLVDWVSR 803
E ++L R+ H IV+L E + +V +Y P GE H + G+ +
Sbjct: 41 LTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG---GELFSHLSKEGRFSEERARF 97
Query: 804 YNIAVGIAQGLNYLH-HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVS 862
Y A I L YLH +I+RD+K NILLDA+ ++ DFGLA+ + + +
Sbjct: 98 Y--AAEIVLALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151
Query: 863 MVAGSYGYIAPEY----GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
G+ Y+APE GY V D +S GV+L E+LTGK P
Sbjct: 152 TFCGTPEYLAPEVLLGKGYGKAV----DWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 75/222 (33%), Positives = 110/222 (49%), Gaps = 32/222 (14%)
Query: 697 LACVKESNIIGMGGNGIVYKAEFHRP-HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
L VK +G G +G+VYK H+P + A+KK+ D D E L RE+ L
Sbjct: 3 LERVKV---LGQGSSGVVYKV-RHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCE 57
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
+V+ G + E + +V +YM SL + L K+ GK+ ++ IA I +GL+
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLAY--IARQILKGLD 113
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFG----LARMMLHKNETVSMVAGSYGYI 871
YLH +IHRDIK +N+L+++ E +IADFG L + N V G+ Y+
Sbjct: 114 YLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV----GTVTYM 167
Query: 872 APE------YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPA 907
+PE Y Y +DI+S G+ LLE GK P P
Sbjct: 168 SPERIQGESYSY------AADIWSLGLTLLECALGKFPFLPP 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 9/217 (4%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G +G+V K HRP + K R + + + RE+ +L + IV G
Sbjct: 9 LGAGNSGVVSKVL-HRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+N ++ + +YM SL + + + G++ + + IAV + +GL YLH + +
Sbjct: 68 FYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKHK--I 122
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKS 885
IHRD+K +NIL+++ + ++ DFG++ ++ N G+ Y+APE KS
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKTFVGTSSYMAPERIQGNDYSVKS 180
Query: 886 DIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922
DI+S G+ L+EL TG+ P P I E +L I
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDPPDGIFE-LLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 73/215 (33%), Positives = 111/215 (51%), Gaps = 37/215 (17%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-----REVSLLGRLRHRNI 759
+G G G+VYKA + +VA+KK+ R DN+ E RE+SLL L+H NI
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEG----IPSTALREISLLKELKHPNI 60
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
V+LL +H E + +V++Y D L + L K G L + + + +GL Y H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDMD-LKKYLD-KRPGPLSPNLIKSI--MYQLLRGLAYCHS 116
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLAR-----MMLHKNETVSMVAGSYGYIAPE 874
++HRD+K NIL++ + ++ADFGLAR + + +E V++ Y APE
Sbjct: 117 HR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTL-----WYRAPE 168
Query: 875 -----YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
Y+ V DI+S G + E++TGK PL
Sbjct: 169 ILLGSKHYSTAV----DIWSVGCIFAEMITGK-PL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 39/223 (17%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG- 764
IG G G VY + +K++ S+ + +D EV +L +L H NI++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 765 YLHNETNVMMVYDYMPNDSLGEALH-GKEAGKLL-----VDWVSRYNIAVGIAQGLNYLH 818
+ + +V +Y L + + K+ GK +DW V + L YLH
Sbjct: 68 FEEK-GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF------VQLCLALKYLH 120
Query: 819 --HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM---VAGSYGYIAP 873
++HRDIK NI L +N ++ DFG+++++ + TV + V G+ Y++P
Sbjct: 121 SRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLSP 172
Query: 874 E----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSK 912
E Y + KSDI+S G VL EL T K F G
Sbjct: 173 ELCQNKPY----NYKSDIWSLGCVLYELCTLK----HPFEGEN 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-27
Identities = 73/224 (32%), Positives = 105/224 (46%), Gaps = 35/224 (15%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G+V A R VA+KK+ +D+ + RE+ LL LRH NI+ LL
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 764 -----GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
+ +V +V + M D L + + + L D + +Y I +GL YLH
Sbjct: 66 DILRPPSPEDFNDVYIVTELMETD-LHKVIKSPQ--PLTDDHI-QY-FLYQILRGLKYLH 120
Query: 819 --HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM----VAGSYGYIA 872
+ VIHRD+K +NIL+++N + +I DFGLAR + + V + Y A
Sbjct: 121 SAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW-YRA 174
Query: 873 PE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS 911
PE YT + DI+S G + ELLT K P F G
Sbjct: 175 PELLLSSSRYTKAI----DIWSVGCIFAELLTRK----PLFPGR 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG- 764
IG G +G VYKA VA+KK+ + E + E+ ++ +H NIV
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL---IINEILIMKDCKHPNIVDYYDS 83
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKL--LVDWVSRYNIAVGIA-------QGLN 815
YL + + +V +YM + G L ++ IA QGL
Sbjct: 84 YLVGDE-LWVVMEYM------------DGGSLTDIITQNFVRMNEPQIAYVCREVLQGLE 130
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL-ARMMLHKNETVSMVAGSYGYIAPE 874
YLH VIHRDIKS+NILL + ++ADFG A++ K++ S+V Y ++APE
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPY-WMAPE 186
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
K DI+S G++ +E+ G+ P
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 14/214 (6%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRS-DNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G G+VYKA +VA+KK+ +++ L RE+ LL L H NI++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL-REIKLLKELNHPNIIKLLD 65
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
++ ++ +V+++M D L + + K+ + L + + + + QGL + H
Sbjct: 66 VFRHKGDLYLVFEFMDTD-LYKLI--KDRQRGLPESLIKS-YLYQLLQGLAFCH---SHG 118
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKV-DE 883
++HRD+K N+L++ ++ADFGLAR + + Y APE K
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178
Query: 884 KSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEW 917
DI+S G + ELL+ + P F G +I +
Sbjct: 179 PVDIWSVGCIFAELLSRR----PLFPGKSEIDQL 208
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 64/237 (27%), Positives = 98/237 (41%), Gaps = 16/237 (6%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRL 762
+IG G G V + + A+K + + S ++ E +L L H +V L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
+E N+ +V D + LG L H + K + V + I L YLH
Sbjct: 66 WYSFQDEENMYLVVDLL----LGGDLRYHLSQKVKFSEEQVKFW--ICEIVLALEYLH-- 117
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLK 880
+IHRDIK +NILLD I DF +A + + + +G+ GY+APE
Sbjct: 118 -SKGIIHRDIKPDNILLDEQGHVHITDFNIAT-KVTPDTLTTSTSGTPGYMAPEVLCRQG 175
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937
D +S GV E L GK P G S+ I + + + ++ A + A
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYR---GHSRTIRDQIRAKQETADVLYPATWSTEA 229
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 88/304 (28%), Positives = 139/304 (45%), Gaps = 46/304 (15%)
Query: 695 EILACVKESNIIGMGGNGIVYKAEFHRPH-----MVVAVKKLWRSDNDIESGDDLFREVS 749
L+ V+ +G G G VYK E P+ VA+K L + + + + + +E
Sbjct: 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEFRQEAE 60
Query: 750 LLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEAL------------HGKEAGKLL 797
L+ L+H NIV LLG E M+++Y+ + L E L G E K
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 798 VDWVSRYNIAVGIAQGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855
+D +IA+ IA G+ YL HH +HRD+ + N L+ L +I+DFGL+R +
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR-DI 174
Query: 856 HKNETVSMVAGS---YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSK 912
+ + + + S ++ PE K +SDI+SFGVVL E+ + L P +G S
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS--YGLQPYYGFSN 232
Query: 913 DIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
+ V+ MI+S + L P C V + + C ++P RP +D+
Sbjct: 233 ---QEVIEMIRSRQ-----LLPCPED-CPAR------VYALMIECWNEIPARRPRFKDIH 277
Query: 973 TMLG 976
T L
Sbjct: 278 TRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 13/212 (6%)
Query: 698 ACVKESNIIGMGGNGIVYKAEFH---RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL 754
+ V +IG G G V + + + VA+K L +D + D E S++G+
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR-LDFLTEASIMGQF 62
Query: 755 RHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
H NI+RL G + VM++ +YM N SL + L + GK + GIA G+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND-GKF--TVGQLVGMLRGIASGM 119
Query: 815 NYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG--SYGYIA 872
YL +HRD+ + NIL+++NL +++DFGL+R + T + G + A
Sbjct: 120 KYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA 176
Query: 873 PEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
PE K SD++SFG+V+ E+++ G+ P
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+ +G G G VY+ + + + VAVK L D ++ +E +++ ++H N+V+LL
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
G E ++ ++M +L + L +E + V+ V +A I+ + YL +
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLE---KK 123
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS---YGYIAPEYGYTLK 880
IHRD+ + N L+ N ++ADFGL+R+M +T + AG+ + APE K
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLDPA 907
KSD+++FGV+L E+ T M P
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 5/202 (2%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
N IG G G+V+K V A+K++ S + ++ E +L +L I+R
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
++ + +V +Y N L + L + L D V R+ I + + GL +LH
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL--GLAHLHSK--- 120
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
++HRDIKS N+ LDA +I D G+A+++ + + G+ Y++PE +E
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 884 KSDIYSFGVVLLELLTGKMPLD 905
KSD+++ GVVL E TGK P D
Sbjct: 181 KSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 79/223 (35%), Positives = 113/223 (50%), Gaps = 38/223 (17%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLW---RSDNDIESGDDLFREVSLLGRLR-HRNIVR 761
+G G GIV+KA R VVA+KK++ R+ D + FRE+ L L H NIV+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQR---TFREIMFLQELGDHPNIVK 71
Query: 762 LLGYLH--NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
LL + N+ ++ +V++YM D LH +L D RY I + + L Y+H
Sbjct: 72 LLNVIKAENDKDIYLVFEYMETD-----LHAVIRANILEDVHKRY-IMYQLLKALKYIH- 124
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM------VAGSYGYIAP 873
VIHRD+K +NILL+++ ++ADFGLAR + E VA + Y AP
Sbjct: 125 --SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW-YRAP 181
Query: 874 E-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS 911
E YT V D++S G +L E+L GK P F G+
Sbjct: 182 EILLGSTRYTKGV----DMWSVGCILGEMLLGK----PLFPGT 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 705 IIGMGGNGIVYKAEFHRP-HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G VYKA H+ VVA+K + + D++ ++ +E+S+L + IV+
Sbjct: 10 KLGEGSYGSVYKA-IHKETGQVVAIKVV-PVEEDLQ---EIIKEISILKQCDSPYIVKYY 64
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAV---GIAQGLNYLHHD 820
G T++ +V +Y S+ + + K+ ++ IA +GL YLH
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIM------KITNKTLTEEEIAAILYQTLKGLEYLH-- 116
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLK 880
IHRDIK+ NILL+ +A++ADFG++ + + V G+ ++APE +
Sbjct: 117 -SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 881 VDEKSDIYSFGVVLLELLTGKMPL 904
+ K+DI+S G+ +E+ GK P
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 69/206 (33%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKK--LWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G VYKA R + VVA+K L ++++IE D+ +E+ L + R I +
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE---DIQQEIQFLSQCRSPYITKYY 65
Query: 764 G-YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
G +L + + ++ +Y S + L + GKL +++ I + GL YLH +
Sbjct: 66 GSFLKG-SKLWIIMEYCGGGSCLDLL---KPGKLDETYIA--FILREVLLGLEYLHEE-- 117
Query: 823 PPVIHRDIKSNNILLDANLEARIADFG----LARMMLHKNETVSMVAGSYGYIAPEYGYT 878
IHRDIK+ NILL + ++ADFG L M +N V G+ ++APE
Sbjct: 118 -GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV----GTPFWMAPEVIKQ 172
Query: 879 LKVDEKSDIYSFGVVLLELLTGKMPL 904
DEK+DI+S G+ +EL G+ PL
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 47/229 (20%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD-----LFREVSLLGRLRHRNIV 760
+G G +VYKA +VA+KK+ + + D RE+ LL L+H NI+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKI--KLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 761 RLLGYLHNETNVMMVYDYMPND----------SLGEALHGKEAGKLLVDWVSRYNIAVGI 810
LL +++N+ +V+++M D L A K + +
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPA-DIK-------------SYMLMT 111
Query: 811 AQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGY 870
+GL YLH + ++HRD+K NN+L+ ++ ++ADFGLAR N ++ + Y
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168
Query: 871 IAPE--YG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
APE +G Y + V D++S G + ELL P G DI
Sbjct: 169 RAPELLFGARHYGVGV----DMWSVGCIFAELLLRV----PFLPGDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 29/209 (13%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G G V+ + VAVK L E +E ++ +LRH +V+L
Sbjct: 14 LGAGQFGEVWMGTW-NGTTKVAVKTLKPGTMSPE---AFLQEAQIMKKLRHDKLVQLYAV 69
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQGLNYLHHDC 821
E + +V +YM SL + L E KL LVD +A IA+G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD------MAAQIAEGMAYLE--- 120
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY--GYIAPE---YG 876
IHRD+ + NIL+ NL +IADFGLAR ++ +E + + + APE YG
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANYG 179
Query: 877 -YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+T+ KSD++SFG++L E++T G++P
Sbjct: 180 RFTI----KSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 69/214 (32%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G G+V K +VA+KK S++D + REV +L +LRH NIV L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-HDCQPP 824
+ + +V++Y+ +L E L G L D V Y + Q + Y H H+
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEASPGG-LPPDAVRSYIWQ--LLQAIAYCHSHNI--- 121
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV--SMVAGSYGYIAPEY--GYTLK 880
IHRDIK NIL+ + ++ DFG AR + + + VA + Y APE G T
Sbjct: 122 -IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW-YRAPELLVGDT-N 178
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
+ D+++ G ++ ELL G+ P F G DI
Sbjct: 179 YGKPVDVWAIGCIMAELLDGE----PLFPGDSDI 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 5e-23
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIES-GDDLFREVSLLGRLRHRNIVRLLG 764
IG G G+VYKA VVA+KK+ R D + E RE+SLL L H NIV+LL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-HDCQP 823
+H E + +V++++ D L + + + + + Y + QGL + H H
Sbjct: 67 VIHTENKLYLVFEFLHQD-LKKFMDASPLSGIPLPLIKSY--LFQLLQGLAFCHSHR--- 120
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLAR-----MMLHKNETVSMVAGSYGYIAPEY--- 875
V+HRD+K N+L++ ++ADFGLAR + + +E V++ Y APE
Sbjct: 121 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL-----WYRAPEILLG 174
Query: 876 --GYTLKVDEKSDIYSFGVVLLELLTGK 901
Y+ V DI+S G + E++T +
Sbjct: 175 CKYYSTAV----DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 6e-23
Identities = 69/211 (32%), Positives = 106/211 (50%), Gaps = 20/211 (9%)
Query: 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI---ESGDDLFREVSLLGRLRHR 757
++ ++G G G VY+ AVK++ +D+ E+ L +E++LL +L+H
Sbjct: 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
NIV+ LG E N+ + + +P SL + L K+ G + Y I GL YL
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQ--ILLGLEYL 118
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY-- 875
H +HRDIK NIL+D N ++ADFG+A+ ++ + S Y ++APE
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY-WMAPEVIA 174
Query: 876 ---GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
GY L DI+S G +LE+ TGK P
Sbjct: 175 QQGGYGLAA----DIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 7e-23
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G G V K + H P V KK+ + RE+ ++ R IV G
Sbjct: 13 LGAGNGGSVSKVK-HIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL---HHDCQ 822
NE N+ M ++M SL K+ G + V+ + + IAV + +GL YL H
Sbjct: 72 FLNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--- 124
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----YGYT 878
++HRDIK +NIL+++ + ++ DFG++ ++ N G+ Y++PE YT
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVSGELI--NSIADTFVGTSTYMSPERIQGGKYT 180
Query: 879 LKVDEKSDIYSFGVVLLELLTGKMPLD 905
+K SD++S G+ ++EL GK P
Sbjct: 181 VK----SDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 9e-23
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKK--LWRSDNDIESGDDLFREVSLLGRLRHRNIVR 761
+IG+G +VY A + VA+K+ L + + D+L +EV + + H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV---DELRKEVQAMSQCNHPNVVK 63
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
+ +V Y+ SL + + L D + + +GL YLH +
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGL-DEAIIATVLKEVLKGLEYLHSNG 122
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM-----VAGSYGYIAPE-- 874
Q IHRDIK+ NILL + +IADFG++ L + G+ ++APE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVS-ASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 875 ---YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
+GY D K+DI+SFG+ +EL TG P
Sbjct: 179 EQVHGY----DFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG- 764
+GMG G+V A VA+KK+ + + +RE+ LL LRH NI+ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
++ ++ V + + D LH + L +Y I +GL Y+H
Sbjct: 78 FISPLEDIYFVTELLGTD-----LHRLLTSRPLEKQFIQY-FLYQILRGLKYVH---SAG 128
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL-KVDE 883
V+HRD+K +NIL++ N + +I DFGLAR+ + V+ Y Y APE T K D
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRY-YRAPEIMLTWQKYDV 185
Query: 884 KSDIYSFGVVLLELLTGKMPLDP 906
+ DI+S G + E+L GK PL P
Sbjct: 186 EVDIWSAGCIFAEMLEGK-PLFP 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 14/213 (6%)
Query: 698 ACVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRL 754
+ + + +IG G G V++ P + VA+K L + + D E S++G+
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFLSEASIMGQF 63
Query: 755 RHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
H NI+RL G + M++ +YM N +L + L + V GIA G+
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGM 120
Query: 815 NYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS---YGYI 871
YL +HRD+ + NIL+++NLE +++DFGL+R++ E +G +
Sbjct: 121 KYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177
Query: 872 APEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
APE K SD++SFG+V+ E+++ G+ P
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 705 IIGMGGNGIVYKA----EFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
++G G G VYK E + + VA+K L R + ++ ++ E ++ + H ++V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVDHPHVV 72
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALH---GKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
RLLG + V ++ MP L + + + L++W V IA+G++YL
Sbjct: 73 RLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 818 --HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS---YGYIA 872
++HRD+ + N+L+ +I DFGLA+ +L +E G ++A
Sbjct: 126 EEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAK-LLDVDEKEYHAEGGKVPIKWMA 179
Query: 873 PEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLD 905
E KSD++S+GV + EL+T G P +
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 5e-22
Identities = 74/205 (36%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G G VY A R + VVA+KK+ + E D+ +EV L +LRH N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
E +V +Y LG A E K + V I G QGL YLH +
Sbjct: 83 CYLREHTAWLVMEY----CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER-- 136
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE- 883
IHRDIK+ NILL ++ADFG A ++ N S V Y ++APE L +DE
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---SFVGTPY-WMAPE--VILAMDEG 189
Query: 884 ----KSDIYSFGVVLLELLTGKMPL 904
K D++S G+ +EL K PL
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 7e-22
Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 18/211 (8%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR----EVSLLGRLRHRNI 759
++G G G VY ++ ++ AVK++ +++ + + + EV LL L+H NI
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLI-AVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
V+ LG ++ + + +++P S+ L G L +Y I G+ YLH+
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQ--ILDGVAYLHN 120
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMM----LH--KNETVSMVAGSYGYIAP 873
+C V+HRDIK NN++L N ++ DFG AR + LH + + + G+ ++AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 874 EYGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
E KSDI+S G + E+ TGK PL
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 7e-22
Identities = 73/234 (31%), Positives = 107/234 (45%), Gaps = 21/234 (8%)
Query: 687 QRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR 746
Q LN T E+ + + +G G G V A + VA+KKL R +R
Sbjct: 4 QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETNVMMVYD-YMPNDSLGEALHGKEAGKLLVDWVSRYN 805
E+ LL + H N++ LL +++ D Y+ +G L+ + L D ++
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF- 122
Query: 806 IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA 865
+ I +GL Y+H +IHRD+K +NI ++ + E +I DFGLAR E VA
Sbjct: 123 LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD--EMTGYVA 177
Query: 866 GSYGYIAPE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
+ Y APE Y V DI+S G ++ ELLTGK F GS I
Sbjct: 178 TRW-YRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTGK----TLFPGSDHI 222
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 8e-22
Identities = 71/231 (30%), Positives = 106/231 (45%), Gaps = 53/231 (22%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIES-GDDLFREVSLLGRLRHRNIVRLLG 764
IG G G+VYKA +VA+KK+ R + + E RE+SLL L H NIVRLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 765 YLHNETNVMMVYDYM-----------PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQG 813
+H+E + +V++++ P L L +LL QG
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL--------------QG 111
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR-----MMLHKNETVSMVAGSY 868
+ Y H V+HRD+K N+L+D ++ADFGLAR + + +E V++
Sbjct: 112 IAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTL----- 163
Query: 869 GYIAPEY-----GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
Y APE Y+ V DI+S G + E++ + P F G +I
Sbjct: 164 WYRAPEILLGSRQYSTPV----DIWSIGCIFAEMVNRR----PLFPGDSEI 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIES-GDDLFREVSLLGRLRHRNIVRLLG 764
IG G G V+KA+ H +VA+K++ R D+D E RE+ LL L+H+NIVRL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 765 YLHNETNVMMVYDYMPND--SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
LH++ + +V++Y D ++ +G +D + + +GL + H
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGD------IDPEIVKSFMFQLLKGLAFCH---S 117
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLAR-----MMLHKNETVSMVAGSYGYIAPE--Y 875
V+HRD+K N+L++ N E ++ADFGLAR + + E V++ Y P+ +
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL-----WYRPPDVLF 172
Query: 876 GYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
G L D++S G + EL PL P
Sbjct: 173 GAKL-YSTSIDMWSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 71/212 (33%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRL 762
N IG G G VY A ++AVK++ DND ++ ++ E+ +L L+H N+V+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 763 LGY-LH-NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
G +H + + M +Y +L E L V + Y + + +GL YLH
Sbjct: 65 YGVEVHREKVYIFM--EYCSGGTLEELLEHGRILDEHV--IRVY--TLQLLEGLAYLH-- 116
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMV------AGSYGYIAPE 874
++HRDIK NI LD N ++ DFG A + KN T +M AG+ Y+APE
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL--KNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 875 Y--GYTLKVDEKS-DIYSFGVVLLELLTGKMP 903
G K ++ DI+S G V+LE+ TGK P
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 65/217 (29%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 697 LACVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGR 753
++CVK +IG G G V + P + VA+K L +S + D E S++G+
Sbjct: 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQ 61
Query: 754 LRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQG 813
H NI+ L G + VM++ ++M N +L L + G+ V + + GIA G
Sbjct: 62 FDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTV--IQLVGMLRGIAAG 118
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG---- 869
+ YL + +HRD+ + NIL+++NL +++DFGL+R L + + S G
Sbjct: 119 MKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR-FLEDDTSDPTYTSSLGGKIP 174
Query: 870 --YIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ APE K SD++S+G+V+ E+++ G+ P
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 70/224 (31%), Positives = 104/224 (46%), Gaps = 38/224 (16%)
Query: 706 IGMGGNGIVYKAEFHR-----PHMVVAVKKLWR-SDNDIESGDDLFREVSLLGRLRHRNI 759
+G G G V+ E + +VAVK L + ND D RE LL +H NI
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNFQHENI 70
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLL--------VDWVSRYNIAVG 809
V+ G +MV++YM + L + L HG +A L + IAV
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 810 IAQGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM----LHKNETVSM 863
IA G+ YL H +HRD+ + N L+ +L +I DFG++R + ++ +M
Sbjct: 131 IASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 864 VAGSYGYIAPE---YGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ ++ PE Y K +SD++SFGVVL E+ T GK P
Sbjct: 186 L--PIRWMPPESIMYR---KFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRS---DNDIESGDDLFREVSLLGRLRHRNIVRL 762
+G+GG G V + + A+K + + + + +F E +L H IV+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQE--HIFSEKEILEECNHPFIVKL 58
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
++ + M+ +Y L L + G L ++ +R+ IA + YLH+
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILR--DRG-LFDEYTARFYIA-CVVLAFEYLHNR-- 112
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY----GYT 878
+I+RD+K N+LLD+N ++ DFG A+ + +T + G+ Y+APE GY
Sbjct: 113 -GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC-GTPEYVAPEIILNKGYD 170
Query: 879 LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKD 913
V D +S G++L ELLTG+ P FG +
Sbjct: 171 FSV----DYWSLGILLYELLTGRPP----FGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-----IESGDDLFREVSLLGRLRHRN 758
N IG G GIVY+A +VA+KK+ R DN+ I S RE++LL LRH N
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISS----LREITLLLNLRHPN 67
Query: 759 IVRLLGYLHNE--TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN------IAVGI 810
IV L + + ++ +V +Y D LL + + ++ + + +
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQD----------LASLLDNMPTPFSESQVKCLMLQL 117
Query: 811 AQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGY 870
+GL YLH + +IHRD+K +N+LL +IADFGLAR + ++ + Y
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWY 174
Query: 871 IAPEYGYTLKVDEKS-DIYSFGVVLLELLTGKMPLDPA 907
APE + D+++ G +L ELL K PL P
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK-PLLPG 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 40/221 (18%)
Query: 700 VKESNIIGMGGNGIVYKAEF----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
+K +G G G V + VAVK L S + D RE+ +L L
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRTLD 64
Query: 756 HRNIVRLLG--YLHNETNVMMVYDYMPNDSLGEALHGKEA----GKLLVDWVSRYNIAVG 809
H NIV+ G ++ ++ +Y+P+ SL + L +LL + +
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL-----LF--SSQ 117
Query: 810 IAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG 869
I +G++YL IHRD+ + NIL+++ +I+DFGLA+++ + Y
Sbjct: 118 ICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD--------YY 166
Query: 870 YI-----------APEYGYTLKVDEKSDIYSFGVVLLELLT 899
Y+ APE T K SD++SFGV L EL T
Sbjct: 167 YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 12/214 (5%)
Query: 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDNDIESGDDLFREVSLLGR 753
E+L IG G G V K ++ K++ + + + E L EV++L
Sbjct: 3 EVLET------IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRE 55
Query: 754 LRHRNIVRLLGYLHNETN--VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIA 811
L+H NIVR + + +N + +V +Y L + + + + ++ + I +
Sbjct: 56 LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 812 QGLNYLHH--DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG 869
L H+ D V+HRD+K NI LDAN ++ DFGLA+++ H + G+
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY 175
Query: 870 YIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y++PE + DEKSDI+S G ++ EL P
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 4e-21
Identities = 78/285 (27%), Positives = 127/285 (44%), Gaps = 32/285 (11%)
Query: 698 ACVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRL 754
+C+K +IG G G V P + VA+K L + + D E S++G+
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQF 62
Query: 755 RHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
H NI+ L G + VM+V +YM N SL L K G+ V + + GIA G+
Sbjct: 63 DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR-KHDGQFTV--IQLVGMLRGIASGM 119
Query: 815 NYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS---YGYI 871
YL +HRD+ + NIL+++NL +++DFGL+R++ E G +
Sbjct: 120 KYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176
Query: 872 APEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930
APE K SD++S+G+V+ E+++ G+ P W +S KA +E
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY------------WEMSNQDVIKAIEE 224
Query: 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
C +++L C K RP ++++L
Sbjct: 225 GYRLPAPMDCPAALHQLMLD------CWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 9/199 (4%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G G V++ + + + VA+K L +D+ D +EV L RLRH++++ L
Sbjct: 14 LGSGYFGEVWEGLW-KNRVRVAIKIL--KSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
V ++ + M SL L E G++L S ++A +A+G+ YL +
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRSPE-GQVL-PVASLIDMACQVAEGMAYLE---EQNS 125
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKS 885
IHRD+ + NIL+ +L ++ADFGLAR++ S Y + APE KS
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKS 185
Query: 886 DIYSFGVVLLELLT-GKMP 903
D++SFG++L E+ T G++P
Sbjct: 186 DVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVK--KLWRSDNDIESGDDLFREVSLLGRLRH---RNI 759
+IG G G VY+ + VVA+K L D+D+ D+ REV+LL +LR NI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS---DIQREVALLSQLRQSQPPNI 64
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIA---QGLNY 816
+ G + ++ +Y S+ + +AG + +Y I+V I L Y
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPI----AEKY-ISVIIREVLVALKY 116
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYG 876
+H VIHRDIK+ NIL+ ++ DFG+A ++ + S G+ ++APE
Sbjct: 117 IHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 877 YTLKV-DEKSDIYSFGVVLLELLTGKMPL 904
K D K+DI+S G+ + E+ TG P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G G V ++ VAVK L +D + E S++ LRH N+V+LLG
Sbjct: 14 IGKGEFGDVMLGDYRGQK--VAVKCL---KDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+ + +V +YM SL + L + G+ ++ + A+ + +G+ YL +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLE---EKNF 123
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY--GYIAPEYGYTLKVDE 883
+HRD+ + N+L+ +L A+++DFGLA K + +G + APE K
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLA-----KEASQGQDSGKLPVKWTAPEALREKKFST 178
Query: 884 KSDIYSFGVVLLELLT-GKMP 903
KSD++SFG++L E+ + G++P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 57/185 (30%), Positives = 92/185 (49%), Gaps = 20/185 (10%)
Query: 726 VAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLG 785
VAVK L D + D E ++ +LRH +++L E + +V + M SL
Sbjct: 33 VAVKTLKPGTMDPK---DFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89
Query: 786 EALHGKEAGKL----LVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL 841
E L G L L+D +A +A G+ YL IHRD+ + N+L+ N
Sbjct: 90 EYLQGGAGRALKLPQLID------MAAQVASGMAYLE---AQNYIHRDLAARNVLVGENN 140
Query: 842 EARIADFGLARMMLHKNETVSMVAGSY--GYIAPEYGYTLKVDEKSDIYSFGVVLLELLT 899
++ADFGLAR ++ ++ + + + APE + KSD++SFG++L E++T
Sbjct: 141 ICKVADFGLAR-VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
Query: 900 -GKMP 903
G+MP
Sbjct: 200 YGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 33/218 (15%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR--------EVSLLGRLRH 756
+IG G G VY A ++AVK++ D + E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 757 RNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL---LVDWVSRYNIAVGIAQG 813
NIV+ LG+ E + + +Y+P S+G L + G+ LV + + + +G
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQ-----VLEG 120
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM--LHKNETVSMVAGSYGYI 871
L YLH ++HRD+K++N+L+DA+ +I+DFG+++ ++ N+ + GS ++
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 872 APE------YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
APE GY+ KV DI+S G V+LE+ G+ P
Sbjct: 178 APEVIHSYSQGYSAKV----DIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 68/214 (31%), Positives = 108/214 (50%), Gaps = 24/214 (11%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESG-------DDLFREVSLLGRLRHR 757
+IG G G VY ++AVK++ S D L RE++LL L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYNIAVGIAQGLN 815
NIV+ LG + ++ + +Y+P S+ L +G L+ ++V + I +GLN
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGLN 120
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR------MMLHKNETVSMVAGSYG 869
YLH+ +IHRDIK NIL+D +I+DFG+++ + N + GS
Sbjct: 121 YLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 870 YIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
++APE K+DI+S G +++E+LTGK P
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 49/231 (21%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVK-----KLWRSDNDIESGDDLFREVSLLGRL-RHRN 758
IIG G V A+ + A+K +L + + + + E +L RL H
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-EKKV---KYVKIEKEVLTRLNGHPG 63
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQ---GLN 815
I++L +E N+ V +Y PN L + + ++ G L Y A+ L
Sbjct: 64 IIKLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFY-----AAEILLALE 116
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM--LHKNETVSMVA-------- 865
YLH +IHRD+K NILLD ++ +I DFG A+++ E+ A
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 866 ----------GSYGYIAPEYGYTL---KVDEKSDIYSFGVVLLELLTGKMP 903
G+ Y++PE L + SD+++ G ++ ++LTGK P
Sbjct: 174 KNRRRFASFVGTAEYVSPE---LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 46/229 (20%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
+ E + +G G G V K M+ A+K + N + + RE+ + +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPY 60
Query: 759 IVRLLG--YLHNETNVMMVYDYMPNDSLGEALHG-----------KEAGKLLVDWVSRYN 805
IV+ G + +++ + +Y SL ++++ K GK
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGK---------- 109
Query: 806 IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA 865
IA + +GL+YLH +IHRDIK +NILL + ++ DFG++ E V+ +A
Sbjct: 110 IAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS------GELVNSLA 160
Query: 866 GSYG----YIAPEY----GYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
G++ Y+APE Y++ SD++S G+ LLE+ + P P
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSI----TSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 70/225 (31%), Positives = 111/225 (49%), Gaps = 40/225 (17%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD-----LFREVSLLGRLRHRNIV 760
IG G G+VYK + +VA+KK+ +ES ++ RE+SLL L+H NIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-----RLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLL-VDWVSRYNIAVGIAQGLNYLHH 819
L L E+ + ++++++ D L + L G+ + + V Y I QG+ + H
Sbjct: 63 CLQDVLMQESRLYLIFEFLSMD-LKKYLDSLPKGQYMDAELVKSY--LYQILQGILFCH- 118
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLAR-----MMLHKNETVSMVAGSYGYIAPE 874
V+HRD+K N+L+D ++ADFGLAR + ++ +E V++ Y APE
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL-----WYRAPE 171
Query: 875 Y-----GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
Y+ V DI+S G + E+ T K P F G +I
Sbjct: 172 VLLGSPRYSTPV----DIWSIGTIFAEMATKK----PLFHGDSEI 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 77/282 (27%), Positives = 131/282 (46%), Gaps = 33/282 (11%)
Query: 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH 756
L +KE +G G G+V+ ++ R + VA+K + + S +D E ++ +L H
Sbjct: 6 LTFMKE---LGSGQFGVVHLGKW-RAQIKVAIKAI---NEGAMSEEDFIEEAKVMMKLSH 58
Query: 757 RNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNY 816
+V+L G + + +V ++M N L L ++ GKL D + ++ + +G+ Y
Sbjct: 59 PKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDML--LSMCQDVCEGMEY 115
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG-SYGYIAPEY 875
L + IHRD+ + N L+ + +++DFG+ R +L T S A + PE
Sbjct: 116 LE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEV 172
Query: 876 GYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934
K KSD++SFGV++ E+ T GKMP + K E V+ MI P
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE-----KKSNYE-VVEMI---SRGFRLYRP 223
Query: 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976
+A V E M C + P+GRPT +++ +
Sbjct: 224 KLA--SMTVYEVMY-------SCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD----LFREVSLLGRLRH 756
+ +G G Y+A + ++AVK++ N ++ L +E+ L+ RL H
Sbjct: 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 757 RNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNY 816
+I+R+LG +++ + ++M S+ L A K V + Y + +GL+Y
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV--IINY--TEQLLRGLSY 118
Query: 817 LHHDCQPPVIHRDIKSNNILLDAN-LEARIADFGLARMMLHK----NETVSMVAGSYGYI 871
LH + +IHRD+K N+L+D+ RIADFG A + K E + G+ ++
Sbjct: 119 LHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 872 APEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
APE + D++S G V++E+ T K P
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 70/223 (31%), Positives = 106/223 (47%), Gaps = 53/223 (23%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGD---DLFREVSLLGRLRHR--NIV 760
IG G G VYK F + V+AVK++ R+ N E+ DL +V L H IV
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL--DVVLKS---HDCPYIV 77
Query: 761 RLLGYLHNETNVMM---------------VYDYMPNDSLGEALHGKEAGKLLVDWVSRYN 805
+ GY +++V + + +P D LG+
Sbjct: 78 KCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGK------------------- 118
Query: 806 IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA-RMMLHKNETVSMV 864
+ V I + L+YL VIHRD+K +NILLDA+ ++ DFG++ R++ K +T S
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-- 174
Query: 865 AGSYGYIAPEY----GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
AG Y+APE K D ++D++S G+ L+EL TG+ P
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 40/224 (17%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL------FREVSLLGRLRHRNI 759
IG G G+V+K +VA+KK +ES DD RE+ +L +L+H N+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF------VESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH- 818
V L+ + + +V++Y + L E E V I Q +N+ H
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNEL----EKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML-HKNETVSMVAGSYGYIAPE--- 874
H+C IHRD+K NIL+ + ++ DFG AR++ ++ VA + Y APE
Sbjct: 119 HNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW-YRAPELLV 173
Query: 875 ----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
YG + D+++ G V ELLTG+ PL P G D+
Sbjct: 174 GDTQYGPPV------DVWAIGCVFAELLTGQ-PLWP---GKSDV 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 32/221 (14%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
++G G G+V K + +VA+KK S++D RE+ +L +LRH N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 765 YLHNETNVMMVYDYMPN---DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-HD 820
+ + +V++++ + D L + +G + + V +Y I +G+ + H H+
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESR-----VRKY--LFQILRGIEFCHSHN 120
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE------ 874
+IHRDIK NIL+ + ++ DFG AR + E + + Y APE
Sbjct: 121 ----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 875 -YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
YG + DI++ G ++ E+LTG +P F G DI
Sbjct: 177 KYGRAV------DIWAVGCLVTEMLTG----EPLFPGDSDI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 21/205 (10%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G G V+ ++ VAVK L +++ E +L+ L+H +VRL
Sbjct: 14 LGAGQFGEVWMG-YYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAV 69
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+ E + ++ +YM SL + L E GK+L+ + + IA+G+ Y+ +
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNY 124
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY--GYIAPE---YG-YTL 879
IHRD+++ N+L+ +L +IADFGLAR ++ NE + + + APE +G +T+
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 183
Query: 880 KVDEKSDIYSFGVVLLELLT-GKMP 903
KSD++SFG++L E++T GK+P
Sbjct: 184 ----KSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 72/239 (30%), Positives = 101/239 (42%), Gaps = 51/239 (21%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-----REVSLLGRLRHRNIV 760
+G G G VYKA + VVA+KK+ + + D F RE+ +L +L+H N+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKIL-----MHNEKDGFPITALREIKILKKLKHPNVV 70
Query: 761 RLL--------GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQ 812
L+ +V MV YM +D G L + KL + + + +
Sbjct: 71 PLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSVKLTESQIK--CYMLQLLE 126
Query: 813 GLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG--- 869
G+NYLH + ++HRDIK+ NIL+D +IADFGLAR G G
Sbjct: 127 GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR-PYDGPPPNPKGGGGGGTRK 182
Query: 870 ---------YIAPEY-----GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
Y PE YT V DI+ G V E+ T + P G DI
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR----PILQGKSDI 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 3e-19
Identities = 70/203 (34%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G G VY A R + VVA+KK+ + E D+ +EV L R++H N + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
E +V +Y LG A E K + V I G QGL YLH
Sbjct: 93 CYLREHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---N 145
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL---KV 881
+IHRDIK+ NILL + ++ADFG A + N V G+ ++APE + +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV----GTPYWMAPEVILAMDEGQY 201
Query: 882 DEKSDIYSFGVVLLELLTGKMPL 904
D K D++S G+ +EL K PL
Sbjct: 202 DGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH 756
L +KE +G G G+V+ ++ R + VA+K + S DD E ++ +L H
Sbjct: 6 LTFLKE---LGSGQFGVVHLGKW-RGKIDVAIKMI---REGAMSEDDFIEEAKVMMKLSH 58
Query: 757 RNIVRLLGYLHNETNVMMVYDYMPNDSLGEALH---GKEAGKLLVDWVSRYNIAVGIAQG 813
N+V+L G + + +V +YM N L L GK + L+D + + +
Sbjct: 59 PNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD------MCSDVCEA 112
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG-SYGYIA 872
+ YL + IHRD+ + N L+ + +++DFGLAR +L T S +
Sbjct: 113 MEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAP 169
Query: 873 PEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLD 905
PE + KSD++SFGV++ E+ + GKMP +
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-19
Identities = 71/203 (34%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI-ESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G G VY A + VVAVKK+ S E D+ +EV L +L+H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
E +V +Y LG A E K + V I G QGL YLH
Sbjct: 89 CYLKEHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL---KV 881
+IHRDIK+ NILL + ++ADFG A N V G+ ++APE + +
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV----GTPYWMAPEVILAMDEGQY 197
Query: 882 DEKSDIYSFGVVLLELLTGKMPL 904
D K D++S G+ +EL K PL
Sbjct: 198 DGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 70/216 (32%), Positives = 118/216 (54%), Gaps = 25/216 (11%)
Query: 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL 754
E L VK+ +G G G V+ ++ H VA+K L + E+ E +L+ +L
Sbjct: 6 ETLKLVKK---LGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQL 58
Query: 755 RHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
+H +VRL + E + ++ +YM N SL + L E KL ++ ++A IA+G+
Sbjct: 59 QHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGM 115
Query: 815 NYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY--GYIA 872
++ + IHRD+++ NIL+ L +IADFGLAR ++ NE + + + A
Sbjct: 116 AFIE---RKNYIHRDLRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTA 171
Query: 873 PE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
PE YG +T+ KSD++SFG++L E++T G++P
Sbjct: 172 PEAINYGTFTI----KSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 79/272 (29%), Positives = 130/272 (47%), Gaps = 37/272 (13%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVK--KLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G VYK +R VVA+K L ++++IE D+ +E+++L + I R
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE---DIQQEITVLSQCDSPYITRYY 68
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
G T + ++ +Y+ G AL + G L +++ I I +GL+YLH + +
Sbjct: 69 GSYLKGTKLWIIMEYLGG---GSALDLLKPGPLEETYIA--TILREILKGLDYLHSERK- 122
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
IHRDIK+ N+LL + ++ADFG+A + + G+ ++APE D
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 884 KSDIYSFGVVLLELLTGKMP---LDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQC 940
K+DI+S G+ +EL G+ P L P VL +I N P++ GQ
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPM---------RVLFLIPKNSP------PTLEGQY 225
Query: 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
+E + C K P+ RPT ++++
Sbjct: 226 SKPFKEFVEA------CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 6e-19
Identities = 55/163 (33%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 503 LDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRI 562
L L + L G IP I+ L S+NL N G IP ++ ++ +L +LD+S NS G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 563 PENFGASPALEMLNLSYNKLEGPVPS--NGILMNINPNELIGNAGLCG-SVLPPCSQNLT 619
PE+ G +L +LNL+ N L G VP+ G L++ NAGLCG L C +L+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLS 542
Query: 620 --AKPGQTRKMHINHIIFGFIIGTLVIVSLGIVFFAGKWAYRR 660
AK G I FG + L +V + ++ + R
Sbjct: 543 VGAKIG---------IAFGVSVAFLFLVICAMCWWKRRQNILR 576
|
Length = 623 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 15/211 (7%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G VYK +VA+K++ D + + RE+SL+ L+H NIVRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEI-HLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 766 LHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
+H E +M+V++YM D L + + HG +D + + + +G+ + H +
Sbjct: 67 IHTENKLMLVFEYMDKD-LKKYMDTHGVRGA---LDPNTVKSFTYQLLKGIAFCH---EN 119
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
V+HRD+K N+L++ E ++ADFGLAR T S + Y AP+ +
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYS 179
Query: 884 KS-DIYSFGVVLLELLTGKMPLDPAFGGSKD 913
S DI+S G ++ E++TG+ P F G+ +
Sbjct: 180 TSIDIWSVGCIMAEMITGR----PLFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 6e-19
Identities = 76/237 (32%), Positives = 118/237 (49%), Gaps = 47/237 (19%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGD-DLFREVSLLGRLRHRNIVRL 762
IG G G VYKA +VA+KK+ R DN+ E RE+ +L +L HRNIV L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 763 ----------LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQ 812
L + ++ +V++YM +D +G E+G LV + S +I + Q
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL----ESG--LVHF-SEDHIKSFMKQ 124
Query: 813 ---GLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM------LHKNETVSM 863
GLNY H + +HRDIK +NILL+ + ++ADFGLAR+ + N+ +++
Sbjct: 125 LLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181
Query: 864 VAGSYGYIAPEYGYTLKVDEKS----DIYSFGVVLLELLTGKMPLDPAFGGSKDIVE 916
Y PE L +E+ D++S G +L EL T K P F ++++ +
Sbjct: 182 -----WYRPPEL---LLGEERYGPAIDVWSCGCILGELFTKK----PIFQANQELAQ 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
E ++G G GIVY A + +A+K++ + D L E++L L+HRNIV
Sbjct: 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSYLKHRNIV 68
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
+ LG + + +P SL L K G L + + I +GL YLH +
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 821 CQPPVIHRDIKSNNILLDA-NLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY---- 875
++HRDIK +N+L++ + +I+DFG ++ + N G+ Y+APE
Sbjct: 128 ---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKG 184
Query: 876 --GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
GY +DI+S G ++E+ TGK P
Sbjct: 185 PRGY----GAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 37/215 (17%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL---FREVSLLGRLRHRNIVRL 762
IG G G VYKA +VA+K + +E GDD +E+S+L RH NIV
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVI-----KLEPGDDFEIIQQEISMLKECRHPNIVAY 65
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEA--GKLLVDWVSRYNIAVGIAQGLNYLHHD 820
G + +V +Y SL + +L + +V R + +GL YLH
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHET 120
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLA----RMMLHKNETVSMVAGSYGYIAPE-- 874
IHRDIK NILL + + ++ADFG++ + + S + Y ++APE
Sbjct: 121 ---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK---SFIGTPY-WMAPEVA 173
Query: 875 -----YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
GY D K DI++ G+ +EL + P+
Sbjct: 174 AVERKGGY----DGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 7e-19
Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G G+V A R VA+KK+ + + RE+ +L +H NI+ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71
Query: 765 YLHNETN----VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
L V +V D M +D L +H + L + RY + +GL Y+H
Sbjct: 72 ILRPPGADFKDVYVVMDLMESD-LHHIIHSDQP---LTEEHIRY-FLYQLLRGLKYIHSA 126
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY----GYIAPE-- 874
VIHRD+K +N+L++ + E RI DFG+AR + Y Y APE
Sbjct: 127 N---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 875 ---YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
YT + D++S G + E+L G+ L P
Sbjct: 184 LSLPEYTTAI----DMWSVGCIFAEML-GRRQLFP 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 7e-19
Identities = 69/214 (32%), Positives = 108/214 (50%), Gaps = 24/214 (11%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMV-VAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRL 762
+ IG G G+V A H+P V VA+KK+ ++ L RE+ +L R +H NI+ +
Sbjct: 11 SYIGEGAYGMVCSA-THKPTGVKVAIKKISPFEHQTFCQRTL-REIKILRRFKHENIIGI 68
Query: 763 LGYLHNET-----NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
L + + +V +V + M D L+ + L + +Y + I +GL Y+
Sbjct: 69 LDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFL-YQILRGLKYI 122
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML----HKNETVSMVAGSYGYIAP 873
H V+HRD+K +N+LL+ N + +I DFGLAR+ H VA + Y AP
Sbjct: 123 H---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW-YRAP 178
Query: 874 EYGYTLKVDEKS-DIYSFGVVLLELLTGKMPLDP 906
E K K+ DI+S G +L E+L+ + PL P
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFP 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-18
Identities = 73/221 (33%), Positives = 110/221 (49%), Gaps = 31/221 (14%)
Query: 706 IGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
+G G G V+ AE + + M+VAVK L D + + D RE LL L+H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSR-----------YNIA 807
+ G + ++MV++YM + L + L HG +A +LVD R +IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDA-MILVDGQPRQAKGELGLSQMLHIA 129
Query: 808 VGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG- 866
IA G+ YL +HRD+ + N L+ ANL +I DFG++R + + V G
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD--YYRVGGH 184
Query: 867 ---SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
++ PE K +SD++SFGV+L E+ T GK P
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 72/214 (33%), Positives = 108/214 (50%), Gaps = 19/214 (8%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKK--LWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G +GIV+KA+ VA+KK L R + I + RE+ L +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ--ALREIKALQACQHPYVVKLL 65
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
+ + ++V +YMP+D L E L +E L V Y + +G+ Y+H
Sbjct: 66 DVFPHGSGFVLVMEYMPSD-LSEVLRDEER-PLPEAQVKSYMRM--LLKGVAYMH---AN 118
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV-SMVAGSYGYIAPE--YGYTLK 880
++HRD+K N+L+ A+ +IADFGLAR+ + + S + Y APE YG K
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG-ARK 177
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
D D+++ G + ELL G P F G DI
Sbjct: 178 YDPGVDLWAVGCIFAELLNGS----PLFPGENDI 207
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 37/272 (13%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVK--KLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G V+K +R VVA+K L ++++IE D+ +E+++L + + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE---DIQQEITVLSQCDSPYVTKYY 68
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
G +T + ++ +Y+ G AL E G L D I I +GL+YLH + +
Sbjct: 69 GSYLKDTKLWIIMEYLGG---GSALDLLEPGPL--DETQIATILREILKGLDYLHSEKK- 122
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
IHRDIK+ N+LL + E ++ADFG+A + + G+ ++APE D
Sbjct: 123 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 884 KSDIYSFGVVLLELLTGKMP---LDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQC 940
K+DI+S G+ +EL G+ P L P VL +I N P++ G
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELHPM---------KVLFLIPKNNP------PTLEGNY 225
Query: 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
+E + C K P RPT ++++
Sbjct: 226 SKPLKEFVEA------CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 70/204 (34%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G G VY A R VVA+KK+ + E D+ +EV L +LRH N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-HDCQP 823
E +V +Y LG A E K + V + G QGL YLH H+
Sbjct: 83 CYLREHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL---K 880
+IHRD+K+ NILL ++ DFG A +M N V G+ ++APE + +
Sbjct: 136 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV----GTPYWMAPEVILAMDEGQ 190
Query: 881 VDEKSDIYSFGVVLLELLTGKMPL 904
D K D++S G+ +EL K PL
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G +VYKA VVA+KK+ + D ++ D +E+ LL +L H N+++ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 765 YLHNETNVMMVYDYMPNDSLGEAL-HGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
+ +V + L + H K+ +L+ + + V + L ++H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLI-PERTIWKYFVQLCSALEHMH---SK 125
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKN-ETVSMVAGSYGYIAPEY----GYT 878
++HRDIK N+ + A ++ D GL R K S+V Y Y++PE GY
Sbjct: 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPERIHENGY- 183
Query: 879 LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSK 912
+ KSDI+S G +L E+ + P F G K
Sbjct: 184 ---NFKSDIWSLGCLLYEMAALQSP----FYGDK 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 65/252 (25%), Positives = 106/252 (42%), Gaps = 48/252 (19%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSD----NDIESGDDLFREVSLLGRLRHRNIVR 761
I G G V+ A+ + A+K + ++D N ++ + E +L + + +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQ---VLTERDILSQAQSPYVVK 57
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
L + N+ +V +Y+P L L G L D Y I L YLH
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIY--IAEIVLALEYLH--- 110
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM--------VAGSYGYIAP 873
+IHRD+K +NIL+D+N ++ DFGL+++ L + + + G+ YIAP
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 874 E------YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS----------KDIVEW 917
E + T D +S G +L E L G P F G +EW
Sbjct: 171 EVILGQGHSKT------VDWWSLGCILYEFLVGI----PPFHGETPEEIFQNILNGKIEW 220
Query: 918 VLSMIKSNKAQD 929
+ S++A D
Sbjct: 221 PEDVEVSDEAID 232
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLL 763
+IG G G VYKA + +VA+K + D + +++ E ++L + H NI
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILRKYSNHPNIATFY 69
Query: 764 G-YLHNETNVM-----MVYDYMPNDSLGEALHG-KEAGKLLV-DWVSRYNIAVGIAQGLN 815
G ++ +V + S+ + + G ++ GK L +W++ Y I +GL
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-Y-ILRETLRGLA 127
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE- 874
YLH + VIHRDIK NILL N E ++ DFG++ + + G+ ++APE
Sbjct: 128 YLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184
Query: 875 ----YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
D +SD++S G+ +EL GK PL
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-18
Identities = 56/201 (27%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G G+V K + H+P ++ +KL + + + RE+ +L IV G
Sbjct: 13 LGAGNGGVVTKVQ-HKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+++ + + ++M SL + L KEA ++ + + + +IAV +GL YL Q +
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAV--LRGLAYLREKHQ--I 125
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKS 885
+HRD+K +NIL+++ E ++ DFG++ ++ + + G+ Y++PE +S
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 886 DIYSFGVVLLELLTGKMPLDP 906
DI+S G+ L+EL G+ P+ P
Sbjct: 184 DIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 54/227 (23%)
Query: 706 IGMGGNGIVYKAEFHRP-HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH-RNIVRLL 763
+G G G+V K H P ++AVK++ + N E L ++ + R V
Sbjct: 9 LGRGAYGVVDKMR-HVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFY 66
Query: 764 GYLHNETNV---MMVYD----------YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGI 810
G L E +V M V D Y ++ E + GK IAV I
Sbjct: 67 GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK--------------IAVSI 112
Query: 811 AQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMV----AG 866
+ L YLH + VIHRD+K +N+L++ N + ++ DFG++ ++ S+ AG
Sbjct: 113 VKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD-----SVAKTIDAG 165
Query: 867 SYGYIAPE--------YGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
Y+APE GY D KSD++S G+ ++EL TG+ P D
Sbjct: 166 CKPYMAPERINPELNQKGY----DVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGD---DLFREVSLLGRLRHRNIVRL 762
+G G G VYKA+ + A K + IES + D E+ +L +H NIV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII-----QIESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAG--KLLVDWVSRYNIAVGIAQGLNYLHHD 820
E + ++ ++ +L + E G + + +V R + + LN+LH
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ-----MLEALNFLHSH 122
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY--GYT 878
VIHRD+K+ NILL + + ++ADFG++ + G+ ++APE T
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 879 LK---VDEKSDIYSFGVVLLELLTGKMP 903
K D K+DI+S G+ L+EL + P
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 4e-18
Identities = 71/237 (29%), Positives = 110/237 (46%), Gaps = 33/237 (13%)
Query: 687 QRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR 746
Q +N T E+ ++ +G G G V A R VA+KKL+R +R
Sbjct: 4 QEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY---MPNDSLGEALHGKEAGKLL-VDWVS 802
E+ LL ++H N++ LL + ++ +D+ MP G + GKL+ + +S
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP-------FMGTDLGKLMKHEKLS 116
Query: 803 RYNIAVGIAQ---GLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859
I + Q GL Y+H +IHRD+K N+ ++ + E +I DFGLAR +
Sbjct: 117 EDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDS 170
Query: 860 TVSMVAGSYGYIAPE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS 911
++ + Y APE YT V DI+S G ++ E+LTGK P F G
Sbjct: 171 EMTGYVVTRWYRAPEVILNWMHYTQTV----DIWSVGCIMAEMLTGK----PLFKGH 219
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 65/217 (29%), Positives = 118/217 (54%), Gaps = 30/217 (13%)
Query: 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHR 757
+K +G G G V+ A +++ H VAVK + +E+ E +++ L+H
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHD 61
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQG 813
+V+L + E + ++ ++M SL + L E K L+D+ ++ IA+G
Sbjct: 62 KLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEG 114
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY--GYI 871
+ ++ Q IHRD+++ NIL+ A+L +IADFGLAR ++ NE + + +
Sbjct: 115 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWT 170
Query: 872 APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
APE +G +T+ KSD++SFG++L+E++T G++P
Sbjct: 171 APEAINFGSFTI----KSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 28/231 (12%)
Query: 706 IGMGGNGIVYKAEFHRPHMV---VAVKKLWRSDNDIESG-DDLFREVSLLGRLRHRNIVR 761
+G G G V K + VAVK L I +G + RE S++ +L H IVR
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTL--KQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
L+G E +M+V + P L + L + L + + +A G+ YL
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLE- 112
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV-SMVAGSY--GYIAPEYG 876
+HRD+ + N+LL +A+I+DFG++R + ++ + AG + + APE
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 877 YTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNK 926
K KSD++S+GV L E + G P +G K V++M++S +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKP----YGEMKGAE--VIAMLESGE 215
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G G +Y A+ +K++ + ++ + +EV LL +++H NIV
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKL-----LVDWVSRYNIAVGIAQGLNYLHH 819
+ +V +Y L + ++ ++ G L ++ W V I+ GL ++H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRIN-RQRGVLFSEDQILSWF------VQISLGLKHIH- 118
Query: 820 DCQPPVIHRDIKSNNILLDAN-LEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYT 878
++HRDIKS NI L N + A++ DFG+AR + E G+ Y++PE
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 879 LKVDEKSDIYSFGVVLLELLTGKMPLD 905
+ K+DI+S G VL EL T K P +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 28/225 (12%)
Query: 691 FTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSL 750
FT+ ++ K+ IG G G V K ++AVK++ RS D + L ++ +
Sbjct: 1 FTAEDL----KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDV 55
Query: 751 LGRLRH-RNIVRLLGYLHNETNVMMVYDYMPN--DSLGEALHGKEAGKLLVDWVSRYNIA 807
+ R IV+ G L E + + + M D + ++ + + + + IA
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK--IA 113
Query: 808 VGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV--SMVA 865
V + LNYL + + +IHRD+K +NILLD N ++ DFG++ +++ + A
Sbjct: 114 VATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDA 168
Query: 866 GSYGYIAPEY-------GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
G Y+APE GY D +SD++S G+ L E+ TGK P
Sbjct: 169 GCRPYMAPERIDPSARDGY----DVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 67/241 (27%), Positives = 107/241 (44%), Gaps = 57/241 (23%)
Query: 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF--REVSLLGRLR--- 755
+E IG G G VYKA VA+KK+ R E G L RE++LL +L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLS-EEGIPLSTLREIALLKQLESFE 59
Query: 756 HRNIVRLLG-----YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRY------ 804
H NIVRLL E + +V++++ D L ++S+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD--------------LATYLSKCPKPGLP 105
Query: 805 -----NIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859
++ + +G+++LH ++HRD+K NIL+ ++ + +IADFGLAR+ +
Sbjct: 106 PETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA 162
Query: 860 TVSMVAGSYGYIAPE------YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKD 913
S+V + Y APE Y + D++S G + EL P F G+ +
Sbjct: 163 LTSVVVTLW-YRAPEVLLQSSYATPV------DMWSVGCIFAELFR----RRPLFRGTSE 211
Query: 914 I 914
Sbjct: 212 A 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 11/146 (7%)
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
+ +L ++ + +V +Y+ + K G L DW +Y + G+ L
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDL 113
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGY 877
H +IHRDIK N+L+D ++ DFGL+R L + V G+ Y+APE
Sbjct: 114 HQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV----GTPDYLAPETIL 166
Query: 878 TLKVDEKSDIYSFGVVLLELLTGKMP 903
+ D+ SD +S G V+ E L G P
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 58/192 (30%), Positives = 87/192 (45%), Gaps = 31/192 (16%)
Query: 726 VAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLG 785
VAVK L R D + +D +EV +L RL NI RLLG + + M+ +YM N L
Sbjct: 49 VAVKVL-RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 786 EALHGKEA-------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD 838
+ L A + + + +A IA G+ YL +HRD+ + N L+
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVG 164
Query: 839 ANLEARIADFGLARMMLHKNETVSMVAGSYGYI-----------APEYGYTLKVDEKSDI 887
N +IADFG++R ++ + Y + A E K KSD+
Sbjct: 165 KNYTIKIADFGMSR---------NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215
Query: 888 YSFGVVLLELLT 899
++FGV L E+LT
Sbjct: 216 WAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 9e-18
Identities = 72/250 (28%), Positives = 115/250 (46%), Gaps = 44/250 (17%)
Query: 706 IGMGGNGIVYKAEF--HRPHMVVAVKKLWRSDNDIESGDDL--FREVSLLGRLRHRNIVR 761
IG G G VYKA+ + A+KK + D + +G RE++LL L+H N+V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 762 LLGYL--HNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
L+ H + +V +++DY +D ++A ++ + ++ I G++YLH
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 820 DCQPPVIHRDIKSNNILLDANLEAR----IADFGLARM-------MLHKNETVSMVAGSY 868
+ V+HRD+K NIL+ R I D GLAR+ + + V +
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV----TI 179
Query: 869 GYIAPE--YG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923
Y APE G YT + DI++ G + ELLT L+P F G + + K
Sbjct: 180 WYRAPELLLGARHYTKAI----DIWAIGCIFAELLT----LEPIFKGREA------KIKK 225
Query: 924 SNKAQDEALD 933
SN Q + L+
Sbjct: 226 SNPFQRDQLE 235
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-17
Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 9/217 (4%)
Query: 687 QRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR 746
Q LN T E+ + + +G G G V A + + VAVKKL R I +R
Sbjct: 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 65
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETNVMMVYD-YMPNDSLGEALHGKEAGKLLVDWVSRYN 805
E+ LL ++H N++ LL ++ D Y+ +G L+ + L D ++
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 806 IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA 865
I I +GL Y+H +IHRD+K +N+ ++ + E +I DFGLAR H ++ ++
Sbjct: 126 I-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV 178
Query: 866 GSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGK 901
+ Y APE + ++ DI+S G ++ ELLTG+
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 704 NIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
+IG G G VY + AVK L R D+E + +E ++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 761 RLLGY-LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
LLG L +E + ++V YM + L + + + D + + +A+G+ YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG---FGLQVAKGMEYL-- 114
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG-----YIAPE 874
+HRD+ + N +LD + ++ADFGLAR + K E S+ + ++A E
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK-EYYSVHNHTGAKLPVKWMALE 172
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
T K KSD++SFGV+L EL+T P
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 18/171 (10%)
Query: 740 SGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL--- 796
S + +E ++ +LRH +V+L + E + +V +YM SL + L G+ L
Sbjct: 44 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLP 102
Query: 797 -LVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855
LVD ++ + + +NY +HRD+++ NIL+ NL ++ADFGLAR ++
Sbjct: 103 QLVDMAAQIASGMAYVERMNY---------VHRDLRAANILVGENLVCKVADFGLAR-LI 152
Query: 856 HKNETVSMVAGSY--GYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
NE + + + APE + KSD++SFG++L EL T G++P
Sbjct: 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-17
Identities = 54/201 (26%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G G+V+K H+P ++ +KL + + + RE+ +L IV G
Sbjct: 13 LGAGNGGVVFKVS-HKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+++ + + ++M SL + L K+AG++ + + +IAV +GL YL + +
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAV--IKGLTYLRE--KHKI 125
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKS 885
+HRD+K +NIL+++ E ++ DFG++ ++ + + G+ Y++PE +S
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 886 DIYSFGVVLLELLTGKMPLDP 906
DI+S G+ L+E+ G+ P+ P
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 70/218 (32%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G G+VYKA + +A+KK+ D RE+SLL ++H NIVRL
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGK-LLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+H+E + +V++Y+ D + K + Y I GIA Y H
Sbjct: 70 VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCHSH---R 122
Query: 825 VIHRDIKSNNILLDANLEA-RIADFGLARMMLHKNETVSMVAGSYGYIAPE-----YGYT 878
V+HRD+K N+L+D A ++ADFGLAR T + + Y APE Y+
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182
Query: 879 LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVE 916
V DI+S G + E++ K P F G +I E
Sbjct: 183 TPV----DIWSVGCIFAEMVNQK----PLFPGDSEIDE 212
|
Length = 294 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 73/296 (24%), Positives = 131/296 (44%), Gaps = 56/296 (18%)
Query: 706 IGMGGNGIVYKAEF-----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
IG G G V++A + P +VAVK L + + + D RE +L+ H NIV
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDHPNIV 71
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEA------------------GKLLVDWVS 802
+LLG + ++++YM L E L + L +
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 803 RYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM-------L 855
+ IA +A G+ YL + +HRD+ + N L+ N+ +IADFGL+R +
Sbjct: 132 QLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIV 915
+N+ + + ++ PE + + +SD++++GVVL E+ + M P +G +
Sbjct: 189 SENDAIPI-----RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM--QPYYGMAH--- 238
Query: 916 EWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
E V+ ++ D ++ + E+ ++R LC +KLP RP+ +
Sbjct: 239 EEVIYYVR---------DGNVLSCPDNCPLELYNLMR---LCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI 759
+ IG G G+V+ + V A+K + S +D E ++ +L H +
Sbjct: 6 LTLVQEIGSGQFGLVWLGYWLEKRKV-AIKTIREG---AMSEEDFIEEAQVMMKLSHPKL 61
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALH---GKEAGKLLVDWVSRYNIAVGIAQGLNY 816
V+L G + + +V+++M + L + L GK + + L+ + + + +G+ Y
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLG------MCLDVCEGMAY 115
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS---YGYIAP 873
L VIHRD+ + N L+ N +++DFG+ R +L T S G+ + +P
Sbjct: 116 LESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS--TGTKFPVKWSSP 170
Query: 874 EYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLD 905
E K KSD++SFGV++ E+ + GK P +
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 72/221 (32%), Positives = 105/221 (47%), Gaps = 32/221 (14%)
Query: 706 IGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
+G G G V+ AE H + M+VAVK L + + D RE LL L+H++IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTVLQHQHIV 70
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEA-----------GKLLVDWVSRYNIA 807
R G ++MV++YM + L L HG +A G+L + + IA
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM--LAIA 128
Query: 808 VGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS 867
IA G+ YL +HRD+ + N L+ L +I DFG++R + + V G
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD--YYRVGGR 183
Query: 868 ----YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
++ PE K +SDI+SFGVVL E+ T GK P
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 27/190 (14%)
Query: 732 WRSDNDIE---------SGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPN- 781
WR D+ S D+ E ++ +L H +V+L G + + +V +YM N
Sbjct: 25 WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84
Query: 782 ---DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD 838
+ L E + +LL + + +G+ YL IHRD+ + N L+D
Sbjct: 85 CLLNYLREHGKRFQPSQLL-------EMCKDVCEGMAYLE---SKQFIHRDLAARNCLVD 134
Query: 839 ANLEARIADFGLARMMLHKNETVSMVAGSY--GYIAPEYGYTLKVDEKSDIYSFGVVLLE 896
+++DFGL+R +L +E S V + + PE K KSD+++FGV++ E
Sbjct: 135 DQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWE 193
Query: 897 LLT-GKMPLD 905
+ + GKMP +
Sbjct: 194 VYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 33/199 (16%)
Query: 720 HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779
+P +V AVK L R+D + +D +E+ ++ RL++ NI+RLLG ++ + M+ +YM
Sbjct: 42 GQPVLV-AVKML-RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYM 99
Query: 780 PNDSLGEALHGKEAGKLL-----VDWVSRYNI---AVGIAQGLNYLHHDCQPPVIHRDIK 831
N L + L +E + VS N+ AV IA G+ YL +HRD+
Sbjct: 100 ENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLA 156
Query: 832 SNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY-----------GYIAPEYGYTLK 880
+ N L+ + +IADFG++R ++ +G Y ++A E K
Sbjct: 157 TRNCLVGNHYTIKIADFGMSR---------NLYSGDYYRIQGRAVLPIRWMAWESILLGK 207
Query: 881 VDEKSDIYSFGVVLLELLT 899
SD+++FGV L E+ T
Sbjct: 208 FTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 68/215 (31%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLG 764
+G G G VY A +VA+KK+ + E +L REV L +L H NIV+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPNIVKLKE 65
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+ V++YM + L GK + V R +I I QGL ++H
Sbjct: 66 VFRENDELYFVFEYMEGNLYQ--LMKDRKGKPFSESVIR-SIIYQILQGLAHIHKH---G 119
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY-----GYTL 879
HRD+K N+L+ +IADFGLAR + + V+ + Y APE Y+
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRW-YRAPEILLRSTSYSS 178
Query: 880 KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
V DI++ G ++ EL T + P F GS +I
Sbjct: 179 PV----DIWALGCIMAELYTLR----PLFPGSSEI 205
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG- 764
+G G G+V K HRP ++ +KL + + + RE+ +L IV G
Sbjct: 9 LGAGNGGVVTKVL-HRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 765 -YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
Y E ++ M ++M SL + L K+AG++ + + + +IAV +GL YL +
Sbjct: 68 FYSDGEISICM--EHMDGGSLDQVL--KKAGRIPENILGKISIAV--LRGLTYLREKHK- 120
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
++HRD+K +NIL+++ E ++ DFG++ L + S V G+ Y++PE
Sbjct: 121 -IMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFV-GTRSYMSPERLQGTHYTV 177
Query: 884 KSDIYSFGVVLLELLTGKMPLDP 906
+SDI+S G+ L+E+ G+ P+ P
Sbjct: 178 QSDIWSLGLSLVEMAIGRYPIPP 200
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 7/201 (3%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G G G VYK + + A+K++ S + E D + E+ +L + H NI+
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHPNIISYKE 66
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+ + +V +Y P L +A+ ++ + L+ + I + + +GL LH +
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQK 123
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEK 884
++HRD+KS NILL AN +I D G+++++ K G+ Y+APE K
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQIGTPHYMAPEVWKGRPYSYK 181
Query: 885 SDIYSFGVVLLELLTGKMPLD 905
SDI+S G +L E+ T P +
Sbjct: 182 SDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 65/185 (35%), Positives = 91/185 (49%), Gaps = 23/185 (12%)
Query: 725 VVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG--YLHNETNVMMVYDYMPND 782
VVAVKKL S E D RE+ +L L+H NIV+ G Y N+ +V +Y+P
Sbjct: 35 VVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 783 SLGEAL----HGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD 838
SL + L + KLL+ A I +G+ YL +HRD+ + NIL++
Sbjct: 93 SLRDYLQKHRERLDHRKLLL-------YASQICKGMEYLG---SKRYVHRDLATRNILVE 142
Query: 839 ANLEARIADFGLARMMLHKNE--TVSMVAGS--YGYIAPEYGYTLKVDEKSDIYSFGVVL 894
+ +I DFGL +++ E V S + Y APE K SD++SFGVVL
Sbjct: 143 SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVL 201
Query: 895 LELLT 899
EL T
Sbjct: 202 YELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 18/201 (8%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IIG G G V + E+ VAVK + + D ++ E +++ +L H+N+VRLLG
Sbjct: 13 IIGEGEFGAVLQGEYTGQK--VAVKNI-KCDVTAQA---FLEETAVMTKLHHKNLVRLLG 66
Query: 765 Y-LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
LHN ++M + M +L L + G+ LV + ++ +A+G+ YL
Sbjct: 67 VILHNGLYIVM--ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLE---SK 119
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
++HRD+ + NIL+ + A+++DFGLAR+ + + + APE K
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL---PVKWTAPEALKHKKFSS 176
Query: 884 KSDIYSFGVVLLELLT-GKMP 903
KSD++S+GV+L E+ + G+ P
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD---LFREVSLLGRLRHR 757
+ ++G G G VY +AVK++ + E+ + L E+ LL L+H
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
IV+ G L ++ + + +YMP S+ + L K G L +Y I +G+ YL
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQ--ILEGVEYL 120
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM--LHKNET-VSMVAGSYGYIAPE 874
H + ++HRDIK NIL D+ ++ DFG ++ + + + T + V G+ +++PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 875 ------YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
YG K+D++S G ++E+LT K P
Sbjct: 178 VISGEGYG------RKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 75/273 (27%), Positives = 128/273 (46%), Gaps = 39/273 (14%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVK--KLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G V+K +R VVA+K L ++++IE D+ +E+++L + + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE---DIQQEITVLSQCDSPYVTKYY 68
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAV---GIAQGLNYLHHD 820
G T + ++ +Y+ G AL AG + IA I +GL+YLH +
Sbjct: 69 GSYLKGTKLWIIMEYLGG---GSALDLLRAGPF-----DEFQIATMLKEILKGLDYLHSE 120
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLK 880
+ IHRDIK+ N+LL + ++ADFG+A + + G+ ++APE
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEW-VLSMIKSNKAQDEALDPSIAGQ 939
D K+DI+S G+ +EL G+ P + D+ VL +I N P++ G+
Sbjct: 178 YDSKADIWSLGITAIELAKGEPP-------NSDMHPMRVLFLIPKNNP------PTLTGE 224
Query: 940 CKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
+E + C K P RPT ++++
Sbjct: 225 FSKPFKEFIDA------CLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 706 IGMGGNGIVYKAEFH-RPHMVVAVKKLW---------RSDNDIESGDDLFREVSLLG-RL 754
+G G G VYK ++A+K++ + + D +S D+ EV+++ +L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERD-KSIGDIVSEVTIIKEQL 66
Query: 755 RHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHG-KEAGKLLVD---WVSRYNIAVGI 810
RH NIVR + +V D + LGE + KE + + W NI V +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW----NIFVQM 122
Query: 811 AQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGY 870
L YLH + + ++HRD+ NNI+L + + I DFGLA+ ++ V G+ Y
Sbjct: 123 VLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQK-QPESKLTSVVGTILY 179
Query: 871 IAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAF 908
PE EK+D+++FG +L ++ T L P F
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCT----LQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 36/210 (17%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G G VYK + + VAVK RS + +E +L + H NIV+L+G
Sbjct: 3 IGKGNFGDVYKGVL-KGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAG----KLLVDWVSRYNIAVGIAQGLNYLHHDC 821
+ + +V + +P SL L K+ KLL +++ A G+ YL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL-------QMSLDAAAGMEYLESKN 113
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG-------YIAPE 874
IHRD+ + N L+ N +I+DFG++R E + S G + APE
Sbjct: 114 ---CIHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPE 165
Query: 875 ---YG-YTLKVDEKSDIYSFGVVLLELLTG 900
YG YT +SD++S+G++L E +
Sbjct: 166 ALNYGRYT----SESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
N IG G G VYK HRP + K+ +++ + RE+ +L + H N+V+
Sbjct: 80 NRIGSGAGGTVYKV-IHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
+ + ++ ++M SL E L D +A I G+ YLH +
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQ--FLAD------VARQILSGIAYLH---RR 187
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
++HRDIK +N+L+++ +IADFG++R++ + + G+ Y++PE T
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247
Query: 884 K-----SDIYSFGVVLLELLTGKMPL 904
DI+S GV +LE G+ P
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 73/244 (29%), Positives = 119/244 (48%), Gaps = 30/244 (12%)
Query: 697 LACVKESNIIGMGGNGIVYKAEFHRPHM----VVAVKKLWRSDNDIESGDDLFREVSLLG 752
L+ V+ +G G +YK + P M +VA+K L + N+ + + +E SL+
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEASLMA 62
Query: 753 RLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEAL-----------HGKEAG--KLLVD 799
L H NIV LLG + E V M+++Y+ L E L E G K +D
Sbjct: 63 ELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122
Query: 800 WVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM----L 855
+IA+ IA G+ YL +H+D+ + NIL+ L +I+D GL+R +
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADY 179
Query: 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS-KDI 914
++ + S++ ++ PE K SDI+SFGVVL E+ + L P +G S +++
Sbjct: 180 YRVQPKSLL--PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS--FGLQPYYGFSNQEV 235
Query: 915 VEWV 918
+E V
Sbjct: 236 IEMV 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 64/187 (34%), Positives = 97/187 (51%), Gaps = 25/187 (13%)
Query: 726 VAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLG 785
VAVK L ES E ++ +LRH +V+L + E + +V +YM SL
Sbjct: 33 VAVKTLKPGTMSPES---FLEEAQIMKKLRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLL 88
Query: 786 EALHGKEAGKL----LVDWVSRYNIAVGIA--QGLNYLHHDCQPPVIHRDIKSNNILLDA 839
+ L E L LVD ++ +A G+A + +NY IHRD++S NIL+
Sbjct: 89 DFLKDGEGRALKLPNLVDMAAQ--VAAGMAYIERMNY---------IHRDLRSANILVGD 137
Query: 840 NLEARIADFGLARMMLHKNETVSMVAGSY--GYIAPEYGYTLKVDEKSDIYSFGVVLLEL 897
L +IADFGLAR ++ NE + + + APE + KSD++SFG++L EL
Sbjct: 138 GLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 898 LT-GKMP 903
+T G++P
Sbjct: 197 VTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 75/222 (33%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRS-DNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G GIV A+ + VA+KK+ + DN I++ L RE+ LL L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL-REIKLLRHLDHENVIAIKD 71
Query: 765 YL---HNET--NVMMVYDYMPNDSLGEALHG-KEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
+ H E +V +VY+ M D LH + + L D +Y + + +GL Y+H
Sbjct: 72 IMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFL-YQLLRGLKYIH 125
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY--- 875
V+HRD+K +N+LL+AN + +I DFGLAR K + ++ + Y APE
Sbjct: 126 ---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 876 --GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIV 915
YT + D++S G + ELL K P F G KD V
Sbjct: 183 CSEYTTAI----DVWSVGCIFAELLGRK----PLFPG-KDYV 215
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 7/204 (3%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
++G G GIV+ +V +K++ + E +L L H NI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+ +M+V +Y P +L E + + L D + + + + +A LHH
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA-----LHHVHTKL 121
Query: 825 VIHRDIKSNNILLDAN-LEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
++HRD+K+ NILLD + + +I DFG+++++ K++ V G+ YI+PE ++
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA-YTVVGTPCYISPELCEGKPYNQ 180
Query: 884 KSDIYSFGVVLLELLTGKMPLDPA 907
KSDI++ G VL EL + K + A
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 18/180 (10%)
Query: 730 KLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALH 789
+L +S + +E +E LL +++H NIV + ++ +V +Y L + +
Sbjct: 34 RLPKSSSAVEDSR---KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIK 90
Query: 790 GKEAGKL-----LVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEAR 844
+ GKL ++ W V + G+ ++H + V+HRDIKS NI L N + +
Sbjct: 91 -LQRGKLFPEDTILQWF------VQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVK 140
Query: 845 IADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
+ DFG AR++ G+ Y+ PE + + KSDI+S G +L EL T K P
Sbjct: 141 LGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 3e-16
Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 9/217 (4%)
Query: 687 QRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR 746
Q LN T E+ + +G G G V A R VAVKKL R + +R
Sbjct: 4 QELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR 63
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETNVMMVYD-YMPNDSLGEALHGKEAGKLLVDWVSRYN 805
E+ LL ++H N++ LL T++ + Y+ + +G L+ + L D ++
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123
Query: 806 IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA 865
I + +GL Y+H +IHRD+K +N+ ++ + E RI DFGLAR +E VA
Sbjct: 124 I-YQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQA--DDEMTGYVA 177
Query: 866 GSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGK 901
+ Y APE + ++ DI+S G ++ ELL GK
Sbjct: 178 TRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G V+K +VA+K++ R +++ + REVSLL L+H NIV L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQ---GLNYLHHDCQ 822
+H E + +V++Y+ +D L + L G L+ S +N+ + + Q GL+Y H
Sbjct: 72 IHTERCLTLVFEYLDSD-LKQYL--DNCGNLM----SMHNVKIFMFQLLRGLSYCHKR-- 122
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD 882
++HRD+K N+L++ E ++ADFGLAR +T S + Y P+ L
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD--VLLGST 179
Query: 883 EKS---DIYSFGVVLLELLTGKMPLDPAFGGS 911
E S D++ G +L E+ TG+ P F GS
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR----PMFPGS 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 44/164 (26%), Positives = 83/164 (50%), Gaps = 5/164 (3%)
Query: 742 DDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWV 801
D E+ +L L+H NI+ + ++ +++ +Y +L + + ++ + V
Sbjct: 44 RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMV 103
Query: 802 SRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861
Y I ++Y+H + ++HRDIK+ NI L ++ DFG+++++ +
Sbjct: 104 LWYLFQ--IVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158
Query: 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
V G+ Y++PE +K + KSDI++ G VL ELLT K D
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-16
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G G VYK HRP V K R + D + + E+ +L + IV G
Sbjct: 9 LGKGNYGSVYKV-LHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
E V M +YM SL + G A + + + V R I + +GL +L + +
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR-ITYAVVKGLKFLKEEHN--I 124
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY---------- 875
IHRD+K N+L++ N + ++ DFG++ ++ ++ G Y+APE
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI--GCQSYMAPERIKSGGPNQNP 182
Query: 876 GYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
YT+ +SD++S G+ +LE+ G+ P P
Sbjct: 183 TYTV----QSDVWSLGLSILEMALGRYPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-16
Identities = 42/90 (46%), Positives = 57/90 (63%), Gaps = 2/90 (2%)
Query: 166 SLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGE 225
LD +G G +P L+ L+ + LSGN++ G IPP LG ++SLE + L YN+F G
Sbjct: 424 GLDNQG--LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 226 IPAEFGNLTNLRYLDLAVGSLSGQIPPALG 255
IP G LT+LR L+L SLSG++P ALG
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 8e-16
Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 21/211 (9%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G VYK +VA+K++ R +++ + REVSLL L+H NIV L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQ---GLNYLHHDCQ 822
+H E ++ +V++Y+ D L + L + G ++ +N+ + + Q GLNY H +
Sbjct: 73 IHTEKSLTLVFEYLDKD-LKQYL--DDCGNS----INMHNVKLFLFQLLRGLNYCH---R 122
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE--YGYTLK 880
V+HRD+K N+L++ E ++ADFGLAR +T S + Y P+ G T
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST-D 181
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLDPAFGGS 911
+ D++ G + E+ TG+ P F GS
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR----PLFPGS 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 66/270 (24%), Positives = 117/270 (43%), Gaps = 19/270 (7%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G VY+A + VA+KK+ D D ++ D +E+ LL +L H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+ + +V + L + + K L+ + + V + L ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRR 126
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEK 884
V+HRDIK N+ + A ++ D GL R K + G+ Y++PE + + K
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 885 SDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQ 944
SDI+S G +L E+ + P +G ++ S+ K + D PS H
Sbjct: 187 SDIWSLGCLLYEMAALQSPF---YGDKMNL----YSLCKKIEQCDYPPLPS-----DHYS 234
Query: 945 EEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974
EE+ ++ +C P+ RP + V +
Sbjct: 235 EEL---RQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-15
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 40/204 (19%)
Query: 721 RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMP 780
RP ++VAVK L R D + + +D +EV +L RL+ NI+RLLG +E + M+ +YM
Sbjct: 45 RP-LLVAVKIL-RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYME 102
Query: 781 NDSLGEALH---------------GKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
N L + L + + S ++A+ IA G+ YL
Sbjct: 103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNF 159
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY-----------GYIAPE 874
+HRD+ + N L+ NL +IADFG++R ++ AG Y ++A E
Sbjct: 160 VHRDLATRNCLVGENLTIKIADFGMSR---------NLYAGDYYRIQGRAVLPIRWMAWE 210
Query: 875 YGYTLKVDEKSDIYSFGVVLLELL 898
K SD+++FGV L E+L
Sbjct: 211 CILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 31/194 (15%)
Query: 724 MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDS 783
++VAVK L R D + + +D +E+ ++ RL+ NI+RLL + M+ +YM N
Sbjct: 47 VLVAVKML-REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 784 LGEAL-------HGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNIL 836
L + L ++A + + + + +A IA G+ YL +HRD+ + N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCL 162
Query: 837 LDANLEARIADFGLARMMLHKNETVSMVAGSY-----------GYIAPEYGYTLKVDEKS 885
+ N +IADFG++R ++ +G Y +++ E K S
Sbjct: 163 VGKNYTIKIADFGMSR---------NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS 213
Query: 886 DIYSFGVVLLELLT 899
D+++FGV L E+LT
Sbjct: 214 DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 62/237 (26%), Positives = 93/237 (39%), Gaps = 52/237 (21%)
Query: 705 IIGMGGNGIVYKAEF-----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRN 758
+G G G V KAE VAVK L + + D L E+ ++ + +H+N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHKN 77
Query: 759 IVRLLG----------------------YLHNETNVMMVYDYMPNDSLGEALHGKEAGKL 796
I+ LLG +L E L
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT------- 130
Query: 797 LVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856
D VS A +A+G+ +L IHRD+ + N+L+ + +IADFGLAR + H
Sbjct: 131 QKDLVS---FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 857 KNETVSMVAGS--YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS 911
+ G ++APE + +SD++SFGV+L E+ T GGS
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--------LGGS 233
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRS----DNDIESGDDLFREVSLLGRLRHRNIV 760
++G G G V AE + A+K L + D+D+E + R V L H +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVEC-TMVERRVLALA-WEHPFLT 59
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
L + ++ V +Y+ L H + +G+ Y A I GL +LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFY--AAEIICGLQFLHKK 115
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLK 880
+I+RD+K +N+LLD + +IADFG+ + ++ S G+ YIAPE K
Sbjct: 116 ---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK 172
Query: 881 VDEKSDIYSFGVVLLELLTGKMP 903
+E D +SFGV+L E+L G+ P
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 49/230 (21%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G VYK +VA+K++ R +++ + RE SLL L+H NIV L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDW----VSRYNIAVGIAQ---GLNYLH 818
+H + + +V++Y+ D K +D +S +N+ + + Q GL Y H
Sbjct: 72 IHTKKTLTLVFEYLDTDL-----------KQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLAR-----MMLHKNETVSM-------VAG 866
V+HRD+K N+L+ E ++ADFGLAR + NE V++ + G
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG 177
Query: 867 SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVE 916
S EY +L D++ G + E+ TG+ P F GS D+ +
Sbjct: 178 S-----TEYSTSL------DMWGVGCIFYEMATGR----PLFPGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 20/166 (12%)
Query: 747 EVSLLGRLRHRNIVRLLGYL--HNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRY 804
E+ LL L+H IV+ G L E + + +YMP S+ + L K G L +Y
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKY 111
Query: 805 NIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM- 863
I +G++YLH + ++HRDIK NIL D+ ++ DFG ++ + +T+ M
Sbjct: 112 TRQ--ILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICMS 162
Query: 864 ------VAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
V G+ +++PE K+D++S G ++E+LT K P
Sbjct: 163 GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-15
Identities = 41/89 (46%), Positives = 54/89 (60%)
Query: 239 LDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEI 298
L L L G IP + +L+ L ++ L N+ G IPP LGSITSL LDLS N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 299 PVKLAELKNLQLLNLMCNQLTGLIPDKLG 327
P L +L +L++LNL N L+G +P LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 21/216 (9%)
Query: 700 VKESNIIGMGGNGIVYKA----EFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
+K ++G G G VYK E + VA+K L + ++ + E ++ +
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP-KANVEFMDEALIMASMD 67
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKE---AGKLLVDWVSRYNIAVGIAQ 812
H ++VRLLG + T + +V MP+ L + +H + +LL++W V IA+
Sbjct: 68 HPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAK 120
Query: 813 GLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY--GY 870
G+ YL + ++HRD+ + N+L+ + +I DFGLAR++ + + G +
Sbjct: 121 GMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 871 IAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLD 905
+A E + K +SD++S+GV + EL+T G P D
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 70/228 (30%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 700 VKESNII-----GMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVS 749
+K NI+ G G G V+ AE + + ++VAVK L D + D RE
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAE 59
Query: 750 LLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLL-------VDW 800
LL L+H +IV+ G ++MV++YM + L + L HG +A + +
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 801 VSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860
+IA IA G+ YL +HRD+ + N L+ NL +I DFG++R + +
Sbjct: 120 SQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-- 174
Query: 861 VSMVAG----SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
V G ++ PE K +SD++S GVVL E+ T GK P
Sbjct: 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 13/205 (6%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWR----SDNDIESGDDLFREVSLLGRLRHRNIV 760
++G G G V AE + AVK L + D+D+E R ++L G+ H +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFLT 59
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
+L + + V +Y+ L H + +G+ Y A I GL +LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFY--AAEIVLGLQFLH-- 113
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLK 880
+ +I+RD+K +N+LLD+ +IADFG+ + + T S G+ YIAPE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP 172
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLD 905
D ++ GV+L E+L G+ P +
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-15
Identities = 56/190 (29%), Positives = 95/190 (50%), Gaps = 12/190 (6%)
Query: 715 YKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE--TNV 772
Y E VAVK L + ++ DL +E+ +L L H NIV+ G + +
Sbjct: 25 YDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83
Query: 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKS 832
++ +++P+ SL E L + K+ + +Y AV I +G++YL +HRD+ +
Sbjct: 84 KLIMEFLPSGSLKEYL-PRNKNKINLKQQLKY--AVQICKGMDYLG---SRQYVHRDLAA 137
Query: 833 NNILLDANLEARIADFGLARMMLHKNETVSM---VAGSYGYIAPEYGYTLKVDEKSDIYS 889
N+L+++ + +I DFGL + + E ++ + + APE K SD++S
Sbjct: 138 RNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWS 197
Query: 890 FGVVLLELLT 899
FGV L ELLT
Sbjct: 198 FGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 69/231 (29%), Positives = 101/231 (43%), Gaps = 43/231 (18%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+IG G G+V A VA+KK+ + + RE+ LL LRH +IV +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 765 YL----HNE-TNVMMVYDYM---------PNDSLGEALHGKEAGKLLVDWVSRYNIAVGI 810
+ E ++ +V++ M ND L H +LL
Sbjct: 67 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL------------- 113
Query: 811 AQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET----VSMVAG 866
+ L Y+H V HRD+K NIL +A+ + +I DFGLAR+ + T VA
Sbjct: 114 -RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169
Query: 867 SYGYIAPEY--GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIV 915
+ Y APE + K DI+S G + E+LTGK P F G K++V
Sbjct: 170 RW-YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK----PLFPG-KNVV 214
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-15
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G GIV A + VAVKKL R + +RE+ LL + H+NI+ LL
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 766 ------LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
L +V +V + M + +L + +H + +D + + G+ +LH
Sbjct: 89 FTPQKSLEEFQDVYLVMELM-DANLCQVIH------MELDHERMSYLLYQMLCGIKHLH- 140
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL 879
+IHRD+K +NI++ ++ +I DFGLAR V Y Y APE +
Sbjct: 141 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-YRAPEVILGM 197
Query: 880 KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEW 917
E DI+S G ++ EL+ G + F G+ I +W
Sbjct: 198 GYKENVDIWSVGCIMGELVKGSV----IFQGTDHIDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-15
Identities = 70/251 (27%), Positives = 117/251 (46%), Gaps = 46/251 (18%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRL--- 762
+G G NG+V+ A VAVKK+ +D +S RE+ ++ RL H NIV++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 763 -----------LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIA 811
+G L +V +V +YM D L L E G L + + +
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVL---EQGPLSEEHARLF--MYQLL 124
Query: 812 QGLNYLHHDCQPPVIHRDIKSNNILLDA-NLEARIADFGLARMM----LHKNETVSMVAG 866
+GL Y+H V+HRD+K N+ ++ +L +I DFGLAR++ HK +S
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY-LSEGLV 180
Query: 867 SYGYIAPEY-----GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI--VEWVL 919
+ Y +P YT + D+++ G + E+LTGK P F G+ ++ ++ +L
Sbjct: 181 TKWYRSPRLLLSPNNYT----KAIDMWAAGCIFAEMLTGK----PLFAGAHELEQMQLIL 232
Query: 920 SMIKSNKAQDE 930
+ + +D
Sbjct: 233 ESVPVVREEDR 243
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 53/166 (31%), Positives = 84/166 (50%), Gaps = 20/166 (12%)
Query: 747 EVSLLGRLRHRNIVRLLGYL--HNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRY 804
E+ LL LRH IV+ G L E + + +YMP S+ + L K G L + RY
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRY 111
Query: 805 NIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM- 863
I QG++YLH + ++HRDIK NIL D+ ++ DFG ++ + +T+ M
Sbjct: 112 TRQ--ILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI----QTICMS 162
Query: 864 ------VAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
V G+ +++PE K+D++S ++E+LT K P
Sbjct: 163 GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 71/233 (30%), Positives = 112/233 (48%), Gaps = 52/233 (22%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-----REVSLLGRLRHRN 758
N I G G+VY+A + +VA+KKL +E + F RE+++L +L+H N
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKL-----KMEKEKEGFPITSLREINILLKLQHPN 65
Query: 759 IVRL----LGYLHNETNVMMVYDYMPND--SLGEALHGK----EAGKLLVDWVSRYNIAV 808
IV + +G N + MV +Y+ +D SL E + E L++ +S
Sbjct: 66 IVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS------ 117
Query: 809 GIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH--KNETVSMVAG 866
G+ +LH + ++HRD+K++N+LL+ +I DFGLAR K T +V
Sbjct: 118 ----GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-- 168
Query: 867 SYGYIAPE--YG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
+ Y APE G Y+ + D++S G + ELLT P F G +I
Sbjct: 169 TLWYRAPELLLGAKEYSTAI----DMWSVGCIFAELLTK----KPLFPGKSEI 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 5e-15
Identities = 48/167 (28%), Positives = 85/167 (50%), Gaps = 20/167 (11%)
Query: 742 DDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEAL-HGKEAGKLLVDW 800
+ + E +L +RH +V L G +++N+ +V +Y+P GE H +++G+
Sbjct: 46 EHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG---GELFSHLRKSGRFPEPV 102
Query: 801 VSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860
Y A + L YLH +++RD+K N+LLD++ +I DFG A+ + + T
Sbjct: 103 ARFY--AAQVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT 157
Query: 861 VSMVAGSYGYIAPEY----GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
+ G+ Y+APE GY V D ++ G+++ E+L G P
Sbjct: 158 LC---GTPEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 70/298 (23%), Positives = 132/298 (44%), Gaps = 49/298 (16%)
Query: 700 VKESNIIGMGGNGIVYKAEFHRP-----HMVVAVKKLW-RSDNDIESGDDLFREVSLLGR 753
++E +G G G V+ A+ +V VK L D +++S + RE+ + +
Sbjct: 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRK 64
Query: 754 LRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDW-----VSRYNIAV 808
L H+N+VRLLG M+ +Y L + L ++ + + +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 809 GIAQGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR------MMLHKNET 860
IA G+++L +HRD+ + N L+ + E +++ L++ +N
Sbjct: 125 QIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 861 VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVL 919
+ + ++APE KSD++SFGV++ E+ T G++P F G D E VL
Sbjct: 180 IPL-----RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP----FYGLSD--EEVL 228
Query: 920 SMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977
+ +++ K L+ + C + ++ C A PK RP+ ++++ LGE
Sbjct: 229 NRLQAGK-----LELPVPEGCPSR------LYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-15
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRS----DNDIESGDDLFREVSLLGRLRHRNIV 760
++G G G V+ AE + A+K L + D+D+E R +SL H +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL--AWEHPFLT 59
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
L + N+ V +Y+ L H + K + + Y A I GL +LH
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFY--AAEIICGLQFLH-- 113
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLK 880
+++RD+K +NILLD + +IADFG+ + + + G+ YIAPE K
Sbjct: 114 -SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 881 VDEKSDIYSFGVVLLELLTGKMPL 904
+ D +SFGV+L E+L G+ P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 53/163 (32%), Positives = 88/163 (53%), Gaps = 10/163 (6%)
Query: 744 LFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSR 803
+E ++ +LRH +V L + E + +V ++M SL + L KE +
Sbjct: 48 FLQEAQIMKKLRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFL--KEGDGKYLKLPQL 104
Query: 804 YNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM 863
++A IA G+ Y+ + IHRD+++ NIL+ NL +IADFGLAR ++ NE +
Sbjct: 105 VDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLAR-LIEDNEYTAR 160
Query: 864 VAGSY--GYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ + APE + KSD++SFG++L EL+T G++P
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 57/181 (31%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 746 REVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN 805
RE SLL L+H NIV L +H + + V++YM D L + + G + YN
Sbjct: 52 REASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTD-LAQYMIQHPGG------LHPYN 104
Query: 806 IAVGIAQ---GLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVS 862
+ + + Q GL Y+H ++HRD+K N+L+ E ++ADFGLAR ++T S
Sbjct: 105 VRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161
Query: 863 MVAGSYGYIAPE--YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLS 920
+ Y P+ G T DI+ G + +E+L G+ PAF G D+ E +
Sbjct: 162 SEVVTLWYRPPDVLLGAT-DYSSALDIWGAGCIFIEMLQGQ----PAFPGVSDVFEQLEK 216
Query: 921 M 921
+
Sbjct: 217 I 217
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 9e-15
Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 38/224 (16%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI---ESGDDLFREVSLLGRLRHRNIVRL 762
IG G GIV A VAVKK+ D+ + + LF EV ++ +H NIV +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 763 LG-YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN--------IAVGIAQG 813
YL + + +V +++ G L D V+ + + + +
Sbjct: 82 YSSYLVGD-ELWVVMEFL-------------EGGALTDIVTHTRMNEEQIATVCLAVLKA 127
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL-ARMMLHKNETVSMVAGSYGYIA 872
L++LH VIHRDIKS++ILL ++ +++DFG A++ S+V Y ++A
Sbjct: 128 LSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY-WMA 183
Query: 873 PEYGYTLKVDEKSDIYSFGVVLLELLTGKMPL--DPAFGGSKDI 914
PE L + DI+S G++++E++ G+ P +P K I
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-14
Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G G+V+ R VA+KK+ ++ S +FRE+ +L +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 766 LHNE-----TNVMMVYDYMPNDSLGEALHGKEAGKLLVD--WVSRYNIAV---GIAQGLN 815
L + +V + M +D LH K++V +S ++ V I +GL
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSD-----LH-----KIIVSPQPLSSDHVKVFLYQILRGLK 117
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM---VAGSYGYIA 872
YLH ++HRDIK N+L+++N +I DFGLAR+ +E+ M V Y Y A
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE-EPDESKHMTQEVVTQY-YRA 172
Query: 873 PEY-----GYTLKVDEKSDIYSFGVVLLELLTGKM 902
PE YT V DI+S G + ELL ++
Sbjct: 173 PEILMGSRHYTSAV----DIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR---HRNIVRL 762
IG+G G VYKA VA+K + N+ REV+LL RL H NIVRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 763 LGY-----LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
+ ET V +V++++ D L L L + + ++ +GL++L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGLPAETIK--DLMRQFLRGLDFL 124
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGY 877
H +C ++HRD+K NIL+ + + ++ADFGLAR+ + +V + Y APE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW-YRAPEVLL 180
Query: 878 TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKD 913
D++S G + E+ K P F G+ +
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRK----PLFCGNSE 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
++G G G+V K +VA+KK S+ + E + RE+ +L L+ NIV L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+ +V++Y+ + L E L G + + V Y I Q + +H +
Sbjct: 68 AFRRRGKLYLVFEYVEKNML-ELLEEMPNG-VPPEKVRSY-----IYQLIKAIHWCHKND 120
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVD 882
++HRDIK N+L+ N ++ DFG AR + + VA + Y +PE
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPELLLGAPYG 179
Query: 883 EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
+ D++S G +L EL G+ P F G +I
Sbjct: 180 KAVDMWSVGCILGELSDGQ----PLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 20/222 (9%)
Query: 687 QRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR 746
+ +N T E+ +G G G V A R VA+KKL R +R
Sbjct: 4 EEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63
Query: 747 EVSLLGRLRHRNIVRLLGY------LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDW 800
E++LL ++H N++ LL + +V YM D K G L +
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL------QKIMGHPLSED 117
Query: 801 VSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860
+Y + + GL Y+H +IHRD+K N+ ++ + E +I DFGLAR H +
Sbjct: 118 KVQY-LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAE 170
Query: 861 VSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGK 901
++ + Y APE + ++ DI+S G ++ E+LTGK
Sbjct: 171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 29/199 (14%)
Query: 724 MVVAVKKLWRSDNDI---ESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMP 780
M V K+L D DI ++ +F + S H +V L E+ + V +Y+
Sbjct: 25 MKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVIEYVN 79
Query: 781 NDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN 840
L H + KL + Y+ + +A LNYLH + +I+RD+K +N+LLD+
Sbjct: 80 GGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNYLH---ERGIIYRDLKLDNVLLDSE 132
Query: 841 LEARIADFGLARMMLHKNETVSMVAGSYGYIAPE------YGYTLKVDEKSDIYSFGVVL 894
++ D+G+ + L +T S G+ YIAPE YG+++ D ++ GV++
Sbjct: 133 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV------DWWALGVLM 186
Query: 895 LELLTGKMPLDPAFGGSKD 913
E++ G+ P D GS D
Sbjct: 187 FEMMAGRSPFDIV--GSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-14
Identities = 78/292 (26%), Positives = 133/292 (45%), Gaps = 49/292 (16%)
Query: 706 IGMGGNGIVYKAEF-----HRPHMV--VAVKKLWRSDNDIESGDDLFREVSLLGRL-RHR 757
+G G G V AE +P+ V VAVK L +SD + DL E+ ++ + +H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 84
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL------------LVDWVSRYN 805
NI+ LLG + + ++ +Y +L E L + + + + +
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 806 IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA 865
A +A+G+ YL IHRD+ + N+L+ + +IADFGLAR + H +
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 866 GSY--GYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKD---IVEWVLS 920
G ++APE + +SD++SFGV+L E+ T GGS VE +
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGSPYPGVPVEELFK 253
Query: 921 MIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
++K D+ PS C + E+ +++R C +P RPT + ++
Sbjct: 254 LLKEGHRMDK---PS---NCTN---ELYMMMRD---CWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 52/292 (17%)
Query: 706 IGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDD---LFREVSLLGRLRHR 757
+G G G+VY+ P VA+K + N+ S + E S++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTV----NENASMRERIEFLNEASVMKEFNCH 69
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGK-----EAGKLLVDWVSR-YNIAVGIA 811
++VRLLG + ++V + M L L + L + + +A IA
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 812 QGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG-- 869
G+ YL +HRD+ + N ++ +L +I DFG+ R + ET G G
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI---YETDYYRKGGKGLL 183
Query: 870 ---YIAPEYGYTLK---VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923
++APE +LK KSD++SFGVVL E+ T + P G S E VL +
Sbjct: 184 PVRWMAPE---SLKDGVFTTKSDVWSFGVVLWEMAT--LAEQPYQGLSN---EEVLKFVI 235
Query: 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
D ++ +++L ++R +C PK RPT ++++ L
Sbjct: 236 DGGHLD---------LPENCPDKLLELMR---MCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 21/177 (11%)
Query: 746 REVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL-----LVDW 800
+EV++L ++H NIV+ N+ +V DY L + ++ + G L ++DW
Sbjct: 48 KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDW 106
Query: 801 VSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860
V I L ++H ++HRDIKS NI L + ++ DFG+AR++ E
Sbjct: 107 F------VQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157
Query: 861 VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAF--GGSKDIV 915
G+ Y++PE + KSDI++ G VL E+ T L AF G K++V
Sbjct: 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT----LKHAFEAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 4/200 (2%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G VY+A VA+KK+ + D ++ D +E+ LL +L H N+++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+ + +V + L + + + K L+ + + V + + ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEK 884
V+HRDIK N+ + A ++ D GL R K + G+ Y++PE + + K
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 885 SDIYSFGVVLLELLTGKMPL 904
SDI+S G +L E+ + P
Sbjct: 187 SDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-14
Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 21/152 (13%)
Query: 18 DDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENG-----LLHCNWTGVWC-----NSRGF 67
+E+S L ++K+ L +P NG H W+G C + F
Sbjct: 371 LEEVSALQTLKSSL----------GLPLRFGWNGDPCVPQQH-PWSGADCQFDSTKGKWF 419
Query: 68 VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
++ L L N L G + +I LR L S+N+ N ++P SL ++T+L+ +D+S N+F
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 128 GSFPTGLGKASGLTSVNASSNNFSGFLPEDLG 159
GS P LG+ + L +N + N+ SG +P LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G V+K +VA+K++ R +++ + REVSLL L+H NIV L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAV---GIAQGLNYLHHDCQ 822
+H + ++ +V++Y+ D L + + + G ++ S +N+ + I +GL Y H +
Sbjct: 73 VHTDKSLTLVFEYLDKD-LKQYM--DDCGNIM----SMHNVKIFLYQILRGLAYCH---R 122
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD 882
V+HRD+K N+L++ E ++ADFGLAR +T S + Y P+ L
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD--VLLGSS 180
Query: 883 EKS---DIYSFGVVLLELLTGKMPLDPAFGGS 911
E S D++ G + E+ +G+ P F GS
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGR----PLFPGS 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-14
Identities = 69/225 (30%), Positives = 99/225 (44%), Gaps = 52/225 (23%)
Query: 768 NETNVMM---VYDYMPNDSL----------GEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
N NV+M V DY L EAG L + Q L
Sbjct: 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI-------------QVL 153
Query: 815 NYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVS-----MVAGSYG 869
+HH +IHRDIKS NILL +N ++ DFG ++M TVS G+
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY---AATVSDDVGRTFCGTPY 210
Query: 870 YIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929
Y+APE +K+D++S GV+L ELLT K P D +++ E M K+ +
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GENMEE---VMHKTLAGRY 262
Query: 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974
+ L PSI+ EM ++ A+L + PK RP+ ++ M
Sbjct: 263 DPLPPSIS-------PEMQEIVT-ALLSSD--PKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 45/159 (28%), Positives = 86/159 (54%), Gaps = 10/159 (6%)
Query: 747 EVSLLGRLRHRNIVRLLGYLHNE-TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN 805
E S++ +LRH N+V+LLG + E + +V +YM SL + L + G+ ++
Sbjct: 49 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLK 106
Query: 806 IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA 865
++ + + + YL + +HRD+ + N+L+ + A+++DFGL + +T +
Sbjct: 107 FSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-- 161
Query: 866 GSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ APE K KSD++SFG++L E+ + G++P
Sbjct: 162 -PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLL 763
++G G G VYK + + A+K + D + +++ +E+++L + HRNI
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYY 69
Query: 764 GYLHNET------NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
G + + +V ++ S+ + + + L +W++ I I +GL++L
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHL 127
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGY 877
H Q VIHRDIK N+LL N E ++ DFG++ + + G+ ++APE
Sbjct: 128 H---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE--- 181
Query: 878 TLKVDE--------KSDIYSFGVVLLELLTGKMPL 904
+ DE KSD++S G+ +E+ G PL
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-14
Identities = 39/88 (44%), Positives = 55/88 (62%)
Query: 287 LDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSL 346
L L + + G IP +++L++LQ +NL N + G IP LG +T LEVL+L NS GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 347 PMRLGQSSPLRRLDASSNLLSGEIPTGL 374
P LGQ + LR L+ + N LSG +P L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 79/297 (26%), Positives = 135/297 (45%), Gaps = 53/297 (17%)
Query: 706 IGMGGNGIVYKAEFH-----RP-HMV-VAVKKLWR--SDNDIESGDDLFREVSLLGRL-R 755
+G G G V +AE + RP V VAVK L +D D+ DL E+ L+ + +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA---DLISEMELMKLIGK 76
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGK------------EAGKLLVDWVSR 803
H+NI+ LLG E + ++ +Y +L E L + + + + +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 804 YNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM 863
+ A +A+G+ YL IHRD+ + N+L+ + +IADFGLAR + +
Sbjct: 137 VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 864 VAGSY--GYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKD---IVEWV 918
G ++APE + +SD++SFG+++ E+ T GGS VE +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT--------LGGSPYPGIPVEEL 245
Query: 919 LSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
+++ D+ PS C H E+ +++R C +P RPT + ++ L
Sbjct: 246 FKLLREGHRMDK---PS---NCTH---ELYMLMR---ECWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 58/182 (31%), Positives = 89/182 (48%), Gaps = 18/182 (9%)
Query: 725 VVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN--ETNVMMVYDYMPND 782
+VAVK L + + ++ +E+++L L H NIV+ G + ++ +Y+P
Sbjct: 35 MVAVKTL-KRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLG 93
Query: 783 SLGEAL--HGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN 840
SL + L H +LL+ A I +G+ YLH IHRD+ + N+LLD +
Sbjct: 94 SLRDYLPKHKLNLAQLLL-------FAQQICEGMAYLH---SQHYIHRDLAARNVLLDND 143
Query: 841 LEARIADFGLARMML--HKNETVSMVAGS-YGYIAPEYGYTLKVDEKSDIYSFGVVLLEL 897
+I DFGLA+ + H+ V S + A E K SD++SFGV L EL
Sbjct: 144 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203
Query: 898 LT 899
LT
Sbjct: 204 LT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL-G 764
IG G +G VY A VA+K++ + + E+ ++ +H NIV L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDS 84
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
YL + + +V +Y+ SL + + + + V R Q L +LH +
Sbjct: 85 YLVGD-ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSN---Q 135
Query: 825 VIHRDIKSNNILLDANLEARIADFGL-ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
VIHRDIKS+NILL + ++ DFG A++ +++ +MV Y ++APE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAYGP 194
Query: 884 KSDIYSFGVVLLELLTGKMP 903
K DI+S G++ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 40/301 (13%)
Query: 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL-FREVSLLGRLRHRNI 759
++ ++G GG G V + + A KKL + G+ + E +L ++ R +
Sbjct: 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFV 62
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
V L + + +V M L H G+ + A I GL LH
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDL--KFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH- 119
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL 879
Q +++RD+K NILLD + RI+D GLA + + + +T+ G+ GY+APE
Sbjct: 120 --QERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKNE 176
Query: 880 KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939
+ D ++ G +L E++ G+ P + K + E ++ +
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPFQQ----------------RKKKIKREEVERLV--- 217
Query: 940 CKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNGGHNLSKERPI 999
K VQEE + K P R + ML P+ + CQ GG KE P+
Sbjct: 218 -KEVQEEY----------SEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263
Query: 1000 F 1000
F
Sbjct: 264 F 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-13
Identities = 79/235 (33%), Positives = 118/235 (50%), Gaps = 10/235 (4%)
Query: 81 SVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGK-ASG 139
SEN+ L L SL++ N S++ + L LT L S+D+ NN I P +G S
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNN-ITDIPPLIGLLKSN 141
Query: 140 LTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLT 199
L ++ S N LP L N +L++LD + +P NL L L LSGN ++
Sbjct: 142 LKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199
Query: 200 GKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKK 259
+PPE+ LS+LE + L N+ E+ + NL NL L+L+ + +P ++G L
Sbjct: 200 -DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS-NNKLEDLPESIGNLSN 256
Query: 260 LTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLM 314
L T+ L N LGS+T+L LDLS N +S +P+ L L+LL +
Sbjct: 257 LETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNL 309
|
Length = 394 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD---LFREVSLLGRLRHRNIVR 761
++G G G VY +AVK++ E+ + L E+ LL L H IV+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 762 LLGYLHN--ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
G L + E + + ++MP S+ + L K G L + +Y I +G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQ--ILEGVSYLHS 124
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM-------VAGSYGYIA 872
+ ++HRDIK NIL D+ ++ DFG ++ + +T+ + V G+ +++
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRL----QTICLSGTGMKSVTGTPYWMS 177
Query: 873 PEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
PE K+DI+S G ++E+LT K P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLL 763
++G G G VYK + + A+K + ++++ E ++ E+++L + HRNI
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE---EIKLEINMLKKYSHHRNIATYY 79
Query: 764 GYL------HNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
G ++ + +V ++ S+ + + + L DW++ I I +GL +L
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHL 137
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGY 877
H VIHRDIK N+LL N E ++ DFG++ + + G+ ++APE
Sbjct: 138 HAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE--- 191
Query: 878 TLKVDE--------KSDIYSFGVVLLELLTGKMPL 904
+ DE +SDI+S G+ +E+ G PL
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 65/244 (26%), Positives = 98/244 (40%), Gaps = 65/244 (26%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL-FR-EVSLLGRLRHRNIVRL 762
+IG G G V+ V A+K L +SD I+ R E +L IV+L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM-IKRNQIAHVRAERDILADADSPWIVKL 66
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNI---------AVGIAQG 813
+E ++ +V +YMP G L++ + R ++ +
Sbjct: 67 YYSFQDEEHLYLVMEYMP-------------GGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM------------------- 854
L+ +H + IHRDIK +NIL+DA+ ++ADFGL + M
Sbjct: 114 LDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 855 --------LHKNETV--SMVAGSYGYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTG 900
HK V + G+ YIAPE Y L+ D +S GV+L E+L G
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECD----WWSLGVILYEMLYG 226
Query: 901 KMPL 904
P
Sbjct: 227 FPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-13
Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 38/210 (18%)
Query: 746 REVSLLGRLRHRNIVRLLGYLHNETN-VMMVYDYMPNDSLGE------ALHGKEAGKLLV 798
RE +L RL H NIV LL + V++Y+P +L E AL E G+L+
Sbjct: 27 RETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLM- 85
Query: 799 DWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMML 855
Q L+ L ++HRD+K NI++ A++ DFG+ ++
Sbjct: 86 ------------LQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLP 133
Query: 856 HKNETVSM-------VAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAF 908
+ V G+ Y APE V SD+Y++G++ LE LTG+ + A
Sbjct: 134 GVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGA- 192
Query: 909 GGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938
+I+ LS D +L P IAG
Sbjct: 193 -SVAEILYQQLS------PVDVSLPPWIAG 215
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 52/197 (26%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G G VYKA+ ++ +A K+ + ++ E +D E+ +L H IV+LLG
Sbjct: 20 LGDGAFGKVYKAK-NKETGALAAAKVIETKSE-EELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+ + + ++ ++ P ++ + + G ++ I V Q L L + +
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRG------LTEPQIQVICRQMLEALQYLHSMKI 131
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGY--TLK--- 880
IHRD+K+ N+LL + + ++ADFG++ + + G+ ++APE T+K
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 881 VDEKSDIYSFGVVLLEL 897
D K+DI+S G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
I+G G G VYKA +H + K+ D +E + E+ +L + I+
Sbjct: 7 EILGHGNGGTVYKA-YHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
G E + + ++M SL ++ K +L IAV + +GL YL
Sbjct: 66 GAFFVENRISICTEFMDGGSLD--VYRKIPEHVL------GRIAVAVVKGLTYL---WSL 114
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
++HRD+K +N+L++ + ++ DFG++ ++ N G+ Y+APE +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 884 KSDIYSFGVVLLELLTGKMP 903
SD++S G+ +EL G+ P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-13
Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G VYK + +VA+K + R + + RE SLL L+H NIV L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+H + + +V++Y+ D L + + K G L + V + + +GL+Y+H Q +
Sbjct: 72 IHTKETLTLVFEYVHTD-LCQYMD-KHPGGLHPENVKLF--LFQLLRGLSYIH---QRYI 124
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKS 885
+HRD+K N+L+ E ++ADFGLAR + T S + Y P+ L E S
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPD--VLLGSTEYS 182
Query: 886 ---DIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
D++ G + +E++ G AF G KDI
Sbjct: 183 TCLDMWGVGCIFVEMIQGV----AAFPGMKDI 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 37/99 (37%), Positives = 56/99 (56%), Gaps = 3/99 (3%)
Query: 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG 866
A IA GL +LH +I+RD+K +N++LDA +IADFG+ + + +T G
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCG 163
Query: 867 SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
+ YIAPE + D ++FGV+L E+L G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-13
Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G GIV A VA+KKL R ++ +RE+ L+ + H+NI+ LL
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83
Query: 766 ------LHNETNVMMVYDYMPNDSLGEALH----GKEAGKLLVDWVSRYNIAVGIAQGLN 815
L +V +V + M + +L + + + LL Y + GI
Sbjct: 84 FTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSYLL------YQMLCGI----K 132
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM---VAGSYGYIA 872
+LH +IHRD+K +NI++ ++ +I DFGLAR + M V Y Y A
Sbjct: 133 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRY-YRA 185
Query: 873 PEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEW 917
PE + E DI+S G ++ E++ G + F G+ I +W
Sbjct: 186 PEVILGMGYKENVDIWSVGCIMGEMIRGTV----LFPGTDHIDQW 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVK----KLWRSDNDI---ESGDDLFREVSLLGRLRHR 757
+IG G V E + + A+K +L D DI ++ +F S H
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-----NHP 56
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
+V L E+ + V +++ L H + KL + Y+ + +A LN+L
Sbjct: 57 FLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNFL 112
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE--- 874
H + +I+RD+K +N+LLDA ++ D+G+ + + +T S G+ YIAPE
Sbjct: 113 H---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 875 ---YGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
YG+++ D ++ GV++ E++ G+ P D
Sbjct: 170 GEDYGFSV------DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 50/288 (17%)
Query: 712 GIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYL 766
G VYK VA+K L + + ++ E + RL+H NIV LLG +
Sbjct: 19 GKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77
Query: 767 HNETNVMMVYDYMPNDSLGEAL-----HGKEAG-------KLLVDWVSRYNIAVGIAQGL 814
E + M++ Y + L E L H K ++ +I IA G+
Sbjct: 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM 137
Query: 815 NYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY---G 869
+L HH V+H+D+ + N+L+ L +I+D GL R ++ + ++ S
Sbjct: 138 EFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFR-EVYAADYYKLMGNSLLPIR 191
Query: 870 YIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS-KDIVEWVLSMIKSNKAQ 928
+++PE K SDI+S+GVVL E+ + L P G S +D++E MI++ +
Sbjct: 192 WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS--YGLQPYCGYSNQDVIE----MIRNRQVL 245
Query: 929 DEALD-PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
D P+ V + + C + P RP +D+ + L
Sbjct: 246 PCPDDCPA-------------WVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 74/297 (24%), Positives = 119/297 (40%), Gaps = 42/297 (14%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL-FREVSLLGRLRHRNIVRLLG 764
+G GG G V + + A KKL + G+ + E +L ++ R IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+ ++ +V M L H G+ A I GL +LH Q
Sbjct: 61 AFETKDDLCLVMTLMNGGDL--KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRR 115
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEK 884
+++RD+K N+LLD + RI+D GLA + + + AG+ GY+APE D
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 885 SDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQ 944
D ++ G L E++ G+ P F K+ VE K
Sbjct: 175 VDWFALGCTLYEMIAGRSP----FRQRKEKVE------------------------KEEL 206
Query: 945 EEMLLVLRIAVLCTAKLP-KGRPTMRDVITMLGEAKPRRKSICQNGGHNLSKERPIF 1000
+ L +AV + P K P +D+ L + P ++ C+ G + +E P+F
Sbjct: 207 KRR--TLEMAV----EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 47/169 (27%), Positives = 84/169 (49%), Gaps = 19/169 (11%)
Query: 740 SGDDLFREVS----LLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALH---GKE 792
SG F+E++ +G L H IVRLLG + ++ +V P SL + +
Sbjct: 48 SGRQTFQEITDHMLAMGSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSL 106
Query: 793 AGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR 852
+ L++W V IA+G+ YL ++HR++ + NILL ++ +IADFG+A
Sbjct: 107 DPQRLLNW------CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157
Query: 853 MML--HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT 899
++ K S ++A E + +SD++S+GV + E+++
Sbjct: 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G G G V+ A+K + + ++ + E +L + H I+RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
H++ + M+ +Y+P L L + +G+ + + A I L YLH
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL--RNSGRF-SNSTGLF-YASEIVCALEYLH---SKE 121
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEK 884
+++RD+K NILLD ++ DFG A+ + + T + G+ Y+APE + ++
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT---LCGTPEYLAPEVIQSKGHNKA 178
Query: 885 SDIYSFGVVLLELLTGKMPL--DPAFGGSKDIVE 916
D ++ G+++ E+L G P D FG + I+
Sbjct: 179 VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 27/191 (14%)
Query: 724 MVVAVKKLWRSDNDI---ESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMP 780
M V K+L D DI ++ +F + S + +V L + + +V +Y+
Sbjct: 25 MKVVKKELVHDDEDIDWVQTEKHVFEQAS-----SNPFLVGLHSCFQTTSRLFLVIEYVN 79
Query: 781 NDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN 840
L H + KL + Y + IA LN+LH + +I+RD+K +N+LLDA+
Sbjct: 80 GGDL--MFHMQRQRKLPEEHARFYAAEICIA--LNFLH---ERGIIYRDLKLDNVLLDAD 132
Query: 841 LEARIADFGLARMMLHKNETVSMVAGSYGYIAPE------YGYTLKVDEKSDIYSFGVVL 894
++ D+G+ + L +T S G+ YIAPE YG+++ D ++ GV++
Sbjct: 133 GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV------DWWALGVLM 186
Query: 895 LELLTGKMPLD 905
E++ G+ P D
Sbjct: 187 FEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G GIV A +VAVKK+ R E LF EV ++ +H N+V
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVE--- 81
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVS--RYN------IAVGIAQGLNY 816
M Y+ D L + E G L D V+ R N + + + + L+
Sbjct: 82 ---------MYNSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLKALSV 131
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYG 876
LH VIHRDIKS++ILL + +++DFG + + + G+ ++APE
Sbjct: 132 LHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI 188
Query: 877 YTLKVDEKSDIYSFGVVLLELLTGKMP 903
L + DI+S G++++E++ G+ P
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 81/263 (30%), Positives = 108/263 (41%), Gaps = 65/263 (24%)
Query: 706 IGMGGNGIVYKAEF--HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRL 762
+G G GIV A VA+KK+ + RE+ LL R H+NI L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 763 LG------------YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGI 810
YL+ E +M D L + + +G+ L D + I I
Sbjct: 68 YDMDIVFPGNFNELYLYEE---LMEAD------LHQIIR---SGQPLTDAHFQSFI-YQI 114
Query: 811 AQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM--LHKNETVSM---VA 865
GL Y+H V+HRD+K N+L++A+ E +I DFGLAR M VA
Sbjct: 115 LCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 866 GSYGYIAPEY-----GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIV----- 915
+ Y APE YT + D++S G +L ELL K P F G KD V
Sbjct: 172 TRW-YRAPEIMLSFQSYTKAI----DVWSVGCILAELLGRK----PVFKG-KDYVDQLNQ 221
Query: 916 ---------EWVLSMIKSNKAQD 929
E LS I S KAQ+
Sbjct: 222 ILQVLGTPDEETLSRIGSPKAQN 244
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-13
Identities = 35/89 (39%), Positives = 53/89 (59%)
Query: 191 LGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQI 250
LGL L G IP ++ +L L++I L N+ G IP G++T+L LDL+ S +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 251 PPALGRLKKLTTVYLYKNNFTGKIPPELG 279
P +LG+L L + L N+ +G++P LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-13
Identities = 69/265 (26%), Positives = 124/265 (46%), Gaps = 38/265 (14%)
Query: 724 MVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYDYMPND 782
+ VAVK L + D + DL E+ ++ + +H+NI+ LLG + + ++ +Y
Sbjct: 45 VTVAVKML-KDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKG 103
Query: 783 SLGEALHGK---------EAGKLLVDWVSRYNI---AVGIAQGLNYLHHDCQPPVIHRDI 830
+L E L + + KL + ++ ++ A +A+G+ YL IHRD+
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDL 160
Query: 831 KSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY--GYIAPEYGYTLKVDEKSDIY 888
+ N+L+ + +IADFGLAR + + + G ++APE + +SD++
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220
Query: 889 SFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEM 947
SFGV+L E+ T G P P VE + ++K D+ C H E+
Sbjct: 221 SFGVLLWEIFTLGGSPY-PGIP-----VEELFKLLKEGHRMDK------PANCTH---EL 265
Query: 948 LLVLRIAVLCTAKLPKGRPTMRDVI 972
+++R C +P RPT + ++
Sbjct: 266 YMIMR---ECWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 58/191 (30%), Positives = 90/191 (47%), Gaps = 19/191 (9%)
Query: 726 VAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLG 785
VAVK L + D E + +E L+ H NIV+LLG ++ + M L
Sbjct: 29 VAVKTLRKGATDQEKKE-FLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLL 87
Query: 786 EALHGKEAGKL---LVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL----- 837
L + L+ +I + +A+G YL Q IHRD+ + N L+
Sbjct: 88 SYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGY 144
Query: 838 DANLEARIADFGLARMMLHKNETVSMVAGS----YGYIAPEYGYTLKVDEKSDIYSFGVV 893
DA+ +I DFGLAR ++K++ G ++APE K +SD++SFGV+
Sbjct: 145 DADRVVKIGDFGLAR-DIYKSDYYR-KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVL 202
Query: 894 LLELLT-GKMP 903
+ E+LT G+ P
Sbjct: 203 MWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 26/233 (11%)
Query: 706 IGMGGNGIVYKAEF--HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V K + + + VA+K L +++N+ D++ RE ++ +L + IVR++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQ---GLNYLHHD 820
G E +M+V + L + L GK+ D ++ N+ + Q G+ YL
Sbjct: 62 GVCEAE-ALMLVMEMASGGPLNKFLSGKK------DEITVSNVVELMHQVSMGMKYLE-- 112
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMM-LHKNETVSMVAGSY--GYIAPEYGY 877
+HRD+ + N+LL A+I+DFGL++ + + + AG + + APE
Sbjct: 113 -GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 878 TLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929
K +SD++S+G+ + E + G+ P G V+S I+ K D
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMSFIEQGKRLD 218
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 36/234 (15%)
Query: 746 REVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALH--GKEAGKLL-----V 798
+E LL +L+H NIV E ++Y M G+ H ++ GKLL V
Sbjct: 48 QEAQLLSQLKHPNIVAYRESWEGEDG--LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVV 105
Query: 799 DWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858
+W V IA L YLH + ++HRD+K+ N+ L ++ D G+AR++ ++
Sbjct: 106 EWF------VQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156
Query: 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWV 918
+ S + G+ Y++PE + KSD+++ G + E+ T L AF +KD+ V
Sbjct: 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT----LKHAF-NAKDMNSLV 211
Query: 919 LSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
+I+ L P + E L +L K P+ RP+++ ++
Sbjct: 212 YRIIEGK------LPPMPKDYSPELGE-----LIATMLS--KRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G GIV A VAVKK+ R E LF EV ++ H N+V
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL---LFNEVVIMRDYHHENVVD--- 83
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVS--RYN------IAVGIAQGLNY 816
M Y+ D L + E G L D V+ R N + + + + L+Y
Sbjct: 84 ---------MYNSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLSVLRALSY 133
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYG 876
LH+ VIHRDIKS++ILL ++ +++DFG + + + G+ ++APE
Sbjct: 134 LHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI 190
Query: 877 YTLKVDEKSDIYSFGVVLLELLTGKMP 903
L + DI+S G++++E++ G+ P
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 65/232 (28%), Positives = 97/232 (41%), Gaps = 43/232 (18%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIES-GDDLFREVSLLGRLRHRN-IVRL 762
IG G G VYKA +VA+KK R + D E RE+SLL L IVRL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 763 LGYLHNETN-----VMMVYDYMPND--SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
L H E + +V++Y+ +D ++ L + + + +G+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ--LLKGVA 124
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEA-RIADFGLARMMLHKNETVSMVAGSYG----- 869
+ H + V+HRD+K N+L+D +IAD GL R S+ SY
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-------AFSIPVKSYTHEIVT 174
Query: 870 --YIAPEY-----GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
Y APE Y+ V DI+S G + E+ + P F G ++
Sbjct: 175 LWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRKQ----PLFPGDSEL 218
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 49/146 (33%), Positives = 69/146 (47%), Gaps = 9/146 (6%)
Query: 431 LEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKI 490
L + N L G IP+DIS L +++S N + +P S+ SI SL+ S+N+ I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 491 PNELQACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNRFSGEIPKAVATMPTLA 549
P L SL +L+L+ NSLSG +PA++ S N +N IP A P L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHL- 541
Query: 550 ILDMSNNSLFGRIPENFGASPALEML 575
S+ +I FG S A L
Sbjct: 542 -------SVGAKIGIAFGVSVAFLFL 560
|
Length = 623 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 48/191 (25%), Positives = 87/191 (45%), Gaps = 49/191 (25%)
Query: 687 QRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF- 745
+ F + ++ ++ IG G G V+KA + +VA+KK+ +N+ E F
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEG----FP 55
Query: 746 ----REVSLLGRLRHRNIVRLLGYLHNETN--------VMMVYDYMPND----------- 782
RE+ +L L+H N+V L+ + +V+++ +D
Sbjct: 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK 115
Query: 783 -SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL 841
+L E K+ K+L++ GL Y+H + ++HRD+K+ NIL+ +
Sbjct: 116 FTLSEI---KKVMKMLLN-------------GLYYIHRN---KILHRDMKAANILITKDG 156
Query: 842 EARIADFGLAR 852
++ADFGLAR
Sbjct: 157 ILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 57/215 (26%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 701 KESNIIGMGGNGIVYKA----EFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH 756
K+ ++G G G VYK E + + VA+K+L R ++ ++ E ++ + +
Sbjct: 10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDN 68
Query: 757 RNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKE---AGKLLVDWVSRYNIAVGIAQG 813
++ RLLG T V ++ MP L + + + + L++W V IA+G
Sbjct: 69 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY--GYI 871
+NYL + ++HRD+ + N+L+ +I DFGLA+++ + G ++
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 872 APEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLD 905
A E +SD++S+GV + EL+T G P D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 68/233 (29%), Positives = 111/233 (47%), Gaps = 32/233 (13%)
Query: 706 IGMGGNGIVYKAEFH--RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V K + + VAVK L +ND D+L RE +++ +L + IVR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 764 GYLHNETNVMMVYDYMP----NDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
G E + M+V + N L + H E K + + V + ++ G+ YL
Sbjct: 63 GICEAE-SWMLVMELAELGPLNKFLQKNKHVTE--KNITELVHQ------VSMGMKYLE- 112
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG-----YIAPE 874
+ +HRD+ + N+LL A+I+DFGL++ L +E A ++G + APE
Sbjct: 113 --ETNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYK-AKTHGKWPVKWYAPE 168
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNK 926
K KSD++SFGV++ E + G+ P G V MI+S +
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE------VTQMIESGE 215
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 27/227 (11%)
Query: 699 CVKESNIIGMGGNGIVYKA-EFHRPHMVVAVKKLWRSDNDIESGDDL--FREVSLLGRLR 755
CV E IG G G V+KA + VA+K++ R E G L REV++L L
Sbjct: 5 CVAE---IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTG-EEGMPLSTIREVAVLRHLE 59
Query: 756 ---HRNIVRL-----LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIA 807
H N+VRL + ET + +V++++ D E G V + ++
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDMM 116
Query: 808 VGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS 867
+ +GL++LH V+HRD+K NIL+ ++ + ++ADFGLAR+ + S+V
Sbjct: 117 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 173
Query: 868 YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
+ Y APE D++S G + E+ K P F GS D+
Sbjct: 174 W-YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDV 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 32/221 (14%)
Query: 700 VKESNIIGMGGNGIVYKAEFHRP--HMVVAVKKL--WRSDNDIESGDDLFREVSLLGRL- 754
+K ++IG G G V +A + M A+K L + S+ND D E+ +L +L
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR---DFAGELEVLCKLG 60
Query: 755 RHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEAL---------------HGKEAGKLLVD 799
H NI+ LLG N + + +Y P +L + L HG A L
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT-ASTLTSQ 119
Query: 800 WVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR-MMLHKN 858
+ ++ A +A G+ YL + IHRD+ + N+L+ NL ++IADFGL+R ++
Sbjct: 120 QLLQF--ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK 174
Query: 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT 899
+T+ + + I Y++ KSD++SFGV+L E+++
Sbjct: 175 KTMGRLPVRWMAIE-SLNYSVYT-TKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 72/290 (24%), Positives = 127/290 (43%), Gaps = 48/290 (16%)
Query: 705 IIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRN 758
+G G G V +A + M VAVK L + + L E+ ++ L H N
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKML-KPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL- 817
IV LLG ++++ +Y L L K L ++ + ++ V A+G+ +L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV--AKGMAFLA 158
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS----YGYIAP 873
+C IHRD+ + N+LL +I DFGLAR +++ + V V G+ ++AP
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV--VKGNARLPVKWMAP 212
Query: 874 EYGYTLKVDEKSDIYSFGVVLLELLT------GKMPLDPAFGGSKDIVEWVLSMIKSNKA 927
E + +SD++S+G++L E+ + MP+D F +IK
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF----------YKLIKEGYR 262
Query: 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977
Q +H E+ +++ C P RPT + ++ ++G+
Sbjct: 263 MA---------QPEHAPAEIYDIMKT---CWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 21/183 (11%)
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHG-KEAGKLL-----VDW 800
E LL +L H IV+ ++ +Y L L K GK L +W
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 801 VSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860
+ + G++Y+H Q ++HRD+K+ NI L NL +I DFG++R+++ +
Sbjct: 112 F------IQLLLGVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL 161
Query: 861 VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLS 920
+ G+ Y++PE D KSDI+S G +L E+ L AF G + + VL
Sbjct: 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC----LAHAFEGQ-NFLSVVLR 216
Query: 921 MIK 923
+++
Sbjct: 217 IVE 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G G G VYKA+ ++ A K + +S+ ++E D E+ +L H NIV+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELE---DYMVEIDILASCDHPNIVKLLD 69
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQ---GLNYLHHDC 821
+ E N+ ++ ++ ++ + E ++ I V Q LNYLH +
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERP------LTEPQIRVVCKQTLEALNYLHEN- 122
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY-----G 876
+IHRD+K+ NIL + + ++ADFG++ + G+ ++APE
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 877 YTLKVDEKSDIYSFGVVLLEL 897
D K+D++S G+ L+E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 69/246 (28%), Positives = 107/246 (43%), Gaps = 18/246 (7%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD--NDIESGDDLFREVSLLGRLRHRNIVRL 762
+IG G G V A AVK L + E + LL ++H +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
+ V DY+ GE + + + ++ +R+ A IA L YLH
Sbjct: 62 HFSFQTADKLYFVLDYING---GELFYHLQRERCFLEPRARF-YAAEIASALGYLH---S 114
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD 882
+++RD+K NILLD+ + DFGL + + N T S G+ Y+APE + D
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 883 EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942
D + G VL E+L G L P + S++ E +++ NK L P+I +H
Sbjct: 175 RTVDWWCLGAVLYEMLYG---LPPFY--SRNTAEMYDNIL--NKPLQ--LKPNITNSARH 225
Query: 943 VQEEML 948
+ E +L
Sbjct: 226 LLEGLL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD---LFREVSLLGRLRHRNIVRL 762
+G G G VYKA + AVK + +E GDD + +E+ ++ +H NIV
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII-----KLEPGDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALH-GKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
G + + + +Y SL + H +L + +V R + QGL YLH
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKG 126
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLK- 880
+ +HRDIK NILL N + ++ADFG+A + G+ ++APE K
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 881 --VDEKSDIYSFGVVLLELLTGKMPL 904
++ DI++ G+ +EL + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 67/245 (27%), Positives = 110/245 (44%), Gaps = 26/245 (10%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWR----SDNDIESGDDLFREVSLLGRLRHRNIV 760
++G G G V AE + A+K L + D+D+E R ++L G+
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK------P 60
Query: 761 RLLGYLHNETNVM----MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNY 816
L LH+ M V +Y+ L ++ G+ Y A IA GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFY--AAEIAIGLFF 116
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYG 876
LH +I+RD+K +N++LD+ +IADFG+ + + T G+ YIAPE
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII 173
Query: 877 YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936
+ D ++FGV+L E+L G+ P + G +D E S+++ N A +++
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDED--ELFQSIMEHNVAYPKSMSKEA 228
Query: 937 AGQCK 941
CK
Sbjct: 229 VAICK 233
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-12
Identities = 34/80 (42%), Positives = 47/80 (58%)
Query: 128 GSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK 187
G P + K L S+N S N+ G +P LG+ TSLE LD + F GS+P S L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 188 LKFLGLSGNNLTGKIPPELG 207
L+ L L+GN+L+G++P LG
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-12
Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 18/152 (11%)
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEAL-HGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
IV L ++++ +V DYM S GE H ++ G+ D Y IA+ + L
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYM---SGGELFWHLQKEGRFSEDRAKFY-----IAELVLAL 109
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY-- 875
H + +++RD+K NILLDA + DFGL++ L N+T + G+ Y+APE
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 876 ---GYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
GYT V D +S GV++ E+ G P
Sbjct: 170 DEKGYTKHV----DFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-12
Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 18/246 (7%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD--NDIESGDDLFREVSLLGRLRHRNIVRL 762
+IG G G V A+ AVK L + E + LL ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
+ V DY+ GE + + + +R+ A IA L YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNG---GELFFHLQRERSFPEPRARF-YAAEIASALGYLH---S 114
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD 882
+I+RD+K NILLD+ + DFGL + + ++T S G+ Y+APE D
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 883 EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942
D + G VL E+L G L P + S+D E M + + L P+I+ +H
Sbjct: 175 RTVDWWCLGAVLYEMLYG---LPPFY--SRDTAE----MYDNILNKPLRLKPNISVSARH 225
Query: 943 VQEEML 948
+ E +L
Sbjct: 226 LLEGLL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 7e-12
Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 3/99 (3%)
Query: 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG 866
A + L +LH + VI+RD+K +NILLDA ++ADFG+ + + T + G
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158
Query: 867 SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
+ YIAPE L+ D ++ GV++ E++ G+ P +
Sbjct: 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 8/135 (5%)
Query: 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG 866
A I+ GL +LH + +I+RD+K +N++LD+ +IADFG+ + + T G
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCG 163
Query: 867 SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926
+ YIAPE + D +++GV+L E+L G+ P D G +D E S+++ N
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD---GEDED--ELFQSIMEHNV 218
Query: 927 AQDEALDPSIAGQCK 941
+ ++L CK
Sbjct: 219 SYPKSLSKEAVSICK 233
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKL---WRSDNDIESGDDLFREVSLLGRLRHRNIVRL 762
IG G G VYK + + AVK L D +IE+ ++ + + H N+V+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP-----NHPNVVKF 84
Query: 763 LGYLHNETNVM-----MVYDYMPNDSLGEALHGK-EAGKLLVDWVSRYNIAVGIAQGLNY 816
G + ++ +V + S+ E + G G+ L + + Y I G GL +
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY-ILYGALLGLQH 143
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM----LHKNETVSMVAGSYGYIA 872
LH++ +IHRD+K NNILL ++ DFG++ + L +N +V G+ ++A
Sbjct: 144 LHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV----GTPFWMA 196
Query: 873 PEY-----GYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
PE Y D + D++S G+ +EL G PL
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 698 ACVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRL 754
+K I+G G G + + P + VA+ L +D + E LG+
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-RGFLAEALTLGQF 63
Query: 755 RHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
H NIVRL G + +M+V +YM N +L L K G+L+ + + G+A G+
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQL--MGMLPGLASGM 120
Query: 815 NYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG---YI 871
YL + +H+ + ++ +L++++L +I+ F R+ K+E + +
Sbjct: 121 KYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWA 175
Query: 872 APEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
APE SD++SFG+V+ E+++ G+ P
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 44/268 (16%)
Query: 724 MVVAVKKLWRSDNDIESG-DDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYDYMPN 781
+ VAVK L D+ E DL E+ ++ + +H+NI+ LLG + + ++ +Y
Sbjct: 48 VTVAVKML--KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105
Query: 782 DSLGEALHGKEAGKLLVDW-VSRY-----------NIAVGIAQGLNYLHHDCQPPVIHRD 829
+L E L + + + ++R + +A+G+ YL IHRD
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRD 162
Query: 830 IKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY--GYIAPEYGYTLKVDEKSDI 887
+ + N+L+ N +IADFGLAR + + + G ++APE + +SD+
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 888 YSFGVVLLELLTGKMPLDPAFGGSKD---IVEWVLSMIKSNKAQDEALDPSIAGQCKHVQ 944
+SFGV++ E+ T GGS VE + ++K D+ C +
Sbjct: 223 WSFGVLMWEIFT--------LGGSPYPGIPVEELFKLLKEGHRMDK------PANCTN-- 266
Query: 945 EEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
E+ +++R C +P RPT + ++
Sbjct: 267 -ELYMMMRD---CWHAIPSHRPTFKQLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 9e-12
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD---LFREVSLLGRLRHRNIVRL 762
+G GG G V+ A+ +VA+K++ + + ++ + E +L + +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRM--KKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
L ++ + + +Y+P L+ +L + +R+ +A ++ LH +
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFE-AVDALH---E 119
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD 882
IHRD+K N L+DA+ ++ DFGL++ ++ + V GS Y+APE D
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVVGSPDYMAPEVLRGKGYD 176
Query: 883 EKSDIYSFGVVLLELLTGKMPLDPAFGGS 911
D +S G +L E L G P F GS
Sbjct: 177 FTVDYWSLGCMLYEFLCGF----PPFSGS 201
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 700 VKESNIIGMGGNGIVYKA----EFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
+K+ ++G G G VYK + + VA+K L R + ++ ++ E ++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKANKEILDEAYVMAGVG 67
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALH---GKEAGKLLVDWVSRYNIAVGIAQ 812
+ RLLG T V +V MP L + + + + L++W V IA+
Sbjct: 68 SPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAK 120
Query: 813 GLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS---YG 869
G++YL + ++HRD+ + N+L+ + +I DFGLAR +L +ET G
Sbjct: 121 GMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLAR-LLDIDETEYHADGGKVPIK 176
Query: 870 YIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLD 905
++A E + +SD++S+GV + EL+T G P D
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-11
Identities = 82/276 (29%), Positives = 135/276 (48%), Gaps = 11/276 (3%)
Query: 328 ELTKLEVLELWKNSLIGSL--PMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLIL 385
L++L L+L S I SL L PL LD + N L I L + NLT L L
Sbjct: 65 SLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDL 123
Query: 386 FNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDD 445
NN+ + P+ +L + + +N I ++P L NLP+L+ L+++ N+L+ +P
Sbjct: 124 DNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKL 181
Query: 446 ISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDL 505
+S ++L+ +D+S N + LP I + +L+ S NN ++ + L +LS L+L
Sbjct: 182 LSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLS-NNSIIELLSSLSNLKNLSGLEL 239
Query: 506 SSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPEN 565
S+N L ++P SI + L +L+L NN+ ++ ++ L LD+S NSL +P
Sbjct: 240 SNNKLE-DLPESIGNLSNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNALPLI 296
Query: 566 F-GASPALEMLNLSYNKLEGPVPSNGILMNINPNEL 600
+LNL + N IL+N N
Sbjct: 297 ALLLLLLELLLNLLLTLKALELKLNSILLNNNILSN 332
|
Length = 394 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRS----DNDIESGDDLFREVSLLGRLRHRNIV 760
++G G G V AE AVK L + D+D+E R ++L + +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLAL--AWENPFLT 59
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
L + ++ V +++ L H ++ G+ + + Y A I GL +LH
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFY--AAEIVCGLQFLHSK 115
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLK 880
+I+RD+K +N++LD + +IADFG+ + + + S G+ YIAPE LK
Sbjct: 116 ---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 881 VDEKSDIYSFGVVLLELLTGKMPL 904
D +SFGV+L E+L G+ P
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 71/295 (24%), Positives = 128/295 (43%), Gaps = 50/295 (16%)
Query: 705 IIGMGGNGIVYKA-EFH---RP-HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI 759
+G G G V KA F R + VAVK L + + E DL E +LL ++ H ++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSEL-RDLLSEFNLLKQVNHPHV 65
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALH--------------GKEAGKLLVDWVSRYN 805
++L G + ++++ +Y SL L + + L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 806 I------AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859
+ A I++G+ YL + ++HRD+ + N+L+ + +I+DFGL+R + ++
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 860 TVSMVAGS--YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVE 916
V G ++A E + +SD++SFGV+L E++T G P P E
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIAP-----E 236
Query: 917 WVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
+ +++K+ + + S EEM + + C + P RPT D+
Sbjct: 237 RLFNLLKTGYRMERPENCS---------EEM---YNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 4/200 (2%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESG-DDLFREVSLLGRLRHRNIVRLLG 764
+G GG G V + + A KKL + G + E +L ++ R IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+T++ +V M L ++ + I GL +LH Q
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEK 884
+I+RD+K N+LLD + RI+D GLA + AG+ G++APE + D
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFS 177
Query: 885 SDIYSFGVVLLELLTGKMPL 904
D ++ GV L E++ + P
Sbjct: 178 VDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 69/247 (27%), Positives = 101/247 (40%), Gaps = 57/247 (23%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD--NDIESGDDL----------FREVSLL 751
+G G G V KA +VA+KK+ + ND+ L RE+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 752 GRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN------ 805
++H NI+ L+ + +V D M +D K +VD R
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDL-----------KKVVDRKIRLTESQVKC 123
Query: 806 IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR------------- 852
I + I GLN LH + +HRD+ NI +++ +IADFGLAR
Sbjct: 124 ILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 853 ---MMLHKNETVSMVAGSYGYIAPE--YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPA 907
M + T +V + Y APE G K D++S G + ELLTGK P
Sbjct: 181 DETMQRREEMTSKVV--TLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGK----PL 233
Query: 908 FGGSKDI 914
F G +I
Sbjct: 234 FPGENEI 240
|
Length = 335 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD---ND-IESGDDLFREVSLLGRLRHRNIV 760
++G G G V AE+ + + A+K L + D D +ES R RH +V
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSR---YNIAVGIAQGLNYL 817
L E +V V +Y L +H + R Y A + GL YL
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE------PRAVFY--AACVVLGLQYL 117
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM-MLHKNETVSMVAGSYGYIAPEY- 875
H + +++RD+K +N+LLD +IADFGL + M + T S G+ ++APE
Sbjct: 118 H---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT-STFCGTPEFLAPEVL 173
Query: 876 ---GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
YT V D + GV++ E+L G+ P
Sbjct: 174 TETSYTRAV----DWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 8/152 (5%)
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNI 806
E LL + H +++R+ L + MV + +D L L K + L +D I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSD-LYTYL-TKRSRPLPID--QALII 162
Query: 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG 866
I +GL YLH +IHRD+K+ NI ++ + I D G A+ + + +AG
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LAG 218
Query: 867 SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELL 898
+ APE K + K+DI+S G+VL E+L
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-11
Identities = 30/80 (37%), Positives = 46/80 (57%)
Query: 152 GFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSS 211
GF+P D+ L+S++ G+ G++P S ++ L+ L LS N+ G IP LGQL+S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 212 LETIILGYNAFEGEIPAEFG 231
L + L N+ G +PA G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G +G V+ A VA+K++ + + + E+ ++ L++ NIV L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI--NLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+ +V +Y+ SL + + + + V R + Q L +LH + V
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---QV 136
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKS 885
IHRDIKS+N+LL + ++ DFG + + S + G+ ++APE K
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 886 DIYSFGVVLLELLTGKMP 903
DI+S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 32/221 (14%)
Query: 700 VKESNIIGMGGNGIVYKAEFHRP--HMVVAVKKLWRSDNDIESGDD---LFREVSLLGRL 754
+K ++IG G G V KA + M A+K++ + S DD E+ +L +L
Sbjct: 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM----KEYASKDDHRDFAGELEVLCKL 64
Query: 755 -RHRNIVRLLGYLHNETNVMMVYDYMPNDSLGE--------------ALHGKEAGKLLVD 799
H NI+ LLG + + + +Y P+ +L + A+ A L
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 800 WVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR-MMLHKN 858
+ + A +A+G++YL Q IHRD+ + NIL+ N A+IADFGL+R ++
Sbjct: 125 QLLHF--AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 179
Query: 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT 899
+T+ + + I Y++ SD++S+GV+L E+++
Sbjct: 180 KTMGRLPVRWMAIE-SLNYSVYT-TNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 706 IGMGGNGIV---YKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRL 762
IG G GIV Y A R VA+KKL R + +RE+ L+ + H+NI+ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 763 LGY------LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNY 816
L L +V +V + M + +L + + ++ +D + + G+ +
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELM-DANLCQVI------QMELDHERMSYLLYQMLCGIKH 141
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYG 876
LH +IHRD+K +NI++ ++ +I DFGLAR V Y Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVI 197
Query: 877 YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEW 917
+ E DI+S G ++ E++ G + F G+ I +W
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNI 806
E +L + H IV+L E + ++ D++ L L KE + + ++ +
Sbjct: 48 ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEV--MFTEEDVKFYL 104
Query: 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG 866
A +A L++LH +I+RD+K NILLD ++ DFGL++ + + G
Sbjct: 105 A-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160
Query: 867 SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
+ Y+APE + +D +SFGV++ E+LTG +P
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-11
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 706 IGMGGNGIV---YKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRL 762
IG G GIV Y A R VA+KKL R + +RE+ L+ + H+NI+ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 763 LGY------LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNY 816
L L +V +V + M + +L + + ++ +D + + G+ +
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELM-DANLCQVI------QMELDHERMSYLLYQMLCGIKH 134
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYG 876
LH +IHRD+K +NI++ ++ +I DFGLAR V Y Y APE
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVI 190
Query: 877 YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEW 917
+ E DI+S G ++ E++ K+ F G I +W
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 705 IIGMGGNGIVYKAEFHRPH---MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVR 761
IG G G VY+ + P + VAVK ++ + +E ++ + H +IV+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVK-TCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
L+G + V+ M LGE + K +D S + ++ L YL
Sbjct: 72 LIGVI----TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE--- 124
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMM-LHKNETVSMVAGSYGYIAPEYGYTLK 880
+HRDI + N+L+ + ++ DFGL+R + S ++APE +
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 881 VDEKSDIYSFGVVLLELLT-GKMP 903
SD++ FGV + E+L G P
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-11
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 28/212 (13%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF----REVSLLGRLRHRN-- 758
+IG G G V V A+K L + + I+ D F R++ + H N
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAFFWEERDI-----MAHANSE 103
Query: 759 -IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
IV+L ++ + MV +YMP L + + + W Y V +A L+ +
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE---KWARFYTAEVVLA--LDAI 158
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV--SMVAGSYGYIAPEY 875
H IHRD+K +N+LLD + ++ADFG M + N V G+ YI+PE
Sbjct: 159 H---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYISPEV 214
Query: 876 GYTLKVD----EKSDIYSFGVVLLELLTGKMP 903
+ D + D +S GV L E+L G P
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 60/235 (25%), Positives = 93/235 (39%), Gaps = 48/235 (20%)
Query: 698 ACVKESNIIGMGGNGIVYKAEF-HRPH----MVVAVKKLWRSDNDIESGDDLFREVSLLG 752
+ +G G G VY+ + R + VAVK L + D E ++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEALIMS 64
Query: 753 RLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALH------GKEAGKLLVDWVSRYNI 806
+ H+NIVRL+G ++ + M L L + + + D +
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL---FC 121
Query: 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD---ANLEARIADFGLAR----------- 852
A +A+G YL + IHRDI + N LL A+IADFG+AR
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 853 ---MMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
M+ K ++ PE K+D++SFGV+L E+ + G MP
Sbjct: 179 GRAMLPIK------------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 9e-11
Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G +G VY A VA+K++ + + + E+ ++ ++ NIV L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+ +V +Y+ SL + + + + V R + Q L++LH + V
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN---QV 136
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKS 885
IHRDIKS+NILL + ++ DFG + + S + G+ ++APE K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 886 DIYSFGVVLLELLTGKMP 903
DI+S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 9e-11
Identities = 58/202 (28%), Positives = 85/202 (42%), Gaps = 9/202 (4%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD--NDIESGDDLFREVSLLGRLRHRNIVRL 762
+IG G G V A+ AVK L + E + LL L+H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
+ V DY+ GE + + ++ +R+ A +A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNG---GELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---S 114
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD 882
+I+RD+K NILLD+ + DFGL + + ET S G+ Y+APE D
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 883 EKSDIYSFGVVLLELLTGKMPL 904
D + G VL E+L G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 64/208 (30%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 706 IGMGGNGIVYKAEFHRPHMV--VAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G V E HR V VK+L S E +EV L H N+++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ-LLFLQEVQPYRELNHPNVLQCL 61
Query: 764 GYLHNETNVMMVYDYMPNDSLGEAL---HGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
G ++V ++ P L L G A D + R +A +A GL +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR--MACEVASGLLWLH-- 117
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN--ETVSMVAGSYGYIAPE---- 874
Q IH D+ N L A+L +I D+GLA ++ T A ++APE
Sbjct: 118 -QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 875 YGYTLKV---DEKSDIYSFGVVLLELLT 899
G L +KS+I+S GV + EL T
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 32/217 (14%)
Query: 704 NIIGMGGNGIVYKAEFHRP--HMVVAVKKL--WRSDNDIESGDDLFREVSLLGRL-RHRN 758
++IG G G V KA + M A+K++ + S +D D E+ +L +L H N
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPN 57
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEAL---------------HGKEAGKLLVDWVSR 803
I+ LLG + + + +Y P+ +L + L + A L +
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST-ASTLSSQQLLH 116
Query: 804 YNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR-MMLHKNETVS 862
+ A +A+G++YL Q IHRD+ + NIL+ N A+IADFGL+R ++ +T+
Sbjct: 117 F--AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 171
Query: 863 MVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT 899
+ + I Y++ SD++S+GV+L E+++
Sbjct: 172 RLPVRWMAIE-SLNYSVYT-TNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF---REVSLLGRLRHRNIVRL 762
IG G G VYKA + A+K + +E G+D +E+ ++ +H NIV
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI-----KLEPGEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALH-GKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
G + + ++ SL + H + + +VSR + QGL YLH
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKG 126
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLK- 880
+ +HRDIK NILL N ++ADFG++ + G+ ++APE +
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 881 --VDEKSDIYSFGVVLLELLTGKMPL 904
++ DI++ G+ +EL + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 692 TSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSL 750
TSS L+ + +G G G V A+ A+K L + + ++ + +E S+
Sbjct: 12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSI 71
Query: 751 LGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEAL-HGKEAGKLLVDWVSRYNIAVG 809
L L H IV ++ +E V + +++ GE H ++AG+ D Y+ +
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVG---GELFTHLRKAGRFPNDVAKFYHAELV 128
Query: 810 IAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG 869
+A YLH +I+RD+K N+LLD ++ DFG A+ + + T + G+
Sbjct: 129 LA--FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT---LCGTPE 180
Query: 870 YIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y+APE + + D ++ GV+L E + G P
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWR----SDNDIESGDDLFREVSLLGRLRHRNIV 760
++G G G V A + AVK L + D+D+E R +SL H +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSL--ARNHPFLT 59
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
+L + V +++ L H +++ + Y A I L +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFY--AAEITSALMFLH-- 113
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLK 880
+I+RD+K +N+LLD ++ADFG+ + + +T S G+ YIAPE +
Sbjct: 114 -DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLD 905
D ++ GV+L E+L G P +
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDNDIESGDDLFREVSLLGRLRHRNIVRLL- 763
IG G GIV A VAVK + R E LF EV ++ +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL---LFNEVVIMRDYQHQNVVEMYK 85
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVS--RYN------IAVGIAQGLN 815
YL E + ++ +++ G L D VS R N + + Q L
Sbjct: 86 SYLVGE-ELWVLMEFL-------------QGGALTDIVSQTRLNEEQIATVCESVLQALC 131
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY 875
YLH VIHRDIKS++ILL + +++DFG + + G+ ++APE
Sbjct: 132 YLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV 188
Query: 876 GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
+ DI+S G++++E++ G+ P
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 10/198 (5%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G +G VY A VA++++ + + + E+ ++ ++ NIV L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+ +V +Y+ SL + + + + V R + Q L +LH + V
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QV 137
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKS 885
IHRDIKS+NILL + ++ DFG + + S + G+ ++APE K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 886 DIYSFGVVLLELLTGKMP 903
DI+S G++ +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 56/232 (24%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLG 764
IG G V KA+ + A+K + + +E ++L RE+ L RL H NI+RL+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65
Query: 765 YLHNETN----------VMMVYDYMPNDS--LGEALHGKEAGKLLVDWVSRYNIAVGIAQ 812
L + M +Y+ + L E V Y + Q
Sbjct: 66 VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKR------------VKSY-----MYQ 108
Query: 813 GLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK---NETVSMVAGSYG 869
L L H + + HRDIK NIL+ ++ ++ADFG R + K E +S +
Sbjct: 109 LLKSLDHMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYIS----TRW 163
Query: 870 YIAPE-------YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
Y APE YG K DI++ G V E+L+ L P F G+ ++
Sbjct: 164 YRAPECLLTDGYYGP------KMDIWAVGCVFFEILS----LFPLFPGTNEL 205
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 78/306 (25%), Positives = 117/306 (38%), Gaps = 58/306 (18%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IIG GG G VY + A+K L + ++ G+ L L R ++ L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--------ALNERIMLSLVS 52
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNI---------AVGIAQGLN 815
V M Y + D L L G L +S++ + A I GL
Sbjct: 53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQHGVFSEAEMRFYAAEIILGLE 111
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE- 874
++H+ V++RD+K NILLD + RI+D GLA K S+ G++GY+APE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPEV 166
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934
+ D +D +S G +L +LL G P K ++ + L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------RMTLTMAVELPD 220
Query: 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNGGHNLS 994
S + + + + E +L RDV LG C G
Sbjct: 221 SFSPELRSLLEGLL-------------------QRDVNRRLG---------CLGRGAQEV 252
Query: 995 KERPIF 1000
KE P F
Sbjct: 253 KEHPFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 28/213 (13%)
Query: 707 GMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYL 766
IV+ A+ + +VAVKK+ E L +E+ +L+H NI+ +
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 767 HNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH-DCQP 823
++ + +V M S + L H E L I + L+Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA----IAFILKDVLNALDYIHSKGF-- 122
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI-------APE-- 874
IHR +K+++ILL + + ++ + M+ + +V +PE
Sbjct: 123 --IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 875 ----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
GY +EKSDIYS G+ EL G +P
Sbjct: 181 QQNLQGY----NEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL-FREVSLLGRLRHRN---IV 760
IIG GG G VY + A+K L + ++ G+ L E +L + + IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
+ H + + D M L L HG + K + R+ A I GL ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-----RF-YATEIILGLEHMH 114
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE-YGY 877
+ V++RD+K NILLD + RI+D GLA K S+ G++GY+APE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPEVLQK 169
Query: 878 TLKVDEKSDIYSFGVVLLELLTGKMPL 904
D +D +S G +L +LL G P
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 705 IIGMGGNGIVY---KAEFHRPHMVVAVKKLWRSD--NDIESGDDLFREVSLLGRLRHRNI 759
++G G G V+ K H + A+K L ++ ++ + E +L +R
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 760 VRLLGY-LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVG-IAQGLNYL 817
+ L Y +T + ++ DY+ L L +E K I G I L +L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-----EQEVQIYSGEIVLALEHL 121
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML-HKNETVSMVAGSYGYIAPEY- 875
H + +I+RDIK NILLD+N + DFGL++ + E G+ Y+AP+
Sbjct: 122 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 876 -GYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
G D+ D +S GV++ ELLTG P
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 75/300 (25%), Positives = 120/300 (40%), Gaps = 42/300 (14%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL-FREVSLLGRLRHRNIVRLL 763
++G GG G V + + A KKL + G+ + E +L ++ R +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL- 65
Query: 764 GYLHNETNVM-MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
Y + + + +V M L H G D A + GL L +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDL--KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD 882
+++RD+K NILLD RI+D GLA + + + ETV G+ GY+APE K
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGRVGTVGYMAPEVINNEKYT 179
Query: 883 EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942
D + G ++ E++ G+ P F K+ V+ E +D + K
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSP----FRKRKERVKR------------EEVDRRV----KE 219
Query: 943 VQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNGGHNLSKERPIFGN 1002
QEE + K + + + ML P+ + C+ G K+ PIF N
Sbjct: 220 DQEEY----------SEKFSE---DAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 8e-10
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 744 LFREVSLLGRLRHRNIVRLLGYLHNETNVMMV--------YDYMPNDSLGEALHGKEAGK 795
L E+ LGRL H NI+++ L +E N M+ Y +M + EA K+
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD----EAFDWKDRPL 265
Query: 796 LLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855
L +R I + + Y+H +IHRDIK NI L+ + + + DFG A M
Sbjct: 266 L---KQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA--MP 316
Query: 856 HKNETVSMVAGSYGYIAPEYGYTLKVD---EKSDIYSFGVVLLELLTGKMPLDPAFGGSK 912
+ E + G G +A L D E +DI+S G++LL++L+ P G
Sbjct: 317 FEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD--FCPIGDGGG 374
Query: 913 DIVEWVLSMIKSNKAQDEAL-DP 934
+ +L +I S DE DP
Sbjct: 375 KPGKQLLKIIDSLSVCDEEFPDP 397
|
Length = 501 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-10
Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 24/211 (11%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF--REVSLLGRLRHRNIVRL 762
+IG G G V V A+K L + + I+ D F E ++ +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
++ + MV +YMP L + + + W Y V +A L+ +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE---KWAKFYTAEVVLA--LDAIH---S 160
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMV-----AGSYGYIAPEYGY 877
+IHRD+K +N+LLD + ++ADFG M + MV G+ YI+PE
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM----DETGMVRCDTAVGTPDYISPEVLK 216
Query: 878 TLKVD----EKSDIYSFGVVLLELLTGKMPL 904
+ D + D +S GV L E+L G P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-09
Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 35/233 (15%)
Query: 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
K NIIG G G+VY+A VA+KK+ + D ++ RE+ ++ L H NI+
Sbjct: 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ-DPQYKN-----RELLIMKNLNHINII 122
Query: 761 RLLGYLH------NETNVMM--VYDYMPNDSLGEALH-GKEAGKLLVDWVSRYNIAVGIA 811
L Y + NE N+ + V +++P H + L + V Y+ +
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ--LC 180
Query: 812 QGLNYLHHDCQPPVIHRDIKSNNILLDANLEA-RIADFGLARMMLHKNETVSMVAGSYGY 870
+ L Y+H + HRD+K N+L+D N ++ DFG A+ +L +VS + + Y
Sbjct: 181 RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-Y 236
Query: 871 IAPEY-----GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWV 918
APE YT + D++S G ++ E++ G P F G + + V
Sbjct: 237 RAPELMLGATNYTTHI----DLWSLGCIIAEMILGY----PIFSGQSSVDQLV 281
|
Length = 440 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 51/196 (26%), Positives = 77/196 (39%), Gaps = 37/196 (18%)
Query: 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG 866
A I GL LH + +++RD+K NILLD RI+D GLA + + + ET+ G
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVG 163
Query: 867 SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926
+ GY+APE + D + G ++ E++ GK P F K+ V+
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP----FRQRKEKVKR--------- 210
Query: 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSIC 986
E ++ + K QEE K R + L P + C
Sbjct: 211 ---EEVERRV----KEDQEEY-------------SEKFSEAARSICRQLLTKDPGFRLGC 250
Query: 987 QNGGHNLSKERPIFGN 1002
+ G K P F
Sbjct: 251 RGEGAEEVKAHPFFRT 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 13/162 (8%)
Query: 747 EVSLLGRLRHRNIVRLLGY-LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN 805
E +L +R + L Y +T + ++ DY+ L L+ +E S
Sbjct: 54 ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE-----SEVR 108
Query: 806 IAVG-IAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN-ETVSM 863
+ + I L++LH Q +I+RDIK NILLD+ + DFGL++ L + E
Sbjct: 109 VYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS 165
Query: 864 VAGSYGYIAPEY--GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
G+ Y+APE G + D+ D +S GV+ ELLTG P
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 47/228 (20%)
Query: 705 IIGMGGNGIVYKAEFHRPHMV---VAVKKLWRSDN----DIESGDDLFREVSLLGRLRHR 757
I+G G G V + + + VAVK + + D +IE + E + + H
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIE---EFLSEAACMKDFDHP 61
Query: 758 NIVRLLGY------LHNETNVMMVYDYMPNDSLGEALHGKEAG----KLLVDWVSRYNIA 807
N+++L+G L M++ +M + L L G KL + + ++
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF--M 119
Query: 808 VGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS 867
V IA G+ YL + IHRD+ + N +L ++ +ADFGL++ + +G
Sbjct: 120 VDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK---------KIYSGD 167
Query: 868 Y-----------GYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
Y +IA E KSD+++FGV + E+ T G+ P
Sbjct: 168 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-09
Identities = 63/235 (26%), Positives = 98/235 (41%), Gaps = 49/235 (20%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWR--SDNDIESGDDLFREVSLLGRLRHRNIVRL 762
+IG GG G VY A VA+KK+ S+N + L RE + L H IV +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHPGIVPV 67
Query: 763 LGYLHNETNVMMVYDYMP----------------NDSLGEALHGKEAGKLLVDWVSRYNI 806
+ ++ + VY MP +SL + L K + + +I
Sbjct: 68 YS-ICSDGDP--VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL------SI 118
Query: 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM------------- 853
I + Y+H V+HRD+K +NILL E I D+G A
Sbjct: 119 FHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 854 ----MLHKNETV-SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
+ + + T+ + G+ Y+APE + E +DIY+ GV+L ++LT P
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 35/98 (35%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 810 IAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG 869
A+ L L + + VI+RD+K NILLD + DFGL ++ + ++ + G+
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE 158
Query: 870 YIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y+APE +GYT V D ++ GV+L E+LTG P
Sbjct: 159 YLAPELLLGHGYTKAV----DWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL-FREVSLLGRLRHRNIVRLLG 764
+G GG G V + + A KKL + +SG+ + E +L ++ IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
++T++ +V M L H G+ ++ + + I G+ +LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDL--KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMD 115
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE------YGYT 878
+++RD+K N+LLD R++D GLA + L +T++ AG+ GY+APE Y Y
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 879 LKVDEKSDIYSFGVVLLELLTGKMPL 904
+ D ++ G + E++ G+ P
Sbjct: 175 V------DWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 2/95 (2%)
Query: 810 IAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG 869
I L+YLH + V++RD+K N++LD + +I DFGL + + T+ G+
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 161
Query: 870 YIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
Y+APE D + GVV+ E++ G++P
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 9/202 (4%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD--NDIESGDDLFREVSLLGRLRHRNIVRL 762
+IG G G V A+ AVK L + N E + LL ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
+ V D++ GE + + + +R+ A IA L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNG---GELFFHLQRERSFPEPRARFYAA-EIASALGYLH---S 114
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD 882
+++RD+K NILLD+ + DFGL + + +++T + G+ Y+APE D
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 883 EKSDIYSFGVVLLELLTGKMPL 904
D + G VL E+L G P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 15/100 (15%)
Query: 810 IAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG 869
I L YLH C V++RD+K N++LD + +I DFGL + + T+ G+
Sbjct: 104 IVSALGYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160
Query: 870 YIAPE------YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y+APE YG + D + GVV+ E++ G++P
Sbjct: 161 YLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 3e-09
Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 38/201 (18%)
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETN----VMMVY----DYMPNDSLGEALHGKEAGKLLV 798
EV+++ L+H+NIVR + N+ N ++M + D N + GK +V
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 799 DWVSRYNIAVGIAQGLNYLHHDCQPP----VIHRDIKSNNILLDANLE------------ 842
D I + L Y H+ P V+HRD+K NI L +
Sbjct: 122 D------ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 843 -----ARIADFGLARMMLHKNETVSMVAGSYGYIAPEY--GYTLKVDEKSDIYSFGVVLL 895
A+I DFGL++ + ++ S V Y Y +PE T D+KSD+++ G ++
Sbjct: 176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPY-YWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 896 ELLTGKMPLDPAFGGSKDIVE 916
EL +GK P A S+ I E
Sbjct: 235 ELCSGKTPFHKANNFSQLISE 255
|
Length = 1021 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 70/288 (24%), Positives = 118/288 (40%), Gaps = 40/288 (13%)
Query: 706 IGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
+G G G+VY+ VAVK + S + + + E S++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVV 72
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHG------KEAGKLLVDWVSRYNIAVGIAQGL 814
RLLG + ++V + M + L L G+ +A IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 815 NYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG----- 869
YL+ +HRD+ + N ++ + +I DFG+ R + ET G G
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY---ETDYYRKGGKGLLPVR 186
Query: 870 YIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929
++APE SD++SFGVVL E+ + + P G S E VL +
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS--LAEQPYQGLSN---EQVLKFV------- 234
Query: 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977
+D Q + E + ++R +C PK RPT +++ +L +
Sbjct: 235 --MDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 68/277 (24%), Positives = 111/277 (40%), Gaps = 44/277 (15%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G G V+ + VAVK R + +E +L + H NIVRL+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+ + +V + + L E +L V + + + A G+ YL
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQ--MVENAAAGMEYLESKH---C 115
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG-------YIAPE---Y 875
IHRD+ + N L+ +I+DFG++R E + A + G + APE Y
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNY 170
Query: 876 GYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934
G + +SD++SFG++L E + G +P SN+ EA++
Sbjct: 171 G---RYSSESDVWSFGILLWEAFSLGAVPY-ANL---------------SNQQTREAIEQ 211
Query: 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
+ C + + V R+ C P RP+ V
Sbjct: 212 GVRLPCPELCPDA--VYRLMERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 24/157 (15%)
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
+ N ++L + +++ DY+ + L + L + GKL V I + + LN
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVK--KIIRQLVEALN 123
Query: 816 YLH-HDCQPPVIHRDIKSNNILLD-ANLEARIADFGLARMMLHKNETVSMVAGSYGYIAP 873
LH H+ +IH DIK N+L D A + D+GL +++ T S G+ Y +P
Sbjct: 124 DLHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKII----GTPSCYDGTLDYFSP 175
Query: 874 EYGYTLKV-----DEKSDIYSFGVVLLELLTGKMPLD 905
E K+ D D ++ GV+ ELLTGK P
Sbjct: 176 E-----KIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 31/227 (13%)
Query: 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL-FREVSLLGRLRHRNI 759
++ ++G GG G V + + A K+L + G+ + E +L ++ + +
Sbjct: 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFV 62
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN----------IAVG 809
V L Y Y D+L L G L + N A
Sbjct: 63 VNL------------AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE 110
Query: 810 IAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG 869
I GL LH + ++RD+K NILLD RI+D GLA + + + E++ G+ G
Sbjct: 111 ILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVG 166
Query: 870 YIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVE 916
Y+APE + D + G ++ E++ G+ P F G K+ V+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP----FRGRKEKVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 56/267 (20%), Positives = 118/267 (44%), Gaps = 35/267 (13%)
Query: 713 IVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-REVSLLGRLRHRNIVRLLGYLHNETN 771
+YK F+ + V ++ + + D+ E+ L R+ NI+++ G++ + +
Sbjct: 35 SIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 772 ----VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIH 827
+ ++ +Y L E L ++ + + ++ ++A+ +GL L+ P +
Sbjct: 93 DLPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYTNKP--Y 146
Query: 828 RDIKSNNILLDANLEARIADFGLARMMLHK--NETVSMVAGSYGYIAPEYGYTLKVDEKS 885
+++ S + L+ N + +I GL +++ MV SY + + + K
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFS---EYTIKD 203
Query: 886 DIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQE 945
DIYS GVVL E+ TGK+P + +K+I + + I N + LD + +C
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENL--TTKEIYDLI---INKNNSLKLPLDCPLEIKC----- 253
Query: 946 EMLLVLRIAVLCTAKLPKGRPTMRDVI 972
I CT+ RP +++++
Sbjct: 254 -------IVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKL--WRSDNDIESGDDLFREV-SLLGRLRHRNIVR 761
+IG G G V + V A+K L W E+ FRE +L ++ I
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA--CFREERDVLVNGDNQWITT 65
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIA-QGLNYLHHD 820
L +E N+ +V DY L L K +L D Y + IA ++ LH+
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY- 123
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA-GSYGYIAPEYGYTL 879
+HRDIK +NIL+D N R+ADFG ++ S VA G+ YI+PE +
Sbjct: 124 -----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 880 -----KVDEKSDIYSFGVVLLELLTGKMPL 904
K + D +S GV + E+L G+ P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 64/217 (29%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKL--WRSDNDIESGDDLFREVSLLGRLRHRNIV-- 760
+IG G G V + + A+K L W E+ FRE RN++
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETA--CFRE--------ERNVLVN 57
Query: 761 ---RLLGYLH----NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQG 813
+ + LH +E + +V DY L L K +L D Y IA+
Sbjct: 58 GDCQWITTLHYAFQDENYLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFY-----IAEM 111
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA-GSYGYIA 872
+ +H Q +HRDIK +N+LLD N R+ADFG M S VA G+ YI+
Sbjct: 112 VLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYIS 171
Query: 873 PEYGYTL-----KVDEKSDIYSFGVVLLELLTGKMPL 904
PE + K + D +S GV + E+L G+ P
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 3/95 (3%)
Query: 810 IAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG 869
I L YLH V++RDIK N++LD + +I DFGL + + T+ G+
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160
Query: 870 YIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
Y+APE D + GVV+ E++ G++P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 7/157 (4%)
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNI 806
E ++L ++H IV L+ + ++ +Y+ L +H + G + D Y
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLS 107
Query: 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG 866
+ +A L +LH +I+RD+K NILLDA ++ DFGL + +H+ G
Sbjct: 108 EISLA--LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCG 162
Query: 867 SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
+ Y+APE + D +S G ++ ++LTG P
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-09
Identities = 49/174 (28%), Positives = 74/174 (42%), Gaps = 26/174 (14%)
Query: 741 GDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDW 800
G RE+ +L + HR I+ L+ ++ V MV D L + L
Sbjct: 130 GKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD-LFTYVDRSGPLPL---- 184
Query: 801 VSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA-RMMLHKNE 859
I + + L YLH +IHRD+K+ NI LD A + DFG A ++ H +
Sbjct: 185 EQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 860 TVSMVAGSYGYI------APEYGYTLKVD---EKSDIYSFGVVLLELLTGKMPL 904
YG+ +PE L +D K+DI+S G+VL E+ + L
Sbjct: 242 -----PQCYGWSGTLETNSPEL---LALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-08
Identities = 37/122 (30%), Positives = 61/122 (50%), Gaps = 3/122 (2%)
Query: 383 LILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQI 442
L L N G P +S + L + + N I G IP LG++ SL+ L+++ N+ G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 443 PDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQ-AKIPNELQAC-PSL 500
P+ + TSL ++++ N L +P+++ + +N IP L+AC P L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG-LRACGPHL 541
Query: 501 SV 502
SV
Sbjct: 542 SV 543
|
Length = 623 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 13/152 (8%)
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
I +L ++ N+ +V +Y P L +L + + D Y + +A ++ +H
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQFDEDMAQFYLAELVLA--IHSVH 119
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFG-LARMMLHKNETVSMVAGSYGYIAPEYGY 877
Q +HRDIK N+L+D ++ADFG AR+ +K + G+ YIAPE
Sbjct: 120 ---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 878 TLKVDEKS------DIYSFGVVLLELLTGKMP 903
T+ D K D +S GV+ E++ G+ P
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 23/203 (11%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
++G G G V+K VAVK + D E E +L + H NIV+L+G
Sbjct: 2 LLGKGNFGEVFKGTLKD-KTPVAVKTC-KEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-HDCQP 823
+ +V + +P L K+ +L + ++ A+ A G+ YL +C
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKF--ALDAAAGMAYLESKNC-- 114
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG----SYGYIAPE---YG 876
IHRD+ + N L+ N +I+DFG++R +++ + +G + APE YG
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYG 169
Query: 877 YTLKVDEKSDIYSFGVVLLELLT 899
+ +SD++S+G++L E +
Sbjct: 170 ---RYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 64/245 (26%), Positives = 102/245 (41%), Gaps = 52/245 (21%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR---EVSLLGRLRHRNIVRL 762
+G G G V+ + A+K L ++ + + R E +L L H + L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVL--DKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIA-VGIAQGLNYLHHDC 821
ET + +V DY P L L ++ GK L + V+R+ A V +A L YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQ-RQPGKCLSEEVARFYAAEVLLA--LEYLH--L 121
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLA-------------------RMMLHK--NET 860
+++RD+K NILL + ++DF L+ R ++ +ET
Sbjct: 122 LG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 861 VSMVA--------GSYGYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAF 908
S G+ YIAPE G+ VD ++ G++L E+L G P
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVD----WWTLGILLYEMLYGTTPF---K 233
Query: 909 GGSKD 913
G ++D
Sbjct: 234 GSNRD 238
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 810 IAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG 869
I L+YLH +++RD+K N++LD + +I DFGL + + T+ G+
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160
Query: 870 YIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
Y+APE D + GVV+ E++ G++P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 34/90 (37%), Positives = 46/90 (51%), Gaps = 18/90 (20%)
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA-GSYGYIAPE---------- 874
+HRDIK +N+LLD N R+ADFG +L S VA G+ YI+PE
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 875 -YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
YG + D +S GV + E+L G+ P
Sbjct: 184 RYG------PECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-08
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF--REVSLLGRLRHRNIVRL 762
+IG G G V V A+K L + + I+ D F E ++ +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
++ + MV +YMP L + + + W Y V +A L+ +H
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTAEVVLA--LDAIH---S 160
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV--SMVAGSYGYIAPEYGYTLK 880
IHRD+K +N+LLD + ++ADFG M ++K V G+ YI+PE +
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 881 VD----EKSDIYSFGVVLLELLTGKMPL 904
D + D +S GV L E+L G P
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD----NDIESGDDLFREVSLLGRLRHRNIV 760
+I G G VY A+KK+ + + N I+ +F E +L + +V
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQ---VFVERDILTFAENPFVV 64
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
+ + ++ MV +Y+ L K G L VD Y +A L YLH+
Sbjct: 65 SMFCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLA--LEYLHN- 119
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM----------------V 864
++HRD+K +N+L+ + ++ DFGL+++ L + T ++ V
Sbjct: 120 --YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL-MSLTTNLYEGHIEKDTREFLDKQV 176
Query: 865 AGSYGYIAPEY----GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
G+ YIAPE GY V D ++ G++L E L G +P
Sbjct: 177 CGTPEYIAPEVILRQGYGKPV----DWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 24/179 (13%)
Query: 744 LFREVSLLGRLRHRNIVRLLGYLHNETNVMMV-YDYMPNDSLGEALH-GKEAGKLLVDWV 801
L +E LL L H+NI+ +L + V Y YM +L L + +
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114
Query: 802 SRYNI---AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM---- 854
S + A+ IA G++YLH + VIH+DI + N ++D L+ +I D L+R +
Sbjct: 115 STQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
Query: 855 ---LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP---LDP 906
L NE + ++A E + SD++SFGV+L EL+T G+ P +DP
Sbjct: 172 YHCLGDNENRPV-----KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-08
Identities = 45/177 (25%), Positives = 81/177 (45%), Gaps = 39/177 (22%)
Query: 810 IAQGLNYL-HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS- 867
+A+G+++L +C IHRD+ + NILL +I DFGLAR + +N++ +V G+
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI--RNDSNYVVKGNA 276
Query: 868 ---YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT------GKMPLDPAFGGSKDIVEWV 918
++APE + +SD++S+G++L E+ + MP+D F
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF---------- 326
Query: 919 LSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
MIK + EM +++ C P RPT + ++ ++
Sbjct: 327 YKMIKEGYRMLSP---------ECAPSEMYDIMKS---CWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 52/183 (28%), Positives = 85/183 (46%), Gaps = 14/183 (7%)
Query: 726 VAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLG 785
V VK+L R ++ E L+H N+++ LG T ++V ++ P L
Sbjct: 25 VVVKEL-RVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLK 83
Query: 786 EALHGKEAGKLLV-DWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEAR 844
L +L+ D + +A IA GL +LH + IH D+ N LL A+L +
Sbjct: 84 GYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVK 140
Query: 845 IADFGLARMMLHKNE--TVSMVAGSYGYIAPE-----YGYTLKVDE--KSDIYSFGVVLL 895
I D+GL+ ++ T + +IAPE +G L VD+ +S+++S GV +
Sbjct: 141 IGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIW 200
Query: 896 ELL 898
EL
Sbjct: 201 ELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 67/265 (25%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSD----NDIESGDDLFREVSLLGRLRHRNIVR 761
IG+G G V + + A+K L ++D N + E +L + +V+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAH---VKAERDILAEADNEWVVK 65
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
L ++ N+ V DY+P + L + + ++R+ IA + + +H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG---IFEEDLARFYIA-ELTCAIESVH--- 118
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLA------------------------------ 851
+ IHRDIK +NIL+D + ++ DFGL
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 852 -------------RMMLHKNETVSMVAGSYGYIAPEY----GYTLKVDEKSDIYSFGVVL 894
R H+ + G+ YIAPE GYT + D +S GV+L
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT----QLCDWWSVGVIL 234
Query: 895 LELLTGKMP-LDPAFGGSK-DIVEW 917
E+L G+ P L ++ ++ W
Sbjct: 235 YEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 19/171 (11%)
Query: 746 REVSLLGRLRHRNIVRLLGYL--HNETNVMMVYDYMPNDSLGEALHGKEAGK-----LLV 798
RE++LL L+H N++ L H++ V +++DY +D L + A K + +
Sbjct: 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD-LWHIIKFHRASKANKKPMQL 105
Query: 799 DWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEAR----IADFGLARMM 854
++ I G++YLH + V+HRD+K NIL+ R IAD G AR+
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
Query: 855 ---LHKNETVSMVAGSYGYIAPEYGYTLKVDEKS-DIYSFGVVLLELLTGK 901
L + V ++ Y APE + K+ DI++ G + ELLT +
Sbjct: 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 65/288 (22%), Positives = 115/288 (39%), Gaps = 40/288 (13%)
Query: 706 IGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
+G G G+VY+ P VA+K + + + + + E S++ ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVV 72
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHG------KEAGKLLVDWVSRYNIAVGIAQGL 814
RLLG + +++ + M L L + +A IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 815 NYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG----- 869
YL+ + +HRD+ + N ++ + +I DFG+ R + ET G G
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDYYRKGGKGLLPVR 186
Query: 870 YIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929
+++PE SD++SFGVVL E+ T + P G S E VL + D
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPYQGMSN---EQVLRFVMEGGLLD 241
Query: 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977
+ C ++ + +C PK RP+ ++I+ + E
Sbjct: 242 K------PDNCPD------MLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKL---WRSDNDIESGDDLFREVSLLGRLRHRNIVRL 762
IG G G V+K + AVK L D +IE+ ++ + +S H N+V+
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKF 80
Query: 763 LGYLH-----NETNVMMVYDYMPNDSLGEALHGK-EAGKLLVDWVSRYNIAVGIAQGLNY 816
G + N + +V + S+ + + G + G+ + + + Y + + GL +
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL-MGLQH 139
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY- 875
LH + IHRD+K NNILL ++ DFG++ + + G+ ++APE
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196
Query: 876 ----GYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
D + D++S G+ +EL G PL
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 35/100 (35%), Positives = 61/100 (61%), Gaps = 12/100 (12%)
Query: 810 IAQGLNYL-HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS- 867
+AQG+++L +C IHRD+ + N+LL A+I DFGLAR ++ N++ +V G+
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIM--NDSNYVVKGNA 274
Query: 868 ---YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
++APE + +SD++S+G++L E+ + GK P
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 705 IIGMGGNGIVY---KAEFHRPHMVVAVKKLWRSD--NDIESGDDLFREVSLLGRLRHRNI 759
++G G G V+ K H + A+K L ++ ++ + E ++L +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 760 VRLLGY-LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
+ L Y E + ++ DY+ + L+ ++ D V Y+ + +A L +LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS--EDEVRFYSGEIILA--LEHLH 122
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML--HKNETVSMVAGSYGYIAPEY- 875
+ +++RDIK NILLD+ + DFGL++ L K T S G+ Y+APE
Sbjct: 123 ---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF-CGTIEYMAPEII 178
Query: 876 ----GYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
G+ V D +S G+++ ELLTG P
Sbjct: 179 RGKGGHGKAV----DWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-07
Identities = 50/190 (26%), Positives = 88/190 (46%), Gaps = 37/190 (19%)
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGK----------EAGKL 796
E+ L H IV+ ++ ++++ +Y L + + + E G L
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 797 LVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856
Y I + L+ +H ++HRD+KS NI L ++ DFG ++
Sbjct: 175 F------YQIVLA----LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK---Q 218
Query: 857 KNETVSM-VAGSYG----YIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG- 910
+++VS+ VA S+ Y+APE + +K+D++S GV+L ELLT P F G
Sbjct: 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP----FKGP 274
Query: 911 -SKDIVEWVL 919
++I++ VL
Sbjct: 275 SQREIMQQVL 284
|
Length = 478 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-----IE-SGDDLF--REVSLLGRLRHR 757
+G G G VYKA+ +K + D D IE +G + RE++LL L+H
Sbjct: 9 VGRGTYGHVYKAK----------RKDGKDDRDYALKQIEGTGISMSACREIALLRELKHP 58
Query: 758 NIVRLLGYL--HNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSR-----YNIAVGI 810
N++ L H + V +++DY +D L + A K V ++ I
Sbjct: 59 NVISLQKVFLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117
Query: 811 AQGLNYLHHDCQPPVIHRDIKSNNILLDANLEAR----IADFGLARMM---LHKNETVSM 863
G++YLH + V+HRD+K NIL+ R IAD G AR+ L +
Sbjct: 118 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 864 VAGSYGYIAPEYGYTLKVDEKS-DIYSFGVVLLELLTGK 901
V ++ Y APE + K+ DI++ G + ELLT +
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 29/174 (16%)
Query: 810 IAQGLNYL-HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS- 867
+A+G+ +L C IHRD+ + NILL N +I DFGLAR + + V GS
Sbjct: 183 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGSA 236
Query: 868 ---YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIK 923
++APE + +SD++SFGV+L E+ + G P P +++ + + +
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-PGVQINEEFCQRLKDGTR 295
Query: 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977
+A + A P I RI + C PK RPT ++ +LG+
Sbjct: 296 M-RAPENA-TPEI--------------YRIMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 28/78 (35%), Positives = 42/78 (53%)
Query: 366 LSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNL 425
L G IP + +L + L NS G P SL + SL + + N +G+IP LG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 426 PSLQRLEMANNNLTGQIP 443
SL+ L + N+L+G++P
Sbjct: 490 TSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 24/189 (12%)
Query: 726 VAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLG 785
V +K L D + F SL+ +L H+++V+L G + N+ MV +Y+ L
Sbjct: 33 VVLKVLGSDHRDSLA---FFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLD 88
Query: 786 EALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL-------D 838
LH +E + + W + ++A +A L+YL ++H ++ NIL+
Sbjct: 89 VFLH-REKNNVSLHW--KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEG 142
Query: 839 ANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY--GYTLKVDEKSDIYSFGVVLLE 896
+++D G+ +L + E V + +IAPE + +D +SFG LLE
Sbjct: 143 YVPFIKLSDPGIPITVLSREERVERIP----WIAPECIRNGQASLTIAADKWSFGTTLLE 198
Query: 897 LLT-GKMPL 904
+ + G+ PL
Sbjct: 199 ICSNGEEPL 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-07
Identities = 69/238 (28%), Positives = 114/238 (47%), Gaps = 55/238 (23%)
Query: 260 LTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLT 319
+ T+Y N T IP L ++ ++LS N+I+ E+P +L LQ L+L N+++
Sbjct: 222 IKTLYANSNQLT-SIPATLPD--TIQEMELSINRIT-ELPERLPSA--LQSLDLFHNKIS 275
Query: 320 GLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGN 379
L P+ L E +L L ++ NS I +LP L P+G
Sbjct: 276 CL-PENLPE--ELRYLSVYDNS-IRTLPAHL--------------------PSG------ 305
Query: 380 LTKLILFNNSFS---GTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANN 436
+T L + +NS + T P L T +N L S +P L P LQ L+++ N
Sbjct: 306 ITHLNVQSNSLTALPETLPPGLKTL-----EAGENALTS--LPASLP--PELQVLDVSKN 356
Query: 437 NLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNEL 494
+T +P+ +L +++ +D+S N L + LP ++ + +LQ AS NNL ++P L
Sbjct: 357 QIT-VLPE--TLPPTITTLDVSRNALTN-LPENLPA--ALQIMQASRNNL-VRLPESL 407
|
Length = 754 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 706 IGMGGNGIVYKAEFHRPHMV--VAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V + + ++ + VAVK + + +D E + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 764 GY-LHNETN-----VMMVYDYMPNDSLGEALHGKEAG--------KLLVDWVSRYNIAVG 809
G L + +++ +M + L L G ++LV +++
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT------D 120
Query: 810 IAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN--ETVSMVAGS 867
IA G+ YL IHRD+ + N +L+ N+ +ADFGL++ + + + +
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 868 YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+IA E KSD++SFGV + E+ T G+ P
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-06
Identities = 55/242 (22%), Positives = 99/242 (40%), Gaps = 55/242 (22%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-------NDIESGDDLFREVSLLGRLRHR 757
+IG G G V + V A+K L ++D I + D+ E L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW----- 62
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
+V++ ++ N+ ++ +++P + L K+ L + +++ IA + ++ +
Sbjct: 63 -VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT---LTEEETQFYIAETVL-AIDSI 117
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLA-------RMMLHKNETVSM------- 863
H Q IHRDIK +N+LLD+ +++DFGL R ++N S+
Sbjct: 118 H---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 864 ---------------------VAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKM 902
G+ YIAPE ++ D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 903 PL 904
P
Sbjct: 235 PF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 28/196 (14%)
Query: 726 VAVKKLWRSDNDIESGDDL---FREVSLLGRLRHRNIVRLLGY-LHNETN-----VMMVY 776
VAVK L DI S D+ RE + + H N+++L+G L + M++
Sbjct: 30 VAVKML---KADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVIL 86
Query: 777 DYMPNDSLGEALH----GKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKS 832
+M + L L G+E L + + R+ + IA G+ YL IHRD+ +
Sbjct: 87 PFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF--MIDIASGMEYLSSK---NFIHRDLAA 141
Query: 833 NNILLDANLEARIADFGLARMM----LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIY 888
N +L+ N+ +ADFGL++ + ++ S + ++A E SD++
Sbjct: 142 RNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVKWLALESLADNVYTTHSDVW 199
Query: 889 SFGVVLLELLT-GKMP 903
+FGV + E++T G+ P
Sbjct: 200 AFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 22/150 (14%)
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSL----GEALHGKEAGKLLVDWVSRYNIAVGIAQG 813
N+V L Y+ +E +V +V + L + L+ E + + W + +A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPE--ECVKRWAAEMVVA------ 97
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK--NETVSMVAGSYGYI 871
L+ LH + ++ RD+ NNILLD ++ F + E V + Y
Sbjct: 98 LDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149
Query: 872 APEYGYTLKVDEKSDIYSFGVVLLELLTGK 901
APE G + E D +S G +L ELLTGK
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 11/95 (11%)
Query: 810 IAQGLNYL-HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS- 867
+A+G+ +L C IHRD+ + NILL N +I DFGLAR + + V G
Sbjct: 182 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGDA 235
Query: 868 ---YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT 899
++APE + +SD++SFGV+L E+ +
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 11/95 (11%)
Query: 810 IAQGLNYL-HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS- 867
+A+G+ +L +C +HRD+ + N+LL +I DFGLAR ++H + VS GS
Sbjct: 246 VARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS--KGST 299
Query: 868 ---YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT 899
++APE + SD++S+G++L E+ +
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 34/116 (29%), Positives = 49/116 (42%), Gaps = 24/116 (20%)
Query: 311 LNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEI 370
L L L G IP+ + +L L+ + L NS+ G++P LG + L LD S
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLS-------- 474
Query: 371 PTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLP 426
NSF+G+ P SL SL + + N +SG +P LG
Sbjct: 475 ----------------YNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 706 IGMGGNGIV----YKAEFHRPHMVVAVKKLWRSDNDIESG-DDLFREVSLLGRLRHRNIV 760
+G G G V YK E P VA+K+ +S + D +F E +L + H V
Sbjct: 38 LGTGSFGRVILATYKNEDFPP---VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
L G +E+ + +V +++ GE K + V + A I YL
Sbjct: 95 NLYGSFKDESYLYLVLEFVIG---GEFFTFLRRNKRFPNDVGCF-YAAQIVLIFEYLQ-- 148
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLK 880
+++RD+K N+LLD + ++ DFG A+++ + T + G+ YIAPE +
Sbjct: 149 -SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT---LCGTPEYIAPEILLNVG 204
Query: 881 VDEKSDIYSFGVVLLELLTGKMPL 904
+ +D ++ G+ + E+L G P
Sbjct: 205 HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 56/236 (23%), Positives = 99/236 (41%), Gaps = 43/236 (18%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLL 763
+IG G G V + + A+K L ++D + E + E +L +V++
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
++ N+ ++ +++P + L K+ L + +++ IA + ++ +H Q
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDT---LSEEATQFYIAETVL-AIDAIH---QL 120
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLA------------RMMLH--------------- 856
IHRDIK +N+LLDA +++DFGL R + H
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 857 KNET--------VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
K ET G+ YIAPE ++ D +S GV++ E+L G P
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 810 IAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS-- 867
+A+G+ +L IHRD+ + NILL N +I DFGLAR + + V
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 868 YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT 899
++APE + +SD++SFGV+L E+ +
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 810 IAQGLNYL-HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS- 867
+A G+ +L +C +HRD+ + N+L+ +I DFGLAR ++ + +S GS
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS--KGST 301
Query: 868 ---YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT 899
++APE + SD++SFG++L E+ T
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 9e-06
Identities = 58/244 (23%), Positives = 98/244 (40%), Gaps = 58/244 (23%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGD--DLFREVSLLGRLRHRNIVRL 762
+IG G G V + + A+KKL +S+ +E + E +L + +V+L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM-LEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
+E + ++ +Y+P + L K+ + +R+ IA I ++ +H +
Sbjct: 67 YYSFQDENYLYLIMEYLPGGDMMTLLMKKD---TFTEEETRFYIAETIL-AIDSIH---K 119
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM------------------- 863
IHRDIK +N+LLDA +++DFGL L K+
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLC-TGLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 864 --------------------VAGSYGYIAPE----YGYTLKVDEKSDIYSFGVVLLELLT 899
G+ YIAPE GY ++ D +S GV++ E+L
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN----KECDWWSLGVIMYEMLV 234
Query: 900 GKMP 903
G P
Sbjct: 235 GYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 66/306 (21%), Positives = 104/306 (33%), Gaps = 59/306 (19%)
Query: 182 FRNLQKLKFLGLSGNNLTGK----IPPELGQLSSLETIILGYNAFEGEIPAE-------F 230
L L+ L L GN L + + L SL+ + L N G IP
Sbjct: 19 LPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN-ETGRIPRGLQSLLQGL 77
Query: 231 GNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTV-YLYKNN---------FTGKIPPELGS 280
L+ LDL+ +L L L + +++ L NN K +L
Sbjct: 78 TKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPP 137
Query: 281 ITSLAFLDLSDNQISGEIPVKLAEL----KNLQLLNLMCNQLTG----LIPDKLGELTKL 332
+L L L N++ G LA+ ++L+ LNL N + + + L L
Sbjct: 138 --ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNL 195
Query: 333 EVLELWKNSL----IGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNN 388
EVL+L N L +L L L L+ N L+ L +
Sbjct: 196 EVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASA----------- 244
Query: 389 SFSGTFPVSLSTCKSLVRVRVQNNLI----SGTIPVGLGNLPSLQRLEMANNNLTGQIPD 444
LS SL+ + + N I + + L SL L++ N +
Sbjct: 245 --------LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQ 296
Query: 445 DISLST 450
++ S
Sbjct: 297 LLAESL 302
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-05
Identities = 62/245 (25%), Positives = 97/245 (39%), Gaps = 83/245 (33%)
Query: 410 QNNLISGTIPVGL-GNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNH---LESY 465
N L S +P L GN+ + L +N LT IP +L ++ +++S N L
Sbjct: 208 NNELKS--LPENLQGNI---KTLYANSNQLT-SIPA--TLPDTIQEMELSINRITELPER 259
Query: 466 LPSSILSIPSLQTFMASHNNLQA---KIPNELQACPSLSVLDLSSNSLSGEIPASIASCE 522
LPS+ LQ+ HN + +P EL+ LSV D S +L +P+ I
Sbjct: 260 LPSA------LQSLDLFHNKISCLPENLPEELR---YLSVYDNSIRTLPAHLPSGI---- 306
Query: 523 KLVSLNLRNNRFS---GEIPKAVATM---------------PTLAILDMSNN-------- 556
LN+++N + +P + T+ P L +LD+S N
Sbjct: 307 --THLNVQSNSLTALPETLPPGLKTLEAGENALTSLPASLPPELQVLDVSKNQITVLPET 364
Query: 557 ------------SLFGRIPENFGASPALEMLNLSYNKL------------EGPVPSNGIL 592
+ +PEN A AL+++ S N L EGP P+ I+
Sbjct: 365 LPPTITTLDVSRNALTNLPENLPA--ALQIMQASRNNLVRLPESLPHFRGEGPQPTR-II 421
Query: 593 MNINP 597
+ NP
Sbjct: 422 VEYNP 426
|
Length = 754 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 747 EVSLLGRLRHRNIVRLLG-YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN 805
E +L + H +I++L G + +N+ +++ Y + L+ A K +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD------LYCYLAAKRNIAICDILA 186
Query: 806 IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM-V 864
I + + + YLH + +IHRDIK+ NI ++ + + DFG A + N
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 865 AGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
AG+ APE DI+S G+VL E+ T L
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-05
Identities = 17/48 (35%), Positives = 25/48 (52%), Gaps = 7/48 (14%)
Query: 17 ADDELSTLLSIKAGL-IDPLNMLEDWKMPSNAAENGLLHCNWTGVWCN 63
+D+ LL+ K+ L DP L W PS++ C+WTGV C+
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWN-PSSSD-----PCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 39/115 (33%), Positives = 60/115 (52%), Gaps = 24/115 (20%)
Query: 805 NIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM-LHKNETVSM 863
NI G +GLNYLH Q IHR+IK+++IL+ + ++ GL+ + L +N +
Sbjct: 105 NILFGALRGLNYLH---QNGYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAK 159
Query: 864 VAGSYG--------YIAPE------YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
V + +++PE YGY +K SDIYS G+ EL TG++P
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVK----SDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 45/184 (24%), Positives = 80/184 (43%), Gaps = 4/184 (2%)
Query: 424 NLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASH 483
+ L + + +++ L +D++ N L S S +L + +L + +
Sbjct: 67 SRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRS-NISELLELTNLTSLDLDN 125
Query: 484 NNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVA 543
NN+ P +L LDLS N + +P+ + + L +L+L N S ++PK ++
Sbjct: 126 NNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLS 183
Query: 544 TMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGN 603
+ L LD+S N +P ALE L+LS N + + S L N++ EL N
Sbjct: 184 NLSNLNNLDLSGN-KISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNN 242
Query: 604 AGLC 607
Sbjct: 243 KLED 246
|
Length = 394 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 60/254 (23%), Positives = 99/254 (38%), Gaps = 69/254 (27%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSD----NDIESGDDLFREVSLLGRLRHRNIVR 761
+G+G G V A H + A+K L + D N + + E +L + +V+
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAH---VKAERDILAEADNEWVVK 65
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
L ++ N+ V DY+P + L E + + ++R+ IA + + +H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRME---VFPEVLARFYIA-ELTLAIESVH--- 118
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLA------------------------------ 851
+ IHRDIK +NIL+D + ++ DFGL
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 852 ---------RMML--------HKNETVSMVAGSYGYIAPEY----GYTLKVDEKSDIYSF 890
R+ H+ + G+ YIAPE GYT + D +S
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT----QLCDWWSV 234
Query: 891 GVVLLELLTGKMPL 904
GV+L E+L G+ P
Sbjct: 235 GVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 5e-05
Identities = 19/60 (31%), Positives = 30/60 (50%)
Query: 475 SLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRF 534
+L++ S+N L + P+L VLDLS N+L+ P + + L SL+L N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 68/237 (28%), Positives = 103/237 (43%), Gaps = 22/237 (9%)
Query: 356 LRRLD--ASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNL 413
LR +D S NL EIP L + NL L L + S P S+ L + +
Sbjct: 636 LRNIDLRGSKNLK--EIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCE 692
Query: 414 ISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSI 473
+P G+ NL SL RL ++ + PD +ST++S++D+ +E PS+ L +
Sbjct: 693 NLEILPTGI-NLKSLYRLNLSGCSRLKSFPD---ISTNISWLDLDETAIEE-FPSN-LRL 746
Query: 474 PSLQTF----MASH---NNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVS 526
+L M S +Q P PSL+ L LS E+P+SI + KL
Sbjct: 747 ENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEH 806
Query: 527 LNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
L + N +P + + +L LD+S S P+ S + LNLS +E
Sbjct: 807 LEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD---ISTNISDLNLSRTGIE 859
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 30/101 (29%), Positives = 54/101 (53%), Gaps = 11/101 (10%)
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALH--GKEAGKLLVDWVSRYNIAVGIAQGLNY 816
IV L L + NV +V +Y+ + LH G ++ V ++S +A L+Y
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE------VALALDY 119
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857
LH + +IHRD+K +N+L+ ++ DFGL+++ L++
Sbjct: 120 LH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-04
Identities = 82/328 (25%), Positives = 116/328 (35%), Gaps = 71/328 (21%)
Query: 82 VSENIRGLRSLSSLNICCN----EFASSLPKSLANLTALKSMDVSQNN------FIGSFP 131
+E + L L L + N E A +L +L +LK + +S N + S
Sbjct: 15 ATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLL 74
Query: 132 TGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKF- 190
GL K GL ++ S N LESL +LQ+LK
Sbjct: 75 QGLTKGCGLQELDLSDNALGP------DGCGVLESL------------LRSSSLQELKLN 116
Query: 191 ---LGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGE----IPAEFGNLTNLRYLDLAV 243
LG G L K +L +LE ++LG N EG + +L+ L+LA
Sbjct: 117 NNGLGDRGLRLLAKGLKDLP--PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLAN 174
Query: 244 GSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLA 303
+ AL L + +L LDL++N ++ E LA
Sbjct: 175 NGIGDAGIRALAE--------------------GLKANCNLEVLDLNNNGLTDEGASALA 214
Query: 304 E----LKNLQLLNLMCNQLTG-----LIPDKLGELTKLEVLELWKNSL----IGSLPMRL 350
E LK+L++LNL N LT L L L L L N + L L
Sbjct: 215 ETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVL 274
Query: 351 GQSSPLRRLDASSNLLSGEIPTGLCDSG 378
+ L LD N E L +S
Sbjct: 275 AEKESLLELDLRGNKFGEEGAQLLAESL 302
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 47/188 (25%), Positives = 89/188 (47%), Gaps = 21/188 (11%)
Query: 726 VAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLG 785
V +K L S DI F S++ ++ H++IV L G + +MV +++ L
Sbjct: 35 VILKVLDPSHRDISLA--FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92
Query: 786 EALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL-------D 838
+H +++ L W ++ +A +A L+YL ++H ++ + NILL +
Sbjct: 93 LFMH-RKSDVLTTPW--KFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGE 146
Query: 839 ANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE-YGYTLKVDEKSDIYSFGVVLLEL 897
+++D G+ +L + E V + +IAPE + + +D +SFG L E+
Sbjct: 147 CGPFIKLSDPGIPITVLSRQECVERIP----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
Query: 898 -LTGKMPL 904
G++PL
Sbjct: 203 CYNGEIPL 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 50/213 (23%), Positives = 76/213 (35%), Gaps = 70/213 (32%)
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRY 804
E +L + +VRL ++ N+ V DY+P + L G L +++
Sbjct: 51 ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAEL 110
Query: 805 NIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL-------------- 850
AV + + IHRDIK +NIL+D + ++ DFGL
Sbjct: 111 TCAVESVHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 851 -----------------------------------ARMMLHKNETVSMVAGSYGYIAPEY 875
AR H+ + G+ YIAPE
Sbjct: 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQ--HQRCLAHSLVGTPNYIAPEV 219
Query: 876 ----GYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
GYT + D +S GV+L E+L G+ P
Sbjct: 220 LLRTGYT----QLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 5e-04
Identities = 22/56 (39%), Positives = 26/56 (46%), Gaps = 2/56 (3%)
Query: 187 KLKFLGLSGNNLTGKIPPE-LGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDL 241
LK L LS N LT IP L +L+ + L N P F L +LR LDL
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDL 55
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 7e-04
Identities = 21/60 (35%), Positives = 30/60 (50%)
Query: 451 SLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSL 510
+L +D+S N L + +P+L+ S NNL + P PSL LDLS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 8e-04
Identities = 29/112 (25%), Positives = 53/112 (47%), Gaps = 20/112 (17%)
Query: 806 IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMV- 864
I G+ + L+Y+HH +HR +K+++IL+ + + ++ M++ + + +V
Sbjct: 106 ILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH 162
Query: 865 ------AGSYGYIAPEY------GYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
+++PE GY D KSDIYS G+ EL G +P
Sbjct: 163 DFPKYSVKVLPWLSPEVLQQNLQGY----DAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 9e-04
Identities = 65/288 (22%), Positives = 108/288 (37%), Gaps = 59/288 (20%)
Query: 287 LDLSDNQISGE----IPVKLAELKNLQLLNLMCNQL------TGLIPDKLGELTKLEVLE 336
L L N + E + L +L+ L L N+ + L + L+ L+
Sbjct: 28 LRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELD 87
Query: 337 LWKNSLIGSLP---MRLGQSSPLRRLDASSNLLSGE----IPTGLCDSG-NLTKLILFNN 388
L N+L L +SS L+ L ++N L + GL D L KL+L N
Sbjct: 88 LSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRN 147
Query: 389 SFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQ----IPD 444
G +C++L + + L+ L +ANN + + +
Sbjct: 148 RLEGA------SCEAL----------AKALRA----NRDLKELNLANNGIGDAGIRALAE 187
Query: 445 DISLSTSLSFVDISWNHLE----SYLPSSILSIPSLQTFMASHNNLQAKIPNEL-----Q 495
+ + +L +D++ N L S L ++ S+ SL+ NNL L
Sbjct: 188 GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLS 247
Query: 496 ACPSLSVLDLSSNSLSGEIPASIASCE------KLVSLNLRNNRFSGE 537
SL L LS N ++ + + E L+ L+LR N+F E
Sbjct: 248 PNISLLTLSLSCNDITDD--GAKDLAEVLAEKESLLELDLRGNKFGEE 293
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 20/60 (33%), Positives = 32/60 (53%)
Query: 499 SLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSL 558
+L LDLS+N L+ + L L+L N + P+A + +P+L LD+S N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 0.001
Identities = 86/362 (23%), Positives = 147/362 (40%), Gaps = 65/362 (17%)
Query: 113 LTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGS 172
LT L+++D+ + + P L A+ L ++ S + LP + LE LD
Sbjct: 633 LTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691
Query: 173 FFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEF-- 230
+PT NL+ L L LSG + K P++ +++ + L A E E P+
Sbjct: 692 ENLEILPTGI-NLKSLYRLNLSGCSRL-KSFPDIS--TNISWLDLDETAIE-EFPSNLRL 746
Query: 231 GNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLS 290
NL L ++ L ++ P L L T+ + P SL L LS
Sbjct: 747 ENLDELILCEMKSEKLWERVQP----LTPLMTM----------LSP------SLTRLFLS 786
Query: 291 DNQISGEIPVKLAELKNLQLLNLM-CNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMR 349
D E+P + L L+ L + C L L P + L LE L+L S + + P
Sbjct: 787 DIPSLVELPSSIQNLHKLEHLEIENCINLETL-PTGI-NLESLESLDLSGCSRLRTFP-- 842
Query: 350 LGQSSPLRRLDASSNLLSGEIP-TGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVR 408
D S+N+ + TG + ++ + FS + ++ C +L RV
Sbjct: 843 ----------DISTNISDLNLSRTG------IEEVPWWIEKFSNLSFLDMNGCNNLQRVS 886
Query: 409 VQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPS 468
+ N+ L+ LE + + G + + S + S S V ++ +++ S LPS
Sbjct: 887 L--------------NISKLKHLETVDFSDCGAL-TEASWNGSPSEVAMATDNIHSKLPS 931
Query: 469 SI 470
++
Sbjct: 932 TV 933
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 41/155 (26%), Positives = 61/155 (39%), Gaps = 25/155 (16%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVA--VKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRL 762
+I G I+Y +F VV + K +R D+ R R R R R+
Sbjct: 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYR----HPELDEKLR------RERTRREARI 52
Query: 763 LGYLH-NETNVMMVYDYMPNDSLGEALHGKEAGKLLVD--WVSRYNI--AVGIAQGLNYL 817
L V +VYD P+ G + G+LL D +R ++ VG G L
Sbjct: 53 LAKAREAGVPVPIVYDVDPD--NGLIVMEYIEGELLKDALEEARPDLLREVGRLVGK--L 108
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR 852
H ++H D+ ++NI+L DFGL
Sbjct: 109 HKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 21/60 (35%), Positives = 33/60 (55%)
Query: 283 SLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSL 342
+L LDLS+N+++ L NL++L+L N LT + P+ L L L+L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 55/234 (23%), Positives = 94/234 (40%), Gaps = 48/234 (20%)
Query: 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRY---------NIAVGIAQGLNYLHHDCQ 822
+M + Y N++ + + G L+DW+ ++ I L+Y H +
Sbjct: 193 LMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH 252
Query: 823 PPVIHRDIKSNNILLDAN----------------LEARIADFGLARMMLHKNETVSMVAG 866
++H D+K NIL++ + RI D G H + +
Sbjct: 253 --LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSR---TAIVS 307
Query: 867 SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926
+ Y +PE L +D++S G ++ EL TGK+ D + D +E + M K+
Sbjct: 308 TRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD-----THDNLEHLHLMEKTLG 362
Query: 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVL--CT-----AKLPKGRPTMRDVIT 973
L AG+C +E LL L CT A++ + RP +R+VI
Sbjct: 363 ----RLPSEWAGRCG-TEEARLLYNSAGQLRPCTDPKHLARIARARP-VREVIR 410
|
Length = 467 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 16/32 (50%), Positives = 22/32 (68%), Gaps = 1/32 (3%)
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHK 857
IHRDIK +NIL+D +++DFGL+ HK
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS-TGFHK 153
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1009 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.26 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.15 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.13 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.07 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.03 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.02 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.01 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.0 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.98 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.96 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.96 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.95 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.9 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.87 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.7 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.59 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.57 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.52 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.46 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.43 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.43 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.42 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.38 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-121 Score=1171.46 Aligned_cols=922 Identities=38% Similarity=0.657 Sum_probs=803.3
Q ss_pred hHHhHHHHHHHHhhccCCCCCCCCCCCCCccccCCcCCceeeeEEeCCCCceeEEeccccccccccccccccCCCCCeEe
Q 037197 17 ADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLN 96 (1009)
Q Consensus 17 ~~~~~~~ll~~k~~~~d~~~~l~~W~~~~~~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~ 96 (1009)
.++|+.||++||+++.||.+.+.+|+. +.+||.|.||+|+..++|+.|||+++.++|.++..+..+++|+.|+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~-------~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~ 99 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNS-------SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTIN 99 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCC-------CCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEE
Confidence 578999999999999999888999963 3469999999998888999999999999999999999999999999
Q ss_pred cccCcccccCCcccc-ccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccC
Q 037197 97 ICCNEFASSLPKSLA-NLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFE 175 (1009)
Q Consensus 97 L~~n~~~~~~~~~l~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~ 175 (1009)
|++|.+++.+|..+. ++++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.
T Consensus 100 Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~ 177 (968)
T PLN00113 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177 (968)
T ss_pred CCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccc
Confidence 999999999998765 999999999999999998886 56899999999999999999999999999999999999999
Q ss_pred CcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccC
Q 037197 176 GSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALG 255 (1009)
Q Consensus 176 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 255 (1009)
+.+|..++++++|++|+|++|.+++.+|..++++++|++|+|++|++++.+|..|+++++|++|++++|.+++.+|..++
T Consensus 178 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~ 257 (968)
T PLN00113 178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG 257 (968)
T ss_pred ccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEE
Q 037197 256 RLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVL 335 (1009)
Q Consensus 256 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 335 (1009)
++++|++|+|++|.+++.+|..+.++++|+.|+|++|.+.+.+|..+..+++|++|++++|.+++..|..+..+++|+.|
T Consensus 258 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L 337 (968)
T PLN00113 258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVL 337 (968)
T ss_pred CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccc
Q 037197 336 ELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLIS 415 (1009)
Q Consensus 336 ~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~ 415 (1009)
++++|.+.+.+|..++.+.+|+.|++++|.+++.+|..++.+++|+.|++++|++.+.+|..+..+++|+.|++++|+++
T Consensus 338 ~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~ 417 (968)
T PLN00113 338 QLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417 (968)
T ss_pred ECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccc
Q 037197 416 GTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQ 495 (1009)
Q Consensus 416 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 495 (1009)
+.+|..+.++++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+ ..++|+.|++++|++++.+|..+.
T Consensus 418 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~ 496 (968)
T PLN00113 418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLG 496 (968)
T ss_pred eECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhh
Confidence 9999999999999999999999999999999999999999999999999888766 468999999999999999999999
Q ss_pred cCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEE
Q 037197 496 ACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEML 575 (1009)
Q Consensus 496 ~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 575 (1009)
.+++|+.|+|++|++++.+|..+.++++|+.|+|++|.++|.+|..+..+++|+.|||++|+++|.+|..+..+++|+.|
T Consensus 497 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l 576 (968)
T PLN00113 497 SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQV 576 (968)
T ss_pred hhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCccccCCCCCCcccccCCcccccCcCCCCCCC----CCCCCCCCCCCCCcccccccceeeehhhhhhHHHHHHhhh
Q 037197 576 NLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSVL----PPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVF 651 (1009)
Q Consensus 576 ~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lcg~~~----~~c~~~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~ 651 (1009)
|+++|+++|.+|..+++.++...++.||+++||.+. ++|.... +.....+++++++++++++++++++
T Consensus 577 ~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (968)
T PLN00113 577 NISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR--------KTPSWWFYITCTLGAFLVLALVAFG 648 (968)
T ss_pred eccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc--------ccceeeeehhHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999753 4564321 1112222223233333322222222
Q ss_pred hccccceecccccccccchhccccCCCCcchhhhhcc---ccCCHHHHHhcCCcCceeccCCceEEEEEEECCCCeEEEE
Q 037197 652 FAGKWAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQR---LNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAV 728 (1009)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vav 728 (1009)
++ ++++|++...... ...... |....+.. ..++..++...|+..+.||+|+||.||+|++..+++.|||
T Consensus 649 ~~-~~~~~~~~~~~~~-----~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vav 720 (968)
T PLN00113 649 FV-FIRGRNNLELKRV-----ENEDGT--WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVV 720 (968)
T ss_pred HH-HHHhhhccccccc-----cccccc--ccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEE
Confidence 22 1222221111110 000011 11111111 1234456677888999999999999999999888999999
Q ss_pred EEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHH
Q 037197 729 KKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAV 808 (1009)
Q Consensus 729 K~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~ 808 (1009)
|++..... ...+|++.+++++||||++++++|.+++..++||||+++|+|.++++. ++|.++.+|+.
T Consensus 721 K~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~ 787 (968)
T PLN00113 721 KEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAI 787 (968)
T ss_pred EEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHH
Confidence 99854321 112568899999999999999999999999999999999999999953 68999999999
Q ss_pred HHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchH
Q 037197 809 GIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIY 888 (1009)
Q Consensus 809 ~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~ 888 (1009)
|+++|++|||..+.++|+||||||+||+++.++.+++. ||....... .....+++.|+|||+..+..++.++|||
T Consensus 788 ~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~ 862 (968)
T PLN00113 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIY 862 (968)
T ss_pred HHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchh
Confidence 99999999997767799999999999999999888875 665543211 1223578999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 037197 889 SFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTM 968 (1009)
Q Consensus 889 SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 968 (1009)
||||++|||+||+.||+..........+|+....... ......|+.+........+++.++.+++.+||+.||++||+|
T Consensus 863 S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~ 941 (968)
T PLN00113 863 GFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA 941 (968)
T ss_pred hHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc-chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCH
Confidence 9999999999999999866666667788876543332 234556666654444445667788899999999999999999
Q ss_pred HHHHHHHhhcCCCcc
Q 037197 969 RDVITMLGEAKPRRK 983 (1009)
Q Consensus 969 ~evl~~L~~~~~~~~ 983 (1009)
+||+++|+++.....
T Consensus 942 ~evl~~L~~~~~~~~ 956 (968)
T PLN00113 942 NDVLKTLESASRSSS 956 (968)
T ss_pred HHHHHHHHHhhcccc
Confidence 999999999876443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-64 Score=640.99 Aligned_cols=515 Identities=34% Similarity=0.586 Sum_probs=489.5
Q ss_pred CCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCC-CCcCCeEEecCCCCCCCCCCccccCCCCCCeee
Q 037197 90 RSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLG-KASGLTSVNASSNNFSGFLPEDLGNATSLESLD 168 (1009)
Q Consensus 90 ~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 168 (1009)
.+++.|+|++|.+++.+|..+..+++|++|+|++|++.+.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 4688999999999999999999999999999999999999998765 899999999999999998885 5689999999
Q ss_pred ccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCcccc
Q 037197 169 FRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSG 248 (1009)
Q Consensus 169 L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 248 (1009)
|++|.+.+.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 226 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG 226 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCC
Q 037197 249 QIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGE 328 (1009)
Q Consensus 249 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~ 328 (1009)
.+|..++++++|++|++++|.+++.+|..+.++++|++|+|++|++.+.+|..+..+++|++|++++|.+++.+|..+.+
T Consensus 227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~ 306 (968)
T PLN00113 227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306 (968)
T ss_pred cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEE
Q 037197 329 LTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVR 408 (1009)
Q Consensus 329 l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~ 408 (1009)
+++|+.|++++|.+.+..|..+..+++|+.|++++|.+.+.+|..+..+.+|+.|++++|++++.+|..+..+++|+.|+
T Consensus 307 l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~ 386 (968)
T PLN00113 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI 386 (968)
T ss_pred CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccC
Q 037197 409 VQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQA 488 (1009)
Q Consensus 409 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 488 (1009)
+++|.+.+.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++.+
T Consensus 387 l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~ 466 (968)
T PLN00113 387 LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG 466 (968)
T ss_pred CcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCC
Q 037197 489 KIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGA 568 (1009)
Q Consensus 489 ~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 568 (1009)
.+|..++ .++|+.|||++|++++.+|..+.++++|+.|+|++|++++.+|..+.++++|+.|+|++|+++|.+|..|..
T Consensus 467 ~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 545 (968)
T PLN00113 467 GLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSE 545 (968)
T ss_pred ecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhC
Confidence 8888764 689999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcEEecCCCccccCCCCC-CcccccCCcccccCcCCC
Q 037197 569 SPALEMLNLSYNKLEGPVPSN-GILMNINPNELIGNAGLC 607 (1009)
Q Consensus 569 l~~L~~L~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~lc 607 (1009)
++.|+.|||++|+++|.+|.. ..+..+....+.+|+-.+
T Consensus 546 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 546 MPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred cccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 999999999999999999974 223334444556665443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-49 Score=435.33 Aligned_cols=291 Identities=43% Similarity=0.744 Sum_probs=248.5
Q ss_pred cchhhhhccccCCHHHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCce
Q 037197 680 PWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI 759 (1009)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpni 759 (1009)
+...+++.++ ..+++.|...+.||+|+||.||+|...+ ++.||||++....... ..+|..|++++.+++|||+
T Consensus 61 ~~~~fs~~el----~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nl 133 (361)
T KOG1187|consen 61 PLRSFSYDEL----RKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNL 133 (361)
T ss_pred CcceeeHHHH----HHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCc
Confidence 3455667777 7889999999999999999999999988 5899999885443221 4457899999999999999
Q ss_pred eeEEeEEEcCC-eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC
Q 037197 760 VRLLGYLHNET-NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD 838 (1009)
Q Consensus 760 v~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~ 838 (1009)
|+++|||.+++ +.++|||||++|+|.++++..... .++|.+|++||.++|+||+|||+.+.++||||||||+|||+|
T Consensus 134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 99999999998 599999999999999999986643 589999999999999999999999988999999999999999
Q ss_pred CCCcEEEcccccceecccCCCceeee-cccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC-CCCccHHH
Q 037197 839 ANLEARIADFGLARMMLHKNETVSMV-AGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAF-GGSKDIVE 916 (1009)
Q Consensus 839 ~~~~~kl~DfGls~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~-~~~~~~~~ 916 (1009)
+++++||+|||+|+............ .||.+|+|||+...+..++|+|||||||++.|++||+.|.+... .+...+..
T Consensus 212 ~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~ 291 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVE 291 (361)
T ss_pred CCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHH
Confidence 99999999999996653312222222 79999999999999999999999999999999999999988654 33456899
Q ss_pred HHHHHHhhccccccccCccccc-cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 917 WVLSMIKSNKAQDEALDPSIAG-QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
|+......+ ...+++|+.+.. .+. ..+++.++.+++.+|++.+|++||+|.||+++|+.+...
T Consensus 292 w~~~~~~~~-~~~eiiD~~l~~~~~~-~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 292 WAKPLLEEG-KLREIVDPRLKEGEYP-DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHCc-chhheeCCCccCCCCC-hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 998888877 579999999873 332 226788899999999999999999999999999666543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=377.38 Aligned_cols=253 Identities=26% Similarity=0.454 Sum_probs=212.6
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC-eEEEEEec
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET-NVMMVYDY 778 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-~~~lV~E~ 778 (1009)
.+..+.||+|..|+|||++|+.+++.+|+|.+.. ..+.+..+++.+|++++++++||+||++||.|.... ...++|||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4567789999999999999999999999999943 455677888999999999999999999999999888 59999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
|++|||++++..... +++...-+|+.+|++||.|||+. .+||||||||+|||++..|+|||+|||.++.+.+.
T Consensus 160 MDgGSLd~~~k~~g~----i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGR----IPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999976532 78888889999999999999963 29999999999999999999999999999887544
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
....++||..|||||.+.+..|+.++||||||++++|+++|++||.+......++.+.+....... .|.++.
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p-------pP~lP~ 304 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP-------PPRLPE 304 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC-------CCCCCc
Confidence 566789999999999999999999999999999999999999999865333344444444333222 123332
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. ....++..++..|+++||.+||+++|+++
T Consensus 305 ~-----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 305 G-----EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred c-----cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2 11235667888999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=389.40 Aligned_cols=259 Identities=37% Similarity=0.578 Sum_probs=211.6
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC-eEEEEEecc
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET-NVMMVYDYM 779 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-~~~lV~E~~ 779 (1009)
...+.||+|+||+||+|.+++ ...||||++.....+....+++.+|+.++++++|||||+++|+|.+.. ..++|||||
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g-~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRG-TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhcccCCceeEEEEEeCC-ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 334459999999999999986 334999999776555555667889999999999999999999999887 799999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCC-eEEeccCCCcEEeCCCC-cEEEcccccceecccC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP-VIHRDIKSNNILLDANL-EARIADFGLARMMLHK 857 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~dlk~~NIll~~~~-~~kl~DfGls~~~~~~ 857 (1009)
++|+|.++++.. .+..+++..+++++.|||+|+.|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999874 233489999999999999999999999 7 99999999999999997 9999999999876543
Q ss_pred CCceeeecccCcccCCcccC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NETVSMVAGSYGYIAPEYGY--TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
....+...||+.|||||++. ...|+.|+|||||||++|||+||+.||..... .+.+......+ ..+.
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v~~~~------~Rp~ 266 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAVVVGG------LRPP 266 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcC------CCCC
Confidence 33444478999999999998 66899999999999999999999999984322 23333332222 1233
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
+...+. ..+..++.+||+.||++||++.|++..|+.+...-
T Consensus 267 ~p~~~~------~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 267 IPKECP------PHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCccCC------HHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 332222 24556788999999999999999999999876543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=391.02 Aligned_cols=250 Identities=27% Similarity=0.393 Sum_probs=215.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCC-CChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
..|+..+.||+|||+.||.+++..+|+.||+|++.+.. ......++..+|+++.++++|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56899999999999999999999999999999997643 23456778889999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
|.|+.++|.++++.+.. +++.++..++.||+.||.|||+. +|+|||||..|++++++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krrk~----ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKP----LTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcCC----CCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999975433 88999999999999999999999 999999999999999999999999999999877
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
+++...+.+|||-|+|||++.....+..+||||+||++|-|+.|++||+. +++.+.......... .-|+
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-----k~vkety~~Ik~~~Y-----~~P~- 239 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-----KTVKETYNKIKLNEY-----SMPS- 239 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-----chHHHHHHHHHhcCc-----cccc-
Confidence 77777889999999999999988899999999999999999999999972 333333333322221 1111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
....+..+++.++++.+|.+|||+++|+.
T Consensus 240 --------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 240 --------HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11123457888999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=368.55 Aligned_cols=202 Identities=31% Similarity=0.509 Sum_probs=183.7
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
...|...+.||+|+||+||+|+++.++..||||.+.+........+....|+++++.++|||||++++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 45677778899999999999999999999999999776555666677779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC------CcEEEccccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN------LEARIADFGL 850 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~------~~~kl~DfGl 850 (1009)
|||.||+|.++++.+.. +++.....++.|+|.|+++||++ +||||||||.|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999987754 88889999999999999999999 99999999999999764 4689999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
|+.+. ........+|+|-|||||++...+|+.|+|+||+|+++||+++|+.||+.
T Consensus 162 AR~L~-~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 162 ARFLQ-PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhCC-chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 99874 44555678999999999999999999999999999999999999999983
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=357.95 Aligned_cols=263 Identities=26% Similarity=0.362 Sum_probs=218.9
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEe-EEEcCCe-EEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG-YLHNETN-VMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~-~~~~~~~-~~l 774 (1009)
...|++.+.||+|.||+|||+.+..+|..||.|.+.-...+....++...|+.+|++++|||||++++ -+.++.. +++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 34578888999999999999999999999999999866666677777889999999999999999998 4544444 899
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP--VIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
|||||..|+|...++..+..+..+++...|+++.|++.||.++|+. .+. |+||||||.||+++.+|.||++|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999987777777799999999999999999999994 224 8899999999999999999999999999
Q ss_pred ecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 853 MMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
++..........+|||.||+||.+.+..|+.||||||+||++|||+.-+.||.. +.+.+...+..+...
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-----~n~~~L~~KI~qgd~------ 245 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-----DNLLSLCKKIEQGDY------ 245 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-----ccHHHHHHHHHcCCC------
Confidence 987777777788999999999999999999999999999999999999999973 244444433322211
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
+.+.+ .-...++..|+..|+.+||+.||+...+++.+..
T Consensus 246 -~~~p~-----~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 -PPLPD-----EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -CCCcH-----HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11110 1123456778899999999999997666665544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=370.34 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=205.4
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChh-----hHHHHHHHHHHHhccCCCceeeEEeEEEcC
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE-----SGDDLFREVSLLGRLRHRNIVRLLGYLHNE 769 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~ 769 (1009)
.+.+.|-..+.+|+|+||.|-+|..+.+|+.||||++.+...... ......+|+++|++++|||||+++++|+..
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 345668889999999999999999999999999999976543221 223345999999999999999999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC---CcEEEc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN---LEARIA 846 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~ 846 (1009)
+..|+|||||+||.|.+.+-.+.. +.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence 999999999999999999866544 55556667899999999999999 99999999999999765 679999
Q ss_pred ccccceecccCCCceeeecccCcccCCcccCCCCCC---cccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh
Q 037197 847 DFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD---EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 847 DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
|||+|+... ......+.+|||.|.|||++.+..++ .+.|+||+||++|-+++|.+||...... ..+.+. +.
T Consensus 322 DFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-~sl~eQ----I~ 395 (475)
T KOG0615|consen 322 DFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-PSLKEQ----IL 395 (475)
T ss_pred ccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-ccHHHH----Hh
Confidence 999999864 45667788999999999998765433 3789999999999999999999854332 122222 22
Q ss_pred hccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.++ +.-......+...+...++.+|+..||++||++.|+++
T Consensus 396 ~G~---------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGR---------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCc---------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 222 11111112223345667899999999999999999875
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=384.13 Aligned_cols=473 Identities=28% Similarity=0.417 Sum_probs=331.5
Q ss_pred eeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCC
Q 037197 68 VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASS 147 (1009)
Q Consensus 68 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~ 147 (1009)
...+++++|.+. .+.+.+.++..|+.|++++|+++ ++|++++.+..++.|+.|.|++. ++|+.++.+.+|++|+.++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 467889999886 45577889999999999999984 67889999999999999999986 7899999999999999999
Q ss_pred CCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCC
Q 037197 148 NNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIP 227 (1009)
Q Consensus 148 n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~ 227 (1009)
|.+. .+|+.++.+-.|+.|+..+|++. ..|..+.++.+|..|++.+|+++...|..+ +++.|++|+..+|-++ .+|
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tlP 199 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TLP 199 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cCC
Confidence 9998 78889999999999999999998 788889999999999999999995444444 4999999999999887 889
Q ss_pred ccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccc-cccccccccccccccCCCcchhhhccc
Q 037197 228 AEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELG-SITSLAFLDLSDNQISGEIPVKLAELK 306 (1009)
Q Consensus 228 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 306 (1009)
..++.+.+|..|+|.+|.+. .+| .|.++..|++|+++.|.|. .+|.+.. .+++|..|||.+|+++ +.|+.++-++
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLr 275 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLR 275 (565)
T ss_pred hhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhh
Confidence 99999999999999999998 566 8999999999999999998 5666655 8899999999999998 8899999999
Q ss_pred CCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCC--Cceee-------ccCccc----ccc-CCc
Q 037197 307 NLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP--LRRLD-------ASSNLL----SGE-IPT 372 (1009)
Q Consensus 307 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~--L~~L~-------Ls~N~l----~~~-~~~ 372 (1009)
+|.+||+|+|.|++. |..++++ .|+.|-+.+|.+...-...+.+-+. |++|. +|.-.= .+. .+.
T Consensus 276 sL~rLDlSNN~is~L-p~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~ 353 (565)
T KOG0472|consen 276 SLERLDLSNNDISSL-PYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSE 353 (565)
T ss_pred hhhhhcccCCccccC-Ccccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCC
Confidence 999999999999976 6678999 9999999999974321111111110 11111 000000 000 000
Q ss_pred Cc---cCCCCCceeecccccccccCCcccccCcc---ccEEEcccCccccccCCccCCCCcccE-EEeecccccccCCcC
Q 037197 373 GL---CDSGNLTKLILFNNSFSGTFPVSLSTCKS---LVRVRVQNNLISGTIPVGLGNLPSLQR-LEMANNNLTGQIPDD 445 (1009)
Q Consensus 373 ~l---~~l~~L~~L~l~~N~l~~~~p~~l~~~~~---L~~L~L~~N~l~~~~p~~~~~l~~L~~-L~L~~N~l~~~~p~~ 445 (1009)
.+ ..+.+.+.|++++-+++. +|........ ...++++.|++. ++|..+..+..+.+ +.+++|.+. .+|..
T Consensus 354 ~~~~~~~~i~tkiL~~s~~qlt~-VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~ 430 (565)
T KOG0472|consen 354 SFPDIYAIITTKILDVSDKQLTL-VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLE 430 (565)
T ss_pred cccchhhhhhhhhhccccccccc-CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHH
Confidence 11 112344555555555552 2322222211 445555555555 55555554444433 333333332 55555
Q ss_pred CcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccce
Q 037197 446 ISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLV 525 (1009)
Q Consensus 446 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~ 525 (1009)
++.+++|+.|+|++|-+.+ +|..++++..|++|++++|++. .+|..+..+..|+.+-.++|++....|..+.+|.+|.
T Consensus 431 l~~l~kLt~L~L~NN~Ln~-LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~ 508 (565)
T KOG0472|consen 431 LSQLQKLTFLDLSNNLLND-LPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLT 508 (565)
T ss_pred HHhhhcceeeecccchhhh-cchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcc
Confidence 5555556666665555554 4555555555666666666554 4555555555555555555666544444466666666
Q ss_pred eeeecCcccccCCCcccccccccceecCCccccc
Q 037197 526 SLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLF 559 (1009)
Q Consensus 526 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 559 (1009)
.|||.+|.|. .+|..+++|.+|++|+|++|+|+
T Consensus 509 tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 509 TLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred eeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 6666666665 56666666666666666666665
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=353.66 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=205.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh-hhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI-ESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.+.|+..++||+|+||+||.++.+++++.||+|++++..... ...+....|..++.+++||.||+++-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 356889999999999999999999999999999997764322 3456677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
+||+.||.|...+++... +++..+.-++..|+.||.|||+. +|||||+||+|||+|.+|+++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999976543 77887777899999999999999 99999999999999999999999999999765
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
..+....+++||+.|||||++....++.++|.||+|+++|||++|.+||.. .+..++..+..+.... ..+..
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-----~~~~~~~~~I~~~k~~---~~p~~ 248 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-----EDVKKMYDKILKGKLP---LPPGY 248 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-----ccHHHHHHHHhcCcCC---CCCcc
Confidence 666666778999999999999999999999999999999999999999973 3444555444433210 01111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCC
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT 967 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs 967 (1009)
+ .. +...++.+.+..||++|.-
T Consensus 249 l-------s~---~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 249 L-------SE---EARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred C-------CH---HHHHHHHHHhccCHHHhcC
Confidence 1 12 2345777888999999863
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=371.89 Aligned_cols=255 Identities=31% Similarity=0.465 Sum_probs=205.9
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
++..+.||+|.||.||.|.+.. ...||+|.++.. ....+.+.+|+++|++++|++||+++++|..++.++||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 4556779999999999999987 568999998543 344567779999999999999999999999988999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
+.|+|.++++... +..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+...+...
T Consensus 284 ~~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 284 PKGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred ccCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999999998733 23377888999999999999999999 999999999999999999999999999995433333
Q ss_pred ceee-ecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 860 TVSM-VAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 860 ~~~~-~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
.... ..-+..|.|||.+...+++.|||||||||+||||+| |+.||... ...+. ...+..|.. ... +
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-----sn~ev-~~~le~GyR---lp~---P 426 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-----SNEEV-LELLERGYR---LPR---P 426 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-----CHHHH-HHHHhccCc---CCC---C
Confidence 2222 223458999999999999999999999999999999 99998632 22222 333333321 111 1
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
..|+ + ++.++|..||+.+|++|||+..+...++++...
T Consensus 427 ~~CP---~---~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 427 EGCP---D---EVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCC---H---HHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 1222 2 456788999999999999999999999987643
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=386.20 Aligned_cols=479 Identities=27% Similarity=0.401 Sum_probs=402.6
Q ss_pred CCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeec
Q 037197 90 RSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDF 169 (1009)
Q Consensus 90 ~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 169 (1009)
..|+.|.+++|.+. .+-+.+.+|..|.+|++++|+++ ..|.+++.+..++.|+.++|+++ .+|+.++.+.+|..|+.
T Consensus 45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~ 121 (565)
T KOG0472|consen 45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC 121 (565)
T ss_pred cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence 35788999999885 45567899999999999999987 67889999999999999999998 89999999999999999
Q ss_pred cCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccc
Q 037197 170 RGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQ 249 (1009)
Q Consensus 170 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 249 (1009)
++|.+. .+|+.++.+..|..|+..+|+++ ..|..++++.+|..|++.+|++....|..+. ++.|++||.-.|-++ .
T Consensus 122 s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-t 197 (565)
T KOG0472|consen 122 SSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-T 197 (565)
T ss_pred ccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-c
Confidence 999998 78888999999999999999999 7899999999999999999999955555555 999999999999887 8
Q ss_pred cCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhh-cccCCCeEeccccccCCCCCcCCCC
Q 037197 250 IPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLA-ELKNLQLLNLMCNQLTGLIPDKLGE 328 (1009)
Q Consensus 250 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~~~~l~~ 328 (1009)
+|+.++.+.+|..|+|..|+|. ..| +|.+++.|++|+++.|+|. .+|.... ++.+|..|||..|+++. .|+.+.-
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke-~Pde~cl 273 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKE-VPDEICL 273 (565)
T ss_pred CChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeecccccccc-CchHHHH
Confidence 8999999999999999999999 566 7999999999999999998 6666554 89999999999999995 5888999
Q ss_pred CCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCC---CCceeec--cccccc---c------c-
Q 037197 329 LTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSG---NLTKLIL--FNNSFS---G------T- 393 (1009)
Q Consensus 329 l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~---~L~~L~l--~~N~l~---~------~- 393 (1009)
+.+|+.||+++|.++ .+|..++++ .|+.|.+.+|.+... -..+-..+ -|++|.= ..-.++ | .
T Consensus 274 LrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTi-Rr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~ 350 (565)
T KOG0472|consen 274 LRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTI-RREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTL 350 (565)
T ss_pred hhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHH-HHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCC
Confidence 999999999999998 578889999 999999999988632 22221111 1222211 001111 0 1
Q ss_pred CC---cccccCccccEEEcccCccccccCCccCCCCc---ccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCC
Q 037197 394 FP---VSLSTCKSLVRVRVQNNLISGTIPVGLGNLPS---LQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLP 467 (1009)
Q Consensus 394 ~p---~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 467 (1009)
.+ .....+.+.+.|++++-+++ .+|.....-.+ .+..+++.|++. .+|..+..+..+...-+..|+..+++|
T Consensus 351 ~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~ 428 (565)
T KOG0472|consen 351 PSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVP 428 (565)
T ss_pred CCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccch
Confidence 11 12344567889999999999 56655433333 789999999998 889888888777665555555567799
Q ss_pred CcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccc
Q 037197 468 SSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPT 547 (1009)
Q Consensus 468 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 547 (1009)
..++.+++|..|++++|-+. .+|.+++.+..|+.||+|.|++. .+|..+..+..|+.+-.++|++....|..+.+|.+
T Consensus 429 ~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~n 506 (565)
T KOG0472|consen 429 LELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRN 506 (565)
T ss_pred HHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhh
Confidence 99999999999999999887 68999999999999999999998 89999888889999988999998666666999999
Q ss_pred cceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCCC
Q 037197 548 LAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSN 589 (1009)
Q Consensus 548 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 589 (1009)
|.+|||.+|.+. .||+.++++++|++|+|++|++. .|..
T Consensus 507 L~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr~ 545 (565)
T KOG0472|consen 507 LTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPRH 545 (565)
T ss_pred cceeccCCCchh-hCChhhccccceeEEEecCCccC--CCHH
Confidence 999999999998 88899999999999999999999 4543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=339.23 Aligned_cols=267 Identities=23% Similarity=0.324 Sum_probs=210.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+....+|+|+||.|||++++++|+.||||++..++.++...+-.++|++++++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45677788999999999999999999999999999888888888888899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
||+..-|.++= ....+ .+.....+++.|+++|+.|+|++ +++||||||+||+++.+|.+|+||||+|+.+..+
T Consensus 82 ~~dhTvL~eLe-~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDHTVLHELE-RYPNG---VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecchHHHHHHH-hccCC---CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 99766555544 33333 78888899999999999999999 9999999999999999999999999999999877
Q ss_pred CCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHH----------HHHhhcc
Q 037197 858 NETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVL----------SMIKSNK 926 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~----------~~~~~~~ 926 (1009)
++..+.++.|..|.|||.+.+ .+|....||||+||++.||++|.+-|... .+.+.+....+ +.+....
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~-SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR-SDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc-chHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 777778889999999998765 78999999999999999999999776521 11112222111 1111111
Q ss_pred ccccccCccccc---cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 927 AQDEALDPSIAG---QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 927 ~~~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
.+..+.-|.... .....+....-++.++..|++.||++|++.+|++
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 111111111110 0011122223467889999999999999998876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=361.17 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=214.7
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.+....|+..+.||+|+.|.||.|....+++.||||++.... +...+-+++|+.+|+..+|+|||++++.|..++..|
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 344566788888999999999999999999999999996553 344566779999999999999999999988889999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+|||||+||+|.|.+.... +++.++..|+.++++||+|||.+ +|+|||||.+||+++.+|.+||+|||++..
T Consensus 347 VVMEym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred EEEeecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeec
Confidence 9999999999999996554 88999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
+..........+|||.|||||+.....|.+|.||||||++++||+.|++||-. ++..+.+.-....+..
T Consensus 419 i~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln-----E~PlrAlyLIa~ng~P------ 487 (550)
T KOG0578|consen 419 ISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN-----ENPLRALYLIATNGTP------ 487 (550)
T ss_pred cccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC-----CChHHHHHHHhhcCCC------
Confidence 87776677788999999999999999999999999999999999999999963 2223333333333331
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+. ........+.++..+|+..||++|+++.|+++
T Consensus 488 -~lk----~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 488 -KLK----NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -CcC----CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 111 11112234667888999999999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=322.45 Aligned_cols=201 Identities=26% Similarity=0.381 Sum_probs=181.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.+.|+..+.||.|+||.|..++.+.+|..+|+|++.+... ...+.+...+|..+++.+.||+++++++.|.+....|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3457888999999999999999999999999999965532 233455566899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||++||-|..++++... +++..+.-+|.||+.|++|||+. +|++||+||+|||+|++|.+||+|||+|+...
T Consensus 123 meyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999987654 78888888999999999999999 99999999999999999999999999999874
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPA 907 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~ 907 (1009)
.. ..+.+|||.|+|||++....+..++|.|||||++|||+.|.+||...
T Consensus 196 ~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 196 GR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred Cc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 32 56789999999999999999999999999999999999999999743
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=350.85 Aligned_cols=250 Identities=25% Similarity=0.313 Sum_probs=203.9
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhH-HHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESG-DDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV 775 (1009)
..|..++.||.|+|++||+|+.+.+++.||||++.+...-.+.. +-+..|-++|.++ .||.|++++-.|+++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 35788889999999999999999999999999997664433333 3344899999999 899999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
+||+++|+|.++|+..+. +++.-..-++.+|+.|++|||++ |||||||||+|||+|+|++++|+|||.|+.+.
T Consensus 153 Le~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999987654 77777777999999999999999 99999999999999999999999999998764
Q ss_pred cCCC-------------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH
Q 037197 856 HKNE-------------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 856 ~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
.... ....++||..|.+||++.....+..+|+|+|||++|+|+.|++||....+ .-.+++.+
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-----yliFqkI~ 300 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-----YLIFQKIQ 300 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-----HHHHHHHH
Confidence 3211 12458999999999999999999999999999999999999999974321 11222222
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.-. -.+...++ ..+.+|+.+.+..||.+|++..++.+
T Consensus 301 ~l~--------y~fp~~fp------~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 301 ALD--------YEFPEGFP------EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred Hhc--------ccCCCCCC------HHHHHHHHHHHccCccccccHHHHhh
Confidence 211 12222222 23456888999999999999977654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=337.25 Aligned_cols=261 Identities=25% Similarity=0.356 Sum_probs=207.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||.|.-++||+|+....++.||||++...... ...+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-hhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4688888999999999999999999999999999654333 335677799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
||.+||+.+.++.....+ +++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.|||+|||.+..+.+.
T Consensus 105 fMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999997654333 78888899999999999999999 9999999999999999999999999998776554
Q ss_pred CCc---e-eeecccCcccCCcccC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 858 NET---V-SMVAGSYGYIAPEYGY--TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 858 ~~~---~-~~~~gt~~y~aPE~~~--~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
+.. . ..+.||+.|||||++. ...|+.|+||||||++..||.+|..||....+ .+.....++...+...
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-----mkvLl~tLqn~pp~~~- 253 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-----MKVLLLTLQNDPPTLL- 253 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-----HHHHHHHhcCCCCCcc-
Confidence 422 2 4568999999999844 34589999999999999999999999974322 1222222222111000
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
......+.....-..+.+++..|+.+||.+|||++++++
T Consensus 254 ---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 ---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000011111112235778899999999999999999874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=366.09 Aligned_cols=279 Identities=27% Similarity=0.450 Sum_probs=224.6
Q ss_pred hcCCcCceeccCCceEEEEEEECCCC---eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPH---MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
...++.++||.|.||.||+|..+..+ ..||||.++.. ....++.+|+.|+.||.+++||||+++.|+......+++
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 34567889999999999999988654 67999999543 445667788899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
|+|||++|+|+.+++.+.+. +++.+...+..+||.|+.||-+. ++|||||.++|||++.+-.+||+|||+++.+
T Consensus 708 iTEyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999999887643 89999999999999999999988 9999999999999999999999999999987
Q ss_pred ccCCCceeeecc---cCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 855 LHKNETVSMVAG---SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 855 ~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
.++........| ..+|.|||.+..+++|.+|||||||||+||.++ |.+||-+..+. + |.+.+..+...
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--d----VIkaIe~gyRL-- 853 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--D----VIKAIEQGYRL-- 853 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--H----HHHHHHhccCC--
Confidence 554433222222 358999999999999999999999999999988 99998754332 2 22333333211
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCcccccccCCCCCCCCccccc
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNGGHNLSKERPIFG 1001 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1009)
+.+++....+.+||..||++|-.+||++.+++..|.++..+.-+-...++..-.-..|...
T Consensus 854 ----------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~~lld 914 (996)
T KOG0196|consen 854 ----------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQPLLD 914 (996)
T ss_pred ----------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcccccC
Confidence 1122233467789999999999999999999999999877665544444444444444444
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=351.39 Aligned_cols=249 Identities=29% Similarity=0.404 Sum_probs=214.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|...+.||+|+||.||||+.+.+.+.||+|.+.+............+|++++++++||||+.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999999999999999998877666667778899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+.| +|..++..... ++++.+..|+.+++.||.|||+. +|.|||+||.||+++..+.+|++|||+|+-+...
T Consensus 82 ~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9976 99999976654 88999999999999999999999 9999999999999999999999999999988777
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
....+...|||-|||||...++.|+..+|+||+||++||+++|++||-. ..+.+.++....... ..|
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~~d~v-----~~p--- 220 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSILKDPV-----KPP--- 220 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHhcCCC-----CCc---
Confidence 7777788999999999999999999999999999999999999999962 233333333322211 111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
......+..++...+.+||.+|.+-.+++.
T Consensus 221 ------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 221 ------STASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ------ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 122335667888999999999999888763
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=369.46 Aligned_cols=259 Identities=29% Similarity=0.426 Sum_probs=210.7
Q ss_pred CCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 700 VKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
....+.||+|+||+||+|+... ....||||.++.. .+.+..++|.+|++.+..++|||||+++|.|.+++..++
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 4456779999999999998543 3578999999654 344467788899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccc----------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEE
Q 037197 775 VYDYMPNDSLGEALHGKEAG----------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEAR 844 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 844 (1009)
|+|||..|+|.++++.+... +.+++..+.+.||.|||.|++||-++ .+|||||..+|+||+++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEE
Confidence 99999999999999754321 22378899999999999999999998 999999999999999999999
Q ss_pred EcccccceecccCCCce--eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHH
Q 037197 845 IADFGLARMMLHKNETV--SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSM 921 (1009)
Q Consensus 845 l~DfGls~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 921 (1009)
|+|||+++.....+... ....-..+|||||.+..++||.+||||||||++||+++ |+.||..... +.|...
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------~EVIe~ 717 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------QEVIEC 717 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch------HHHHHH
Confidence 99999999765544321 12234569999999999999999999999999999999 9999875432 234455
Q ss_pred HhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 922 IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
++.+.. -...+..+. ++..|+..||+..|++||+++||-..|+....
T Consensus 718 i~~g~l---------L~~Pe~CP~---~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 718 IRAGQL---------LSCPENCPT---EVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHcCCc---------ccCCCCCCH---HHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 555442 112222222 45678899999999999999999999988764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=342.17 Aligned_cols=264 Identities=27% Similarity=0.344 Sum_probs=207.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC--CeEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE--TNVMMV 775 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~lV 775 (1009)
+.|+.++.||+|.||.||||++..+|+.||+|+++....+.+......+||.+|++++||||+++.+...+. ..+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456677889999999999999999999999999987665566666677999999999999999999988766 689999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
+|||+. +|.-++.... ..+++.++..++.|++.||+|+|++ +|+|||||.+|||+|.+|.+||+|||+|+++.
T Consensus 197 FeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999964 5777765432 2389999999999999999999999 99999999999999999999999999999876
Q ss_pred cCC-CceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 856 HKN-ETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 856 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
... ...+..+.|..|.|||.+.+ ..|+.+.|+||.|||+.||++|++.|.. .+-++++...++.-....+...
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G-----~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG-----RTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC-----ccHHHHHHHHHHHhCCCChhcc
Confidence 554 34667788999999998765 4699999999999999999999988863 2233333333333222222222
Q ss_pred c--ccc--------ccCchHHHHH-----HHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 P--SIA--------GQCKHVQEEM-----LLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~--~~~--------~~~~~~~~~~-----~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+ .+. ..+.....+. ...+.|+..++..||++|.|+.++++
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 2 110 0111112221 22567888999999999999998875
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=358.47 Aligned_cols=367 Identities=24% Similarity=0.237 Sum_probs=294.9
Q ss_pred hhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCccccccccccccccccc
Q 037197 213 ETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDN 292 (1009)
Q Consensus 213 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 292 (1009)
++|++++|+++..-+..|.++++|++++|..|.++ .+|.......+|+.|+|.+|.|+..-.+.+..++.|+.||||.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 45667777776666666777777777777777766 55655555566777777777777666666777777777777777
Q ss_pred ccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCc
Q 037197 293 QISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPT 372 (1009)
Q Consensus 293 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~ 372 (1009)
.|+...-..|..-.++++|+|++|.|+.+..+.|..+.+|..|.|++|+++...+..|.+++.|+.|+|..|+|.-.--.
T Consensus 160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~l 239 (873)
T KOG4194|consen 160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGL 239 (873)
T ss_pred hhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhh
Confidence 77744444566666777777777777777777777777777777777777777777777777777777777777644456
Q ss_pred CccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCC
Q 037197 373 GLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSL 452 (1009)
Q Consensus 373 ~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 452 (1009)
.|..+++|+.|.|..|.++..-...|..|.++++|+|..|++...--.++.+|++|+.|+||+|.|...-++.....++|
T Consensus 240 tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL 319 (873)
T KOG4194|consen 240 TFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKL 319 (873)
T ss_pred hhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccc
Confidence 77788888888888888888888888999999999999999987777888999999999999999988888888889999
Q ss_pred cEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCc---cccccccceeeee
Q 037197 453 SFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPA---SIASCEKLVSLNL 529 (1009)
Q Consensus 453 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~---~~~~l~~L~~L~L 529 (1009)
++|+|++|+|+...+.+|..+..|++|+|++|.++..-...|..+.+|++|||++|.|+..+.+ .|..|++|+.|.|
T Consensus 320 ~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l 399 (873)
T KOG4194|consen 320 KELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRL 399 (873)
T ss_pred eeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheee
Confidence 9999999999999999999999999999999999877777899999999999999999876643 4677999999999
Q ss_pred cCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCc
Q 037197 530 RNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNK 581 (1009)
Q Consensus 530 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 581 (1009)
.+|+|.......|..++.|+.|||.+|.|..+-|+.|..+ .|+.|-++.-.
T Consensus 400 ~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSss 450 (873)
T KOG4194|consen 400 TGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSS 450 (873)
T ss_pred cCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccc
Confidence 9999985555789999999999999999999999999888 88887766433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=352.65 Aligned_cols=257 Identities=32% Similarity=0.467 Sum_probs=210.8
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
+...+.||+|.||+||+|+|.+ .||||++......+++.+.|..|+.++++-+|.||+=+.|||..... .+|+.||
T Consensus 394 v~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwC 469 (678)
T KOG0193|consen 394 VLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWC 469 (678)
T ss_pred hhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhc
Confidence 4567789999999999999987 59999998887778888888899999999999999999999998877 9999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc--cC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML--HK 857 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~--~~ 857 (1009)
+|.+|+.++|..+. .++..+...||.||++|+.|||.+ +|||||||..||++.+++.|||+|||++..-. ..
T Consensus 470 eGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 470 EGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred cCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999999987653 389999999999999999999999 99999999999999999999999999986532 22
Q ss_pred CCceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 858 NETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
+.......|...|||||++. ..+|+..+||||||+|+|||++|..||.. ... +.+.-++..| ...+
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~-----dqIifmVGrG-----~l~p 612 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNR-----DQIIFMVGRG-----YLMP 612 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CCh-----hheEEEeccc-----ccCc
Confidence 33444566788999999876 34689999999999999999999999972 221 1111111111 1223
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.........+. ++.+|+..||..++++||.+.+++..|+++.+
T Consensus 613 d~s~~~s~~pk---~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 613 DLSKIRSNCPK---AMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cchhhhccCHH---HHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 33323333333 45578889999999999999999999999887
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=313.81 Aligned_cols=265 Identities=24% Similarity=0.342 Sum_probs=209.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.+|...+.+|+|.||.||+|++..+|+.||||+++.............+|++.++.++||||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35777888999999999999999999999999998765544555678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
||+ .+|+..++... ..++..++..++.++++|++|+|++ .|+||||||.|+|++.+|.+||+|||+++.+..+
T Consensus 82 fm~-tdLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 994 67999997653 3488889999999999999999999 9999999999999999999999999999999887
Q ss_pred CCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
+......+-|..|.|||.+.+ +.|+...||||.||++.||+-|.+-|. +..++.+...-...-|.+. +...|.+
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp----G~sDidQL~~If~~LGTP~-~~~WP~~ 229 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP----GDSDIDQLSKIFRALGTPT-PDQWPEM 229 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC----CCchHHHHHHHHHHcCCCC-cccCccc
Confidence 776666678899999998765 569999999999999999999885553 3333333222222222221 1111111
Q ss_pred ccc--------Cc------hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 937 AGQ--------CK------HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 937 ~~~--------~~------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
... ++ -......+..+++.+|+..||.+|++++|+++.
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 100 00 011122335778889999999999999998764
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.81 Aligned_cols=358 Identities=22% Similarity=0.208 Sum_probs=242.8
Q ss_pred CCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcc
Q 037197 139 GLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILG 218 (1009)
Q Consensus 139 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 218 (1009)
.-+.||+++|+++..-+..|.++++|+.+++..|.++ .+|.......+|+.|+|.+|.|+..-.+.+..++.|++|||+
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3456777777777766777777777777777777776 566655555667777777777776666677777777777777
Q ss_pred cccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCc
Q 037197 219 YNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEI 298 (1009)
Q Consensus 219 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 298 (1009)
.|.|+.+.-..|..-.++++|+|++|+|+......|..+.+|.+|.|+.|+++...+..|.++++|+.|+|..|+|.-.-
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive 237 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE 237 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence 77777555456666667777777777777777777777777777777777777655666666777777777777776332
Q ss_pred chhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCC
Q 037197 299 PVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSG 378 (1009)
Q Consensus 299 ~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~ 378 (1009)
-..|.++++|+.|.|..|.|..+-.+.|..+.++++|+|..|+++..-..++.+++.|+.|+||+|.|...-++.+....
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftq 317 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQ 317 (873)
T ss_pred hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcc
Confidence 44677777777777777777777777777777777777777777766667777777777777777777766666666667
Q ss_pred CCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCc---CCcCCCCCcEE
Q 037197 379 NLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPD---DISLSTSLSFV 455 (1009)
Q Consensus 379 ~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L 455 (1009)
.|+.|+|++|+|+...+.+|..+..|++|+|++|++...-...|..+++|++|||++|.|+..+.+ .|..+++|+.|
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL 397 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL 397 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence 777777777777766677777777777777777777655555666677777777777776655543 23444455555
Q ss_pred ecccCcccccCCCcccCCcccchhccccCcccCCcccccccC
Q 037197 456 DISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQAC 497 (1009)
Q Consensus 456 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 497 (1009)
+|.+|+|..+...+|.++++|+.|+|.+|.|..+-|++|..+
T Consensus 398 ~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m 439 (873)
T KOG4194|consen 398 RLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM 439 (873)
T ss_pred eecCceeeecchhhhccCcccceecCCCCcceeecccccccc
Confidence 555555554444444444444444444444444444444443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.61 Aligned_cols=268 Identities=24% Similarity=0.286 Sum_probs=207.9
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCC-e
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNET-N 771 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~-~ 771 (1009)
..+.++|+..+.||.|.||.||+|+.+.++..||||++++.....+ ...-++|++.+++++ ||||+++.+++.+.+ .
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 4467889999999999999999999999999999999976643322 122239999999998 999999999998877 8
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
+|+||||| ..+|+++++.+ ...+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|
T Consensus 85 L~fVfE~M-d~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccc
Confidence 99999999 68899999876 34599999999999999999999999 9999999999999998999999999999
Q ss_pred eecccCCCceeeecccCcccCCccc-CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 852 RMMLHKNETVSMVAGSYGYIAPEYG-YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
+.... ....+.++.|..|.|||++ ...-|+.+.|||++||+++|+.+-++-|....+ .+++.+.+ .--|.+..+
T Consensus 158 Rev~S-kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~KIc---~VLGtP~~~ 232 (538)
T KOG0661|consen 158 REVRS-KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIYKIC---EVLGTPDKD 232 (538)
T ss_pred ccccc-CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHHHHH---HHhCCCccc
Confidence 98743 3455667889999999985 567799999999999999999998877753211 11222211 111111111
Q ss_pred ccC-------------ccccc-cCch-HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 931 ALD-------------PSIAG-QCKH-VQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 931 ~~~-------------~~~~~-~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
... |...+ .... ......+.++++.+|++.||++|||+.|+++.
T Consensus 233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111 11110 0000 11233457789999999999999999999874
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=355.12 Aligned_cols=244 Identities=24% Similarity=0.353 Sum_probs=199.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.|...++||+|.||+|+.+..+.+++.+|||++++... .....+..+.|.+++... +||.++.++..|+..+++|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 457888999999999999999999999999999987642 334456677888887776 599999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+.||++..+.+... +++.++.-++..|+.||.|||++ +||+||||.+|||+|.+|.+||+|||+++.-.
T Consensus 448 mey~~Ggdm~~~~~~~~-----F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 448 MEYVAGGDLMHHIHTDV-----FSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEecCCCcEEEEEeccc-----ccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999555554322 88888888999999999999999 99999999999999999999999999999766
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
..+....+++|||.|||||++.+..|+.+.|.|||||++|||+.|..||....+ +++.+.+ +. ++ +.
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE--ee~FdsI---~~-----d~---~~ 586 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE--EEVFDSI---VN-----DE---VR 586 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHH---hc-----CC---CC
Confidence 566677889999999999999999999999999999999999999999973221 1222222 11 11 11
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTM 968 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 968 (1009)
++ .-...+.+.|+.+++.++|++|--+
T Consensus 587 yP------~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 YP------RFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CC------CcccHHHHHHHHHHhccCcccccCC
Confidence 11 1112345678889999999988643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=350.37 Aligned_cols=259 Identities=25% Similarity=0.326 Sum_probs=210.0
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC---hhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCe
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND---IESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETN 771 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~ 771 (1009)
....|...+.||+|+||+|+.|.+..+++.||+|++.+.... ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 356788999999999999999999999999999977554111 123345558999999998 9999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-CcEEEccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN-LEARIADFGL 850 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfGl 850 (1009)
+++||||+.+|.|.+++..... +.+..+.+++.|++.|++|+|++ +|+||||||+||+++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~----l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGR----LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCC----CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999987332 67788888999999999999999 99999999999999999 9999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCC-CC-cccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLK-VD-EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
+......+......+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+. .+...............
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~~~~l~~ki~~~~~~~ 242 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SNVPNLYRKIRKGEFKI 242 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----ccHHHHHHHHhcCCccC
Confidence 987643445667789999999999998877 76 789999999999999999999984 23333333322111111
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
...++ ..++..++.+|+..||.+|+++.|++ .-.-++.
T Consensus 243 p~~~~-------------S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 243 PSYLL-------------SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred CCCcC-------------CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 11110 23456788999999999999999999 4444443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.38 Aligned_cols=257 Identities=29% Similarity=0.419 Sum_probs=202.0
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC--eEEEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET--NVMMVY 776 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~--~~~lV~ 776 (1009)
.+...+.||+|+||+||++...++|+..|||.+..... ...+...+|+.+|++++|||||+++|.....+ .+++.|
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 35677889999999999999999899999999865421 12556779999999999999999999854444 699999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC-CCcEEEcccccceecc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA-NLEARIADFGLARMML 855 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGls~~~~ 855 (1009)
||+++|+|.+++.+... .+++..+..++.||++||+|||++ +||||||||+|||++. ++.+||+|||.++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999987653 278888899999999999999999 9999999999999999 7999999999998765
Q ss_pred cC---CCceeeecccCcccCCcccCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 856 HK---NETVSMVAGSYGYIAPEYGYTLK-VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 856 ~~---~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
.. ........||+.|||||++..+. ...++||||+||++.||+||+.||... ....+++.......
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~------ 239 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGRED------ 239 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccC------
Confidence 31 12334578999999999988533 345999999999999999999999742 12222222222111
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.-|.+.... .+ +..+++.+|+..+|++|||++++++---...
T Consensus 240 ~~P~ip~~l---s~---~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 240 SLPEIPDSL---SD---EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CCCCCCccc---CH---HHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 122332221 22 3456778999999999999999998654443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=340.33 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=208.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
..|+..+.||+|.||.||||.+..+++.||+|++..... ....+++.+|+.++.+++++||.++|+.+..+..+|++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 346677889999999999999999999999999965433 3345677899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
||.||++.+.++.... +++....-|+.+++.|+.|||++ +.+|||||+.||++..+|.+|++|||.+..+...
T Consensus 92 y~~gGsv~~lL~~~~~----~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNI----LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HhcCcchhhhhccCCC----CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999976543 35666666889999999999999 9999999999999999999999999999888666
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
......++|||.|||||++....|+.|+||||||++.+||++|.+|+....+... -....+-..|.+.
T Consensus 165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv------------lflIpk~~PP~L~ 232 (467)
T KOG0201|consen 165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV------------LFLIPKSAPPRLD 232 (467)
T ss_pred hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE------------EEeccCCCCCccc
Confidence 6666788999999999999988999999999999999999999999975443210 0001112223444
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.+.. .+.+++..|+++||+.||+++++++
T Consensus 233 ~~~S~------~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 GDFSP------PFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccCH------HHHHHHHHHhhcCcccCcCHHHHhh
Confidence 43332 3567888999999999999998875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=338.16 Aligned_cols=248 Identities=21% Similarity=0.256 Sum_probs=197.7
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.+.|+..++||+|+||.||.|+-+++|..+|+|+++++.- ...+.+.+..|-.+|...++|.||+++-.|++.+++|+|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 3568899999999999999999999999999999987742 334566777899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||++||++..+|..... +++..+..++.+++-|++.+|.. |+|||||||+|+|||..|++||+|||++.-+.
T Consensus 220 MEylPGGD~mTLL~~~~~----L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDT----LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEecCCccHHHHHHhcCc----CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999976654 67777777899999999999999 99999999999999999999999999985431
Q ss_pred cC----------------------CCc-------------------------eeeecccCcccCCcccCCCCCCcccchH
Q 037197 856 HK----------------------NET-------------------------VSMVAGSYGYIAPEYGYTLKVDEKSDIY 888 (1009)
Q Consensus 856 ~~----------------------~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDv~ 888 (1009)
.. +.. ....+|||.|+|||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 000 0135699999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCC
Q 037197 889 SFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT 967 (1009)
Q Consensus 889 SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs 967 (1009)
|+|||+|||+.|.+||... +..+..+..+...... ..|.-. ....+...+|.+|+. ||++|--
T Consensus 373 SLG~ImyEmLvGyPPF~s~-----tp~~T~rkI~nwr~~l---~fP~~~-------~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSE-----TPQETYRKIVNWRETL---KFPEEV-------DLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHhhhc---cCCCcC-------cccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999999743 2233333333222111 111111 011345678888888 8888864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=352.38 Aligned_cols=263 Identities=26% Similarity=0.380 Sum_probs=202.7
Q ss_pred hcCCcCceeccCCceEEEEEEEC-----CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcC-C
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNE-T 770 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~-~ 770 (1009)
++|+..+.||+|+||.||+|.+. .+++.||||++... ........+.+|+++++++ +||||+++++++... .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 56888999999999999999752 33568999998643 2233345677999999999 899999999988764 4
Q ss_pred eEEEEEeccCCCChhhhhcCCccc--------------------------------------------------------
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAG-------------------------------------------------------- 794 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 794 (1009)
.+++||||+++|+|.++++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999998753210
Q ss_pred --cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC--ceeeecccCcc
Q 037197 795 --KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE--TVSMVAGSYGY 870 (1009)
Q Consensus 795 --~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y 870 (1009)
...+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++....... ......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 12377888899999999999999998 999999999999999999999999999986533221 11223456789
Q ss_pred cCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHH
Q 037197 871 IAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLL 949 (1009)
Q Consensus 871 ~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1009)
+|||++.+..++.++|||||||++|||++ |..||...... ..+......+.. ....... ...
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-----~~~~~~~~~~~~------~~~~~~~------~~~ 305 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-----EEFCQRLKDGTR------MRAPENA------TPE 305 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHhcCCC------CCCCCCC------CHH
Confidence 99999988889999999999999999997 99999743221 111122221110 1111111 124
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 950 VLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 950 l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
+.+++.+|++.||++||++.|+++.|+++..+
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 66899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=329.88 Aligned_cols=261 Identities=23% Similarity=0.288 Sum_probs=202.4
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh------------hhHHHHHHHHHHHhccCCCceee
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI------------ESGDDLFREVSLLGRLRHRNIVR 761 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~Hpniv~ 761 (1009)
....+.|+..+.||+|.||.|-+|....+++.||||++.+..... ...++..+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 445688999999999999999999999999999999997653211 12357789999999999999999
Q ss_pred EEeEEEcC--CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC
Q 037197 762 LLGYLHNE--TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA 839 (1009)
Q Consensus 762 l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~ 839 (1009)
++++..+. +.+|+|+|||..|.+...=-. +..+++.++++++.+++.||+|||.+ +||||||||+|+|+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 99998764 679999999998877544222 22278899999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceecccC-----CCceeeecccCcccCCcccCCCC----CCcccchHhHHHHHHHHHhCCCCCCCCCCC
Q 037197 840 NLEARIADFGLARMMLHK-----NETVSMVAGSYGYIAPEYGYTLK----VDEKSDIYSFGVVLLELLTGKMPLDPAFGG 910 (1009)
Q Consensus 840 ~~~~kl~DfGls~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~SlGvvl~elltg~~Pf~~~~~~ 910 (1009)
+|+|||+|||.+...... +.......|||.|+|||...++. ...+.||||+||++|.|+.|+.||-..
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~--- 322 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD--- 322 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc---
Confidence 999999999999876222 22334478999999999876532 346899999999999999999999732
Q ss_pred CccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 911 SKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
...+...+.+. ..+ .++...+.-..+..++.+++.+||++|.+..+|..-....
T Consensus 323 --~~~~l~~KIvn----------~pL--~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 323 --FELELFDKIVN----------DPL--EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred --hHHHHHHHHhc----------Ccc--cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 22222222211 111 1111122333466788999999999999999987655433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=341.06 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=208.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccC-CCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRS-DNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.-|+.++.||.|+-|.|..|++..+|+.+|||++.+. .........+-+|+-+|+-+.||||+++|++|++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3466788999999999999999999999999999765 333444556669999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++|-|.+++-.++. +++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|..- .
T Consensus 92 Eyv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE-V 163 (786)
T ss_pred EecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc-c
Confidence 99999999999976554 78888889999999999999999 9999999999999999999999999999754 3
Q ss_pred CCCceeeecccCcccCCcccCCCCCC-cccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVD-EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
++....+.+|+|.|.|||++.+.+|. .++||||+|||+|.|+||+.||+ ++++... ...++.|.- + +...
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----DdNir~L-LlKV~~G~f--~-MPs~ 234 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----DDNIRVL-LLKVQRGVF--E-MPSN 234 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----CccHHHH-HHHHHcCcc--c-CCCc
Confidence 45566678999999999999999986 79999999999999999999998 3333333 333443321 0 0111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+. .+...|+.+|+.+||++|.|+.||.+
T Consensus 235 Is----------~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 235 IS----------SEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred CC----------HHHHHHHHHHhccCccccccHHHHhh
Confidence 11 23456888999999999999999976
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=347.24 Aligned_cols=261 Identities=26% Similarity=0.375 Sum_probs=207.1
Q ss_pred CcCceeccCCceEEEEEEECCCCe---E-EEEEEcccC-CCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHM---V-VAVKKLWRS-DNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~---~-vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
...+.||+|+||.||+|..+..+. . ||||..+.+ ....++..++++|+++|++++|||||++||++..+..+++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 344889999999999998875422 3 899998753 34566778888999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
||+|.||+|.++++.... .++..++..++.++|.||+|||++ +++||||.++|+|++.++.+||+|||+++.-.
T Consensus 240 mEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 999999999999987654 388999999999999999999999 99999999999999999999999999987542
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
..........-...|+|||.+....++.++|||||||++||+++ |..||..... .++.+++. ..+. ..
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--~~v~~kI~---~~~~------r~ 382 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--YEVKAKIV---KNGY------RM 382 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--HHHHHHHH---hcCc------cC
Confidence 11111111124569999999999999999999999999999999 8889874321 12222221 2221 11
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCccc
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKS 984 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 984 (1009)
... ...+. .+..++.+|+..+|++||+|.++.+.++.+......
T Consensus 383 ~~~---~~~p~---~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 383 PIP---SKTPK---ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCC---CCCHH---HHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111 12223 344567799999999999999999999998776654
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=340.12 Aligned_cols=254 Identities=23% Similarity=0.354 Sum_probs=218.0
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe-EEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN-VMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~lV~ 776 (1009)
+.|...+.+|+|+||.++.++++.++..|++|.+.........+....+|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788899999999999999999999999999997766555555677799999999999999999999988887 99999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
+||+||++.+.+.+.. +..+++.+.++++.|++.|+.|||++ .|+|||||+.||++++++.|||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999997765 34589999999999999999999988 999999999999999999999999999999877
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.........|||.|++||.+.+.+|..|+|+|||||++|||++-+++|... +...-+.+..... +. .+
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~ki~~~~------~~-Pl 226 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILKINRGL------YS-PL 226 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHHHhhcc------CC-CC
Confidence 766778889999999999999999999999999999999999999999732 3334443333222 11 11
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
++. ...++..++..|++.+|+.||++.+++.+
T Consensus 227 p~~------ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 PSM------YSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred Ccc------ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 112 22356678889999999999999999987
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=312.30 Aligned_cols=266 Identities=23% Similarity=0.264 Sum_probs=206.8
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc--CCeE
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN--ETNV 772 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~ 772 (1009)
+-.+.|+..+.|++|.||.||+|+++.+++.||+|+++.......-.-..++|+.++.+++|||||.+-++... -+.+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 33566888999999999999999999999999999998765444445567799999999999999999998754 3569
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
|+|||||+ .+|..+++... ..+...+..-++.|+++|++|||.+ .|+|||||++|+|++..|.+||+|||+|+
T Consensus 153 y~VMe~~E-hDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred eeeHHHHH-hhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhh
Confidence 99999996 45888887654 2377778888999999999999999 99999999999999999999999999999
Q ss_pred ecccCCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 853 MMLHKNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
.+..+-...+..+.|..|.|||.+.+. .|+.+.||||+|||+.||+++++-|....+ .+++...+ ... +. ..+.
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE-~dQl~~If-~ll--Gt-Pte~ 300 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE-IDQLDKIF-KLL--GT-PSEA 300 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch-HHHHHHHH-HHh--CC-Cccc
Confidence 998887777888899999999987654 589999999999999999999987763211 11222211 111 11 1222
Q ss_pred cCccccc-------------------cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 LDPSIAG-------------------QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~-------------------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.|.+.. .+.... -...-++++...+..||.+|.|+.|.++
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhc
Confidence 2222211 111110 0123456788999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=336.12 Aligned_cols=245 Identities=30% Similarity=0.468 Sum_probs=199.7
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccC
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMP 780 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~ 780 (1009)
.+.+-+|.|+.|.||.|+.+. +.||||+++. .--.+++-|++++||||+.|.|+|.....++||||||.
T Consensus 127 sELeWlGSGaQGAVF~Grl~n--etVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLHN--ETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhhccCcccceeeeeccC--ceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 345679999999999999884 7899998732 11257888999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCc
Q 037197 781 NDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860 (1009)
Q Consensus 781 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~ 860 (1009)
.|-|.++++.... ++......+..+||.|+.|||.+ .|||||||.-||||+.+..|||+|||.++...+. .+
T Consensus 196 ~GqL~~VLka~~~----itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-ST 267 (904)
T KOG4721|consen 196 QGQLYEVLKAGRP----ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-ST 267 (904)
T ss_pred cccHHHHHhccCc----cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hh
Confidence 9999999986554 67777788999999999999999 9999999999999999999999999999887544 45
Q ss_pred eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccC
Q 037197 861 VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQC 940 (1009)
Q Consensus 861 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
...++||..|||||++...+.++|.||||||||||||+||..||.+.... +.+ .+. -...+.-.....+
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----AII-----wGV-GsNsL~LpvPstc 336 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----AII-----WGV-GSNSLHLPVPSTC 336 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----eeE-----Eec-cCCcccccCcccC
Confidence 55689999999999999999999999999999999999999999743211 111 111 0111221222222
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 941 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
+ ..+.-|+..||+..|..||++++++.-|+-+.+.
T Consensus 337 P------~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 337 P------DGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred c------hHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 2 2345678899999999999999999998766554
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=342.71 Aligned_cols=244 Identities=21% Similarity=0.267 Sum_probs=197.2
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999865321 2233455668999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCcee
Q 037197 783 SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVS 862 (1009)
Q Consensus 783 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 862 (1009)
+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 9999986543 278888889999999999999998 999999999999999999999999999976433334445
Q ss_pred eecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCch
Q 037197 863 MVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942 (1009)
Q Consensus 863 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
...||+.|+|||++.+..++.++||||+||++|||++|+.||... +......... .+. ..+....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~~~~~~~~-~~~-------~~~p~~~-- 218 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELIL-MEE-------IRFPRTL-- 218 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC-----CHHHHHHHHH-cCC-------CCCCCCC--
Confidence 567999999999998889999999999999999999999999632 1111111111 111 1111111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 943 VQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 943 ~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
..++.+++.+|++.||++|| ++.++++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 ----SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 12456788899999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=335.75 Aligned_cols=264 Identities=22% Similarity=0.318 Sum_probs=198.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||.||+|....+++.||+|++..... ......+.+|+++++.++||||+++++++.++...++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 568889999999999999999998899999999865432 2233456789999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|++ ++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 678777765432 267788889999999999999998 9999999999999999999999999999765433
Q ss_pred CCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc------
Q 037197 858 NETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE------ 930 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------ 930 (1009)
........+++.|+|||++.+ ..++.++||||+||++|||++|+.||.... +....+............
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK----DIQDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc----cHHHHHHHHHHHhCCCChhhccch
Confidence 333444568899999998764 457889999999999999999999997432 222222222111000000
Q ss_pred ----ccCcc-ccc-cCchHHH------HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ----ALDPS-IAG-QCKHVQE------EMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ----~~~~~-~~~-~~~~~~~------~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..++. +.. ....... ....+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 000 0000000 0124567889999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.73 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=211.2
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-----CeE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE-----TNV 772 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----~~~ 772 (1009)
++|.+.+.+|.|||+.||.++...++..||+|++.... .+..+..++|++..++++||||++++++...+ .+.
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 57889999999999999999999999999999996654 45677888999999999999999999986443 348
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
|++++|...|||.+.+.....++..+++.+.++|+.+|++||++||+. .+++.||||||.||++.+++.+++.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999988777777799999999999999999999998 4469999999999999999999999999987
Q ss_pred ecccCC---------CceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHH
Q 037197 853 MMLHKN---------ETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLS 920 (1009)
Q Consensus 853 ~~~~~~---------~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 920 (1009)
...-.. ........|..|.|||.+. ....++++|||||||++|+|+.|..||+...+.+..+.-
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL---- 253 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL---- 253 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE----
Confidence 653221 1223345788999999765 445789999999999999999999999854332222111
Q ss_pred HHhhccccccccCccccc-cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 921 MIKSNKAQDEALDPSIAG-QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.+..+.+.- +-.. ....+.+++.+|+++||.+||++.+++..+.++.
T Consensus 254 ---------Av~n~q~s~P~~~~---yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 ---------AVQNAQISIPNSSR---YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------eeeccccccCCCCC---ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111110 1111 2234667888999999999999999999988764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=318.24 Aligned_cols=265 Identities=23% Similarity=0.342 Sum_probs=220.6
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
...+|++.+.+|+|.||.|-+|.....|+.||||.++++... .+....+.+|+++|+.++||||+.+|++|++.+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 345677888999999999999999888999999999876543 3334456699999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||..+|.|+||+..+.. +++.+...++.||+.|+.|+|.+ +++|||+|.+|||+|+++++||+|||++..+
T Consensus 131 vMEYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 9999999999999987654 88899999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCC-cccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVD-EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
. .......++|+|-|.+||+..+.+|. +..|-||+||++|-|+.|.+||+. .+....+++ +..+. ...
T Consensus 204 ~-~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-----~Dhk~lvrQ-Is~Ga----YrE 272 (668)
T KOG0611|consen 204 A-DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-----RDHKRLVRQ-ISRGA----YRE 272 (668)
T ss_pred c-cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-----chHHHHHHH-hhccc----ccC
Confidence 3 44566778999999999999998875 789999999999999999999983 233333332 22221 222
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCccccccc
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQN 988 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~ 988 (1009)
|.-.. ....+|++|+.++|++|.|+.+|..-..--....+..+++
T Consensus 273 P~~PS----------dA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~~~V~~~ 317 (668)
T KOG0611|consen 273 PETPS----------DASGLIRWMLMVNPERRATIEDIASHWWVNWGYNMPVIQE 317 (668)
T ss_pred CCCCc----------hHHHHHHHHHhcCcccchhHHHHhhhheeecccccccccc
Confidence 22221 1235888999999999999999998887766666666655
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.26 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=197.0
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhh-HHHHHHHHHHHhccCCCceeeEEeEEEc----CCeEEEEEe
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIES-GDDLFREVSLLGRLRHRNIVRLLGYLHN----ETNVMMVYD 777 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~Hpniv~l~~~~~~----~~~~~lV~E 777 (1009)
...||+|++|.||+|... |+.||||++......... .+.+.+|++++++++||||+++++++.+ ....++|||
T Consensus 25 ~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred CeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 357999999999999984 789999999765333222 3556699999999999999999999876 356899999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.++++... .+++....+++.|++.|++|||+.. +++||||||+||++++++.+||+|||+++.....
T Consensus 103 y~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 103 YCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred eCCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999997643 2788899999999999999999742 7889999999999999999999999998765332
Q ss_pred CCceeeecccCcccCCcccCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NETVSMVAGSYGYIAPEYGYT--LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
. ....+++.|+|||+..+ ..++.++|||||||++|||++|+.||.... ..+........+. .+.
T Consensus 177 ~---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-----~~~~~~~i~~~~~------~~~ 242 (283)
T PHA02988 177 P---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-----TKEIYDLIINKNN------SLK 242 (283)
T ss_pred c---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcCC------CCC
Confidence 1 23457889999999865 678999999999999999999999997431 1222222222211 111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
+...+ ...+.+++.+||+.||++|||++|+++.|+.++
T Consensus 243 ~~~~~------~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 LPLDC------PLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCcC------cHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111 124667889999999999999999999998764
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=370.31 Aligned_cols=484 Identities=26% Similarity=0.321 Sum_probs=279.3
Q ss_pred EeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCC
Q 037197 71 LDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNF 150 (1009)
Q Consensus 71 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l 150 (1009)
+|.+...+. .||..+..-..++.|+++.|.+-...-+.+...-+|+.||||+|++. .+|..+..+.+|+.|+++.|-+
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 445555443 45555544444677777777654322233444444777777766653 5666677777777777777766
Q ss_pred CCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccc
Q 037197 151 SGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEF 230 (1009)
Q Consensus 151 ~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~ 230 (1009)
. ..|.+..++.+|++|.|.+|.+. ..|.++..+++|++|+++.|.+. .+|..+..++.++.+..++|..... +
T Consensus 81 ~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----l 153 (1081)
T KOG0618|consen 81 R-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----L 153 (1081)
T ss_pred h-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----h
Confidence 6 55666666777777777766665 56666667777777777777666 5666666666667777766622111 2
Q ss_pred cCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCe
Q 037197 231 GNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQL 310 (1009)
Q Consensus 231 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 310 (1009)
+... .+.+++..|.+.+.++..+..++. .|+|++|.+. . -.+..+.+|+.|....|+++... -..++|+.
T Consensus 154 g~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~ 223 (1081)
T KOG0618|consen 154 GQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELE----ISGPSLTA 223 (1081)
T ss_pred cccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceEE----ecCcchhe
Confidence 2222 566666666666666655555554 5666666665 1 23445566666666666665211 12345666
Q ss_pred EeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccc
Q 037197 311 LNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSF 390 (1009)
Q Consensus 311 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l 390 (1009)
|+.++|.++...+. ..-.+|+++++++|++++. |.++..+.+|+.++..+|+++ .+|..+....+|+.|.+..|.+
T Consensus 224 L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel 299 (1081)
T KOG0618|consen 224 LYADHNPLTTLDVH--PVPLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNEL 299 (1081)
T ss_pred eeeccCcceeeccc--cccccceeeecchhhhhcc-hHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhh
Confidence 66666666533221 1123566666666666533 366666666666666666664 5555555666666666666666
Q ss_pred cccCCcccccCccccEEEcccCccccccCCccCCCCc-ccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCc
Q 037197 391 SGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPS-LQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSS 469 (1009)
Q Consensus 391 ~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 469 (1009)
. .+|..+...++|++|+|..|+|....+..+..+.. |..|+.+.|++.....-.=.....|+.|++.+|+++...-..
T Consensus 300 ~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~ 378 (1081)
T KOG0618|consen 300 E-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPV 378 (1081)
T ss_pred h-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhh
Confidence 5 45555556666666666666666333333333332 555555555554222111223345666666666666555555
Q ss_pred ccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccc
Q 037197 470 ILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLA 549 (1009)
Q Consensus 470 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 549 (1009)
+.+.+.|+.|+|++|+|.......+.++..|+.|+||+|+|+ .+|+.+.++..|++|...+|+|. ..| ++..++.|+
T Consensus 379 l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~ 455 (1081)
T KOG0618|consen 379 LVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLK 455 (1081)
T ss_pred hccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcce
Confidence 556666666666666666544455566666666666666666 55566666666666666666665 455 566666666
Q ss_pred eecCCccccccccCcCcCCCCCCcEEecCCCc
Q 037197 550 ILDMSNNSLFGRIPENFGASPALEMLNLSYNK 581 (1009)
Q Consensus 550 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 581 (1009)
.+|+|.|+|+...-..-..-++|++|||++|.
T Consensus 456 ~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 456 VLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred EEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 66666666654332222222566666666665
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.70 Aligned_cols=253 Identities=24% Similarity=0.276 Sum_probs=199.1
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh-hhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI-ESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
|+..+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|++++++++|++|+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 567789999999999999999999999999986543222 2233456899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 82 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05631 82 MNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG- 155 (285)
T ss_pred cCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence 99999998885432 12378889999999999999999998 9999999999999999999999999999875322
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...+... .. .+..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~---~~----~~~~ 226 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--VKREEVDRRVKED---QE----EYSE 226 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc--hhHHHHHHHhhcc---cc----cCCc
Confidence 2233456899999999999889999999999999999999999999743221 1111111111111 00 1111
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPT-----MRDVIT 973 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 973 (1009)
.. ...+..++.+|++.||++||+ ++|+++
T Consensus 227 ~~------s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 227 KF------SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cC------CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11 124567889999999999997 677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.51 Aligned_cols=281 Identities=27% Similarity=0.404 Sum_probs=208.6
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhc--cCCCceeeEEeEEEcCC----eEE
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGR--LRHRNIVRLLGYLHNET----NVM 773 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~Hpniv~l~~~~~~~~----~~~ 773 (1009)
.+..++||+|.||.||||+..+ +.||||++. .+..+.+..|-++.+. ++|+||++++++-+.+. .++
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~--~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDN--RLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred hhhHHHhhcCccceeehhhccC--ceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 4556789999999999999885 899999993 3445566677766554 58999999999876665 899
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhc------CCCCeEEeccCCCcEEeCCCCcEEEcc
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD------CQPPVIHRDIKSNNILLDANLEARIAD 847 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~dlk~~NIll~~~~~~kl~D 847 (1009)
+|+||.+.|||.+|++.+- ++|....+|+..+++||+|||+. ++|+|+|||||++|||+..|+++.|+|
T Consensus 285 LVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 9999999999999998764 89999999999999999999986 478999999999999999999999999
Q ss_pred cccceecccCC--CceeeecccCcccCCcccCCCC-C-----CcccchHhHHHHHHHHHhCCCCCCC--------CCC--
Q 037197 848 FGLARMMLHKN--ETVSMVAGSYGYIAPEYGYTLK-V-----DEKSDIYSFGVVLLELLTGKMPLDP--------AFG-- 909 (1009)
Q Consensus 848 fGls~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~-----~~~sDv~SlGvvl~elltg~~Pf~~--------~~~-- 909 (1009)
||+|..+.... ......+||.+|||||++.+.- + -.+.||||+|.|+|||++....+++ .++
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99998875443 2333478999999999876442 2 2478999999999999996654431 111
Q ss_pred -CCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCccccccc
Q 037197 910 -GSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQN 988 (1009)
Q Consensus 910 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~ 988 (1009)
+...-.+.+...+- .+..+|.+....... ..+..+.+.+..||+.||+.|.|+.=|-+.+.++..-... +.
T Consensus 440 vG~hPt~e~mq~~VV-----~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~--~~ 511 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVV-----RKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED--SS 511 (534)
T ss_pred hcCCCCHHHHHHHHH-----hhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc--cC
Confidence 11111112222221 222334444332222 4566678889999999999999999988888877654433 34
Q ss_pred CCCCCCCCcccc
Q 037197 989 GGHNLSKERPIF 1000 (1009)
Q Consensus 989 ~~~~~~~~~~~~ 1000 (1009)
+.+..+...|+-
T Consensus 512 ~~s~~~~~~~~~ 523 (534)
T KOG3653|consen 512 GESSSSLVTPVD 523 (534)
T ss_pred CccccccCCCCc
Confidence 444444555544
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.18 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=198.9
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||+|.+..+++.||+|+++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 458888999999999999999999999999999865432 2233456699999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|++ ++|.+++..... .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLD-SDLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCC-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 997 489988864432 267888889999999999999998 9999999999999999999999999999765433
Q ss_pred CCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc-cc------
Q 037197 858 NETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA-QD------ 929 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~------ 929 (1009)
........+++.|+|||+..+ ..++.++||||+||++|||++|+.||.... ..+.+......... ..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST-----VKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCChHHhhcc
Confidence 333344567899999998764 568899999999999999999999996422 11222111111000 00
Q ss_pred -------cccCccccccC--chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 930 -------EALDPSIAGQC--KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 930 -------~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
....+...... ........+..+++.+|++.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00001000000 000011234568899999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=339.14 Aligned_cols=244 Identities=20% Similarity=0.277 Sum_probs=194.7
Q ss_pred eccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCCh
Q 037197 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSL 784 (1009)
Q Consensus 706 iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL 784 (1009)
||+|+||.||+|.+..+++.||+|++.+... .......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999999999999999864321 223345666899999999999999999999999999999999999999
Q ss_pred hhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCceeee
Q 037197 785 GEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMV 864 (1009)
Q Consensus 785 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 864 (1009)
.+++..... +++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 81 ~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 153 (312)
T cd05585 81 FHHLQREGR----FDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153 (312)
T ss_pred HHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence 999975432 78888899999999999999998 99999999999999999999999999997643333334456
Q ss_pred cccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHH
Q 037197 865 AGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQ 944 (1009)
Q Consensus 865 ~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1009)
.||+.|+|||+..+..++.++||||+||++|||++|+.||... +..+.......... .+....
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~~~~~~~~~~--------~~~~~~---- 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEMYRKILQEPL--------RFPDGF---- 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHHHHHHHcCCC--------CCCCcC----
Confidence 7899999999999888999999999999999999999999732 22222222221110 111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037197 945 EEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975 (1009)
Q Consensus 945 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 975 (1009)
...+.+++.+|++.||++||++.++.+.+
T Consensus 217 --~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 217 --DRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred --CHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 12456788899999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.76 Aligned_cols=266 Identities=20% Similarity=0.274 Sum_probs=201.6
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||+|+||.||+|+++.+++.||+|++..........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 57888999999999999999999999999999976544444556677999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
++++++..+..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 82 VEKNMLELLEEMPN----GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred CCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99887766553321 278888899999999999999998 99999999999999999999999999998764332
Q ss_pred -CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH-----------hhcc
Q 037197 859 -ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI-----------KSNK 926 (1009)
Q Consensus 859 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~-----------~~~~ 926 (1009)
.......|++.|+|||+..+..++.++||||+||++|||++|+.||...... .... .+.... ....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI-DQLF-TIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH-HHHH-HHHHhhCCCCHHHHHhhhccc
Confidence 2223456899999999998888999999999999999999999999742211 1111 111100 0000
Q ss_pred ccccccCccccccCch----HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALDPSIAGQCKH----VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.......+........ .......+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000000 0001234778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=361.42 Aligned_cols=260 Identities=28% Similarity=0.424 Sum_probs=208.0
Q ss_pred cCCcCceeccCCceEEEEEEECCCC-----eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPH-----MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
..+..+.||+|+||.||.|...+.. ..||||.+.+. .+.+...+|.+|..+|+.++|||||+++|++-+....+
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 3456778999999999999876432 34999998654 34566788889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCcc---ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 774 MVYDYMPNDSLGEALHGKEA---GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
+++|||++|+|..+|+..+. ....++....+.++.|||+|+.||+++ ++|||||..+|+|+++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999986632 133478889999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCceeee--cccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 851 ARMMLHKNETVSMV--AGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 851 s~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
|+.+.+.+...... .-...|||||.+..+.++.|+|||||||++||++| |..||....+ .+ +...+..+..
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----~~-v~~~~~~ggR 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----FE-VLLDVLEGGR 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----HH-HHHHHHhCCc
Confidence 99665444333222 23458999999999999999999999999999999 9999974322 11 2222222221
Q ss_pred cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
++ ....|+ + .+.++|..||+.+|++||++..+++++..+..
T Consensus 923 ----L~--~P~~CP---~---~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 923 ----LD--PPSYCP---E---KLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred ----cC--CCCCCC---h---HHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 11 111222 2 45588999999999999999999999887654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=305.34 Aligned_cols=254 Identities=24% Similarity=0.307 Sum_probs=204.3
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.+.|+..+.||+|+|+.||+..+..+|+.+|+|.+....-.....++..+|+++.+.++||||+++.+.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 45667888899999999999999999999999998865544444567777999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC---CCcEEEcccccce
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA---NLEARIADFGLAR 852 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~DfGls~ 852 (1009)
+|+|.|+.|..-+-.+ ..+++..+-..+.||+++|.|.|.+ +|||||+||+|+++.. .-.+|++|||++.
T Consensus 89 Fe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999997655333 3377788888999999999999999 9999999999999954 3469999999999
Q ss_pred ecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 853 MMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
.+. .+......+|||+|||||+....+|+..+|||+.||++|-|+.|.+||.... ...+.+.+ ..+. -.+
T Consensus 162 ~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--~~rlye~I----~~g~---yd~ 231 (355)
T KOG0033|consen 162 EVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYEQI----KAGA---YDY 231 (355)
T ss_pred EeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHH----hccc---cCC
Confidence 886 5566777899999999999999999999999999999999999999997321 11222222 2221 111
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
++. ..++..+ +...++++|+..||.+|.|+.|++
T Consensus 232 ~~~---~w~~is~---~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 232 PSP---EWDTVTP---EAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CCc---ccCcCCH---HHHHHHHHHhccChhhhccHHHHh
Confidence 211 1112223 344678899999999999988754
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=370.90 Aligned_cols=487 Identities=27% Similarity=0.323 Sum_probs=367.3
Q ss_pred ceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecC
Q 037197 67 FVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNAS 146 (1009)
Q Consensus 67 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls 146 (1009)
+++.|+++.|.+....-+.+.+.-+|++||+++|++ +..|..+..+.+|+.|+++.|.+. ..|.+.+++.+|++|+|.
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~-~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~ 99 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQI-SSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK 99 (1081)
T ss_pred HHHhhhccccccccCchHHhhheeeeEEeecccccc-ccCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence 377778888776654444555555588888888887 567888888888888888888775 567788888888888888
Q ss_pred CCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccC
Q 037197 147 SNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEI 226 (1009)
Q Consensus 147 ~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~ 226 (1009)
+|.+. .+|..+..+.+|+.||++.|.+. .+|..+..+..+..+..++|.... .++... .+.++|..|.+.+.+
T Consensus 100 ~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~----~lg~~~-ik~~~l~~n~l~~~~ 172 (1081)
T KOG0618|consen 100 NNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQ----RLGQTS-IKKLDLRLNVLGGSF 172 (1081)
T ss_pred cchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhh----hhcccc-chhhhhhhhhcccch
Confidence 88887 78888888888888888888887 778888888888888888883221 233322 788888888888888
Q ss_pred CccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhccc
Q 037197 227 PAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELK 306 (1009)
Q Consensus 227 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 306 (1009)
+..+.+++. .|||.+|.+. -..+..+.+|+.|....|++.... -..++|+.|+.++|.++...+ -..-.
T Consensus 173 ~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~--~p~p~ 241 (1081)
T KOG0618|consen 173 LIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDV--HPVPL 241 (1081)
T ss_pred hcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecc--ccccc
Confidence 888877776 7888888876 234667788888888888877321 234778888888888873222 22235
Q ss_pred CCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecc
Q 037197 307 NLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILF 386 (1009)
Q Consensus 307 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~ 386 (1009)
+|+++++++|++++. |++++.+.+|+.++..+|++ ..+|..+...++|+.|.+.+|.+. -+|......+.|+.|+|.
T Consensus 242 nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l-~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 242 NLQYLDISHNNLSNL-PEWIGACANLEALNANHNRL-VALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cceeeecchhhhhcc-hHHHHhcccceEecccchhH-HhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeeh
Confidence 788888888888866 48888888888888888888 467778888888888888888887 667777778888888888
Q ss_pred cccccccCCcccccCcc-ccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCccccc
Q 037197 387 NNSFSGTFPVSLSTCKS-LVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESY 465 (1009)
Q Consensus 387 ~N~l~~~~p~~l~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 465 (1009)
.|++....+..+.-... |..|+.+.|++....-..=..++.|+.|.+.+|.|+...-+.+.+...|+.|+|++|+|..+
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f 398 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF 398 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence 88888554444444443 77777788888733322223466788888888888877666777888888888888888888
Q ss_pred CCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCC-Cccccc
Q 037197 466 LPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEI-PKAVAT 544 (1009)
Q Consensus 466 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~ 544 (1009)
+...+.+++.|++|+||+|+++ .+|+.+..+..|++|...+|+|. ..| .+..++.|+.+|||.|+|+... |.....
T Consensus 399 pas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~ 475 (1081)
T KOG0618|consen 399 PASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS 475 (1081)
T ss_pred CHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC
Confidence 7788888888888888888887 57788888888888888888887 666 7888888888888888887433 333322
Q ss_pred ccccceecCCccccccccCcCcCCCCCCcEEecCCC
Q 037197 545 MPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYN 580 (1009)
Q Consensus 545 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 580 (1009)
++|++|||++|.-.-..-..|..+.++...++.-|
T Consensus 476 -p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 476 -PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred -cccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 78888888888743344455556666666666666
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=331.56 Aligned_cols=265 Identities=26% Similarity=0.392 Sum_probs=201.0
Q ss_pred hcCCcCceeccCCceEEEEEEECC----------------CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceee
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHR----------------PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVR 761 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~ 761 (1009)
++|...+.||+|+||.||+|.+.. ++..||+|.+.... ......++.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 467888899999999999997542 34579999986432 2334556779999999999999999
Q ss_pred EEeEEEcCCeEEEEEeccCCCChhhhhcCCcc---------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 037197 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEA---------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVI 826 (1009)
Q Consensus 762 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iv 826 (1009)
+++++.+.+..++||||+++|+|.+++..... ....+++..+++++.||+.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999864321 112367888999999999999999998 999
Q ss_pred EeccCCCcEEeCCCCcEEEcccccceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh--CCC
Q 037197 827 HRDIKSNNILLDANLEARIADFGLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT--GKM 902 (1009)
Q Consensus 827 H~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt--g~~ 902 (1009)
||||||+||+++.++.+||+|||+++........ .....++..|+|||+.....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433221 122345778999999888889999999999999999987 556
Q ss_pred CCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 903 PLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 903 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
||.... ..+....+......... .........+ ...+.+++.+||+.||++|||+.|+.+.|++
T Consensus 241 p~~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~------~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELT--DEQVIENAGEFFRDQGR---QVYLFRPPPC------PQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCC--HHHHHHHHHHHhhhccc---cccccCCCCC------CHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 776321 12222322222211110 0000001111 1246778999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=336.22 Aligned_cols=246 Identities=21% Similarity=0.281 Sum_probs=198.6
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+|+..+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 57788999999999999999998899999999864322 12334556689999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 82 YVPGGELFSYLRNSGR----FSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred CCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999975432 78888889999999999999998 9999999999999999999999999999765332
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ......... .+. ..+.
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-----~~~~~~~i~-~~~-------~~~~ 218 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-----PFGIYEKIL-AGK-------LEFP 218 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHH-hCC-------cCCC
Confidence 223568999999999988889999999999999999999999997421 122222221 111 0111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPT-----MRDVIT 973 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 973 (1009)
... ...+.+++.+|++.||.+||+ +.|+++
T Consensus 219 ~~~------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 219 RHL------DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ccC------CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 111 124567889999999999995 777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=343.02 Aligned_cols=261 Identities=26% Similarity=0.376 Sum_probs=203.2
Q ss_pred HhcCCcCceeccCCceEEEEEEE-----CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCC
Q 037197 697 LACVKESNIIGMGGNGIVYKAEF-----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNET 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~ 770 (1009)
.++|+..+.||+|+||.||+|.+ .+++..||||+++.... ....+.+.+|+++++.+ +||||++++++|.+++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 34688899999999999999974 34567899999864432 33345677999999999 8999999999999999
Q ss_pred eEEEEEeccCCCChhhhhcCCcc---------------------------------------------------------
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEA--------------------------------------------------------- 793 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 793 (1009)
..++||||+++|+|.++++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999865321
Q ss_pred --------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 794 --------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 794 --------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
....+++..+.+++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 012468889999999999999999998 999999999999999999999999999986643322
Q ss_pred c--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 860 T--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 860 ~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
. .....++..|+|||+..+..++.++|||||||++|||++ |..||...... ....++ +..+.. ...+..
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~----~~~~~~---~~~~~~ 341 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKM----IKEGYR---MLSPEC 341 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHH----HHhCcc---CCCCCC
Confidence 1 112334567999999988899999999999999999998 88898643221 112222 222210 001111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
. ..++.+++.+|++.||++||++.|+++.|++.
T Consensus 342 ---~------~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 342 ---A------PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---C------CHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1 12466889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=326.87 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=210.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCC-CChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
++|+..+.||+|+||.||+|+...+++.||||.+.... .+......+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46788899999999999999999889999999875432 23344456678999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++.........+++..++.++.|+++||+|||++ +++|+||||+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998865433334478888999999999999999998 999999999999999999999999999987644
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.........+++.|+|||...+..++.++||||+|+++|||++|+.||..... +...+.... .... .+..
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~-~~~~------~~~~ 228 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQKI-EQCD------YPPL 228 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHHH-hcCC------CCCC
Confidence 33333345688899999998888889999999999999999999999864322 222222221 1111 1111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
. .......+.+++.+||+.+|++||++.|+++.++.++
T Consensus 229 ~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 P-----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred C-----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0 0011234667889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=336.99 Aligned_cols=244 Identities=21% Similarity=0.259 Sum_probs=195.6
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
+.||+|+||.||++.+..+++.||+|++..... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999999999999999865321 2233445668999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCcee
Q 037197 783 SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVS 862 (1009)
Q Consensus 783 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 862 (1009)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 9999886543 278889999999999999999998 999999999999999999999999999876433333344
Q ss_pred eecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCch
Q 037197 863 MVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942 (1009)
Q Consensus 863 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
...|++.|+|||+..+..++.++|||||||++|||++|+.||.... ............. .+....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~~~~~~~~~~~--------~~p~~~-- 218 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFELILMEEI--------RFPRTL-- 218 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCCC--------CCCCCC--
Confidence 5678999999999988889999999999999999999999996321 1111111111110 111111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 943 VQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 943 ~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
...+.+++.+|++.||++|| ++.++++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 ----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ----CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 12356788899999999998 7887764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=338.93 Aligned_cols=246 Identities=20% Similarity=0.253 Sum_probs=198.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|+..+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 567888999999999999999999999999999865421 2233456679999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGR----FPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999975432 67788888999999999999998 999999999999999999999999999986533
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
. .....|++.|+|||++.+..++.++|||||||++|||++|+.||... ...+..... ..+. ..+
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-----~~~~~~~~i-~~~~-------~~~ 234 (329)
T PTZ00263 171 R---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD-----TPFRIYEKI-LAGR-------LKF 234 (329)
T ss_pred C---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC-----CHHHHHHHH-hcCC-------cCC
Confidence 2 22457899999999998888999999999999999999999999632 112222221 1111 011
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT-----MRDVI 972 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl 972 (1009)
..... ..+.+++.+|++.||++||+ ++|++
T Consensus 235 p~~~~------~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 235 PNWFD------GRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred CCCCC------HHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 11111 23567889999999999997 56665
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=336.61 Aligned_cols=244 Identities=20% Similarity=0.277 Sum_probs=196.4
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
+.||+|+||.||++.+..+++.||+|++.+... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999999999999999965422 2233456678999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCcee
Q 037197 783 SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVS 862 (1009)
Q Consensus 783 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 862 (1009)
+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 9999886543 278889999999999999999998 999999999999999999999999999876433333334
Q ss_pred eecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCch
Q 037197 863 MVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942 (1009)
Q Consensus 863 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
...||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+....... . +..+....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-----~~~~~~~~~~~-~-------~~~~p~~~-- 218 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILM-E-------DIKFPRTL-- 218 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC-----CHHHHHHHhcc-C-------CccCCCCC--
Confidence 567999999999998888999999999999999999999999632 11222211111 1 01111111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 943 VQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 943 ~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
..++.+++.+|++.||++|| ++.|+++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 219 ----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred ----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 12456788899999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=338.09 Aligned_cols=255 Identities=20% Similarity=0.252 Sum_probs=201.9
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+..+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 578889999999999999999998999999998654221 2234556789999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLGV----LSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred CCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999965432 78888889999999999999998 999999999999999999999999999976533
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
......|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.......... ....+...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~---~~~~~~~~ 223 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST-----PNETWENLKYWKE---TLQRPVYD 223 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC-----HHHHHHHHHhccc---cccCCCCC
Confidence 2334568999999999988899999999999999999999999997421 1111111111110 01111111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
... .....++.+++.+|+..+|++||++.|+++.
T Consensus 224 ~~~---~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPR---FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccc---cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 0112245678889999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=341.50 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=202.7
Q ss_pred hcCCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 771 (1009)
++|+..+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+++++.+ +||||++++++|.....
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 468889999999999999998643 33579999996543 233455677999999999 89999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCcc----------------------------------------------------------
Q 037197 772 VMMVYDYMPNDSLGEALHGKEA---------------------------------------------------------- 793 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 793 (1009)
.++||||+++|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999854321
Q ss_pred --------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCc--eee
Q 037197 794 --------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET--VSM 863 (1009)
Q Consensus 794 --------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~--~~~ 863 (1009)
....+++.++++++.||++||+|||+. +|+||||||+||++++++.+||+|||+++........ ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 012368888999999999999999998 9999999999999999999999999999865433211 112
Q ss_pred ecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCch
Q 037197 864 VAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942 (1009)
Q Consensus 864 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1009)
..+++.|+|||+.....++.++|||||||++|||++ |+.||...... .. .......+. .+......
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-~~----~~~~~~~~~------~~~~~~~~-- 340 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-SK----FYKMVKRGY------QMSRPDFA-- 340 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-HH----HHHHHHccc------CccCCCCC--
Confidence 234567999999888889999999999999999997 99999743221 11 111111111 11111111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 943 VQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 943 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
..++.+++.+|++.||++||++.+++++|+++.
T Consensus 341 ----~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 341 ----PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 124667889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=297.71 Aligned_cols=251 Identities=28% Similarity=0.393 Sum_probs=207.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhH-HHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESG-DDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.+.|+.++.||+|-||.||.|+.+.++-.||+|++.++....... .++.+|+++-+.++||||+++|+||.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 356889999999999999999999999999999998765433333 3455999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
+||..+|++...++..... .+++.....++.|+|.|+.|+|.. +|+||||||+|+|++.++..|++|||.+...
T Consensus 101 lEya~~gel~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~- 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA- 174 (281)
T ss_pred EEecCCchHHHHHHhcccc--cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec-
Confidence 9999999999999854432 267888888999999999999998 9999999999999999999999999998653
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
+.......+||..|.|||+..+...+.+.|+|++|++.||++.|.+||+... .+ +..+-+.+ .+..+|.
T Consensus 175 -p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~-etYkrI~k--------~~~~~p~ 243 (281)
T KOG0580|consen 175 -PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HS-ETYKRIRK--------VDLKFPS 243 (281)
T ss_pred -CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hH-HHHHHHHH--------ccccCCc
Confidence 2455667889999999999999999999999999999999999999998433 11 11111111 1122221
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. .. ....+++.+|+..+|.+|.+..|+++
T Consensus 244 ~------is---~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 244 T------IS---GGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred c------cC---hhHHHHHHHHhccCccccccHHHHhh
Confidence 1 11 23457888999999999999999876
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.68 Aligned_cols=264 Identities=27% Similarity=0.360 Sum_probs=204.8
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc-----CC
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN-----ET 770 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-----~~ 770 (1009)
+...|...+.||+|+||.|+++.++.+|+.||||++..........++.++|+++++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666788999999999999999999999999998777777788999999999999999999999998754 45
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
.+|+|+|+| ..+|...++.... ++.....-++.|+++||.|+|+. +|+|||+||+|++++.+...||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~~~~----L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQD----LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCcc----ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 689999999 6789999976653 67778888999999999999999 999999999999999999999999999
Q ss_pred ceecccC--CCceeeecccCcccCCccc-CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCC-------------CCccH
Q 037197 851 ARMMLHK--NETVSMVAGSYGYIAPEYG-YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFG-------------GSKDI 914 (1009)
Q Consensus 851 s~~~~~~--~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~-------------~~~~~ 914 (1009)
|+..... ....+..+.|..|.|||.+ ....|+.+.||||.||++.||++|++-|..... +..+.
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 9987542 3345667789999999975 466799999999999999999999988763110 00111
Q ss_pred HHHHH-----HHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 915 VEWVL-----SMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 915 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+. ..++. ....-...+...++... ...++++.+|+..||.+|+|++|+++
T Consensus 252 l~~i~s~~ar~yi~s---lp~~p~~~f~~~fp~a~---p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKS---LPQIPKQPFSSIFPNAN---PLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhccHHHHHHHHh---CCCCCCCCHHHHcCCCC---HHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111 00100 00111111122222222 23457788999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=323.49 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=201.0
Q ss_pred hcCCcCceeccCCceEEEEEEEC---CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFH---RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
+.|+..+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 45788899999999999999875 346789999986542 23334567799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++|+|.+++..... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999975432 378999999999999999999998 9999999999999999999999999987653
Q ss_pred ccCCC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 855 LHKNE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 855 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
..... ......++..|+|||......++.++|||||||++||+++ |+.||..... .+.+. .+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----~~~~~-~~~~~~------ 225 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----QDVIK-AVEDGF------ 225 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHH-HHHCCC------
Confidence 22211 1112234578999999888899999999999999999875 9999964321 11121 111111
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
.......+ ...+.+++.+||+.+|++||++.++.+.|+++
T Consensus 226 ~~~~~~~~------~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLPAPRNC------PNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCC------CHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11111111 12456788899999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=339.38 Aligned_cols=259 Identities=21% Similarity=0.241 Sum_probs=196.8
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.+|+..+.||+|+||.||++.+..+++.||+|... ...+.+|++++++++||||+++++++......++|+|
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 46999999999999999999999999999999752 2345689999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
++. ++|.+++..... +++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 164 ~~~-~~L~~~l~~~~~----l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RYK-TDLYCYLAAKRN----IAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cCC-CCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 995 788888865432 78888999999999999999998 9999999999999999999999999999754322
Q ss_pred C-CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCC--CCccHHHHHHHHHhhccccc-c---
Q 037197 858 N-ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFG--GSKDIVEWVLSMIKSNKAQD-E--- 930 (1009)
Q Consensus 858 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~-~--- 930 (1009)
. .......||+.|+|||++....++.++|||||||++|||++|+.||-.... +..+....+...+....... +
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 2 233345799999999999888899999999999999999999988743211 11011111111111000000 0
Q ss_pred -----------------ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 931 -----------------ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 931 -----------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
...+..............++..++.+|++.||++|||++|++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 000000000111112234577899999999999999999998
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.80 Aligned_cols=200 Identities=24% Similarity=0.435 Sum_probs=175.6
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||.||++++..++..||+|.+.... ......++.+|++++++++||||+++++++..++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 56888899999999999999999999999999986532 23345667799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++..... +++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999975432 788888999999999999999852 6999999999999999999999999998765322
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
......|++.|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22345689999999999888899999999999999999999999963
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.09 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=212.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
++|+..+.||+|+||.||+|....+++.||+|.++.... +....+.+.+|++++++++|+|++++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 468888999999999999999998899999998864332 2333566779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++.........+++.+++.++.++++|++|||+. +|+||||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999865443344578999999999999999999998 999999999999999999999999999887644
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.........+++.|+|||+..+..++.++||||||+++|+|++|+.||.... .+..+...... .+. . +..
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~-~~~-----~-~~~ 228 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIE-KCD-----Y-PPL 228 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhh-cCC-----C-CCC
Confidence 4433344568889999999888889999999999999999999999986332 12222222111 110 0 111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.. ......+.+++.+|++.+|++||++.+++++|+++.
T Consensus 229 ~~-----~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 PA-----DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred Ch-----hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 10 011234667889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=335.27 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=194.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
..|+..+.||+|+||.||+|.+..+++.||||++.... .......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 44667788999999999999999889999999985432 23344567799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+... .++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 153 ~~~~~~L~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 153 FMDGGSLEGTHI--------ADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred cCCCCccccccc--------CCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999999865421 35567778999999999999998 9999999999999999999999999999876443
Q ss_pred CCceeeecccCcccCCcccCC-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYT-----LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
........|+..|+|||++.. ...+.++|||||||++|||++|+.||...... +....+..... ..
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~-~~------ 292 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAICM-SQ------ 292 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhc-cC------
Confidence 333345678999999998642 23456899999999999999999999732211 22222111111 10
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
.+..... ...++.+++.+||+.||++||++.|+++-
T Consensus 293 ~~~~~~~------~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEAPAT------ASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCc------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111 11246678899999999999999999874
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=332.86 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=193.8
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHH---HhccCCCceeeEEeEEEcCCeEEEE
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSL---LGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~---l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
|+..+.||+|+||.||+|.+..+++.||||++++... .....+.+.+|+++ ++.++||||+++++++.+++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 5667899999999999999999999999999965421 12223444456554 4567899999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|..+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999888643 278899999999999999999998 99999999999999999999999999987543
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
..........|++.|+|||+..+..++.++|||||||++|||++|+.||... +..+.......... .
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~-----~~~~~~~~i~~~~~--------~ 219 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD-----DEEEVFDSIVNDEV--------R 219 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCC--------C
Confidence 3333444567999999999998888999999999999999999999999732 11222222211111 1
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
+.... ...+..++.+|++.||++|| ++.++++
T Consensus 220 ~p~~~------~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 YPRFL------SREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCC------CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11111 12356788899999999999 4555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=345.22 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=206.4
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeE-EE-----c-CC
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGY-LH-----N-ET 770 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~-~~-----~-~~ 770 (1009)
++++.++|.+|||+.||.|.+...|..||+|++... +........+|+++|++|+ |||||.+++. .. . .-
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 356778899999999999999997799999998654 4555666779999999996 9999999993 21 1 24
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
++++.||||+||+|-|++..+...+ +++.++++|+.|+++|+++||.. +++|||||||-+|||++.++..||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 6899999999999999998665443 89999999999999999999987 78899999999999999999999999999
Q ss_pred ceecccCCC---------ceeeecccCcccCCccc---CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHH
Q 037197 851 ARMMLHKNE---------TVSMVAGSYGYIAPEYG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWV 918 (1009)
Q Consensus 851 s~~~~~~~~---------~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 918 (1009)
+........ ......-|+.|+|||++ .+..+++|+|||+|||+||-|+..+.||+..-.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------- 263 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------- 263 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------
Confidence 875422221 11123568999999974 466799999999999999999999999984211
Q ss_pred HHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 919 LSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
..+++..+. ++........+..||..||++||++||++.+|+..+.+++..+
T Consensus 264 ----------laIlng~Y~--~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 ----------LAILNGNYS--FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ----------eeEEecccc--CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 122222221 1111233445778999999999999999999999999887654
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=333.31 Aligned_cols=245 Identities=22% Similarity=0.332 Sum_probs=194.2
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999975422 223344566888888776 899999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 99998886543 278888899999999999999998 99999999999999999999999999997643333344
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC---CccHHHHHHHHHhhccccccccCccccc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG---SKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......++...+..... .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-------~~p~ 226 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-------RIPR 226 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-------CCCC
Confidence 4567899999999999889999999999999999999999999632111 11223333333222210 1111
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTM 968 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 968 (1009)
.. ...+..++.+|++.||++||++
T Consensus 227 ~~------~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 SL------SVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CC------CHHHHHHHHHHhcCCHHHcCCC
Confidence 11 1245678899999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=333.17 Aligned_cols=239 Identities=23% Similarity=0.330 Sum_probs=191.9
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||.||+|+++.+++.||+|++.+... .......+..|.++++.. +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999864321 123345566888888776 699999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 g~L~~~i~~~~~----l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 81 GDLMFHIQKSRR----FDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred chHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 999998865432 78888999999999999999998 99999999999999999999999999987653333444
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
....||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+...... .+. ...+. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-----~~~~~~~~i~-~~~----~~~~~---~~- 219 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE-----NEDDLFEAIL-NDE----VVYPT---WL- 219 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC-----CHHHHHHHHh-cCC----CCCCC---CC-
Confidence 4567999999999998888999999999999999999999999732 1222222221 111 11111 11
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCH
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRPTM 968 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RPs~ 968 (1009)
..++.+++.+|++.||++||++
T Consensus 220 -----~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 220 -----SQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -----CHHHHHHHHHHcccCHHHCCCC
Confidence 1245678899999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=309.54 Aligned_cols=272 Identities=23% Similarity=0.314 Sum_probs=207.8
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCc-eeeEEeEEEcCC------
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN-IVRLLGYLHNET------ 770 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn-iv~l~~~~~~~~------ 770 (1009)
..|+..+.||+|+||+||+|+.+.+|+.||+|+++....+........+|+.++++++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4466667799999999999999999999999999766544344566789999999999999 999999998877
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
..++||||+ .-+|..++..........+...+..++.|+++||+|||++ +|+||||||.||+++++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 789999999 5679999876653212356678888999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
|+.+.-+....+..++|..|.|||++.+. .|+...||||+||+++||++++.-|... .+ .+.......--....
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~----se-~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD----SE-IDQLFRIFRLLGTPN 241 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC----cH-HHHHHHHHHHcCCCC
Confidence 99776566666777889999999998765 6999999999999999999998777632 22 222222222111111
Q ss_pred cccCccc------cccCc------hHHH----HHHHHHHHHHHhccCCCCCCCCHHHHHHH--Hhhc
Q 037197 930 EALDPSI------AGQCK------HVQE----EMLLVLRIAVLCTAKLPKGRPTMRDVITM--LGEA 978 (1009)
Q Consensus 930 ~~~~~~~------~~~~~------~~~~----~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~ 978 (1009)
+...|.. ...+. .... ......+++.+|++.+|.+|.|++.+++. +...
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1111111 10000 1111 11346778889999999999999988875 4444
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=331.13 Aligned_cols=243 Identities=25% Similarity=0.329 Sum_probs=191.5
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||.||+|.+..+++.||+|+++.... .....+....|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999865321 122334455677776654 899999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 g~L~~~~~~~~~----~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 81 GDLMFHIQSSGR----FDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 999999865432 78888888999999999999998 99999999999999999999999999998654444444
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+..... ... .+.+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-----~~~~~~~i-~~~-------~~~~~~~~- 219 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-----EDELFDSI-LND-------RPHFPRWI- 219 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----HHHHHHHH-HcC-------CCCCCCCC-
Confidence 45678999999999988889999999999999999999999997321 12222221 111 11111111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
..++.+++.+|++.||++||++.+.+
T Consensus 220 -----~~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 220 -----SKEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred -----CHHHHHHHHHHccCCHHHcCCChHHH
Confidence 12345788899999999999976433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.43 Aligned_cols=270 Identities=26% Similarity=0.369 Sum_probs=198.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC-----eE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET-----NV 772 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-----~~ 772 (1009)
-.|...+++|.|+||.||+|....+++.||||+...... ---+|+++|+.++|||||++.-+|.... +.
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 356778899999999999999999999999999854321 1127999999999999999999885432 45
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-CcEEEcccccc
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN-LEARIADFGLA 851 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfGls 851 (1009)
.+|||||+ .+|.++++.....+..++...+.-++.||++||+|||+. +|+||||||.|+|+|.+ |.+||||||.|
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 78999995 679998875433333467777777999999999999998 99999999999999987 89999999999
Q ss_pred eecccCCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH-------Hh
Q 037197 852 RMMLHKNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSM-------IK 923 (1009)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~-------~~ 923 (1009)
+........ .....|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.. ..+.++++..+.-. +.
T Consensus 174 K~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 174 KVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHHhCCCCHHHHh
Confidence 988554443 556678899999987654 699999999999999999999988863 22223333333211 11
Q ss_pred hccc-cccccCccccccCc---hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhhcC
Q 037197 924 SNKA-QDEALDPSIAGQCK---HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT--MLGEAK 979 (1009)
Q Consensus 924 ~~~~-~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~~ 979 (1009)
.... ..+...|.+....- .......+..+++.+++..+|.+|.++.|+++ .+.++.
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 1110 01112222322111 01112245677889999999999999999884 344443
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=324.27 Aligned_cols=250 Identities=23% Similarity=0.271 Sum_probs=195.2
Q ss_pred eccCCceEEEEEEECCCCeEEEEEEcccCCCCh-hhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCCh
Q 037197 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI-ESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSL 784 (1009)
Q Consensus 706 iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL 784 (1009)
||+|+||+||++.+..+++.||+|++....... ...+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999999999999999986442221 2234556899999999999999999999999999999999999999
Q ss_pred hhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCceeee
Q 037197 785 GEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMV 864 (1009)
Q Consensus 785 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 864 (1009)
.+++.........+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 988864433334488999999999999999999998 99999999999999999999999999998765444334445
Q ss_pred cccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHH
Q 037197 865 AGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQ 944 (1009)
Q Consensus 865 ~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1009)
.|++.|+|||+..+..++.++||||||+++|||++|+.||....... .... +....... ...+...
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~-~~~~~~~~-------~~~~~~~----- 223 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKE-LKQRILND-------SVTYPDK----- 223 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHH-HHHhhccc-------CCCCccc-----
Confidence 78999999999998899999999999999999999999997432110 1111 11111000 0011111
Q ss_pred HHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 945 EEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 945 ~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
....+.+++.+|++.||++|| +++++++
T Consensus 224 -~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 -FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred -CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 112456788899999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=335.58 Aligned_cols=241 Identities=22% Similarity=0.310 Sum_probs=193.4
Q ss_pred ceeccCCceEEEEEEE---CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccC
Q 037197 704 NIIGMGGNGIVYKAEF---HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMP 780 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~ 780 (1009)
+.||+|+||.||+++. ..+++.||+|++............+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999876 3568999999996543333334556689999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCc
Q 037197 781 NDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860 (1009)
Q Consensus 781 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~ 860 (1009)
+|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 999999986543 278899999999999999999998 9999999999999999999999999999876444344
Q ss_pred eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccC
Q 037197 861 VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQC 940 (1009)
Q Consensus 861 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
.....|++.|+|||+.....++.++|||||||++|||++|+.||... +............. .+....
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-----~~~~~~~~i~~~~~--------~~p~~~ 221 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK-----DRKETMTMILKAKL--------GMPQFL 221 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC-----CHHHHHHHHHcCCC--------CCCCCC
Confidence 44567899999999998888899999999999999999999999732 11222222111110 011111
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 037197 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMRD 970 (1009)
Q Consensus 941 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~e 970 (1009)
...+..++.+|++.||++||++.+
T Consensus 222 ------~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 ------SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ------CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 123557888999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=335.26 Aligned_cols=248 Identities=20% Similarity=0.255 Sum_probs=198.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCC-eEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPH-MVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~-~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
.+.|+..+.||+|+||.||+|.+..++ ..||+|++..... .....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 456888999999999999999876544 7899999854322 22334566789999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKR----FPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999975432 78888899999999999999998 9999999999999999999999999999865
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. .....+..+. ..+.+
T Consensus 182 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~-~~~~~i~~~~---~~~p~ 249 (340)
T PTZ00426 182 DT---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-----PL-LIYQKILEGI---IYFPK 249 (340)
T ss_pred CC---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-----HH-HHHHHHhcCC---CCCCC
Confidence 32 2234578999999999988889999999999999999999999997321 11 1111111111 00111
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
... ..+.+++.+|++.||++|+ +++|+++
T Consensus 250 ----~~~------~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 250 ----FLD------NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ----CCC------HHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 111 2345788899999999995 7887765
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=310.72 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=211.2
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|.+.+.+|+|+||.||||.++.+|.++|||++... ...+++.+|+.++++++.|+||++||.|.....+|+|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3466778899999999999999999999999998543 345677899999999999999999998888889999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
||..||+.|.++.++ .++++.++..|+.+.++||+|||.. .-+|||||..|||++.+|.+|++|||.+..+.+.
T Consensus 109 YCGAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 109 YCGAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred hcCCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 999999999997654 3488889999999999999999998 8899999999999999999999999999888766
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
......+.|||.|||||++....|+.++||||+|++..||..|++||.+..+-.. .-++...-.
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IFMIPT~PP 246 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IFMIPTKPP 246 (502)
T ss_pred HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eEeccCCCC
Confidence 6667778999999999999999999999999999999999999999985433210 001111112
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.-+....+...++-.++++|+-+.|++|.|+.++++
T Consensus 247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 233444555567888999999999999999887764
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=334.75 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=195.5
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-----CeEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE-----TNVM 773 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----~~~~ 773 (1009)
+|+..+.||+|+||.||+|.+..+++.||||++...........++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 47778899999999999999999999999999865433334445677999999999999999999987543 3579
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||++ ++|.+++..... +++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD----LTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhccc----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 689988865432 78889999999999999999999 999999999999999999999999999976
Q ss_pred cccCCC---ceeeecccCcccCCcccCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh-----
Q 037197 854 MLHKNE---TVSMVAGSYGYIAPEYGYT--LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK----- 923 (1009)
Q Consensus 854 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~----- 923 (1009)
...... ......|++.|+|||+..+ ..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHH
Confidence 432221 2234568999999998765 5788999999999999999999999964211 011111110000
Q ss_pred ------hcc---c---cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 924 ------SNK---A---QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 924 ------~~~---~---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
... . ........+...... ....+.+++.+|++.||++||+++|+++-
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPN---ADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCC---CChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 0 000000000000011 11245678999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.49 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=197.1
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
++||+|+||.||+|.+..+++.||+|++++... .......+.+|..+++++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999999999999999999965432 223344566899999888 799999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 99999886543 278899999999999999999998 99999999999999999999999999987543333444
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC---CccHHHHHHHHHhhccccccccCccccc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG---SKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
....||+.|+|||++.+..++.++|||||||++|||++|+.||+..... .....++....+..... .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~p~ 226 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-------RIPR 226 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-------CCCC
Confidence 4567899999999999889999999999999999999999999742111 11222333333322210 1111
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCC------HHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPT------MRDVI 972 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs------~~evl 972 (1009)
.. ..++.+++.+|++.||.+||+ +.+++
T Consensus 227 ~~------~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 227 SL------SVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CC------CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 11 124567889999999999997 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=316.89 Aligned_cols=251 Identities=25% Similarity=0.428 Sum_probs=199.2
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||+|.++. +..+|+|.+.... ....++.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 347778899999999999998876 5689999885432 224567799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.++++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.++.....
T Consensus 80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 80 FMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred cCCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 9999999999975432 278899999999999999999998 9999999999999999999999999998765332
Q ss_pred CCc-eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NET-VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
... .....++..|+|||+.....++.++||||||+++|||++ |+.||... +..+.+..... +. ....+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~-----~~~~~~~~i~~-~~---~~~~~~ 224 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK-----SNYEVVEMISR-GF---RLYRPK 224 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHHC-CC---CCCCCC
Confidence 221 112234568999999888889999999999999999999 89999632 12222222211 11 111111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
. ....+.+++.+|++.+|++||++.|+++.|.
T Consensus 225 ~---------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 L---------ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred C---------CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1 1134678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=324.69 Aligned_cols=264 Identities=24% Similarity=0.316 Sum_probs=194.1
Q ss_pred cCCcCceeccCCceEEEEEEECC-CCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc---CCCceeeEEeEEE-----cC
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHR-PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL---RHRNIVRLLGYLH-----NE 769 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~Hpniv~l~~~~~-----~~ 769 (1009)
+|+..+.||+|+||.||+|++.. +++.||+|++............+.+|+++++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 57888999999999999999854 478899999865543333344555677776655 6999999999885 34
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFG 849 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 849 (1009)
...++||||++ ++|.+++..... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 56899999996 689998865432 2378889999999999999999998 99999999999999999999999999
Q ss_pred cceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 850 LARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 850 ls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
+++..... .......|++.|+|||......++.++|||||||++|||++|+.||..... .+....+........ .
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~--~~~~~~i~~~~~~~~--~ 230 (290)
T cd07862 156 LARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPG--E 230 (290)
T ss_pred ceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCC--h
Confidence 99865433 233345689999999998888899999999999999999999999974321 122222221111000 0
Q ss_pred ccc-------CccccccCchHH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 930 EAL-------DPSIAGQCKHVQ-----EEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 930 ~~~-------~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.. ...+........ .....+.+++.+|++.||++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 000000000000 11124567899999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=335.22 Aligned_cols=244 Identities=20% Similarity=0.258 Sum_probs=195.5
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
+.||+|+||.||++.+..+++.||+|++..... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999865322 1223455668999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 783 SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH-DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 783 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence 9999886543 27888999999999999999997 6 99999999999999999999999999987643333344
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ ..+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-----~~~~~~~i~~~~--------~~~p~~~- 219 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILMEE--------IRFPRTL- 219 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-----HHHHHHHHhcCC--------CCCCCCC-
Confidence 45679999999999988889999999999999999999999996321 111111111111 0111111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
..++.+++.+|++.||++|+ ++.++++
T Consensus 220 -----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 220 -----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 12456788899999999996 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=328.52 Aligned_cols=260 Identities=24% Similarity=0.388 Sum_probs=203.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCe----EEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHM----VVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
..|+..+.||+|+||.||+|++..+++ .||+|++... ......+++.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 358888999999999999999865554 4899998543 2234456677999999999999999999999765 567
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+|+||+++|+|.++++.... .+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999999976432 278888899999999999999998 999999999999999999999999999987
Q ss_pred cccCCCce--eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 854 MLHKNETV--SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
........ ....++..|+|||+.....++.++||||||+++|||++ |+.||+... ..+ +......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-----~~~-~~~~~~~~~~--- 229 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASE-ISSILEKGER--- 229 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHH-HHHHHhCCCC---
Confidence 64333221 12234568999999988899999999999999999998 999986321 111 1122221110
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCcc
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRK 983 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 983 (1009)
. .....+ ...+..++.+|++.+|++||++.+++..+.++.....
T Consensus 230 ~---~~~~~~------~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 230 L---PQPPIC------TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred C---CCCCCC------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 0 001111 1245678899999999999999999999998876553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=348.23 Aligned_cols=258 Identities=24% Similarity=0.283 Sum_probs=206.9
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC-----
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET----- 770 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----- 770 (1009)
..++|+..+.||+|+||+||+|.+..+++.||||++............+.+|+..+..++|+|++++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 456899999999999999999999999999999999765544555566779999999999999999988765332
Q ss_pred ---eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcc
Q 037197 771 ---NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIAD 847 (1009)
Q Consensus 771 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 847 (1009)
.+++||||+++|+|.++++.+......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 36899999999999999976544444588889999999999999999998 999999999999999999999999
Q ss_pred cccceecccCC--CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc
Q 037197 848 FGLARMMLHKN--ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN 925 (1009)
Q Consensus 848 fGls~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 925 (1009)
||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +....+.......
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~~~~~~~~~~ 261 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEEVMHKTLAGR 261 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHhcCC
Confidence 99998764322 2233457899999999999888999999999999999999999999732 2233333222111
Q ss_pred cccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 926 KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
. ++ +.... ..++..++.+|++.||++||++.++++.
T Consensus 262 ~------~~-~~~~~------~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 Y------DP-LPPSI------SPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C------CC-CCCCC------CHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 11 11111 1245678899999999999999999763
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.40 Aligned_cols=244 Identities=22% Similarity=0.337 Sum_probs=193.3
Q ss_pred ceeccCCceEEEEEEEC---CCCeEEEEEEcccCCC--ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 704 NIIGMGGNGIVYKAEFH---RPHMVVAVKKLWRSDN--DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+.||+|+||.||+++.. .+++.||+|++.+... .......+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999864 4688999999865321 122234556899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.+++..... +.+..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREGI----FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999865432 67778888999999999999998 99999999999999999999999999987654433
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
.......|++.|+|||+.....++.++|||||||++|||++|+.||... +....+........ .+.+.+
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~-----~~~~~~~~~~~~~~----~~~~~~-- 223 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE-----NRKKTIDKILKGKL----NLPPYL-- 223 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC-----CHHHHHHHHHcCCC----CCCCCC--
Confidence 3344457899999999998888899999999999999999999999732 12222222221111 111111
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
...+.+++.+|++.||++|| ++.++++
T Consensus 224 --------~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 224 --------TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --------CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 12456788999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.74 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=209.9
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
++|+..+.||+|+||.||+|....+++.||||.+..... +.....++.+|+++++.++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 357778899999999999999988899999998865432 2334456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++.........+++..++.++.|+++|++|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875333334578999999999999999999998 999999999999999999999999999876644
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.........+++.|+|||+..+..++.++||||||+++|+|++|..||...... ......... ....+..
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~-------~~~~~~~ 228 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIE-------QCDYPPL 228 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhhh-------cCCCCCC
Confidence 333333456888999999998888999999999999999999999998632211 112211111 0111111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.. . .....+..++.+|++.+|++|||+.+|++.++++.
T Consensus 229 ~~--~---~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 PS--D---HYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred Cc--c---cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 10 0 11224667888999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=332.26 Aligned_cols=244 Identities=24% Similarity=0.331 Sum_probs=194.4
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||.||+|++..+++.||+|++.+... .......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 368999999999999999899999999865321 123344566888888866 799999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.+++..... +++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 81 GDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 999998865432 78888889999999999999998 99999999999999999999999999997654444444
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
....|++.|+|||+.....++.++||||+||++|||++|+.||.... ............ ...+. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-----~~~~~~~i~~~~-----~~~p~---~~- 219 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-----EDDLFESILHDD-----VLYPV---WL- 219 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCC-----CCCCC---CC-
Confidence 45678999999999988889999999999999999999999997422 122222221111 11111 11
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCC-------CHHHHHH
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRP-------TMRDVIT 973 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RP-------s~~evl~ 973 (1009)
..++.+++.+|++.||++|| ++.++++
T Consensus 220 -----~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 220 -----SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred -----CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 12456788899999999999 6777763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=324.43 Aligned_cols=258 Identities=23% Similarity=0.377 Sum_probs=208.0
Q ss_pred CCcCceeccCCceEEEEEEECC----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 700 VKESNIIGMGGNGIVYKAEFHR----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
....++||.|-||.||+|.... ..-.||||..+.. .+.+..+.|+.|+-+|+.++||||++++|+|.+. ..|+|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 3456789999999999998643 3456899998553 4456688899999999999999999999999865 68999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
||.++.|-|.++++.+... ++......++.||+.||+|||+. .+|||||..+|||+....-||++|||+++.+.
T Consensus 469 mEL~~~GELr~yLq~nk~s---L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDS---LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EecccchhHHHHHHhcccc---chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 9999999999999876543 78888888999999999999999 99999999999999999999999999999886
Q ss_pred cCCCce-eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 856 HKNETV-SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 856 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
+..... +...-...|||||.+.-++++.+||||.|||.+||++. |..||....+.+. ... .+...+
T Consensus 543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV------I~~------iEnGeR 610 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV------IGH------IENGER 610 (974)
T ss_pred ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce------EEE------ecCCCC
Confidence 665432 23334568999999999999999999999999999988 9999985443311 001 111122
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCcc
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRK 983 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 983 (1009)
...+..|+. .+..++.+||+.+|.+||++.|+...|.++...++
T Consensus 611 lP~P~nCPp------~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 611 LPCPPNCPP------ALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred CCCCCCCCh------HHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 223333432 34568889999999999999999999988766443
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=324.61 Aligned_cols=256 Identities=25% Similarity=0.297 Sum_probs=211.4
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh-hhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCe
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI-ESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETN 771 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~ 771 (1009)
..+...|+..+.||+|.||.||+++.+.+|+.+|+|.+.+..... .....+.+|+++|+++. |||||.++++|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 445667888899999999999999999999999999997664322 23567779999999998 9999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC----CcEEEcc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN----LEARIAD 847 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~----~~~kl~D 847 (1009)
+++|||++.||.|.+.+... .+++..+..++.|++.++.|+|+. ||+|||+||+|+++... +.+|++|
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEee
Confidence 99999999999999999765 178889999999999999999998 99999999999999643 4799999
Q ss_pred cccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 848 FGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 848 fGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
||++..... .......+||+.|+|||+.....|+..+||||+||++|.|++|..||...... .... .+..+.
T Consensus 183 FGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~-----~~~~-~i~~~~- 254 (382)
T KOG0032|consen 183 FGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF-----EIFL-AILRGD- 254 (382)
T ss_pred CCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh-----HHHH-HHHcCC-
Confidence 999998866 66777889999999999999999999999999999999999999999743221 1111 222221
Q ss_pred cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.++.++.+... -..+..++.+|+..||.+|+++.++++
T Consensus 255 -~~f~~~~w~~i-------s~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 255 -FDFTSEPWDDI-------SESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -CCCCCCCcccc-------CHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 11222222211 123456888999999999999999998
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=338.76 Aligned_cols=253 Identities=25% Similarity=0.292 Sum_probs=201.7
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+|+..+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 578889999999999999999989999999998654221 2334556689999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 82 YMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999997652 278888889999999999999998 9999999999999999999999999999865433
Q ss_pred C-----------------------------CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Q 037197 858 N-----------------------------ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAF 908 (1009)
Q Consensus 858 ~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~ 908 (1009)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 12234568999999999998899999999999999999999999997432
Q ss_pred CCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 037197 909 GGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT-MRDVITM 974 (1009)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~evl~~ 974 (1009)
............. ....+.... ....+..++.+|+. ||++||+ +.|+++-
T Consensus 235 -----~~~~~~~i~~~~~---~~~~p~~~~-------~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 -----LQETYNKIINWKE---SLRFPPDPP-------VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -----HHHHHHHHhccCC---cccCCCCCC-------CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1222222211110 001111110 11245678889997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=345.49 Aligned_cols=252 Identities=21% Similarity=0.274 Sum_probs=201.8
Q ss_pred cCCcCceeccCCceEEEEEEECCC-CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRP-HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|...+.||+|+||.||+|....+ ++.||+|.+... +......+.+|+++++.++||||+++++++..++..++|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 488889999999999999998877 788888877433 23334455689999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.++++........+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999998865443344578889999999999999999998 9999999999999999999999999999876433
Q ss_pred CC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.+..... +. .++
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~-----~~~~~~~~~~~-~~-----~~~- 290 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP-----SQREIMQQVLY-GK-----YDP- 290 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHh-CC-----CCC-
Confidence 22 233456899999999998888999999999999999999999999632 12222222211 11 011
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.... ...+.+++.+|++.||++||++.+++.
T Consensus 291 ~~~~~------s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 FPCPV------SSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCccC------CHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11111 124667889999999999999999864
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=328.49 Aligned_cols=243 Identities=26% Similarity=0.358 Sum_probs=192.2
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhc-cCCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGR-LRHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~-l~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||.||+|.+..+++.||+|+++.... ..........|..+++. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999865421 11223445577888776 4899999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 99999986543 267888889999999999999998 99999999999999999999999999987643333344
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+.... +.... +.+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~-i~~~~-------~~~~~~~- 219 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----EEELFQS-IRMDN-------PCYPRWL- 219 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----HHHHHHH-HHhCC-------CCCCccC-
Confidence 45678999999999988889999999999999999999999997321 1121111 11111 1111111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRPTMR-DVI 972 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~-evl 972 (1009)
..++.+++.+|++.||++||++. ++.
T Consensus 220 -----~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 220 -----TREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -----CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 12356788899999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.03 Aligned_cols=250 Identities=34% Similarity=0.552 Sum_probs=192.4
Q ss_pred cCceeccCCceEEEEEEEC----CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 702 ESNIIGMGGNGIVYKAEFH----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 702 ~~~~iG~G~~g~Vyk~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
..+.||.|.||.||+|.+. ..+..|+||.+.. .......+.+.+|++.+++++||||++++|++...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 3467999999999999988 4468899999944 3334456788899999999999999999999998888999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.++++... ...+++.+++.|+.||++||+|||+. +++|+||+++||++++++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999998762 22379999999999999999999998 9999999999999999999999999999876322
Q ss_pred CCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 858 NET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 858 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
... .........|+|||......++.++||||||+++||+++ |+.||... +........ ..+.. .
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~~-~~~~~------~ 224 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEKL-KQGQR------L 224 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHHH-HTTEE------T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccc-ccccc------c
Confidence 221 122345678999999988889999999999999999999 78888632 222333332 22221 1
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 975 (1009)
.....++ ..+.+++.+||+.+|++||++.++++.|
T Consensus 225 ~~~~~~~------~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCP------KDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSB------HHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchh------HHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111111 2356788999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=329.99 Aligned_cols=243 Identities=24% Similarity=0.280 Sum_probs=194.1
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCC-CceeeEEeEEEcCCeEEEEEe
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRH-RNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H-pniv~l~~~~~~~~~~~lV~E 777 (1009)
|+..+.||+|+||.||+|++..+++.||+|++.+... .....+.+..|+++++.++| ++|+++++++.+.+..|+|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 6778899999999999999999999999999865321 22334556689999999976 568899999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 82 YVNGGDLMYHIQQVGK----FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred CCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999865432 67888899999999999999998 9999999999999999999999999998754333
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+....... .. ..+.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~~~~~~i~~-~~-------~~~~ 221 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-----EDELFQSIME-HN-------VSYP 221 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHc-CC-------CCCC
Confidence 344455679999999999998889999999999999999999999997321 1111111111 11 1111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTM 968 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 968 (1009)
... ..++.+++.+|++.||.+|++.
T Consensus 222 ~~~------~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KSL------SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCC------CHHHHHHHHHHhhcCHHHcCCC
Confidence 111 1245678889999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.89 Aligned_cols=243 Identities=26% Similarity=0.327 Sum_probs=192.1
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||.||+|.++.+++.||+|.++.... ..........|..++... +||||+++++++.+.++.++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999865321 112334556788887754 899999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.+++..... +++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 g~L~~~i~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 81 GDLMFHIQDKGR----FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 999999865432 67888888999999999999998 99999999999999999999999999987543333444
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
....||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+.... +.... +.+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~-----~~~~~~~~-~~~~~-------~~~~~~~- 219 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD-----DEDELFES-IRVDT-------PHYPRWI- 219 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-----CHHHHHHH-HHhCC-------CCCCCCC-
Confidence 5567899999999999889999999999999999999999999632 11122211 11111 1111111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRPTMR-DVI 972 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~-evl 972 (1009)
..++.+++.+|++.||++||++. ++.
T Consensus 220 -----~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 -----TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -----CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12456788899999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=328.29 Aligned_cols=200 Identities=23% Similarity=0.439 Sum_probs=174.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||.||+|.+..++..||+|.+.... ......++.+|++++++++||||+++++++.++++.++|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 56888999999999999999999999999999886532 23345667799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++.... .+++.....++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999996543 2678888899999999999999742 7999999999999999999999999998765322
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
......+++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22335688999999999888899999999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=335.50 Aligned_cols=263 Identities=25% Similarity=0.357 Sum_probs=204.3
Q ss_pred HhcCCcCceeccCCceEEEEEEECCC-----CeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCC
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRP-----HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNET 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~ 770 (1009)
.++|...+.||+|+||.||+|.+... +..||||++.... .....+.+.+|+++++++. ||||+++++++.+..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45688889999999999999987432 3579999996432 2334566779999999996 999999999999999
Q ss_pred eEEEEEeccCCCChhhhhcCCcc---------------------------------------------------------
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEA--------------------------------------------------------- 793 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 793 (1009)
..++||||+++|+|.++++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998864321
Q ss_pred -----------------------------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC
Q 037197 794 -----------------------------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD 838 (1009)
Q Consensus 794 -----------------------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~ 838 (1009)
....+++..+..++.|+++|++|||+. +|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 012367888899999999999999998 999999999999999
Q ss_pred CCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHH
Q 037197 839 ANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIV 915 (1009)
Q Consensus 839 ~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~ 915 (1009)
.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~----- 346 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD----- 346 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-----
Confidence 999999999999986543222 1223346778999999888889999999999999999997 99998643211
Q ss_pred HHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 916 EWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
..+...+..+. ....... ....+.+++.+||+.+|++||++.++.+.|+++.+
T Consensus 347 ~~~~~~~~~~~------~~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 STFYNKIKSGY------RMAKPDH------ATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHhcCC------CCCCCcc------CCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111111111 1111111 12346678999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=337.16 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=207.3
Q ss_pred CCcCceeccCCceEEEEEEECCCC----eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPH----MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.+..++||+|+||+||||.+-..| .+||+|++... ...+...++++|+-+|.+++|||++|++|+|.... ..+|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 456789999999999999986554 46888887543 34555677889999999999999999999998776 8899
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
++||+.|+|.|+++.++.. +.....+.|..|||+|+.|||.+ .+|||||.++|||+.+...+||.|||+++...
T Consensus 776 tq~mP~G~LlDyvr~hr~~---igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDN---IGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHhcccchHHHHHHHhhcc---ccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 9999999999999876543 77788899999999999999998 99999999999999999999999999999876
Q ss_pred cCCCceee--ecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 856 HKNETVSM--VAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 856 ~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
..+..... ..-.+.|||-|.+..+.++.++|||||||++||++| |..|++... .+.+...+..+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~------~~eI~dlle~ge------ 917 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP------AEEIPDLLEKGE------ 917 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC------HHHhhHHHhccc------
Confidence 55433322 233568999999999999999999999999999999 999987432 122333332221
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
+.++.+-...++..++.+||..|++.||+++++.+.+.++....
T Consensus 918 ------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 918 ------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred ------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 11222223346777899999999999999999999998876543
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.01 Aligned_cols=255 Identities=33% Similarity=0.512 Sum_probs=204.1
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
|+..+.||+|+||+||+++...+++.||+|++..............+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 56678999999999999999999999999999776444443344457999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
++++|.+++... ..+++..++.++.|+++||++||+. +|+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999722 2278999999999999999999999 999999999999999999999999999986533344
Q ss_pred ceeeecccCcccCCcccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 860 TVSMVAGSYGYIAPEYGY-TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
......+++.|+|||+.. ...++.++||||+|+++|+|++|..||... ...+....+........ ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~--~~~~~~~~~~~~~~~~~----------~~ 221 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES--NSDDQLEIIEKILKRPL----------PS 221 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS--SHHHHHHHHHHHHHTHH----------HH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc--cchhhhhhhhhcccccc----------cc
Confidence 555667899999999988 788999999999999999999999999743 11112222221111110 00
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...........+.+++.+|++.||++||++.++++
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000001146778999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=315.78 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=202.9
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
.|...+.||+|+||.||+|.+...++.||+|.+... .....++.+|++++++++||||+++++++..+...++||||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 467778899999999999999988999999998543 23345677999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.+++..... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 84 MTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999865432 2378889999999999999999998 99999999999999999999999999997664332
Q ss_pred Cce-eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 859 ETV-SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 859 ~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
... .....++.|+|||+..+..++.++||||||+++|||++ |..||... +..+.... ...+. .+..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~~~~~~~-~~~~~------~~~~ 226 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYEL-LEKGY------RMER 226 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH-HHCCC------CCCC
Confidence 111 11223568999999888889999999999999999998 99998632 12222211 11111 1111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
.... ...+.+++.+|++.+|++||++.+++++|+.+
T Consensus 227 ~~~~------~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGC------PPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCC------CHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111 12466788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=335.32 Aligned_cols=254 Identities=21% Similarity=0.280 Sum_probs=198.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.+.|+..+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+++++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 4568889999999999999999999999999999864321 122234456899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++|+|.++++... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~~~-----l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 122 MEYMPGGDLVNLMSNYD-----IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999986532 56677778899999999999998 99999999999999999999999999998764
Q ss_pred cCCC-ceeeecccCcccCCcccCCC----CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 856 HKNE-TVSMVAGSYGYIAPEYGYTL----KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 856 ~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
.... ......||+.|+|||++... .++.++|||||||++|||++|+.||... +.......... .. ..
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~~-~~--~~ 265 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----SLVGTYSKIMD-HK--NS 265 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC-----CHHHHHHHHHc-CC--Cc
Confidence 3322 22345799999999987543 4788999999999999999999999732 22222222211 11 00
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKG--RPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~ 973 (1009)
. .+... .....++.+++.+|++.+|++ ||++.|+++
T Consensus 266 ~---~~~~~----~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 266 L---TFPDD----IEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred C---CCCCc----CCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 1 01110 011124567888999999998 999999965
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=295.92 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=207.6
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC------hhhHHHHHHHHHHHhcc-CCCceeeEEeEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND------IESGDDLFREVSLLGRL-RHRNIVRLLGYL 766 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~ 766 (1009)
.++.+.|...+.+|.|..++|.+..++.++..+|+|++...... .+-.+.-.+|+.+++++ .||+|+.+.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34566788889999999999999999999999999998643221 11123344799999998 699999999999
Q ss_pred EcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEc
Q 037197 767 HNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIA 846 (1009)
Q Consensus 767 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 846 (1009)
+.+..+++|+|.|+.|-|.|++...- .+++.+..+|+.|+.+|++|||.. .|||||+||+|||++++.++||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEe
Confidence 99999999999999999999997653 388999999999999999999999 99999999999999999999999
Q ss_pred ccccceecccCCCceeeecccCcccCCcccC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHH
Q 037197 847 DFGLARMMLHKNETVSMVAGSYGYIAPEYGY------TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLS 920 (1009)
Q Consensus 847 DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 920 (1009)
|||+++.+. +++.....+|||+|+|||.+. ...|+...|+|++||++|-++.|.+||.. .-.-.+..
T Consensus 166 DFGFa~~l~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH------RkQmlMLR 238 (411)
T KOG0599|consen 166 DFGFACQLE-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH------RKQMLMLR 238 (411)
T ss_pred ccceeeccC-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH------HHHHHHHH
Confidence 999999874 455666789999999999754 33478899999999999999999999952 11122334
Q ss_pred HHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 921 MIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
++..++- +.-.|... +......+++.+|+++||.+|.|++|+++
T Consensus 239 ~ImeGky--qF~speWa-------dis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 239 MIMEGKY--QFRSPEWA-------DISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHhccc--ccCCcchh-------hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 4444431 22222222 22334567899999999999999999875
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=329.35 Aligned_cols=244 Identities=25% Similarity=0.310 Sum_probs=195.2
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||.||+|.+..+++.||+|++++... .......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999899999999965421 123344556888888887 799999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 99999886543 278899999999999999999998 99999999999999999999999999987543333334
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ......... ... ..+....
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~~~~~~i~-~~~-------~~~~~~~- 219 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----EDELFQSIL-EDE-------VRYPRWL- 219 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HHHHHHHHH-cCC-------CCCCCcC-
Confidence 44578999999999998899999999999999999999999996321 112222111 111 0111111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRPTM-----RDVIT 973 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RPs~-----~evl~ 973 (1009)
...+.+++.+|++.||++||++ .++++
T Consensus 220 -----~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 220 -----SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1245678899999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=332.14 Aligned_cols=240 Identities=27% Similarity=0.325 Sum_probs=190.7
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHH-HHhccCCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVS-LLGRLRHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||+||+|.+..+++.||+|++.+... .......+++|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999865321 1222344555554 56789999999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 99999986543 278888888999999999999998 99999999999999999999999999987643333444
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
....||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+.......... ...+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~----~~~~~~----- 219 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DTAEMYDNILNKPL----RLKPNI----- 219 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC-----CHHHHHHHHHcCCC----CCCCCC-----
Confidence 4567899999999998888999999999999999999999999732 22222222221110 111111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHH
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRPTMR 969 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 969 (1009)
...+.+++.+|++.||++||++.
T Consensus 220 -----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 -----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 12456788899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=340.81 Aligned_cols=385 Identities=27% Similarity=0.415 Sum_probs=276.5
Q ss_pred CCCCCeeeccCCccC-CcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEE
Q 037197 161 ATSLESLDFRGSFFE-GSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYL 239 (1009)
Q Consensus 161 l~~L~~L~L~~n~~~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 239 (1009)
|+-.+-.|+++|.|+ +..|..+..+++++.|.|.+.++. .+|+.++.+.+|++|.+++|++. .+-.+++.|+.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 444555666777666 456777777777777777777777 67888888888888888888877 555667777777777
Q ss_pred EeccCccccc-cCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEecccccc
Q 037197 240 DLAVGSLSGQ-IPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQL 318 (1009)
Q Consensus 240 ~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l 318 (1009)
++.+|++... +|..+.++..|+.|||++|+++ +.|..+...+++-.|+||+|+|..+....|.++..|-+|+||+|++
T Consensus 84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL 162 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL 162 (1255)
T ss_pred hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence 7777776533 5666666666777777777666 5666666666666677777766633223455666666666666666
Q ss_pred CCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeeccccccc-ccCCcc
Q 037197 319 TGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFS-GTFPVS 397 (1009)
Q Consensus 319 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~-~~~p~~ 397 (1009)
..+ |..+..+..|++|+|++|.+.- .-...+..+++|+.|.+++.+-+ ..+|.+
T Consensus 163 e~L-PPQ~RRL~~LqtL~Ls~NPL~h------------------------fQLrQLPsmtsL~vLhms~TqRTl~N~Pts 217 (1255)
T KOG0444|consen 163 EML-PPQIRRLSMLQTLKLSNNPLNH------------------------FQLRQLPSMTSLSVLHMSNTQRTLDNIPTS 217 (1255)
T ss_pred hhc-CHHHHHHhhhhhhhcCCChhhH------------------------HHHhcCccchhhhhhhcccccchhhcCCCc
Confidence 644 3345556666666666665432 22223334555555666554332 356777
Q ss_pred cccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccc
Q 037197 398 LSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQ 477 (1009)
Q Consensus 398 l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 477 (1009)
+..+.+|..++++.|.+. .+|+.+.++++|+.|+||+|+|+ .+....+...+|+.|+||.|+++. +|.+++.++.|+
T Consensus 218 ld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~-LP~avcKL~kL~ 294 (1255)
T KOG0444|consen 218 LDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTV-LPDAVCKLTKLT 294 (1255)
T ss_pred hhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhcc-chHHHhhhHHHH
Confidence 777888888888888887 78888888888888888888887 555666777888999999999986 788999999999
Q ss_pred hhccccCcccC-CcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCcc
Q 037197 478 TFMASHNNLQA-KIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNN 556 (1009)
Q Consensus 478 ~L~l~~N~l~~-~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 556 (1009)
.|++.+|+++- -+|..++.+.+|+++..++|.|. ..|..++.+.+|+.|+|++|+|. .+|+.+.-|+.|+.|||..|
T Consensus 295 kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreN 372 (1255)
T KOG0444|consen 295 KLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLREN 372 (1255)
T ss_pred HHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCC
Confidence 99999998874 37899999999999999999997 88999999999999999999998 78999999999999999998
Q ss_pred ccccccCcCcCCCCCCcEEecC
Q 037197 557 SLFGRIPENFGASPALEMLNLS 578 (1009)
Q Consensus 557 ~l~~~~p~~~~~l~~L~~L~ls 578 (1009)
+=---+|.--..-..|+.-|+.
T Consensus 373 pnLVMPPKP~da~~~lefYNID 394 (1255)
T KOG0444|consen 373 PNLVMPPKPNDARKKLEFYNID 394 (1255)
T ss_pred cCccCCCCcchhhhcceeeecc
Confidence 7543333322222445544443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=336.70 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=196.9
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+..+.||+|+||.||+|++..+++.||||++..... .......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 57888999999999999999999999999999965321 12333456689999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..+...
T Consensus 82 ~~~~g~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 82 YLPGGDMMTLLMKKDT----FTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCcHHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999875432 78889999999999999999998 9999999999999999999999999998754321
Q ss_pred CC--------------------------------------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh
Q 037197 858 NE--------------------------------------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT 899 (1009)
Q Consensus 858 ~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt 899 (1009)
.. ......||+.|+|||+.....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10 0012358999999999988889999999999999999999
Q ss_pred CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 037197 900 GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT---MRDVIT 973 (1009)
Q Consensus 900 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs---~~evl~ 973 (1009)
|..||.... ..+........... . .+.... ... ..+.+++.+|+. +|.+|++ +.|+++
T Consensus 235 G~~Pf~~~~-----~~~~~~~i~~~~~~---~---~~~~~~-~~s---~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDN-----PQETYRKIINWKET---L---QFPDEV-PLS---PEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCC-----HHHHHHHHHcCCCc---c---CCCCCC-CCC---HHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999997321 22222222211110 0 000000 111 234567778886 9999998 888766
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=314.92 Aligned_cols=251 Identities=26% Similarity=0.373 Sum_probs=205.4
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
|+..+.||+|++|.||+|.+..+++.|++|.+............+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 66778899999999999999998999999998655444555667779999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
++++|.++++... ...+++.+++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 82 ENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999997642 22378889999999999999999998 999999999999999999999999999987654443
Q ss_pred ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccccc
Q 037197 860 TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1009)
......+++.|+|||+..+..++.++||||||+++|||++|+.||.... ....... +..+. .+.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~-~~~~~------~~~~~~- 223 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-----QGALILK-IIRGV------FPPVSQ- 223 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----HHHHHHH-HHcCC------CCCCcc-
Confidence 3344568899999999988889999999999999999999999997432 1111111 11111 111111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 940 CKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 940 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.....+.+++.+|++.+|++||++.++++
T Consensus 224 -----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 224 -----MYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred -----ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 11234678899999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=319.93 Aligned_cols=258 Identities=30% Similarity=0.480 Sum_probs=203.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCC-----eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPH-----MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNV 772 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 772 (1009)
+.|+..+.||+|+||.||+|.....+ ..||+|.+.... .......+.+|++++++++||||+++++++.+....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 35778889999999999999876554 789999986432 233445677999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhcCCccc------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC
Q 037197 773 MMVYDYMPNDSLGEALHGKEAG------------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN 840 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~ 840 (1009)
+++|||+++++|.+++...... ...+++.+++.++.|++.||+|||+. +++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 9999999999999998754211 13478888999999999999999998 99999999999999999
Q ss_pred CcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHH
Q 037197 841 LEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEW 917 (1009)
Q Consensus 841 ~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 917 (1009)
+.++|+|||+++.....+. ......+++.|+|||+.....++.++|||||||++|||++ |..||..... .++...
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--~~~~~~ 238 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QEVIEM 238 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH
Confidence 9999999999976533321 2223456788999999888889999999999999999998 9999864321 122222
Q ss_pred HHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 918 VLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
+..+.. +.....+ ..++.+++.+||+.||++||++.|+++.|+.
T Consensus 239 ----i~~~~~------~~~~~~~------~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ----IRSRQL------LPCPEDC------PARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcCCc------CCCcccC------CHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 221110 1111111 2356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=351.58 Aligned_cols=265 Identities=25% Similarity=0.272 Sum_probs=204.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
++|+..+.||+|+||.||+|.+..+++.||+|++...... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4688889999999999999999999999999998654322 233456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCcc-------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccc
Q 037197 777 DYMPNDSLGEALHGKEA-------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFG 849 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 849 (1009)
||+++|+|.++++.... .....++..+++++.||++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 112356677889999999999999998 99999999999999999999999999
Q ss_pred cceecccCC------------------CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCC
Q 037197 850 LARMMLHKN------------------ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS 911 (1009)
Q Consensus 850 ls~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~ 911 (1009)
+++...... .......||+.|+|||+..+..++.++|||||||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 998652111 0111246899999999999889999999999999999999999999742111
Q ss_pred ccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHhhcCCC
Q 037197 912 KDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-TMRDVITMLGEAKPR 981 (1009)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~L~~~~~~ 981 (1009)
...... ...++.-..... +....+.+++.+|++.||++|| ++.++++.|+.....
T Consensus 238 ----ki~~~~--------~i~~P~~~~p~~---~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 ----KISYRD--------VILSPIEVAPYR---EIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred ----hhhhhh--------hccChhhccccc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 110000 000110000001 1112456788899999999995 677788888877543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=315.77 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=203.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCC---CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
++|+..+.||+|+||.||+|.+... ...||||.++... ......++.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4588889999999999999998643 4689999985432 33345567799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++++|.+++..... .+++.++++++.|++.|++|||+. +|+||||||+||++++++.++++|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999976432 378999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCCcee--eecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 855 LHKNETVS--MVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 855 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
........ ...+++.|+|||......++.++||||||+++|||++ |..||.... ..+.. ..+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-----~~~~~-~~~~~~~~---- 226 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-----NQDVI-KAVEDGYR---- 226 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-----HHHHH-HHHHcCCC----
Confidence 42222111 2234568999999888889999999999999999998 999986322 11111 11111110
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
.+ .... ....+.+++.+|++.+|++||++.|+++.|+++
T Consensus 227 -~~-~~~~------~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 -LP-PPMD------CPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CC-CCCC------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0111 123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=333.10 Aligned_cols=253 Identities=20% Similarity=0.204 Sum_probs=198.7
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+..+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 57888999999999999999999999999999965432 22233455589999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 82 YQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999976522 378888888999999999999998 9999999999999999999999999999876443
Q ss_pred CC-ceeeecccCcccCCcccC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 858 NE-TVSMVAGSYGYIAPEYGY------TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 858 ~~-~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ............. ...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~~~~~~i~~~~~-~~~ 229 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-----SAKTYNNIMNFQR-FLK 229 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC-----HHHHHHHHHcCCC-ccC
Confidence 32 223457899999999876 4567889999999999999999999997321 1222222221111 000
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+.. ......+..++.+|++ +|++||++.++++
T Consensus 230 --~~~~-------~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 --FPED-------PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --CCCC-------CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0100 0111235567889997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=330.53 Aligned_cols=245 Identities=26% Similarity=0.304 Sum_probs=191.3
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHH-HHHhccCCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREV-SLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~-~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||.||+|++..+++.||+|++.+.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999999998999999998643211 12223344444 456788999999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.+++..... +.+.....++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~L~~~~~~~~~----~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 81 GELFYHLQRERC----FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred CcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence 999999875432 66777778999999999999998 99999999999999999999999999997654434444
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
....||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+......... ....+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~i~~~~----~~~~~~~----- 219 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----NTAEMYDNILNKP----LQLKPNI----- 219 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC-----CHHHHHHHHHhCC----cCCCCCC-----
Confidence 5567999999999999889999999999999999999999999732 1222222221111 0111111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
...+.+++.+|++.||.+||++.+.+.+
T Consensus 220 -----~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 220 -----TNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred -----CHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1235578889999999999998754443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=328.43 Aligned_cols=243 Identities=23% Similarity=0.277 Sum_probs=193.8
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEe
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
|+..+.||+|+||.||+|.+..+++.||+|++.+... ..........|..++..+ +|++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 6778899999999999999999999999999865422 122234456788888777 58999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... +++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 82 YVNGGDLMYQIQQVGR----FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred CCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999865432 78888999999999999999998 9999999999999999999999999999765433
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
........||+.|+|||++....++.++|||||||++|||++|+.||.... ......... ... ..+.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-----~~~~~~~i~-~~~-------~~~p 221 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDELFQSIM-EHN-------VAYP 221 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-----HHHHHHHHH-hCC-------CCCC
Confidence 334445678999999999998899999999999999999999999997421 111111111 111 0111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTM 968 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 968 (1009)
... ..++..++.+|++.||++|++.
T Consensus 222 ~~~------s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSM------SKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcC------CHHHHHHHHHHcccCHHhcCCC
Confidence 111 1245678899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=334.80 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=194.0
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+..+.||+|+||+||+|++..+++.||+|++.+... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 46778899999999999999999999999999965432 22334566789999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRMEV----FPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999875432 67888888999999999999998 9999999999999999999999999997543110
Q ss_pred C-----------------------------------------------CceeeecccCcccCCcccCCCCCCcccchHhH
Q 037197 858 N-----------------------------------------------ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSF 890 (1009)
Q Consensus 858 ~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~Sl 890 (1009)
. .......||+.|+|||++....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 00123468999999999988889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHH--hccCCCCCCCCH
Q 037197 891 GVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVL--CTAKLPKGRPTM 968 (1009)
Q Consensus 891 Gvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dp~~RPs~ 968 (1009)
||++|||++|+.||..... ............ .. .+.... ... .++.+++.+ |...+|..||++
T Consensus 235 G~il~elltG~~Pf~~~~~-----~~~~~~i~~~~~---~~---~~~~~~-~~s---~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTP-----TETQLKVINWEN---TL---HIPPQV-KLS---PEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCH-----HHHHHHHHcccc---cc---CCCCCC-CCC---HHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999974321 111111111110 00 011000 011 133456656 556667779999
Q ss_pred HHHHH
Q 037197 969 RDVIT 973 (1009)
Q Consensus 969 ~evl~ 973 (1009)
.|+++
T Consensus 300 ~~~l~ 304 (381)
T cd05626 300 DDIKA 304 (381)
T ss_pred HHHhc
Confidence 99986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=332.54 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=196.7
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 4678999999999999999999999999999999854322 122234456899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++|+|.+++.... +++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~~~-----~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 122 MEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999996532 67778888999999999999998 99999999999999999999999999998764
Q ss_pred cCCC-ceeeecccCcccCCcccCCC----CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 856 HKNE-TVSMVAGSYGYIAPEYGYTL----KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 856 ~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
.... ......||+.|+|||++... .++.++||||+||++|||++|+.||... +..............
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~-----~~~~~~~~i~~~~~~--- 265 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD-----SLVGTYSKIMDHKNS--- 265 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCcc---
Confidence 3322 22356799999999987643 3788999999999999999999999732 222222222211110
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKG--RPTMRDVITM 974 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~ 974 (1009)
. .+... ......+..++.+|+..++.+ |+++.|+++-
T Consensus 266 ~---~~p~~----~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 L---NFPED----VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred c---CCCCc----ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 01100 011123456777888755544 8899998774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=331.63 Aligned_cols=201 Identities=30% Similarity=0.419 Sum_probs=172.0
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC----
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET---- 770 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~---- 770 (1009)
.+.++|+..+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4567899999999999999999999999999999999765444455667779999999999999999999986443
Q ss_pred --eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 771 --NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 771 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
..++||||+++ ++.+.++.. +++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhcc------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence 57999999965 566666432 67788888999999999999998 9999999999999999999999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
|+++.... ........+|+.|+|||.+.+..++.++||||+||++|+|++|+.||..
T Consensus 168 g~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 168 GLARTACT-NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred CCcccccc-CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 99975422 2222345688999999999988999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=328.57 Aligned_cols=262 Identities=26% Similarity=0.374 Sum_probs=202.3
Q ss_pred hcCCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEc-CC
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHN-ET 770 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~-~~ 770 (1009)
++|+..+.||+|+||.||+|...+ +++.||+|+++... .....+.+.+|+++++++ +||||++++++|.. +.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 468889999999999999997543 35789999986432 233345677899999999 89999999998764 45
Q ss_pred eEEEEEeccCCCChhhhhcCCccc--------------------------------------------------------
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAG-------------------------------------------------------- 794 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 794 (1009)
..++||||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 689999999999999998643210
Q ss_pred -cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCc--eeeecccCccc
Q 037197 795 -KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET--VSMVAGSYGYI 871 (1009)
Q Consensus 795 -~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~--~~~~~gt~~y~ 871 (1009)
...+++..+.+++.||++||+|||+. +|+||||||+||++++++.++|+|||++..+...... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 12478999999999999999999998 9999999999999999999999999999876433221 12234567899
Q ss_pred CCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHH
Q 037197 872 APEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLV 950 (1009)
Q Consensus 872 aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 950 (1009)
|||+..+..++.++|||||||++|||++ |+.||...... ..+. .....+.. +.... ....++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~----~~~~~~~~------~~~~~------~~~~~~ 305 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFC----RRLKEGTR------MRAPE------YATPEI 305 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHH----HHHhccCC------CCCCc------cCCHHH
Confidence 9999999999999999999999999998 99999643221 1111 11111110 00110 112346
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 951 LRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 951 ~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.+++.+|++.+|++||++.|+++.|+++..
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=320.04 Aligned_cols=253 Identities=24% Similarity=0.268 Sum_probs=198.9
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
|+..+.||+|+||.||++.+..+++.||+|++...... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 67788999999999999999988999999998653322 22234456899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 82 MNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999886432 22378889999999999999999998 99999999999999999999999999998753322
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
......|++.|+|||+..+..++.++||||+||++|||++|+.||..... ....+.+...+.... ..+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~-------~~~~~ 226 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE--KVKREEVERRVKEDQ-------EEYSE 226 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch--hhHHHHHHHHhhhcc-------cccCc
Confidence 22345689999999999888899999999999999999999999974221 111122222221111 01111
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
. ....+.+++.+|++.||++|| ++.++++
T Consensus 227 ~------~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 227 K------FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred c------cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 1 112356788999999999999 7777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.96 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=201.0
Q ss_pred CCcCceeccCCceEEEEEEECCC---CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe-----
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN----- 771 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~----- 771 (1009)
|+..+.||+|+||.||+|.+..+ +..||+|+++...........+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 46678899999999999987653 4789999986544444445667799999999999999999998865544
Q ss_pred -EEEEEeccCCCChhhhhcCCcc--ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 772 -VMMVYDYMPNDSLGEALHGKEA--GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 772 -~~lV~E~~~~gsL~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
.++||||+++|+|.+++..... ....+++.....++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 7999999999999999854321 223478889999999999999999998 9999999999999999999999999
Q ss_pred ccceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhc
Q 037197 849 GLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSN 925 (1009)
Q Consensus 849 Gls~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 925 (1009)
|+++........ ......+..|+|||+.....++.++||||||+++|||++ |..||..... .+..... ..+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-----~~~~~~~-~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-----HEIYDYL-RHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH-HcC
Confidence 999876443321 112234678999999888889999999999999999999 8899864221 1222111 111
Q ss_pred cccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 926 KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
. ....... ...++.+++.+|++.||++||++.|+++.|+++
T Consensus 232 ~------~~~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 N------RLKQPED------CLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C------CCCCCcC------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 0111111 123567888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=331.63 Aligned_cols=201 Identities=23% Similarity=0.348 Sum_probs=174.0
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+..+.||+|+||+||+|.+..+++.||+|++.+... .......+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 57888999999999999999999999999999865321 12233456689999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 82 FLPGGDMMTLLMKKDT----LTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred CCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999975432 78888999999999999999998 9999999999999999999999999998754321
Q ss_pred CC-----------------------------------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCC
Q 037197 858 NE-----------------------------------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKM 902 (1009)
Q Consensus 858 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~ 902 (1009)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 0123479999999999988889999999999999999999999
Q ss_pred CCCC
Q 037197 903 PLDP 906 (1009)
Q Consensus 903 Pf~~ 906 (1009)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9973
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=315.18 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=201.0
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||+|.... +..||+|.+... ....+.+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 457888999999999999999765 677999987543 2234667799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.++++.... ..+++.++..++.|+++|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999975432 2367888899999999999999998 9999999999999999999999999999876432
Q ss_pred CCc-eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NET-VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
... .....++..|+|||+.....++.++||||||+++|+|++ |+.||..... ..... .+..... .+.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~----~~~~~~~-----~~~ 225 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--SDVMS----ALQRGYR-----MPR 225 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--HHHHH----HHHcCCC-----CCC
Confidence 211 122335668999999888889999999999999999998 9999963211 11111 1111111 011
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
. ... . .++.+++.+|++.+|++||+++++.+.|+++
T Consensus 226 ~-~~~---~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 226 M-ENC---P---DELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred C-CCC---C---HHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1 111 1 2456788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.98 Aligned_cols=259 Identities=22% Similarity=0.359 Sum_probs=201.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
.++|+..+.||+|+||.||+|.+.. ++..||+|++.... ......++.+|+.+++.++||||+++++++.++..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4668889999999999999998652 35789999985432 23345567799999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccc------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEE
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAG------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARI 845 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 845 (1009)
.++||||+++++|.++++..... ....++..+..++.|+++|++|||+. +++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653221 22367888899999999999999998 9999999999999999999999
Q ss_pred cccccceecccCCCce--eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHH
Q 037197 846 ADFGLARMMLHKNETV--SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 846 ~DfGls~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
+|||+++......... ....+++.|+|||+.....++.++|||||||++|||++ |..||.... ..+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-----~~~~~~~~~ 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-----NEQVLRFVM 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH
Confidence 9999987653322111 12334678999999888889999999999999999999 788886321 112221111
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
... . +...... ...+.+++.+|++.+|++||++.|+++.|++
T Consensus 236 -~~~----~--~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 -EGG----L--LDKPDNC------PDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -cCC----c--CCCCCCC------CHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111 0 0111111 1246778999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=320.85 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=203.4
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.+...+|+..+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..+...+
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 3445678889999999999999999988899999999865432 23456779999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++++|.++++... +++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 94 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 94 VVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred EeecccCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchh
Confidence 9999999999999986432 67888899999999999999998 999999999999999999999999999876
Q ss_pred cccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
............+++.|+|||......++.++|||||||++|+|++|+.||..... ..+.........
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-----~~~~~~~~~~~~------- 233 (296)
T cd06654 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIATNGT------- 233 (296)
T ss_pred ccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-----HHhHHHHhcCCC-------
Confidence 54333333345688999999998888889999999999999999999999964321 111111111111
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+... .. ......+.+++.+|+..+|++||++.|+++
T Consensus 234 ~~~~-~~---~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PELQ-NP---EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCC-Cc---cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0000 00 111134567889999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.75 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=201.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|++|.||+|.+.. ++.||+|.++... ...+++.+|++++++++||||+++++++...+..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 457888999999999999999765 5789999985432 234567799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999997654 22378999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCc-eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NET-VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
... ......+..|+|||+.....++.++||||||+++|||++ |+.||.... ..... ..+..... ..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~-~~~~~~~~------~~ 224 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-----NAEVL-QQVDQGYR------MP 224 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-----HHHHH-HHHHcCCC------CC
Confidence 211 111122357999999888889999999999999999999 999986321 11111 11111110 00
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
.... ....+.+++.+|++.+|++||++.++++.|+++
T Consensus 225 ~~~~------~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 225 CPPG------CPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCc------CCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 1111 113467788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=318.06 Aligned_cols=251 Identities=22% Similarity=0.265 Sum_probs=195.1
Q ss_pred eccCCceEEEEEEECCCCeEEEEEEcccCCCChh-hHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCCh
Q 037197 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE-SGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSL 784 (1009)
Q Consensus 706 iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL 784 (1009)
||+|+||.||++..+.+++.||+|.+........ .......|++++++++||||+++++++.++.+.++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999999999999999999854322221 223445799999999999999999999999999999999999999
Q ss_pred hhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCceeee
Q 037197 785 GEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMV 864 (1009)
Q Consensus 785 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 864 (1009)
.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~ 154 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQR 154 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeecc
Confidence 98886433 23378888899999999999999998 9999999999999999999999999999766432 223345
Q ss_pred cccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHH
Q 037197 865 AGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQ 944 (1009)
Q Consensus 865 ~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1009)
.+++.|+|||+..+..++.++||||+||++|||++|+.||...... ............. .... .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~------~~~~----~~~~~- 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLED------EVKF----EHQNF- 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhcc------cccc----ccccC-
Confidence 6899999999998888999999999999999999999999743221 1111111111110 0000 00011
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 945 EEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 945 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
..++.+++.+|++.||++||++.|+++...
T Consensus 223 --~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 --TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred --CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 124567889999999999999988775443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=324.01 Aligned_cols=266 Identities=22% Similarity=0.323 Sum_probs=198.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|...+.||+|+||.||+|.+..+++.||+|++..... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 457888999999999999999998899999999865432 2233456689999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++ +|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 85 YLDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 9975 78888754422 267888888999999999999998 9999999999999999999999999999765443
Q ss_pred CCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc--------cc
Q 037197 858 NETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK--------AQ 928 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--------~~ 928 (1009)
........+++.|+|||+..+ ..++.++||||+|+++|||++|+.||...... +....+........ ..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE--DELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhhcch
Confidence 333344567899999998754 46789999999999999999999999643211 11111111110000 00
Q ss_pred ccccC---ccccc--cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 929 DEALD---PSIAG--QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 929 ~~~~~---~~~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
....+ +.... ..........++.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 00000 00000111234568899999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.67 Aligned_cols=256 Identities=27% Similarity=0.413 Sum_probs=205.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
...|+..+.||.|+||.||+|.+.. +..+|+|.+.... .....++.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 3457888899999999999999988 8899999986542 223456778999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.++++.... ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 82 ELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999976432 2378899999999999999999998 999999999999999999999999999976643
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
.........++..|+|||......++.++||||||+++|+|++ |+.||.... ..+...... .+. .+.
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-----~~~~~~~~~-~~~------~~~ 224 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-----NHEVYDQIT-AGY------RMP 224 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-----HHHHHHHHH-hCC------cCC
Confidence 3222223345678999999888889999999999999999998 899996422 111221111 111 111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
..... ...+.+++.+|++.||++|||++++++.|+.+
T Consensus 225 ~~~~~------~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 225 CPAKC------PQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCC------CHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11111 12466788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=322.69 Aligned_cols=250 Identities=30% Similarity=0.406 Sum_probs=201.3
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
....|...+-||.|+||.||-|.+..+.++||||++..+.. ..+...++.+|+.++++++|||++.+-|+|-.+...|+
T Consensus 24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 34556677789999999999999999999999999976643 45567788899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||| -||-.|++.... .++.+.++..|+.+.+.||+|||+. +.||||||..|||+++.|.||++|||.+...
T Consensus 104 VMEYC-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 104 VMEYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHH-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhc
Confidence 99999 667777775433 3377888888999999999999999 9999999999999999999999999998665
Q ss_pred ccCCCceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
. ....++|||.|||||++. .+.|+-|+||||+|++..||...++|+-.... .....-..+..
T Consensus 177 ~----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----MSALYHIAQNe------ 241 (948)
T KOG0577|consen 177 A----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNE------ 241 (948)
T ss_pred C----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----HHHHHHHHhcC------
Confidence 3 345678999999999854 67899999999999999999999999753211 11111111111
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.|.+. ..+....+..++..|+++-|.+|||..++++
T Consensus 242 -sPtLq-----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 -SPTLQ-----SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -CCCCC-----CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 12222 1233345778889999999999999887654
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=310.16 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=195.5
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDS 783 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gs 783 (1009)
+.||+|+||.||+|.+..+++.||+|.+... ...+....+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3589999999999999988999999987543 233445667799999999999999999999999999999999999999
Q ss_pred hhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCc--e
Q 037197 784 LGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET--V 861 (1009)
Q Consensus 784 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~--~ 861 (1009)
|.++++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+|++|||++......... .
T Consensus 80 L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 80 FLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 999996532 2378889999999999999999998 9999999999999999999999999998754322111 1
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccC
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQC 940 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
.....+..|+|||......++.++||||||+++|||++ |..||..... ......+.... ........
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~------~~~~~~~~~~~------~~~~~~~~ 221 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN------QQTREAIEQGV------RLPCPELC 221 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH------HHHHHHHHcCC------CCCCcccC
Confidence 11123457999999988889999999999999999998 8888863211 11111111111 11111111
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 941 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
...+.+++.+|++.+|++||++.|+.++|.
T Consensus 222 ------~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 ------PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ------CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 124677899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.42 Aligned_cols=258 Identities=28% Similarity=0.414 Sum_probs=202.6
Q ss_pred hcCCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNV 772 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 772 (1009)
+.|+..+.||+|+||.||+|.+.. +++.||||.+..... .+..+.+.+|++++++++||||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 457778899999999999998753 357899999865422 33456777999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhcCCcc----------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc
Q 037197 773 MMVYDYMPNDSLGEALHGKEA----------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE 842 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 842 (1009)
++||||+++++|.++++.... ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999975421 223478889999999999999999998 9999999999999999999
Q ss_pred EEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHH
Q 037197 843 ARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVL 919 (1009)
Q Consensus 843 ~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 919 (1009)
+||+|||+++....... ......+++.|+|||++....++.++||||||+++|||++ |+.||..... ......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--~~~~~~-- 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--EEVIEC-- 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH--
Confidence 99999999976532221 1223345678999999998899999999999999999998 9999863221 111111
Q ss_pred HHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 920 SMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
+..+.. +...... ...+.+++.+||+.||++||++.||++.|++
T Consensus 237 --~~~~~~------~~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 --ITQGRL------LQRPRTC------PSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred --HHcCCc------CCCCCCC------CHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111110 0001111 1246678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=332.31 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=197.0
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC-----eEEE
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET-----NVMM 774 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-----~~~l 774 (1009)
|+..+.||+|+||.||+|.+..+++.||+|++.....+.....++.+|+++++.++||||+++++++...+ ..|+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 67788999999999999999988999999998654444445567789999999999999999999998776 7899
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 82 v~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 82 VTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred Eeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 999996 57888775433 278889999999999999999998 9999999999999999999999999999865
Q ss_pred ccCC-CceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc-------
Q 037197 855 LHKN-ETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN------- 925 (1009)
Q Consensus 855 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~------- 925 (1009)
.... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||...... +....+.......
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHHH
Confidence 3322 222334578899999987764 4789999999999999999999999743211 1111111000000
Q ss_pred --------cccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 926 --------KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 926 --------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
........+..............++.+++.+|++.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000000000012346678999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=332.67 Aligned_cols=245 Identities=25% Similarity=0.306 Sum_probs=192.5
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHH-HHhccCCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVS-LLGRLRHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||.||+|.+..+++.||+|++.+... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 468999999999999999999999999864321 1223344455554 46779999999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.+++.... .+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 99998886543 278888899999999999999998 99999999999999999999999999987543333344
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
....|++.|+|||++.+..++.++|||||||++|||++|+.||... +..+........ .....+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~-----~~~~~~~~~~~~----~~~~~~~~----- 219 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR-----DVAEMYDNILHK----PLVLRPGA----- 219 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC-----CHHHHHHHHHcC----CccCCCCC-----
Confidence 4567999999999999888999999999999999999999999632 222222222111 11111111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
...+.+++.+|++.+|++||++.+.+++
T Consensus 220 -----~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 220 -----SLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred -----CHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 1235578889999999999988754443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.33 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=198.7
Q ss_pred CcCceeccCCceEEEEEEECCCCe--EEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC------CeE
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHM--VVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE------TNV 772 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------~~~ 772 (1009)
...+.||+|+||.||+|.+...+. .||+|.++.........+.+.+|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999877664 699999866544455566777999999999999999999987432 246
Q ss_pred EEEEeccCCCChhhhhcCCc--cccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 773 MMVYDYMPNDSLGEALHGKE--AGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
++||||+++|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999874322 1223478999999999999999999998 999999999999999999999999999
Q ss_pred ceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 851 ARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 851 s~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
++.+...... .....+++.|+|||+.....++.++||||||+++|||++ |+.||..... .+ ....+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~-~~~~~~~~~~ 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----SE-IYDYLRQGNR 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HH-HHHHHHcCCC
Confidence 9876433221 122345678999999988889999999999999999999 8889863211 11 1122222211
Q ss_pred cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
. .....+ ...+.+++.+|++.+|++||++.|+++.|+++
T Consensus 233 ~------~~~~~~------~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 L------KQPPDC------LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C------CCCCCC------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 011111 12466889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=346.73 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=204.7
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc--CCeEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN--ETNVM 773 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~~ 773 (1009)
..+.|++.+.||+|+||+||+|.+..++..||+|.+............+..|+.++++++||||++++++|.+ ...+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4567899999999999999999999999999999987655455556677899999999999999999998854 35689
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcC----CCCeEEeccCCCcEEeCCC---------
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC----QPPVIHRDIKSNNILLDAN--------- 840 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----~~~ivH~dlk~~NIll~~~--------- 840 (1009)
+||||+++|+|.+++.........+++..++.|+.||+.||+|||+.. ..+||||||||+|||++.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999999754333334899999999999999999999852 1259999999999999642
Q ss_pred --------CcEEEcccccceecccCCCceeeecccCcccCCcccCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCC
Q 037197 841 --------LEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYT--LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG 910 (1009)
Q Consensus 841 --------~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~ 910 (1009)
+.+||+|||++..+.... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~--- 246 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA--- 246 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC---
Confidence 348999999997653322 2234568999999998753 45889999999999999999999999632
Q ss_pred CccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH--HHHhhcC
Q 037197 911 SKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI--TMLGEAK 979 (1009)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl--~~L~~~~ 979 (1009)
...... ...+.... ...+.. ...++..++.+||+.+|++||++.|++ ..+..+.
T Consensus 247 -~~~~ql-i~~lk~~p------~lpi~~-------~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 247 -NNFSQL-ISELKRGP------DLPIKG-------KSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred -CcHHHH-HHHHhcCC------CCCcCC-------CCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 122222 22222111 000110 113466788999999999999999998 4555443
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=325.75 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=194.7
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||.||+|.+..+++.||+|++.+... .....+.+.+|+.++.++ +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999965422 123344566899998888 699999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 99999886543 278899999999999999999998 99999999999999999999999999997643333444
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC-CccHHHHHHHHHhhccccccccCccccccC
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG-SKDIVEWVLSMIKSNKAQDEALDPSIAGQC 940 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
....||+.|+|||+..+..++.++|||||||++|||++|+.||...... ......++...+.... ..+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~p~~~ 226 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-------IRIPRFL 226 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-------CCCCCCC
Confidence 5567999999999998889999999999999999999999999643221 1122233333322211 0111111
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHH
Q 037197 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMR 969 (1009)
Q Consensus 941 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 969 (1009)
+ ..+.+++.+|++.||++|+++.
T Consensus 227 ~------~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 227 S------VKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred C------HHHHHHHHHHhccCHHHcCCCC
Confidence 1 2345788899999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=327.27 Aligned_cols=240 Identities=26% Similarity=0.326 Sum_probs=188.6
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHH-HHhccCCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVS-LLGRLRHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||.||+|++..+++.||+|++.+... .......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999864321 1222334455554 67889999999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.+++.... .+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 99998886432 267778888999999999999998 99999999999999999999999999987543333334
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
....|++.|+|||++.+..++.++|||||||++|||++|+.||... +.......... .. ..+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~i~~-~~-------~~~~~~-- 218 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DVSQMYDNILH-KP-------LQLPGG-- 218 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-----CHHHHHHHHhc-CC-------CCCCCC--
Confidence 4567899999999998888999999999999999999999999632 22222222211 10 011111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHH
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRPTMR 969 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 969 (1009)
....+.+++.+|++.||.+||++.
T Consensus 219 ----~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 ----KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ----CCHHHHHHHHHHccCCHhhcCCCC
Confidence 112456788999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=333.82 Aligned_cols=201 Identities=25% Similarity=0.334 Sum_probs=171.7
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+..+.||+|+||.||+|++..+++.||+|++.+... .......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 47788999999999999999999999999999865322 12334556689999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++.... .+++.....++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999986543 267778888999999999999998 9999999999999999999999999997532100
Q ss_pred C-----------------------------------------------CceeeecccCcccCCcccCCCCCCcccchHhH
Q 037197 858 N-----------------------------------------------ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSF 890 (1009)
Q Consensus 858 ~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~Sl 890 (1009)
. .......||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 00112468999999999988899999999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 037197 891 GVVLLELLTGKMPLDP 906 (1009)
Q Consensus 891 Gvvl~elltg~~Pf~~ 906 (1009)
||++|||++|+.||..
T Consensus 235 Gvil~elltG~~Pf~~ 250 (382)
T cd05625 235 GVILYEMLVGQPPFLA 250 (382)
T ss_pred hHHHHHHHhCCCCCCC
Confidence 9999999999999973
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=333.62 Aligned_cols=253 Identities=19% Similarity=0.241 Sum_probs=194.3
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+..+.||+|+||.||+|....+++.||||++.+... .....+.+.+|++++++++||||+++++++.+..+.|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 57788999999999999999999999999999854321 12234456689999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~~~----~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 82 FLPGGDLMTMLIKYDT----FSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred CCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999865432 67788888999999999999998 9999999999999999999999999998643211
Q ss_pred CC-----------------------------------------------ceeeecccCcccCCcccCCCCCCcccchHhH
Q 037197 858 NE-----------------------------------------------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSF 890 (1009)
Q Consensus 858 ~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~Sl 890 (1009)
.. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0012468999999999988889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCC---CC
Q 037197 891 GVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGR---PT 967 (1009)
Q Consensus 891 Gvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Ps 967 (1009)
||++|||++|+.||.... ............. ....+.. ... ..++.+++.+|+. +|.+| ++
T Consensus 235 Gvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~---~~~~p~~----~~~---s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 235 GAIMFECLIGWPPFCSEN-----SHETYRKIINWRE---TLYFPDD----IHL---SVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred chhhhhhhcCCCCCCCCC-----HHHHHHHHHccCC---ccCCCCC----CCC---CHHHHHHHHHHhc-CHhhcCCCCC
Confidence 999999999999996322 1111221111110 0000110 001 1235567889997 66665 58
Q ss_pred HHHHHHH
Q 037197 968 MRDVITM 974 (1009)
Q Consensus 968 ~~evl~~ 974 (1009)
+.|+++.
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 8888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=330.10 Aligned_cols=201 Identities=27% Similarity=0.382 Sum_probs=172.5
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-----
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE----- 769 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~----- 769 (1009)
.+.++|+..+.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 456789999999999999999999998899999999976554555566777999999999999999999988643
Q ss_pred -CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 770 -TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 770 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
...++||||+++ ++.+.+... +++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~~------l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999965 576666432 67888889999999999999998 9999999999999999999999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
|+++..... .......+|+.|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus 164 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 164 GLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred cccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999765322 222345689999999999888899999999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.01 Aligned_cols=265 Identities=23% Similarity=0.277 Sum_probs=198.1
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
|+..+.||+|++|.||+|.+..+++.||+|++.....+......+.+|+.++++++||||+++++++.++...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 66778999999999999999988999999998655444444466779999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
+ ++|.+++..... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 82 S-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred C-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 7 689888865433 23378899999999999999999998 999999999999999999999999999976543333
Q ss_pred ceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH--------------Hhh
Q 037197 860 TVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSM--------------IKS 924 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~--------------~~~ 924 (1009)
......+++.|+|||+..+ ..++.++||||||+++|||++|+.||...... .......... ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 3334456889999998754 45788999999999999999999999742111 0111110000 000
Q ss_pred ccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 925 NKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...........+...... ...++.+++.+|++.||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKN---LDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCC---CCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000000000 1234567899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=334.85 Aligned_cols=201 Identities=24% Similarity=0.345 Sum_probs=171.9
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+..+.||+|+||.||+|++..+++.||||++.+... .......+.+|++++++++||||+++++++.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 47888999999999999999999999999999854321 12234556689999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++.... .+++.....++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999997543 267778888999999999999998 9999999999999999999999999997532100
Q ss_pred C-------------------------------------------CceeeecccCcccCCcccCCCCCCcccchHhHHHHH
Q 037197 858 N-------------------------------------------ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVL 894 (1009)
Q Consensus 858 ~-------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl 894 (1009)
. .......||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 001134689999999999988899999999999999
Q ss_pred HHHHhCCCCCCC
Q 037197 895 LELLTGKMPLDP 906 (1009)
Q Consensus 895 ~elltg~~Pf~~ 906 (1009)
|||++|+.||..
T Consensus 235 yell~G~~Pf~~ 246 (376)
T cd05598 235 YEMLVGQPPFLA 246 (376)
T ss_pred eehhhCCCCCCC
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.23 Aligned_cols=255 Identities=24% Similarity=0.287 Sum_probs=199.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.+.|+..+.||+|+||.||+|+...+++.||+|++..... .....+.+|+.++++++||||+++++++..++..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 4568889999999999999999998899999999854422 23345668999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.++++... .+++..+..++.|+++|++|||+. +|+|||++|+||+++.++.++|+|||++.....
T Consensus 86 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 86 EYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 9999999999986543 268888999999999999999998 999999999999999999999999999987643
Q ss_pred CCCceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 857 KNETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
.........+++.|+|||... ...++.++||||+||++|||++|+.||....... ....... .....
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-----~~~~~~~-----~~~~~ 228 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----ALFLMSK-----SNFQP 228 (267)
T ss_pred cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-----hheeeec-----CCCCC
Confidence 333333456888999999864 3457889999999999999999999986322110 0000000 00111
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
+.... .. .....+.+++.+|++.+|++||+++++++.
T Consensus 229 ~~~~~-~~---~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 229 PKLKD-KT---KWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCCcc-cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 11111 01 112356688899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.03 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=198.0
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||+|.+.+ +..||+|.+.... ...+++.+|++++++++||||+++++++.+....++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 346778899999999999998876 4569999985432 223567799999999999999999999999889999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... .+++.+++.++.||+.|++|||+. +++|+||||+||+++.++.+||+|||.++.....
T Consensus 80 ~~~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 80 YMSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 9999999999975432 378999999999999999999998 9999999999999999999999999998765433
Q ss_pred CCc-eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NET-VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
... .....++..|+|||+.....++.++||||||+++|||++ |+.||..... ...... +..+.. +.
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~-~~~~~~------~~ 221 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-----SETVEK-VSQGLR------LY 221 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHH-HhcCCC------CC
Confidence 221 112234567999999888889999999999999999999 9999863221 111111 111110 00
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
.... ....+.+++.+||+.+|++||++.++++.++
T Consensus 222 ~~~~------~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHL------ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCC------CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0111 1135677899999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=316.31 Aligned_cols=260 Identities=27% Similarity=0.398 Sum_probs=203.6
Q ss_pred hcCCcCceeccCCceEEEEEEEC-----CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNV 772 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 772 (1009)
..|...+.||+|+||.||++... .++..||+|.+... .......+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 35778889999999999999852 34567999988543 233455677999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhcCCcc---------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcE
Q 037197 773 MMVYDYMPNDSLGEALHGKEA---------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEA 843 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 843 (1009)
++||||+++++|.++++.... ....+++.+++.++.|++.||+|||++ +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999999875431 122379999999999999999999998 99999999999999999999
Q ss_pred EEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHH
Q 037197 844 RIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLS 920 (1009)
Q Consensus 844 kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 920 (1009)
+|+|||+++....... ......+++.|+|||+.....++.++||||||+++|||++ |..||..... .....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-----~~~~~- 233 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEVIE- 233 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH-
Confidence 9999999976533221 1122334678999999988889999999999999999998 9999864321 11111
Q ss_pred HHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 921 MIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.+..+.. ....... ..++.+++.+|++.+|.+||++.|+.+.|+++..
T Consensus 234 ~i~~~~~------~~~~~~~------~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 234 CITQGRV------LQRPRTC------PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHcCCc------CCCCCCC------CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1111110 0011111 1246789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=321.19 Aligned_cols=269 Identities=25% Similarity=0.335 Sum_probs=205.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCe--EEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHM--VVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l 774 (1009)
+.|+..+.||+|+||.||+|.+..++. .+|+|.+... ........+.+|++++.++ +||||+++++++..++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457788899999999999999877664 4577776432 2233345667899999999 89999999999999999999
Q ss_pred EEeccCCCChhhhhcCCcc------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc
Q 037197 775 VYDYMPNDSLGEALHGKEA------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE 842 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 842 (1009)
||||+++++|.++++.... ....+++.+++.++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999975431 122478899999999999999999998 9999999999999999999
Q ss_pred EEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHH
Q 037197 843 ARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSM 921 (1009)
Q Consensus 843 ~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 921 (1009)
+||+|||++...... ........+..|+|||+.....++.++|||||||++|||+| |..||..... .+... .
T Consensus 163 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~-~ 235 (303)
T cd05088 163 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYE-K 235 (303)
T ss_pred EEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----HHHHH-H
Confidence 999999998642111 11112234568999999888888999999999999999998 9999863211 11111 1
Q ss_pred HhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCcccccccC
Q 037197 922 IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNG 989 (1009)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~~ 989 (1009)
..... ....... ....+.+++.+|++.+|++||++.++++.++++.+.+.....++
T Consensus 236 ~~~~~------~~~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~~ 291 (303)
T cd05088 236 LPQGY------RLEKPLN------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 291 (303)
T ss_pred HhcCC------cCCCCCC------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhhhh
Confidence 11110 0001111 11245678999999999999999999999999887776544433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=329.97 Aligned_cols=201 Identities=27% Similarity=0.386 Sum_probs=172.5
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-----
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE----- 769 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~----- 769 (1009)
.+.++|+..+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 356789999999999999999999999899999999976544455566778999999999999999999987543
Q ss_pred -CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 770 -TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 770 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
...++||||+++ ++.+.+... +++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHhc------CCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence 357999999965 677776432 67788889999999999999998 9999999999999999999999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
|+++..... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 171 G~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 171 GLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred CCccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 999765322 222345689999999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.46 Aligned_cols=248 Identities=28% Similarity=0.419 Sum_probs=201.2
Q ss_pred eeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCCh
Q 037197 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSL 784 (1009)
Q Consensus 705 ~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL 784 (1009)
++|+|.||+||-|++..+...+|||.+... +....+...+|+...++++|.|||+++|.+.++++.-+.||.++||||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 799999999999999999999999998543 344456677999999999999999999999999999999999999999
Q ss_pred hhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC-CCCcEEEcccccceecccCCCceee
Q 037197 785 GEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD-ANLEARIADFGLARMMLHKNETVSM 863 (1009)
Q Consensus 785 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~DfGls~~~~~~~~~~~~ 863 (1009)
.++++...+. ..-.+...--+.+||++||.|||.+ .|||||||-+||+++ -.|.+||+|||.++++..-+.....
T Consensus 660 SsLLrskWGP-lKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 660 SSLLRSKWGP-LKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHHHhccCC-CccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 9999876432 1124555556789999999999999 999999999999996 4789999999999988766666667
Q ss_pred ecccCcccCCcccCCC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 864 VAGSYGYIAPEYGYTL--KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 864 ~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
+.||..|||||++..+ .|..++|||||||++.||.||++||-..... .+. +++-+. -...|.++
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp----qAA---MFkVGm---yKvHP~iP---- 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP----QAA---MFKVGM---YKVHPPIP---- 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh----hHh---hhhhcc---eecCCCCc----
Confidence 8899999999998755 4889999999999999999999999743222 111 111111 11123332
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
.+...+...++.+|+.+||.+||++.++++.
T Consensus 802 --eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 --EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred --HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 3334556788999999999999999999863
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=326.41 Aligned_cols=252 Identities=22% Similarity=0.265 Sum_probs=195.1
Q ss_pred CCcCceeccCCceEEEEEEEC---CCCeEEEEEEcccCCC--ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEE
Q 037197 700 VKESNIIGMGGNGIVYKAEFH---RPHMVVAVKKLWRSDN--DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~ 773 (1009)
|+..+.||+|+||.||+++.. .+++.||+|++.+... .....+.+.+|+++++++ +||+|+++++++..++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 677889999999999998864 4688999999864321 122334566899999999 5999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDN----FSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999865432 78888899999999999999998 999999999999999999999999999986
Q ss_pred cccCC-CceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 854 MLHKN-ETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 854 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
+.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+...+...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~------ 226 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER--NTQSEVSRRILKC------ 226 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC--CCHHHHHHHHhcC------
Confidence 54333 223345789999999998764 4788999999999999999999999643221 1112222221111
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
++.+..... ..+.+++.+|++.||++|| ++.++++
T Consensus 227 -~~~~~~~~~------~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 -DPPFPSFIG------PEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -CCCCCCCCC------HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111211111 2355788899999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=309.75 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=195.7
Q ss_pred eeccCCceEEEEEEE--CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 705 IIGMGGNGIVYKAEF--HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 705 ~iG~G~~g~Vyk~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
.||+|+||.||+|.+ ..++..||+|++..........+++.+|+.++++++||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999965 4567899999986554444556677799999999999999999999864 4678999999999
Q ss_pred ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce-
Q 037197 783 SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV- 861 (1009)
Q Consensus 783 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~- 861 (1009)
+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999996543 278889999999999999999998 99999999999999999999999999998764433211
Q ss_pred --eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 862 --SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 862 --~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
....+++.|+|||......++.++||||||+++|||++ |+.||..... ..+. ..+..+.. +....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~-~~i~~~~~------~~~~~ 221 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----NEVT-QMIESGER------MECPQ 221 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHH-HHHHCCCC------CCCCC
Confidence 12233578999999887888999999999999999998 9999974321 1222 22222211 11111
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
... .++.+++.+|++.||++||++.+|++.|++.
T Consensus 222 ~~~------~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCP------PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCC------HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111 2456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=328.20 Aligned_cols=255 Identities=20% Similarity=0.269 Sum_probs=195.7
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 4679999999999999999999999999999999854321 122234456899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++|+|.+++.... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 122 ~Ey~~gg~L~~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 122 MEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 99999999999986532 67777788999999999999998 99999999999999999999999999998764
Q ss_pred cCCC-ceeeecccCcccCCcccCCC----CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 856 HKNE-TVSMVAGSYGYIAPEYGYTL----KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 856 ~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
.... ......||+.|+|||++... .++.++|||||||++|||++|+.||... +.......... ......
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~~-~~~~~~ 267 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----SLVGTYSKIMN-HKNSLT 267 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC-----CHHHHHHHHHc-CCCccc
Confidence 3322 23346799999999987643 3788999999999999999999999732 22222222211 110000
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKG--RPTMRDVITM 974 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~ 974 (1009)
+... . .....+..++.+|+..++.+ ||++.|+++-
T Consensus 268 -----~~~~-~---~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 268 -----FPDD-N---DISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -----CCCc-C---CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1100 0 11123456788999844433 7788888773
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=323.65 Aligned_cols=243 Identities=23% Similarity=0.276 Sum_probs=193.2
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEEEEe
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
|+..+.||+|+||.||+|.+..+++.||+|++.+... .....+.+..|.++++.+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 5677899999999999999999999999999865321 1223345668888888885 5788899999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~i~~~~~----l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 82 YVNGGDLMYHIQQVGK----FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred CCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999865432 78889999999999999999998 9999999999999999999999999998764333
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.... ....+........ .+.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~~~~~~i~~~~~--------~~p 221 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-----EDELFQSIMEHNV--------SYP 221 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCC--------CCC
Confidence 333445668999999999988889999999999999999999999997421 1122222211111 111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTM 968 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 968 (1009)
... ..++.+++.+|++.+|++|++.
T Consensus 222 ~~~------~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 KSL------SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ccC------CHHHHHHHHHHcccCHhhCCCC
Confidence 111 1245678889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=310.75 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=200.9
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh---hhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI---ESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
+.|+..+.||+|++|.||+|....+++.||+|.+....... .....+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 35788899999999999999999889999999986543222 223456689999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++++|.+++..... +++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999865432 67888889999999999999998 9999999999999999999999999999765
Q ss_pred ccCCCce---eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 855 LHKNETV---SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 855 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
....... ....++..|+|||+..+..++.++||||+|+++|||++|+.||.... ....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~------ 223 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE-----AMAAIFKIATQP------ 223 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc-----hHHHHHHHhccC------
Confidence 3322111 23457789999999988889999999999999999999999996321 111111111111
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
..+.+.... ...+..++.+|++.+|++||++.|+++.
T Consensus 224 ~~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 TNPQLPSHV------SPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCccC------CHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111111111 1245678889999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=308.95 Aligned_cols=253 Identities=22% Similarity=0.340 Sum_probs=207.1
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||.|+||.||.++...+++.|++|.+...........++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47788999999999999999999999999999866554455566778999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.+++.... ...+++.++..++.|+++|++|||+. +++|+||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997653 22378889999999999999999998 99999999999999999999999999998764444
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
.......+++.|+|||+..+..++.++||||||+++|||++|+.||... +..+.+..... +.. .+ ...
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~-~~~-----~~-~~~ 223 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-----NPLNLVVKIVQ-GNY-----TP-VVS 223 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHc-CCC-----CC-Ccc
Confidence 3344556899999999988888899999999999999999999999632 22222222221 110 00 001
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
....++..++.+|++.+|++||++.|+++.
T Consensus 224 ------~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 224 ------VYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ------ccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 111245678889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=315.11 Aligned_cols=259 Identities=28% Similarity=0.420 Sum_probs=203.0
Q ss_pred cCCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.|...+.||+|+||.||+|++.. ++..|++|.+... .....+.+.+|++++++++||||+++++++......+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 46777899999999999998542 4567899988433 2233456679999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCcc------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC
Q 037197 774 MVYDYMPNDSLGEALHGKEA------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL 841 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~ 841 (1009)
+||||+++++|.+++..... ....+++..+++++.|++.|++|||++ +|+||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999975431 112378899999999999999999998 999999999999999999
Q ss_pred cEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHH
Q 037197 842 EARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWV 918 (1009)
Q Consensus 842 ~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 918 (1009)
.++|+|||++........ ......+++.|+|||+.....++.++||||||+++|||++ |+.||..... .+.+
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~~ 235 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-----TEVI 235 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHH
Confidence 999999999976533221 1223445778999999888889999999999999999999 9999864321 1122
Q ss_pred HHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 919 LSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.. ...+.. . ...... ...+.+++.+|++.+|++||++.+|+++|+++.+
T Consensus 236 ~~-~~~~~~-~-----~~~~~~------~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 236 EC-ITQGRV-L-----ERPRVC------PKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HH-HhCCCC-C-----CCCccC------CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11 111110 0 001111 1246688999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=312.27 Aligned_cols=250 Identities=22% Similarity=0.380 Sum_probs=196.9
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||+|+||.||+|.+..+++.||+|.+.... ......++.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4677889999999999999999889999999985442 233445677999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999997653 156777888999999999999998 9999999999999999999999999999765322
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHHHHHhhccccccccCccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSK--DIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
......+++.|+|||+..+..++.++||||||+++|+|++|+.||........ ....+........ .+..
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~ 220 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------PPVL 220 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-------CCCC
Confidence 22335688999999999888899999999999999999999999975332111 1111111111100 1111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
.. .. ...++.+++.+|++.+|++||++.|+++.
T Consensus 221 ~~--~~---~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PV--GQ---FSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC--Cc---CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 10 00 11245678899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.72 Aligned_cols=263 Identities=26% Similarity=0.349 Sum_probs=202.8
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCe--EEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHM--VVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l 774 (1009)
++|+..+.||+|+||.||+|....++. .+++|.++.. ......+.+.+|+++++++ +||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 457888899999999999999877654 4688887532 2233455677999999999 79999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccc------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc
Q 037197 775 VYDYMPNDSLGEALHGKEAG------------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE 842 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 842 (1009)
||||+++++|.++++..... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence 99999999999999653211 12378889999999999999999998 9999999999999999999
Q ss_pred EEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHH
Q 037197 843 ARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSM 921 (1009)
Q Consensus 843 ~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 921 (1009)
+||+|||++...... ........+..|+|||+.....++.++|||||||++|||++ |..||.... .......
T Consensus 158 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~-----~~~~~~~- 230 (297)
T cd05089 158 SKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-----CAELYEK- 230 (297)
T ss_pred EEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH-
Confidence 999999998643111 11111223457999999888889999999999999999998 999996321 1222221
Q ss_pred HhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCcc
Q 037197 922 IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRK 983 (1009)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 983 (1009)
...+. .......+. ..+.+++.+|++.+|.+||++.++++.|+++...++
T Consensus 231 ~~~~~------~~~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 231 LPQGY------RMEKPRNCD------DEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HhcCC------CCCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11111 111111111 245678999999999999999999999999886663
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.92 Aligned_cols=248 Identities=20% Similarity=0.240 Sum_probs=198.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|+..+.||+|.-|+||.+..++++..+|+|++.+.... .....++..|-+||+.++||.++.+|+.|+.+.+.++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 3456678899999999999999999999999999765432 344566778999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
|||+||+|..+.+++..+. +++..+.-++..|+-||+|||.. |||.|||||+||||.++|++-|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~--fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKR--FSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhCCCCc--cchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999998776544 66777777899999999999998 999999999999999999999999998753210
Q ss_pred ---------------------------------CCC-----------------------ceeeecccCcccCCcccCCCC
Q 037197 857 ---------------------------------KNE-----------------------TVSMVAGSYGYIAPEYGYTLK 880 (1009)
Q Consensus 857 ---------------------------------~~~-----------------------~~~~~~gt~~y~aPE~~~~~~ 880 (1009)
... ....++||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 011356899999999999999
Q ss_pred CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccC
Q 037197 881 VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAK 960 (1009)
Q Consensus 881 ~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 960 (1009)
.+.+.|.|+|||++|||+.|+.||..... ...+...+. .. ..+. ..+.....+.+||++.+.+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~-~~Tl~NIv~----~~--------l~Fp----~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNN-KETLRNIVG----QP--------LKFP----EEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCc-hhhHHHHhc----CC--------CcCC----CCCcchhHHHHHHHHHhcc
Confidence 99999999999999999999999974322 222222221 11 1111 1123344567889999999
Q ss_pred CCCCCCC
Q 037197 961 LPKGRPT 967 (1009)
Q Consensus 961 dp~~RPs 967 (1009)
||.+|.-
T Consensus 375 dP~kRlg 381 (459)
T KOG0610|consen 375 DPSKRLG 381 (459)
T ss_pred Chhhhhc
Confidence 9999986
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.97 Aligned_cols=265 Identities=26% Similarity=0.321 Sum_probs=198.1
Q ss_pred CCcCceeccCCceEEEEEE----ECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC--CeEE
Q 037197 700 VKESNIIGMGGNGIVYKAE----FHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE--TNVM 773 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~ 773 (1009)
|+..+.||+|+||+||++. ...++..||+|.++... .......+.+|++++++++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 3788899999999998765 33567899999986542 223455677999999999999999999988653 4689
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++++|.+++.... +++.+++.++.|+++|++|||+. +|+||||||+||++++++.++|+|||++..
T Consensus 85 lv~e~~~~~~l~~~~~~~~-----l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEecCCCCCCHHHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence 9999999999999996532 78999999999999999999998 999999999999999999999999999986
Q ss_pred cccCCCc---eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc---
Q 037197 854 MLHKNET---VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA--- 927 (1009)
Q Consensus 854 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--- 927 (1009)
....... .....++..|+|||......++.++||||||+++|||++|+.||........+..............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 6433221 1122345679999998888899999999999999999999999864321111111000000000000
Q ss_pred cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
............ ...++.+++.+|++.+|++||++++++++|+++.
T Consensus 237 ~~~~~~~~~~~~------~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKN------CPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCC------CCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000000011111 1235778899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=309.77 Aligned_cols=249 Identities=26% Similarity=0.413 Sum_probs=196.8
Q ss_pred ceeccCCceEEEEEEECCCC---eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccC
Q 037197 704 NIIGMGGNGIVYKAEFHRPH---MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMP 780 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~ 780 (1009)
+.||+|+||.||+|.....+ ..||+|.+...... ...+++.+|++++++++||||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 46899999999999876544 78999998655432 34556779999999999999999999876 456899999999
Q ss_pred CCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCc
Q 037197 781 NDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860 (1009)
Q Consensus 781 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~ 860 (1009)
+++|.+++.... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++........
T Consensus 79 ~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 79 LGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 999999997654 378899999999999999999998 9999999999999999999999999999876443322
Q ss_pred ee---eecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 861 VS---MVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 861 ~~---~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.. ...++..|+|||......++.++||||||+++|||++ |+.||..... .++..++ ..... . ..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~----~~~~~---~---~~ 219 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAML----ESGER---L---PR 219 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH----HcCCc---C---CC
Confidence 11 1123457999999988889999999999999999998 9999974321 1222222 22211 0 01
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.... ...+.+++.+|+..+|++||++.++++.|+++.
T Consensus 220 ~~~~------~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 PEEC------PQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCC------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1111 135668999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=337.52 Aligned_cols=261 Identities=21% Similarity=0.319 Sum_probs=189.8
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC--------
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE-------- 769 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-------- 769 (1009)
..|+..+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 46889999999999999999999889999999884321 2234799999999999999999876432
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC-cEEEccc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-EARIADF 848 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Df 848 (1009)
..+++||||++ +++.+++.........+++..+..++.||++||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 24679999997 467777654332333478888899999999999999998 999999999999999765 7999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
|+++.+.... ......||+.|+|||++.+ ..++.++||||+||++|||++|.+||..... ...+...+ ... +..
T Consensus 216 Gla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~-~~~--~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS-VDQLVRII-QVL--GTP 290 (440)
T ss_pred ccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHH-HHh--CCC
Confidence 9998764332 2234568999999998765 4689999999999999999999999974211 11111111 110 000
Q ss_pred ccc---ccCcc-----ccccC-chHH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 928 QDE---ALDPS-----IAGQC-KHVQ-----EEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 928 ~~~---~~~~~-----~~~~~-~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+ ...+. +.... .... ....++.+++.+|++.||++|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000 00000 00000 0000 01135678999999999999999999883
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=315.03 Aligned_cols=265 Identities=26% Similarity=0.378 Sum_probs=202.8
Q ss_pred hcCCcCceeccCCceEEEEEEECCC----------------CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceee
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRP----------------HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVR 761 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~ 761 (1009)
++|+..+.||+|+||.||+|.+... +..||+|.+..... ....+.+.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678889999999999999987653 35689999864432 344566779999999999999999
Q ss_pred EEeEEEcCCeEEEEEeccCCCChhhhhcCCcc-------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCc
Q 037197 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEA-------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNN 834 (1009)
Q Consensus 762 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 834 (1009)
+++++..+...++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999976541 112478999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh--CCCCCCCCCCC
Q 037197 835 ILLDANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT--GKMPLDPAFGG 910 (1009)
Q Consensus 835 Ill~~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt--g~~Pf~~~~~~ 910 (1009)
|+++.++.++|+|||+++....... ......+++.|+|||+.....++.++||||||+++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999976533321 2223445678999999888889999999999999999998 677875321
Q ss_pred CccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 911 SKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
..+..+.+......... ....+. ... ...++.+++.+|++.||++||++.|+++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~--~~~~~~----~~~---~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGR--QIYLPR----PPN---CPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhccccccc--cccCCC----ccC---CCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11222222111111110 000000 001 11357789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=317.24 Aligned_cols=261 Identities=26% Similarity=0.374 Sum_probs=203.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECCC-----CeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCC
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRP-----HMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNET 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~ 770 (1009)
.++|+..+.||+|+||.||+|.+... ...||+|.+..... ......+.+|+++++++ +||||+++++++..++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34678889999999999999987643 37899999864322 33345677999999999 8999999999999999
Q ss_pred eEEEEEeccCCCChhhhhcCCc------------cccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC
Q 037197 771 NVMMVYDYMPNDSLGEALHGKE------------AGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD 838 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~ 838 (1009)
..++||||+++|+|.++++... .....+++..+++++.|++.|++|||+. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 9999999999999999996532 1223478999999999999999999998 999999999999999
Q ss_pred CCCcEEEcccccceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHH
Q 037197 839 ANLEARIADFGLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIV 915 (1009)
Q Consensus 839 ~~~~~kl~DfGls~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~ 915 (1009)
.++.+|++|||+++.+...... .....++..|+|||+..+..++.++|||||||++||+++ |..||.... ..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~ 241 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VE 241 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-----HH
Confidence 9999999999999876433211 112234568999999888889999999999999999998 999986321 11
Q ss_pred HHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 916 EWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
+. ......+. .+..... ....+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus 242 ~~-~~~~~~~~------~~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 EL-FKLLKEGY------RMEKPQN------CTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH-HHHHHcCC------cCCCCCC------CCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 11111111 0011111 1124667899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=313.87 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=197.9
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCe----EEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHM----VVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
+.|+..+.||+|+||+||+|.+..+++ .|++|.+... .......++..|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 356778899999999999999876665 4777776432 122233456678889999999999999998864 4578
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+|+||+++|+|.++++.... .+++..+..++.||+.|++|||+. +++||||||+||++++++.+||+|||.++.
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 89999999999999975432 378899999999999999999998 999999999999999999999999999986
Q ss_pred cccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 854 MLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
...... ......++..|+|||+.....++.++||||||+++||+++ |+.||..... ... ...+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~----~~~~~~~~~--- 229 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEV----PDLLEKGER--- 229 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHH----HHHHHCCCc---
Confidence 543322 2223456778999999888889999999999999999998 9999864321 111 111221111
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
...+. .+. ..+..++.+|+..+|++||++.|+++.|..+..
T Consensus 230 ~~~~~---~~~------~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 LAQPQ---ICT------IDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCC---CCC------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11111 111 234568889999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=327.33 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=203.7
Q ss_pred HhcCCcCceeccCCceEEEEEEEC-----CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCC
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNET 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~ 770 (1009)
.++|...+.||+|+||.||+|++. ..++.||+|++..... ....+.+.+|++++.++. ||||+++++++....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 345778889999999999999864 3457899999965432 233456779999999997 999999999999999
Q ss_pred eEEEEEeccCCCChhhhhcCCcc---------------------------------------------------------
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEA--------------------------------------------------------- 793 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 793 (1009)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999975321
Q ss_pred -------------------------------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEE
Q 037197 794 -------------------------------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNIL 836 (1009)
Q Consensus 794 -------------------------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIl 836 (1009)
....+++....+++.|++.||+|||+. +|+||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 112367778889999999999999988 9999999999999
Q ss_pred eCCCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 037197 837 LDANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKD 913 (1009)
Q Consensus 837 l~~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~ 913 (1009)
+++++.+|++|||+++....... ......+++.|+|||......++.++||||||+++|||++ |..||.....
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~---- 347 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM---- 347 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc----
Confidence 99999999999999986533221 1122356788999999888889999999999999999998 8999863221
Q ss_pred HHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 914 IVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.+.....+..+. .+...... ..++.+++.+||+.+|++||+++|+++.|+++.
T Consensus 348 -~~~~~~~~~~~~------~~~~p~~~------~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 -NEQFYNAIKRGY------RMAKPAHA------SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -hHHHHHHHHcCC------CCCCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111222222221 11111111 124667888999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.84 Aligned_cols=251 Identities=22% Similarity=0.353 Sum_probs=202.7
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
|+..+.||+|+||.||++.+..++..||+|.++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 6778899999999999999999999999999864432 334566778999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
++++|.+++..... ..+++...+.++.|++.|+.|||+. +|+|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999998864332 2367888889999999999999998 999999999999999999999999999987654444
Q ss_pred ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccccc
Q 037197 860 TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1009)
......+++.|+|||+.....++.++||||||+++|+|++|+.||... +........ ..+. .. .+...
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~~~~~~~~-~~~~-----~~-~~~~~ 223 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SWKNLILKV-CQGS-----YK-PLPSH 223 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CHHHHHHHH-hcCC-----CC-CCCcc
Confidence 444567889999999998888999999999999999999999999732 222222211 1111 00 11111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 940 CKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 940 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
. ...+.+++.+||+.||++||++.|++..
T Consensus 224 ~------~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 Y------SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred c------CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1 1235678899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=315.64 Aligned_cols=260 Identities=24% Similarity=0.365 Sum_probs=202.2
Q ss_pred CCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 700 VKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
|+..+.||+|+||.||+|.... ....+|+|.+.... ......++.+|+.++++++||||+++++++..++..++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5677889999999999998753 23678999885432 23334567799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCcc--------------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCc
Q 037197 775 VYDYMPNDSLGEALHGKEA--------------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNN 834 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 834 (1009)
||||+++++|.+++..... ....+++..++.++.|++.|++|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999864321 112478899999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEcccccceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCC
Q 037197 835 ILLDANLEARIADFGLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGS 911 (1009)
Q Consensus 835 Ill~~~~~~kl~DfGls~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~ 911 (1009)
|++++++.+||+|||+++........ .....++..|+|||+..+..++.++||||||+++|||++ |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 99999999999999999765333221 122345678999999888889999999999999999999 999986321
Q ss_pred ccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 912 KDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
..+. ........ ........ ...+.+++.+|++.+|++||++.|+++.|+++..+
T Consensus 235 --~~~~-~~~~~~~~------~~~~~~~~------~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 235 --PERL-FNLLKTGY------RMERPENC------SEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred --HHHH-HHHHhCCC------CCCCCCCC------CHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1111 11221111 11111111 12466789999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=310.29 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=201.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCC---eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPH---MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
+.|+..+.||+|+||.||+|....++ ..||+|.+.... .....+++..|++++++++|||++++.+++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 35777889999999999999987544 379999985432 23345667799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++++|.+++..... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999965432 278889999999999999999998 9999999999999999999999999999766
Q ss_pred ccCCCcee---eecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 855 LHKNETVS---MVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 855 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
........ ....++.|+|||+.....++.++|||||||++|||++ |+.||..... ..+.... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~i-~~~~~--- 228 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAI-NDGFR--- 228 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHH-hcCCC---
Confidence 43322111 1123457999999888889999999999999999998 9999963221 1222221 11110
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.+.. .. ....+.+++.+|++.+|++||++.++++.|+++.
T Consensus 229 --~~~~-~~------~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 229 --LPAP-MD------CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred --CCCC-CC------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 0110 01 1134678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=313.75 Aligned_cols=262 Identities=25% Similarity=0.380 Sum_probs=207.2
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
...+.+.||+|-||.|..+.... +..||||.++.... ...+.+|.+|+++|.+++||||++++|+|..++.+++|+||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34567789999999999999877 79999999965433 23356778999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
|++|+|.+++..+.... .......+|+.||+.|++||.+. .+||||+.+.|+|+++++++||+|||+++-+...+
T Consensus 617 mEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999998774322 34556677999999999999998 99999999999999999999999999999765554
Q ss_pred Cce--eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh--CCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 859 ETV--SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT--GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 859 ~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
... ...+-..+|||||.+..++++.+||||+||+++||+++ ...||.... +++.++..-++...... .
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt--~e~vven~~~~~~~~~~------~ 763 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT--DEQVVENAGEFFRDQGR------Q 763 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh--HHHHHHhhhhhcCCCCc------c
Confidence 322 23445679999999999999999999999999999877 778887432 22333333333222221 1
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
.........+ .++.+++.+||+.+.++||+++++...|.+.
T Consensus 764 ~~l~~P~~cp---~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVLSRPPACP---QGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eeccCCCcCc---HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111112222 2456889999999999999999999988764
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=314.52 Aligned_cols=265 Identities=26% Similarity=0.367 Sum_probs=199.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCC--------------CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRP--------------HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~ 763 (1009)
++|+..+.||+|+||.||++.+... ...||+|.++.. ........+.+|++++++++|||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4678888999999999999987542 245899998643 2233455677999999999999999999
Q ss_pred eEEEcCCeEEEEEeccCCCChhhhhcCCcc--------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcE
Q 037197 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEA--------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNI 835 (1009)
Q Consensus 764 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NI 835 (1009)
+++......++||||+++++|.+++..... ....+++..++.++.|++.|++|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999865321 112368889999999999999999998 999999999999
Q ss_pred EeCCCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh--CCCCCCCCCCCC
Q 037197 836 LLDANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT--GKMPLDPAFGGS 911 (1009)
Q Consensus 836 ll~~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt--g~~Pf~~~~~~~ 911 (1009)
+++.++.+||+|||++........ ......+++.|+|||+.....++.++||||||+++|+|++ |..||.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-- 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-- 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence 999999999999999976533221 1122334678999999888889999999999999999998 6667763221
Q ss_pred ccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 912 KDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
.+....+...............+. . . ...+.+++.+|++.+|++||++.+|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~---~---~---~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTP---L---C---PSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCC---C---C---CHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 122222211111110000000000 1 1 1256789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=315.69 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=203.1
Q ss_pred hcCCcCceeccCCceEEEEEEE-----CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEF-----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 771 (1009)
++|...+.||+|+||.||+|.+ ..++..||+|+++... .....+.+.+|+++++++ +||||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 5688899999999999999975 3345689999986542 233345677999999999 79999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++||||+++|+|.++++.... ..+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.++++|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999975432 2278999999999999999999998 9999999999999999999999999999
Q ss_pred eecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 852 RMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 852 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
........ ......+++.|+|||......++.++||||+||++|||++ |+.||...... .........+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-----~~~~~~~~~~~-- 261 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-----SKFYKLIKEGY-- 261 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-----HHHHHHHHcCC--
Confidence 86543322 1112345678999999888889999999999999999998 99998643221 11111222111
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
.+..... ...++.+++.+|++.+|++||++.|+++.|+++
T Consensus 262 ----~~~~~~~------~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 ----RMAQPEH------APAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----cCCCCCC------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000000 112467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.90 Aligned_cols=259 Identities=23% Similarity=0.375 Sum_probs=203.2
Q ss_pred HhcCCcCceeccCCceEEEEEEECCC-----CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRP-----HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
.++|+..+.||+|+||.||+|..... +..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 35678889999999999999988643 4789999985432 23344567799999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccc------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEE
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAG------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARI 845 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 845 (1009)
.++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 99999999999999999754321 12368889999999999999999998 9999999999999999999999
Q ss_pred cccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHH
Q 037197 846 ADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 846 ~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
+|||+++....... ......++..|+|||......++.++|||||||++||+++ |..||.... ...... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~~~~~----~~ 234 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--NEEVLK----FV 234 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--HHHHHH----HH
Confidence 99999876543321 2223446778999999888889999999999999999998 999986321 111121 11
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
..+. .+.....+ ...+.+++.+|++.+|++|||+.|+++.|++
T Consensus 235 ~~~~------~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGG------HLDLPENC------PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCC------CCCCCCCC------CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111 11111111 2356689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.18 Aligned_cols=255 Identities=24% Similarity=0.285 Sum_probs=200.0
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
..++|+..+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 3456788889999999999999999889999999985442 22334566899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|.+++.... .+++.+...++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 85 MEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred EeccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 99999999999986543 278889999999999999999998 99999999999999999999999999987664
Q ss_pred cCCCceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
..........|++.|+|||+.. ...++.++|||||||++|||++|+.||...... ..+....... ..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-----~~~~~~~~~~-----~~ 227 (267)
T cd06645 158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-----RALFLMTKSN-----FQ 227 (267)
T ss_pred CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-----hhHHhhhccC-----CC
Confidence 4333334557899999999864 445788999999999999999999998633211 1111111111 01
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+...... .. ...+.+++.+|++.+|++||++.++++
T Consensus 228 ~~~~~~~~-~~---~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 PPKLKDKM-KW---SNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCcccccC-CC---CHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11111000 11 123567889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=314.06 Aligned_cols=265 Identities=25% Similarity=0.388 Sum_probs=200.2
Q ss_pred hcCCcCceeccCCceEEEEEEECC----------------CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceee
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHR----------------PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVR 761 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~ 761 (1009)
++|+..+.||+|+||.||++.+.. ++..||+|++.... ......++.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 458888999999999999986432 34579999985432 2334566779999999999999999
Q ss_pred EEeEEEcCCeEEEEEeccCCCChhhhhcCCccc-------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCc
Q 037197 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAG-------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNN 834 (1009)
Q Consensus 762 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 834 (1009)
+++++..++..++||||+++++|.+++...... ...+++.+++.++.|++.|++|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998764321 12367888999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh--CCCCCCCCCCC
Q 037197 835 ILLDANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT--GKMPLDPAFGG 910 (1009)
Q Consensus 835 Ill~~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt--g~~Pf~~~~~~ 910 (1009)
|+++.++.++|+|||+++.+..... ......+++.|+|||+.....++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 9999999999999999976533221 1112234578999998888889999999999999999998 7788863221
Q ss_pred CccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 911 SKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
......+........ .....+.. ..+ ...+.+++.+|++.||++||++.|+++.|++
T Consensus 240 -~~~~~~~~~~~~~~~--~~~~~~~~-~~~------~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 -EQVIENTGEFFRDQG--RQVYLPKP-ALC------PDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -HHHHHHHHHHHhhcc--ccccCCCC-CCC------CHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111211111111110 00111111 111 1346689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=307.68 Aligned_cols=250 Identities=25% Similarity=0.389 Sum_probs=197.1
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
.|+..+.||+|+||.||+|.++. +..+|+|.+..... ...++.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 46778889999999999999875 66899999854322 234677899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.++++.... .+++..++.++.|+++|++|||+. +++||||||+||+++.++.+|++|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 81 MANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred CCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 999999999975432 378999999999999999999998 99999999999999999999999999997653322
Q ss_pred Cce-eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 859 ETV-SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 859 ~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
... ....++..|+|||......++.++||||||+++|||++ |+.||..... .+... ...... ....
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~-~~~~~~------~~~~ 222 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-----SEVVE-SVSAGY------RLYR 222 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH-HHHcCC------cCCC
Confidence 111 11123457999999888889999999999999999999 8999863211 11111 111111 1111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
... ...++.+++.+|++.+|++||++.|+++.|.
T Consensus 223 ~~~------~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 223 PKL------APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCC------CCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 111 1224678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=307.41 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=202.8
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc-CCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN-ETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~~~~lV~E 777 (1009)
+|+..+.||+|++|.||++.+..+++.||+|++..........+.+.+|++++++++|||++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3778899999999999999999889999999986554444455667799999999999999999998764 446799999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++..... ..+++.++..++.+++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999975322 2378899999999999999999998 9999999999999999999999999999876444
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
........+++.|+|||+..+..++.++||||+|+++|+|++|+.||... +......... .+.. +...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-----~~~~~~~~~~-~~~~------~~~~ 223 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----DMNSLVYRII-EGKL------PPMP 223 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHH-hcCC------CCCc
Confidence 33444556889999999998888999999999999999999999998632 2222222221 1110 1111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. .....+.+++.+|++.+|++||++.|+++
T Consensus 224 ~------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 K------DYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred c------ccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1 11134667899999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=314.13 Aligned_cols=258 Identities=28% Similarity=0.421 Sum_probs=200.3
Q ss_pred hcCCcCceeccCCceEEEEEEEC----CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFH----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
..|+..+.||+|+||.||+|... ..+..||+|.+.... .......+.+|++++++++||||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 34677788999999999999853 346789999986432 2334456778999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCcc-------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC
Q 037197 774 MVYDYMPNDSLGEALHGKEA-------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN 840 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~ 840 (1009)
+||||+++++|.+++..... ....+++.+...++.|++.||+|||+. +++||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 99999999999999853321 123478888999999999999999998 99999999999999999
Q ss_pred CcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHH
Q 037197 841 LEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEW 917 (1009)
Q Consensus 841 ~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 917 (1009)
+.+||+|||+++....... ......++..|+|||+..+..++.++||||||+++|||++ |..||.... . ..
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-----~-~~ 234 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-----N-QE 234 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----H-HH
Confidence 9999999999976543321 1223345678999999888889999999999999999999 999986321 1 12
Q ss_pred HHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 918 VLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
+...+..... ......+. .++..++.+|++.||++||++.++.+.|..
T Consensus 235 ~~~~~~~~~~------~~~~~~~~------~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQL------LPCSEDCP------PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCc------CCCCCCCC------HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 2222222211 01111111 245678889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=317.80 Aligned_cols=264 Identities=22% Similarity=0.309 Sum_probs=208.0
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.+...+|+..+.||+|+||.||+|....+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..+++.+
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 445678999999999999999999998889999999986442 223455668999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++++|.+++.... +++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 93 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 93 VVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred EeecccCCCCHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceE
Confidence 9999999999999986432 67888899999999999999998 999999999999999999999999999876
Q ss_pred cccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
............+++.|+|||...+..++.++|||||||++|++++|+.||...... .........+ .
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~-----~~~~~~~~~~-------~ 232 (297)
T cd06656 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----RALYLIATNG-------T 232 (297)
T ss_pred ccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-----hheeeeccCC-------C
Confidence 544333334456888999999988888999999999999999999999999642211 0000000000 0
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhhcCCCcc
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT--MLGEAKPRRK 983 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~~~~~~ 983 (1009)
+... . .......+.+++.+|++.+|++||++.++++ .++..++..+
T Consensus 233 ~~~~-~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 233 PELQ-N---PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred CCCC-C---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence 0000 0 0111123567888999999999999999998 5555544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=324.96 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=197.4
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-----
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE----- 769 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~----- 769 (1009)
++.++|+..+.||+|+||.||+|.+..+++.||||++............+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 456789999999999999999999998899999999865543334456677999999999999999999987543
Q ss_pred -CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 770 -TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 770 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
...++++|++ +++|.++++... +++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQK-----LSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 4579999988 889988885432 78889999999999999999998 9999999999999999999999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh-cc
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS-NK 926 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~ 926 (1009)
|+++..... .....+++.|+|||+..+ ..++.++|||||||++|+|++|+.||.... ..+.+...... +.
T Consensus 163 g~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~~~~~~~~ 234 (343)
T cd07878 163 GLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND-----YIDQLKRIMEVVGT 234 (343)
T ss_pred ccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHHhCC
Confidence 999865332 234568999999998766 568899999999999999999999996321 11111111110 00
Q ss_pred ccccccC-----------ccccccCchHH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALD-----------PSIAGQCKHVQ-----EEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~-----------~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+... ..+........ .....+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 00000000000 00123567899999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=312.00 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=198.0
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
|+..+.||+|+||.||+|.+..++..+++|.+... .....+.+.+|+++++.++|||++++++++..++..++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 56778899999999999999998999999998443 2344566778999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
++++|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+|++|||++........
T Consensus 85 ~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 85 AGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 9999999876432 2378899999999999999999998 999999999999999999999999999876543333
Q ss_pred ceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 860 TVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
......+++.|+|||+.. ...++.++|||||||++|||++|+.||.... ..+.+........ .....+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~~~~~~~~~~--~~~~~~ 231 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSEP--PTLAQP 231 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-----HHHHHHHHhhcCC--CCCCCc
Confidence 334456889999999863 4457789999999999999999999986321 1222222211111 001111
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
... ..++.+++.+|++.+|++||++.++++.
T Consensus 232 ---~~~------~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 ---SRW------SSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---ccc------CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011 1245678899999999999999988643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=321.05 Aligned_cols=195 Identities=29% Similarity=0.365 Sum_probs=171.6
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-C-----CceeeEEeEEEcCCeE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-H-----RNIVRLLGYLHNETNV 772 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H-----pniv~l~~~~~~~~~~ 772 (1009)
+|.+.++||+|+||.|.||.+..+++.||||+++.. .....+...|+.+|..++ | -|+|++++||...++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 788899999999999999999999999999999544 455667778999999996 4 3899999999999999
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC--cEEEccccc
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL--EARIADFGL 850 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~--~~kl~DfGl 850 (1009)
++|+|.+ .-+|+++++.+.-.. ++......|+.||+.||..||.. +|||+||||+|||+...+ .+||+|||.
T Consensus 264 ciVfELL-~~NLYellK~n~f~G--lsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFRG--LSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 9999988 778999998775443 67788888999999999999998 999999999999997643 799999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~ 905 (1009)
|+..... ......+..|.|||++.+.+|+.+.||||||||++||++|.+-|.
T Consensus 338 Sc~~~q~---vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 338 SCFESQR---VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred ccccCCc---ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 9875332 225667889999999999999999999999999999999976665
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=316.20 Aligned_cols=199 Identities=24% Similarity=0.423 Sum_probs=173.1
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
.|+..+.||+|+||.||++.+..++..||+|.+.... ......++.+|++++++++||||+++++++.++++.++||||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 5788899999999999999999999999999985432 233445677999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.++++... .+++..+..++.|+++||+|||+.+ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999997542 2678888899999999999999732 8999999999999999999999999998755322
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
......+++.|+|||...+..++.++||||||+++|+|++|+.||..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 22345688999999998888899999999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=308.76 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=204.6
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||+|+||.||++....+++.||+|.+...........++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 47788899999999999999998899999999865443344456777999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.+++..... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999865432 2367888899999999999999998 99999999999999999999999999998664433
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
.......+++.|+|||+..+..++.++||||||+++|+|++|+.||... +....+........ +....
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~~~~-------~~~~~ 223 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMKNLVLKIIRGSY-------PPVSS 223 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHHHHHHHHhcCCC-------CCCcc
Confidence 3333456788999999988888999999999999999999999998632 22233322221111 11111
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. ...++..++.+|++.+|++||++.||++
T Consensus 224 ~------~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 224 H------YSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred c------CCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1 1234667889999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=311.74 Aligned_cols=253 Identities=22% Similarity=0.261 Sum_probs=197.3
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh-hhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI-ESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
|+..+.||+|+||+||+|.+..+++.||+|.+....... .....+.+|++++++++|++++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 556688999999999999999999999999985543222 2234456899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG- 155 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence 99999999886432 22378999999999999999999998 9999999999999999999999999998765322
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
.......|++.|+|||+..+..++.++|+||||+++|||++|+.||...... ...+.+........ ..+..
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~--~~~~~~~~~~~~~~-------~~~~~ 226 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK--VKREEVDRRVLETE-------EVYSA 226 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhhhccc-------cccCc
Confidence 2223456899999999998888999999999999999999999999742211 11111111111110 11111
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPT-----MRDVIT 973 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 973 (1009)
.. ...+.+++.+|++.||++||+ +.++++
T Consensus 227 ~~------~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 227 KF------SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cC------CHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11 123567888999999999999 556555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=309.26 Aligned_cols=254 Identities=24% Similarity=0.315 Sum_probs=214.1
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
..+..-|...+.||+|-|..|-.|++--+|+.||||++.+...+......+|+|++.|+-++|||||++|++......+|
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 34566688889999999999999999999999999999998888888889999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC-CCCcEEEcccccce
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD-ANLEARIADFGLAR 852 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~DfGls~ 852 (1009)
+|.|.-++|+|.|||..+..+ +.+.-..+++.||+.|+.|+|.. ++||||+||+||.+- +-|-||+.|||++-
T Consensus 94 LiLELGD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred EEEEecCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccc
Confidence 999999999999999877654 77788888999999999999998 899999999998774 56899999999998
Q ss_pred ecccCCCceeeecccCcccCCcccCCCCCC-cccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 853 MMLHKNETVSMVAGSYGYIAPEYGYTLKVD-EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
.+. ++......+|+..|-|||++.+..|+ ++.||||+||++|.|++|+.||+..... +. ...+
T Consensus 168 kf~-PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----ET----------LTmI 231 (864)
T KOG4717|consen 168 KFQ-PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----ET----------LTMI 231 (864)
T ss_pred cCC-CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----hh----------hhhh
Confidence 763 45566778899999999999988886 6899999999999999999999854322 11 1122
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+|=.+. ...+ ...+...+|.+|+..||.+|.+.+|++.
T Consensus 232 mDCKYt-vPsh---vS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 232 MDCKYT-VPSH---VSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hccccc-Cchh---hhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 221111 1111 2235667899999999999999999875
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=308.99 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=201.2
Q ss_pred hcCCcCceeccCCceEEEEEEECCC---CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
.+|+..+.||+|+||.||+|.+..+ +..||+|.++... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4678889999999999999987633 3479999986533 23345567799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++++|.+++..... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999975432 268889999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCCcee---eecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 855 LHKNETVS---MVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 855 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
........ ...++..|+|||+.....++.++||||||+++||+++ |+.||..... .+....+ ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~----~~~~---- 226 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAI----EEGY---- 226 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHH----hCCC----
Confidence 44332111 1123467999999988889999999999999999887 9999863221 1112211 1111
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
....... ....+.+++.+|++.+|++||++.++++.|.++
T Consensus 227 --~~~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 --RLPAPMD------CPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --cCCCCCC------CCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011111 112456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=310.60 Aligned_cols=263 Identities=24% Similarity=0.315 Sum_probs=205.2
Q ss_pred HhcCCcCceeccCCceEEEEEEECC----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc-CCe
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN-ETN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~~ 771 (1009)
.++|+..+.||+|+||.||+|.+.. .+..|++|++... ........+.+|+.++++++||||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3567888999999999999999876 3578999988533 334445667799999999999999999998765 567
Q ss_pred EEEEEeccCCCChhhhhcCCccc----cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAG----KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIAD 847 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 847 (1009)
.++++||+++++|.+++...... ...+++.+++.++.|++.||+|||+. +++||||||+||++++++.+|++|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998754322 13488999999999999999999998 999999999999999999999999
Q ss_pred cccceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhh
Q 037197 848 FGLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKS 924 (1009)
Q Consensus 848 fGls~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 924 (1009)
||+++.+...... .....++..|+|||+.....++.++||||||+++||+++ |+.||..... .++..+ ...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~----~~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAY----LKD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHH----HHc
Confidence 9999865333211 112335668999999888889999999999999999999 9999974311 112222 111
Q ss_pred ccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 925 NKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
+.. ......+ ...+.+++.+|++.||++||++.|+++.|+++.++
T Consensus 235 ~~~------~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 GYR------LAQPINC------PDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCC------CCCCCcC------CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 110 0011111 12456788999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=311.63 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=197.3
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcC-----
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNE----- 769 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~----- 769 (1009)
+.+.|+..+.||+|+||.||+|....+++.||+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 4566888889999999999999999999999999986542 2345667899999998 799999999998653
Q ss_pred -CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 770 -TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 770 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
...++||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 468999999999999999875432 2378888899999999999999998 9999999999999999999999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
|++..............|++.|+|||+.. ...++.++||||+||++|||++|+.||..... ..... .. .
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~~~~~-~~-~ 229 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRALF-LI-P 229 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----HHHHH-HH-h
Confidence 99986543333344566889999999875 34578899999999999999999999963221 11111 10 0
Q ss_pred hccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. .......+. .. ...+.+++.+|+..+|++||++.|+++
T Consensus 230 ~-~~~~~~~~~----~~------~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 R-NPAPRLKSK----KW------SKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred c-CCCCCCCCC----Cc------CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 000111111 11 124567889999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=311.89 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=201.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCe----EEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHM----VVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
+.|+..+.||+|+||+||+|.+..++. .||+|++... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 457788999999999999999876655 4899998543 2233445677999999999999999999999764 568
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
++|||+++|+|.++++.... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999975432 378889999999999999999998 999999999999999999999999999987
Q ss_pred cccCCCce--eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 854 MLHKNETV--SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
........ ....+++.|+|||......++.++||||||+++|||++ |..||+.... .....++ ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~----~~~~~~-- 230 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLL----EKGERL-- 230 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH----HCCCcC--
Confidence 64332211 11234578999999888889999999999999999998 9999864221 1222222 111110
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
..... ....+.+++.+|++.||++||++.|+++.|+++....
T Consensus 231 ----~~~~~------~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 ----PQPPI------CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ----CCCcc------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 00111 1124567889999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=312.30 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=199.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||+|++..+++.||+|.+... .....+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 5588888999999999999999999999999998543 33445667789999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|..++..... .+++..+..++.|+++|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 9999999988754332 278899999999999999999998 9999999999999999999999999998764333
Q ss_pred CCceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 858 NETVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
........+++.|+|||+.. ...++.++|||||||++|||++|+.||.... ..+.+........
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~------ 232 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSEP------ 232 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-----HHHHHHHHhcCCC------
Confidence 33334556888999999874 3456889999999999999999999986321 1122222211111
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.... . .....++.+++.+|++.+|++||++.|+++
T Consensus 233 -~~~~~-~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 -PTLSQ-P---SKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -ccCCC-C---cccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11100 0 011224667889999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=311.59 Aligned_cols=258 Identities=26% Similarity=0.375 Sum_probs=200.7
Q ss_pred HhcCCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
.+.|+..+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.++++++|+||+++++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3568888999999999999999977 67899999885432 23334567799999999999999999999999889
Q ss_pred EEEEEeccCCCChhhhhcCCcc---ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC---cEEE
Q 037197 772 VMMVYDYMPNDSLGEALHGKEA---GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL---EARI 845 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl 845 (1009)
.++||||+++++|.++++.... ....+++.++.+++.||+.|++|||+. +++||||||+||+++.++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999975432 123478999999999999999999998 999999999999998754 5999
Q ss_pred cccccceecccCCCce--eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHH
Q 037197 846 ADFGLARMMLHKNETV--SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 846 ~DfGls~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
+|||+++......... .....+..|+|||+..+..++.++|||||||++|||++ |..||..... .+.+ ..+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-----~~~~-~~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-----QEVM-EFV 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH-HHH
Confidence 9999998663222111 12223468999999988889999999999999999997 9999974221 1111 122
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
..... ....... ...+.+++.+|++.+|++||++.+|++.|+
T Consensus 235 ~~~~~------~~~~~~~------~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGR------LDPPKGC------PGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCc------CCCCCCC------CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11110 0111111 124667889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=314.51 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=201.7
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
..+|+..+.||.|++|.||+|.+..+++.||+|.+.... ....+.+.+|+++++.++|||++++++++..++..++||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 356888899999999999999999889999999985432 233456679999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 96 EYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 999999999998643 278899999999999999999998 999999999999999999999999999876544
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.........+++.|+|||...+..++.++|||||||++|+|++|+.||..... ............ .....
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-----~~~~~~~~~~~~--~~~~~--- 237 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRALYLIATNGT--PELQN--- 237 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcCC--cccCC---
Confidence 33333345688899999998888899999999999999999999999974321 111111111111 00000
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
... ....+.+++.+|+..||++||++.+++.
T Consensus 238 ~~~------~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 PEK------LSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccc------CCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 001 1124567889999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=313.93 Aligned_cols=266 Identities=25% Similarity=0.299 Sum_probs=192.8
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc---CCCceeeEEeEEEc-----CC
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL---RHRNIVRLLGYLHN-----ET 770 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~-----~~ 770 (1009)
+|+..+.||+|+||.||+|.+..+++.||+|.+..............+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 36778899999999999999999999999999865433333333455677666655 79999999998764 34
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
..++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 5899999997 588888865432 2378889999999999999999998 999999999999999999999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc----
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK---- 926 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---- 926 (1009)
++...... ......+++.|+|||++.+..++.++||||+||++|||++|++||..... .+....+........
T Consensus 155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH--HHHHHHHHHHhCCCChhhC
Confidence 98654322 22334678899999999888899999999999999999999999863211 111111111110000
Q ss_pred ccc-cccCccccccCch-----HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQD-EALDPSIAGQCKH-----VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~-~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
... ......+...... ..+....+.+++.+|++.||++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 0000000000000 0011234568899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=312.41 Aligned_cols=266 Identities=23% Similarity=0.302 Sum_probs=200.9
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||+|+||.||+|.+..+++.||+|++..........+.+.+|++++++++|||++++++++..+...++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 57888899999999999999998899999999865543333345566999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
++++++..+..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 82 CDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred cCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99998888875432 278999999999999999999998 99999999999999999999999999998765444
Q ss_pred CceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc-----------c
Q 037197 859 ETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN-----------K 926 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-----------~ 926 (1009)
.......++..|+|||+..+ ..++.++||||||+++|||++|+.||...... +....+....... .
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV--DQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChHHhhhccccc
Confidence 33334567889999998765 45788999999999999999999999743221 1111111110000 0
Q ss_pred ccccccCccccccCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALDPSIAGQCKH---VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.......+........ .......+.+++.+|++.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000110000000 0011234678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=315.43 Aligned_cols=266 Identities=23% Similarity=0.323 Sum_probs=198.0
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 468888999999999999999998899999999864432 2233456689999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|++ ++|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 996 689888865422 267888899999999999999998 9999999999999999999999999999765433
Q ss_pred CCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc--ccc-----
Q 037197 858 NETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK--AQD----- 929 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~----- 929 (1009)
........+++.|+|||+..+ ..++.++|||||||++|||++|+.||..... ......+........ ...
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV--EEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCChhhchhhhcc
Confidence 333334457889999998754 3578899999999999999999999974321 111111111110000 000
Q ss_pred -ccc---CccccccCch--HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 930 -EAL---DPSIAGQCKH--VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 930 -~~~---~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.. .+.....+.. .......+.+++.+|++.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 0111000000 0001224567899999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=312.17 Aligned_cols=253 Identities=23% Similarity=0.288 Sum_probs=198.8
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChh-hHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE-SGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
|+..+.||+|+||.||++.+..+++.||+|.+........ ....+.+|+.++++++|++++++++++.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 5667889999999999999999999999999865432222 234456899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.+++..... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~- 155 (285)
T cd05630 82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG- 155 (285)
T ss_pred cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-
Confidence 999999999864332 2378888999999999999999998 9999999999999999999999999998765322
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
.......|++.|+|||+..+..++.++||||+|+++|||++|+.||....... ............ ...+..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~~~~~~~~-------~~~~~~ 226 (285)
T cd05630 156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEV-------QEEYSE 226 (285)
T ss_pred ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--hHHHHHhhhhhh-------hhhcCc
Confidence 22234568999999999988889999999999999999999999997432211 111111111110 001111
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPT-----MRDVIT 973 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 973 (1009)
.+ ...+.+++.+|++.||++||+ +.|+++
T Consensus 227 ~~------~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 KF------SPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cC------CHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11 123567889999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=305.59 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=192.7
Q ss_pred eccCCceEEEEEEEC--CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCC
Q 037197 706 IGMGGNGIVYKAEFH--RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDS 783 (1009)
Q Consensus 706 iG~G~~g~Vyk~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gs 783 (1009)
||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|++++++++||||+++++++.. ...++||||+++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 899999999999775 446679999985442 23334567799999999999999999998864 57899999999999
Q ss_pred hhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce--
Q 037197 784 LGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV-- 861 (1009)
Q Consensus 784 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~-- 861 (1009)
|.+++..... .+++..+++++.|+++|++|||++ +++||||||+||+++.++.+||+|||++..........
T Consensus 81 L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKKD---EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999865332 378899999999999999999998 99999999999999999999999999997654333211
Q ss_pred -eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccccc
Q 037197 862 -SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939 (1009)
Q Consensus 862 -~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1009)
....+++.|+|||+.....++.++||||||+++||+++ |..||..... ..+ ...+..+.. +.....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~-~~~~~~~~~------~~~~~~ 222 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----PEV-MSFIEQGKR------LDCPAE 222 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----HHH-HHHHHCCCC------CCCCCC
Confidence 11223568999999888889999999999999999996 9999974321 111 122222211 111111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 940 CKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 940 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
+ ..++.+++.+||..+|++||++.+|.+.|+++
T Consensus 223 ~------~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 C------PPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred C------CHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1 13456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.51 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=202.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||+|.+..++..||+|.+... ...+++.+|++++++++||||+++++++.++...++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 4678888999999999999999988899999998543 125677799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++.... ..+++..+..++.|+++|++|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 999999999986433 2378999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
........++..|+|||+..+..++.++||||||+++|+|++|+.||...... +.+.. .... ..+.+.
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-----~~~~~-~~~~------~~~~~~ 220 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-----RAIFM-IPNK------PPPTLS 220 (256)
T ss_pred ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-----hhhhh-hccC------CCCCCC
Confidence 43344456888999999988888999999999999999999999999743221 11100 0000 000010
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
........+.+++.+|++.+|++||++.|+++
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 ----DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ----chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01111234677889999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=314.47 Aligned_cols=262 Identities=25% Similarity=0.384 Sum_probs=204.1
Q ss_pred HhcCCcCceeccCCceEEEEEEEC-------CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEc
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFH-------RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHN 768 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~ 768 (1009)
.++|+..+.||+|+||.||+|++. .++..||+|.+.... ......++.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 355788899999999999999753 234579999985432 233456677999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCChhhhhcCCccc------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEE
Q 037197 769 ETNVMMVYDYMPNDSLGEALHGKEAG------------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNIL 836 (1009)
Q Consensus 769 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIl 836 (1009)
....++||||+++|+|.+++...... ...+++.++..++.||++||+|||+. +|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 99999999999999999999754321 12478888999999999999999998 9999999999999
Q ss_pred eCCCCcEEEcccccceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 037197 837 LDANLEARIADFGLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKD 913 (1009)
Q Consensus 837 l~~~~~~kl~DfGls~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~ 913 (1009)
+++++.+||+|||.++........ .....+++.|+|||+..+..++.++||||||+++|||++ |..||... .
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~ 244 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----P 244 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----C
Confidence 999999999999999876433321 122335678999999888889999999999999999998 78888532 2
Q ss_pred HHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 914 IVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
..+... .+..+... .....+ ...+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 245 ~~~~~~-~~~~~~~~------~~~~~~------~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 245 VEELFK-LLKEGHRM------DKPANC------TNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHH-HHHcCCcC------CCCCCC------CHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 222222 22222110 011111 1246678899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=307.85 Aligned_cols=256 Identities=25% Similarity=0.344 Sum_probs=204.5
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc--CCeEEEEEe
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN--ETNVMMVYD 777 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~~lV~E 777 (1009)
|+..+.||.|+||.||+|.+..+++.||+|.+..........+++..|++++++++||||+++++++.. +...++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 677789999999999999999989999999987655555556677799999999999999999998754 456899999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcC--CCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC--QPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|+++++|.+++.........+++..++.++.|+++|++|||..+ ..+++|+||+|+||+++.++.+|++|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999999764333345889999999999999999999221 2299999999999999999999999999998765
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
..........+++.|+|||+.....++.++||||||+++|+|++|+.||.... .... ...+..+. .+.
T Consensus 162 ~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~-~~~~~~~~------~~~ 229 (265)
T cd08217 162 HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQL-ASKIKEGK------FRR 229 (265)
T ss_pred CCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHH-HHHHhcCC------CCC
Confidence 44433444568999999999988889999999999999999999999997422 1111 12221111 111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+... ....+..++.+|++.+|++||++.++++
T Consensus 230 ~~~~------~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 230 IPYR------YSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred Cccc------cCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1111 1235668889999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=308.70 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=195.0
Q ss_pred ceeccCCceEEEEEEECCCCe--EEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEeccC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHM--VVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYDYMP 780 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E~~~ 780 (1009)
++||+|+||.||+|.+.+++. .+|+|.+... ......+.+.+|+++++++ +||||+++++++......++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999999987664 4688887532 2234445677999999999 89999999999999999999999999
Q ss_pred CCChhhhhcCCcc------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 781 NDSLGEALHGKEA------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 781 ~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
+|+|.++++.... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence 9999999975431 112368889999999999999999998 9999999999999999999999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
|++...... ........++.|+|||+.....++.++||||||+++|||++ |..||.... ...... .+....
T Consensus 157 gl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~-~~~~~~- 228 (270)
T cd05047 157 GLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYE-KLPQGY- 228 (270)
T ss_pred CCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----HHHHHH-HHhCCC-
Confidence 998532111 11112233567999999888889999999999999999997 999996321 111111 111111
Q ss_pred cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
....... ....+.+++.+|++.+|.+||++.|+++.|+++.
T Consensus 229 -----~~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 -----RLEKPLN------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -----CCCCCCc------CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0001111 1124668899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.54 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=199.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||.||+|.+.++ ..||+|++..... ..+++.+|++++++++||||+++++++.+ ...++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 4588889999999999999998765 4699999864322 23567799999999999999999998754 56799999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.++++.... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+|||.++.....
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999975432 2368889999999999999999998 9999999999999999999999999999766433
Q ss_pred CCce-eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NETV-SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
.... ....++..|+|||+.....++.++||||||+++|||++ |..||..... . .+........ ...
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-----~-~~~~~~~~~~------~~~ 223 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----R-EVLDQVERGY------RMP 223 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-----H-HHHHHHhcCC------CCC
Confidence 3211 22345678999999888889999999999999999999 8888864321 1 1111111111 000
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.. .+....+.+++.+|++.+|++||++.++++.|++..
T Consensus 224 ~~------~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 CP------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred Cc------cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 11 112235678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.29 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=198.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||.||+|.... +..||+|.+..... ..+.+.+|+.++++++|||++++++++.+ ...++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence 467888999999999999998775 66799999865432 23567799999999999999999998854 56789999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.++++.... ..+++.+++.++.|++.|++|||+. +|+||||||+||++++++.++|+|||.+..+...
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999975432 2368899999999999999999998 9999999999999999999999999999876433
Q ss_pred CCc-eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NET-VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
... .....++..|+|||+.....++.++||||||+++|||++ |+.||.... ..+....... .. ...
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~~~~~~~~~~-~~------~~~ 223 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-----NREVLEQVER-GY------RMP 223 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHc-CC------CCC
Confidence 221 112334568999999888889999999999999999999 899986321 1122221111 11 011
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
.... ....+.+++.+|++.+|++|||+.++.+.|++
T Consensus 224 ~~~~------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQD------CPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCc------CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111 11246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=312.33 Aligned_cols=259 Identities=23% Similarity=0.293 Sum_probs=199.5
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEE-----
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLH----- 767 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~----- 767 (1009)
.++.++|+..+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 345678899999999999999999999989999999874321 2234566899999999 6999999999873
Q ss_pred cCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcc
Q 037197 768 NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIAD 847 (1009)
Q Consensus 768 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 847 (1009)
.++..++||||+++++|.++++........+++..+..++.|+++|+.|||+. +|+||||||+||++++++.++++|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEcc
Confidence 44678999999999999998864332333478888999999999999999998 999999999999999999999999
Q ss_pred cccceecccCCCceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH
Q 037197 848 FGLARMMLHKNETVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 848 fGls~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
||+++.............|++.|+|||++. ...++.++||||+||++|||++|+.||..... ...+....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-----~~~~~~~~ 242 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-----MRALFKIP 242 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-----hHHHhhcc
Confidence 999987644333334456889999999864 34578899999999999999999999864321 11111110
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
. .. .....++. .+ ...+..++.+|++.||++||++.|+++-
T Consensus 243 ~-~~-~~~~~~~~---~~------~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 R-NP-PPTLHQPE---LW------SNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred c-cC-CCcccCCC---Cc------CHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 00 00111111 01 1246678899999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=306.53 Aligned_cols=253 Identities=27% Similarity=0.434 Sum_probs=199.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.+.|+..+.||+|+||.||+|...+ ++.||+|.+.... ....++.+|++++++++||||+++++++. .+..++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 3568888999999999999998765 6789999986443 23456779999999999999999999875 45689999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++..... ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.++++|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999865432 2378889999999999999999998 999999999999999999999999999977642
Q ss_pred CCC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 857 KNE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 857 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
... ......++..|+|||+.....++.++||||||+++||+++ |+.||.... ..+..... .... ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~-~~~~------~~ 222 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-----NPEVIQNL-ERGY------RM 222 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-----hHHHHHHH-HcCC------CC
Confidence 221 2222345678999999888889999999999999999999 999996322 11111111 1111 11
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
...... . .++.+++.+|++.+|++||++++++..|++
T Consensus 223 ~~~~~~---~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNC---P---EELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCC---C---HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111111 1 246778899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=310.82 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=198.8
Q ss_pred cCCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.|+..+.||+|+||.||+|.+.. .+..||+|++.... .......+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 35667789999999999998754 35789999986432 2233455668999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCc------------cccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC
Q 037197 774 MVYDYMPNDSLGEALHGKE------------AGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL 841 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~ 841 (1009)
+++||+++++|.+++.... ..+..+++..+..++.|++.||+|+|+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 1122478888899999999999999998 999999999999999999
Q ss_pred cEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHH
Q 037197 842 EARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWV 918 (1009)
Q Consensus 842 ~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 918 (1009)
.+||+|||+++....... ......+++.|+|||......++.++||||||+++|||++ |..||... ...++.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-----~~~~~~ 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-----SNQDVI 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----CHHHHH
Confidence 999999999876533321 1223345678999999888889999999999999999998 88888632 112222
Q ss_pred HHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 919 LSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
.. +..... ......+. ..+..++.+|++.+|++||+++++++.|++
T Consensus 237 ~~-i~~~~~------~~~~~~~~------~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EM-IRNRQV------LPCPDDCP------AWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-HHcCCc------CCCCCCCC------HHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22 221110 01111121 235678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.12 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=202.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
..|+..+.||.|+||.||+|.+..++..||+|.+..... ......+.+|++++++++||||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 356777889999999999999998899999999864422 3344567789999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++.... +++.+...++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 83 ~~~~~~L~~~i~~~~-----l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 83 YLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred cCCCCcHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999999986432 67788888999999999999998 9999999999999999999999999999776444
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
........++..|+|||+..+..++.++||||||+++|||++|+.||...... ...... ... ..+.+.
T Consensus 155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~-~~~------~~~~~~ 222 (277)
T cd06640 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----RVLFLI-PKN------NPPTLT 222 (277)
T ss_pred ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----hHhhhh-hcC------CCCCCc
Confidence 33334456788999999988888999999999999999999999998743211 111111 000 011111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
......+.+++.+|++.+|++||++.|+++.
T Consensus 223 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 ------GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ------hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1223456789999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=313.03 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=200.9
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 346667789999999999999998899999999864432 2344567799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++... .+++..+..++.|+++|++|||+. +++|+||+|+||++++++.++++|||++......
T Consensus 83 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 83 YLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred ccCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 99999999998643 268888899999999999999998 9999999999999999999999999999766443
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
........++..|+|||+..+..++.++||||||+++|||++|+.||...... .... .+... ..+.+.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~-~~~~~------~~~~~~ 222 (277)
T cd06642 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----RVLF-LIPKN------SPPTLE 222 (277)
T ss_pred chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----hHHh-hhhcC------CCCCCC
Confidence 33333456788999999998888999999999999999999999998643221 1111 11111 111121
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.. ....+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~------~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 223 GQ------YSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred cc------cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11 1234667889999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.78 Aligned_cols=362 Identities=30% Similarity=0.438 Sum_probs=240.4
Q ss_pred cCCeEEecCCCCCC-CCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhh
Q 037197 138 SGLTSVNASSNNFS-GFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETII 216 (1009)
Q Consensus 138 ~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 216 (1009)
+-.+-.|+++|.++ +.+|.....++.++.|.|...++. .+|..++.|.+|++|.+++|++. .+-..++.++.|+.+.
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 34455566666665 456777777777777777777776 67888888888888888888877 4556677888888888
Q ss_pred cccccccc-cCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccC
Q 037197 217 LGYNAFEG-EIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQIS 295 (1009)
Q Consensus 217 L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 295 (1009)
+.+|++.. -+|..+..|..|..||||+|++. ..|..+...+++-.|+|++|+|..+.-..|.+++.|-+||||+|++.
T Consensus 85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence 88887764 36778888899999999999988 77888888899999999999998544455668899999999999998
Q ss_pred CCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccC-ccCCccccCCCCCceeeccCccccccCCcCc
Q 037197 296 GEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLI-GSLPMRLGQSSPLRRLDASSNLLSGEIPTGL 374 (1009)
Q Consensus 296 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l 374 (1009)
.+|..+..+.+|++|.|++|.+...-...+-.+++|++|.+++.+-+ ..+|..+..+.+|..+|+|.|.+. ..|+.+
T Consensus 164 -~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecl 241 (1255)
T KOG0444|consen 164 -MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECL 241 (1255)
T ss_pred -hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHH
Confidence 77888899999999999999887544444555667777777765532 345555555555666666666555 455555
Q ss_pred cCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcE
Q 037197 375 CDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSF 454 (1009)
Q Consensus 375 ~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 454 (1009)
..+.+|+.|+||+|+|+ .+....+.-.+|++|+||.|+++ .+|+.++.++.|+.
T Consensus 242 y~l~~LrrLNLS~N~it-------------------------eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k 295 (1255)
T KOG0444|consen 242 YKLRNLRRLNLSGNKIT-------------------------ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK 295 (1255)
T ss_pred hhhhhhheeccCcCcee-------------------------eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH
Confidence 55555555555555554 22223333344444444444444 44444444455555
Q ss_pred EecccCccc--ccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCc
Q 037197 455 VDISWNHLE--SYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNN 532 (1009)
Q Consensus 455 L~Ls~N~l~--~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N 532 (1009)
|.+.+|+++ | +|+.|+.+.+|+.+.+++|++. ..|+.+..|+.|+.|.|+.|+|- .+|+.+.-|+.|+.|||..|
T Consensus 296 Ly~n~NkL~FeG-iPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreN 372 (1255)
T KOG0444|consen 296 LYANNNKLTFEG-IPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLREN 372 (1255)
T ss_pred HHhccCcccccC-CccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCC
Confidence 555444432 2 4555555555555555555554 45555555555555555555554 45555555566666666555
Q ss_pred c
Q 037197 533 R 533 (1009)
Q Consensus 533 ~ 533 (1009)
.
T Consensus 373 p 373 (1255)
T KOG0444|consen 373 P 373 (1255)
T ss_pred c
Confidence 4
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=332.18 Aligned_cols=288 Identities=19% Similarity=0.222 Sum_probs=205.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC------CCceeeEEeEEEcC-
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR------HRNIVRLLGYLHNE- 769 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------Hpniv~l~~~~~~~- 769 (1009)
.++|+..+.||+|+||+||+|.+..+++.||||+++.. .........|+++++.++ |++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 46789999999999999999999988999999998542 122233446777766664 45689999998765
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeccCCCcEEeCCCC-------
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH-DCQPPVIHRDIKSNNILLDANL------- 841 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~dlk~~NIll~~~~------- 841 (1009)
.++++|||++ +++|.+++.... .+++..+..|+.||+.||+|||+ . +||||||||+||+++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccc
Confidence 5789999988 778888886543 27888999999999999999997 5 999999999999998765
Q ss_pred ---------cEEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCc
Q 037197 842 ---------EARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSK 912 (1009)
Q Consensus 842 ---------~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~ 912 (1009)
.+||+|||.+... ........||+.|+|||++.+..++.++|||||||++|||++|+.||+.... .
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~---~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDE---RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN--L 351 (467)
T ss_pred ccccCCCCceEEECCCCccccC---ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--H
Confidence 4999999987543 2223456789999999999999999999999999999999999999974221 1
Q ss_pred cHHHHHHHHH--------------------hhccccccccCccc----cc-cCchHHHHHHHHHHHHHHhccCCCCCCCC
Q 037197 913 DIVEWVLSMI--------------------KSNKAQDEALDPSI----AG-QCKHVQEEMLLVLRIAVLCTAKLPKGRPT 967 (1009)
Q Consensus 913 ~~~~~~~~~~--------------------~~~~~~~~~~~~~~----~~-~~~~~~~~~~~l~~l~~~cl~~dp~~RPs 967 (1009)
+....+.... ..........++.. .. ...........+.+++.+||+.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 1111111100 00000000000000 00 00000011234678999999999999999
Q ss_pred HHHHHH--HHhhcCCCcccccccCCCCCCCCcccccCCCc
Q 037197 968 MRDVIT--MLGEAKPRRKSICQNGGHNLSKERPIFGNSPV 1005 (1009)
Q Consensus 968 ~~evl~--~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1009)
++|+++ .+....... .+...|...+|+++|-|.
T Consensus 432 a~e~L~Hp~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 466 (467)
T PTZ00284 432 ARQMTTHPYVLKYYPEC-----RQHPNYPDNRSMLRPTPI 466 (467)
T ss_pred HHHHhcCccccccCCcc-----ccCCCCCCccccCCCCCC
Confidence 999997 554433322 223456678888888774
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.32 Aligned_cols=268 Identities=27% Similarity=0.378 Sum_probs=208.5
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc--CCCceeeEEeEEEcC--
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL--RHRNIVRLLGYLHNE-- 769 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~Hpniv~l~~~~~~~-- 769 (1009)
..+.+.....+.||+|.||.||+|.++ |+.||||++... .....++|.++.+.+ +|+||+.+++.-..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 345667788999999999999999998 578999999432 235677888887764 999999999875433
Q ss_pred --CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEeccCCCcEEeCCCCc
Q 037197 770 --TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD-----CQPPVIHRDIKSNNILLDANLE 842 (1009)
Q Consensus 770 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dlk~~NIll~~~~~ 842 (1009)
..+|+|++|.+.|||.|++.... ++....++++..+|.||+|||.. .+|.|.|||||++||++.+++.
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~t-----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRNT-----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhcc-----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 35799999999999999997643 78899999999999999999975 4789999999999999999999
Q ss_pred EEEcccccceecccCC----CceeeecccCcccCCcccCCCC----C--CcccchHhHHHHHHHHHhC----------CC
Q 037197 843 ARIADFGLARMMLHKN----ETVSMVAGSYGYIAPEYGYTLK----V--DEKSDIYSFGVVLLELLTG----------KM 902 (1009)
Q Consensus 843 ~kl~DfGls~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDv~SlGvvl~elltg----------~~ 902 (1009)
+.|+|+|+|....... ......+||.+|||||++...- + -..+||||||.|+||++.. +.
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 9999999998775543 2344578999999999865321 1 2468999999999999762 36
Q ss_pred CCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 903 PLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 903 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
||.+..+.+..+.+. +..+ -.+-+.|.++.... ..+.+..+.++++.||..+|..|-|+--+.+.|.++.+
T Consensus 435 Pyyd~Vp~DPs~eeM-rkVV-----Cv~~~RP~ipnrW~-s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEM-RKVV-----CVQKLRPNIPNRWK-SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CcccCCCCCCCHHHH-hcce-----eecccCCCCCcccc-cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 777655544433322 1111 12223444443333 24567778899999999999999999999999988874
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.81 Aligned_cols=256 Identities=26% Similarity=0.469 Sum_probs=200.9
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCe---EEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHM---VVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
..|+..+.||+|+||.||+|.+..+++ .||||.+.... ......++..|+.++++++||||+++++++.++...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 346788899999999999999876554 69999985432 34445677799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++++|.+++..... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 83 ITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999999875432 278899999999999999999998 9999999999999999999999999998765
Q ss_pred ccCCCcee---eec--ccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 855 LHKNETVS---MVA--GSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 855 ~~~~~~~~---~~~--gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
........ ... .+..|+|||+.....++.++||||||+++||+++ |..||..... .+...++ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i----~~~~-- 228 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAI----EQDY-- 228 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHH----HcCC--
Confidence 43222111 111 1357999999988889999999999999999887 9999864221 1222222 1111
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
.......+ ...+.+++.+|++.+|++||++.++++.|+.+
T Consensus 229 ----~~~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ----RLPPPMDC------PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----cCCCcccC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00001111 12456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=315.26 Aligned_cols=267 Identities=24% Similarity=0.356 Sum_probs=197.4
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||+|+||.||+|.+..+|+.||+|++............+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 36778899999999999999999999999999865543333445667899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
++ ++|.+++..... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCNG---DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 578887754322 278899999999999999999998 99999999999999999999999999997654333
Q ss_pred CceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc-----cccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK-----AQDEAL 932 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 932 (1009)
.......+++.|+|||++.+. .++.++|||||||++|||++|+.|+......... .+.+........ ......
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH-HHHHHHHhCCCChHHhHHhhhcc
Confidence 333345678899999987654 4689999999999999999999997532221111 111111100000 000000
Q ss_pred C----ccccccCc---hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 933 D----PSIAGQCK---HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 933 ~----~~~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+ +....... .......++.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 00000000 00011234567899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.75 Aligned_cols=254 Identities=26% Similarity=0.334 Sum_probs=202.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||.|+||.||+|.+..+++.+|+|.+..... ...+.+.+|++++++++||||+++++++.++...++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 467888899999999999999988889999999865432 245667799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++.... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 81 YCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 999999999986542 1278889999999999999999998 9999999999999999999999999999766443
Q ss_pred CCceeeecccCcccCCcccCCC---CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTL---KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
........++..|+|||..... .++.++||||||+++|||++|+.||..... ........... ...+
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~-----~~~~~~~~~~~-----~~~~ 224 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP-----MRALFLISKSN-----FPPP 224 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcc-----CCCc
Confidence 3333445688899999998766 788999999999999999999999974221 11111111110 0001
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
... .......++.+++.+|+..+|.+||++.+++.
T Consensus 225 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLK----DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc----chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111 11122345678999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=314.90 Aligned_cols=259 Identities=24% Similarity=0.402 Sum_probs=200.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCe----EEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHM----VVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
+.|+..+.||+|+||.||+|.+..++. .||+|.+.... .......+.+|+.++++++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456778899999999999999876664 57888875432 233344567999999999999999999998754 467
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+|+||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999875432 278888999999999999999998 999999999999999999999999999987
Q ss_pred cccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 854 MLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
....... .....++..|+|||+..+..++.++||||||+++|||++ |+.||.... ...... ....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~----~~~~~~~--- 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPD----LLEKGER--- 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHH----HHHCCCC---
Confidence 6433221 112334678999999888889999999999999999998 899986321 111222 2221111
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
... ...+ ...+..++.+|+..+|++||+++|+++.|+++....
T Consensus 230 ~~~---~~~~------~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 230 LPQ---PPIC------TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCC---CCCC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 000 0111 124667889999999999999999999999976443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.55 Aligned_cols=262 Identities=28% Similarity=0.368 Sum_probs=196.7
Q ss_pred hcCCcCceeccCCceEEEEEEE----CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc--CCe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEF----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN--ETN 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~ 771 (1009)
+.|+..+.||+|+||.||+|.. ..+++.||+|++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 3577888999999999999974 346789999998543 23334566799999999999999999998743 346
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence 8999999999999999965432 278899999999999999999998 9999999999999999999999999999
Q ss_pred eecccCCCce---eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCC----------ccHHHHH
Q 037197 852 RMMLHKNETV---SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS----------KDIVEWV 918 (1009)
Q Consensus 852 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~----------~~~~~~~ 918 (1009)
+......... ....++..|+|||+..+..++.++||||||+++|||++|..|+....... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 8764332211 11123446999999888889999999999999999999887654211000 0000001
Q ss_pred HHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 919 LSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
........ ..... .. ...++.+++.+|++.+|++|||+.|+++.|+.++
T Consensus 236 ~~~~~~~~------~~~~~---~~---~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 236 IELLKNNG------RLPAP---PG---CPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHHHhcCC------cCCCC---CC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 11111100 00000 11 1134678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=325.88 Aligned_cols=201 Identities=23% Similarity=0.355 Sum_probs=173.5
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+..+.||+|+||.||+|....+++.||+|++..... .......+.+|++++.+++||+|+++++++.+++..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 47788999999999999999999999999999864321 22334556689999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 82 FLPGGDMMTLLMKKDT----LSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred CCCCccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999975432 78888889999999999999998 9999999999999999999999999998754221
Q ss_pred CC-----------------------------------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCC
Q 037197 858 NE-----------------------------------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKM 902 (1009)
Q Consensus 858 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~ 902 (1009)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 0113468999999999998899999999999999999999999
Q ss_pred CCCC
Q 037197 903 PLDP 906 (1009)
Q Consensus 903 Pf~~ 906 (1009)
||..
T Consensus 235 Pf~~ 238 (360)
T cd05627 235 PFCS 238 (360)
T ss_pred CCCC
Confidence 9974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.00 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=201.8
Q ss_pred ceeccCCceEEEEEEECCC---CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccC
Q 037197 704 NIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMP 780 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~ 780 (1009)
+.||+|+||.||+|..... +..||+|.+....... ..+.+.+|++.++.++|+|++++++++.++...++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 4689999999999999866 8899999996553322 45677799999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccc-----cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 781 NDSLGEALHGKEAG-----KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 781 ~gsL~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
+++|.+++...... ...+++.+++.++.|+++|++|||+. +++||||||+||++++++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999775221 23489999999999999999999998 99999999999999999999999999998765
Q ss_pred cCC--CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 856 HKN--ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 856 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
... .......+++.|+|||......++.++||||+|+++|||++ |..||... ........ ...+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~-~~~~~------ 224 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-----SNEEVLEY-LRKGY------ 224 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH-HHcCC------
Confidence 433 22334457789999999888889999999999999999999 69999743 11122211 11111
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
........ ..++.+++.+|++.+|++||++.|+++.|+
T Consensus 225 ~~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 RLPKPEYC------PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCccC------ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11111111 235677889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=320.23 Aligned_cols=262 Identities=26% Similarity=0.363 Sum_probs=200.4
Q ss_pred hcCCcCceeccCCceEEEEEEEC-----CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEc-CC
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHN-ET 770 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~-~~ 770 (1009)
++|+..+.||+|+||.||+|.+. .+++.||||+++... .......+.+|++++.++ +||||+++++++.. +.
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46889999999999999999843 457899999996532 233345677999999999 68999999998765 45
Q ss_pred eEEEEEeccCCCChhhhhcCCccc--------------------------------------------------------
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAG-------------------------------------------------------- 794 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 794 (1009)
..++||||+++|+|.++++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 679999999999999998643210
Q ss_pred -------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC--ceeeec
Q 037197 795 -------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE--TVSMVA 865 (1009)
Q Consensus 795 -------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~--~~~~~~ 865 (1009)
...+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12367888899999999999999998 999999999999999999999999999976533221 111233
Q ss_pred ccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHH
Q 037197 866 GSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQ 944 (1009)
Q Consensus 866 gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1009)
+++.|+|||......++.++||||||+++|||++ |..||...... .........+.. ...+.. .
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~~~~---~~~~~~---~---- 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCRRLKEGTR---MRAPDY---T---- 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-----HHHHHHHhccCC---CCCCCC---C----
Confidence 4668999999888889999999999999999997 99998643211 111111221110 001111 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 945 EEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 945 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
..++.+++.+|++.+|++||++.|+++.|+.+..
T Consensus 308 --~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 --TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1246678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.10 Aligned_cols=262 Identities=27% Similarity=0.409 Sum_probs=202.9
Q ss_pred cCCcCceeccCCceEEEEEEECC----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc--CCeE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHR----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN--ETNV 772 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~ 772 (1009)
.|+..+.||+|+||.||+|.+.. ++..||||++...... .....+.+|++++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46777899999999999998653 4789999999655332 345667799999999999999999999877 5678
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++++|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999976542 378999999999999999999998 99999999999999999999999999998
Q ss_pred ecccCCCcee---eecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCc---------cHHHHHHH
Q 037197 853 MMLHKNETVS---MVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSK---------DIVEWVLS 920 (1009)
Q Consensus 853 ~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~---------~~~~~~~~ 920 (1009)
.......... ...++..|+|||......++.++||||||+++|||++|+.|+........ .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 7643322111 12345579999998888899999999999999999999999864322110 01111111
Q ss_pred HHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 921 MIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
....... ......+ ..++.+++.+|++.+|++||++.|++++|+.+.
T Consensus 238 ~~~~~~~------~~~~~~~------~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 238 LLKEGER------LPRPPSC------PDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHcCCc------CCCCccC------CHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1111110 0000111 135678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.70 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=202.0
Q ss_pred CCcCceeccCCceEEEEEEECC-CCeEEEEEEcccCC--------CChhhHHHHHHHHHHHhc-cCCCceeeEEeEEEcC
Q 037197 700 VKESNIIGMGGNGIVYKAEFHR-PHMVVAVKKLWRSD--------NDIESGDDLFREVSLLGR-LRHRNIVRLLGYLHNE 769 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~Hpniv~l~~~~~~~ 769 (1009)
|+..+.||+|+||.||+|.+.. .++.+|+|.+.... .......++.+|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 6777889999999999999987 67899999885432 122234456688888765 7999999999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH-DCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
+..++||||+++++|.+++.........+++..+++++.|++.|+.|||+ . +++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999885433333448889999999999999999996 4 8999999999999999999999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
|.+....... ......++..|+|||+..+..++.++||||||+++|||++|+.||... +.............
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~~~-- 230 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NMLSLATKIVEAVY-- 230 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CHHHHHHHHhhccC--
Confidence 9998754433 334456888999999998888999999999999999999999998632 22222222111111
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
.+..... ....+.+++.+|++.||++||++.|+.+++++
T Consensus 231 ----~~~~~~~------~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 ----EPLPEGM------YSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ----CcCCccc------CCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1111101 11346678889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=314.29 Aligned_cols=263 Identities=25% Similarity=0.386 Sum_probs=204.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECC-------CCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEc
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR-------PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHN 768 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~ 768 (1009)
.++|...+.||+|+||.||+|.+.. +...||+|.+.... ......++.+|+++++++ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3568889999999999999998643 23579999986432 233445677899999999 79999999999999
Q ss_pred CCeEEEEEeccCCCChhhhhcCCccc------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEE
Q 037197 769 ETNVMMVYDYMPNDSLGEALHGKEAG------------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNIL 836 (1009)
Q Consensus 769 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIl 836 (1009)
.+..++||||+++|+|.+++...... ...+++.++.+++.|++.||+|||+. +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 99999999999999999999764321 12478899999999999999999998 9999999999999
Q ss_pred eCCCCcEEEcccccceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 037197 837 LDANLEARIADFGLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKD 913 (1009)
Q Consensus 837 l~~~~~~kl~DfGls~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~ 913 (1009)
+++++.+||+|||.++........ .....+++.|+|||+..+..++.++|||||||++|||++ |..||... .
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-----~ 247 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-----P 247 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-----C
Confidence 999999999999998765332211 111223468999999888889999999999999999998 88888632 1
Q ss_pred HHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 914 IVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
..+ +......... ....... ..++.+++.+|++.+|++||++.|+++.|+++.+.
T Consensus 248 ~~~-~~~~~~~~~~------~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 VEE-LFKLLKEGHR------MDKPSNC------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHH-HHHHHHcCCC------CCCCCcC------CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 112 2222222210 0111111 12566788999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=316.77 Aligned_cols=200 Identities=22% Similarity=0.282 Sum_probs=167.2
Q ss_pred cCceeccC--CceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 702 ESNIIGMG--GNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 702 ~~~~iG~G--~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
..++||+| +||+||++..+.+++.||+|++............+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34679999 7889999999999999999999655443444455668999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
++|+|.+++...... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFMD--GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999999654322 278889999999999999999998 999999999999999999999999986543322111
Q ss_pred -------ceeeecccCcccCCcccCC--CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 860 -------TVSMVAGSYGYIAPEYGYT--LKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 860 -------~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
......++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 1122346678999999765 4588999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=315.22 Aligned_cols=266 Identities=24% Similarity=0.375 Sum_probs=200.6
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
.|+..+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 57788999999999999999998899999999866544443455677999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
++++++.++...... +++.++..++.|+++|++|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~~----~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 82 VDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred CCccHHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999888754322 78999999999999999999998 99999999999999999999999999998764444
Q ss_pred CceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh-------cccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS-------NKAQDE 930 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 930 (1009)
.......++..|+|||+..+ ..++.++||||||+++|||++|+.||..... .+....+...... ......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCCchhhHHHhccch
Confidence 33344567889999998764 4477899999999999999999999863211 0100000000000 000000
Q ss_pred ----ccCccccccCc---hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ----ALDPSIAGQCK---HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ----~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+....... ........+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000000 00011235778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=308.50 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=201.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
.++|+..+.||+|+||.||+|..++ .+..||+|.+.... .......+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678899999999999999997652 35689999885442 23334556789999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCcc------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEE
Q 037197 772 VMMVYDYMPNDSLGEALHGKEA------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARI 845 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 845 (1009)
.++||||+++|+|.++++.... +....++..+.+++.|++.||+|||+. +|+||||||+||+++.++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999965321 123356777888999999999999998 9999999999999999999999
Q ss_pred cccccceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHH
Q 037197 846 ADFGLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 846 ~DfGls~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
+|||+++........ .....++..|+|||......++.++|||||||++|||++ |..||..... .+......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLKFVM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH
Confidence 999998765332211 122234678999999888889999999999999999998 7888864221 12111111
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
..+. ....... ...+.+++.+|++.||++||++.|+++.|.+..
T Consensus 236 ~~~~-------~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 DGGY-------LDQPDNC------PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred cCCC-------CCCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111 0111111 135678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.07 Aligned_cols=250 Identities=28% Similarity=0.402 Sum_probs=197.0
Q ss_pred ceeccCCceEEEEEEECC-CC--eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccC
Q 037197 704 NIIGMGGNGIVYKAEFHR-PH--MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMP 780 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~ 780 (1009)
+.||+|++|.||+|.+.. .+ ..||+|.+...... ...+.+.+|++++++++||||+++++++.+ ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999998765 23 36999998655433 455677799999999999999999999988 88999999999
Q ss_pred CCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCc
Q 037197 781 NDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860 (1009)
Q Consensus 781 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~ 860 (1009)
+++|.+++..... ..+++...+.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 79 LGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 9999999976542 3378999999999999999999998 9999999999999999999999999999876443221
Q ss_pred ---eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 861 ---VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 861 ---~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.....++..|+|||+.....++.++||||||+++|||++ |+.||.... ..+.......... ... .
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~~---~~~---~ 222 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-----GSQILKKIDKEGE---RLE---R 222 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHhcCC---cCC---C
Confidence 112346778999999888889999999999999999999 999996321 1122221111110 000 1
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
... ....+.+++.+|++.+|++||++.|+++.|.+
T Consensus 223 ~~~------~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 223 PEA------CPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred Ccc------CCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 111 11246678899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.96 Aligned_cols=258 Identities=28% Similarity=0.475 Sum_probs=200.8
Q ss_pred hcCCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNV 772 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 772 (1009)
++|+..+.||+|+||.||+|.+.. ++..||+|++.... ......++.+|++++++++||||+++++++.++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888899999999999998753 57899999986432 233345677899999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhcCCcc------------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCc
Q 037197 773 MMVYDYMPNDSLGEALHGKEA------------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNN 834 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 834 (1009)
++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 999999999999999964321 122367888999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCC
Q 037197 835 ILLDANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGS 911 (1009)
Q Consensus 835 Ill~~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~ 911 (1009)
|++++++.++|+|||++........ .......+..|+|||......++.++|||||||++|||++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~---- 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM---- 236 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----
Confidence 9999999999999999876533221 1122234567999999888889999999999999999998 88888532
Q ss_pred ccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 912 KDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
...+... .+..+.. . ...... ..++.+++.+|++.+|++||++.|+++.|++
T Consensus 237 -~~~~~~~-~~~~~~~----~--~~~~~~------~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 -AHEEVIY-YVRDGNV----L--SCPDNC------PLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -CHHHHHH-HHhcCCC----C--CCCCCC------CHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1122222 2222211 0 011111 1346778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=325.47 Aligned_cols=261 Identities=20% Similarity=0.215 Sum_probs=196.2
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
..|...+.||+|+||.||+|.+..+++.||||.... ....+|++++++++||||+++++++..++..++|||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468888999999999999999999999999996421 234589999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
++. ++|.+++..... .+++.+++.|+.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 241 ~~~-~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 994 788888764322 389999999999999999999998 9999999999999999999999999999865332
Q ss_pred CC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCC--CCccHHHHHHHHHhhccccccccC
Q 037197 858 NE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFG--GSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 858 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..|+-.... ........+...+.........+.
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 21 12235689999999999988999999999999999999998876532211 111111222222222111000000
Q ss_pred cc--------------------ccc-cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 PS--------------------IAG-QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~~--------------------~~~-~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+. ... ...........+.+++.+|++.||.+|||+.|+++
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 000 00000011124667999999999999999999985
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=318.67 Aligned_cols=202 Identities=26% Similarity=0.308 Sum_probs=172.1
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+..+.||+|+||.||++++..+++.||+|++.+... .....+.+.+|+.+++.++|+||+++++++.++++.++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 57888999999999999999999999999999864321 12233456689999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 82 YYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred cCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999965321 267888888999999999999998 9999999999999999999999999998765433
Q ss_pred CC-ceeeecccCcccCCcccCC-----CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 858 NE-TVSMVAGSYGYIAPEYGYT-----LKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 858 ~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
.. ......||+.|+|||++.. ..++.++||||+||++|||++|+.||..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 32 2233568999999998752 4578899999999999999999999963
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=310.19 Aligned_cols=249 Identities=29% Similarity=0.407 Sum_probs=202.4
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|++++++++|||++++++++.++...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 5777888999999999999999999999999986543 233345667899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.++++.. .+++..++.++.|++.|++|||+. +++||||+|+||++++++.++++|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999999754 378899999999999999999998 99999999999999999999999999998775443
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
.......+++.|+|||+..+..++.++||||||+++|||++|+.||..... ...... +... ..+.+..
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-----~~~~~~-~~~~------~~~~~~~ 220 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-----MRVLFL-IPKN------NPPSLEG 220 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-----HHHHHH-hhhc------CCCCCcc
Confidence 334455688899999998888899999999999999999999999964321 111111 1111 1111111
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. . ....+.+++.+|+..+|++||+++++++
T Consensus 221 ~--~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 N--K---FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c--c---cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1 0 1123567888999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.12 Aligned_cols=250 Identities=26% Similarity=0.430 Sum_probs=200.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||+|... ++.||+|.+.... ...+++.+|+.++++++|+||+++++++.+....++|||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 45778889999999999999876 6789999995542 245677899999999999999999999998999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.++++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.++.....
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 81 YMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 9999999999975432 2378999999999999999999998 9999999999999999999999999999866322
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.. ....+..|+|||+.....++.++||||||+++||+++ |+.||.... ...+......+. ....
T Consensus 156 ~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~~~~------~~~~ 220 (256)
T cd05039 156 QD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPHVEKGY------RMEA 220 (256)
T ss_pred cc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHhcCC------CCCC
Confidence 11 2334568999999888889999999999999999997 999986321 111222222211 0111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
.... ...+.+++.+|++.+|++||++.|++++|+.+
T Consensus 221 ~~~~------~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 PEGC------PPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ccCC------CHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1111 13466788999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.01 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=200.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||.|+||.||+|.+..++..||+|.+... .....+.+.+|++++++++||||+++++++..+...++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 35678888899999999999999888999999998543 2344556779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++..... .+++..+..++.|++.|+.|||+. +|+|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 82 EFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 99999999999865432 378889999999999999999999 999999999999999999999999999876544
Q ss_pred CCCceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
.........+++.|+|||... ...++.++||||||+++|||++|+.||.... ..+.+........
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~----- 225 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-----PMRVLLKILKSEP----- 225 (280)
T ss_pred cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC-----HHHHHHHHhcCCC-----
Confidence 333344566899999999863 3456789999999999999999999997431 1222222211110
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.+.. ... ....+.+++.+|++.+|++||++.++++
T Consensus 226 --~~~~~-~~~---~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 --PTLDQ-PSK---WSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred --CCcCC-ccc---CCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 11100 000 1124567888999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.75 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=204.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||+||+|.+..+++.||+|++.... .......+.+|+++++.++||||+++++++.....+++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 45777889999999999999999889999999885432 23345677799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++.... .+++..+..++.+++.|+.|||+.+ +++||||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999986543 2788888999999999999999732 8999999999999999999999999998654222
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCC------ccHHHHHHHHHhhccccccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS------KDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 931 (1009)
. .....++..|+|||++....++.++|||||||++|++++|+.||....... ..+..++.......
T Consensus 158 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (284)
T cd06620 158 I--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------ 229 (284)
T ss_pred c--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence 1 223568899999999888889999999999999999999999997533211 11222322222111
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
.+.+.. .+....+.+++.+|++.||++||++.|+++..--+
T Consensus 230 -~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 230 -PPRLPS-----SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred -CCCCCc-----hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 111110 01123466788999999999999999999874433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=317.44 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=203.2
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+-|.++.-||.|+||.||||..+.++...|.|++... ..+..++++-|+++|..++||+||++++.|..++.+|+..|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 3455667799999999999999998888888988433 34557788899999999999999999999888899999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
||.||-++..+-.-. ..+++.++..+++|++.||.|||++ .|||||||+.|||++-+|.++++|||.+......
T Consensus 110 FC~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred ecCCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH
Confidence 999999988764432 2378888888999999999999999 9999999999999999999999999998665444
Q ss_pred CCceeeecccCcccCCcc-----cCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 858 NETVSMVAGSYGYIAPEY-----GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~-----~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
-.....+.|||.|||||+ ....+|+.++||||||+++.||..+.+|.... ...+.+....+...
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-----npMRVllKiaKSeP------ 252 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIAKSEP------ 252 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-----chHHHHHHHhhcCC------
Confidence 455667899999999997 44778999999999999999999999997633 33333333333221
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
|.+. ...+ ....+.++..+|+..+|..||+++++++
T Consensus 253 -PTLl-qPS~---Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 253 -PTLL-QPSH---WSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -Cccc-Ccch---hhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1221 1222 2334667888999999999999988763
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.85 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=194.0
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDS 783 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gs 783 (1009)
++||+|+||.||+|...+ +..||+|.+.... .......+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD-KTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecC-CcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 368999999999998764 7889999985432 23334466799999999999999999999999999999999999999
Q ss_pred hhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCc-ee
Q 037197 784 LGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET-VS 862 (1009)
Q Consensus 784 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~-~~ 862 (1009)
|.+++..... .+++..++.++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||++......... ..
T Consensus 79 L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 79 FLSFLRKKKD---ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 9999865432 268899999999999999999998 9999999999999999999999999998754322211 11
Q ss_pred eecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 863 MVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 863 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
...+++.|+|||+.....++.++||||||+++||+++ |..||.... ... ....+.... ........
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~-----~~~-~~~~~~~~~------~~~~~~~~- 219 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT-----NQQ-AREQVEKGY------RMSCPQKC- 219 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC-----HHH-HHHHHHcCC------CCCCCCCC-
Confidence 2234567999999888889999999999999999998 999986321 111 111221111 11111111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
...+.+++.+|++.+|++||++.|++++|.
T Consensus 220 -----~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 -----PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -----CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 135677899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.03 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=189.7
Q ss_pred eeccCCceEEEEEEECC--CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 705 IIGMGGNGIVYKAEFHR--PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 705 ~iG~G~~g~Vyk~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
.||+|+||.||+|.... ++..+|+|.++.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999998653 456799998865432 233346778999999999999999999999999999999999999
Q ss_pred ChhhhhcCCcc-ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC--
Q 037197 783 SLGEALHGKEA-GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE-- 859 (1009)
Q Consensus 783 sL~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~-- 859 (1009)
+|.++++.... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 223356777788999999999999998 999999999999999999999999999875432221
Q ss_pred ceeeecccCcccCCcccCCC-------CCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 860 TVSMVAGSYGYIAPEYGYTL-------KVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
......+++.|+|||+.... .++.++||||||+++|||++ |+.||...... +.... ..... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~~~---~~~~~--~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--QVLTY---TVREQ--QLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--HHHHH---Hhhcc--cCCC
Confidence 11224567889999986532 35789999999999999996 99999643221 11111 11111 1122
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
.++.+..... ..+.+++.+|+ .+|++||++.||++.|+
T Consensus 231 ~~~~~~~~~~------~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLPLS------DRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCCCC------hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222221111 13456778998 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.22 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=200.1
Q ss_pred cCCcCceeccCCceEEEEEEE----CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC--CeE
Q 037197 699 CVKESNIIGMGGNGIVYKAEF----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE--TNV 772 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~ 772 (1009)
-|+..+.||+|+||.||++.. ..++..||+|.+.... .......+.+|++++++++|||++++++++.+. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 367888999999999999974 3567899999985432 234456677999999999999999999998775 568
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 999999999999999865422 378899999999999999999998 99999999999999999999999999998
Q ss_pred ecccCCCc---eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCC----------CCccHHHHHH
Q 037197 853 MMLHKNET---VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFG----------GSKDIVEWVL 919 (1009)
Q Consensus 853 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~----------~~~~~~~~~~ 919 (1009)
........ .....++..|+|||+..+..++.++||||||+++|||++++.|+..... +......++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76433221 1223456689999998888899999999999999999998776532110 1111111211
Q ss_pred HHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 920 SMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
....+.. ...... ....+.+++.+|++.+|++||++.++++.++++
T Consensus 238 -~~~~~~~------~~~~~~------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 -VLEEGKR------LPRPPN------CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHHcCcc------CCCCCC------CCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111110 000111 123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.12 Aligned_cols=258 Identities=24% Similarity=0.406 Sum_probs=202.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCe----EEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHM----VVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.+|+..+.||+|+||.||+|.+..++. .||+|.+..... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 457788999999999999999876554 589998855432 3345667799999999999999999999987 7889
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++|+|.++++.... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999976432 278899999999999999999998 999999999999999999999999999987
Q ss_pred cccCCCcee--eecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 854 MLHKNETVS--MVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
......... ...++..|+|||......++.++|+||||+++||+++ |+.||.... ..++ ...+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~-~~~~~~~~~--- 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-----AVEI-PDLLEKGER--- 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-----HHHH-HHHHhCCCC---
Confidence 643322111 1223568999999888889999999999999999999 999997431 1122 222222110
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
...+. .+ ...+..++.+|+..+|++||++.++++.|.++...
T Consensus 230 ~~~~~---~~------~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 230 LPQPP---IC------TIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCC---CC------CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00011 11 12456788999999999999999999999998553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.15 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=208.5
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccC
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMP 780 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~ 780 (1009)
.....||-|.||.||.|.|+.....||||.++. +....++|++|+.+|+.++|||+|+++|+|..+..+|||+|||.
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 456689999999999999999999999999943 35667889999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCc
Q 037197 781 NDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860 (1009)
Q Consensus 781 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~ 860 (1009)
+|+|.||++.... ..++....+.++.||+.|++||..+ .+|||||..+|+|+.++..|||+|||+++.+..+..
T Consensus 347 yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY- 420 (1157)
T KOG4278|consen 347 YGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY- 420 (1157)
T ss_pred CccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCce-
Confidence 9999999987653 3366777788999999999999998 999999999999999999999999999998854432
Q ss_pred eeeecc---cCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 861 VSMVAG---SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 861 ~~~~~g---t~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
+...| ...|.|||-+.-..++.|+|||+|||++||+.| |-.||.. .++ ..|...+..+... .-
T Consensus 421 -TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-----idl-SqVY~LLEkgyRM------~~ 487 (1157)
T KOG4278|consen 421 -TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-----IDL-SQVYGLLEKGYRM------DG 487 (1157)
T ss_pred -ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-----ccH-HHHHHHHhccccc------cC
Confidence 22333 458999998888889999999999999999999 7788862 222 2333444333211 11
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
...|+ .++.++++.||+.+|.+||+++|+-+.++.+...
T Consensus 488 PeGCP------pkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 488 PEGCP------PKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred CCCCC------HHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 11222 2466788999999999999999999999987653
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=307.87 Aligned_cols=256 Identities=29% Similarity=0.409 Sum_probs=198.7
Q ss_pred cCCcCceeccCCceEEEEEEEC-----CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
+|...+.||+|+||.||++... .++..||+|.+... .......+.+|++++++++||||+++++++.+....+
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 4667788999999999999743 34678999988543 2334556779999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccc-----------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc
Q 037197 774 MVYDYMPNDSLGEALHGKEAG-----------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE 842 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 842 (1009)
+||||+++++|.++++..... ...+++..++.++.|++.|++|||+. +++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 999999999999999754321 12378899999999999999999998 9999999999999999999
Q ss_pred EEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHH
Q 037197 843 ARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVL 919 (1009)
Q Consensus 843 ~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 919 (1009)
+||+|||++........ ......+++.|+|||+.....++.++|||||||++|||++ |+.||..... ...+.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~ 235 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-----TEAIE 235 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-----HHHHH
Confidence 99999999976533221 1122334678999999888889999999999999999998 9999863221 11121
Q ss_pred HHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 920 SMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
... .+.. ... ...+ . ..+.+++.+||+.||++||++.|+++.|++
T Consensus 236 ~~~-~~~~---~~~---~~~~---~---~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CIT-QGRE---LER---PRTC---P---PEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHH-cCcc---CCC---CCCC---C---HHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111 1110 001 1111 1 235678899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.00 Aligned_cols=263 Identities=25% Similarity=0.341 Sum_probs=197.6
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
|+..+.||.|++|.||+|++..+++.||||++............+.+|++++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 67788999999999999999988999999998654433344456779999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
. ++|.+++..... ..+++..+..++.|+++|++|||+. +++||||+|+||+++.++.+|++|||++........
T Consensus 82 ~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 82 H-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred c-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 5 689988865432 2378889999999999999999998 999999999999999999999999999876543333
Q ss_pred ceeeecccCcccCCcccCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc---
Q 037197 860 TVSMVAGSYGYIAPEYGYTLK-VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS--- 935 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 935 (1009)
......+++.|+|||+..+.. ++.++||||||+++|||+||+.||.... ....................+.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-----EIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHHhCCCChhhhhhhhH
Confidence 333445678999999876544 5889999999999999999999996321 1111111111111000000000
Q ss_pred -------cc----ccCchH-HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 -------IA----GQCKHV-QEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 -------~~----~~~~~~-~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+. ...... ......+.+++.+|++.||++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 000000 001123567899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=302.67 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=191.3
Q ss_pred ceeccCCceEEEEEEECC---CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEE-cCCeEEEEEecc
Q 037197 704 NIIGMGGNGIVYKAEFHR---PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLH-NETNVMMVYDYM 779 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~-~~~~~~lV~E~~ 779 (1009)
+.||+|+||.||+|.+.. ....||+|++... ......+.+.+|+.+++.++||||+++++++. .+...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 368999999999998643 3467999987432 22344566779999999999999999999775 455689999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
.+++|.++++.... ..++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 80 KHGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 99999999975432 256677788999999999999998 999999999999999999999999999976533221
Q ss_pred ----ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhC-CCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 860 ----TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTG-KMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 860 ----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
......+++.|+|||+.....++.++||||||+++|||++| .+||... +........ ..+. .+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~~~~~~~~~-~~~~------~~ 221 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDITVYL-LQGR------RL 221 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH-hcCC------CC
Confidence 11123456789999998888899999999999999999995 5556422 112222211 1111 01
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
...... ...+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 222 ~~~~~~------~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 LQPEYC------PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCcC------CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 111111 1246678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=310.23 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=198.3
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcC----
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNE---- 769 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~---- 769 (1009)
++.++|+..+.||+|+||.||+|....+++.||+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 34677999999999999999999999889999999985432 2234556899999998 899999999998653
Q ss_pred -CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 770 -TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 770 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
+..++||||+++++|.++++........+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeec
Confidence 358999999999999999865333333478899999999999999999998 9999999999999999999999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCCC-----CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYTL-----KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
|++..............++..|+|||+.... .++.++|||||||++|||++|+.||..... ...+....
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-----~~~~~~~~- 246 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-----VKTLFKIP- 246 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-----HHHHHHHh-
Confidence 9987654333223345678899999986433 368899999999999999999999964221 11111111
Q ss_pred hccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
... .....++ .+....+..++.+|++.+|++||++.|+++
T Consensus 247 ~~~-~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 RNP-PPTLLHP---------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cCC-CCCCCcc---------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110 0111111 111234678899999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=303.23 Aligned_cols=249 Identities=28% Similarity=0.407 Sum_probs=197.8
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChh-------hHHHHHHHHHHHhccCCCceeeEEeEEEcCCeE
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE-------SGDDLFREVSLLGRLRHRNIVRLLGYLHNETNV 772 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 772 (1009)
|...+.||+|++|.||+|.+..+++.||+|.+........ ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 6677899999999999999988899999998865432211 124456899999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
++||||+++++|.+++..... +++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGA----FEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHhccC----ccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999965432 68888889999999999999998 99999999999999999999999999988
Q ss_pred ecccCCC------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 853 MMLHKNE------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 853 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
....... ......+++.|+|||...+..++.++||||+|+++|+|++|+.||..... ...+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~--- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-----LQAIFKIGE--- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-----HHHHHHHhc---
Confidence 7642211 11234578899999998888889999999999999999999999974211 111111111
Q ss_pred ccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+.+.... ...+..++.+|++.||++||++.|+++
T Consensus 227 ----~~~~~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ----NASPEIPSNI------SSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----cCCCcCCccc------CHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111221111 124567888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=309.78 Aligned_cols=263 Identities=22% Similarity=0.313 Sum_probs=196.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|++|.||+|..+.+++.||+|.+..... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 567888999999999999999998899999999865422 2223445689999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|++ ++|.+++..... .+++.....++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLD-TDLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCC-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 997 489998865432 378888899999999999999998 9999999999999999999999999998754332
Q ss_pred CCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc-ccccc---
Q 037197 858 NETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA-QDEAL--- 932 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--- 932 (1009)
........++..|+|||+..+ ..++.++||||+|+++|||++|+.||...... .+.+......-.. ..+..
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV----EDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH----HHHHHHHHHhcCCCChhhhhhh
Confidence 222233346789999998765 45789999999999999999999999643211 1111111100000 00000
Q ss_pred ---------------CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 933 ---------------DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 933 ---------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+...... ......+.+++.+|++.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPR-LDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcC-CCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000 011145678999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=307.35 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=204.2
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
.|+..+.||+|++|.||+|.++.+++.||+|.+..... .....++.+|++++++++||||+++++++..+...++|+||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46677789999999999999998899999999865432 34456677999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH-DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
+++++|.+++.... ..+++.....++.|+++|++|||+ . +++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999997543 237888888999999999999999 7 9999999999999999999999999998765332
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
... ...++..|+|||+..+..++.++||||||+++|+|++|+.||...........+.+........ +...
T Consensus 155 ~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~ 225 (265)
T cd06605 155 LAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-------PRLP 225 (265)
T ss_pred Hhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-------CCCC
Confidence 221 2668889999999988899999999999999999999999997543332333333333222111 1111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.. ....++.+++.+|+..+|++||++.|++.
T Consensus 226 ~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 SG-----KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hh-----hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 10 01234667889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=319.09 Aligned_cols=191 Identities=26% Similarity=0.297 Sum_probs=164.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
..|+..+.||+|+||.||+|.+..+++.||+|..... ....|+.++++++||||+++++++..+...++|||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4688999999999999999999998999999985322 23469999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+ .++|.+++.... ..+++..+..|+.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 138 ~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~- 209 (357)
T PHA03209 138 HY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV- 209 (357)
T ss_pred cc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc-
Confidence 99 468888876432 2378999999999999999999998 999999999999999999999999999975322
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCC
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf 904 (1009)
........||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 22233456899999999998889999999999999999999855544
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.08 Aligned_cols=248 Identities=27% Similarity=0.425 Sum_probs=199.8
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccC--CCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe--EEEEE
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRS--DNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN--VMMVY 776 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~--~~lV~ 776 (1009)
+...+||+|+|-+||||.+..+|..||--.++.. ...+...+++..|+++|+.++||||+++|.+|.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3456899999999999999999999886433322 2345556888999999999999999999999987654 78899
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-CcEEEcccccceecc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN-LEARIADFGLARMML 855 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfGls~~~~ 855 (1009)
|.+..|+|..|.++.+. .+.....+|+.||++||.|||++ .|+|+|||||-+||+|+.+ |.|||+|.|+|+...
T Consensus 123 EL~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999987765 67788899999999999999998 7899999999999999764 899999999998763
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
. ...+...|||.|||||+.. ..|++..||||||+-++||+|+.+||.. ... .+.+.+.+..|.... .
T Consensus 198 ~--s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE----C~n-~AQIYKKV~SGiKP~-----s 264 (632)
T KOG0584|consen 198 K--SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE----CTN-PAQIYKKVTSGIKPA-----A 264 (632)
T ss_pred c--cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh----hCC-HHHHHHHHHcCCCHH-----H
Confidence 3 3344588999999999855 7899999999999999999999999972 222 344444444443111 1
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+. ... ..++.++|.+|+.. .++|||+.|++.
T Consensus 265 l~-kV~-----dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 265 LS-KVK-----DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hh-ccC-----CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 11 111 12466789999999 999999999985
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=321.45 Aligned_cols=239 Identities=24% Similarity=0.273 Sum_probs=184.9
Q ss_pred eccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc---CCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL---RHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 706 iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
||+|+||+||+|++..+++.||+|++.+... ..........|..++.+. +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999999999999999999854321 112233445677776665 699999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.+++..... +++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 81 g~L~~~l~~~~~----~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 81 GELFWHLQKEGR----FSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred ChHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence 999998865432 78889999999999999999998 99999999999999999999999999987643333344
Q ss_pred eeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccC
Q 037197 862 SMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQC 940 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
....||+.|+|||++.+. .++.++||||+||++|||++|+.||... +..+... .+..+.. ......+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-----~~~~~~~-~i~~~~~--~~~~~~~---- 221 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-----DTQQMYR-NIAFGKV--RFPKNVL---- 221 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-----CHHHHHH-HHHcCCC--CCCCccC----
Confidence 456799999999987654 4789999999999999999999999632 2222222 2221110 0000001
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHH
Q 037197 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMR 969 (1009)
Q Consensus 941 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 969 (1009)
...+..++.+|++.||++||++.
T Consensus 222 ------~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 222 ------SDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred ------CHHHHHHHHHHcCCCHHHCCCCC
Confidence 12345688899999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=302.05 Aligned_cols=254 Identities=28% Similarity=0.413 Sum_probs=201.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|...+ ++.||||.+.... ...+++.+|+.++++++||||+++++++..+...++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 4568888999999999999999875 5789999986432 23456779999999999999999999999989999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+.....
T Consensus 81 e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999976432 2378889999999999999999998 999999999999999999999999999976643
Q ss_pred CCC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 857 KNE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 857 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
... .......+..|+|||...+..++.++||||+|+++||+++ |+.||.... ......... .+. ..
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----~~~~~~~~~-~~~------~~ 223 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-----NREVLEQVE-RGY------RM 223 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH-cCC------CC
Confidence 221 1112234568999999988889999999999999999999 999986321 111111111 110 00
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
...... ...+.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 ~~~~~~------~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNC------PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCC------CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011111 1246678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=302.30 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=196.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|...+.||+|++|.||+|.+..+ ..||+|.+.... ...+.+.+|++++++++|||++++++++.. +..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence 4577788999999999999998774 468999875432 234567789999999999999999998854 56789999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.++++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 81 FMGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999999975432 2368889999999999999999998 9999999999999999999999999999765433
Q ss_pred CCc-eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NET-VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
... .....++..|+|||+.....++.++||||||+++|||++ |+.||..... .+.... ..... .+.
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~-~~~~~------~~~ 223 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-----REVLEQ-VERGY------RMP 223 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH-HHcCC------CCC
Confidence 221 122345678999999888889999999999999999999 8999864221 111111 11111 011
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
... .....+.+++.+|++.+|++||++.++++.|++
T Consensus 224 ~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQ------GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCc------ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111 112346678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=311.62 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=199.3
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.+.|.....||+|+||.||++....++..||||.+... .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 34455556799999999999999888999999998543 2334456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++... .+++.++..++.||+.|++|||+. +|+||||||+||++++++.++|+|||++.....
T Consensus 99 e~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 99 EFLEGGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred eCCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 999999999988543 267888999999999999999998 999999999999999999999999999876543
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.........+++.|+|||+.....++.++||||||+++|||++|+.||.... ....+.. +... ..+..
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~~~~-~~~~------~~~~~ 238 (292)
T cd06658 171 EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-----PLQAMRR-IRDN------LPPRV 238 (292)
T ss_pred ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHH-HHhc------CCCcc
Confidence 3333344568899999999888889999999999999999999999986321 1111111 1111 11111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
.... .....+..++.+|+..||++|||+.|+++.
T Consensus 239 ~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 KDSH----KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccc----ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1100 111235578889999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.53 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=203.0
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
.|+..+.||.|+||+||+|....++..||+|++....... ....+.+|++.++.++|+|++++++.+..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 5788899999999999999998889999999986543322 456777999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.++++.... ...+++.....++.|++.|++|||+. +++||||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975432 12378889999999999999999998 99999999999999999999999999997765443
Q ss_pred Cc----eeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 859 ET----VSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 859 ~~----~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
.. .....++..|+|||+.... .++.++||||||+++|||++|+.||...... +......... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~~-------~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-----KVLMLTLQND-------P 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-----hhHHHHhcCC-------C
Confidence 22 2334688899999987766 7889999999999999999999999743221 1111111111 0
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.+.... ........+.+++.+|++.||++||++.|+++
T Consensus 225 ~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGA-DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCcc-ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111000 00111234567889999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.38 Aligned_cols=259 Identities=23% Similarity=0.385 Sum_probs=201.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCC---CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
+.|+..+.||+|+||.||+|.+... ...||||...... .....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3467788999999999999987543 4578999885432 23445677799999999999999999999876 45789
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++++|.+++..... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999965432 378999999999999999999998 9999999999999999999999999999765
Q ss_pred ccCCC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 855 LHKNE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 855 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
..... ......+++.|+|||......++.++||||||+++||+++ |..||...... +...+ +..+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~----~~~~~------ 225 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGR----IENGE------ 225 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH----HHcCC------
Confidence 43321 1112234568999999888889999999999999999996 99999743221 11111 11111
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.......+ ...+.+++.+|+..+|++||++.++++.|+++....
T Consensus 226 ~~~~~~~~------~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 226 RLPMPPNC------PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred cCCCCCCC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 00111111 124667888999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=312.82 Aligned_cols=263 Identities=25% Similarity=0.391 Sum_probs=203.4
Q ss_pred hcCCcCceeccCCceEEEEEEEC-------CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcC
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFH-------RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNE 769 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 769 (1009)
++|+..+.||+|+||.||+|++. .....||+|.+.... .......+.+|+++++++ +||||+++++++.+.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 46788899999999999999763 235679999986432 234456677999999999 699999999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCcc------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEA------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL 837 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 837 (1009)
...++||||+++|+|.+++..... ....+++.++..++.|++.||+|||++ +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999965421 123478889999999999999999998 99999999999999
Q ss_pred CCCCcEEEcccccceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccH
Q 037197 838 DANLEARIADFGLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDI 914 (1009)
Q Consensus 838 ~~~~~~kl~DfGls~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~ 914 (1009)
++++.+||+|||.++........ .....+++.|+|||+.....++.++||||||+++|||++ |..||.... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-----~ 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-----V 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-----H
Confidence 99999999999999765432211 112234467999999888889999999999999999999 888986321 1
Q ss_pred HHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 915 VEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.... .....+.. ......+ ..++.+++.+|++.+|++||++.|+++.|.++....
T Consensus 243 ~~~~-~~~~~~~~------~~~~~~~------~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 243 EELF-KLLREGHR------MDKPSNC------THELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHH-HHHHcCCC------CCCCCCC------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1111 12221110 0111111 124567889999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=306.79 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=196.9
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|++.+.||+||.+.|||+...+ .+.||+|++.....+.....-+..|+..|.++ .|.+|+++++|-..+++.|+|||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 47888899999999999999877 56788887766667777788888999999999 49999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|= ..+|..+++.+.. ...+| .+..+..|++.|+.++|.+ ||||.||||.|+++- .|.+||+|||.|..+..+
T Consensus 441 ~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred cc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 54 7789999976643 22345 5566899999999999999 999999999999994 569999999999877544
Q ss_pred CC--ceeeecccCcccCCcccCCC-----------CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh
Q 037197 858 NE--TVSMVAGSYGYIAPEYGYTL-----------KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS 924 (1009)
Q Consensus 858 ~~--~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 924 (1009)
.. .....+||+-||+||.+... +++.+|||||+||++|+|+.|+.||.. +...+..+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-------~~n~~aKl--- 582 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-------IINQIAKL--- 582 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-------HHHHHHHH---
Confidence 32 33456899999999975532 356899999999999999999999972 22222222
Q ss_pred ccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 925 NKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+.+|.-...++...+.. ++++++..|++.||++||++.|+++
T Consensus 583 ----~aI~~P~~~Iefp~~~~~~-~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 583 ----HAITDPNHEIEFPDIPEND-ELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ----HhhcCCCccccccCCCCch-HHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2233332222222222221 2678999999999999999999974
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=303.24 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=193.9
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC---hhhHHHHHHHHHHHhccCCCceeeEEeEEEc--CCeEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND---IESGDDLFREVSLLGRLRHRNIVRLLGYLHN--ETNVM 773 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~~ 773 (1009)
.|+..+.||+|+||.||+|.+..++..||+|++...... ......+.+|++++++++||||+++++++.+ +...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 578889999999999999999988999999988644322 2234456689999999999999999998865 36789
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++++|.+++..... +++...+.++.|++.||+|||+. +|+||||+|+||+++.++.++|+|||++..
T Consensus 83 l~~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 99999999999999965432 67888889999999999999998 999999999999999999999999999876
Q ss_pred cccCC---CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 854 MLHKN---ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
..... .......++..|+|||+..+..++.++||||+||++|||++|+.||... +....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~-----~~~~~~~~~~~~~----- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY-----EAMAAIFKIATQP----- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc-----chHHHHHHHhcCC-----
Confidence 53211 1222345788999999998888999999999999999999999999742 1122222111111
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+.+.... ...+..++ +|+..+|++||+++|+++
T Consensus 226 -~~~~~~~~~------~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -TNPQLPSHI------SEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCCchhc------CHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 112221111 11233444 688899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=318.31 Aligned_cols=255 Identities=22% Similarity=0.235 Sum_probs=194.1
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+|+..+.||+|+||.||++++..+++.||+|++.+... .......+.+|..++..++|++|+++++++.+++..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 57888999999999999999999999999999854321 12223345588999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.++++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 82 y~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 82 YYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred CCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999975322 267888888999999999999998 9999999999999999999999999999876443
Q ss_pred CC-ceeeecccCcccCCcccCC-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 858 NE-TVSMVAGSYGYIAPEYGYT-----LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 858 ~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
.. ......|++.|+|||++.. ..++.++|||||||++|||++|+.||... +..+..........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~-----~~~~~~~~i~~~~~----- 225 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHEE----- 225 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC-----CHHHHHHHHHcCCC-----
Confidence 32 2234569999999998764 46788999999999999999999999632 22222222211110
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKG--RPTMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~ 973 (1009)
...+....... ..++.+++.+|+..++++ |++++++++
T Consensus 226 -~~~~p~~~~~~---~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 226 -RFQFPSHITDV---SEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -cccCCCccccC---CHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 00111111111 124556777888866544 467777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=306.78 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=201.2
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC--CeEEEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE--TNVMMVY 776 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~lV~ 776 (1009)
+|...+.||.|++|.||+|.+..+++.||+|.+..... .....++.+|++++++++||||+++++++.+. ...++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46778899999999999999998899999999865432 24456678999999999999999999988653 4689999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++.........+++.....++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998764332333478888899999999999999998 999999999999999999999999999875533
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
... ....++..|+|||...+..++.++||||+|+++|+|++|+.||+..........+...... ... ........
T Consensus 158 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~ 232 (287)
T cd06621 158 SLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMP--NPELKDEP 232 (287)
T ss_pred ccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCC--chhhccCC
Confidence 221 2345778999999988888999999999999999999999999754221111122211111 111 00111111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
... ......+.+++.+|++.+|++|||+.|+++
T Consensus 233 ~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 GNG----IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCC----CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 011235678999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=301.58 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=188.6
Q ss_pred eeccCCceEEEEEEECCC--CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 705 IIGMGGNGIVYKAEFHRP--HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 705 ~iG~G~~g~Vyk~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
.||+|+||.||+|..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 589999999999975442 3456677764432 2234567779999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC--Cc
Q 037197 783 SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN--ET 860 (1009)
Q Consensus 783 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~--~~ 860 (1009)
+|.++++.........++.....++.||++||+|||+. +++||||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976543333356777788999999999999998 99999999999999999999999999986432211 12
Q ss_pred eeeecccCcccCCcccCC-------CCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 861 VSMVAGSYGYIAPEYGYT-------LKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 861 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
.....++..|+|||+... ..++.++||||||+++|||++ |..||... ...+.+........ ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-----~~~~~~~~~~~~~~--~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL-----SDREVLNHVIKDQQ--VKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhhcc--cccC
Confidence 234557889999998642 345789999999999999997 56777532 11222222222211 2233
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
++.+...+. ..+.+++.+|+ .+|++||+++|+++.|.
T Consensus 231 ~~~~~~~~~------~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS------ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc------HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333332222 23456777899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=304.19 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=196.2
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
++.+.....||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|++++++++|+||+++++++..++..++||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 344555678999999999999999889999999885432 234456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC-CCcEEEcccccceecc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA-NLEARIADFGLARMML 855 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGls~~~~ 855 (1009)
||+++++|.++++..... ...++..+..++.|+++|++|||+. +|+||||||+||+++. ++.++|+|||.+....
T Consensus 85 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 85 EQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred ecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999754221 1137778888999999999999998 9999999999999986 6799999999987654
Q ss_pred cCCCceeeecccCcccCCcccCCC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTL--KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
..........+++.|+|||+.... .++.++||||||+++|+|++|+.||...... ....+..... . ..
T Consensus 161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~--~~~~~~~~~~--~------~~ 230 (268)
T cd06624 161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP--QAAMFKVGMF--K------IH 230 (268)
T ss_pred cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh--hhhHhhhhhh--c------cC
Confidence 333333344678999999987553 3788999999999999999999999643211 1111110000 0 11
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.+.... ..++..++.+|++.+|++||++.|+++
T Consensus 231 ~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 231 PEIPESL------SAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCCccc------CHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1111111 124567889999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=317.65 Aligned_cols=256 Identities=22% Similarity=0.247 Sum_probs=194.1
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+..+.||+|+||.||+++++.+++.||+|++.+... .......+.+|+.++..++|++|+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 57788999999999999999999999999999854221 12223345589999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.++++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 82 y~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 82 YYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred ccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999975322 267888888999999999999998 9999999999999999999999999999765433
Q ss_pred CC-ceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 858 NE-TVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 858 ~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||... +..+..........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-----~~~~~~~~i~~~~~----- 225 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHKE----- 225 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-----CHHHHHHHHhCCCc-----
Confidence 32 223457899999999875 345788999999999999999999999732 22233322221111
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKG--RPTMRDVITM 974 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~ 974 (1009)
...+........ ..+..++.+|+..++++ |+++.|+++-
T Consensus 226 -~~~~p~~~~~~s---~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 -RFQFPAQVTDVS---EDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -cccCCCccccCC---HHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 001111111111 23456777877655444 6888888755
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=311.23 Aligned_cols=265 Identities=27% Similarity=0.331 Sum_probs=198.1
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC--CeEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE--TNVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~l 774 (1009)
.+.|+..+.||+|+||.||+|.+..+++.||+|++..............+|++++++++|+|++++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4568889999999999999999999999999999865443333334556899999999999999999998755 56899
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||++ ++|.+++.... ..+++.++..++.|+++|++|||+. +++||||||+||+++.++.+||+|||.+...
T Consensus 86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 57888876532 2378899999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
...........+++.|+|||...+ ..++.++||||+|+++|||++|+.||.... ..+.+...............
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~-----~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS-----EIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCChhhc
Confidence 544333333445788999998764 457899999999999999999999997321 12222222111000000000
Q ss_pred c-----------ccccc-CchH----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 P-----------SIAGQ-CKHV----QEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~-----------~~~~~-~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+ .+... .... ......+..++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 00000 0000 001234567899999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=300.48 Aligned_cols=250 Identities=24% Similarity=0.425 Sum_probs=197.5
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
.|+..+.||+|+||.||+|.+.. +..+|+|.+..... ...++.+|++++++++|||++++++++......++||||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 46777889999999999998865 67899998854322 234677899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.++++.... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 81 MEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred CCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 999999999875432 267888899999999999999998 99999999999999999999999999987653322
Q ss_pred Cc-eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 859 ET-VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 859 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.. .....++.+|+|||+..+..++.++||||||+++|||++ |+.||.... ....+... ..+. ....+..
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~-~~~~---~~~~~~~ 225 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----NSEVVETI-NAGF---RLYKPRL 225 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----HHHHHHHH-hCCC---CCCCCCC
Confidence 11 112234568999999888889999999999999999998 999986321 12222211 1110 1111211
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
. ...+.+++.+|++.+|++||++.|++++|.
T Consensus 226 ---~------~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---A------SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---C------CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1 135678899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=300.65 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=196.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEE-EcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYL-HNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~-~~~~~~~lV~ 776 (1009)
+.|+..+.||+|+||.||+|... +..||+|.+... ...+.+.+|+.++++++|+|++++++++ .+++..++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 45788899999999999999875 677999988432 2245677999999999999999999975 4556789999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.++++.... ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+|++|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 80 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred ECCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 99999999999875432 2378889999999999999999998 999999999999999999999999999876432
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
.. ....++..|+|||+.....++.++||||||+++|||++ |+.||... ........ +..+. .+.
T Consensus 155 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~-~~~~~------~~~ 219 (256)
T cd05082 155 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPR-VEKGY------KMD 219 (256)
T ss_pred cC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHH-HhcCC------CCC
Confidence 22 22334568999999888889999999999999999998 99998632 22222221 11111 111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
..... ...+.+++.+|++.+|++||++.++++.|+++
T Consensus 220 ~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 APDGC------PPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCC------CHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11111 12456788999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.92 Aligned_cols=197 Identities=27% Similarity=0.387 Sum_probs=160.0
Q ss_pred CceeccCCceEEEEEEECC--CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc--CCeEEEEEec
Q 037197 703 SNIIGMGGNGIVYKAEFHR--PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN--ETNVMMVYDY 778 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~~lV~E~ 778 (1009)
.+.||+|+||.||+|.+.. +++.||+|.+.... ......+|++++++++||||+++++++.. +...++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 4579999999999999763 56899999985432 22446689999999999999999998854 4568999999
Q ss_pred cCCCChhhhhcCCcc-----ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe----CCCCcEEEcccc
Q 037197 779 MPNDSLGEALHGKEA-----GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL----DANLEARIADFG 849 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~DfG 849 (1009)
++ ++|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 85 578887753221 122478888999999999999999998 99999999999999 456789999999
Q ss_pred cceecccCCC---ceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 037197 850 LARMMLHKNE---TVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPA 907 (1009)
Q Consensus 850 ls~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~ 907 (1009)
+++....... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9987643321 2234568999999998876 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=301.62 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=202.1
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||+|+||.||++....+++.||+|.+............+.+|++++++++|||++++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 46778899999999999999998999999999876544445566777999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-CcEEEcccccceecccC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN-LEARIADFGLARMMLHK 857 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfGls~~~~~~ 857 (1009)
+++++|.+++.... ...+++..+..++.++++|++|||++ +++|+||+|+||+++++ +.+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997543 22378888999999999999999998 99999999999999865 46899999999876433
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
. ......+++.|+|||......++.++||||||+++|+|++|+.||... +....+........ . .+.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-----~~~~~~~~~~~~~~--~-----~~~ 222 (256)
T cd08220 156 S-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-----NLPALVLKIMSGTF--A-----PIS 222 (256)
T ss_pred c-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-----chHHHHHHHHhcCC--C-----CCC
Confidence 2 223356788999999998888899999999999999999999999642 22222222211111 0 111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.. ....+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~------~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 DR------YSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CC------cCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 1124567889999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=302.43 Aligned_cols=254 Identities=26% Similarity=0.334 Sum_probs=186.9
Q ss_pred eeccCCceEEEEEEECC--CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 705 IIGMGGNGIVYKAEFHR--PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 705 ~iG~G~~g~Vyk~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
.||+|+||.||+|.... ....+|+|.+.... .......+.+|++.++.++||||+++++++......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999997543 34678889875432 2333455679999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccc-cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC--
Q 037197 783 SLGEALHGKEAG-KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE-- 859 (1009)
Q Consensus 783 sL~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~-- 859 (1009)
+|.+++...... ....++.....++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999765421 22246777888999999999999998 999999999999999999999999999865432221
Q ss_pred ceeeecccCcccCCcccC-------CCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 860 TVSMVAGSYGYIAPEYGY-------TLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
......+++.|+|||+.. ...++.++|||||||++|||++ |..||..... ............ ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~~~~~--~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-----EQVLKQVVREQD--IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHHhhccC--ccC
Confidence 112234567899999853 3456789999999999999999 7888863211 111222222111 112
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
..+.+..... ..+..++..|+ .||++||+++||++.|.
T Consensus 231 ~~~~~~~~~~------~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLKYS------DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccccCC------HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222222211 23345667888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=309.52 Aligned_cols=265 Identities=23% Similarity=0.275 Sum_probs=195.7
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.+.|+..+.||+|+||.||+|....++..||+|++..... ......+.+|+++++.++|+||+++++++..++..++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3568888999999999999999998899999999865432 222345668999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||++ +++.+++..... .+++.++..++.|+++||+|||+. +|+|+||||+||+++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHPG---GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 677777654322 256777888999999999999998 999999999999999999999999999876533
Q ss_pred CCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc----------
Q 037197 857 KNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN---------- 925 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---------- 925 (1009)
.........+++.|+|||+..+ ..++.++||||||+++|||++|+.||+..... .+.+......-
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV----FEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH----HHHHHHHHHHcCCCChhhhhh
Confidence 3333334457889999998765 35788999999999999999999999743221 11111111000
Q ss_pred -----cccccccCccccccCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 926 -----KAQDEALDPSIAGQCKH---VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 926 -----~~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
....+............ .......+.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000000 0011235668899999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=309.70 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=199.1
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC---hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND---IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+|+..+.||+|+||.||+|.+..+++.||||.+...... ......+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 367788999999999999999988999999999755332 22234456899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+ +++|.+++.... ..+++..+..++.||++||+|||++ +|+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 999999997643 2388999999999999999999998 99999999999999999999999999998765
Q ss_pred cCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc----c----
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN----K---- 926 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~----~---- 926 (1009)
..........+++.|+|||...+ ..++.++|||||||++|||++|..||..... . +....+....... .
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-I-DQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-H-HHHHHHHHHcCCCchhhhhhcc
Confidence 44333344456788999998754 4578999999999999999999877763221 1 1111111100000 0
Q ss_pred ccccccCccccccCc---hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALDPSIAGQCK---HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
............... ........+.+++.+|++.+|++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000000 00111245678999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=309.19 Aligned_cols=266 Identities=23% Similarity=0.284 Sum_probs=197.4
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCe-----E
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETN-----V 772 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~-----~ 772 (1009)
+|+..+.||+|+||.||+|.+..+++.||+|++............+.+|+++++++. ||||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 578889999999999999999999999999998655433334456778999999995 6999999999877665 8
Q ss_pred EEEEeccCCCChhhhhcCCccc-cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC-CCcEEEccccc
Q 037197 773 MMVYDYMPNDSLGEALHGKEAG-KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA-NLEARIADFGL 850 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGl 850 (1009)
|+||||+++ +|.+++...... ...+++..++.++.||++||+|||+. +|+||||+|+||+++. ++.+||+|||.
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999985 798888654322 33478999999999999999999998 9999999999999998 88999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh-cccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS-NKAQ 928 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~ 928 (1009)
+..+...........+++.|+|||+..+ ..++.++||||||+++|+|++|..||.... + .......... +...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~----~-~~~~~~~~~~~~~~~ 232 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS----E-LQQLLHIFKLLGTPT 232 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC----H-HHHHHHHHHHhCCCC
Confidence 9865433333333456889999998754 457899999999999999999999996321 1 1111111111 0000
Q ss_pred ccccC-----------ccccc-cCch-HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 929 DEALD-----------PSIAG-QCKH-VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 929 ~~~~~-----------~~~~~-~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..... +.... .... ......++.+++.+|+++||++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 00000 0000 0112234678999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=305.08 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=200.1
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCC----
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNET---- 770 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~---- 770 (1009)
..++|+..+.||+|++|.||+|.+..+++.|++|++.... ...+++.+|+++++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 3577899999999999999999999889999999985442 2345677999999999 7999999999986544
Q ss_pred --eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 771 --NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 771 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
..++||||+++++|.++++........+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 48999999999999999865432233478899999999999999999998 9999999999999999999999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCC-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYT-----LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
|.+..............+++.|+|||+... ..++.++||||||+++|+|++|+.||..... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~ 232 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-----MRALFKIPR 232 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-----HHHHHHhhc
Confidence 998766443333445568899999997642 3467899999999999999999999963211 111111111
Q ss_pred hccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.. .+.+. ........+.+++.+|++.||++|||+.|+++
T Consensus 233 -~~------~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 -NP------PPTLK----SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -cC------CCCCC----chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 10 11111 11112235668899999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.80 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=201.6
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||+|+||.||+|.+..+++.||+|++..........+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 57888999999999999999998899999999866544444556778999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
++++.+..+..... .+++.+++.++.|+++|++|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 82 VERTLLELLEASPG----GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99877776664432 278889999999999999999998 99999999999999999999999999998764443
Q ss_pred C-ceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc-------ccc
Q 037197 859 E-TVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK-------AQD 929 (1009)
Q Consensus 859 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-------~~~ 929 (1009)
. ......++..|+|||+..+. .++.++||||||+++|+|++|+.||...... +............. ...
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhcccC
Confidence 2 33345678899999998877 7889999999999999999999998632111 11111111000000 000
Q ss_pred cccCc-cccccC-ch-H----H-HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 930 EALDP-SIAGQC-KH-V----Q-EEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 930 ~~~~~-~~~~~~-~~-~----~-~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+.. ...... .. . . ....++.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 000000 00 0 0 01345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=301.61 Aligned_cols=253 Identities=29% Similarity=0.406 Sum_probs=201.8
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||+|+||.||+|....+++.||+|.++...........+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 47788899999999999999988899999999976654444667778999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.+++.... ..++..+..++.++++|++|||+. +|+|+||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999997543 267888889999999999999998 99999999999999999999999999998764433
Q ss_pred Cce----eeecccCcccCCcccCCCC---CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 859 ETV----SMVAGSYGYIAPEYGYTLK---VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 859 ~~~----~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
... ....+++.|+|||+..... .+.++||||||+++||+++|+.||...... ...... +...
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~----~~~~~~-~~~~------ 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----FQIMFH-VGAG------ 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch----HHHHHH-HhcC------
Confidence 221 1345788999999987665 889999999999999999999999743211 111111 1111
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+.+.... .....+.+++.+|++.+|++||++.|++.
T Consensus 223 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 HKPPIPDSL----QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCccc----ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111111 11223557888999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=313.60 Aligned_cols=261 Identities=26% Similarity=0.383 Sum_probs=202.8
Q ss_pred hcCCcCceeccCCceEEEEEEECC-------CCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcC
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHR-------PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNE 769 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 769 (1009)
.+|+..+.||+|+||.||+|.+.. .+..||+|.+... ........+.+|+++++++ +||||+++++++..+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 457888999999999999997642 2347899988543 2233456777999999999 799999999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCcc------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEA------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL 837 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 837 (1009)
+..++||||+++|+|.+++..... ....+++.++..++.|+++||+|||+. +|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence 999999999999999999875421 122478889999999999999999998 99999999999999
Q ss_pred CCCCcEEEcccccceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccH
Q 037197 838 DANLEARIADFGLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDI 914 (1009)
Q Consensus 838 ~~~~~~kl~DfGls~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~ 914 (1009)
++++.+||+|||+++........ .....++..|+|||+.....++.++||||||+++|||++ |..||... +.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~ 242 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-----PV 242 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC-----CH
Confidence 99999999999999765432211 112233467999999988889999999999999999998 88888632 22
Q ss_pred HHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 915 VEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.+.... +..... ......+ ...+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus 243 ~~~~~~-~~~~~~------~~~~~~~------~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 EELFKL-LKEGHR------MDKPANC------THELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHH-HHcCCC------CCCCCCC------CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 222222 111110 0111111 1246678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.50 Aligned_cols=241 Identities=21% Similarity=0.335 Sum_probs=184.9
Q ss_pred ceeccCCceEEEEEEECCC------------CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 704 NIIGMGGNGIVYKAEFHRP------------HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
+.||+|+||.||+|....+ ...||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 3589999999999985432 3468889875432 2334466689999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc-------EE
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE-------AR 844 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~-------~k 844 (1009)
.++||||+++++|..+++.... .+++..+++++.||++|++|||+. +|+||||||+||+++.++. ++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999999998865322 278888999999999999999998 9999999999999987654 89
Q ss_pred EcccccceecccCCCceeeecccCcccCCcccC-CCCCCcccchHhHHHHHHHHH-hCCCCCCCCCCCCccHHHHHHHHH
Q 037197 845 IADFGLARMMLHKNETVSMVAGSYGYIAPEYGY-TLKVDEKSDIYSFGVVLLELL-TGKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 845 l~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~ell-tg~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
++|||++...... ....++..|+|||... ...++.++|||||||++|||+ +|..||..... .+. ....
T Consensus 153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~-~~~~ 222 (262)
T cd05077 153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-----AEK-ERFY 222 (262)
T ss_pred eCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-----hHH-HHHH
Confidence 9999998654322 2345778899999876 566889999999999999998 58888763211 111 1110
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
... ..... + ....+.+++.+||+.||++||++.++++.++
T Consensus 223 ~~~---~~~~~-------~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQ---CMLVT-------P----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcC---ccCCC-------C----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 00000 0 1124667899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=312.97 Aligned_cols=252 Identities=25% Similarity=0.310 Sum_probs=209.9
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
...|...+.||+|.|+.|..|.+..++..||||.+.++..+......+++|+++|+.++|||||+++.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 45678889999999999999999999999999999998888777788889999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+.+|.+.+++..+.. ..+..+..++.|+..|++|+|++ .|||||||++||+++++..+||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec-
Confidence 99999999999987654 33366667899999999999999 99999999999999999999999999999885
Q ss_pred CCCceeeecccCcccCCcccCCCCCC-cccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVD-EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
.+......+|++.|.|||+..+.++. +.+|+||+|+++|-|+.|..||+...- .+.-++.
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------------------k~Lr~rv 267 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------------------KELRPRV 267 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------------------ccccchh
Confidence 55666778999999999999888764 799999999999999999999984211 1111111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 975 (1009)
+.+.+.-......+.-.++++++-.+|.+|++++++..--
T Consensus 268 l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 268 LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 1111111111112234688899999999999999987643
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.04 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=195.3
Q ss_pred ceeccCCceEEEEEEECCCC------eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 704 NIIGMGGNGIVYKAEFHRPH------MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.||+|+||.||+|++.+.. +.||+|.+.... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 35899999999999886533 789999885432 22345567799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccc---cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC-----cEEEcccc
Q 037197 778 YMPNDSLGEALHGKEAG---KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-----EARIADFG 849 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-----~~kl~DfG 849 (1009)
|+++++|.++++..... ...+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999754321 23378899999999999999999998 999999999999999877 89999999
Q ss_pred cceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 850 LARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 850 ls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
++........ ......++..|+|||+..+..++.++||||||+++|||++ |+.||..... .+.. ..+..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----~~~~-~~~~~~~ 230 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----QEVL-QHVTAGG 230 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----HHHH-HHHhcCC
Confidence 9976533321 1122345678999999988889999999999999999998 9999863211 1111 1111111
Q ss_pred ccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
. . ... ... ...+.+++.+|++.+|++||++.++++.|++
T Consensus 231 ~---~---~~~---~~~---~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 R---L---QKP---ENC---PDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred c---c---CCc---ccc---hHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 0 011 111 1345678999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=300.95 Aligned_cols=254 Identities=25% Similarity=0.397 Sum_probs=199.3
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+.. +..+|+|.+... ......+.+|++++++++|+||+++++++.+ ...++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 3568888999999999999998765 567999988543 2334567799999999999999999999887 7789999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++..... ...++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999976432 2378888999999999999999998 999999999999999999999999999976543
Q ss_pred CCC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 857 KNE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 857 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
... ......++..|+|||+.....++.++|+||||+++|++++ |+.||..... .+...++ ..+.. .
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~----~~~~~------~ 222 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRAL----ERGYR------M 222 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH----hCCCC------C
Confidence 221 1122335577999999988889999999999999999999 9999863211 1122211 11110 0
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
.... ....++.+++.+|++.+|++||++.++.+.|+++
T Consensus 223 ~~~~------~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 223 PRPE------NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCcc------cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 0001 1123466788999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=313.07 Aligned_cols=252 Identities=29% Similarity=0.437 Sum_probs=199.2
Q ss_pred CCcCceeccCCceEEEEEEECCC---CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.+..++||+|.||.|++|.|... ...||||.++..... ....+|.+|+.+|.+++|||++++||+..+ ....+||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 44567899999999999998743 367999999654332 356788899999999999999999999987 6789999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
|.++.|||.+.++.. .+..+-......++.|||.|+.||.++ +.||||+..+|+++-....|||+|||+.+-+..
T Consensus 190 ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999872 334467778888999999999999999 999999999999999999999999999998765
Q ss_pred CCCceee---ecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 857 KNETVSM---VAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 857 ~~~~~~~---~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
.+....+ ..-.+.|+|||.+..++++.+||||+|||++|||+| |+.||-.... . .+...+..+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----~-qIL~~iD~~------- 331 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----I-QILKNIDAG------- 331 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----H-HHHHhcccc-------
Confidence 5433222 223468999999999999999999999999999999 8888863211 1 122222211
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
+.....+. ...++..++..||..+|++||++..+.+.+-
T Consensus 332 --erLpRPk~---csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 332 --ERLPRPKY---CSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred --ccCCCCCC---ChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 11111222 2335678889999999999999999985543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=305.85 Aligned_cols=266 Identities=24% Similarity=0.319 Sum_probs=201.2
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||+|+||.||+|.+..+++.||+|++............+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 36778899999999999999998899999999976544344456777999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+ +++|.+++.... ..+++.+++.++.||++||+|||+. +++|+||||+||+++.++.++++|||.+.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999986543 2378999999999999999999998 99999999999999999999999999998764433
Q ss_pred C-ceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc-----cccc
Q 037197 859 E-TVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA-----QDEA 931 (1009)
Q Consensus 859 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 931 (1009)
. ......++..|+|||+..+. .++.++||||+|+++|||++|.+||..... ......+......... ..+.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhccCc
Confidence 1 23345688899999987644 468999999999999999999887753211 1111111111100000 0000
Q ss_pred cC---ccccccCc-----hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 LD---PSIAGQCK-----HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ~~---~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+ -....... ...+....+.+++.+|++.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 00000000 00011245778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=301.20 Aligned_cols=239 Identities=23% Similarity=0.335 Sum_probs=188.4
Q ss_pred ceeccCCceEEEEEEECCCC----------eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 704 NIIGMGGNGIVYKAEFHRPH----------MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
+.||+|+||.||+|.+..++ ..|++|.+..... ....+.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 36899999999999998766 4578887744321 15667799999999999999999999988 7789
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC-------cEEEc
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-------EARIA 846 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-------~~kl~ 846 (1009)
+||||+++|+|.++++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+|++
T Consensus 77 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 99999999999999976542 378888999999999999999998 999999999999999887 79999
Q ss_pred ccccceecccCCCceeeecccCcccCCcccCCC--CCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHh
Q 037197 847 DFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL--KVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 847 DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
|||++..... .....++..|+|||+.... .++.++||||||+++|||++ |..||...... .+.....
T Consensus 151 Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-----~~~~~~~- 220 (259)
T cd05037 151 DPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-----EKERFYQ- 220 (259)
T ss_pred CCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-----hHHHHHh-
Confidence 9999976533 2234466789999998766 78899999999999999999 57777643211 1111110
Q ss_pred hccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
.. .....+. ...+.+++.+|+..+|++||++.|+++.|+
T Consensus 221 ~~---~~~~~~~-----------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQ---HRLPMPD-----------CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cC---CCCCCCC-----------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0000000 045678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=303.40 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=203.1
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||+|+||.||+|....++..||+|.+..........+.+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 36778899999999999999999999999999865433334455667999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC-cEEEcccccceecccC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-EARIADFGLARMMLHK 857 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGls~~~~~~ 857 (1009)
+++++|.+++..... ..+++..+..++.|+++|++|||+. +++|+||||+||++++++ .+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999965432 2368899999999999999999998 999999999999999886 4699999999776544
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
........|++.|+|||+.....++.++||||||+++|||++|+.||... +..+++....... ..+ ..
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~------~~~-~~ 223 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKICQGY------FAP-IS 223 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHhccc------CCC-CC
Confidence 33334456889999999988888999999999999999999999998632 2333333322211 111 11
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
... ...+.+++.+|++.+|++||++.|+++
T Consensus 224 ~~~------~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNF------SRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCC------CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111 124567888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=305.87 Aligned_cols=260 Identities=25% Similarity=0.318 Sum_probs=197.7
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
|+..+.||.|++|.||+|.+..+|..||+|++............+.+|++++++++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56678899999999999999988999999998655433334456778999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
+ ++|.+++..... ..+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 689999865542 2378999999999999999999998 999999999999999999999999999976543332
Q ss_pred ceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc--------
Q 037197 860 TVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE-------- 930 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 930 (1009)
......+++.|+|||+..+. .++.++||||||+++|+|++|+.||..... .....+.+ .......+
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-IDQLFRIF----RTLGTPDEDVWPGVTS 229 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH----HHhCCCChHHhhhhhh
Confidence 22334568899999987654 568899999999999999999999963211 11111111 10000000
Q ss_pred ----------ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ----------ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ----------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+........ ....+.+++.+|++.+|++||+++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPN---LDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccchhhhcCC---CCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000011 1134668999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=305.86 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=197.8
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||+|+||.||+|.+..++..||+|.+... ........+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 467788999999999999999988999999988543 2233446777999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.++++.... ...+++..+..++.|+++|+.|||+.+ +|+||||||+||+++.++.++|+|||.+..+...
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 999999999875421 223789999999999999999999632 8999999999999999999999999998765322
Q ss_pred CceeeecccCcccCCcccCCC------CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTL------KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
......+++.|+|||...+. .++.++|||||||++|+|++|+.||..... ......+.... .+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~-~~~------ 226 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFAQLSAIV-DGD------ 226 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHHHHHHHh-hcC------
Confidence 22334578899999987543 347899999999999999999999964211 11111111111 111
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+.+... ....+..++.+|++.+|++||++.++++
T Consensus 227 ~~~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 PPTLPSG------YSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCCcc------cCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1111111 1224567888999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=307.36 Aligned_cols=254 Identities=25% Similarity=0.389 Sum_probs=194.3
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHH-HhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSL-LGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+..+.||+|+||.||+|.+..+|+.||+|++...... ....+++.|+.. ++..+||||+++++++..+...++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 477788999999999999999999999999998654332 223455566665 666799999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|++ |+|.++++........+++..++.++.|++.|++|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 7888887654333345899999999999999999999752 8999999999999999999999999999765322
Q ss_pred CCceeeecccCcccCCcccCC----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 858 NETVSMVAGSYGYIAPEYGYT----LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
.......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... .+.+....... .
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~-------~ 225 (283)
T cd06617 158 -VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQLKQVVEEP-------S 225 (283)
T ss_pred -cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHHHHHHHhcC-------C
Confidence 12233467889999998754 45688999999999999999999999643221 11111111111 1
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.+... .. ..++..++.+|+..+|++||++.++++
T Consensus 226 ~~~~~~--~~---~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLPAE--KF---SPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCcc--cc---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111100 01 124567888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=319.85 Aligned_cols=260 Identities=22% Similarity=0.228 Sum_probs=194.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECC--CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR--PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
..+|+..+.||+|+||.||++...+ .++.||+|.+... ....+|++++++++||||+++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 4568899999999999999997643 4678999987432 234589999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+. ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++..
T Consensus 164 v~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSG----PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999995 67888884332 378999999999999999999998 9999999999999999999999999999765
Q ss_pred ccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC-CccHHHHHHHHHhhcc-c---
Q 037197 855 LHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG-SKDIVEWVLSMIKSNK-A--- 927 (1009)
Q Consensus 855 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~-~--- 927 (1009)
..... ......||+.|+|||++....++.++|||||||++|||++|+.||...... .......+........ .
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 43322 223457899999999998888999999999999999999999999643221 1111111111111000 0
Q ss_pred ------------cccccCccccccCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 928 ------------QDEALDPSIAGQCKHV---QEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 928 ------------~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
......+... .+.. .....++..++.+|+..||++||++.|++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYT--IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred ccchhHHHHHHhhcccccCCcc--ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 0000 001234567889999999999999999875
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=308.36 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=198.4
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
.|.....||+|+||.||+|....+++.||+|.+.... ....+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 3445557999999999999998889999999985432 23345677999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.+++... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 100 LQGGALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 9999999987542 278889999999999999999998 99999999999999999999999999987654333
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
.......+++.|+|||+..+..++.++||||||+++|||++|+.||.... ....+.. +.... .+...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~~~~~~-~~~~~------~~~~~- 238 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS-----PVQAMKR-LRDSP------PPKLK- 238 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHH-HhccC------CCCcc-
Confidence 33344568899999999988889999999999999999999999996321 1111111 11111 00000
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
.... ....+.+++.+|++.+|++||++.|+++.
T Consensus 239 ~~~~---~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHK---ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCC---CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0001 11235678889999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=302.78 Aligned_cols=240 Identities=21% Similarity=0.329 Sum_probs=183.8
Q ss_pred eeccCCceEEEEEEECC------------------------CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCcee
Q 037197 705 IIGMGGNGIVYKAEFHR------------------------PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760 (1009)
Q Consensus 705 ~iG~G~~g~Vyk~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv 760 (1009)
.||+|+||.||+|.... ....||+|++.... ......+++|+.++++++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999997532 12468899885432 23345677899999999999999
Q ss_pred eEEeEEEcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC
Q 037197 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN 840 (1009)
Q Consensus 761 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~ 840 (1009)
++++++.+....++||||+++|+|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 999999999999999999999999999865322 267888899999999999999998 99999999999999764
Q ss_pred C-------cEEEcccccceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHH-hCCCCCCCCCCCC
Q 037197 841 L-------EARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELL-TGKMPLDPAFGGS 911 (1009)
Q Consensus 841 ~-------~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~ell-tg~~Pf~~~~~~~ 911 (1009)
+ .+|++|||.+...... ....+++.|+|||.... ..++.++||||||+++||++ +|+.||......
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~- 228 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS- 228 (274)
T ss_pred CcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH-
Confidence 3 4899999988654222 22346788999998764 56889999999999999995 699998643211
Q ss_pred ccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 912 KDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
..... ..... ...... ...+.+++.+||+.+|++||++.++++.|.
T Consensus 229 -~~~~~----~~~~~--------~~~~~~------~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 -EKERF----YEKKH--------RLPEPS------CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHHH----HHhcc--------CCCCCC------ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111 11111 010000 124667899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.20 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=195.7
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC----hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND----IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
+|+..+.||+|+||.||+|... +++.+|+|.+...... ......+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 3677889999999999999875 4889999988643221 2223456689999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++|+|||.+...
T Consensus 80 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999996543 267888889999999999999998 9999999999999999999999999998764
Q ss_pred ccCC------CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 855 LHKN------ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 855 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
.... .......++..|+|||+..+..++.++||||||+++|||++|+.||..... . ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~-~~~~~~~~~~--- 224 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR----L-AAMFYIGAHR--- 224 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh----H-HHHHHhhhcc---
Confidence 2211 112234578899999999888899999999999999999999999963211 1 1111111100
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+.+.... ...+..++.+|++.+|++||++.|+++
T Consensus 225 --~~~~~~~~~~------~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 --GLMPRLPDSF------SAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --CCCCCCCCCC------CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111121111 124567889999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=299.89 Aligned_cols=250 Identities=29% Similarity=0.390 Sum_probs=198.9
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC---hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND---IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+|+..+.||+|+||.||+|....++..|++|.+...... .+..+.+.+|++++++++||||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 366778999999999999999988999999998654321 23445677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|.+++.... .+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999996543 267888899999999999999998 99999999999999999999999999987653
Q ss_pred cCCCceeeecccCcccCCcccCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLK-VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
... ......+++.|+|||...... ++.++|+||||+++|+|++|+.||.... ............. .+
T Consensus 154 ~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~------~~ 221 (258)
T cd06632 154 EFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-----GVAAVFKIGRSKE------LP 221 (258)
T ss_pred ccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-----HHHHHHHHHhccc------CC
Confidence 332 233456888999999877666 8899999999999999999999997432 1111111111000 01
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+.... ...+.+++.+|++.+|++||++.+++.
T Consensus 222 ~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHL------SDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCc------CHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111111 124567888999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=302.00 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=201.6
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|++++++++||||+++++++.++...++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 457788899999999999999988899999999854422 2344567789999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 83 ~~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 83 YLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred eCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 99999999998643 268888999999999999999998 9999999999999999999999999998766443
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
........++..|+|||+.....++.++|||||||++|+|++|..||..... ..+... +.... .+.+.
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~~~------~~~~~ 222 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFL-IPKNN------PPTLE 222 (277)
T ss_pred hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHH-HhcCC------CCCCC
Confidence 3333345678899999998888889999999999999999999999964221 111111 11111 11111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
... ...+.+++.+|++.+|++||++.++++.
T Consensus 223 ~~~------~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNY------SKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ccc------CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111 1245678899999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=306.37 Aligned_cols=266 Identities=22% Similarity=0.256 Sum_probs=199.6
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC--CeEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE--TNVMMV 775 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~lV 775 (1009)
+.|+..+.||+|+||.||+|.+..+++.||+|.++...........+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 467888899999999999999998899999999975544333344567899999999999999999998877 889999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||++ ++|.+++..... .+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 589998865432 378999999999999999999998 99999999999999999999999999998765
Q ss_pred cCCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh----------
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS---------- 924 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---------- 924 (1009)
..........+++.|+|||...+. .++.++|+||+|+++|||++|+.||..... .+....+......
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE--IDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchHHHHHhh
Confidence 543333445578899999987654 468899999999999999999999973211 1111111100000
Q ss_pred -----c-cccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 925 -----N-KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 925 -----~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. ..........+...+... .....+.+++.+|++.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhcccccc-CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000000000011111110 01234567889999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=299.42 Aligned_cols=253 Identities=27% Similarity=0.449 Sum_probs=205.4
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
.|+..+.||+|++|.||+|.+..+++.||+|++...... .....+.+|++.+++++|+|++++++++..+...++||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 467788999999999999999999999999998655332 4456677999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH-DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
+++++|.+++.... .+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 99999999997542 37889999999999999999999 8 9999999999999999999999999999876544
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
........++..|+|||......++.++||||||+++|+|++|+.||..... ....+.+..... . ..+...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~-~------~~~~~~ 224 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICD-G------PPPSLP 224 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhc-C------CCCCCC
Confidence 4443355678899999998888899999999999999999999999975432 122222222111 1 011111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.. . ....+..++.+|++.+|++||++.|+++
T Consensus 225 ~~--~---~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 225 AE--E---FSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cc--c---CCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 11 0 1134667888999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=303.05 Aligned_cols=241 Identities=20% Similarity=0.323 Sum_probs=186.3
Q ss_pred ceeccCCceEEEEEEECCCCe-------EEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 704 NIIGMGGNGIVYKAEFHRPHM-------VVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.||+|+||.||+|.+...+. .||+|.+... .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 358999999999998865443 4888887432 2233456778999999999999999999999989999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc--------EEEccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE--------ARIADF 848 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~--------~kl~Df 848 (1009)
||+++|+|.++++.... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++. ++++||
T Consensus 79 e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 79 EYVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred ecCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999999976532 378888899999999999999998 9999999999999987765 699999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCC-CCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGK-MPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
|.+..... .....+++.|+|||++.+ ..++.++||||||+++|||++|. .||.... ...... .. ...
T Consensus 153 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-----~~~~~~-~~-~~~ 221 (258)
T cd05078 153 GISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-----SQKKLQ-FY-EDR 221 (258)
T ss_pred ccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-----HHHHHH-HH-Hcc
Confidence 98865432 223457889999998876 45789999999999999999985 5554211 111111 11 110
Q ss_pred ccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
..+... ...++.+++.+|++.+|++||+++++++.|+
T Consensus 222 -------~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -------HQLPAP------KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------ccCCCC------CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011111 1124678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=315.70 Aligned_cols=274 Identities=22% Similarity=0.314 Sum_probs=205.4
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC------eEEE
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET------NVMM 774 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------~~~l 774 (1009)
...+.||+|+||.||+|+++.+|+.||||.+.... .....+...+|++++++++|||||++++.-++.. ...+
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34567999999999999999999999999996543 3444666779999999999999999999865443 5689
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe--CCCC--cEEEccccc
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL--DANL--EARIADFGL 850 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll--~~~~--~~kl~DfGl 850 (1009)
|||||.+|||...+.+.. ....+++.+.+.+..+++.||.|||.+ +|+||||||.||++ +++| ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999997643 345589999999999999999999998 99999999999999 3444 379999999
Q ss_pred ceecccCCCceeeecccCcccCCcccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH-hhcccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGY-TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI-KSNKAQ 928 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~ 928 (1009)
|+...+ +......+||..|.+||... .+.|+..+|.|||||++|+.+||..||.+..+.. ...+.+.... +.....
T Consensus 171 Arel~d-~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk-~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 171 ARELDD-NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK-NNKEIMWHIITKKPSGV 248 (732)
T ss_pred cccCCC-CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc-ccchhhhhhhccCCCce
Confidence 998754 44777889999999999887 5889999999999999999999999998654432 1111111111 111111
Q ss_pred ccccCccc----------cccCchHHHHHHHHHHHHHHhccCCCCCCC--CHHHHHHHHhhcCCC
Q 037197 929 DEALDPSI----------AGQCKHVQEEMLLVLRIAVLCTAKLPKGRP--TMRDVITMLGEAKPR 981 (1009)
Q Consensus 929 ~~~~~~~~----------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP--s~~evl~~L~~~~~~ 981 (1009)
.....+.. +..+.-.......+.+....++..+|.+|. .+.+..+.+.++...
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 11111111 111111122233455666788889999998 777777776666543
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=298.04 Aligned_cols=247 Identities=26% Similarity=0.365 Sum_probs=194.9
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDS 783 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gs 783 (1009)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|++++++++||||+++++++.+....++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 368999999999999988 899999998654332 345667799999999999999999999999999999999999999
Q ss_pred hhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce--
Q 037197 784 LGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV-- 861 (1009)
Q Consensus 784 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~-- 861 (1009)
|.+++..... .+++..+..++.+++.|++|||++ +++||||||+||+++.++.++|+|||++..........
T Consensus 79 l~~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 79 LLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9999965432 368888899999999999999998 99999999999999999999999999997653222111
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccC
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQC 940 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (1009)
.....+..|+|||...+..++.++|+||||+++|||++ |..||...... .... .+.... .......
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~----~~~~~~------~~~~~~~- 219 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRE----RIESGY------RMPAPQL- 219 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHH----HHhcCC------CCCCCcc-
Confidence 11223567999999888889999999999999999999 88888643211 1111 111110 0001111
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 941 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
....+.+++.+|++.+|++||++.|+++.|+
T Consensus 220 -----~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 -----CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -----CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1124677899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.03 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=193.9
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC---hhhHHHHHHHHHHHhccCCCceeeEEeEEEcC--CeE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND---IESGDDLFREVSLLGRLRHRNIVRLLGYLHNE--TNV 772 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~ 772 (1009)
..|+..+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 3577889999999999999999999999999988543211 22345666899999999999999999998764 467
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
++||||+++++|.+++..... +++....+++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA----LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999865432 67788889999999999999998 99999999999999999999999999987
Q ss_pred ecccCC---CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 853 MMLHKN---ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 853 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
...... .......++..|+|||...+..++.++||||||+++|||++|+.||... +....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-----~~~~~~~~~~~~~---- 225 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF-----EAMAAIFKIATQP---- 225 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc-----chHHHHHHHhcCC----
Confidence 653211 1223345788999999988888999999999999999999999999632 1111121111110
Q ss_pred cccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+... ......+..++.+|+. +|++||+++|+++
T Consensus 226 --~~~~~~------~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 --TNPVLP------PHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --CCCCCc------hhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 011111 1122345567778884 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=306.27 Aligned_cols=245 Identities=21% Similarity=0.298 Sum_probs=197.7
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+|+..+.||+|+||.||++.+..+++.||+|++..... .....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 57788899999999999999998899999999865432 22334567799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 82 YVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred cCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999987653 278888899999999999999998 9999999999999999999999999999876433
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
.....+++.|+|||.......+.++||||||+++|+|++|+.||.... ... ....+..+. ..+.
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~-~~~~~~~~~-------~~~~ 218 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQ-IYEKILEGK-------VRFP 218 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHH-HHHHHhcCC-------ccCC
Confidence 234468899999999888888999999999999999999999997422 111 111111111 1111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVI 972 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl 972 (1009)
... ...+.+++.+|++.+|++|+ +++|++
T Consensus 219 ~~~------~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 219 SFF------SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ccC------CHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 111 12456788999999999998 566655
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=306.47 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=201.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|....++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 467888999999999999999988888999999985432 233456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++.... +++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 96 e~~~~~~L~~~~~~~~-----l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 96 EYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred ecCCCCcHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999986532 67888899999999999999998 999999999999999999999999999876544
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.........+++.|+|||......++.++||||||+++|++++|+.||...... ..+......+. +.+
T Consensus 168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~-----~~~~~~~~~~~-------~~~ 235 (293)
T cd06647 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----RALYLIATNGT-------PEL 235 (293)
T ss_pred cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-----hheeehhcCCC-------CCC
Confidence 443334456888999999988888899999999999999999999999743221 11100000010 001
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
. ........+..++.+|++.+|++||++.+++..
T Consensus 236 ~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 Q----NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 001112245678899999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=302.19 Aligned_cols=258 Identities=22% Similarity=0.333 Sum_probs=198.7
Q ss_pred CCcCceeccCCceEEEEEEECC---CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC------
Q 037197 700 VKESNIIGMGGNGIVYKAEFHR---PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET------ 770 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------ 770 (1009)
|+..+.||+|+||.||+|.+.. +++.||||++..........+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 4567789999999999998653 4789999999765545555667789999999999999999999886432
Q ss_pred eEEEEEeccCCCChhhhhcCCc--cccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKE--AGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
..++++||+++|+|.+++.... .....+++....+++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875332 1122478888999999999999999998 9999999999999999999999999
Q ss_pred ccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhc
Q 037197 849 GLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSN 925 (1009)
Q Consensus 849 Gls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 925 (1009)
|.++....... ......+++.|++||......++.++||||||+++|||++ |+.||..... .+...++ ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~----~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYL----IKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHH----HcC
Confidence 99986533221 1122345678999999888888999999999999999999 8888863221 1111111 111
Q ss_pred cccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 926 KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
.. ...... ....+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~------~~~~~~------~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR------LKQPPD------CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc------CCCCCC------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 000001 112567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=302.88 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=199.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
..|+..+.||+|++|.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++...++.++|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 3456667999999999999999888999999988533 22334567799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+......
T Consensus 97 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 97 FLEGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred ccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 99999999998662 268888899999999999999998 9999999999999999999999999988755433
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
........+++.|+|||...+..++.++||||||+++|||++|+.||... +....+..... .. .+...
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~-----~~~~~~~~~~~-~~------~~~~~ 236 (285)
T cd06648 169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE-----PPLQAMKRIRD-NL------PPKLK 236 (285)
T ss_pred CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC-----CHHHHHHHHHh-cC------CCCCc
Confidence 33333456889999999988888999999999999999999999998632 22222222111 11 01111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.. . .....+.+++.+|++.+|++||++.++++
T Consensus 237 ~~-~---~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 NL-H---KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cc-c---cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 00 0 01124677899999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=300.20 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=195.9
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh--------hhHHHHHHHHHHHhccCCCceeeEEeEEEcCC
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI--------ESGDDLFREVSLLGRLRHRNIVRLLGYLHNET 770 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~ 770 (1009)
+|...+.||+|+||.||+|....+++.||+|.+....... ...+.+.+|++++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3667789999999999999998889999999885421111 11235568999999999999999999999999
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
..++||||+++++|.++++... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999997652 278888888999999999999998 999999999999999999999999999
Q ss_pred ceecccCCC--ceeeecccCcccCCcccCCCC--CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 851 ARMMLHKNE--TVSMVAGSYGYIAPEYGYTLK--VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 851 s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
++....... ......++..|+|||...... ++.++||||||+++||+++|+.||.... .. ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~-~~~~~~~~~~- 228 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----AI-AAMFKLGNKR- 228 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----hH-HHHHHhhccc-
Confidence 876432211 122345788999999876544 7899999999999999999999986321 11 1111111110
Q ss_pred ccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
........... .....+.+++.+|++.+|++||++.++++
T Consensus 229 -~~~~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 -SAPPIPPDVSM------NLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -cCCcCCccccc------cCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 01111111111 11235667888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=309.21 Aligned_cols=256 Identities=21% Similarity=0.262 Sum_probs=199.6
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh-hhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI-ESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+|+..+.||+|+||.||+|....+++.||+|.+....... .....+.+|+++++.++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5778889999999999999999989999999997654332 344567799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+.+++|.+++..... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 82 YCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred ecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999875432 2378888889999999999999998 9999999999999999999999999998754322
Q ss_pred CC-----------------------------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Q 037197 858 NE-----------------------------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAF 908 (1009)
Q Consensus 858 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~ 908 (1009)
.. ......|+..|+|||+..+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11 0112357889999999988889999999999999999999999996332
Q ss_pred CCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 909 GGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
. ............ .+... ......+.+++.+|++.||++||+.+..++++.
T Consensus 237 ~-----~~~~~~~~~~~~--------~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 237 R-----DETFSNILKKEV--------TFPGS----PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred h-----HHHHHHHhcCCc--------cCCCc----cccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 1 111111111110 01100 002235677889999999999999444444433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=301.99 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=199.3
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC----hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND----IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
.|+..+.||+|++|.||+|....+++.||+|.+...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 367788999999999999999888999999998643311 1234567799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC-cEEEccccccee
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-EARIADFGLARM 853 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGls~~ 853 (1009)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999996543 378888999999999999999998 999999999999998776 599999999877
Q ss_pred cccCC----CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 854 MLHKN----ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 854 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
+.... .......++..|+|||...+..++.++||||+|+++|+|++|+.||...... .....+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~---- 227 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASAT---- 227 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHHHhccC----
Confidence 64332 1122346788999999988888899999999999999999999999643221 1122221111110
Q ss_pred cccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+.... ....++.+++.+|+..+|++||++.|++.
T Consensus 228 --~~~~~~~------~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 --TAPSIPE------HLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --CCCCCch------hhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111111 11234667889999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=303.55 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=196.0
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEc------
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHN------ 768 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~------ 768 (1009)
..+.|+..+.||+|+||.||+|.+..+++.||+|.+... .....++..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 456788889999999999999999988999999998543 23345566899999998 79999999999853
Q ss_pred CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 769 ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 769 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
....++||||+++|+|.+++..... ..+++..++.++.|++.|++|||+. +|+|+||+|+||++++++.++|+||
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence 4678999999999999999865432 2367778888999999999999998 9999999999999999999999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
|++..............+++.|+|||.+. ...++.++|||||||++|||++|+.||...... ..+.. ..
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-----~~~~~-~~ 239 (282)
T cd06636 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-----RALFL-IP 239 (282)
T ss_pred cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-----hhhhh-Hh
Confidence 99876543333334456889999999865 345788999999999999999999999642211 11110 10
Q ss_pred hccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.. ..+... ... ....+.+++.+|++.||++||++.|+++
T Consensus 240 ~~------~~~~~~--~~~---~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 RN------PPPKLK--SKK---WSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hC------CCCCCc--ccc---cCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 011110 001 1124677899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=309.87 Aligned_cols=196 Identities=27% Similarity=0.397 Sum_probs=159.0
Q ss_pred CceeccCCceEEEEEEECC--CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEE--cCCeEEEEEec
Q 037197 703 SNIIGMGGNGIVYKAEFHR--PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLH--NETNVMMVYDY 778 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~--~~~~~~lV~E~ 778 (1009)
...||+|+||.||+|.... ++..||+|.+.... ....+.+|++++++++||||+++++++. .+...++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 4579999999999999764 56889999985432 2345668999999999999999999885 35678999999
Q ss_pred cCCCChhhhhcCCcc-----ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe----CCCCcEEEcccc
Q 037197 779 MPNDSLGEALHGKEA-----GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL----DANLEARIADFG 849 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~DfG 849 (1009)
++ ++|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 86 577777643211 122478888999999999999999998 99999999999999 556789999999
Q ss_pred cceecccCCC---ceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 850 LARMMLHKNE---TVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 850 ls~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
+++....... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 9987643321 2234567899999998765 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=302.44 Aligned_cols=253 Identities=26% Similarity=0.361 Sum_probs=203.2
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
..+.|+..+.||+|++|.||+|.+..++..||+|++..... ..+.+.+|++++++++|+|++++++++......++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 45667888899999999999999998889999999865422 455677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
+||+++++|.+++.... ..+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 94 MEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 99999999999997653 2388999999999999999999998 99999999999999999999999999987654
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
..........+++.|+|||+..+..++.++||||||+++|+|++|+.||..... ............ .....+
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--~~~~~~- 239 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-----LRALFLITTKGI--PPLKNP- 239 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcCC--CCCcch-
Confidence 333333344578899999998888899999999999999999999999863211 111111111110 000000
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
......+.+++.+|++.+|.+||++.++++
T Consensus 240 --------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 --------EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --------hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 001134667889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=305.05 Aligned_cols=257 Identities=19% Similarity=0.235 Sum_probs=200.8
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+..+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+++++.++||||+++++++..+++.++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999999999999999998654321 2334566699999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++.....
T Consensus 82 ~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 82 YVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999996543 278888888999999999999998 9999999999999999999999999988632110
Q ss_pred C---------------CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH
Q 037197 858 N---------------ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 858 ~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
. .......++..|+|||+.....++.++|+||||+++|||++|+.||... ...+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-----~~~~~~~~~~ 229 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-----TPEELFGQVI 229 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHH
Confidence 0 0111235678899999988888999999999999999999999999632 1222222211
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
... ...+...... ...+..++.+|++.+|++||++.++.+.++..
T Consensus 230 ~~~-----~~~~~~~~~~------~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 230 SDD-----IEWPEGDEAL------PADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred hcc-----cCCCCccccC------CHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 111 1111111111 12356788999999999999987777777664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.15 Aligned_cols=259 Identities=24% Similarity=0.411 Sum_probs=200.3
Q ss_pred hcCCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNV 772 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 772 (1009)
+.|+..+.||+|+||.||+|+.+. +.+.|++|.+.... .....+.+.+|++++++++||||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 457788899999999999999753 34679999885432 222356677999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhcCCcccc-----ccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcc
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGK-----LLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIAD 847 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 847 (1009)
++||||+++|+|.++++...... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999997654221 1479999999999999999999998 999999999999999999999999
Q ss_pred cccceecccCC-CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhc
Q 037197 848 FGLARMMLHKN-ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSN 925 (1009)
Q Consensus 848 fGls~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 925 (1009)
||++....... .......+++.|+|||......++.++||||||+++|+|++ |..||..... .. .+. ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~---~~~-~~~~~ 234 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EE---VLN-RLQAG 234 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HH---HHH-HHHcC
Confidence 99986543222 12223345678999999888888999999999999999999 8888863211 11 111 11111
Q ss_pred cccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 926 KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
... .. ....++ ..+.+++.+|++.+|++||++.|+++.|.+
T Consensus 235 ~~~--~~---~~~~~~------~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 KLE--LP---VPEGCP------SRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CcC--CC---CCCCCC------HHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 100 00 011111 246678999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=296.40 Aligned_cols=251 Identities=29% Similarity=0.449 Sum_probs=198.9
Q ss_pred CcCceeccCCceEEEEEEECCCC----eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPH----MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+..+.||.|+||.||++.+...+ ..||+|.+.... .....+.+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 45678999999999999998766 899999995442 2224567779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++....... +++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~~--~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhhcc--CCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999997543211 68899999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcee-eecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 857 KNETVS-MVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 857 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
...... ...+++.|+|||......++.++||||+|+++|+|++ |..||... +....... ...... .
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~-~~~~~~------~ 223 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLEY-LKKGYR------L 223 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHH-HhcCCC------C
Confidence 322111 2336789999999888889999999999999999998 78888631 11222221 111110 0
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 975 (1009)
..... ...++.+++.+|+..+|++|||+.|+++.|
T Consensus 224 ~~~~~------~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPEN------CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCc------CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11111 122466788999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=302.06 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=199.1
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC---CCceeeEEeEEEcCCeEEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR---HRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---Hpniv~l~~~~~~~~~~~lV 775 (1009)
.|+..+.||+|+||.||+|.+..+++.||+|.+.... .....+++.+|++++++++ |||++++++++.++...++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 3667788999999999999998889999999986432 2333456678999999986 99999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|.++++.. .+++...+.++.|+++|+.|||+. +|+|+||+|+||+++.++.++++|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 81 MEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 9999999999998653 378899999999999999999998 99999999999999999999999999998775
Q ss_pred cCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
..........|+..|+|||+... ..++.++||||||+++|+|++|+.||.... ....+... . ....+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-----~~~~~~~~-~------~~~~~ 220 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-----AFRAMMLI-P------KSKPP 220 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-----hhhhhhcc-c------cCCCC
Confidence 54444444568889999998764 446889999999999999999999997432 11111110 0 00111
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+... ....++.+++.+|++.||++||++.|++.
T Consensus 221 ~~~~~-----~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDN-----GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcc-----cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 12111 01234667889999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=330.47 Aligned_cols=254 Identities=27% Similarity=0.411 Sum_probs=194.4
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc-------
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN------- 768 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~------- 768 (1009)
....|++.++||+||||.|||++.+-+|+.||||++.... ......++++|++.+++++|||||+++..|.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3456778889999999999999999999999999997765 55667788899999999999999999811100
Q ss_pred --------------------------------------------------------------------------------
Q 037197 769 -------------------------------------------------------------------------------- 768 (1009)
Q Consensus 769 -------------------------------------------------------------------------------- 768 (1009)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHH
Q 037197 769 ------------------------E--------TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNY 816 (1009)
Q Consensus 769 ------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~ 816 (1009)
+ ..+||-||||+..++.++++.+.... .....|+++.+|++||+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence 0 23589999999999999997665321 466788999999999999
Q ss_pred HHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc------c------------CCCceeeecccCcccCCcccCC
Q 037197 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML------H------------KNETVSMVAGSYGYIAPEYGYT 878 (1009)
Q Consensus 817 LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~------~------------~~~~~~~~~gt~~y~aPE~~~~ 878 (1009)
+|+. |||||||||.||++++++.|||+|||+|+... . .....+..+||.-|+|||...+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 99999999999999999999999999998721 0 0113456789999999998765
Q ss_pred C---CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHH
Q 037197 879 L---KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAV 955 (1009)
Q Consensus 879 ~---~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 955 (1009)
. +|+.|+|+||+|||++||+. ||....+ ...+...++.+ .++........++..-.+++.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME-----Ra~iL~~LR~g---------~iP~~~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME-----RASILTNLRKG---------SIPEPADFFDPEHPEEASLIR 852 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHH-----HHHHHHhcccC---------CCCCCcccccccchHHHHHHH
Confidence 4 49999999999999999996 5652211 12222222222 121111111233334467899
Q ss_pred HhccCCCCCCCCHHHHHH
Q 037197 956 LCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 956 ~cl~~dp~~RPs~~evl~ 973 (1009)
++++.||.+|||+.|++.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 999999999999999875
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.98 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=207.8
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||+|+||.||++.+..++..||+|++............+.+|++++++++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 36777889999999999999998899999999976655555667777999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.+++.........+++.++..++.++++|++|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999976543334489999999999999999999998 99999999999999999999999999998765544
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
.......+++.|+|||......++.++||||+|+++|+|++|+.||.... ..+....... .. .+.+..
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~-~~------~~~~~~ 225 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILK-GQ------YPPIPS 225 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhc-CC------CCCCCC
Confidence 33444568889999999888889999999999999999999999986321 2222222111 11 111111
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.. ...+..++.+|+..+|++||++.|+++
T Consensus 226 ~~------~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 226 QY------SSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CC------CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11 124567888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=300.30 Aligned_cols=250 Identities=24% Similarity=0.275 Sum_probs=200.8
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh-hhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI-ESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+|+..+.||.|+||.||+|.+..+++.||+|.+.+..... ...+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 3677889999999999999999889999999996543322 345667799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQKV----KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999996542 378889999999999999999998 9999999999999999999999999998765433
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
. ......++..|+|||+.....++.++|+||+|+++|+|++|+.||...... ...++....... .. ...
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~---~~----~~~ 222 (258)
T cd05578 154 T-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQETA---DV----LYP 222 (258)
T ss_pred c-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhccc---cc----cCc
Confidence 2 233456788999999988888999999999999999999999999743321 122222222111 11 111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCH--HHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTM--RDVI 972 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~--~evl 972 (1009)
... ...+.+++.+|++.||++||++ +|++
T Consensus 223 ~~~------~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 ATW------STEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccC------cHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111 1356678899999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=312.27 Aligned_cols=201 Identities=27% Similarity=0.400 Sum_probs=172.8
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-----
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE----- 769 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~----- 769 (1009)
.+.++|+..+.||+|+||.||+|.+..+++.||+|.+.+..........+.+|++++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 356789999999999999999999999999999999865544455556777999999999999999999988643
Q ss_pred -CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 770 -TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 770 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
...++||||+. ++|.+.+... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 35799999995 5788887532 67788888999999999999998 9999999999999999999999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
|+++...... ......+++.|+|||...+..++.++|||||||++|+|++|+.||..
T Consensus 163 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 163 GLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred ccceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 9998653322 22334578899999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=301.22 Aligned_cols=267 Identities=24% Similarity=0.351 Sum_probs=198.1
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||.|++|.||+|++..+++.||||++..... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 36778899999999999999998999999999865432 22345566899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++ +|.+++..... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.++++|||++.......
T Consensus 80 ~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 80 MDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred CCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 975 88888865432 23478999999999999999999998 99999999999999999999999999997654332
Q ss_pred CceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc-------ccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA-------QDE 930 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 930 (1009)
.......+++.|+|||+..+ ..++.++||||||+++|+|++|+.||...... +....+......... ...
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhHHHHhcCc
Confidence 22233456889999998755 35688999999999999999999999743211 111111110000000 000
Q ss_pred ccCccccccCch-----HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ALDPSIAGQCKH-----VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.....+...... .......+.+++.+|++.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000000 0111234678999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=298.41 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=204.7
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||+|+||.||++.+..+++.+|+|.+...........++.+|++++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 36778899999999999999998899999999876544445556677999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.+++.........+++..++.++.|+++|++|||+. +++|+||+|+||+++.++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876443334578999999999999999999998 9999999999999999999999999999776443
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
......+++.|+|||...+..++.++|+||+|+++|||++|+.||.... ..+.. ..+..+. -+.+..
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~~~~-~~~~~~~------~~~~~~ 223 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----MQDLR-YKVQRGK------YPPIPP 223 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHH-HHHhcCC------CCCCch
Confidence 2233457889999999988889999999999999999999999997422 11111 1111111 011111
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
....++..++.+|++.+|++||++.|+++
T Consensus 224 ------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 224 ------IYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ------hhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 12234678899999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=302.60 Aligned_cols=251 Identities=29% Similarity=0.408 Sum_probs=196.5
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
..+.|+..+.||+|+||.||+|....+++.||+|++..... ..+...++.+|+++++.++||||+++++++.+++..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 34568888999999999999999998899999999864432 23344567799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||++ |++.+++..... .+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++...
T Consensus 93 v~e~~~-g~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 93 VMEYCL-GSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EHHhhC-CCHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceec
Confidence 999996 667777653321 378889999999999999999998 9999999999999999999999999998754
Q ss_pred ccCCCceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
... ....+++.|+|||+.. ...++.++||||||+++|||++|+.||.... ........ ....
T Consensus 166 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-----~~~~~~~~-~~~~----- 230 (307)
T cd06607 166 SPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHI-AQND----- 230 (307)
T ss_pred CCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-----HHHHHHHH-hcCC-----
Confidence 322 2345788999999864 4568899999999999999999999986321 11111111 1110
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
.+.+.. ......+..++.+||+.+|++||++.+++..
T Consensus 231 -~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 -SPTLSS-----NDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CCCCCc-----hhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011100 0112346788899999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=302.84 Aligned_cols=265 Identities=25% Similarity=0.331 Sum_probs=196.2
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|++|.||+|.+..+++.||+|.+............+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 45788899999999999999999889999999986654333444567799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC-CCcEEEcccccceeccc
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA-NLEARIADFGLARMMLH 856 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGls~~~~~ 856 (1009)
|++ +++.+++..... ...++.....++.||+.||+|||+. +++||||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 578887754332 2257778888999999999999998 9999999999999985 56799999999976533
Q ss_pred CCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh-ccccccccC-
Q 037197 857 KNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS-NKAQDEALD- 933 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~- 933 (1009)
.........+++.|+|||+..+ ..++.++||||+|+++|+|+||+.||..... .+.+...... +.......+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE-----IDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChhhccc
Confidence 3223333456889999998765 4578999999999999999999999964211 1111111110 000000000
Q ss_pred -----------ccccccC--chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 -----------PSIAGQC--KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 -----------~~~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+...... ........++.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 000011234667899999999999999999985
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=295.62 Aligned_cols=247 Identities=27% Similarity=0.436 Sum_probs=194.2
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||++.. +++.||+|.+... .....+.+|+.++++++|||++++++++... ..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 4578889999999999999975 4678999998543 2235677999999999999999999998765 4799999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++..... ..+++..++.++.|+++|++|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 79 LMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred CCCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 9999999999975432 2368888999999999999999998 9999999999999999999999999998754321
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
......+..|+|||+.....++.++||||||+++|||++ |+.||.... ..+... .+..+. .+..
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~-~~~~~~------~~~~ 218 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVKE-CVEKGY------RMEP 218 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHHH-HHhCCC------CCCC
Confidence 112234568999999888889999999999999999998 999986422 222221 111111 0011
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
.... ...+.+++.+|++.+|++||+++++++.|++
T Consensus 219 ~~~~------~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGC------PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111 1345678899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=304.12 Aligned_cols=272 Identities=21% Similarity=0.297 Sum_probs=198.5
Q ss_pred CCHHHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC
Q 037197 691 FTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET 770 (1009)
Q Consensus 691 ~~~~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~ 770 (1009)
|...+..+.|+..+.||+|+||.||+|....+++.||||.+............+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred CcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 33455667899999999999999999999999999999998654333333445668999999999999999999986543
Q ss_pred --------eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc
Q 037197 771 --------NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE 842 (1009)
Q Consensus 771 --------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 842 (1009)
..++||||+. +++.+++.... ..+++.+++.++.|+++||+|||++ +++|+||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~ 157 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGI 157 (310)
T ss_pred ccccCCCceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCc
Confidence 4599999996 57888875432 2378899999999999999999998 9999999999999999999
Q ss_pred EEEcccccceecccCCC----ceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHH
Q 037197 843 ARIADFGLARMMLHKNE----TVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEW 917 (1009)
Q Consensus 843 ~kl~DfGls~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~ 917 (1009)
+||+|||++..+..... ......++..|+|||...+. .++.++||||||+++|||++|+.||..... ......
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~~~~ 235 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQLTL 235 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence 99999999976643321 12234567889999987654 468899999999999999999999864221 111111
Q ss_pred HHHHHhhcccccccc---------C-ccccccCc-hHHH------HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 918 VLSMIKSNKAQDEAL---------D-PSIAGQCK-HVQE------EMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 918 ~~~~~~~~~~~~~~~---------~-~~~~~~~~-~~~~------~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+..... ....+.. + ..+..... .... ....+.+++.+|++.||++||+++|+++
T Consensus 236 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 236 ISQLCG--SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHhC--CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 111110 0000000 0 00000000 0000 1123567999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=306.54 Aligned_cols=205 Identities=27% Similarity=0.363 Sum_probs=169.1
Q ss_pred cCCcCceeccCCceEEEEEEECC--CCeEEEEEEcccCC-CChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC--CeEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHR--PHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE--TNVM 773 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~ 773 (1009)
+|+..+.||+|+||.||+|.... ++..||+|.+.... ..........+|++++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36778889999999999999988 78999999997643 1122345667899999999999999999999888 8899
Q ss_pred EEEeccCCCChhhhhcCCccc-cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC----CCcEEEccc
Q 037197 774 MVYDYMPNDSLGEALHGKEAG-KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA----NLEARIADF 848 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Df 848 (1009)
+||||+++ ++.+++...... ...+++..++.++.|++.|++|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 677766433222 22478889999999999999999998 9999999999999999 899999999
Q ss_pred ccceecccCCC---ceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 037197 849 GLARMMLHKNE---TVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPA 907 (1009)
Q Consensus 849 Gls~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~ 907 (1009)
|++........ ......+++.|+|||+..+ ..++.++||||||+++|+|++|+.||...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 99986543322 2223457889999998765 45789999999999999999999999744
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=293.16 Aligned_cols=250 Identities=27% Similarity=0.405 Sum_probs=203.9
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
+|+..+.||+|++|.||+|.+..+++.||+|.+..........+.+.+|++++++++|||++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 36778899999999999999998899999999976654435566777999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.+++.... .+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999987542 378999999999999999999998 99999999999999999999999999998775544
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
.......++..|+|||......++.++||||+|+++|+|++|+.||.... . ........... .+.+..
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~-~~~~~~~~~~~-------~~~~~~ 221 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----P-MAALFRIVQDD-------HPPLPE 221 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----H-HHHHHHHhccC-------CCCCCC
Confidence 43344568889999999877778899999999999999999999987322 1 11111111111 111111
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.. ...+..++.+|++.+|++||++.|++.
T Consensus 222 ~~------~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GI------SPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CC------CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11 124567888999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=297.83 Aligned_cols=202 Identities=26% Similarity=0.336 Sum_probs=178.0
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChh-hHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE-SGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|..-++||+|+||.||-++.+.+|+.||.|++.+...... .....+.|-.++.+++.+.||.+--+|+..+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 346667889999999999999999999999998855432222 2334558999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
..|.||+|.-.|..... ..+++..+.-++.+|+-||++||+. +||.||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 265 tlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999988876643 3389999999999999999999999 999999999999999999999999999998744
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~ 905 (1009)
+......+||.+|||||++....|+...|.||+||++|||+.|+.||.
T Consensus 340 -g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr 387 (591)
T KOG0986|consen 340 -GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFR 387 (591)
T ss_pred -CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchh
Confidence 344555689999999999999999999999999999999999999997
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=295.35 Aligned_cols=245 Identities=24% Similarity=0.342 Sum_probs=195.7
Q ss_pred eccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCCh
Q 037197 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSL 784 (1009)
Q Consensus 706 iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL 784 (1009)
||.|++|.||+|.+..+++.||+|++.+.... ....+.+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999988999999999654332 23445677999999999999999999999999999999999999999
Q ss_pred hhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCceeee
Q 037197 785 GEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMV 864 (1009)
Q Consensus 785 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 864 (1009)
.+++..... +++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~~~~----l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~ 152 (262)
T cd05572 81 WTILRDRGL----FDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTF 152 (262)
T ss_pred HHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccc
Confidence 999976432 78888899999999999999998 99999999999999999999999999998764432 22334
Q ss_pred cccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHH
Q 037197 865 AGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQ 944 (1009)
Q Consensus 865 ~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1009)
.+++.|+|||......++.++|+||+|+++|+|++|+.||..... +............. ........
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~------~~~~~~~~---- 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---DPMEIYNDILKGNG------KLEFPNYI---- 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---CHHHHHHHHhccCC------CCCCCccc----
Confidence 678899999998888899999999999999999999999974332 12222222221010 11111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 037197 945 EEMLLVLRIAVLCTAKLPKGRPT-----MRDVIT 973 (1009)
Q Consensus 945 ~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 973 (1009)
..++..++.+|++.+|++||+ +.|+++
T Consensus 220 --~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 --DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred --CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 235678899999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=306.17 Aligned_cols=269 Identities=28% Similarity=0.403 Sum_probs=198.9
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcC--Ce
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNE--TN 771 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~--~~ 771 (1009)
.+.++|+..+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 456788899999999999999999998899999999865433344455677899999999 999999999998643 46
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 899999997 5899988654 378888889999999999999998 9999999999999999999999999999
Q ss_pred eecccCCC-----ceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc
Q 037197 852 RMMLHKNE-----TVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN 925 (1009)
Q Consensus 852 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 925 (1009)
........ ......+++.|+|||.... ..++.++||||||+++|+|++|+.||...... +..+.+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~--~~~~~~~~~~~~~ 232 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL--NQLEKIIEVIGPP 232 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCC
Confidence 86543321 2223467889999997654 45788999999999999999999999632211 1111000000000
Q ss_pred ----------cccccccCccccccCch----HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 926 ----------KAQDEALDPSIAGQCKH----VQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 926 ----------~~~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
......++......... ......++.+++.+|++.||++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000000 00112356789999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=298.65 Aligned_cols=262 Identities=26% Similarity=0.351 Sum_probs=198.4
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC--CeEEEEEe
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE--TNVMMVYD 777 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~lV~E 777 (1009)
|+..+.||+|+||.||+|....+++.||+|++............+.+|++++++++|||++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5667889999999999999999899999999976643344455677999999999999999999999887 88999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|++ ++|.+++.... ..+++.+++.++.|+++|++|||+. +++|+||+|+||++++++.++++|||.+......
T Consensus 81 ~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 997 48888886542 2378999999999999999999998 9999999999999999999999999999876443
Q ss_pred CC-ceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NE-TVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
.. ......++..|+|||...+ ..++.++||||||+++|||++|+.||..... ...+...............+.
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-----LEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCchhhccc
Confidence 31 2233456788999997654 4578999999999999999999999974321 111221111110000000000
Q ss_pred c---------------cccCchHHH--HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 I---------------AGQCKHVQE--EMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~---------------~~~~~~~~~--~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. ......... ....+.+++.+|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 000000000 1345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=301.28 Aligned_cols=254 Identities=29% Similarity=0.405 Sum_probs=198.0
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|+..+.||+|+||.||+|++..++..||+|++...... ......+.+|++++++++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4477788999999999999999988999999998654322 233456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||++ |++.+.+.... ..+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9996 57777765432 2378999999999999999999998 999999999999999999999999998865432
Q ss_pred CCCceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 857 KNETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
.....+++.|+|||++. ...++.++|||||||++|||++|+.||.... .............
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~~~~~~~~~~------- 241 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNES------- 241 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHhccC-------
Confidence 22345788999999863 4568899999999999999999999986321 1111111111111
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
+... .. .....+..++.+|++.+|++||++.++++......
T Consensus 242 ~~~~--~~---~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 242 PTLQ--SN---EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCCC--Cc---cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0000 00 11124667888999999999999999998655444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=299.44 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=196.6
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
|+....||+|+||.||+|....+++.||||++... .......+.+|+.+++.++|+|++++++++...+..++||||+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33446799999999999999988999999998433 2234456779999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
++++|.+++.... +++.....++.|++.|++|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 100 ~~~~L~~~~~~~~-----~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 100 EGGALTDIVTHTR-----MNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred CCCcHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 9999999875432 67888899999999999999998 999999999999999999999999999876544333
Q ss_pred ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccccc
Q 037197 860 TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1009)
......+++.|+|||+.....++.++|+||+|+++|+|++|+.||... +..+.+. ...... .+.+..
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~-----~~~~~~~-~~~~~~------~~~~~~- 238 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPLKAMK-MIRDNL------PPKLKN- 238 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHH-HHHhhC------CcccCC-
Confidence 334456889999999988888899999999999999999999998632 1111111 111111 111110
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 940 CKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 940 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
... ....+..++.+|++.+|.+||++.++++
T Consensus 239 ~~~---~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 LHK---VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccc---CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 001 1123557888999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=297.05 Aligned_cols=245 Identities=24% Similarity=0.257 Sum_probs=186.9
Q ss_pred eeccCCceEEEEEEECCCCeEEEEEEcccCCCChhh-HHHHHHHHHHH---hccCCCceeeEEeEEEcCCeEEEEEeccC
Q 037197 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIES-GDDLFREVSLL---GRLRHRNIVRLLGYLHNETNVMMVYDYMP 780 (1009)
Q Consensus 705 ~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l---~~l~Hpniv~l~~~~~~~~~~~lV~E~~~ 780 (1009)
+||+|+||.||++.+..+++.||+|.+......... .....+|..++ ...+||+|+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999988999999998654332222 22233444433 33479999999999999999999999999
Q ss_pred CCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCc
Q 037197 781 NDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860 (1009)
Q Consensus 781 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~ 860 (1009)
+++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||++.......
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999986543 278999999999999999999998 99999999999999999999999999987653322
Q ss_pred eeeecccCcccCCcccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccccc
Q 037197 861 VSMVAGSYGYIAPEYGY-TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939 (1009)
Q Consensus 861 ~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1009)
.....|++.|+|||... +..++.++||||+||++|||++|..||....... .. .+...... ....+...
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~-~~~~~~~~-------~~~~~~~~ 221 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KH-EIDRMTLT-------VNVELPDS 221 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HH-HHHHHhhc-------CCcCCccc
Confidence 22346899999999875 4567899999999999999999999997432221 11 11111110 11111111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 037197 940 CKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVITM 974 (1009)
Q Consensus 940 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 974 (1009)
. ..++.+++.+|++.||++|| +++|+++.
T Consensus 222 ~------~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 222 F------SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred c------CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1 12456788899999999999 58888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=274.94 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=193.7
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEec
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
.+....||.|.-|.|+|++.+.+|..+|||.+++... .+..++++..++++... ++|.||+.+|||.....+++.||.
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 4556679999999999999999999999999987654 44567777888876665 599999999999999999999998
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
|. -.++.+++... .++++...-++...+++||.||..+| +|+|||+||+|||+|+.|++|++|||.+.++.+..
T Consensus 173 Ms-~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 173 MS-TCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HH-HHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 84 33555554332 23777778889999999999999876 99999999999999999999999999998875433
Q ss_pred CceeeecccCcccCCcccCC---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 859 ETVSMVAGSYGYIAPEYGYT---LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
..+..+|.+.|||||.+.. .+|+.++||||||++++||.||..||..-..+ .+......... .|.
T Consensus 247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td----Fe~ltkvln~e-------PP~ 314 (391)
T KOG0983|consen 247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD----FEVLTKVLNEE-------PPL 314 (391)
T ss_pred -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc----HHHHHHHHhcC-------CCC
Confidence 3345678899999998753 46889999999999999999999999742222 22222222211 122
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+...-. -...+.+++..|+.+|+.+||...++++
T Consensus 315 L~~~~g----FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 315 LPGHMG----FSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCcccC----cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 221111 1234667888999999999998877654
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=292.46 Aligned_cols=251 Identities=28% Similarity=0.376 Sum_probs=204.4
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC--CeEEEEEe
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE--TNVMMVYD 777 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~lV~E 777 (1009)
|+..+.||+|++|.||+|....+++.|++|++..........+.+.+|++++++++||||+++++.+.+. ...++|||
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 6677899999999999999998899999999976544445566777999999999999999999999988 88999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++.... .+++..++.++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 82 YVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred ecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999997654 389999999999999999999998 9999999999999999999999999999876544
Q ss_pred CC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
.. ......++..|+|||.......+.++||||||+++|+|++|..||.... +....+.... ... ..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~-~~~-----~~~~ 224 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIG-SSG-----EPPE 224 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhcc-ccC-----CCcC
Confidence 32 1344568889999999888889999999999999999999999997433 1111111111 000 0111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.... ...+.+++.+|++.+|++||++.|+++
T Consensus 225 ~~~~~------~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 IPEHL------SEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCccc------CHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11111 235667888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=308.49 Aligned_cols=269 Identities=24% Similarity=0.306 Sum_probs=201.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-----Ce
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE-----TN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----~~ 771 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||.+............+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4568889999999999999999999999999999865433344455677899999999999999999987644 35
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 78988886543 278889999999999999999998 9999999999999999999999999999
Q ss_pred eecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc---
Q 037197 852 RMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA--- 927 (1009)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--- 927 (1009)
..............++..|+|||.... ..++.++|||||||++|+|++|+.||..... ......+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCChHHh
Confidence 876443333344567889999998654 4588999999999999999999999963211 0111111111000000
Q ss_pred --------------cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--Hhhc
Q 037197 928 --------------QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM--LGEA 978 (1009)
Q Consensus 928 --------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~ 978 (1009)
.....++...... .....++.+++.+|++.+|++||++.|+++- ++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLF---PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHc---ccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000000000000 1122446789999999999999999999876 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=300.70 Aligned_cols=266 Identities=25% Similarity=0.313 Sum_probs=197.3
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC-----
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET----- 770 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----- 770 (1009)
..+.|+..+.||+|+||.||+|.++.+++.||+|++............+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 456788999999999999999999988999999998655433333456668999999999999999999987654
Q ss_pred -----eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEE
Q 037197 771 -----NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARI 845 (1009)
Q Consensus 771 -----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 845 (1009)
..++|+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 78999999976 6777665432 2378899999999999999999998 9999999999999999999999
Q ss_pred cccccceecccCCC-ceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh
Q 037197 846 ADFGLARMMLHKNE-TVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 846 ~DfGls~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
+|||.+........ ......++..|+|||...+ ..++.++|||||||++|||++|+.||.... .....+.+.....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~--~~~~~~~~~~~~~ 235 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ--ELAQLELISRLCG 235 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhC
Confidence 99999986644332 2223346778999997654 457889999999999999999999997421 1111111111111
Q ss_pred hccc--cccc--------cCc------cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 924 SNKA--QDEA--------LDP------SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 924 ~~~~--~~~~--------~~~------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.... .... .++ ......... ...+.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFI---PTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCC---CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000 000 000001111 235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=296.71 Aligned_cols=262 Identities=23% Similarity=0.267 Sum_probs=193.2
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcC--CeEEEEE
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNE--TNVMMVY 776 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~--~~~~lV~ 776 (1009)
|+..+.||+|+||.||+|....+++.||+|+++....+.. ....++|+.+++++. |||++++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 5567889999999999999998899999999865433222 234568999999885 99999999999887 8899999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||++ +++.+.+.... ..+++.+++.++.|++.||+|||+. +++||||+|+||+++. +.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 80 ELMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred ecCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 9996 57888776532 2378999999999999999999998 9999999999999999 9999999999976533
Q ss_pred CCCceeeecccCcccCCcccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc-------cc
Q 037197 857 KNETVSMVAGSYGYIAPEYGY-TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK-------AQ 928 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-------~~ 928 (1009)
.. ......+++.|+|||+.. ...++.++||||+||++|||++|+.||..... .+...+......... ..
T Consensus 152 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 152 KP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred CC-CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcc
Confidence 22 223345788999999754 45578899999999999999999999964221 111222211110000 00
Q ss_pred ccccCccccccCc-----hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 929 DEALDPSIAGQCK-----HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 929 ~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
....+..+..... ........+.+++.+|++++|++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000000 00112356788999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=306.67 Aligned_cols=265 Identities=23% Similarity=0.307 Sum_probs=198.2
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc----CCeE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN----ETNV 772 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~----~~~~ 772 (1009)
.+.|+..+.||+|+||.||+|....+++.||+|++............+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999999999999999987654444455667789999999999999999998753 3568
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
++||||+. ++|.+++..... +++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP----LTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 689998865432 78899999999999999999998 99999999999999999999999999997
Q ss_pred ecccCCC----ceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 853 MMLHKNE----TVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 853 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
....... ......++..|+|||++.. ..++.++||||||+++|||++|+.||...... .....+.... +..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~--g~~ 231 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVL--GSP 231 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHh--CCC
Confidence 6543221 1223467889999998654 45889999999999999999999999642110 1111111100 000
Q ss_pred ccccc---------------CccccccCch-HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 928 QDEAL---------------DPSIAGQCKH-VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 928 ~~~~~---------------~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+.. .......... ......++..++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000 0000000000 0112345778999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=292.94 Aligned_cols=246 Identities=20% Similarity=0.226 Sum_probs=188.3
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHH-HhccCCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSL-LGRLRHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||.||+|.+..+++.||+|.+.+.... ......+..|..+ ....+|||++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999999988999999998654321 1222334455544 4455899999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
++|.++++... .+++..+..++.|+++||.|||+. +++||||+|+||++++++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~ 150 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----N 150 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----c
Confidence 99999996543 268888889999999999999998 999999999999999999999999999875432 2
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
....+++.|+|||...+..++.++||||+|+++|||++|..||.... .............. ........
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~----~~~~~~~~-- 219 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-----PDAVFDNILSRRIN----WPEEVKEF-- 219 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcccC----CCCccccc--
Confidence 23457889999999887778999999999999999999999996321 12222221111110 01111111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 975 (1009)
....+.+++.+|++.+|++||++.++.+.+
T Consensus 220 ----~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 220 ----CSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ----CCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 112456788999999999999887665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=336.23 Aligned_cols=254 Identities=28% Similarity=0.344 Sum_probs=202.1
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.-+++....||.|.||.||.|...++|+..|+|-++....+........+|+.++..++|||+|+++|+-.+.+..++.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 44567888999999999999999999999999998876655545556667999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
||||++|+|.+.+...+. .++.....+..|++.|++|||++ |||||||||.||+++.+|-+|.+|||.|..+.
T Consensus 1313 MEyC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999999965432 55666666889999999999999 99999999999999999999999999998875
Q ss_pred cCCC----ceeeecccCcccCCcccCCCC---CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 856 HKNE----TVSMVAGSYGYIAPEYGYTLK---VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 856 ~~~~----~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
...+ .....+||+.|||||++.+.. ...+.||||+|||+.||+||+.||...... .+.+.. +.-+
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne----~aIMy~-V~~g--- 1457 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE----WAIMYH-VAAG--- 1457 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch----hHHHhH-Hhcc---
Confidence 5432 223567999999999987544 446899999999999999999999754332 111111 1111
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
-.|.++.. ...+-.+++..|+..||++|.++.|+++
T Consensus 1458 ---h~Pq~P~~------ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1458 ---HKPQIPER------LSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ---CCCCCchh------hhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 12223222 1123356778999999999988886654
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=289.16 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=200.9
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
|+..+.||+|++|.||++.+..+++.|++|++..... .....+.+|++++++++||+++++++++......++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 5677889999999999999998899999999965432 34567779999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
++++|.+++.... ..+++..+..++.|+++|++|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999987653 2378999999999999999999998 999999999999999999999999999977644332
Q ss_pred ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccccc
Q 037197 860 TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1009)
.....++..|+|||+.....++.++||||||+++|+|++|+.||.... ..+......... ......+
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~--~~~~~~~----- 220 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP-----PMKALFKIATNG--PPGLRNP----- 220 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc-----hHHHHHHHHhcC--CCCcCcc-----
Confidence 344568889999999888888999999999999999999999987321 112221111110 0111110
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 940 CKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 940 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
......+.+++.+|++.||++||++.|+++
T Consensus 221 ----~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 ----EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ----cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 001234667889999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=295.99 Aligned_cols=244 Identities=23% Similarity=0.264 Sum_probs=189.6
Q ss_pred eccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCCh
Q 037197 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSL 784 (1009)
Q Consensus 706 iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL 784 (1009)
||+|+||+||++.+..+++.||+|.+...... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999988999999998654322 22234556899999999999999999999999999999999999999
Q ss_pred hhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCceeee
Q 037197 785 GEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMV 864 (1009)
Q Consensus 785 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 864 (1009)
.+++..... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+..... .......
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGR 154 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccc
Confidence 999875432 2378899999999999999999998 999999999999999999999999999876533 2223344
Q ss_pred cccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHH
Q 037197 865 AGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQ 944 (1009)
Q Consensus 865 ~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1009)
.++..|+|||+..+..++.++||||+|+++|+|++|+.||...... .. ...+...... .........
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~-~~~~~~~~~~-------~~~~~~~~~---- 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VE-KEELKRRTLE-------MAVEYPDKF---- 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-cc-HHHHHhcccc-------ccccCCccC----
Confidence 5788999999988888999999999999999999999999743221 01 1111111000 011111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHH
Q 037197 945 EEMLLVLRIAVLCTAKLPKGRPTMRD 970 (1009)
Q Consensus 945 ~~~~~l~~l~~~cl~~dp~~RPs~~e 970 (1009)
...+..++.+|++.+|++||++.|
T Consensus 222 --~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 222 --SPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred --CHHHHHHHHHHccCChhHccCCCc
Confidence 124567889999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=298.25 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=192.4
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEEEEec
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...++||||
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45567899999999999999999999999998654332 34456778999999996 99999999999999999999999
Q ss_pred cCCCChhhhhcCC-ccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 779 MPNDSLGEALHGK-EAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 779 ~~~gsL~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
+. +++.++.... ......+++.....++.++++||+|||+.+ +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 4555543211 111133788889999999999999999742 8999999999999999999999999999765332
Q ss_pred CCceeeecccCcccCCcccCCC---CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTL---KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
. ......+++.|+|||++... .++.++||||+||++|||++|+.||.... .....+....... .+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~-------~~ 229 (288)
T cd06616 162 I-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGD-------PP 229 (288)
T ss_pred C-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCC-------CC
Confidence 2 22233578899999987765 68899999999999999999999997421 1112221111110 11
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
.+..... .....++.+++.+|++.+|++||++.|+++.
T Consensus 230 ~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEE--REFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCC--CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111100 1122356788999999999999999998873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=295.89 Aligned_cols=262 Identities=23% Similarity=0.311 Sum_probs=199.9
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
|+..+.||+|++|.||+|....+++.+|+|++............+.+|++++++++||||+++++++.++...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45677899999999999999988999999998765444444567779999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
++ ++.+++.... ..+++.+++.++.|+++|++|||+. +|+|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 8888876542 2378899999999999999999998 999999999999999999999999999987654432
Q ss_pred ceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc---
Q 037197 860 TVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS--- 935 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 935 (1009)
......++..|+|||...+. .++.++||||+|+++|+|++|+.||..... .+.+...............+.
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-----IDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCchHhcccchh
Confidence 33335577889999987766 788999999999999999999999863221 111111111000000000000
Q ss_pred --------ccc-----cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 --------IAG-----QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 --------~~~-----~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.. ..........++.+++.+|++.||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00001122345778999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=280.94 Aligned_cols=203 Identities=23% Similarity=0.313 Sum_probs=180.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.+.|+..+++|+|.||.|..++.+.+++.||+|++++.-. .......-..|-++++..+||.+..+--.|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3567889999999999999999999999999999976532 222334455799999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+.||.|.-.+.+.+. +++....-+-..|+.||.|||++ +||.||+|.+|.++|+||++||+|||+++.-.
T Consensus 247 MeyanGGeLf~HLsrer~----FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERV----FSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehhhhhc----ccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999888865443 77777777888999999999999 99999999999999999999999999998766
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
..+...+.++|||.|+|||++....|..+.|.|.+|||+|||++|+.||..
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 666788889999999999999999999999999999999999999999974
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=297.33 Aligned_cols=260 Identities=18% Similarity=0.217 Sum_probs=184.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCC---CeEEEEEEcccCCCChhhH---------HHHHHHHHHHhccCCCceeeEEeE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESG---------DDLFREVSLLGRLRHRNIVRLLGY 765 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~---~~~vavK~~~~~~~~~~~~---------~~~~~E~~~l~~l~Hpniv~l~~~ 765 (1009)
++|+..+.||+|+||.||+|.+..+ +..+|+|+........... .....+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5789999999999999999998876 6677777643322111100 112234445667789999999997
Q ss_pred EEcCC----eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC
Q 037197 766 LHNET----NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL 841 (1009)
Q Consensus 766 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~ 841 (1009)
+.... ..++++|++. .++.+.+..... .++..+..|+.|+++|++|||+. +|+||||||+||+++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIKC----KNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhcc----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 65443 4477888773 456666543221 46677888999999999999998 999999999999999999
Q ss_pred cEEEcccccceecccCCC-------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccH
Q 037197 842 EARIADFGLARMMLHKNE-------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914 (1009)
Q Consensus 842 ~~kl~DfGls~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~ 914 (1009)
.++|+|||+++.+..... ......||+.|+|||+..+..++.++|||||||++|||++|+.||....... ..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-~~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-NL 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-HH
Confidence 999999999987643221 1223468999999999998899999999999999999999999997542211 11
Q ss_pred HHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 915 VEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
........... ...+.+ ..... ...+.+++..|+..+|++||++.++++.++
T Consensus 243 ~~~~~~~~~~~-----~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDFIKR-----LHEGKI--KIKNA---NKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHHHHH-----hhhhhh--ccCCC---CHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111110000 000000 01111 134667888999999999999999998763
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=305.28 Aligned_cols=270 Identities=23% Similarity=0.317 Sum_probs=196.7
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-----Ce
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE-----TN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----~~ 771 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|++... ........+.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 46788999999999999999999999999999998532 2233445677899999999999999999987644 35
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++|+||++ +++.+++.... +++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~-----l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQH-----LSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhcc-cCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 799999996 57888775432 78888999999999999999998 9999999999999999999999999999
Q ss_pred eecccCCC---ceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 852 RMMLHKNE---TVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 852 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
........ ......+++.|+|||...+ ..++.++||||+||++|+|++|+.||..... ......+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~ 231 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQ 231 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCH
Confidence 76543221 1223467889999998644 5688999999999999999999999963211 0111111110000000
Q ss_pred --cccccC-------ccccccCc-----hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--Hhhc
Q 037197 928 --QDEALD-------PSIAGQCK-----HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM--LGEA 978 (1009)
Q Consensus 928 --~~~~~~-------~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~ 978 (1009)
.....+ ........ .......++..++.+|++.+|++||++.|+++. ++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 000000 00000000 001112346789999999999999999999885 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=293.46 Aligned_cols=262 Identities=24% Similarity=0.302 Sum_probs=195.8
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc---CCCceeeEEeEEEcCCe-----
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL---RHRNIVRLLGYLHNETN----- 771 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~~~~----- 771 (1009)
|+..+.||+|+||.||+|+++.+++.||+|++............+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667889999999999999998899999999975544333344555777776665 69999999999987776
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.+++|||+. ++|.+++..... ..+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||.+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 999999996 579888865432 2378899999999999999999998 9999999999999999999999999999
Q ss_pred eecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccc--
Q 037197 852 RMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD-- 929 (1009)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 929 (1009)
..+..... .....+++.|+|||+..+..++.++||||||+++|||++|+.||..... .+.............
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 155 RIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-----ADQLDKIFDVIGLPSEE 228 (287)
T ss_pred eeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-----HHHHHHHHHHcCCCChH
Confidence 77643322 2233478899999999888899999999999999999999999874221 122222211110000
Q ss_pred c----------ccCccccccCch-HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 930 E----------ALDPSIAGQCKH-VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 930 ~----------~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. ............ ..+....+.+++.+|++.||++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000000000 1122345678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=319.22 Aligned_cols=273 Identities=22% Similarity=0.216 Sum_probs=187.3
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCC-eEEEEEE--------------ccc-CCCChhhHHHHHHHHHHHhccCCC
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPH-MVVAVKK--------------LWR-SDNDIESGDDLFREVSLLGRLRHR 757 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~-~~vavK~--------------~~~-~~~~~~~~~~~~~E~~~l~~l~Hp 757 (1009)
..+.++|+..+.||+|+||+||++..+... ..+++|. +.+ ..........+.+|++++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 345678999999999999999998765322 1122221 100 011122334566899999999999
Q ss_pred ceeeEEeEEEcCCeEEEEEeccCCCChhhhhcCCcc-ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEE
Q 037197 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEA-GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNIL 836 (1009)
Q Consensus 758 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIl 836 (1009)
||+++++++...+..|+|+|++. +++.+++..... ........+...|+.|++.||+|||+. +|+||||||+||+
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 99999999999999999999995 567776643321 111133456678999999999999998 9999999999999
Q ss_pred eCCCCcEEEcccccceecccCCC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCC-CCCCCCCCccH
Q 037197 837 LDANLEARIADFGLARMMLHKNE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP-LDPAFGGSKDI 914 (1009)
Q Consensus 837 l~~~~~~kl~DfGls~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~P-f~~~~~~~~~~ 914 (1009)
++.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|..+ +..... ..
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~---~~ 376 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG---KP 376 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC---CH
Confidence 99999999999999987644332 22345789999999999888999999999999999999998864 432211 11
Q ss_pred HHHHHHHHhhcccc-ccccCc-----------cccccCchHHHH------HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 915 VEWVLSMIKSNKAQ-DEALDP-----------SIAGQCKHVQEE------MLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 915 ~~~~~~~~~~~~~~-~~~~~~-----------~~~~~~~~~~~~------~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+...+...... .+..+. .+.......... ...+..++.+|++.||++||++.|+++
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11111111111000 000000 000000000000 123556788999999999999999986
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=305.13 Aligned_cols=268 Identities=23% Similarity=0.354 Sum_probs=199.6
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC---
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET--- 770 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~--- 770 (1009)
..+.++|+..+.||+|+||.||+|.+..++..||||++............+.+|++++++++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 44567899999999999999999999988999999998654333334456779999999999999999999987553
Q ss_pred ---eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcc
Q 037197 771 ---NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIAD 847 (1009)
Q Consensus 771 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 847 (1009)
.+++||||+ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++++|
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 468999999 78999888643 278889999999999999999998 999999999999999999999999
Q ss_pred cccceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 848 FGLARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 848 fGls~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
||++...... .....+++.|+|||...+ ..++.++|+||+|+++|++++|+.||..... ............
T Consensus 162 fg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-----~~~~~~~~~~~~ 233 (343)
T cd07880 162 FGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH-----LDQLMEIMKVTG 233 (343)
T ss_pred cccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcC
Confidence 9999765322 223457889999998765 4578999999999999999999999973211 111111111100
Q ss_pred ccccccC---------------cccc-ccCch-HHHHHHHHHHHHHHhccCCCCCCCCHHHHH--HHHhhc
Q 037197 927 AQDEALD---------------PSIA-GQCKH-VQEEMLLVLRIAVLCTAKLPKGRPTMRDVI--TMLGEA 978 (1009)
Q Consensus 927 ~~~~~~~---------------~~~~-~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl--~~L~~~ 978 (1009)
.....+. +... ..... .......+.+++.+|++.||++||++.+++ ..++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0000000 0000 00000 001122467899999999999999999998 344444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=297.28 Aligned_cols=262 Identities=25% Similarity=0.355 Sum_probs=200.0
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
|+..+.||+|++|.||+|+...+++.||+|.+..........+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 45567899999999999999999999999999765433444566778999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
+ ++|.+++.... ..+++..+..++.|+++|++|||+. +|+||||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 58999997653 2378999999999999999999998 999999999999999999999999999987644433
Q ss_pred ceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc-------
Q 037197 860 TVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA------- 931 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 931 (1009)
......++..|+|||..... .++.++||||||+++||+++|+.||.... ....+...........+.
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS-----EIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 33344567789999987766 78899999999999999999999996421 111111111100000000
Q ss_pred ---cCccccc----cC-chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 ---LDPSIAG----QC-KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ---~~~~~~~----~~-~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+..... .. .........+.+++.+|++.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 00 000011235788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=290.02 Aligned_cols=244 Identities=20% Similarity=0.221 Sum_probs=188.1
Q ss_pred HHhcCCcCcee--ccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeE
Q 037197 696 ILACVKESNII--GMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNV 772 (1009)
Q Consensus 696 ~~~~~~~~~~i--G~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~ 772 (1009)
..+.|+..+.+ |+|+||.||++..+.+++.+|+|.+....... .|+.....+ +||||+++++++...+..
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 34556666665 99999999999999999999999985432111 122222222 799999999999999999
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC-cEEEcccccc
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-EARIADFGLA 851 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGls 851 (1009)
++||||+++++|.+++.... .+++.++..++.|+++|++|||+. +++||||||+||+++.++ .++|+|||++
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 99999999999999997653 388999999999999999999998 999999999999999998 9999999998
Q ss_pred eecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 852 RMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
...... ....+++.|+|||+..+..++.++||||+|+++|||++|+.||........+...+.... .. .
T Consensus 158 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~----~-- 226 (267)
T PHA03390 158 KIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK----K-- 226 (267)
T ss_pred eecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc----c--
Confidence 765322 224578899999999888899999999999999999999999974433222222222211 00 0
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCC-HHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT-MRDVI 972 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~evl 972 (1009)
..... .....+.+++.+|++.+|++||+ ++|++
T Consensus 227 --~~~~~------~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 227 --LPFIK------NVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred --CCccc------ccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 00000 11124567888999999999996 58776
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=275.58 Aligned_cols=208 Identities=28% Similarity=0.370 Sum_probs=173.6
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCC----eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc-C
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPH----MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN-E 769 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~ 769 (1009)
+....|+.++.||+|.||.||||..+++. +.+|+|+++.............+|+..++.++||||+.+..++-. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 45667899999999999999999766543 379999997765555556677899999999999999999998866 7
Q ss_pred CeEEEEEeccCCCChhhhhcCCcc-ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC----CcEE
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEA-GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN----LEAR 844 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~----~~~k 844 (1009)
..+++++||.+. +|...|+-+.. ....++......|+.||+.|+.|||++ .|+|||+||.||++..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 889999999965 57777764332 224578888899999999999999999 99999999999999877 8999
Q ss_pred EcccccceecccCCC---ceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 845 IADFGLARMMLHKNE---TVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 845 l~DfGls~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
|+|+|+++.+..+-. ....++.|..|.|||.+.+. .||.+.|||+.||++.||+|-++-|..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999999998865543 23346678999999987755 589999999999999999998877753
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=295.35 Aligned_cols=248 Identities=29% Similarity=0.383 Sum_probs=193.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|...+.||+|+||.||+|++..+++.||+|++..... .......+.+|++++++++|||++++++++.++...|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 346667789999999999999998899999999865433 2233456678999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+. |++.+++.... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 101 e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 101 EYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred ecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 9995 57777775432 2378899999999999999999998 999999999999999999999999998864321
Q ss_pred CCCceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 857 KNETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
.....++..|+|||++. ...++.++||||||+++|||++|..||.... ....+........ .....
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-----~~~~~~~~~~~~~--~~~~~ 242 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNDS--PTLQS 242 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcCC--CCCCc
Confidence 22346788999999874 4568889999999999999999999986431 1222222211111 00001
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
... ...+..++.+|++.+|++||++.+++.
T Consensus 243 ----~~~------~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 243 ----NEW------TDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ----ccc------CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011 123567888999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=293.53 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=196.3
Q ss_pred eccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCCh
Q 037197 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSL 784 (1009)
Q Consensus 706 iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL 784 (1009)
||+|+||.||++.+..+++.||+|.+..... .....+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5899999999999998899999999865432 123455677899999999999999999999999999999999999999
Q ss_pred hhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC-----
Q 037197 785 GEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE----- 859 (1009)
Q Consensus 785 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~----- 859 (1009)
.++++... .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997543 378899999999999999999998 999999999999999999999999999876433211
Q ss_pred ---ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 860 ---TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 860 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
......++..|+|||.......+.++||||||+++|++++|+.||.... .......... +. .. .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~-~~-----~~--~ 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----PEEIFQNILN-GK-----IE--W 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhc-CC-----cC--C
Confidence 2234457889999999888888999999999999999999999997322 1222222111 11 00 0
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
..... ....+..++.+|++.+|++||++.++.+.|+.
T Consensus 221 ~~~~~----~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 221 PEDVE----VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred Ccccc----CCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00100 12345678899999999999999777666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=300.96 Aligned_cols=271 Identities=26% Similarity=0.327 Sum_probs=205.0
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC-----eEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET-----NVM 773 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-----~~~ 773 (1009)
+|+..+.||+|++|.||+|+...+++.||+|++..........+.+.+|++++++++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 477888999999999999999988999999998765443455567789999999999999999999987765 789
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||++ ++|.++++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||.+..
T Consensus 81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 57988886543 388999999999999999999998 999999999999999999999999999987
Q ss_pred cccCC---CceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc-cc
Q 037197 854 MLHKN---ETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK-AQ 928 (1009)
Q Consensus 854 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~ 928 (1009)
..... .......+++.|+|||+..+. .++.++||||+|+++|+|++|+.||..... .+.......... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~ 227 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-----IDQLNLIVEVLGTPS 227 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-----HHHHHHHHHhcCCCC
Confidence 65443 123344678899999998877 789999999999999999999999964321 111111111000 00
Q ss_pred cccc---C-cc----c---cc----cCc-hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhhcCCCc
Q 037197 929 DEAL---D-PS----I---AG----QCK-HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM--LGEAKPRR 982 (1009)
Q Consensus 929 ~~~~---~-~~----~---~~----~~~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~--L~~~~~~~ 982 (1009)
.+.. . .. + .. ... ........+.+++.+|++.+|++||++.++++. ++......
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~ 299 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence 0000 0 00 0 00 000 000112346789999999999999999999983 66655433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=288.53 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=194.6
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCC---CChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC--CeEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD---NDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE--TNVM 773 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~ 773 (1009)
.|+..+.||+|+||.||+|.+..++..||+|.+.... ........+.+|++++++++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 5778899999999999999999999999999875332 1223345667899999999999999999998764 4588
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++++|.+++..... +++....+++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~----l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGA----LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 99999999999999865432 67888889999999999999998 999999999999999999999999999976
Q ss_pred cccC---CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 854 MLHK---NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
.... ........++..|+|||+..+..++.++|||||||++|+|++|+.||... .....+.+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~----- 225 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY-----EAMAAIFKIATQP----- 225 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc-----CHHHHHHHHHcCC-----
Confidence 5321 11223356888999999988888899999999999999999999999732 1122222221111
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+.+... ....+..++.+|+. +|.+||++.+++.
T Consensus 226 -~~~~~p~~------~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 -TKPMLPDG------VSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -CCCCCCcc------cCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111111 11245678889999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-34 Score=280.99 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=194.1
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHH-HhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSL-LGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
+....||.|+||+|+|..++.+|+..|||+++.... ....+++..|.+. ++.-+.||||++||++..++..|+.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 344569999999999999999999999999965543 3445667778776 55558999999999999999999999999
Q ss_pred CCCChhhhhcC-CccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 780 PNDSLGEALHG-KEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 780 ~~gsL~~~l~~-~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
..|++.+-+. ....+..+++...-.|+.-.+.||.||.... .|+|||+||+|||++..|.+|++|||.+..+.+.
T Consensus 146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S- 221 (361)
T KOG1006|consen 146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS- 221 (361)
T ss_pred -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence 5566543321 1112233677777778888999999998875 8999999999999999999999999999776332
Q ss_pred CceeeecccCcccCCcccCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYT--LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
...+.-+|...|||||.+.. ..|+.+|||||+|+++||+.||++|+..+ .++.+.+...+... |.+
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w----~svfeql~~Vv~gd--------pp~ 289 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW----DSVFEQLCQVVIGD--------PPI 289 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH----HHHHHHHHHHHcCC--------CCe
Confidence 23344568889999998753 34899999999999999999999999843 33444444433322 222
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
........+....+.+.+..|+.+|-..||...++.+.
T Consensus 290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11112223344567788999999999999999998753
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=297.72 Aligned_cols=197 Identities=25% Similarity=0.312 Sum_probs=163.2
Q ss_pred eeccC--CceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 705 IIGMG--GNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 705 ~iG~G--~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
.||+| +||+||++.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 35555 9999999999988999999998765444445566778999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCc--
Q 037197 783 SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET-- 860 (1009)
Q Consensus 783 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~-- 860 (1009)
++.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+.........
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 85 SANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999876432 2378888889999999999999998 9999999999999999999999999865433221111
Q ss_pred -----eeeecccCcccCCcccCC--CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 861 -----VSMVAGSYGYIAPEYGYT--LKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 861 -----~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
.....++..|+|||+..+ ..++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 111234567999999765 3478999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=290.06 Aligned_cols=244 Identities=26% Similarity=0.289 Sum_probs=186.7
Q ss_pred eeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhH-HHHHHHH---HHHhccCCCceeeEEeEEEcCCeEEEEEeccC
Q 037197 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESG-DDLFREV---SLLGRLRHRNIVRLLGYLHNETNVMMVYDYMP 780 (1009)
Q Consensus 705 ~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~E~---~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~ 780 (1009)
+||+|+||.||+|.+..+++.||+|.+.+........ ..+..|. +.++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999889999999986543322221 2223443 34445689999999999999999999999999
Q ss_pred CCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCc
Q 037197 781 NDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860 (1009)
Q Consensus 781 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~ 860 (1009)
+++|.+++.... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 999999886543 388999999999999999999998 99999999999999999999999999987653222
Q ss_pred eeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccccc
Q 037197 861 VSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939 (1009)
Q Consensus 861 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1009)
.....|+..|+|||....+ .++.++||||+|+++|||++|+.||........ .. +...... .++.+...
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~-~~~~~~~-------~~~~~~~~ 221 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE-IDRMTLT-------MAVELPDS 221 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HH-HHHHhhc-------cCCCCCCc
Confidence 2234688999999997644 688999999999999999999999975322111 11 1111110 11111111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 940 CKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 940 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
. ..++..++.+|+..+|.+|| ++.|+++
T Consensus 222 ~------s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 222 F------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred C------CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1 12456788899999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=299.42 Aligned_cols=265 Identities=25% Similarity=0.281 Sum_probs=193.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-------
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE------- 769 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------- 769 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|++............+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4678899999999999999999999899999999865433333334567899999999999999999987443
Q ss_pred -CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 770 -TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 770 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
...++||||+++ ++.+.+.... ..+++.++..++.|+++||+|||+. +|+|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 346999999964 6777665432 2388999999999999999999998 9999999999999999999999999
Q ss_pred ccceecccCCC-----------ceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHH
Q 037197 849 GLARMMLHKNE-----------TVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVE 916 (1009)
Q Consensus 849 Gls~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~ 916 (1009)
|++........ ......+++.|+|||...+ ..++.++||||||+++|||++|+.||..... ..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-----~~ 234 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-----ID 234 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-----HH
Confidence 99976533221 1122356788999998654 4578999999999999999999999963211 11
Q ss_pred HHHHHHhhcccc-----------ccccCccccccCch-H----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 917 WVLSMIKSNKAQ-----------DEALDPSIAGQCKH-V----QEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 917 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~-~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
............ ....+.......+. . ......+.+++.+|++.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111111100000 00000000000000 0 011135678999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=297.69 Aligned_cols=264 Identities=25% Similarity=0.326 Sum_probs=196.8
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc-CCeEE
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN-ETNVM 773 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~~~~ 773 (1009)
.+.++|+..+.||.|+||.||+|.+..+++.||+|++.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35678999999999999999999999999999999986544334445667799999999999999999998865 56789
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+ +++|.++++... +++.....++.|+++||+|||+. +|+||||+|+||++++++.++|+|||.+..
T Consensus 87 lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELL-GTDLHRLLTSRP-----LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehh-ccCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 999998 568988886432 57777778999999999999998 999999999999999999999999999875
Q ss_pred cccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh---------
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK--------- 923 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~--------- 923 (1009)
... ......+++.|+|||+..+ ..++.++||||||+++|+|++|+.||..... ......+.....
T Consensus 158 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHHh
Confidence 422 1223456789999998655 5688999999999999999999999963221 000000100000
Q ss_pred --hccccccccCccccccCc-hH----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 924 --SNKAQDEALDPSIAGQCK-HV----QEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 924 --~~~~~~~~~~~~~~~~~~-~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
.... .+.. ........ .. ......+.+++.+|++.+|++||++.+++..
T Consensus 233 ~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENT-LRFV-QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhh-HHHH-hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000 00000000 00 0112356788999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=295.47 Aligned_cols=253 Identities=28% Similarity=0.380 Sum_probs=195.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.+.|+..+.||+|+||.||+|.+..++..||+|.+..... ......++.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 3447777889999999999999998899999999864322 233345677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+. |++.+.+.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++....
T Consensus 94 ~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99996 67877775432 2268888899999999999999998 99999999999999999999999999987653
Q ss_pred cCCCceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
.. ....+++.|+|||... ...++.++|||||||++|||++|+.||..... ............
T Consensus 167 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~------ 231 (308)
T cd06634 167 PA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNES------ 231 (308)
T ss_pred Cc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----HHHHHHHhhcCC------
Confidence 22 2345788999999864 35678899999999999999999999863211 111111111110
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
+.... ......+..++.+||+.+|++||++.++++.-..
T Consensus 232 -~~~~~-----~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 232 -PALQS-----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred -CCcCc-----ccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 11100 0112345678899999999999999999876443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=294.54 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=198.3
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+|+..+.||+|+||.||+|....+++.||+|++..+.. .......+.+|++++++++ ||||+++++++.+++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 57788899999999999999998899999999865432 2233455668999999998 999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 82 EYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999997653 389999999999999999999998 999999999999999999999999999876543
Q ss_pred CCC--------------------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHH
Q 037197 857 KNE--------------------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVE 916 (1009)
Q Consensus 857 ~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~ 916 (1009)
... ......++..|+|||......++.++||||||++++++++|+.||.... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~ 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-----EYL 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-----HHH
Confidence 221 1223457789999999888888999999999999999999999997432 111
Q ss_pred HHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCH----HHHH
Q 037197 917 WVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTM----RDVI 972 (1009)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~----~evl 972 (1009)
.......... .+...+ ...+..++.+|++.+|++||++ .+++
T Consensus 230 ~~~~~~~~~~----~~~~~~----------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 230 TFQKILKLEY----SFPPNF----------PPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HHHHHHhcCC----CCCCcc----------CHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 1111111111 011111 1245678899999999999999 6665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=291.01 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=197.8
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCC---CChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD---NDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+|...+.||+|+||.||++.+...+..+++|.++... .......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4677889999999999999988766666666654322 2223344566899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|.++++........+++.+++.++.|+++|+.|||+. +++|+||+|+||+++. +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999875433344589999999999999999999998 9999999999999975 579999999998764
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
..........+++.|+|||......++.++|+||||+++|+|++|..||... ........... + ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~~~~~-~------~~~~ 224 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVLRIVE-G------PTPS 224 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHc-C------CCCC
Confidence 4444344456788999999988888899999999999999999999998632 22222222211 1 1111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.... ...++.+++.+|++.+|++||++.|+++
T Consensus 225 ~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 LPET------YSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred Ccch------hcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1111 1234567888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=300.56 Aligned_cols=263 Identities=23% Similarity=0.257 Sum_probs=194.9
Q ss_pred HHhcCC-cCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChh------------hHHHHHHHHHHHhccCCCceeeE
Q 037197 696 ILACVK-ESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE------------SGDDLFREVSLLGRLRHRNIVRL 762 (1009)
Q Consensus 696 ~~~~~~-~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~Hpniv~l 762 (1009)
+.++|. ..+.||+|+||.||+|.+..+++.||||++........ ....+.+|++++++++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 345554 45679999999999999998899999999865432210 01246689999999999999999
Q ss_pred EeEEEcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc
Q 037197 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE 842 (1009)
Q Consensus 763 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 842 (1009)
++++..++..++||||+. |+|.+++.... .+++.....++.|++.||+|||+. +|+||||+|+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGI 157 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCC
Confidence 999999999999999996 68999886533 278888899999999999999998 9999999999999999999
Q ss_pred EEEcccccceecccC--------------CCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCC
Q 037197 843 ARIADFGLARMMLHK--------------NETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPA 907 (1009)
Q Consensus 843 ~kl~DfGls~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~ 907 (1009)
++++|||.+...... ........+++.|+|||++.+. .++.++||||+|+++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999765411 1112223467789999987654 4688999999999999999999999743
Q ss_pred CCCCccHHHHHHHHHhhcccccccc----------------CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 037197 908 FGGSKDIVEWVLSMIKSNKAQDEAL----------------DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971 (1009)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ev 971 (1009)
.. .+....+....... ....+ .+....... ....++.+++.+|++.+|++||++.|+
T Consensus 238 ~~--~~~~~~i~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~R~s~~~~ 310 (335)
T PTZ00024 238 NE--IDQLGRIFELLGTP--NEDNWPQAKKLPLYTEFTPRKPKDLKTIFP---NASDDAIDLLQSLLKLNPLERISAKEA 310 (335)
T ss_pred CH--HHHHHHHHHHhCCC--chhhCcchhhcccccccCcCCcccHHHhCc---CCChHHHHHHHHHcCCCchhccCHHHH
Confidence 21 11111121111110 00000 000000000 112346788999999999999999999
Q ss_pred HH
Q 037197 972 IT 973 (1009)
Q Consensus 972 l~ 973 (1009)
+.
T Consensus 311 l~ 312 (335)
T PTZ00024 311 LK 312 (335)
T ss_pred hc
Confidence 85
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=301.34 Aligned_cols=263 Identities=22% Similarity=0.292 Sum_probs=195.7
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC------C
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE------T 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------~ 770 (1009)
.++|...+.||+|+||.||+|.+..+++.||+|++.+..........+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 4678888999999999999999998899999999865433333345677999999999999999999998654 3
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
.+++|+||+. .++.++... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMGH------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4699999996 467666521 267888889999999999999998 999999999999999999999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
++.... ......+++.|+|||...+ ..++.++|||||||++|||++|+.||.... ....+...........
T Consensus 164 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 164 ARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQLTQILKVTGVPG 235 (342)
T ss_pred CcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCC
Confidence 875422 2223456889999998765 458899999999999999999999997421 1111111111000000
Q ss_pred --------------------cccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhhcCC
Q 037197 930 --------------------EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT--MLGEAKP 980 (1009)
Q Consensus 930 --------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~~~ 980 (1009)
......+.... ......+.+++.+|++.||++||++.|+++ .++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF---PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHh---cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000000000 011234668999999999999999999994 4666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=249.29 Aligned_cols=199 Identities=30% Similarity=0.476 Sum_probs=174.8
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
.|+..+.||+|.||+||||+..++++.||+|+++..+.+........+|+-+++.++|+|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 35556789999999999999999999999999988777777778889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
| ..+|..+...-.+. ++.+....++.|+++|+.+.|++ .+.|||+||.|.+++.+|+.|++|||+++-+.-+-
T Consensus 83 c-dqdlkkyfdslng~---~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGD---LDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred h-hHHHHHHHHhcCCc---CCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 9 55688777654433 67788888999999999999999 99999999999999999999999999999876555
Q ss_pred CceeeecccCcccCCcccCCCC-CCcccchHhHHHHHHHHHhCCCCC
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLK-VDEKSDIYSFGVVLLELLTGKMPL 904 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~Pf 904 (1009)
.-....+.|..|.+|.++.+.+ |+...|+||-||++.|+.....|.
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence 4555566788999999988766 789999999999999999855554
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=293.84 Aligned_cols=254 Identities=20% Similarity=0.268 Sum_probs=188.0
Q ss_pred CceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCChhhhhc
Q 037197 710 GNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALH 789 (1009)
Q Consensus 710 ~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~ 789 (1009)
++|.||.++...+++.||+|++..........+.+.+|++++++++||||+++++++.+.+..+++|||+++|+|.++++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 44556666666678999999997654445566778899999999999999999999999999999999999999999997
Q ss_pred CCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC-------cee
Q 037197 790 GKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE-------TVS 862 (1009)
Q Consensus 790 ~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~-------~~~ 862 (1009)
..... .+++.....++.|+++||+|||++ +|+||||||+||+++.++.+|++|||.+........ ...
T Consensus 92 ~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 THFPE--GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 54322 267788888999999999999998 999999999999999999999999998876533221 122
Q ss_pred eecccCcccCCcccCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc-------------
Q 037197 863 MVAGSYGYIAPEYGYT--LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA------------- 927 (1009)
Q Consensus 863 ~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~------------- 927 (1009)
...++..|+|||++.. ..++.++|||||||++|||++|+.||...... ............
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-----QMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhccCccccccCchhhhcC
Confidence 3456778999998765 35788999999999999999999999743211 111111110000
Q ss_pred -ccc----ccCccccc--cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 928 -QDE----ALDPSIAG--QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 928 -~~~----~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
... ..++.... ..........++.+++.+||+.||++||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 00000000 00001112235678999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=299.22 Aligned_cols=264 Identities=24% Similarity=0.328 Sum_probs=195.8
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC----
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE---- 769 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~---- 769 (1009)
..+.++|+..+.||+|+||.||+|.+..+++.||+|++..........+.+.+|++++++++||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 3456789999999999999999999988899999999865443344456677999999999999999999987543
Q ss_pred --CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcc
Q 037197 770 --TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIAD 847 (1009)
Q Consensus 770 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 847 (1009)
...+++++++ +++|.+++.... +++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQK-----LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEec
Confidence 3468888877 789988886432 78889999999999999999998 999999999999999999999999
Q ss_pred cccceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 848 FGLARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 848 fGls~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
||++..... ......+++.|+|||...+ ..++.++|||||||++|||++|+.||..... ............
T Consensus 164 fg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~ 235 (345)
T cd07877 164 FGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQLKLILRLVG 235 (345)
T ss_pred ccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhC
Confidence 999875422 2233467889999998755 4678899999999999999999999963211 111111111000
Q ss_pred -ccccccC--------------ccccc-cCch-HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 927 -AQDEALD--------------PSIAG-QCKH-VQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 927 -~~~~~~~--------------~~~~~-~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
....... +.... .+.. ......++.+++.+|++.||++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000 00000 0000 00012246689999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=272.93 Aligned_cols=254 Identities=24% Similarity=0.290 Sum_probs=200.3
Q ss_pred HHhcCCc-CceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEc----C
Q 037197 696 ILACVKE-SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHN----E 769 (1009)
Q Consensus 696 ~~~~~~~-~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~----~ 769 (1009)
+++.|.+ .++||-|-.|.|..+.++.+++.+|+|++..+ .+..+|++..=.. .|||||.++++|++ .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 4555554 35799999999999999999999999998443 4566888885555 69999999998754 4
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC---CCcEEEc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA---NLEARIA 846 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~ 846 (1009)
..+.+|||.|+||.|...++.+. ...+++.++-.|+.||+.|+.|||+. .|.||||||+|+|++. +-.+|++
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence 56799999999999999997764 34589999999999999999999999 9999999999999965 4579999
Q ss_pred ccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 847 DFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 847 DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
|||+|+.... .......+-||.|.|||++...+|+..+|+||+||++|-|+.|.+||..... ..+..-++..+..+.
T Consensus 207 DfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 207 DFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTGQ 283 (400)
T ss_pred ccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhccC
Confidence 9999986533 2344556789999999999999999999999999999999999999975433 223333344443332
Q ss_pred ccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
-++-+++. ........++++.++..+|++|.|+.|+++
T Consensus 284 --y~FP~pEW-------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 --YEFPEPEW-------SCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred --ccCCChhH-------hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 12222222 122334567888999999999999999875
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=290.38 Aligned_cols=264 Identities=24% Similarity=0.279 Sum_probs=195.6
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEEEEec
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
|+..+.||+|++|+||+|....+++.||||++...... .......+|+..+++++ |||++++++++.+++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 56678899999999999999988999999998654322 22234457999999998 99999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+ +|+|.+++.... ...+++.++..++.|++++|.|||++ +++|+||+|+||++++++.++|+|||.+.......
T Consensus 80 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 80 M-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred C-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 9 889999886653 12378999999999999999999998 99999999999999999999999999998654322
Q ss_pred CceeeecccCcccCCcccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh--------ccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGY-TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS--------NKAQD 929 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~~~ 929 (1009)
......++..|+|||+.. ...++.++|+||||+++|||++|+.||...... +....+...... +....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI--DQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH--HHHHHHHHhcCCCChhhhhhHhhhh
Confidence 223345788999999764 455789999999999999999999998643211 111100000000 00000
Q ss_pred cccCccccccCch-----HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 930 EALDPSIAGQCKH-----VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 930 ~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+..+...... .......+.+++.+|++.+|++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0001011000000 0011245778999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=302.46 Aligned_cols=262 Identities=26% Similarity=0.343 Sum_probs=198.2
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe---
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN--- 771 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~--- 771 (1009)
++.++|+..+.||+|++|.||+|.+..+++.||+|++............+.+|+.++++++|||++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34567888999999999999999999989999999986544344445667789999999999999999998766554
Q ss_pred ---EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 772 ---VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 772 ---~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
.++|+||+ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence 89999999 67999998652 278899999999999999999998 9999999999999999999999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
|++...... .....++..|+|||.... ..++.++||||||+++||+++|+.||..... ...+.........
T Consensus 163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-----~~~~~~i~~~~~~ 234 (343)
T cd07851 163 GLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-----IDQLKRIMNLVGT 234 (343)
T ss_pred ccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHhcCC
Confidence 999765332 233457889999998654 3678899999999999999999999963211 1111111111000
Q ss_pred cccccCccc----------------cccCch-HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 928 QDEALDPSI----------------AGQCKH-VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 928 ~~~~~~~~~----------------~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+.+...+ ...+.. ......++.+++.+|++.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000 000000 0011345778999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=292.70 Aligned_cols=254 Identities=27% Similarity=0.436 Sum_probs=192.6
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|+..+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++.+. +||||+++++++.++...++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 457788999999999999999998899999999965432 23345566777766666 5999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||++ +++.++...... .+++..+..++.|+++|++|||+. .+|+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 567776644222 378889999999999999999973 1899999999999999999999999999876533
Q ss_pred CCCceeeecccCcccCCcccCCCC----CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLK----VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
.. ......+++.|+|||++.... ++.++||||||+++|||++|+.||...... .+..........
T Consensus 168 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~------ 236 (296)
T cd06618 168 SK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FEVLTKILQEEP------ 236 (296)
T ss_pred CC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HHHHHHHhcCCC------
Confidence 22 222335778999999876543 788999999999999999999999632111 111211111111
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
+...... ....++.+++.+|++.||++||++.++++.
T Consensus 237 -~~~~~~~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 -PSLPPNE----GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111000 112346778899999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-33 Score=319.79 Aligned_cols=202 Identities=26% Similarity=0.303 Sum_probs=173.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.+.|.+.++||+|+||.|..++++.++++||+|++.+-.- ......-|.+|-.+|..-+.+-|+.++-+|++..++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 3568899999999999999999999999999999855211 123344566899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
||||+||+|-.++.... . +++.-+.-++..|+-||.-+|+. |+|||||||+|||+|..|++||+|||.+-.+.
T Consensus 154 MdY~pGGDlltLlSk~~--~--~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFD--R--LPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EecccCchHHHHHhhcC--C--ChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 99999999999997665 3 44444445788999999999998 99999999999999999999999999998776
Q ss_pred cCCC-ceeeecccCcccCCcccC----C-CCCCcccchHhHHHHHHHHHhCCCCCC
Q 037197 856 HKNE-TVSMVAGSYGYIAPEYGY----T-LKVDEKSDIYSFGVVLLELLTGKMPLD 905 (1009)
Q Consensus 856 ~~~~-~~~~~~gt~~y~aPE~~~----~-~~~~~~sDv~SlGvvl~elltg~~Pf~ 905 (1009)
..+. .....+|||.|++||++. + +.|.+.+|.||+||++|||+.|..||.
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 5543 455678999999999754 3 578899999999999999999999997
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=316.02 Aligned_cols=260 Identities=29% Similarity=0.450 Sum_probs=206.3
Q ss_pred CCcCceeccCCceEEEEEEECC-------CCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCe
Q 037197 700 VKESNIIGMGGNGIVYKAEFHR-------PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 771 (1009)
.+..+.+|+|+||.|++|.... ....||||.++..... ...+.+..|+++|+.+ +||||+.++|+|..++.
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3455589999999999997441 1568999999766554 6677888999999999 69999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCc---c--cc-------ccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC
Q 037197 772 VMMVYDYMPNDSLGEALHGKE---A--GK-------LLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA 839 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~---~--~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~ 839 (1009)
.++|+||+..|+|.++++..+ . .. ..++....+.++.|||.|++||++. ++||||+..+||++++
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecC
Confidence 999999999999999998766 0 00 2378889999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceecccCCCce-eeecc--cCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHH
Q 037197 840 NLEARIADFGLARMMLHKNETV-SMVAG--SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIV 915 (1009)
Q Consensus 840 ~~~~kl~DfGls~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~ 915 (1009)
+..+||+|||+++...+.+... ....+ ...|||||.+....|+.+||||||||++||++| |..||.... ...++.
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~~~l~ 532 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PTEELL 532 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cHHHHH
Confidence 9999999999998765444333 22222 346999999999999999999999999999999 999986411 112222
Q ss_pred HHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 916 EWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
+.++.|.. ...+..+ . .++..+++.||+.+|++||++.|+++.++....
T Consensus 533 ----~~l~~G~r------~~~P~~c---~---~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 533 ----EFLKEGNR------MEQPEHC---S---DEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred ----HHHhcCCC------CCCCCCC---C---HHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 23333331 1111122 2 245578899999999999999999999999643
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=291.56 Aligned_cols=258 Identities=24% Similarity=0.274 Sum_probs=198.3
Q ss_pred CCcCceeccCCceEEEEEEEC---CCCeEEEEEEcccCCC--ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEE
Q 037197 700 VKESNIIGMGGNGIVYKAEFH---RPHMVVAVKKLWRSDN--DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~ 773 (1009)
|+..+.||+|++|.||++... .+++.||||.+++... .....+.+.+|+++++++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 667788999999999999864 3568899999864321 122334566899999999 5999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++++|.+++.... .+++.....++.|+++||+|||+. +++||||+|+||+++.++.++++|||++..
T Consensus 82 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999986532 267888888999999999999998 999999999999999999999999999876
Q ss_pred cccCCC-ceeeecccCcccCCcccCCCC--CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 854 MLHKNE-TVSMVAGSYGYIAPEYGYTLK--VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
...... ......+++.|+|||...+.. .+.++||||||+++|||++|+.||..... ..............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~------ 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKS------ 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHcc------
Confidence 543332 122345788999999876554 78899999999999999999999963211 11112222211111
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.+...... ...+.+++.+|++.||++|||+.++.+.|+...
T Consensus 228 --~~~~~~~~------~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 228 --KPPFPKTM------SAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred --CCCCCccc------CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 11111111 123567888999999999999999998887754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=282.66 Aligned_cols=239 Identities=26% Similarity=0.300 Sum_probs=193.3
Q ss_pred eccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCCh
Q 037197 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSL 784 (1009)
Q Consensus 706 iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL 784 (1009)
||+|+||.||++.+..+++.||+|.+...... ......+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999988999999998654322 22445667899999999999999999999999999999999999999
Q ss_pred hhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCceeee
Q 037197 785 GEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMV 864 (1009)
Q Consensus 785 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 864 (1009)
.+++.... .+++.....++.|+++|+.|+|+. +++|+||+|+||+++.++.++|+|||.+.............
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence 99997553 278899999999999999999998 99999999999999999999999999998764443334455
Q ss_pred cccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHH
Q 037197 865 AGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQ 944 (1009)
Q Consensus 865 ~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1009)
.++..|+|||...+...+.++|+||||+++|++++|+.||..... .+......... ..+....
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~--------~~~~~~~---- 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKDP--------LRFPEFL---- 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCC--------CCCCCCC----
Confidence 678899999998888889999999999999999999999963221 22222211111 1111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHH
Q 037197 945 EEMLLVLRIAVLCTAKLPKGRPTMRD 970 (1009)
Q Consensus 945 ~~~~~l~~l~~~cl~~dp~~RPs~~e 970 (1009)
...+.+++.+|+..||++||++.+
T Consensus 217 --~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 --SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --CHHHHHHHHHHhcCCHhhCCCccc
Confidence 124567889999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=294.48 Aligned_cols=262 Identities=24% Similarity=0.277 Sum_probs=190.9
Q ss_pred cCCcCceeccCCceEEEEEEECCC--CeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEc----CCe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRP--HMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHN----ETN 771 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~----~~~ 771 (1009)
+|+..+.||+|+||.||++....+ +..||+|++..........+.+.+|+++++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 367778999999999999999887 88999999865433333455677899999999 59999999987532 245
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++++||++ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999985 68998886443 278899999999999999999998 9999999999999999999999999999
Q ss_pred eecccCCC----ceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH----
Q 037197 852 RMMLHKNE----TVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI---- 922 (1009)
Q Consensus 852 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~---- 922 (1009)
+....... ......|++.|+|||+..+ ..++.++||||+|+++|+|++|+.||..... ......+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~ 230 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY--VDQLNQILQVLGTPD 230 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH--HHHHHHHHHHhCCCC
Confidence 86543221 1223468899999998655 4688999999999999999999999864211 01111100000
Q ss_pred -------hhcc------ccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 923 -------KSNK------AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 923 -------~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.... .........+..... .....+.+++.+|++.||++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFP---NANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCC---CCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 000000000000000 01235678999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=289.02 Aligned_cols=252 Identities=25% Similarity=0.305 Sum_probs=191.2
Q ss_pred CCcCceeccCCceEEEEEEEC---CCCeEEEEEEcccCCC--ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEE
Q 037197 700 VKESNIIGMGGNGIVYKAEFH---RPHMVVAVKKLWRSDN--DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~ 773 (1009)
|+..+.||+|+||.||+|... .+|..||+|++..... .....+.+.+|+++++++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 667789999999999999874 3688999999864321 122335566899999999 5999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++++|.+++..... +++.....++.|+++||+|||+. +++||||+|+||+++.++.+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 82 LILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999865432 67888888899999999999998 999999999999999999999999999976
Q ss_pred cccCC-CceeeecccCcccCCcccCCC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 854 MLHKN-ETVSMVAGSYGYIAPEYGYTL--KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
..... .......++..|+|||..... .++.++||||||+++|+|++|+.||..... ...............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~----- 228 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE----- 228 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC-----
Confidence 54332 222345688899999987643 467899999999999999999999963211 112222222211111
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
+.+.... ...+..++.+|++.||++|| ++.+++.
T Consensus 229 ---~~~~~~~------~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ---PPYPQEM------SALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---CCCCccC------CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1111111 12355788899999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=273.19 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=193.6
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
++||+|+|+.|-.++...++..||||++.+.. .-.+.++++|++++..+ .|+||+.++++|++++.+|+|||.|.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 46999999999999999999999999997653 34467899999999999 5999999999999999999999999999
Q ss_pred ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC---cEEEcccccceecccCC-
Q 037197 783 SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL---EARIADFGLARMMLHKN- 858 (1009)
Q Consensus 783 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~DfGls~~~~~~~- 858 (1009)
+|...|+.+.. +++.++-+++++|+.||.+||.+ ||.|||+||+|||-.... -+||+||.+..-.....
T Consensus 162 plLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 162 PLLSHIQKRKH----FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred hHHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999987654 88889999999999999999999 999999999999997654 48999998875432111
Q ss_pred ------CceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCC-------CCCC--ccHHHHH
Q 037197 859 ------ETVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTGKMPLDPA-------FGGS--KDIVEWV 918 (1009)
Q Consensus 859 ------~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~-------~~~~--~~~~~~~ 918 (1009)
......+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+||... ..++ ..=.+..
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 1233567888999999632 345889999999999999999999999642 1111 1112222
Q ss_pred HHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 919 LSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...++.++- +.-|... .++.. +..+++...+..|+.+|.++.+++.
T Consensus 315 FesIQEGkY--eFPdkdW----ahIS~---eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 315 FESIQEGKY--EFPDKDW----AHISS---EAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHhccCC--cCChhhh----HHhhH---HHHHHHHHHHhccHHhhhhhhhccC
Confidence 233333321 1111111 12222 3345677788899999999988876
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=297.44 Aligned_cols=261 Identities=25% Similarity=0.324 Sum_probs=190.3
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-------
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE------- 769 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------- 769 (1009)
..+|+..+.||.|+||.||+|....+++.||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 3578889999999999999999999999999999865432 3445677999999999999999999876543
Q ss_pred -------CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC-CC
Q 037197 770 -------TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA-NL 841 (1009)
Q Consensus 770 -------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~ 841 (1009)
...++||||++ ++|.+++... .+++.....++.||++|++|||+. +|+||||||+||+++. ++
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 35799999996 5888887543 267888899999999999999998 9999999999999975 55
Q ss_pred cEEEcccccceecccCCC---ceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHH
Q 037197 842 EARIADFGLARMMLHKNE---TVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEW 917 (1009)
Q Consensus 842 ~~kl~DfGls~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~ 917 (1009)
.++++|||.++....... ......++..|+|||.... ..++.++|||||||++|||++|+.||..... ...
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-----~~~ 227 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE-----LEQ 227 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHH
Confidence 789999999976532211 1223457889999997643 5678899999999999999999999964321 111
Q ss_pred HHHHHhhcccccc------------ccC--cccccc-Cch-HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 918 VLSMIKSNKAQDE------------ALD--PSIAGQ-CKH-VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 918 ~~~~~~~~~~~~~------------~~~--~~~~~~-~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
............. ... ...... ... ......++.+++.+|++.||++||++.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 228 MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 1111100000000 000 000000 000 0011234668999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=287.46 Aligned_cols=245 Identities=23% Similarity=0.349 Sum_probs=191.2
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
.+++|.|.||+||-|+++.+|+.||||++.+-.-...+..+..+|+.++++++||.||.+...|+..+..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 5689999999999999999999999999977655555556777999999999999999999999999999999999955
Q ss_pred ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC---CcEEEcccccceecccCCC
Q 037197 783 SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN---LEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 783 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~DfGls~~~~~~~~ 859 (1009)
+..++|-....++ +++....-++.||+.||.|||.+ +|||+|+||+|||+... .++||+|||+|+.+. ...
T Consensus 648 DMLEMILSsEkgR--L~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg-Eks 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGR--LPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG-EKS 721 (888)
T ss_pred hHHHHHHHhhccc--chHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecc-hhh
Confidence 4555543333333 55555556789999999999998 99999999999999653 579999999999874 345
Q ss_pred ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccccc
Q 037197 860 TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1009)
.....+|||.|+|||++..+.|...-|+||.||++|.-++|.+||.. ++++-+.+... ..+-|.
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE----dEdIndQIQNA--------aFMyPp---- 785 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE----DEDINDQIQNA--------AFMYPP---- 785 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC----ccchhHHhhcc--------ccccCC----
Confidence 66678999999999999999999999999999999999999999973 33433333211 111110
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 037197 940 CKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971 (1009)
Q Consensus 940 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ev 971 (1009)
..+.+.....+++|...+++.-.+|-+....
T Consensus 786 -~PW~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 786 -NPWSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred -CchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 1112222334567777777777778776654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=276.91 Aligned_cols=201 Identities=26% Similarity=0.331 Sum_probs=174.5
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.|....+||+|+||.|..|..+.+.+.||||++++.-.- ....+--+.|-++|..- +-|.++.+..+|+.-+.+|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 477888999999999999999999999999999765321 12223334677777665 5789999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+.||+|--.+++... +.+..+.-+|..||-||-+||++ ||+.||||.+||++|.+|++||+|||+++.-.-
T Consensus 430 EyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999888876543 45556666899999999999999 999999999999999999999999999987666
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
.+.+...++|||.|+|||++...+|..+.|.||+||++|||+.|++||+.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 66778889999999999999999999999999999999999999999984
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=296.67 Aligned_cols=253 Identities=22% Similarity=0.312 Sum_probs=205.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEE-----cCC
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLH-----NET 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~-----~~~ 770 (1009)
.+.|.+.+.||+|.+|.||+++.+.+++.+|+|+.... .+..+++..|.++++.. +|||++.++|+|. .++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 45678889999999999999999999999999998544 33344556788898888 6999999999874 357
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
.+|+|||||.+||..|++++.. ...+.|..+.-|+..++.|+.|||.+ .++|||||-.||+++.++.||++|||.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeee
Confidence 8999999999999999998766 33478888888999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN 925 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 925 (1009)
+......-.......|||.|||||++. ...|+..+|+||+|++..||.-|.+|+.+..+. +.++...
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------raLF~Ip 241 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------RALFLIP 241 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------hhhccCC
Confidence 988766556667788999999999864 334778999999999999999999998754332 1111111
Q ss_pred cccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 926 KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.-.....+......++-+++..|+..|-++||++.++++
T Consensus 242 --------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 --------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111122233445567888999999999999999988763
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=311.11 Aligned_cols=148 Identities=26% Similarity=0.329 Sum_probs=131.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
++|+..+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.+++.++||||+++++++....+.|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 568888999999999999999998899999999865432 2233455668999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
||+++++|.++++.... +++..++.|+.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~----l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999965432 67788899999999999999998 99999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=251.49 Aligned_cols=205 Identities=25% Similarity=0.376 Sum_probs=168.8
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhc-cCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGR-LRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
..+..||+|++|.|-+.++..+|+..|+|++...-. .+..++.+.|+.+..+ ..+|.+|.+||.+.+....|+.||.|
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 344569999999999999999999999999976544 3445666788887544 58999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
.-||+.+-+.--.....+++...-+|+..+.+||.|||++. .++|||+||+|||++.+|++|+||||.+..+.+. -
T Consensus 128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS-i 203 (282)
T KOG0984|consen 128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS-I 203 (282)
T ss_pred -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh-h
Confidence 56777665433333344788888899999999999999985 8999999999999999999999999999876432 2
Q ss_pred ceeeecccCcccCCcccC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC
Q 037197 860 TVSMVAGSYGYIAPEYGY----TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG 910 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~ 910 (1009)
..+...|...|||||.+. ...|+.||||||+|+++.||.++++||+.+...
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 223356788999999754 447899999999999999999999999876554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=290.21 Aligned_cols=240 Identities=22% Similarity=0.242 Sum_probs=192.1
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.+.|.....+|.|+|+.|-.+.+..+++..+||++.++. .+..+|+.++... +||||+++.+.+.++.+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 344566666999999999999999999999999996542 2233677776666 799999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe-CCCCcEEEcccccceec
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL-DANLEARIADFGLARMM 854 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll-~~~~~~kl~DfGls~~~ 854 (1009)
||.+.++-+.+.+...+. +. ..+..|+.+|+.|+.|||++ |+||||+||+|||+ +.+++++|+|||.++..
T Consensus 395 ~e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred ehhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999999988887765542 22 56667999999999999998 99999999999999 68999999999999876
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
... ....+-|..|.|||+.....+++++|+||||+++|+|++|+.||.....+ ..+..++..++
T Consensus 467 ~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i~~~~-------- 530 (612)
T KOG0603|consen 467 ERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRIQMPK-------- 530 (612)
T ss_pred chh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhhcCCc--------
Confidence 433 22335577899999999999999999999999999999999999754333 23344443332
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
++. ........++.+|++.||.+||++.++..
T Consensus 531 -~s~------~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 -FSE------CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -ccc------ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 111 11123457888999999999999999864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=278.33 Aligned_cols=260 Identities=26% Similarity=0.332 Sum_probs=199.4
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhh-----HHHHHHHHHHHhccCCCceeeEEeEEEcC-
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIES-----GDDLFREVSLLGRLRHRNIVRLLGYLHNE- 769 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~E~~~l~~l~Hpniv~l~~~~~~~- 769 (1009)
..++|=...+||+|||+.||||.+....+.||||+-.....+.+. .+...+|.++.+.++||.||++|+||.-+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 456677788999999999999999988999999987655443322 34566899999999999999999999754
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC---CCcEEEc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA---NLEARIA 846 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~ 846 (1009)
+.++-|.|||+|.+|+-|++.+.. +++.++..|+.||+.||.||... .++|||-||||.|||+-. -|.+||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 557889999999999999987654 88999999999999999999987 789999999999999943 5789999
Q ss_pred ccccceecccCCC-------ceeeecccCcccCCcccCC----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHH
Q 037197 847 DFGLARMMLHKNE-------TVSMVAGSYGYIAPEYGYT----LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIV 915 (1009)
Q Consensus 847 DfGls~~~~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~ 915 (1009)
|||+++.+.+... ......||..|++||.+.- .+++.|.||||+||++|+.+.|+.||.......+.
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI-- 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI-- 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--
Confidence 9999998865432 2345789999999997543 35788999999999999999999999743222111
Q ss_pred HHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 916 EWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.+.. ++...-. .++..+....+...+|++|+++.-++|....++..
T Consensus 694 ------LqeNT----IlkAtEV-qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 ------LQENT----ILKATEV-QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ------Hhhhc----hhcceec-cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11111 1110000 11111111123446788999999999988877653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=272.35 Aligned_cols=223 Identities=23% Similarity=0.192 Sum_probs=176.1
Q ss_pred CCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCChhhhh
Q 037197 709 GGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEAL 788 (1009)
Q Consensus 709 G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l 788 (1009)
|.+|.||++.+..+++.||+|+++... ...+|...+....||||+++++++.+.+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999999999999999985532 1224555555667999999999999999999999999999999998
Q ss_pred cCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCceeeecccC
Q 037197 789 HGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY 868 (1009)
Q Consensus 789 ~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~gt~ 868 (1009)
..... +++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+...... .....++.
T Consensus 77 ~~~~~----l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~ 146 (237)
T cd05576 77 SKFLN----IPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVEN 146 (237)
T ss_pred HHhcC----CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCc
Confidence 65432 78889999999999999999998 9999999999999999999999999987654322 22234567
Q ss_pred cccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHH
Q 037197 869 GYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEML 948 (1009)
Q Consensus 869 ~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1009)
.|+|||......++.++||||+|+++|||++|+.|+...... . .......+.... ..
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------~------~~~~~~~~~~~~------~~ 203 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------I------NTHTTLNIPEWV------SE 203 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------c------ccccccCCcccC------CH
Confidence 899999988888899999999999999999999887532110 0 000000111111 12
Q ss_pred HHHHHHHHhccCCCCCCCCHHHH
Q 037197 949 LVLRIAVLCTAKLPKGRPTMRDV 971 (1009)
Q Consensus 949 ~l~~l~~~cl~~dp~~RPs~~ev 971 (1009)
.+..++.+|++.||++||++.+.
T Consensus 204 ~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHHHHccCCHHHhcCCCcc
Confidence 45678899999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=260.26 Aligned_cols=267 Identities=21% Similarity=0.325 Sum_probs=197.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc--------
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN-------- 768 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-------- 768 (1009)
...|.....||+|.||.||+|+.+.+++.||+|+...............+|++++..++|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 455667778999999999999999999999998775543334456678899999999999999999987743
Q ss_pred CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 769 ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 769 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
....|+||++|+. +|.-++..... .++..++.+++.++..||.|+|.. .|+|||+|+.|++++.+|.+||+||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence 3458999999964 57777755432 277788888999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCC----ceeeecccCcccCCcccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh
Q 037197 849 GLARMMLHKNE----TVSMVAGSYGYIAPEYGY-TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 849 Gls~~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
|+++.+..... ..+..+.|..|.+||.+. .++++++.|||.-||++.||+||.+-+....+. .....+... -
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq--qql~~Is~L-c 245 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ--QQLHLISQL-C 245 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH--HHHHHHHHH-h
Confidence 99987644332 233456688999999765 557999999999999999999999877632211 111111111 1
Q ss_pred hcccccc-----------cc--CccccccCchHHHHHH------HHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 924 SNKAQDE-----------AL--DPSIAGQCKHVQEEML------LVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 924 ~~~~~~~-----------~~--~~~~~~~~~~~~~~~~------~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..-..+. .+ .|...+......+.+. +..+++.+++..||.+|+++++++.
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1100000 00 1111222333333444 5678889999999999999988764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=262.46 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=203.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCC-----CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEE-cCCe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRP-----HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLH-NETN 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~-~~~~ 771 (1009)
.+++...++-+|.||.||.|.+++. .+.|.+|.++. ...+-+...++.|.-.+....|||+..+.+++. +.+.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 3466677789999999999987653 24466776643 344555677778999999999999999999875 4567
Q ss_pred EEEEEeccCCCChhhhhcCCc----cccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcc
Q 037197 772 VMMVYDYMPNDSLGEALHGKE----AGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIAD 847 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 847 (1009)
.+++|.++.-|+|..++...+ .....++..+...++.|++.|++|||++ +|||.||..+|.++|+.-++|++|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEecc
Confidence 899999999999999997322 2234477888889999999999999999 999999999999999999999999
Q ss_pred cccceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhh
Q 037197 848 FGLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKS 924 (1009)
Q Consensus 848 fGls~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 924 (1009)
-.+++.+...+.. ......+..||+||.+....|+.++|||||||++|||+| |+.|+.+. +. ..+..+++.
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI-----DP-fEm~~ylkd 513 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI-----DP-FEMEHYLKD 513 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc-----CH-HHHHHHHhc
Confidence 9999987655432 122334668999999999999999999999999999999 99998732 22 233444444
Q ss_pred ccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 925 NKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
|... .-+-+|+ + +++.++.-||+.+|++||++++++..|.+.-
T Consensus 514 GyRl------aQP~NCP---D---eLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 514 GYRL------AQPFNCP---D---ELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ccee------cCCCCCc---H---HHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 4421 1111232 2 5677888999999999999999999998753
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=277.14 Aligned_cols=204 Identities=25% Similarity=0.339 Sum_probs=173.1
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
|-.++.||-|+||+|..+...++...||.|.+++.+. ...+...+..|..||..-+.+-||++|-.|++++.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 6678899999999999999999999999999976542 234455667899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec----
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM---- 854 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~---- 854 (1009)
++||++-.++.+..- +++.-+.-++..+..|+++.|.. |+|||||||+|||||.||++||+|||+++-+
T Consensus 711 IPGGDmMSLLIrmgI----FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGI----FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred cCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999998866543 56666666788899999999988 9999999999999999999999999998632
Q ss_pred -----ccCCCce---------------------------------eeecccCcccCCcccCCCCCCcccchHhHHHHHHH
Q 037197 855 -----LHKNETV---------------------------------SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLE 896 (1009)
Q Consensus 855 -----~~~~~~~---------------------------------~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~e 896 (1009)
...++.. -..+||+-|+|||++....++..+|.||.||+|||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 1111100 03469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCC
Q 037197 897 LLTGKMPLDPAFGG 910 (1009)
Q Consensus 897 lltg~~Pf~~~~~~ 910 (1009)
|+.|++||-...++
T Consensus 864 m~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPG 877 (1034)
T ss_pred HhhCCCCccCCCCC
Confidence 99999999755444
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=277.25 Aligned_cols=202 Identities=25% Similarity=0.385 Sum_probs=179.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCC-CChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
..++.+..||.|+||.|-.+..+.....+|+|.+++.+ .+..+.+.++.|-.+|...+.|.||++|..|.+..++|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34566778999999999999988766668999987765 34556677889999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
|-|-||.+...++.+.. ++.....-++.-+++|++|||++ +||.|||||+|.+++.+|-+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999987654 67777777888999999999999 999999999999999999999999999998855
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPA 907 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~ 907 (1009)
.. ...+++|||.|.|||++..+..+.+.|.||+|+++|||++|.+||...
T Consensus 573 g~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 573 GR-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred CC-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 44 445689999999999999999999999999999999999999999843
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=296.53 Aligned_cols=262 Identities=18% Similarity=0.184 Sum_probs=169.3
Q ss_pred HhcCCcCceeccCCceEEEEEEECCC----CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeE------E
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRP----HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY------L 766 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~------~ 766 (1009)
.+.|+..+.||+|+||.||+|.+..+ +..||+|++..... .+....| .++...+.+++.++.. .
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 45788999999999999999999988 89999998743211 1111111 1222222233222221 2
Q ss_pred EcCCeEEEEEeccCCCChhhhhcCCccc----------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEecc
Q 037197 767 HNETNVMMVYDYMPNDSLGEALHGKEAG----------------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDI 830 (1009)
Q Consensus 767 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl 830 (1009)
..+...++||||+++++|.++++..... ........+..++.|+++||+|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 4566799999999999999998654210 00112334557899999999999998 9999999
Q ss_pred CCCcEEeCC-CCcEEEcccccceecccCC-CceeeecccCcccCCcccCCC----------------------CCCcccc
Q 037197 831 KSNNILLDA-NLEARIADFGLARMMLHKN-ETVSMVAGSYGYIAPEYGYTL----------------------KVDEKSD 886 (1009)
Q Consensus 831 k~~NIll~~-~~~~kl~DfGls~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 886 (1009)
||+|||++. ++.+||+|||+++.+.... .......+++.|+|||..... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 5799999999998653322 233456789999999954211 2345679
Q ss_pred hHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccc---cccCccc----cccCchHHHHHHHHHHHHHHhcc
Q 037197 887 IYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD---EALDPSI----AGQCKHVQEEMLLVLRIAVLCTA 959 (1009)
Q Consensus 887 v~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~ 959 (1009)
|||+||++|||+++..|++. +...........+.... ....+.. ...++..-.......+++.+|++
T Consensus 362 VwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999998776542 11111111111110000 0001100 00000000011124578999999
Q ss_pred CCCCCCCCHHHHHH
Q 037197 960 KLPKGRPTMRDVIT 973 (1009)
Q Consensus 960 ~dp~~RPs~~evl~ 973 (1009)
.||++|||++|+++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=264.60 Aligned_cols=262 Identities=18% Similarity=0.267 Sum_probs=199.1
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-C-C----ceeeEEeEEEcC
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-H-R----NIVRLLGYLHNE 769 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H-p----niv~l~~~~~~~ 769 (1009)
+.++|.+...+|+|.||.|-++.+..++..||||+++.- ....+...-|+++++++. + | -+|.+.++|.-.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 477899999999999999999999999999999999532 344566668999999993 2 2 378888999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC----------
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA---------- 839 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---------- 839 (1009)
++.++|+|.+ |-|+.+++..+. ..+++...+..|+.|+++++++||+. +++|-|+||+||++.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence 9999999988 789999997654 34578888899999999999999999 9999999999999931
Q ss_pred ----------CCcEEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCC
Q 037197 840 ----------NLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFG 909 (1009)
Q Consensus 840 ----------~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~ 909 (1009)
...++|+|||.|++... .....+.|..|.|||++.+-.++..+||||+||+|+|+.||..-|+.-.
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe- 313 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE- 313 (415)
T ss_pred CccceeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC-
Confidence 33589999999986422 2356678999999999999999999999999999999999999886322
Q ss_pred CCccHHHHHH-----------------HHHhhccccc--cc-cC---ccccccCc-------hHHHHHHHHHHHHHHhcc
Q 037197 910 GSKDIVEWVL-----------------SMIKSNKAQD--EA-LD---PSIAGQCK-------HVQEEMLLVLRIAVLCTA 959 (1009)
Q Consensus 910 ~~~~~~~~~~-----------------~~~~~~~~~~--~~-~~---~~~~~~~~-------~~~~~~~~l~~l~~~cl~ 959 (1009)
..+.+ +.++ +....++ .+ +. .+ ......+. ..-.+..++++|+.+|+.
T Consensus 314 n~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~r-ldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 314 NLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGR-LDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred cHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhccc-ccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 11111 1111 1111110 00 00 00 00000111 122345668999999999
Q ss_pred CCCCCCCCHHHHH
Q 037197 960 KLPKGRPTMRDVI 972 (1009)
Q Consensus 960 ~dp~~RPs~~evl 972 (1009)
.||.+|+|+.|++
T Consensus 392 fDP~~RiTl~EAL 404 (415)
T KOG0671|consen 392 FDPARRITLREAL 404 (415)
T ss_pred cCccccccHHHHh
Confidence 9999999999975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=260.94 Aligned_cols=240 Identities=30% Similarity=0.414 Sum_probs=191.4
Q ss_pred CceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCChhhhhc
Q 037197 710 GNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALH 789 (1009)
Q Consensus 710 ~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~ 789 (1009)
+||.||+|....+++.||+|++....... ..+.+.+|++.+++++|+|++++++++......++||||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK-KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc-HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999999889999999986543221 15677799999999999999999999999999999999999999999987
Q ss_pred CCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCceeeecccCc
Q 037197 790 GKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG 869 (1009)
Q Consensus 790 ~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~gt~~ 869 (1009)
.... +++..++.++.+++++++|||+. +++|+||+|+||+++.++.++++|||.+....... ......++..
T Consensus 80 ~~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 151 (244)
T smart00220 80 KRGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE 151 (244)
T ss_pred hccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence 5443 68889999999999999999998 99999999999999999999999999998764432 3334567889
Q ss_pred ccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHH
Q 037197 870 YIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLL 949 (1009)
Q Consensus 870 y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1009)
|+|||......++.++||||+|+++|++++|..||... .+...... ......... .... .. ...+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~----~~~~~~~~-~~~~~~~~~---~~~~-~~------~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD----DQLLELFK-KIGKPKPPF---PPPE-WK------ISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CcHHHHHH-HHhccCCCC---cccc-cc------CCHH
Confidence 99999988888899999999999999999999998642 11122221 111111000 0000 00 1134
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHH
Q 037197 950 VLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 950 l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 667899999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=286.13 Aligned_cols=244 Identities=26% Similarity=0.393 Sum_probs=185.4
Q ss_pred CCcCceeccCCceE-EEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEe
Q 037197 700 VKESNIIGMGGNGI-VYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~-Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
|...+++|.|+.|+ ||+|... ++.||||++-. +....+.+|+..++.- +|||||++++.-+++...|+..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 44456789999995 8999987 57999999832 3344566999999988 59999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC---C--CcEEEcccccce
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA---N--LEARIADFGLAR 852 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~--~~~kl~DfGls~ 852 (1009)
.| ..+|.|++...............+.+..|++.||+|||+. +||||||||.||||+. + .+++|+|||+++
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99 7899999987411111111134466889999999999998 9999999999999976 3 479999999999
Q ss_pred ecccCCC---ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 853 MMLHKNE---TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 853 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
.+..... ......||-+|+|||++....-+.+.||||+||++|+.++ |..||........++ +......
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI-------l~~~~~L 732 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI-------LTGNYTL 732 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh-------hcCccce
Confidence 8865543 2345678999999999988888889999999999999999 599997533221111 1111100
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
. .+. ...+. +..++|.+|++++|..||++.+|+
T Consensus 733 ~-----~L~----~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 733 V-----HLE----PLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred e-----eec----cCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0 000 01111 456789999999999999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=249.51 Aligned_cols=203 Identities=24% Similarity=0.356 Sum_probs=176.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l 774 (1009)
.+.|...++||+|+|..|..++++.+.+.||+|++++.-. +.+..+=...|-.+..+- +||.+|.+..+|+.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 3457888999999999999999999999999999976532 222233333566665555 79999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
|.||++||+|--.+++.+. ++++.+.-+...|.-||.|||++ ||+.||+|.+||++|..|.+|++|+|+++.-
T Consensus 329 vieyv~ggdlmfhmqrqrk----lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhhhhc----CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999766655433 77788777899999999999999 9999999999999999999999999999887
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
..++.....++|||-|+|||++.+..|....|.|++||+++||+.|+.||+.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 6777788889999999999999999999999999999999999999999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=277.43 Aligned_cols=260 Identities=21% Similarity=0.296 Sum_probs=175.0
Q ss_pred HhcCCcCceeccCCceEEEEEEEC----------------CCCeEEEEEEcccCCCChh------------hHHHHHHHH
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFH----------------RPHMVVAVKKLWRSDNDIE------------SGDDLFREV 748 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~----------------~~~~~vavK~~~~~~~~~~------------~~~~~~~E~ 748 (1009)
.+.|+..++||+|+||.||+|... ..++.||||++........ ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 457889999999999999999752 2356899999854321100 011223477
Q ss_pred HHHhccCCCce-----eeEEeEEEc--------CCeEEEEEeccCCCChhhhhcCCccc--------------------c
Q 037197 749 SLLGRLRHRNI-----VRLLGYLHN--------ETNVMMVYDYMPNDSLGEALHGKEAG--------------------K 795 (1009)
Q Consensus 749 ~~l~~l~Hpni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~ 795 (1009)
.++.+++|.++ +++++||.. ++..++||||+++++|.++++..... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 677787753 35689999999999999999753210 1
Q ss_pred ccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC-ceeeecccCcccCCc
Q 037197 796 LLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE-TVSMVAGSYGYIAPE 874 (1009)
Q Consensus 796 ~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~-~~~~~~gt~~y~aPE 874 (1009)
...++..+..++.|+++||+|+|+. +|+||||||+||+++.++.+||+|||++........ ......+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1246778889999999999999998 999999999999999999999999999976533221 112234578999999
Q ss_pred ccCCCC----------------------CCcccchHhHHHHHHHHHhCCC-CCCCCCCC-------CccHHHHHHHHHhh
Q 037197 875 YGYTLK----------------------VDEKSDIYSFGVVLLELLTGKM-PLDPAFGG-------SKDIVEWVLSMIKS 924 (1009)
Q Consensus 875 ~~~~~~----------------------~~~~sDv~SlGvvl~elltg~~-Pf~~~~~~-------~~~~~~~~~~~~~~ 924 (1009)
.+.... ...+.||||+||++|||++|.. ||.....- ..+...|.. ...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~ 458 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKG 458 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcc
Confidence 764322 1234799999999999999875 66532110 011111211 000
Q ss_pred ccccccccCccccccCchHHHHHHHHHHHHHHhccCCC---CCCCCHHHHH
Q 037197 925 NKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLP---KGRPTMRDVI 972 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp---~~RPs~~evl 972 (1009)
. ..+-.. .........+++.+++..+| .+|+|++|++
T Consensus 459 ~-----~~~~~~------~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 459 Q-----KYDFSL------LDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred c-----CCCccc------ccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 0 011000 01112235568888998766 6899999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=242.41 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=196.8
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEe-EEEcCCe
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLG-YLHNETN 771 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~-~~~~~~~ 771 (1009)
.++.+.|.+.+.+|+|.||.+-.+.++.+.+.+++|.++++ .....+|.+|..---.+ .|.||+.-|+ .|+..+.
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 34567799999999999999999999999999999999665 44566777888764455 5999998887 4788889
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC--CCCcEEEcccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD--ANLEARIADFG 849 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~DfG 849 (1009)
+++++||++.|+|.+-+...+ +.+....+++.|++.|+.|+|++ .+||||||.+|||+- +..++|++|||
T Consensus 97 YvF~qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred EEEeeccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecc
Confidence 999999999999999886543 66777888999999999999999 999999999999993 34589999999
Q ss_pred cceecccCCCceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh
Q 037197 850 LARMMLHKNETVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS 924 (1009)
Q Consensus 850 ls~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 924 (1009)
..+.. +........+..|.+||... .....+.+|+|.||+++|.++||++||+.....+....+|..-....
T Consensus 169 ~t~k~---g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 169 LTRKV---GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK 245 (378)
T ss_pred ccccc---CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence 98754 23333344567899998643 22356889999999999999999999986665666666665432211
Q ss_pred ccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037197 925 NKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 975 (1009)
.+..+..+....+. ++++..+-+.++|++|-...++.++.
T Consensus 246 --------~~~~P~~F~~fs~~---a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 246 --------NPALPKKFNPFSEK---ALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred --------CccCchhhcccCHH---HHHHHHHhcCCcccccchhHHHHHHH
Confidence 12333333333333 44566799999999995555555544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=249.06 Aligned_cols=198 Identities=28% Similarity=0.430 Sum_probs=165.2
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-----CeEEEE
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE-----TNVMMV 775 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----~~~~lV 775 (1009)
+..+.||.|+||.||.+.+..+|+.||.|++..-...-...+.+|+|++++..++|.|++..++..+.. .+.|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 455679999999999999999999999999976555566678999999999999999999999876543 246888
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
+|.| ..+|...+-.. ..++.....-+..||++||.|||+. +|.||||||.|.+++.+...||+|||+++...
T Consensus 136 TELm-QSDLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHH-HhhhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 8888 45666665332 2366667777899999999999999 99999999999999999999999999998764
Q ss_pred cCC-CceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 856 HKN-ETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 856 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
..+ ...+..+.|..|.|||++++. .|+.+.||||.||++.|++..+.-|..
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 333 344455678899999998764 589999999999999999999888863
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=249.88 Aligned_cols=265 Identities=22% Similarity=0.308 Sum_probs=199.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-----C---CceeeEEeEEE--
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-----H---RNIVRLLGYLH-- 767 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----H---pniv~l~~~~~-- 767 (1009)
.+|...++||-|-|++||.+.+....+.||+|+.+.. ....+..+.|+++|++++ | .+||+++++|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 6789999999999999999999999999999998432 444567779999999983 3 37999999986
Q ss_pred --cCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-----
Q 037197 768 --NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN----- 840 (1009)
Q Consensus 768 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~----- 840 (1009)
.+.++++|+|++ |.+|..+|......+ ++.....+|++||+.||.|||.+| ||||-||||+|||+...
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~ 229 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPA 229 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchh
Confidence 456899999999 888999987655433 677788899999999999999998 99999999999999300
Q ss_pred --------------------------------------------------------------------------------
Q 037197 841 -------------------------------------------------------------------------------- 840 (1009)
Q Consensus 841 -------------------------------------------------------------------------------- 840 (1009)
T Consensus 230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~ 309 (590)
T KOG1290|consen 230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI 309 (590)
T ss_pred hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 037197 841 -------------------------------------------------------------------------------- 840 (1009)
Q Consensus 841 -------------------------------------------------------------------------------- 840 (1009)
T Consensus 310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~ 389 (590)
T KOG1290|consen 310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC 389 (590)
T ss_pred CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence
Q ss_pred -CcEEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC-----CccH
Q 037197 841 -LEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG-----SKDI 914 (1009)
Q Consensus 841 -~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~-----~~~~ 914 (1009)
-++||+|||-|+.+.. ..+.-..|..|.|||++.+..|+..+||||++|+++||+||.+-|++-... ++.+
T Consensus 390 di~vKIaDlGNACW~~k---hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 390 DIRVKIADLGNACWVHK---HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred ceeEEEeeccchhhhhh---hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 0144555555544311 122334677899999999999999999999999999999999999864332 1223
Q ss_pred HHHHH-------HHHhhccccccccCcc-----------------ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 037197 915 VEWVL-------SMIKSNKAQDEALDPS-----------------IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRD 970 (1009)
Q Consensus 915 ~~~~~-------~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~e 970 (1009)
+..++ .....++...+.++.. +...+.-..++..++..++.-|++.+|++|||+.+
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 32222 2233333333333321 11123334566778999999999999999999999
Q ss_pred HHH
Q 037197 971 VIT 973 (1009)
Q Consensus 971 vl~ 973 (1009)
.++
T Consensus 547 cl~ 549 (590)
T KOG1290|consen 547 CLK 549 (590)
T ss_pred Hhc
Confidence 884
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=232.27 Aligned_cols=206 Identities=20% Similarity=0.309 Sum_probs=168.1
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcC--CeEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNE--TNVM 773 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~--~~~~ 773 (1009)
.+.|+..+.+|+|-++.||.|....+.+.++||+++ +...+++.+|+++++.+. ||||+++++...+. ....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 356788889999999999999988889999999984 345677889999999996 99999999998765 4679
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-CcEEEcccccce
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN-LEARIADFGLAR 852 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfGls~ 852 (1009)
+|+||+.+.+...+-.. ++...+.-.+.+++.||.|+|+. ||+|||+||.||++|.. ...+++|+|+|.
T Consensus 112 LiFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hHhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 99999999877766422 45556666899999999999999 99999999999999975 469999999999
Q ss_pred ecccCCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHH
Q 037197 853 MMLHKNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWV 918 (1009)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 918 (1009)
++.. +......+.+..|.-||.+-.. .++..-|+|||||++..|+..+.||-......+++++.+
T Consensus 182 FYHp-~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa 247 (338)
T KOG0668|consen 182 FYHP-GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA 247 (338)
T ss_pred hcCC-CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH
Confidence 8744 3444445567778999987644 478899999999999999999999965443344444443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=240.98 Aligned_cols=261 Identities=24% Similarity=0.310 Sum_probs=201.2
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC------C
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE------T 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------~ 770 (1009)
..+|...+.+|.|+- .|.-|.+.-.++.||+|+...+.......++..+|...+..+.|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777788999998 788888888899999999987766677788899999999999999999999998543 3
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
..|+|||+| ..+|...++.. ++-.....|..|++.|+.|||+. +|+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 579999999 67898888732 56677888999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
++..... -..+..+.|..|.|||++.+..+.+..||||+||++.||++|+.-|. +.+.+-+|.+.....+..-..
T Consensus 165 ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 165 ARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred hcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCHH
Confidence 9764322 23344567889999999988889999999999999999999998876 344444554433222221111
Q ss_pred ccC---------------------------ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ALD---------------------------PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ~~~---------------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.++ ..+........-..-....++.+|+..+|++|.+++++++
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 110 0000000000011223567888999999999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=236.81 Aligned_cols=212 Identities=34% Similarity=0.557 Sum_probs=182.8
Q ss_pred eccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCChh
Q 037197 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLG 785 (1009)
Q Consensus 706 iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL~ 785 (1009)
||+|++|.||++....+++.+++|++....... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999998888999999986543221 3456779999999999999999999999999999999999999999
Q ss_pred hhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC-CCcEEEcccccceecccCCCceeee
Q 037197 786 EALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA-NLEARIADFGLARMMLHKNETVSMV 864 (1009)
Q Consensus 786 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGls~~~~~~~~~~~~~ 864 (1009)
+++.... ..+++..+..++.++++++++||+. +++|+||+|+||+++. ++.++++|||.+.............
T Consensus 80 ~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 80 DLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred HHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 9987542 2378889999999999999999998 9999999999999999 8999999999998764433223345
Q ss_pred cccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchH
Q 037197 865 AGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHV 943 (1009)
Q Consensus 865 ~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1009)
.+...|++||..... ..+.++|+|++|++++++
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577899999988776 788999999999999999
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 944 QEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 944 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 245678889999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=256.76 Aligned_cols=198 Identities=23% Similarity=0.339 Sum_probs=170.0
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC----hh--hHHHHHHHHHHHhccC---CCceeeEEeEEEcC
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND----IE--SGDDLFREVSLLGRLR---HRNIVRLLGYLHNE 769 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~----~~--~~~~~~~E~~~l~~l~---Hpniv~l~~~~~~~ 769 (1009)
.|...+.+|.|+||.|+.|.++.....|+||.+.+...- .+ ....+--|+++|..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 477888999999999999999998999999999765311 11 1122336999999997 99999999999999
Q ss_pred CeEEEEEecc-CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 770 TNVMMVYDYM-PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 770 ~~~~lV~E~~-~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
+++|++||-. ++-+|.++|..++. +++.++..|++||+.|++|||+. +|||||||-+||.++.+|-+|++||
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~----m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPR----MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCc----cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 9999999964 45589999976654 78888899999999999999999 9999999999999999999999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCCCCCC-cccchHhHHHHHHHHHhCCCCCC
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD-EKSDIYSFGVVLLELLTGKMPLD 905 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~SlGvvl~elltg~~Pf~ 905 (1009)
|.+... .......++||.+|.|||++.+.+|- ..-|||++|+++|-++....||.
T Consensus 715 gsaa~~--ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYT--KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhh--cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998764 34456678999999999999888764 56899999999999999988875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-28 Score=264.02 Aligned_cols=253 Identities=26% Similarity=0.324 Sum_probs=201.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.+.|.....+|.|.||.|||++++.+++..|+|+++....+ ...-..+|+-+++..+||||+.++|.+-..+..|+.|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 45677788899999999999999999999999999765433 2344558999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
|||.+|+|.+.-+.... +++.++..+++..++|++|||+. +-+|||||-.||++++.|.+|+.|||.+..+..
T Consensus 92 EycgggslQdiy~~Tgp----lselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGP----LSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EecCCCcccceeeeccc----chhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999998765543 78888888999999999999998 889999999999999999999999999987755
Q ss_pred CCCceeeecccCcccCCccc---CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 857 KNETVSMVAGSYGYIAPEYG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
.-.....+.|||.|||||+. ..+.|..++|||++|++..|+-.-.+|.... ...+...-+-+++...
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-----hpmr~l~LmTkS~~qp----- 234 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-----HPMRALFLMTKSGFQP----- 234 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-----chHHHHHHhhccCCCC-----
Confidence 55666778999999999974 3556889999999999999998888775422 2222332332332211
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
|.+.+ -. ..-..+-++++.|+..+|++||++..++
T Consensus 235 p~lkD-k~---kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 235 PTLKD-KT---KWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CcccC-Cc---cchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 12211 11 1122356788899999999999987654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=232.94 Aligned_cols=199 Identities=32% Similarity=0.471 Sum_probs=171.9
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
|+..+.||.|++|.||+|....+++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 45677899999999999999988899999999654322 24567779999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC-
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN- 858 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~- 858 (1009)
++++|.+++...... +++.....++.++++++.+||+. +++|+|++|+||+++.++.++++|||.+.......
T Consensus 80 ~~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 80 EGGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 999999999764321 67888899999999999999998 99999999999999999999999999998764432
Q ss_pred CceeeecccCcccCCccc-CCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 037197 859 ETVSMVAGSYGYIAPEYG-YTLKVDEKSDIYSFGVVLLELLTGKMPLD 905 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlGvvl~elltg~~Pf~ 905 (1009)
.......++..|++||.. ....++.++|||+||++++||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 122345677889999988 66778889999999999999999999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=239.76 Aligned_cols=201 Identities=23% Similarity=0.282 Sum_probs=169.9
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC------CCceeeEEeEEEcC
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR------HRNIVRLLGYLHNE 769 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------Hpniv~l~~~~~~~ 769 (1009)
...+|......|+|-|++|..|.+...|..||||+++.... -.+.-++|+++|+++. --|+++++..|...
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 45678888889999999999999999899999999976532 2345568999999994 35899999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC-cEEEccc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-EARIADF 848 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Df 848 (1009)
+++++|+|-+ .-+|.++++.... ...+.......++.|+.-||.+|... +|+|.||||+|||+++.. ..|||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccC
Confidence 9999999977 6789999976543 33477778888999999999999998 999999999999999864 6799999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
|.|....... .+.+..+..|.|||++.+..|+...|+||+||.|||+.||+.-|..
T Consensus 582 GSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 582 GSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 9997654332 3334456689999999999999999999999999999999988863
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-27 Score=244.20 Aligned_cols=410 Identities=21% Similarity=0.246 Sum_probs=221.2
Q ss_pred CeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeecc-ccccccCCccCCCCcchhhhhcc
Q 037197 140 LTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSG-NNLTGKIPPELGQLSSLETIILG 218 (1009)
Q Consensus 140 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~ 218 (1009)
-+.++|..|+|+...|.+|+.+++|+.|||++|.|+.+.|.+|.++++|..|-+.+ |+|+......|++|.+|+.|.+.
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence 34566666666655556677777777777777777777777777777777766655 77775444577778888888888
Q ss_pred cccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCC------------CCCccccccccccc
Q 037197 219 YNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTG------------KIPPELGSITSLAF 286 (1009)
Q Consensus 219 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~------------~~~~~~~~l~~L~~ 286 (1009)
-|++.-...+.|..|++|..|.+.+|.+...--..|..+..++++.+..|.+.. ..|..++......-
T Consensus 149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p 228 (498)
T KOG4237|consen 149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP 228 (498)
T ss_pred hhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence 888777777777888888888888877774444477777777777777776321 22333333344444
Q ss_pred ccccccccCCCcchhhhcc-cCCCeEeccccccCCC-CCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCc
Q 037197 287 LDLSDNQISGEIPVKLAEL-KNLQLLNLMCNQLTGL-IPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSN 364 (1009)
Q Consensus 287 L~Ls~N~l~~~~~~~l~~l-~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N 364 (1009)
..+.++++..+.+..|... ..+..=..+.+...+. +...|..+++|+.|+|++|+++++-+.+|.+...++.|.|..|
T Consensus 229 ~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N 308 (498)
T KOG4237|consen 229 YRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRN 308 (498)
T ss_pred HHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcc
Confidence 4444444443333322211 1111111111111112 1223445555555555555555444444444444444444444
Q ss_pred cccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccc-cCCccCCCCcccEEEeecccccccCC
Q 037197 365 LLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGT-IPVGLGNLPSLQRLEMANNNLTGQIP 443 (1009)
Q Consensus 365 ~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p 443 (1009)
+|...-...|.++..|+.|+|.+|+|+...|.+|..+.+|.+|.|-.|.+.-. --.|++. .|..+.-.|. |
T Consensus 309 ~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-------Wlr~~~~~~~-~ 380 (498)
T KOG4237|consen 309 KLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-------WLRKKSVVGN-P 380 (498)
T ss_pred hHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-------HHhhCCCCCC-C
Confidence 44433333344444444444444444444444444444444444444333200 0000000 0011111111 1
Q ss_pred cCCcCCCCCcEEecccCccccc---CCCcccCCcccchhccccCcccCCcccccccCCcCc-EEEeecCCCCCCCCcccc
Q 037197 444 DDISLSTSLSFVDISWNHLESY---LPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLS-VLDLSSNSLSGEIPASIA 519 (1009)
Q Consensus 444 ~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~-~LdLs~N~l~~~~p~~~~ 519 (1009)
. -+....++.+.++.+.+..+ .|+..+..+ ++.-| ..++-+. +..-|++.++ .+|..+.
T Consensus 381 ~-Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~------------s~~cP---~~c~c~~tVvRcSnk~lk-~lp~~iP 443 (498)
T KOG4237|consen 381 R-CQSPGFVRQIPISDVAFGDFRCGGPEELGCLT------------SSPCP---PPCTCLDTVVRCSNKLLK-LLPRGIP 443 (498)
T ss_pred C-CCCCchhccccchhccccccccCCccccCCCC------------CCCCC---CCcchhhhhHhhcccchh-hcCCCCC
Confidence 1 12233455566665554432 111110000 00011 1122222 2234444444 5555442
Q ss_pred ccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCC
Q 037197 520 SCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYN 580 (1009)
Q Consensus 520 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 580 (1009)
..-.+|+|.+|.++ .+|.+ .+.+| .+|+|+|+++..--..|.+++.|.+|-||||
T Consensus 444 --~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 444 --VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred --chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 24567899999998 78887 67788 8999999999888889999999999999987
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-27 Score=242.16 Aligned_cols=276 Identities=20% Similarity=0.215 Sum_probs=183.5
Q ss_pred eeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccc-cccCCCCCCCCCCCcCCeEEecC
Q 037197 68 VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQ-NNFIGSFPTGLGKASGLTSVNAS 146 (1009)
Q Consensus 68 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls 146 (1009)
.+.|+|..|+|+...+..|+.+++|++|||+.|+|+.+-|++|.+|..|..|-+.+ |+|+...-..|++|+.|+.|.+.
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence 46677777777766666777777777777777777777777777777766665555 66654444556777777777777
Q ss_pred CCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccc------------cccCCccCCCCcchhh
Q 037197 147 SNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNL------------TGKIPPELGQLSSLET 214 (1009)
Q Consensus 147 ~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l------------~~~~p~~l~~l~~L~~ 214 (1009)
-|++.......|..+++|..|.+.+|.+..+--.+|..+..++.+.+..|.+ ....|..++...-..-
T Consensus 149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p 228 (498)
T KOG4237|consen 149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP 228 (498)
T ss_pred hhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence 7777766666777777777777777777644344677777777777766652 2233444444444444
Q ss_pred hhcccccccccCCccccC-CCCccEEEeccCccccccC-cccCCCCCCcEEEcccCCcCCCCCccccccccccccccccc
Q 037197 215 IILGYNAFEGEIPAEFGN-LTNLRYLDLAVGSLSGQIP-PALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDN 292 (1009)
Q Consensus 215 L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 292 (1009)
..+.++++..+-+..|.. +.++..=-.+.+...+..| ..|.+|++|++|+|++|+|+.+-+.+|.++..+++|.|..|
T Consensus 229 ~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N 308 (498)
T KOG4237|consen 229 YRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRN 308 (498)
T ss_pred HHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcc
Confidence 555555555433333322 1122211122232322333 34778888888888888888888888888888888888888
Q ss_pred ccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccC
Q 037197 293 QISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLI 343 (1009)
Q Consensus 293 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 343 (1009)
+|...-...|.++..|+.|+|.+|+|+...|.+|..+.+|..|+|-.|.+.
T Consensus 309 ~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 309 KLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred hHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 887666667888888888888888888888888888888888888777763
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=234.31 Aligned_cols=208 Identities=29% Similarity=0.414 Sum_probs=170.9
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECC---CCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcC
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHR---PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNE 769 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 769 (1009)
..+.+.|..+++||.|.|++||++.+.. ..+.||+|.+... ....++..|++++..+ .+.||+++.+++...
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 4566779999999999999999998877 7889999998543 3456688999999999 599999999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-CcEEEccc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN-LEARIADF 848 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Df 848 (1009)
+...+|+||++.....++... ++..++..++..++.||+++|.. |||||||||+|++++.. ++-.|+||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 999999999999999988754 45667777899999999999999 99999999999999864 67899999
Q ss_pred ccceecccCC--------------------------------------------CceeeecccCcccCCcccCC-CCCCc
Q 037197 849 GLARMMLHKN--------------------------------------------ETVSMVAGSYGYIAPEYGYT-LKVDE 883 (1009)
Q Consensus 849 Gls~~~~~~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~ 883 (1009)
|+|..+.... .......||+||.|||++.. ...+.
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9997211000 00113469999999998764 45688
Q ss_pred ccchHhHHHHHHHHHhCCCCCCCCCCCCccHH
Q 037197 884 KSDIYSFGVVLLELLTGKMPLDPAFGGSKDIV 915 (1009)
Q Consensus 884 ~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~ 915 (1009)
+.||||.||++.-+++++.||-........+.
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ 289 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALA 289 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHH
Confidence 99999999999999999999965443333333
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-24 Score=271.89 Aligned_cols=336 Identities=23% Similarity=0.281 Sum_probs=170.5
Q ss_pred ccccccCccCcccccccc------cCCCCCCCCCCCc-CCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCc
Q 037197 108 KSLANLTALKSMDVSQNN------FIGSFPTGLGKAS-GLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPT 180 (1009)
Q Consensus 108 ~~l~~l~~L~~L~Ls~n~------l~~~~p~~l~~l~-~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~ 180 (1009)
.+|.++++|+.|.+..+. +...+|..+..++ +|+.|.+.++.+. .+|..+ ...+|++|++++|.+. .+|.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 345556666666554432 2223455554443 4666666666554 445544 3566666666666655 4555
Q ss_pred cccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCC
Q 037197 181 SFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKL 260 (1009)
Q Consensus 181 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 260 (1009)
.+..+++|+.|+|++|.....+|. ++.+++|++|+|++|.....+|..++++++|++|++++|...+.+|..+ ++++|
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL 706 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL 706 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence 566666666666666543334443 5566666666666655444566666666666666666654444555444 56666
Q ss_pred cEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCC-------CCCcCCCCCCccc
Q 037197 261 TTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG-------LIPDKLGELTKLE 333 (1009)
Q Consensus 261 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-------~~~~~l~~l~~L~ 333 (1009)
+.|++++|.....+|.. ..+|++|+|++|.+. .+|..+ .+++|++|++.++.... ..+..+...++|+
T Consensus 707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~ 781 (1153)
T PLN03210 707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLT 781 (1153)
T ss_pred CEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccch
Confidence 66666666544444432 245666666666665 444433 35566666655532211 1111112234555
Q ss_pred EEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCc
Q 037197 334 VLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNL 413 (1009)
Q Consensus 334 ~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~ 413 (1009)
.|++++|...+.+|..++++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|.. ..+|+.|+|++|.
T Consensus 782 ~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~ 857 (1153)
T PLN03210 782 RLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTG 857 (1153)
T ss_pred heeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCC
Confidence 55555555544555555555555555555543333344433 3445555555554333233221 1344444555554
Q ss_pred cccccCCccCCCCcccEEEeecc-cccccCCcCCcCCCCCcEEeccc
Q 037197 414 ISGTIPVGLGNLPSLQRLEMANN-NLTGQIPDDISLSTSLSFVDISW 459 (1009)
Q Consensus 414 l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~ 459 (1009)
++ .+|.++..+++|+.|+|++| +++ .+|..+..+++|+.+++++
T Consensus 858 i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~ 902 (1153)
T PLN03210 858 IE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSD 902 (1153)
T ss_pred Cc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCC
Confidence 44 34444444444555554442 222 3333344444444444443
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-24 Score=270.85 Aligned_cols=340 Identities=24% Similarity=0.276 Sum_probs=251.6
Q ss_pred CccccCCCCccEEEeccCc------cccccCcccCCC-CCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcc
Q 037197 227 PAEFGNLTNLRYLDLAVGS------LSGQIPPALGRL-KKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIP 299 (1009)
Q Consensus 227 ~~~~~~l~~L~~L~L~~n~------l~~~~~~~l~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 299 (1009)
+.+|.++++|+.|.+..+. +...+|..|..+ .+|+.|++.++.+. .+|..| ...+|+.|+|++|++. .++
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence 4567888888888886553 333466666665 45888888888887 567666 4678888888888887 567
Q ss_pred hhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCC
Q 037197 300 VKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGN 379 (1009)
Q Consensus 300 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~ 379 (1009)
..+..+++|+.|+|++|.....+|. ++.+++|+.|+|++|.....+|..++.+.+|+.|++++|..-+.+|..+ .+++
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s 705 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS 705 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence 7777888888888887764445554 7778888888888888777788888888888888888875555667655 6788
Q ss_pred CceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccc-------cccCCcCCcCCCCC
Q 037197 380 LTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNL-------TGQIPDDISLSTSL 452 (1009)
Q Consensus 380 L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l-------~~~~p~~~~~l~~L 452 (1009)
|+.|++++|...+.+|.. ..+|+.|++++|.+. .+|..+ .+++|+.|++.++.. ....+......++|
T Consensus 706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL 780 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL 780 (1153)
T ss_pred CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccc
Confidence 888888888766555543 357788888888886 566554 577888888876432 11122223345678
Q ss_pred cEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCc
Q 037197 453 SFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNN 532 (1009)
Q Consensus 453 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N 532 (1009)
+.|+|++|...+.+|..+.++++|+.|++++|...+.+|..+ .+++|+.|+|++|..-..+|.. ..+|+.|+|++|
T Consensus 781 ~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n 856 (1153)
T PLN03210 781 TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRT 856 (1153)
T ss_pred hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCC
Confidence 888888887777788888888888888888876555677665 6888888898887654455553 357888889988
Q ss_pred ccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCc
Q 037197 533 RFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNK 581 (1009)
Q Consensus 533 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 581 (1009)
.++ .+|.++..+++|+.|+|++|+--..+|..+..++.|+.++++++.
T Consensus 857 ~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 857 GIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 887 688888888889999988844334577778888888888888763
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-23 Score=243.40 Aligned_cols=263 Identities=27% Similarity=0.338 Sum_probs=163.8
Q ss_pred CCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEc
Q 037197 258 KKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLEL 337 (1009)
Q Consensus 258 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 337 (1009)
..-..|+|++|.++ .+|..+. ++|+.|++++|+|+ .+|. .+++|++|++++|+|+.+ |.. .++|+.|++
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSL-PVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccCcc-cCc---ccccceeec
Confidence 34567888888887 5676664 46788888888887 3553 246777777777777754 322 346666666
Q ss_pred cCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccc
Q 037197 338 WKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGT 417 (1009)
Q Consensus 338 ~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~ 417 (1009)
++|.++. +|.. ...|+.|++++|+++ .+|.. + ++|+.|++++|++++
T Consensus 270 s~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p------------------------~~L~~LdLS~N~L~~- 316 (788)
T PRK15387 270 FSNPLTH-LPAL---PSGLCKLWIFGNQLT-SLPVL---P------------------------PGLQELSVSDNQLAS- 316 (788)
T ss_pred cCCchhh-hhhc---hhhcCEEECcCCccc-ccccc---c------------------------cccceeECCCCcccc-
Confidence 6666553 2221 133555555555554 22221 2 344555555555542
Q ss_pred cCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccC
Q 037197 418 IPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQAC 497 (1009)
Q Consensus 418 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 497 (1009)
+|... .+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+++ |.. ..+|+.|++++|+|+. +|.. .
T Consensus 317 Lp~lp---~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~-LP~l---~ 381 (788)
T PRK15387 317 LPALP---SELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTS-LPAL---P 381 (788)
T ss_pred CCCCc---ccccccccccCccc-ccccc---ccccceEecCCCccCCC-CCC---Ccccceehhhcccccc-Cccc---c
Confidence 22211 23455556666655 23431 23566666666666653 322 2355666677777664 4432 2
Q ss_pred CcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEec
Q 037197 498 PSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNL 577 (1009)
Q Consensus 498 ~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 577 (1009)
.+|+.|+|++|+|++ +|.. .++|+.|+|++|+|+ .+|..+ .+|+.|+|++|+|+ .+|..+.+++.|+.|+|
T Consensus 382 ~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL 452 (788)
T PRK15387 382 SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 452 (788)
T ss_pred cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence 467888888888884 5543 356888888888888 467543 46778899999987 67888888889999999
Q ss_pred CCCccccCCCC
Q 037197 578 SYNKLEGPVPS 588 (1009)
Q Consensus 578 s~N~l~g~ip~ 588 (1009)
++|+|+|.+|.
T Consensus 453 s~N~Ls~~~~~ 463 (788)
T PRK15387 453 EGNPLSERTLQ 463 (788)
T ss_pred CCCCCCchHHH
Confidence 99999988775
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=260.60 Aligned_cols=195 Identities=18% Similarity=0.251 Sum_probs=138.8
Q ss_pred hccCC-CceeeEEeEE-------EcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCC
Q 037197 752 GRLRH-RNIVRLLGYL-------HNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823 (1009)
Q Consensus 752 ~~l~H-pniv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~ 823 (1009)
+.++| +||++++++| .+.+.++.++||+ +++|.++++... ..+++.+++.++.||++||+|||++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~--- 99 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ--- 99 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 34556 6888888887 2334578889987 669999996532 2388999999999999999999998
Q ss_pred CeEEeccCCCcEEeCC-------------------CCcEEEcccccceecccCC--------C--------ceeeecccC
Q 037197 824 PVIHRDIKSNNILLDA-------------------NLEARIADFGLARMMLHKN--------E--------TVSMVAGSY 868 (1009)
Q Consensus 824 ~ivH~dlk~~NIll~~-------------------~~~~kl~DfGls~~~~~~~--------~--------~~~~~~gt~ 868 (1009)
+|+||||||+|||++. ++.+|++|||+++...... . ......||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999954 4456677777765421100 0 011235788
Q ss_pred cccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHH
Q 037197 869 GYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEML 948 (1009)
Q Consensus 869 ~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1009)
.|+|||++.+..++.++|||||||++|||++|..|+... ...+.... .. ...+.. .....
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-------~~~~~~~~-~~-----~~~~~~-------~~~~~ 239 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-------SRTMSSLR-HR-----VLPPQI-------LLNWP 239 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-------HHHHHHHH-Hh-----hcChhh-------hhcCH
Confidence 899999999889999999999999999999998886521 11111111 00 111111 11122
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 949 LVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 949 ~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
....++.+|++++|.+||++.|+++
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhh
Confidence 3446778999999999999999975
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-23 Score=244.26 Aligned_cols=267 Identities=27% Similarity=0.409 Sum_probs=187.6
Q ss_pred CCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEec
Q 037197 234 TNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNL 313 (1009)
Q Consensus 234 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 313 (1009)
.+-..|+|++|.++ .+|..+. ++|+.|++.+|+++. +|.. +++|++|+|++|+|+ .+|.. .++|+.|++
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccCc---ccccceeec
Confidence 45678999999998 6787775 489999999999994 6643 589999999999999 45643 468999999
Q ss_pred cccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeeccccccccc
Q 037197 314 MCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGT 393 (1009)
Q Consensus 314 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~ 393 (1009)
++|.++.+ |.. ..+|+.|++++|+++. +|. ..++|+.|++++|++++ +|.. ...|+.|++++|++++
T Consensus 270 s~N~L~~L-p~l---p~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~- 336 (788)
T PRK15387 270 FSNPLTHL-PAL---PSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS- 336 (788)
T ss_pred cCCchhhh-hhc---hhhcCEEECcCCcccc-ccc---cccccceeECCCCcccc-CCCC---cccccccccccCcccc-
Confidence 99999864 433 3578899999999985 343 24679999999999985 4432 2356777777777763
Q ss_pred CCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCC
Q 037197 394 FPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSI 473 (1009)
Q Consensus 394 ~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 473 (1009)
+|.. ..+|+.|+|++|+|++ +|... ++|+.|++++|+|+ .+|.. .
T Consensus 337 LP~l---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~-~LP~l---------------------------~ 381 (788)
T PRK15387 337 LPTL---PSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLT-SLPAL---------------------------P 381 (788)
T ss_pred cccc---ccccceEecCCCccCC-CCCCC---cccceehhhccccc-cCccc---------------------------c
Confidence 3321 1345556666665552 33221 23444555555554 23322 1
Q ss_pred cccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecC
Q 037197 474 PSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDM 553 (1009)
Q Consensus 474 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 553 (1009)
.+|+.|++++|+|++ +|.. .++|+.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|..+.++++|+.|+|
T Consensus 382 ~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL 452 (788)
T PRK15387 382 SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 452 (788)
T ss_pred cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence 234555555555553 3322 2468888888888884 5654 346788999999998 78999999999999999
Q ss_pred CccccccccCcCcCC
Q 037197 554 SNNSLFGRIPENFGA 568 (1009)
Q Consensus 554 s~N~l~~~~p~~~~~ 568 (1009)
++|+|++.+|..+..
T Consensus 453 s~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 453 EGNPLSERTLQALRE 467 (788)
T ss_pred CCCCCCchHHHHHHH
Confidence 999999988887644
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=204.82 Aligned_cols=170 Identities=21% Similarity=0.208 Sum_probs=125.7
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|+|.++++.+. ..+++.+++.|+.|+++||+|||++ + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997542 2389999999999999999999998 5 999999999999999 99998653322
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCc
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1009)
..|++.|+|||++.+..++.++|||||||++|||++|+.||.........+..+. ..... .++..... .
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~----~~~~~----~~~~~~~~-~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILL----NGMPA----DDPRDRSN-L 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH----HHhcc----CCcccccc-H
Confidence 2588999999999999999999999999999999999999964322211122211 11110 00000000 0
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 942 HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 942 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.......++.+++.+|++.+|++||++.|+++.+....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 11111125788999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-23 Score=206.44 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=189.2
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
..+|.+...|..|+|++.+ ..+++|++...........+|.+|.-.++-+.||||.++++.|.......++..||+.|
T Consensus 195 ~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3457888899999999986 35667777655555555667779999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEc--ccccceecccCCCc
Q 037197 783 SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIA--DFGLARMMLHKNET 860 (1009)
Q Consensus 783 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~--DfGls~~~~~~~~~ 860 (1009)
||+..+++.. ....+..++.+++.+||+|++|||+. .+-|.---+.++.|++|++.+++|+ |--++..
T Consensus 273 slynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq------- 342 (448)
T KOG0195|consen 273 SLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------- 342 (448)
T ss_pred HHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee-------
Confidence 9999998653 45578889999999999999999997 4445556789999999999888875 3322211
Q ss_pred eeeecccCcccCCcccCCCCCC---cccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 861 VSMVAGSYGYIAPEYGYTLKVD---EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 861 ~~~~~gt~~y~aPE~~~~~~~~---~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
.....-.|.||+||.+...+-+ .++|+|||++++||+.|...||.+..+-+- .-+...+.+...++
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-----------gmkialeglrv~ip 411 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-----------GMKIALEGLRVHIP 411 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-----------hhhhhhccccccCC
Confidence 1112346899999987765543 579999999999999999999986543211 11112233343443
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.... ..+.+++.-|+++||.+||.+..++-.|+++.
T Consensus 412 pgis------~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 412 PGIS------RHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCcc------HHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2221 23456788999999999999999999998864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.5e-22 Score=217.21 Aligned_cols=166 Identities=20% Similarity=0.171 Sum_probs=129.2
Q ss_pred HHhcCCcCceeccCCceEEEEEEECC-CCeEEEEEEcccCCC---ChhhHHHHHHHHHHHhccCCCceee-EEeEEEcCC
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHR-PHMVVAVKKLWRSDN---DIESGDDLFREVSLLGRLRHRNIVR-LLGYLHNET 770 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~-l~~~~~~~~ 770 (1009)
+.++|...+.||+|+||+||+|.+.. +++.||||++..... .......+.+|++++++++|+|+++ ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 45679999999999999999998875 678889998743211 1223455669999999999999985 4432 4
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEecc-CCCcEEeCCCCcEEEcccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDI-KSNNILLDANLEARIADFG 849 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl-k~~NIll~~~~~~kl~DfG 849 (1009)
..++||||++|++|... ... . ...++.++++||+|||+. ||+|||| ||+||+++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~~-------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RPH-------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHHh-Ccc-------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 57999999999999732 111 1 134688999999999998 9999999 9999999999999999999
Q ss_pred cceecccCCC--------ceeeecccCcccCCcccCCC
Q 037197 850 LARMMLHKNE--------TVSMVAGSYGYIAPEYGYTL 879 (1009)
Q Consensus 850 ls~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~ 879 (1009)
+++.+..... ......+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9997754431 11345678889999986643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=197.63 Aligned_cols=260 Identities=19% Similarity=0.224 Sum_probs=199.7
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+.++.||+|+||.++.|+.--.++.||||.-.... ...+...|.+..+.+ ..+.|..++-|..++.+-.+|+|
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4888999999999999999998889999999864432 234455677777777 57999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC-----cEEEcccccce
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-----EARIADFGLAR 852 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-----~~kl~DfGls~ 852 (1009)
.+ |-||+|++.-.... ++......||+|++.-++|+|++ ..|.|||||+|+||+..+ .+.++|||+|+
T Consensus 105 LL-GPSLEDLFD~CgR~---FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRR---FSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHHhcCc---ccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 88 88999988644332 88899999999999999999999 999999999999997543 58999999999
Q ss_pred ecccCCC-------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc
Q 037197 853 MMLHKNE-------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN 925 (1009)
Q Consensus 853 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 925 (1009)
.+.++.. ..+...||.+||+-....+++.+.+.|+-|+|-++++.+-|..||...... ...+ ++.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~--tnK~------kYe 249 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD--TNKE------KYE 249 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc--chHH------HHH
Confidence 9876652 334567999999999999999999999999999999999999999854332 1111 111
Q ss_pred cccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 926 KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
+.-+..-.-.+...|...++++...++.++ +.+-++-|..+-+...+.++..
T Consensus 250 KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 250 KIGETKRSTPIEVLCEGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred HhccccccCCHHHHHhcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHH
Confidence 111112222333455556666666666665 4556666877666666655543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-22 Score=238.80 Aligned_cols=289 Identities=24% Similarity=0.381 Sum_probs=181.1
Q ss_pred CCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcc
Q 037197 139 GLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILG 218 (1009)
Q Consensus 139 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 218 (1009)
+.+.|++++++++ .+|..+. ++|+.|+|++|.++ .+|..+. .+|+.|++++|+++ .+|..+. ++|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 4456666666665 3454442 35666666666666 3444433 36667777777666 4555443 356777777
Q ss_pred cccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCc
Q 037197 219 YNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEI 298 (1009)
Q Consensus 219 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 298 (1009)
+|+++ .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|+|++|++++ +|..+. ++|+.|++++|+++ .+
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt-~L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLT-AL 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccc-cC
Confidence 77766 5555543 46777777777776 3555443 467778888887773 454443 46788888888887 34
Q ss_pred chhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCC
Q 037197 299 PVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSG 378 (1009)
Q Consensus 299 ~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~ 378 (1009)
|..+. ++|+.|++++|.++++ |..+. ++|+.|++++|+++. +|..+ .+.|+.|++++|.++ .+|..+. .
T Consensus 320 P~~l~--~sL~~L~Ls~N~Lt~L-P~~l~--~sL~~L~Ls~N~L~~-LP~~l--p~~L~~LdLs~N~Lt-~LP~~l~--~ 388 (754)
T PRK15370 320 PETLP--PGLKTLEAGENALTSL-PASLP--PELQVLDVSKNQITV-LPETL--PPTITTLDVSRNALT-NLPENLP--A 388 (754)
T ss_pred Ccccc--ccceeccccCCccccC-Chhhc--CcccEEECCCCCCCc-CChhh--cCCcCEEECCCCcCC-CCCHhHH--H
Confidence 54332 5788888888888763 44443 678888888888763 45444 257888888888887 4555543 3
Q ss_pred CCceeecccccccccCCccc----ccCccccEEEcccCccccccCCccCCCCcccEEEeeccccccc-CCcCCcCCCCCc
Q 037197 379 NLTKLILFNNSFSGTFPVSL----STCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQ-IPDDISLSTSLS 453 (1009)
Q Consensus 379 ~L~~L~l~~N~l~~~~p~~l----~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~ 453 (1009)
.|+.|++++|+++ .+|..+ ..++.+..|++.+|.++. ..+.+|+.| ++.+.+.|. ++...+....++
T Consensus 389 sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~ 460 (754)
T PRK15370 389 ALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVR 460 (754)
T ss_pred HHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCccccccccccccc
Confidence 6888888888887 445443 345778899999998872 345566666 455555543 333444444555
Q ss_pred EEecccCccccc
Q 037197 454 FVDISWNHLESY 465 (1009)
Q Consensus 454 ~L~Ls~N~l~~~ 465 (1009)
....-.+.+++.
T Consensus 461 ~~~~l~~a~~~W 472 (754)
T PRK15370 461 VTRPLHQAVQGW 472 (754)
T ss_pred ccchHHHHHhcc
Confidence 444444444443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=189.82 Aligned_cols=201 Identities=21% Similarity=0.241 Sum_probs=170.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCC-CceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH-RNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~l~~~~~~~~~~~lV 775 (1009)
...|+.++.||.|+||.+|.|....+|+.||||.-... ....+...|.++.+.+++ ..|..+..|..++.+-.+|
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc----CCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 45688999999999999999999999999999986333 334556789999999864 7888889999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC---CcEEEcccccce
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN---LEARIADFGLAR 852 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~DfGls~ 852 (1009)
||.. |-||++++.-.... ++..+.+-.+-|++.-++|+|.+ +++||||||+|++.+-+ .++.++|||+|+
T Consensus 90 MdLL-GPsLEdLfnfC~R~---ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRR---FTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHHhhh---hhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9988 88999998654332 78888898999999999999999 99999999999999654 468999999999
Q ss_pred ecccCCC-------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Q 037197 853 MMLHKNE-------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAF 908 (1009)
Q Consensus 853 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~ 908 (1009)
.+.+... ......||.+|.+-....+.+.+.+.|+-|+|.++.++--|..||+...
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 8755431 2335678999999888777788899999999999999999999998543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-20 Score=206.55 Aligned_cols=262 Identities=21% Similarity=0.209 Sum_probs=193.4
Q ss_pred cCCcCceeccCCceEEEEEEECCCC-eEEEEEEcccCCCChhhHHHHHHHHHHHhccC----CCceeeEEeEE-EcCCeE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPH-MVVAVKKLWRSDNDIESGDDLFREVSLLGRLR----HRNIVRLLGYL-HNETNV 772 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~----Hpniv~l~~~~-~~~~~~ 772 (1009)
+|+..+.||+|+||.||.|....++ ..+|+|.-....... ...+..|..++..+. -+++..+++.. ..+.+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 7899999999999999999988764 678888775432211 114557888888886 26899999999 577889
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-----CcEEEcc
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN-----LEARIAD 847 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-----~~~kl~D 847 (1009)
++||+.+ |.+|.++..... ...++..+..+|+.|++.+|+++|+. |++||||||.|+.++.. ..+.+.|
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred EEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 9999977 999999886555 22378889999999999999999999 99999999999999865 4699999
Q ss_pred cccce--ecccCCC-------c-eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHH
Q 037197 848 FGLAR--MMLHKNE-------T-VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEW 917 (1009)
Q Consensus 848 fGls~--~~~~~~~-------~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~ 917 (1009)
||+++ .+..... . .....||..|++++...+.+.+.+.|+||++.++.|+..|..||........ ...
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~ 248 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSK 248 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHH
Confidence 99998 3322211 1 2345699999999999999999999999999999999999999964332211 111
Q ss_pred HHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 918 VLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
+....... .... .....+.+.. .+...+-..+...+|....+...+.+.....
T Consensus 249 ~~~~~~~~-----~~~~----~~~~~~~~~~---~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 249 FEKDPRKL-----LTDR----FGDLKPEEFA---KILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHhhhh-----cccc----ccCCChHHHH---HHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111100 0110 1111223333 3333444588999999999999998887655
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=224.23 Aligned_cols=223 Identities=29% Similarity=0.492 Sum_probs=114.0
Q ss_pred chhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCccccccccccccccc
Q 037197 211 SLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLS 290 (1009)
Q Consensus 211 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 290 (1009)
+...|+++++.++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|++|++++|+++ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 3456666666666 4554442 35667777777666 3444332 36666666666666 3454332 356666666
Q ss_pred ccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccC
Q 037197 291 DNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEI 370 (1009)
Q Consensus 291 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~ 370 (1009)
+|++. .+|..+. .+|+.|++++|+|+. +|..+. ++|+.|++++|++++ +
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-------------------------L 298 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-------------------------L 298 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-------------------------C
Confidence 66665 4454443 356666666666653 233322 245555555544432 2
Q ss_pred CcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCC
Q 037197 371 PTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLST 450 (1009)
Q Consensus 371 ~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 450 (1009)
|..+. .+|+.|++++|+++. +|..+ .++|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+ .+
T Consensus 299 P~~lp--~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~ 367 (754)
T PRK15370 299 PAHLP--SGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL--PP 367 (754)
T ss_pred cccch--hhHHHHHhcCCcccc-CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh--cC
Confidence 22221 234445555555542 22222 1345555555555552 444332 45666666666665 344433 24
Q ss_pred CCcEEecccCcccccCCCcccCCcccchhccccCccc
Q 037197 451 SLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQ 487 (1009)
Q Consensus 451 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 487 (1009)
+|+.|+|++|+|+.+ |..+. ..|+.|++++|+++
T Consensus 368 ~L~~LdLs~N~Lt~L-P~~l~--~sL~~LdLs~N~L~ 401 (754)
T PRK15370 368 TITTLDVSRNALTNL-PENLP--AALQIMQASRNNLV 401 (754)
T ss_pred CcCEEECCCCcCCCC-CHhHH--HHHHHHhhccCCcc
Confidence 566666666666643 22221 24555555555554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-19 Score=199.40 Aligned_cols=262 Identities=28% Similarity=0.384 Sum_probs=196.6
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChh-hHHHHHHHHHHHhccCCC-ceeeEEeEEEcCCeEEEEEe
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE-SGDDLFREVSLLGRLRHR-NIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~Hp-niv~l~~~~~~~~~~~lV~E 777 (1009)
|...+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +++++.+++......++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 556678999999999999988 6789999876544433 466777999999999988 79999999987777899999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC-cEEEcccccceeccc
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-EARIADFGLARMMLH 856 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGls~~~~~ 856 (1009)
|+.++++.+++...... ..++......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999777654321 2377788888999999999999999 999999999999999988 799999999986544
Q ss_pred CCC------ceeeecccCcccCCcccCC---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 857 KNE------TVSMVAGSYGYIAPEYGYT---LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 857 ~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
... ......++..|+|||.... .......|+||+|++++++++|..||...... .........+.....
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~ 232 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPT 232 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCC
Confidence 332 2456789999999999877 57889999999999999999999997643221 011112122211110
Q ss_pred cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
. ........... ......+..++.+|+..+|..|.+..+....
T Consensus 233 ~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P--SLASPLSPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c--ccccccCcccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 00001110000 1112345678889999999999999887765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-21 Score=225.57 Aligned_cols=254 Identities=21% Similarity=0.264 Sum_probs=186.9
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEccc---C-CCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWR---S-DNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~---~-~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
...+++|.|++|.|+.+........++.|.++. + .........+..|+-+-..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 356789999999888888776666666665532 1 111111222447888888899999988888777666666669
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
|||++ +|..++.... .+...++..+++|++.|++|+|+. ||.|||+|++|++++.+|.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 9999987652 166677778999999999999999 999999999999999999999999999877644
Q ss_pred CCC----ceeeecccCcccCCcccCCCCCCc-ccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 857 KNE----TVSMVAGSYGYIAPEYGYTLKVDE-KSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 857 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~-~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
+.+ .....+|+-.|+|||.....+|++ ..||||.|++++.|.+|+.||......+..+. .. .+.. ...
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~----~~-~~~~-~~~- 545 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK----TN-NYSD-QRN- 545 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh----hh-cccc-ccc-
Confidence 432 345678999999999999999885 68999999999999999999975443322220 00 0000 000
Q ss_pred cCccccccCchHH-HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 LDPSIAGQCKHVQ-EEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.......+. ........++.++++.+|.+|-|+.++++
T Consensus 546 ----~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 ----IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ----cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111111111 12233557888999999999999999976
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=183.00 Aligned_cols=141 Identities=17% Similarity=0.121 Sum_probs=107.4
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhh------------------------HHHHHHHHHHHhccCCCc
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIES------------------------GDDLFREVSLLGRLRHRN 758 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~Hpn 758 (1009)
.+.||+|+||.||+|.+. +|+.||||+++........ .....+|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999997 6999999999654221111 011225999999998887
Q ss_pred eeeEEeEEEcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHH-HhcCCCCeEEeccCCCcEEe
Q 037197 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL-HHDCQPPVIHRDIKSNNILL 837 (1009)
Q Consensus 759 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~dlk~~NIll 837 (1009)
+.....+... ..++||||++++++........ .+++.....++.|++.+|+|+ |+. +|+||||||+||++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~----~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA----PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence 6544333222 2389999999887765432221 277888999999999999999 677 99999999999999
Q ss_pred CCCCcEEEcccccceec
Q 037197 838 DANLEARIADFGLARMM 854 (1009)
Q Consensus 838 ~~~~~~kl~DfGls~~~ 854 (1009)
+ ++.++++|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.6e-19 Score=184.31 Aligned_cols=236 Identities=18% Similarity=0.226 Sum_probs=150.0
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChh-hHHHHHHHHHHHhccCC----------CceeeEEeE---
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE-SGDDLFREVSLLGRLRH----------RNIVRLLGY--- 765 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~H----------pniv~l~~~--- 765 (1009)
+...+.||.|+++.||.+++..+++.+|+|++........ ..+++.+|.-....+.+ -.++-.++.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4567789999999999999999999999999876543222 23444455544444322 122222222
Q ss_pred ------EEcC---C-----eEEEEEeccCCCChhhhhc---CCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 037197 766 ------LHNE---T-----NVMMVYDYMPNDSLGEALH---GKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHR 828 (1009)
Q Consensus 766 ------~~~~---~-----~~~lV~E~~~~gsL~~~l~---~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 828 (1009)
+... . ..+++|+-+ .++|.+++. .............+..+..|+++.+++||+. |+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 1111 1 236788877 677877753 2222233356677788889999999999999 99999
Q ss_pred ccCCCcEEeCCCCcEEEcccccceecccCCCceeeecccCcccCCcccCC--------CCCCcccchHhHHHHHHHHHhC
Q 037197 829 DIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYT--------LKVDEKSDIYSFGVVLLELLTG 900 (1009)
Q Consensus 829 dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~SlGvvl~elltg 900 (1009)
||+|+|++++++|.++|+||+....... .......+..|.|||.... ..++.+.|.|++|+++|.|++|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE---EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc---eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999988765422 1111344578999996533 3578899999999999999999
Q ss_pred CCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCC
Q 037197 901 KMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGR 965 (1009)
Q Consensus 901 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 965 (1009)
+.||+..... ..+...-..|.+.++ .+..++..+++.+|++|
T Consensus 247 ~lPf~~~~~~--------------------~~~~~~f~~C~~~Pe---~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPE--------------------ADPEWDFSRCRDMPE---PVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGG--------------------STSGGGGTTSS---H---HHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcc--------------------ccccccchhcCCcCH---HHHHHHHHHccCCcccC
Confidence 9999843211 111102224554444 34567889999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.5e-20 Score=212.68 Aligned_cols=247 Identities=20% Similarity=0.246 Sum_probs=180.4
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC--ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN--DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.+...+.+|.+.|=+|.+|++.+ |. |+||++-+... .-....+-.+|++ .+.++|||++++.-........|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 46677889999999999999987 64 88898865532 2223344445666 66679999999998888888889999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
+|+ ..+|+|.+..++- +...+...|+.|++.|+.-+|.. ||+|||||.+|||++.-..+.|+||..-+...-
T Consensus 101 qyv-khnLyDRlSTRPF----L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRPF----LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHH-hhhhhhhhccchH----HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccC
Confidence 998 6779999876543 67777788999999999999999 999999999999999999999999976554221
Q ss_pred CC---Cceeeeccc----CcccCCcccCCC----------C-CCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHH
Q 037197 857 KN---ETVSMVAGS----YGYIAPEYGYTL----------K-VDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEW 917 (1009)
Q Consensus 857 ~~---~~~~~~~gt----~~y~aPE~~~~~----------~-~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 917 (1009)
+. .....+..| .+|+|||.+... . .+++.||||+||++.|+++ |++||.- .
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--------S-- 242 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--------S-- 242 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--------H--
Confidence 11 122223333 479999975431 1 5789999999999999999 7888862 1
Q ss_pred HHHHHhhccccccccCccccccCchHHHHH--HHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 918 VLSMIKSNKAQDEALDPSIAGQCKHVQEEM--LLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
+...+... ...++. ...+.+ ..+.+++..|++.||++|.++++.++.-+
T Consensus 243 --QL~aYr~~--~~~~~e------~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 243 --QLLAYRSG--NADDPE------QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred --HHHhHhcc--CccCHH------HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 11111111 011111 011111 13567889999999999999999999843
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-19 Score=184.49 Aligned_cols=174 Identities=14% Similarity=0.151 Sum_probs=132.5
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhh-HHH------HHHHHHHHhccCCCceeeEEeEEEc
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIES-GDD------LFREVSLLGRLRHRNIVRLLGYLHN 768 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~-~~~------~~~E~~~l~~l~Hpniv~l~~~~~~ 768 (1009)
+.++|+..+++|.|+||.||.+.. . +..+|+|.++......+. ... +.+|++.+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~-~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-D-YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-C-CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 457799999999999999999765 3 568999999654332222 122 3489999999999999999998653
Q ss_pred C--------CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC
Q 037197 769 E--------TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN 840 (1009)
Q Consensus 769 ~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~ 840 (1009)
. ...++||||++|.+|.++.. .+. ....+++.++..+|.. |++|||++|+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 3 35799999999999988732 222 2456999999999999 99999999999999998
Q ss_pred CcEEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh
Q 037197 841 LEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT 899 (1009)
Q Consensus 841 ~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt 899 (1009)
+ ++++|||........... ..+...+.+..++|+|+||+++.....
T Consensus 172 g-i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 8 999999988654221111 013344456678999999998776543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=176.33 Aligned_cols=141 Identities=18% Similarity=0.150 Sum_probs=109.5
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhh------------------------HHHHHHHHHHHhccCCCc
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIES------------------------GDDLFREVSLLGRLRHRN 758 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~Hpn 758 (1009)
.+.||+|++|.||+|.+. +|+.||||+++........ ......|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 457999999999999987 6999999998754221100 111237899999999998
Q ss_pred eeeEEeEEEcCCeEEEEEeccCCCChhhh-hcCCccccccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeccCCCcEE
Q 037197 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEA-LHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH-DCQPPVIHRDIKSNNIL 836 (1009)
Q Consensus 759 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~dlk~~NIl 836 (1009)
+.....+.... .++||||++++++... +... .++..+...++.|++.++.++|+ . ||+||||||+||+
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIl 150 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDV-----PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNIL 150 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhc-----cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEE
Confidence 76555444332 4899999998865433 3221 25677888899999999999999 7 9999999999999
Q ss_pred eCCCCcEEEcccccceecc
Q 037197 837 LDANLEARIADFGLARMML 855 (1009)
Q Consensus 837 l~~~~~~kl~DfGls~~~~ 855 (1009)
++ ++.++|+|||++....
T Consensus 151 l~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EE-CCCEEEEEcccceecC
Confidence 99 8899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.1e-21 Score=212.08 Aligned_cols=231 Identities=27% Similarity=0.350 Sum_probs=102.0
Q ss_pred Eecccccccc-ccccccccCCCCCeEecccCccccc----CCccccccCccCcccccccccCCCCCCCCCCCcCCeEEec
Q 037197 71 LDLSNMSLNG-SVSENIRGLRSLSSLNICCNEFASS----LPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNA 145 (1009)
Q Consensus 71 l~l~~~~l~~-~~~~~l~~l~~L~~L~L~~n~~~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 145 (1009)
|+|.++.+++ .....+..+.+|++|+++++.+++. +++.+...+.|++|+++++.+.+ .+..+
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~----------- 70 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGL----------- 70 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHH-----------
Confidence 5555555552 2333445555566666665555332 33344444555555555554431 00000
Q ss_pred CCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccc---cceeeeccccccc----cCCccCCCC-cchhhhhc
Q 037197 146 SSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK---LKFLGLSGNNLTG----KIPPELGQL-SSLETIIL 217 (1009)
Q Consensus 146 s~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~---L~~L~L~~n~l~~----~~p~~l~~l-~~L~~L~L 217 (1009)
..++..+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++
T Consensus 71 ------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L 144 (319)
T cd00116 71 ------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVL 144 (319)
T ss_pred ------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEc
Confidence 112233444445555555555444333333333333 5555555555442 111222333 44455555
Q ss_pred cccccccc----CCccccCCCCccEEEeccCccccc----cCcccCCCCCCcEEEcccCCcCCCC----Ccccccccccc
Q 037197 218 GYNAFEGE----IPAEFGNLTNLRYLDLAVGSLSGQ----IPPALGRLKKLTTVYLYKNNFTGKI----PPELGSITSLA 285 (1009)
Q Consensus 218 ~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~ 285 (1009)
++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++.. +..+..+++|+
T Consensus 145 ~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~ 224 (319)
T cd00116 145 GRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLE 224 (319)
T ss_pred CCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCC
Confidence 55544421 222344445555555555555532 2223334445555555555554321 12233344555
Q ss_pred cccccccccCCCcchhhhc-----ccCCCeEeccccccC
Q 037197 286 FLDLSDNQISGEIPVKLAE-----LKNLQLLNLMCNQLT 319 (1009)
Q Consensus 286 ~L~Ls~N~l~~~~~~~l~~-----l~~L~~L~L~~N~l~ 319 (1009)
+|++++|.+++.....+.. .+.|+.|++++|.++
T Consensus 225 ~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 225 VLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred EEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 5555555554322222221 145555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-18 Score=169.53 Aligned_cols=186 Identities=14% Similarity=0.044 Sum_probs=136.7
Q ss_pred cCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChh--hHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEEEEec
Q 037197 702 ESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE--SGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 702 ~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
....|++|+||+||.+.. .+..++.+.+........ ....+.+|+++++++. |+++++++++ +..+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 456799999999997765 467788777744322111 1224568999999995 5889999987 346999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEecc-CCCcEEeCCCCcEEEcccccceecccC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDI-KSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl-k~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
++|.+|.+.... ....++.|++++++++|+. ||+|||| ||+||+++.++.++|+|||++......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998754321 0123678999999999999 9999999 799999999999999999999865433
Q ss_pred CCc----e---------eeecccCcccCCcccC-CCCCC-cccchHhHHHHHHHHHhCCCCCCCC
Q 037197 858 NET----V---------SMVAGSYGYIAPEYGY-TLKVD-EKSDIYSFGVVLLELLTGKMPLDPA 907 (1009)
Q Consensus 858 ~~~----~---------~~~~gt~~y~aPE~~~-~~~~~-~~sDv~SlGvvl~elltg~~Pf~~~ 907 (1009)
... . .....++.|++|+... -...+ ...+.++-|.-+|.++|+..|+-..
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 210 0 0123567888887422 11223 5678999999999999999887543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.2e-21 Score=211.64 Aligned_cols=234 Identities=26% Similarity=0.305 Sum_probs=134.8
Q ss_pred ceeEEeccccccccc----cccccccCCCCCeEecccCcccc------cCCccccccCccCcccccccccCCCCCCCCCC
Q 037197 67 FVEKLDLSNMSLNGS----VSENIRGLRSLSSLNICCNEFAS------SLPKSLANLTALKSMDVSQNNFIGSFPTGLGK 136 (1009)
Q Consensus 67 ~v~~l~l~~~~l~~~----~~~~l~~l~~L~~L~L~~n~~~~------~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~ 136 (1009)
.++.|+++++.++.. +++.+...+.|++|+++++.+.+ .++..+..+++|++|+|++|.+.+..+..+..
T Consensus 24 ~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~ 103 (319)
T cd00116 24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLES 103 (319)
T ss_pred hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHH
Confidence 388999999998653 56677888899999999998862 34456777888888888888887665555555
Q ss_pred CcC---CeEEecCCCCCCC----CCCccccCC-CCCCeeeccCCccCCc----CCccccCccccceeeecccccccc---
Q 037197 137 ASG---LTSVNASSNNFSG----FLPEDLGNA-TSLESLDFRGSFFEGS----VPTSFRNLQKLKFLGLSGNNLTGK--- 201 (1009)
Q Consensus 137 l~~---L~~L~Ls~n~l~~----~~p~~l~~l-~~L~~L~L~~n~~~~~----~p~~~~~l~~L~~L~L~~n~l~~~--- 201 (1009)
+.+ |++|++++|++++ .+...+..+ ++|++|++++|.+++. ++..+..+++|++|++++|.+++.
T Consensus 104 l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 183 (319)
T cd00116 104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183 (319)
T ss_pred HhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHH
Confidence 544 7888888777763 222344455 6777777777776632 223344555666666666666531
Q ss_pred -CCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCccccc
Q 037197 202 -IPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGS 280 (1009)
Q Consensus 202 -~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~ 280 (1009)
++..+..+++|++|+|++|.+++.... .+...+..+++|++|++++|.+++.....+..
T Consensus 184 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~--------------------~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~ 243 (319)
T cd00116 184 ALAEGLKANCNLEVLDLNNNGLTDEGAS--------------------ALAETLASLKSLEVLNLGDNNLTDAGAAALAS 243 (319)
T ss_pred HHHHHHHhCCCCCEEeccCCccChHHHH--------------------HHHHHhcccCCCCEEecCCCcCchHHHHHHHH
Confidence 122223334445555554444322111 11223344455555555555554322222211
Q ss_pred -----ccccccccccccccCCC----cchhhhcccCCCeEeccccccCC
Q 037197 281 -----ITSLAFLDLSDNQISGE----IPVKLAELKNLQLLNLMCNQLTG 320 (1009)
Q Consensus 281 -----l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~ 320 (1009)
.+.|+.|++++|.++.. +...+..+++|+++++++|.++.
T Consensus 244 ~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 244 ALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred HHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 24566666666665421 22233444556666666666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-19 Score=200.21 Aligned_cols=188 Identities=24% Similarity=0.346 Sum_probs=157.3
Q ss_pred eccCCceEEEEEE---ECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 706 IGMGGNGIVYKAE---FHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 706 iG~G~~g~Vyk~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+|+|+||.|+.+. -.+.+..+|.|+.++.............|..++...+ ||.++++.-.++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999998653 3445788999988766443333334447888888886 99999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
|.+...+..... +++.........++-+++++|.. +|+|||+|++||+++.+|.+++.|||+++........
T Consensus 82 g~lft~l~~~~~----f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEVM----FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhccccCCc----hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999888866543 56666666778899999999999 9999999999999999999999999999876544333
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
+||..|||||+.. ....++|.||||++++||+||..||..
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999977 567889999999999999999999973
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-18 Score=191.18 Aligned_cols=219 Identities=25% Similarity=0.433 Sum_probs=166.8
Q ss_pred HhccCCCceeeEEeEEEcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCe-EEec
Q 037197 751 LGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV-IHRD 829 (1009)
Q Consensus 751 l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~d 829 (1009)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.... ..++|.....++.+|+.|++|+|+. +| +|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 467899999999999999999999999999999999997633 3389999999999999999999987 45 8999
Q ss_pred cCCCcEEeCCCCcEEEcccccceecccCC--CceeeecccCcccCCcccCCC-------CCCcccchHhHHHHHHHHHhC
Q 037197 830 IKSNNILLDANLEARIADFGLARMMLHKN--ETVSMVAGSYGYIAPEYGYTL-------KVDEKSDIYSFGVVLLELLTG 900 (1009)
Q Consensus 830 lk~~NIll~~~~~~kl~DfGls~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~SlGvvl~elltg 900 (1009)
++++|.++|....+|++|||+........ ..........-|.|||.+... ..+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987653211 111112234468999986543 146789999999999999999
Q ss_pred CCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 901 KMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 901 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
+.||+........ .+.+.. ++. .....+.|.+.... +...++..++..||..+|++||+++.+-..++.+..
T Consensus 155 ~~~~~~~~~~~~~-~eii~~-~~~--~~~~~~rP~i~~~~----e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP-DEIILR-VKK--GGSNPFRPSIELLN----ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCCh-HHHHHH-HHh--cCCCCcCcchhhhh----hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999864333222 222222 222 12344555554221 112256778899999999999999999999998877
Q ss_pred Ccc
Q 037197 981 RRK 983 (1009)
Q Consensus 981 ~~~ 983 (1009)
..+
T Consensus 227 ~~~ 229 (484)
T KOG1023|consen 227 GGS 229 (484)
T ss_pred ccc
Confidence 553
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-20 Score=171.50 Aligned_cols=165 Identities=30% Similarity=0.547 Sum_probs=118.6
Q ss_pred CCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchh
Q 037197 134 LGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLE 213 (1009)
Q Consensus 134 l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 213 (1009)
+-++++.+.|.||+|+++ .+|+.++.+.+|+.|++++|+++ .+|.+++.+++|+.|++.-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 344556666666677666 56667777777777777777777 67777888888888888888877 6777888888888
Q ss_pred hhhcccccccc-cCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCccccccccccccccccc
Q 037197 214 TIILGYNAFEG-EIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDN 292 (1009)
Q Consensus 214 ~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 292 (1009)
.|||.+|++.. .+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+++|.+. .+|..++.++.|++|++.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 88888777763 46666777777777777777775 66777777777777777777776 56777777777777777777
Q ss_pred ccCCCcchhhhc
Q 037197 293 QISGEIPVKLAE 304 (1009)
Q Consensus 293 ~l~~~~~~~l~~ 304 (1009)
+++ .+|..+++
T Consensus 184 rl~-vlppel~~ 194 (264)
T KOG0617|consen 184 RLT-VLPPELAN 194 (264)
T ss_pred eee-ecChhhhh
Confidence 776 45544443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.7e-20 Score=168.41 Aligned_cols=166 Identities=25% Similarity=0.518 Sum_probs=114.8
Q ss_pred ccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCc
Q 037197 374 LCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLS 453 (1009)
Q Consensus 374 l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 453 (1009)
+..+.+.+.|.|++|+++ .+|..+..+.+|+.|++.+|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 344556666667777766 55566677777777777777776 66777777777777777777776 6777777777777
Q ss_pred EEecccCccc-ccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCc
Q 037197 454 FVDISWNHLE-SYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNN 532 (1009)
Q Consensus 454 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N 532 (1009)
.|||++|++. ...|..|..+..|..|+++.|.+. .+|..++.+++|+.|.+..|.+- ..|.+++.++.|++|++.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 7777777765 346666777777777777777775 56666777777777777777665 56666666777777777777
Q ss_pred ccccCCCcccccc
Q 037197 533 RFSGEIPKAVATM 545 (1009)
Q Consensus 533 ~l~~~~p~~~~~l 545 (1009)
+++ .+|.+++++
T Consensus 184 rl~-vlppel~~l 195 (264)
T KOG0617|consen 184 RLT-VLPPELANL 195 (264)
T ss_pred eee-ecChhhhhh
Confidence 766 556555543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-17 Score=172.24 Aligned_cols=195 Identities=22% Similarity=0.304 Sum_probs=134.0
Q ss_pred CCCceeeEEeEEEc---------------------------CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHH
Q 037197 755 RHRNIVRLLGYLHN---------------------------ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIA 807 (1009)
Q Consensus 755 ~Hpniv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~ 807 (1009)
+|||||++.++|.+ ....|+||... ..+|.+++..+.. +...+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~~-----s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRHR-----SYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCCC-----chHHHHHHH
Confidence 59999999987643 23479999887 5689999876543 333444588
Q ss_pred HHHHHHHHHHHhcCCCCeEEeccCCCcEEeC--CC--CcEEEcccccceecccCC------CceeeecccCcccCCcccC
Q 037197 808 VGIAQGLNYLHHDCQPPVIHRDIKSNNILLD--AN--LEARIADFGLARMMLHKN------ETVSMVAGSYGYIAPEYGY 877 (1009)
Q Consensus 808 ~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~--~~--~~~kl~DfGls~~~~~~~------~~~~~~~gt~~y~aPE~~~ 877 (1009)
.|+++|+.|||.+ ||.|||+|++||++. +| ....|+|||.+---...+ ...-..-|.-.-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999993 33 357899999774221111 0111223556789999866
Q ss_pred CCC-----C-CcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHH
Q 037197 878 TLK-----V-DEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVL 951 (1009)
Q Consensus 878 ~~~-----~-~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 951 (1009)
..+ . -.|+|.|+.|.+.||+++...||..--+. .-..+.+.+.--|.+++.++. .+.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-----------~L~~r~Yqe~qLPalp~~vpp------~~r 487 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-----------LLDTRTYQESQLPALPSRVPP------VAR 487 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-----------eechhhhhhhhCCCCcccCCh------HHH
Confidence 432 1 25899999999999999999999741110 011111333344555544443 245
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHH
Q 037197 952 RIAVLCTAKLPKGRPTMRDVITML 975 (1009)
Q Consensus 952 ~l~~~cl~~dp~~RPs~~evl~~L 975 (1009)
+++...++.||.+|+++.-....+
T Consensus 488 qlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHhcCCccccCCccHHHhHH
Confidence 677889999999999876555544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.8e-17 Score=165.08 Aligned_cols=136 Identities=17% Similarity=0.230 Sum_probs=105.0
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-----CCCceeeEEeEEEcCC---e-
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-----RHRNIVRLLGYLHNET---N- 771 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~Hpniv~l~~~~~~~~---~- 771 (1009)
...+.||+|+||.||. +..++.. +||++.... ....+.+.+|+++++.+ +||||++++|+++++. .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 4567899999999995 6665555 689885432 22345677999999999 5799999999998763 4
Q ss_pred EEEEEec--cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHH-HHHHhcCCCCeEEeccCCCcEEeCC----CCcEE
Q 037197 772 VMMVYDY--MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL-NYLHHDCQPPVIHRDIKSNNILLDA----NLEAR 844 (1009)
Q Consensus 772 ~~lV~E~--~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~dlk~~NIll~~----~~~~k 844 (1009)
+.+|+|| +.+++|.+++.+.. +++. ..++.+++.++ +|||++ +|+||||||+||+++. +++++
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence 3478999 55799999996532 3443 24577888777 999999 9999999999999974 34799
Q ss_pred Ecccccc
Q 037197 845 IADFGLA 851 (1009)
Q Consensus 845 l~DfGls 851 (1009)
|+||+-+
T Consensus 150 LiDg~G~ 156 (210)
T PRK10345 150 VCDNIGE 156 (210)
T ss_pred EEECCCC
Confidence 9995434
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.5e-17 Score=193.00 Aligned_cols=248 Identities=18% Similarity=0.165 Sum_probs=179.6
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC---CCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR---HRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---Hpniv~l~~~~~~~~~~~l 774 (1009)
+.|.+.+.||+|+||+||+|...+ |+.||+|+=+.+..+. +.-=.+++.+++ -+.|..+..++.-.+..++
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 347788899999999999999998 9999999875443322 222223344444 2344555555556677899
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC-------CCcEEEcc
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA-------NLEARIAD 847 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-------~~~~kl~D 847 (1009)
|+||.+.|+|.+++..... .+|.-.+.++.|+++.+++||.. +|||+||||+|+++.. ..-++|+|
T Consensus 772 v~ey~~~Gtlld~~N~~~~----m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNKV----MDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeccccccHHHhhccCCC----CCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999984433 88999999999999999999999 9999999999999942 23589999
Q ss_pred cccceecc--cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc
Q 037197 848 FGLARMML--HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN 925 (1009)
Q Consensus 848 fGls~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 925 (1009)
||.+..+. ..+......++|-.+-.+|+..++.++...|.|.++.+++-|+.|++- . +..+
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~---------------q--~~~g 907 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM---------------E--VKNG 907 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH---------------H--hcCC
Confidence 99997653 223456667888899999999999999999999999999999999842 1 1111
Q ss_pred cccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 926 KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
. ....+..+.... ..+.+. ++...+|+.|-..=|...++...|+++..++
T Consensus 908 ~--~~~~~~~~~Ry~--~~~~W~---~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 908 S--SWMVKTNFPRYW--KRDMWN---KFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred c--ceeccccchhhh--hHHHHH---HHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 1 111121111100 012222 4555667755555688888888888776544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=166.59 Aligned_cols=143 Identities=17% Similarity=0.190 Sum_probs=109.6
Q ss_pred CCcCceeccCCceEEEEEE-ECCCCeEEEEEEcccCCCChh----------------------hHHHHHHHHHHHhccCC
Q 037197 700 VKESNIIGMGGNGIVYKAE-FHRPHMVVAVKKLWRSDNDIE----------------------SGDDLFREVSLLGRLRH 756 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~-~~~~~~~vavK~~~~~~~~~~----------------------~~~~~~~E~~~l~~l~H 756 (1009)
|+..+.||+|+||.||+|. +..+|+.||+|+++....... ....+..|++.++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6677899999999999998 666799999999865421100 01223479999999975
Q ss_pred --CceeeEEeEEEcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCC-eEEeccCCC
Q 037197 757 --RNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP-VIHRDIKSN 833 (1009)
Q Consensus 757 --pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~dlk~~ 833 (1009)
..+.+++++ . ..++||||++++++........ ..+..+...++.|++.++++||+. + |+||||||+
T Consensus 110 ~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 110 AGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred cCCCCCeeeEe---c-CceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 334455543 2 3489999999988877642222 145556678999999999999999 8 999999999
Q ss_pred cEEeCCCCcEEEcccccceec
Q 037197 834 NILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 834 NIll~~~~~~kl~DfGls~~~ 854 (1009)
||+++ ++.++++|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.8e-16 Score=187.02 Aligned_cols=153 Identities=31% Similarity=0.539 Sum_probs=109.4
Q ss_pred cChHHhHHHHHHHHhhccCCCCCCCCCCCCCccccCCcCCceeeeEEeCC---C--CceeEEeccccccccccccccccC
Q 037197 15 SNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWCNS---R--GFVEKLDLSNMSLNGSVSENIRGL 89 (1009)
Q Consensus 15 ~~~~~~~~~ll~~k~~~~d~~~~l~~W~~~~~~~~~~~~~C~w~gv~C~~---~--~~v~~l~l~~~~l~~~~~~~l~~l 89 (1009)
...++|..||++||+++.+|.. .+|.. +.|. ..+|.|.||.|+. . .+|+.|+|+++++.|.+|+.+..+
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~--~~W~g-~~C~---p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLR--FGWNG-DPCV---PQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred ccCchHHHHHHHHHHhcCCccc--CCCCC-CCCC---CcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence 3456789999999999987653 58963 2210 0123799999953 1 258888888888888888777777
Q ss_pred CCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCC-CCCCeee
Q 037197 90 RSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNA-TSLESLD 168 (1009)
Q Consensus 90 ~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l-~~L~~L~ 168 (1009)
++|+.|+|++|.+.+.+|..++.+++|++|||++|+++|.+|..++++++|++|+|++|+++|.+|..++.+ .++..++
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 777777777777777777777777777777777777777777777777777777777777777777666543 3455556
Q ss_pred ccCCc
Q 037197 169 FRGSF 173 (1009)
Q Consensus 169 L~~n~ 173 (1009)
+.+|.
T Consensus 522 ~~~N~ 526 (623)
T PLN03150 522 FTDNA 526 (623)
T ss_pred ecCCc
Confidence 55554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=158.95 Aligned_cols=136 Identities=20% Similarity=0.366 Sum_probs=111.8
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChh------hHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE------SGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.||+|++|.||+|.+. +..|++|+......... ......+|++++..+.|++++....++.+.+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeC--CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 56899999999999873 56788887643321111 12345689999999999999888888777778899999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
|++|++|.+++.... + .+..++.+++.+++++|+. +++|||++|+||+++ ++.++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999985431 1 7778999999999999998 999999999999999 78999999998854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.2e-16 Score=182.59 Aligned_cols=163 Identities=25% Similarity=0.387 Sum_probs=122.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
..|..+++|..|++|.||.++++.+.+.+|+|+= +. ..+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiN-kq-------~lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQ-------NLILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccc-cc-------chhhhc--cccccCCccee-----------------
Confidence 4578889999999999999999999999999442 21 111111 23333444443
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+-...++.... ++ .+++.+++|+|+. +|||||+||+|.+|+.-|++|++|||+++.....
T Consensus 136 ----gDc~tllk~~g~----lP--------vdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGP----LP--------VDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhcccCCC----Cc--------chhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 444444443221 11 1237899999999 9999999999999999999999999998753110
Q ss_pred C---------------CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 858 N---------------ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 858 ~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
. -..+..+|||.|+|||++..+.|....|.|++|+++||.+.|+.||..
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG 260 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 260 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC
Confidence 0 023456899999999999999999999999999999999999999974
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-16 Score=174.75 Aligned_cols=123 Identities=27% Similarity=0.439 Sum_probs=107.4
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFG 849 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 849 (1009)
.+.|+.|++|+..+|.+|+.+++.... .++.....++.|++.|++| + +.+|+|+||.||+...+.++||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~-~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEE-RSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccc-cchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 457999999999999999976654333 6788888999999999999 5 89999999999999999999999999
Q ss_pred cceecccCC------CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh
Q 037197 850 LARMMLHKN------ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT 899 (1009)
Q Consensus 850 ls~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt 899 (1009)
+........ ...+...||..||+||.+.+..|+.|+||||||++++|+++
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 998764433 13345679999999999999999999999999999999998
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-15 Score=156.29 Aligned_cols=137 Identities=20% Similarity=0.149 Sum_probs=106.5
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChh--------------------hHHHHHHHHHHHhccCCC--
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE--------------------SGDDLFREVSLLGRLRHR-- 757 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~--------------------~~~~~~~E~~~l~~l~Hp-- 757 (1009)
|...+.||+|+||.||++... +|+.||||+++....... .......|+.++.++.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 667788999999999999886 589999998754321110 112245788889988777
Q ss_pred ceeeEEeEEEcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe
Q 037197 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL 837 (1009)
Q Consensus 758 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 837 (1009)
.+++.++. ...++||||+++++|.+.... .....++.++++++.++|+. +|+||||||+||++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 44555442 345899999999999776431 12345788999999999998 99999999999999
Q ss_pred CCCCcEEEcccccceec
Q 037197 838 DANLEARIADFGLARMM 854 (1009)
Q Consensus 838 ~~~~~~kl~DfGls~~~ 854 (1009)
++++.++|+|||.+...
T Consensus 159 ~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 159 DDDEKIYIIDWPQMVST 175 (198)
T ss_pred cCCCcEEEEECCccccC
Confidence 99999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.3e-16 Score=184.60 Aligned_cols=117 Identities=37% Similarity=0.599 Sum_probs=102.8
Q ss_pred cCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecC
Q 037197 499 SLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLS 578 (1009)
Q Consensus 499 ~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 578 (1009)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|+.++++++|+.|||+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccCCCCCC--cccccCCcccccCcCCCCCCC-CCCC
Q 037197 579 YNKLEGPVPSNG--ILMNINPNELIGNAGLCGSVL-PPCS 615 (1009)
Q Consensus 579 ~N~l~g~ip~~~--~~~~~~~~~~~~n~~lcg~~~-~~c~ 615 (1009)
+|+|+|.+|... .+.......+.+|+++||.|. ++|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 999999999742 122334567889999999764 6774
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.8e-15 Score=154.69 Aligned_cols=132 Identities=20% Similarity=0.360 Sum_probs=105.1
Q ss_pred eeccCCceEEEEEEECCCCeEEEEEEcccCCCCh------hhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI------ESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 705 ~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
.||+|+||.||+|.+. +..|++|+........ ....++.+|+++++.++|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 3799999999999854 5678888864322111 1124555899999999988766555555566677999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
++|++|.+++.... . .++.+++++++++|+. +++|||++|+||+++ ++.++++|||.+..
T Consensus 79 ~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999875421 0 6789999999999998 999999999999999 88999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.2e-15 Score=176.54 Aligned_cols=138 Identities=17% Similarity=0.283 Sum_probs=110.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEc-ccCCCC-----hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDND-----IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~-~~~~~~-----~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
..|...+.||+|+||.||+|.+.... +++|+. .+.... ....+.+.+|++++++++|++++....++.+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44567889999999999999886643 333332 111111 1123456689999999999999988888877778
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++||||+++++|.+++. .+..++.+++++++|||+. +++|||+||+||++ .++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999999874 2356899999999999998 99999999999999 6779999999998
Q ss_pred ee
Q 037197 852 RM 853 (1009)
Q Consensus 852 ~~ 853 (1009)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 65
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.3e-14 Score=146.33 Aligned_cols=138 Identities=20% Similarity=0.200 Sum_probs=97.8
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHH----------------------HHHHHHHhccCCC--c
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL----------------------FREVSLLGRLRHR--N 758 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------~~E~~~l~~l~Hp--n 758 (1009)
.+.||+|+||+||+|.+. +++.||||++............. ..|.+.+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 58899999986542221111111 2456666666433 3
Q ss_pred eeeEEeEEEcCCeEEEEEeccCCCChhh-hhcCCccccccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeccCCCcEE
Q 037197 759 IVRLLGYLHNETNVMMVYDYMPNDSLGE-ALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH-DCQPPVIHRDIKSNNIL 836 (1009)
Q Consensus 759 iv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~dlk~~NIl 836 (1009)
+.+.+++ ...++||||++++.+.. .+.... .. .+...++.+++.++.++|. . +|+||||||+||+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEE
Confidence 4455543 23589999999954322 111110 11 4556789999999999998 7 9999999999999
Q ss_pred eCCCCcEEEcccccceecc
Q 037197 837 LDANLEARIADFGLARMML 855 (1009)
Q Consensus 837 l~~~~~~kl~DfGls~~~~ 855 (1009)
++ ++.++++|||.+....
T Consensus 148 i~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EE-CCcEEEEECccccccc
Confidence 99 8899999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=136.01 Aligned_cols=134 Identities=22% Similarity=0.222 Sum_probs=111.7
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCC--CceeeEEeEEEcCCeEEEEEeccC
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH--RNIVRLLGYLHNETNVMMVYDYMP 780 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H--pniv~l~~~~~~~~~~~lV~E~~~ 780 (1009)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++++++++...++..+++|||++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred ceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 4679999999999999865 6789999854322 3556789999999976 589999999888888999999999
Q ss_pred CCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 781 NDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 781 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
++.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 77 g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8877654 3345566789999999999986445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.2e-13 Score=143.42 Aligned_cols=138 Identities=18% Similarity=0.222 Sum_probs=105.5
Q ss_pred cCceec-cCCceEEEEEEECCCCeEEEEEEcccCCC-----------ChhhHHHHHHHHHHHhccCCCce--eeEEeEEE
Q 037197 702 ESNIIG-MGGNGIVYKAEFHRPHMVVAVKKLWRSDN-----------DIESGDDLFREVSLLGRLRHRNI--VRLLGYLH 767 (1009)
Q Consensus 702 ~~~~iG-~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~Hpni--v~l~~~~~ 767 (1009)
....|| .|+.|+||++... +..++||.+..... .......+.+|++++.++.|+++ ++.+++..
T Consensus 35 ~~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 35 QARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred cCceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 345788 8999999999876 56789998854211 11223456789999999998775 67777644
Q ss_pred cC-Ce---EEEEEeccCC-CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc
Q 037197 768 NE-TN---VMMVYDYMPN-DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE 842 (1009)
Q Consensus 768 ~~-~~---~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 842 (1009)
.. .. .++||||+++ .+|.+++.... ++.. .+.++++++++||.. ||+||||||.||+++.++.
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~-----l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~ 180 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEAP-----LSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGK 180 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcCC-----CCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCC
Confidence 32 22 3599999997 69998885432 3332 357899999999999 9999999999999999999
Q ss_pred EEEccccccee
Q 037197 843 ARIADFGLARM 853 (1009)
Q Consensus 843 ~kl~DfGls~~ 853 (1009)
++|+|||.+..
T Consensus 181 v~LIDfg~~~~ 191 (239)
T PRK01723 181 FWLIDFDRGEL 191 (239)
T ss_pred EEEEECCCccc
Confidence 99999998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.5e-15 Score=175.79 Aligned_cols=257 Identities=24% Similarity=0.272 Sum_probs=187.4
Q ss_pred cCCcCceeccCCceEEEEEEEC-CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFH-RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.|...+.||+|+|+.|-..... .....+|+|.+...............|..+-+.+. |+|++.+++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4666777999999999988764 33556777777554333333444446888877776 999999999999999999999
Q ss_pred eccCCCChhhhh-cCCccccccccHHHHHHHHHHHHHHHHHHH-hcCCCCeEEeccCCCcEEeCCCC-cEEEccccccee
Q 037197 777 DYMPNDSLGEAL-HGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-HDCQPPVIHRDIKSNNILLDANL-EARIADFGLARM 853 (1009)
Q Consensus 777 E~~~~gsL~~~l-~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGls~~ 853 (1009)
||..++++.+-+ +....+ .+....-.+..|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~---~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTG---TSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCCccC---CCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988 433212 233333447899999999999 77 999999999999999999 999999999998
Q ss_pred ccc-CC--Cceeeecc-cCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 854 MLH-KN--ETVSMVAG-SYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 854 ~~~-~~--~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
+.. .+ .......| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...........|.........
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 252 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQ-- 252 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccccc--
Confidence 766 33 23344567 9999999987774 44678999999999999999999998554443333444322110000
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 975 (1009)
.... ........+..+++..+|+.|.+.+++...=
T Consensus 253 -----~~~~-------~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~ 287 (601)
T KOG0590|consen 253 -----LPWN-------SISDQAHDLLHKILKENPSNRLSIEELKLDN 287 (601)
T ss_pred -----Cccc-------cCChhhhhcccccccCCchhccccccccccc
Confidence 0011 1111234566688889999999988876543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.1e-15 Score=164.42 Aligned_cols=170 Identities=31% Similarity=0.561 Sum_probs=85.2
Q ss_pred EEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcc
Q 037197 407 VRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNL 486 (1009)
Q Consensus 407 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 486 (1009)
.+|+.|++. .+|..++.+..|+.+.|.+|.|. .+|..++++..|++|||+.|+++. .|..++.++ |+.|.+++|++
T Consensus 80 aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~-lp~~lC~lp-Lkvli~sNNkl 155 (722)
T KOG0532|consen 80 ADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSH-LPDGLCDLP-LKVLIVSNNKL 155 (722)
T ss_pred hhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhc-CChhhhcCc-ceeEEEecCcc
Confidence 344444444 44444444444444444444444 444444444455555555555443 333334333 44445555555
Q ss_pred cCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCc
Q 037197 487 QAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENF 566 (1009)
Q Consensus 487 ~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 566 (1009)
+ .+|+.++.++.|..||.|.|.+. .+|..++++.+|+.|+++.|++. .+|.++..|+ |..||+|.|+++ .||-.|
T Consensus 156 ~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~f 230 (722)
T KOG0532|consen 156 T-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDF 230 (722)
T ss_pred c-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhh
Confidence 4 34555555555555555555554 44555555555555555555554 4455555333 555555555555 555555
Q ss_pred CCCCCCcEEecCCCccccC
Q 037197 567 GASPALEMLNLSYNKLEGP 585 (1009)
Q Consensus 567 ~~l~~L~~L~ls~N~l~g~ 585 (1009)
.++..|++|-|.+|+|+.+
T Consensus 231 r~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 231 RKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred hhhhhheeeeeccCCCCCC
Confidence 5555555555555555543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.7e-14 Score=155.85 Aligned_cols=191 Identities=31% Similarity=0.496 Sum_probs=144.5
Q ss_pred ceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecc
Q 037197 357 RRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANN 436 (1009)
Q Consensus 357 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 436 (1009)
...||+.|++. ++|..++.+..|+.+.|..|.+. .+|..+.++..|+.|+|+.|+++ ..|..++.|+ |+.|-+++|
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN 153 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN 153 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence 44566677766 67777777777777888888777 67778888888888888888887 7777777765 888888888
Q ss_pred cccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCc
Q 037197 437 NLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPA 516 (1009)
Q Consensus 437 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~ 516 (1009)
+++ .+|+.++....|..||.+.|++.. +|..++++.+|+.|.+..|++. .+|.++..| .|..||+|.|+++ .+|.
T Consensus 154 kl~-~lp~~ig~~~tl~~ld~s~nei~s-lpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv 228 (722)
T KOG0532|consen 154 KLT-SLPEEIGLLPTLAHLDVSKNEIQS-LPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPV 228 (722)
T ss_pred ccc-cCCcccccchhHHHhhhhhhhhhh-chHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecch
Confidence 887 788888888888888888888887 5667788888888888888887 456666643 4778888888887 7888
Q ss_pred cccccccceeeeecCcccccCCCccccccc---ccceecCCccc
Q 037197 517 SIASCEKLVSLNLRNNRFSGEIPKAVATMP---TLAILDMSNNS 557 (1009)
Q Consensus 517 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~---~L~~L~Ls~N~ 557 (1009)
.|..|+.|++|-|.+|.|. ..|..+...- --++|+..-.+
T Consensus 229 ~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 229 DFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred hhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 8888888888888888887 5666554332 23556655553
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=6.2e-13 Score=148.93 Aligned_cols=250 Identities=21% Similarity=0.205 Sum_probs=185.1
Q ss_pred hcCCcCceecc--CCceEEEEEEE--CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeE
Q 037197 698 ACVKESNIIGM--GGNGIVYKAEF--HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNV 772 (1009)
Q Consensus 698 ~~~~~~~~iG~--G~~g~Vyk~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~ 772 (1009)
..|...+.+|. |.+|.||++.. ..++..+|+|+-+...........-.+|+...++++ |++.++.+..+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 44667778999 99999999998 888899999986655554555566668888888884 99999999999999999
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHH----HHHHHHhcCCCCeEEeccCCCcEEeCCC-CcEEEcc
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQ----GLNYLHHDCQPPVIHRDIKSNNILLDAN-LEARIAD 847 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~D 847 (1009)
++-+|++ +.++.++.+.... .++....+.+..+..+ |+.++|+. +++|-|+||.||+...+ ...+++|
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 9999998 5778887765432 2566777888888888 99999999 99999999999999999 8899999
Q ss_pred cccceecccCCC-----ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH
Q 037197 848 FGLARMMLHKNE-----TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 848 fGls~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
||+...+....- ......+...|++||...+ -++.++|+|++|.+..+..++-.+...... ..|..
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----~~W~~--- 337 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN-----SSWSQ--- 337 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC-----CCccc---
Confidence 999988766541 1122367789999998554 568899999999999999987766542100 11110
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+..+++.- .+.. ...++...+..|++.+|-.|++.+++.+
T Consensus 338 -----~r~~~ip~e--~~~~---~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 -----LRQGYIPLE--FCEG---GSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----cccccCchh--hhcC---cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 011111100 0101 1112333677899999999998877654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=7e-14 Score=142.95 Aligned_cols=202 Identities=23% Similarity=0.336 Sum_probs=141.4
Q ss_pred HHhccCCCceeeEEeEEEcCC-----eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCC
Q 037197 750 LLGRLRHRNIVRLLGYLHNET-----NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824 (1009)
Q Consensus 750 ~l~~l~Hpniv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ 824 (1009)
-+-++.|.|+|+++.|+.+.. ...++.|||..|++..++++.......+....-.+++.||+.||.|||+. .|+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 355667999999999986543 47899999999999999987766555567777778999999999999996 889
Q ss_pred eEEeccCCCcEEeCCCCcEEEcccccceecc--cC--CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhC
Q 037197 825 VIHRDIKSNNILLDANLEARIADFGLARMML--HK--NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTG 900 (1009)
Q Consensus 825 ivH~dlk~~NIll~~~~~~kl~DfGls~~~~--~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg 900 (1009)
|+|+++..+-|++..+|-+|+.---...... .. ........+-++|.+||+....+.+.++|||+||.-..||.-+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999988875321111100 00 0112223456899999998888889999999999999999887
Q ss_pred CCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 901 KMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 901 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..--.... ........+...+. ...++.- +..+.+|++..|..||+|++++.
T Consensus 279 Eiq~tnse-S~~~~ee~ia~~i~------~len~lq--------------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNSE-SKVEVEENIANVII------GLENGLQ--------------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCCc-ceeehhhhhhhhee------eccCccc--------------cCcCcccccCCCCCCcchhhhhc
Confidence 75321110 10111111110000 0000000 23566999999999999998764
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-12 Score=150.40 Aligned_cols=179 Identities=34% Similarity=0.556 Sum_probs=83.2
Q ss_pred CCCCCeeeccCCccCCcCCccccCcc-ccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEE
Q 037197 161 ATSLESLDFRGSFFEGSVPTSFRNLQ-KLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYL 239 (1009)
Q Consensus 161 l~~L~~L~L~~n~~~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 239 (1009)
++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++|+.|
T Consensus 115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L 191 (394)
T COG4886 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL 191 (394)
T ss_pred ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence 344444444444444 3333333332 4555555555544 33344444555555555555544 333333344445555
Q ss_pred EeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccC
Q 037197 240 DLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLT 319 (1009)
Q Consensus 240 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 319 (1009)
++++|++. .+|.....+..|++|.+++|.+. ..+..+..+.++..|.+++|++. ..+..++.++++++|++++|+++
T Consensus 192 ~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 192 DLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred eccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc
Confidence 55555444 33333333344555555555322 23334444555555555555554 22444455555555555555555
Q ss_pred CCCCcCCCCCCcccEEEccCCccCccCC
Q 037197 320 GLIPDKLGELTKLEVLELWKNSLIGSLP 347 (1009)
Q Consensus 320 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 347 (1009)
.... +..+.+++.|++++|.+....+
T Consensus 269 ~i~~--~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 269 SISS--LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred cccc--ccccCccCEEeccCccccccch
Confidence 4322 4555555555555555544433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=7.9e-13 Score=151.97 Aligned_cols=199 Identities=35% Similarity=0.511 Sum_probs=116.3
Q ss_pred cccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCC-CCCeeeccCCccCCcCCccccCccccceeeeccc
Q 037197 118 SMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNAT-SLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGN 196 (1009)
Q Consensus 118 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~-~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n 196 (1009)
.|+++.|.+... +..+..++.++.|++.+|.++ .+|.....++ +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 355555554222 222334455666666666665 4455555553 6666666666665 44445566666666666666
Q ss_pred cccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCc
Q 037197 197 NLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPP 276 (1009)
Q Consensus 197 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 276 (1009)
+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|.+++|.+. ..+..+.++.++..|.+.+|++.. .+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence 666 45554445566666666666666 45554445555666666666433 345556666666666666666653 355
Q ss_pred ccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcC
Q 037197 277 ELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDK 325 (1009)
Q Consensus 277 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 325 (1009)
.++.+++++.|++++|+++. ++. ++.+.+++.|++++|.+....+..
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhh
Confidence 56666677777777777763 333 666777777777777776655543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.3e-12 Score=143.07 Aligned_cols=151 Identities=21% Similarity=0.231 Sum_probs=102.1
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhh---------------------------------
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIES--------------------------------- 740 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~--------------------------------- 740 (1009)
.+....|+ .+.||.|++|.||+|+.++ |+.||||+.+........
T Consensus 114 ~~~F~~fd-~~plasaSigQVh~A~l~~-G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 114 EELFAEFE-EKPLAAASIAQVHRARLVD-GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred HHHHhhCC-CcceeeeehhheEEEEecC-CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 44445555 3689999999999999875 899999998543110000
Q ss_pred -----HHHHHHHHHHHhcc----CCCceeeEEeEE-EcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHH
Q 037197 741 -----GDDLFREVSLLGRL----RHRNIVRLLGYL-HNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGI 810 (1009)
Q Consensus 741 -----~~~~~~E~~~l~~l----~Hpniv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i 810 (1009)
.-++.+|++.+.++ +|.+-+.+-.++ ......++||||++|++|.++......+ . .+.+++..+
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~ 265 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENL 265 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHH
Confidence 00233466655555 232222322222 2234579999999999999876432111 1 233466666
Q ss_pred HH-HHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 811 AQ-GLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 811 ~~-~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
++ .+..+|.. |++|+|++|.||+++.+++++++|||++..+.
T Consensus 266 ~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 266 ARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 66 46788887 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4e-11 Score=135.34 Aligned_cols=171 Identities=20% Similarity=0.214 Sum_probs=129.3
Q ss_pred EEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCCChhhhhcCCcccc
Q 037197 716 KAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGK 795 (1009)
Q Consensus 716 k~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~ 795 (1009)
.|..+.++.+|.|...+.+.. +......+-++.++.++||+|+++++.++.++..|+|+|.+. .|..++...
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----
Confidence 566677788888888865533 445566688899999999999999999999999999999874 366666542
Q ss_pred ccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCceeeecccCcccCCcc
Q 037197 796 LLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY 875 (1009)
Q Consensus 796 ~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~ 875 (1009)
........+.||+.||.+||..| +++|++|..+.|++++.|+.||++|.++.....-+.......--..|..|+.
T Consensus 102 ---~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 102 ---GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE 176 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence 23344457889999999999775 9999999999999999999999999988654322221122222235667764
Q ss_pred cCCCCCCcccchHhHHHHHHHHHhCC
Q 037197 876 GYTLKVDEKSDIYSFGVVLLELLTGK 901 (1009)
Q Consensus 876 ~~~~~~~~~sDv~SlGvvl~elltg~ 901 (1009)
+.... -..|.|.||++++|++.|.
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCcc
Confidence 33222 3469999999999999993
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.9e-12 Score=146.03 Aligned_cols=154 Identities=17% Similarity=0.140 Sum_probs=99.1
Q ss_pred CHHHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC---------------------------h-----h
Q 037197 692 TSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND---------------------------I-----E 739 (1009)
Q Consensus 692 ~~~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~---------------------------~-----~ 739 (1009)
..+++...|+. +.||+|++|.||+|+++++|+.||||+.+..... . +
T Consensus 114 ~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e 192 (537)
T PRK04750 114 PVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE 192 (537)
T ss_pred CHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence 34556667776 7899999999999999988999999998643100 0 0
Q ss_pred hHH------HHHHHHHHHhccC----CCceeeEEeEEEc-CCeEEEEEeccCCCChhhhh--cCCccccccccHHHHHHH
Q 037197 740 SGD------DLFREVSLLGRLR----HRNIVRLLGYLHN-ETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYNI 806 (1009)
Q Consensus 740 ~~~------~~~~E~~~l~~l~----Hpniv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~~~~~~~~~i 806 (1009)
..+ ++.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++- .........+.......+
T Consensus 193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~ 272 (537)
T PRK04750 193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF 272 (537)
T ss_pred HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH
Confidence 011 1224554444442 3333333333322 34568999999999998752 222111111222222223
Q ss_pred HHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC----cEEEcccccceeccc
Q 037197 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL----EARIADFGLARMMLH 856 (1009)
Q Consensus 807 ~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~DfGls~~~~~ 856 (1009)
+.|+. .. |++|+|++|.||+++.++ +++++|||++..+..
T Consensus 273 ~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 273 FTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33433 34 999999999999999988 999999999987644
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.9e-13 Score=141.56 Aligned_cols=250 Identities=24% Similarity=0.281 Sum_probs=151.5
Q ss_pred cccccccCCCCCeEecccCccccc----CCccccccCccCccccccc---ccCCCCCC-------CCCCCcCCeEEecCC
Q 037197 82 VSENIRGLRSLSSLNICCNEFASS----LPKSLANLTALKSMDVSQN---NFIGSFPT-------GLGKASGLTSVNASS 147 (1009)
Q Consensus 82 ~~~~l~~l~~L~~L~L~~n~~~~~----~~~~l~~l~~L~~L~Ls~n---~l~~~~p~-------~l~~l~~L~~L~Ls~ 147 (1009)
+.+.+..+.+++.|+|++|.|..+ +.+.+.+.++|++.++|+- +...++|. ++-.+++|++||||.
T Consensus 22 v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSD 101 (382)
T KOG1909|consen 22 VEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSD 101 (382)
T ss_pred HHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccc
Confidence 334566677777777777777543 4456677777777777753 22223443 334556888888888
Q ss_pred CCCCCCCCcc----ccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhccccccc
Q 037197 148 NNFSGFLPED----LGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFE 223 (1009)
Q Consensus 148 n~l~~~~p~~----l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 223 (1009)
|-|....+.. +..+++|++|.|.+|.+.-.....++. .|..|. .|+. .++-+.|+++..++|++.
T Consensus 102 NA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk-------~~~~~~Lrv~i~~rNrle 170 (382)
T KOG1909|consen 102 NAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK-------AASKPKLRVFICGRNRLE 170 (382)
T ss_pred cccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc-------cCCCcceEEEEeeccccc
Confidence 8877555543 456788888888888776332222221 222222 1111 122345666666666665
Q ss_pred ccCC----ccccCCCCccEEEeccCccccc----cCcccCCCCCCcEEEcccCCcCCCC----Ccccccccccccccccc
Q 037197 224 GEIP----AEFGNLTNLRYLDLAVGSLSGQ----IPPALGRLKKLTTVYLYKNNFTGKI----PPELGSITSLAFLDLSD 291 (1009)
Q Consensus 224 ~~~~----~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~Ls~ 291 (1009)
.... ..|...+.|+.+.++.|.|... +...|..+++|+.|||++|.++... ...+..+++|+.|++++
T Consensus 171 n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~d 250 (382)
T KOG1909|consen 171 NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGD 250 (382)
T ss_pred cccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccc
Confidence 4322 2345566777777777766422 2334666777777777777776432 23445566777777777
Q ss_pred cccCCCcchhhh-----cccCCCeEeccccccCCC----CCcCCCCCCcccEEEccCCcc
Q 037197 292 NQISGEIPVKLA-----ELKNLQLLNLMCNQLTGL----IPDKLGELTKLEVLELWKNSL 342 (1009)
Q Consensus 292 N~l~~~~~~~l~-----~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l 342 (1009)
|.+.......|. ..++|+.|.|.+|.|+.. +...+...+.|+.|+|++|++
T Consensus 251 cll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 251 CLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 777755554443 256788888888877632 223345577888888888887
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=2e-10 Score=115.12 Aligned_cols=140 Identities=16% Similarity=0.169 Sum_probs=99.7
Q ss_pred ceeccCCceEEEEEEECC------CCeEEEEEEcccCCC-----------C---------hhhHHHHH----HHHHHHhc
Q 037197 704 NIIGMGGNGIVYKAEFHR------PHMVVAVKKLWRSDN-----------D---------IESGDDLF----REVSLLGR 753 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~------~~~~vavK~~~~~~~-----------~---------~~~~~~~~----~E~~~l~~ 753 (1009)
..||.|--+.||.|...+ .+..+|||+.+.+.. + ......+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998654 357899998764310 1 11122333 79999999
Q ss_pred cC--CCceeeEEeEEEcCCeEEEEEeccCCCChh-hhhcCCccccccccHHHHHHHHHHHHHHHHHH-HhcCCCCeEEec
Q 037197 754 LR--HRNIVRLLGYLHNETNVMMVYDYMPNDSLG-EALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL-HHDCQPPVIHRD 829 (1009)
Q Consensus 754 l~--Hpniv~l~~~~~~~~~~~lV~E~~~~gsL~-~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~d 829 (1009)
+. .-++.+++++ ..-++||||+.++.+. ..++.. .++..+...+..+++.++..+ |.. ++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 84 3567777765 3458999999765432 122221 133445566789999999999 777 999999
Q ss_pred cCCCcEEeCCCCcEEEcccccceeccc
Q 037197 830 IKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 830 lk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
+++.||+++ ++.+.++|||.+....+
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 999999997 46899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.4e-10 Score=116.23 Aligned_cols=130 Identities=17% Similarity=0.087 Sum_probs=94.3
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCcee-eEEeEEEcCCeEEEEEeccCC
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV-RLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv-~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
++.++.|.++.||++... +..|++|....... ......+|+++++.+.+.+++ +++.+.. ...++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 356889999999999875 67899999744321 122345788888888655544 4555433 335799999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcC--CCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC--QPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
.++.+.- . ....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 76 ~~l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 76 SELLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred Ccccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9876530 0 01235678999999999872 12359999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4e-12 Score=131.94 Aligned_cols=183 Identities=25% Similarity=0.210 Sum_probs=107.7
Q ss_pred CccccceeeeccccccccCCcc----CCCCcchhhhhcccccccccCCc-------------cccCCCCccEEEeccCcc
Q 037197 184 NLQKLKFLGLSGNNLTGKIPPE----LGQLSSLETIILGYNAFEGEIPA-------------EFGNLTNLRYLDLAVGSL 246 (1009)
Q Consensus 184 ~l~~L~~L~L~~n~l~~~~p~~----l~~l~~L~~L~L~~n~l~~~~~~-------------~~~~l~~L~~L~L~~n~l 246 (1009)
..++|++|+||+|-+....+.. +.++..|++|+|.+|.+.-..-. -.+.-++|++++.++|++
T Consensus 90 ~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrl 169 (382)
T KOG1909|consen 90 GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRL 169 (382)
T ss_pred cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccc
Confidence 3345666666666554333332 23455666666666655421111 123346788888888888
Q ss_pred cccc----CcccCCCCCCcEEEcccCCcCCCC----CcccccccccccccccccccCCCcc----hhhhcccCCCeEecc
Q 037197 247 SGQI----PPALGRLKKLTTVYLYKNNFTGKI----PPELGSITSLAFLDLSDNQISGEIP----VKLAELKNLQLLNLM 314 (1009)
Q Consensus 247 ~~~~----~~~l~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~----~~l~~l~~L~~L~L~ 314 (1009)
.... ...|...+.|+.+.++.|.|.... ...+..+++|+.|||.+|-++.... ..+..+++|+.|+++
T Consensus 170 en~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~ 249 (382)
T KOG1909|consen 170 ENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLG 249 (382)
T ss_pred ccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccc
Confidence 6432 234666788888888888876332 2345567888888888888874433 345566778888888
Q ss_pred ccccCCCCCcCC-----CCCCcccEEEccCCccCcc----CCccccCCCCCceeeccCccc
Q 037197 315 CNQLTGLIPDKL-----GELTKLEVLELWKNSLIGS----LPMRLGQSSPLRRLDASSNLL 366 (1009)
Q Consensus 315 ~N~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~~----~~~~~~~~~~L~~L~Ls~N~l 366 (1009)
+|.++......| ...++|++|.+.+|.++.. +.......+.|+.|+|++|.+
T Consensus 250 dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 250 DCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 888775543332 2256677777777776531 122233344455555555555
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2e-11 Score=123.29 Aligned_cols=140 Identities=26% Similarity=0.247 Sum_probs=95.1
Q ss_pred ccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccc
Q 037197 200 GKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELG 279 (1009)
Q Consensus 200 ~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~ 279 (1009)
|.....+..+..|++|||++|.|+ .+.++..-++.++.|++|+|.+... ..++.+++|+.|||++|.++ .+..+-.
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~ 349 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHL 349 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHh
Confidence 344444555667888888888877 6666777777888888888887643 23777777888888877777 3444445
Q ss_pred cccccccccccccccCCCcchhhhcccCCCeEeccccccCCCC-CcCCCCCCcccEEEccCCccCcc
Q 037197 280 SITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLI-PDKLGELTKLEVLELWKNSLIGS 345 (1009)
Q Consensus 280 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~ 345 (1009)
.+.+++.|.|+.|.|. .-..+..+-+|..||+++|+|.... ...++++|-|+++.|.+|.+.+.
T Consensus 350 KLGNIKtL~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 350 KLGNIKTLKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhcCEeeeehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 6677777777777775 2245666777777777777776431 24567777777777777776543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.1e-11 Score=123.17 Aligned_cols=131 Identities=27% Similarity=0.296 Sum_probs=69.2
Q ss_pred CCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEe
Q 037197 233 LTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLN 312 (1009)
Q Consensus 233 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 312 (1009)
...|++||||+|.|+ .+..+..-+++++.|++++|.|+.. ..+..+++|+.||||+|.++ .+..+-..+-|++.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 345566666666665 3444444555566666666665522 22555555666666666555 3444444555555555
Q ss_pred ccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccc
Q 037197 313 LMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSG 392 (1009)
Q Consensus 313 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~ 392 (1009)
|+.|.|..+ ..++++-+|..||+++|+|... .--..+++++.|+.+.|.+|.+.+
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~l-----------------------deV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEEL-----------------------DEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhH-----------------------HHhcccccccHHHHHhhcCCCccc
Confidence 555555433 2344444455555544444321 112345666667777777776664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.8e-11 Score=133.94 Aligned_cols=250 Identities=18% Similarity=0.124 Sum_probs=175.8
Q ss_pred HhcCCcCceeccCCceEEEEEEEC-CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFH-RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l 774 (1009)
...|..+..||.|.|+.|++...+ .++..|++|...+..........-+.|+.+...+ .|.++++.+..|..-...|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 456788889999999999998766 6688999998866544443333344777777776 58999998888877777889
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-CcEEEccccccee
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN-LEARIADFGLARM 853 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfGls~~ 853 (1009)
--|||++++....+. -...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||....
T Consensus 344 p~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred chhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 999999998877662 223367778888999999999999987 99999999999999886 7889999998864
Q ss_pred cccCCCceeeecccCcc-cCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 854 MLHKNETVSMVAGSYGY-IAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
+..... .....+..| .+|+......+-.+.|+||||..+.+.+++..--.. .. .| ..+.
T Consensus 417 ~~~~~~--~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~~------~~-----------~~i~ 476 (524)
T KOG0601|consen 417 LAFSSG--VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-GV------QS-----------LTIR 476 (524)
T ss_pred cceecc--cccccccccccchhhccccccccccccccccccccccccCcccCcc-cc------cc-----------eeee
Confidence 321111 111122233 355555667788899999999999999998743221 11 11 0011
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
.... ........++..+...+..+++..||.+.+.....+.
T Consensus 477 ~~~~----p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 477 SGDT----PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cccc----cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 1111 1111111344556678889999999999887665443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2e-11 Score=130.00 Aligned_cols=185 Identities=22% Similarity=0.205 Sum_probs=107.0
Q ss_pred cccCccCcccccccccCCCCC-CCCCCCcCCeEEecCCCCCCCCCC--ccccCCCCCCeeeccCCccCCcCCcc-ccCcc
Q 037197 111 ANLTALKSMDVSQNNFIGSFP-TGLGKASGLTSVNASSNNFSGFLP--EDLGNATSLESLDFRGSFFEGSVPTS-FRNLQ 186 (1009)
Q Consensus 111 ~~l~~L~~L~Ls~n~l~~~~p-~~l~~l~~L~~L~Ls~n~l~~~~p--~~l~~l~~L~~L~L~~n~~~~~~p~~-~~~l~ 186 (1009)
.++.+|++..|.++.+....- .....|++++.||||.|-+..-.| .....|++|+.|+|+.|.+.--.... -..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 566777777777766542211 244567777888888777664322 33456777888888877765222211 13456
Q ss_pred ccceeeeccccccccCC-ccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCcccccc-CcccCCCCCCcEEE
Q 037197 187 KLKFLGLSGNNLTGKIP-PELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQI-PPALGRLKKLTTVY 264 (1009)
Q Consensus 187 ~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~ 264 (1009)
.|+.|.|+.|.++...- ..+..+++|+.|+|..|..-.........+..|++|||++|++-... -...+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 77777888887764321 22345677777777777533344444555667777777777665221 13455666666666
Q ss_pred cccCCcCCCC-Ccc-----cccccccccccccccccC
Q 037197 265 LYKNNFTGKI-PPE-----LGSITSLAFLDLSDNQIS 295 (1009)
Q Consensus 265 L~~n~l~~~~-~~~-----~~~l~~L~~L~Ls~N~l~ 295 (1009)
++.|.+...- |+. ...+++|++|+++.|+|.
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 6666665431 211 123345555555555553
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.9e-11 Score=138.03 Aligned_cols=218 Identities=32% Similarity=0.366 Sum_probs=120.1
Q ss_pred cccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccce
Q 037197 111 ANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKF 190 (1009)
Q Consensus 111 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~ 190 (1009)
..+..++.+++..|.+.. +-..+..+.+|+.|++..|+|.. +...+..+++|++|++++|.|+...+ +..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhh
Confidence 345555666666665542 23345566666666666666652 22225566666666666666664322 455555666
Q ss_pred eeeccccccccCCccCCCCcchhhhhcccccccccCC-ccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCC
Q 037197 191 LGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIP-AEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNN 269 (1009)
Q Consensus 191 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 269 (1009)
|++++|.|+. + ..+..+.+|+.+++++|++....+ . ...+.+|+.+++..|.+... ..+..+..+..+++..|.
T Consensus 145 L~l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchh-c-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccc
Confidence 7777776662 2 334556666666777766664333 2 45566666666666666422 223333444444666666
Q ss_pred cCCCCCccccccc--ccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCcc
Q 037197 270 FTGKIPPELGSIT--SLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSL 342 (1009)
Q Consensus 270 l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 342 (1009)
++..-+ +..+. .|+.+++++|.+. ..+..+..+.++..|++.+|++... ..+...+.+..+....|.+
T Consensus 220 i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~ 289 (414)
T KOG0531|consen 220 ISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKL 289 (414)
T ss_pred ceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchh
Confidence 653322 11222 2667777777766 3334555566666677776666543 2234445555555555554
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.4e-10 Score=141.98 Aligned_cols=248 Identities=23% Similarity=0.254 Sum_probs=148.5
Q ss_pred CCCeEecccCc--ccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeee
Q 037197 91 SLSSLNICCNE--FASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLD 168 (1009)
Q Consensus 91 ~L~~L~L~~n~--~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 168 (1009)
.|++|-+..|. +.....+.|..++.|++||||+|.-.+.+|..++.|.+|++|+|+++.++ .+|..+++|+.|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 67888888875 44344455788899999999988877888999999999999999999888 8888899999999999
Q ss_pred ccCCccCCcCCccccCccccceeeecccccc--ccCCccCCCCcchhhhhcccccccccCCccccCCCCcc----EEEec
Q 037197 169 FRGSFFEGSVPTSFRNLQKLKFLGLSGNNLT--GKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLR----YLDLA 242 (1009)
Q Consensus 169 L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~--~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~ 242 (1009)
+..+.....+|..+..|.+|++|.+...... ...-..+.++.+|+.+....... .+-..+..++.|. .+.+.
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~ 702 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIE 702 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhc
Confidence 9888766666777777889999888765422 22223344455555555433222 1112233333333 23322
Q ss_pred cCccccccCcccCCCCCCcEEEcccCCcCCCCCccccc------ccccccccccccccCCCcchhhhcccCCCeEecccc
Q 037197 243 VGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGS------ITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCN 316 (1009)
Q Consensus 243 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~------l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 316 (1009)
.+... ..+..++.+.+|+.|.+.++.+.......... ++++..+...++..- ..+.+.-..++|+.|.+..+
T Consensus 703 ~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~ 780 (889)
T KOG4658|consen 703 GCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSC 780 (889)
T ss_pred ccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecc
Confidence 22222 34556777788888888888776433322211 112222222222211 22233334466777777766
Q ss_pred ccCCCCCcCCCCCCcccEEEccCCccC
Q 037197 317 QLTGLIPDKLGELTKLEVLELWKNSLI 343 (1009)
Q Consensus 317 ~l~~~~~~~l~~l~~L~~L~L~~N~l~ 343 (1009)
.....+......+..++.+.+..+.+.
T Consensus 781 ~~~e~~i~~~k~~~~l~~~i~~f~~~~ 807 (889)
T KOG4658|consen 781 RLLEDIIPKLKALLELKELILPFNKLE 807 (889)
T ss_pred cccccCCCHHHHhhhcccEEecccccc
Confidence 555444444455555554444444443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-09 Score=102.92 Aligned_cols=133 Identities=23% Similarity=0.407 Sum_probs=101.6
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcc-cCCCChhh-----HHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLW-RSDNDIES-----GDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~-~~~~~~~~-----~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
..+++|+-+.+|.+.+.+ ..+++|.-. +.-..++- ..+-.+|++++.+++--.|...+=|..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 357899999999997754 346666432 22222221 2344579999999876677666667777788899999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
|++|..|.+.+... +..++..+-.-+.-||.. +|+|+|+.++||++..++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999998654 234677788888999999 999999999999998775 99999999864
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.7e-11 Score=138.21 Aligned_cols=240 Identities=28% Similarity=0.333 Sum_probs=119.1
Q ss_pred cchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccc
Q 037197 210 SSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDL 289 (1009)
Q Consensus 210 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 289 (1009)
+.++.++...+.+.+..-. ...+..++.+.+..|.+.. +-..+..+++|+.|++.+|.|... ...+..+++|++|+|
T Consensus 49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~l 125 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDL 125 (414)
T ss_pred chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheec
Confidence 3455666655554422111 1344555666666666653 333455666666677777766632 222455666666666
Q ss_pred cccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCcccccc
Q 037197 290 SDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGE 369 (1009)
Q Consensus 290 s~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 369 (1009)
++|.|+... .+..++.|+.|++++|.|+.. ..+..++.|+.+++++|.+....+.
T Consensus 126 s~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~--------------------- 180 (414)
T KOG0531|consen 126 SFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIEND--------------------- 180 (414)
T ss_pred ccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhh---------------------
Confidence 666665332 344555566666666666543 2344455555555555555433220
Q ss_pred CCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCC--cccEEEeecccccccCCcCCc
Q 037197 370 IPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLP--SLQRLEMANNNLTGQIPDDIS 447 (1009)
Q Consensus 370 ~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~ 447 (1009)
. ...+.+++.+++.+|.+.. ...+..+..+..+++.+|.++..-+ +..+. .|+.+++++|++. .++..+.
T Consensus 181 --~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~ 252 (414)
T KOG0531|consen 181 --E-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLE 252 (414)
T ss_pred --h-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-ccccccc
Confidence 0 2233344444444444431 1122233334444555555542211 11122 2666666666665 3334455
Q ss_pred CCCCCcEEecccCcccccCCCcccCCcccchhccccCccc
Q 037197 448 LSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQ 487 (1009)
Q Consensus 448 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 487 (1009)
.+..+..|+++.|++... ..+...+.+..+.+..|.+.
T Consensus 253 ~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 253 NLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred ccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 556666666666666542 12333444455555555444
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=8.8e-09 Score=109.67 Aligned_cols=279 Identities=13% Similarity=0.136 Sum_probs=175.9
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeE------EE-cCCeE
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGY------LH-NETNV 772 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~------~~-~~~~~ 772 (1009)
..++.+|+|+.+.+|..-.-. ..+.|+++.+... .. .+.++.|... .||-+-.-+.+ .- .+...
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa--~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPA--AQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecchhh---chhheeecCCCch--HH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 345679999999999764332 2344776554221 11 1233334444 56655442222 11 22337
Q ss_pred EEEEeccCCC-ChhhhhcC--CccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccc
Q 037197 773 MMVYDYMPND-SLGEALHG--KEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFG 849 (1009)
Q Consensus 773 ~lV~E~~~~g-sL~~~l~~--~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 849 (1009)
.+.|..+.+. -..++... ++..-...+|...++++..++.+.+.||.. |.+-+|+.++|+|+++++.+.+.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 8889888775 22222221 112223478999999999999999999999 99999999999999999999999876
Q ss_pred cceecccCCCceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhC-CCCCCCCCCCCc---cHH-HHHH
Q 037197 850 LARMMLHKNETVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTG-KMPLDPAFGGSK---DIV-EWVL 919 (1009)
Q Consensus 850 ls~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg-~~Pf~~~~~~~~---~~~-~~~~ 919 (1009)
.-... ..+......+|.+.|.+||... +...+..+|.|.+||++++++.| +.||.......+ ... +...
T Consensus 163 sfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 163 SFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 44332 3444556678899999999643 44567889999999999999886 999975322111 111 1111
Q ss_pred HHHhhccccccccCcc-ccccCchHHHHHHHHHHHHHHhccCC--CCCCCCHHHHHHHHhhcCCCcccccccCCCCCC
Q 037197 920 SMIKSNKAQDEALDPS-IAGQCKHVQEEMLLVLRIAVLCTAKL--PKGRPTMRDVITMLGEAKPRRKSICQNGGHNLS 994 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~d--p~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~ 994 (1009)
..+.+.+.......+. ...-+..... .+..+..+|+... +.-||+++.++..|..+..+-+.|.....|-|.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp---~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H~y~ 316 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPP---DVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMHVYP 316 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCH---HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhccccccc
Confidence 1221111111111111 1111111112 2344556787754 567999999999999999988888888887544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.00 E-value=3e-10 Score=111.61 Aligned_cols=122 Identities=25% Similarity=0.428 Sum_probs=33.3
Q ss_pred CCcccEEEeecccccccCCcCCc-CCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEE
Q 037197 425 LPSLQRLEMANNNLTGQIPDDIS-LSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVL 503 (1009)
Q Consensus 425 l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 503 (1009)
..++++|+|++|.|+ .+ +.++ .+.+|+.|+|++|.|+.+. .+..++.|+.|
T Consensus 18 ~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~l~--------------------------~l~~L~~L~~L 69 (175)
T PF14580_consen 18 PVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITKLE--------------------------GLPGLPRLKTL 69 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S--T--------------------------T----TT--EE
T ss_pred ccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCcccc--------------------------CccChhhhhhc
Confidence 335566666666665 22 2333 3455666666666665431 23344555555
Q ss_pred EeecCCCCCCCCccc-cccccceeeeecCcccccCC-CcccccccccceecCCccccccccCc----CcCCCCCCcEEe
Q 037197 504 DLSSNSLSGEIPASI-ASCEKLVSLNLRNNRFSGEI-PKAVATMPTLAILDMSNNSLFGRIPE----NFGASPALEMLN 576 (1009)
Q Consensus 504 dLs~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~ 576 (1009)
++++|+|+. +++.+ ..+++|++|+|++|+|...- -..++.+++|+.|+|.+|+++.. +. .+..+|+|+.||
T Consensus 70 ~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 70 DLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp E--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred ccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence 555555552 22222 23555555555555554311 13455566666666666666532 21 234566666665
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.1e-11 Score=125.51 Aligned_cols=161 Identities=24% Similarity=0.219 Sum_probs=78.9
Q ss_pred CCCCCCeeeccCCccCCcCC-ccccCccccceeeeccccccccC--CccCCCCcchhhhhcccccccccCCcc-ccCCCC
Q 037197 160 NATSLESLDFRGSFFEGSVP-TSFRNLQKLKFLGLSGNNLTGKI--PPELGQLSSLETIILGYNAFEGEIPAE-FGNLTN 235 (1009)
Q Consensus 160 ~l~~L~~L~L~~n~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~--p~~l~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~ 235 (1009)
++.+|+...|.++.+....- .....|++++.|||++|-+..-. -.-...|++|+.|+|+.|++....... -..+++
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 34455555555554431111 23445556666666666554211 122345566666666666654221111 123456
Q ss_pred ccEEEeccCccccc-cCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcc--hhhhcccCCCeEe
Q 037197 236 LRYLDLAVGSLSGQ-IPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIP--VKLAELKNLQLLN 312 (1009)
Q Consensus 236 L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~~l~~l~~L~~L~ 312 (1009)
|+.|.|+.|.++-. +...+..+++|+.|+|..|...........-+..|+.|||++|++-. .+ ...+.++.|..|+
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhhh
Confidence 66666666666522 12223345666666666664222222223344566666666666542 22 2345566666666
Q ss_pred ccccccCCC
Q 037197 313 LMCNQLTGL 321 (1009)
Q Consensus 313 L~~N~l~~~ 321 (1009)
++.+.+..+
T Consensus 278 ls~tgi~si 286 (505)
T KOG3207|consen 278 LSSTGIASI 286 (505)
T ss_pred ccccCcchh
Confidence 666666543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.8e-10 Score=111.79 Aligned_cols=109 Identities=28% Similarity=0.366 Sum_probs=44.2
Q ss_pred CCcccchhccccCcccCCcccccc-cCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCccc-ccccccc
Q 037197 472 SIPSLQTFMASHNNLQAKIPNELQ-ACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAV-ATMPTLA 549 (1009)
Q Consensus 472 ~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~ 549 (1009)
+...+++|+|.+|.|+.+ +.++ .+.+|+.||||+|.|+.. + .+..++.|+.|+|++|+|+ .++..+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--
T ss_pred cccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCC-ccccchHHhCCcCC
Confidence 334566677777776642 3455 478899999999999854 3 4778999999999999999 465555 4799999
Q ss_pred eecCCcccccccc-CcCcCCCCCCcEEecCCCccccC
Q 037197 550 ILDMSNNSLFGRI-PENFGASPALEMLNLSYNKLEGP 585 (1009)
Q Consensus 550 ~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~ 585 (1009)
.|+|++|+|...- -..+..++.|++|+|.+|+++..
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~ 128 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK 128 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch
Confidence 9999999997532 24567899999999999999754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.2e-09 Score=109.99 Aligned_cols=143 Identities=18% Similarity=0.215 Sum_probs=108.3
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCC--CceeeEEeEEEcC---CeEEEEEec
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH--RNIVRLLGYLHNE---TNVMMVYDY 778 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H--pniv~l~~~~~~~---~~~~lV~E~ 778 (1009)
+.|+.|..+.||++...+ |+.+++|........ ........|+++++.+.+ ..+.+++.+.... +..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 568999999999998865 678999997543221 134456689999999965 4467788877654 256899999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC------------------------------------- 821 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------------------------------------- 821 (1009)
++|+++.+.+... .++..++..++.++++++++||+..
T Consensus 82 i~G~~l~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 82 VDGRVLRDRLLRP-----ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred eCCEecCCCCCCC-----CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 9999888765321 1566677778888888888888521
Q ss_pred ----------------CCCeEEeccCCCcEEeCC--CCcEEEccccccee
Q 037197 822 ----------------QPPVIHRDIKSNNILLDA--NLEARIADFGLARM 853 (1009)
Q Consensus 822 ----------------~~~ivH~dlk~~NIll~~--~~~~kl~DfGls~~ 853 (1009)
...++|+|+.+.||+++. ++.+.++||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 256799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.1e-10 Score=136.95 Aligned_cols=266 Identities=22% Similarity=0.232 Sum_probs=128.0
Q ss_pred CCeEEecCCCC--CCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhh
Q 037197 139 GLTSVNASSNN--FSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETII 216 (1009)
Q Consensus 139 ~L~~L~Ls~n~--l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 216 (1009)
.|++|-+..|. +....+..|..++.|+.|||++|.-.+.+|..+++|-+||+|+|++..++ .+|..+++|..|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 45555555554 33233334556666666666666555566666666666666666666666 5666666666666666
Q ss_pred cccccccccCCccccCCCCccEEEeccCcc--ccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccc----ccccc
Q 037197 217 LGYNAFEGEIPAEFGNLTNLRYLDLAVGSL--SGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLA----FLDLS 290 (1009)
Q Consensus 217 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l--~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~Ls 290 (1009)
+.++.-...+|.....|++|++|.+..-.. ....-..+..+.+|+.+....... .+-..+..+..|. .+.+.
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~ 702 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIE 702 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhc
Confidence 666655445555556666777766654431 111222233344444444322221 0111122222222 23322
Q ss_pred ccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCC------cccEEEccCCccCccCCccccCCCCCceeeccCc
Q 037197 291 DNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELT------KLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSN 364 (1009)
Q Consensus 291 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~------~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N 364 (1009)
.+... ..+..+..+.+|+.|.+.++.+............ ++..+...++.. -..+.+..-.++|+.|.+.++
T Consensus 703 ~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~-~r~l~~~~f~~~L~~l~l~~~ 780 (889)
T KOG4658|consen 703 GCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHM-LRDLTWLLFAPHLTSLSLVSC 780 (889)
T ss_pred ccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcccc-ccccchhhccCcccEEEEecc
Confidence 22222 3344566666777777777666543222211111 111111111110 011222233455666666666
Q ss_pred cccccCCcCccCCCCCceeeccccccccc-CCcccccCccccEEEc
Q 037197 365 LLSGEIPTGLCDSGNLTKLILFNNSFSGT-FPVSLSTCKSLVRVRV 409 (1009)
Q Consensus 365 ~l~~~~~~~l~~l~~L~~L~l~~N~l~~~-~p~~l~~~~~L~~L~L 409 (1009)
.....+......+..+..+.+..+.+.+. .-.....++++..+.+
T Consensus 781 ~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l 826 (889)
T KOG4658|consen 781 RLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPL 826 (889)
T ss_pred cccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEeccc
Confidence 55544444444455555555555555544 2333444444444333
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1e-09 Score=80.92 Aligned_cols=41 Identities=34% Similarity=0.750 Sum_probs=30.5
Q ss_pred HHhHHHHHHHHhhcc-CCCCCCCCCCCCCccccCCcCCceeeeEEeC
Q 037197 18 DDELSTLLSIKAGLI-DPLNMLEDWKMPSNAAENGLLHCNWTGVWCN 63 (1009)
Q Consensus 18 ~~~~~~ll~~k~~~~-d~~~~l~~W~~~~~~~~~~~~~C~w~gv~C~ 63 (1009)
++|++|||+||+++. ||.+.+.+|+... +.+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~-----~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSS-----DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT-------S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcC-----CCCCeeeccEEeC
Confidence 579999999999998 5778999998542 2579999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.6e-08 Score=96.57 Aligned_cols=145 Identities=17% Similarity=0.245 Sum_probs=102.7
Q ss_pred cCceeccCCceEEEEEEECCCCeEEEEEEcccC-CCChh-----hHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 702 ESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRS-DNDIE-----SGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 702 ~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~-~~~~~-----~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
...++-||+-+.|+++.+. |+...||.-... -..+. ...+..+|++.+.++.--.|.-..=++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 4567899999999999887 466666643222 11111 234556899999998655555545555555566899
Q ss_pred EeccCC-CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC---cEEEcccccc
Q 037197 776 YDYMPN-DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL---EARIADFGLA 851 (1009)
Q Consensus 776 ~E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~DfGls 851 (1009)
|||++| .++.+++...-... .........+..|-+.+.-||.. +|+|+||..+||++..++ .+.++|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecch
Confidence 999977 47888876443221 12222256788999999999999 999999999999997665 3589999998
Q ss_pred ee
Q 037197 852 RM 853 (1009)
Q Consensus 852 ~~ 853 (1009)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 53
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=6.8e-10 Score=130.66 Aligned_cols=204 Identities=20% Similarity=0.224 Sum_probs=144.6
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.+...+-+-+|+++.++-+.-..+|...++|....... .....+....+-.+.-...||-+++..--+......++|+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 345566678899999999888777675556555432211 0111122222323333334566666555555677889999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
+|..+++|...++.-.. .+..........+.++.+|||+. .+.|+|++|.|.+...++..++.|||.......
T Consensus 884 ~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred HHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 99999999999986652 23333334566788999999997 799999999999999999999999984322100
Q ss_pred ---------------------CC----------CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 037197 857 ---------------------KN----------ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905 (1009)
Q Consensus 857 ---------------------~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~ 905 (1009)
.. .......+|+.|.+||...+......+|.|+.|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 00 00123568999999999999999999999999999999999999998
Q ss_pred CCC
Q 037197 906 PAF 908 (1009)
Q Consensus 906 ~~~ 908 (1009)
...
T Consensus 1037 a~t 1039 (1205)
T KOG0606|consen 1037 AET 1039 (1205)
T ss_pred Ccc
Confidence 543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.8e-09 Score=84.67 Aligned_cols=60 Identities=40% Similarity=0.631 Sum_probs=35.4
Q ss_pred cceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCcc
Q 037197 523 KLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKL 582 (1009)
Q Consensus 523 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 582 (1009)
+|++|+|++|+|+...+..|..+++|++||+++|+++...|..|..+++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544445556666666666666666655556666666666666666654
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.6e-09 Score=85.39 Aligned_cols=61 Identities=41% Similarity=0.624 Sum_probs=47.9
Q ss_pred CcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCcccc
Q 037197 498 PSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSL 558 (1009)
Q Consensus 498 ~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 558 (1009)
|+|++|++++|+|+...+..|.++++|++|++++|+++...|..|..+++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4677888888888766667778888888888888888876677788888888888888865
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.1e-07 Score=102.26 Aligned_cols=171 Identities=19% Similarity=0.287 Sum_probs=130.0
Q ss_pred CceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEE----cCCeEEEEEeccCC-CCh
Q 037197 710 GNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLH----NETNVMMVYDYMPN-DSL 784 (1009)
Q Consensus 710 ~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~----~~~~~~lV~E~~~~-gsL 784 (1009)
...+.||+....+|..|+.|+++.... ........-+++++++.|+|||++.+++. .+....+||+|.++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 345799999999999999999943221 12223345688899999999999999876 33457999999887 478
Q ss_pred hhhhcCCccc-----------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 785 GEALHGKEAG-----------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 785 ~~~l~~~~~~-----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
.++-...... ....++...|.++.|+..||.++|+. |..-+-+.+.+|+++.+.+++|+..|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 7765433222 23367889999999999999999999 999999999999999999999998887765
Q ss_pred cccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCC
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKM 902 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~ 902 (1009)
...+. .+| +. --.+-|.-.||.++..|.||..
T Consensus 443 l~~d~------------~~~--le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 443 LQEDP------------TEP--LE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ecCCC------------Ccc--hh---HHhhhhHHHHHHHHHHHhhccc
Confidence 43222 011 11 1235689999999999999964
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=1e-07 Score=95.48 Aligned_cols=127 Identities=22% Similarity=0.201 Sum_probs=80.6
Q ss_pred EEEEEEECCCCeEEEEEEcccCCCC-----------h-------------hhHHHHHHHHHHHhccCCC--ceeeEEeEE
Q 037197 713 IVYKAEFHRPHMVVAVKKLWRSDND-----------I-------------ESGDDLFREVSLLGRLRHR--NIVRLLGYL 766 (1009)
Q Consensus 713 ~Vyk~~~~~~~~~vavK~~~~~~~~-----------~-------------~~~~~~~~E~~~l~~l~Hp--niv~l~~~~ 766 (1009)
.||.|...+ |..+|+|..+..... . .......+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 489998866 789999987542100 0 0122344799999999755 566777553
Q ss_pred EcCCeEEEEEeccC--CCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHH-HhcCCCCeEEeccCCCcEEeCCCCcE
Q 037197 767 HNETNVMMVYDYMP--NDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL-HHDCQPPVIHRDIKSNNILLDANLEA 843 (1009)
Q Consensus 767 ~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~dlk~~NIll~~~~~~ 843 (1009)
.-.+||||++ |..+..+.... ++......++.+++..+..+ |.. ||+|+|+.+.||+++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eE
Confidence 2379999998 55555443322 11223344677888866664 676 99999999999999888 99
Q ss_pred EEcccccceec
Q 037197 844 RIADFGLARMM 854 (1009)
Q Consensus 844 kl~DfGls~~~ 854 (1009)
.++|||.+...
T Consensus 146 ~iIDf~qav~~ 156 (188)
T PF01163_consen 146 YIIDFGQAVDS 156 (188)
T ss_dssp EE--GTTEEET
T ss_pred EEEecCcceec
Confidence 99999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.5e-07 Score=98.56 Aligned_cols=143 Identities=13% Similarity=0.056 Sum_probs=98.5
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh---------hhHHHHHHHHHHHhccCC--CceeeEEeEEEc----
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI---------ESGDDLFREVSLLGRLRH--RNIVRLLGYLHN---- 768 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~H--pniv~l~~~~~~---- 768 (1009)
+.+-......|+++... |+.|.||+........ .....+.+|...+.++.. -.+++.++|.+.
T Consensus 28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 44444444557777654 6789999763322100 011136688888888743 334455666543
Q ss_pred -CCeEEEEEeccCCC-ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC-------
Q 037197 769 -ETNVMMVYDYMPND-SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA------- 839 (1009)
Q Consensus 769 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~------- 839 (1009)
....++|||++++. +|.+++..... ...+...+..++.++++.++-||.. ||+|+|++++||+++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCC
Confidence 23468999999886 89999853211 1234556667899999999999999 9999999999999975
Q ss_pred CCcEEEccccccee
Q 037197 840 NLEARIADFGLARM 853 (1009)
Q Consensus 840 ~~~~kl~DfGls~~ 853 (1009)
++.+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999998753
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1e-09 Score=123.54 Aligned_cols=129 Identities=30% Similarity=0.368 Sum_probs=90.3
Q ss_pred CCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeee
Q 037197 450 TSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNL 529 (1009)
Q Consensus 450 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~L 529 (1009)
..|...+.++|.+.. +..++.-++.|+.|+|++|+++.. +.+..|+.|+.|||++|.|+-..--....+. |..|+|
T Consensus 164 n~L~~a~fsyN~L~~-mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 164 NKLATASFSYNRLVL-MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hhHhhhhcchhhHHh-HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeee
Confidence 356667777777765 445566677888888888888754 3777888888888888888733333333444 888888
Q ss_pred cCcccccCCCcccccccccceecCCccccccccCc-CcCCCCCCcEEecCCCcccc
Q 037197 530 RNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPE-NFGASPALEMLNLSYNKLEG 584 (1009)
Q Consensus 530 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~g 584 (1009)
+||.++. -..+.+|++|+.||||+|-|++.-.- -+..+.+|..|+|.+|+|..
T Consensus 240 rnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 240 RNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 8888862 23466788888888888887764322 23456777888888888754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.1e-07 Score=93.89 Aligned_cols=136 Identities=21% Similarity=0.172 Sum_probs=96.7
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccCC------------------CC--hhhHHHHHHHHHHHhccCCC--c
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD------------------ND--IESGDDLFREVSLLGRLRHR--N 758 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~------------------~~--~~~~~~~~~E~~~l~~l~Hp--n 758 (1009)
..++.||.|--+.||.|.... |..+|||.-+.-. .. ........+|.++|.++.-. .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456889999999999999886 8899999543110 00 11234455899999998644 6
Q ss_pred eeeEEeEEEcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC
Q 037197 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD 838 (1009)
Q Consensus 759 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~ 838 (1009)
|.+.+++ +.-.+||||++|--|...-- +....-.|+..|++-+...-.. ||||+|+.+-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 7777765 44589999998866654321 1122223455566655555566 999999999999999
Q ss_pred CCCcEEEccccccee
Q 037197 839 ANLEARIADFGLARM 853 (1009)
Q Consensus 839 ~~~~~kl~DfGls~~ 853 (1009)
+||.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999976544
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.1e-09 Score=93.83 Aligned_cols=110 Identities=28% Similarity=0.382 Sum_probs=63.1
Q ss_pred cccEEEeecccccccCCcC---CcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEE
Q 037197 427 SLQRLEMANNNLTGQIPDD---ISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVL 503 (1009)
Q Consensus 427 ~L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 503 (1009)
.+..++|+++++- .+++. +.....|+.++|++|.+..+.+..-...+.++.|++++|.|+ .+|.++..++.|+.|
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 3455666666653 34433 233445666677777777654444344456667777777766 355556666666666
Q ss_pred EeecCCCCCCCCccccccccceeeeecCcccccCCCc
Q 037197 504 DLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPK 540 (1009)
Q Consensus 504 dLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 540 (1009)
+++.|.|. ..|..+..|.+|..|+..+|.+. +||.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~ 140 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDV 140 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcH
Confidence 66666665 44555555555555555555554 3443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.46 E-value=4.3e-08 Score=99.75 Aligned_cols=188 Identities=24% Similarity=0.304 Sum_probs=110.7
Q ss_pred CCCceeeccCccccc--cCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCcccc-ccCCccCCCCcccE
Q 037197 354 SPLRRLDASSNLLSG--EIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISG-TIPVGLGNLPSLQR 430 (1009)
Q Consensus 354 ~~L~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~ 430 (1009)
+.++.+||.+|.|+. ++-..+..++.|+.|+++.|++...+-..-....+|+.|.|.+..+.- .....+..+|.++.
T Consensus 71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vte 150 (418)
T KOG2982|consen 71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTE 150 (418)
T ss_pred hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhh
Confidence 445555666665552 333334456666666666666654332222345667777777766652 23344567788888
Q ss_pred EEeecccccccCCcCCcCCCCCcEEecccCcccccCCC--cccCCcccchhccccCcccCCcccccccCCcCcEEEeecC
Q 037197 431 LEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPS--SILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSN 508 (1009)
Q Consensus 431 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N 508 (1009)
|.|+.|++. .+++..|.++..-|. .+..++.+..+.++-|++... .|++..+-+..|
T Consensus 151 lHmS~N~~r--------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e~ 209 (418)
T KOG2982|consen 151 LHMSDNSLR--------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVCEG 209 (418)
T ss_pred hhhccchhh--------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeeecC
Confidence 888887554 334455555543322 223445556666666666543 356677777888
Q ss_pred CCCCCCC-ccccccccceeeeecCcccccCC-CcccccccccceecCCcccccccc
Q 037197 509 SLSGEIP-ASIASCEKLVSLNLRNNRFSGEI-PKAVATMPTLAILDMSNNSLFGRI 562 (1009)
Q Consensus 509 ~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~ 562 (1009)
.|...-. ..+..++.+-.|+|+.|+|..-. -+.+..++.|..|.+++|+|....
T Consensus 210 PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l 265 (418)
T KOG2982|consen 210 PLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPL 265 (418)
T ss_pred cccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccc
Confidence 7754332 33455666778888888886321 245667777777777777776433
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.1e-08 Score=115.42 Aligned_cols=179 Identities=27% Similarity=0.281 Sum_probs=109.0
Q ss_pred CccccCCCCCCeeeccCCccCCcCCccccCc-cccceeeecccccc----------ccCCccCCCCcchhhhhccccccc
Q 037197 155 PEDLGNATSLESLDFRGSFFEGSVPTSFRNL-QKLKFLGLSGNNLT----------GKIPPELGQLSSLETIILGYNAFE 223 (1009)
Q Consensus 155 p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l-~~L~~L~L~~n~l~----------~~~p~~l~~l~~L~~L~L~~n~l~ 223 (1009)
|-.|...++|++|.|.++.+.. ...+..+ ..|+.|-- .|.++ |.+-.++ ..-.|.+.+.++|++.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~-~Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSP-VWNKLATASFSYNRLV 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccch-hhhhHhhhhcchhhHH
Confidence 5567778889999999888763 1112222 22333321 22221 1111111 1234667777777776
Q ss_pred ccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhh
Q 037197 224 GEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLA 303 (1009)
Q Consensus 224 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 303 (1009)
....++.-++.|+.|+|++|+++... .+..+++|++|||++|.++ .+|..-..-..|..|.|++|.++. -..+.
T Consensus 178 -~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrnN~l~t--L~gie 251 (1096)
T KOG1859|consen 178 -LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRNNALTT--LRGIE 251 (1096)
T ss_pred -hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeeeecccHHHh--hhhHH
Confidence 55666777777888888888876443 6777788888888888877 344321112247788888887762 24567
Q ss_pred cccCCCeEeccccccCCCC-CcCCCCCCcccEEEccCCccC
Q 037197 304 ELKNLQLLNLMCNQLTGLI-PDKLGELTKLEVLELWKNSLI 343 (1009)
Q Consensus 304 ~l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~ 343 (1009)
++++|+.||+++|-|.+.- -..++.|..|+.|+|.+|.+-
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 7778888888888776431 123455677777778777763
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.7e-06 Score=89.27 Aligned_cols=107 Identities=22% Similarity=0.279 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHhccC--CCceeeEEeEEEcC----CeEEEEEeccCCC-ChhhhhcCCccccccccHHHHHHHHHHHHHH
Q 037197 741 GDDLFREVSLLGRLR--HRNIVRLLGYLHNE----TNVMMVYDYMPND-SLGEALHGKEAGKLLVDWVSRYNIAVGIAQG 813 (1009)
Q Consensus 741 ~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~ 813 (1009)
.....+|...+.++. .-.+++.+++.... ...++|+|++++. +|.+++..... .+......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence 345667888777774 33456677776543 2358999999884 89999875332 3445667789999999
Q ss_pred HHHHHhcCCCCeEEeccCCCcEEeCCCC---cEEEcccccceec
Q 037197 814 LNYLHHDCQPPVIHRDIKSNNILLDANL---EARIADFGLARMM 854 (1009)
Q Consensus 814 L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~DfGls~~~ 854 (1009)
++-||.. ||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.7e-08 Score=101.32 Aligned_cols=250 Identities=22% Similarity=0.176 Sum_probs=153.5
Q ss_pred cccccCCCCCeEecccCccccc----CCccccccCccCccccccccc---CCCCC-------CCCCCCcCCeEEecCCCC
Q 037197 84 ENIRGLRSLSSLNICCNEFASS----LPKSLANLTALKSMDVSQNNF---IGSFP-------TGLGKASGLTSVNASSNN 149 (1009)
Q Consensus 84 ~~l~~l~~L~~L~L~~n~~~~~----~~~~l~~l~~L~~L~Ls~n~l---~~~~p-------~~l~~l~~L~~L~Ls~n~ 149 (1009)
+.+..+..++.++||+|.|..+ +...+++-.+|++.++|.-.. ...+| .++.+|++|+..+||.|.
T Consensus 24 eel~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNA 103 (388)
T COG5238 24 EELEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNA 103 (388)
T ss_pred HHHHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccc
Confidence 4455688888889998888764 445566677888888876421 12233 346678899999999999
Q ss_pred CCCCCCcc----ccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhccccccccc
Q 037197 150 FSGFLPED----LGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGE 225 (1009)
Q Consensus 150 l~~~~p~~----l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 225 (1009)
|....|+. ++.-+.|++|.|++|.+.-.....++. .|.+ |..|+- ..+-+.|++...+.|++..-
T Consensus 104 fg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigk--al~~--la~nKK-------aa~kp~Le~vicgrNRleng 172 (388)
T COG5238 104 FGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGK--ALFH--LAYNKK-------AADKPKLEVVICGRNRLENG 172 (388)
T ss_pred cCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHH--HHHH--HHHHhh-------hccCCCceEEEeccchhccC
Confidence 88777754 456788999999988876332222321 1111 122221 12334566666666666522
Q ss_pred CCc----cccCCCCccEEEeccCcccccc-----CcccCCCCCCcEEEcccCCcCCCCC----ccccccccccccccccc
Q 037197 226 IPA----EFGNLTNLRYLDLAVGSLSGQI-----PPALGRLKKLTTVYLYKNNFTGKIP----PELGSITSLAFLDLSDN 292 (1009)
Q Consensus 226 ~~~----~~~~l~~L~~L~L~~n~l~~~~-----~~~l~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~Ls~N 292 (1009)
... .|..-.+|+.+.+..|.|.... --.+..+.+|+.|||.+|.++-... ..++..+.|+.|.+.+|
T Consensus 173 s~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDC 252 (388)
T COG5238 173 SKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDC 252 (388)
T ss_pred cHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccch
Confidence 111 1222346777777777765321 1123456778888888887764322 23445566888888888
Q ss_pred ccCCCcchhhh------cccCCCeEeccccccCCCCCcC-------CCCCCcccEEEccCCccCc
Q 037197 293 QISGEIPVKLA------ELKNLQLLNLMCNQLTGLIPDK-------LGELTKLEVLELWKNSLIG 344 (1009)
Q Consensus 293 ~l~~~~~~~l~------~l~~L~~L~L~~N~l~~~~~~~-------l~~l~~L~~L~L~~N~l~~ 344 (1009)
-++.....++- ..++|..|-..+|.+.+-+-.. =.+++-|..|.+.+|++..
T Consensus 253 lls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~E 317 (388)
T COG5238 253 LLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIKE 317 (388)
T ss_pred hhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcchh
Confidence 87755544332 2467888888888775432211 1357778888888888753
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.2e-08 Score=91.92 Aligned_cols=105 Identities=27% Similarity=0.370 Sum_probs=44.8
Q ss_pred CcEEecccCcccccCCCcc---cCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeee
Q 037197 452 LSFVDISWNHLESYLPSSI---LSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLN 528 (1009)
Q Consensus 452 L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~ 528 (1009)
+..+||+.++|-. +++.. .....|+..++++|.+....+..-...+.++.|+|++|.|+ .+|.++..++.|+.||
T Consensus 29 ~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 29 LHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 4455555555432 12221 22233333444555444322222222234444444444444 3444444444444444
Q ss_pred ecCcccccCCCcccccccccceecCCccccc
Q 037197 529 LRNNRFSGEIPKAVATMPTLAILDMSNNSLF 559 (1009)
Q Consensus 529 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 559 (1009)
++.|.|. ..|..+..|.+|..||..+|.+-
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 4444444 34444444444444444444443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1009 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-49 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-08 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-49 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-48 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-47 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-32 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-31 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-31 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-31 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-30 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-29 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-28 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-27 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-27 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-26 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-18 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-18 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-18 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-18 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-18 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-18 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-18 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-18 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-18 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-18 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-18 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-17 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-17 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-17 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-07 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 8e-07 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 8e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-06 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 3e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-06 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 5e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 2ft3_A | 332 | Crystal Structure Of The Biglycan Dimer Core Protei | 2e-05 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 549 bits (1418), Expect = 0.0
Identities = 188/571 (32%), Positives = 276/571 (48%), Gaps = 14/571 (2%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
E LD+S+ + + + + +L L+I N+ + ++++ T LK +++S N F+G
Sbjct: 203 EFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 129 SFPTGLGKASGLTSVNASSNNFSGFLPEDL-GNATSLESLDFRGSFFEGSVPTSFRNLQK 187
P L ++ + N F+G +P+ L G +L LD G+ F G+VP F +
Sbjct: 262 PIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 188 LKFLGLSGNNLTGKIPPE-LGQLSSLETIILGYNAFEGEIPAEFGNLT-NLRYLDLAVGS 245
L+ L LS NN +G++P + L ++ L+ + L +N F GE+P NL+ +L LDL+ +
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 246 LSGQIPPALGR--LKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLA 303
SG I P L + L +YL N FTGKIPP L + + L L LS N +SG IP L
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 304 ELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASS 363
L L+ L L N L G IP +L + LE L L N L G +P L + L + S+
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 364 NLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLG 423
N L+GEIP + NL L L NNSFSG P L C+SL+ + + NL +GTIP +
Sbjct: 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF 559
Query: 424 NLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWN--HLESYLPSSILSIPSLQTFMA 481
+A N + G+ I + N + + + +
Sbjct: 560 KQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615
Query: 482 SHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKA 541
+ S+ LD+S N LSG IP I S L LNL +N SG IP
Sbjct: 616 TSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE 675
Query: 542 VATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELI 601
V + L ILD+S+N L GRIP+ A L ++LS N L GP+P G P + +
Sbjct: 676 VGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFL 735
Query: 602 GNAGLCGSVLPPCSQNLTAKPGQTRKMHINH 632
N GLCG LP C + ++ H +H
Sbjct: 736 NNPGLCGYPLPRCDPSNADGYAHHQRSHHHH 766
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 485 bits (1250), Expect = e-158
Identities = 187/582 (32%), Positives = 277/582 (47%), Gaps = 47/582 (8%)
Query: 18 DDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWCNSRGFVEKLDLSNMS 77
E+ L+S K L D N+L DW N C + GV C V +DLS+
Sbjct: 11 YREIHQLISFKDVLPDK-NLLPDWSSNKN-------PCTFDGVTCRD-DKVTSIDLSSKP 61
Query: 78 LNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKA 137
LN S ++ SL +LT L+S+ +S ++ GS G +
Sbjct: 62 LNVGFS---------------------AVSSSLLSLTGLESLFLSNSHINGSVS-GFKCS 99
Query: 138 SGLTSVNASSNNFSGFLPED--LGNATSLESLDFRGSFFEGSVPTS-FRNLQKLKFLGLS 194
+ LTS++ S N+ SG + LG+ + L+ L+ + + S L L+ L LS
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 195 GNNLTGKIPPEL---GQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIP 251
N+++G L+ + + N G++ NL +LD++ + S I
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI- 216
Query: 252 PALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLL 311
P LG L + + N +G + + T L L++S NQ G IP LK+LQ L
Sbjct: 217 PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQYL 274
Query: 312 NLMCNQLTGLIPDKL-GELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEI 370
+L N+ TG IPD L G L L+L N G++P G S L L SSN SGE+
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334
Query: 371 PTG-LCDSGNLTKLILFNNSFSGTFPVSLSTCK-SLVRVRVQNNLISGTIPVGLGN--LP 426
P L L L L N FSG P SL+ SL+ + + +N SG I L
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394
Query: 427 SLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNL 486
+LQ L + NN TG+IP +S + L + +S+N+L +PSS+ S+ L+ N L
Sbjct: 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNML 454
Query: 487 QAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMP 546
+ +IP EL +L L L N L+GEIP+ +++C L ++L NNR +GEIPK + +
Sbjct: 455 EGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE 514
Query: 547 TLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPS 588
LAIL +SNNS G IP G +L L+L+ N G +P+
Sbjct: 515 NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 319 bits (821), Expect = 6e-96
Identities = 120/394 (30%), Positives = 190/394 (48%), Gaps = 17/394 (4%)
Query: 207 GQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLY 266
+++S++ N + + +LT L L L+ ++G + LT++ L
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108
Query: 267 KNNFTGKIPP--ELGSITSLAFLDLSDNQISGEIPV-KLAELKNLQLLNLMCNQLTGLIP 323
+N+ +G + LGS + L FL++S N + V +L +L++L+L N ++G
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 324 DKL---GELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNL 380
+L+ L + N + G + + + L LD SSN S IP L D L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSAL 225
Query: 381 TKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTG 440
L + N SG F ++STC L + + +N G IP L SLQ L +A N TG
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLAENKFTG 283
Query: 441 QIPDDISLS-TSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNE-LQACP 498
+IPD +S + +L+ +D+S NH +P S L++ S NN ++P + L
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343
Query: 499 SLSVLDLSSNSLSGEIPASIASC-EKLVSLNLRNNRFSGEIPKAV--ATMPTLAILDMSN 555
L VLDLS N SGE+P S+ + L++L+L +N FSG I + TL L + N
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403
Query: 556 NSLFGRIPENFGASPALEMLNLSYNKLEGPVPSN 589
N G+IP L L+LS+N L G +PS+
Sbjct: 404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 437
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 2e-81
Identities = 116/378 (30%), Positives = 169/378 (44%), Gaps = 22/378 (5%)
Query: 255 GRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLM 314
++ + N + L S+T L L LS++ I+G + +L L+L
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 315 CNQLTGLIPDK--LGELTKLEVLELWKNSLIGSLPMRLGQSSP-LRRLDASSNLLSGEIP 371
N L+G + LG + L+ L + N+L + G L LD S+N +SG
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 372 TGLCDSGNLTKL---ILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSL 428
G S +L + N SG +S C +L + V +N S IP LG+ +L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSAL 225
Query: 429 QRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQA 488
Q L+++ N L+G IS T L ++IS N +P L SLQ + N
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK--SLQYLSLAENKFTG 283
Query: 489 KIPNELQA-CPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAV-ATMP 546
+IP+ L C +L+ LDLS N G +P SC L SL L +N FSGE+P M
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343
Query: 547 TLAILDMSNNSLFGRIPENFG-ASPALEMLNLSYNKLEGPVPSNGILMNINPNEL----I 601
L +LD+S N G +PE+ S +L L+LS N GP+ N L N L +
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN--LCQNPKNTLQELYL 401
Query: 602 GNAGLCGSVLPPCSQNLT 619
N G G +PP N +
Sbjct: 402 QNNGFTGK-IPPTLSNCS 418
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-19
Identities = 29/127 (22%), Positives = 54/127 (42%), Gaps = 2/127 (1%)
Query: 68 VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
++++ G S S+ L++ N + +PK + ++ L +++ N+
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 128 GSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTS--FRNL 185
GS P +G GL ++ SSN G +P+ + T L +D + G +P F
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729
Query: 186 QKLKFLG 192
KFL
Sbjct: 730 PPAKFLN 736
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-14
Identities = 29/91 (31%), Positives = 49/91 (53%)
Query: 66 GFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNN 125
G + LD+S L+G + + I + L LN+ N+ + S+P + +L L +D+S N
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 126 FIGSFPTGLGKASGLTSVNASSNNFSGFLPE 156
G P + + LT ++ S+NN SG +PE
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-119
Identities = 114/631 (18%), Positives = 206/631 (32%), Gaps = 92/631 (14%)
Query: 14 ESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAA------ENGLLHCNWT--------- 58
D + LS A I L++ N NW
Sbjct: 11 ALTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWG 70
Query: 59 ---GVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEF----ASSLPKSLA 111
GV NS G V L L +G V + I L L L + + PK ++
Sbjct: 71 AQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGIS 130
Query: 112 NLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRG 171
+ + + ++ +F + L
Sbjct: 131 ANMSDEQKQKMRMHYQKTFVDYDPREDFS----------------------DLIKDCINS 168
Query: 172 SFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFG 231
+ S+ S R K +G NN+T + + +L+ L +G + F E E
Sbjct: 169 DPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAW 227
Query: 232 NLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSD 291
N Y LK LT V +Y K+P L ++ + ++++
Sbjct: 228 ENENSEYA-----QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC 282
Query: 292 NQI--------SGEIPVKLAELKNLQLLNLMCNQLTGL-IPDKLGELTKLEVLELWKNSL 342
N+ + + +Q++ + N L + L ++ KL +LE N L
Sbjct: 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQL 342
Query: 343 IGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLC-DSGNLTKLILFNNSFSGTFP--VSLS 399
G LP G L L+ + N ++ IP C + + L +N P
Sbjct: 343 EGKLPA-FGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAK 399
Query: 400 TCKSLVRVRVQNNLISG-------TIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSL 452
+ + + N I + ++ + ++NN ++ + S + L
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL 459
Query: 453 SFVDISWNHLES-------YLPSSILSIPSLQTFMASHNNLQAKIPNELQAC--PSLSVL 503
S +++ N L + + L + N L K+ ++ +A P L +
Sbjct: 460 SSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGI 518
Query: 504 DLSSNSLSGEIPASIASCEKLVSLNLRN------NRFSGEIPKAVATMPTLAILDMSNNS 557
DLS NS S P + L +RN NR E P+ + P+L L + +N
Sbjct: 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577
Query: 558 LFGRIPENFGASPALEMLNLSYNKLEGPVPS 588
+ ++ E + + +L++ N S
Sbjct: 578 I-RKVNEKITPN--ISVLDIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 6e-71
Identities = 75/439 (17%), Positives = 135/439 (30%), Gaps = 45/439 (10%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
+ + N + + NL L ++V +
Sbjct: 209 RQFYMGNSPFVAENICEAWENENSEYAQ-----QYKTEDLKWDNLKDLTDVEVYNCPNLT 263
Query: 129 SFPTGLGKASGLTSVNASSNNF--------SGFLPEDLGNATSLESLDFRG-SFFEGSVP 179
PT L + +N + N D ++ + + V
Sbjct: 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323
Query: 180 TSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYL 239
TS + ++KL L N L G P G L ++ L YN G + L
Sbjct: 324 TSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENL 382
Query: 240 DLAVGSLSGQIPPAL--GRLKKLTTVYLYKNNFTG-------KIPPELGSITSLAFLDLS 290
A L IP + ++ + N + P +++ ++LS
Sbjct: 383 SFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLS 441
Query: 291 DNQISGEIPVKLAELKNLQLLNLMCNQLTGL-------IPDKLGELTKLEVLELWKNSLI 343
+NQIS + L +NLM N LT + + L ++L N L
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL- 500
Query: 344 GSLP--MRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFN------NSFSGTFP 395
L R L +D S N S PT +S L + N N +P
Sbjct: 501 TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP 559
Query: 396 VSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFV 455
++ C SL ++++ +N I + + P++ L++ +N +
Sbjct: 560 EGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMY 616
Query: 456 DISWNHLESYLPSSILSIP 474
+ ++ + L I
Sbjct: 617 MLFYDKTQDIRGCDALDIK 635
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-103
Identities = 112/301 (37%), Positives = 170/301 (56%), Gaps = 15/301 (4%)
Query: 691 FTSSEILACVK---ESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR- 746
F+ E+ NI+G GG G VYK +VAVK+L + + G+ F+
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRL--KEERTQGGELQFQT 76
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNI 806
EV ++ HRN++RL G+ T ++VY YM N S+ L + + +DW R I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVS-MVA 865
A+G A+GL YLH C P +IHRD+K+ NILLD EA + DFGLA++M +K+ V+ V
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 866 GSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLD---PAFGGSKDIVEWVLSMI 922
G+ G+IAPEY T K EK+D++ +GV+LLEL+TG+ D A +++WV ++
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML-GEAKPR 981
K K + +D + G + EE+ ++++A+LCT P RP M +V+ ML G+
Sbjct: 257 KEKKL-EALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313
Query: 982 R 982
R
Sbjct: 314 R 314
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = 8e-97
Identities = 95/303 (31%), Positives = 155/303 (51%), Gaps = 17/303 (5%)
Query: 683 LIAFQRLNFTSSEILACVK---ESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE 739
L+ F+ ++ +IG G G VYK R VA+K+ +
Sbjct: 21 LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRR---TPESS 76
Query: 740 SGDDLFR-EVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLV 798
G + F E+ L RH ++V L+G+ ++++Y YM N +L L+G + + +
Sbjct: 77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136
Query: 799 DWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858
W R I +G A+GL+YLH +IHRD+KS NILLD N +I DFG+++ +
Sbjct: 137 SWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD 193
Query: 859 ET-VS-MVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAF-GGSKDIV 915
+T +S +V G+ GYI PEY ++ EKSD+YSFGVVL E+L + + + ++
Sbjct: 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
Query: 916 EWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
EW + + + ++ +DP++A + + E + AV C A + RP+M DV+ L
Sbjct: 254 EWAVESHNNGQL-EQIVDPNLADKIR--PESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
Query: 976 GEA 978
A
Sbjct: 311 EYA 313
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 318 bits (816), Expect = 3e-96
Identities = 101/548 (18%), Positives = 192/548 (35%), Gaps = 32/548 (5%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
+ L+L + L+ + +L+ L++ N L ++D+S N
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 129 SFPTGLGKASGLTSVNASSNNFSGFLPEDLGNA--TSLESLDFRGSFFEGSVPTSFRNLQ 186
+ + L + S+N E+L +SL+ L+ + + P F +
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
Query: 187 KLKFLGLSGNNLTGKIPPELG---QLSSLETIILGYNAFEGEIPAEFGNL--TNLRYLDL 241
+L L L+ L + +L +S+ + L + F L TNL LDL
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 242 AVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDN--------- 292
+ +L+ + L +L +L NN L + ++ +L+L +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 293 QISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSL----IGSLPM 348
+ LK L+ LN+ N + G+ + L L+ L L + + +
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 349 RLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVS-LSTCKSLVRV 407
SPL L+ + N +S G+L L L N +++ +
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI 435
Query: 408 RVQNNLISGTIPVGLGNLPSLQRLEMANNNLTG--QIPDDISLSTSLSFVDISWNHLESY 465
+ N +PSLQRL + L P +L+ +D+S N++ +
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495
Query: 466 LPSSILSIPSLQTFMASHNNLQ--------AKIPNELQACPSLSVLDLSSNSLSGEIPAS 517
+ + L+ HNNL L+ L +L+L SN
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
Query: 518 IASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGAS-PALEMLN 576
+L ++L N + +L L++ N + + FG + L L+
Sbjct: 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELD 615
Query: 577 LSYNKLEG 584
+ +N +
Sbjct: 616 MRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = 5e-91
Identities = 112/548 (20%), Positives = 192/548 (35%), Gaps = 36/548 (6%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
E D S++ L V +++ +++ LN+ N+ + + L S+DV N
Sbjct: 7 EVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 129 SFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKL 188
P K L +N N S + T+L L + + F + L
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 189 KFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFG--NLTNLRYLDLAVGSL 246
L LS N L+ QL +L+ ++L N + E ++L+ L+L+ +
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183
Query: 247 SGQIPPALGRLKKLTTVYLYKNNFTGKIPPELG---SITSLAFLDLSDNQISGEIPVKLA 303
P + +L ++L + +L + TS+ L LS++Q+S
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243
Query: 304 ELK--NLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDA 361
LK NL +L+L N L + D L +LE L N++ L +R L+
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 362 SSNL---------LSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNN 412
+ L L L + +N G + +L + + N+
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 413 LISGTIP-----VGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLP 467
S V L + L L + N ++ D S L +D+ N + L
Sbjct: 364 FTSLRTLTNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422
Query: 468 SSILS-IPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSG--EIPASIASCEKL 524
+ ++ S+N N PSL L L +L P+ L
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482
Query: 525 VSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSL--------FGRIPENFGASPALEMLN 576
L+L NN + + + L ILD+ +N+L G L +LN
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542
Query: 577 LSYNKLEG 584
L N +
Sbjct: 543 LESNGFDE 550
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 5e-82
Identities = 92/476 (19%), Positives = 164/476 (34%), Gaps = 24/476 (5%)
Query: 140 LTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLT 199
+ S + +P+DL T++ L+ + +F +L L + N ++
Sbjct: 6 HEVADCSHLKLTQ-VPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 200 GKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKK 259
P +L L+ + L +N F TNL L L S+ + K
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 260 LTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKN--LQLLNLMCNQ 317
L T+ L N + + +L L LS+N+I +L N L+ L L NQ
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 318 LTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP---LRRLDASSNLLSGEIPT-- 372
+ P + +L L L L SL +L +R L S++ LS T
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 373 GLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLE 432
NLT L L N+ + S + L ++ N I L L +++ L
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302
Query: 433 MANN---------NLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASH 483
+ + +L L +++ N + + + +L+ S+
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362
Query: 484 NNLQAKIPNELQ----ACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIP 539
+ + A L +L+L+ N +S + + L L+L N E+
Sbjct: 363 SFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422
Query: 540 KAV-ATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMN 594
+ + + +S N +F P+L+ L L L+ S
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-21
Identities = 33/140 (23%), Positives = 52/140 (37%), Gaps = 3/140 (2%)
Query: 449 STSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSN 508
+ S D S L +P + + ++ +HN L+ L+ LD+ N
Sbjct: 3 TVSHEVADCSHLKLTQ-VPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 509 SLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGA 568
++S P L LNL++N S K A L L + +NS+ F
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 569 SPALEMLNLSYNKLEGPVPS 588
L L+LS+N L
Sbjct: 120 QKNLITLDLSHNGLSSTKLG 139
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 1e-92
Identities = 97/291 (33%), Positives = 147/291 (50%), Gaps = 20/291 (6%)
Query: 690 NFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIES--GDDLFR- 746
NF I N +G GG G+VYK + VAVKKL + DI + F
Sbjct: 26 NFDERPISV---GGNKMGEGGFGVVYKGYV--NNTTVAVKKL-AAMVDITTEELKQQFDQ 79
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNI 806
E+ ++ + +H N+V LLG+ + ++ +VY YMPN SL + L + L W R I
Sbjct: 80 EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL-SWHMRCKI 138
Query: 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET-VS-MV 864
A G A G+N+LH + IHRDIKS NILLD A+I+DFGLAR +T ++ +
Sbjct: 139 AQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRI 195
Query: 865 AGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS 924
G+ Y+APE ++ KSDIYSFGVVLLE++TG +D + +++ +
Sbjct: 196 VGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLDIKEEIEDE 253
Query: 925 NKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
K ++ +D + + + +A C + RP ++ V +L
Sbjct: 254 EKTIEDYIDKKMNDADS---TSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 308 bits (790), Expect = 1e-90
Identities = 105/631 (16%), Positives = 199/631 (31%), Gaps = 80/631 (12%)
Query: 17 ADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNW------------TGVWCNS 64
+ L +I L +W+ S N + NW GV ++
Sbjct: 267 YIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN 321
Query: 65 RGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLP-KSLANLTALKSMDVSQ 123
G V L L+ G V + I L L L+ + S LT S +
Sbjct: 322 NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKH 381
Query: 124 NNFIGSFPTGLGKASGLTSVNASSNNFSG---FLPEDLGNATSLESLDFRGSFFE-GSVP 179
+ L L + + + P + SL+ +
Sbjct: 382 RIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFIS 441
Query: 180 TSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYL 239
+ + L KL+ + + + T E Y + NL +L +
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDV 496
Query: 240 DLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTG---------KIPPELGSITSLAFLDLS 290
+L Q+P L L +L ++ + N ++ + + + +
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG 556
Query: 291 DNQISG-EIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMR 349
N + L ++ L LL+ + N++ L + G KL L+L N + +P
Sbjct: 557 YNNLEEFPASASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLKLDYNQIE-EIPED 613
Query: 350 LGQSSP-LRRLDASSNLLSGEIP--TGLCDSGNLTKLILFNNSFSG-----TFPVSLSTC 401
+ + L S N L IP + + N + +
Sbjct: 614 FCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672
Query: 402 KSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNH 461
+ V + N I + + ++NN +T IP++
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSL-------------- 717
Query: 462 LESYLPSSILSIPSLQTFMASHNNLQAKIPNELQAC--PSLSVLDLSSNSLSGEIPASIA 519
+ + L T N L + ++ +A P LS +D+S N S P
Sbjct: 718 --KPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPL 773
Query: 520 SCEKLVSLNLR------NNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALE 573
+ +L + +R NR + P + T P+L L + +N + ++ E +P L
Sbjct: 774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLY 830
Query: 574 MLNLSYNKL-EGPVPSNGILMNINPNELIGN 603
+L+++ N V S + L+ +
Sbjct: 831 ILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 7e-05
Identities = 13/125 (10%), Positives = 30/125 (24%), Gaps = 10/125 (8%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASS------LPKSLANLTALKSMDVS 122
+D+S + S L + I A P + +L + +
Sbjct: 756 SNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIG 814
Query: 123 QNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSF 182
N+ I L L ++ + N + +
Sbjct: 815 SND-IRKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDA 871
Query: 183 RNLQK 187
+++
Sbjct: 872 LGIER 876
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 8e-89
Identities = 94/538 (17%), Positives = 187/538 (34%), Gaps = 31/538 (5%)
Query: 70 KLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGS 129
++ + +N+ S +L++ N S + L+ +D+S+
Sbjct: 11 TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 130 FPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLK 189
S L+++ + N +SL+ L + +L+ LK
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 190 FLGLSGNNLTG-KIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRY----LDLAVG 244
L ++ N + K+P L++LE + L N + + L + LDL++
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 245 SLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQISGEIPVK-- 301
++ I P + +L + L N + + + + L L + E ++
Sbjct: 188 PMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 302 ----LAELKNLQLLNLMCNQL---TGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSS 354
L L NL + L I D LT + L ++ +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNF 304
Query: 355 PLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLI 414
+ L+ + L +L +L +N F S SL + + N +
Sbjct: 305 GWQHLELVNCKFGQFPTLKL---KSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGL 359
Query: 415 S--GTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSIL- 471
S G SL+ L+++ N + + + L +D ++L+ S+
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 472 SIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEI-PASIASCEKLVSLNLR 530
S+ +L SH + + SL VL ++ NS P L L+L
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 531 NNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPS 588
+ P A ++ +L +L+MS+N+ F + +L++L+ S N +
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 4e-84
Identities = 116/546 (21%), Positives = 184/546 (33%), Gaps = 49/546 (8%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
+ LDLS + + L LS+L + N S + + L++L+ + + N
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 129 SFPTGLGKASGLTSVNASSNNFSGF-LPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK 187
+G L +N + N F LPE N T+LE LD + + T R L +
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 188 LKF----LGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAE-FGNLTNLRYLDLA 242
+ L LS N + I P + L + L N + L L L
Sbjct: 175 MPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 243 VGSLSGQ------IPPALGRLKKLTTVYL---YKNNFTGKIPPELGSITSLAFLDLSDNQ 293
+G + AL L LT Y + + I +T+++ L
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 294 ISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQS 353
I + Q L L+ + KL L +L + + +
Sbjct: 294 IERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS--- 348
Query: 354 SPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNL 413
L LD S N SF G S SL + + N
Sbjct: 349 --LEFLDLSRN----------------------GLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 414 ISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLS-TSLSFVDISWNHLESYLPSSILS 472
+ T+ L L+ L+ ++NL + LS +L ++DIS H
Sbjct: 385 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443
Query: 473 IPSLQTFMASHNNLQAKI-PNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRN 531
+ SL+ + N+ Q P+ +L+ LDLS L P + S L LN+ +
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503
Query: 532 NRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASP-ALEMLNLSYNKLEGPVPSNG 590
N F + +L +LD S N + + P +L LNL+ N
Sbjct: 504 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQS 563
Query: 591 ILMNIN 596
L I
Sbjct: 564 FLQWIK 569
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 8e-76
Identities = 93/467 (19%), Positives = 164/467 (35%), Gaps = 30/467 (6%)
Query: 141 TSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTG 200
+ NF +P++L S ++LD + SF + +L+ L LS +
Sbjct: 10 ITYQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 201 KIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKL 260
LS L T+IL N + F L++L+ L +L+ +G LK L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 261 TTVYLYKNNFTG-KIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQL----LNLMC 315
+ + N K+P ++T+L LDLS N+I L L + L L+L
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 316 NQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQS-SPLRRLDASSNLLSGEIPTGL 374
N + + P E+ +L L L N ++ Q + L E
Sbjct: 187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
Query: 375 CDSGNLTKL---------ILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNL 425
D L L + + + + + ++ + + I
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYN 303
Query: 426 PSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNN 485
Q LE+ N + L+F + S + +PSL+ S N
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNG 358
Query: 486 LQAK--IPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAV- 542
L K SL LDLS N + + ++ E+L L+ +++ +V
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 543 ATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSN 589
++ L LD+S+ F +LE+L ++ N + +
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-50
Identities = 76/407 (18%), Positives = 137/407 (33%), Gaps = 26/407 (6%)
Query: 69 EKLDLSNMSLNGSVSEN-IRGLRSLSSLNICCNEFASS---LPKSLANLTALKSMDVSQN 124
KL L N + +V + I+GL L + EF + + L L ++ + +
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 125 N------FIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSV 178
++ + ++S + S +D + L+ F
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFP 320
Query: 179 PTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNA--FEGEIPAEFGNLTNL 236
++L++L F G N L SLE + L N F+G T+L
Sbjct: 321 TLKLKSLKRLTFTSNKGGN-----AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 237 RYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQIS 295
+YLDL+ + + L++L + +N S+ +L +LD+S
Sbjct: 376 KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 296 GEIPVKLAELKNLQLLNLMCNQLTGLI-PDKLGELTKLEVLELWKNSLIGSLPMRLGQSS 354
L +L++L + N PD EL L L+L + L P S
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 355 PLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTC-KSLVRVRVQNNL 413
L+ L+ S N +L L N + L SL + + N
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
Query: 414 ISGTIPVG--LGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDIS 458
+ T L + ++L + + P D + ++I+
Sbjct: 555 FACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ-GMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-16
Identities = 39/189 (20%), Positives = 62/189 (32%), Gaps = 29/189 (15%)
Query: 50 NGLLHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSL-PK 108
+ L + V+ + R + LD+S+ + + GL SL L + N F + P
Sbjct: 406 SNLKQMSEFSVFLSLRN-LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
Query: 109 SLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLD 168
L L +D+SQ PT S L +N S NNF SL+ LD
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 524
Query: 169 FRGSFFEGSVPTSFRNL-QKLKFLGLSGNNLTG--------------------------K 201
+ + S ++ L FL L+ N+
Sbjct: 525 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA 584
Query: 202 IPPELGQLS 210
P + +
Sbjct: 585 TPSDKQGMP 593
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 1e-82
Identities = 97/336 (28%), Positives = 146/336 (43%), Gaps = 36/336 (10%)
Query: 18 DDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWCNSRGF---VEKLDLS 74
+ LL IK L +P L W + W GV C++ V LDLS
Sbjct: 5 PQDKQALLQIKKDLGNP-TTLSSWL-----PTTDCCNRTWLGVLCDTDTQTYRVNNLDLS 58
Query: 75 NMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVS-QNNFIGSFPTG 133
++L +P SLANL L + + NN +G P
Sbjct: 59 GLNLPKPYP----------------------IPSSLANLPYLNFLYIGGINNLVGPIPPA 96
Query: 134 LGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGL 193
+ K + L + + N SG +P+ L +L +LDF + G++P S +L L +
Sbjct: 97 IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156
Query: 194 SGNNLTGKIPPELGQLSSLETII-LGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPP 252
GN ++G IP G S L T + + N G+IP F NL NL ++DL+ L G
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASV 215
Query: 253 ALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLN 312
G K ++L KN+ + ++G +L LDL +N+I G +P L +LK L LN
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274
Query: 313 LMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPM 348
+ N L G IP + G L + +V N + P+
Sbjct: 275 VSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPL 309
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 1e-78
Identities = 86/332 (25%), Positives = 127/332 (38%), Gaps = 52/332 (15%)
Query: 287 LDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG--LIPDKLGELTKLEVLELWKNSLIG 344
D + G + + + L+L L IP L L L L +
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI---- 86
Query: 345 SLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSL 404
N L G IP + L L + + + SG P LS K+L
Sbjct: 87 -------------------NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 405 VRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLES 464
V + N +SGT+P + +LP+L + N ++G I
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI---------------------- 165
Query: 465 YLPSSILSIPSLQTFMA-SHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEK 523
P S S L T M S N L KIP +L+ +DLS N L G+ S +
Sbjct: 166 --PDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKN 222
Query: 524 LVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
++L N + ++ K V L LD+ NN ++G +P+ L LN+S+N L
Sbjct: 223 TQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 584 GPVPSNGILMNINPNELIGNAGLCGSVLPPCS 615
G +P G L + + N LCGS LP C+
Sbjct: 282 GEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 6e-75
Identities = 83/292 (28%), Positives = 128/292 (43%), Gaps = 11/292 (3%)
Query: 129 SFPTGLGKASGLTSVNASS----NNFSGFLPEDLGNATSLESLDFRGSFFEGS--VPTSF 182
LG + L+S ++ + G L + + +LD G +P+S
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 183 RNLQKLKFLGLSG-NNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDL 241
NL L FL + G NNL G IPP + +L+ L + + + G IP + L LD
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 242 AVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLA-FLDLSDNQISGEIPV 300
+ +LSG +PP++ L L + N +G IP GS + L + +S N+++G+IP
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 301 KLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLD 360
A L NL ++L N L G G + + L KNSL L ++G S L LD
Sbjct: 193 TFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLD 250
Query: 361 ASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNN 412
+N + G +P GL L L + N+ G P + + NN
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-LQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 47/179 (26%), Positives = 89/179 (49%), Gaps = 8/179 (4%)
Query: 418 IPVGLGNLPSLQ----RLEMANNNLTGQIPDDISLSTSLSFVDISWNHL--ESYLPSSIL 471
I LGN +L + N G + D + + ++ +D+S +L +PSS+
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 472 SIPSLQT-FMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLR 530
++P L ++ NNL IP + L L ++ ++SG IP ++ + LV+L+
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 531 NNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPAL-EMLNLSYNKLEGPVPS 588
N SG +P +++++P L + N + G IP+++G+ L + +S N+L G +P
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 2e-82
Identities = 96/539 (17%), Positives = 180/539 (33%), Gaps = 17/539 (3%)
Query: 62 CNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDV 121
C + + + N+ LN + + S L N + + + L L +D+
Sbjct: 8 CIEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDL 64
Query: 122 SQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTS 181
++ L ++ ++N L +L+ L F +
Sbjct: 65 TRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIP 124
Query: 182 FRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDL 241
N + L+ L L N+++ P+ L+ + NA + +L L L
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL 184
Query: 242 AVGSLS-GQIPPALGRLKKLTTVYLYKNNFTGKIPPELG--SITSLAFLDLSDNQISGEI 298
+ I P ++ I L +I SL D
Sbjct: 185 NLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDIS 244
Query: 299 PVKLAELKNLQL--LNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPL 356
P L + + +NL + + + + L+ L+L + LP L S L
Sbjct: 245 PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH-LSELPSGLVGLSTL 303
Query: 357 RRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGT-FPVSLSTCKSLVRVRVQNNLI- 414
++L S+N + +LT L + N+ L ++L + + ++ I
Sbjct: 304 KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
Query: 415 -SGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILS- 472
S + L NL LQ L ++ N + L +D+++ L+ S
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
Query: 473 IPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEI---PASIASCEKLVSLNL 529
+ L+ SH+ L P+L L+L N S+ + +L L L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 530 RNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPS 588
S A ++ + +D+S+N L E + LNL+ N + +PS
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPS 541
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 8e-78
Identities = 96/530 (18%), Positives = 176/530 (33%), Gaps = 16/530 (3%)
Query: 68 VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
E L+ S L + L +L+ L++ + + + L ++ ++ N I
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 128 GSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK 187
T L L + S L N +LESL + +K
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 188 LKFLGLSGNNLTGKIPPELGQLSSLE--TIILGYNAFEGEIPAEFGNLTNLRYLDLAVGS 245
LK L N + ++ L ++ L N I + + L+
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQ 213
Query: 246 LSGQIPPALG--RLKKLTTVYLYKNNFTGKIPPELGSI--TSLAFLDLSDNQISGEIPVK 301
I L ++ L + P + S+ ++L +
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 302 LAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDA 361
LQ L+L L+ +P L L+ L+ L L N + L L
Sbjct: 274 FHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332
Query: 362 SSNLLSGEIPTG-LCDSGNLTKLILFNN--SFSGTFPVSLSTCKSLVRVRVQNNLISGTI 418
N E+ TG L + NL +L L ++ S + L L + + N
Sbjct: 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLK 392
Query: 419 PVGLGNLPSLQRLEMANNNLTGQIPDDI-SLSTSLSFVDISWNHLESYLPSSILSIPSLQ 477
P L+ L++A L + L +++S + L+ +P+LQ
Sbjct: 393 TEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQ 452
Query: 478 TFMASHNNLQAKI---PNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRF 534
N+ N LQ L +L LS LS + S + + ++L +NR
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512
Query: 535 SGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEG 584
+ +A++ + + L++++N + +P +NL N L+
Sbjct: 513 TSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 41/195 (21%), Positives = 65/195 (33%), Gaps = 6/195 (3%)
Query: 411 NNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSI 470
L IP L S + LE + N L S +L+F+D++ + +
Sbjct: 22 LGLNE--IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTF 77
Query: 471 LSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLR 530
S L T + + N L L +L L +S + + + L SL L
Sbjct: 78 QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137
Query: 531 NNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEM--LNLSYNKLEGPVPS 588
+N S L +LD NN++ E+ + LNL+ N + G P
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPG 197
Query: 589 NGILMNINPNELIGN 603
G
Sbjct: 198 AFDSAVFQSLNFGGT 212
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 1e-71
Identities = 99/550 (18%), Positives = 189/550 (34%), Gaps = 32/550 (5%)
Query: 59 GVWCNSRGFVE--KLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTAL 116
G V + L+ V ++I S ++++ N S +N + L
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSEL 58
Query: 117 KSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEG 176
+ +D+S+ L+++ + N F P TSLE+L +
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 177 SVPTSFRNLQKLKFLGLSGNNLTG-KIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTN 235
L LK L ++ N + K+P L++L + L YN + + L
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
Query: 236 LR----YLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLS 290
LD+++ + I + KL + L N + I L ++ L L
Sbjct: 179 NPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 291 DNQISGEIPVK------LAELKNLQL--LNLMCNQLTGLIPDKLGELTKLEVLELWKNSL 342
+ E ++ + L ++ + L K L + + L S+
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
Query: 343 IGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCK 402
+ + + L L L L L L N S +F
Sbjct: 298 --KYLEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGSISF--KKVALP 350
Query: 403 SLVRVRVQNNLISGTIPVGLGNL--PSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWN 460
SL + + N +S + +L SL+ L+++ N + + L +D +
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHS 409
Query: 461 HLESYLPSSIL-SIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASI- 518
L+ S S+ L S+ N + SL+ L ++ NS +++
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469
Query: 519 ASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLS 578
A+ L L+L + T+ L +L+MS+N+L ++ +L L+ S
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529
Query: 579 YNKLEGPVPS 588
+N++E
Sbjct: 530 FNRIETSKGI 539
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-65
Identities = 103/504 (20%), Positives = 176/504 (34%), Gaps = 41/504 (8%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
+ LDLS + + GL LS+L + N S P S + LT+L+++ +
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 129 SFPTGLGKASGLTSVNASSNNFSGF-LPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK 187
+G+ L +N + N LP N T+L +D ++ + + L++
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
Query: 188 LKF----LGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAE-FGNLTNLRYLDLA 242
L +S N + I + Q L + L N I NL L L
Sbjct: 179 NPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 243 VGSLSGQI------PPALGRLKKLTTVYLY--KNNFTGKIPPELGSITSLAFLDLSDNQI 294
+G + P + L +T N + + +++ + L+ I
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
Query: 295 SGEIPVKLAELKNLQLLNLMCNQLTGL-------------------IPDKLGELTKLEVL 335
+ + Q L+++ QL I K L L L
Sbjct: 298 KY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYL 355
Query: 336 ELWKNSL--IGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGT 393
+L +N+L G ++ LR LD S N + L L +++
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRV 414
Query: 394 FPVS-LSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDI-SLSTS 451
S + + L+ + + L SL L+MA N+ ++ + +T+
Sbjct: 415 TEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN 474
Query: 452 LSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLS 511
L+F+D+S LE ++ LQ SHNNL + SLS LD S N +
Sbjct: 475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534
Query: 512 GEIPASIASCEKLVSLNLRNNRFS 535
+ L NL NN +
Sbjct: 535 TSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-50
Identities = 85/471 (18%), Positives = 154/471 (32%), Gaps = 54/471 (11%)
Query: 128 GSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK 187
GS + +T S +P+D+ +S +++D + + SF N +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 188 LKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLS 247
L++L LS + L L +IL N + P F LT+L L L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 248 GQIPPALGRLKKLTTVYLYKNNFTG-KIPPELGSITSLAFLDLSDNQISGEIPVKLAELK 306
+G+L L + + N K+P ++T+L +DLS N I L L+
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 307 NLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLL 366
+ L++ N I + + Q L L N
Sbjct: 178 ENPQV--------------------NLSLDMSLNP-IDFIQDQAFQGIKLHELTLRGNFN 216
Query: 367 SGEIPTGLCDS-GNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNL 425
S I + L L F + + +I GL ++
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI---------------FEPSIMEGLCDV 261
Query: 426 PSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNN 485
++ + N ++S + ++ ++ + Q+
Sbjct: 262 -TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQ 318
Query: 486 LQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVA-- 543
L+ +L P L L L+ N S I + L L+L N S + +
Sbjct: 319 LKQFPTLDL---PFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDL 373
Query: 544 TMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMN 594
+L LD+S N + NF L+ L+ ++ L+ V ++
Sbjct: 374 GTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR-VTEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-46
Identities = 65/465 (13%), Positives = 138/465 (29%), Gaps = 54/465 (11%)
Query: 69 EKLDLSNMSLNG-SVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVS---QN 124
+KL++++ ++ + L +L +++ N + L L +++S
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 125 NFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNA----------------------- 161
N I + L + N S + +
Sbjct: 191 NPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250
Query: 162 ----------TSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSS 211
+++ + F L + + L+G ++ ++ +
Sbjct: 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFK 308
Query: 212 LETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFT 271
+++ + + + P +L L+ L L G I L L+ + L +N +
Sbjct: 309 WQSLSIIRCQLK-QFP--TLDLPFLKSLTLT--MNKGSISFKKVALPSLSYLDLSRNALS 363
Query: 272 GKIP--PELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIP-DKLGE 328
SL LDLS N + L+ LQ L+ + L +
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422
Query: 329 LTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTG-LCDSGNLTKLILFN 387
L KL L++ + + L L + N + ++ NLT L L
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482
Query: 388 NSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDIS 447
T L + + +N + L SL L+ + N +
Sbjct: 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQH 542
Query: 448 LSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPN 492
SL+F +++ N + + I ++ +
Sbjct: 543 FPKSLAFFNLTNNSV-----ACICEHQKFLQWVKEQKQFLVNVEQ 582
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-25
Identities = 40/238 (16%), Positives = 82/238 (34%), Gaps = 10/238 (4%)
Query: 368 GEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPS 427
G + + N+T + S P + + S + + N + N
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 428 LQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQ 487
LQ L+++ + LS + ++ N ++S+ P S + SL+ +A L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 488 AKIPNELQACPSLSVLDLSSNSLSG-EIPASIASCEKLVSLNLRNNRFSGEIPKAVATM- 545
+ + +L L+++ N + ++PA ++ LV ++L N + +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 546 ---PTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNEL 600
LDMS N + I + L L L N + + +
Sbjct: 178 ENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVH 234
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 5e-71
Identities = 72/301 (23%), Positives = 115/301 (38%), Gaps = 34/301 (11%)
Query: 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI 759
++ + G G V+KA+ + VAVK D + EV L ++H NI
Sbjct: 26 LQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENI 80
Query: 760 VRLLGY----LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
++ +G + ++ ++ + SL + L +V W +IA +A+GL
Sbjct: 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLA 135
Query: 816 YLHHD-------CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM--VAG 866
YLH D +P + HRDIKS N+LL NL A IADFGLA G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 867 SYGYIAPEY-----GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSM 921
+ Y+APE + + D+Y+ G+VL EL + D E +
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255
Query: 922 IKSNKAQDEA-----LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976
S + E P + M ++ C + R + V +
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYW-QKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314
Query: 977 E 977
+
Sbjct: 315 Q 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-65
Identities = 88/279 (31%), Positives = 139/279 (49%), Gaps = 27/279 (9%)
Query: 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI 759
+ IG G G V++AE+H VAVK L D E ++ REV+++ RLRH NI
Sbjct: 39 LNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
V +G + N+ +V +Y+ SL LH A + L D R ++A +A+G+NYLH+
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQL-DERRRLSMAYDVAKGMNYLHN 155
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL 879
PP++HR++KS N+L+D ++ DFGL+R+ + AG+ ++APE
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 880 KVDEKSDIYSFGVVLLELLTGKMP---LDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936
+EKSD+YSFGV+L EL T + P L+PA +V V + I
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPA-----QVVAAVGF---------KCKRLEI 260
Query: 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
++ ++ C P RP+ ++ +L
Sbjct: 261 PRNL---NPQVAAIIE---GCWTNEPWKRPSFATIMDLL 293
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 4e-61
Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 29/277 (10%)
Query: 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI 759
++ ++G G G+V KA++ VA+K++ S+++ + E+ L R+ H NI
Sbjct: 10 IEVEEVVGRGAFGVVCKAKWR--AKDVAIKQI-ESESERK---AFIVELRQLSRVNHPNI 63
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
V+L G N V +V +Y SL LHG E + + +QG+ YLH
Sbjct: 64 VKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYY-TAAHAMSWCLQCSQGVAYLHS 120
Query: 820 DCQPPVIHRDIKSNNILLDANLE-ARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYT 878
+IHRD+K N+LL A +I DFG A ++ GS ++APE
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD---IQTHMTNNKGSAAWMAPEVFEG 177
Query: 879 LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938
EK D++S+G++L E++T + P F ++ + + P +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNG------TRPPLI- 226
Query: 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
K++ + + ++ C +K P RP+M +++ ++
Sbjct: 227 --KNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIM 258
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-60
Identities = 84/288 (29%), Positives = 137/288 (47%), Gaps = 36/288 (12%)
Query: 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-----IESGDDLFREVSLLGRL 754
++ IG GG G+V+K + VVA+K L D++ IE + REV ++ L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 755 RHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
H NIV+L G +HN MV +++P L L K + W + + + IA G+
Sbjct: 81 NHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGI 135
Query: 815 NYLHHDCQPPVIHRDIKSNNILLDANLE-----ARIADFGLARMMLHKNETVSMVAGSYG 869
Y+ + PP++HRD++S NI L + E A++ADFGL++ +VS + G++
Sbjct: 136 EYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSVSGLLGNFQ 191
Query: 870 YIAPE--YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927
++APE EK+D YSF ++L +LTG+ P F ++MI+
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFINMIREEGL 247
Query: 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
+ P+I C + + LC + PK RP ++ L
Sbjct: 248 R-----PTIPEDCPPR------LRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 6e-59
Identities = 88/285 (30%), Positives = 127/285 (44%), Gaps = 42/285 (14%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDNDIESGDDLF-REVSLLGRLRHRNIVR 761
IIG+GG G VY+A + VAVK D DI + +E L L+H NI+
Sbjct: 13 EIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
L G E N+ +V ++ L L GK + N AV IA+G+NYLH +
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEA 125
Query: 822 QPPVIHRDIKSNNILLD--------ANLEARIADFGLARMMLHKNETVSMVAGSYGYIAP 873
P+IHRD+KS+NIL+ +N +I DFGLAR T AG+Y ++AP
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAAGAYAWMAP 183
Query: 874 EYGYTLKVDEKSDIYSFGVVLLELLTGKMP---LDPAFGGSKDIVEWVLSMIKSNKAQDE 930
E + SD++S+GV+L ELLTG++P +D + V
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-----AVAYGVAM---------N 229
Query: 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
L I C ++ C P RP+ +++ L
Sbjct: 230 KLALPIPSTCPEP------FAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-58
Identities = 56/284 (19%), Positives = 108/284 (38%), Gaps = 38/284 (13%)
Query: 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI 759
+ + +G ++K + + VK L D D E L H N+
Sbjct: 12 LNFLTKLNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 760 VRLLGYLHN--ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
+ +LG + + ++ +MP SL LH + D A+ +A+G+ +L
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV--DQSQAVKFALDMARGMAFL 127
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE--- 874
H +P + + S ++++D ++ ARI+ + + ++APE
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM-----YAPAWVAPEALQ 181
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMP---LDPAFGGSKDIVEWVLSMIKSNKAQDEA 931
+D++SF V+L EL+T ++P L +I V E
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-----EIGMKVAL---------EG 227
Query: 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
L P+I + +++I C + P RP ++ +L
Sbjct: 228 LRPTIPPGI---SPHVSKLMKI---CMNEDPAKRPKFDMIVPIL 265
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-58
Identities = 105/470 (22%), Positives = 173/470 (36%), Gaps = 36/470 (7%)
Query: 116 LKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFE 175
L S ++Q+ I + N + + + + +L
Sbjct: 3 LGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL--G 57
Query: 176 GSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTN 235
L L + S N LT P L L+ L I++ N P NLTN
Sbjct: 58 IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN 113
Query: 236 LRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQIS 295
L L L ++ L L L + L N + L +TSL L NQ++
Sbjct: 114 LTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVT 168
Query: 296 GEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP 355
P LA L L+ L++ N+++ + L +LT LE L N + P LG +
Sbjct: 169 DLKP--LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTN 222
Query: 356 LRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLIS 415
L L + N L L NLT L L NN S P LS L +++ N IS
Sbjct: 223 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278
Query: 416 GTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPS 475
P L L +L LE+ N L P IS +L+++ + +N++ S + S+
Sbjct: 279 NISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD--ISPVSSLTK 332
Query: 476 LQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFS 535
LQ +N + + L +++ L N +S P +A+ ++ L L + ++
Sbjct: 333 LQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388
Query: 536 GEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGP 585
A + + +L P + ++++N
Sbjct: 389 NAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-56
Identities = 112/472 (23%), Positives = 189/472 (40%), Gaps = 36/472 (7%)
Query: 68 VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
K L ++ +VS L +++L S + L L ++ S N
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLT 81
Query: 128 GSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK 187
P L + L + ++N + L N T+L L + P +NL
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIADI--TPLANLTNLTGLTLFNNQITDIDP--LKNLTN 135
Query: 188 LKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLS 247
L L LS N ++ L L+SL+ + G + NLT L LD++ +S
Sbjct: 136 LNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVS 190
Query: 248 GQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKN 307
L +L L ++ N + I P LG +T+L L L+ NQ+ LA L N
Sbjct: 191 D--ISVLAKLTNLESLIATNNQISD-ITP-LGILTNLDELSLNGNQLKD--IGTLASLTN 244
Query: 308 LQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLS 367
L L+L NQ++ L P L LTKL L+L N + P L + L L+ + N L
Sbjct: 245 LTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE 300
Query: 368 GEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPS 427
P + + NLT L L+ N+ S P +S+ L R+ NN +S L NL +
Sbjct: 301 DISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTN 354
Query: 428 LQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQ 487
+ L +N ++ P ++ T ++ + ++ + P + + S+ + +
Sbjct: 355 INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKNVTGAL 411
Query: 488 AKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIP 539
P + S + D++ N S + + V++ FSG +
Sbjct: 412 I-APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 8e-54
Identities = 98/423 (23%), Positives = 163/423 (38%), Gaps = 33/423 (7%)
Query: 184 NLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAV 243
L + L N+T + L + T+ + L NL ++ +
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL--GIKSIDGVEYLNNLTQINFSN 77
Query: 244 GSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLA 303
L+ I P L L KL + + N L ++T+L L L +NQI+ P L
Sbjct: 78 NQLTD-ITP-LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--LK 131
Query: 304 ELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASS 363
L NL L L N ++ + L LT L+ L N + P L + L RLD SS
Sbjct: 132 NLTNLNRLELSSNTISDISA--LSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISS 186
Query: 364 NLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLG 423
N +S + L NL LI NN S P L +L + + N + L
Sbjct: 187 NKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLA 240
Query: 424 NLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASH 483
+L +L L++ANN ++ P +S T L+ + + N + + S + + +L +
Sbjct: 241 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNE 296
Query: 484 NNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVA 543
N L+ P + +L+ L L N++S P ++S KL L NN+ S ++A
Sbjct: 297 NQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLA 350
Query: 544 TMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGN 603
+ + L +N + + L L+ + ++I
Sbjct: 351 NLTNINWLSAGHNQI--SDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVT 408
Query: 604 AGL 606
L
Sbjct: 409 GAL 411
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 6e-57
Identities = 68/329 (20%), Positives = 112/329 (34%), Gaps = 54/329 (16%)
Query: 689 LNFTSSEILACVKE---SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF 745
+ +SE + +IG G G VYK VAVK + +
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVF-----SFANRQNFI 53
Query: 746 RE--VSLLGRLRHRNIVRLLGY-----LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLV 798
E + + + H NI R + ++V +Y PN SL + L
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----S 108
Query: 799 DWVSRYNIAVGIAQGLNYLHHD------CQPPVIHRDIKSNNILLDANLEARIADFGLAR 852
DWVS +A + +GL YLH + +P + HRD+ S N+L+ + I+DFGL+
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 853 MMLH--------KNETVSMVAGSYGYIAPEY-------GYTLKVDEKSDIYSFGVVLLEL 897
+ ++ G+ Y+APE ++ D+Y+ G++ E+
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
Query: 898 LTGKMPLDP---------AFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEML 948
L P AF M E P K +
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVL--VSREKQRPKFPEAWKENSLAVR 286
Query: 949 LVLRIAVLCTAKLPKGRPTMRDVITMLGE 977
+ C + + R T + + E
Sbjct: 287 SLKETIEDCWDQDAEARLTAQXAEERMAE 315
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-56
Identities = 67/314 (21%), Positives = 124/314 (39%), Gaps = 47/314 (14%)
Query: 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI 759
++ +IG G G VY +H VA++ + ++ + REV + RH N+
Sbjct: 35 LEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
V +G + ++ ++ +L + K+++D IA I +G+ YLH
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLH- 147
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMM-----LHKNETVSMVAGSYGYIAPE 874
++H+D+KS N+ D N + I DFGL + + + + + G ++APE
Sbjct: 148 --AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 875 ---------YGYTLKVDEKSDIYSFGVVLLELLTGKMP---LDPAFGGSKDIVEWVLSMI 922
L + SD+++ G + EL + P I+ + + +
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-----AIIWQMGTGM 259
Query: 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982
K N +Q I+ I + C A + RPT ++ ML + R
Sbjct: 260 KPNLSQIGM-GKEIS--------------DILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304
Query: 983 KSICQNGGHNLSKE 996
+ + G S E
Sbjct: 305 RRLSHPGHFWKSAE 318
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 4e-56
Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 34/278 (12%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G G VYK ++H VAVK L + + EV +L + RH NI+ +GY
Sbjct: 32 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+ +V + SL LH E K + +IA A+G++YLH +
Sbjct: 89 S-TAPQLAIVTQWCEGSSLYHHLHASE-TKF--EMKKLIDIARQTARGMDYLH---AKSI 141
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM--VAGSYGYIAPE---YGYTLK 880
IHRD+KSNNI L + +I DFGLA + + ++GS ++APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 881 VDEKSDIYSFGVVLLELLTGKMP---LDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937
+SD+Y+FG+VL EL+TG++P ++ + ++ M+ L P ++
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNR--------DQIIEMVGRGS-----LSPDLS 248
Query: 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
+ + M ++ C K RP+ ++ +
Sbjct: 249 KVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-56
Identities = 70/289 (24%), Positives = 115/289 (39%), Gaps = 44/289 (15%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
++G G G K V+ +K+L R D + + +EV ++ L H N+++ +
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ--RTFLKEVKVMRCLEHPNVLKFI 73
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
G L+ + + + +Y+ +L + + W R + A IA G+ YLH
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQY--PWSQRVSFAKDIASGMAYLH---SM 127
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM--------------VAGSYG 869
+IHRD+ S+N L+ N +ADFGLAR+M+ + V G+
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 870 YIAPE---YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926
++APE DEK D++SFG+VL E++ DP +
Sbjct: 188 WMAPEMINGR---SYDEKVDVFSFGIVLCEIIGRVNA-DPDYLPRTMDFG---------L 234
Query: 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
LD C I V C P+ RP+ + L
Sbjct: 235 NVRGFLDRYCPPNCPPS------FFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-54
Identities = 101/499 (20%), Positives = 183/499 (36%), Gaps = 32/499 (6%)
Query: 104 SSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATS 163
+P +L + K++D+S N L ++ S + +
Sbjct: 20 YKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 164 LESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAF- 222
L +L G+ + +F L L+ L NL +G L +L+ + + +N
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 223 EGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLY---KNNFTGKIPPELG 279
++P F NLTNL +LDL+ + L L ++ + L N I P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 280 SITSLAFLDLSDNQISGEIP-VKLAELKNLQLLNLM------CNQLTGLIPDKLGELTKL 332
L L L +N S + + L L++ L+ L L L L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 333 EVLELWKNSLIGSLPMRLGQSSPLRRL---DASSNLLSGEIPTGLCDSGNLTKLILFNNS 389
+ E L L + + L + S + + + L L N
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCK 315
Query: 390 FSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLT--GQIPDDIS 447
F + L + K L +N +LPSL+ L+++ N L+ G
Sbjct: 316 FGQFPTLKLKSLKRL---TFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 448 LSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNE--LQACPSLSVLDL 505
+TSL ++D+S+N + + + S+ L + L+ H+NL+ ++ + +L LD+
Sbjct: 371 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDI 428
Query: 506 SSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAV-ATMPTLAILDMSNNSLFGRIPE 564
S L L + N F + + L LD+S L ++
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSP 487
Query: 565 N-FGASPALEMLNLSYNKL 582
F + +L++LN++ N+L
Sbjct: 488 TAFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 1e-53
Identities = 100/529 (18%), Positives = 179/529 (33%), Gaps = 40/529 (7%)
Query: 60 VWCNSRGF----------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKS 109
C F + LDLS L S + L L++ E + +
Sbjct: 12 YQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 110 LANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDF 169
+L+ L ++ ++ N S L + A N + +G+ +L+ L+
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 170 RG-SFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLE----TIILGYNAFEG 224
+P F NL L+ L LS N + +L L + ++ L N
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN- 190
Query: 225 EIPAEFGNLTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGK---IPPELGS 280
I L L L S + + L L L F + + +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 281 ITSLAFLDLSDNQISG------EIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEV 334
+ L L + + +++ +I L N+ +L+ + + +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQH 308
Query: 335 LELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNN--SFSG 392
LEL ++L L+RL +SN + + D +L L L N SF G
Sbjct: 309 LELVNCKFGQFPTLKLKS---LKRLTFTSNKGG-NAFSEV-DLPSLEFLDLSRNGLSFKG 363
Query: 393 TFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLS--T 450
S SL + + N + T+ L L+ L+ ++NL Q+ +
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLR 421
Query: 451 SLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNE-LQACPSLSVLDLSSNS 509
+L ++DIS H + SL+ + N+ Q + +L+ LDLS
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 510 LSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSL 558
L P + S L LN+ +N+ + +L + + N
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 7e-47
Identities = 101/488 (20%), Positives = 173/488 (35%), Gaps = 32/488 (6%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
+ LDLS + + L LS+L + N S + + L++L+ + + N
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 129 SFPTGLGKASGLTSVNASSNNFSGF-LPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK 187
+G L +N + N F LPE N T+LE LD + + T R L +
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 188 LKF----LGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAE-FGNLTNLRYLDLA 242
+ L LS N + I P + L + L N + L L L
Sbjct: 175 MPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 243 VGSLSGQI------PPALGRLKKLTTVYL---YKNNFTGKIPPELGSITSLAFLDLSDNQ 293
+G + AL L LT Y + + I +T+++ L
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 294 ISGEIP--VKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLG 351
I + ++L+L+N Q L +L L+ L N G+ +
Sbjct: 294 IE-RVKDFSYNFGWQHLELVNCKFGQFPTL------KLKSLKRLTFTSNK-GGNAFSEVD 345
Query: 352 QSSPLRRLDASSNLLSGEIPTGLCDSG--NLTKLILFNNSFSGTFPVSLSTCKSLVRVRV 409
S L LD S N LS + D G +L L L N T + + L +
Sbjct: 346 LPS-LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 403
Query: 410 QNNLISGTIPVG-LGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPS 468
Q++ + +L +L L++++ + + +SL + ++ N +
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
Query: 469 SILS-IPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSL 527
I + + +L S L+ P + SL VL+++SN L L +
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI 523
Query: 528 NLRNNRFS 535
L N +
Sbjct: 524 WLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-46
Identities = 83/487 (17%), Positives = 162/487 (33%), Gaps = 70/487 (14%)
Query: 141 TSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTG 200
+ NF +P++L S ++LD + SF + +L+ L LS +
Sbjct: 10 ITYQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65
Query: 201 KIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKL 260
I + +L++L L L + A L L
Sbjct: 66 TIEDGA-----------------------YQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102
Query: 261 TTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQI-SGEIPVKLAELKNLQLLNLMCNQLT 319
+ + N +G + +L L+++ N I S ++P + L NL+ L+L N++
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 320 GLIPDKLGELTKLEV----LELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLC 375
+ L L ++ + L+L N + + + L +L +N S +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNP-MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCI 221
Query: 376 DS-GNLTKLILFNNSFSGTF---PVSLSTCKSLVRVRV------QNNLISGTIPVGLGNL 425
L L F S + L + + + I L
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 426 PSLQRLEMANNNLTGQIPDDISLS--------------------TSLSFVDISWNHLESY 465
++ + + + ++ D SL + + N +
Sbjct: 282 TNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN- 339
Query: 466 LPSSILSIPSLQTFMASHNNLQAK--IPNELQACPSLSVLDLSSNSLSGEIPASIASCEK 523
S + +PSL+ S N L K SL LDLS N + + ++ E+
Sbjct: 340 -AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ 397
Query: 524 LVSLNLRNNRFSGEIPKAV-ATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKL 582
L L+ +++ +V ++ L LD+S+ F +LE+L ++ N
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
Query: 583 EGPVPSN 589
+ +
Sbjct: 458 QENFLPD 464
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 67/413 (16%), Positives = 127/413 (30%), Gaps = 66/413 (15%)
Query: 69 EKLDLSNMSLN-GSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVS---QN 124
++L++++ + + E L +L L++ N+ S L L + +++S
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 125 NFIGSFPTGLGKASGLTSVNASSNNFSGFLPED--------------------------- 157
N + G K L + +N S + +
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 158 ----LGNATSLESLDFRGS---FFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELG--- 207
L +L +FR + ++ + F L + L + ++
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFG 305
Query: 208 -----------------QLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLS--G 248
+L SL+ + N G + +L +L +LDL+ LS G
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG-GNAFS-EVDLPSLEFLDLSRNGLSFKG 363
Query: 249 QIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVK-LAELKN 307
+ L + L N + + L LD + + L+N
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 308 LQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMR-LGQSSPLRRLDASSNLL 366
L L++ L+ LEVL++ NS + + L LD S L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 367 SGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIP 419
PT +L L + +N SL ++ + N + P
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-27
Identities = 67/287 (23%), Positives = 113/287 (39%), Gaps = 15/287 (5%)
Query: 68 VEKLDLSNMSLNGSVSENI-RGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNF 126
+E+ L+ + ++ L ++SS ++ + + + +++ N
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI-ERVK-DFSYNFGWQHLELV-NCK 315
Query: 127 IGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSF--FEGSVPTSFRN 184
G FPT K L + +SN E + SLE LD + F+G S
Sbjct: 316 FGQFPTL--KLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 185 LQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAE--FGNLTNLRYLDLA 242
LK+L LS N + + L LE + ++ + ++ F +L NL YLD++
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDIS 429
Query: 243 VGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQISGEIPVK 301
L L + + N+F P+ + +L FLDLS Q+ P
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
Query: 302 LAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPM 348
L +LQ+LN+ NQL + LT L+ + L N S P
Sbjct: 490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-20
Identities = 41/222 (18%), Positives = 80/222 (36%), Gaps = 19/222 (8%)
Query: 375 CDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMA 434
C N K+ P +L S + + N + + P LQ L+++
Sbjct: 14 CMELNFYKI-----------PDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 435 NNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNEL 494
+ + LS + ++ N ++S + + SLQ +A NL + +
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 495 QACPSLSVLDLSSNSL-SGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAI--- 550
+L L+++ N + S ++P ++ L L+L +N+ + + + +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 551 -LDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGI 591
LD+S N + I L L L N V I
Sbjct: 181 SLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCI 221
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 6e-53
Identities = 108/482 (22%), Positives = 188/482 (39%), Gaps = 30/482 (6%)
Query: 112 NLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRG 171
+ A D +F S P+GL + + S++ S N + DL +L+ L +
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 172 SFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPE-LGQLSSLETIILGYNAF-EGEIPAE 229
S +F +L L+ L LS N+L+ + G LSSL+ + L N + + +
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 230 FGNLTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLD 288
F NLTNL+ L + +I L L + + + L SI + L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 289 LSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPM 348
L ++ + + + L +++ L L L L ++
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 349 RLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFP-VSLSTCKSLVRV 407
+ L R + + D L L FN S S + ++ R+
Sbjct: 239 SFNELLKLLRYILELSEVE-------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRL 291
Query: 408 RVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLS-TSLSFVDISWNHLES-- 464
+ + + L ++R+ + N+ + +P S SL F+D+S N +
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEY 350
Query: 465 -YLPSSILSIPSLQTFMASHNNLQA--KIPNELQACPSLSVLDLSSNSLSGEIPASIASC 521
+ + PSLQT + S N+L++ K L +L+ LD+S N+ +P S
Sbjct: 351 LKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWP 409
Query: 522 EKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNK 581
EK+ LNL + + + TL +LD+SNN+L P L+ L +S NK
Sbjct: 410 EKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNL-DSFSLFL---PRLQELYISRNK 462
Query: 582 LE 583
L+
Sbjct: 463 LK 464
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 5e-51
Identities = 91/530 (17%), Positives = 189/530 (35%), Gaps = 33/530 (6%)
Query: 62 CNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDV 121
C++ G D + S S+ + ++ SL++ N+ L L+ + +
Sbjct: 4 CDASGVC---DGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57
Query: 122 SQNNFIGSFPTG-LGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRG-SFFEGSVP 179
+ I + L ++ S N+ S G +SL+ L+ G + V
Sbjct: 58 KSSR-INTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116
Query: 180 TSFRNLQKLKFLGLSGNNLTGKIPPE-LGQLSSLETIILGYNAFEGEIPAEFGNLTNLRY 238
+ F NL L+ L + +I L+SL + + + ++ ++ +
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176
Query: 239 LDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEI 298
L L + + + L + + L N L + + + S
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
Query: 299 PVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRR 358
EL L L +++ + T + + + + ++ +RR
Sbjct: 237 DESFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRR 290
Query: 359 LDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTI 418
L L ++ T + ++ + N+ KSL + + NL+
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEY 350
Query: 419 ---PVGLGNLPSLQRLEMANNNLT--GQIPDDISLSTSLSFVDISWNHLESYLPSSILSI 473
G PSLQ L ++ N+L + + + +L+ +DIS N +P S
Sbjct: 351 LKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWP 409
Query: 474 PSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNR 533
++ S ++ + + +L VLD+S+N+L + +L L + N+
Sbjct: 410 EKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLD-SFSLFL---PRLQELYISRNK 462
Query: 534 FSGEIPKAVATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYNKL 582
+P A + P L ++ +S N L +P+ F +L+ + L N
Sbjct: 463 LK-TLPDA-SLFPVLLVMKISRNQL-KSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-35
Identities = 72/426 (16%), Positives = 134/426 (31%), Gaps = 23/426 (5%)
Query: 69 EKLDLSNMSLNG-SVSENIRGLRSLSSLNICCNEFASSLPK-SLANLTALKSMDVSQNNF 126
+ L+L V+ L +L +L I E S + + A LT+L +++ +
Sbjct: 101 KYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160
Query: 127 IGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQ 186
L + + + + L +S+ L+ R + + +
Sbjct: 161 RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDE 220
Query: 187 KLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSL 246
+ + +L L IL + EF + T D
Sbjct: 221 VSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV------EFDDCTLNGLGDFNPSES 274
Query: 247 SGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELK 306
+ +++ + + + + + + ++++ LK
Sbjct: 275 DVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLK 334
Query: 307 NLQLLNLMCNQLTGLIPDK---LGELTKLEVLELWKNSL--IGSLPMRLGQSSPLRRLDA 361
+L+ L+L N + G L+ L L +N L + L L LD
Sbjct: 335 SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI 394
Query: 362 SSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVG 421
S N +P + L L + +L + V NN + + +
Sbjct: 395 SRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQ---TLEVLDVSNNNLD-SFSL- 448
Query: 422 LGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMA 481
LP LQ L ++ N L +PD SL L + IS N L+S + SLQ
Sbjct: 449 --FLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWL 504
Query: 482 SHNNLQ 487
N
Sbjct: 505 HTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-32
Identities = 63/409 (15%), Positives = 129/409 (31%), Gaps = 61/409 (14%)
Query: 193 LSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPP 252
+ T IP L ++++++ L +N + NL+ L L
Sbjct: 12 GRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILK---------- 58
Query: 253 ALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQISGEIPVKLAELKNLQLL 311
++ I + S+ SL LDLSDN +S L +L+ L
Sbjct: 59 ---------------SSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYL 103
Query: 312 NLMCNQLTGLIPDKL-GELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEI 370
NLM N L L LT L+ L + +
Sbjct: 104 NLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR----------------------- 140
Query: 371 PTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQR 430
+L +L + S SL + + + + + + + + + L S++
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200
Query: 431 LEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKI 490
LE+ + NL + + S + S + L ++ + ++
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE--- 257
Query: 491 PNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAI 550
C + D + + + L++ ++ + + +
Sbjct: 258 ---FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR 314
Query: 551 LDMSNNSLFGRIPENFGAS-PALEMLNLSYNKLEGPVPSNGILMNINPN 598
+ + N+ +F +P +F +LE L+LS N + N P+
Sbjct: 315 ITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 53/322 (16%), Positives = 99/322 (30%), Gaps = 16/322 (4%)
Query: 34 PLNMLEDWKMPSNAAENGLLHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLS 93
L + +P + + + + G F E L L L S
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS-EVEFDDCTLNG 265
Query: 94 SLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGF 153
+ +E ++ + + Q T + + ++
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325
Query: 154 LPEDLGNATSLESLDFRGSFFEGSV---PTSFRNLQKLKFLGLSGNNLT--GKIPPELGQ 208
+ SLE LD + L+ L LS N+L K L
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
Query: 209 LSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKN 268
L +L ++ + N F +P +R+L+L+ + + + + L + + N
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNN 441
Query: 269 NFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGE 328
N L L L +S N++ +P + L ++ + NQL +
Sbjct: 442 NLD-SFSLFL---PRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDR 495
Query: 329 LTKLEVLELWKNSLIGSLPMRL 350
LT L+ + L N S P
Sbjct: 496 LTSLQKIWLHTNPWDCSCPRID 517
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 8e-18
Identities = 37/207 (17%), Positives = 83/207 (40%), Gaps = 6/207 (2%)
Query: 400 TCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISW 459
+C + ++ + +IP GL +++ L+++ N +T D+ +L + +
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 460 NHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSG-EIPASI 518
+ + + + S+ SL+ S N+L + + SL L+L N + +
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 519 ASCEKLVSLNLRNNRFSGEIPKAV-ATMPTLAILDMSNNSLFGRIPENFGASPALEMLNL 577
+ L +L + N EI + A + +L L++ SL ++ + + L L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 578 SYNKLEGPVP-SNGILMNINPNELIGN 603
++ + IL ++ EL
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDT 206
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 7e-52
Identities = 64/351 (18%), Positives = 116/351 (33%), Gaps = 27/351 (7%)
Query: 80 GSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASG 139
GS + +L + L+ + D ++ + S
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-----NSN 56
Query: 140 LTSVNASSNNFSGFLPEDLGNATS--LESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNN 197
+ + + L +AT +L+ R P L L+ + +
Sbjct: 57 NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 198 LTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRL 257
L ++P + Q + LET+ L N +PA +L LR L + ++P L
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 258 KKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQ 317
E + +L L L I +P +A L+NL+ L + +
Sbjct: 174 ---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217
Query: 318 LTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDS 377
L+ L + L KLE L+L + + + P G +PL+RL +P +
Sbjct: 218 LSAL-GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276
Query: 378 GNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSL 428
L KL L P ++ + + V +L + P+
Sbjct: 277 TQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 6e-47
Identities = 54/328 (16%), Positives = 108/328 (32%), Gaps = 21/328 (6%)
Query: 127 IGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQ 186
+GS +SG ++ + + L + D N
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSN 56
Query: 187 KLKFLGLSGNNLTGKIPPELGQLSS--LETIILGYNAFEGEIPAEFGNLTNLRYLDLAVG 244
+ +G L L + + L + P + L++L+++ +
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114
Query: 245 SLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIP----- 299
L ++P + + L T+ L +N +P + S+ L L + E+P
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 300 ----VKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP 355
+ L NLQ L L + L P + L L+ L++ + L +L +
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIRSL-PASIANLQNLKSLKIRNSPLS-ALGPAIHHLPK 230
Query: 356 LRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLIS 415
L LD P L +LIL + S T P+ + L ++ ++ +
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290
Query: 416 GTIPVGLGNLPSLQRLEMANNNLTGQIP 443
+P + LP+ + + +
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-46
Identities = 57/335 (17%), Positives = 118/335 (35%), Gaps = 24/335 (7%)
Query: 154 LPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLE 213
+++ E+L F+GS Q+ + + ++ +
Sbjct: 4 SHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQ 59
Query: 214 TIILGYNAFEGEIPAEFGNLT--NLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFT 271
A + + T L+L L Q P RL L + +
Sbjct: 60 IETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
Query: 272 GKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLM-CNQLTGL--------I 322
++P + L L L+ N + +P +A L L+ L++ C +LT L
Sbjct: 118 -ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA 175
Query: 323 PDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTK 382
+ L L+ L L + SLP + L+ L ++ LS + + L +
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEE 233
Query: 383 LILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQI 442
L L + +P L R+ +++ T+P+ + L L++L++ ++
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 443 PDDISLSTSLSFVDISWN---HLESYLPSSILSIP 474
P I+ + + + + L+ + P + + P
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQHRPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-44
Identities = 60/330 (18%), Positives = 98/330 (29%), Gaps = 21/330 (6%)
Query: 254 LGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNL 313
+Y + L D + + A N Q+
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETR 63
Query: 314 MCNQLTGLIPDKLGELT--KLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIP 371
L D L + T LEL L P + + S L+ + + L E+P
Sbjct: 64 TGRALKAT-ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELP 120
Query: 372 TGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVR--VRVQNNLIS-------GTIPVGL 422
+ L L L N P S+++ L +R L
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 423 GNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMAS 482
L +LQ L + + +P I+ +L + I + L + L +I +P L+
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLR 237
Query: 483 HNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAV 542
P L L L S +P I +L L+LR +P +
Sbjct: 238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297
Query: 543 ATMPTLAILDMSNNSLFGRIPENFGASPAL 572
A +P I+ + + A PA
Sbjct: 298 AQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 41/274 (14%), Positives = 90/274 (32%), Gaps = 16/274 (5%)
Query: 70 KLDLSNMSLNGSVSENIRGLRS--LSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
+++ + ++ + +L + P L+ L+ M + +
Sbjct: 59 QIETRTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAG-L 116
Query: 128 GSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRG---------SFFEGSV 178
P + + +GL ++ + N LP + + L L R
Sbjct: 117 MELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDA 175
Query: 179 PTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRY 238
+ L L+ L L + +P + L +L+++ + + + +L L
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEE 233
Query: 239 LDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEI 298
LDL + PP G L + L + +P ++ +T L LDL +
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 299 PVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKL 332
P +A+L ++ + + L +
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 32/161 (19%), Positives = 60/161 (37%), Gaps = 11/161 (6%)
Query: 69 EKLDLSNMSL---------NGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSM 119
+L + + S +GL +L SL + SLP S+ANL LKS+
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSL 211
Query: 120 DVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVP 179
+ + + + + L ++ P G L+ L + ++P
Sbjct: 212 KIRNSP-LSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270
Query: 180 TSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYN 220
L +L+ L L G ++P + QL + I++ +
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 16/91 (17%), Positives = 33/91 (36%), Gaps = 3/91 (3%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNIC-CNEFASSLPKSLANLTALKSMDVSQNNFI 127
E+LDL + + G L L + C+ +LP + LT L+ +D+ +
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL-LTLPLDIHRLTQLEKLDLRGCVNL 290
Query: 128 GSFPTGLGKASGLTSVNASSNNFSGFLPEDL 158
P+ + + + + L +
Sbjct: 291 SRLPSLIAQLPANCIILV-PPHLQAQLDQHR 320
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 7e-52
Identities = 110/683 (16%), Positives = 213/683 (31%), Gaps = 88/683 (12%)
Query: 62 CNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDV 121
C+ G +L V + L + L + N + S L L+ +++
Sbjct: 2 CSFDG--RIAFYRFCNLT-QVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLEL 55
Query: 122 SQNNFIGSFPTG-LGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSV-- 178
+ L ++ S+ P+ L L +V
Sbjct: 56 GSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115
Query: 179 PTSFRNLQKLKFLGLSGNNLTG-KIPPELGQLSSLETIILGYNAFEGEIPAEFGNLT--N 235
FRNL+ L L LS N + + P G+L+SL++I N E L
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175
Query: 236 LRYLDLAVGSLSGQIPPALGRLKK------LTTVYLYKNNFTGKIPPELGSITSLAFLDL 289
L + LA SL ++ G+ L + + N +T I
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT------------GN 223
Query: 290 SDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTK--LEVLELWKNSLIGSLP 347
N IS L ++ + + + L + + L+L +
Sbjct: 224 FSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS 283
Query: 348 MRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRV 407
L+ L+ + N ++ NL L L N + + + +
Sbjct: 284 RVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYI 343
Query: 408 RVQNNLISGTIPVGLGNLPSLQRLEMANNNLTG---------------QIPDDISLSTSL 452
+Q N I+ L LQ L++ +N LT ++ ++ +
Sbjct: 344 DLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTA 403
Query: 453 SFVDISWNHLESYLPSSIL-SIPSLQTFMASHNNLQAKIPNEL-QACPSLSVLDLSSNSL 510
+ + +S N LE+ L +P LQ + + N + ++ PSL L L N L
Sbjct: 404 NLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENML 463
Query: 511 SGEIPASI-----ASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPEN 565
+ L L L +N + P + + L L +++N L +
Sbjct: 464 QLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHND 523
Query: 566 FGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLC---------------GSV 610
LE+L++S N+L P+ + ++++ ++ N +C ++
Sbjct: 524 L--PANLEILDISRNQLL--APNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTI 579
Query: 611 LPPCSQNLTAKPGQTRKMHINHI---------------IFGFIIGTLVIVSLGIVFFAGK 655
P + P + + + FI+ T+ + +
Sbjct: 580 AGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVT 639
Query: 656 WAYRRWYLYNSFFDDLFKKSCKE 678
++ L K +
Sbjct: 640 KFRGFCFICYKTAQRLVFKDHPQ 662
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 4e-51
Identities = 97/517 (18%), Positives = 171/517 (33%), Gaps = 83/517 (16%)
Query: 82 VSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLT 141
++ L + + +P N+ + + + + + P G G+ +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 142 SVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGK 201
L+ S+P +L+ L S N+LT +
Sbjct: 62 VSRLRDCLD-----------RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-E 105
Query: 202 IPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLT 261
+P L SL A P L YL ++ L ++P L L
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFLK 156
Query: 262 TVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGL 321
+ + N+ K+P S+ + +NQ+ E+P +L L L + N L L
Sbjct: 157 IIDVDNNSLK-KLPDLPPSLEF---IAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKL 210
Query: 322 IPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLT 381
LE + N ++ LP L L + A +NLL +P +L
Sbjct: 211 PD----LPLSLESIVAGNN-ILEELP-ELQNLPFLTTIYADNNLLK-TLPDLP---PSLE 260
Query: 382 KLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQ 441
L + +N + P + L + +S P+L L ++N +
Sbjct: 261 ALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELP-------PNLYYLNASSNEIR-S 311
Query: 442 IPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLS 501
+ D SL +++S N L LP+ P L+ +AS N+L ++P Q +L
Sbjct: 312 LCDLP---PSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPELPQ---NLK 360
Query: 502 VLDLSSNSLSGEIPASIASCE----------------KLVSLNLRNNRFSGEIPKAVATM 545
L + N L E P S E L L++ N E P
Sbjct: 361 QLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDI---P 415
Query: 546 PTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKL 582
++ L M++ + + LE ++
Sbjct: 416 ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 3e-49
Identities = 95/460 (20%), Positives = 169/460 (36%), Gaps = 70/460 (15%)
Query: 124 NNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFR 183
++ + P T + + + P G + R
Sbjct: 20 SSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL---------- 69
Query: 184 NLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAV 243
++ L L+ L+ +P L SL + N+ E+P +L +L + +
Sbjct: 70 -DRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 244 GSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLA 303
+LS P L + + N PEL + + L +D+ +N + ++P
Sbjct: 124 KALSDLPP-------LLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK-KLP---D 170
Query: 304 ELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASS 363
+L+ + NQL L +L L L + NSL LP L + A +
Sbjct: 171 LPPSLEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGN 224
Query: 364 NLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLG 423
N+L L + LT + NN T P + ++L V++N ++ +P
Sbjct: 225 NILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL---NVRDNYLT-DLPELPQ 277
Query: 424 NLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASH 483
+L L E + L+ L +L +++ S N + S L PSL+ S+
Sbjct: 278 SLTFLDVSENIFSGLS-------ELPPNLYYLNASSNEIRS-LCDLP---PSLEELNVSN 326
Query: 484 NNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVA 543
N L ++P P L L S N L+ E+P + L L++ N E P
Sbjct: 327 NKLI-ELPALP---PRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFP---D 374
Query: 544 TMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
++ L M+++ +PE L+ L++ N L
Sbjct: 375 IPESVEDLRMNSH--LAEVPELPQN---LKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-48
Identities = 100/484 (20%), Positives = 168/484 (34%), Gaps = 71/484 (14%)
Query: 52 LLHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLA 111
W G ++ +S + R L + SSLP+
Sbjct: 41 NAWSEWERNAPPGNGEQREMAVSRLRDCL--------DRQAHELELNNLGL-SSLPELPP 91
Query: 112 NLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRG 171
+L +L S N+ + P L N + S P LE L
Sbjct: 92 HLESL---VASCNS-LTELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSN 140
Query: 172 SFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFG 231
+ E +P +N LK + + N+L K+P L + G N E E+P E
Sbjct: 141 NQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLE-ELP-ELQ 192
Query: 232 NLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSD 291
NL L + SL ++P L+ + N PEL ++ L + +
Sbjct: 193 NLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNILE--ELPELQNLPFLTTIYADN 246
Query: 292 NQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLG 351
N + +P +L+ LN+ N LT L P+ LT L+V E + L P
Sbjct: 247 NLLK-TLP---DLPPSLEALNVRDNYLTDL-PELPQSLTFLDVSENIFSGLSELPPN--- 298
Query: 352 QSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQN 411
L L+ASSN + + +L +L + NN P + L
Sbjct: 299 ----LYYLNASSNEIR-SLCDLP---PSLEELNVSNNKLI-ELPALPPRLERL---IASF 346
Query: 412 NLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSIL 471
N ++ +P NL ++L + N L + PD L +HL +P
Sbjct: 347 NHLA-EVPELPQNL---KQLHVEYNPLR-EFPDIPESVEDLRM----NSHLAE-VPELP- 395
Query: 472 SIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRN 531
+L+ N L+ + P+ + S+ L ++S + + + +KL +
Sbjct: 396 --QNLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEH 449
Query: 532 NRFS 535
+
Sbjct: 450 HHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-47
Identities = 104/413 (25%), Positives = 160/413 (38%), Gaps = 64/413 (15%)
Query: 184 NLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNL---------- 233
+ L+ +NLT ++P E + S ++ +E P G
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 234 ---TNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLS 290
L+L LS +P L+ L N+ T ++P S+ SL + +
Sbjct: 68 CLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 291 DNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRL 350
+S P L+ L + NQL L P+ L + L+++++ NSL LP
Sbjct: 123 LKALSDLPP-------LLEYLGVSNNQLEKL-PE-LQNSSFLKIIDVDNNSLK-KLPDLP 172
Query: 351 GQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQ 410
L + A +N L E+P L + LT + NNS P + +S+V
Sbjct: 173 PS---LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AG 223
Query: 411 NNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSI 470
NN++ L NLP L + NN L +PD SL +++ N+L LP
Sbjct: 224 NNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLTD-LPELP 276
Query: 471 LSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLR 530
S+ L + L PN L L+ SSN + + S L LN+
Sbjct: 277 QSLTFLDVSENIFSGLSELPPN-------LYYLNASSNEIR-SLCDLPPS---LEELNVS 325
Query: 531 NNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
NN+ E+P A P L L S N L +PE L+ L++ YN L
Sbjct: 326 NNKLI-ELP---ALPPRLERLIASFNHL-AEVPELPQ---NLKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-36
Identities = 87/367 (23%), Positives = 136/367 (37%), Gaps = 72/367 (19%)
Query: 250 IPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELK--- 306
I P L + +N T ++P E ++ S + ++ P E +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 307 ------------------------------NLQLLNLMCNQLTGLIPDKLGELTKLEVLE 336
+L+ L CN LT L P+ L L V
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLTEL-PELPQSLKSLLVDN 120
Query: 337 LWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPV 396
+L P+ L L S+N L ++P L +S L + + NNS P
Sbjct: 121 NNLKALSDLPPL-------LEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPD 170
Query: 397 SLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVD 456
SL + NN + +P L NLP L + NN+L ++PD SL +
Sbjct: 171 LPP---SLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPL---SLESIV 221
Query: 457 ISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPA 516
N LE + ++P L T A +N L+ +P+ PSL L++ N L+ ++P
Sbjct: 222 AGNNILEE--LPELQNLPFLTTIYADNNLLK-TLPDLP---PSLEALNVRDNYLT-DLPE 274
Query: 517 SIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLN 576
S L + S P L L+ S+N + + + P+LE LN
Sbjct: 275 LPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSNEI-RSLCDLP---PSLEELN 323
Query: 577 LSYNKLE 583
+S NKL
Sbjct: 324 VSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 29/149 (19%), Positives = 53/149 (35%), Gaps = 20/149 (13%)
Query: 465 YLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIAS---- 520
++ +S LQ + +NL ++P E + S + + + P
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 521 ---------CEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPA 571
+ L L N S +P+ P L L S NSL +PE + +
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELP---PHLESLVASCNSL-TELPELPQSLKS 115
Query: 572 LEMLNLSYNKLEGPVPSNGILMNINPNEL 600
L + N + L +P + ++ N+L
Sbjct: 116 LLVDNNNLKALSD-LPPLLEYLGVSNNQL 143
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 5e-51
Identities = 77/314 (24%), Positives = 120/314 (38%), Gaps = 68/314 (21%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V++ + VAVK D E E+ LRH NI+ +
Sbjct: 14 ECVGKGRYGEVWRGSWQ--GENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFI 68
Query: 764 GY----LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
H+ T + ++ Y SL + L +D VS I + IA GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHI 123
Query: 820 D-----CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMV----AGSYGY 870
+ +P + HRD+KS NIL+ N + IAD GLA M + + G+ Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 871 IAPE------YGYTLKVDEKSDIYSFGVVLLELLTGKM----------------PLDPAF 908
+APE ++ DI++FG+VL E+ + P DP+F
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 909 GGSKDIVEWVLSM-----IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPK 963
+D+ + V I + D L S+A ++ C + P
Sbjct: 244 ---EDMRKVVCVDQQRPNIPNRWFSDPTL-TSLA--------------KLMKECWYQNPS 285
Query: 964 GRPTMRDVITMLGE 977
R T + L +
Sbjct: 286 ARLTALRIKKTLTK 299
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-50
Identities = 74/372 (19%), Positives = 139/372 (37%), Gaps = 27/372 (7%)
Query: 92 LSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFS 151
++L P A+L + + + + +T + + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 152 GFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSS 211
+ + T+LE L+ G+ P NL KL L + N +T L L++
Sbjct: 58 SI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 212 LETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFT 271
L + L + P NLT + L+L L + L + + ++
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK 168
Query: 272 GKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTK 331
+ ++T L L L+ NQI P LA L +L NQ+T + P + +T+
Sbjct: 169 D--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 332 LEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFS 391
L L++ N + P L S L L+ +N +S + D L L + +N S
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278
Query: 392 GTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTS 451
L+ L + + NN + +G L +L L ++ N++T P ++ +
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334
Query: 452 LSFVDISWNHLE 463
+ D + ++
Sbjct: 335 MDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 8e-50
Identities = 79/379 (20%), Positives = 139/379 (36%), Gaps = 49/379 (12%)
Query: 180 TSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYL 239
+L + L ++T +L S+ +++ I LTNL YL
Sbjct: 16 FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYL 71
Query: 240 DLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIP 299
+L ++ L L KLT +Y+ N T L ++T+L L L+++ IS P
Sbjct: 72 NLNGNQITD--ISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP 127
Query: 300 VKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRL 359
LA L + LNL N + L +T L L + ++ + P + + L L
Sbjct: 128 --LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182
Query: 360 DASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIP 419
+ N + P L +L + N + ++ L +++ NN I+ P
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP 238
Query: 420 VGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTF 479
L NL L LE+ N ++ +++ + L+
Sbjct: 239 --LANLSQLTWLEIGTNQISD--------------------------INAVKDLTKLKML 270
Query: 480 MASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIP 539
N + I L L+ L L++N L E I L +L L N + P
Sbjct: 271 NVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
Query: 540 KAVATMPTLAILDMSNNSL 558
+A++ + D +N +
Sbjct: 329 --LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-44
Identities = 75/352 (21%), Positives = 133/352 (37%), Gaps = 28/352 (7%)
Query: 233 LTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDN 292
L L + + L + L K + T + S+ L ++
Sbjct: 2 AATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGE 54
Query: 293 QISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQ 352
+++ I + L NL+ LNL NQ+T + P L L KL L + N + + L
Sbjct: 55 KVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQN 108
Query: 353 SSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNN 412
+ LR L + + +S P L + + L L N + LS L + V +
Sbjct: 109 LTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTES 165
Query: 413 LISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILS 472
+ P + NL L L + N + P ++ TSL + N + + + +
Sbjct: 166 KVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVAN 219
Query: 473 IPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNN 532
+ L + +N + + L L+ L++ +N +S ++ KL LN+ +N
Sbjct: 220 MTRLNSLKIGNNKIT-DLSP-LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSN 275
Query: 533 RFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEG 584
+ S + + L L ++NN L E G L L LS N +
Sbjct: 276 QISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-37
Identities = 60/274 (21%), Positives = 114/274 (41%), Gaps = 19/274 (6%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
L + + + ++ L +L L + + S + LANLT + S+++ N+ +
Sbjct: 91 TNLYIGTNKI--TDISALQNLTNLRELYLNEDNI-SDIS-PLANLTKMYSLNLGANHNL- 145
Query: 129 SFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKL 188
S + L +GL + + + + N T L SL + E P +L L
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKDV--TPIANLTDLYSLSLNYNQIEDISP--LASLTSL 201
Query: 189 KFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSG 248
+ N +T P + ++ L ++ +G N P NL+ L +L++ +S
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD 257
Query: 249 QIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNL 308
A+ L KL + + N + L +++ L L L++NQ+ E + L NL
Sbjct: 258 --INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313
Query: 309 QLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSL 342
L L N +T + P L L+K++ + +
Sbjct: 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 50/247 (20%), Positives = 95/247 (38%), Gaps = 33/247 (13%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
+L L+ +++ + L + SLN+ N S L+N+T L + V+++
Sbjct: 113 RELYLNEDNISDI--SPLANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKD 169
Query: 129 SFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVP--------- 179
P + + L S++ + N L + TSL + P
Sbjct: 170 VTP--IANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDITPVANMTRLNS 225
Query: 180 -----------TSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPA 228
+ NL +L +L + N ++ + L+ L+ + +G N +
Sbjct: 226 LKIGNNKITDLSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--IS 281
Query: 229 EFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLD 288
NL+ L L L L + +G L LTT++L +N+ T P L S++ + D
Sbjct: 282 VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSAD 339
Query: 289 LSDNQIS 295
++ I
Sbjct: 340 FANQVIK 346
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-50
Identities = 74/312 (23%), Positives = 114/312 (36%), Gaps = 60/312 (19%)
Query: 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-REVSLLGRLRHRN 758
++ IG G G V+ ++ VAVK E E+ +RH N
Sbjct: 39 IQMVKQIGKGRYGEVWMGKWR--GEKVAVKVF----FTTEEASWFRETEIYQTVLMRHEN 92
Query: 759 IVRLLGY----LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
I+ + + T + ++ DY N SL + L +D S +A GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGL 147
Query: 815 NYLH-----HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMV----A 865
+LH +P + HRD+KS NIL+ N IAD GLA + V +
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 866 GSYGYIAPE------YGYTLKVDEKSDIYSFGVVLLELLTGKM----------------P 903
G+ Y+ PE + +D+YSFG++L E+ + P
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 904 LDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPK 963
DP++ D+ E V + L PS E + + ++ C A P
Sbjct: 268 SDPSYE---DMREIVC---------IKKLRPSF-PNRWSSDECLRQMGKLMTECWAHNPA 314
Query: 964 GRPTMRDVITML 975
R T V L
Sbjct: 315 SRLTALRVKKTL 326
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 8e-50
Identities = 56/411 (13%), Positives = 130/411 (31%), Gaps = 20/411 (4%)
Query: 177 SVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNL 236
++ +N + K ++ ++L + +++ + L N A+ T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 237 RYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISG 296
L+L+ L L L L T+ L N EL S+ L ++N IS
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 297 EIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIG-SLPMRLGQSSP 355
+ + + + L N++T L G ++++ L+L N + + S
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 356 LRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLIS 415
L L+ N + ++ + + L L L +N + + + + ++NN +
Sbjct: 171 LEHLNLQYNFIY-DVKGQVVFA-KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 416 GTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPS 475
I L +L+ ++ N D S + ++ ++ +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 476 LQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSG----EIPASIASCEKLVSLNLRN 531
+ +L + + S G + + + ++
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 532 NRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKL 582
++ I + L+ +L ++ A L+
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ 396
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-46
Identities = 70/444 (15%), Positives = 146/444 (32%), Gaps = 24/444 (5%)
Query: 154 LPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLE 213
+ E N + S + ++ + ++ +K L LSGN L+ +L + LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 214 TIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGK 273
+ L N + +L+ LR LDL + L + T++ NN + +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 274 IPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKL-GELTKL 332
+ G + L++N+I+ + +Q L+L N++ + +L L
Sbjct: 114 VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 333 EVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSG 392
E L L N + + ++ + L+ LD SSN L+ + + +T + L NN
Sbjct: 172 EHLNLQYNFIY-DVKGQVVFAK-LKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 393 TFPVSLSTCKSLVRVRVQNNLIS-GTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTS 451
+L ++L ++ N GT+ +Q + A + + T
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV--AKQTVKKLTGQNEEECTV 285
Query: 452 LSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQA----KIPNELQACPSLSVLDLSS 507
+ E + +L+ + + Q ++ E + +D
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 508 NSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTL--AILDMSNNSLFGRIPEN 565
I + ++L + ++ L + E
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405
Query: 566 FGASPALEMLNLSYNKLEGPVPSN 589
L + Y ++ S
Sbjct: 406 QSPLQLLRAIVKRYEEMYVEQQSV 429
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-40
Identities = 63/453 (13%), Positives = 146/453 (32%), Gaps = 30/453 (6%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
+ +++ SL +++ + ++ L++ N + LA T L+ +++S +N +
Sbjct: 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS-SNVLY 71
Query: 129 SFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKL 188
L S L +++ ++N +L S+E+L + + + + +
Sbjct: 72 ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKKNI 125
Query: 189 KFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEG-EIPAEFGNLTNLRYLDLAVGSLS 247
L+ N +T + G S ++ + L N + + L +L+L +
Sbjct: 126 Y---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 248 GQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKN 307
+ + KL T+ L N + PE S + ++ L +N++ I L +N
Sbjct: 183 -DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238
Query: 308 LQLLNLMCNQL-TGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLL 366
L+ +L N G + D + +++ + L + + + L
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYC 295
Query: 367 SGEIPTGLCDSGNLTKLILFNNSF-------SGTFPVSLSTCKSLVRVRVQNNLISGTIP 419
++P D L L ++ + + I
Sbjct: 296 CEDLPAPFAD--RLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVID 353
Query: 420 VGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTF 479
+ LE L Q+ + L L + LQ
Sbjct: 354 QVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIE-LQHATEEQSPLQLL 412
Query: 480 MASHNNLQAK-IPNELQACPSLSVLDLSSNSLS 511
A + + + ++ D+ + +
Sbjct: 413 RAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-40
Identities = 64/460 (13%), Positives = 141/460 (30%), Gaps = 24/460 (5%)
Query: 81 SVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGL 140
++ E + + + +L + +K +D+S N L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 141 TSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTG 200
+N SSN DL + ++L +LD ++ ++ L + NN++
Sbjct: 61 ELLNLSSNVLYET--LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 201 KIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPAL-GRLKK 259
++ GQ + I L N + G + ++YLDL + + L
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 260 LTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLT 319
L + L N + ++ L LDLS N+++ + + + ++L N+L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 320 GLIPDKLGELTKLEVLELWKNSL-IGSLPMRLGQSSPLRRLDASSN-LLSGEIPTGLCDS 377
I L LE +L N G+L ++ ++ + + L+G+
Sbjct: 228 L-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 378 GNLTKLILFNNSFSGTFPVSLS--TCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMAN 435
F L K + Q + + N + ++
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQARQREIDALK 345
Query: 436 NNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQ--AKIPNE 493
I + ++ L+ + + + L + E
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405
Query: 494 LQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNR 533
L + + E + + ++ ++
Sbjct: 406 QSPLQLLRAIVKRYEEMYVEQQSVQN--NAIRDWDMYQHK 443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 9e-48
Identities = 72/319 (22%), Positives = 120/319 (37%), Gaps = 60/319 (18%)
Query: 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-REVSLLGR 753
I + IG G G V++ ++ VAVK + E E+
Sbjct: 39 TIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIF----SSREERSWFREAEIYQTVM 92
Query: 754 LRHRNIVRLLG----YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVG 809
LRH NI+ + T + +V DY + SL + L+ V +A+
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALS 147
Query: 810 IAQGLNYLHHD-----CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMV 864
A GL +LH + +P + HRD+KS NIL+ N IAD GLA +T+ +
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 865 ----AGSYGYIAPE------YGYTLKVDEKSDIYSFGVVLLELLTGKM------------ 902
G+ Y+APE + +++DIY+ G+V E+
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267
Query: 903 ----PLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCT 958
P DP+ ++ + V ++ L P+I + E + ++ +I C
Sbjct: 268 YDLVPSDPSVE---EMRKVVC---------EQKLRPNIPNRW-QSCEALRVMAKIMRECW 314
Query: 959 AKLPKGRPTMRDVITMLGE 977
R T + L +
Sbjct: 315 YANGAARLTALRIKKTLSQ 333
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 9e-43
Identities = 54/337 (16%), Positives = 117/337 (34%), Gaps = 23/337 (6%)
Query: 177 SVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNL 236
++ +N + K ++ ++L + +++ + L N A+ T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 237 RYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISG 296
L+L+ L L L L T+ L N EL S+ L ++N IS
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 297 EIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIG-SLPMRLGQSSP 355
+ + + + L N++T L G ++++ L+L N + + S
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 356 LRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLIS 415
L L+ N + ++ + + L L L +N + + + + ++NN +
Sbjct: 171 LEHLNLQYNFIY-DVKGQVVFA-KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 416 GTIPVGLGNLPSLQRLEMANNNLT-GQIPDDISLSTSLSFVDISWNHLESYLPSSILSIP 474
I L +L+ ++ N G + D S + + V + ++P
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 475 SLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLS 511
+L + + A ++ L +
Sbjct: 287 TLG----HYGAYCCEDLPAPFA---DRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-38
Identities = 69/341 (20%), Positives = 124/341 (36%), Gaps = 44/341 (12%)
Query: 274 IPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLE 333
I + ++D+ + + N++ L+L N L+ + L TKLE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 334 VLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGT 393
+L L N L +L L S LR LD ++N + E+ G ++ L NN+ S
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVG----PSIETLHAANNNISR- 113
Query: 394 FPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTG-QIPDDISLSTSL 452
VS S + + + NN I+ + G +Q L++ N + + + S +L
Sbjct: 114 --VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 453 SFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSG 512
+++ +N + + ++ L LDLSSN L+
Sbjct: 172 EHLNLQYNFIYD-------------------------VKGQVV-FAKLKTLDLSSNKLA- 204
Query: 513 EIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSL-FGRIPENFGASPA 571
+ S + ++LRNN+ I KA+ L D+ N G + + F +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 572 LEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSVLP 612
++ + K + L C LP
Sbjct: 264 VQTVAKQTVKKL----TGQNEEECTVPTLGHYGAYCCEDLP 300
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 49/310 (15%), Positives = 115/310 (37%), Gaps = 19/310 (6%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
+ +++ SL +++ + ++ L++ N + LA T L+ +++S N +
Sbjct: 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV-LY 71
Query: 129 SFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKL 188
L S L +++ ++N +L S+E+L + + + + +
Sbjct: 72 ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKKNI 125
Query: 189 KFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEG-EIPAEFGNLTNLRYLDLAVGSLS 247
L+ N +T + G S ++ + L N + + L +L+L +
Sbjct: 126 Y---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 248 GQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKN 307
+ + KL T+ L N + PE S + ++ L +N++ I L +N
Sbjct: 183 -DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238
Query: 308 LQLLNLMCNQLTGL-IPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLL 366
L+ +L N + D + +++ + L + + + L
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYC 295
Query: 367 SGEIPTGLCD 376
++P D
Sbjct: 296 CEDLPAPFAD 305
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 52/305 (17%), Positives = 105/305 (34%), Gaps = 16/305 (5%)
Query: 81 SVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGL 140
++ E + + + +L + +K +D+S N L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 141 TSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTG 200
+N SSN DL + ++L +LD ++ ++ L + NN++
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 201 KIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSG-QIPPALGRLKK 259
++ GQ + I L N + G + ++YLDL + +
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 260 LTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLT 319
L + L N + ++ L LDLS N+++ + + + ++L N+L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 320 GLIPDKLGELTKLEVLELWKNSL-IGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSG 378
I L LE +L N G+L ++ ++ + + C
Sbjct: 228 L-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 379 NLTKL 383
L
Sbjct: 287 TLGHY 291
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-43
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
K IG G VYK + VA +L E +L L+H NIV
Sbjct: 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 761 RLLGY----LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNY 816
R + + +++V + M + +L L K + + + + I +GL +
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSW--CRQILKGLQF 144
Query: 817 LHHDCQPPVIHRDIKSNNILLDANL-EARIADFGLARMMLHKNETVSMVAGSYGYIAPEY 875
LH PP+IHRD+K +NI + +I D GLA + + +++ G+ ++APE
Sbjct: 145 LH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVI-GTPEFMAPEM 201
Query: 876 GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y K DE D+Y+FG+ +LE+ T + P
Sbjct: 202 -YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-41
Identities = 80/386 (20%), Positives = 144/386 (37%), Gaps = 27/386 (6%)
Query: 226 IPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSL 284
I + + + + + L V + K+P L S +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 285 AFLDLSDNQISGEIPVK-LAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLI 343
L+L+D QI EI A +Q L + N + L P + L VL L +N +
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND-L 129
Query: 344 GSLPMRLGQSSP-LRRLDASSNLLSGEIPTG-LCDSGNLTKLILFNNSFSGTFPVSLSTC 401
SLP + ++P L L S+N L I + +L L L +N + V LS
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLI 185
Query: 402 KSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNH 461
SL V NL+S L +++ L+ ++N++ + ++ L+ + + N+
Sbjct: 186 PSLFHANVSYNLLST-----LAIPIAVEELDASHNSIN-VVRGP--VNVELTILKLQHNN 237
Query: 462 LESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASC 521
L + +L+ P L S+N L+ + + L L +S+N L +
Sbjct: 238 LTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294
Query: 522 EKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNK 581
L L+L +N + + L L + +NS+ + L+ L LS+N
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHND 350
Query: 582 LEGPVPSNGILMNINPNELIGNAGLC 607
+ + N+ + C
Sbjct: 351 WD-CNSLRALFRNVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-40
Identities = 69/368 (18%), Positives = 140/368 (38%), Gaps = 26/368 (7%)
Query: 124 NNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFR 183
+ L V+ + + + + + F+ S
Sbjct: 7 QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLD 66
Query: 184 NLQKLKFLGLSGNNLTGKIPPE-LGQLSSLETIILGYNAFEGEIPAE-FGNLTNLRYLDL 241
+ ++++ L L+ + +I +++ + +G+NA +P F N+ L L L
Sbjct: 67 SFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 124
Query: 242 AVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQISGEIP 299
LS +P KLTT+ + NN +I + + TSL L LS N+++ +
Sbjct: 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD 181
Query: 300 VKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRL 359
L+ + +L N+ N L+ L +E L+ NS I + + L L
Sbjct: 182 --LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS-INVVRGPVNVE--LTIL 231
Query: 360 DASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIP 419
N L+ + L + L ++ L N + L R+ + NN + +
Sbjct: 232 KLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALN 288
Query: 420 VGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTF 479
+ +P+L+ L++++N+L + + L + + N + + L S +L+
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LKLSTH--HTLKNL 344
Query: 480 MASHNNLQ 487
SHN+
Sbjct: 345 TLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-37
Identities = 62/364 (17%), Positives = 124/364 (34%), Gaps = 26/364 (7%)
Query: 104 SSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATS 163
+ +L + + F + V ++ L +
Sbjct: 11 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 164 LESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQ-LSSLETIILGYNAF 222
+E L+ E +F ++ L + N + +PP + Q + L ++L N
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 223 EGEIPAE-FGNLTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPELGS 280
+P F N L L ++ +L +I L + L N T +
Sbjct: 130 S-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDL--SL 184
Query: 281 ITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKN 340
I SL ++S N +S LA ++ L+ N + + + +L +L+L N
Sbjct: 185 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHN 236
Query: 341 SLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNNSFSGTFPVSLS 399
+L L L +D S N L +I L +L + NN +
Sbjct: 237 NLT-DTAWLLNYPG-LVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQ 292
Query: 400 TCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISW 459
+L + + +N + + L+ L + +N++ + +S +L + +S
Sbjct: 293 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSH 348
Query: 460 NHLE 463
N +
Sbjct: 349 NDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 62/370 (16%), Positives = 125/370 (33%), Gaps = 24/370 (6%)
Query: 71 LDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSF 130
+ + + + L + + + L + ++ ++++ + I
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN-DLQIEEI 84
Query: 131 PTG-LGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLK 189
T A + + N P N L L + F N KL
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 144
Query: 190 FLGLSGNNLTGKIPPELGQ-LSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSG 248
L +S NNL +I + Q +SL+ + L N + + +L + +++ LS
Sbjct: 145 TLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS- 199
Query: 249 QIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNL 308
L + + N+ + L L L N ++ + L L
Sbjct: 200 ----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTAW-LLNYPGL 250
Query: 309 QLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSG 368
++L N+L ++ ++ +LE L + N + +L + L+ LD S N L
Sbjct: 251 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHLL- 308
Query: 369 EIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSL 428
+ L L L +NS + LST +L + + +N L ++
Sbjct: 309 HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNV 363
Query: 429 QRLEMANNNL 438
R + + +
Sbjct: 364 ARPAVDDADQ 373
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-30
Identities = 64/325 (19%), Positives = 119/325 (36%), Gaps = 46/325 (14%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
E L+L+++ + + ++ L + N P N+ L + + N +
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE-RNDLS 130
Query: 129 SFPTGL-GKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK 187
S P G+ LT+++ S+NN LE ++ +F+
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNN--------------LERIE----------DDTFQATTS 166
Query: 188 LKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLS 247
L+ L LS N LT + + SL + YN + LD + S++
Sbjct: 167 LQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN 218
Query: 248 GQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVK-LAELK 306
+ + +LT + L NN T L + L +DLS N++ +I +++
Sbjct: 219 -VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQ 272
Query: 307 NLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLL 366
L+ L + N+L + + L+VL+L N + + Q L L N +
Sbjct: 273 RLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHN-HLLHVERNQPQFDRLENLYLDHNSI 330
Query: 367 SGEIPTGLCDSGNLTKLILFNNSFS 391
+ L L L +N +
Sbjct: 331 V-TLKLSTHH--TLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 38/200 (19%), Positives = 72/200 (36%), Gaps = 9/200 (4%)
Query: 387 NNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDI 446
+L V + L + + + N+ + ++P +
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL 64
Query: 447 -SLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDL 505
+ ++++ +E + ++Q N ++ P+ Q P L+VL L
Sbjct: 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124
Query: 506 SSNSLSGEIPASI-ASCEKLVSLNLRNNRFSGEIPKAV-ATMPTLAILDMSNNSLFGRIP 563
N LS +P I + KL +L++ NN I +L L +S+N L +
Sbjct: 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVD 181
Query: 564 ENFGASPALEMLNLSYNKLE 583
P+L N+SYN L
Sbjct: 182 --LSLIPSLFHANVSYNLLS 199
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 2e-40
Identities = 76/326 (23%), Positives = 126/326 (38%), Gaps = 47/326 (14%)
Query: 233 LTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDN 292
L++ L+ +P L +TT+ + NN T +P + +L ++S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 293 QISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQ 352
Q++ +PV L L + + L L + L L ++ N L SLP+
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPPG 142
Query: 353 SSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNN 412
L+ L S N L+ +P L KL +NN + + P+ S L + V +N
Sbjct: 143 ---LQELSVSDNQLA-SLPALP---SELCKLWAYNNQLT-SLPMLPS---GLQELSVSDN 191
Query: 413 LISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILS 472
++ ++P L +L NN LT +P + L + +S N L S LP
Sbjct: 192 QLA-SLPTLPSEL---YKLWAYNNRLT-SLPALP---SGLKELIVSGNRLTS-LPVLP-- 240
Query: 473 IPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNN 532
L+ M S N L + +P L L + N L+ +P S+ ++NL N
Sbjct: 241 -SELKELMVSGNRLTS-LPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 533 RFSGEIPKAVATMPTLAILDMSNNSL 558
S E T + +
Sbjct: 295 PLS-ERTLQALREITS--APGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-38
Identities = 69/352 (19%), Positives = 131/352 (37%), Gaps = 48/352 (13%)
Query: 256 RLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMC 315
+ + ++ T +P L + L + DN ++ +P A L+ L +
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLP---ALPPELRTLEVSG 90
Query: 316 NQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLC 375
NQLT L P L +L + L S L +L N L+ +P
Sbjct: 91 NQLTSL-PVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLPVLP- 140
Query: 376 DSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMAN 435
L +L + +N + + P S L NN ++ ++P+ L Q L +++
Sbjct: 141 --PGLQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPSGL---QELSVSD 190
Query: 436 NNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQ 495
N L +P S L + N L S LP+ L+ + S N L + +P
Sbjct: 191 NQLA-SLPTLPS---ELYKLWAYNNRLTS-LPALP---SGLKELIVSGNRLTS-LPVLPS 241
Query: 496 ACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSN 555
L L +S N L+ +P + L+SL++ N+ + +P+++ + + +++
Sbjct: 242 ---ELKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293
Query: 556 NSLFGRIPENFGASPALEMLNLSYNKLEGPVPS----NGILMNINPNELIGN 603
N L R + + + + + S L + L+
Sbjct: 294 NPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPA 345
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-38
Identities = 76/345 (22%), Positives = 125/345 (36%), Gaps = 44/345 (12%)
Query: 185 LQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVG 244
L + + LT +P L + T+++ N +PA L L +++
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 245 SLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAE 304
L+ +P L +L+ + + L L + NQ++ +P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQLT-SLP---VL 139
Query: 305 LKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSN 364
LQ L++ NQL L P EL KL N+ + SLPM L+ L S N
Sbjct: 140 PPGLQELSVSDNQLASL-PALPSELCKLWAY----NNQLTSLPMLPSG---LQELSVSDN 191
Query: 365 LLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGN 424
L+ +PT L KL +NN + + P S K L V N ++ ++PV
Sbjct: 192 QLA-SLPTLP---SELYKLWAYNNRLT-SLPALPSGLKEL---IVSGNRLT-SLPVLPSE 242
Query: 425 LPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHN 484
L + L ++ N LT +P + L + + N L LP S++ + S T N
Sbjct: 243 L---KELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGN 294
Query: 485 NLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNL 529
L + L+ S ++ L
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-37
Identities = 79/371 (21%), Positives = 141/371 (38%), Gaps = 46/371 (12%)
Query: 162 TSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNA 221
L+ S ++P + L + NNLT +P +L +LE + N
Sbjct: 40 NGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQ 92
Query: 222 FEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSI 281
+P L L + L +P L +L +++ N T +P +
Sbjct: 93 LT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKL------WIFGNQLT-SLPVLPPGL 143
Query: 282 TSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNS 341
L +SDNQ++ +P +EL L N NQLT L P + L+ L + N
Sbjct: 144 QEL---SVSDNQLA-SLPALPSELCKLWAYN---NQLTSL-PM---LPSGLQELSVSDNQ 192
Query: 342 LIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTC 401
L SLP + L +L A +N L+ +P L +LI+ N + + PV S
Sbjct: 193 LA-SLPTLPSE---LYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLT-SLPVLPS-- 241
Query: 402 KSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNH 461
L + V N ++ ++P+ L L + N LT ++P+ + +S + V++ N
Sbjct: 242 -ELKELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295
Query: 462 LESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASC 521
L ++ I S + + + +L +++ L A
Sbjct: 296 LSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH--LAAADWLVPAREGEPAPA 353
Query: 522 EKLVSLNLRNN 532
++ +N
Sbjct: 354 DRWHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-37
Identities = 80/408 (19%), Positives = 134/408 (32%), Gaps = 75/408 (18%)
Query: 111 ANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFR 170
++V + + + P L +T++ NN + LP L +L+
Sbjct: 37 CLNNGNAVLNVG-ESGLTTLPDCLPAH--ITTLVIPDNNLT-SLPALPPE---LRTLEVS 89
Query: 171 GSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEF 230
G+ S+P L +L +L P L S L + + N +P
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHL-----PAL--PSGLCKLWIFGNQLT-SLPVLP 140
Query: 231 GNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLS 290
L L D + SL P L KL + Y N T +P + L +S
Sbjct: 141 PGLQELSVSDNQLASL----PALPSELCKL---WAYNNQLT-SLPMLPSGLQE---LSVS 189
Query: 291 DNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRL 350
DNQ++ +P +EL L N N+LT L P + L+ L + N L SLP+
Sbjct: 190 DNQLA-SLPTLPSELYKLWAYN---NRLTSL-PA---LPSGLKELIVSGNRL-TSLPVLP 240
Query: 351 GQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQ 410
+ L+ L S N L+ +P L L ++ N +
Sbjct: 241 SE---LKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT------------------- 274
Query: 411 NNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVD---ISWNHLESYLP 467
+P L +L S + + N L+ + + TS I ++ + P
Sbjct: 275 ------RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAP 328
Query: 468 SSILSIPSLQTFMASHN----NLQAKIPNELQACPSLSVLDLSSNSLS 511
++ A + + L + LS
Sbjct: 329 RETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-34
Identities = 62/346 (17%), Positives = 109/346 (31%), Gaps = 43/346 (12%)
Query: 68 VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
+ L + + +L S+ LR+L + N+ +SLP L L + +
Sbjct: 63 ITTLVIPDNNLT-SLPALPPELRTL---EVSGNQL-TSLPVLPPGLLELSIFSNPLTH-L 116
Query: 128 GSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK 187
+ P+ GL + N + LP L+ L + S+P L K
Sbjct: 117 PALPS------GLCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLA-SLPALPSELCK 165
Query: 188 LKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLS 247
L N LT +P L L + N +P L L + L+
Sbjct: 166 LW---AYNNQLT-SLPMLPSGLQELS---VSDNQLA-SLPTLPSELYKLWAYNN---RLT 214
Query: 248 GQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKN 307
+P LK+L + N T +P + L +S N+++ +P
Sbjct: 215 -SLPALPSGLKEL---IVSGNRLTS-LPVLPSELKE---LMVSGNRLT-SLP---MLPSG 262
Query: 308 LQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLS 367
L L++ NQLT L P+ L L+ + L N L ++ + + +
Sbjct: 263 LLSLSVYRNQLTRL-PESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRF 320
Query: 368 GEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNL 413
L + + ++N
Sbjct: 321 DMAGASAPRETRALHLAA-ADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-38
Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 63/283 (22%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-----REVSLLGRLRHRNIV 760
+G GG VY AE ++ VA+K + + REV +L H+NIV
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAI-FIP---PREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
++ + +V +Y+ +L E + G L VD I G+ + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAIN--FTNQILDGIKHAH-- 128
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET-VSMVAGSYGYIAPEYGYTL 879
++HRDIK NIL+D+N +I DFG+A+ + + T + V G+ Y +PE
Sbjct: 129 -DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 880 KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939
DE +DIYS G+VL E+L G+ P F G + A+ SIA
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP----FNG------------------ETAV--SIA-- 221
Query: 940 CKHVQEEM----------------LLVLRIAVLCTAKLPKGRP 966
KH+Q+ + ++LR T K R
Sbjct: 222 IKHIQDSVPNVTTDVRKDIPQSLSNVILR----ATEKDKANRY 260
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 9e-38
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRS---DNDIESGDDLFREVSLLGRLRHRNIVRL 762
+G G VY+AE + VA+K + + + + EV + +L+H +I+ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMV--QRVQNEVKIHCQLKHPSILEL 76
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
Y + V +V + N + L K K + +R+ + I G+ YLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMH-QIITGMLYLHSHG- 132
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----YGYT 878
++HRD+ +N+LL N+ +IADFGLA + +E + G+ YI+PE +
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH- 189
Query: 879 LKVDEKSDIYSFGVVLLELLTGKMPLD 905
+SD++S G + LL G+ P D
Sbjct: 190 ---GLESDVWSLGCMFYTLLIGRPPFD 213
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-37
Identities = 78/477 (16%), Positives = 163/477 (34%), Gaps = 40/477 (8%)
Query: 127 IGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQ 186
+ L V+ + + + + + F+ S + +
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75
Query: 187 KLKFLGLSGNNLTGKIPPE-LGQLSSLETIILGYNAFEGEIPAE-FGNLTNLRYLDLAVG 244
+++ L L+ + +I +++ + +G+NA +P F N+ L L L
Sbjct: 76 QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN 133
Query: 245 SLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQISGEIPVKL 302
LS +P KLTT+ + NN +I + + TSL L LS N+++ + + L
Sbjct: 134 DLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 190
Query: 303 AELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDAS 362
+ +L N+ N L+ L +E L+ NS I + + L L
Sbjct: 191 --IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS-INVVRGPVNVE--LTILKLQ 240
Query: 363 SNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGL 422
N L+ + L + L ++ L N + L R+ + NN + + +
Sbjct: 241 HNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYG 297
Query: 423 GNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMAS 482
+P+L+ L++++N+L + + L + + N + + L S +L+ S
Sbjct: 298 QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LKLSTH--HTLKNLTLS 353
Query: 483 HNNLQ----AKIPNELQACPSLSVLDLSSNSLSGEIPASIASC-------EKLVSLNLRN 531
HN+ + + +V D + C + +
Sbjct: 354 HNDWDCNSLRALFRNVA---RPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIAL 410
Query: 532 NRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPS 588
++ +A ++ + + E L N+L V
Sbjct: 411 TSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQ 467
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-36
Identities = 71/472 (15%), Positives = 151/472 (31%), Gaps = 34/472 (7%)
Query: 104 SSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATS 163
+ +L + + F + V ++ L +
Sbjct: 17 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76
Query: 164 LESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQ-LSSLETIILGYNAF 222
+E L+ E +F ++ L + N + +PP + Q + L ++L N
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 223 EGEIPAE-FGNLTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPELGS 280
+P F N L L ++ +L +I L + L N T +
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDL--SL 190
Query: 281 ITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKN 340
I SL ++S N +S LA ++ L+ N + + +L +L+L N
Sbjct: 191 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHN 242
Query: 341 SLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNNSFSGTFPVSLS 399
+L L L +D S N L +I L +L + NN +
Sbjct: 243 NLT-DTAWLLNYPG-LVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQ 298
Query: 400 TCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISW 459
+L + + +N + + L+ L + +N++ + +S +L + +S
Sbjct: 299 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSH 354
Query: 460 NHLE-SYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLS-------VLDLSSNSLS 511
N + + L + ++ A + C + ++ S+
Sbjct: 355 NDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVV 414
Query: 512 GEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIP 563
++ + C ++N + + + L+ N L +
Sbjct: 415 EKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ 466
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 5e-34
Identities = 71/493 (14%), Positives = 155/493 (31%), Gaps = 31/493 (6%)
Query: 71 LDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSF 130
+ + + + L + + + L + ++ ++++ + I
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN-DLQIEEI 90
Query: 131 PTG-LGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLK 189
T A + + N P N L L + F N KL
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150
Query: 190 FLGLSGNNLTGKIPPELGQ-LSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSG 248
L +S NNL +I + Q +SL+ + L N + + +L + +++ LS
Sbjct: 151 TLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS- 205
Query: 249 QIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNL 308
L + + N+ + L L L N ++ + L L
Sbjct: 206 ----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTAW-LLNYPGL 256
Query: 309 QLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSG 368
++L N+L ++ ++ +LE L + N + +L + L+ LD S N L
Sbjct: 257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHLL- 314
Query: 369 EIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSL 428
+ L L L +NS + LST +L + + +N L ++
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNV 369
Query: 429 QRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQA 488
R + + + +I + + + +L +L + + Q
Sbjct: 370 ARPAVDDADQHCKIDYQLEHG-------LCCKESDKPYLDRLLQYIALTSVVEKVQRAQG 422
Query: 489 KIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTL 548
+ S+ + + + ++ L + + E + + L
Sbjct: 423 RCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGL 482
Query: 549 AILDMSNNSLFGR 561
+N +
Sbjct: 483 HAEIDTNLRRYRL 495
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 87/523 (16%), Positives = 167/523 (31%), Gaps = 31/523 (5%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
E L+L+++ + + ++ L + N P N+ L + + N +
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE-RNDLS 136
Query: 129 SFPTGL-GKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK 187
S P G+ LT+++ S+NN + TSL++L + V +
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPS 193
Query: 188 LKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLS 247
L +S N L+ L ++E + +N+ + L L L +L+
Sbjct: 194 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT 245
Query: 248 GQIPPALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQISGEIPVKLAELK 306
L L V L N KI + L L +S+N++ + + +
Sbjct: 246 D--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 301
Query: 307 NLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLL 366
L++L+L N L + + +LE L L NS I +L L L+ L S N
Sbjct: 302 TLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNS-IVTLK--LSTHHTLKNLTLSHNDW 357
Query: 367 SGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLS---TCKSLVRVRVQNNLISGTIPVGLG 423
L N+ + + + L CK + + L + +
Sbjct: 358 DCNSLRALFR--NVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVE 415
Query: 424 NLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASH 483
+ Q A + + ++ LE+ + + L
Sbjct: 416 KVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQ 475
Query: 484 NNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFS-GEIPKAV 542
L + E+ +L L + L+ L R + +A
Sbjct: 476 EQLLQGLHAEI--DTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEAD 533
Query: 543 ATMPTLAILDMSNNSLFGRIPENFGAS-PALEMLNLSYNKLEG 584
A L+ N +L ++ + +L K++
Sbjct: 534 AKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQ 576
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 82/516 (15%), Positives = 167/516 (32%), Gaps = 49/516 (9%)
Query: 69 EKLDLSNMSLNGSVSENI-RGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
+KL + ++ + ++ + + L+ L + N+ +S N L ++ +S NN +
Sbjct: 102 QKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS-NNNL 159
Query: 128 GSFPTGLGKA-SGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQ 186
+A + L ++ SSN + DL SL + + ++
Sbjct: 160 ERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL-----STLAIPI 211
Query: 187 KLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSL 246
++ L S N++ + + L + L +N + N L +DL+ L
Sbjct: 212 AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNEL 266
Query: 247 SGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAEL 305
+I ++++L +Y+ N + I +L LDLS N + + +
Sbjct: 267 E-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF 323
Query: 306 KNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLD----- 360
L+ L L N + L KL L+ L L N + L ++ +D
Sbjct: 324 DRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380
Query: 361 -ASSNLLSGEIPTGLCDSGNLTKLILFNN--SFSGTFPVSLSTCKSLVRVRVQNNLISGT 417
L + D L +L+ + S + C + + +L
Sbjct: 381 CKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYI 440
Query: 418 IPVGLGNLPSLQRLEMANNNLTGQIPD---------------DISLSTSLSFVDISWNHL 462
G L ++LE N L ++ + T+L + + L
Sbjct: 441 TQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGL 500
Query: 463 ESYLPSSILSIPSLQTFMASHNNLQAKIPNELQA-CPSLSVLDLSSNSLSGEIPASIAS- 520
+ L+ A E A L+ + +L ++ A
Sbjct: 501 ARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQ 560
Query: 521 CEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNN 556
E +L+ + K T + ++
Sbjct: 561 AELRQETSLKRQKVKQLEAKKNRNPDTRRVSHHHHH 596
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G GG ++ V A K + +S + + E+S+ L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+ + V +V + SL E K L Y I G YLH +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYY--LRQIVLGCQYLHRNR--- 161
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY----GYTLK 880
VIHRD+K N+ L+ +LE +I DFGLA + + E ++ G+ YIAPE G+
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH--- 218
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLD 905
+ D++S G ++ LL GK P +
Sbjct: 219 -SFEVDVWSIGCIMYTLLVGKPPFE 242
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-37
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G GG ++ V A K + +S + + E+S+ L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+ + V +V + SL E K L Y I G YLH +
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYY--LRQIVLGCQYLHRNR--- 135
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----YGYTLK 880
VIHRD+K N+ L+ +LE +I DFGLA + + E ++ G+ YIAPE G+
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH--- 192
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLD 905
+ D++S G ++ LL GK P +
Sbjct: 193 -SFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-37
Identities = 73/430 (16%), Positives = 146/430 (33%), Gaps = 46/430 (10%)
Query: 179 PTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRY 238
S L L L +++T + +L+ L +I N + TNL Y
Sbjct: 35 TISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTY 89
Query: 239 LDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEI 298
L L+ + + L KLT + N T K+ + L +L+ + N ++
Sbjct: 90 LACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT--- 140
Query: 299 PVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRR 358
+ ++ L L+ N+ + + T+L L+ N + L + Q+ L R
Sbjct: 141 EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNR 195
Query: 359 LDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTI 418
L+ +N ++ ++ L + LT L +N + + ++ L N ++ +
Sbjct: 196 LNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT-EL 248
Query: 419 PVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQT 478
V L L L +L +I L+ + + + L
Sbjct: 249 DV--STLSKLTTLHCIQTDLL-----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYL 301
Query: 479 FMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEI 538
+ ++ L P L L L++ L+ E+ ++ KL SL+ N +
Sbjct: 302 LDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DF 354
Query: 539 PKAVATMPTLAILDMSNNSLFGRIPENFGASP-----ALEMLNLSYNKLEGPVPSNGILM 593
+V +P L + E + + ++L+ N + G+
Sbjct: 355 S-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYD 413
Query: 594 NINPNELIGN 603
N
Sbjct: 414 QATNTITWEN 423
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 87/408 (21%), Positives = 144/408 (35%), Gaps = 46/408 (11%)
Query: 109 SLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLD 168
S L L S+D ++ I G+ K +GLT + +SNN + DL T+L L
Sbjct: 37 SEEQLATLTSLDCHNSS-ITDMT-GIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLA 91
Query: 169 FRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPA 228
+ L KL +L N LT K+ + Q L + N EI
Sbjct: 92 CDSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID- 143
Query: 229 EFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLD 288
+ T L LD + + +LTT+ N T ++ L L+
Sbjct: 144 -VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLN 197
Query: 289 LSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPM 348
N I+ ++ L + L L+ N+LT + + LT+L + N L L
Sbjct: 198 CDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-ELD- 249
Query: 349 RLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVR 408
+ S L L L + + N + + ++ L +
Sbjct: 250 -VSTLSKLTTLHCIQTDL-----LEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLD 303
Query: 409 VQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPS 468
Q I+ + L P L L + N LT ++ D+S +T L + H++ + S
Sbjct: 304 CQAAGIT-ELD--LSQNPKLVYLYLNNTELT-EL--DVSHNTKLKSLSCVNAHIQDF--S 355
Query: 469 SILSIPSLQTFMASHNNLQAKIPNELQA-----CPSLSVLDLSSNSLS 511
S+ IP+L + L S +LD N ++
Sbjct: 356 SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN 403
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-29
Identities = 73/422 (17%), Positives = 139/422 (32%), Gaps = 56/422 (13%)
Query: 68 VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
+ LD N S+ + I L L+ L N ++L L+ T L + +N +
Sbjct: 44 LTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACD-SNKL 97
Query: 128 GSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK 187
+ + + LT +N +N + D+ L L+ + + S + +
Sbjct: 98 TNLD--VTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLT-EIDVS--HNTQ 149
Query: 188 LKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLS 247
L L N ++ + L T+ +N E+ L L+ +++
Sbjct: 150 LTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT 204
Query: 248 GQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKN 307
++ L + +LT + N T +I + +T L + D S N ++ L++L
Sbjct: 205 -KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTT 258
Query: 308 L----------------QLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLG 351
L QL+ + + T+L +L+ + L L
Sbjct: 259 LHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LS 315
Query: 352 QSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQN 411
Q+ L L ++ L+ E+ L L N F S+ +L
Sbjct: 316 QNPKLVYLYLNNTELT-ELDVSHNT--KLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAE 370
Query: 412 NLISGTIPVGLGNLP-----SLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYL 466
L N S L+ N + I + I+W +L +
Sbjct: 371 GQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDN 428
Query: 467 PS 468
P+
Sbjct: 429 PA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-29
Identities = 56/326 (17%), Positives = 109/326 (33%), Gaps = 33/326 (10%)
Query: 258 KKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQ 317
+ + +L LD ++ I+ ++ + +L L L N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75
Query: 318 LTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDS 377
+T L L + T L L N L +L + + L L+ +N L+ ++
Sbjct: 76 ITTL---DLSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT-KLDVSQNP- 127
Query: 378 GNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNN 437
LT L N+ + + +S L + N + + L L+ + N
Sbjct: 128 -LLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181
Query: 438 LTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQAC 497
+T D+S + L+ ++ N++ L + L S N L ++
Sbjct: 182 ITE---LDVSQNKLLNRLNCDTNNITK-LDLNQN--IQLTFLDCSSNKLTE---IDVTPL 232
Query: 498 PSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNS 557
L+ D S N L+ E+ S + KL +L+ EI + L
Sbjct: 233 TQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCR 286
Query: 558 LFGRIPENFGASPALEMLNLSYNKLE 583
+ + + L +L+ +
Sbjct: 287 KIKEL--DVTHNTQLYLLDCQAAGIT 310
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 55/240 (22%), Positives = 104/240 (43%), Gaps = 35/240 (14%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN--IVR 761
IG GG+ V++ + + A+K + + D ++ D E++ L +L+ + I+R
Sbjct: 34 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-HD 820
L Y + + MV + D L L K+ + Y + + ++ +H H
Sbjct: 93 LYDYEITDQYIYMVMECGNID-LNSWL--KKKKSIDPWERKSY--WKNMLEAVHTIHQHG 147
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA----GSYGYIAPE-- 874
++H D+K N L+ + ++ DFG+A M + +T S+V G+ Y+ PE
Sbjct: 148 ----IVHSDLKPANFLIV-DGMLKLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 875 ---------YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN 925
K+ KSD++S G +L + GK P F + + + ++I N
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPN 256
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 60/274 (21%), Positives = 113/274 (41%), Gaps = 31/274 (11%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G G + +K++ S + ++ REV++L ++H NIV+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
++ +V DY L + ++ ++ D + + V I L ++H
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW--FVQICLALKHVH---DRK 145
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----YGYTLK 880
++HRDIKS NI L + ++ DFG+AR++ E G+ Y++PE Y
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY--- 202
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQC 940
+ KSDI++ G VL EL T K AF + ++ I + +
Sbjct: 203 -NNKSDIWALGCVLYELCTLK----HAFEA-GSMKN-LVLKII--SGSFPPVSLHYSYDL 253
Query: 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974
+ + ++ + P+ RP++ ++
Sbjct: 254 RSLVSQLF----------KRNPRDRPSVNSILEK 277
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 60/286 (20%), Positives = 116/286 (40%), Gaps = 47/286 (16%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH--RNIVR 761
IG GG+ V++ + + A+K + + D ++ D E++ L +L+ I+R
Sbjct: 15 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-HD 820
L Y + + MV + N L L K+ + Y + + ++ +H H
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSY--WKNMLEAVHTIHQHG 128
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA----GSYGYIAPE-- 874
++H D+K N L+ + ++ DFG+A M + +T S+V G+ Y+ PE
Sbjct: 129 ----IVHSDLKPANFLIV-DGMLKLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 875 ---------YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN 925
K+ KSD++S G +L + GK P F + + + ++I N
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPN 237
Query: 926 KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
+ + V + L + PK R ++ ++
Sbjct: 238 HEIE--FPDIPEKDLQDVLKCCL----------KRDPKQRISIPEL 271
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 80/288 (27%), Positives = 121/288 (42%), Gaps = 68/288 (23%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-----REVSLLGRLRHRNIV 760
+G GG V+ A R H VAVK L R+D + D F RE L H IV
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVL-RAD---LARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 761 RLL--GYLHNETNVM--MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNY 816
+ G + +V +Y+ +L + +H G + + Q LN+
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIE--VIADACQALNF 131
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV---SMVAGSYGYIAP 873
H Q +IHRD+K NI++ A ++ DFG+AR + +V + V G+ Y++P
Sbjct: 132 SH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 874 EYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933
E VD +SD+YS G VL E+LTG+ P F G D +
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTG------------------DSPV- 225
Query: 934 PSIAGQCKHVQEEML---------------LVLRIAVLCTAKLPKGRP 966
S+A +HV+E+ + +VL+ AK P+ R
Sbjct: 226 -SVA--YQHVREDPIPPSARHEGLSADLDAVVLK----ALAKNPENRY 266
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 69/303 (22%), Positives = 106/303 (34%), Gaps = 68/303 (22%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-----REVSLLGRLRHRNIV 760
+G GG G VY+AE +VA+K + S D +F RE GRL+ ++V
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLM-SET---LSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
+ + + + + + L L + G L I I L+ H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVA--IVRQIGSALDAAHAA 153
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET-VSMVAGSYGYIAPEYGYTL 879
HRD+K NIL+ A+ A + DFG+A + T + G+ Y+APE
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 880 KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939
++DIY+ VL E LTG P + G S+ G
Sbjct: 211 HATYRADIYALTCVLYECLTGSPP----YQGD---------------------QLSVMGA 245
Query: 940 CKHVQEEM---------------LLVLRIAVLCTAKLPKGRPT-----MRDVITMLGEAK 979
H+ + + ++ R AK P+ R L A
Sbjct: 246 --HINQAIPRPSTVRPGIPVAFDAVIAR----GMAKNPEDRYVTCGDLSAAAHAALATAD 299
Query: 980 PRR 982
R
Sbjct: 300 QDR 302
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 65/276 (23%), Positives = 107/276 (38%), Gaps = 30/276 (10%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G G K ++ K+L L EV+LL L+H NIVR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 765 YLHNETN--VMMVYDYMPNDSLGEAL-HGKEAGKLL---VDWVSRYNIAVGIAQGLNYLH 818
+ + TN + +V +Y L + G + + L + + L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL----RVMTQLTLALKECH 128
Query: 819 --HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYG 876
D V+HRD+K N+ LD ++ DFGLAR++ H G+ Y++PE
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 877 YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936
+ +EKSDI+S G +L EL P F E + I+ + + +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALM----PPFTA-FSQKE-LAGKIR--EGKFRRIPYRY 240
Query: 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
+ + + ML RP++ +++
Sbjct: 241 SDELNEIITRML----------NLKDYHRPSVEEIL 266
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-36
Identities = 28/299 (9%), Positives = 72/299 (24%), Gaps = 49/299 (16%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+ +G +V+ A+K ++N + L RL +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 764 GYLH--------------------------NETNVMMVYDYMPND--SLGEALHGKEAGK 795
N +++ D L L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 796 LLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855
++ + + + + L ++H +N+ + + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 856 HKNETVSMVAGSYGYIAPEY--GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKD 913
+ Y E+ T + + G+ + + +P FG
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGLVTP 298
Query: 914 IVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEML-LVLRIAVLCTAKLPKGRPTMRDV 971
++ ++L C + + + L+ R + R +
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFG---SCTPLPDFVKTLIGR----FLNFDRRRRLLPLEA 350
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 61/289 (21%), Positives = 114/289 (39%), Gaps = 59/289 (20%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+IG GG G V+KA+ +K++ + + REV L +L H NIV
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNN-EKAEREVKALAKLDHVNIVHYN 70
Query: 764 GY----------------LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIA 807
G + + ++ +L + + + KL
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL--F 128
Query: 808 VGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS 867
I +G++Y+H +I+RD+K +NI L + +I DFGL + + + G+
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-GT 184
Query: 868 YGYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923
Y++PE Y ++ D+Y+ G++L ELL D AF SK + ++
Sbjct: 185 LRYMSPEQISSQDY----GKEVDLYALGLILAELLH---VCDTAFETSK-----FFTDLR 232
Query: 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
+ + K + +++L +K P+ RP +++
Sbjct: 233 DGI-----ISDIFDKKEKTLLQKLL----------SKKPEDRPNTSEIL 266
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 25/216 (11%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G GG V E A+K++ ++ + ++ RE + H NI+RL+ Y
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 766 LHNETN----VMMVYDYMPNDSLGEAL-HGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
E ++ + +L + K+ G L + + +GI +GL +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLGICRGLEAIH-- 151
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA---------GSYGYI 871
HRD+K NILL + + D G E + Y
Sbjct: 152 -AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 872 APE----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
APE + +DE++D++S G VL ++ G+ P
Sbjct: 211 APELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGP 245
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRS---DNDIESGDDLFREVSLLGRLRHRNIVRL 762
+G G G VY A + ++A+K L+++ +E L REV + LRH NI+RL
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQSHLRHPNILRL 74
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-HDC 821
GY H+ T V ++ +Y P ++ L ++ K + Y +A L+Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY--ITELANALSYCHSKR- 129
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----YGY 877
VIHRDIK N+LL + E +IADFG + + + + G+ Y+ PE +
Sbjct: 130 ---VIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 878 TLKVDEKSDIYSFGVVLLELLTGKMPLD 905
DEK D++S GV+ E L GK P +
Sbjct: 185 ----DEKVDLWSLGVLCYEFLVGKPPFE 208
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 78/329 (23%), Positives = 135/329 (41%), Gaps = 17/329 (5%)
Query: 261 TTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG 320
V ++ F +P + T LDL N+I + A +L+ L L N ++
Sbjct: 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA 70
Query: 321 LIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP-LRRLDASSNLLSGEIPTGL-CDSG 378
+ P L L L L N + +P+ + L +LD S N + + + D
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNR-LKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLY 128
Query: 379 NLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVG-LGNLPSLQRLEMANNN 437
NL L + +N + S SL ++ ++ ++ +IP L +L L L + + N
Sbjct: 129 NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLN 187
Query: 438 LTGQIPDDI-SLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNE-LQ 495
+ I D L ++IS + + L +L + +H NL A +P ++
Sbjct: 188 IN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVR 245
Query: 496 ACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMS 554
L L+LS N +S I S+ +L + L + + P A + L +L++S
Sbjct: 246 HLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304
Query: 555 NNSLFGRIPEN-FGASPALEMLNLSYNKL 582
N L + E+ F + LE L L N L
Sbjct: 305 GNQL-TTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-35
Identities = 60/314 (19%), Positives = 119/314 (37%), Gaps = 10/314 (3%)
Query: 249 QIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVK-LAELKN 307
+P + + + L KN E S L L+L++N +S + L N
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFN 81
Query: 308 LQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP-LRRLDASSNLL 366
L+ L L N+L + L+ L L++ +N I L + Q L+ L+ N L
Sbjct: 82 LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENK-IVILLDYMFQDLYNLKSLEVGDNDL 140
Query: 367 SGEIPTG-LCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNL 425
I +L +L L + + +LS L+ +R+++ I+ L
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199
Query: 426 PSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNN 485
L+ LE+++ + + +L+ + I+ +L + ++ + L+ S+N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP 259
Query: 486 LQAKIPNELQACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNRFSGEIPKAVAT 544
+ + L L + L L+ + L LN+ N+ + +
Sbjct: 260 ISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHS 318
Query: 545 MPTLAILDMSNNSL 558
+ L L + +N L
Sbjct: 319 VGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-35
Identities = 81/331 (24%), Positives = 127/331 (38%), Gaps = 22/331 (6%)
Query: 54 HCNWTG--VWCNSRGF----------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNE 101
C+ V C+ + F LDL + + L L + N
Sbjct: 8 ECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI 67
Query: 102 FASSLPKSLANLTALKSMDVSQNNFIGSFPTG-LGKASGLTSVNASSNNFSGFLPEDLGN 160
++ P + NL L+++ + +N + P G S LT ++ S N L +
Sbjct: 68 VSAVEPGAFNNLFNLRTLGLR-SNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126
Query: 161 ATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPE-LGQLSSLETIILGY 219
+L+SL+ + +F L L+ L L NLT IP E L L L + L +
Sbjct: 127 LYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRH 185
Query: 220 NAFEGEIPAE-FGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPE- 277
I F L L+ L+++ + P LT++ + N T +P
Sbjct: 186 LNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA 243
Query: 278 LGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLEL 337
+ + L FL+LS N IS L EL LQ + L+ QL + P L L VL +
Sbjct: 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV 303
Query: 338 WKNSLIGSLPMRLGQSSP-LRRLDASSNLLS 367
N + +L + S L L SN L+
Sbjct: 304 SGNQ-LTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-34
Identities = 69/378 (18%), Positives = 124/378 (32%), Gaps = 65/378 (17%)
Query: 141 TSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTG 200
+V F +PE + T LD + + F + L+ L L+ N ++
Sbjct: 14 RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS- 69
Query: 201 KIPPE-LGQLSSLETIILGYNAFEGEIPAE-FGNLTNLRYLDLAVGSLSGQIPP-ALGRL 257
+ P L +L T+ L N + IP F L+NL LD++ + + L
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDL 127
Query: 258 KKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQISGEIPVK-LAELKNLQLLNLMC 315
L ++ + N+ I + SL L L ++ IP + L+ L L +L L
Sbjct: 128 YNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRH 185
Query: 316 NQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLC 375
+ + L +L+VLE+ + ++ L L + L+ +P
Sbjct: 186 LNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAV 244
Query: 376 DS-GNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVG-LGNLPSLQRLEM 433
L L L N S L L +++ ++ + L L+ L +
Sbjct: 245 RHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNV 303
Query: 434 ANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNE 493
+ N LT ++ +
Sbjct: 304 SGNQLT--------------------------------TLE----------------ESV 315
Query: 494 LQACPSLSVLDLSSNSLS 511
+ +L L L SN L+
Sbjct: 316 FHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 46/234 (19%), Positives = 92/234 (39%), Gaps = 9/234 (3%)
Query: 353 SSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNN 412
S+ R + +P G+ L L N ++ L + + N
Sbjct: 10 SAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 413 LISGTIPVG-LGNLPSLQRLEMANNNLTGQIPDDI-SLSTSLSFVDISWNHLESYLPSSI 470
++S + G NL +L+ L + +N L IP + + ++L+ +DIS N + L
Sbjct: 67 IVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMF 124
Query: 471 LSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPA-SIASCEKLVSLNL 529
+ +L++ N+L SL L L +L+ IP +++ L+ L L
Sbjct: 125 QDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRL 183
Query: 530 RNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
R+ + + + L +L++S+ + N L L++++ L
Sbjct: 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT 237
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 3e-35
Identities = 60/286 (20%), Positives = 116/286 (40%), Gaps = 47/286 (16%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH--RNIVR 761
IG GG+ V++ + + A+K + + D ++ D E++ L +L+ I+R
Sbjct: 62 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-HD 820
L Y + + MV + N L L K+ + Y + + ++ +H H
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSY--WKNMLEAVHTIHQHG 175
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA----GSYGYIAPE-- 874
++H D+K N L+ + ++ DFG+A M + +T S+V G+ Y+ PE
Sbjct: 176 ----IVHSDLKPANFLIV-DGMLKLIDFGIANQM--QPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 875 ---------YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN 925
K+ KSD++S G +L + GK P F + + + ++I N
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPN 284
Query: 926 KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
+ + V + L + PK R ++ ++
Sbjct: 285 HEIE--FPDIPEKDLQDVLKCCL----------KRDPKQRISIPEL 318
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 61/235 (25%), Positives = 104/235 (44%), Gaps = 42/235 (17%)
Query: 688 RLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRP----HMVVAVKKLWRSDNDIESGDD 743
L +K ++G G G VYK + + VA+K+L R ++ +
Sbjct: 8 LLRILKETEFKKIK---VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE 63
Query: 744 LFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVD 799
+ E ++ + + ++ RLLG T V ++ MP L + + + + L++
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVR-EHKDNIGSQYLLN 121
Query: 800 WVSRYNIAVGIAQGLNYL-HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858
W V IA+G+NYL +HRD+ + N+L+ +I DFGLA+ +L
Sbjct: 122 W------CVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAK-LLGAE 170
Query: 859 ETVSMVAGSYGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
E G G + A E + YT +SD++S+GV + EL+T G P
Sbjct: 171 EKEYHAEG--GKVPIKWMALESILHRIYT----HQSDVWSYGVTVWELMTFGSKP 219
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-34
Identities = 67/285 (23%), Positives = 108/285 (37%), Gaps = 52/285 (18%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G G V+ + +VAVK R + +E +L + H NIVRL+G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+ + +V + + L E +L V + + A G+ YL
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR-TEGARLRVK--TLLQMVGDAAAGMEYLE---SKCC 234
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI-----APE---YG- 876
IHRD+ + N L+ +I+DFG++R + V +G + APE YG
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEA---DGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 877 YTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGG--SKDIVEWVLS---MIKSNKAQDE 930
Y+ +SD++SFG++L E + G P + ++ E+V + D
Sbjct: 292 YSS----ESDVWSFGILLWETFSLGASP----YPNLSNQQTREFVEKGGRLPCPELCPDA 343
Query: 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
V M C A P RP+ + L
Sbjct: 344 ------------VFRLME-------QCWAYEPGQRPSFSTIYQEL 369
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 45/223 (20%), Positives = 90/223 (40%), Gaps = 31/223 (13%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRS---------------DNDIESGDDLFREVSL 750
+ G + E + A+KK +S + DD E+ +
Sbjct: 39 LNQGKFNKIILCE-KD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 751 LGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSL------GEALHGKEAGKLLVDWVSRY 804
+ +++ + G + N V ++Y+YM NDS+ L + + +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 805 NIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMV 864
+ +Y+H+ + + HRD+K +NIL+D N +++DFG + M ++ +
Sbjct: 157 --IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKGS 210
Query: 865 AGSYGYIAPE--YGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
G+Y ++ PE + K DI+S G+ L + +P
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 62/295 (21%), Positives = 117/295 (39%), Gaps = 57/295 (19%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G GG G+V++A+ A+K++ + ++ + + REV L +L H IVR
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-EKVMREVKALAKLEHPGIVRYFNA 71
Query: 766 LHNETNVM---------MVY---DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQG 813
+ +Y ++L + ++G+ + +I + IA+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEA 130
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA-------- 865
+ +LH ++HRD+K +NI + ++ DFGL M E +++
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 866 ----GSYGYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEW 917
G+ Y++PE Y K DI+S G++L ELL F + V
Sbjct: 188 TGQVGTKLYMSPEQIHGNSY----SHKVDIFSLGLILFELLY-------PFSTQMERVR- 235
Query: 918 VLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
L+ +++ K P + E ++V + P RP ++I
Sbjct: 236 TLTDVRNLK-----FPPLFTQKY---PCEYVMVQD----MLSPSPMERPEAINII 278
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G VY+A + VA+KK+ D ++ D +E+ LL +L H N+++
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 765 YLHNETNVMMVYDYMPNDSLGEAL-HGKEAGKLL---VDWVSRYNIAVGIAQGLNYLHHD 820
+ + +V + L + H K+ +L+ W V + L ++H
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCSALEHMH-- 153
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----YG 876
V+HRDIK N+ + A ++ D GL R K + G+ Y++PE G
Sbjct: 154 -SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 212
Query: 877 YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSK 912
Y + KSDI+S G +L E+ + F G K
Sbjct: 213 Y----NFKSDIWSLGCLLYEMAALQ----SPFYGDK 240
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
++G G GIVY + +A+K++ + D L E++L L+H+NIV+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+ + + +P SL L K + I +GL YLH +
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDNQ--- 142
Query: 825 VIHRDIKSNNILLDA-NLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE------YGY 877
++HRDIK +N+L++ + +I+DFG ++ + N G+ Y+APE GY
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 878 TLKVDEKSDIYSFGVVLLELLTGKMP 903
+DI+S G ++E+ TGK P
Sbjct: 203 GK----AADIWSLGCTIIEMATGKPP 224
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 76/330 (23%), Positives = 138/330 (41%), Gaps = 40/330 (12%)
Query: 260 LTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVK-LAELKNLQLLNLMCNQL 318
L V K+P +L A LDL +N+I+ EI LKNL L L+ N++
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKI 88
Query: 319 TGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDS- 377
+ + P L KLE L L KN L LP ++ ++ L+ L N ++ ++ + +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQL-KELPEKMPKT--LQELRVHENEIT-KVRKSVFNGL 144
Query: 378 GNLTKLILFNNSFSGTF--PVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMAN 435
+ + L N + + K L +R+ + I+ TIP GL PSL L +
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 201
Query: 436 NNLTGQIPDDISLS--TSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNE 493
N +T ++ SL +L+ + +S+N + + S+ + P L+ ++N L +P
Sbjct: 202 NKIT-KVDAA-SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGG 258
Query: 494 LQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDM 553
L + V+ L +N++S + +N F P + + + +
Sbjct: 259 LADHKYIQVVYLHNNNIS----------------AIGSNDFCP--PGYNTKKASYSGVSL 300
Query: 554 SNNSL-FGRIPEN-FGASPALEMLNLSYNK 581
+N + + I + F + L K
Sbjct: 301 FSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 57/309 (18%), Positives = 112/309 (36%), Gaps = 31/309 (10%)
Query: 54 HCNWTGVWCNSRGF----------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFA 103
C+ V C+ G LDL N + + + L++L +L + N+ +
Sbjct: 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 104 SSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATS 163
P + A L L+ + +S+N + P + L + N +
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQ-LKELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQ 146
Query: 164 LESLDFRG-SFFEGSVP-TSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNA 221
+ ++ + +F+ ++KL ++ ++ N+T IP L SL + L N
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 203
Query: 222 FEGEIPAE-FGNLTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPELG 279
++ A L NL L L+ S+S + +L L ++L N K+P L
Sbjct: 204 IT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260
Query: 280 SITSLAFLDLSDNQISG------EIPVKLAELKNLQLLNLMCNQL--TGLIPDKLGELTK 331
+ + L +N IS P + + ++L N + + P +
Sbjct: 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 320
Query: 332 LEVLELWKN 340
++L
Sbjct: 321 RAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 17/233 (7%)
Query: 356 LRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLIS 415
LR + S L ++P L + L L NN + K+L + + NN IS
Sbjct: 33 LRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 416 GTIPVG-LGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIP 474
I G L L+RL ++ N L ++P+ + +L + + N + S +
Sbjct: 90 -KISPGAFAPLVKLERLYLSKNQLK-ELPEK--MPKTLQELRVHENEITKVRKSVFNGLN 145
Query: 475 SLQTFMASHNNLQ-AKIPNE-LQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNN 532
+ N L+ + I N Q LS + ++ +++ IP + L L+L N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGN 202
Query: 533 RFSGEIPKAV-ATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYNKLE 583
+ + ++ A + LA L +S NS+ + +P L L+L+ NKL
Sbjct: 203 KIT-KVDAASLKGLNNLAKLGLSFNSI-SAVDNGSLANTPHLRELHLNNNKLV 253
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G G G VY A + ++A+K L++S L RE+ + LRH NI+R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
Y H+ + ++ ++ P L + L ++ G+ + + +A L+Y H
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATF--MEELADALHYCHERK--- 134
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----YGYTLK 880
VIHRDIK N+L+ E +IADFG + + + G+ Y+ PE +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHA--PSLRRRTMCGTLDYLPPEMIEGKTH--- 189
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLD 905
DEK D++ GV+ E L G P D
Sbjct: 190 -DEKVDLWCAGVLCYEFLVGMPPFD 213
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 78/416 (18%), Positives = 142/416 (34%), Gaps = 46/416 (11%)
Query: 177 SVPTSFRNLQKLKFLGLSGNNLTGKIPPE-LGQLSSLETIILGYNAFEGEIPAE-FGNLT 234
VP ++ + LS N++ ++ +L L+ + + I F L+
Sbjct: 24 QVPELPAHVNYVD---LSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS 79
Query: 235 NLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPE--LGSITSLAFLDLSD 291
+L L L Q+ A L L + L + N G + +TSL L L D
Sbjct: 80 SLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRD 138
Query: 292 NQISGEIPVKL-AELKNLQLLNLMCNQLTGLIPDKLGELTK--LEVLELWKNSLIGSLPM 348
N I P ++ +L+L N++ + + L +L L +L
Sbjct: 139 NNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL------ 192
Query: 349 RLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVR 408
D + L E + ++T L L N F + + +++
Sbjct: 193 ----------QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQ 242
Query: 409 VQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPS 468
+LI + + N G + + D+S + + + L
Sbjct: 243 ---SLILSNSYNMGSSFGHTNFKDPDNFTFKGLEA------SGVKTCDLSKSKIFA-LLK 292
Query: 469 SILS-IPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASI-ASCEKLVS 526
S+ S L+ + N + N L L+LS N L I + + + +KL
Sbjct: 293 SVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEV 351
Query: 527 LNLRNNRFSGEIPKAV-ATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYN 580
L+L N + +P L L + N L +P+ F +L+ + L N
Sbjct: 352 LDLSYNHIR-ALGDQSFLGLPNLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 78/455 (17%), Positives = 146/455 (32%), Gaps = 89/455 (19%)
Query: 91 SLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNF 150
++ +++ N A S + L L+ + V Q
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNT---------------- 74
Query: 151 SGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPE-LGQL 209
FR L L L L N ++ L
Sbjct: 75 -------------------------------FRGLSSLIILKLDYNQFL-QLETGAFNGL 102
Query: 210 SSLETIILGYNAF-EGEIPAE-FGNLTNLRYLDLAVGSLSGQIPP--ALGRLKKLTTVYL 265
++LE + L + F LT+L L L ++ +I P +++ + L
Sbjct: 103 ANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDL 161
Query: 266 YKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDK 325
N SI L+ L L ++ L ++ L
Sbjct: 162 TFNKVK--------SICEEDLLNFQGKH------FTLLRLSSITLQDMNEYWLGWEKCGN 207
Query: 326 LGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLIL 385
+ T + L+L N S+ R + ++ S L + N
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQ-SLILSNSYNMGSSFGHTNFKDPD- 265
Query: 386 FNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGL-GNLPSLQRLEMANNNLTGQIPD 444
N +F G + T + + I + + + L++L +A N + +I D
Sbjct: 266 -NFTFKGLEASGVKT------CDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDD 316
Query: 445 DI--SLSTSLSFVDISWNHLESYLPSSIL-SIPSLQTFMASHNNLQAKIPNEL-QACPSL 500
+ L T L +++S N L S + S + ++ L+ S+N+++A + ++ P+L
Sbjct: 317 NAFWGL-THLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNL 373
Query: 501 SVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNRF 534
L L +N L +P I L + L N +
Sbjct: 374 KELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 85/405 (20%), Positives = 139/405 (34%), Gaps = 76/405 (18%)
Query: 55 CNWTGVWCNSRGF---------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASS 105
C +RG V +DLS S+ + L+ L L +
Sbjct: 10 VIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV 69
Query: 106 LPK-SLANLTALKSMDVSQNNFIGSFPTG-LGKASGLTSVNASSNNF-SGFLPEDL-GNA 161
+ + L++L + + N TG + L + + N L +
Sbjct: 70 IRNNTFRGLSSLIILKLDYNQ-FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL 128
Query: 162 TSLESLDFRGSFFEGSVP-TSFRNLQKLKFLGLSGN-----------NLTGKIPPELGQL 209
TSLE L R + + P + F N+++ L L+ N N GK L +L
Sbjct: 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL-RL 187
Query: 210 SSLETIILGYNAFEGEIPAEFGNLTNLRYLDLA----VGSLSGQIPPALGRLK------- 258
SS+ + E T++ LDL+ S++ + A+ K
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247
Query: 259 ----------------------------KLTTVYLYKNNFTGKIPPEL-GSITSLAFLDL 289
+ T L K+ + + T L L L
Sbjct: 248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTL 306
Query: 290 SDNQISGEIPVK-LAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPM 348
+ N+I+ +I L +L LNL N L + L KLEVL+L N I +L
Sbjct: 307 AQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH-IRALGD 364
Query: 349 RL--GQSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNNSF 390
+ G + L+ L +N L +P G+ D +L K+ L N +
Sbjct: 365 QSFLGLPN-LKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-22
Identities = 56/398 (14%), Positives = 117/398 (29%), Gaps = 89/398 (22%)
Query: 194 SGNNLTG--KIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIP 251
L ++P + + L N+ F L +L++L + + I
Sbjct: 18 INRGLHQVPELPA------HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR 71
Query: 252 P-ALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQI-SGEIPVKL-AELKN 307
L L + L N F ++ + +L L L+ + + L +
Sbjct: 72 NNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS 130
Query: 308 LQLLNLMCNQLTGLIPDKL-GELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLL 366
L++L L N + + P + + VL+L N + +S L
Sbjct: 131 LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV---------KSICEEDLLNFQGK- 180
Query: 367 SGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLP 426
+ T L L + + L K +
Sbjct: 181 ------------HFTLLRLSSITLQDMNEYWLGWEKCGNPFK----------------NT 212
Query: 427 SLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNL 486
S+ L+++ N + + + + + S+N
Sbjct: 213 SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN-------------------SYNMG 253
Query: 487 QAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAV-ATM 545
+ + + + L ++ + + +L ++ + K+V +
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVK--------------TCDLSKSKIF-ALLKSVFSHF 298
Query: 546 PTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYNKL 582
L L ++ N + +I +N F L LNLS N L
Sbjct: 299 TDLEQLTLAQNEI-NKIDDNAFWGLTHLLKLNLSQNFL 335
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-15
Identities = 48/321 (14%), Positives = 97/321 (30%), Gaps = 83/321 (25%)
Query: 307 NLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP-LRRLDASSNL 365
++ ++L N + L L L+ L++ + + + + L L N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 366 LSGEIPTGLCDS-GNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGL-G 423
++ TG + NL L L NL +
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQC-----------------------NLDGAVLSGNFFK 126
Query: 424 NLPSLQRLEMANNNLTGQIPDDI-SLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMAS 482
L SL+ L + +NN+ P +D+++N ++S + L + Q +
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS-ICEEDLL--NFQGKHFT 183
Query: 483 HNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAV 542
L S+++ D++ L E + + +L+L N F + K
Sbjct: 184 LLRLS-----------SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232
Query: 543 ---------------------------------------ATMPTLAILDMSNNSLFGRIP 563
+ D+S + +F +
Sbjct: 233 FDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALL 291
Query: 564 EN-FGASPALEMLNLSYNKLE 583
++ F LE L L+ N++
Sbjct: 292 KSVFSHFTDLEQLTLAQNEIN 312
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 22/99 (22%), Positives = 38/99 (38%), Gaps = 3/99 (3%)
Query: 498 PSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAV-ATMPTLAILDMSNN 556
++ +DLS NS++ S + + L L + I + +L IL + N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 557 SLFGRIPEN-FGASPALEMLNLSYNKLEGPVPSNGILMN 594
++ F LE+L L+ L+G V S
Sbjct: 90 QF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 31/236 (13%)
Query: 699 CVKESNIIGMGGNGIVYKAEFH----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL 754
+K +G G G V + VAVK L + ++ DL +E+ +L L
Sbjct: 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNL 80
Query: 755 RHRNIVRLLG--YLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAV 808
H NIV+ G + ++ +++P+ SL E L K K+ + + AV
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKY------AV 133
Query: 809 GIAQGLNYLH-HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS 867
I +G++YL +HRD+ + N+L+++ + +I DFGL + + E ++
Sbjct: 134 QICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD- 188
Query: 868 YGYI-----APEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEW 917
APE K SD++SFGV L ELLT P K I
Sbjct: 189 -RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
V + +IG G G VY + AVK L DI E ++
Sbjct: 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFS 84
Query: 756 HRNIVRLLGY-LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
H N++ LLG L +E + ++V YM + L + + + D + + +A+G+
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGM 141
Query: 815 NYLH-HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI-- 871
YL +HRD+ + N +LD ++ADFGLAR M + E S+ + +
Sbjct: 142 KYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPV 196
Query: 872 ---APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
A E +T KSD++SFGV+L EL+T G P
Sbjct: 197 KWMALESLQTQKFT----TKSDVWSFGVLLWELMTRGAPP 232
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-33
Identities = 85/464 (18%), Positives = 172/464 (37%), Gaps = 32/464 (6%)
Query: 141 TSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTG 200
V+ S N +P+DL L+ ++ + +L KL+ L +S N +
Sbjct: 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ- 58
Query: 201 KIPPE-LGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSL-SGQIPPALGRLK 258
+ LE + L +N +I NL++LDL+ + + I G +
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMS 115
Query: 259 KLTTVYLYKNNFTGKIPPELGSITSLA-FLDLSDNQISGEIPVKLAEL--KNLQLLNLMC 315
+L + L + + + L L + E P L + ++L ++
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175
Query: 316 NQLTGLIPDKLGELTKLEVLEL------WKNSLIGSLPMRLGQSSPLRRLDASSNLLSGE 369
+ ++ + + LE+ + K S S+ +L + L L ++ +
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 370 IPTGL---CDSGNLTKLILFNNSFSG-----TFPVSLSTCKSLVRVRVQNNLISGTIPVG 421
+ + + N G F S ++ K+L +V +++
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295
Query: 422 LGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMA 481
++ + S + +D S N L + + + L+T +
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355
Query: 482 SHNNLQA--KIPNELQACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNRFSGEI 538
N L+ KI SL LD+S NS+S + + + L+SLN+ +N + I
Sbjct: 356 QMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI 415
Query: 539 PKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKL 582
+ + P + +LD+ +N + IP+ AL+ LN++ N+L
Sbjct: 416 FRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-33
Identities = 97/480 (20%), Positives = 182/480 (37%), Gaps = 31/480 (6%)
Query: 123 QNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSF 182
N + P L T +N S N S D+ + + L L + + + F
Sbjct: 8 SKNGLIHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVF 65
Query: 183 RNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEG-EIPAEFGNLTNLRYLDL 241
+ Q+L++L LS N L KI +L+ + L +NAF+ I EFGN++ L++L L
Sbjct: 66 KFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122
Query: 242 AVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSI---TSLAFLDLSDNQISGEI 298
+ L + L + + + K PE SL + ++ + +
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL 182
Query: 299 PVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPM---------R 349
V + + NL+L N+ C L L KL+ N + ++ +
Sbjct: 183 DVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ 242
Query: 350 LGQSSPLRRLDASSNLLSGEIPTGLCDSGN-----LTKLILFNNSFSGTFPVSLSTCKSL 404
L + + S+ L G++ D L+ + ++ F ++
Sbjct: 243 LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNM 302
Query: 405 VRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLES 464
+ + + L+ +NN LT + ++ T L + + N L+
Sbjct: 303 NIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE 362
Query: 465 --YLPSSILSIPSLQTFMASHNNLQAKIPNEL-QACPSLSVLDLSSNSLSGEIPASIASC 521
+ + SLQ S N++ SL L++SSN L+ I +
Sbjct: 363 LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP- 421
Query: 522 EKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYN 580
++ L+L +N+ IPK V + L L++++N L +P+ F +L+ + L N
Sbjct: 422 -RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-32
Identities = 90/466 (19%), Positives = 166/466 (35%), Gaps = 31/466 (6%)
Query: 68 VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
L++S ++ + +I L L L I N L+ +D+S N +
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK-L 81
Query: 128 GSFPTGLGKASGLTSVNASSNNFSGF-LPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQ 186
L ++ S N F + ++ GN + L+ L + E S +L
Sbjct: 82 VKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139
Query: 187 KLKFLGLSGNNLTGKIPPELGQ---LSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAV 243
K L + G K PE Q SL + F + + NL ++
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199
Query: 244 GSLSGQIPPALGRLKKLTT------VYLYKNNFTGKIPPELG---SITSLAFLDLSDNQI 294
+ L L KL T + L T + T++ + +S+ ++
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKL 259
Query: 295 SGEIPVKLAE-----LKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMR 349
G++ + + LK L + ++ + + + + + + M
Sbjct: 260 QGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT-RMVHML 318
Query: 350 L-GQSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNNSFSGTFPVSLSTCK--SLV 405
+ SP LD S+NLL+ + C L LIL N ++ T + SL
Sbjct: 319 CPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQ 377
Query: 406 RVRVQNNLISGTIPVGL-GNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLES 464
++ + N +S G SL L M++N LT I L + +D+ N ++S
Sbjct: 378 QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR--CLPPRIKVLDLHSNKIKS 435
Query: 465 YLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSL 510
+P ++ + +LQ + N L++ SL + L +N
Sbjct: 436 -IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 72/420 (17%), Positives = 130/420 (30%), Gaps = 50/420 (11%)
Query: 190 FLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQ 249
+ S N L +P +L + + N ++ +L+ LR L ++ +
Sbjct: 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 250 IPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVK--LAELKN 307
++L + L N KI +L LDLS N +P+ +
Sbjct: 61 DISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQ 116
Query: 308 LQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLS 367
L+ L L L + L +VL L
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVL-----------------------LVLGETYGE 153
Query: 368 GEIPTGLCDSGNLTKLILF--NNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNL 425
E P GL D + I+F N F VS+ T +L ++ L L L
Sbjct: 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSIL 213
Query: 426 PSLQR------LEMANNNLTGQIPDDIS---LSTSLSFVDISWNHLESYLPSSIL----- 471
LQ L + N T I T++ + IS L+ L
Sbjct: 214 AKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273
Query: 472 SIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRN 531
S+ +L + + ++++ + + + + + L+ N
Sbjct: 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333
Query: 532 NRFSGEIPKAVATMPTLAILDMSNNSL--FGRIPENFGASPALEMLNLSYNKLEGPVPSN 589
N + + + + L L + N L +I E +L+ L++S N +
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-20
Identities = 70/350 (20%), Positives = 122/350 (34%), Gaps = 17/350 (4%)
Query: 1 MQTHLLFLYCYIVESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGV 60
+ LL L E + L + ++ P N ++ + + + + +
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK--EFHFILDVSVKTVANLELS-- 195
Query: 61 WCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMD 120
N + +E S + + L +L+ NI + L T +
Sbjct: 196 --NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253
Query: 121 VSQNNFIGSFPTGLGKASG-----LTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFE 175
+S G SG L+ S+ F +++ +F S
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
Query: 176 GSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFE--GEIPAEFGNL 233
+ L S N LT + G L+ LET+IL N + +I +
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM 373
Query: 234 TNLRYLDLAVGSLSGQIPPAL-GRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDN 292
+L+ LD++ S+S K L ++ + N T I L + LDL N
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSN 431
Query: 293 QISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSL 342
+I IP ++ +L+ LQ LN+ NQL + LT L+ + L N
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 7e-20
Identities = 62/365 (16%), Positives = 110/365 (30%), Gaps = 48/365 (13%)
Query: 261 TTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG 320
V KN +P +L L++S N IS + L L++L + N++
Sbjct: 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 321 LIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDS-GN 379
L +LE L+L N L + + L+ LD S N +
Sbjct: 60 LDISVFKFNQELEYLDLSHNKL-VKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQ 116
Query: 380 LTKLILFNNSF-SGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLP--SLQRLEMANN 436
L L L + S V + + P GL + SL + N
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176
Query: 437 NLTGQIPDDISLSTSLSFVDISWN------HLESYLPSSILSIPSLQTFMASHNNLQAKI 490
+ + +L +I + + + + P L ++
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
Query: 491 PNELQACP---SLSVLDLSSNSLSGEIPASIA-----SCEKLVSLNLRNNRFS------- 535
+ ++ +S+ L G++ S + L + ++ F
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
Query: 536 ----------------GEIPKAVATMPT-LAILDMSNNSLFGRIPENFGASPALEMLNLS 578
+ + + LD SNN L + EN G LE L L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 579 YNKLE 583
N+L+
Sbjct: 357 MNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 57/280 (20%), Positives = 95/280 (33%), Gaps = 51/280 (18%)
Query: 431 LEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKI 490
++ + N L +P D+S + ++IS N++ S ILS+ L+ + SHN +Q
Sbjct: 5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 491 PNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAI 550
+ + L LDLS N L SC V+L
Sbjct: 62 ISVFKFNQELEYLDLSHNKLVK------ISCHPTVNLK---------------------H 94
Query: 551 LDMSNNSLFGRIPEN--FGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCG 608
LD+S N+ +P FG L+ L LS LE +NI+ L+
Sbjct: 95 LDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGE 153
Query: 609 SVLPPCSQNLTAKPGQTRKMHIN-------HIIFGFIIGTLVIVSLGIVFFAGKWAYRRW 661
P Q+ T +HI H I + T+ + L +
Sbjct: 154 KEDPEGLQDF-----NTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC------VLE 202
Query: 662 YLYNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVK 701
S+F + K + + T + + ++
Sbjct: 203 DNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ 242
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 56/240 (23%), Positives = 102/240 (42%), Gaps = 24/240 (10%)
Query: 705 IIGMGGNGIVYKAEFHRP-HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
I+G G V++ H+ + A+K + + + D RE +L +L H+NIV+L
Sbjct: 16 ILGQGATANVFRGR-HKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 764 GYLHNET--NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
T + +++ ++ P SL L L + + + G+N+L +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLRENG 132
Query: 822 QPPVIHRDIKSNNILL----DANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE--- 874
++HR+IK NI+ D ++ DFG AR + + VS+ G+ Y+ P+
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHPDMYE 188
Query: 875 -----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929
+ K D++S GV TG +P P G ++ + V+ I + K
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITGKPSG 246
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 23/223 (10%)
Query: 704 NIIGMGGNGIVYKAEFHRP----HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI 759
+G G G V + +VAVK L ++D + +E+ +L L H +I
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 760 VRLLG--YLHNETNVMMVYDYMPNDSLGEALHGKEAG-KLLVDWVSRYNIAVGIAQGLNY 816
++ G ++ +V +Y+P SL + L G L+ + A I +G+ Y
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAY 149
Query: 817 LH-HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI---A 872
LH IHRD+ + N+LLD + +I DFGLA+ + +E + + A
Sbjct: 150 LHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205
Query: 873 PEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDI 914
PE K SD++SFGV L ELLT P + I
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 38/224 (16%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
+ IIG G +G V P + VA+K L ++ D E S++G+
Sbjct: 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFD 108
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIA 811
H NI+RL G + M+V +YM N SL L + G+ LV G+
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGM------LRGVG 161
Query: 812 QGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG 869
G+ YL +HRD+ + N+L+D+NL +++DFGL+R++ + G G
Sbjct: 162 AGMRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG--G 214
Query: 870 YI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
I APE + ++ SD++SFGVV+ E+L G+ P
Sbjct: 215 KIPIRWTAPEAIAFRTFS----SASDVWSFGVVMWEVLAYGERP 254
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 49/216 (22%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 706 IGMGGNGIVYKAEFHRPH--MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V + + + VA+K L + + +++ RE ++ +L + IVRL+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQGLNYL-- 817
G E +M+V + L + L + ++ + + ++ G+ YL
Sbjct: 77 GVCQAEA-LMLVMEMAGGGPLHKFLV-GKREEIPVSNVAEL------LHQVSMGMKYLEE 128
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI-----A 872
+ +HRD+ + N+LL A+I+DFGL++ + + + + G A
Sbjct: 129 KN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA--GKWPLKWYA 181
Query: 873 PE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
PE + ++ +SD++S+GV + E L+ G+ P
Sbjct: 182 PECINFRKFS----SRSDVWSYGVTMWEALSYGQKP 213
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-33
Identities = 62/298 (20%), Positives = 123/298 (41%), Gaps = 50/298 (16%)
Query: 706 IGMGGNGIVYKAEFHRP-HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G G G+V+K H+P +V+A K + + + + RE+ +L IV G
Sbjct: 41 LGAGNGGVVFKV-SHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+++ + + ++M SL + L K+AG++ + + +++ + +GL YL +
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGK--VSIAVIKGLTYLREKHK-- 152
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM---VAGSYGYIAPE----YGY 877
++HRD+K +NIL+++ E ++ DFG++ + SM G+ Y++PE Y
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTHY 207
Query: 878 TLKVDEKSDIYSFGVVLLELLTGKMPLDP----AFGGSKDIVEWVLSMIKSNKAQDEALD 933
+SDI+S G+ L+E+ G+ P+ P + + +
Sbjct: 208 ----SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 934 PSIAGQCKHVQEEMLLVLRIAV---------------------LCTAKLPKGRPTMRD 970
+ G + +L V C K P R ++
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 61/303 (20%), Positives = 118/303 (38%), Gaps = 68/303 (22%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
++G G G V KA A+KK+ ++ + + + EV LL L H+ +VR
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST---ILSEVMLLASLNHQYVVRYYA 69
Query: 765 -------------YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIA 811
+ ++ + + +Y N +L + + + L + + I
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQIL 126
Query: 812 QGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA------ 865
+ L+Y+H +IHRD+K NI +D + +I DFGLA+ + + + + +
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 866 --------GSYGYIAPE-------YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG 910
G+ Y+A E Y +EK D+YS G++ E++ P G
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHY------NEKIDMYSLGIIFFEMIY------PFSTG 231
Query: 911 SKDIVEWVLSMIKSNKAQ-DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMR 969
+ + +L ++S + D + K + ++ P RP R
Sbjct: 232 MERVN--ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLI----------DHDPNKRPGAR 279
Query: 970 DVI 972
++
Sbjct: 280 TLL 282
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-33
Identities = 60/239 (25%), Positives = 101/239 (42%), Gaps = 30/239 (12%)
Query: 699 CVKESNIIGMGGNGIVYKAEFH----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL 754
+K + +G G G V + +VAVK+L + + D RE+ +L L
Sbjct: 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKAL 81
Query: 755 RHRNIVRLLG--YLHNETNVMMVYDYMPNDSLGEALHGKEAG---KLLVDWVSRYNIAVG 809
IV+ G Y ++ +V +Y+P+ L + L A L+ + +
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY------SSQ 135
Query: 810 IAQGLNYLH-HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY 868
I +G+ YL C +HRD+ + NIL+++ +IADFGLA+++ + +
Sbjct: 136 ICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP-- 189
Query: 869 GYI-----APEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSM 921
G APE +SD++SFGVVL EL T P+ + +
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
+ ++G G G V P + VA+K L + + D E S++G+
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFD 104
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIA 811
H NI+RL G + VM+V +YM N SL L + + LV GIA
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGM------LRGIA 157
Query: 812 QGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG 869
G+ YL +HRD+ + NIL+++NL +++DFGL R++ E G
Sbjct: 158 SGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 870 YI---APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
I +PE Y +T SD++S+G+VL E+++ G+ P
Sbjct: 213 PIRWTSPEAIAYRKFT----SASDVWSYGIVLWEVMSYGERP 250
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 705 IIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSD--NDIESGDDLFREVSLLGRLRHRNI 759
+G G G+V + E+ P + VAVK L + D + E+ DD REV+ + L HRN+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQGLN 815
+RL G + + MV + P SL + L K G L + AV +A+G+
Sbjct: 84 IRLYG-VVLTPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRY------AVQVAEGMG 135
Query: 816 YL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS---YGY 870
YL IHRD+ + N+LL +I DFGL R + ++ M + +
Sbjct: 136 YLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 871 IAPE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
APE ++ SD + FGV L E+ T G+ P
Sbjct: 191 CAPESLKTRTFSH----ASDTWMFGVTLWEMFTYGQEP 224
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 57/217 (26%), Positives = 107/217 (49%), Gaps = 25/217 (11%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRP----HMVVAVKKLWRSDNDIESGDDLFREVSLLGRL 754
+++ ++G G G V+K + + V +K + + +S + + +G L
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGSL 72
Query: 755 RHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAG---KLLVDWVSRYNIAVGIA 811
H +IVRLLG + + +V Y+P SL + + +LL++W V IA
Sbjct: 73 DHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIA 125
Query: 812 QGLNYLH-HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGY 870
+G+ YL H +HR++ + N+LL + + ++ADFG+A +L ++ + + +
Sbjct: 126 KGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVAD-LLPPDDKQLLYSEAKTP 180
Query: 871 I---APEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
I A E + K +SD++S+GV + EL+T G P
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
+G G G V++ + + AVKK + E+ L IV
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKK-------VRLEVFRVEELVACAGLSSPRIV 113
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
L G + V + + + SLG+ + K+ G L D Y +GL YLH
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYY--LGQALEGLEYLHTR 169
Query: 821 CQPPVIHRDIKSNNILLDAN-LEARIADFGLARMMLHKNETVSM-----VAGSYGYIAPE 874
++H D+K++N+LL ++ A + DFG A + S+ + G+ ++APE
Sbjct: 170 R---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 875 ----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
KV DI+S ++L +L G P
Sbjct: 227 VVMGKPCDAKV----DIWSSCCMMLHMLNGCHP 255
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-32
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRPH---MVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
V + +IG G G VY + AVK L DI E ++
Sbjct: 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFS 148
Query: 756 HRNIVRLLGY-LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
H N++ LLG L +E + ++V YM + L + + + D + + +A+G+
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGM 205
Query: 815 NYL-HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI-- 871
+L +HRD+ + N +LD ++ADFGLAR M + E S+ + +
Sbjct: 206 KFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVHNKTGAKLPV 260
Query: 872 ---APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
A E +T KSD++SFGV+L EL+T G P
Sbjct: 261 KWMALESLQTQKFT----TKSDVWSFGVLLWELMTRGAPP 296
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 704 NIIGMGGNGIVYKAEFHRP----HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI 759
++G G G VYK + + VA+K+L R ++ ++ E ++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHV 79
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAG---KLLVDWVSRYNIAVGIAQGLNY 816
RLLG T V ++ MP L + + + + L++W V IA+G+NY
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNY 132
Query: 817 L-HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI---- 871
L +HRD+ + N+L+ +I DFGLA+ +L E G G +
Sbjct: 133 LEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAK-LLGAEEKEYHAEG--GKVPIKW 185
Query: 872 -APEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
A E +SD++S+GV + EL+T G P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
+IG G G+VY E+ + A+K L +++ + RE L+ L
Sbjct: 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLN 80
Query: 756 HRNIVRLLGY-LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
H N++ L+G L E ++ YM + L + + + + D +S + +A+G+
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS---FGLQVARGM 137
Query: 815 NYL-HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI-- 871
YL +HRD+ + N +LD + ++ADFGLAR + E S+ + +
Sbjct: 138 EYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARLPV 192
Query: 872 ---APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
A E +T KSD++SFGV+L ELLT G P
Sbjct: 193 KWTALESLQTYRFT----TKSDVWSFGVLLWELLTRGAPP 228
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-32
Identities = 56/240 (23%), Positives = 102/240 (42%), Gaps = 24/240 (10%)
Query: 705 IIGMGGNGIVYKAEFHRP-HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
I+G G V++ H+ + A+K + + + D RE +L +L H+NIV+L
Sbjct: 16 ILGQGATANVFRGR-HKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 764 GYLHNET--NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
T + +++ ++ P SL L L + + + G+N+L +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLRENG 132
Query: 822 QPPVIHRDIKSNNILL----DANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE--- 874
++HR+IK NI+ D ++ DFG AR + + VS+ G+ Y+ P+
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHPDMYE 188
Query: 875 -----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929
+ K D++S GV TG +P P G ++ + V+ I + K
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITGKPSG 246
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 34/237 (14%)
Query: 706 IGMGGNGIVYKAEFHRP-HMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLL 763
IG G G V K H+P ++AVK++ RS D + L ++ ++ R IV+
Sbjct: 30 IGRGAYGSVNKM-VHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 764 GYLHNETNVMMVYDYMPN--DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
G L E + + + M D + ++ + + + + I + + LN+L +
Sbjct: 88 GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKALNHLKENL 145
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMM---LHKNETVSMVAGSYGYIAPE---- 874
+ +IHRDIK +NILLD + ++ DFG++ + + K G Y+APE
Sbjct: 146 K--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA----GCRPYMAPERIDP 199
Query: 875 ----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927
GY D +SD++S G+ L EL TG+ P + V L+ +
Sbjct: 200 SASRQGY----DVRSDVWSLGITLYELATGRFPYPK-----WNSVFDQLTQVVKGDP 247
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 705 IIGMGGNGIVYKAEFHRPHMV--VAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRL 762
+G G G V K + +V VAVK L ND D+L E +++ +L + IVR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQGLNYL- 817
+G E+ M+V + L + L ++ + +++ ++ G+ YL
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIEL------VHQVSMGMKYLE 134
Query: 818 -HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS---YGYIAP 873
+ +HRD+ + N+LL A+I+DFGL++ + + AP
Sbjct: 135 ESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189
Query: 874 E---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
E Y ++ KSD++SFGV++ E + G+ P
Sbjct: 190 ECINYYKFSS----KSDVWSFGVLMWEAFSYGQKP 220
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-32
Identities = 50/217 (23%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRP--HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH 756
+ +G G G V + + + VA+K L + + +++ RE ++ +L +
Sbjct: 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDN 395
Query: 757 RNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQ 812
IVRL+G E +M+V + L + L GK ++ + + ++
Sbjct: 396 PYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAEL------LHQVSM 447
Query: 813 GLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGY 870
G+ YL + +HR++ + N+LL A+I+DFGL++ + + + +
Sbjct: 448 GMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 871 I---APEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ APE K +SD++S+GV + E L+ G+ P
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 48/231 (20%), Positives = 81/231 (35%), Gaps = 47/231 (20%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLG 764
+ GG VY+A+ A+K+L N+ E + +EV + +L H NIV+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 765 YLHNETN----------VMMVY------DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAV 808
++ +++ L I
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV----------LKIFY 143
Query: 809 GIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH---------KNE 859
+ + ++H +PP+IHRD+K N+LL ++ DFG A + H +
Sbjct: 144 QTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 860 TVSMVAGSYG---YIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
V Y PE Y + EK DI++ G +L L + P
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSN-FPIGEKQDIWALGCILYLLCFRQHP 252
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-32
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+ +G G G VY+ + + + VAVK L + D ++ +E +++ ++H N+V+LL
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDT--MEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQGLNYLH- 818
G E ++ ++M +L + L ++ L+ +A I+ + YL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY------MATQISSAMEYLEK 336
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG-SYGYIAPEYGY 877
+ IHR++ + N L+ N ++ADFGL+R+M T A + APE
Sbjct: 337 KNF----IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 392
Query: 878 TLKVDEKSDIYSFGVVLLELLT-GKMP 903
K KSD+++FGV+L E+ T G P
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 704 NIIGMGGNGIVYKAEFH----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI 759
+G G G V + VVAVKKL + + E D RE+ +L L+H NI
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTE-EHLRDFEREIEILKSLQHDNI 73
Query: 760 VRLLG--YLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQG 813
V+ G Y N+ ++ +Y+P SL + L + ++ L+ + I +G
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQY------TSQICKG 126
Query: 814 LNYLH-HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI- 871
+ YL IHRD+ + NIL++ +I DFGL +++ E + I
Sbjct: 127 MEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 872 --APEYGYTLKVDEKSDIYSFGVVLLELLT 899
APE K SD++SFGVVL EL T
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLG 764
+G G G V+K F + V+AVK++ R + E + ++ ++ + IV+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
T+V + + M + E L + G + + + + V I + L YL
Sbjct: 92 TFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLKEKHG-- 145
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMM---LHKNETVSMVAGSYGYIAPE------- 874
VIHRD+K +NILLD + ++ DFG++ + K+ + G Y+APE
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA----GCAAYMAPERIDPPDP 201
Query: 875 --YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
Y D ++D++S G+ L+EL TG+ P
Sbjct: 202 TKPDY----DIRADVWSLGISLVELATGQFPYKN 231
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 704 NIIGMGGNGIVYKAEFH----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI 759
+G G G V + VVAVKKL + + E D RE+ +L L+H NI
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTE-EHLRDFEREIEILKSLQHDNI 104
Query: 760 VRLLG--YLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQG 813
V+ G Y N+ ++ +Y+P SL + L + ++ L+ + I +G
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQY------TSQICKG 157
Query: 814 LNYLH-HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI- 871
+ YL IHRD+ + NIL++ +I DFGL +++ E + I
Sbjct: 158 MEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213
Query: 872 --APEYGYTLKVDEKSDIYSFGVVLLELLT 899
APE K SD++SFGVVL EL T
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-31
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 15/212 (7%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL- 763
+G GG G V + VA+K+ R + ++ + E+ ++ +L H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 764 -----GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
L ++ +Y L + L+ E L + R + I+ L YLH
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLH 138
Query: 819 HDCQPPVIHRDIKSNNILLDANLEAR---IADFGLARMMLHKNETVSMVAGSYGYIAPEY 875
+ +IHRD+K NI+L + I D G A+ + V G+ Y+APE
Sbjct: 139 ---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQYLAPEL 194
Query: 876 GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPA 907
K D +SFG + E +TG P P
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 39/225 (17%)
Query: 699 CVKESNIIGMGGNGIVYKAEFH----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL 754
CV +IG G G VYK + + VA+K L ++ + D E ++G+
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQF 103
Query: 755 RHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGI 810
H NI+RL G + +M++ +YM N +L + L K+ G+ LV GI
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGM------LRGI 156
Query: 811 AQGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY 868
A G+ YL + +HRD+ + NIL+++NL +++DFGL+R++ E +G
Sbjct: 157 AAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG-- 209
Query: 869 GYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
G I APE Y +T SD++SFG+V+ E++T G+ P
Sbjct: 210 GKIPIRWTAPEAISYRKFT----SASDVWSFGIVMWEVMTYGERP 250
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 96/472 (20%), Positives = 183/472 (38%), Gaps = 44/472 (9%)
Query: 138 SGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNN 197
+ V+ S+ N + +P+DL ++L + L +L+ L LS N
Sbjct: 31 ELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNR 87
Query: 198 LTGKIPPEL-GQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPA--L 254
+ + + LE + + +N + I + +LR+LDL+ +P
Sbjct: 88 IR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEF 142
Query: 255 GRLKKLTTVYLYKNNFTGKIPPELGSITSLA--FLDLSDNQISGEIPVKLAELKNLQLLN 312
G L KLT + L F ++ + L+ LDL I G L N +L+
Sbjct: 143 GNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLH 200
Query: 313 LMCNQLTGLIPDKLGELTKLEVLELWKNSL-------IGSLPMRLGQSSPLRRLDASSNL 365
L+ + + + L L+L L + + L + L +
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE 260
Query: 366 LSGEIPTGL---CDSGNLTKLILFNNSFSG-----TFPVSLSTCKSLVRVRVQNNLISGT 417
+ + L + L ++N + + F S + KSL+ V+N + +
Sbjct: 261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFS 320
Query: 418 IPVGLGNLPSLQRLEMANNNLTGQIPDDISLS-TSLSFVDISWNHLESYLPSSILSIPSL 476
+ ++ ++ I S +S +F++ + N + ++ L
Sbjct: 321 KEALYSVFAEMNIKMLSISDTP-FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL 379
Query: 477 QTFMASHNNLQ-----AKIPNELQACPSLSVLDLSSNSL-SGEIPASIASCEKLVSLNLR 530
QT + N L+ A + + SL LD+S NSL S + A E ++ LNL
Sbjct: 380 QTLILQRNGLKNFFKVALMTKNMS---SLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436
Query: 531 NNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKL 582
+N +G + + + P + +LD+ NN + IP++ AL+ LN++ N+L
Sbjct: 437 SNMLTGSVFRCLP--PKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-25
Identities = 88/481 (18%), Positives = 165/481 (34%), Gaps = 45/481 (9%)
Query: 62 CNSRGF----------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSL- 110
++R + L LS S++ +I L L L + N SL +
Sbjct: 38 YSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVF 96
Query: 111 ANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGF-LPEDLGNATSLESLDF 169
L+ +DVS N + + + L ++ S N+F + ++ GN T L L
Sbjct: 97 LFNQDLEYLDVSHNR-LQNISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGL 153
Query: 170 RGSFFEGSVPTSFRNLQ-KLKFLGLSGNNLTGKIPPELGQLSSLETIILGYN-------A 221
+ F +L L L ++ G L ++ ++ +
Sbjct: 154 SAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQV 213
Query: 222 FEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSI 281
L+N++ D L + R L V L T K +L
Sbjct: 214 NMSVNALGHLQLSNIKLNDENCQRLMTFLSELT-RGPTLLNVTLQHIETTWKCSVKLFQF 272
Query: 282 ---TSLAFLDLSDNQISGEIPVKLA-----ELKNLQLLNLMCNQLTGLIPDKLGELTKLE 333
+ +L++ + I+ I + LK+L + ++ ++
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMN 332
Query: 334 VLELWKNSLIGSLPMR-LGQSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNNSFS 391
+ L + + M S L+ + N+ + + C + L LIL N
Sbjct: 333 IKMLSISDT-PFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNGLK 390
Query: 392 GTFPVS--LSTCKSLVRVRVQ-NNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISL 448
F V+ SL + V N+L S S+ L +++N LTG + L
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR--CL 448
Query: 449 STSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNE-LQACPSLSVLDLSS 507
+ +D+ N + S +P + + +LQ + N L++ +P+ SL + L
Sbjct: 449 PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHD 506
Query: 508 N 508
N
Sbjct: 507 N 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 7e-21
Identities = 63/369 (17%), Positives = 122/369 (33%), Gaps = 23/369 (6%)
Query: 88 GLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASS 147
L L+ L + +F +A+L + + I T + T ++
Sbjct: 144 NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203
Query: 148 NNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPP--- 204
+ S F + + +L L G + N+T +
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263
Query: 205 -------ELGQLSSLETIILGYNAFEGEIPAEFGN-----LTNLRYLDLAVGSLSGQIPP 252
+ +E + + I E L +L +
Sbjct: 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEA 323
Query: 253 ALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLN 312
++ L ++ S +S FL+ + N + + + LK LQ L
Sbjct: 324 LYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLI 383
Query: 313 LMCNQLTGL--IPDKLGELTKLEVLELWKNSL-IGSLPMRLGQSSPLRRLDASSNLLSGE 369
L N L + ++ LE L++ NSL + + + L+ SSN+L+G
Sbjct: 384 LQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443
Query: 370 IPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVG-LGNLPSL 428
+ L + L L NN + P ++ ++L + V +N + ++P G L SL
Sbjct: 444 VFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSL 499
Query: 429 QRLEMANNN 437
Q + + +N
Sbjct: 500 QYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 6e-20
Identities = 42/233 (18%), Positives = 86/233 (36%), Gaps = 10/233 (4%)
Query: 163 SLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAF 222
++ +L S L+ L + + + +L +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 223 EGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSIT 282
+ ++ +L+ + + LK+L T+ L +N
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTK 400
Query: 283 SLAFLDLSDNQI----SGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELW 338
+++ L+ D + S A +++ +LNL N LTG + L K++VL+L
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLH 458
Query: 339 KNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNNSF 390
N + S+P + L+ L+ +SN L +P G+ D +L + L +N +
Sbjct: 459 NNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 64/363 (17%), Positives = 114/363 (31%), Gaps = 46/363 (12%)
Query: 261 TTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG 320
+ V N T +P +L L LS N IS ++ L L++L L N++
Sbjct: 34 SMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS 90
Query: 321 LIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDS-GN 379
L LE L++ N L ++ + LR LD S N +
Sbjct: 91 LDFHVFLFNQDLEYLDVSHNRL-QNIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTK 147
Query: 380 LTKLILFNNSF-SGTFPVSLSTCKSLVRVRVQNNLISGTIPVGL--GNLPSLQRLEMANN 436
LT L L F S + + + + I G L N L + N+
Sbjct: 148 LTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNS 207
Query: 437 NLTGQIPDDISLSTSLSFVDISWNHLESY----LPSSILSIPSLQTFMASHNNLQAKIPN 492
+ Q+ ++ L +I N S + P+L H K
Sbjct: 208 LFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSV 267
Query: 493 ELQAC---PSLSVLDLSSNSLSGEIPASIA-----SCEKLVSLNLRNNRF---------- 534
+L + L++ + +++ I + + L+ +++N F
Sbjct: 268 KLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSV 327
Query: 535 -------------SGEIPKAVATMPT-LAILDMSNNSLFGRIPENFGASPALEMLNLSYN 580
+ I P+ L+ + N + + L+ L L N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 581 KLE 583
L+
Sbjct: 388 GLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 35/205 (17%), Positives = 71/205 (34%), Gaps = 10/205 (4%)
Query: 71 LDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSF 130
+ N S ++ + ++ + ++ ++ +QN F S
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
Query: 131 PTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRG----SFFEGSVPTSFRNLQ 186
G L ++ N + ++ SL+ S + + +
Sbjct: 370 FQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428
Query: 187 KLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSL 246
+ L LS N LTG + L ++ + L N IP + +L L+ L++A L
Sbjct: 429 SILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
Query: 247 SGQIPP-ALGRLKKLTTVYLYKNNF 270
+P RL L ++L+ N +
Sbjct: 486 KS-VPDGVFDRLTSLQYIWLHDNPW 509
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-31
Identities = 61/301 (20%), Positives = 98/301 (32%), Gaps = 78/301 (25%)
Query: 706 IGMGGNGIVYKAEFHRPHM-VVAVKKLWRSDNDIESGDDLF-----REVSLLGRLRHRNI 759
I GG G +Y A + V +K L + SGD E L + H +I
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGL------VHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 760 VR-------------LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNI 806
V+ +GY+ VM +Y+ SL + KL V
Sbjct: 142 VQIFNFVEHTDRHGDPVGYI-----VM---EYVGGQSLKRSK----GQKLPVAEAIA--Y 187
Query: 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG 866
+ I L+YLH +++ D+K NI+L + ++ D G + N + G
Sbjct: 188 LLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI---NSF-GYLYG 239
Query: 867 SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926
+ G+ APE +DIY+ G L L G V+ +
Sbjct: 240 TPGFQAPEI-VRTGPTVATDIYTVGRTLAALTLDLPT----RNG--RYVDGL-------- 284
Query: 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT----MR-DVITMLGEAKPR 981
++ L+ R P+ R T M + +L E +
Sbjct: 285 -PEDDPVLKTYDSYGR------LLRR----AIDPDPRQRFTTAEEMSAQLTGVLREVVAQ 333
Query: 982 R 982
Sbjct: 334 D 334
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 55/224 (24%), Positives = 99/224 (44%), Gaps = 41/224 (18%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRPH---MVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
V + I+G G G VY+ + + VAVK + D +++ + E ++ L
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLD 71
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIA 811
H +IV+L+G + E ++ + P LG L + L LV + ++ I
Sbjct: 72 HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLE-RNKNSLKVLTLVLY------SLQIC 123
Query: 812 QGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG 869
+ + YL + +HRDI NIL+ + ++ DFGL+R + ++ S
Sbjct: 124 KAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY----KASVT 174
Query: 870 YI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ +PE + +T SD++ F V + E+L+ GK P
Sbjct: 175 RLPIKWMSPESINFRRFTT----ASDVWMFAVCMWEILSFGKQP 214
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 6e-31
Identities = 59/280 (21%), Positives = 105/280 (37%), Gaps = 42/280 (15%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLL 763
++G G G + + VAVK++ REV LL H N++R
Sbjct: 31 VLGHGAEGTIVYRGMFD-NRDVAVKRILPECFSF-----ADREVQLLRESDEHPNVIRYF 84
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-HDCQ 822
+ + + +L E + K+ L ++ + GL +LH +
Sbjct: 85 CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSLN-- 138
Query: 823 PPVIHRDIKSNNILL-----DANLEARIADFGLARMMLHKNETVSM---VAGSYGYIAPE 874
++HRD+K +NIL+ ++A I+DFGL + + + S V G+ G+IAPE
Sbjct: 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 875 Y---GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931
DI+S G V +++ P FG S ++ +
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--P-FGKSLQRQ--ANILLGACSLDCLH 251
Query: 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
+ + L+ + A P+ RP+ + V
Sbjct: 252 PEKHEDVIARE------LIEK----MIAMDPQKRPSAKHV 281
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVS-LLGRLRHRNIVRLLG 764
+G G G+V K ++AVK++ R+ + + L ++ + + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHG--KEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
L E +V + + M + SL + + + D + + IAV I + L +LH
Sbjct: 74 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLHSKLS 130
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMM---LHKNETVSMVAGSYGYIAPE----- 874
VIHRD+K +N+L++A + ++ DFG++ + + K+ + AG Y+APE
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD----IDAGCKPYMAPERINPE 184
Query: 875 ---YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
GY KSDI+S G+ ++EL + P D
Sbjct: 185 LNQKGY----SVKSDIWSLGITMIELAILRFPYDS 215
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 39/223 (17%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
++ IG G G V++ + P + VA+K ++ + +E + +
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFD 74
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIA 811
H +IV+L+G + V ++ + L L ++ L L+ + A ++
Sbjct: 75 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK-YSLDLASLILY------AYQLS 126
Query: 812 QGLNYL-HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGY 870
L YL +HRDI + N+L+ +N ++ DFGL+R M S G
Sbjct: 127 TALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGK 178
Query: 871 I-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ APE + +T SD++ FGV + E+L G P
Sbjct: 179 LPIKWMAPESINFRRFTS----ASDVWMFGVCMWEILMHGVKP 217
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 36/215 (16%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+ +G G G VY+ + + + VAVK L D ++ +E +++ ++H N+V+LL
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQGLNYL-H 818
G E ++ ++M +L + L ++ L+ +A I+ + YL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY------MATQISSAMEYLEK 129
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI-----AP 873
+ IHRD+ + N L+ N ++ADFGL+R+M + A + AP
Sbjct: 130 KNF----IHRDLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAP 181
Query: 874 E---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
E Y +++ KSD+++FGV+L E+ T G P
Sbjct: 182 ESLAYNKFSI----KSDVWAFGVLLWEIATYGMSP 212
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-30
Identities = 72/439 (16%), Positives = 143/439 (32%), Gaps = 66/439 (15%)
Query: 159 GNATSLESLDF--RGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETII 216
N SL F S +++ +K G + N + E ++ +
Sbjct: 8 NNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAV-SLLKE-CLINQFSELQ 65
Query: 217 LGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPP 276
L +P + L++ +L +P L+ L N + +P
Sbjct: 66 LNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYL---DACDNRLS-TLPE 117
Query: 277 ELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLE 336
S+ L D+ +NQ++ +P L+ +N NQLT L P+ T LEVL
Sbjct: 118 LPASLKHL---DVDNNQLT-MLP---ELPALLEYINADNNQLTML-PE---LPTSLEVLS 166
Query: 337 LWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPV 396
+ N L LP L LD S+NLL +P + + + +F
Sbjct: 167 VRNNQL-TFLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFR-------- 213
Query: 397 SLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVD 456
+ N I+ IP + +L + + +N L+ +I + +S T+
Sbjct: 214 ------------CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYH 260
Query: 457 ISWNHLE-----SYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLS 511
+ L+ F + + ++I + + + + LS
Sbjct: 261 GPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLS 320
Query: 512 G------------EIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLF 559
++ A + L ++ + + ++ L ++ L
Sbjct: 321 DTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLV 380
Query: 560 GRIPENFGASPALEMLNLS 578
+ E + +L+L
Sbjct: 381 HQASEGLFDNDTGALLSLG 399
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-27
Identities = 60/323 (18%), Positives = 102/323 (31%), Gaps = 74/323 (22%)
Query: 287 LDLSDNQISG---EIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLI 343
+ N ISG + + + L N+ L+ + L + + L+L + +L
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNL- 71
Query: 344 GSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKS 403
SLP L + L+ + N L +P +L L +N S
Sbjct: 72 SSLPDNLPPQ--ITVLEITQNALI-SLPELP---ASLEYLDACDNRLS------------ 113
Query: 404 LVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLE 463
T+P +L + L++ NN LT +P+ L +++ N L
Sbjct: 114 -------------TLPELPASL---KHLDVDNNQLT-MLPELP---ALLEYINADNNQLT 153
Query: 464 SYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEK 523
LP SL+ +N L +P + SL LD+S+N L +PA
Sbjct: 154 M-LPELP---TSLEVLSVRNNQLTF-LPELPE---SLEALDVSTNLLE-SLPAVPVRNHH 204
Query: 524 LVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
+ N + IPEN + + L N L
Sbjct: 205 SEETEI--------------------FFRCRENRI-THIPENILSLDPTCTIILEDNPLS 243
Query: 584 GPVPSNGILMNINPNELIGNAGL 606
+ + P+
Sbjct: 244 SRIRESLSQQTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 66/379 (17%), Positives = 119/379 (31%), Gaps = 37/379 (9%)
Query: 69 EKLDLSNMSLNGSVSE-NIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
EK L + N +VS + S L + SSLP +L + ++++QN +
Sbjct: 37 EKQALPGENRNEAVSLLKECLINQFSELQLNRLNL-SSLPDNL--PPQITVLEITQNA-L 92
Query: 128 GSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK 187
S P L ++A N S LPE + L+ LD + +P L+
Sbjct: 93 ISLPELPA---SLEYLDACDNRLS-TLPELPAS---LKHLDVDNNQLT-MLPELPALLEY 144
Query: 188 LKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLS 247
+ N LT +P L L + N +P +L LD++ L
Sbjct: 145 I---NADNNQLT-MLPELPTSLEVLS---VRNNQLT-FLPEL---PESLEALDVSTNLLE 193
Query: 248 GQIPPALGRLKKLTTV----YLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLA 303
+P R +N T IP + S+ + L DN +S I L+
Sbjct: 194 -SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLS 251
Query: 304 ELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASS 363
+ + + + + + + + Q + +
Sbjct: 252 QQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHA 309
Query: 364 NLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLG 423
N S L D+ + F + L + +R Q+ ++
Sbjct: 310 NTFS-AFLDRLSDTVSARNTSGFREQVAAW----LEKLSASAELRQQSFAVAADATESCE 364
Query: 424 NLPSLQRLEMANNNLTGQI 442
+ +L + L Q
Sbjct: 365 DRVALTWNNLRKTLLVHQA 383
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 72/284 (25%), Positives = 116/284 (40%), Gaps = 47/284 (16%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVK--KLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G +V A VA+K L + ++ +L +E+ + + H NIV
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD---ELLKEIQAMSQCHHPNIVSYY 79
Query: 764 GYLHNETNVMMVYDYMPNDSLGEAL-HGKEAGKLLVDWVSRYNIAV---GIAQGLNYLHH 819
+ + +V + S+ + + H G+ + IA + +GL YLH
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM-----VAGSYGYIAPE 874
+ Q IHRD+K+ NILL + +IADFG++ + + G+ ++APE
Sbjct: 140 NGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 875 -----YGYTLKVDEKSDIYSFGVVLLELLTGKMP---LDPAFGGSKDIVEWVLSMIKSNK 926
GY D K+DI+SFG+ +EL TG P P VL + N
Sbjct: 197 VMEQVRGY----DFKADIWSFGITAIELATGAAPYHKYPPM---------KVLMLTLQND 243
Query: 927 A---QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT 967
+ D + + +M+ LC K P+ RPT
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMI------SLCLQKDPEKRPT 281
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 78/278 (28%), Positives = 128/278 (46%), Gaps = 53/278 (19%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVK--KLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G V+K +R VVA+K L ++++IE D+ +E+++L + + +
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE---DIQQEITVLSQCDSPYVTKYY 86
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
G +T + ++ +Y+ S + L E G L ++ I I +GL+YLH +
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIA--TILREILKGLDYLHSE--- 138
Query: 824 PVIHRDIKSNNILLDANLEARIADFG----LARMMLHKNETVSMVAGSYGYIAPE----Y 875
IHRDIK+ N+LL + E ++ADFG L + +N + V + ++APE
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN---TFVGTPF-WMAPEVIKQS 194
Query: 876 GYTLKVDEKSDIYSFGVVLLELLTGKMP---LDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932
Y D K+DI+S G+ +EL G+ P L P VL +I N
Sbjct: 195 AY----DSKADIWSLGITAIELARGEPPHSELHPM---------KVLFLIPKNNP----- 236
Query: 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRD 970
P++ G +E + C K P RPT ++
Sbjct: 237 -PTLEGNYSKPLKEFV------EACLNKEPSFRPTAKE 267
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
+ IG G G+V+ + V A+K + S +D E ++ +L H
Sbjct: 9 ELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI---REGAMSEEDFIEEAEVMMKLSHPK 64
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL- 817
+V+L G + + +V ++M + L + L + + + + + +G+ YL
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG---MCLDVCEGMAYLE 121
Query: 818 -HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI---AP 873
VIHRD+ + N L+ N +++DFG+ R +L T S G+ + +P
Sbjct: 122 EAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS--TGTKFPVKWASP 174
Query: 874 E---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
E + Y+ KSD++SFGV++ E+ + GK+P
Sbjct: 175 EVFSFSRYSS----KSDVWSFGVLMWEVFSEGKIP 205
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-30
Identities = 70/234 (29%), Positives = 108/234 (46%), Gaps = 53/234 (22%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL----FREVSLLGRLRHRNI 759
+ +G G VYKA + +VA+KK+ + + E+ D + RE+ LL L H NI
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNI 74
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
+ LL +++N+ +V+D+M D L + + L + Y + QGL YLH
Sbjct: 75 IGLLDAFGHKSNISLVFDFMETD-LEVIIKDN-SLVLTPSHIKAYMLM--TLQGLEYLHQ 130
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG---------- 869
++HRD+K NN+LLD N ++ADFGLA+ S+G
Sbjct: 131 HW---ILHRDLKPNNLLLDENGVLKLADFGLAK--------------SFGSPNRAYTHQV 173
Query: 870 ----YIAPE--YG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
Y APE +G Y + V D+++ G +L ELL P G D+
Sbjct: 174 VTRWYRAPELLFGARMYGVGV----DMWAVGCILAELLLRV----PFLPGDSDL 219
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 44/210 (20%), Positives = 74/210 (35%), Gaps = 19/210 (9%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLG 764
+G G G V+K + AVK+ + EV ++ +H VRL
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+ + + SL + + G L + L +LH
Sbjct: 125 AWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVW-GYLRDTLLALAHLH---SQG 177
Query: 825 VIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY---GYTLKV 881
++H D+K NI L ++ DFGL + G Y+APE Y
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPELLQGSY---- 232
Query: 882 DEKSDIYSFGVVLLELLTGKMPLDPAFGGS 911
+D++S G+ +LE+ ++ GG
Sbjct: 233 GTAADVFSLGLTILEVACN---MELPHGGE 259
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-29
Identities = 71/283 (25%), Positives = 120/283 (42%), Gaps = 51/283 (18%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V H+ A+K + ++ S L EV++L L H NI++L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWV---SRYN------IAVGIAQGL 814
+ ++ N +V + G E L D + ++N I + G+
Sbjct: 103 DFFEDKRNYYLVMECYK---------GGE----LFDEIIHRMKFNEVDAAVIIKQVLSGV 149
Query: 815 NYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMMLHKNETVSMVAGSYGYI 871
YLH ++HRD+K N+LL + + +I DFGL+ + + + G+ YI
Sbjct: 150 TYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERLGTAYYI 205
Query: 872 APEYGYTLK--VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQ- 928
APE L+ DEK D++S GV+L LL G P FGG D + +L ++ K
Sbjct: 206 APE---VLRKKYDEKCDVWSIGVILFILLAGYPP----FGGQTD--QEILRKVEKGKYTF 256
Query: 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
D +++ K L+ ++ L + R + +
Sbjct: 257 DSPEWKNVSEGAKD------LIKQM--LQ--FDSQRRISAQQA 289
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 24/213 (11%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
++ +G G G V+ + VA+K L + S + +E ++ +LRH
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGT--MSPEAFLQEAQVMKKLRHEK 240
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQGL 814
+V+L + E + +V +YM SL + L G+ L LVD A IA G+
Sbjct: 241 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM------AAQIASGM 293
Query: 815 NYLH-HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS--YGYI 871
Y+ + +HRD+++ NIL+ NL ++ADFGLAR ++ NE + +
Sbjct: 294 AYVERMNY----VHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWT 348
Query: 872 APEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
APE + KSD++SFG++L EL T G++P
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+IG G G+VY+A+ +VA+KK+ D + RE+ ++ +L H NIVRL
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK-----NRELQIMRKLDHCNIVRLRY 114
Query: 765 YLH------NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
+ + +E + +V DY+P A H A + L + + + L Y+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIH 173
Query: 819 -HDCQPPVIHRDIKSNNILLDANLEA-RIADFGLARMMLHKNETVSMVAGSYGYIAPE-- 874
+ HRDIK N+LLD + ++ DFG A+ ++ VS + Y Y APE
Sbjct: 174 SFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELI 228
Query: 875 ---YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
YT + D++S G VL ELL G+ P+ P
Sbjct: 229 FGATDYTSSI----DVWSAGCVLAELLLGQ-PIFP 258
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
+ +G G G+V ++ R VA+K + S D+ E ++ L H
Sbjct: 25 DLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEK 80
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL- 817
+V+L G + + ++ +YM N L L + + + + + YL
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE---MCKDVCEAMEYLE 137
Query: 818 -HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI---AP 873
+HRD+ + N L++ +++DFGL+R +L T S GS + P
Sbjct: 138 SKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS--VGSKFPVRWSPP 190
Query: 874 E---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
E Y ++ KSDI++FGV++ E+ + GKMP
Sbjct: 191 EVLMYSKFSS----KSDIWAFGVLMWEIYSLGKMP 221
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
+ +G G G+V ++ + VAVK + S D+ F+E + +L H
Sbjct: 9 EITLLKELGSGQFGVVKLGKW-KGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPK 64
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL- 817
+V+ G E + +V +Y+ N L L G + + + +G+ +L
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE---MCYDVCEGMAFLE 121
Query: 818 -HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI---AP 873
H IHRD+ + N L+D +L +++DFG+ R +L S G+ + AP
Sbjct: 122 SHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS--VGTKFPVKWSAP 174
Query: 874 E---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
E Y Y+ KSD+++FG+++ E+ + GKMP
Sbjct: 175 EVFHYFKYSS----KSDVWAFGILMWEVFSLGKMP 205
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 46/212 (21%), Positives = 82/212 (38%), Gaps = 24/212 (11%)
Query: 707 GMGGNGIVYKAEFHRP-HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
G V A ++P V V+++ E L E+ + H NIV
Sbjct: 36 GFEDLMTVNLA-RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+ + +V +M S + + + ++ I G+ + L+Y+HH
Sbjct: 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIA--YILQGVLKALDYIHHM---GY 149
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI-------APE---- 874
+HR +K+++IL+ + + ++ M+ + +V Y +PE
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 875 --YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
GY D KSDIYS G+ EL G +P
Sbjct: 210 NLQGY----DAKSDIYSVGITACELANGHVPF 237
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-29
Identities = 73/286 (25%), Positives = 119/286 (41%), Gaps = 57/286 (19%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
++G G G V K + AVK + ++ + + REV LL +L H NI++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWV---SRYN------IAVGIAQGL 814
L + ++ +V + G E L D + R++ I + G+
Sbjct: 88 EILEDSSSFYIVGELYT---------GGE----LFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 815 NYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMMLHKNETVSMVAGSYGYI 871
Y+H ++HRD+K NILL + + + +I DFGL+ +N + G+ YI
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYYI 190
Query: 872 APE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926
APE Y EK D++S GV+L LL+G P F G + +L +++ K
Sbjct: 191 APEVLRGTYD------EKCDVWSAGVILYILLSGTPP----FYGKNE--YDILKRVETGK 238
Query: 927 AQ-DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
D +I+ K + +ML P R T
Sbjct: 239 YAFDLPQWRTISDDAKDLIRKML----------TFHPSLRITATQC 274
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 34/222 (15%)
Query: 704 NIIGMGGNGIVYKAEFHRPH---MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
I+G G G V + + + VAVK + ++ ++ E + + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 761 RLLG-----YLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYNIAVGIAQG 813
RLLG M++ +M L L E G + + V IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 814 LNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI 871
+ YL + +HRD+ + N +L ++ +ADFGL++ + + G +
Sbjct: 160 MEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY---RQGRIAKM 211
Query: 872 -----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
A E YT KSD+++FGV + E+ T G P
Sbjct: 212 PVKWIAIESLADRVYT----SKSDVWAFGVTMWEIATRGMTP 249
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-29
Identities = 66/296 (22%), Positives = 106/296 (35%), Gaps = 51/296 (17%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRL 762
I+G G +G V VAVK++ DI E+ LL H N++R
Sbjct: 21 KILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDHPNVIRY 74
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAV---GIAQGLNYLHH 819
+ + + + N +L + + K + YN IA G+ +LH
Sbjct: 75 YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 820 DCQPPVIHRDIKSNNILLD-------------ANLEARIADFGLARMM----LHKNETVS 862
+IHRD+K NIL+ NL I+DFGL + + ++
Sbjct: 134 LK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 863 MVAGSYGYIAPE-------YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIV 915
+G+ G+ APE ++ DI+S G V +L+ P FG
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH--P-FGDKYSRE 247
Query: 916 EWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
++ I S D S+ + + +M+ P RPT V
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMI----------DHDPLKRPTAMKV 293
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 42/234 (17%)
Query: 699 CVKESNIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGR 753
V+ +G G VYK VA+K L + + ++ E L R
Sbjct: 10 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRAR 68
Query: 754 LRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRY------- 804
L+H N+V LLG + + + M++ Y + L E L + D
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 805 ---NIAVGIAQGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859
++ IA G+ YL HH V+H+D+ + N+L+ L +I+D GL R ++ +
Sbjct: 129 DFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFR-EVYAAD 182
Query: 860 TVSMVAGSYGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ APE YG ++ SDI+S+GVVL E+ + G P
Sbjct: 183 Y--YKLLGNSLLPIRWMAPEAIMYGKFS----IDSDIWSYGVVLWEVFSYGLQP 230
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 66/229 (28%), Positives = 107/229 (46%), Gaps = 47/229 (20%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL--FREVSLLGRLRHRNIVR 761
IG G G+VYKA+ + A+KK+ R + + E G RE+S+L L+H NIV+
Sbjct: 8 EKIGEGTYGVVYKAQ-NNYGETFALKKI-RLEKEDE-GIPSTTIREISILKELKHSNIVK 64
Query: 762 LLGYLHNETNVMMVYDYMPND------SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
L +H + +++V++++ D L A L+ + G+
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ----------LLNGIA 114
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM---LHK--NETVSMVAGSYGY 870
Y H V+HRD+K N+L++ E +IADFGLAR + K +E V++ Y
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-----WY 166
Query: 871 IAPE--YG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
AP+ G Y+ +D I+S G + E++ G P F G +
Sbjct: 167 RAPDVLMGSKKYSTTID----IWSVGCIFAEMVNGT----PLFPGVSEA 207
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 35/223 (15%)
Query: 704 NIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
++G G G V +A+ + + VAVK L ++ RE + + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 761 RLLG------YLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYNIAVGIAQ 812
+L+G M++ +M + L L + + V IA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 813 GLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGY 870
G+ YL + IHRD+ + N +L ++ +ADFGL+R + + G
Sbjct: 149 GMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY---RQGCASK 200
Query: 871 I-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ A E YT SD+++FGV + E++T G+ P
Sbjct: 201 LPVKWLALESLADNLYT----VHSDVWAFGVTMWEIMTRGQTP 239
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 71/227 (31%), Positives = 110/227 (48%), Gaps = 43/227 (18%)
Query: 706 IGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
+G G G V+ AE + + M+VAVK L D + + D RE LL L+H +IV
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSR----------YNIAV 808
+ G + ++MV++YM + L + L HG +A L+ + +IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 809 GIAQGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG 866
IA G+ YL H +HRD+ + N L+ ANL +I DFG++R + + G
Sbjct: 141 QIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVG 192
Query: 867 SYGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ + PE Y +T +SD++SFGV+L E+ T GK P
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTT----ESDVWSFGVILWEIFTYGKQP 235
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-29
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 24/213 (11%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
++ +G G G V+ + VA+K L + S + +E ++ +LRH
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGT--MSPEAFLQEAQVMKKLRHEK 323
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQGL 814
+V+L + E + +V +YM SL + L G+ L LVD A IA G+
Sbjct: 324 LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM------AAQIASGM 376
Query: 815 NYLH-HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS--YGYI 871
Y+ + +HRD+++ NIL+ NL ++ADFGLAR++ NE + +
Sbjct: 377 AYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT 431
Query: 872 APEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
APE + KSD++SFG++L EL T G++P
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-29
Identities = 71/287 (24%), Positives = 117/287 (40%), Gaps = 58/287 (20%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRL 762
++G G G V + AVK + + + L REV LL +L H NI++L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWV---SRYN------IAVGIAQG 813
+ ++ +V + G E L D + R++ I + G
Sbjct: 92 YEFFEDKGYFYLVGEVYT---------GGE----LFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 814 LNYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMMLHKNETVSMVAGSYGY 870
+ Y+H + ++HRD+K N+LL + RI DFGL+ ++ + G+ Y
Sbjct: 139 ITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYY 194
Query: 871 IAPE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN 925
IAPE Y EK D++S GV+L LL+G P F G+ + +L ++
Sbjct: 195 IAPEVLHGTYD------EKCDVWSTGVILYILLSGCPP----FNGANE--YDILKKVEKG 242
Query: 926 KAQDEALD-PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
K E ++ K + +ML +P R + RD
Sbjct: 243 KYTFELPQWKKVSESAKDLIRKML----------TYVPSMRISARDA 279
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 45/229 (19%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL--FREVSLLGRLRHRNIVR 761
IG G G V+KA+ H +VA+K++ R D+D E G RE+ LL L+H+NIVR
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDE-GVPSSALREICLLKELKHKNIVR 65
Query: 762 LLGYLHNETNVMMVYDYMPND------SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
L LH++ + +V+++ D S L + L + +GL
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ----------LLKGLG 115
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR-----MMLHKNETVSMVAGSYGY 870
+ H V+HRD+K N+L++ N E ++A+FGLAR + + E V++ Y
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL-----WY 167
Query: 871 IAPE--YG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
P+ +G Y+ +D ++S G + EL PL F G+
Sbjct: 168 RPPDVLFGAKLYSTSID----MWSAGCIFAELANAGRPL---FPGNDVD 209
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 36/214 (16%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V+ + H VAVK L S D E +L+ +L+H+ +VRL
Sbjct: 19 ERLGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQGLNYLHH 819
+ E + ++ +YM N SL + L KL L+D +A IA+G+ ++
Sbjct: 75 AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIE- 126
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI-----APE 874
+ IHRD+++ NIL+ L +IADFGLAR++ T APE
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR----EGAKFPIKWTAPE 180
Query: 875 ---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
YG +T+ KSD++SFG++L E++T G++P
Sbjct: 181 AINYGTFTI----KSDVWSFGILLTEIVTHGRIP 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 73/294 (24%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVK-----------KLWRSDNDIESGDDLFREVSLLG 752
+G G G V + H A+K + N + ++++ E+SLL
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 753 RLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWV---SRYN---- 805
L H NI++L ++ +V ++ G E L + + +++
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYE---------GGE----LFEQIINRHKFDECDA 148
Query: 806 --IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMMLHKNET 860
I I G+ YLH ++HRDIK NILL ++ L +I DFGL+ K+
Sbjct: 149 ANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYK 204
Query: 861 VSMVAGSYGYIAPEYGYTLK--VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWV 918
+ G+ YIAPE LK +EK D++S GV++ LL G P FGG D + +
Sbjct: 205 LRDRLGTAYYIAPE---VLKKKYNEKCDVWSCGVIMYILLCGYPP----FGGQND--QDI 255
Query: 919 LSMIKSNKAQ-DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
+ ++ K D +I+ + K L+ + L R T +
Sbjct: 256 IKKVEKGKYYFDFNDWKNISDEAKE------LIKLM--LT--YDYNKRCTAEEA 299
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 65/218 (29%), Positives = 114/218 (52%), Gaps = 34/218 (15%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
+K +G G G V+ A + H VAVK + + + S + E +++ L+H
Sbjct: 189 SLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTM-KPGS--MSVEAFLAEANVMKTLQHDK 244
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQGL 814
+V+L + E + ++ ++M SL + L E K L+D + IA+G+
Sbjct: 245 LVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLID------FSAQIAEGM 297
Query: 815 NYL-HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI-- 871
++ + IHRD+++ NIL+ A+L +IADFGLAR++ T G+ I
Sbjct: 298 AFIEQRNY----IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR--EGAKFPIKW 351
Query: 872 -APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
APE +G +T+ KSD++SFG++L+E++T G++P
Sbjct: 352 TAPEAINFGSFTI----KSDVWSFGILLMEIVTYGRIP 385
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLG 764
+G G G VYK + + A+K + D + +++ +E+++L + HRNI G
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 765 -YLH-----NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
++ + + +V ++ S+ + + + L +W++ I I +GL++LH
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH 146
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE---- 874
VIHRDIK N+LL N E ++ DFG++ + + G+ ++APE
Sbjct: 147 QHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203
Query: 875 -----YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
Y D KSD++S G+ +E+ G PL
Sbjct: 204 DENPDATY----DFKSDLWSLGITAIEMAEGAPPL 234
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 27/254 (10%), Positives = 67/254 (26%), Gaps = 45/254 (17%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVK-----------------------KLWRSDNDIESG 741
++G +A V +L R + +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 742 DDLFREVSLLGRLRHRNIVRL--LGYLHNETNVMMVYDYMPND-----SLGEALHGKEAG 794
R + ++ ++ + + V+ + P + GE L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 795 KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854
+ +R + + + + L LHH ++H ++ +I+LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 855 LHKNETVS-MVAGSYGYIAPE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAF 908
+ A + + D ++ G+ + + +P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----N 317
Query: 909 GGS--KDIVEWVLS 920
EW+
Sbjct: 318 TDDAALGGSEWIFR 331
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 35/270 (12%), Positives = 81/270 (30%), Gaps = 56/270 (20%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLR-------- 755
++G +A V + ++ + + EV L LR
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 756 -----------------HRNIVRLLGYLHNET--NVMMVYDYMPND--SLGEALHGKEAG 794
+ ++R+ + + +Y M ++ + GE L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 795 KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854
+ +R + + + + L LHH ++H ++ +I+LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 855 LHKNETVSMVAGSYGYIAPEY-----------GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
++ + + S G+ PE + D ++ G+V+ + +P
Sbjct: 255 --RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
Query: 904 LDPAFGGS--KDIVEWVLSMIK--SNKAQD 929
EW+ K +
Sbjct: 313 ----ITKDAALGGSEWIFRSCKNIPQPVRA 338
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+IG G G+V++A+ VA+KK+ D ++ RE+ ++ ++H N+V L
Sbjct: 47 VIGNGSFGVVFQAK-LVESDEVAIKKV-LQDKRFKN-----RELQIMRIVKHPNVVDLKA 99
Query: 765 YLH------NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
+ + +E + +V +Y+P + H + + + + + + + L Y+H
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL-YMYQLLRSLAYIH 158
Query: 819 -HDCQPPVIHRDIKSNNILLDAN-LEARIADFGLARMMLHKNETVSMVAGSYGYIAPE-- 874
+ HRDIK N+LLD ++ DFG A++++ VS + Y Y APE
Sbjct: 159 SIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-YRAPELI 213
Query: 875 ---YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
YT + DI+S G V+ EL+ G+ PL P
Sbjct: 214 FGATNYTTNI----DIWSTGCVMAELMQGQ-PLFP 243
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 69/335 (20%), Positives = 115/335 (34%), Gaps = 73/335 (21%)
Query: 260 LTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVK-LAELKNLQLLNLMCNQL 318
L V +P E+ LDL +N IS E+ L++L L L+ N++
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 319 TGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSG 378
+ + L KL+ L + S N L EIP L
Sbjct: 91 SKIHEKAFSPLRKLQKLYI------------------------SKNHLV-EIPPNL---- 121
Query: 379 NLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVG-LGNLPSLQRLEMANNN 437
SLV +R+ +N I +P G L ++ +EM N
Sbjct: 122 ---------------P-------SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNP 158
Query: 438 LT-GQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNE-LQ 495
L L+++ IS L + +P + +L HN +Q I E L
Sbjct: 159 LENSGFEPGAFDGLKLNYLRISEAKL-TGIPKDLPE--TLNELHLDHNKIQ-AIELEDLL 214
Query: 496 ACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSN 555
L L L N + S++ L L+L NN+ S +P + + L ++ +
Sbjct: 215 RYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHT 273
Query: 556 NSLFGRIPEN-------FGASPALEMLNLSYNKLE 583
N++ ++ N ++L N +
Sbjct: 274 NNI-TKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 61/310 (19%), Positives = 115/310 (37%), Gaps = 34/310 (10%)
Query: 54 HCNWTGVWCNSRGF----------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFA 103
HC+ V C+ G LDL N ++ ++ +GL+ L +L + N+ +
Sbjct: 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 104 SSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATS 163
K+ + L L+ + +S+N+ + P L S L + N +
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNH-LVEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRN 148
Query: 164 LESLDFRG-SFFEGSVPT-SFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNA 221
+ ++ G +F L KL +L +S LT IP +L +L + L +N
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNK 204
Query: 222 FEGEIPAE-FGNLTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPELG 279
+ I E + L L L + I +L L L ++L N + ++P L
Sbjct: 205 IQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261
Query: 280 SITSLAFLDLSDNQISGEIPVK-------LAELKNLQLLNLMCNQLT--GLIPDKLGELT 330
+ L + L N I+ ++ V + ++L N + + P +T
Sbjct: 262 DLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320
Query: 331 KLEVLELWKN 340
++
Sbjct: 321 DRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 61/315 (19%), Positives = 119/315 (37%), Gaps = 33/315 (10%)
Query: 235 NLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQ 293
+LR + + L +P + T + L N+ + ++ + + L L L +N+
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNK 89
Query: 294 ISGEIPVK-LAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQ 352
IS +I K + L+ LQ L + N L IP L + L L + N I +P +
Sbjct: 90 IS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNR-IRKVPKGVFS 144
Query: 353 SSP-LRRLDASSNLL-SGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQ 410
+ ++ N L + G D L L + +G + ++L + +
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG---IPKDLPETLNELHLD 201
Query: 411 NNLISGTIPVG-LGNLPSLQRLEMANNNLTGQIPDDI--SLSTSLSFVDISWNHLESYLP 467
+N I I + L L RL + +N + I + L +L + + N L +P
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFL-PTLRELHLDNNKLSR-VP 257
Query: 468 SSILSIPSLQTFMASHNNLQAKIPNE-------LQACPSLSVLDLSSNSLS-GEIPASIA 519
+ + + LQ NN+ K+ + + L +N + E+ +
Sbjct: 258 AGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATF 316
Query: 520 SC-EKLVSLNLRNNR 533
C +++ N +
Sbjct: 317 RCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 33/174 (18%), Positives = 59/174 (33%), Gaps = 30/174 (17%)
Query: 427 SLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNL 486
L+ ++ ++ L +P +IS T+L +D+ N + + L + +N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISPDTTL--LDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 487 QAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMP 546
L L +S N L EIP ++ S LV L + +NR ++P
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS--SLVELRIHDNRIR-KVP------- 139
Query: 547 TLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNEL 600
F + + + N LE G + N L
Sbjct: 140 ----------------KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYL 177
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 69/228 (30%), Positives = 104/228 (45%), Gaps = 42/228 (18%)
Query: 704 NIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
+G G G V+ AE H + M+VAVK L + + D RE LL L+H++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQH 104
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSR---------YNIA 807
IVR G ++MV++YM + L L HG +A L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 808 VGIAQGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA 865
+A G+ YL H +HRD+ + N L+ L +I DFG++R + + + +
Sbjct: 165 SQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRV-- 216
Query: 866 GSYGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
G + PE Y +T +SD++SFGVVL E+ T GK P
Sbjct: 217 GGRTMLPIRWMPPESILYRKFT----TESDVWSFGVVLWEIFTYGKQP 260
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 67/229 (29%), Positives = 109/229 (47%), Gaps = 47/229 (20%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL--FREVSLLGRLRHRNIVR 761
+G G G+VYKA+ +VA+K++ R D + E G RE+SLL L H NIV
Sbjct: 27 EKVGEGTYGVVYKAK-DSQGRIVALKRI-RLDAEDE-GIPSTAIREISLLKELHHPNIVS 83
Query: 762 LLGYLHNETNVMMVYDYMPND------SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
L+ +H+E + +V+++M D L + L + +G+
Sbjct: 84 LIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ----------LLRGVA 133
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM---LHK--NETVSMVAGSYGY 870
+ H ++HRD+K N+L++++ ++ADFGLAR + +E V++ Y
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL-----WY 185
Query: 871 IAPE--YG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
AP+ G Y+ VD I+S G + E++TGK P F G D
Sbjct: 186 RAPDVLMGSKKYSTSVD----IWSIGCIFAEMITGK----PLFPGVTDD 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 47/229 (20%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL--FREVSLLGRLRHRNIVR 761
+ +G G VYK + +VA+K++ R ++ E G REVSLL L+H NIV
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEI-RLEH--EEGAPCTAIREVSLLKDLKHANIVT 64
Query: 762 LLGYLHNETNVMMVYDYMPND------SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
L +H E ++ +V++Y+ D G ++ L + +GL
Sbjct: 65 LHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ----------LLRGLA 114
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR-----MMLHKNETVSMVAGSYGY 870
Y H V+HRD+K N+L++ E ++ADFGLAR + NE V++ Y
Sbjct: 115 YCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL-----WY 166
Query: 871 IAPE--YG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
P+ G Y+ ++D ++ G + E+ TG+ P F GS
Sbjct: 167 RPPDILLGSTDYSTQID----MWGVGCIFYEMATGR----PLFPGSTVE 207
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 40/216 (18%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
++G G G V K + AVK + ++ + + REV LL +L H NI++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWV---SRYN------IAVGIAQGLN 815
L + ++ +V + G E L D + R++ I + G+
Sbjct: 89 ILEDSSSFYIVGELYT---------GGE----LFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 816 YLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMMLHKNETVSMVAGSYGYIA 872
Y+H + ++HRD+K NILL + + + +I DFGL+ +N + G+ YIA
Sbjct: 136 YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYYIA 191
Query: 873 PE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
PE Y EK D++S GV+L LL+G P
Sbjct: 192 PEVLRGTYD------EKCDVWSAGVILYILLSGTPP 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESG-DDLFREVSLLGRLRHRNIVRL 762
+G G G VYKA +VA+K++ +ES ++ +E+S++ + ++V+
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV-----PVESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
G T++ +V +Y S+ + + + L D ++ I +GL YLH
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIAT--ILQSTLKGLEYLHFM-- 144
Query: 823 PPVIHRDIKSNNILLDANLEARIADFG----LARMMLHKNETVSMVAGSYGYIAPE---- 874
IHRDIK+ NILL+ A++ADFG L M +N +++ + ++APE
Sbjct: 145 -RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN---TVIGTPF-WMAPEVIQE 199
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
GY + +DI+S G+ +E+ GK P
Sbjct: 200 IGY----NCVADIWSLGITAIEMAEGKPPY 225
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 36/212 (16%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G V ++ VAVK + ++D + E S++ +LRH N+V+LL
Sbjct: 199 QTIGKGEFGDVMLGDYR--GNKVAVKCI-KNDATAQ---AFLAEASVMTQLRHSNLVQLL 252
Query: 764 GY-LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL-HHDC 821
G + + + +V +YM SL + L + G+ ++ ++ + + + YL ++
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 310
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI-----APE-- 874
+HRD+ + N+L+ + A+++DFGL + G + APE
Sbjct: 311 ----VHRDLAARNVLVSEDNVAKVSDFGLTKEAS--------STQDTGKLPVKWTAPEAL 358
Query: 875 -YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
++ KSD++SFG++L E+ + G++P
Sbjct: 359 REKKFST----KSDVWSFGILLWEIYSFGRVP 386
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 35/214 (16%)
Query: 706 IGMGGNGIVYKAEFHRP-HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G V A H VA+K + ++ + S LFREV ++ L H NIV+L
Sbjct: 23 IGKGNFAKVKLAR-HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 765 YLHNETNVMMVYDYMPNDSLGE-----ALHGK----EAGKLLVDWVSRYNIAVGIAQGLN 815
+ E + ++ +Y GE HG+ EA I +
Sbjct: 82 VIETEKTLYLIMEYASG---GEVFDYLVAHGRMKEKEARSKFRQ----------IVSAVQ 128
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY 875
Y H ++HRD+K+ N+LLDA++ +IADFG + + G+ Y APE
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFCGAPPYAAPEL 184
Query: 876 ----GYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
Y + D++S GV+L L++G +P D
Sbjct: 185 FQGKKYDGP---EVDVWSLGVILYTLVSGSLPFD 215
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 46/217 (21%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G V ++ VAVK + + + E S++ +LRH N+V+LL
Sbjct: 27 QTIGKGEFGDVMLGDYR--GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLL 80
Query: 764 GY-LHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIAQGLNYL- 817
G + + + +V +YM SL + L + L L+ ++ + + + YL
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK------FSLDVCEAMEYLE 134
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG------YI 871
++ +HRD+ + N+L+ + A+++DFGL + +
Sbjct: 135 GNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASST---------QDTGKLPVKWT 181
Query: 872 APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
APE ++ KSD++SFG++L E+ + G++P
Sbjct: 182 APEALREKKFS----TKSDVWSFGILLWEIYSFGRVP 214
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 34/211 (16%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD---LFREVSLLGRLRHRNIVRL 762
IG G +G VY A VA++++ +++ + E+ ++ ++ NIV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-----NLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 763 LG-YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
L YL + + +V +Y+ SL + + + ++ + Q L +LH +
Sbjct: 83 LDSYLVGDE-LWVVMEYLAGGSLTDVVT---ETCMDEGQIAA--VCRECLQALEFLHSN- 135
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFG----LARMMLHKNETVSMVAGSYGYIAPE--- 874
VIHRDIKS+NILL + ++ DFG + ++ +MV Y ++APE
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGTPY-WMAPEVVT 189
Query: 875 -YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
Y K DI+S G++ +E++ G+ P
Sbjct: 190 RKAY----GPKVDIWSLGIMAIEMIEGEPPY 216
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 51/216 (23%), Positives = 86/216 (39%), Gaps = 42/216 (19%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G G V A + A KK+ + +E D +E+ ++ L H NI+RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 765 YLHNETNVMMVYDYMPNDSLGEAL-----HG----KEAGKLLVDWVSRYNIAVGIAQGLN 815
+ T++ +V + GE +A +++ D + +
Sbjct: 74 TFEDNTDIYLVMELCTG---GELFERVVHKRVFRESDAARIMKD----------VLSAVA 120
Query: 816 YLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMMLHKNETVSMVAGSYGYIA 872
Y H + V HRD+K N L + ++ DFGLA + + G+ Y++
Sbjct: 121 YCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRTKVGTPYYVS 176
Query: 873 PE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
P+ YG + D +S GV++ LL G P
Sbjct: 177 PQVLEGLYG------PECDEWSAGVMMYVLLCGYPP 206
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 42/233 (18%), Positives = 82/233 (35%), Gaps = 51/233 (21%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRP-------HMVVAVKKLWRSDNDIESGDDLFREVSLL 751
+ + +G G ++K V +K L + F S++
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFFEAASMM 66
Query: 752 GRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIA 811
+L H+++V G ++V +++ SL L K + + W +A +A
Sbjct: 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWK--LEVAKQLA 123
Query: 812 QGLNYL--HHDCQPPVIHRDIKSNNILLDA--------NLEARIADFGLARMMLHKNETV 861
+++L + +IH ++ + NILL +++D G++ +L K
Sbjct: 124 AAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---- 174
Query: 862 SMVAGSYGYI-----APE---YG--YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
PE L +D +SFG L E+ + G P
Sbjct: 175 -----DILQERIPWVPPECIENPKNLNL----ATDKWSFGTTLWEICSGGDKP 218
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 9e-28
Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 31/219 (14%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR 755
++ IG G G V++ + P M VA+K ++ + +E + +
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFD 449
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKL----LVDWVSRYNIAVGIA 811
H +IV+L+G + E V ++ + L L ++ L L+ + A ++
Sbjct: 450 HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILY------AYQLS 501
Query: 812 QGLNYLH-HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGY 870
L YL +HRDI + N+L+ +N ++ DFGL+R M S G
Sbjct: 502 TALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGK 553
Query: 871 I-----APEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ APE + SD++ FGV + E+L G P
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 32/221 (14%)
Query: 704 NIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
+G G G+VY+ P VA+K + + + E S++ +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHH 89
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSR------YNIAVGIAQ 812
+VRLLG + +++ + M L L ++ +A IA
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 813 GLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYI- 871
G+ YL+ +HRD+ + N ++ + +I DFG+ R + ET G G +
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRKGGKGLLP 203
Query: 872 ----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+PE G +T SD++SFGVVL E+ T + P
Sbjct: 204 VRWMSPESLKDGVFT----TYSDVWSFGVVLWEIATLAEQP 240
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 52/215 (24%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL---FREVSLLGRLRHRNIVRL 762
+G G G VYKA+ + A K + + +S ++L E+ +L H IV+L
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVI-----ETKSEEELEDYIVEIEILATCDHPYIVKL 81
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
LG +++ + ++ ++ P ++ + + L + + + + LN+LH
Sbjct: 82 LGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQV--VCRQMLEALNFLHSK-- 136
Query: 823 PPVIHRDIKSNNILLDANLEARIADFG----LARMMLHKNETVSMVAGSYGYIAPE---- 874
+IHRD+K+ N+L+ + R+ADFG + + ++ S + Y ++APE
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD---SFIGTPY-WMAPEVVMC 191
Query: 875 -----YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
Y D K+DI+S G+ L+E+ + P
Sbjct: 192 ETMKDTPY----DYKADIWSLGITLIEMAQIEPPH 222
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 56/245 (22%), Positives = 84/245 (34%), Gaps = 50/245 (20%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVK---KLWRSDNDIESGDDLFREVSLLGRLRHRNIVRL 762
IG G G+V A ++ + A+K K + + + + EV L+ +L H NI RL
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 763 LGYLHNETNVMMVYDYM------------------------------PNDSLGEALHGKE 792
+E + +V + P E
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 793 AGKLLVDWVSRYN------IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEAR-- 844
I I L+YLH + HRDIK N L N
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 845 IADFGLARMMLHKNE----TVSMVAGSYGYIAPE--YGYTLKVDEKSDIYSFGVVLLELL 898
+ DFGL++ N ++ AG+ ++APE K D +S GV+L LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 899 TGKMP 903
G +P
Sbjct: 271 MGAVP 275
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 26/219 (11%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL--FREVSLLGRLRHRNIVR 761
IG G G+V+K +VA+KK D + RE+ +L +L+H N+V
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESED-DPVIKKIALREIRMLKQLKHPNLVN 66
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
LL + + +V++Y + + L + + + + + +I Q +N+ H
Sbjct: 67 LLEVFRRKRRLHLVFEYCDHT-VLHEL--DRYQRGVPEHLVK-SITWQTLQAVNFCHKHN 122
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVS-MVAGSYGYIAPE--YG-- 876
IHRD+K NIL+ + ++ DFG AR++ ++ VA + Y +PE G
Sbjct: 123 ---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW-YRSPELLVGDT 178
Query: 877 -YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
Y V D+++ G V ELL+G P + G D+
Sbjct: 179 QYGPPV----DVWAIGCVFAELLSGV----PLWPGKSDV 209
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 40/228 (17%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL--FREVSLLGRLRHRNIVR 761
+G G VYK + VA+K++ + D+ E G RE+SL+ L+H NIVR
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEV-KLDS--EEGTPSTAIREISLMKELKHENIVR 67
Query: 762 LLGYLHNETNVMMVYDYMPND--SLGEALHGKEAGKLLVDWVSRYNIAVGIAQ---GLNY 816
L +H E + +V+++M ND ++ + L + Q GL +
Sbjct: 68 LYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL----ELNLVKYFQWQLLQGLAF 123
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM---LHK--NETVSMVAGSYGYI 871
H + ++HRD+K N+L++ + ++ DFGLAR ++ +E V++ Y
Sbjct: 124 CHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL-----WYR 175
Query: 872 APE--YG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
AP+ G Y+ +D I+S G +L E++TGK P F G+ D
Sbjct: 176 APDVLMGSRTYSTSID----IWSCGCILAEMITGK----PLFPGTNDE 215
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 45/219 (20%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLW--RSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V+ E + +K + RS +E + E+ +L L H NI+++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME---QIEAEIEVLKSLDHPNIIKIF 86
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVG-------------I 810
+ N+ +V + GE L++ + +
Sbjct: 87 EVFEDYHNMYIVMETCEG---GE----------LLERIVSAQARGKALSEGYVAELMKQM 133
Query: 811 AQGLNYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMMLHKNETVSMVAGS 867
L Y H V+H+D+K NIL + +I DFGLA + +E + AG+
Sbjct: 134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEHSTNAAGT 189
Query: 868 YGYIAPE---YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y+APE K DI+S GVV+ LLTG +P
Sbjct: 190 ALYMAPEVFKRDV----TFKCDIWSAGVVMYFLLTGCLP 224
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 51/218 (23%), Positives = 85/218 (38%), Gaps = 42/218 (19%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G G +V + A + L RE + L+H NIVRL
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 765 YLHNETNVMMVYDYMPNDSLGE-----ALHG----KEAGKLLVDWVSRYNIAVGIAQGLN 815
+ E + +++D + GE +A + I + +
Sbjct: 78 SISEEGHHYLIFDLVTG---GELFEDIVAREYYSEADASHCIQQ----------ILEAVL 124
Query: 816 YLH-HDCQPPVIHRDIKSNNILL-----DANLEARIADFGLARMMLHKNETVSMVAGSYG 869
+ H V+HR++K N+LL A + ++ADFGLA + + + AG+ G
Sbjct: 125 HCHQMG----VVHRNLKPENLLLASKLKGAAV--KLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 870 YIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y++PE Y V D+++ GV+L LL G P
Sbjct: 179 YLSPEVLRKDPYGKPV----DLWACGVILYILLVGYPP 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 34/211 (16%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD---LFREVSLLGRLRHRNIVRL 762
IG G GIV A VAVK + D+ LF EV ++ +H N+V +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMM-----DLRKQQRRELLFNEVVIMRDYQHFNVVEM 107
Query: 763 LG-YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
YL E + ++ +++ +L + + +L + ++ + + Q L YLH
Sbjct: 108 YKSYLVGE-ELWVLMEFLQGGALTDIVS---QVRLNEEQIAT--VCEAVLQALAYLH--- 158
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFG----LARMMLHKNETVSMVAGSYGYIAPE--- 874
VIHRDIKS++ILL + +++DFG +++ + + S+V Y ++APE
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK---SLVGTPY-WMAPEVIS 214
Query: 875 -YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
Y + DI+S G++++E++ G+ P
Sbjct: 215 RSLY----ATEVDIWSLGIMVIEMVDGEPPY 241
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G GIV A VA+KKL R + +RE+ L+ + H+NI+ LL
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 764 ------GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
L +V +V + M + L + + + L Y + + G+ +L
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQME-----LDHERMSY-LLYQMLCGIKHL 143
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGY 877
H +IHRD+K +NI++ ++ +I DFGLAR V Y Y APE
Sbjct: 144 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVIL 199
Query: 878 TLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
+ E DI+S G ++ E++ G L P
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGG-VLFP 227
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLL 763
+G G I K + + AVK + + + +E++ L H NIV+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA-----NTQKEITALKLCEGHPNIVKLH 72
Query: 764 GYLHNETNVMMVYDYMPNDSLGEAL-----HG----KEAGKLLVDWVSRYNIAVGIAQGL 814
H++ + +V + + GE EA ++ + +
Sbjct: 73 EVFHDQLHTFLVMELLNG---GELFERIKKKKHFSETEASYIMRK----------LVSAV 119
Query: 815 NYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMMLHKNETVSMVAGSYGYI 871
+++H V+HRD+K N+L + NLE +I DFG AR+ N+ + + Y
Sbjct: 120 SHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176
Query: 872 APE----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
APE GY DE D++S GV+L +L+G++P
Sbjct: 177 APELLNQNGY----DESCDLWSLGVILYTMLSGQVP 208
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-27
Identities = 67/259 (25%), Positives = 98/259 (37%), Gaps = 53/259 (20%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL---------FREVSLLGRLR 755
I G G V + VA+K+++ + +D + + L RE+ LL
Sbjct: 29 FISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 756 HRNIVRLL-----GYLHNETNVMMVYDYMPNDSLGEALHG--KEAGKLLVDWVSRYNIAV 808
H NI+ L + +V + M D L + ++ +Y
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-----LAQVIHDQRIVISPQHIQY-FMY 141
Query: 809 GIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY 868
I GL+ LH + V+HRD+ NILL N + I DF LAR V +
Sbjct: 142 HILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 869 GYIAPE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS------KDIVEW 917
Y APE G+T V D++S G V+ E+ K F GS IVE
Sbjct: 199 -YRAPELVMQFKGFTKLV----DMWSAGCVMAEMFNRK----ALFRGSTFYNQLNKIVEV 249
Query: 918 V-------LSMIKSNKAQD 929
V + M S A+D
Sbjct: 250 VGTPKIEDVVMFSSPSARD 268
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 57/306 (18%), Positives = 100/306 (32%), Gaps = 90/306 (29%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G GG G+V++A+ A+K++ + ++ + + REV L +L H IVR
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-EKVMREVKALAKLEHPGIVRYFN 71
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEA------------------------------- 793
+ E+ +
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 794 -------------GKLLVDWVSRYN------------IAVGIAQGLNYLHHDCQPPVIHR 828
+ L DW++R I + IA+ + +LH ++HR
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHR 188
Query: 829 DIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA------------GSYGYIAPEYG 876
D+K +NI + ++ DFGL M E +++ G+ Y++PE
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 877 YTLKVDEKSDIYSFGVVLLELLT-----------------GKMPLDPAFGGSKDIVEWVL 919
+ K DI+S G++L ELL K PL V
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQ-KYPQEHMMVQ 307
Query: 920 SMIKSN 925
M+ +
Sbjct: 308 DMLSPS 313
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-27
Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 47/225 (20%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVK-----KLWRSDNDIESG-DDLFREVSLLGRLR-HR 757
+IG G + +V + AVK S +E + RE +L ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEAL-----HG----KEAGKLLVDWVSRYNIAV 808
+I+ L+ + + + +V+D M GE KE ++
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRK---GELFDYLTEKVALSEKETRSIMRS--------- 208
Query: 809 GIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY 868
+ + +++LH + ++HRD+K NILLD N++ R++DFG + + E + + G+
Sbjct: 209 -LLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKLRELCGTP 263
Query: 869 GYIAPE----------YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
GY+APE GY +V D+++ GV+L LL G P
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEV----DLWACGVILFTLLAGSPP 304
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 61/226 (26%), Positives = 92/226 (40%), Gaps = 42/226 (18%)
Query: 704 NIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
+G G G VY+ + + VAVK L + D E ++ + H+N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQN 94
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEAL-----HGKEAGKL-LVDWVSRYNIAVGIAQ 812
IVR +G ++ + M L L + L ++D + +A IA
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH---VARDIAC 151
Query: 813 GLNYL--HHDCQPPVIHRDIKSNNILLDANLEAR---IADFGLARMMLHKNETVSMVAGS 867
G YL +H IHRDI + N LL R I DFG+AR + ++ G
Sbjct: 152 GCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASY--YRKGG 203
Query: 868 YGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ PE G +T K+D +SFGV+L E+ + G MP
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTS----KTDTWSFGVLLWEIFSLGYMP 245
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-27
Identities = 71/273 (26%), Positives = 117/273 (42%), Gaps = 52/273 (19%)
Query: 687 QRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL-- 744
+ + ++ + IG G G+V A + + VA+KK+ + E
Sbjct: 16 EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI----SPFEHQTYCQR 71
Query: 745 -FREVSLLGRLRHRNIVRLL-----GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLV 798
RE+ +L R RH NI+ + + +V +V D M D L+ + L
Sbjct: 72 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLS 126
Query: 799 DWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858
+ Y I +GL Y+H V+HRD+K +N+LL+ + +I DFGLAR+ +
Sbjct: 127 NDHICY-FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 859 ETVSM----VAGSYGYIAPE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFG 909
+ VA + Y APE GYT + DI+S G +L E+L+ + P F
Sbjct: 183 DHTGFLTEYVATRW-YRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNR----PIFP 233
Query: 910 GS------KDIVEWV-------LSMIKSNKAQD 929
G I+ + L+ I + KA++
Sbjct: 234 GKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 39/216 (18%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G G +V + + A K + L RE + +L+H NIVRL
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 765 YLHNETNVMMVYDYMPNDSLGE-----ALHG----KEAGKLLVDWVSRYNIAVGIAQGLN 815
+ E+ +V+D + GE +A + I + +
Sbjct: 73 SIQEESFHYLVFDLVTG---GELFEDIVAREFYSEADASHCIQQ----------ILESIA 119
Query: 816 YLH-HDCQPPVIHRDIKSNNILLDANLEA---RIADFGLARMMLHKNETVSMVAGSYGYI 871
Y H + ++HR++K N+LL + + ++ADFGLA + + +E AG+ GY+
Sbjct: 120 YCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPGYL 174
Query: 872 APE----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
+PE Y+ V DI++ GV+L LL G P
Sbjct: 175 SPEVLKKDPYSKPV----DIWACGVILYILLVGYPP 206
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL--FREVSLLGRLRHRNIVR 761
+G G G VYKA + VA+K++ R +++ E G REVSLL L+HRNI+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEE-GVPGTAIREVSLLKELQHRNIIE 97
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
L +H+ + ++++Y ND L + + + + + + + + G+N+ H
Sbjct: 98 LKSVIHHNHRLHLIFEYAEND-LKKYMD--KNPDVSMRVIKSF--LYQLINGVNFCHSRR 152
Query: 822 QPPVIHRDIKSNNILLDANLEAR-----IADFGLARMMLHKNETVSMVAGSYGYIAPE-- 874
+HRD+K N+LL + + I DFGLAR + + Y PE
Sbjct: 153 ---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209
Query: 875 YG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
G Y+ V DI+S + E+L P F G +I
Sbjct: 210 LGSRHYSTSV----DIWSIACIWAEMLMKT----PLFPGDSEI 244
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVS---LLGRLRHRNIVR 761
+ G G G V + M VA+KK+ I+ RE+ L L H NIV+
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKV------IQDPRFRNRELQIMQDLAVLHHPNIVQ 83
Query: 762 LLGYLH-------NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
L Y + + + +V +Y+P+ + + + + + +
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-FLFQLIRSI 142
Query: 815 NYLHHDCQPPVIHRDIKSNNILLD-ANLEARIADFGLARMMLHKNETVSMVAGSYGYIAP 873
LH V HRDIK +N+L++ A+ ++ DFG A+ + V+ + Y Y AP
Sbjct: 143 GCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-YRAP 200
Query: 874 E-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
E YT V DI+S G + E++ G+ P+
Sbjct: 201 ELIFGNQHYTTAV----DIWSVGCIFAEMMLGE-PIFR 233
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 67/250 (26%), Positives = 103/250 (41%), Gaps = 45/250 (18%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V A R VA+KKL R +RE+ LL ++H N++ LL
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 764 ------GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
L N + +V +M D L + + K + +Y + + +GL Y+
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQTD-LQKIMGLK-----FSEEKIQY-LVYQMLKGLKYI 142
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE--- 874
H V+HRD+K N+ ++ + E +I DFGLAR E V + Y APE
Sbjct: 143 H---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVVTRW-YRAPEVIL 196
Query: 875 --YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS------KDIVEWV-------L 919
Y V DI+S G ++ E+LTGK F G I++ +
Sbjct: 197 SWMHYNQTV----DIWSVGCIMAEMLTGK----TLFKGKDYLDQLTQILKVTGVPGTEFV 248
Query: 920 SMIKSNKAQD 929
+ A+
Sbjct: 249 QKLNDKAAKS 258
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 63/246 (25%), Positives = 89/246 (36%), Gaps = 11/246 (4%)
Query: 123 QNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSF 182
+ P G+ ++ +N N + LE L + +F
Sbjct: 51 VRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAF 108
Query: 183 RNLQKLKFLGLSGNNLTGKIPPE-LGQLSSLETIILGYNAFEGEIPAE-FGNLTNLRYLD 240
L L L L N LT IP LS L+ + L N E IP+ F + +LR LD
Sbjct: 109 NGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLD 166
Query: 241 LAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIP 299
L I A L L + L N P L + L LDLS N +S P
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRP 224
Query: 300 VKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP-LRR 358
L +LQ L ++ +Q+ + + L L + L N+L LP L L R
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLER 283
Query: 359 LDASSN 364
+ N
Sbjct: 284 IHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 58/234 (24%), Positives = 93/234 (39%), Gaps = 10/234 (4%)
Query: 353 SSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNN 412
S+ ++ L E+P G+ S N L L N S + L +++ N
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 413 LISGTIPVG-LGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSIL 471
I TI +G L +L LE+ +N LT + L + + N +ES +
Sbjct: 99 HIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFN 157
Query: 472 SIPSLQTFMASHNNLQAKIPNE-LQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLR 530
IPSL+ + I + +L L+L+ +L EIP + KL L+L
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLS 215
Query: 531 NNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYNKLE 583
N S P + + L L M + + I N F +L +NL++N L
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQI-QVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-23
Identities = 59/303 (19%), Positives = 106/303 (34%), Gaps = 58/303 (19%)
Query: 259 KLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQL 318
+ + V + N ++P + T+ L+L +NQI L++L++L L N +
Sbjct: 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 319 TGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP-LRRLDASSNLLSGEIPTGL-CD 376
+ L L LEL+ N + ++P L+ L +N + IP+
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNR-LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNR 158
Query: 377 SGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVG-LGNLPSLQRLEMAN 435
+L +L L +S I G L +L+ L +A
Sbjct: 159 IPSLRRLDLGEL-----------------------KRLS-YISEGAFEGLSNLRYLNLAM 194
Query: 436 NNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQ 495
NL +IP+ L L +D+S NHL + I P Q
Sbjct: 195 CNLR-EIPNLTPL-IKLDELDLSGNHLSA--------IR----------------PGSFQ 228
Query: 496 ACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSN 555
L L + + + + + + LV +NL +N + + L + + +
Sbjct: 229 GLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHH 288
Query: 556 NSL 558
N
Sbjct: 289 NPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 65/315 (20%), Positives = 104/315 (33%), Gaps = 64/315 (20%)
Query: 179 PTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRY 238
P+ + + NL ++P + ++ + L N + F +L +L
Sbjct: 36 PSVCSCSNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEI 92
Query: 239 LDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQISG 296
L L+ + I A L L T+ L+ N T IP ++ L L L +N I
Sbjct: 93 LQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE- 149
Query: 297 EIPVKL-AELKNLQLLNLM-CNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSS 354
IP + +L+ L+L +L+ + L+ L L L
Sbjct: 150 SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL----------------- 192
Query: 355 PLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLI 414
+ L EIP L L +L L N S P S L ++ + + I
Sbjct: 193 -------AMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
Query: 415 SGTIPVG-LGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSIL-S 472
I NL SL + +A+NNLT LP +
Sbjct: 244 Q-VIERNAFDNLQSLVEINLAHNNLT-------------------------LLPHDLFTP 277
Query: 473 IPSLQTFMASHNNLQ 487
+ L+ HN
Sbjct: 278 LHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 66/303 (21%), Positives = 103/303 (33%), Gaps = 65/303 (21%)
Query: 54 HCNWTG--VWCNSRGF----------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNE 101
C+ V C + L+L + + + LR L L + N
Sbjct: 40 SCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 102 FASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNA 161
+ + L L ++++ N LT++
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNR--------------LTTIP----------NGAFVYL 135
Query: 162 TSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNA 221
+ L+ L R + E +F + L+ L L +LS + A
Sbjct: 136 SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELK----------RLSYISE-----GA 180
Query: 222 FEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPE-LGS 280
FEG L+NLRYL+LA+ +L P L L KL + L N+ + I P
Sbjct: 181 FEG--------LSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLS-AIRPGSFQG 229
Query: 281 ITSLAFLDLSDNQISGEIPVK-LAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWK 339
+ L L + +QI I L++L +NL N LT L D L LE + L
Sbjct: 230 LMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHH 288
Query: 340 NSL 342
N
Sbjct: 289 NPW 291
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 51/234 (21%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVK---KLWRSDNDIESGDDLFREVSLLGRLRHRNIVR 761
+IG G +V + AVK + + S +DL RE S+ L+H +IV
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVG------------ 809
LL ++ + MV+++M + L + V R +
Sbjct: 91 LLETYSSDGMLYMVFEFM------------DGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 810 IAQGLNYLH-HDCQPPVIHRDIKSNNILL-----DANLEARIADFGLARMMLHKNETVSM 863
I + L Y H ++ +IHRD+K + +LL A + ++ FG+A +
Sbjct: 139 ILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPV--KLGGFGVAIQLGESGLVAGG 192
Query: 864 VAGSYGYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKD 913
G+ ++APE Y + D++ GV+L LL+G +P F G+K+
Sbjct: 193 RVGTPHFMAPEVVKREPY----GKPVDVWGCGVILFILLSGCLP----FYGTKE 238
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 39/227 (17%)
Query: 704 NIIGMGGNGIVYKAEF-----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHR 757
+G G G V +A + VAVK L +S + + L E+ ++ L +H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHE 110
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN----------IA 807
NIV LLG + V+++ +Y L L K + N +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 808 VGIAQGLNYL-HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG 866
+AQG+ +L +C IHRD+ + N+LL A+I DFGLAR +++ + +
Sbjct: 171 SQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN---YIVK 223
Query: 867 SYGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ APE YT+ +SD++S+G++L E+ + G P
Sbjct: 224 GNARLPVKWMAPESIFDCVYTV----QSDVWSYGILLWEIFSLGLNP 266
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 61/260 (23%), Positives = 103/260 (39%), Gaps = 13/260 (5%)
Query: 283 SLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSL 342
S + + ++ +P + + L L N+L L +LT+L L L N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 343 -IGSLPMRLGQSSP-LRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSL-S 399
+ + L+ LD S N + + + L L +++ S+
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123
Query: 400 TCKSLVRVRVQNNLISGTIPVG-LGNLPSLQRLEMANNNLTGQIPDDI-SLSTSLSFVDI 457
+ ++L+ + + + G L SL+ L+MA N+ DI + +L+F+D+
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 458 SWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPAS 517
S LE P++ S+ SLQ SHNN + + SL VLD S N +
Sbjct: 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241
Query: 518 I--ASCEKLVSLNLRNNRFS 535
L LNL N F+
Sbjct: 242 ELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 68/316 (21%), Positives = 112/316 (35%), Gaps = 68/316 (21%)
Query: 54 HCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANL 113
C+ T + CNS+G SV I S + L + N+ S L
Sbjct: 6 SCSGTEIRCNSKGLT------------SVPTGI--PSSATRLELESNKLQSLPHGVFDKL 51
Query: 114 TALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSF 173
T L + +S N L+ S + G TSL+ LD +
Sbjct: 52 TQLTKLSLSSNG--------------LSFKGCCSQSDFGT--------TSLKYLDLSFNG 89
Query: 174 FEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNL 233
++ ++F L++L+ L +NL + F +L
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV-----------------------FLSL 125
Query: 234 TNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSD 291
NL YLD++ L L + + N+F P+ + +L FLDLS
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 292 NQISGEIPVK-LAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRL 350
Q+ ++ L +LQ+LN+ N L L L+VL+ N ++ + +
Sbjct: 185 CQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQE 242
Query: 351 GQSSP--LRRLDASSN 364
Q P L L+ + N
Sbjct: 243 LQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 38/172 (22%), Positives = 65/172 (37%), Gaps = 9/172 (5%)
Query: 417 TIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESY--LPSSILSIP 474
++P G+ S RLE+ +N L T L+ + +S N L S
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 475 SLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNR 533
SL+ S N + + + L LD ++L S+ S L+ L++ +
Sbjct: 79 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 534 FSGEIPKAV-ATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYNKLE 583
+ + +L +L M+ NS + F L L+LS +LE
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 33/159 (20%), Positives = 62/159 (38%), Gaps = 9/159 (5%)
Query: 435 NNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAK--IPN 492
+ LT +P I +S + +++ N L+S + L S N L K
Sbjct: 16 SKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72
Query: 493 ELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAV-ATMPTLAIL 551
SL LDLS N + + ++ E+L L+ +++ +V ++ L L
Sbjct: 73 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 131
Query: 552 DMSNNSLFGRIPEN-FGASPALEMLNLSYNKLEGPVPSN 589
D+S+ F +LE+L ++ N + +
Sbjct: 132 DISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 33/158 (20%), Positives = 63/158 (39%), Gaps = 5/158 (3%)
Query: 69 EKLDLSNMSLNGSVSENI-RGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
E LD + +L ++ LR+L L+I + L++L+ + ++ N+F
Sbjct: 104 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163
Query: 128 GSFPTG-LGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQ 186
+F + LT ++ S P + +SL+ L+ + F ++ L
Sbjct: 164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223
Query: 187 KLKFLGLSGNNLTGKIPPEL--GQLSSLETIILGYNAF 222
L+ L S N++ + SSL + L N F
Sbjct: 224 SLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 29/144 (20%), Positives = 49/144 (34%), Gaps = 27/144 (18%)
Query: 451 SLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSL 510
S + + + L S +P+ I S N LQ+ L+ L LSSN L
Sbjct: 8 SGTEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 511 SGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASP 570
S + G +L LD+S N + + NF
Sbjct: 65 S--------------FKGCCSQSDFG--------TTSLKYLDLSFNGV-ITMSSNFLGLE 101
Query: 571 ALEMLNLSYNKLEGPVPSNGILMN 594
LE L+ ++ L+ + + ++
Sbjct: 102 QLEHLDFQHSNLKQ-MSEFSVFLS 124
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 61/226 (26%), Positives = 92/226 (40%), Gaps = 42/226 (18%)
Query: 704 NIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
+G G G VY+ + + VAVK L + D E ++ + H+N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQN 135
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEAL-----HGKEAGKL-LVDWVSRYNIAVGIAQ 812
IVR +G ++ + M L L + L ++D + +A IA
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH---VARDIAC 192
Query: 813 GLNYL--HHDCQPPVIHRDIKSNNILLDANLEAR---IADFGLARMMLHKNETVSMVAGS 867
G YL +H IHRDI + N LL R I DFG+AR + ++ G
Sbjct: 193 GCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRAGY--YRKGG 244
Query: 868 YGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ PE G +T K+D +SFGV+L E+ + G MP
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTS----KTDTWSFGVLLWEIFSLGYMP 286
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 69/208 (33%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKL-WRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G G VY A R VVA+KK+ + E D+ +EV L +LRH N ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 765 -YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
YL +V +Y S + L + L ++ + G QGL YLH
Sbjct: 122 CYLRE-HTAWLVMEYCLG-SASDLLEVHK-KPLQEVEIAA--VTHGALQGLAYLHSH--- 173
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE-------YG 876
+IHRD+K+ NILL ++ DFG A +M N S V Y ++APE
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPY-WMAPEVILAMDEGQ 229
Query: 877 YTLKVDEKSDIYSFGVVLLELLTGKMPL 904
Y D K D++S G+ +EL K PL
Sbjct: 230 Y----DGKVDVWSLGITCIELAERKPPL 253
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 42/237 (17%), Positives = 86/237 (36%), Gaps = 42/237 (17%)
Query: 693 SSEILACVKESNIIGMGGNGIVYKAEFHRP-HMVVAVKKLWRSDNDIESGDDLFREVSLL 751
S E IG G G V+K R + A+K+ + + REV
Sbjct: 6 KSRYTTEFHELEKIGSGEFGSVFKC-VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 752 GRL-RHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYNIAV 808
L +H ++VR + ++++ +Y SL +A+ + + + ++ +
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK--DLLL 122
Query: 809 GIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN-------------------LEARIADFG 849
+ +GL Y+H ++H DIK +NI + + +I D G
Sbjct: 123 QVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 850 LARMMLHKNETVSMVAGSYGYIAPE-----YGYTLKVDEKSDIYSFGVVLLELLTGK 901
+ + G ++A E Y + K+DI++ + ++ +
Sbjct: 180 HVTRI---SSPQVEE-GDSRFLANEVLQENYTH----LPKADIFALALTVVCAAGAE 228
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-26
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G GIV A VA+KKL R + +RE+ L+ + H+NI+ LL
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 764 ------GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
L +V +V + M + L + L Y + + G+ +L
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDAN-----LC-QVIQMELDHERMSY-LLYQMLCGIKHL 180
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGY 877
H +IHRD+K +NI++ ++ +I DFGLAR V Y Y APE
Sbjct: 181 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVIL 236
Query: 878 TLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
+ E DI+S G ++ E++ K L P
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHK-ILFP 264
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 41/231 (17%)
Query: 699 CVKESNIIGMGGNGIVYKAEFHRP--HMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-R 755
+K ++IG G G V KA + M A+K++ + + D E+ +L +L
Sbjct: 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 84
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN---------- 805
H NI+ LLG + + + +Y P+ +L + L + + +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 806 --IAVGIAQGLNYL-HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVS 862
A +A+G++YL IHRD+ + NIL+ N A+IADFGL+R E
Sbjct: 145 LHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR----GQEVY- 195
Query: 863 MVAGSYGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
V + G + A E Y YT SD++S+GV+L E+++ G P
Sbjct: 196 -VKKTMGRLPVRWMAIESLNYSVYT----TNSDVWSYGVLLWEIVSLGGTP 241
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 48/226 (21%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVK-------KLWRSDNDIESGDDLFREVSLLGRL-RH 756
I+G G + +V + AVK + ++ E + +EV +L ++ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 757 RNIVRLLGYLHNETNVMMVYDYMPNDSLGE-----ALHG----KEAGKLLVDWVSRYNIA 807
NI++L T +V+D M GE KE K++
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKK---GELFDYLTEKVTLSEKETRKIMRA-------- 132
Query: 808 VGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS 867
+ + + LH ++HRD+K NILLD ++ ++ DFG + + E + V G+
Sbjct: 133 --LLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGT 186
Query: 868 YGYIAPE----------YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y+APE GY +V D++S GV++ LL G P
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 49/225 (21%)
Query: 705 IIGMGGNGIVYKAEFHRP-HMVVAVK-----KLW-RSDNDIESGDDLFREVSLLGRLRHR 757
+G G G V A F R VA+K K S + + ++ E+ +L +L H
Sbjct: 17 TLGSGACGEVKLA-FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWV---SRY------NIAV 808
I+++ + + + +V + M GE L D V R
Sbjct: 76 CIIKIKNF-FDAEDYYIVLELMEG---GE----------LFDKVVGNKRLKEATCKLYFY 121
Query: 809 GIAQGLNYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMMLHKNETVSMVA 865
+ + YLH + +IHRD+K N+LL + + +I DFG ++++ + + +
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC 177
Query: 866 GSYGYIAPE-------YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
G+ Y+APE GY V D +S GV+L L+G P
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPP 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 75/248 (30%), Positives = 111/248 (44%), Gaps = 44/248 (17%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL-- 763
+G G G V A + + VAVKKL R I +RE+ LL ++H N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 764 ----GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
L +V +V M D L+ + L D ++ + I +GL Y+H
Sbjct: 97 FTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQF-LIYQILRGLKYIH- 149
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----- 874
+IHRD+K +N+ ++ + E +I DFGLAR +E VA + Y APE
Sbjct: 150 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTGYVATRW-YRAPEIMLNW 204
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS------KDIVEWV-------LSM 921
Y V DI+S G ++ ELLTG+ F G+ K I+ V L
Sbjct: 205 MHYNQTV----DIWSVGCIMAELLTGR----TLFPGTDHIDQLKLILRLVGTPGAELLKK 256
Query: 922 IKSNKAQD 929
I S A++
Sbjct: 257 ISSESARN 264
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 49/224 (21%)
Query: 706 IGMGGNGIVYKAEFHRP-HMVVAVK-----KLW-RSDNDIESGDDLFREVSLLGRLRHRN 758
+G G G V A F R VA++ K S + + ++ E+ +L +L H
Sbjct: 143 LGSGACGEVKLA-FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWV---SRYN------IAVG 809
I+++ + + + +V + M GE L D V R
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEG---GE----------LFDKVVGNKRLKEATCKLYFYQ 247
Query: 810 IAQGLNYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMMLHKNETVSMVAG 866
+ + YLH + +IHRD+K N+LL + + +I DFG ++++ + + + G
Sbjct: 248 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCG 303
Query: 867 SYGYIAPE-------YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
+ Y+APE GY V D +S GV+L L+G P
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPP 343
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 42/216 (19%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
++G G V+ + + A+K + + L E+++L +++H NIV L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCI--KKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWV---SRY------NIAVGIAQGLN 815
+ T+ +V + GE L D + Y + + +
Sbjct: 74 IYESTTHYYLVMQLVSG---GE----------LFDRILERGVYTEKDASLVIQQVLSAVK 120
Query: 816 YLH-HDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMMLHKNETVSMVAGSYGYI 871
YLH + ++HRD+K N+L + N + I DFGL++M +N +S G+ GY+
Sbjct: 121 YLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTACGTPGYV 174
Query: 872 APE----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
APE Y+ V D +S GV+ LL G P
Sbjct: 175 APEVLAQKPYSKAV----DCWSIGVITYILLCGYPP 206
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 62/263 (23%), Positives = 106/263 (40%), Gaps = 60/263 (22%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL---FREVSLLGRLRHRNIVR 761
++G G G+V A +VA+KK+ + RE+ +L +H NI+
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKI----EPFDKPLFALRTLREIKILKHFKHENIIT 73
Query: 762 LL-----GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNY 816
+ N V ++ + M D LH + ++L D +Y + +
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQY-FIYQTLRAVKV 127
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG------- 869
LH VIHRD+K +N+L+++N + ++ DFGLAR++ S G
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 870 ---YIAPE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIV------ 915
Y APE Y+ + D++S G +L EL + P F G +D
Sbjct: 185 TRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR----PIFPG-RDYRHQLLLI 235
Query: 916 ---------EWVLSMIKSNKAQD 929
+ L I+S +A++
Sbjct: 236 FGIIGTPHSDNDLRCIESPRARE 258
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 37/229 (16%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVK-----KLWRSDNDIESG------------------- 741
IG G G+V A + A+K KL R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 742 DDLFREVSLLGRLRHRNIVRLLGYLH--NETNVMMVYDYMPNDSLGEALHGKEAGKLLVD 799
+ +++E+++L +L H N+V+L+ L NE ++ MV++ + G + L D
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ---GPVMEVPTLKPLSED 137
Query: 800 WVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859
Y + +G+ YLH+ +IHRDIK +N+L+ + +IADFG++ +
Sbjct: 138 QARFY--FQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 860 TVSMVAGSYGYIAPE--YGYTLKVD-EKSDIYSFGVVLLELLTGKMPLD 905
+S G+ ++APE + D+++ GV L + G+ P
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 63/237 (26%), Positives = 96/237 (40%), Gaps = 50/237 (21%)
Query: 704 NIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
IG G G V++A P +VAVK L + + + D RE +L+ + N
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPN 111
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYN----------- 805
IV+LLG + ++++YM L E L L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 806 -------IAVGIAQGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856
IA +A G+ YL +HRD+ + N L+ N+ +IADFGL+R +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 857 KNETVSMVAGSYGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ A I PE Y YT +SD++++GVVL E+ + G P
Sbjct: 227 ADY---YKADGNDAIPIRWMPPESIFYNRYT----TESDVWAYGVVLWEIFSYGLQP 276
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL--FREVSLLGRLRHRNIVR 761
++G G G+V K +VA+KK +D + RE+ LL +LRH N+V
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK-MVKKIAMREIKLLKQLRHENLVN 88
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
LL + +V++++ + + + L G L V +Y I G+ + H
Sbjct: 89 LLEVCKKKKRWYLVFEFVDHT-ILDDLELFPNG-LDYQVVQKY--LFQIINGIGFCHSHN 144
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVS-MVAGSYGYIAPE--YG-- 876
+IHRDIK NIL+ + ++ DFG AR + E VA + Y APE G
Sbjct: 145 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW-YRAPELLVGDV 200
Query: 877 -YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
Y V D+++ G ++ E+ G+ P F G DI
Sbjct: 201 KYGKAV----DVWAIGCLVTEMFMGE----PLFPGDSDI 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 54/239 (22%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-----REVSLLGRLRHRN 758
IG G G V+KA + VA+KK+ +N+ E F RE+ +L L+H N
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEG----FPITALREIKILQLLKHEN 77
Query: 759 IVRLLGYLHNE--------TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGI 810
+V L+ + ++ +V+D+ +D L L K + + R +
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVL-VKFTLSEIKRV-----M 130
Query: 811 AQ---GLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS 867
GL Y+H + ++HRD+K+ N+L+ + ++ADFGLAR + +
Sbjct: 131 QMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF---SLAKNSQPNR 184
Query: 868 YG-------YIAPE--YG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
Y Y PE G Y + D++ G ++ E+ T P G+ +
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS----PIMQGNTEQ 235
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 57/251 (22%), Positives = 95/251 (37%), Gaps = 41/251 (16%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLL 763
++G G + V AVK + +FREV +L + + HRN++ L+
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGK------EAGKLLVDWVSRYNIAVGIAQGLNYL 817
+ E +V++ M S+ +H + EA ++ D +A L++L
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD----------VASALDFL 127
Query: 818 HHDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMM-------LHKNETVSMVAGS 867
H + HRD+K NIL + +I DF L + + GS
Sbjct: 128 H---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 868 YGYIAPE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922
Y+APE D++ D++S GV+L LL+G P F G
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP----FVGRCGSDCGWDRGE 240
Query: 923 KSNKAQDEALD 933
Q+ +
Sbjct: 241 ACPACQNMLFE 251
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 68/232 (29%), Positives = 101/232 (43%), Gaps = 42/232 (18%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-----REVSLLGRLR--- 755
IG+G G VYKA VA+K + R N G REV+LL RL
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGG-GGGGLPISTVREVALLRRLEAFE 72
Query: 756 HRNIVRLLGYLH-----NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGI 810
H N+VRL+ E V +V++++ D L L L + +
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDL--MRQF 129
Query: 811 AQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM----MLHKNETVSMVAG 866
+GL++LH +C ++HRD+K NIL+ + ++ADFGLAR+ M V++
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL--- 183
Query: 867 SYGYIAPE--YG--YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
Y APE Y V D++S G + E+ K P F G+ +
Sbjct: 184 --WYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRK----PLFCGNSEA 225
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-26
Identities = 64/238 (26%), Positives = 98/238 (41%), Gaps = 43/238 (18%)
Query: 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVR 761
IG+G + + +M AVK + +S D E+ +L R +H NI+
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------EEIEILLRYGQHPNIIT 80
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGK------EAGKLLVDWVSRYNIAVGIAQGLN 815
L + V +V + M L + + + EA +L I + +
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT----------ITKTVE 130
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEA----RIADFGLARMMLHKNETVSMVAGSYGYI 871
YLH V+HRD+K +NIL RI DFG A+ + +N + + ++
Sbjct: 131 YLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 872 APE----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAF-GGSKDIVEWVLSMIKS 924
APE GY DI+S GV+L +LTG P F G D E +L+ I S
Sbjct: 188 APEVLERQGYDAAC----DIWSLGVLLYTMLTGYTP----FANGPDDTPEEILARIGS 237
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 57/231 (24%), Positives = 89/231 (38%), Gaps = 44/231 (19%)
Query: 704 NIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHR 757
+G G G V +A+ VAVK L + L E+ +L + H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHL 91
Query: 758 NIVRLLGY-LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN----------- 805
N+V LLG +M++ ++ +L L K +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 806 -IAVGIAQGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVS 862
+ +A+G+ +L IHRD+ + NILL +I DFGLAR + +
Sbjct: 152 CYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDI---YKDPD 203
Query: 863 MVAGSYGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
V + APE YT +SD++SFGV+L E+ + G P
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYT----IQSDVWSFGVLLWEIFSLGASP 250
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 43/218 (19%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G G +V + + A K + L RE + +L+H NIVRL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 765 YLHNETNVMMVYDYMPNDSLGE-----ALHG----KEAGKLLVDWVSRYNIAVGIAQGLN 815
+ E+ +V+D + GE +A + I + +
Sbjct: 96 SIQEESFHYLVFDLVTG---GELFEDIVAREFYSEADASHCIQQ----------ILESIA 142
Query: 816 YLH-HDCQPPVIHRDIKSNNILL-----DANLEARIADFGLARMMLHKNETVSMVAGSYG 869
Y H + ++HR++K N+LL A + ++ADFGLA + + +E AG+ G
Sbjct: 143 YCHSNG----IVHRNLKPENLLLASKAKGAAV--KLADFGLAIEV-NDSEAWHGFAGTPG 195
Query: 870 YIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y++PE Y+ V DI++ GV+L LL G P
Sbjct: 196 YLSPEVLKKDPYSKPV----DIWACGVILYILLVGYPP 229
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 30/221 (13%), Positives = 68/221 (30%), Gaps = 32/221 (14%)
Query: 706 IGMGGNGIVYKAEF-----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
+G G VY+A + +K + + + L +
Sbjct: 73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ--KPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEAL-HGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
+ + ++V + +L A+ K + ++ + A+ + + +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH- 189
Query: 820 DCQPPVIHRDIKSNNILL-----------DANLEARIADFGLARMM--LHKNETVSMVAG 866
+IH DIK +N +L D + + D G + M K +
Sbjct: 190 --DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 867 SYGYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
+ G+ E + ++ D + + +L G
Sbjct: 248 TSGFQCVEMLSNKPWNYQI----DYFGVAATVYCMLFGTYM 284
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 70/248 (28%), Positives = 114/248 (45%), Gaps = 44/248 (17%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL-- 763
+G G G V A R VA+KKL+R +RE+ LL +RH N++ LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 764 ----GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
L + T+ +V +M D L + L + ++ + + +GL Y+H
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGTD-----LGKLMKHEKLGEDRIQF-LVYQMLKGLRYIH- 145
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----- 874
+IHRD+K N+ ++ + E +I DFGLAR +E V + Y APE
Sbjct: 146 --AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVTRW-YRAPEVILNW 200
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS------KDIVEWV-------LSM 921
YT V DI+S G ++ E++TGK F GS K+I++ +
Sbjct: 201 MRYTQTV----DIWSVGCIMAEMITGK----TLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252
Query: 922 IKSNKAQD 929
++S++A++
Sbjct: 253 LQSDEAKN 260
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 47/218 (21%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G G IVY+ + A+K L ++ + + E+ +L RL H NI++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK----KIVRTEIGVLLRLSHPNIIKLKE 115
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWV---SRY------NIAVGIAQGLN 815
T + +V + + G E L D + Y + I + +
Sbjct: 116 IFETPTEISLVLELV---------TGGE----LFDRIVEKGYYSERDAADAVKQILEAVA 162
Query: 816 YLH-HDCQPPVIHRDIKSNNILL-----DANLEARIADFGLARMMLHKNETVSMVAGSYG 869
YLH + ++HRD+K N+L DA L +IADFGL++++ + V G+ G
Sbjct: 163 YLHENG----IVHRDLKPENLLYATPAPDAPL--KIADFGLSKIV-EHQVLMKTVCGTPG 215
Query: 870 YIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y APE Y +V D++S G++ LL G P
Sbjct: 216 YCAPEILRGCAYGPEV----DMWSVGIITYILLCGFEP 249
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 55/288 (19%), Positives = 115/288 (39%), Gaps = 67/288 (23%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRS----DNDIESGDDLFREVSLLGRLRHR--NI 759
+G GG G VY ++ VA+K + + ++ +G + EV LL ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGE-----ALHGK----EAGKLLVDWVSRYNIAVGI 810
+RLL + + +++ + + + + G A +
Sbjct: 111 IRLLDWFERPDSFVLILERP--EPVQDLFDFITERGALQEELARSFFWQ----------V 158
Query: 811 AQGLNYLHHDCQPPVIHRDIKSNNILLDAN-LEARIADFGLARMMLHKNETVSMVAGSYG 869
+ + + H+ V+HRDIK NIL+D N E ++ DFG ++ K+ + G+
Sbjct: 159 LEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 213
Query: 870 YIAPEY----GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN 925
Y PE+ Y + + ++S G++L +++ G +P F ++I+ +
Sbjct: 214 YSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFF---- 262
Query: 926 KAQDEALDPS-IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
++ +C+H+ L + P RPT ++
Sbjct: 263 --------RQRVSSECQHLIRWCLAL----------RPSDRPTFEEIQ 292
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 65/237 (27%), Positives = 102/237 (43%), Gaps = 50/237 (21%)
Query: 704 NIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
+G G G V KA + VAVK L + + DL E ++L ++ H +
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVNHPH 87
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYN----------- 805
+++L G + ++++ +Y SL L K L SR +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 806 -------IAVGIAQGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856
A I+QG+ YL ++HRD+ + NIL+ + +I+DFGL+R +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDV-- 200
Query: 857 KNETVSMVAGSYGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
E S V S G I A E YT +SD++SFGV+L E++T G P
Sbjct: 201 -YEEDSYVKRSQGRIPVKWMAIESLFDHIYTT----QSDVWSFGVLLWEIVTLGGNP 252
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 704 NIIGMGGNGIVYKAEFH-------RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-R 755
+G G G V AE + + VAVK L + D + DL E+ ++ + +
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGK 99
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN---------- 805
H+NI+ LLG + + ++ +Y +L E L + + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 806 --IAVGIAQGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861
+A+G+ YL IHRD+ + N+L+ N +IADFGLAR + N
Sbjct: 160 VSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDI---NNID 211
Query: 862 SMVAGSYGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ G + APE YT +SD++SFGV++ E+ T G P
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYT----HQSDVWSFGVLMWEIFTLGGSP 259
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 59/230 (25%), Positives = 92/230 (40%), Gaps = 41/230 (17%)
Query: 704 NIIGMGGNGIVYKAE-----FHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHR 757
+G G G V +A M VAVK L + + + L E+ +L L H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHM 87
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSL--------GEALHGKEAGKLLVDWVSR------ 803
NIV LLG +++ +Y L + K + ++ D
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 804 YNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM 863
+ + +A+G+ +L IHRD+ + NILL +I DFGLAR + +
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI---KNDSNY 201
Query: 864 VAGSYGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
V + APE YT +SD++S+G+ L EL + G P
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTF----ESDVWSYGIFLWELFSLGSSP 247
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 58/305 (19%), Positives = 108/305 (35%), Gaps = 30/305 (9%)
Query: 141 TSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTG 200
SS + + +P L +++SLD + + + L+ L L+ N +
Sbjct: 34 GICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN- 89
Query: 201 KIPPEL-GQLSSLETIILGYNAFEGEIPAE-FGNLTNLRYLDLAVGSLSGQIPP--ALGR 256
I + L SLE + L YN + + F L++L +L+L +
Sbjct: 90 TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSH 147
Query: 257 LKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMC 315
L KL + + + KI + +T L L++ + + P L ++N+ L L
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM 207
Query: 316 NQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLC 375
Q L+ + + +E LEL L + LS L
Sbjct: 208 KQHILLLEIFVDVTSSVECLELRDTDLDTF----------------HFSELSTGETNSLI 251
Query: 376 DSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVG-LGNLPSLQRLEMA 434
+ + + S L+ L+ + N + ++P G L SLQ++ +
Sbjct: 252 KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLH 309
Query: 435 NNNLT 439
N
Sbjct: 310 TNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 66/337 (19%), Positives = 121/337 (35%), Gaps = 53/337 (15%)
Query: 58 TGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALK 117
+ C+ G S+ SLN S+ + ++ SL++ N L L+
Sbjct: 26 ASLSCDRNGIC---KGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQ 79
Query: 118 SMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGS 177
++ ++ N I + FS SLE LD ++
Sbjct: 80 ALVLTSNG-INTIEEDS---------------FSSL--------GSLEHLDLSYNYLSNL 115
Query: 178 VPTSFRNLQKLKFLGLSGNNLTGKIPPE--LGQLSSLETIILGYNAFEGEIPAE-FGNLT 234
+ F+ L L FL L GN + L+ L+ + +G +I + F LT
Sbjct: 116 SSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174
Query: 235 NLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQI 294
L L++ L P +L ++ ++ + L+ + + S
Sbjct: 175 FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI--------LLLEIFVDVTS---- 222
Query: 295 SGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSS 354
V+ EL++ L ++L+ + L + +++ SL + L Q S
Sbjct: 223 ----SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQIS 277
Query: 355 PLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNNSF 390
L L+ S N L +P G+ D +L K+ L N +
Sbjct: 278 GLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 67/354 (18%), Positives = 116/354 (32%), Gaps = 66/354 (18%)
Query: 241 LAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPV 300
+ S A + + IP L ++ LDLS+N+I+
Sbjct: 14 IISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNS 70
Query: 301 KLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLD 360
L NLQ L L N + + D L LE L+L
Sbjct: 71 DLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL----------------------- 107
Query: 361 ASSNLLSGEIPTGLCDS-GNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIP 419
S N LS + + +LT L L N + SL
Sbjct: 108 -SYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSL--------------------- 144
Query: 420 VGLGNLPSLQRLEMANNNLTGQIPDDI--SLSTSLSFVDISWNHLESYLPSSILSIPSLQ 477
+L LQ L + N + +I L T L ++I + L+SY P S+ SI ++
Sbjct: 145 --FSHLTKLQILRVGNMDTFTKIQRKDFAGL-TFLEELEIDASDLQSYEPKSLKSIQNVS 201
Query: 478 TFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIAS--------CEKLVSLNL 529
+ + + S+ L+L L + +++ ++ +
Sbjct: 202 HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 530 RNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYNKL 582
+ ++ K + + L L+ S N L +P+ F +L+ + L N
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 48/238 (20%), Positives = 91/238 (38%), Gaps = 37/238 (15%)
Query: 354 SPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNL 413
SS L+ IP+GL + + L L NN + L C +L + + +N
Sbjct: 31 DRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG 87
Query: 414 ISGTIPVGL-GNLPSLQRLEMANNNLTGQIPDDI--SLSTSLSFVDISWNHLESYLPSSI 470
I+ TI +L SL+ L+++ N L+ + L +SL+F+++ N ++ +S+
Sbjct: 88 IN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPL-SSLTFLNLLGNPYKTLGETSL 144
Query: 471 LS-IPSLQTFMASHNNLQAKIPNE-LQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLN 528
S + LQ + + KI + L L++ ++ L P S+ S + + L
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLI 204
Query: 529 LRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYNKLEGP 585
L + + E + ++E L L L+
Sbjct: 205 LHMKQHI-------------------------LLLEIFVDVTSSVECLELRDTDLDTF 237
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 36/215 (16%), Positives = 81/215 (37%), Gaps = 15/215 (6%)
Query: 69 EKLDLSNMSLNGSVSENI-RGLRSLSSLNICCNEFASSLPKSL-ANLTALKSMDVSQNNF 126
E LDLS L ++S + + L SL+ LN+ N + + SL ++LT L+ + V +
Sbjct: 103 EHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161
Query: 127 IGSFPTG-LGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNL 185
+ L + +++ + P+ L + ++ L +
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVT 221
Query: 186 QKLKFLGLSGNNLTG----KIPP----ELGQLSSLETIILGYNAFEGEIPAEFGNLTNLR 237
++ L L +L ++ L + + + + + ++ ++ L
Sbjct: 222 SSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLL 280
Query: 238 YLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFT 271
L+ + L +P RL L ++L+ N +
Sbjct: 281 ELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 40/230 (17%)
Query: 704 NIIGMGGNGIVYKA-EFHRPHMVVAVKKLWRSDNDIESGDDL--FREVSLLGRLR---HR 757
IG G G V+KA + VA+K++ R E G L REV++L L H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEE-GMPLSTIREVAVLRHLETFEHP 74
Query: 758 NIVRLLGYLH-----NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQ 812
N+VRL ET + +V++++ D L L + + + + +
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDM--MFQLLR 131
Query: 813 GLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM----MLHKNETVSMVAGSY 868
GL++LH V+HRD+K NIL+ ++ + ++ADFGLAR+ M + V++
Sbjct: 132 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL----- 183
Query: 869 GYIAPE--YG--YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914
Y APE Y V D++S G + E+ K P F GS D+
Sbjct: 184 WYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK----PLFRGSSDV 225
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 704 NIIGMGGNGIVYKAEFH-------RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-R 755
+G G G V AE + + VAVK L + D + DL E+ ++ + +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGK 145
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN---------- 805
H+NI+ LLG + + ++ +Y +L E L + + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 806 --IAVGIAQGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861
+A+G+ YL IHRD+ + N+L+ N +IADFGLAR + N
Sbjct: 206 VSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDI---NNID 257
Query: 862 SMVAGSYGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ G + APE YT +SD++SFGV++ E+ T G P
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGVLMWEIFTLGGSP 305
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 64/242 (26%), Positives = 109/242 (45%), Gaps = 41/242 (16%)
Query: 689 LNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREV 748
+N ++ + + +G GGNG+V+ A + VA+KK+ D +S RE+
Sbjct: 2 MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREI 59
Query: 749 SLLGRLRHRNIVRLL--------------GYLHNETNVMMVYDYMPNDSLGEALHGKEAG 794
++ RL H NIV++ G L +V +V +YM D L
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-----LANVLEQ 114
Query: 795 KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA-NLEARIADFGLARM 853
L++ +R + +GL Y+H V+HRD+K N+ ++ +L +I DFGLAR+
Sbjct: 115 GPLLEEHARL-FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 854 M-LHKNETVSM---VAGSYGYIAPE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
M H + + + + Y +P YT + D+++ G + E+LTGK L
Sbjct: 171 MDPHYSHKGHLSEGLVTKW-YRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK-TL 224
Query: 905 DP 906
Sbjct: 225 FA 226
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 46/221 (20%), Positives = 84/221 (38%), Gaps = 42/221 (19%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRS------DNDIESGDDLFREVSLLGRLRHRNI 759
+G G G V+ A + V VK + + + + E+++L R+ H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 760 VRLLGYLHNETNVMMV----------YDY-MPNDSLGEALHGKEAGKLLVDWVSRYNIAV 808
+++L N+ +V + + + L E A +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE----PLASYIFRQ--------- 138
Query: 809 GIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY 868
+ + YL +IHRDIK NI++ + ++ DFG A + + + G+
Sbjct: 139 -LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFCGTI 193
Query: 869 GYIAPEY----GYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
Y APE Y + +++S GV L L+ + P
Sbjct: 194 EYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFC 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 49/248 (19%), Positives = 95/248 (38%), Gaps = 64/248 (25%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF--REVSLLGRLRHRNIVRL 762
+G G GIV + A+KK+ + D + RE+ ++ L H NI++L
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQ--------DPRYKNRELDIMKVLDHVNIIKL 65
Query: 763 LGYLH--------------------------------------NETNVMMVYDYMPNDSL 784
+ Y + + ++ +Y+P+
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH 125
Query: 785 GEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-EA 843
+G+ + + + + + ++H + HRDIK N+L+++
Sbjct: 126 KVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTL 181
Query: 844 RIADFGLARMMLHKNETVSMVAGSYGYIAPE-----YGYTLKVDEKSDIYSFGVVLLELL 898
++ DFG A+ ++ +V+ + + Y APE YT + D++S G V EL+
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRF-YRAPELMLGATEYTPSI----DLWSIGCVFGELI 236
Query: 899 TGKMPLDP 906
GK PL
Sbjct: 237 LGK-PLFS 243
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 55/219 (25%), Positives = 86/219 (39%), Gaps = 36/219 (16%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRS--DNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V + AVK L + ++ +E+ LL RLRH+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 764 GYLHNETNVMM-------------VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGI 810
L+NE M + D +P +A +
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV----CQAHGYFCQLID-------- 120
Query: 811 AQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH--KNETVSMVAGSY 868
GL YLH ++H+DIK N+LL +I+ G+A + ++T GS
Sbjct: 121 --GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 869 GYIAPE--YGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
+ PE G K DI+S GV L + TG P +
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 49/242 (20%), Positives = 92/242 (38%), Gaps = 52/242 (21%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLL 763
++G+G NG V + R A+K + +EV + +IV +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKL-------LYDSPKARQEVDHHWQASGGPHIVCIL 88
Query: 764 GY----LHNETNVMMVYDYMPN----DSLGEALHG----KEAGKLLVDWVSRYNIAVGIA 811
H + ++++ + M + E +EA +++ D I
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD----------IG 138
Query: 812 QGLNYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMMLHKNETVSMVAGSY 868
+ +LH + HRD+K N+L + + ++ DFG A+ + +
Sbjct: 139 TAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPCYTP 193
Query: 869 GYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS--KDIVEWVLSMI 922
Y+APE Y D+ D++S GV++ LL G P F + + I + I
Sbjct: 194 YYVAPEVLGPEKY----DKSCDMWSLGVIMYILLCGFPP----FYSNTGQAISPGMKRRI 245
Query: 923 KS 924
+
Sbjct: 246 RL 247
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 56/237 (23%), Positives = 99/237 (41%), Gaps = 50/237 (21%)
Query: 704 NIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHR 757
++G G G V A + + VAVK L + D + L E+ ++ +L H
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSHE 109
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYN---------- 805
NIV LLG + ++++Y L L ++ + +++ ++
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 806 -------IAVGIAQGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856
A +A+G+ +L +HRD+ + N+L+ +I DFGLAR +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDI-- 222
Query: 857 KNETVSMVAGSYGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ V + APE G YT KSD++S+G++L E+ + G P
Sbjct: 223 -MSDSNYVVRGNARLPVKWMAPESLFEGIYT----IKSDVWSYGILLWEIFSLGVNP 274
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 73/216 (33%), Positives = 101/216 (46%), Gaps = 38/216 (17%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD---LFREVSLLGRLRHRNIVRL 762
+G+G G V E VAVK L R I S D + RE+ L RH +I++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQK--IRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 763 LGYLHNETNVMMVYDYMPNDSLGE-----ALHGK----EAGKLLVDWVSRYNIAVGIAQG 813
+ T+ MV +Y+ GE HG+ EA +L +S
Sbjct: 77 YQVISTPTDFFMVMEYVSG---GELFDYICKHGRVEEMEARRLFQQILS----------A 123
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAP 873
++Y H V+HRD+K N+LLDA++ A+IADFGL+ MM E + GS Y AP
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGSPNYAAP 179
Query: 874 E----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
E Y + DI+S GV+L LL G +P D
Sbjct: 180 EVISGRLYA---GPEVDIWSCGVILYALLCGTLPFD 212
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G G V A VAVK + ++ +++ +E+ + L H N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 766 LHNETNVMMVYDYMPNDSLGE-----ALHGK----EAGKLLVDWVSRYNIAVGIAQGLNY 816
+ +Y GE +A + ++ G+ Y
Sbjct: 74 RREGNIQYLFLEYCSG---GELFDRIEPDIGMPEPDAQRFFHQLMA----------GVVY 120
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM--VAGSYGYIAPE 874
LH + HRDIK N+LLD +I+DFGLA + + N + + G+ Y+APE
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 875 ----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
+ E D++S G+VL +L G++P D
Sbjct: 178 LLKRREFH---AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 52/238 (21%), Positives = 99/238 (41%), Gaps = 46/238 (19%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRS----DNDIESGDDLFREVSLLGRLR----HR 757
+G GG G V+ + VA+K + R+ + + EV+LL ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRY---------NIAV 808
++RLL + + M+V + L ++ L D+++
Sbjct: 99 GVIRLLDWFETQEGFMLVLER--------PLPAQD----LFDYITEKGPLGEGPSRCFFG 146
Query: 809 GIAQGLNYLHHDCQPPVIHRDIKSNNILLDA-NLEARIADFGLARMMLHKNETVSMVAGS 867
+ + + H V+HRDIK NIL+D A++ DFG ++ +E + G+
Sbjct: 147 QVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFDGT 201
Query: 868 YGYIAPEY----GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSM 921
Y PE+ Y + ++S G++L +++ G +P F ++I+E L
Sbjct: 202 RVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIP----FERDQEILEAELHF 252
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 46/216 (21%), Positives = 86/216 (39%), Gaps = 44/216 (20%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G GIV++ K + D + +E+S+L RHRNI+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIARHRNILHLHES 69
Query: 766 LHNETNVMMVYDYMP-----------NDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
+ ++M+++++ L E +E + + + L
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNE----REIVSYVHQ----------VCEAL 115
Query: 815 NYLHHDCQPPVIHRDIKSNNILL----DANLEARIADFGLARMMLHKNETVSMVAGSYGY 870
+LH + H DI+ NI+ + + +I +FG AR L + ++ + Y
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTI--KIIEFGQAR-QLKPGDNFRLLFTAPEY 169
Query: 871 IAPEYGYTLK---VDEKSDIYSFGVVLLELLTGKMP 903
APE + V +D++S G ++ LL+G P
Sbjct: 170 YAPE---VHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 58/233 (24%), Positives = 104/233 (44%), Gaps = 49/233 (21%)
Query: 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVK---KLWRSDNDIESGDDLFREVSLLGRLRH 756
V ++ I+G G G V+K E + +A K R D E ++ E+S++ +L H
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKE---EVKNEISVMNQLDH 145
Query: 757 RNIVRLLGYLHNETNVMMVYDYMP-----------NDSLGEALHGKEAGKLLVDWVSRYN 805
N+++L ++ ++++V +Y+ + +L E + +
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE----LDTILFMKQ------ 195
Query: 806 IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARI--ADFGLARMMLHKNETVSM 863
I +G+ ++H Q ++H D+K NIL +I DFGLAR E + +
Sbjct: 196 ----ICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLAR-RYKPREKLKV 247
Query: 864 VAGSYGYIAPE---YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKD 913
G+ ++APE Y + V +D++S GV+ LL+G P F G D
Sbjct: 248 NFGTPEFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSP----FLGDND 293
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 70/232 (30%), Positives = 107/232 (46%), Gaps = 43/232 (18%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRL 762
+G G GIV+K+ R VVAVKK++ + + FRE+ +L L H NIV L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 763 LGYLHNETN--VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
L L + + V +V+DYM D LH +L +Y + + + + YLH
Sbjct: 75 LNVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQY-VVYQLIKVIKYLH-- 126
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG----------- 869
++HRD+K +NILL+A ++ADFGL+R ++ + + S
Sbjct: 127 -SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 870 ----------YIAPE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
Y APE YT + D++S G +L E+L GK P+ P
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILGEILCGK-PIFP 232
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-24
Identities = 57/240 (23%), Positives = 93/240 (38%), Gaps = 44/240 (18%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+IG G G VY A VA+KK+ R D+ + RE+++L RL+ I+RL
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 765 YLHNETN-----VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
+ + + +V + +D L + L + + I + G N++H
Sbjct: 93 LIIPDDLLKFDELYIVLEIADSD-LKKLFK---TPIFLTEEHIKT-ILYNLLLGENFIH- 146
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG---------- 869
+ +IHRD+K N LL+ + ++ DFGLAR + + +T +
Sbjct: 147 --ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 870 ------------YIAPE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSK 912
Y APE YT + DI+S G + ELL
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFAELLNMLQSHINDPTNRF 260
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-24
Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 53/240 (22%)
Query: 706 IGMGGNGIVYKAEFHRPH--MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G VYKA+ A+K++ + + + RE++LL L+H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA----CREIALLRELKHPNVISLQ 84
Query: 764 G--YLHNETNVMMVYDYMPND------SLGEALHGKEAGKLLVDWVSRYNIAVGIAQ--- 812
H + V +++DY +D + K+ +L V + Q
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL-----LYQILD 139
Query: 813 GLNYLHHDCQPPVIHRDIKSNNILLDANLEAR----IADFGLARM-------MLHKNETV 861
G++YLH + V+HRD+K NIL+ R IAD G AR+ + + V
Sbjct: 140 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 862 SMVAGSYGYIAPE--YG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVE 916
V + Y APE G YT + DI++ G + ELLT + P F ++ ++
Sbjct: 197 --VT--FWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE----PIFHCRQEDIK 244
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 45/230 (19%)
Query: 706 IGMGGNGIVYKAEFH-------RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHR 757
+G G G V AE VAVK L +SD + DL E+ ++ + +H+
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN------------ 805
NI+ LLG + + ++ +Y +L E L + L + +N
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 806 IAVGIAQGLNYL--HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM 863
A +A+G+ YL IHRD+ + N+L+ + +IADFGLAR + +
Sbjct: 196 CAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARDI---HHIDYY 247
Query: 864 VAGSYGYI-----APE---YG-YTLKVDEKSDIYSFGVVLLELLT-GKMP 903
+ G + APE YT +SD++SFGV+L E+ T G P
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYT----HQSDVWSFGVLLWEIFTLGGSP 293
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 57/230 (24%), Positives = 93/230 (40%), Gaps = 48/230 (20%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVK----KLWRSDNDIESGDDLFREVSLLGRLRHRNIVR 761
+G G IV K + A K + R+ +++ REVS+L ++ H NI+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 762 LLGYLHNETNVMMVYDYMP----------NDSLGEALHGKEAGKLLVDWVSRYNIAVGIA 811
L N T+V+++ + + +SL E +EA + I
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQ----------IL 125
Query: 812 QGLNYLHHDCQPPVIHRDIKSNNILL----DANLEARIADFGLARMMLHKNETVSMVAGS 867
G+NYLH + H D+K NI+L ++ DFGLA + + G+
Sbjct: 126 DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGT 181
Query: 868 YGYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKD 913
++APE L+ D++S GV+ LL+G P F G
Sbjct: 182 PEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASP----FLGDTK 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G G V A VAVK + ++ +++ +E+ + L H N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 766 LHNETNVMMVYDYMPNDSLGE-----ALHGK----EAGKLLVDWVSRYNIAVGIAQGLNY 816
+ +Y GE +A + ++ G+ Y
Sbjct: 74 RREGNIQYLFLEYCSG---GELFDRIEPDIGMPEPDAQRFFHQLMA----------GVVY 120
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM--VAGSYGYIAPE 874
LH + HRDIK N+LLD +I+DFGLA + + N + + G+ Y+APE
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 875 ----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
+ E D++S G+VL +L G++P D
Sbjct: 178 LLKRREFH---AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 60/302 (19%), Positives = 97/302 (32%), Gaps = 23/302 (7%)
Query: 62 CNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLP-KSLANLTALKSMD 120
CN + L + E G RSL L + A + +LK +
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLT 74
Query: 121 VSQNNFIGSFPTGLGKA---SGLTSVNASSNNFSGFLPEDLGNAT--SLESLDFR----G 171
V G + SGL + + +G P L AT L L+ R
Sbjct: 75 VRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134
Query: 172 SFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEI----- 226
+ LK L ++ + ++ +L T+ L N GE
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194
Query: 227 --PAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSI-TS 283
P +F L L + + + SG +L + L N+ +
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254
Query: 284 LAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLI 343
L L+LS + ++P L L +L+L N+L EL ++ L L N +
Sbjct: 255 LNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFL 309
Query: 344 GS 345
S
Sbjct: 310 DS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 9e-23
Identities = 62/318 (19%), Positives = 111/318 (34%), Gaps = 58/318 (18%)
Query: 279 GSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPD---KLGELTKLEVL 335
G + L D + + + +L+ L + ++ I ++ ++ L+ L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 336 ELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFP 395
L + G+ P L +++ +L L L N S++
Sbjct: 101 TLENLEVTGTAPPPLLEATGP----------------------DLNILNLRNVSWAT-RD 137
Query: 396 VSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFV 455
L+ + + P L+ L +A + + + + +LS +
Sbjct: 138 AWLAELQQWL-------------------KPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178
Query: 456 DISWNHL--ESYLPSSIL--SIPSLQTFMASHNNLQA---KIPNELQACPSLSVLDLSSN 508
D+S N E L S++ P+LQ + ++ A L LDLS N
Sbjct: 179 DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238
Query: 509 SLSGEIPASIAS-CEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFG 567
SL A +L SLNL ++PK + L++LD+S N L R P
Sbjct: 239 SLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRL-DRNPS-PD 293
Query: 568 ASPALEMLNLSYNKLEGP 585
P + L+L N
Sbjct: 294 ELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 3e-21
Identities = 58/304 (19%), Positives = 96/304 (31%), Gaps = 58/304 (19%)
Query: 148 NNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTS---FRNLQKLKFLGLSGNNLTGKIPP 204
D+ + SL+ L R + + + L+ L L +TG PP
Sbjct: 54 TEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113
Query: 205 ELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVY 264
L + + + IL NL N+ + + ++ L L +
Sbjct: 114 PLLEATGPDLNIL--------------NLRNVSWATR--DAWLAELQQWL--KPGLKVLS 155
Query: 265 LYKNNFTGKIPPELGSITSLAFLDLSDNQISGEI-------PVKLAELKNLQLLNLMCNQ 317
+ + + ++ +L+ LDLSDN GE P+K L+ L L N
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 318 LTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP-LRRLDASSNLLSGEIPTGLCD 376
+G+ +L+ L+L NSL + L L+ S L ++P GL
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL-- 272
Query: 377 SGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANN 436
L+ L L N P LP + L + N
Sbjct: 273 PAKLSVLDLSYNRLD-------------------------RNPS-PDELPQVGNLSLKGN 306
Query: 437 NLTG 440
Sbjct: 307 PFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 40/203 (19%), Positives = 62/203 (30%), Gaps = 17/203 (8%)
Query: 411 NNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSF-----VDISWNHLESY 465
N L + + + G L+ + DI S SL I L
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88
Query: 466 LPSSILSIPSLQTFMASHNNLQAKIPNELQAC--PSLSVLDLSSNSLSGEIPA----SIA 519
L +L I LQ + + P L P L++L+L + S +
Sbjct: 89 L--RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQW 146
Query: 520 SCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPEN----FGASPALEML 575
L L++ + V P L+ LD+S+N G P L++L
Sbjct: 147 LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206
Query: 576 NLSYNKLEGPVPSNGILMNINPN 598
L +E P L
Sbjct: 207 ALRNAGMETPSGVCSALAAARVQ 229
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 71/220 (32%), Positives = 105/220 (47%), Gaps = 46/220 (20%)
Query: 706 IGMGGNGIVYKAEFHRPHMV----VAVKKLWRSDNDIESGDDL---FREVSLLGRLRHRN 758
+G+G G V + H + VAVK L R I S D + RE+ L RH +
Sbjct: 24 LGVGTFGKVKVGK----HELTGHKVAVKILNRQK--IRSLDVVGKIRREIQNLKLFRHPH 77
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGE-----ALHGK----EAGKLLVDWVSRYNIAVG 809
I++L + +++ MV +Y+ GE +G+ E+ +L +S
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSG---GELFDYICKNGRLDEKESRRLFQQILS------- 127
Query: 810 IAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG 869
G++Y H V+HRD+K N+LLDA++ A+IADFGL+ MM E + GS
Sbjct: 128 ---GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGSPN 180
Query: 870 YIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
Y APE Y + DI+S GV+L LL G +P D
Sbjct: 181 YAAPEVISGRLYA---GPEVDIWSSGVILYALLCGTLPFD 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 48/222 (21%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVK----KLWRSDNDIESGDDLFREVSLLGRLRHRNIVR 761
+G G IV K A K + S S +++ REV++L +RH NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 762 LLGYLHNETNVMMVYDYMP----------NDSLGEALHGKEAGKLLVDWVSRYNIAVGIA 811
L N+T+V+++ + + +SL E EA + L I
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTE----DEATQFLKQ----------IL 118
Query: 812 QGLNYLHHDCQPPVIHRDIKSNNILL------DANLEARIADFGLARMMLHKNETVSMVA 865
G++YLH + H D+K NI+L + + ++ DFG+A + +
Sbjct: 119 DGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRI--KLIDFGIAHKI-EAGNEFKNIF 172
Query: 866 GSYGYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
G+ ++APE L+ D++S GV+ LL+G P
Sbjct: 173 GTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASP 210
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 61/260 (23%), Positives = 102/260 (39%), Gaps = 18/260 (6%)
Query: 84 ENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSV 143
L + + + + A+L + ++ + + G+ + L +
Sbjct: 13 FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTG-VTTIE-GVQYLNNLIGL 68
Query: 144 NASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIP 203
N + P L N T + L+ G+ ++ LQ +K L L+ +T P
Sbjct: 69 ELKDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 204 PELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTV 263
L LS+L+ + L N I LTNL+YL + +S + P L L KLTT+
Sbjct: 125 --LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTL 178
Query: 264 YLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIP 323
N + I P L S+ +L + L +NQIS P LA NL ++ L +T
Sbjct: 179 KADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV 234
Query: 324 DKLGELTKLEVLELWKNSLI 343
L V++ + I
Sbjct: 235 FYNNNLVVPNVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 7e-23
Identities = 59/302 (19%), Positives = 109/302 (36%), Gaps = 46/302 (15%)
Query: 232 NLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSD 291
L N + +++ L +TT+ + T I + + +L L+L D
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 292 NQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLG 351
NQI+ ++ L L + L L N L + + L ++ L+L ++
Sbjct: 73 NQIT-DLAP-LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTST--------QIT 120
Query: 352 QSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQN 411
+PL L NL L L N + P L+ +L + + N
Sbjct: 121 DVTPLAGLS------------------NLQVLYLDLNQITNISP--LAGLTNLQYLSIGN 160
Query: 412 NLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSIL 471
+S P L NL L L+ +N ++ I ++ +L V + N + S +
Sbjct: 161 AQVSDLTP--LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDV--SPLA 214
Query: 472 SIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEI-PASIASCEKLVSLNLR 530
+ +L ++ + + +L V ++ I PA+I+ S NL
Sbjct: 215 NTSNLFIVTLTNQTITNQPVFYNN---NLVVPNVVKGPSGAPIAPATISDNGTYASPNLT 271
Query: 531 NN 532
N
Sbjct: 272 WN 273
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 7e-21
Identities = 63/332 (18%), Positives = 112/332 (33%), Gaps = 68/332 (20%)
Query: 254 LGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNL 313
L + K+N T + + L ++ I + L NL L L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLEL 70
Query: 314 MCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTG 373
NQ+T L P L LTK+ LEL N PL+ + A + L
Sbjct: 71 KDNQITDLAP--LKNLTKITELELSGN--------------PLKNVSAIAGL-------- 106
Query: 374 LCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEM 433
++ L L + + P L+ +L + + N I+ P L L +LQ L +
Sbjct: 107 ----QSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSI 158
Query: 434 ANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNE 493
N ++ D++ + ++ L T A N + I
Sbjct: 159 GNAQVS----------------DLT----------PLANLSKLTTLKADDNKIS-DISP- 190
Query: 494 LQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDM 553
L + P+L + L +N +S P +A+ L + L N + + + ++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKG 248
Query: 554 SNNSLFGRIPENFGASPALEMLNLSYNKLEGP 585
+ + P + NL++N
Sbjct: 249 PSGAPI--APATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 51/258 (19%), Positives = 98/258 (37%), Gaps = 21/258 (8%)
Query: 68 VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
K+ ++ +V+ L +++L+ + + + L L +++ N I
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ-I 75
Query: 128 GSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK 187
L + +T + S N + S+++LD + + T L
Sbjct: 76 TDLA-PLKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQI--TDVTPLAGLSN 130
Query: 188 LKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLS 247
L+ L L N +T I P L L++L+ + +G P NL+ L L +S
Sbjct: 131 LQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186
Query: 248 GQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKN 307
I P L L L V+L N + + P L + ++L + L++ I+ + N
Sbjct: 187 -DISP-LASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVF---YNNN 239
Query: 308 LQLLNLMCNQLTGLIPDK 325
L + N++ I
Sbjct: 240 LVVPNVVKGPSGAPIAPA 257
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 48/317 (15%), Positives = 103/317 (32%), Gaps = 69/317 (21%)
Query: 289 LSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPM 348
I+ P L N + + +T + +L + L + + ++
Sbjct: 4 TQPTAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGT-GVTTIE- 57
Query: 349 RLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVR 408
G+ NL L L +N + P L + +
Sbjct: 58 ------------------------GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91
Query: 409 VQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPS 468
+ N + + + L S++ L++ + +T P
Sbjct: 92 LSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP------------------------- 124
Query: 469 SILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLN 528
+ + +LQ N + I L +L L + + +S P +A+ KL +L
Sbjct: 125 -LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLK 179
Query: 529 LRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPS 588
+N+ S +I +A++P L + + NN + + L ++ L+ +
Sbjct: 180 ADDNKIS-DIS-PLASLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTITNQPVF 235
Query: 589 NGILMNINPNELIGNAG 605
+ + PN + G +G
Sbjct: 236 YNNNLVV-PNVVKGPSG 251
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 9e-15
Identities = 33/200 (16%), Positives = 72/200 (36%), Gaps = 16/200 (8%)
Query: 384 ILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIP 443
I + + FP + +++ + ++ T+ +L + L +T I
Sbjct: 3 ITQPTAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE 57
Query: 444 DDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVL 503
+ +L +++ N + + + ++ + S N L+ + + S+ L
Sbjct: 58 G-VQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTL 112
Query: 504 DLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIP 563
DL+S ++ P +A L L L N+ + I +A + L L + N +
Sbjct: 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQV--SDL 166
Query: 564 ENFGASPALEMLNLSYNKLE 583
L L NK+
Sbjct: 167 TPLANLSKLTTLKADDNKIS 186
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 26/202 (12%), Positives = 53/202 (26%), Gaps = 39/202 (19%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSD--NDIESGDDLFREVSLLGRLRHRNIVRLL 763
G ++A VA+ + + + L R+ + R+L
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFV-DPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
+H ++V +++ SL E R +A + H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIR--AMQSLAAAADAAHRA--- 148
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
V + + + + + +A + +
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPD-------ANP 181
Query: 884 KSDIYSFGVVLLELLTGKMPLD 905
+ DI G L LL + PL
Sbjct: 182 QDDIRGIGASLYALLVNRWPLP 203
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 48/231 (20%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVK----KLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
+G G IV K + A K + R+ S +++ REVS+L ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 761 RLLGYLHNETNVMMVYDYMP----------NDSLGEALHGKEAGKLLVDWVSRYNIAVGI 810
L N T+V+++ + + +SL E +EA + I
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQ----------I 124
Query: 811 AQGLNYLHHDCQPPVIHRDIKSNNILL----DANLEARIADFGLARMMLHKNETVSMVAG 866
G+NYLH + H D+K NI+L ++ DFGLA + + G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFG 180
Query: 867 SYGYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKD 913
+ ++APE L+ D++S GV+ LL+G P F G
Sbjct: 181 TPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASP----FLGDTK 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 39/216 (18%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD---LFREVSLLGRLRHRNIVRL 762
+G G G V A ++ VA+K + R ++ D + RE+S L LRH +I++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQL--LKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 763 LGYLHNETNVMMV--------YDY-MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQG 813
+ T+++MV +DY + + E E + +
Sbjct: 75 YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE----DEGRRFFQQIIC----------A 120
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAP 873
+ Y H ++HRD+K N+LLD NL +IADFGL+ +M + GS Y AP
Sbjct: 121 IEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAP 176
Query: 874 E----YGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
E Y + D++S G+VL +L G++P D
Sbjct: 177 EVINGKLYA---GPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-23
Identities = 47/212 (22%), Positives = 90/212 (42%), Gaps = 35/212 (16%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLW-RSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G G G+V++ A K + ++D E + +E+ + LRH +V L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE---TVRKEIQTMSVLRHPTLVNLHD 221
Query: 765 YLHNETNVMMVYDYM-----------PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQG 813
++ ++M+Y++M ++ + E EA + + + +G
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE----DEAVEYMRQ----------VCKG 267
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEARI--ADFGLARMMLHKNETVSMVAGSYGYI 871
L ++H + +H D+K NI+ + DFGL L ++V + G+ +
Sbjct: 268 LCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEFA 323
Query: 872 APEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
APE V +D++S GV+ LL+G P
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 50/212 (23%), Positives = 88/212 (41%), Gaps = 37/212 (17%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLG 764
+G G V++A + V VK L + RE+ +L LR NI+ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLAD 98
Query: 765 YLHNETN---VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-HD 820
+ + + ++ D + + L D+ R+ + I + L+Y H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTD-----FK--QLYQTLTDYDIRFYM-YEILKALDYCHSMG 150
Query: 821 CQPPVIHRDIKSNNILLD-ANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----- 874
++HRD+K +N+++D + + R+ D+GLA E VA Y + PE
Sbjct: 151 ----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-FKGPELLVDY 205
Query: 875 --YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
Y Y+L D++S G +L ++ K P
Sbjct: 206 QMYDYSL------DMWSLGCMLASMIFRKEPF 231
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 57/303 (18%), Positives = 103/303 (33%), Gaps = 58/303 (19%)
Query: 259 KLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQL 318
+ + V + + ++P + ++ +L+L +N I L +L++L L N +
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 319 TGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTG-LCDS 377
+ L L LEL N L+ IP+G
Sbjct: 112 RQIEVGAFNGLASLNTLEL------------------------FDNWLT-VIPSGAFEYL 146
Query: 378 GNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQN-NLISGTIPVG-LGNLPSLQRLEMAN 435
L +L L NN + + SL+R+ + + I G L +L+ L +
Sbjct: 147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGM 205
Query: 436 NNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQ 495
N+ +P+ L L +++S NH P S + SL+
Sbjct: 206 CNIK-DMPNLTPL-VGLEELEMSGNHFPEIRPGSFHGLSSLKK----------------- 246
Query: 496 ACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSN 555
L + ++ +S + LV LNL +N S + L L + +
Sbjct: 247 -------LWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHH 299
Query: 556 NSL 558
N
Sbjct: 300 NPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 55/235 (23%), Positives = 92/235 (39%), Gaps = 12/235 (5%)
Query: 353 SSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNN 412
S+ ++ + LS E+P G+ N L L N+ + L +++ N
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 413 LISGTIPVG-LGNLPSLQRLEMANNNLTGQIPDDI-SLSTSLSFVDISWNHLESYLPSSI 470
I I VG L SL LE+ +N LT IP + L + + N +ES +
Sbjct: 110 SIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAF 167
Query: 471 LSIPSLQTFMASHNNLQAKIPNE-LQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNL 529
+PSL I + +L L+L ++ ++P + L L +
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEM 225
Query: 530 RNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYNKLE 583
N F P + + +L L + N+ + I N F +L LNL++N L
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQV-SLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 5e-21
Identities = 64/301 (21%), Positives = 100/301 (33%), Gaps = 64/301 (21%)
Query: 193 LSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPP 252
+ L+ ++P + S+ + L N + F +L +L L L S+ QI
Sbjct: 61 CTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEV 116
Query: 253 -ALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQISGEIPVK-LAELKNLQ 309
A L L T+ L+ N T IP ++ L L L +N I IP + +L
Sbjct: 117 GAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLM 174
Query: 310 LLNLM-CNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSG 368
L+L +L + L L+ L L +
Sbjct: 175 RLDLGELKKLEYISEGAFEGLFNLKYLNL------------------------GMCNIK- 209
Query: 369 EIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVG-LGNLPS 427
++P L L +L + N F P S SL ++ V N+ +S I L S
Sbjct: 210 DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLAS 267
Query: 428 LQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSIL-SIPSLQTFMASHNNL 486
L L +A+NNL+ LP + + L HN
Sbjct: 268 LVELNLAHNNLS-------------------------SLPHDLFTPLRYLVELHLHHNPW 302
Query: 487 Q 487
Sbjct: 303 N 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 6e-21
Identities = 57/256 (22%), Positives = 90/256 (35%), Gaps = 23/256 (8%)
Query: 54 HCNWTG--VWCNSRGF----------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNE 101
C+ V C RG L+L ++ ++ R L L L + N
Sbjct: 51 SCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 102 FASSLPKSLANLTALKSMDVSQNNFIGSFPTG-LGKASGLTSVNASSNNFSGFLPEDLGN 160
+ L +L ++++ N + P+G S L + +N
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNW-LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169
Query: 161 ATSLESLDFRGSFFEGSVPT-SFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGY 219
SL LD + +F L LK+L L N+ P L L LE + +
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSG 227
Query: 220 NAFEGEIPAE-FGNLTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPE 277
N F EI F L++L+ L + +S I A L L + L NN + +P +
Sbjct: 228 NHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHD 284
Query: 278 -LGSITSLAFLDLSDN 292
+ L L L N
Sbjct: 285 LFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 29/132 (21%), Positives = 47/132 (35%), Gaps = 5/132 (3%)
Query: 69 EKLDLSNMSLNGSVSENI-RGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
+LDL + +SE GL +L LN+ +P +L L L+ +++S N+
Sbjct: 174 MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI-KDMP-NLTPLVGLEELEMSGNH-F 230
Query: 128 GSFPTG-LGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQ 186
G S L + ++ S SL L+ + F L+
Sbjct: 231 PEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290
Query: 187 KLKFLGLSGNNL 198
L L L N
Sbjct: 291 YLVELHLHHNPW 302
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 48/222 (21%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVK----KLWRSDNDIESGDDLFREVSLLGRLRHRNIVR 761
+G G +V K + A K + +S S +D+ REVS+L ++H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 762 LLGYLHNETNVMMVYDYMP----------NDSLGEALHGKEAGKLLVDWVSRYNIAVGIA 811
L N+T+V+++ + + +SL E +EA + L I
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTE----EEATEFLKQ----------IL 124
Query: 812 QGLNYLHHDCQPPVIHRDIKSNNILL------DANLEARIADFGLARMMLHKNETVSMVA 865
G+ YLH + H D+K NI+L + +I DFGLA + +
Sbjct: 125 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRI--KIIDFGLAH-KIDFGNEFKNIF 178
Query: 866 GSYGYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
G+ ++APE L+ D++S GV+ LL+G P
Sbjct: 179 GTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASP 216
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-23
Identities = 54/248 (21%), Positives = 93/248 (37%), Gaps = 55/248 (22%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL- 763
+IG G G V +A VVA+KK+ R D+ + RE+++L RL H ++V++L
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 764 ----GYLHNETNVMMVYDYMPNDSLGEALHGK--EAGKLLVDWVSRYNIAVGIAQGLNYL 817
+ + +V + +D K L + + + + G+ Y+
Sbjct: 120 IVIPKDVEKFDELYVVLEIADSD-----FK-KLFRTPVYLTELHIKT-LLYNLLVGVKYV 172
Query: 818 H-HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYG------- 869
H ++HRD+K N L++ + ++ DFGLAR + + S + S
Sbjct: 173 HSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 870 --------------------YIAPE-----YGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904
Y APE YT + D++S G + ELL
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI----DVWSIGCIFAELLNMIKEN 284
Query: 905 DPAFGGSK 912
Sbjct: 285 VAYHADRG 292
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-23
Identities = 42/215 (19%), Positives = 88/215 (40%), Gaps = 41/215 (19%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLW-RSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
+G G G+V++ V K + D + E+S++ +L H ++ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISIMNQLHHPKLINLHD 115
Query: 765 YLHNETNVMMVYDYMP-----------NDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQG 813
++ ++++ +++ + + E E + +G
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE----AEVINYMRQ----------ACEG 161
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDANLEAR--IADFGLARMMLHKNETVSMVAGSYGYI 871
L ++H + ++H DIK NI+ + + I DFGLA + + +E V + + +
Sbjct: 162 LKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFA 217
Query: 872 APEYGYTLK---VDEKSDIYSFGVVLLELLTGKMP 903
APE + V +D+++ GV+ LL+G P
Sbjct: 218 APE---IVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-23
Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 49/221 (22%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLL 763
++G+G NG V + R A+K ++ REV L R + +IVR++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKM-------LQDCPKARREVELHWRASQCPHIVRIV 121
Query: 764 GYLHN----ETNVMMVYDYMPN----DSLGEALHG----KEAGKLLVDWVSRYNIAVGIA 811
N +++V + + + + +EA +++ I
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS----------IG 171
Query: 812 QGLNYLHHDCQPPVIHRDIKSNNILL-----DANLEARIADFGLARMMLHKNETVSMVAG 866
+ + YLH + HRD+K N+L +A L ++ DFG A+ + +++
Sbjct: 172 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL--KLTDFGFAK-ETTSHNSLTTPCY 225
Query: 867 SYGYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
+ Y+APE Y D+ D++S GV++ LL G P
Sbjct: 226 TPYYVAPEVLGPEKY----DKSCDMWSLGVIMYILLCGYPP 262
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-22
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRS----DNDIESGDDLFREVSLLGRLRHRNIVR 761
IG G G V + + + A+K + + N++ + +F+E+ ++ L H +V
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRN---VFKELQIMQGLEHPFLVN 79
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYNIAVGIAQGLNYLH- 818
L +E ++ MV D + G+ L H ++ + V + + L+YL
Sbjct: 80 LWYSFQDEEDMFMVVDLLLG---GD-LRYHLQQNVHFKEETVKLF--ICELVMALDYLQN 133
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE---- 874
+IHRD+K +NILLD + I DF +A M+ + + +M AG+ Y+APE
Sbjct: 134 QR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM-AGTKPYMAPEMFSS 188
Query: 875 ---YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
GY+ V D +S GV ELL G+ P
Sbjct: 189 RKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 46/230 (20%), Positives = 91/230 (39%), Gaps = 50/230 (21%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVK---KLWRSDNDIESGDDLFREVSLLGRLRHR-NIVR 761
+G G +V + A K K R + ++ E+++L + ++
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA---EILHEIAVLELAKSCPRVIN 93
Query: 762 LLGYLHNETNVMMVYDYM------------PNDSLGEALHGKEAGKLLVDWVSRYNIAVG 809
L N + ++++ +Y + + E + +L+
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE----NDVIRLIKQ---------- 139
Query: 810 IAQGLNYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMMLHKNETVSMVAG 866
I +G+ YLH Q ++H D+K NILL + +I DFG++R + + + G
Sbjct: 140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACELREIMG 195
Query: 867 SYGYIAPEYGYTLK---VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKD 913
+ Y+APE L + +D+++ G++ LLT P F G +
Sbjct: 196 TPEYLAPE---ILNYDPITTATDMWNIGIIAYMLLTHTSP----FVGEDN 238
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-22
Identities = 31/184 (16%), Positives = 59/184 (32%), Gaps = 7/184 (3%)
Query: 138 SGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNN 197
S + S SL + T +K L ++ +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIH 77
Query: 198 LTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRL 257
T P + LS+LE + + + LT+L LD++ + I + L
Sbjct: 78 AT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 258 KKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQ 317
K+ ++ L N I P L ++ L L++ + + + + L L
Sbjct: 136 PKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192
Query: 318 LTGL 321
+ G
Sbjct: 193 IGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-20
Identities = 33/185 (17%), Positives = 74/185 (40%), Gaps = 10/185 (5%)
Query: 208 QLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYK 267
+ +LG ++ A+ +LT + ++ V L+G + + + +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 268 NNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLG 327
+ T P + +++L L + ++ + L+ L +L LL++ + I K+
Sbjct: 76 IHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 328 ELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFN 387
L K+ ++L N I + L L+ L+ + + G+ D L +L F+
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFS 190
Query: 388 NSFSG 392
+ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 32/159 (20%), Positives = 68/159 (42%), Gaps = 7/159 (4%)
Query: 379 NLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNL 438
+LT + L N + + + ++ + + N + P + L +L+RL + ++
Sbjct: 45 SLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDV 100
Query: 439 TGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACP 498
T ++S TSL+ +DIS + + + + I ++P + + S+N I L+ P
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLP 159
Query: 499 SLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGE 537
L L++ + + I KL L + G+
Sbjct: 160 ELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 27/153 (17%), Positives = 56/153 (36%), Gaps = 7/153 (4%)
Query: 89 LRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSN 148
+ SL+ + + + L + +K + ++ + ++ + S L +
Sbjct: 43 MNSLTYITLANINV-TDL-TGIEYAHNIKDLTINNIH-ATNY-NPISGLSNLERLRIMGK 98
Query: 149 NFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQ 208
+ + +L TSL LD S + S+ T L K+ + LS N I P L
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKT 157
Query: 209 LSSLETIILGYNAFEGEIPAEFGNLTNLRYLDL 241
L L+++ + ++ + L L
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYA 188
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 33/178 (18%), Positives = 69/178 (38%), Gaps = 7/178 (3%)
Query: 379 NLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNL 438
+ S T ++ + SL + + N ++ G+ +++ L + N +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLT--GIEYAHNIKDLTINNIHA 78
Query: 439 TGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACP 498
T P IS ++L + I + S ++ + SL SH+ I ++ P
Sbjct: 79 TNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 499 SLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNN 556
++ +DLS N +I + + +L SLN++ + + P L L +
Sbjct: 137 KVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 33/184 (17%), Positives = 75/184 (40%), Gaps = 16/184 (8%)
Query: 402 KSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDIS-LS--TSLSFVDIS 458
K+ + + + + + + SL + +AN N+T D++ + ++ + I+
Sbjct: 23 KAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-----DLTGIEYAHNIKDLTIN 74
Query: 459 WNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASI 518
H +Y + I + +L+ ++ + L SL++LD+S ++ I I
Sbjct: 75 NIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 519 ASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLS 578
+ K+ S++L N +I + T+P L L++ + + P L L
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV--HDYRGIEDFPKLNQLYAF 189
Query: 579 YNKL 582
+
Sbjct: 190 SQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 28/200 (14%), Positives = 64/200 (32%), Gaps = 34/200 (17%)
Query: 287 LDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSL 346
L + + + A++ +L + L +T L + ++ L +
Sbjct: 28 GLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNI------ 76
Query: 347 PMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVR 406
+P+ L NL +L + + +LS SL
Sbjct: 77 --HATNYNPISGLS------------------NLERLRIMGKDVTSDKIPNLSGLTSLTL 116
Query: 407 VRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYL 466
+ + ++ +I + LP + ++++ N I + L ++I ++ + Y
Sbjct: 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY- 174
Query: 467 PSSILSIPSLQTFMASHNNL 486
I P L A +
Sbjct: 175 -RGIEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 19/161 (11%), Positives = 63/161 (39%), Gaps = 12/161 (7%)
Query: 424 NLPSLQRLEMANNNLTGQIPDDISLS--TSLSFVDISWNHLESYLPSSILSIPSLQTFMA 481
+ + ++ +I+ + SL+++ ++ ++ + I +++
Sbjct: 21 TFKAYLNGLLGQSSTA-----NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTI 73
Query: 482 SHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKA 541
++ + + +L L + ++ + +++ L L++ ++ I
Sbjct: 74 NNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
Query: 542 VATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKL 582
+ T+P + +D+S N I P L+ LN+ ++ +
Sbjct: 132 INTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 7e-10
Identities = 28/132 (21%), Positives = 51/132 (38%), Gaps = 5/132 (3%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
+ L ++N+ + I GL +L L I + S +L+ LT+L +D+S +
Sbjct: 69 KDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 129 SFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKL 188
S T + + S++ S N + L L+SL+ + + KL
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKL 183
Query: 189 KFLGLSGNNLTG 200
L + G
Sbjct: 184 NQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 12/92 (13%), Positives = 36/92 (39%), Gaps = 4/92 (4%)
Query: 498 PSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNS 557
SL+ + L++ +++ I + L + N + ++ + L L +
Sbjct: 44 NSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKD 99
Query: 558 LFGRIPENFGASPALEMLNLSYNKLEGPVPSN 589
+ N +L +L++S++ + + +
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 48/234 (20%), Positives = 89/234 (38%), Gaps = 12/234 (5%)
Query: 352 QSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQN 411
+ P L +P G+ ++ L N S S C++L + + +
Sbjct: 9 YNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 412 NLISGTIPVG-LGNLPSLQRLEMANNNLTGQIPDDI-SLSTSLSFVDISWNHLESYLPSS 469
N+++ I L L++L++++N + L + + L+ L
Sbjct: 66 NVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPG 123
Query: 470 ILS-IPSLQTFMASHNNLQAKIPNE-LQACPSLSVLDLSSNSLSGEIPASIASCEKLVSL 527
+ + +LQ N LQA +P++ + +L+ L L N +S + L L
Sbjct: 124 LFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 528 NLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYN 580
L NR + P A + L L + N+L +P AL+ L L+ N
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 52/254 (20%), Positives = 86/254 (33%), Gaps = 34/254 (13%)
Query: 261 TTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG 320
T + +P + + + L N+IS +NL +L L N L
Sbjct: 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70
Query: 321 LIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP-LRRLDASSNLLSGEIPTGLCDSGN 379
+ L LE L+L N+ + S+ L L L E+ GL
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL----- 124
Query: 380 LTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVG-LGNLPSLQRLEMANNNL 438
F G +L + +Q+N + +P +L +L L + N +
Sbjct: 125 ----------FRG--------LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRI 165
Query: 439 TGQIPDDI--SLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQA 496
+ +P+ L SL + + N + P + + L T NNL A L
Sbjct: 166 S-SVPERAFRGL-HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223
Query: 497 CPSLSVLDLSSNSL 510
+L L L+ N
Sbjct: 224 LRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 55/248 (22%), Positives = 95/248 (38%), Gaps = 43/248 (17%)
Query: 60 VWCNSRGF----------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKS 109
C +G +++ L ++ + + R R+L+ L + N A +
Sbjct: 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 110 LANLTALKSMDVSQNNFIGSFPTG-LGKASGLTSVNASSNNFSGFLPEDLGNATSLESLD 168
L L+ +D+S N + S L +++ L+ L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG--------------LQELG 121
Query: 169 FRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPE-LGQLSSLETIILGYNAFEGEIP 227
P FR L L++L L N L +P + L +L + L N +P
Sbjct: 122 ----------PGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVP 169
Query: 228 AE-FGNLTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSL 284
F L +L L L ++ + P A L +L T+YL+ NN + +P E L + +L
Sbjct: 170 ERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRAL 227
Query: 285 AFLDLSDN 292
+L L+DN
Sbjct: 228 QYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 17/220 (7%)
Query: 249 QIPPALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQISGEIPVK-LAELK 306
+P + ++L+ N + +P + +L L L N ++ I L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLA 80
Query: 307 NLQLLNLMCN-QLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRL--GQSSPLRRLDASS 363
L+ L+L N QL + P L +L L L + + L L G ++ L+ L
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG-LQELGPGLFRGLAA-LQYLYLQD 138
Query: 364 NLLSGEIPTGLCDS-GNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVG- 421
N L +P GNLT L L N S + SL R+ + N ++ +
Sbjct: 139 NALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHA 196
Query: 422 LGNLPSLQRLEMANNNLTGQIPDDI-SLSTSLSFVDISWN 460
+L L L + NNL+ +P + + +L ++ ++ N
Sbjct: 197 FRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 32/170 (18%), Positives = 61/170 (35%), Gaps = 9/170 (5%)
Query: 417 TIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSL 476
+PVG+ + QR+ + N ++ +L+ + + N L ++ + L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 477 QTFMASHNNLQAKIPNE-LQACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNRF 534
+ S N + L L L L E+ + L L L++N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 535 SGEIPKAV-ATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYNKL 582
+P + L L + N + +PE F +L+ L L N++
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRV 189
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 28/152 (18%), Positives = 53/152 (34%), Gaps = 8/152 (5%)
Query: 435 NNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNEL 494
L +P I + + + N + +S + +L N L
Sbjct: 20 QQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 495 QACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNRFSGEIPKAV-ATMPTLAILD 552
L LDLS N+ + + +L +L+L E+ + + L L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLY 135
Query: 553 MSNNSLFGRIPEN-FGASPALEMLNLSYNKLE 583
+ +N+L +P++ F L L L N++
Sbjct: 136 LQDNAL-QALPDDTFRDLGNLTHLFLHGNRIS 166
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 25/103 (24%), Positives = 40/103 (38%), Gaps = 4/103 (3%)
Query: 482 SHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKA 541
LQA +P + + + L N +S AS +C L L L +N + A
Sbjct: 19 PQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 542 VATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYNKLE 583
+ L LD+S+N+ + F L L+L L+
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 2e-21
Identities = 50/233 (21%), Positives = 92/233 (39%), Gaps = 16/233 (6%)
Query: 110 LANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDF 169
++ + + + T + + + + A++++ + + ++ L
Sbjct: 17 DDAFAETIKDNLKKKS-VTDAVT-QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 72
Query: 170 RGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAE 229
+ + + NL+ L +L L N + + L L L+++ L +N +I
Sbjct: 73 --NGNKLTDIKPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING- 126
Query: 230 FGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDL 289
+L L L L ++ I L RL KL T+ L N + I P L +T L L L
Sbjct: 127 LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 182
Query: 290 SDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSL 342
S N IS ++ LA LKNL +L L + + L ++ SL
Sbjct: 183 SKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.6 bits (237), Expect = 2e-20
Identities = 50/298 (16%), Positives = 95/298 (31%), Gaps = 18/298 (6%)
Query: 284 LAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLI 343
+ I P NL +T + EL ++ + + I
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD-I 55
Query: 344 GSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKS 403
S+ + + +L + N L+ +I L + NL L L N L K
Sbjct: 56 KSVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSS--LKDLKK 110
Query: 404 LVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLE 463
L + +++N IS I GL +LP L+ L + NN +T +S T L + + N +
Sbjct: 111 LKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 166
Query: 464 SYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEK 523
+ + LQ S N++ L +L VL+L S + ++
Sbjct: 167 DI--VPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVV 222
Query: 524 LVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNK 581
++ + + + + F + ++
Sbjct: 223 PNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHG 280
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 86.7 bits (214), Expect = 1e-17
Identities = 39/307 (12%), Positives = 97/307 (31%), Gaps = 22/307 (7%)
Query: 380 LTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLT 439
+ + I + FP ++ ++ ++ + L S+ ++ N+++
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 440 GQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPS 499
+ I +++ + ++ N L + ++ +L N ++ + + L+
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKK 110
Query: 500 LSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLF 559
L L L N +S +I + +L SL L NN+ + ++ + L L + +N +
Sbjct: 111 LKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI- 165
Query: 560 GRIPENFGASPALEMLNLSYNKLE--GPVPSNGIL----MNINPNELIGNAGLCGSVLPP 613
L+ L LS N + + L + V+P
Sbjct: 166 -SDIVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 224
Query: 614 CSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVFFAGKWAYRRWYLYNSFFDDLFK 673
+N + + + + V F F + +
Sbjct: 225 TVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQ 284
Query: 674 KSCKEWP 680
+ +
Sbjct: 285 PLKEVYT 291
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-21
Identities = 82/482 (17%), Positives = 143/482 (29%), Gaps = 106/482 (21%)
Query: 162 TSLESLDFRGSFF-EGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYN 220
++SLD + + LQ+ + + L LT +SS
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT---EARCKDISSA-------- 51
Query: 221 AFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGR-LK----KLTTVYLYKNNFTGK-- 273
L L+L L + + L+ K+ + L TG
Sbjct: 52 ---------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 102
Query: 274 --IPPELGSITSLAFLDLSDNQISGEIPVKLAEL-----KNLQLLNLMCNQLTGLIPDKL 326
+ L ++ +L L LSDN + L E L+ L L L+ + L
Sbjct: 103 GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162
Query: 327 GELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGE----IPTGLCDSG-NLT 381
+ L + L S+N ++ + GL DS L
Sbjct: 163 ASV--------------------LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202
Query: 382 KLILFNNSFS----GTFPVSLSTCKSLVRVRVQNNLISGT-----IPVGLGNLPSLQRLE 432
L L + + +++ SL + + +N + P L L+ L
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262
Query: 433 MANNNLTGQ----IPDDISLSTSLSFVDISWNHLE----SYLPSSILSI-PSLQTFMASH 483
+ +T + + + SL + ++ N L L ++L L++
Sbjct: 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 322
Query: 484 NNLQAK----IPNELQACPSLSVLDLSSNSLSGEIPASIA-----SCEKLVSLNLRNNRF 534
+ A + L L L +S+N L + L L L +
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
Query: 535 SGE----IPKAVATMPTLAILDMSNNSLFGRIPENFGAS----------PALEMLNLSYN 580
S + + +L LD+SNN L + G LE L L
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNCL-----GDAGILQLVESVRQPGCLLEQLVLYDI 437
Query: 581 KL 582
Sbjct: 438 YW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-17
Identities = 72/515 (13%), Positives = 152/515 (29%), Gaps = 112/515 (21%)
Query: 68 VEKLDLSNMSLN-GSVSENIRGLRSLSSLNICCN----EFASSLPKSLANLTALKSMDVS 122
++ LD+ L+ +E + L+ + + + +L AL +++
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 123 QNNFIGSFPTGLGKA-----SGLTSVNASSNNFS----GFLPEDLGNATSLESLDFRGSF 173
N + + + ++ + + G L L +L+ L +
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 174 FEGSVPTSF-----RNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPA 228
+ +L+ L L +L+ L +
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV------------------- 165
Query: 229 EFGNLTNLRYLDLAVGSLSGQ----IPPALGRLK-KLTTVYLYKNNFTGK----IPPELG 279
+ + L ++ ++ + L +L + L T + +
Sbjct: 166 -LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224
Query: 280 SITSLAFLDLSDNQISGE-----IPVKLAELKNLQLLNLMCNQLT----GLIPDKLGELT 330
S SL L L N++ P L L+ L + +T G + L
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE 284
Query: 331 KLEVLELWKNSLIGSLPMRLGQS-----SPLRRLDASSNLLSGE----IPTGLCDSGNLT 381
L+ L L N L L ++ L L S + + L + L
Sbjct: 285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLL 344
Query: 382 KLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQ 441
+L + NN + + L + Q L+ L +A+ +++
Sbjct: 345 ELQISNNRLED------AGVRELCQGLGQPG-------------SVLRVLWLADCDVSDS 385
Query: 442 ----IPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQAC 497
+ + + SL +D+S N L + IL + +++ L+
Sbjct: 386 SCSSLAATLLANHSLRELDLSNNCLG---DAGILQL--VESVRQPGCLLE---------- 430
Query: 498 PSLSVLDLSSNSLSGEIPASIASCEK----LVSLN 528
L L S E+ + + EK L ++
Sbjct: 431 ----QLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 54/335 (16%), Positives = 104/335 (31%), Gaps = 73/335 (21%)
Query: 282 TSLAFLDLSDNQISGEIPVKLAE-LKNLQLLNLMCNQLT----GLIPDKLGELTKLEVLE 336
+ LD+ ++S +L L+ Q++ L LT I L L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 337 LWKNSLIGSLPMRLGQ-----SSPLRRLDASSNLLSGE----IPTGLCDSGNLTKLILFN 387
L N L + Q S +++L + L+G + + L L +L L +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 388 NSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDIS 447
N L C+ L L L++L++ +L+ + ++
Sbjct: 123 NLLGDAGLQLL--CEGL-----------------LDPQCRLEKLQLEYCSLSAASCEPLA 163
Query: 448 L----STSLSFVDISWNHLE----SYLPSSILSIP--SLQTFMASHNNLQAK----IPNE 493
+ +S N + L L L+ + + +
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVL-CQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222
Query: 494 LQACPSLSVLDLSSNSLSGE-----IPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTL 548
+ + SL L L SN L P + +L +L + + + + +
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV--- 279
Query: 549 AILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
A +L+ L+L+ N+L
Sbjct: 280 -----------------LRAKESLKELSLAGNELG 297
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 35/159 (22%), Positives = 58/159 (36%), Gaps = 29/159 (18%)
Query: 448 LSTSLSFVDISWNHL-ESYLPSSILSIPSLQTFMASHNNLQAK----IPNELQACPSLSV 502
+S + +DI L ++ + + Q L I + L+ P+L+
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 503 LDLSSNSLSGEIPASIASC-----EKLVSLNLRNNRFSGE----IPKAVATMPTLAILDM 553
L+L SN L + K+ L+L+N +G + + T+PTL L +
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 554 SNNSLFGRIPENFGA----------SPALEMLNLSYNKL 582
S+N L + G LE L L Y L
Sbjct: 121 SDNLL-----GDAGLQLLCEGLLDPQCRLEKLQLEYCSL 154
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-21
Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G G+ +VAVK + R E+ + RE+ LRH NIVR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKEV 84
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGK--EAGKLLVDWVSRYNIAVGIAQ---GLNYLHHD 820
+ T++ ++ +Y GE L+ + AG+ D + Q G++Y H
Sbjct: 85 ILTPTHLAIIMEYASG---GE-LYERICNAGRFSEDEARFF-----FQQLLSGVSYCHSM 135
Query: 821 CQPPVIHRDIKSNNILLDANLEAR--IADFGLARMMLHKNETVSMVAGSYGYIAPE---- 874
+ HRD+K N LLD + R I DFG ++ + G+ YIAPE
Sbjct: 136 Q---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLLR 191
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905
Y K +D++S GV L +L G P +
Sbjct: 192 QEYDGK---IADVWSCGVTLYVMLVGAYPFE 219
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 9e-21
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 30/212 (14%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD----NDIESGDDLFREVSLLGRLRHRNIV 760
I+G G V A A+K L + N + + RE ++ RL H V
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY---VTRERDVMSRLDHPFFV 93
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEAL-HGKEAGKLLVDWVSRYNIAVGIAQGLNYLH- 818
+L ++ + Y N GE L + ++ G +R+ A I L YLH
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKN---GELLKYIRKIGSFDET-CTRFYTA-EIVSALEYLHG 148
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE---TVSMVAGSYGYIAPE- 874
+IHRD+K NILL+ ++ +I DFG A+++ +++ S V G+ Y++PE
Sbjct: 149 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPEL 203
Query: 875 ---YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
D+++ G ++ +L+ G P
Sbjct: 204 LTEKSACKSS----DLWALGCIIYQLVAGLPP 231
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 49/257 (19%), Positives = 93/257 (36%), Gaps = 41/257 (15%)
Query: 141 TSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTG 200
+ NF P++L S ++LD + SF + +L+ L LS +
Sbjct: 10 ITYQCMELNFYKI-PDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65
Query: 201 KIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPP-ALGRLKK 259
I + +L++L L L + + A L
Sbjct: 66 TIEDGA-----------------------YQSLSHLSTLILTGNPIQ-SLALGAFSGLSS 101
Query: 260 LTTVYLYKNNFTGKIPPEL-GSITSLAFLDLSDNQISGEIPVK--LAELKNLQLLNLMCN 316
L + + N + G + +L L+++ N I + + L NL+ L+L N
Sbjct: 102 LQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSN 159
Query: 317 QLTGLIPDKLGELTKLEV----LELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPT 372
++ + L L ++ + L+L N + + + L+ L +N L +P
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNP-MNFIQPGAFKEIRLKELALDTNQLK-SVPD 217
Query: 373 GLCDS-GNLTKLILFNN 388
G+ D +L K+ L N
Sbjct: 218 GIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 52/254 (20%), Positives = 88/254 (34%), Gaps = 35/254 (13%)
Query: 261 TTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG 320
T + NF KIP L S LDLS N + LQ+L+L ++
Sbjct: 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 321 LIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNL 380
+ L+ L L L N + QS L+ +GL +L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPI---------QS------------LALGAFSGLS---SL 102
Query: 381 TKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGL-GNLPSLQRLEMANNNLT 439
KL+ + + + K+L + V +NLI NL +L+ L++++N +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 440 GQIPDDI-----SLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNEL 494
I + +D+S N + + L+ N L++
Sbjct: 163 -SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIF 220
Query: 495 QACPSLSVLDLSSN 508
SL + L +N
Sbjct: 221 DRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 18/222 (8%)
Query: 369 EIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGL-GNLPS 427
+IP L + L L N S + L + + I TI G +L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 428 LQRLEMANNNLTGQIPDDISLS-TSLSFVDISWNHLESYLPSSILSIP-SLQTFMASHNN 485
L L + N + + +SL + +L S L + + +L+ +HN
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNL 135
Query: 486 LQA-KIPNELQACPSLSVLDLSSNSLSGEIPASI-ASCEKL----VSLNLRNNRFSGEIP 539
+Q+ K+P +L LDLSSN + I + ++ +SL+L N + I
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193
Query: 540 KAVATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYN 580
L L + N L +P+ F +L+ + L N
Sbjct: 194 PGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 55/302 (18%), Positives = 87/302 (28%), Gaps = 90/302 (29%)
Query: 55 CNWTGVWCNSRGF----------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFAS 104
C F + LDLS L S + L L++ E +
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 105 SLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSL 164
+ +L+ L ++ ++ N + S L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNP--------------IQS-----------LA--------- 92
Query: 165 ESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEG 224
+F L L+ L L+SLE
Sbjct: 93 --------------LGAFSGLSSLQKLVAVET-----------NLASLENFP-------- 119
Query: 225 EIPAEFGNLTNLRYLDLAVGSL-SGQIPPALGRLKKLTTVYLYKNNFTGKIPPE----LG 279
G+L L+ L++A + S ++P L L + L N I L
Sbjct: 120 -----IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLH 173
Query: 280 SITSLAF-LDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELW 338
+ L LDLS N ++ I + L+ L L NQL + LT L+ + L
Sbjct: 174 QMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 232
Query: 339 KN 340
N
Sbjct: 233 TN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 38/151 (25%), Positives = 62/151 (41%), Gaps = 8/151 (5%)
Query: 435 NNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNEL 494
N +IPD++ S +D+S+N L S S P LQ S +Q
Sbjct: 16 ELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 495 QACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNRFSGEIPKAVAT-MPTLAILD 552
Q+ LS L L+ N + + + L L + + + TL L+
Sbjct: 73 QSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELN 130
Query: 553 MSNNSL-FGRIPENFGASPALEMLNLSYNKL 582
+++N + ++PE F LE L+LS NK+
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-20
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWR----SDNDIESGDDLFREVSLLGRLRHRNIV 760
++G GG G V+ + + A KKL + + E +L ++ R IV
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG---AMVEKKILAKVHSRFIV 248
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALH--GKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
L +T++ +V M + ++ ++ Y I GL +LH
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY--TAQIVSGLEHLH 306
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE---- 874
Q +I+RD+K N+LLD + RI+D GLA + AG+ G++APE
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y V D ++ GV L E++ + P
Sbjct: 364 EEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 3e-20
Identities = 53/207 (25%), Positives = 83/207 (40%), Gaps = 21/207 (10%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWR----SDNDIESGDDLFREVSLLGRLRHRNIV 760
++G GG G V + + A KKL + E +L ++ R +V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM---ALNEKQILEKVNSRFVV 247
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
L + + +V M L ++ Y A I GL LH
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY--AAEICCGLEDLH-- 303
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----YG 876
+ +++RD+K NILLD + RI+D GLA + V G+ GY+APE
Sbjct: 304 -RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNER 361
Query: 877 YTLKVDEKSDIYSFGVVLLELLTGKMP 903
YT D ++ G +L E++ G+ P
Sbjct: 362 YTFSP----DWWALGCLLYEMIAGQSP 384
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 49/234 (20%), Positives = 91/234 (38%), Gaps = 16/234 (6%)
Query: 110 LANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDF 169
++ + + + + + + A++++ + + ++ L
Sbjct: 20 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 75
Query: 170 RGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAE 229
+ + + NL+ L +L L N + + L L L+++ L +N +I
Sbjct: 76 --NGNKLTDIKPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING- 129
Query: 230 FGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDL 289
+L L L L ++ I L RL KL T+ L N + I P L +T L L L
Sbjct: 130 LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 185
Query: 290 SDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLI 343
S N IS ++ LA LKNL +L L + + L ++ SL+
Sbjct: 186 SKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 48/271 (17%), Positives = 104/271 (38%), Gaps = 20/271 (7%)
Query: 313 LMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPT 372
+ + + D + L K S+ ++ + + + ++ A+++ + +
Sbjct: 9 TVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-Q 62
Query: 373 GLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLE 432
G+ N+TKL L N + P L+ K+L + + N + + L +L L+ L
Sbjct: 63 GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLS 118
Query: 433 MANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPN 492
+ +N ++ I + + L + + N + + + + L T N + I
Sbjct: 119 LEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP 173
Query: 493 ELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILD 552
L L L LS N +S ++ A +A + L L L + + + + +
Sbjct: 174 -LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 230
Query: 553 MSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
++ SL PE E N+ ++ E
Sbjct: 231 NTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 46/220 (20%), Positives = 94/220 (42%), Gaps = 16/220 (7%)
Query: 379 NLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNL 438
K L S + V+ + S+ ++ N+ I ++ G+ LP++ +L + N L
Sbjct: 25 ETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKL 80
Query: 439 TGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACP 498
T I +L +L ++ + N ++ SS+ + L++ HN + I L P
Sbjct: 81 T-DIKPLANL-KNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGIS-DING-LVHLP 134
Query: 499 SLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSL 558
L L L +N ++ +I ++ KL +L+L +N+ S +I +A + L L +S N +
Sbjct: 135 QLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHI 190
Query: 559 FGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPN 598
L++L L + ++ + +
Sbjct: 191 --SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 228
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 42/178 (23%), Positives = 69/178 (38%), Gaps = 12/178 (6%)
Query: 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIG 128
KL L+ L + + + L++L L + N+ SL +L LKS+ + N I
Sbjct: 71 TKLFLNGNKL--TDIKPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNG-IS 125
Query: 129 SFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKL 188
GL L S+ +N + L T L++L + S L KL
Sbjct: 126 DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKL 180
Query: 189 KFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSL 246
+ L LS N+++ + L L +L+ + L + NL + GSL
Sbjct: 181 QNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-19
Identities = 61/211 (28%), Positives = 87/211 (41%), Gaps = 28/211 (13%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-----REV-SLLGRLRHRN 758
IIG GG G VY + A+K L I+ R + SL+
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCL--DKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEAL-HGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
IV + H + + D M G+ H + G + Y A I GL ++
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNG---GDLHYHLSQHGVFSEADMRFY--AAEIILGLEHM 308
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE--- 874
H V++RD+K NILLD + RI+D GLA K + + V G++GY+APE
Sbjct: 309 H---NRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASV-GTHGYMAPEVLQ 363
Query: 875 --YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y D +S G +L +LL G P
Sbjct: 364 KGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-19
Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR---EVSLLGRLRHRNIVR 761
+IG G G V + V A+K L + ++ + E +L + I
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKIL--NKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALH--GKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
L ++ N+ +V DY G+ L K +L + Y + ++ +H
Sbjct: 139 LHYAFQDDNNLYLVMDYYVG---GDLLTLLSKFEDRLPEEMARFY--LAEMVIAIDSVH- 192
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA-GSYGYIAPE---- 874
Q +HRDIK +NIL+D N R+ADFG ++ S VA G+ YI+PE
Sbjct: 193 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 875 -----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y + D +S GV + E+L G+ P
Sbjct: 251 MEGGKGRYGPEC----DWWSLGVCMYEMLYGETP 280
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-18
Identities = 50/206 (24%), Positives = 82/206 (39%), Gaps = 21/206 (10%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWR----SDNDIESGDDLFREVSLLGRLRHRNIVR 761
+G G G V + A+K L + + +++ E +L RH +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH---TLTENRVLQNSRHPFLTA 212
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
L + V +Y L H D Y I L+YLH +
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFY--GAEIVSALDYLHSEK 268
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----YGY 877
V++RD+K N++LD + +I DFGL + + T+ G+ Y+APE Y
Sbjct: 269 N--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY 326
Query: 878 TLKVDEKSDIYSFGVVLLELLTGKMP 903
V D + GVV+ E++ G++P
Sbjct: 327 GRAV----DWWGLGVVMYEMMCGRLP 348
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 53/209 (25%), Positives = 83/209 (39%), Gaps = 17/209 (8%)
Query: 209 LSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKN 268
++S + +P + L L+ L L +LT + L +
Sbjct: 9 VASHLEVNCDKRNL-TALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 269 NFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGE 328
T G++ L LDLS NQ+ +P+ L L +L++ N+LT L L
Sbjct: 66 ELT--KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122
Query: 329 LTKLEVLELWKNSLIGSLP----MRLGQSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKL 383
L +L+ L L N L +LP + L +L ++N L+ E+P GL + NL L
Sbjct: 123 LGELQELYLKGNEL-KTLPPGLLTPTPK---LEKLSLANNNLT-ELPAGLLNGLENLDTL 177
Query: 384 ILFNNSFSGTFPVSLSTCKSLVRVRVQNN 412
+L NS T P L + N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 45/241 (18%), Positives = 81/241 (33%), Gaps = 48/241 (19%)
Query: 55 CNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLT 114
+ V C+ R ++ ++ + + L++ N + +L T
Sbjct: 10 ASHLEVNCDKRNL------------TALPPDL--PKDTTILHLSENLLYTFSLATLMPYT 55
Query: 115 ALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFF 174
L +++ + + G L +++ S N
Sbjct: 56 RLTQLNLDRAE-LTKLQVD-GTLPVLGTLDLSHNQLQ----------------------- 90
Query: 175 EGSVPTSFRNLQKLKFLGLSGNNLTGKIPPEL-GQLSSLETIILGYNAFEGEIPAE-FGN 232
S+P + L L L +S N LT +P L L+ + L N + +P
Sbjct: 91 --SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTP 146
Query: 233 LTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSD 291
L L LA +L+ ++P L L+ L T+ L +N+ IP L F L
Sbjct: 147 TPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHG 204
Query: 292 N 292
N
Sbjct: 205 N 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 53/254 (20%), Positives = 82/254 (32%), Gaps = 61/254 (24%)
Query: 282 TSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNS 341
S ++ ++ +P L K+ +L+L N L L T+L L L +
Sbjct: 10 ASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 342 LIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTC 401
L +L L L L L +N
Sbjct: 67 L--------------TKLQVDGTL------------PVLGTLDLSHNQLQ---------- 90
Query: 402 KSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDI--SLSTSLSFVDISW 459
++P+ LP+L L+++ N LT +P L L + +
Sbjct: 91 ---------------SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGL-GELQELYLKG 133
Query: 460 NHLESYLPSSIL-SIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASI 518
N L++ LP +L P L+ ++NNL L +L L L NSL IP
Sbjct: 134 NELKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGF 191
Query: 519 ASCEKLVSLNLRNN 532
L L N
Sbjct: 192 FGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 48/193 (24%), Positives = 77/193 (39%), Gaps = 13/193 (6%)
Query: 395 PVSLSTCK-SLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLS 453
P+ + S + V ++ +P L L ++ N L + T L+
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 454 FVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGE 513
+++ L L P L T SHN LQ+ +P Q P+L+VLD+S N L+
Sbjct: 59 QLNLDRAELTKLQVDGTL--PVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-S 114
Query: 514 IPASI-ASCEKLVSLNLRNNRFSGEIPKAV-ATMPTLAILDMSNNSLFGRIPEN-FGASP 570
+P +L L L+ N +P + P L L ++NN+L +P
Sbjct: 115 LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNL-TELPAGLLNGLE 172
Query: 571 ALEMLNLSYNKLE 583
L+ L L N L
Sbjct: 173 NLDTLLLQENSLY 185
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 47/257 (18%), Positives = 85/257 (33%), Gaps = 17/257 (6%)
Query: 211 SLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNN 269
S + + EIP++ N L + L I A L + + +N+
Sbjct: 10 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQND 65
Query: 270 FTGKIPPE-LGSITSLAFLDLSD-NQISGEIPVK-LAELKNLQLLNLMCNQLTGLIPDKL 326
I + ++ L + + N + I + L NLQ L + + L
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHK 124
Query: 327 GELTKLEVLELWKNSLIGSLPMRL--GQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLI 384
+ +L++ N I ++ G S L + N + EI + L +L
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELN 183
Query: 385 L-FNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIP 443
L NN+ V + + I GL NL L+ NL ++P
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS--TYNLK-KLP 240
Query: 444 DDISLSTSLSFVDISWN 460
L +L +++
Sbjct: 241 TLEKL-VALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 41/231 (17%), Positives = 76/231 (32%), Gaps = 12/231 (5%)
Query: 123 QNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTS- 181
Q + + P+ L + LE ++ + +
Sbjct: 17 QESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 74
Query: 182 FRNLQKLKFLGLSGNNLTGKIPPE-LGQLSSLETIILGYNAFEGEIPAE-FGNLTNLRYL 239
F NL KL + + N I PE L +L+ +++ + +P + L
Sbjct: 75 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLL 133
Query: 240 DLAVGSLSGQIPPAL--GRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSD-NQISG 296
D+ I G + ++L KN +I + T L L+LSD N +
Sbjct: 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE- 191
Query: 297 EIPVK-LAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSL 346
E+P +L++ ++ L L L KL + + +L
Sbjct: 192 ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL 242
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 50/293 (17%), Positives = 95/293 (32%), Gaps = 56/293 (19%)
Query: 54 HCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANL 113
HC+ C + ++ R+ L + + +
Sbjct: 8 HCSNRVFLCQESKVT------------EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGF 53
Query: 114 TALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPE----DLGNATSLESLDF 169
L+ +++SQN+ + + FS LP+ + A +L ++
Sbjct: 54 GDLEKIEISQNDVLEVIEADV---------------FSN-LPKLHEIRIEKANNLLYIN- 96
Query: 170 RGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQ-LSSLETIILGYNAFEGEIPA 228
P +F+NL L++L +S + +P + + N I
Sbjct: 97 ---------PEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER 146
Query: 229 E-FGNLT-NLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLA 285
F L+ L L + +I + +L + L NN ++P + +
Sbjct: 147 NSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205
Query: 286 FLDLSDNQISGEIPVK-LAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLEL 337
LD+S +I +P L LK L+ + L L L +L L L
Sbjct: 206 ILDISRTRIH-SLPSYGLENLKKLRARST--YNLKKLPT--LEKLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 49/302 (16%), Positives = 101/302 (33%), Gaps = 67/302 (22%)
Query: 287 LDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSL 346
+++++ EIP L +N L + +L + LE +E+ +N ++ +
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 347 PMRLGQSSP-LRRLDAS-SNLLSGEIPTGLCDS-GNLTKLILFNNSFSGTFPVSLSTCKS 403
+ + P L + +N L I + NL L++ N
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK------------ 117
Query: 404 LVRVRVQNNLISGTIPVGL-GNLPSLQRLEMANNNLTGQIPDDI--SLSTSLSFVDISWN 460
+P + L++ +N I + LS + ++ N
Sbjct: 118 -------------HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 164
Query: 461 HLESYLPSSILSIPSLQTFMASHNNLQAKIPNE-LQACPSLSVLDLSSNSLSGEIPASI- 518
++ + +S + L S NN ++PN+ +LD+S + +P+
Sbjct: 165 GIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGL 222
Query: 519 ASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLS 578
+ +KL + + N + +PTL L AL +L+
Sbjct: 223 ENLKKLRARSTYNLK----------KLPTLEKL------------------VALMEASLT 254
Query: 579 YN 580
Y
Sbjct: 255 YP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 43/229 (18%), Positives = 90/229 (39%), Gaps = 19/229 (8%)
Query: 371 PTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVG-LGNLPSLQ 429
+C + + + + P L + + +R + I G L+
Sbjct: 3 HHRICHC-SNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLR-VIQKGAFSGFGDLE 57
Query: 430 RLEMANNNLTGQIPDDI--SLSTSLSFVDIS-WNHLESYLPSSILS-IPSLQTFMASHNN 485
++E++ N++ I D+ +L L + I N+L Y+ +P+LQ + S+
Sbjct: 58 KIEISQNDVLEVIEADVFSNL-PKLHEIRIEKANNL-LYINPEAFQNLPNLQYLLISNTG 115
Query: 486 LQAKIPNEL-QACPSLSVLDLSSNSLSGEIPASIAS--CEKLVSLNLRNNRFSGEIPKAV 542
++ +P+ +LD+ N I + + V L L N EI +
Sbjct: 116 IK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSA 173
Query: 543 ATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYNKLEGPVPSNG 590
L L++S+N+ +P + F + +L++S ++ +PS G
Sbjct: 174 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG 221
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 9e-04
Identities = 17/96 (17%), Positives = 32/96 (33%), Gaps = 11/96 (11%)
Query: 496 ACP------SLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLA 549
C S V + ++ EIP+ + + L + A + L
Sbjct: 1 GCHHRICHCSNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLE 57
Query: 550 ILDMSNNSLFGRIPEN-FGASPALEMLNLS-YNKLE 583
+++S N + I + F P L + + N L
Sbjct: 58 KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL 93
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 177 SVPTS-FRNLQKLKFLGLSGNNLTGKIPPE-LGQLSSLETIILGYNAFEGEIPAE-FGNL 233
++P++ + +KL L N L+ +P + +L+ L + L N + +PA F L
Sbjct: 30 AIPSNIPADTKKLD---LQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKEL 84
Query: 234 TNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPEL-GSITSLAFLDLSD 291
NL L + L +P +L L + L +N +PP + S+T L +L L
Sbjct: 85 KNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGY 142
Query: 292 NQISGEIPVKL-AELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSL 342
N++ +P + +L +L+ L L NQL + +LT+L+ L+L N L
Sbjct: 143 NELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQL 193
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 10/167 (5%)
Query: 179 PTSFRNLQKLKFLGLSGNNLTGKIPPEL-GQLSSLETIILGYNAFEGEIPAE-FGNLTNL 236
+F L KL+ L L+ N L +P + +L +LET+ + N + +P F L NL
Sbjct: 54 SKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNL 111
Query: 237 RYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPEL-GSITSLAFLDLSDNQI 294
L L L +PP L KLT + L N +P + +TSL L L +NQ+
Sbjct: 112 AELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL 169
Query: 295 SGEIPVKL-AELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKN 340
+P +L L+ L L NQL + L KL++L+L +N
Sbjct: 170 K-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 44/182 (24%), Positives = 78/182 (42%), Gaps = 8/182 (4%)
Query: 91 SLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGL-GKASGLTSVNASSNN 149
L++ N+ +S K+ LT L+ + ++ N + + P G+ + L ++ + N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK-LQTLPAGIFKELKNLETLWVTDNK 96
Query: 150 FSGFLPEDLGNATSLESLDFRGSFFEGSVPTS-FRNLQKLKFLGLSGNNLTGKIPPEL-G 207
+L L + + S+P F +L KL +L L N L +P +
Sbjct: 97 LQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154
Query: 208 QLSSLETIILGYNAFEGEIPAE-FGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLY 266
+L+SL+ + L N + +P F LT L+ L L L A L+KL + L
Sbjct: 155 KLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213
Query: 267 KN 268
+N
Sbjct: 214 EN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 51/231 (22%), Positives = 88/231 (38%), Gaps = 33/231 (14%)
Query: 353 SSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNN 412
++ +D SS L+ IP+ + + KL L +N S + L + + +N
Sbjct: 15 NNNKNSVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDN 71
Query: 413 LISGTIPVGL-GNLPSLQRLEMANNNLTGQIPDDISLS-TSLSFVDISWNHLESYLPSSI 470
+ T+P G+ L +L+ L + +N L +P + +L+ + + N L+S
Sbjct: 72 KLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS------ 123
Query: 471 LSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNL 529
L ++ + L L+ L L N L +P + L L L
Sbjct: 124 ---------------LPPRVFDSL---TKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRL 164
Query: 530 RNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYN 580
NN+ A + L L + NN L F + L+ML L N
Sbjct: 165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 38/151 (25%), Positives = 62/151 (41%), Gaps = 9/151 (5%)
Query: 435 NNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNEL 494
N L + S + + + VD S L + +PS+I + + N L +
Sbjct: 1 NEALCKKDGGVCSCNNNKNSVDCSSKKLTA-IPSNIPA--DTKKLDLQSNKLSSLPSKAF 57
Query: 495 QACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNRFSGEIPKAVATMPT-LAILD 552
L +L L+ N L +PA I + L +L + +N+ +P V LA L
Sbjct: 58 HRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELR 115
Query: 553 MSNNSLFGRIPEN-FGASPALEMLNLSYNKL 582
+ N L +P F + L L+L YN+L
Sbjct: 116 LDRNQL-KSLPPRVFDSLTKLTYLSLGYNEL 145
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 44/216 (20%), Positives = 81/216 (37%), Gaps = 60/216 (27%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLL 763
++G+G NG V + R A+K ++ REV L R + +IVR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKM-------LQDCPKARREVELHWRASQCPHIVRIV 77
Query: 764 GY----LHNETNVMMVYDYMPN----DSLGEALHG----KEAGKLLVDWVSRYNIAVGIA 811
+++V + + + + +EA +++ I
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS----------IG 127
Query: 812 QGLNYLH-HDCQPPVIHRDIKSNNILL---DANLEARIADFGLARMMLHKNETVSMVAGS 867
+ + YLH + + HRD+K N+L N ++ DFG A+ +
Sbjct: 128 EAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK--------- 174
Query: 868 YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y D+ D++S GV++ LL G P
Sbjct: 175 Y-------------DKSCDMWSLGVIMYILLCGYPP 197
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-18
Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 26/211 (12%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR---EVSLLGRLRHRNIVR 761
+IG G G V V A+K L S ++ D E ++ +V+
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
L ++ + MV +YMP G+ ++ + W Y + L+ +H
Sbjct: 134 LFYAFQDDRYLYMVMEYMPG---GDLVNLMSNYDVPEKWARFY--TAEVVLALDAIH--- 185
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA-GSYGYIAPE------ 874
IHRD+K +N+LLD + ++ADFG M + A G+ YI+PE
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 875 --YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y + D +S GV L E+L G P
Sbjct: 246 GDGYYGREC----DWWSVGVFLYEMLVGDTP 272
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 50/206 (24%), Positives = 79/206 (38%), Gaps = 22/206 (10%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWR----SDNDIESGDDLFREVSLLGRLRHRNIVR 761
+G G G V A+K L + + +++ E +L RH +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH---TVTESRVLQNTRHPFLTA 69
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
L + V +Y L H + Y I L YLH
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY--GAEIVSALEYLH--- 122
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----YGY 877
V++RDIK N++LD + +I DFGL + + T+ G+ Y+APE Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 878 TLKVDEKSDIYSFGVVLLELLTGKMP 903
V D + GVV+ E++ G++P
Sbjct: 183 GRAV----DWWGLGVVMYEMMCGRLP 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 6e-18
Identities = 61/272 (22%), Positives = 97/272 (35%), Gaps = 76/272 (27%)
Query: 704 NIIGMGGNGIVYKAE-----FHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHR 757
+G G G V +A+ VAVK L + L E+ +L + H
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHL 86
Query: 758 NIVRLLG-----------------------YLHNETNVMMVY-----------DYM---- 779
N+V LLG YL ++ N + Y DY+
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 780 -----PNDSLGEALHGKEAGKLLVDWVSRYN--------------------IAVGIAQGL 814
DS+ + +G + +S + +A+G+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 815 NYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGS--YGYIA 872
+L IHRD+ + NILL +I DFGLAR + + V ++A
Sbjct: 207 EFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263
Query: 873 PEYGYTLKVDEKSDIYSFGVVLLELLT-GKMP 903
PE + +SD++SFGV+L E+ + G P
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 47/236 (19%), Positives = 79/236 (33%), Gaps = 40/236 (16%)
Query: 89 LRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSN 148
S +L + + + +NL + + VS + + +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHS-------------- 75
Query: 149 NFSGFLPE----DLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPP 204
F L + ++ N +L +D P + + L LKFLG+ L P
Sbjct: 76 -FYN-LSKVTHIEIRNTRNLTYID----------PDALKELPLLKFLGIFNTGLK-MFPD 122
Query: 205 E--LGQLSSLETIILGYNAFEGEIPAE-FGNLTN-LRYLDLAVGSLSGQIPPALGRLKKL 260
+ + + N + IP F L N L L + + KL
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKL 181
Query: 261 TTVYLYKNNFTGKIPPEL--GSITSLAFLDLSDNQISGEIPVK-LAELKNLQLLNL 313
VYL KN + I + G + + LD+S ++ +P K L LK L N
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 38/257 (14%), Positives = 72/257 (28%), Gaps = 47/257 (18%)
Query: 287 LDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSL 346
++ I IP + Q L L+ L + L + + + + + L
Sbjct: 16 FRVTCKDIQ-RIPSLPP---STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQL 71
Query: 347 PMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSF-----SGTFPVSLSTC 401
+ NL +T + + N
Sbjct: 72 ES-----------HSFYNL------------SKVTHIEIRNTRNLTYIDPDAL----KEL 104
Query: 402 KSLVRVRVQNNLISGTIP--VGLGNLPSLQRLEMANNNLTGQIPDDI--SLSTSLSFVDI 457
L + + N + P + + LE+ +N IP + L + +
Sbjct: 105 PLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163
Query: 458 SWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNEL--QACPSLSVLDLSSNSLSGEIP 515
N S + + L + N I + S+LD+S S++ +P
Sbjct: 164 YNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALP 221
Query: 516 ASIASCEKLVSLNLRNN 532
+ E L L RN
Sbjct: 222 SKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 33/191 (17%), Positives = 78/191 (40%), Gaps = 14/191 (7%)
Query: 403 SLVRVRVQNNLISGTIPVG-LGNLPSLQRLEMANNNLTGQIPDDI--SLSTSLSFVDISW 459
S +++ + TIP NLP++ R+ ++ + Q+ +L + ++ ++I
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNL-SKVTHIEIRN 89
Query: 460 NHLESYLPSSILS-IPSLQTFMASHNNLQAKIPNE--LQACPSLSVLDLSSNSLSGEIPA 516
+Y+ L +P L+ + L+ P+ + + +L+++ N IP
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 517 SIAS--CEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPEN--FGASPAL 572
+ C + ++L L NN F+ + L + ++ N I ++ G
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 573 EMLNLSYNKLE 583
+L++S +
Sbjct: 208 SLLDVSQTSVT 218
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 31/216 (14%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL---FREVSLLGRLRHRNIVR 761
+IG G V + + V A+K + + D+ ++ E +L R I +
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIM--NKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALH--GKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
L +E + +V +Y G+ L K ++ + Y I ++ +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVG---GDLLTLLSKFGERIPAEMARFY--LAEIVMAIDSVH- 179
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA-GSYGYIAPE---- 874
+ +HRDIK +NILLD R+ADFG + S+VA G+ Y++PE
Sbjct: 180 --RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 875 -------YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y + D ++ GV E+ G+ P
Sbjct: 238 VGGGPGTGSYGPEC----DWWALGVFAYEMFYGQTP 269
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 29/208 (13%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSD----NDIESGDDLFREVSLLGRLRHRNIVR 761
+G G G V + A+K L + IE E +L + +V+
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH---TLNEKRILQAVNFPFLVK 105
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEA-LHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-H 819
L + +N+ MV +Y+ GE H + G+ +R+ A I YLH
Sbjct: 106 LEFSFKDNSNLYMVMEYVAG---GEMFSHLRRIGRFSEP-HARFYAA-QIVLTFEYLHSL 160
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----Y 875
D +I+RD+K N+L+D ++ DFG A+ + + T + G+ +APE
Sbjct: 161 D----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---LCGTPEALAPEIILSK 213
Query: 876 GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
GY V D ++ GV++ E+ G P
Sbjct: 214 GYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 53/234 (22%), Positives = 94/234 (40%), Gaps = 44/234 (18%)
Query: 162 TSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNA 221
+ + + L + + + +++ + L ++ + LG N
Sbjct: 19 AETIKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNK 74
Query: 222 FEGEIPAEFGNLTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPEL-G 279
+I A LTNL YL L L +P +L L + L +N +P +
Sbjct: 75 LH-DISA-LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFD 130
Query: 280 SITSLAFLDLSDNQISGEIPVKL-AELKNLQLLNLMCNQLTGL---IPDKLGELTKLEVL 335
+T+L +L+L+ NQ+ +P + +L NL L+L NQL L + DK LT+L+ L
Sbjct: 131 KLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDK---LTQLKDL 186
Query: 336 ELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNN 388
L++N L +S +P G+ D +L + L +N
Sbjct: 187 RLYQNQL---------KS----------------VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 50/214 (23%), Positives = 82/214 (38%), Gaps = 37/214 (17%)
Query: 234 TNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQ 293
+L S++ L + + ++ + + ++ +L L N+
Sbjct: 19 AETIKANLKKKSVTD--AVTQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNK 74
Query: 294 ISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRL-GQ 352
+ +I L EL NL L L NQL L +LT L+ L L +N L SLP + +
Sbjct: 75 LH-DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDK 131
Query: 353 SSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQN 411
+ L L+ + N L +P G+ D NLT+L L N
Sbjct: 132 LTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-------------------- 170
Query: 412 NLISGTIPVGL-GNLPSLQRLEMANNNLTGQIPD 444
++P G+ L L+ L + N L +PD
Sbjct: 171 -----SLPEGVFDKLTQLKDLRLYQNQLKS-VPD 198
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWR----SDNDIESGDDLFREVSLLGR-LRHRNI 759
+IG G V + + A+K + + D DI+ + E + + H +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW---VQTEKHVFEQASNHPFL 72
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEAL-HGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
V L E+ + V +Y+ G+ + H + KL + Y + I+ LNYLH
Sbjct: 73 VGLHSCFQTESRLFFVIEYVNG---GDLMFHMQRQRKLPEEHARFY--SAEISLALNYLH 127
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE---- 874
+ +I+RD+K +N+LLD+ ++ D+G+ + L +T S G+ YIAPE
Sbjct: 128 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 184
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y V D ++ GV++ E++ G+ P
Sbjct: 185 EDYGFSV----DWWALGVLMFEMMAGRSP 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 47/233 (20%), Positives = 74/233 (31%), Gaps = 17/233 (7%)
Query: 232 NLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSD 291
L N +L S++ + L + +N + + T+L L LS
Sbjct: 17 GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSH 72
Query: 292 NQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLG 351
NQIS ++ L +L L+ L++ N+L L L L L N L + L
Sbjct: 73 NQIS-DLS-PLKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNELRDTDS--LI 125
Query: 352 QSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQN 411
L L +N L I L L L L N + T L+ K + + +
Sbjct: 126 HLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTG 181
Query: 412 NLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLES 464
L ++ + P IS S + W
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVY 232
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 50/234 (21%), Positives = 90/234 (38%), Gaps = 17/234 (7%)
Query: 184 NLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAV 243
L L ++T + +LS ++ + + + TNL+ L L+
Sbjct: 17 GLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSH 72
Query: 244 GSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLA 303
+S + P L L KL + + +N + L+ L L +N++ L
Sbjct: 73 NQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELRDTDS--LI 125
Query: 304 ELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASS 363
LKNL++L++ N+L ++ LG L+KLEVL+L N I + L + + +D +
Sbjct: 126 HLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNE-ITNTGG-LTRLKKVNWIDLTG 181
Query: 364 NLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGT 417
E + + + + P +S S V V L T
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 44/234 (18%), Positives = 75/234 (32%), Gaps = 39/234 (16%)
Query: 110 LANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDF 169
L ++ + + + + SG+ + N ++N SL +
Sbjct: 15 DPGLANAVKQNLGKQS-VTDL-VSQKELSGVQNFNGDNSNI-----------QSLAGMQ- 60
Query: 170 RGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAE 229
LK L LS N ++ + P L L+ LE + + N + +
Sbjct: 61 --------------FFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NL--N 101
Query: 230 FGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDL 289
L L L L L LK L + + N I LG ++ L LDL
Sbjct: 102 GIPSACLSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDL 157
Query: 290 SDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLI 343
N+I+ L LK + ++L + EL ++ I
Sbjct: 158 HGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 44/246 (17%), Positives = 85/246 (34%), Gaps = 23/246 (9%)
Query: 289 LSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPM 348
I+ P L N NL +T L+ EL+ ++ + I SL
Sbjct: 4 QRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNS-NIQSLAG 58
Query: 349 RLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVR 408
+ + L+ L S N +S ++ + L D L +L + N + + L
Sbjct: 59 -MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRL---F 112
Query: 409 VQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPS 468
+ NN + T L +L +L+ L + NN L I + + L +D+ N + +
Sbjct: 113 LDNNELRDTDS--LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNT--G 166
Query: 469 SILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEI--PASIASCEKLVS 526
+ + + + + P L + + + G P I++ V
Sbjct: 167 GLTRLKKVNWIDLTGQKCVNEPVKYQ---PELYITNTVKD-PDGRWISPYYISNGGSYVD 222
Query: 527 LNLRNN 532
+
Sbjct: 223 GCVLWE 228
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 37/201 (18%), Positives = 73/201 (36%), Gaps = 17/201 (8%)
Query: 382 KLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQ 441
+ I + FP + V+ + + T V L +Q N+N+
Sbjct: 1 ESIQRPTPINQVFP--DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-S 55
Query: 442 IPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLS 501
+ + T+L + +S N + S + + L+ + N L+ + LS
Sbjct: 56 L-AGMQFFTNLKELHLSHNQISDL--SPLKDLTKLEELSVNRNRLK-NLNGI--PSACLS 109
Query: 502 VLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGR 561
L L +N L S+ + L L++RNN+ I + + L +LD+ N +
Sbjct: 110 RLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEI--T 163
Query: 562 IPENFGASPALEMLNLSYNKL 582
+ ++L+ K
Sbjct: 164 NTGGLTRLKKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 33/176 (18%), Positives = 67/176 (38%), Gaps = 19/176 (10%)
Query: 410 QNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLS--TSLSFVDISWNHLESYLP 467
+ I+ P L + + + ++T D +S + + + ++++S
Sbjct: 5 RPTPINQVFP--DPGLANAVKQNLGKQSVT----DLVSQKELSGVQNFNGDNSNIQSL-- 56
Query: 468 SSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSL 527
+ + +L+ SHN + + L+ L L ++ N L + L L
Sbjct: 57 AGMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNGI--PSACLSRL 111
Query: 528 NLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
L NN ++ + L IL + NN L + G LE+L+L N++
Sbjct: 112 FLDNNELRD--TDSLIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 41/228 (17%), Positives = 71/228 (31%), Gaps = 17/228 (7%)
Query: 68 VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFI 127
K +L S+ + + + L + + N + S + T LK + +S N I
Sbjct: 21 AVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHLSHNQ-I 75
Query: 128 GSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQK 187
+ L + L ++ + N L L + E S +L+
Sbjct: 76 SDL-SPLKDLTKLEELSVNRNRLKNLNGIPS---ACLSRLFLDNN--ELRDTDSLIHLKN 129
Query: 188 LKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLS 247
L+ L + N L I LG LS LE + L N L + ++DL
Sbjct: 130 LEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NTG-GLTRLKKVNWIDLTGQKCV 185
Query: 248 GQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQIS 295
+ L TV + P + + S +
Sbjct: 186 NEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 13/102 (12%), Positives = 33/102 (32%), Gaps = 7/102 (6%)
Query: 482 SHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKA 541
++ + +L S++ + + + N N+ +
Sbjct: 4 QRPTPINQVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AG 58
Query: 542 VATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
+ L L +S+N + LE L+++ N+L+
Sbjct: 59 MQFFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLK 98
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 59/346 (17%), Positives = 98/346 (28%), Gaps = 75/346 (21%)
Query: 280 SITSLAFLDLSDNQISGE----IPVKLAELKNLQLLNLMCNQLTG----LIPDKLGELTK 331
+ S+ L + I+ E + L E +++ + L N + + + +
Sbjct: 2 ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 61
Query: 332 LEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFS 391
LE+ E R+ + L L + L +N+F
Sbjct: 62 LEIAEFSDIFT--------------GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 107
Query: 392 GT----FPVSLSTCKSLVRVRVQNNLIS--GTIPVGLGNLPSLQRLEMANNNLTGQIPDD 445
T LS L + + NN + + L L + A N
Sbjct: 108 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA-LQELAVNKKAKNA-------- 158
Query: 446 ISLSTSLSFVDISWNHLE----SYLPSSILSIPSLQTFMASHNNL-----QAKIPNELQA 496
L + N LE + S L T N + + + L
Sbjct: 159 ----PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY 214
Query: 497 CPSLSVLDLSSNSLSGE----IPASIASCEKLVSLNLRNNRFSGEIPKAVATM------P 546
C L VLDL N+ + + ++ S L L L + S AV
Sbjct: 215 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI 274
Query: 547 TLAILDMSNNSLFGRIPENFGAS----------PALEMLNLSYNKL 582
L L + N + E P L L L+ N+
Sbjct: 275 GLQTLRLQYNEI-----ELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 53/342 (15%), Positives = 89/342 (26%), Gaps = 69/342 (20%)
Query: 90 RSLSSLNICCN----EFASSLPKSLANLTALKSMDVSQNNF-------IGSFPTGLGKAS 138
S+ ++ + E S+ L ++K + +S N + +
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSE---NIASKK 60
Query: 139 GLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNL 198
L S E L + KL + LS N
Sbjct: 61 DLEIAEFSDIFTGRVKDEIPEALRLLLQ--------------ALLKCPKLHTVRLSDNAF 106
Query: 199 TGK----IPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPAL 254
+ L + + LE + L N G +A +
Sbjct: 107 GPTAQEPLIDFLSKHTPLEHLYLHNNGL-GPQAGAK----------IARALQELAVNKKA 155
Query: 255 GRLKKLTTVYLYKNNFTGK----IPPELGSITSLAFLDLSDNQISGE-IPVKLAEL---- 305
L ++ +N S L + + N I E I L E
Sbjct: 156 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215
Query: 306 KNLQLLNLMCNQLTG----LIPDKLGELTKLEVLELWKNSL-------IGSLPMRLGQSS 354
+ L++L+L N T + L L L L L + ++
Sbjct: 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA-FSKLENI 274
Query: 355 PLRRLDASSNLLSGEIPTGLCDS-----GNLTKLILFNNSFS 391
L+ L N + + L +L L L N FS
Sbjct: 275 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 53/313 (16%), Positives = 100/313 (31%), Gaps = 63/313 (20%)
Query: 211 SLETIILGYNAFEGE----IPAEFGNLTNLRYLDLAVGSLSGQ----IPPALGRLKKLTT 262
S+E L +A E + A +++ + L+ ++ + + + K L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 263 VYLYKNNFTGKIPPE-----------LGSITSLAFLDLSDNQISGEIPVKLAEL----KN 307
+ FTG++ E L L + LSDN L +
Sbjct: 65 AEF-SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 308 LQLLNLMCNQLT-------------GLIPDKLGELTKLEVLELWKNSLIGSLPMR----- 349
L+ L L N L + K L + +N + + M+
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR-LENGSMKEWAKT 182
Query: 350 LGQSSPLRRLDASSNLLSGE-----IPTGLCDSGNLTKLILFNNSFS--GTFPVS--LST 400
L + N + E + GL L L L +N+F+ G+ ++ L +
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242
Query: 401 CKSLVRVRVQNNLIS--GTIPVG----LGNLPSLQRLEMANNNLTGQIPDDISLS----- 449
+L + + + L+S G V LQ L + N + +
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 302
Query: 450 TSLSFVDISWNHL 462
L F++++ N
Sbjct: 303 PDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 59/303 (19%), Positives = 103/303 (33%), Gaps = 54/303 (17%)
Query: 68 VEKLDLSNMSLNGSVSENIRGLR----------SLSSLNICCNEF----ASSLPKSLANL 113
+E + S++ E LR L ++ + N F L L+
Sbjct: 62 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 121
Query: 114 TALKSMDVSQNNFIGSFPTGLGK-ASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRG- 171
T L+ + + NN +G P K A L + + NA L S+
Sbjct: 122 TPLEHLYLH-NNGLG--PQAGAKIARALQELAVNKK---------AKNAPPLRSIICGRN 169
Query: 172 SFFEGSVP---TSFRNLQKLKFLGLSGNNLTGK-IPPELGQL----SSLETIILGYNAF- 222
GS+ +F++ + L + + N + + I L + L+ + L N F
Sbjct: 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229
Query: 223 -EG--EIPAEFGNLTNLRYLDLAVGSLSGQ----IPPALGRL--KKLTTVYLYKNNFTGK 273
G + + NLR L L LS + + A +L L T+ L N
Sbjct: 230 HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELD 289
Query: 274 IPPELGS-----ITSLAFLDLSDNQIS--GEIPVKLAE-LKNLQLLNLMCNQLTGLIPDK 325
L + + L FL+L+ N+ S ++ ++ E L + D+
Sbjct: 290 AVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTDE 349
Query: 326 LGE 328
E
Sbjct: 350 EEE 352
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 26/168 (15%), Positives = 59/168 (35%), Gaps = 35/168 (20%)
Query: 451 SLSFVDISWNHLES----YLPSSILSIPSLQTFMASHNNLQAK----IPNELQACPSLSV 502
S+ + + + + + + +L S++ + S N + + + + + L +
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 503 LDLSSNS---LSGEIPA-------SIASCEKLVSLNLRNNRFSGE----IPKAVATMPTL 548
+ S + EIP ++ C KL ++ L +N F + ++ L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 549 AILDMSNNSL-------------FGRIPENFGASPALEMLNLSYNKLE 583
L + NN L + + +P L + N+LE
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 2e-16
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWR----SDNDIESGDDLFREVSLLGR-LRHRNI 759
++G G G V +E + AVK L + D+D+E E +L + +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC---TMVEKRVLALPGKPPFL 404
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEA-LHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
+L + V +Y+ G+ H ++ G+ Y A IA GL +L
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNG---GDLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQ 459
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE---- 874
+I+RD+K +N++LD+ +IADFG+ + + T G+ YIAPE
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 516
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y V D ++FGV+L E+L G+ P
Sbjct: 517 QPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWR----SDNDIESGDDLFREVSLLGR-LRHRNIV 760
+G G G V+ AEF + + A+K L + D+D+E E +L H +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC---TMVEKRVLSLAWEHPFLT 81
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEA-LHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
+ + N+ V +Y+ G+ H + K + + Y A I GL +LH
Sbjct: 82 HMFCTFQTKENLFFVMEYLNG---GDLMYHIQSCHKFDLSRATFY--AAEIILGLQFLH- 135
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----Y 875
+++RD+K +NILLD + +IADFG+ + + + + G+ YIAPE
Sbjct: 136 --SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 193
Query: 876 GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y V D +SFGV+L E+L G+ P
Sbjct: 194 KYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWR----SDNDIESGDDLFREVSLLGR-LRHRNI 759
+IG G V + + A++ + + D DI+ + E + + H +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDW---VQTEKHVFEQASNHPFL 115
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEAL-HGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
V L E+ + V +Y+ G+ + H + KL + Y + I+ LNYLH
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNG---GDLMFHMQRQRKLPEEHARFY--SAEISLALNYLH 170
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE---- 874
+ +I+RD+K +N+LLD+ ++ D+G+ + L +T S G+ YIAPE
Sbjct: 171 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y V D ++ GV++ E++ G+ P
Sbjct: 228 EDYGFSV----DWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-15
Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWR----SDNDIESGDDLFREVSLLGR-LRHRNIV 760
+G G G V A + AVK L + D+D+E E +L H +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVEC---TMTEKRILSLARNHPFLT 87
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEA-LHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
+L + V +++ G+ H +++ + Y A I L +LH
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNG---GDLMFHIQKSRRFDEARARFY--AAEIISALMFLH- 141
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----Y 875
+I+RD+K +N+LLD ++ADFG+ + + T + G+ YIAPE
Sbjct: 142 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 876 GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y V D ++ GV+L E+L G P
Sbjct: 200 LYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 80.2 bits (197), Expect = 1e-15
Identities = 59/330 (17%), Positives = 107/330 (32%), Gaps = 16/330 (4%)
Query: 277 ELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLE 336
E + + + +S L + L LM ++ + + +
Sbjct: 240 EPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHV 299
Query: 337 LWKNSLIGSLPMRLGQSSPLRRLD-----ASSNLLSGEIPTGLCDSGNLTKLILFNNSF- 390
+ SL +L Q + LL DS +L S
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVE 359
Query: 391 -SGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLS 449
S L +CK L + +N TI + + L L + + D
Sbjct: 360 KSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP--- 416
Query: 450 TSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNS 509
+++D + + ++ +H +L + + L+ ++ LDLS N
Sbjct: 417 MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNR 474
Query: 510 LSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFG-RIPENFGA 568
L +P ++A+ L L +N + VA +P L L + NN L + +
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVS 531
Query: 569 SPALEMLNLSYNKLEGPVPSNGILMNINPN 598
P L +LNL N L L + P+
Sbjct: 532 CPRLVLLNLQGNSLCQEEGIQERLAEMLPS 561
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 78.3 bits (192), Expect = 6e-15
Identities = 48/200 (24%), Positives = 75/200 (37%), Gaps = 15/200 (7%)
Query: 147 SNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLS---GNNLTGKIP 203
S S L +L + L+ L+ + ++ R L L + + + L P
Sbjct: 357 SVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP 416
Query: 204 PELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTV 263
L L + L N ++R L LA L+ + L +L +T +
Sbjct: 417 MRAAYLDDLRSKFLLEN------SVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHL 468
Query: 264 YLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGL-I 322
L N +PP L ++ L L SDN + + +A L LQ L L N+L
Sbjct: 469 DLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAA 525
Query: 323 PDKLGELTKLEVLELWKNSL 342
L +L +L L NSL
Sbjct: 526 IQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.2 bits (171), Expect = 2e-12
Identities = 45/254 (17%), Positives = 87/254 (34%), Gaps = 11/254 (4%)
Query: 259 KLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQL 318
L L S L ++ A + L L +
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRD-SATDEQLFRCELSVEKS 361
Query: 319 TGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSG 378
T ++ +L +L+ LE + ++ + + PL + S D
Sbjct: 362 T-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLK---AVDPM 417
Query: 379 NLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNL 438
L + F V + + + + ++ + L L + L++++N L
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRL 475
Query: 439 TGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNL-QAKIPNELQAC 497
+P ++ L + S N LE+ + ++P LQ + +N L Q+ L +C
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQQSAAIQPLVSC 532
Query: 498 PSLSVLDLSSNSLS 511
P L +L+L NSL
Sbjct: 533 PRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 4e-11
Identities = 44/290 (15%), Positives = 84/290 (28%), Gaps = 77/290 (26%)
Query: 275 PPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEV 334
+ + L +LS + LQ C +L L P+ L + +
Sbjct: 342 CRDSATDEQLFRCELSVEK-----------STVLQSELESCKELQELEPENKWCLLTI-I 389
Query: 335 LELWKNSLIGSLPMRLGQSSPLRRLD--------ASSNLLSGEIPTGLCDSGNLTKLILF 386
L + + L S L+ +D + E + ++ L L
Sbjct: 390 LLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA 449
Query: 387 NNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDI 446
+ T L + + + +N + +P L L L+ L+ ++N L
Sbjct: 450 HKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE------- 499
Query: 447 SLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLS 506
++ + P L L L
Sbjct: 500 -------------------------NVD------------------GVANLPRLQELLLC 516
Query: 507 SNSLSG-EIPASIASCEKLVSLNLRNNRFS---GEIPKAVATMPTLAILD 552
+N L + SC +LV LNL+ N G + +P+++ +
Sbjct: 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.8 bits (131), Expect = 1e-07
Identities = 34/212 (16%), Positives = 72/212 (33%), Gaps = 38/212 (17%)
Query: 1 MQTHLLFLYCYIVESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGV 60
+ T +L + + L ++KA +DP+ + S +
Sbjct: 385 LLTIILLMRALDPLLYEKETLQYFSTLKA--VDPMRAAYLDDLRSKFLLENSVLKMEYA- 441
Query: 61 WCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMD 120
V L L++ L +V ++ L ++ L++ N +LP +LA L L+ +
Sbjct: 442 ------DVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQ 492
Query: 121 VSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPT 180
S +N + + G+ L + +N ++
Sbjct: 493 AS-DNALENVD-GVANLPRLQELLLCNNRL-----------QQSAAIQ------------ 527
Query: 181 SFRNLQKLKFLGLSGNNLTGKIPPELGQLSSL 212
+ +L L L GN+L + +L+ +
Sbjct: 528 PLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 56/239 (23%), Positives = 105/239 (43%), Gaps = 32/239 (13%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR--------- 755
+G G V+ A+ + VA+K + E+ +D E+ LL R+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKEDS 82
Query: 756 --HRNIVRLLGY-LHNETNVM---MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVG 809
+I++LL + H N + MV++ + ++L + E + + +V + I+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQ 139
Query: 810 IAQGLNYLHHDCQPPVIHRDIKSNNILLD------ANLEARIADFGLARMMLHKNETVSM 863
+ GL+Y+H C +IH DIK N+L++ ++ +IAD G A +E +
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHYTN 194
Query: 864 VAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922
+ Y +PE +DI+S ++ EL+TG +P G S + ++ I
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDL---FREVSLLGRLRHRNIVRL 762
+G G G V+ A+K L + + E +L + H I+R+
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVL--KKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEAL--HGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-H 819
G + + M+ DY+ GE L +++ + V+++ A + L YLH
Sbjct: 72 WGTFQDAQQIFMIMDYIEG---GE-LFSLLRKSQRFPNP-VAKFYAA-EVCLALEYLHSK 125
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----Y 875
D +I+RD+K NILLD N +I DFG A+ + T + G+ YIAPE
Sbjct: 126 D----IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT---LCGTPDYIAPEVVSTK 178
Query: 876 GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y + D +SFG+++ E+L G P
Sbjct: 179 PYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 26/210 (12%)
Query: 706 IGMGGNGIVY---KAEFHRPHMVVAVKKLWRSDNDIESGDDLFR---EVSLLGRLRHRNI 759
+G GG G V+ K + A+K L + + + D E ++L ++H I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVL-KKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEA-LHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
V L+ + ++ +Y+ GE + + G + D Y I+ L +LH
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSG---GELFMQLEREGIFMEDTACFY--LAEISMALGHLH 138
Query: 819 -HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE--- 874
+I+RD+K NI+L+ ++ DFGL + +H G+ Y+APE
Sbjct: 139 QKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 875 -YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
G+ V D +S G ++ ++LTG P
Sbjct: 195 RSGHNRAV----DWWSLGALMYDMLTGAPP 220
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWR----SDNDIESGDDLFREVSLLGR-LRHRNIV 760
+G G G V +E + AVK L + D+D+E E +L + +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC---TMVEKRVLALPGKPPFLT 84
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEA-LHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
+L + V +Y+ G+ H ++ G+ Y A IA GL +L
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNG---GDLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQ- 138
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE----Y 875
+I+RD+K +N++LD+ +IADFG+ + + T G+ YIAPE
Sbjct: 139 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 196
Query: 876 GYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y V D ++FGV+L E+L G+ P
Sbjct: 197 PYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 63/209 (30%), Positives = 84/209 (40%), Gaps = 27/209 (12%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-----REVSLLGRLRHRNIV 760
IG G G V A + AVK L I + R V LL ++H +V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVL--QKKAILKKKEEKHIMSERNV-LLKNVKHPFLV 102
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEA-LHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH- 818
L + V DY+ GE H + L Y A IA L YLH
Sbjct: 103 GLHFSFQTADKLYFVLDYING---GELFYHLQRERCFLEPRARFY--AAEIASALGYLHS 157
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE---- 874
+ +++RD+K NILLD+ + DFGL + + N T S G+ Y+APE
Sbjct: 158 LN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK 213
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y V D + G VL E+L G P
Sbjct: 214 QPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 6e-15
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 13/99 (13%)
Query: 810 IAQGLNYLH-HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY 868
+A L++LH +I+RD+K NILLD ++ DFGL++ + + G+
Sbjct: 135 LALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 869 GYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
Y+APE G+T D +SFGV++ E+LTG +P
Sbjct: 191 EYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLP 225
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-15
Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 30/214 (14%)
Query: 706 IGMGGNGIVY---KAEFHRPHMVVAVKKLWRSDNDIESGDDLFR---EVSLLGRLRHRN- 758
+G G G V+ K H + A+K L + ++ E +L +R
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVL-KKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGE-ALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
+V L ET + ++ DY+ GE H + + V Y I L +L
Sbjct: 121 LVTLHYAFQTETKLHLILDYING---GELFTHLSQRERFTEHEVQIY--VGEIVLALEHL 175
Query: 818 H-HDCQPPVIHRDIKSNNILLDANLEARIADFGLA-RMMLHKNETVSMVAGSYGYIAPE- 874
H +I+RDIK NILLD+N + DFGL+ + + E G+ Y+AP+
Sbjct: 176 HKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 875 -----YGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
G+ V D +S GV++ ELLTG P
Sbjct: 232 VRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 9/150 (6%)
Query: 194 SGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPP- 252
G LT +IP L ++ I L N + P F LR +DL+ +S ++ P
Sbjct: 19 RGKGLT-EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPD 74
Query: 253 ALGRLKKLTTVYLYKNNFTGKIPPEL-GSITSLAFLDLSDNQISGEIPVKL-AELKNLQL 310
A L+ L ++ LY N T ++P L + SL L L+ N+I+ + V +L NL L
Sbjct: 75 AFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNL 132
Query: 311 LNLMCNQLTGLIPDKLGELTKLEVLELWKN 340
L+L N+L + L ++ + L +N
Sbjct: 133 LSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 9e-13
Identities = 38/134 (28%), Positives = 53/134 (39%), Gaps = 8/134 (5%)
Query: 261 TTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQISGEIPVKL-AELKNLQLLNLMCNQL 318
T + L +N IPP L +DLS+NQIS E+ L++L L L N++
Sbjct: 35 TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 319 TGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP-LRRLDASSNLLSGEIPTGLCDS 377
T L L L++L L N + L + Q L L N L I G
Sbjct: 93 TELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSP 150
Query: 378 -GNLTKLILFNNSF 390
+ + L N F
Sbjct: 151 LRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 28/117 (23%), Positives = 52/117 (44%), Gaps = 6/117 (5%)
Query: 179 PTSFRNLQKLKFLGLSGNNLTGKIPPEL-GQLSSLETIILGYNAFEGEIPAE-FGNLTNL 236
P +F +KL+ + LS N ++ ++ P+ L SL +++L N E+P F L +L
Sbjct: 49 PGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSL 106
Query: 237 RYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDN 292
+ L L ++ + A L L + LY N + ++ + L+ N
Sbjct: 107 QLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 32/127 (25%), Positives = 51/127 (40%), Gaps = 4/127 (3%)
Query: 146 SSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPE 205
N P L +D + P +F+ L+ L L L GN +T ++P
Sbjct: 40 EQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKS 98
Query: 206 L-GQLSSLETIILGYNAFEGEIPAE-FGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTV 263
L L SL+ ++L N + + F +L NL L L L L+ + T+
Sbjct: 99 LFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTM 157
Query: 264 YLYKNNF 270
+L +N F
Sbjct: 158 HLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 34/143 (23%), Positives = 58/143 (40%), Gaps = 8/143 (5%)
Query: 369 EIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGL-GNLPS 427
EIPT L +T++ L N+ P + S K L R+ + NN IS + L S
Sbjct: 25 EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 428 LQRLEMANNNLTGQIPDDI--SLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNN 485
L L + N +T ++P + L SL + ++ N + + + +L N
Sbjct: 82 LNSLVLYGNKIT-ELPKSLFEGL-FSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNK 139
Query: 486 LQAKIPNELQACPSLSVLDLSSN 508
LQ ++ + L+ N
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 30/132 (22%), Positives = 62/132 (46%), Gaps = 10/132 (7%)
Query: 406 RVRVQNNLISGTIPVG-LGNLPSLQRLEMANNNLTGQIPDDI--SLSTSLSFVDISWNHL 462
+R++ N I IP G L+R++++NN ++ ++ D L SL+ + + N +
Sbjct: 36 EIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGL-RSLNSLVLYGNKI 92
Query: 463 ESYLPSSIL-SIPSLQTFMASHNNLQAKIPNEL-QACPSLSVLDLSSNSLSGEIPASIAS 520
LP S+ + SLQ + + N + + + Q +L++L L N L + +
Sbjct: 93 TE-LPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 521 CEKLVSLNLRNN 532
+ +++L N
Sbjct: 151 LRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 24/142 (16%), Positives = 53/142 (37%), Gaps = 6/142 (4%)
Query: 417 TIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSIL-SIPS 475
IP L ++ + + N + P S L +D+S N + L + S
Sbjct: 25 EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRS 81
Query: 476 LQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNRF 534
L + + N + + + SL +L L++N ++ + L L+L +N+
Sbjct: 82 LNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
Query: 535 SGEIPKAVATMPTLAILDMSNN 556
+ + + + ++ N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 21/89 (23%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 498 PSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNRFSGEIPKAV-ATMPTLAILDMSN 555
+++ + L N++ IP + +KL ++L NN+ S E+ + +L L +
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYG 89
Query: 556 NSLFGRIPEN-FGASPALEMLNLSYNKLE 583
N + +P++ F +L++L L+ NK+
Sbjct: 90 NKI-TELPKSLFEGLFSLQLLLLNANKIN 117
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 46/176 (26%), Positives = 63/176 (35%), Gaps = 32/176 (18%)
Query: 217 LGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIP 275
L A F LT L +L+L L + L +L T+ L N +P
Sbjct: 42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLP 99
Query: 276 PEL-GSITSLAFLDLSDNQISGEIPVKL-AELKNLQLLNLMCNQLTGLIPDKLGELTKLE 333
+ +T L L L NQ+ +P + L L+ L L NQL + +LT L+
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQ 158
Query: 334 VLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNN 388
L L N L QS +P G D G L + LF N
Sbjct: 159 TLSLSTNQL---------QS----------------VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 46/175 (26%), Positives = 64/175 (36%), Gaps = 29/175 (16%)
Query: 258 KKLTTV-----------YLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKL-AEL 305
K L +V L +T L +L+L NQ+ + + +L
Sbjct: 24 KSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDL 82
Query: 306 KNLQLLNLMCNQLTGL---IPDKLGELTKLEVLELWKNSLIGSLPM----RLGQSSPLRR 358
L L L NQL L + D LT+L+ L L N L SLP RL + L+
Sbjct: 83 TELGTLGLANNQLASLPLGVFDH---LTQLDKLYLGGNQL-KSLPSGVFDRLTK---LKE 135
Query: 359 LDASSNLLSGEIPTGLCDS-GNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNN 412
L ++N L IP G D NL L L N + L + + N
Sbjct: 136 LRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 44/157 (28%), Positives = 65/157 (41%), Gaps = 14/157 (8%)
Query: 287 LDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSL 346
LDL ++ L L LNL NQL L +LT+L L L N L SL
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQL-ASL 98
Query: 347 PMRLGQS-SPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNNSFS----GTFPVSLST 400
P+ + + L +L N L +P+G+ D L +L L N G F L+
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFD-KLT- 155
Query: 401 CKSLVRVRVQNNLISGTIPVG-LGNLPSLQRLEMANN 436
+L + + N + ++P G L LQ + + N
Sbjct: 156 --NLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 55/228 (24%), Positives = 81/228 (35%), Gaps = 62/228 (27%)
Query: 55 CNWTGVWCNSRGF----------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFAS 104
V C + EKLDL + L RGL L+ LN+ N+ +
Sbjct: 14 EGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT 73
Query: 105 SLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSL 164
+LT L ++ ++ N + S P G+
Sbjct: 74 LSAGVFDDLTELGTLGLANNQ-LASLPLGV------------------------------ 102
Query: 165 ESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPEL-GQLSSLETIILGYNAFE 223
F +L +L L L GN L +P + +L+ L+ + L N +
Sbjct: 103 -----------------FDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144
Query: 224 GEIPAE-FGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNF 270
IPA F LTNL+ L L+ L A RL KL T+ L+ N F
Sbjct: 145 -SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 43/143 (30%), Positives = 61/143 (42%), Gaps = 15/143 (10%)
Query: 309 QLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQS-SPLRRLDASSNLLS 367
+ L+L L L LTKL L L N L +L + + L L ++N L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 368 GEIPTGLCDS-GNLTKLILFNNSF----SGTFPVSLSTCKSLVRVRVQNNLISGTIPVGL 422
+P G+ D L KL L N SG F L+ K L R+ N + +IP G
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFD-RLTKLKEL---RLNTNQLQ-SIPAGA 150
Query: 423 -GNLPSLQRLEMANNNLTGQIPD 444
L +LQ L ++ N L +P
Sbjct: 151 FDKLTNLQTLSLSTNQLQS-VPH 172
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 35/159 (22%), Positives = 63/159 (39%), Gaps = 14/159 (8%)
Query: 429 QRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIP-SLQTFMASHNNLQ 487
++L++ + L T L+++++ +N L++ L + + L T ++N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 488 ---AKIPNELQACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNRFSGEIPKAV- 542
+ + L L L L N L +P+ + KL L L N+ IP
Sbjct: 97 SLPLGVFDHLTQ---LDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151
Query: 543 ATMPTLAILDMSNNSLFGRIPEN-FGASPALEMLNLSYN 580
+ L L +S N L +P F L+ + L N
Sbjct: 152 DKLTNLQTLSLSTNQL-QSVPHGAFDRLGKLQTITLFGN 189
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 31/217 (14%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR----EVSLLGRLRHR-- 757
++IG G G V KA VA+K I++ EV LL +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKI-------IKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 758 ----NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGK--LLVDWVSRYNIAVGIA 811
IV L + ++ +V++ + + +L + L + + ++ ++ A +
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLL--RNTNFRGVSLNLTRKF--AQQMC 167
Query: 812 QGLNYLHHDCQPPVIHRDIKSNNILL--DANLEARIADFGLARMMLHKNETVSMVAGSYG 869
L +L + +IH D+K NILL +I DFG + + + S
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQRIYQYIQSRF 223
Query: 870 YIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
Y +PE + D D++S G +L+E+ TG+ PL
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE-PLFS 259
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR----EVSLLGRLRHR--- 757
+IG G G V KA H+ H VA+K + + R E+ +L LR +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKM-------VRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 758 ---NIVRLLGYLHNETNVMMVYDYMPNDSLGEAL-HGKEAGKLLVDWVSRYNIAVGIAQG 813
N++ +L ++ M ++ + + +L E + K G + V ++ A I Q
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQG-FSLPLVRKF--AHSILQC 212
Query: 814 LNYLHHDCQPPVIHRDIKSNNILL--DANLEARIADFGLARMMLHKNETVSMVAGSYGYI 871
L+ LH + +IH D+K NILL ++ DFG + ++++ V S Y
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQSRFYR 266
Query: 872 APEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906
APE + D++S G +L ELLTG PL P
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY-PLLP 300
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 3e-12
Identities = 71/400 (17%), Positives = 129/400 (32%), Gaps = 43/400 (10%)
Query: 69 EKLDLSNMSL--NGSVSENIRGLRSLSSLNICCNEFASSLPKSLA----NLTALKSMDVS 122
E L L S + + R + +L + + F+ K L + T+L+ ++
Sbjct: 141 ETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFY 200
Query: 123 QNNFIGSFPTGL----GKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSV 178
F P L L SV L A +LE + +
Sbjct: 201 MTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGM 259
Query: 179 PTSFRNLQKLKFLGLSGNNLTGK--IPPELGQLSSLETIILGYNAFEGEIPAE-FGNLTN 235
P + NL + L G + G +P + + + L Y E E N
Sbjct: 260 PEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPN 319
Query: 236 LRYLDLAVGSLSGQIPPALGRL-KKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQI 294
L L+ + + L + K+L + + + + E G ++ + L+
Sbjct: 320 LEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG-- 376
Query: 295 SGEIPVKLAELKNLQLLNLMCNQLT--GL--IPDKLGELTKLEVLELWKNSLIGSLPMRL 350
+ L+ + + + +T L I L L ++ L + I LP+
Sbjct: 377 ----------CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN 426
Query: 351 GQSSPLRRLDASSNLLSGEIPTGLCDSG---------NLTKLILFNNSFSGTFPVSLST- 400
G S L GL D G N+ ++L S + S
Sbjct: 427 GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRG 486
Query: 401 CKSLVRVRVQNNLIS-GTIPVGLGNLPSLQRLEMANNNLT 439
C +L ++ ++ S I + LPSL+ L + +
Sbjct: 487 CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 86/542 (15%), Positives = 161/542 (29%), Gaps = 70/542 (12%)
Query: 94 SLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKA------------SGLT 141
++ +C L + NL +LK + P G L
Sbjct: 56 TMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115
Query: 142 SVNASSNNFS--GFLPEDLGNATSLESLDFRG--SFFEGSVPTSFRNLQKLKFLGLSGNN 197
SV+ S A LE+L F + + + +K+K L + ++
Sbjct: 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESS 175
Query: 198 LTGKIPPELGQLS----SLETIILGYNAFEG----EIPAEFGNLTNLRYLDLA---VGSL 246
+ K L +L+ SLE + F ++ N +L + + + L
Sbjct: 176 FSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILEL 235
Query: 247 SGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELK 306
G A L++ L ++ + L L L LS + +P+
Sbjct: 236 VG-FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAA 293
Query: 307 NLQLLNL-MCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP-LRRLDASSN 364
++ L+L T + + LEVLE L L Q L+RL
Sbjct: 294 QIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGL-EVLAQYCKQLKRLR---- 348
Query: 365 LLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLST-CKSLVRVRVQNNLISGTIPVGLG 423
+ + + S ++L+ C+ L + V + I+ +G
Sbjct: 349 ---------IERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIG 399
Query: 424 -NLPSLQRLEMAN----NNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQT 478
L +L + +T D+ S + + YL L+ L
Sbjct: 400 TYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLR--RFAFYLRQGGLTDLGLSY 457
Query: 479 FMASHNNLQ-----------AKIPNELQACPSLSVLDLSSNSLSGEIPASIA-SCEKLVS 526
N++ + + CP+L L++ S A+ L
Sbjct: 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRY 517
Query: 527 LNLRNNRFSGEIPKAVA---TMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
L ++ R S + + ++ + E + L+Y L
Sbjct: 518 LWVQGYRASMTGQDLMQMARPYWNIELIPSRRVPEVNQQGEIREMEHPAHI--LAYYSLA 575
Query: 584 GP 585
G
Sbjct: 576 GQ 577
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 35/191 (18%), Positives = 68/191 (35%), Gaps = 16/191 (8%)
Query: 179 PTSFRNLQKLKFLGLSGNNLTGKIPPE-LGQLSSLETIILGYNAFEGEIPAE-FGNLTNL 236
+F + L++L LS N+L + L +LE ++L N + F ++ L
Sbjct: 81 SEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQL 138
Query: 237 RYLDLAVGSLSGQIPP----ALGRLKKLTTVYLYKNNFTGKIPPELGSITSL--AFLDLS 290
+ L L+ +S + P +L KL + L N +L + + L L
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
Query: 291 DNQI----SGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSL 346
+N + + + L + L + KL + L+ + +
Sbjct: 198 NNPLECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYK-ESAW 256
Query: 347 PMRLGQSSPLR 357
LG + +R
Sbjct: 257 EAHLGDTLTIR 267
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 45/176 (25%), Positives = 69/176 (39%), Gaps = 26/176 (14%)
Query: 250 IPPALGRLKKLTTVYLYKNNFTGKIPPE--LGSITSLAFLDLSDNQISGEIPVK-LAELK 306
+P L L NN + ++ E +T+L L LS N ++ I + +
Sbjct: 37 LPSYTALL------DLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 307 NLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLP----MRLGQSSPLRRLDAS 362
NL+ L+L N L L +L LEVL L+ N I + + Q L++L S
Sbjct: 89 NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNN-HIVVVDRNAFEDMAQ---LQKLYLS 144
Query: 363 SNLLSGEIPTGLCDSG----NLTKLILFNNSFSGTFPVSLSTCKSLVR--VRVQNN 412
N +S P L G L L L +N L + V+ + + NN
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 40/171 (23%), Positives = 74/171 (43%), Gaps = 16/171 (9%)
Query: 417 TIPVGLGNLPSLQRLEMANNNLTGQIPDDISLS--TSLSFVDISWNHLESYLPSSILS-I 473
+P L L++++NNL+ ++ + + + T+L + +S NHL +++ S +
Sbjct: 32 NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPV 87
Query: 474 PSLQTFMASHNNLQAKIPNE-LQACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRN 531
P+L+ S N+L + +L VL L +N + + + +L L L
Sbjct: 88 PNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145
Query: 532 NRFSGEIP----KAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLS 578
N+ S P K +P L +LD+S+N L + PA L
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 434 ANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILS-IPSLQTFMASHNNLQAKIPN 492
+ L +P + T+L +D+S N+L + + +L + + SHN+L I +
Sbjct: 26 SKQQLP-NVPQSLPSYTAL--LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-ISS 81
Query: 493 E-LQACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNRFSGEIPKAV-ATMPTLA 549
E P+L LDLSSN L + + + + L L L NN + + M L
Sbjct: 82 EAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQ 139
Query: 550 ILDMSNNSLFGRIPE----NFGASPALEMLNLSYNKLE 583
L +S N + R P + P L +L+LS NKL+
Sbjct: 140 KLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 44/267 (16%), Positives = 93/267 (34%), Gaps = 54/267 (20%)
Query: 54 HCNWTGVWCNSRGF----------VEKLDLSNMSLNGSVSENI-RGLRSLSSLNICCNEF 102
C + C+ + LDLS+ +L+ +E L +L SL + N
Sbjct: 17 LCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL 76
Query: 103 ASSLPKSLANLTALKSMDVSQNNFIGSFPTG-LGKASGLTSVNASSNNFSGFLPEDLGNA 161
++ + L+ +D+S N+ + + L + +N+
Sbjct: 77 NFISSEAFVPVPNLRYLDLSSNH-LHTLDEFLFSDLQALEVLLLYNNH------------ 123
Query: 162 TSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPE----LGQLSSLETIIL 217
+ +D +F ++ +L+ L LS N ++ + P E +L L + L
Sbjct: 124 --IVVVD----------RNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDL 170
Query: 218 GYNAFEGEIPAEFGNLTNLRYLDLAVGSLSG-------QIPPALGRL--KKLTTVYLYKN 268
N + + L L L ++ ++L++V ++
Sbjct: 171 SSNKLKKLPLTDLQKLPAWVKNGL---YLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQE 227
Query: 269 NFTGKIPPELGSITSLAFLDLSDNQIS 295
+ +L +I SL F + S+ + S
Sbjct: 228 DLYCMHSKKLHNIFSLDFFNCSEYKES 254
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 4e-12
Identities = 58/278 (20%), Positives = 100/278 (35%), Gaps = 72/278 (25%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR--------HR 757
+G G V+ + + VA+K + +++ E+ D E+ LL +R
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNRE 101
Query: 758 NIVRLLGYLH----NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQG 813
+V+LL N T++ MV++ + L + + L + V + I + QG
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKK--IIQQVLQG 158
Query: 814 LNYLHHDCQPPVIHRDIKSNNILL------------------------------------ 837
L+YLH C+ +IH DIK NILL
Sbjct: 159 LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 838 -------------DANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEK 884
L+ +IAD G A ++ + + Y + E +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 885 SDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922
+DI+S + EL TG +P G E +++I
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALI 311
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 11/107 (10%)
Query: 287 LDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSL 346
L L NQ + +P +L+ K+L L++L N+++ L +T+L L L N L +
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-RCI 93
Query: 347 P----MRLGQSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNN 388
P L LR L N +S +P G + L+ L + N
Sbjct: 94 PPRTFDGLKS---LRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 27/95 (28%), Positives = 42/95 (44%), Gaps = 6/95 (6%)
Query: 177 SVPTSFRNLQKLKFLGLSGNNLTGKIPPEL-GQLSSLETIILGYNAFEGEIPAE-FGNLT 234
VP N + L + LS N ++ + + ++ L T+IL YN IP F L
Sbjct: 45 LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLK 102
Query: 235 NLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKN 268
+LR L L +S +P A L L+ + + N
Sbjct: 103 SLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 30/105 (28%), Positives = 44/105 (41%), Gaps = 7/105 (6%)
Query: 217 LGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKIP 275
L N F +P E N +L +DL+ +S + + + +L T+ L N IP
Sbjct: 38 LDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC-IP 94
Query: 276 PEL-GSITSLAFLDLSDNQISGEIPVKL-AELKNLQLLNLMCNQL 318
P + SL L L N IS +P +L L L + N L
Sbjct: 95 PRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL 138
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 1e-10
Identities = 85/591 (14%), Positives = 173/591 (29%), Gaps = 196/591 (33%)
Query: 443 PDDISLSTSL--SFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSL 500
S+ T + D +N + + ++ LQ ++ L EL+ P+
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAK---YNVSRLQPYLKLRQALL-----ELR--PAK 151
Query: 501 SVLDLSSNSLSGEIPASIASCEK--LVSLNLRNNRFSGEIPKAV--ATM----PTLAILD 552
+VL + G + K + + + ++ + + +L+
Sbjct: 152 NVL------IDG-----VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 553 MSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMN-INPNELIGNAGLCGSVL 611
M L +I N+ S + N+ +L + N L+ VL
Sbjct: 201 MLQK-LLYQIDPNW-TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL--------VL 250
Query: 612 -------------PPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVF------- 651
C LT TR + + + + +
Sbjct: 251 LNVQNAKAWNAFNLSCKILLT-----TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS 305
Query: 652 -FAGKWAYRRWYLYNSFFD-------------DLFKKSCKEWP-----WRLIAFQRLNFT 692
K+ L D + +S ++ W+ + +L
Sbjct: 306 LLL-KY------LDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI 358
Query: 693 SSEILACVKESNIIGMGGNGIVYKAEFHR----------PHMVVAVKKLWR--SDNDIES 740
L ++ + Y+ F R P +++++ +W +D+
Sbjct: 359 IESSLNVLEPAE----------YRKMFDRLSVFPPSAHIPTILLSL--IWFDVIKSDVMV 406
Query: 741 GDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDW 800
+ + SL+ + + + + ++ E V + +Y ALH + +VD
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPS-IYLELKVKLENEY--------ALH-----RSIVD- 451
Query: 801 VSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860
YNI + D PP LD
Sbjct: 452 --HYNIP------KTFDSDDLIPPY-----------LD---------------------- 470
Query: 861 VSMVAGSYGYIAPEYGYTLKVDEKSDIYS-FGVVLLEL--LTGKMPLD-PAFGGSKDIVE 916
Y G+ LK E + + F +V L+ L K+ D A+ S I+
Sbjct: 471 --------QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN 522
Query: 917 WVLSM------IKSNKAQDEALDPSIAG---QCKH--VQEEMLLVLRIAVL 956
+ + I N + E L +I + + + + +LRIA++
Sbjct: 523 TLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALM 573
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 1e-06
Identities = 77/560 (13%), Positives = 144/560 (25%), Gaps = 176/560 (31%)
Query: 8 LYCYIVESNADDELSTLLS---IKAGLIDP---------LNMLEDWKMPSNAAE---NGL 52
C V+ D ++LS I ++ L + +
Sbjct: 33 FDCKDVQ----DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS--KQEEMVQKFVEEV 86
Query: 53 LHCNWTGVWCNSRGFVEKLDLS-NMSLNGSVSENI-RGLRSLSSLNICCNEFASSLPKSL 110
L N+ + S E+ S + + + + + N+ S +
Sbjct: 87 LRINYK--FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV-------SRLQPY 137
Query: 111 ANL-TALKSMDVSQNNFI-GSFPTGLGKASGLTSVNASSNNFSGFLPE-----DLGNATS 163
L AL + ++N I G G GK + + S + +L N S
Sbjct: 138 LKLRQALLELRPAKNVLIDG--VLGSGK-TWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194
Query: 164 LESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSS-LETIILGYNAF 222
E++ L+ L L +I P S I L ++
Sbjct: 195 PETV-----------------LEML-------QKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 223 EGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSIT 282
+ L++L Y+N
Sbjct: 231 QA-------------------------------ELRRLLKSKPYEN-------------- 245
Query: 283 SLAFLD-LSDNQISGEIPVKLAELKNLQLLNLMC------------NQLTGLIP------ 323
L L + + + NL C + L+
Sbjct: 246 CLLVLLNVQNAKA-------------WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLD 292
Query: 324 DKLGELTKLEVLEL---WKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNL 380
LT EV L + + LP + ++P ++++ I GL N
Sbjct: 293 HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR-----RLSIIAESIRDGLATWDNW 347
Query: 381 TKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTI-PVGLGNLPSLQRLEMANNNLT 439
+ + + SL L + ++ P ++P+ L + ++
Sbjct: 348 KH--VNCDKLTTIIESSL---NVLEPAEYRKMFDRLSVFPPSA-HIPT-ILLSLIWFDVI 400
Query: 440 GQIPDDI---SLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNN----LQAKIPN 492
+ SL +E S +SIPS+ + L I +
Sbjct: 401 KSDVMVVVNKLHKYSL---------VEKQPKESTISIPSIYLELKVKLENEYALHRSIVD 451
Query: 493 ELQACPSLSVLDLSSNSLSG 512
+ DL L
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQ 471
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 13/97 (13%), Positives = 27/97 (27%), Gaps = 4/97 (4%)
Query: 177 SVPTSFRNLQKLKFLGLSGNNLTGKIPPE-LGQLSSLETIILGYNAFEGEIPAE-FGNLT 234
+ L L + + L L L + + + + + F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 235 NLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFT 271
L L+L+ +L + + L + L N
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 1e-08
Identities = 20/95 (21%), Positives = 32/95 (33%), Gaps = 4/95 (4%)
Query: 250 IPPALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQISGEIPVK-LAELKN 307
L + LT +Y+ + L + L L + + + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 308 LQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSL 342
L LNL N L L + L+ L+ L L N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 22/125 (17%), Positives = 34/125 (27%), Gaps = 24/125 (19%)
Query: 98 CCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPED 157
C + A L L + + + D
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLE-----------------------LRD 51
Query: 158 LGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIIL 217
L L +L S P +F +L L LS N L + + Q SL+ ++L
Sbjct: 52 LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVL 110
Query: 218 GYNAF 222
N
Sbjct: 111 SGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 20/136 (14%), Positives = 36/136 (26%), Gaps = 27/136 (19%)
Query: 400 TCKSLVRVR-VQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDIS 458
+R ++ + L +L L + N +
Sbjct: 6 CPHGSSGLRCTRDGALD--SLHHLPGAENLTELYIENQQHLQHLELR------------- 50
Query: 459 WNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASI 518
+ + L+ + L+ P+ P LS L+LS N+L +
Sbjct: 51 ----------DLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKT 99
Query: 519 ASCEKLVSLNLRNNRF 534
L L L N
Sbjct: 100 VQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 19/102 (18%), Positives = 35/102 (34%), Gaps = 4/102 (3%)
Query: 363 SNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFP-VSLSTCKSLVRVRVQNNLISGTIPVG 421
+ + + L + NLT+L + N L L + + + + +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 422 -LGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHL 462
P L RL ++ N L + SL + +S N L
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 4e-06
Identities = 23/92 (25%), Positives = 38/92 (41%), Gaps = 2/92 (2%)
Query: 274 IPPELGSITSLAFLDLSDNQISGEIPVK-LAELKNLQLLNLMCNQLTGLIPDKLGELTKL 332
L +L L + + Q + ++ L L L+ L ++ + L + PD +L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 333 EVLELWKNSLIGSLPMRLGQSSPLRRLDASSN 364
L L N+L SL + Q L+ L S N
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 2/101 (1%)
Query: 483 HNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPA-SIASCEKLVSLNLRNNRFSGEIPKA 541
+ + L +L+ L + + + + +L +L + + P A
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 542 VATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKL 582
P L+ L++S N+L + +L+ L LS N L
Sbjct: 76 FHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 23/96 (23%), Positives = 37/96 (38%), Gaps = 4/96 (4%)
Query: 297 EIPVKLAELKNLQLLNLMCNQ-LTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP 355
+ L +NL L + Q L L L L +L L + K+ + + +P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG-LRFVAPDAFHFTP 80
Query: 356 -LRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSF 390
L RL+ S N L + +L +L+L N
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 53/374 (14%), Positives = 110/374 (29%), Gaps = 78/374 (20%)
Query: 253 ALGRLKKLTTVYLYKNNFTGKIPPELGSI-----TSLAFLDLSDNQISGEIPVKLAEL-- 305
+T++ L NN EL S+ L+LS N + + +L ++
Sbjct: 17 FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 306 ---KNLQLLNLMCNQLTGLIPDKLGEL-----TKLEVLELWKNSL-------IGSLPMRL 350
N+ LNL N L+ D+L + + VL+L N
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ--AFS 134
Query: 351 GQSSPLRRLDASSNLLSGEIPTGLCDS-----GNLTKLILFNNSFSGTFPVSLSTCKSLV 405
+ + L+ N L + L N+ L L N+ + C L
Sbjct: 135 NLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS------KNCAELA 188
Query: 406 RVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDIS-----LSTSLSFVDISWN 460
+ S+ L+++ N L + +++ + + +++ N
Sbjct: 189 KFLASIP-------------ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLN 235
Query: 461 HLES----YLPSSILSIPSLQTFMASHNNLQAKIPNELQA-------CPSLSVLDLSSNS 509
L L S+ LQT ++ ++ + +A + ++D +
Sbjct: 236 CLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKE 295
Query: 510 LSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGAS 569
+ I++ + +S + I D++
Sbjct: 296 IHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKH-QTNIEDLNIPD------------ 342
Query: 570 PALEMLNLSYNKLE 583
L + L
Sbjct: 343 -ELRESIQTCKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 57/337 (16%), Positives = 105/337 (31%), Gaps = 56/337 (16%)
Query: 183 RNLQKLKFLGLSGNNLTGKIPPELGQL-----SSLETIILGYNAFEGEIPAEFG-----N 232
+ L LS NNL EL Q +S+ ++ L N+ + E
Sbjct: 19 SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78
Query: 233 LTNLRYLDLAVGSLSGQIPPALGRL-----KKLTTVYLYKNNFTGKIPPELGSI-----T 282
N+ L+L+ LS + L + +T + L N+F+ K E
Sbjct: 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138
Query: 283 SLAFLDLSDNQISGEIPVKLAEL-----KNLQLLNLMCNQLTGLIPDKLGEL-----TKL 332
S+ L+L N + + +L ++ N+ LNL N L +L + +
Sbjct: 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASV 198
Query: 333 EVLELWKNSLIGSLPMRLGQ-----SSPLRRLDASSNLLSGE----IPTGLCDSGNLTKL 383
L+L N L L + + L+ N L G + +L +
Sbjct: 199 TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTV 258
Query: 384 ILFNNSFSGTFPV-------SLSTCKSLVRVRVQNNLISGTIPVGLGNL-----PSLQRL 431
L + + + ++ V I + + + NL
Sbjct: 259 YLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVP 318
Query: 432 EMANNNLT-----GQIPDDISLSTSLSFVDISWNHLE 463
+ N L +D+++ L + L
Sbjct: 319 SLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 9e-10
Identities = 35/112 (31%), Positives = 52/112 (46%), Gaps = 10/112 (8%)
Query: 282 TSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNS 341
+S L+L N++ +L L L+L NQ+ L +LTKL +L L +N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 342 LIGSLPM----RLGQSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNN 388
L SLP +L Q L+ L +N L +P G+ D +L K+ L N
Sbjct: 88 L-QSLPNGVFDKLTQ---LKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 25/92 (27%), Positives = 38/92 (41%), Gaps = 4/92 (4%)
Query: 179 PTSFRNLQKLKFLGLSGNNLTGKIPPEL-GQLSSLETIILGYNAFEGEIPAE-FGNLTNL 236
F L +L L LS N + +P + +L+ L + L N + +P F LT L
Sbjct: 45 HGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQL 102
Query: 237 RYLDLAVGSLSGQIPPALGRLKKLTTVYLYKN 268
+ L L L RL L ++L+ N
Sbjct: 103 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 29/112 (25%), Positives = 47/112 (41%), Gaps = 10/112 (8%)
Query: 234 TNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPEL-GSITSLAFLDLSDN 292
++ L+L L +L +LT + L +N +P + +T L L L +N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86
Query: 293 QISGEIPV----KLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKN 340
++ +P KL +LK L L NQL + LT L+ + L N
Sbjct: 87 KLQ-SLPNGVFDKLTQLKELALDT---NQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 28/162 (17%), Positives = 57/162 (35%), Gaps = 33/162 (20%)
Query: 234 TNLRYLDLAVGSLSGQIPP--ALGRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLS 290
L L + + +L +L + N T I + + + L+
Sbjct: 32 QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLT 89
Query: 291 DNQISGEIPVKL-AELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMR 349
N++ + K+ L++L+ L L N++T + D L+ + +L L+ N +
Sbjct: 90 SNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI------- 141
Query: 350 LGQSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNNSF 390
+ + G D+ +L+ L L N F
Sbjct: 142 --TT----------------VAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 34/228 (14%), Positives = 65/228 (28%), Gaps = 85/228 (37%)
Query: 55 CNWTGVWCNSRGF----------VEKLDLSNMSLNGSVSENI-RGLRSLSSLNICCNEFA 103
C T V C+++ +L L+N + I + L L +N N+
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 104 SSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATS 163
+ + + + ++ N + + +
Sbjct: 71 DIEEGAFEGASGVNEILLTSNR-LENVQHKM----------------------------- 100
Query: 164 LESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFE 223
F+ L+ LK L L N +T + +
Sbjct: 101 ------------------FKGLESLKTLMLRSNRIT-CVGNDS----------------- 124
Query: 224 GEIPAEFGNLTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNF 270
F L+++R L L ++ + P A L L+T+ L N F
Sbjct: 125 ------FIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 26/143 (18%), Positives = 51/143 (35%), Gaps = 7/143 (4%)
Query: 417 TIPVGLGNLPSLQRLEMANNNLTGQIPDDISLS--TSLSFVDISWNHLESYLPSSILSIP 474
IP + L + NN T + L ++ S N + +
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS 81
Query: 475 SLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNR 533
+ + + N L+ + SL L L SN ++ + + L+L +N+
Sbjct: 82 GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 534 FSGEIPKAVATMPTLAILDMSNN 556
+ P A T+ +L+ L++ N
Sbjct: 141 ITTVAPGAFDTLHSLSTLNLLAN 163
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 45/158 (28%), Positives = 65/158 (41%), Gaps = 31/158 (19%)
Query: 234 TNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPEL-GSITSLAFLDLSDN 292
TN + L L ++ P L L +YL N +P + S+T L LDL N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 293 QISGEIPVKL-AELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLG 351
Q++ +P + L +L+ L + CN+LT +P + LT L L L +N L
Sbjct: 99 QLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL--------- 147
Query: 352 QSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNN 388
+S IP G D +LT LF N
Sbjct: 148 KS----------------IPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 34/126 (26%), Positives = 53/126 (42%), Gaps = 5/126 (3%)
Query: 217 LGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPAL-GRLKKLTTVYLYKNNFTGKIP 275
L N P F +L NL+ L L L +P + L +LT + L N T +P
Sbjct: 47 LHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLP 104
Query: 276 PEL-GSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEV 334
+ + L L + N+++ E+P + L +L L L NQL + L+ L
Sbjct: 105 SAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH 163
Query: 335 LELWKN 340
L+ N
Sbjct: 164 AYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 45/138 (32%), Positives = 58/138 (42%), Gaps = 15/138 (10%)
Query: 282 TSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGL---IPDKLGELTKLEVLELW 338
T+ L L DNQI+ P L NL+ L L NQL L + D LT+L VL+L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS---LTQLTVLDLG 96
Query: 339 KNSLIGSLPM----RLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTF 394
N L LP RL L+ L N L+ E+P G+ +LT L L N
Sbjct: 97 TNQL-TVLPSAVFDRLVH---LKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIP 151
Query: 395 PVSLSTCKSLVRVRVQNN 412
+ SL + N
Sbjct: 152 HGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 29/91 (31%), Positives = 37/91 (40%), Gaps = 9/91 (9%)
Query: 182 FRNLQKLKFLGLSGNNLTGKIPP----ELGQLSSLETIILGYNAFEGEIPAEFGNLTNLR 237
F +L +L L L N LT +P L L L + N E+P LT+L
Sbjct: 84 FDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELF---MCCNKLT-ELPRGIERLTHLT 138
Query: 238 YLDLAVGSLSGQIPPALGRLKKLTTVYLYKN 268
+L L L A RL LT YL+ N
Sbjct: 139 HLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 36/142 (25%), Positives = 61/142 (42%), Gaps = 15/142 (10%)
Query: 205 ELGQLSSLETIIL--GYNAFEGEIPAEFGNLTNLRYLDLA---VGSLSGQIPPALGRLKK 259
+ + E + L E ++ A L ++L L+ + +S L ++
Sbjct: 18 KSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISS-----LSGMEN 71
Query: 260 LTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLT 319
L + L +N KI +L L +S NQI+ + + +L NL++L + N++T
Sbjct: 72 LRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKIT 128
Query: 320 GLIP-DKLGELTKLEVLELWKN 340
DKL L KLE L L N
Sbjct: 129 NWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 20/157 (12%)
Query: 397 SLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVD 456
+LST K+ + + N I I L + +L+ L + N + +I + +++ +L +
Sbjct: 43 TLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99
Query: 457 ISWNHLESYLPSSILSIPSLQTFMASHNNLQ-AKIPNELQACPSLSVLDLSSNSLSGEIP 515
IS+N + S S I + +L+ S+N + ++L A L L L+ N L +
Sbjct: 100 ISYNQIAS--LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157
Query: 516 ASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILD 552
NN S + V +P L LD
Sbjct: 158 E--------------NNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 25/102 (24%), Positives = 43/102 (42%), Gaps = 6/102 (5%)
Query: 482 SHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKA 541
++ K+ L + L LS+N++ +I +S++ E L L+L N +I
Sbjct: 33 MIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENL 88
Query: 542 VATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
A TL L +S N + L +L +S NK+
Sbjct: 89 DAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 34/133 (25%), Positives = 56/133 (42%), Gaps = 21/133 (15%)
Query: 264 YLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIP 323
+ K+ L ++ + L LS N I +I L+ ++NL++L+L N + +
Sbjct: 31 HGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKI-- 85
Query: 324 DKLGELT-KLEVLELWKNSL-----IGSLPMRLGQSSPLRRLDASSNLLS--GEIPTGLC 375
+ L + LE L + N + I L LR L S+N ++ GEI L
Sbjct: 86 ENLDAVADTLEELWISYNQIASLSGIEKLVN-------LRVLYMSNNKITNWGEI-DKLA 137
Query: 376 DSGNLTKLILFNN 388
L L+L N
Sbjct: 138 ALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 23/130 (17%), Positives = 40/130 (30%), Gaps = 16/130 (12%)
Query: 154 LPEDLGNATSLESLDFRG---SFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLS 210
+ L + + L ++ L+ L L N + KI
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLIK-KIENLDAVAD 93
Query: 211 SLETIILGYNAFEGEIPAEFGNLTNLRYLDLA---VGSLSGQIPPALGRLKKLTTVYLYK 267
+LE + + YN + + L NLR L ++ + + L L KL + L
Sbjct: 94 TLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDK--LAALDKLEDLLLAG 149
Query: 268 NNFTGKIPPE 277
N
Sbjct: 150 NPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 36/219 (16%), Positives = 70/219 (31%), Gaps = 74/219 (33%)
Query: 301 KLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSL-----IGSLPMRLGQSSP 355
E + ++L + M + + L L + L L N++ + +
Sbjct: 21 VATEAEKVEL-HGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSLSGMEN------- 71
Query: 356 LRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLIS 415
LR L NL+ +I + L +L + N + SLS
Sbjct: 72 LRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-----SLS---------------- 109
Query: 416 GTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPS 475
G+ L +L+ L M+NN +T +W ++ + ++
Sbjct: 110 -----GIEKLVNLRVLYMSNNKIT------------------NWGEID-----KLAALDK 141
Query: 476 LQTFMASHNNLQAKIPNE----------LQACPSLSVLD 504
L+ + + N L ++ P+L LD
Sbjct: 142 LEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 47/162 (29%), Positives = 68/162 (41%), Gaps = 38/162 (23%)
Query: 234 TNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPEL-GSITSLAFLDLSDN 292
YLDL SL L LT +YL N +P + +TSL +L+LS N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 293 QISGEIPVKLAE-LKNLQLLNLMCNQLTGLIP----DKLGELTKLEVLELWKNSLIGSLP 347
Q+ +P + + L L+ L L NQL L P DK LT+L+ L L++N L
Sbjct: 87 QLQ-SLPNGVFDKLTQLKELALNTNQLQSL-PDGVFDK---LTQLKDLRLYQNQL----- 136
Query: 348 MRLGQSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNN 388
+S +P G+ D +L + L +N
Sbjct: 137 ----KS----------------VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 36/133 (27%), Positives = 57/133 (42%), Gaps = 17/133 (12%)
Query: 210 SSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPAL-GRLKKLTTVYLYKN 268
+ + L N+ + F LT+L L L L +P + +L LT + L N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 269 NFTGKIPPEL-GSITSLAFLDLSDNQISGEIPV----KLAELKNLQLLNLMCNQLTGLIP 323
+P + +T L L L+ NQ+ +P KL +LK+L+L NQL +P
Sbjct: 87 QLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQ---NQLKS-VP 140
Query: 324 ----DKLGELTKL 332
D+L L +
Sbjct: 141 DGVFDRLTSLQYI 153
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 42/133 (31%), Positives = 55/133 (41%), Gaps = 13/133 (9%)
Query: 261 TTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG 320
TTV Y T +P G +LDL N + EL +L L L N+L
Sbjct: 10 TTVECYSQGRTS-VPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS 66
Query: 321 LIPDKLGELTKLEVLELWKNSLIGSLPM----RLGQSSPLRRLDASSNLLSGEIPTGLCD 376
L +LT L L L N L SLP +L Q L+ L ++N L +P G+ D
Sbjct: 67 LPNGVFNKLTSLTYLNLSTNQL-QSLPNGVFDKLTQ---LKELALNTNQLQ-SLPDGVFD 121
Query: 377 S-GNLTKLILFNN 388
L L L+ N
Sbjct: 122 KLTQLKDLRLYQN 134
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 33/154 (21%), Positives = 48/154 (31%), Gaps = 31/154 (20%)
Query: 141 TSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTG 200
T+V S + G LD + + F L L L L GN L
Sbjct: 10 TTVECYSQGRTSVPT---GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ- 65
Query: 201 KIPPEL-GQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPP------- 252
+P + +L+SL + L N + F LT L+ L L L +P
Sbjct: 66 SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLT 124
Query: 253 ------------------ALGRLKKLTTVYLYKN 268
RL L ++L+ N
Sbjct: 125 QLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 58/401 (14%), Positives = 118/401 (29%), Gaps = 70/401 (17%)
Query: 69 EKLDLSNMSLNG----SVSENIRGLRSLSSLNI--CCNEF-ASSLPKSLANLTALKSMDV 121
++LDL ++ +S SL SLNI +E S+L + + LKS+ +
Sbjct: 159 KELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKL 218
Query: 122 SQNNFIGSFPTGLGKASGLTSVNASS------NNFSGFLPEDLGNATSLESLDFRGSFFE 175
++ + T L +A L + + L L L L
Sbjct: 219 NRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVP 278
Query: 176 GSVPTSFRNLQKLKFLGLSGNNLTGK-IPPELGQLSSLETIILGYNAFEGEIPAEFGNLT 234
+P + +L L LS + + L Q L+ + + + +
Sbjct: 279 AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCK 338
Query: 235 NLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQI 294
+LR L + + ++T + +S
Sbjct: 339 DLRELRV--------------------------FPSEPFVMEPNVALTEQGLVSVSMG-- 370
Query: 295 SGEIPVKLAELKNLQLLNLMCNQLT--GLIPDKLGE-LTKLEVLELWKNSLIGSLP---- 347
L+ + C Q+T LI + + L
Sbjct: 371 ----------CPKLESVLYFCRQMTNAALI--TIARNRPNMTRFRLCIIEPKAPDYLTLE 418
Query: 348 ------MRLGQSSP-LRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLST 400
+ + LRRL S L + + L + S + +
Sbjct: 419 PLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLS 478
Query: 401 -CKSLVRVRVQN-NLISGTIPVGLGNLPSLQRLEMANNNLT 439
C SL ++ +++ + L +++ L M++ +++
Sbjct: 479 GCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 5e-09
Identities = 71/531 (13%), Positives = 152/531 (28%), Gaps = 93/531 (17%)
Query: 51 GLLHCNWTGVWCNSRGFVEKLDLSNMSLN----GSVSENIRGLRSLSSLNICCNEFASSL 106
G W +S ++E++ L M + ++++ + + L L+ C L
Sbjct: 90 GGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLV-LSSCEGFSTDGL 148
Query: 107 PKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLES 166
A LK +D+ +++ L TSL S
Sbjct: 149 AAIAATCRNLKELDLRESDVDDVSGHWLSHFPD--------------------TYTSLVS 188
Query: 167 LDFRGSFFE---GSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGY---- 219
L+ E ++ LK L L+ K+ L + LE + G
Sbjct: 189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAE 248
Query: 220 --NAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPE 277
+ LR L ++ +P +LTT
Sbjct: 249 VRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTT--------------- 293
Query: 278 LGSITSLAFLDLSDNQISGEIPVKLAE-LKNLQLLNLMCNQLT--GL--IPDKLGELTKL 332
L+LS + VKL LQ L + + + GL + +L +L
Sbjct: 294 ---------LNLSYATVQSYDLVKLLCQCPKLQRLWV-LDYIEDAGLEVLASTCKDLREL 343
Query: 333 EVLELWKNSLIGSLP------MRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILF 386
V + ++ + + P + ++ LI
Sbjct: 344 RVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFC-------RQMTNAA----LITI 392
Query: 387 NNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDI 446
+ L + + + + + L+RL +L+G + D +
Sbjct: 393 ARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRL-----SLSGLLTDKV 447
Query: 447 -----SLSTSLSFVDISWNHLESYLPSSIL-SIPSLQTFMASH-NNLQAKIPNELQACPS 499
+ + + + +++ +L SL+ + +
Sbjct: 448 FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLET 507
Query: 500 LSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAI 550
+ L +SS S+S + +++ + + R + + + + I
Sbjct: 508 MRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPDSRPESCPVERVFI 558
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 35/242 (14%), Positives = 85/242 (35%), Gaps = 21/242 (8%)
Query: 334 VLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSG-NLTKLILFN-NSFS 391
V + W + + + L + +++ + + S N L+L + FS
Sbjct: 85 VPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFS 144
Query: 392 GTFPVSLST-CKSLVRVRVQNNLISGTIPVGLG----NLPSLQRLEMANNNLTGQIPDD- 445
+++ C++L + ++ + + L SL L + + L ++
Sbjct: 145 TDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNI--SCLASEVSFSA 202
Query: 446 ----ISLSTSLSFVDISWNHLESYLPSSILSIPSLQTF------MASHNNLQAKIPNELQ 495
++ +L + ++ L + + P L+ ++ + + L
Sbjct: 203 LERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262
Query: 496 ACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGE-IPKAVATMPTLAILDMS 554
C L L +++ +PA + C +L +LNL + K + P L L +
Sbjct: 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL 322
Query: 555 NN 556
+
Sbjct: 323 DY 324
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 50/324 (15%), Positives = 103/324 (31%), Gaps = 35/324 (10%)
Query: 232 NLTNLRYLDLAVGSLSGQIPPALG-RLKKLTTVYL-YKNNFT--GKIPPELGSITSLAFL 287
+ + +G+ P + R K+ +V L K +F +P G
Sbjct: 39 EIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIE 98
Query: 288 DLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGE-LTKLEVLELWKNSLIGSL 346
+S + L+ + L +T + + + +VL L +
Sbjct: 99 AMSSS------------YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTD 146
Query: 347 PMR-LGQSSP-LRRLDASSNLLSGEIPTGLCD----SGNLTKLILFNNSFSGTFPVSLST 400
+ + + L+ LD + + L +L L + + +F +L
Sbjct: 147 GLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSF-SALER 205
Query: 401 ----CKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLS------T 450
C +L +++ + + L P L+ L + LS
Sbjct: 206 LVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCK 265
Query: 451 SLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQ-AKIPNELQACPSLSVLDLSSNS 509
L + W+ + +YLP+ L T S+ +Q + L CP L L +
Sbjct: 266 ELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYI 325
Query: 510 LSGEIPASIASCEKLVSLNLRNNR 533
+ ++C+ L L + +
Sbjct: 326 EDAGLEVLASTCKDLRELRVFPSE 349
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 27/216 (12%), Positives = 73/216 (33%), Gaps = 16/216 (7%)
Query: 383 LILFNNSFSGTFPVSLSTCKSLVRVRVQNNLIS-GTIPVGLGNLPSLQRLEMAN-NNLTG 440
+ S+ L +R++ +++ + + + + + L +++ +
Sbjct: 86 PDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFST 145
Query: 441 QIPDDISLS-TSLSFVDISWNHLESYLPSSILSI----PSLQTFMAS--HNNLQAK-IPN 492
I+ + +L +D+ + ++ + SL + S + + +
Sbjct: 146 DGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALER 205
Query: 493 ELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLR------NNRFSGEIPKAVATMP 546
+ CP+L L L+ ++ + +L L + A++
Sbjct: 206 LVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCK 265
Query: 547 TLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKL 582
L L +++ +P + L LNLSY +
Sbjct: 266 ELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATV 301
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 58.0 bits (139), Expect = 6e-09
Identities = 27/176 (15%), Positives = 61/176 (34%), Gaps = 21/176 (11%)
Query: 200 GKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALG--RL 257
+ P L + L + + NL+ L++ G L + + L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKP---RPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 258 KKLTT--VYLYKNNFTGKIPPEL-------GSITSLAFLDLSDNQISGEIPVKLAE---L 305
L +Y+ ++ + +L +L + D + + E L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 306 KNLQLLNLMCNQLTG----LIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLR 357
L+ +++ LT L+ D + ++ L+ + + N L + L +S P++
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK 334
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.0 bits (131), Expect = 5e-08
Identities = 22/161 (13%), Positives = 48/161 (29%), Gaps = 21/161 (13%)
Query: 440 GQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQA--C 497
+ + L+ + I + L P+L++ L + ++
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 498 PSLSVLDL---SSNSLSGEIPASIA------SCEKLVSLNLRNNRFSGEIPKAVAT---M 545
P+L L L + L L + + + + +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 546 PTLAILDMSNNSL----FGRIPENFGASPALEMLNLSYNKL 582
P L +D+S L + ++ L+ +N+ YN L
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 52.3 bits (124), Expect = 4e-07
Identities = 31/175 (17%), Positives = 56/175 (32%), Gaps = 17/175 (9%)
Query: 176 GSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTN 235
+ + L L + G N L SL II G +L N
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL-EIISGGLPDSVVEDILGSDLPN 220
Query: 236 LRYLDLAVGSLS-------GQIPPAL--GRLKKLTTVYLYKNNFTGKIPPELGS---ITS 283
L L L VG P R L + + + +
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280
Query: 284 LAFLDLSDNQISGEIPVKLAE----LKNLQLLNLMCNQLTGLIPDKLGELTKLEV 334
L +D+S ++ E L + +K+L+ +N+ N L+ + +L + +++
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKI 335
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.1 bits (121), Expect = 1e-06
Identities = 23/173 (13%), Positives = 55/173 (31%), Gaps = 24/173 (13%)
Query: 380 LTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIP--VGLGNLPSLQRLEMANNN 437
+ L + + +L + + + + ++ + +LP+L++L +
Sbjct: 171 MPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVL---- 226
Query: 438 LTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNEL--- 494
+ D N P+L+ Q +
Sbjct: 227 ---------YVGVEDYGFDGDMNVFRPLFSKDRF--PNLKWLGIVDAEEQNVVVEMFLES 275
Query: 495 QACPSLSVLDLSSNSLSGE----IPASIASCEKLVSLNLRNNRFSGEIPKAVA 543
P L +D+S+ L+ E + + + L +N++ N S E+ K +
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ 328
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 5e-06
Identities = 32/207 (15%), Positives = 63/207 (30%), Gaps = 43/207 (20%)
Query: 329 LTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSG--NLTKLILF 386
L + +L K +L + L+ L+ S L + + S NL KL+L+
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 387 NNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDI 446
F ++ + L P+L+ L + + + +
Sbjct: 228 VGVEDYGFDGDMNVFRPLFS---------------KDRFPNLKWLGIVDAEEQNVVVEMF 272
Query: 447 SLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQ----AKIPNELQACPSLSV 502
S L P L+T S L + + + L
Sbjct: 273 LESDIL---------------------PQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 503 LDLSSNSLSGEIPASIA-SCEKLVSLN 528
+++ N LS E+ + S + ++
Sbjct: 312 INMKYNYLSDEMKKELQKSLPMKIDVS 338
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 9e-06
Identities = 26/188 (13%), Positives = 61/188 (32%), Gaps = 19/188 (10%)
Query: 136 KASGLTSVNASSNNFSGFLPEDLGNA-TSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLS 194
+ ++ S DL ++ L+ ++ + LK L +
Sbjct: 142 EGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEII 201
Query: 195 GNNLTGKIPPELG--QLSSLET--IILGYNAFEGEIPAEF-------GNLTNLRYLDLAV 243
L + ++ L +LE + +G + + NL++L +
Sbjct: 202 SGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVD 261
Query: 244 GSLSGQIPPALGR---LKKLTTVYLYKNNFTGK----IPPELGSITSLAFLDLSDNQISG 296
+ L +L T+ + T + + + I L F+++ N +S
Sbjct: 262 AEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321
Query: 297 EIPVKLAE 304
E+ +L +
Sbjct: 322 EMKKELQK 329
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 31/110 (28%), Positives = 51/110 (46%), Gaps = 11/110 (10%)
Query: 287 LDLSDNQISGEIPVKL-AELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGS 345
L L+DN++ L L +L L L NQLTG+ P+ + ++ L+L +N +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI-KE 92
Query: 346 LPM----RLGQSSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNNSF 390
+ L Q L+ L+ N +S + G + +LT L L +N F
Sbjct: 93 ISNKMFLGLHQ---LKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 6/90 (6%)
Query: 182 FRNLQKLKFLGLSGNNLTGKIPPEL-GQLSSLETIILGYNAFEGEIPAE-FGNLTNLRYL 239
F L L L L N LT I P S ++ + LG N + EI + F L L+ L
Sbjct: 50 FGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTL 107
Query: 240 DLAVGSLSGQIPP-ALGRLKKLTTVYLYKN 268
+L +S + P + L LT++ L N
Sbjct: 108 NLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 31/103 (30%), Positives = 44/103 (42%), Gaps = 5/103 (4%)
Query: 217 LGYNAFEG-EIPAEFGNLTNLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNFTGKI 274
L N FG L +L L+L L+G I P A + + L +N +I
Sbjct: 36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIK-EI 93
Query: 275 PPEL-GSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCN 316
++ + L L+L DNQIS +P L +L LNL N
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 33/135 (24%), Positives = 64/135 (47%), Gaps = 12/135 (8%)
Query: 192 GLSGNNLTGKIPPELG--QLSSLETIIL-GYNAFEGEIPAEFGNLTNLRYLDLA---VGS 245
G SG ++ +I EL +++ ++L + +G+I NL +L L + S
Sbjct: 4 GSSGMDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS 63
Query: 246 LSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVK-LAE 304
+S L +L KL + L +N G + + +L L+LS N++ ++ L +
Sbjct: 64 VSN-----LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKK 118
Query: 305 LKNLQLLNLMCNQLT 319
L+ L+ L+L ++T
Sbjct: 119 LECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 9e-08
Identities = 29/111 (26%), Positives = 47/111 (42%), Gaps = 4/111 (3%)
Query: 232 NLTNLRYLDL-AVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLS 290
+R L L S G+I L + L + L + L L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 291 DNQISGEIPVKLAELKNLQLLNLMCNQLTGL-IPDKLGELTKLEVLELWKN 340
+N+I G + + +L NL LNL N+L + + L +L L+ L+L+
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 30/140 (21%), Positives = 55/140 (39%), Gaps = 9/140 (6%)
Query: 424 NLPSLQRLEMANNNLT-GQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMAS 482
+++ L + N G+I + +L F+ + L S S++ +P L+ S
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 483 HNNLQAKIPNELQACPSLSVLDLSSNSLS--GEIPASIASCEKLVSLNLRNNRFSGEI-- 538
N + + + P+L+ L+LS N L + + E L SL+L N +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDY 138
Query: 539 -PKAVATMPTLAILDMSNNS 557
+P L LD +
Sbjct: 139 RESVFKLLPQLTYLDGYDRE 158
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 23/100 (23%), Positives = 37/100 (37%), Gaps = 5/100 (5%)
Query: 483 HNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAV 542
+ KI +L L L + L + +++ KL L L NR G +
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLA 91
Query: 543 ATMPTLAILDMSNNSL--FGRIPENFGASPALEMLNLSYN 580
+P L L++S N L + E L+ L+L
Sbjct: 92 EKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 29/134 (21%), Positives = 45/134 (33%), Gaps = 26/134 (19%)
Query: 256 RLKKLTTVYLYKNNFT-GKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLM 314
+ + L GKI +L FL L + + + L +L L+ L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 315 CNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGL 374
N++ G + +L L L L N L + PL++L+
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPLKKLE-------------- 120
Query: 375 CDSGNLTKLILFNN 388
L L LFN
Sbjct: 121 ----CLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 24/113 (21%), Positives = 44/113 (38%), Gaps = 8/113 (7%)
Query: 160 NATSLESLDFRGSFF-EGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILG 218
++ L +G + L+FL L L + L +L L+ + L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 219 YNAFEGEIPAEFGNLTNLRYLDLA---VGSLSGQIPPALGRLKKLTTVYLYKN 268
N G + L NL +L+L+ + +S P L +L+ L ++ L+
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP--LKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 34/142 (23%), Positives = 48/142 (33%), Gaps = 24/142 (16%)
Query: 302 LAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSL--IGSLPMRLGQSSPLRRL 359
A ++ L L N N G I E LE L L L + +LP + L++L
Sbjct: 23 PAAVRELVLDNCKSND--GKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKL 76
Query: 360 DASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVS-LSTCKSLVRVRVQNNLISGTI 418
+ S N + G + NLT L L N + L + L + + N
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC------ 130
Query: 419 PVG---------LGNLPSLQRL 431
V LP L L
Sbjct: 131 EVTNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 28/104 (26%), Positives = 47/104 (45%), Gaps = 9/104 (8%)
Query: 485 NLQAKIPNEL--QACPSLSVLDLSSNSLS-GEIPASIASCEKLVSLNLRNNRFSGEIPKA 541
+++ +I EL + ++ L L + + G+I A L L+L N +
Sbjct: 9 DMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV----GLISV 64
Query: 542 --VATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
+ +P L L++S N +FG + P L LNLS NKL+
Sbjct: 65 SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 24/129 (18%), Positives = 45/129 (34%), Gaps = 13/129 (10%)
Query: 196 NNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLA---VGSLSGQIPP 252
L + + + L I L +D + + L G
Sbjct: 6 AELIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG---- 59
Query: 253 ALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQIS--GEIPVKLAELKNLQL 310
L++L T+ + N ++ L L L++N + G++ LA LK+L
Sbjct: 60 -FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTY 117
Query: 311 LNLMCNQLT 319
L ++ N +T
Sbjct: 118 LCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 9e-08
Identities = 28/114 (24%), Positives = 41/114 (35%), Gaps = 4/114 (3%)
Query: 228 AEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFL 287
A++ N R LDL G I L + + N K+ + L L
Sbjct: 13 AQYTNAVRDRELDLR-GYKIPVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69
Query: 288 DLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGL-IPDKLGELTKLEVLELWKN 340
+++N+I L +L L L N L L D L L L L + +N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 21/100 (21%), Positives = 36/100 (36%), Gaps = 5/100 (5%)
Query: 483 HNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAV 542
I N +D S N + ++ +L +L + NNR
Sbjct: 27 RGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLD 84
Query: 543 ATMPTLAILDMSNNSL--FGRIPENFGASPALEMLNLSYN 580
+P L L ++NNSL G + + + +L L + N
Sbjct: 85 QALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 27/119 (22%), Positives = 41/119 (34%), Gaps = 8/119 (6%)
Query: 156 EDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETI 215
NA LD RG + L + + S N + K+ L L+T+
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69
Query: 216 ILGYNAFEGEIPAEFGNLTNLRYLDLA---VGSLSGQIPPALGRLKKLTTVYLYKNNFT 271
++ N L +L L L + L P L LK LT + + +N T
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP--LASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 18/89 (20%), Positives = 32/89 (35%), Gaps = 3/89 (3%)
Query: 254 LGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNL 313
+ + L I ++ +D SDN+I ++ L+ L+ L +
Sbjct: 15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLV 71
Query: 314 MCNQLTGLIPDKLGELTKLEVLELWKNSL 342
N++ + L L L L NSL
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSL 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 24/152 (15%), Positives = 47/152 (30%), Gaps = 32/152 (21%)
Query: 407 VRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYL 466
V++ LI N + L++ + I +L + L
Sbjct: 2 VKLTAELIE-QAA-QYTNAVRDRELDLRGYKIP----------------VIE--NLGATL 41
Query: 467 PSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVS 526
S N ++ K+ L L +++N + + L
Sbjct: 42 DQ-------FDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92
Query: 527 LNLRNNRFS--GEIPKAVATMPTLAILDMSNN 556
L L NN G++ +A++ +L L + N
Sbjct: 93 LILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 22/105 (20%), Positives = 40/105 (38%), Gaps = 11/105 (10%)
Query: 482 SHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPK- 540
+ ++ + LDL + I A+ ++ +++ +N EI K
Sbjct: 5 TAELIE-QAAQ-YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN----EIRKL 57
Query: 541 -AVATMPTLAILDMSNNSLFGRIPENFGAS-PALEMLNLSYNKLE 583
+ L L ++NN + RI E + P L L L+ N L
Sbjct: 58 DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 29/111 (26%), Positives = 51/111 (45%), Gaps = 4/111 (3%)
Query: 232 NLTNLRYLDLA-VGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLS 290
++++ L L S G++ ++L + T I L + L L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 291 DNQISGEIPVKLAELKNLQLLNLMCNQLTGL-IPDKLGELTKLEVLELWKN 340
DN++SG + V + NL LNL N++ L + L +L L+ L+L+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 22/86 (25%), Positives = 32/86 (37%), Gaps = 3/86 (3%)
Query: 472 SIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRN 531
L+ + L I N L L L+LS N +SG + C L LNL
Sbjct: 40 EFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG 97
Query: 532 NRFSG-EIPKAVATMPTLAILDMSNN 556
N+ + + + L LD+ N
Sbjct: 98 NKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 23/99 (23%), Positives = 37/99 (37%), Gaps = 3/99 (3%)
Query: 483 HNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAV 542
+ + K+ L L + L+ I A++ KL L L +NR SG +
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLA 84
Query: 543 ATMPTLAILDMSNNSLFG-RIPENFGASPALEMLNLSYN 580
P L L++S N + E L+ L+L
Sbjct: 85 EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 20/99 (20%), Positives = 35/99 (35%), Gaps = 3/99 (3%)
Query: 411 NNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSI 470
+ G + L+ L N LT I ++ L +++S N + L
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLA 84
Query: 471 LSIPSLQTFMASHNNLQA-KIPNELQACPSLSVLDLSSN 508
P+L S N ++ L+ +L LDL +
Sbjct: 85 EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 9e-06
Identities = 29/104 (27%), Positives = 47/104 (45%), Gaps = 4/104 (3%)
Query: 287 LDLSDNQIS-GEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGS 345
L L +++ + G++ E + L+ L+ + LT + L +L KL+ LEL N + G
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGG 79
Query: 346 LPMRLGQSSPLRRLDASSNLLSG-EIPTGLCDSGNLTKLILFNN 388
L + + L L+ S N + L NL L LFN
Sbjct: 80 LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 23/132 (17%), Positives = 59/132 (44%), Gaps = 9/132 (6%)
Query: 379 NLTKLILFNNSFS-GTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNN 437
++ +L+L N+ + G + L + N ++ +I L L L++LE+++N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNR 75
Query: 438 LTGQIPDDISLSTSLSFVDISWNHLESYLPSSILS-IPSLQTFMASHNNLQAKIPN---- 492
++G + +L+ +++S N ++ L + +L++ + + + +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV-TNLNDYREN 134
Query: 493 ELQACPSLSVLD 504
+ P L+ LD
Sbjct: 135 VFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 25/115 (21%), Positives = 43/115 (37%), Gaps = 4/115 (3%)
Query: 183 RNLQKLKFLGLSGNNLT-GKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDL 241
R +K L L + GK+ + LE + I A L L+ L+L
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLEL 71
Query: 242 AVGSLSGQIPPALGRLKKLTTVYLYKNNFTG-KIPPELGSITSLAFLDLSDNQIS 295
+ +SG + + LT + L N L + +L LDL + +++
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 22/92 (23%), Positives = 41/92 (44%), Gaps = 7/92 (7%)
Query: 495 QACPSLSVLDLSSNSLS-GEIPASIASCEKLVSLNLRNNRFS--GEIPKAVATMPTLAIL 551
+ + L L ++ + G++ E+L L+ N + +PK + L L
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK----LNKLKKL 69
Query: 552 DMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
++S+N + G + P L LNLS NK++
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 9e-04
Identities = 17/66 (25%), Positives = 26/66 (39%), Gaps = 3/66 (4%)
Query: 520 SCEKLVSLNLRNNRFS-GEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLS 578
+ + L L N+R + G++ L L N L I N L+ L LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSI-ANLPKLNKLKKLELS 72
Query: 579 YNKLEG 584
N++ G
Sbjct: 73 DNRVSG 78
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 2e-07
Identities = 39/237 (16%), Positives = 71/237 (29%), Gaps = 55/237 (23%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESG------DDLFREVSLLGRL----- 754
IG G G V++ H VA+K + D+ +G +++ E+ + L
Sbjct: 28 IGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 755 ----RHRNIVRLLG------------------YLHNETNVMMVYDYMPNDSLGEALHGKE 792
R + L Y + + D+ +D L L +
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 793 AGKLLVDWVSR-------YNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARI 845
G L ++ +I + L + HRD+ N+LL ++
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKL 203
Query: 846 ADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSD--IYSFGVVLLELLTG 900
+ S G YTL E+ ++ + +L TG
Sbjct: 204 HYTLNGKSSTI---------PSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 45/331 (13%), Positives = 99/331 (29%), Gaps = 51/331 (15%)
Query: 301 KLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLD 360
+ L L+ + +L L L L+ L SS LR+L+
Sbjct: 21 PIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFH-YEFQNQRFSAEVLSS-LRQLN 78
Query: 361 ASSNLLSGEIPTGLCD-----SGNLTKLILFNNSFSGTFPVSLSTC-KSLVRVRVQNNLI 414
+ ++ T + L ++ L + +L ++ +Q N +
Sbjct: 79 LAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSL 138
Query: 415 S--GTIPVG---LGNLPSLQRLEMANNNLTGQ----IPDDISLSTSLSFVDISWNHLE-- 463
+ L + + L ++NN LT + + ++ +TS++ + + L
Sbjct: 139 GPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDE 198
Query: 464 --SYLPSSILSIPSLQTFMASHNNLQAK----IPNELQACPSLSVLDLSSNSLS------ 511
L + + LQ ++N + + PSL +L L N LS
Sbjct: 199 GLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQV 258
Query: 512 -GEIPASIASCEKLVSLNLRNNRFSGEIPKAVATM---------------PTLAILDMSN 555
++ + ++V S ++ + L + D+ +
Sbjct: 259 LRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLLRDLED 318
Query: 556 NSL----FGRIPENFGASPALEMLNLSYNKL 582
+ R + + L
Sbjct: 319 SRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 55/249 (22%), Positives = 89/249 (35%), Gaps = 81/249 (32%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR----EVSLLGRLRHR--- 757
+G G G V + AVK + + R E +L ++++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKV-------VRNIKKYTRSAKIEADILKKIQNDDIN 94
Query: 758 --NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN---------- 805
NIV+ G ++ ++++ LG +L+ + ++R N
Sbjct: 95 NNNIVKYHGKFMYYDHMCLIFE-----PLGPSLY---------EIITRNNYNGFHIEDIK 140
Query: 806 -IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEA--------------------- 843
+ I + LNYL + H D+K NILLD
Sbjct: 141 LYCIEILKALNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 844 ----RIADFGLARMMLHKNETVSMVAGSYGYIAPE----YGYTLKVDEKSDIYSFGVVLL 895
++ DFG A K++ + + Y APE G+ D SD++SFG VL
Sbjct: 198 STGIKLIDFGCA---TFKSDYHGSIINTRQYRAPEVILNLGW----DVSSDMWSFGCVLA 250
Query: 896 ELLTGKMPL 904
EL TG L
Sbjct: 251 ELYTGS-LL 258
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 35/167 (20%), Positives = 62/167 (37%), Gaps = 30/167 (17%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVK--KLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG GG G++Y A A K+ +N LF E+ R+ ++ ++
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG-----PLFSELKFYQRVAKKDCIKKW 99
Query: 764 GYLHNETNVMM--------------VYDYMPNDSLGEALHG--KEAGKLLVDWVSRYNIA 807
+ + Y +M + LG L + G V +
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTV--LQLG 157
Query: 808 VGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARI--ADFGLAR 852
+ + L Y+H + +H DIK+ N+LL ++ AD+GL+
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 29/123 (23%), Positives = 47/123 (38%), Gaps = 34/123 (27%)
Query: 805 NIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEA-------------------RI 845
++A + L +LH + Q + H D+K NIL + R+
Sbjct: 127 HMAYQLCHALRFLH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 846 ADFGLARMMLHKNETVSMVAGSYGYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGK 901
ADFG A +E + + + Y PE G+ + D++S G +L E G
Sbjct: 184 ADFGSA---TFDHEHHTTIVATRHYRPPEVILELGW----AQPCDVWSIGCILFEYYRGF 236
Query: 902 MPL 904
L
Sbjct: 237 -TL 238
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 38/132 (28%), Positives = 51/132 (38%), Gaps = 35/132 (26%)
Query: 261 TTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG 320
T V +P G T L L++NQI+ P L NLQ L N+LT
Sbjct: 15 TLVNCQNIRLAS-VPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA 71
Query: 321 LIP---DKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDS 377
+ DK LT+L L+L N L +S IP G D+
Sbjct: 72 IPTGVFDK---LTQLTQLDLNDNHL---------KS----------------IPRGAFDN 103
Query: 378 -GNLTKLILFNN 388
+LT + L+NN
Sbjct: 104 LKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 32/94 (34%), Positives = 42/94 (44%), Gaps = 12/94 (12%)
Query: 178 VPTSFRNLQKLKFLGLSGNNLTGKIPPEL-GQLSSLETIILGYNAFEGEIPAE-FGNLTN 235
+PT + L L+ N +T K+ P + L +L+ + N IP F LT
Sbjct: 31 IPTDKQRLW------LNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 236 LRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKN 268
L LDL L IP A LK LT +YLY N
Sbjct: 83 LTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 47/230 (20%), Positives = 81/230 (35%), Gaps = 44/230 (19%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVA----VKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVR 761
IG GG G +Y A+ + V + V K+ SDN LF E+ R ++
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG-----PLFTELKFYQRAAKPEQIQ 97
Query: 762 LLGYLHN--------------ETNVMMVYDYMPNDSLG---EALHGKEAGKLLVDWVSRY 804
Y +M D G + ++ A + V
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV--L 155
Query: 805 NIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARI--ADFGLARMMLHKNETVS 862
+++ I L Y+H +H DIK++N+LL+ ++ D+GLA + +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 863 MVAGS---------YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
A + I G + D+ G +++ LTG +P
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPS--RRGDLEILGYCMIQWLTGHLP 260
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 5e-06
Identities = 41/132 (31%), Positives = 51/132 (38%), Gaps = 35/132 (26%)
Query: 261 TTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG 320
TTV + +P G T+ L L DNQI+ P L L L+L NQLT
Sbjct: 12 TTVDCSGKSLAS-VPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV 68
Query: 321 LIP---DKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDS 377
L DK LT+L L L N L +S IP G D+
Sbjct: 69 LPAGVFDK---LTQLTQLSLNDNQL---------KS----------------IPRGAFDN 100
Query: 378 -GNLTKLILFNN 388
+LT + L NN
Sbjct: 101 LKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 32/95 (33%), Positives = 42/95 (44%), Gaps = 8/95 (8%)
Query: 177 SVPTSFRNLQKLKFLGLSGNNLTGKIPPEL-GQLSSLETIILGYNAFEGEIPAE-FGNLT 234
SVPT + L L N +T K+ P + +L+ L + L N +PA F LT
Sbjct: 23 SVPTGI--PTTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLT 78
Query: 235 NLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKN 268
L L L L IP A LK LT ++L N
Sbjct: 79 QLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 52/222 (23%), Positives = 84/222 (37%), Gaps = 48/222 (21%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD----LFREVSLLGRLR-HRNIV 760
IG G G +Y + + VA+K +E+ L E + L+ I
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIK--------LENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLG---EALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
+ + Y+ + D LG E L + KL + V +A + + ++
Sbjct: 67 NVRWFGVEGD-----YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM--LADQMINRVEFV 119
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEAR---IADFGLARMMLHKN--------ETVSMVAG 866
H +HRDIK +N L+ A I DFGLA+ + E ++ G
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT-G 175
Query: 867 SYGY--IAPEYGYTLKVDEKS---DIYSFGVVLLELLTGKMP 903
+ Y + G E+S D+ S G VL+ L G +P
Sbjct: 176 TARYASVNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 7e-06
Identities = 28/123 (22%), Positives = 49/123 (39%), Gaps = 34/123 (27%)
Query: 805 NIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEA-------------------RI 845
+A I + +N+LH + + H D+K NIL + ++
Sbjct: 122 KMAYQICKSVNFLH-SNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 846 ADFGLARMMLHKNETVSMVAGSYGYIAPE----YGYTLKVDEKSDIYSFGVVLLELLTGK 901
DFG A + +E S + + Y APE G+ + D++S G +L+E G
Sbjct: 179 VDFGSA---TYDDEHHSTLVSTRHYRAPEVILALGW----SQPCDVWSIGCILIEYYLGF 231
Query: 902 MPL 904
+
Sbjct: 232 -TV 233
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 50/222 (22%), Positives = 77/222 (34%), Gaps = 48/222 (21%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD----LFREVSLLGRLRH-RNIV 760
IG G G +Y VA+K +E L E + ++ I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIK--------LECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLG---EALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
+ Y+ M + LG E L + K + V +A + + Y+
Sbjct: 69 TIRWCGAEGD-----YNVMVMELLGPSLEDLFNFCSRKFSLKTVLL--LADQMISRIEYI 121
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEA---RIADFGLARMMLHKN--------ETVSMVAG 866
H IHRD+K +N L+ + I DFGLA+ E ++ G
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT-G 177
Query: 867 SYGY--IAPEYGYTLKVDEKS---DIYSFGVVLLELLTGKMP 903
+ Y I G E+S D+ S G VL+ G +P
Sbjct: 178 TARYASINTHLGI-----EQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 37/234 (15%), Positives = 73/234 (31%), Gaps = 15/234 (6%)
Query: 337 LWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPT----GLCDSGNLTKLILFNNSFS- 391
LW+ + + + L + + + L N+
Sbjct: 48 LWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 107
Query: 392 GTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMAN-NNLTGQIPDDISLS- 449
T LS C L + ++ +S I L +L RL ++ + + + S
Sbjct: 108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 167
Query: 450 TSLSFVDISW-NHLESYLPSSILSI--PSLQTFMASHNNLQ---AKIPNELQACPSLSVL 503
+ L +++SW ++ ++ S + + ++ CP+L L
Sbjct: 168 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 227
Query: 504 DLSS-NSLSGEIPASIASCEKLVSLNLRN-NRFSGEIPKAVATMPTLAILDMSN 555
DLS L + L L+L E + +PTL L +
Sbjct: 228 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 44/239 (18%), Positives = 87/239 (36%), Gaps = 12/239 (5%)
Query: 251 PPALGRLKKLTTVYLYKNNFTGKIP-PELGSITSLAFLDLSDNQIS-GEIPVKLAELKNL 308
P GRL + P E S + +DLS++ I + L++ L
Sbjct: 61 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120
Query: 309 QLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMR-LGQSSP-LRRLDASS-NL 365
Q L+L +L+ I + L + + L L L S ++ L S L L+ S
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 180
Query: 366 LSGEIPTGLCDSG--NLTKLILF--NNSFSGTFPVSLST-CKSLVRVRVQN-NLISGTIP 419
+ + +T+L L + + +L C +LV + + + ++
Sbjct: 181 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 240
Query: 420 VGLGNLPSLQRLEMAN-NNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQ 477
L LQ L ++ ++ + ++ +L + + + L ++P LQ
Sbjct: 241 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 299
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 46/225 (20%), Positives = 79/225 (35%), Gaps = 52/225 (23%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD----LFREVSLLGRLRH-RNIV 760
IG G G++++ + VA+K E L E L I
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLG---EALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
+ + ++ + D LG E L K V V+ A + + +
Sbjct: 70 NVYYFGQEGL-----HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM--AAKQMLARVQSI 122
Query: 818 HHDCQPPVIHRDIKSNNILL------DANLEARIADFGLARMMLHKN--------ETVSM 863
H +++RDIK +N L+ +AN+ + DFG+ + E ++
Sbjct: 123 HEKS---LVYRDIKPDNFLIGRPNSKNANMIYVV-DFGMVKFYRDPVTKQHIPYREKKNL 178
Query: 864 VAGSYGY--IAPEYGYTLKVDEKS---DIYSFGVVLLELLTGKMP 903
G+ Y I G E+S D+ + G V + L G +P
Sbjct: 179 S-GTARYMSINTHLGR-----EQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 49/224 (21%), Positives = 78/224 (34%), Gaps = 50/224 (22%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD----LFREVSLLGRLRH-RNIV 760
IG G G + + + VA+K +E L E +L I
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK--------LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLG---EALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
++ + MV + LG E L + V IA+ + + Y+
Sbjct: 69 QVYYFGPCGKYNAMVLEL-----LGPSLEDLFDLCDRTFSLKTVLM--IAIQLISRMEYV 121
Query: 818 HHDCQPPVIHRDIKSNNILL--DANLEAR---IADFGLARM------MLHKN--ETVSMV 864
H +I+RD+K N L+ N + I DF LA+ H E S+
Sbjct: 122 HSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178
Query: 865 AGSYGY--IAPEYGYTLKVDEKS---DIYSFGVVLLELLTGKMP 903
G+ Y I G E+S D+ + G + + L G +P
Sbjct: 179 -GTARYMSINTHLGK-----EQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 29/181 (16%), Positives = 60/181 (33%), Gaps = 55/181 (30%)
Query: 706 IGMGGNGIVYKAE--------FHRPHMVVAVKKLWRSDNDIESGD-DLFREVSLLGR--- 753
GI+Y+A ++K +++ D LF E + R
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK--------LDAKDGRLFNEQNFFQRAAK 101
Query: 754 ------------LRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWV 801
I +G+ ++ Y ++ SLG +L +D
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQS------ALDVS 151
Query: 802 SR--------YNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARI--ADFGLA 851
+ +A + L +LH + +H ++ + NI +D ++++ A +G A
Sbjct: 152 PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
Query: 852 R 852
Sbjct: 209 F 209
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1009 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.6 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.59 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.58 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.58 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.56 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.38 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.32 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.3 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.27 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.23 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.2 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.98 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.97 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.96 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.92 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.9 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.85 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.82 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.71 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.57 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.4 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.3 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.15 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.1 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.97 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.81 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.77 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.75 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.69 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.58 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.46 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.22 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.11 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.99 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.96 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.8 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.8 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.73 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.73 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.65 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.47 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.47 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.31 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.02 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.97 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.82 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.66 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.46 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.08 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.95 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.47 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.49 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-88 Score=840.89 Aligned_cols=598 Identities=33% Similarity=0.490 Sum_probs=484.1
Q ss_pred HhccChHHhHHHHHHHHhhccCCCCCCCCCCCCCccccCCcCCceeeeEEeCCCCceeEEeccccccccc---cc-----
Q 037197 12 IVESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWCNSRGFVEKLDLSNMSLNGS---VS----- 83 (1009)
Q Consensus 12 ~~~~~~~~~~~~ll~~k~~~~d~~~~l~~W~~~~~~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~l~~~---~~----- 83 (1009)
.+..+.++|++|||+||+++.||. .+++|+. +++||+|+||+|+ .++|++|||+++++.|. ++
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~-------~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~ 75 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKN-LLPDWSS-------NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLS 75 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTT-SSTTCCT-------TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTT
T ss_pred ccccCCHHHHHHHHHHHhhCCCcc-cccCCCC-------CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhc
Confidence 344457899999999999999998 8999973 3579999999998 79999999999999886 44
Q ss_pred ------------------cccccCCCCCeEecccCcccccCCc--cccccCccCcccccccccCCCCCCCC-CCCcCCeE
Q 037197 84 ------------------ENIRGLRSLSSLNICCNEFASSLPK--SLANLTALKSMDVSQNNFIGSFPTGL-GKASGLTS 142 (1009)
Q Consensus 84 ------------------~~l~~l~~L~~L~L~~n~~~~~~~~--~l~~l~~L~~L~Ls~n~l~~~~p~~l-~~l~~L~~ 142 (1009)
+.+..+++|++|+|++|.+++.+|. .++++++|++|||++|.+.+.+|..+ +++++|++
T Consensus 76 L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~ 155 (768)
T 3rgz_A 76 LTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155 (768)
T ss_dssp CTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSE
T ss_pred cCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCE
Confidence 4678889999999999999999988 89999999999999999988887765 55666666
Q ss_pred EecCCCCCCCCCCcc-------------------------ccCCCCCCeeeccCCccCCcCCccccCccccceeeecccc
Q 037197 143 VNASSNNFSGFLPED-------------------------LGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNN 197 (1009)
Q Consensus 143 L~Ls~n~l~~~~p~~-------------------------l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~ 197 (1009)
|+|++|++++..|.. ++++++|++|+|++|.+.+.+|. ++++++|++|+|++|.
T Consensus 156 L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~ 234 (768)
T 3rgz_A 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNK 234 (768)
T ss_dssp EECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSC
T ss_pred EECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCc
Confidence 666666555433322 13455555555555655555554 5556666666666666
Q ss_pred ccccCCccCCCCcchhhhhccccccc----------------------ccCCccccCC-CCccEEEeccCccccccCccc
Q 037197 198 LTGKIPPELGQLSSLETIILGYNAFE----------------------GEIPAEFGNL-TNLRYLDLAVGSLSGQIPPAL 254 (1009)
Q Consensus 198 l~~~~p~~l~~l~~L~~L~L~~n~l~----------------------~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~l 254 (1009)
+++.+|..++.+++|++|+|++|+++ +.+|..+.++ ++|++|+|++|.+++.+|..|
T Consensus 235 l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~ 314 (768)
T 3rgz_A 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314 (768)
T ss_dssp CCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGG
T ss_pred CCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHH
Confidence 65555555555555555555555544 4555555443 666666666666666666666
Q ss_pred CCCCCCcEEEcccCCcCCCCCcc-cccccccccccccccccCCCcchhhhccc-CCCeEeccccccCCCCCcCCCC--CC
Q 037197 255 GRLKKLTTVYLYKNNFTGKIPPE-LGSITSLAFLDLSDNQISGEIPVKLAELK-NLQLLNLMCNQLTGLIPDKLGE--LT 330 (1009)
Q Consensus 255 ~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~~l~~--l~ 330 (1009)
+.+++|++|+|++|.+++.+|.. +..+++|++|+|++|++++.+|..+..++ +|++|++++|++++.+|..+.. ++
T Consensus 315 ~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 394 (768)
T 3rgz_A 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394 (768)
T ss_dssp GGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTC
T ss_pred hcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccC
Confidence 66666666666666666555544 56666666666666666666666666665 6777777777766666666655 67
Q ss_pred cccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcc
Q 037197 331 KLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQ 410 (1009)
Q Consensus 331 ~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~ 410 (1009)
+|+.|++++|.+++.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|++++|++++.+|..+..+++|++|+++
T Consensus 395 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 474 (768)
T 3rgz_A 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474 (768)
T ss_dssp CCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred CccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEec
Confidence 78888888888888888889999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCc
Q 037197 411 NNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKI 490 (1009)
Q Consensus 411 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 490 (1009)
+|++++.+|..+.++++|++|+|++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|++++|++++.+
T Consensus 475 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~i 554 (768)
T 3rgz_A 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554 (768)
T ss_dssp SSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBC
T ss_pred CCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998777
Q ss_pred cccc----------------------------------------------------------------------ccCCcC
Q 037197 491 PNEL----------------------------------------------------------------------QACPSL 500 (1009)
Q Consensus 491 p~~~----------------------------------------------------------------------~~l~~L 500 (1009)
|..+ +.+++|
T Consensus 555 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L 634 (768)
T 3rgz_A 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634 (768)
T ss_dssp CGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCC
T ss_pred ChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccc
Confidence 7544 335789
Q ss_pred cEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCC
Q 037197 501 SVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYN 580 (1009)
Q Consensus 501 ~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 580 (1009)
+.|||++|+++|.+|..|++++.|+.|+|++|+++|.+|..++++++|+.||||+|+++|.||..+..+++|++||||+|
T Consensus 635 ~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N 714 (768)
T 3rgz_A 635 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714 (768)
T ss_dssp CEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred cEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCcccccCCcccccCcCCCCCCCCCCCCCCC
Q 037197 581 KLEGPVPSNGILMNINPNELIGNAGLCGSVLPPCSQNLT 619 (1009)
Q Consensus 581 ~l~g~ip~~~~~~~~~~~~~~~n~~lcg~~~~~c~~~~~ 619 (1009)
+|+|+||.+++|++|+..+|.||+++||.|+++|.....
T Consensus 715 ~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~~~ 753 (768)
T 3rgz_A 715 NLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNA 753 (768)
T ss_dssp EEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSCC-
T ss_pred cccccCCCchhhccCCHHHhcCCchhcCCCCcCCCCCcc
Confidence 999999999999999999999999999999999976653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-66 Score=647.36 Aligned_cols=515 Identities=33% Similarity=0.495 Sum_probs=443.8
Q ss_pred ceeEEecccccccccccccc-ccCCCCCeEecccCcccccCCcc---c----------------------cccCccCccc
Q 037197 67 FVEKLDLSNMSLNGSVSENI-RGLRSLSSLNICCNEFASSLPKS---L----------------------ANLTALKSMD 120 (1009)
Q Consensus 67 ~v~~l~l~~~~l~~~~~~~l-~~l~~L~~L~L~~n~~~~~~~~~---l----------------------~~l~~L~~L~ 120 (1009)
+++.|||++|.+++.++..+ .++++|++|+|++|.+++..|.. + .++++|++|+
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~ 206 (768)
T 3rgz_A 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLD 206 (768)
T ss_dssp TCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEE
T ss_pred CCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEE
Confidence 45666666666666655543 55556666666665555544433 2 5566677777
Q ss_pred ccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccc
Q 037197 121 VSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTG 200 (1009)
Q Consensus 121 Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~ 200 (1009)
|++|.+.+.+|. ++++++|++|+|++|++++.+|..++++++|++|++++|.+.+.+|.. .+++|++|+|++|.+++
T Consensus 207 Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~ 283 (768)
T 3rgz_A 207 VSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTG 283 (768)
T ss_dssp CCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEE
T ss_pred CcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCC
Confidence 777777766665 777777777777777777777777777777777777777777666654 67788888888888888
Q ss_pred cCCccCCCC-cchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcc-cCCCCCCcEEEcccCCcCCCCCccc
Q 037197 201 KIPPELGQL-SSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPA-LGRLKKLTTVYLYKNNFTGKIPPEL 278 (1009)
Q Consensus 201 ~~p~~l~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-l~~l~~L~~L~L~~n~l~~~~~~~~ 278 (1009)
.+|..+..+ ++|++|+|++|++++.+|..|+++++|++|++++|.+++.+|.. ++++++|++|+|++|.+++.+|..+
T Consensus 284 ~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l 363 (768)
T 3rgz_A 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363 (768)
T ss_dssp SCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTH
T ss_pred ccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHH
Confidence 888888775 99999999999999999999999999999999999999888876 9999999999999999999999999
Q ss_pred cccc-ccccccccccccCCCcchhhhc--ccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCC
Q 037197 279 GSIT-SLAFLDLSDNQISGEIPVKLAE--LKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP 355 (1009)
Q Consensus 279 ~~l~-~L~~L~Ls~N~l~~~~~~~l~~--l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 355 (1009)
..++ +|++|+|++|++++.+|..+.. +++|++|++++|++++.+|..+.++++|+.|++++|.+++.+|..++.+++
T Consensus 364 ~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 443 (768)
T 3rgz_A 364 TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSK 443 (768)
T ss_dssp HHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTT
T ss_pred HhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCC
Confidence 9887 9999999999999888888877 788999999999999999999999999999999999999999999999999
Q ss_pred CceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeec
Q 037197 356 LRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMAN 435 (1009)
Q Consensus 356 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 435 (1009)
|+.|++++|.+++.+|..+..+++|+.|++++|++++.+|..+.++++|++|++++|++++.+|.+++.+++|++|+|++
T Consensus 444 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 523 (768)
T 3rgz_A 444 LRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSN 523 (768)
T ss_dssp CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCS
T ss_pred CCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcCCcCCCCCcEEecccCcccccCCCc----------------------------------------------
Q 037197 436 NNLTGQIPDDISLSTSLSFVDISWNHLESYLPSS---------------------------------------------- 469 (1009)
Q Consensus 436 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~---------------------------------------------- 469 (1009)
|+++|.+|..+..+++|+.|++++|++++.+|..
T Consensus 524 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (768)
T 3rgz_A 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603 (768)
T ss_dssp SCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGG
T ss_pred CcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchh
Confidence 9999999999999999999999999988766654
Q ss_pred ------------------------ccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccce
Q 037197 470 ------------------------ILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLV 525 (1009)
Q Consensus 470 ------------------------~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~ 525 (1009)
+..+++|+.|++++|+++|.+|..++.+++|+.|||++|+++|.+|..|+++++|+
T Consensus 604 ~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~ 683 (768)
T 3rgz_A 604 LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLN 683 (768)
T ss_dssp GGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC
T ss_pred hhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCC
Confidence 33457889999999999999999999999999999999999999999999999999
Q ss_pred eeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCc-cccC
Q 037197 526 SLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNK-LEGP 585 (1009)
Q Consensus 526 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~g~ 585 (1009)
.|||++|+++|.+|..++.++.|+.||||+|+|+|.||.. +.+..+....+.+|+ |.|.
T Consensus 684 ~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 684 ILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp EEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred EEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCC
Confidence 9999999999999999999999999999999999999975 344555566677875 7774
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-61 Score=595.01 Aligned_cols=556 Identities=21% Similarity=0.184 Sum_probs=486.1
Q ss_pred ceeeeEEeCC----------CCceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCccccccc
Q 037197 55 CNWTGVWCNS----------RGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQN 124 (1009)
Q Consensus 55 C~w~gv~C~~----------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n 124 (1009)
|.++.|.|+. ..+++.|+|+++.+++..+..+.++++|++|+|++|.+++..|..++++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 5566677743 146899999999999988888999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCc
Q 037197 125 NFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPP 204 (1009)
Q Consensus 125 ~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 204 (1009)
.+++..+..++++++|++|+|++|++++..|..|+++++|++|++++|.+++..|..++++++|++|++++|.+++..+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99876666799999999999999999988888999999999999999999999999999999999999999999987776
Q ss_pred cCC--CCcchhhhhcccccccccCCccccCC---------------------------CCccEEEeccCccccccCcccC
Q 037197 205 ELG--QLSSLETIILGYNAFEGEIPAEFGNL---------------------------TNLRYLDLAVGSLSGQIPPALG 255 (1009)
Q Consensus 205 ~l~--~l~~L~~L~L~~n~l~~~~~~~~~~l---------------------------~~L~~L~L~~n~l~~~~~~~l~ 255 (1009)
.++ .+++|++|++++|++++..|..|+.+ ++|++|++++|.+++..|..|.
T Consensus 164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~ 243 (680)
T 1ziw_A 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243 (680)
T ss_dssp HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence 654 56899999999999999888877765 4567788888888888888888
Q ss_pred CCCC--CcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCC-----CCC----c
Q 037197 256 RLKK--LTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG-----LIP----D 324 (1009)
Q Consensus 256 ~l~~--L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-----~~~----~ 324 (1009)
.++. |++|+|++|.+++..|..|..+++|++|+|++|++++..|..+..+++|++|++++|...+ .+| .
T Consensus 244 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~ 323 (680)
T 1ziw_A 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323 (680)
T ss_dssp GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTT
T ss_pred ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChh
Confidence 7754 9999999999998888888899999999999999998888889999999999998876553 122 2
Q ss_pred CCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccc--cCCcCccC--CCCCceeecccccccccCCccccc
Q 037197 325 KLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSG--EIPTGLCD--SGNLTKLILFNNSFSGTFPVSLST 400 (1009)
Q Consensus 325 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~--~~~~~l~~--l~~L~~L~l~~N~l~~~~p~~l~~ 400 (1009)
.|..+++|++|++++|.+.+..+..+..+++|++|++++|.+.. .....|.. .+.|+.|++++|++++..|..+..
T Consensus 324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 403 (680)
T 1ziw_A 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403 (680)
T ss_dssp TTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred hcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence 67889999999999999999888889999999999999997543 22233333 258999999999999999999999
Q ss_pred CccccEEEcccCccccccC-CccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCccc--ccCCCcccCCcccc
Q 037197 401 CKSLVRVRVQNNLISGTIP-VGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLE--SYLPSSILSIPSLQ 477 (1009)
Q Consensus 401 ~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~ 477 (1009)
+++|+.|++++|++++.+| ..+.++++|++|++++|++++..+..+..+++|+.|++++|.++ +..|..|..+++|+
T Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~ 483 (680)
T 1ziw_A 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483 (680)
T ss_dssp CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence 9999999999999987766 67899999999999999999888999999999999999999987 56889999999999
Q ss_pred hhccccCcccCCcccccccCCcCcEEEeecCCCCCCCC--------ccccccccceeeeecCcccccCCCcccccccccc
Q 037197 478 TFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIP--------ASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLA 549 (1009)
Q Consensus 478 ~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 549 (1009)
.|++++|++++..+..|..+++|+.|+|++|++++..+ ..|.++++|+.|+|++|+++...+..|.++++|+
T Consensus 484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 563 (680)
T 1ziw_A 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcc
Confidence 99999999999888889999999999999999986422 3478899999999999999954455799999999
Q ss_pred eecCCccccccccCcCcCCCCCCcEEecCCCccccCCCCCC--cccccCCcccccCcCCCCCC
Q 037197 550 ILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNG--ILMNINPNELIGNAGLCGSV 610 (1009)
Q Consensus 550 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~~~~~~~~~~n~~lcg~~ 610 (1009)
.|||++|+|++..+..|..+++|+.|+|++|+|++.+|..- .+.++....+.+||+.|+++
T Consensus 564 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred eeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 99999999998888889999999999999999999877532 45666777889999999864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-59 Score=566.49 Aligned_cols=494 Identities=18% Similarity=0.184 Sum_probs=345.4
Q ss_pred CCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeecc
Q 037197 91 SLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFR 170 (1009)
Q Consensus 91 ~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~ 170 (1009)
++++|+|++|.+++..|..|+++++|++|+|++|.+.+..|..++++++|++|+|++|++++..|..|+++++|++|+++
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 113 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence 56777777777776666677777777777777777766666777777777777777777776667777777777777777
Q ss_pred CCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCcc--EEEeccCcccc
Q 037197 171 GSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLR--YLDLAVGSLSG 248 (1009)
Q Consensus 171 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~L~L~~n~l~~ 248 (1009)
+|.+++..|..++++++|++|+|++|.+++..+..+..+++|++|++++|++++..|..|+.+++|+ .|++++|.+++
T Consensus 114 ~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~ 193 (606)
T 3t6q_A 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193 (606)
T ss_dssp TSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCE
T ss_pred ccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCc
Confidence 7777765566677777777777777777654333444477777777777777766666677777777 67777777776
Q ss_pred ccCcccCCCCCCcEEEcccCCc---------------------C-----CCCCccccccc--ccccccccccccCCCcch
Q 037197 249 QIPPALGRLKKLTTVYLYKNNF---------------------T-----GKIPPELGSIT--SLAFLDLSDNQISGEIPV 300 (1009)
Q Consensus 249 ~~~~~l~~l~~L~~L~L~~n~l---------------------~-----~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~ 300 (1009)
..|..+.. .+|+.|++++|.. . ...+..+..+. +|+.|++++|.+++..+.
T Consensus 194 ~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~ 272 (606)
T 3t6q_A 194 IEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272 (606)
T ss_dssp ECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTT
T ss_pred cChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHH
Confidence 66555543 4666777666541 1 11112222222 577777777777766666
Q ss_pred hhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcC-ccCCCC
Q 037197 301 KLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTG-LCDSGN 379 (1009)
Q Consensus 301 ~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~-l~~l~~ 379 (1009)
.|..+++|++|++++|+++ .+|..+.++++|++|++++|.+.+..|..+..+++|+.|++++|.+.+.+|.. +..+++
T Consensus 273 ~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~ 351 (606)
T 3t6q_A 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351 (606)
T ss_dssp TTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTT
T ss_pred HhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCc
Confidence 6777777777777777777 44666777777777777777777776777777777777777777776555443 667777
Q ss_pred CceeecccccccccC--CcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcC-CcCCCCCcEEe
Q 037197 380 LTKLILFNNSFSGTF--PVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDD-ISLSTSLSFVD 456 (1009)
Q Consensus 380 L~~L~l~~N~l~~~~--p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~ 456 (1009)
|++|++++|.+++.. +..+..+++|++|++++|++.+..|..+..+++|++|++++|++++..|.. +..+++|+.|+
T Consensus 352 L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 431 (606)
T 3t6q_A 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431 (606)
T ss_dssp CCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEE
T ss_pred CCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEE
Confidence 777777777777655 666777777777777777777777777777777777777777777665543 67777777777
Q ss_pred cccCcccccCCCcccCCcccchhccccCcccCC---cccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcc
Q 037197 457 ISWNHLESYLPSSILSIPSLQTFMASHNNLQAK---IPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNR 533 (1009)
Q Consensus 457 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~---~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 533 (1009)
+++|.+++..|..+..+++|++|++++|++++. .+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+
T Consensus 432 l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 511 (606)
T 3t6q_A 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511 (606)
T ss_dssp CTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCc
Confidence 777777777777777777777777777777652 23457777777777777777777777777777777777777777
Q ss_pred cccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCCC
Q 037197 534 FSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVP 587 (1009)
Q Consensus 534 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip 587 (1009)
+++.+|..+..++.| .|||++|++++.+|..+..+++|+.|++++|++++..+
T Consensus 512 l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 512 LTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred cCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 777777777777777 77777777777777777777777777777777776554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=569.22 Aligned_cols=523 Identities=20% Similarity=0.206 Sum_probs=472.6
Q ss_pred CceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEec
Q 037197 66 GFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNA 145 (1009)
Q Consensus 66 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 145 (1009)
..++.|+|+++.+++..+..+.++++|++|+|++|.+++..+..|+++++|++|+|++|.+.+..|..++++++|++|+|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 46899999999999998999999999999999999998766668999999999999999999887889999999999999
Q ss_pred CCCCCCCCCCccccCCCCCCeeeccCCccCCcCCcccc--CccccceeeeccccccccCCccCCCC--------------
Q 037197 146 SSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFR--NLQKLKFLGLSGNNLTGKIPPELGQL-------------- 209 (1009)
Q Consensus 146 s~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~--~l~~L~~L~L~~n~l~~~~p~~l~~l-------------- 209 (1009)
++|.+++..|..++++++|++|++++|.+++..+..+. .+++|++|++++|.+++..|..+..+
T Consensus 129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~ 208 (680)
T 1ziw_A 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208 (680)
T ss_dssp CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCH
T ss_pred CCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccC
Confidence 99999999999999999999999999999988777664 56899999999999998888777654
Q ss_pred -------------cchhhhhcccccccccCCccccCCCC--ccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCC
Q 037197 210 -------------SSLETIILGYNAFEGEIPAEFGNLTN--LRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKI 274 (1009)
Q Consensus 210 -------------~~L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 274 (1009)
++|++|++++|.+++..|.+|.+++. |++|++++|++++..|..|+.+++|++|++++|.+++..
T Consensus 209 ~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 288 (680)
T 1ziw_A 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288 (680)
T ss_dssp HHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEEC
T ss_pred hhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccC
Confidence 45678888999999999999998865 999999999999999999999999999999999999999
Q ss_pred CcccccccccccccccccccCC-----Ccch----hhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCcc
Q 037197 275 PPELGSITSLAFLDLSDNQISG-----EIPV----KLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGS 345 (1009)
Q Consensus 275 ~~~~~~l~~L~~L~Ls~N~l~~-----~~~~----~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 345 (1009)
|..|.++++|+.|++++|...+ .+|. .|..+++|++|++++|++++..+..|.++++|++|++++|.+...
T Consensus 289 ~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~ 368 (680)
T 1ziw_A 289 SHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368 (680)
T ss_dssp TTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCC
T ss_pred hhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhh
Confidence 9999999999999999886654 2332 688899999999999999999999999999999999999986432
Q ss_pred --CCccccC--CCCCceeeccCccccccCCcCccCCCCCceeecccccccccCC-cccccCccccEEEcccCccccccCC
Q 037197 346 --LPMRLGQ--SSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFP-VSLSTCKSLVRVRVQNNLISGTIPV 420 (1009)
Q Consensus 346 --~~~~~~~--~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p-~~l~~~~~L~~L~L~~N~l~~~~p~ 420 (1009)
....+.. .++|+.|++++|.+++..|..|..+++|+.|++++|.+++.+| ..+.++++|++|++++|++.+..+.
T Consensus 369 ~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 448 (680)
T 1ziw_A 369 TLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN 448 (680)
T ss_dssp EECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTT
T ss_pred hcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChh
Confidence 2223333 2589999999999999999999999999999999999988666 6899999999999999999999999
Q ss_pred ccCCCCcccEEEeeccccc--ccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcc-------
Q 037197 421 GLGNLPSLQRLEMANNNLT--GQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIP------- 491 (1009)
Q Consensus 421 ~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p------- 491 (1009)
.|..+++|+.|++++|.++ +.+|..+..+++|+.|++++|+++++.+..|.++++|++|++++|++++..+
T Consensus 449 ~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 528 (680)
T 1ziw_A 449 SFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528 (680)
T ss_dssp TTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSC
T ss_pred hhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCc
Confidence 9999999999999999987 6789999999999999999999999999999999999999999999986532
Q ss_pred -cccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcC-CC
Q 037197 492 -NELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFG-AS 569 (1009)
Q Consensus 492 -~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l 569 (1009)
..|..+++|+.|+|++|+++...+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.+|..+. .+
T Consensus 529 ~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 608 (680)
T 1ziw_A 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAF 608 (680)
T ss_dssp CCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHH
T ss_pred chhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccc
Confidence 2478999999999999999966667799999999999999999977777789999999999999999999998887 78
Q ss_pred CCCcEEecCCCccccCCCC
Q 037197 570 PALEMLNLSYNKLEGPVPS 588 (1009)
Q Consensus 570 ~~L~~L~ls~N~l~g~ip~ 588 (1009)
++|+.|++++|++.+..+.
T Consensus 609 ~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 609 RNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TTCSEEECTTCCCCBCCCC
T ss_pred cccCEEEccCCCcccCCcc
Confidence 9999999999999998764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-58 Score=580.79 Aligned_cols=518 Identities=21% Similarity=0.221 Sum_probs=315.2
Q ss_pred ceeeeEEeCCCCceeEEeccccccccccccccccCCCCCeEecccCcccccC-CccccccCccCcccccccccCCCCCCC
Q 037197 55 CNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSL-PKSLANLTALKSMDVSQNNFIGSFPTG 133 (1009)
Q Consensus 55 C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~-~~~l~~l~~L~~L~Ls~n~l~~~~p~~ 133 (1009)
|.|+.|.+ -...++.|||++|.+++..+..+.++++|++|+|++|.+.+.+ |.+|+++++|++|+|++|.+.+..|..
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 45666665 4456667777777776666666777777777777766554444 556677777777777777766666666
Q ss_pred CCCCcCCeEEecCCCCCCCCCCcc--ccCCCCCCeeeccCCccCCcCC-ccccCccccceeeeccccccccCCccCCCC-
Q 037197 134 LGKASGLTSVNASSNNFSGFLPED--LGNATSLESLDFRGSFFEGSVP-TSFRNLQKLKFLGLSGNNLTGKIPPELGQL- 209 (1009)
Q Consensus 134 l~~l~~L~~L~Ls~n~l~~~~p~~--l~~l~~L~~L~L~~n~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l- 209 (1009)
++++++|++|+|++|.+++.+|.. ++++++|++|+|++|.+.+..+ ..|+++++|++|+|++|.+++..+..++.+
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~ 172 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHH
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccccc
Confidence 777777777777777776655544 6667777777777776665543 456667777777777777766666666665
Q ss_pred -cchhhhhcccccccccCCccccCCCC------ccEEEeccCccccccCcccCCC---CCCcEEEcccC---------Cc
Q 037197 210 -SSLETIILGYNAFEGEIPAEFGNLTN------LRYLDLAVGSLSGQIPPALGRL---KKLTTVYLYKN---------NF 270 (1009)
Q Consensus 210 -~~L~~L~L~~n~l~~~~~~~~~~l~~------L~~L~L~~n~l~~~~~~~l~~l---~~L~~L~L~~n---------~l 270 (1009)
++|+.|+|+.|.+.+..|..++.+++ |++|++++|.+++..+..+... .+++.|.++.+ .+
T Consensus 173 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l 252 (844)
T 3j0a_A 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252 (844)
T ss_dssp HCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSS
T ss_pred CCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccccc
Confidence 66777777777766666666555544 6677777776666665554432 45666665532 22
Q ss_pred CCCCCcccccc--cccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCc
Q 037197 271 TGKIPPELGSI--TSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPM 348 (1009)
Q Consensus 271 ~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 348 (1009)
.+..+..|.++ ++|+.|+|++|.+.+..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|.+.+..+.
T Consensus 253 ~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 332 (844)
T 3j0a_A 253 KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332 (844)
T ss_dssp TTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSC
T ss_pred CCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHH
Confidence 22222233332 4566666666666655556666666666666666666666666666666666666666666666666
Q ss_pred cccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcc
Q 037197 349 RLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSL 428 (1009)
Q Consensus 349 ~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L 428 (1009)
.+..+++|+.|++++|.+.+..+..|..+++|+.|++++|.+++. ..+++|+.|++++|+++ .+|.. ..++
T Consensus 333 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~---~~~l 403 (844)
T 3j0a_A 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI---NLTA 403 (844)
T ss_dssp SCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC---CTTC
T ss_pred HhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc---cccc
Confidence 666666666666666666655555566666666666666666532 22556666666666665 33332 3455
Q ss_pred cEEEeecccccccCC-cCCcCCCCCcEEecccCcccccCCC-cccCCcccchhccccCccc-----CCcccccccCCcCc
Q 037197 429 QRLEMANNNLTGQIP-DDISLSTSLSFVDISWNHLESYLPS-SILSIPSLQTFMASHNNLQ-----AKIPNELQACPSLS 501 (1009)
Q Consensus 429 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~ 501 (1009)
+.|++++|++++... ..+..+++|+.|+|++|++++..+. .+..+++|+.|++++|.++ +..+..|..+++|+
T Consensus 404 ~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~ 483 (844)
T 3j0a_A 404 NLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQ 483 (844)
T ss_dssp CEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEE
T ss_pred ceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCccccc
Confidence 666666666653211 1233556666666666666654332 2344566666666666665 23334556666666
Q ss_pred EEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCc
Q 037197 502 VLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNK 581 (1009)
Q Consensus 502 ~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 581 (1009)
.|||++|+|++.+|..|..+++|+.|+|++|+|++..|..+. ++|+.|||++|+|++.+|..|. .|+.|++++|+
T Consensus 484 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np 558 (844)
T 3j0a_A 484 VLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHNK 558 (844)
T ss_dssp CCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEEC
T ss_pred EEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---CcCEEEecCCC
Confidence 666666666666666666666666666666666655454444 5666666666666666665543 45666666666
Q ss_pred cccCCC
Q 037197 582 LEGPVP 587 (1009)
Q Consensus 582 l~g~ip 587 (1009)
+.+..+
T Consensus 559 ~~C~c~ 564 (844)
T 3j0a_A 559 FICECE 564 (844)
T ss_dssp CCCSSS
T ss_pred cccccc
Confidence 665554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=571.25 Aligned_cols=484 Identities=21% Similarity=0.313 Sum_probs=309.8
Q ss_pred ccChHHhHHHHHHHHhhccCCCCC--------CCCCCCCCccccCCcCCcee---eeEEeCCCCceeEEecccccccccc
Q 037197 14 ESNADDELSTLLSIKAGLIDPLNM--------LEDWKMPSNAAENGLLHCNW---TGVWCNSRGFVEKLDLSNMSLNGSV 82 (1009)
Q Consensus 14 ~~~~~~~~~~ll~~k~~~~d~~~~--------l~~W~~~~~~~~~~~~~C~w---~gv~C~~~~~v~~l~l~~~~l~~~~ 82 (1009)
++....|+.||.+||+++.+|... ..+|+. +.+||.| .||+|+..|||++|+|++++++|.+
T Consensus 25 ~~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-------~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~l 97 (636)
T 4eco_A 25 TAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-------NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRV 97 (636)
T ss_dssp CCHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCC-------SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEE
T ss_pred hhhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-------CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcC
Confidence 344567999999999999765322 336863 3579999 9999988899999999999999999
Q ss_pred ccccccCCCCCeEecccCcc------cc------cCCccccccCccCcccccccccCCCCCCCCCC-CcCCeEEecC---
Q 037197 83 SENIRGLRSLSSLNICCNEF------AS------SLPKSLANLTALKSMDVSQNNFIGSFPTGLGK-ASGLTSVNAS--- 146 (1009)
Q Consensus 83 ~~~l~~l~~L~~L~L~~n~~------~~------~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~-l~~L~~L~Ls--- 146 (1009)
|+.+++|++|++|+|++|.+ .+ .+|... +..|+ ++++.|.+.+.+|..++. +..+..+++.
T Consensus 98 p~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~ 174 (636)
T 4eco_A 98 PDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174 (636)
T ss_dssp CGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCC
T ss_pred ChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccc
Confidence 99999999999999999976 33 556555 67788 999999999988877763 2223333333
Q ss_pred -----------------CCCCCCCCCccccCCCCCCeeeccCCccCCc-----------------CCcccc--Cccccce
Q 037197 147 -----------------SNNFSGFLPEDLGNATSLESLDFRGSFFEGS-----------------VPTSFR--NLQKLKF 190 (1009)
Q Consensus 147 -----------------~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~-----------------~p~~~~--~l~~L~~ 190 (1009)
+|++++ +|..++++++|++|+|++|.+++. +|..++ ++++|++
T Consensus 175 ~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~ 253 (636)
T 4eco_A 175 IKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTD 253 (636)
T ss_dssp CCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred cccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCE
Confidence 456666 666666667777777776666664 666666 6666666
Q ss_pred eeeccccccccCCccCCCCcchhhhhccccc-ccc-cCCccccCC------CCccEEEeccCccccccCc--ccCCCCCC
Q 037197 191 LGLSGNNLTGKIPPELGQLSSLETIILGYNA-FEG-EIPAEFGNL------TNLRYLDLAVGSLSGQIPP--ALGRLKKL 260 (1009)
Q Consensus 191 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L~L~~n~l~~~~~~--~l~~l~~L 260 (1009)
|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..++++ ++|++|++++|+++ .+|. .++++++|
T Consensus 254 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L 332 (636)
T 4eco_A 254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKL 332 (636)
T ss_dssp EEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTC
T ss_pred EEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCC
Confidence 6666666666666666666666666666666 666 566666555 66666666666666 5565 66666666
Q ss_pred cEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccC-CCeEeccccccCCCCCcCCCCCC--cccEEEc
Q 037197 261 TTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKN-LQLLNLMCNQLTGLIPDKLGELT--KLEVLEL 337 (1009)
Q Consensus 261 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~~l~~l~--~L~~L~L 337 (1009)
++|++++|.++|.+| .+..+++|++|+|++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++ +|+.|++
T Consensus 333 ~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~L 409 (636)
T 4eco_A 333 GMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDF 409 (636)
T ss_dssp CEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEEC
T ss_pred CEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEEC
Confidence 666666666666666 6666666666666666666 55666666666 666666666666 4455555433 5666666
Q ss_pred cCCccCccCCcccc-------CCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcc
Q 037197 338 WKNSLIGSLPMRLG-------QSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQ 410 (1009)
Q Consensus 338 ~~N~l~~~~~~~~~-------~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~ 410 (1009)
++|.+++..|..+. .+.+|+.|++++|.+ ++..+..+..+++|++|+|+
T Consensus 410 s~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l------------------------~~lp~~~~~~l~~L~~L~Ls 465 (636)
T 4eco_A 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQI------------------------SKFPKELFSTGSPLSSINLM 465 (636)
T ss_dssp CSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCC------------------------CSCCTHHHHTTCCCSEEECC
T ss_pred cCCcCCCcchhhhcccccccccCCCCCEEECcCCcc------------------------CcCCHHHHccCCCCCEEECC
Confidence 66666655555554 444445555555544 42222223334555555555
Q ss_pred cCccccccCCccC--------CCCcccEEEeecccccccCCcCCc--CCCCCcEEecccCcccccCCCcccCCcccchhc
Q 037197 411 NNLISGTIPVGLG--------NLPSLQRLEMANNNLTGQIPDDIS--LSTSLSFVDISWNHLESYLPSSILSIPSLQTFM 480 (1009)
Q Consensus 411 ~N~l~~~~p~~~~--------~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 480 (1009)
+|+++ .+|..+. ++++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+
T Consensus 466 ~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~ 542 (636)
T 4eco_A 466 GNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542 (636)
T ss_dssp SSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEE
T ss_pred CCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEE
Confidence 55555 3333221 1226666666666666 5555554 66666666666666665 455555556666665
Q ss_pred cccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCcccccc
Q 037197 481 ASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFG 560 (1009)
Q Consensus 481 l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 560 (1009)
+++|+ ++++|++.+.+|..+..+++|+.|+|++|+| +.+|..+. ++|+.|||++|++..
T Consensus 543 Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 543 IRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp CCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred CCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence 55443 3345555555555555555555555555555 35555544 556666666665443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-58 Score=563.93 Aligned_cols=511 Identities=20% Similarity=0.279 Sum_probs=394.6
Q ss_pred hccChHHhHHHHHHHHhhccCCCCCCCCCCCCCccccCCcCCcee------------eeEEeCCCCceeEEecccccccc
Q 037197 13 VESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNW------------TGVWCNSRGFVEKLDLSNMSLNG 80 (1009)
Q Consensus 13 ~~~~~~~~~~~ll~~k~~~~d~~~~l~~W~~~~~~~~~~~~~C~w------------~gv~C~~~~~v~~l~l~~~~l~~ 80 (1009)
+++...+|+.||++||+++.|| +|+..........++|+| .||+|+..++|+.|+|++++++|
T Consensus 263 ~~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G 337 (876)
T 4ecn_A 263 ETAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337 (876)
T ss_dssp CCCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEE
T ss_pred ccccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCC
Confidence 3455678999999999999887 897543100111224999 99999988999999999999999
Q ss_pred ccccccccCCCCCeEec-ccCcccccCCcccccc----C-----ccCcc------cc-ccccc-----------CCCCCC
Q 037197 81 SVSENIRGLRSLSSLNI-CCNEFASSLPKSLANL----T-----ALKSM------DV-SQNNF-----------IGSFPT 132 (1009)
Q Consensus 81 ~~~~~l~~l~~L~~L~L-~~n~~~~~~~~~l~~l----~-----~L~~L------~L-s~n~l-----------~~~~p~ 132 (1009)
.+|+.|++|++|++|+| ++|.++|..|-..... + .++.. +. ....+ ....+.
T Consensus 338 ~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i 417 (876)
T 4ecn_A 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417 (876)
T ss_dssp EECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred cCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence 99999999999999999 9999888744321111 0 00000 00 00000 000111
Q ss_pred CCCCCcCCeEEecCC--CCCCCCCCccccCCCCCCeeeccCCccCC-----------------cCCcccc--Ccccccee
Q 037197 133 GLGKASGLTSVNASS--NNFSGFLPEDLGNATSLESLDFRGSFFEG-----------------SVPTSFR--NLQKLKFL 191 (1009)
Q Consensus 133 ~l~~l~~L~~L~Ls~--n~l~~~~p~~l~~l~~L~~L~L~~n~~~~-----------------~~p~~~~--~l~~L~~L 191 (1009)
.......++.+.+.. |++++ +|..|+++++|++|+|++|.+++ .+|..++ ++++|++|
T Consensus 418 ~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L 496 (876)
T 4ecn_A 418 KKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV 496 (876)
T ss_dssp CCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred ccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEE
Confidence 112233344444443 67776 77777777777777777777776 3777776 88888888
Q ss_pred eeccccccccCCccCCCCcchhhhhccccc-ccc-cCCccccCCC-------CccEEEeccCccccccCc--ccCCCCCC
Q 037197 192 GLSGNNLTGKIPPELGQLSSLETIILGYNA-FEG-EIPAEFGNLT-------NLRYLDLAVGSLSGQIPP--ALGRLKKL 260 (1009)
Q Consensus 192 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~-l~~-~~~~~~~~l~-------~L~~L~L~~n~l~~~~~~--~l~~l~~L 260 (1009)
+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..+++++ +|++|+|++|+++ .+|. .++++++|
T Consensus 497 ~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L 575 (876)
T 4ecn_A 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKL 575 (876)
T ss_dssp EEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTC
T ss_pred ECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCC
Confidence 888888888888888888888888888887 887 7777666655 8888888888888 7787 88888888
Q ss_pred cEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccC-CCeEeccccccCCCCCcCCCCCCc--ccEEEc
Q 037197 261 TTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKN-LQLLNLMCNQLTGLIPDKLGELTK--LEVLEL 337 (1009)
Q Consensus 261 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~~l~~l~~--L~~L~L 337 (1009)
+.|+|++|.++ .+| .|..+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|+++ .+|..+..++. |+.|++
T Consensus 576 ~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~L 651 (876)
T 4ecn_A 576 GLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDF 651 (876)
T ss_dssp CEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEEC
T ss_pred CEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEEC
Confidence 89999888888 777 7888888999999998888 78888888888 999999999888 56777776654 889999
Q ss_pred cCCccCccCCccc---c--CCCCCceeeccCccccccCCcCc-cCCCCCceeecccccccccCCcccc--------cCcc
Q 037197 338 WKNSLIGSLPMRL---G--QSSPLRRLDASSNLLSGEIPTGL-CDSGNLTKLILFNNSFSGTFPVSLS--------TCKS 403 (1009)
Q Consensus 338 ~~N~l~~~~~~~~---~--~~~~L~~L~Ls~N~l~~~~~~~l-~~l~~L~~L~l~~N~l~~~~p~~l~--------~~~~ 403 (1009)
++|.+.+.+|... . ...+|+.|++++|.++ .+|..+ ..+++|+.|+|++|+++ .+|..+. ++++
T Consensus 652 s~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~ 729 (876)
T 4ecn_A 652 SYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYL 729 (876)
T ss_dssp CSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGG
T ss_pred cCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCC
Confidence 9998887665332 2 3347889999999998 455554 47888999999999998 4554433 3349
Q ss_pred ccEEEcccCccccccCCccC--CCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhcc
Q 037197 404 LVRVRVQNNLISGTIPVGLG--NLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMA 481 (1009)
Q Consensus 404 L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 481 (1009)
|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+ ++
T Consensus 730 L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------------------~l 789 (876)
T 4ecn_A 730 LTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------------------DA 789 (876)
T ss_dssp CCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB------------------CT
T ss_pred ccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC------------------Cc
Confidence 999999999999 7888887 99999999999999997 79899999999999999987 56
Q ss_pred ccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccc
Q 037197 482 SHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLF 559 (1009)
Q Consensus 482 ~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 559 (1009)
++|++.+.+|..|..+++|+.|+|++|+| +.+|..+. ++|+.|+|++|++....+..+.....+..+.|++|++.
T Consensus 790 s~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 790 EGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp TCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred ccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 78888888898999999999999999999 57888765 58999999999988777777777777888888888765
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=552.90 Aligned_cols=504 Identities=19% Similarity=0.175 Sum_probs=456.9
Q ss_pred eeeEEeCCC----------CceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCccccccccc
Q 037197 57 WTGVWCNSR----------GFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNF 126 (1009)
Q Consensus 57 w~gv~C~~~----------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l 126 (1009)
+.-|.|... ..++.|||++|.+++..+..+.++++|++|+|++|.+++..|..|+++++|++|+|++|.+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 455888542 3589999999999998888999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccC
Q 037197 127 IGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPEL 206 (1009)
Q Consensus 127 ~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l 206 (1009)
++..|..++++++|++|+|++|++++..|..++++++|++|++++|.+.+..+..+..+++|++|++++|.+++..|..+
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 99899999999999999999999998778889999999999999999997655556669999999999999998888889
Q ss_pred CCCcchh--hhhcccccccccCCccccCCCCccEEEeccCcccc--------------------------ccCcccCCCC
Q 037197 207 GQLSSLE--TIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSG--------------------------QIPPALGRLK 258 (1009)
Q Consensus 207 ~~l~~L~--~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--------------------------~~~~~l~~l~ 258 (1009)
+.+++|+ +|++++|++++..|..|.. .+|++|++++|.... ..+..+..+.
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~ 252 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGG
T ss_pred hhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhh
Confidence 9999999 8999999999888877765 589999998875211 0111222222
Q ss_pred --CCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEE
Q 037197 259 --KLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLE 336 (1009)
Q Consensus 259 --~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 336 (1009)
+|+.|++++|.+++..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|++++..|..+.++++|+.|+
T Consensus 253 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 331 (606)
T 3t6q_A 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS 331 (606)
T ss_dssp GSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEE
T ss_pred cCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEE
Confidence 7899999999999888888999999999999999999 7888999999999999999999999899999999999999
Q ss_pred ccCCccCccCCc-cccCCCCCceeeccCccccccC--CcCccCCCCCceeecccccccccCCcccccCccccEEEcccCc
Q 037197 337 LWKNSLIGSLPM-RLGQSSPLRRLDASSNLLSGEI--PTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNL 413 (1009)
Q Consensus 337 L~~N~l~~~~~~-~~~~~~~L~~L~Ls~N~l~~~~--~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~ 413 (1009)
+++|.+.+.++. .+..+++|++|++++|.+++.. +..+..+++|++|++++|++.+..|..+..+++|++|++++|+
T Consensus 332 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 411 (606)
T 3t6q_A 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411 (606)
T ss_dssp CCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCC
T ss_pred CCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCc
Confidence 999999876665 4899999999999999999776 7889999999999999999999999999999999999999999
Q ss_pred cccccCCc-cCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCccccc---CCCcccCCcccchhccccCcccCC
Q 037197 414 ISGTIPVG-LGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESY---LPSSILSIPSLQTFMASHNNLQAK 489 (1009)
Q Consensus 414 l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~l~~N~l~~~ 489 (1009)
+++..|.. +..+++|++|++++|++++..|..+..+++|+.|++++|++++. .+..+..+++|+.|++++|++++.
T Consensus 412 l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 491 (606)
T 3t6q_A 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491 (606)
T ss_dssp EECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEE
T ss_pred CCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCcc
Confidence 99876654 89999999999999999999999999999999999999999873 346789999999999999999999
Q ss_pred cccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccC
Q 037197 490 IPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIP 563 (1009)
Q Consensus 490 ~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 563 (1009)
.|..|..+++|+.|||++|++++..|..+.+++.| .|+|++|++++.+|..+..+++|+.|++++|++++..+
T Consensus 492 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred ChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 99999999999999999999999999999999999 99999999999999999999999999999999987655
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=563.37 Aligned_cols=525 Identities=20% Similarity=0.228 Sum_probs=463.9
Q ss_pred EEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCC-CCCCCCCcCCeEEecCCC
Q 037197 70 KLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSF-PTGLGKASGLTSVNASSN 148 (1009)
Q Consensus 70 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~n 148 (1009)
..|.++++++. +|. -.++|++|+|++|.+++..|..|.++++|++|||++|.+.+.+ |..++++++|++|+|++|
T Consensus 8 ~~dcs~~~L~~-vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSSC-CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCCC-CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 45666777775 444 4578999999999999999999999999999999999877777 788999999999999999
Q ss_pred CCCCCCCccccCCCCCCeeeccCCccCCcCCcc--ccCccccceeeeccccccccCC-ccCCCCcchhhhhccccccccc
Q 037197 149 NFSGFLPEDLGNATSLESLDFRGSFFEGSVPTS--FRNLQKLKFLGLSGNNLTGKIP-PELGQLSSLETIILGYNAFEGE 225 (1009)
Q Consensus 149 ~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~--~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~ 225 (1009)
++++..|..|+++++|++|+|++|.+.+.+|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++.
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 999999999999999999999999999877665 9999999999999999997755 5799999999999999999999
Q ss_pred CCccccCC--CCccEEEeccCccccccCcccCCCCC------CcEEEcccCCcCCCCCcccccc---ccccccccc----
Q 037197 226 IPAEFGNL--TNLRYLDLAVGSLSGQIPPALGRLKK------LTTVYLYKNNFTGKIPPELGSI---TSLAFLDLS---- 290 (1009)
Q Consensus 226 ~~~~~~~l--~~L~~L~L~~n~l~~~~~~~l~~l~~------L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~Ls---- 290 (1009)
.+..|+.+ ++|+.|+++.|.+.+..|..++.+.+ |+.|++++|.+++..+..+... .+++.|+++
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~ 243 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred CHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence 99999988 89999999999999988888777765 9999999999998888877653 567777776
Q ss_pred -----ccccCCCcchhhhcc--cCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccC
Q 037197 291 -----DNQISGEIPVKLAEL--KNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASS 363 (1009)
Q Consensus 291 -----~N~l~~~~~~~l~~l--~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~ 363 (1009)
.|.+.+..+..|..+ ++|+.|++++|.+++..+..|..+++|+.|+|++|.+.+..+..+..+++|+.|++++
T Consensus 244 ~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~ 323 (844)
T 3j0a_A 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323 (844)
T ss_dssp BCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEES
T ss_pred cccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCC
Confidence 344444445556654 7899999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCC
Q 037197 364 NLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIP 443 (1009)
Q Consensus 364 N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 443 (1009)
|.+++..|..|..+++|+.|++++|++++..+..+.++++|+.|++++|.+++ +..+++|+.|++++|+++ .+|
T Consensus 324 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-----i~~~~~L~~L~l~~N~l~-~l~ 397 (844)
T 3j0a_A 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKLV-TLP 397 (844)
T ss_dssp CCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-----CSSCCSCSEEEEESCCCC-CCC
T ss_pred CCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-----ccCCCCcchhccCCCCcc-ccc
Confidence 99998889999999999999999999999888899999999999999999983 333889999999999998 566
Q ss_pred cCCcCCCCCcEEecccCcccccCC-CcccCCcccchhccccCcccCCccc-ccccCCcCcEEEeecCCCC-----CCCCc
Q 037197 444 DDISLSTSLSFVDISWNHLESYLP-SSILSIPSLQTFMASHNNLQAKIPN-ELQACPSLSVLDLSSNSLS-----GEIPA 516 (1009)
Q Consensus 444 ~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~LdLs~N~l~-----~~~p~ 516 (1009)
.. ..+++.|++++|++++... ..+..+++|+.|++++|++++..+. .+..+++|+.|+|++|.++ +..|.
T Consensus 398 ~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~ 474 (844)
T 3j0a_A 398 KI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474 (844)
T ss_dssp CC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSS
T ss_pred cc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchh
Confidence 54 5689999999999998533 2356899999999999999976543 4667899999999999997 45567
Q ss_pred cccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCCCCcccccC
Q 037197 517 SIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNIN 596 (1009)
Q Consensus 517 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~~~~ 596 (1009)
.|..+++|+.|+|++|+|++.+|..|..+++|+.|||++|+|++.+|..+. ++|+.|||++|+|+|.+|.. |..+.
T Consensus 475 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~ 550 (844)
T 3j0a_A 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLS 550 (844)
T ss_dssp CSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCC
T ss_pred hhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcC
Confidence 788999999999999999999999999999999999999999998888876 89999999999999999964 66777
Q ss_pred CcccccCcCCCCCCC
Q 037197 597 PNELIGNAGLCGSVL 611 (1009)
Q Consensus 597 ~~~~~~n~~lcg~~~ 611 (1009)
...+.+||..|.+++
T Consensus 551 ~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 551 VLDITHNKFICECEL 565 (844)
T ss_dssp EEEEEEECCCCSSSC
T ss_pred EEEecCCCccccccc
Confidence 778899999996653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=552.43 Aligned_cols=512 Identities=20% Similarity=0.202 Sum_probs=439.8
Q ss_pred CceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEec
Q 037197 66 GFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNA 145 (1009)
Q Consensus 66 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 145 (1009)
..++.|+|++|.+++..+..+.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..++++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 45889999999998887778999999999999999998888888999999999999999998888889999999999999
Q ss_pred CCCCCCCCCCccccCCCCCCeeeccCCccCC-cCCccccCccccceeeeccccccccCCccCCCCcchh----hhhcccc
Q 037197 146 SSNNFSGFLPEDLGNATSLESLDFRGSFFEG-SVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLE----TIILGYN 220 (1009)
Q Consensus 146 s~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~----~L~L~~n 220 (1009)
++|++++..+..++++++|++|++++|.+.+ .+|..|+++++|++|+|++|++++..|..++.+++|+ +|++++|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 9999987777889999999999999999886 5688899999999999999999988888888887776 6899999
Q ss_pred cccccCCccccCCCCccEEEeccCccc-cccCcccCCCCCCcEEEcccCCcCCC------CCccccccc--ccccccc-c
Q 037197 221 AFEGEIPAEFGNLTNLRYLDLAVGSLS-GQIPPALGRLKKLTTVYLYKNNFTGK------IPPELGSIT--SLAFLDL-S 290 (1009)
Q Consensus 221 ~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~------~~~~~~~l~--~L~~L~L-s 290 (1009)
.+++..+..+... +|++|++++|.++ +..|..+++++.|+.+++..+.+.+. .+..+..+. +++.+++ .
T Consensus 192 ~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 270 (606)
T 3vq2_A 192 PIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270 (606)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECC
T ss_pred CcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccc
Confidence 9986666666555 8999999999886 45677788889999888876554421 111122222 4556666 6
Q ss_pred ccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccC
Q 037197 291 DNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEI 370 (1009)
Q Consensus 291 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~ 370 (1009)
.|.+.+.+|. +..+++|+.|++++|.++.. | .+..+++|+.|++++|.+ +.+| .+ .++.|+.|++++|...+..
T Consensus 271 ~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l-~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~ 344 (606)
T 3vq2_A 271 TNDFSDDIVK-FHCLANVSAMSLAGVSIKYL-E-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF 344 (606)
T ss_dssp CTTCCGGGGS-CGGGTTCSEEEEESCCCCCC-C-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC
T ss_pred cccccccccc-cccCCCCCEEEecCccchhh-h-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch
Confidence 7788877777 89999999999999999765 4 788999999999999999 6777 44 8899999999999665444
Q ss_pred CcCccCCCCCceeeccccccccc--CCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCC-cCCc
Q 037197 371 PTGLCDSGNLTKLILFNNSFSGT--FPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIP-DDIS 447 (1009)
Q Consensus 371 ~~~l~~l~~L~~L~l~~N~l~~~--~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~ 447 (1009)
.+..+++|++|++++|++++. .|..+..+++|++|++++|.+++ +|..+..+++|+.|++++|++++..| ..+.
T Consensus 345 --~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 421 (606)
T 3vq2_A 345 --KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFL 421 (606)
T ss_dssp --CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTT
T ss_pred --hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhh
Confidence 667889999999999999876 48888999999999999999984 66889999999999999999998877 6889
Q ss_pred CCCCCcEEecccCcccccCCCcccCCcccchhccccCcccC-CcccccccCCcCcEEEeecCCCCCCCCcccccccccee
Q 037197 448 LSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQA-KIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVS 526 (1009)
Q Consensus 448 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~ 526 (1009)
.+++|+.|++++|++++..|..+..+++|++|++++|++++ .+|..++.+++|+.|+|++|++++..|..|..+++|++
T Consensus 422 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 501 (606)
T 3vq2_A 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501 (606)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred ccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCE
Confidence 99999999999999999999999999999999999999998 47889999999999999999999999999999999999
Q ss_pred eeecCcccccCCCcccccccccceecCCccccccccCcCcCCCC-CCcEEecCCCccccCCCC
Q 037197 527 LNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASP-ALEMLNLSYNKLEGPVPS 588 (1009)
Q Consensus 527 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~g~ip~ 588 (1009)
|+|++|++++.+|..+..+++|+.|||++|+|+ .+|..+..++ +|++|++++|++.+..|.
T Consensus 502 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp EECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred EECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 999999999988999999999999999999998 6777788887 599999999999987764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-56 Score=538.22 Aligned_cols=487 Identities=20% Similarity=0.203 Sum_probs=436.1
Q ss_pred CceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEec
Q 037197 66 GFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNA 145 (1009)
Q Consensus 66 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 145 (1009)
..++.|+|++|.+++..+..+.++++|++|+|++|.+++..|..|+++++|++|+|++|.+.+..|..++++++|++|+|
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 46899999999999988889999999999999999999999999999999999999999999888889999999999999
Q ss_pred CCCCCCC-CCCccccCCCCCCeeeccCCccCCcCCccccCccccc----eeeeccccccccCCccCCCCcchhhhhcccc
Q 037197 146 SSNNFSG-FLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLK----FLGLSGNNLTGKIPPELGQLSSLETIILGYN 220 (1009)
Q Consensus 146 s~n~l~~-~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~----~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 220 (1009)
++|.+.+ .+|..++++++|++|++++|.+++..|..|+.+++|+ +|++++|.+++..+..+... +|++|++++|
T Consensus 136 ~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n 214 (606)
T 3vq2_A 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGN 214 (606)
T ss_dssp CSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESC
T ss_pred CCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCC
Confidence 9999986 6799999999999999999999998898898888776 79999999996666655554 9999999999
Q ss_pred ccc-ccCCccccCCCCccEEEeccCccccc------cCcccCCCC--CCcEEEc-ccCCcCCCCCccccccccccccccc
Q 037197 221 AFE-GEIPAEFGNLTNLRYLDLAVGSLSGQ------IPPALGRLK--KLTTVYL-YKNNFTGKIPPELGSITSLAFLDLS 290 (1009)
Q Consensus 221 ~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~------~~~~l~~l~--~L~~L~L-~~n~l~~~~~~~~~~l~~L~~L~Ls 290 (1009)
.++ +..|..++++++|+.+++..+.+.+. .+..+..+. .++.+++ ..|.+.+.+|. +..+++|+.|+++
T Consensus 215 ~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~ 293 (606)
T 3vq2_A 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLA 293 (606)
T ss_dssp CSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEE
T ss_pred ccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEec
Confidence 987 46788899999999999876554421 112223322 4667777 77888888887 8999999999999
Q ss_pred ccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCcccccc-
Q 037197 291 DNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGE- 369 (1009)
Q Consensus 291 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~- 369 (1009)
+|.+. .+| .+..+++|+.|++++|++ +.+| .+ .+++|+.|++++|...+.. .+..+++|++|++++|.+++.
T Consensus 294 ~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~ 366 (606)
T 3vq2_A 294 GVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSG 366 (606)
T ss_dssp SCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEE
T ss_pred Cccch-hhh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCc
Confidence 99997 566 889999999999999999 5667 45 9999999999999766544 677899999999999999876
Q ss_pred -CCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccC-CccCCCCcccEEEeecccccccCCcCCc
Q 037197 370 -IPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIP-VGLGNLPSLQRLEMANNNLTGQIPDDIS 447 (1009)
Q Consensus 370 -~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 447 (1009)
.|..+..+++|++|++++|.+++ +|..+..+++|+.|++++|++.+..| ..+..+++|++|++++|++++..|..+.
T Consensus 367 ~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 445 (606)
T 3vq2_A 367 CCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445 (606)
T ss_dssp ECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred chhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhc
Confidence 38888999999999999999985 56899999999999999999998888 6899999999999999999999999999
Q ss_pred CCCCCcEEecccCcccc-cCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCcccccccccee
Q 037197 448 LSTSLSFVDISWNHLES-YLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVS 526 (1009)
Q Consensus 448 ~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~ 526 (1009)
.+++|+.|++++|++++ .+|..|..+++|+.|++++|++++..|..|..+++|+.|+|++|++++.+|..|..+++|+.
T Consensus 446 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 525 (606)
T 3vq2_A 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525 (606)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCE
T ss_pred CCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCE
Confidence 99999999999999998 57999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeecCcccccCCCccccccc-ccceecCCccccccccC
Q 037197 527 LNLRNNRFSGEIPKAVATMP-TLAILDMSNNSLFGRIP 563 (1009)
Q Consensus 527 L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p 563 (1009)
|+|++|+|+ .+|..+..++ +|+.|++++|++.+..+
T Consensus 526 L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 526 LDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp EECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred EECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 999999999 7888899997 59999999999987555
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=507.24 Aligned_cols=492 Identities=18% Similarity=0.176 Sum_probs=390.3
Q ss_pred CCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeec
Q 037197 90 RSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDF 169 (1009)
Q Consensus 90 ~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 169 (1009)
+++++|+|++|.+++..+.+|.++++|++|||++|++++..|..++++++|++|+|++|++++..|..|+++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 46777888888887777777888888888888888777766677778888888888888887766777888888888888
Q ss_pred cCCccCCcCCccccCccccceeeeccccccc-cCCccCCCCcchhhhhcccccccccCCccccCCCCc----cEEEeccC
Q 037197 170 RGSFFEGSVPTSFRNLQKLKFLGLSGNNLTG-KIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNL----RYLDLAVG 244 (1009)
Q Consensus 170 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~~n 244 (1009)
++|.+++..+..|+++++|++|++++|.+++ .+|..|+++++|++|++++|++++..+..|+.+++| ++|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 8888776555567788888888888887775 357778888888888888888877777777777777 77888888
Q ss_pred ccccccCcccCCCCCCcEEEcccCCcCC-CCCcccccccccccccccccccC------CCcchhhhccc--CCCeEeccc
Q 037197 245 SLSGQIPPALGRLKKLTTVYLYKNNFTG-KIPPELGSITSLAFLDLSDNQIS------GEIPVKLAELK--NLQLLNLMC 315 (1009)
Q Consensus 245 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~------~~~~~~l~~l~--~L~~L~L~~ 315 (1009)
.+++..+..+..+ +|+.|++++|.... .++..+..++.++.+.+..+.+. ......+..+. .++.+++++
T Consensus 188 ~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 8877777776655 68888887774432 12334445555555554433222 11122333333 256677777
Q ss_pred c-ccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccC
Q 037197 316 N-QLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTF 394 (1009)
Q Consensus 316 N-~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 394 (1009)
| .+.+..+..+..+++|+.|++++|.+. .+|..+..+ .|+.|++++|.+. .+|. ..+++|+.|++++|.+.+..
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~ 341 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAF 341 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBC
T ss_pred chhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccc
Confidence 7 777777888888888888888888877 467777777 8888888888887 5554 46778899999998887766
Q ss_pred CcccccCccccEEEcccCcccccc--CCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCC-Cccc
Q 037197 395 PVSLSTCKSLVRVRVQNNLISGTI--PVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLP-SSIL 471 (1009)
Q Consensus 395 p~~l~~~~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~ 471 (1009)
+. ..+++|++|++++|++++.. |..+..+++|++|++++|++++..+. +..+++|+.|++++|++++..+ ..+.
T Consensus 342 ~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~ 418 (570)
T 2z63_A 342 SE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFL 418 (570)
T ss_dssp CC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTT
T ss_pred cc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhh
Confidence 55 77889999999999988654 67788899999999999999865554 8889999999999999988766 5788
Q ss_pred CCcccchhccccCcccCCcccccccCCcCcEEEeecCCCC-CCCCccccccccceeeeecCcccccCCCcccccccccce
Q 037197 472 SIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLS-GEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAI 550 (1009)
Q Consensus 472 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 550 (1009)
.+++|+.|++++|.+.+..|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+|++|++++..|..|..+++|+.
T Consensus 419 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 498 (570)
T 2z63_A 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498 (570)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCE
Confidence 9999999999999999989999999999999999999998 578999999999999999999999988999999999999
Q ss_pred ecCCccccccccCcCcCCCCCCcEEecCCCccccCCCCCC
Q 037197 551 LDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNG 590 (1009)
Q Consensus 551 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 590 (1009)
|+|++|++++.+|..|..+++|+.|++++|+++|.+|...
T Consensus 499 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred EeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence 9999999999999999999999999999999999998743
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=496.24 Aligned_cols=493 Identities=19% Similarity=0.248 Sum_probs=376.0
Q ss_pred CceeeeEEeCCCCceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCC
Q 037197 54 HCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTG 133 (1009)
Q Consensus 54 ~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~ 133 (1009)
.|.|.|| |+. ++++++ .+|+.+. ++|++|+|++|.+++..|..++++++|++|+|++|++++..|..
T Consensus 3 ~C~~~~~-c~~---------~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~ 69 (549)
T 2z81_A 3 SCDASGV-CDG---------RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69 (549)
T ss_dssp EECTTSE-EEC---------TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTT
T ss_pred cCCCCce-EEC---------CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhh
Confidence 4999998 854 445555 3555543 78999999999999988999999999999999999999888899
Q ss_pred CCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCC-cCCccccCccccceeeeccccccccCC-ccCCCCcc
Q 037197 134 LGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEG-SVPTSFRNLQKLKFLGLSGNNLTGKIP-PELGQLSS 211 (1009)
Q Consensus 134 l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~ 211 (1009)
++.+++|++|+|++|++++..|..++++++|++|++++|.+++ ..|..++++++|++|++++|.+.+.+| ..|+++++
T Consensus 70 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~ 149 (549)
T 2z81_A 70 FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS 149 (549)
T ss_dssp TTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCE
T ss_pred ccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccc
Confidence 9999999999999999998888889999999999999999987 357789999999999999998544554 68999999
Q ss_pred hhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCC--C-ccccccccccccc
Q 037197 212 LETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKI--P-PELGSITSLAFLD 288 (1009)
Q Consensus 212 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~--~-~~~~~l~~L~~L~ 288 (1009)
|++|++++|++++..|..++++++|++|+++.|.+.......+..+++|++|++++|++++.. | .....+++|+.|+
T Consensus 150 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~ 229 (549)
T 2z81_A 150 LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229 (549)
T ss_dssp EEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEE
T ss_pred cCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhccccee
Confidence 999999999999999999999999999999999987443333467899999999999998742 2 2234578899999
Q ss_pred ccccccCCCcchh----hhcccCCCeEeccccccCCCC------CcCCCCCCcccEEEccCCccCccCCccccCCCCCce
Q 037197 289 LSDNQISGEIPVK----LAELKNLQLLNLMCNQLTGLI------PDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRR 358 (1009)
Q Consensus 289 Ls~N~l~~~~~~~----l~~l~~L~~L~L~~N~l~~~~------~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~ 358 (1009)
+++|.+++..+.. +..+++|+.|++++|.+.+.. ...+..+.+|+.|++.++.+..... +.
T Consensus 230 l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~--~~------- 300 (549)
T 2z81_A 230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL--FY------- 300 (549)
T ss_dssp EESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGG--SC-------
T ss_pred ccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhh--cc-------
Confidence 9999988655543 356788999999999887642 1234556677777777665532110 00
Q ss_pred eeccCccccccCCcCccCCCCCceeecccccccccCCccc-ccCccccEEEcccCccccccC---CccCCCCcccEEEee
Q 037197 359 LDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSL-STCKSLVRVRVQNNLISGTIP---VGLGNLPSLQRLEMA 434 (1009)
Q Consensus 359 L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l-~~~~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~ 434 (1009)
..+..+...++|+.|++++|.+. .+|..+ ..+++|++|++++|++++.+| ..++.+++|++|+|+
T Consensus 301 ----------~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls 369 (549)
T 2z81_A 301 ----------DLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369 (549)
T ss_dssp ----------CCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECT
T ss_pred ----------cchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEcc
Confidence 01111122345666666666665 344443 456666666666666665543 335666677777777
Q ss_pred cccccccCC--cCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCC
Q 037197 435 NNNLTGQIP--DDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSG 512 (1009)
Q Consensus 435 ~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~ 512 (1009)
+|++++..+ ..+..+++|++|++++|++++ +|..+..+++|+.|++++|+++. +|..+ .++|+.|||++|+|++
T Consensus 370 ~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~ 445 (549)
T 2z81_A 370 QNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDS 445 (549)
T ss_dssp TSCCCCHHHHHHHGGGCTTCCEEECTTCCCCC-CCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSC
T ss_pred CCcccccccchhhhhcCCCCCEEECCCCCCcc-CChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhh
Confidence 777664322 345666777777777777764 55666667777777777777663 33333 2588999999999986
Q ss_pred CCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCCC
Q 037197 513 EIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSN 589 (1009)
Q Consensus 513 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 589 (1009)
.+ ..+++|++|+|++|+|+ .+|. ...+++|+.|||++|++++.+|..|..+++|+.|++++|+++|.+|..
T Consensus 446 ~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 516 (549)
T 2z81_A 446 FS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 516 (549)
T ss_dssp CC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHH
T ss_pred hc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccH
Confidence 53 46889999999999998 6776 567999999999999999999999999999999999999999998853
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-52 Score=502.82 Aligned_cols=451 Identities=20% Similarity=0.338 Sum_probs=377.1
Q ss_pred CccCcccccccccCCCCCCCCCCCcCCeEEecCCCCC------CC------CCCccccCCCCCCeeeccCCccCCcCCcc
Q 037197 114 TALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNF------SG------FLPEDLGNATSLESLDFRGSFFEGSVPTS 181 (1009)
Q Consensus 114 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l------~~------~~p~~l~~l~~L~~L~L~~n~~~~~~p~~ 181 (1009)
.+++.|+|++|++.|.+|.+++++++|++|+|++|.+ .+ .+|... +..|+ +++++|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 4677788888888877887788888888888887765 22 233332 34444 555556555555554
Q ss_pred ccC-ccccceeeeccccccccCCccCCCCcchhhhhcc--cccccccCCccccCCCCccEEEeccCccccc---------
Q 037197 182 FRN-LQKLKFLGLSGNNLTGKIPPELGQLSSLETIILG--YNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQ--------- 249 (1009)
Q Consensus 182 ~~~-l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--------- 249 (1009)
+.. +.++..+++....+. ......++.+.++ .|++++ +|.+|+++++|++|+|++|++++.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~------~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~ 230 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIK------KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE 230 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCC------CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT
T ss_pred HHHHHHHHhhcCccccccc------cccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccc
Confidence 442 233333333332222 1122334444443 689998 899999999999999999999986
Q ss_pred --------cCcccC--CCCCCcEEEcccCCcCCCCCcccccccccccccccccc-cCC-Ccchhhhcc------cCCCeE
Q 037197 250 --------IPPALG--RLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQ-ISG-EIPVKLAEL------KNLQLL 311 (1009)
Q Consensus 250 --------~~~~l~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~~~~l~~l------~~L~~L 311 (1009)
+|..++ ++++|++|+|++|.+.+.+|..++++++|++|+|++|+ +++ .+|..++.+ ++|++|
T Consensus 231 ~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L 310 (636)
T 4eco_A 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310 (636)
T ss_dssp TSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEE
T ss_pred ccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEE
Confidence 999999 99999999999999999999999999999999999998 998 899988887 999999
Q ss_pred eccccccCCCCCc--CCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCC-Cceeecccc
Q 037197 312 NLMCNQLTGLIPD--KLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGN-LTKLILFNN 388 (1009)
Q Consensus 312 ~L~~N~l~~~~~~--~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~-L~~L~l~~N 388 (1009)
++++|+++ .+|. .++++++|+.|++++|.++|.+| .++.+++|+.|++++|.++ .+|..+..+++ |+.|++++|
T Consensus 311 ~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N 387 (636)
T 4eco_A 311 YIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHN 387 (636)
T ss_dssp ECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSS
T ss_pred ECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCC
Confidence 99999999 6787 89999999999999999999999 8999999999999999999 88899999999 999999999
Q ss_pred cccccCCcccccCc--cccEEEcccCccccccCCccC-------CCCcccEEEeecccccccCCcC-CcCCCCCcEEecc
Q 037197 389 SFSGTFPVSLSTCK--SLVRVRVQNNLISGTIPVGLG-------NLPSLQRLEMANNNLTGQIPDD-ISLSTSLSFVDIS 458 (1009)
Q Consensus 389 ~l~~~~p~~l~~~~--~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls 458 (1009)
+++ .+|..+..++ +|+.|++++|++++.+|..+. .+++|++|+|++|+++ .+|.. +..+++|+.|+|+
T Consensus 388 ~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls 465 (636)
T 4eco_A 388 KLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLM 465 (636)
T ss_dssp CCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECC
T ss_pred cCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECC
Confidence 999 7888887765 899999999999999999888 8889999999999999 45544 5568999999999
Q ss_pred cCcccccCCCcccCCc-------ccchhccccCcccCCcccccc--cCCcCcEEEeecCCCCCCCCccccccccceeeee
Q 037197 459 WNHLESYLPSSILSIP-------SLQTFMASHNNLQAKIPNELQ--ACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNL 529 (1009)
Q Consensus 459 ~N~l~~~~~~~~~~l~-------~L~~L~l~~N~l~~~~p~~~~--~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~L 529 (1009)
+|+++.+.+..+.... +|+.|++++|+++ .+|..+. .+++|+.|||++|++++ +|..+..+++|+.|+|
T Consensus 466 ~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~L 543 (636)
T 4eco_A 466 GNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543 (636)
T ss_dssp SSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEEC
T ss_pred CCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEEC
Confidence 9999965555544333 9999999999999 6888887 99999999999999997 8999999999999999
Q ss_pred ------cCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCcccc
Q 037197 530 ------RNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEG 584 (1009)
Q Consensus 530 ------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 584 (1009)
++|++.+.+|..++.+++|+.|||++|++ +.+|..+. +.|+.|||++|++..
T Consensus 544 s~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 544 RNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp CSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred CCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence 56889999999999999999999999999 78898876 799999999998764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=490.26 Aligned_cols=490 Identities=20% Similarity=0.189 Sum_probs=434.4
Q ss_pred CceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEec
Q 037197 66 GFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNA 145 (1009)
Q Consensus 66 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 145 (1009)
..++.|||++|.+++..+..+.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..++.+++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 46899999999999888889999999999999999999988899999999999999999999888899999999999999
Q ss_pred CCCCCCCCCCccccCCCCCCeeeccCCccCC-cCCccccCccccceeeeccccccccCCccCCCCcch----hhhhcccc
Q 037197 146 SSNNFSGFLPEDLGNATSLESLDFRGSFFEG-SVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSL----ETIILGYN 220 (1009)
Q Consensus 146 s~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L----~~L~L~~n 220 (1009)
++|++++..+..++++++|++|++++|.+.+ .+|..|+++++|++|++++|.+++..|..++.+++| ++|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 9999997666679999999999999999987 479999999999999999999998888889999888 88999999
Q ss_pred cccccCCccccCCCCccEEEeccCcccc-ccCcccCCCCCCcEEEcccCCc------CCCCCccccccc--ccccccccc
Q 037197 221 AFEGEIPAEFGNLTNLRYLDLAVGSLSG-QIPPALGRLKKLTTVYLYKNNF------TGKIPPELGSIT--SLAFLDLSD 291 (1009)
Q Consensus 221 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l------~~~~~~~~~~l~--~L~~L~Ls~ 291 (1009)
.+++..|..|..+ +|++|++++|.... .++..+..+++++.+.+..+.+ .......+..+. .++.+++++
T Consensus 188 ~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 9998888888877 89999999986442 3456677788888777654322 222223333333 356788888
Q ss_pred c-ccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccC
Q 037197 292 N-QISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEI 370 (1009)
Q Consensus 292 N-~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~ 370 (1009)
| .+.+..|..+..+++|+.|++++|.+++ +|..+..+ +|+.|++++|.+. .+|. ..+++|+.|++++|.+.+..
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~ 341 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAF 341 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBC
T ss_pred chhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccc
Confidence 8 7888889999999999999999999995 67788888 9999999999998 4444 57889999999999998766
Q ss_pred CcCccCCCCCceeecccccccccC--CcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCC-cCCc
Q 037197 371 PTGLCDSGNLTKLILFNNSFSGTF--PVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIP-DDIS 447 (1009)
Q Consensus 371 ~~~l~~l~~L~~L~l~~N~l~~~~--p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~ 447 (1009)
+. ..+++|+.|++++|++++.. |..+.++++|++|++++|.+.+..+. +..+++|+.|++++|++++..| ..+.
T Consensus 342 ~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~ 418 (570)
T 2z63_A 342 SE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFL 418 (570)
T ss_dssp CC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTT
T ss_pred cc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhh
Confidence 65 67899999999999998764 77889999999999999999965554 9999999999999999998766 5788
Q ss_pred CCCCCcEEecccCcccccCCCcccCCcccchhccccCccc-CCcccccccCCcCcEEEeecCCCCCCCCcccccccccee
Q 037197 448 LSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQ-AKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVS 526 (1009)
Q Consensus 448 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~ 526 (1009)
.+++|+.|++++|++++..|..|..+++|+.|++++|+++ +.+|..+..+++|+.|||++|++++..|..|..+++|+.
T Consensus 419 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 498 (570)
T 2z63_A 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498 (570)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCE
Confidence 9999999999999999999999999999999999999998 578999999999999999999999999999999999999
Q ss_pred eeecCcccccCCCcccccccccceecCCccccccccCc
Q 037197 527 LNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPE 564 (1009)
Q Consensus 527 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 564 (1009)
|+|++|++++..|..|..+++|+.|++++|++++..|.
T Consensus 499 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred EeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 99999999998888999999999999999999998775
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=486.64 Aligned_cols=478 Identities=21% Similarity=0.225 Sum_probs=317.2
Q ss_pred EecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCcc
Q 037197 95 LNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFF 174 (1009)
Q Consensus 95 L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~ 174 (1009)
.+.+++.++ .+|+.+. ++|++|+|++|++++..|..++++++|++|+|++|++++..|..|+++++|++|+|++|.+
T Consensus 10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 86 (549)
T 2z81_A 10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86 (549)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence 344445543 3344332 4555555555555555555555555555555555555554445555555555555555555
Q ss_pred CCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccC-cc
Q 037197 175 EGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIP-PA 253 (1009)
Q Consensus 175 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~ 253 (1009)
++..|..|+++++|++|+|++|.+++. ..|..|+++++|++|++++|.+.+.+| ..
T Consensus 87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~-----------------------~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~ 143 (549)
T 2z81_A 87 SSLSSSWFGPLSSLKYLNLMGNPYQTL-----------------------GVTSLFPNLTNLQTLRIGNVETFSEIRRID 143 (549)
T ss_dssp CSCCHHHHTTCTTCCEEECTTCCCSSS-----------------------CSSCSCTTCTTCCEEEEEESSSCCEECTTT
T ss_pred CccCHHHhccCCCCcEEECCCCccccc-----------------------chhhhhhccCCccEEECCCCccccccCHhh
Confidence 544444455555555555555555431 123344555555555555554222222 34
Q ss_pred cCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchh-hhcccCCCeEeccccccCCCC---CcCCCCC
Q 037197 254 LGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVK-LAELKNLQLLNLMCNQLTGLI---PDKLGEL 329 (1009)
Q Consensus 254 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-l~~l~~L~~L~L~~N~l~~~~---~~~l~~l 329 (1009)
|+++++|++|++++|.+++..|..+..+++|+.|++++|.+. .+|.. +..+++|++|++++|++++.. ......+
T Consensus 144 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~ 222 (549)
T 2z81_A 144 FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222 (549)
T ss_dssp TTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCC
T ss_pred hhcccccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhh
Confidence 555555555555555555555555555555555555555554 23332 234566666666666665532 1122345
Q ss_pred CcccEEEccCCccCccCCc----cccCCCCCceeeccCccccccC------CcCccCCCCCceeeccccccccc-----C
Q 037197 330 TKLEVLELWKNSLIGSLPM----RLGQSSPLRRLDASSNLLSGEI------PTGLCDSGNLTKLILFNNSFSGT-----F 394 (1009)
Q Consensus 330 ~~L~~L~L~~N~l~~~~~~----~~~~~~~L~~L~Ls~N~l~~~~------~~~l~~l~~L~~L~l~~N~l~~~-----~ 394 (1009)
++|+.|++++|.+++..+. .+..+..|+.+++++|.+.+.. ...+..+++|+.|++.++.+... +
T Consensus 223 ~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l 302 (549)
T 2z81_A 223 SPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL 302 (549)
T ss_dssp CCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCC
T ss_pred hcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccc
Confidence 6666666666666553332 2345566777777777665421 22345677888888888876532 1
Q ss_pred CcccccCccccEEEcccCccccccCCcc-CCCCcccEEEeecccccccCC---cCCcCCCCCcEEecccCcccccCC--C
Q 037197 395 PVSLSTCKSLVRVRVQNNLISGTIPVGL-GNLPSLQRLEMANNNLTGQIP---DDISLSTSLSFVDISWNHLESYLP--S 468 (1009)
Q Consensus 395 p~~l~~~~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~~--~ 468 (1009)
+..+....+|+.|++++|++. .+|..+ ..+++|++|++++|++++.+| ..++.+++|+.|+|++|++++..+ .
T Consensus 303 ~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 381 (549)
T 2z81_A 303 STVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE 381 (549)
T ss_dssp CHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHH
T ss_pred hhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchh
Confidence 222345678999999999998 677666 579999999999999998764 457889999999999999998643 5
Q ss_pred cccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCccccccccc
Q 037197 469 SILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTL 548 (1009)
Q Consensus 469 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 548 (1009)
.+..+++|++|++++|+++ .+|..+..+++|+.|+|++|++++ +|..+ .++|+.|+|++|+|++.+ ..+++|
T Consensus 382 ~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L 453 (549)
T 2z81_A 382 ILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRL 453 (549)
T ss_dssp HGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTC
T ss_pred hhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChh
Confidence 6889999999999999999 578899999999999999999984 45443 268999999999999753 578999
Q ss_pred ceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCCC-CcccccCCcccccCcCCCCCC
Q 037197 549 AILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSN-GILMNINPNELIGNAGLCGSV 610 (1009)
Q Consensus 549 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~lcg~~ 610 (1009)
+.|||++|+|+ .+|. ...+++|++|||++|++++.+|.. ..+..+....+.+|+..|.++
T Consensus 454 ~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 454 QELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred cEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 99999999998 6776 567999999999999999988863 445566667788999988755
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=428.89 Aligned_cols=259 Identities=32% Similarity=0.481 Sum_probs=203.9
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.++..+.||+|+||+||+|++.. .||||+++......+..+.+.+|++++++++|||||+++|++.+ +..++|||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 346678889999999999998764 58999997666666667778899999999999999999999865 46899999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
||++|+|.++++.... .++|.++..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999976532 389999999999999999999998 9999999999999999999999999999876433
Q ss_pred C--CceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 858 N--ETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 858 ~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
. .......||+.|||||++. ...++.++|||||||++|||+||+.||.... ....+...+..+. .
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-----~~~~~~~~~~~~~-----~ 255 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-----NRDQIIFMVGRGY-----A 255 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHHTTC-----C
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-----hHHHHHHHHhcCC-----C
Confidence 2 2344568999999999875 3468999999999999999999999997422 1223333333222 1
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.|.+........ .++.+++.+||+.||++|||+.||++.|+.++
T Consensus 256 ~p~~~~~~~~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 256 SPDLSKLYKNCP---KAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp CCCSTTSCTTSC---HHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred CCCcccccccch---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 222221112222 24567889999999999999999999998775
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=436.77 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=207.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||+||+|++..+|+.||||++.+........+.+.+|++++++++|||||++++++.+++.+|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57899999999999999999999999999999998766666667778899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
||+||+|.++++... ...+++.++..|+.||+.||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999996543 22368888899999999999999999 9999999999999999999999999999876443
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
.......+||+.|||||++.+..|+.++|||||||++|||+||+.||.. .+..+.+........ +.+.
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-----~~~~~~~~~i~~~~~-------~~~~ 246 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-----GSMKNLVLKIISGSF-------PPVS 246 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-----SSHHHHHHHHHHTCC-------CCCC
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-----cCHHHHHHHHHcCCC-------CCCC
Confidence 3344556899999999999999999999999999999999999999973 233333333332221 1111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+ .++.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~s------~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 247 LHYS------YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TTSC------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCC------HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 24567889999999999999999975
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=487.52 Aligned_cols=463 Identities=23% Similarity=0.327 Sum_probs=388.0
Q ss_pred CCCCeEecccCcccccCCccccccCccCcccc-cccccCCCCCCCCCCC----cCC--eEEe----------cCCCCCCC
Q 037197 90 RSLSSLNICCNEFASSLPKSLANLTALKSMDV-SQNNFIGSFPTGLGKA----SGL--TSVN----------ASSNNFSG 152 (1009)
Q Consensus 90 ~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~L-s~n~l~~~~p~~l~~l----~~L--~~L~----------Ls~n~l~~ 152 (1009)
.+++.|+|++|.+.|.+|++|++|++|++||| ++|.+.|..|-..... +.+ +.+. .....+++
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 46889999999999999999999999999999 8898887754321111 000 0000 00001110
Q ss_pred -----------CCCccccCCCCCCeeeccC--CccCCcCCccccCccccceeeeccccccc-----------------cC
Q 037197 153 -----------FLPEDLGNATSLESLDFRG--SFFEGSVPTSFRNLQKLKFLGLSGNNLTG-----------------KI 202 (1009)
Q Consensus 153 -----------~~p~~l~~l~~L~~L~L~~--n~~~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~ 202 (1009)
..+........++.+.+.. |.+++ +|..|+++++|++|+|++|.+++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 0111112334556666655 88988 89999999999999999999998 39
Q ss_pred CccCC--CCcchhhhhcccccccccCCccccCCCCccEEEeccCc-ccc-ccCcccCCC-------CCCcEEEcccCCcC
Q 037197 203 PPELG--QLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGS-LSG-QIPPALGRL-------KKLTTVYLYKNNFT 271 (1009)
Q Consensus 203 p~~l~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~l~~l-------~~L~~L~L~~n~l~ 271 (1009)
|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..++++ ++|+.|+|++|.++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 99988 99999999999999999999999999999999999998 998 788766555 49999999999999
Q ss_pred CCCCc--ccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCc-ccEEEccCCccCccCCc
Q 037197 272 GKIPP--ELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTK-LEVLELWKNSLIGSLPM 348 (1009)
Q Consensus 272 ~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~ 348 (1009)
.+|. .+.++++|+.|+|++|+++ .+| .+..+++|+.|+|++|+++ .+|..+.++++ |+.|+|++|.++ .+|.
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence 8888 8999999999999999999 888 8999999999999999999 77888999999 999999999998 7788
Q ss_pred cccCCCC--CceeeccCccccccCCcCcc-----CCCCCceeecccccccccCCcc-cccCccccEEEcccCccccccCC
Q 037197 349 RLGQSSP--LRRLDASSNLLSGEIPTGLC-----DSGNLTKLILFNNSFSGTFPVS-LSTCKSLVRVRVQNNLISGTIPV 420 (1009)
Q Consensus 349 ~~~~~~~--L~~L~Ls~N~l~~~~~~~l~-----~l~~L~~L~l~~N~l~~~~p~~-l~~~~~L~~L~L~~N~l~~~~p~ 420 (1009)
.+..... |+.|++++|.+.+.+|...+ .+.+|+.|++++|+++. +|.. +..+++|+.|+|++|+++ .+|.
T Consensus 637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~-lp~~~~~~l~~L~~L~Ls~N~L~-~ip~ 714 (876)
T 4ecn_A 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMT-SIPE 714 (876)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCS-CCHHHHHTTCCCSEEECCSCCCS-CCCT
T ss_pred hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCc-cCHHHHccCCCCCEEECCCCcCC-ccCh
Confidence 8877765 99999999999987764332 34589999999999994 5554 458999999999999999 6666
Q ss_pred ccCC--------CCcccEEEeecccccccCCcCCc--CCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCc
Q 037197 421 GLGN--------LPSLQRLEMANNNLTGQIPDDIS--LSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKI 490 (1009)
Q Consensus 421 ~~~~--------l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 490 (1009)
.+.. +++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|++++|+
T Consensus 715 ~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~----- 787 (876)
T 4ecn_A 715 NSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR----- 787 (876)
T ss_dssp TSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB-----
T ss_pred HHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC-----
Confidence 5443 339999999999999 7888887 89999999999999998 67788888888888888886
Q ss_pred ccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCC
Q 037197 491 PNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASP 570 (1009)
Q Consensus 491 p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 570 (1009)
++++|++.+.+|..|.++++|+.|+|++|+| +.+|..+. ++|+.|||++|++....+..+....
T Consensus 788 -------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~ 851 (876)
T 4ecn_A 788 -------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYI 851 (876)
T ss_dssp -------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHH
T ss_pred -------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccc
Confidence 6788999999999999999999999999999 69999876 6999999999999988888887777
Q ss_pred CCcEEecCCCccc
Q 037197 571 ALEMLNLSYNKLE 583 (1009)
Q Consensus 571 ~L~~L~ls~N~l~ 583 (1009)
.+..+.|++|++.
T Consensus 852 ~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 852 EAGMYVLLYDKTQ 864 (876)
T ss_dssp HTTCCEEECCTTS
T ss_pred cchheeecCCCcc
Confidence 7888899998765
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=474.79 Aligned_cols=458 Identities=19% Similarity=0.200 Sum_probs=314.4
Q ss_pred CeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCC
Q 037197 93 SSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGS 172 (1009)
Q Consensus 93 ~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n 172 (1009)
++|++++|.++ .+|..+. ++|++|+|++|.+.+..|..++++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 45777777776 4565555 67777777777777666666777777777777777777666677777777777777777
Q ss_pred ccCCcCCccccCccccceeeeccccccc-cCCccCCCCcchhhhhcccccccccCCccccCCCCc--cEEEeccCcc--c
Q 037197 173 FFEGSVPTSFRNLQKLKFLGLSGNNLTG-KIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNL--RYLDLAVGSL--S 247 (1009)
Q Consensus 173 ~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~ 247 (1009)
.++ .+|.. .+++|++|+|++|.+++ .+|..|+++++|++|++++|++++ ..++.+++| ++|++++|.+ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 776 44544 66777777777777765 356667777777777777777664 345555555 7777777766 5
Q ss_pred cccCcccCCCC-CCcEEEcccCCcCCCCCc-ccccccccccccccccc-------cCCCcchhhhcccCCCeEecccccc
Q 037197 248 GQIPPALGRLK-KLTTVYLYKNNFTGKIPP-ELGSITSLAFLDLSDNQ-------ISGEIPVKLAELKNLQLLNLMCNQL 318 (1009)
Q Consensus 248 ~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~-------l~~~~~~~l~~l~~L~~L~L~~N~l 318 (1009)
+..|..+..+. +...+++++|.+.+.++. .+..+++|+.|++++|. +.+.+| .+..+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 56666665554 233455666666554433 34556666666666665 444333 455556666666665555
Q ss_pred CCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCc-----cCCCCCceeeccccccccc
Q 037197 319 TGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGL-----CDSGNLTKLILFNNSFSGT 393 (1009)
Q Consensus 319 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l-----~~l~~L~~L~l~~N~l~~~ 393 (1009)
++..+..+ .+ . ...++|+.|++++|.+++.+|..+ ..+++|+.+++++|.+ .
T Consensus 233 ~~~~~~~~-------------------~~-~-~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~ 289 (520)
T 2z7x_B 233 TWNSFIRI-------------------LQ-L-VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--G 289 (520)
T ss_dssp EHHHHHHH-------------------HH-H-HHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--C
T ss_pred CHHHHHHH-------------------HH-H-hhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--e
Confidence 43211100 00 0 012345555555555555555555 5566666666666666 3
Q ss_pred CC-cccccC---ccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccc--cCC
Q 037197 394 FP-VSLSTC---KSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLES--YLP 467 (1009)
Q Consensus 394 ~p-~~l~~~---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~ 467 (1009)
+| ..+..+ .+|+.|++++|.+.... .+..+++|++|++++|++++.+|..+..+++|+.|++++|++++ .+|
T Consensus 290 ~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~ 367 (520)
T 2z7x_B 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIA 367 (520)
T ss_dssp SCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHH
T ss_pred cchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccch
Confidence 33 334333 56777777777775322 12567788888888888887778888888888888888888886 345
Q ss_pred CcccCCcccchhccccCcccCCccc-ccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCccccccc
Q 037197 468 SSILSIPSLQTFMASHNNLQAKIPN-ELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMP 546 (1009)
Q Consensus 468 ~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 546 (1009)
..+..+++|+.|++++|++++.+|. .+..+++|+.|+|++|++++..|..+. ++|+.|+|++|+|+ .+|..+..++
T Consensus 368 ~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~ 444 (520)
T 2z7x_B 368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLE 444 (520)
T ss_dssp HHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCT
T ss_pred HHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCC
Confidence 6778888888888888888875555 478889999999999999888887764 78999999999998 8898888999
Q ss_pred ccceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCC
Q 037197 547 TLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPS 588 (1009)
Q Consensus 547 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~ 588 (1009)
+|+.|||++|+|++..+..|..+++|++|++++|++++..|.
T Consensus 445 ~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 445 ALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 999999999999954444489999999999999999987663
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=430.99 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=208.3
Q ss_pred hcCCcCceeccCCceEEEEEEEC-----CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNV 772 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 772 (1009)
+.|...+.||+|+||+||+|++. .+++.||||+++.. .....+++.+|++++++++|||||+++|+|.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 35677889999999999999875 35789999999643 344556778999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhcCCc---------cccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcE
Q 037197 773 MMVYDYMPNDSLGEALHGKE---------AGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEA 843 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 843 (1009)
++|||||++|+|.++++... .....++|.+++.|+.||++||+|||++ +||||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997643 1233589999999999999999999998 99999999999999999999
Q ss_pred EEcccccceecccCCCce--eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHH
Q 037197 844 RIADFGLARMMLHKNETV--SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLS 920 (1009)
Q Consensus 844 kl~DfGls~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 920 (1009)
||+|||+|+......... ....||+.|||||++.+..++.++|||||||++|||+| |+.||... ...+ +..
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~-----~~~~-~~~ 241 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-----SNNE-VIE 241 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHH-HHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----CHHH-HHH
Confidence 999999998764433222 23568999999999999999999999999999999999 89999742 1222 222
Q ss_pred HHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 921 MIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.+..+.. +.....++ .++.+++.+||+.||++|||++|+++.|+++.
T Consensus 242 ~i~~~~~------~~~p~~~~------~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 242 CITQGRV------LQRPRTCP------QEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHHTCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCCC------CCCCccch------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2333321 11122222 24667899999999999999999999998874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=431.56 Aligned_cols=258 Identities=28% Similarity=0.405 Sum_probs=203.4
Q ss_pred cCCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.|...+.||+|+||+||+|+++. +++.||||+++.. .....+++.+|++++++++|||||+++|+|.+++..+
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35566789999999999998753 5789999999643 3445567889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccc-----------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc
Q 037197 774 MVYDYMPNDSLGEALHGKEAG-----------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE 842 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 842 (1009)
+|||||++|+|.++++..... ...++|.+++.|+.|||+||+|||+. +||||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 999999999999999765321 23589999999999999999999998 9999999999999999999
Q ss_pred EEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHH
Q 037197 843 ARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVL 919 (1009)
Q Consensus 843 ~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 919 (1009)
+||+|||+|+.....+. ......||+.|||||++.+..++.++|||||||++|||+| |+.||... ...+.+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~-----~~~~~~- 270 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL-----SNTEAI- 270 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS-----CHHHHH-
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC-----CHHHHH-
Confidence 99999999987644332 2344679999999999999999999999999999999999 89999742 122222
Q ss_pred HHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 920 SMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
..+..+.. +.....++ .++.+++.+||+.||++|||++||++.|+.+.
T Consensus 271 ~~i~~g~~------~~~p~~~~------~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 271 DCITQGRE------LERPRACP------PEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHHHTCC------CCCCTTCC------HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHcCCC------CCCccccc------HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 22333221 11222222 24567889999999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=431.76 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=207.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|++++++++|||||+++++|.+++.+|+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 457888899999999999999999999999999965432 234567799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
||++|+|.++++... +++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 152 y~~gg~L~~~l~~~~-----l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 152 FLEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CCTTEEHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCCcHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 999999999996532 78999999999999999999999 9999999999999999999999999999987665
Q ss_pred CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||... +..+.+. .+.... .+.+.
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~-~i~~~~------~~~~~ 291 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPLKAMK-MIRDNL------PPRLK 291 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHH-HHHHSS------CCCCS
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHH-HHHcCC------CCCCC
Confidence 55566788999999999999999999999999999999999999999732 2222222 222221 11111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...... .++.+++.+||+.||++|||+.|+++
T Consensus 292 -~~~~~s---~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 -NLHKVS---PSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -CGGGSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001111 24567889999999999999998864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=429.87 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=208.0
Q ss_pred cCCcCceeccCCceEEEEEEEC-----CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.++..+.||+|+||+||+|.+. .+++.||||+++... .....+++.+|+.++++++|||||+++|+|.+++..+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 3456778999999999999874 357899999996543 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCcc------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC
Q 037197 774 MVYDYMPNDSLGEALHGKEA------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL 841 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~ 841 (1009)
+|||||++|+|.++++.+.. .+..++|.++++|+.|||+||+|||++ +||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 99999999999999965431 123589999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecccCC--CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHH
Q 037197 842 EARIADFGLARMMLHKN--ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWV 918 (1009)
Q Consensus 842 ~~kl~DfGls~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 918 (1009)
.+||+|||+++.....+ .......||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+ +
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-----~~~-~ 256 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQD-V 256 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-----HHH-H
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-----HHH-H
Confidence 99999999998764433 22344679999999999999999999999999999999999 899997421 122 2
Q ss_pred HHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 919 LSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
...+..+.. +.....++ ..+.+++.+||+.||++||||+||++.|+..
T Consensus 257 ~~~i~~~~~------~~~p~~~~------~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIRNRQV------LPCPDDCP------AWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHTTCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHcCCC------CCCcccch------HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 233333221 11122222 2466789999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=429.43 Aligned_cols=249 Identities=21% Similarity=0.268 Sum_probs=206.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|+..+.||+|+||+||+|+++.+++.||||++.+... .....+.+.+|++++++++|||||++++++++++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 458899999999999999999999999999999965321 1233466779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
|||+||+|.++++.... +++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999975432 88899999999999999999999 999999999999999999999999999998754
Q ss_pred CC--CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 857 KN--ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 857 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
.. ......+||+.|||||++.+..++.++||||+||++|||++|+.||... +..+..........
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~~i~~~~~-------- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEGLIFAKIIKLEY-------- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCC--------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCC--------
Confidence 33 2345678999999999999999999999999999999999999999732 22333333222211
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
.+..... .++.+++.+|++.||++|||++|+.
T Consensus 252 ~~p~~~s------~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEKFF------PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTTCC------HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCcccC------HHHHHHHHHHccCCHhHCcChHHHc
Confidence 1111111 2356788999999999999998863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=430.23 Aligned_cols=265 Identities=23% Similarity=0.277 Sum_probs=211.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||+||+|+++.+|+.||||+++.... ..+|++++++++|||||++++++.+++.+|+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 457788899999999999999999999999999965321 1379999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC-cEEEcccccceeccc
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-EARIADFGLARMMLH 856 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGls~~~~~ 856 (1009)
||+||+|.++++... .+++.++..++.||+.||+|||++ +||||||||+|||++.++ ++||+|||+|+.+..
T Consensus 131 y~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 999999999997543 289999999999999999999998 999999999999999988 699999999987654
Q ss_pred CCC-----ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 857 KNE-----TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 857 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
... .....+||+.|||||++.+..++.++||||+||++|||+||+.||...... .+...+. .......
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~----~~~~~~~- 276 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--PLCLKIA----SEPPPIR- 276 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--CCHHHHH----HSCCGGG-
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHH----cCCCCch-
Confidence 321 123357999999999999999999999999999999999999999753322 2222221 1111111
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCcccccccCCCCCCCCcccccC
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNGGHNLSKERPIFGN 1002 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1009)
.+...++ ..+.+++.+||+.||++|||+.|+++.|..+.... ...+|||+..
T Consensus 277 ---~~~~~~s------~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~----------~~l~hPw~~~ 328 (336)
T 4g3f_A 277 ---EIPPSCA------PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV----------GGLKSPWKGE 328 (336)
T ss_dssp ---GSCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT----------TSSCSCSSSS
T ss_pred ---hcCccCC------HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh----------hhccCCCcCC
Confidence 1111111 23567888999999999999999999988765322 1267888754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=469.09 Aligned_cols=455 Identities=19% Similarity=0.207 Sum_probs=346.7
Q ss_pred eEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCC
Q 037197 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSN 148 (1009)
Q Consensus 69 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n 148 (1009)
+.||+++++++ .+|..+. ++|++|+|++|.+++..|..+.++++|++|+|++|++++..|..++++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 47899999999 4777665 89999999999999888899999999999999999999888999999999999999999
Q ss_pred CCCCCCCccccCCCCCCeeeccCCccCC-cCCccccCccccceeeeccccccccCCccCCCCcch--hhhhcccccc--c
Q 037197 149 NFSGFLPEDLGNATSLESLDFRGSFFEG-SVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSL--ETIILGYNAF--E 223 (1009)
Q Consensus 149 ~l~~~~p~~l~~l~~L~~L~L~~n~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L--~~L~L~~n~l--~ 223 (1009)
+++ .+|.. .+++|++|+|++|.+++ .+|..|+++++|++|+|++|.+++ ..++.+++| ++|++++|.+ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 999 57766 89999999999999997 578999999999999999999986 457777888 9999999999 8
Q ss_pred ccCCccccCCC-CccEEEeccCccccccCc-ccCCCCCCcEEEcccCC-------cCCCCCccccccccccccccccccc
Q 037197 224 GEIPAEFGNLT-NLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNN-------FTGKIPPELGSITSLAFLDLSDNQI 294 (1009)
Q Consensus 224 ~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~L~~n~-------l~~~~~~~~~~l~~L~~L~Ls~N~l 294 (1009)
+..|..+..+. +...+++++|.+.+.++. .+..+++|+.|++++|. +.+.+| .+..+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 88899888876 355678889998876654 67889999999999998 776665 788999999999999999
Q ss_pred CCCcchhhh---cccCCCeEeccccccCCCCCcCC-----CCCCcccEEEccCCccCccCC-ccccCC---CCCceeecc
Q 037197 295 SGEIPVKLA---ELKNLQLLNLMCNQLTGLIPDKL-----GELTKLEVLELWKNSLIGSLP-MRLGQS---SPLRRLDAS 362 (1009)
Q Consensus 295 ~~~~~~~l~---~l~~L~~L~L~~N~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~~~~-~~~~~~---~~L~~L~Ls 362 (1009)
++..+..+. ..++|++|++++|++++.+|..+ .++++|+.+++++|.+ .+| ..+..+ .+|+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~ 310 (520)
T 2z7x_B 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVS 310 (520)
T ss_dssp EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEE
T ss_pred CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcC
Confidence 864443322 24689999999999998889888 8899999999998887 344 333333 457777777
Q ss_pred CccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccC
Q 037197 363 SNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQI 442 (1009)
Q Consensus 363 ~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 442 (1009)
+|.+.+.. .+..+++|++|++++|++++..|..+..+++|++|++++|++++.. .+
T Consensus 311 ~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~----------------------~~ 366 (520)
T 2z7x_B 311 GTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS----------------------KI 366 (520)
T ss_dssp SSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHH----------------------HH
T ss_pred CCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccc----------------------cc
Confidence 77665321 1134455555555555555544555555555555555555554300 23
Q ss_pred CcCCcCCCCCcEEecccCcccc-cCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCcccccc
Q 037197 443 PDDISLSTSLSFVDISWNHLES-YLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASC 521 (1009)
Q Consensus 443 p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l 521 (1009)
|..+..+++|+.|++++|++++ +.+..+..+++|++|++++|++++..|..+. ++|+.|||++|+++ .+|..+..+
T Consensus 367 ~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l 443 (520)
T 2z7x_B 367 AEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKL 443 (520)
T ss_dssp HHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGC
T ss_pred hHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcC
Confidence 3344444555555555555554 2222345555666666666666555555443 67888888888888 777777788
Q ss_pred ccceeeeecCcccccCCCcc-cccccccceecCCccccccccC
Q 037197 522 EKLVSLNLRNNRFSGEIPKA-VATMPTLAILDMSNNSLFGRIP 563 (1009)
Q Consensus 522 ~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p 563 (1009)
++|++|+|++|+|+ .+|.. +..+++|+.|+|++|++++..+
T Consensus 444 ~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 444 EALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp TTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence 88999999999988 46654 8888999999999999887654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=467.48 Aligned_cols=510 Identities=20% Similarity=0.201 Sum_probs=330.9
Q ss_pred eeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCC
Q 037197 68 VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASS 147 (1009)
Q Consensus 68 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~ 147 (1009)
+++|||++|.|++..+..|.++++|++|+|++|++++..|.+|.+|++|++|+|++|++++..+..|+++++|++|+|++
T Consensus 54 ~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~ 133 (635)
T 4g8a_A 54 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 133 (635)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTT
T ss_pred CCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCC
Confidence 45555555555554444555555555555555555555555555555555555555555544444455555555555555
Q ss_pred CCCCCCCCccccCCCCCCeeeccCCccCC-cCCccccCccccceeeeccccccccCCccCCCCcchh----hhhcccccc
Q 037197 148 NNFSGFLPEDLGNATSLESLDFRGSFFEG-SVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLE----TIILGYNAF 222 (1009)
Q Consensus 148 n~l~~~~p~~l~~l~~L~~L~L~~n~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~----~L~L~~n~l 222 (1009)
|++++..+..|+++++|++|+|++|.+.+ ..|..++.+++|++|+|++|++++..|..|..+.+++ .++++.|.+
T Consensus 134 N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l 213 (635)
T 4g8a_A 134 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 213 (635)
T ss_dssp SCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCC
T ss_pred CcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcc
Confidence 55554444455555555555555555543 2345555555555555555555555555554444333 244555555
Q ss_pred cccCCccccCCCCccEEEeccCccccc-cCcccCCCCCCcEEEcccCC------cCCCCCcccccccccccccccccccC
Q 037197 223 EGEIPAEFGNLTNLRYLDLAVGSLSGQ-IPPALGRLKKLTTVYLYKNN------FTGKIPPELGSITSLAFLDLSDNQIS 295 (1009)
Q Consensus 223 ~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~------l~~~~~~~~~~l~~L~~L~Ls~N~l~ 295 (1009)
+...+..+.. ..++.|++.+|..... .+..+..+..++...+..+. +.......+..+..+..+++..+...
T Consensus 214 ~~i~~~~~~~-~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~ 292 (635)
T 4g8a_A 214 NFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 292 (635)
T ss_dssp CEECTTTTTT-CEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCC
T ss_pred cccCcccccc-hhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhc
Confidence 5333333322 2445555555543322 22334445555544443222 22222333444445555555444332
Q ss_pred C---CcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCc
Q 037197 296 G---EIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPT 372 (1009)
Q Consensus 296 ~---~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~ 372 (1009)
. ..+..+..+.+++.+.+.+|.+.... .+.....|+.|++.+|.+....+. .+..|+.+++++|.+... .
T Consensus 293 ~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~ 365 (635)
T 4g8a_A 293 YYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--F 365 (635)
T ss_dssp SCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--C
T ss_pred ccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--c
Confidence 1 22334566677888888888776542 345567788888888887654443 456677888888876633 2
Q ss_pred CccCCCCCceeecccccccc--cCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCC-cCCcCC
Q 037197 373 GLCDSGNLTKLILFNNSFSG--TFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIP-DDISLS 449 (1009)
Q Consensus 373 ~l~~l~~L~~L~l~~N~l~~--~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l 449 (1009)
....+++|+.|++++|.+.. ..+..+..+.+|+.+++..|.+. ..+..+..+++|+.++++.|++....+ ..+..+
T Consensus 366 ~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l 444 (635)
T 4g8a_A 366 SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 444 (635)
T ss_dssp CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTC
T ss_pred ccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccc
Confidence 34467888888888888753 45556667788888888888887 455667788888888888887765544 456778
Q ss_pred CCCcEEecccCcccccCCCcccCCcccchhccccCccc-CCcccccccCCcCcEEEeecCCCCCCCCccccccccceeee
Q 037197 450 TSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQ-AKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLN 528 (1009)
Q Consensus 450 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~ 528 (1009)
.+++.++++.|++++..+..+..++.++.|++++|++. +..|..|..+++|++|||++|+|++.+|..|.++++|++|+
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~ 524 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 524 (635)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEE
Confidence 88888888888888888888888888888888888754 45677888888888888888888888888888888888888
Q ss_pred ecCcccccCCCcccccccccceecCCccccccccCcCcCCC-CCCcEEecCCCccccCC
Q 037197 529 LRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGAS-PALEMLNLSYNKLEGPV 586 (1009)
Q Consensus 529 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~ls~N~l~g~i 586 (1009)
|++|+|++..|..|..+++|+.|||++|+|++.+|..|..+ ++|++|+|++|++++..
T Consensus 525 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 525 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp CTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred CCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 88888888888888888888888888888888888888887 57888888888887643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=416.71 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=200.0
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc----CCeEEEEE
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN----ETNVMMVY 776 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~----~~~~~lV~ 776 (1009)
+..+.||+|+||+||+|.+..+++.||+|++..........+.+.+|++++++++|||||+++++|.+ +..+|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55667999999999999999999999999997665555566778899999999999999999999865 35689999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC-CCcEEEcccccceecc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA-NLEARIADFGLARMML 855 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGls~~~~ 855 (1009)
|||++|+|.++++... .+++..+..++.||+.||+|||++ .++||||||||+|||++. ++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~- 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK- 182 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC-
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeC-
Confidence 9999999999997543 278999999999999999999998 123999999999999974 799999999999753
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
........+||+.|||||++.+ +++.++|||||||++|||+||+.||.... . ...+...+..+.. .+.
T Consensus 183 -~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~----~-~~~~~~~i~~~~~-----~~~ 250 (290)
T 3fpq_A 183 -RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----N-AAQIYRRVTSGVK-----PAS 250 (290)
T ss_dssp -CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----S-HHHHHHHHTTTCC-----CGG
T ss_pred -CCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC----c-HHHHHHHHHcCCC-----CCC
Confidence 2334456789999999998764 69999999999999999999999996321 1 2222233322211 111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+..... .++.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~------~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 FDKVAI------PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGCCC------HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccCC------HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 23567889999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=413.53 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=190.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.++|+..+.||+|+||+||+|++..+++.||||++.+... .......+.+|++++++++|||||++++++.+++..|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999976533 233355677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+ +|+|.+++..+.. +++.++..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+|+...
T Consensus 92 mEy~-~g~L~~~l~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EECC-CEEHHHHHHHSCS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EeCC-CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 9999 6899999875432 88999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCCceeeecccCcccCCcccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKV-DEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
.. ......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||.. .+..+.... +..+..
T Consensus 164 ~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-----~~~~~~~~~-i~~~~~------- 229 (275)
T 3hyh_A 164 DG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-----ESIPVLFKN-ISNGVY------- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-----SSHHHHHHH-HHHTCC-------
T ss_pred CC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-----CCHHHHHHH-HHcCCC-------
Confidence 32 33445789999999999988776 5799999999999999999999973 222333222 222211
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+....+ .++.+++.+|++.||++|||++|+++
T Consensus 230 ~~p~~~s------~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 TLPKFLS------PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCTTSC------HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCC------HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111111 23567889999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=433.25 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=209.1
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.+.|+..+.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+++|++++|||||+++++|.+++.+|+||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 4568899999999999999999999999999999965432 33456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
|||+||+|.++++... +++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 228 Ey~~gG~L~~~i~~~~-----l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 228 EFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp ECCTTEEHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred eCCCCCcHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 9999999999996432 78899999999999999999999 999999999999999999999999999998766
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
........+||+.|||||++.+..|+.++|||||||++|||++|+.||... +..+.+. .+..... +.+
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~-~i~~~~~------~~~ 367 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPLKAMK-MIRDNLP------PRL 367 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHH-HHHHSCC------CCC
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHH-HHHcCCC------CCC
Confidence 555566788999999999999999999999999999999999999999632 2222222 2222211 111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. ...... .++.+++.+||+.||++|||+.|+++
T Consensus 368 ~-~~~~~s---~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 K-NLHKVS---PSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp S-CTTSSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-ccccCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 001111 24567889999999999999999853
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=416.85 Aligned_cols=265 Identities=26% Similarity=0.318 Sum_probs=201.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHH--HHHHHHhccCCCceeeEEeEEEcCC----e
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF--REVSLLGRLRHRNIVRLLGYLHNET----N 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~--~E~~~l~~l~Hpniv~l~~~~~~~~----~ 771 (1009)
+.|...+.||+|+||+||+|++. |+.||||++... ....+. .|+..+.+++|||||+++++|.+++ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~-----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECcc-----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 34667789999999999999984 789999998432 223333 4566667889999999999997654 5
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEeccCCCcEEeCCCCcEEEc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD-----CQPPVIHRDIKSNNILLDANLEARIA 846 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~ 846 (1009)
+++|||||++|+|.++++... ++|..+.+++.|+++||+|||++ +.++||||||||+|||++.++.+||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~-----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCCcHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 799999999999999997543 79999999999999999999976 25689999999999999999999999
Q ss_pred ccccceecccCCCc----eeeecccCcccCCcccCCC------CCCcccchHhHHHHHHHHHhCCCCCCCCCC-------
Q 037197 847 DFGLARMMLHKNET----VSMVAGSYGYIAPEYGYTL------KVDEKSDIYSFGVVLLELLTGKMPLDPAFG------- 909 (1009)
Q Consensus 847 DfGls~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlGvvl~elltg~~Pf~~~~~------- 909 (1009)
|||+|+........ .....||+.|||||++.+. .++.++|||||||++|||+||+.||.....
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 99999876544322 2345799999999987653 467899999999999999999887653211
Q ss_pred ---CCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 910 ---GSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 910 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
.... ...+...+. ....+|.+..... ..+....+.+++.+||+.||++||||.||++.|+++.++
T Consensus 231 ~~~~~~~-~~~~~~~~~-----~~~~rp~~p~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 231 LVPSDPS-VEEMRKVVC-----EQKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TSCSSCC-HHHHHHHHT-----TSCCCCCCCGGGG-SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccccch-HHHHHHHHh-----cccCCCCCCcccc-chHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1111 222222222 2223444433222 123445677899999999999999999999999988644
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=419.06 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=195.5
Q ss_pred hcCCcCceeccCCceEEEEEEEC---CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFH---RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
++|+..+.||+|+||+||+|++. .+++.||||++.+..........+.+|++++++++|||||++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46889999999999999999874 467899999997654333344567789999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
|||||+||+|.++++... .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999997543 288999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
..........+||+.|||||++.+..++.++||||+||++|||+||+.||... +..+.+........
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~~~~i~~~~~-------- 243 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-----DRKETMTMILKAKL-------- 243 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC--------
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-----CHHHHHHHHHcCCC--------
Confidence 55555556678999999999999999999999999999999999999999732 22333333222211
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTM 968 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 968 (1009)
.+....+ .++.+++.+||+.||++|||+
T Consensus 244 ~~p~~~s------~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 GMPQFLS------PEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CCCTTSC------HHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCCcCC------HHHHHHHHHHcccCHHHCCCC
Confidence 1111111 235678899999999999985
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=455.79 Aligned_cols=527 Identities=18% Similarity=0.177 Sum_probs=431.7
Q ss_pred eccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCC
Q 037197 72 DLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFS 151 (1009)
Q Consensus 72 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~ 151 (1009)
+-++.+++ .+|..+. +++++|||++|.|++..+.+|.++++|++|||++|++++..|.+|+++++|++|+|++|+++
T Consensus 37 ~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~ 113 (635)
T 4g8a_A 37 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 113 (635)
T ss_dssp ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence 44555565 3555442 47999999999999888889999999999999999999877888999999999999999999
Q ss_pred CCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccc-cCCccCCCCcchhhhhcccccccccCCccc
Q 037197 152 GFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTG-KIPPELGQLSSLETIILGYNAFEGEIPAEF 230 (1009)
Q Consensus 152 ~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~ 230 (1009)
+..+..|+++++|++|+|++|.+++..+..|+++++|++|+|++|.+++ .+|..++.+++|++|+|++|++++..+..|
T Consensus 114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l 193 (635)
T 4g8a_A 114 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 193 (635)
T ss_dssp EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccc
Confidence 7777889999999999999999998878889999999999999999976 467888999999999999999999888888
Q ss_pred cCCCCc----cEEEeccCccccccCcccCCCCCCcEEEcccCCcCCC-CCcccccccccccccccccc------cCCCcc
Q 037197 231 GNLTNL----RYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGK-IPPELGSITSLAFLDLSDNQ------ISGEIP 299 (1009)
Q Consensus 231 ~~l~~L----~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~------l~~~~~ 299 (1009)
..+.++ ..++++.|.++...+..+. ...++.+++.+|..... .+..+..+..++...+..+. +.....
T Consensus 194 ~~L~~l~~~~~~~~ls~n~l~~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~ 272 (635)
T 4g8a_A 194 RVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 272 (635)
T ss_dssp HHHHTCTTCCCEEECTTCCCCEECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCT
T ss_pred cchhhhhhhhhhhhcccCcccccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccc
Confidence 776654 4789999999866555544 45678899988876532 23345566666666654433 333344
Q ss_pred hhhhcccCCCeEeccccccCCC---CCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccC
Q 037197 300 VKLAELKNLQLLNLMCNQLTGL---IPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCD 376 (1009)
Q Consensus 300 ~~l~~l~~L~~L~L~~N~l~~~---~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 376 (1009)
..+..+..+..+.+..+..... .+..+..+.+++.+++.+|.+.... .+.....++.|++++|.+.+..+. .
T Consensus 273 ~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~ 347 (635)
T 4g8a_A 273 SALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTL---K 347 (635)
T ss_dssp TTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCC---B
T ss_pred cccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCcc---c
Confidence 5566677777777776654322 3445666788999999998876543 355667899999999998855443 4
Q ss_pred CCCCceeecccccccccCCcccccCccccEEEcccCcccc--ccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcE
Q 037197 377 SGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISG--TIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSF 454 (1009)
Q Consensus 377 l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 454 (1009)
+..|+.+++..|.+... .....+++|+.|++++|.+.. ..+..+..+.+|+.|++..|.+. .++..+..+.+|+.
T Consensus 348 l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~ 424 (635)
T 4g8a_A 348 LKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEH 424 (635)
T ss_dssp CTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCE
T ss_pred chhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccc
Confidence 56889999999987643 345678999999999999963 45566778899999999999987 45667888999999
Q ss_pred EecccCcccccCC-CcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCC-CCCCCccccccccceeeeecCc
Q 037197 455 VDISWNHLESYLP-SSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSL-SGEIPASIASCEKLVSLNLRNN 532 (1009)
Q Consensus 455 L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l-~~~~p~~~~~l~~L~~L~Ls~N 532 (1009)
++++.|+.....+ ..|..+++++.++++.|.+.+..+..+..++.|+.|+|++|++ .+.+|..|..+++|++|+|++|
T Consensus 425 l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N 504 (635)
T 4g8a_A 425 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 504 (635)
T ss_dssp EECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred hhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCC
Confidence 9999988776544 5678999999999999999999999999999999999999985 4567889999999999999999
Q ss_pred ccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCCCCc-c-cccCCcccccCcCCCCCC
Q 037197 533 RFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGI-L-MNINPNELIGNAGLCGSV 610 (1009)
Q Consensus 533 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~-~-~~~~~~~~~~n~~lcg~~ 610 (1009)
+|++.+|..|.++++|+.|+|++|+|++.+|..|..+++|++|||++|+|++.+|..-+ + .++....+.+||.-|.+.
T Consensus 505 ~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 505 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred ccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 99999999999999999999999999999999999999999999999999999987421 2 334555678999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=423.24 Aligned_cols=263 Identities=25% Similarity=0.330 Sum_probs=211.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCC-----CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCC-CceeeEEeEEEc-C
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRP-----HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH-RNIVRLLGYLHN-E 769 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~l~~~~~~-~ 769 (1009)
.++|+..+.||+|+||+||+|.+... ++.||||++.... .....+.+.+|++++++++| ||||+++|+|.+ +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 35788999999999999999997653 4789999996543 33445677899999999965 999999999966 4
Q ss_pred CeEEEEEeccCCCChhhhhcCCcc------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEA------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL 837 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 837 (1009)
+.+++|||||++|+|.++++.... .+..+++.++..++.|||+||+|||++ +||||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceee
Confidence 568999999999999999975432 123489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccH
Q 037197 838 DANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDI 914 (1009)
Q Consensus 838 ~~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~ 914 (1009)
++++.+||+|||+|+....... ......||+.|||||++.+..++.++|||||||++|||+| |+.||......
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~---- 294 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---- 294 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999987654432 2234678999999999999999999999999999999998 99999743221
Q ss_pred HHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 915 VEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
+.+...+..+. .+.....++ .++.+++.+||+.||++|||++|+++.|+++.+
T Consensus 295 -~~~~~~i~~g~------~~~~p~~~~------~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 295 -EEFCRRLKEGT------RMRAPDYTT------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp -HHHHHHHHHTC------CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHHcCC------CCCCCccCC------HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 22333333332 112222222 245678899999999999999999999988753
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=448.69 Aligned_cols=458 Identities=19% Similarity=0.199 Sum_probs=283.4
Q ss_pred CeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCC
Q 037197 93 SSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGS 172 (1009)
Q Consensus 93 ~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n 172 (1009)
+++++++|.+++ +|..+. ++|++|+|++|.+++..|..++++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 566666666653 454443 56666666666666555556666666666666666666555555666666666666666
Q ss_pred ccCCcCCccccCccccceeeeccccccc-cCCccCCCCcchhhhhcccccccccCCccccCCCCc--cEEEeccCcc--c
Q 037197 173 FFEGSVPTSFRNLQKLKFLGLSGNNLTG-KIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNL--RYLDLAVGSL--S 247 (1009)
Q Consensus 173 ~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~ 247 (1009)
.++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++. .+..+++| ++|++++|.+ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence 655 34433 55566666666666554 2335555555555555555555532 22333333 5555555555 4
Q ss_pred cccCcccCCCC-CCcEEEcccCCcCCCCCc-ccccccccccccccccc-----cCCCcchhhhcccCCCeEeccccccCC
Q 037197 248 GQIPPALGRLK-KLTTVYLYKNNFTGKIPP-ELGSITSLAFLDLSDNQ-----ISGEIPVKLAELKNLQLLNLMCNQLTG 320 (1009)
Q Consensus 248 ~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~-----l~~~~~~~l~~l~~L~~L~L~~N~l~~ 320 (1009)
+..|..+..+. ..-.+++++|.+.+.++. .+..+++|+.|++++|+ +.+ ....+..+++|+.|+++++.+++
T Consensus 185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECH
T ss_pred ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcH
Confidence 45555544433 111334455555443332 22334455555555543 111 11223344444444444443332
Q ss_pred CCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCc-----cCCCCCceeecccccccccCC
Q 037197 321 LIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGL-----CDSGNLTKLILFNNSFSGTFP 395 (1009)
Q Consensus 321 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l-----~~l~~L~~L~l~~N~l~~~~p 395 (1009)
. .+.+. +..+ ...+|++|++++|.+++.+|..+ ..+..|+.++++.|.+ .+|
T Consensus 264 ~-------------------~~~~~-~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p 320 (562)
T 3a79_B 264 K-------------------CSVKL-FQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFS 320 (562)
T ss_dssp H-------------------HHHHH-HHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSC
T ss_pred H-------------------HHHHH-HHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecC
Confidence 1 00000 1111 12256666666666665555555 4444555555555554 223
Q ss_pred -ccccc---CccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccC--CCc
Q 037197 396 -VSLST---CKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYL--PSS 469 (1009)
Q Consensus 396 -~~l~~---~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~ 469 (1009)
..+.. ..+|+.|++++|.+.... ....+++|++|++++|++++.+|..+..+++|+.|++++|+++++. |..
T Consensus 321 ~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 398 (562)
T 3a79_B 321 KEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALM 398 (562)
T ss_dssp HHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHT
T ss_pred hhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhh
Confidence 22222 256788888888775321 1257788888888888888878888888888888888888888743 456
Q ss_pred ccCCcccchhccccCcccCCcc-cccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCccccccccc
Q 037197 470 ILSIPSLQTFMASHNNLQAKIP-NELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTL 548 (1009)
Q Consensus 470 ~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 548 (1009)
+..+++|+.|++++|++++.+| ..+..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|
T Consensus 399 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L 475 (562)
T 3a79_B 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQAL 475 (562)
T ss_dssp TTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCC
T ss_pred hcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCC
Confidence 7888888888888888887444 4588889999999999999887777664 78999999999998 788888899999
Q ss_pred ceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCC
Q 037197 549 AILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPS 588 (1009)
Q Consensus 549 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~ 588 (1009)
+.|||++|+|++..+..|..+++|+.|+|++|++++..|.
T Consensus 476 ~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 476 QELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp SEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred CEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 9999999999954444489999999999999999998774
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=402.32 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=190.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC------
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET------ 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------ 770 (1009)
.+.|+..+.||+|+||+||+|+++.+++.||||++.... .....+.+.+|++++++++|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 456889999999999999999999999999999996543 3344567779999999999999999999986543
Q ss_pred ------eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEE
Q 037197 771 ------NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEAR 844 (1009)
Q Consensus 771 ------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 844 (1009)
+.|+|||||++|+|.++++..... ...++..++.|+.||++||+|||++ +|+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence 369999999999999999765432 2245667788999999999999999 999999999999999999999
Q ss_pred EcccccceecccCCC------------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCc
Q 037197 845 IADFGLARMMLHKNE------------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSK 912 (1009)
Q Consensus 845 l~DfGls~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~ 912 (1009)
|+|||+|+....... .....+||+.|||||++.+..++.++|||||||++|||++ ||.. ..
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~----~~ 231 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST----QM 231 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS----HH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC----cc
Confidence 999999987644321 1223579999999999999999999999999999999996 7752 11
Q ss_pred cHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 913 DIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+....+.. +.... ..+ ...........++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~-~~~~~-----~p~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ERVRTLTD-VRNLK-----FPP-------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHH-HHTTC-----CCH-------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHH-HhcCC-----CCC-------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111 11111 111 11122234557889999999999999999976
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=437.47 Aligned_cols=453 Identities=21% Similarity=0.226 Sum_probs=339.3
Q ss_pred eEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCC
Q 037197 69 EKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSN 148 (1009)
Q Consensus 69 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n 148 (1009)
+.+|++++++++ +|..+. ++|++|+|++|.+++..|..++++++|++|+|++|++++..|..++.+++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 789999999996 666554 89999999999999888899999999999999999999888999999999999999999
Q ss_pred CCCCCCCccccCCCCCCeeeccCCccCC-cCCccccCccccceeeeccccccccCCccCCCCcch--hhhhcccccc--c
Q 037197 149 NFSGFLPEDLGNATSLESLDFRGSFFEG-SVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSL--ETIILGYNAF--E 223 (1009)
Q Consensus 149 ~l~~~~p~~l~~l~~L~~L~L~~n~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L--~~L~L~~n~l--~ 223 (1009)
+++ .+|.. .+++|++|+|++|.+++ ..|..|+++++|++|+|++|++++. .+..+++| ++|++++|++ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence 999 67766 89999999999999997 3578999999999999999999863 45555565 9999999999 8
Q ss_pred ccCCccccCCC-CccEEEeccCccccccCc-ccCCCCCCcEEEcccCCc-----CCCCCcccccccccccccccccccCC
Q 037197 224 GEIPAEFGNLT-NLRYLDLAVGSLSGQIPP-ALGRLKKLTTVYLYKNNF-----TGKIPPELGSITSLAFLDLSDNQISG 296 (1009)
Q Consensus 224 ~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~L~~n~l-----~~~~~~~~~~l~~L~~L~Ls~N~l~~ 296 (1009)
+..|..|..+. ..-.++++.|.+.+.++. .+..+++|+.|++++|.. .+ ....+..+++|+.|+++++.+++
T Consensus 185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECH
T ss_pred ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcH
Confidence 88999998876 222668899998876654 467889999999999862 22 22346778889999999888764
Q ss_pred Ccchhh---hcccCCCeEeccccccCCCCCcCC-----CCCCcccEEEccCCccCccCC-ccccC---CCCCceeeccCc
Q 037197 297 EIPVKL---AELKNLQLLNLMCNQLTGLIPDKL-----GELTKLEVLELWKNSLIGSLP-MRLGQ---SSPLRRLDASSN 364 (1009)
Q Consensus 297 ~~~~~l---~~l~~L~~L~L~~N~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~~~~-~~~~~---~~~L~~L~Ls~N 364 (1009)
.....+ ...++|++|++++|.+++.+|..+ .+++.|+.+++..|.+ .+| ..+.. ..+|+.|++++|
T Consensus 264 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n 341 (562)
T 3a79_B 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDT 341 (562)
T ss_dssp HHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESS
T ss_pred HHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCC
Confidence 322111 123489999999999998888777 6777777777777665 233 11111 134555555555
Q ss_pred cccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccc--cC
Q 037197 365 LLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTG--QI 442 (1009)
Q Consensus 365 ~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~ 442 (1009)
.+.... + ...+++|++|++++|++++.+|..++++++|++|+|++|++++ .+
T Consensus 342 ~~~~~~---~-----------------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 395 (562)
T 3a79_B 342 PFIHMV---C-----------------------PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKV 395 (562)
T ss_dssp CCCCCC---C-----------------------CSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHH
T ss_pred Cccccc---C-----------------------ccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccc
Confidence 543211 1 1345555566666666655555666666666666666666654 22
Q ss_pred CcCCcCCCCCcEEecccCcccc-cCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCcccccc
Q 037197 443 PDDISLSTSLSFVDISWNHLES-YLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASC 521 (1009)
Q Consensus 443 p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l 521 (1009)
|..+..+++|+.|++++|++++ +.+..+..+++|++|++++|++++.+|..+. ++|+.|||++|+|+ .+|..+..+
T Consensus 396 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l 472 (562)
T 3a79_B 396 ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHL 472 (562)
T ss_dssp HHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSS
T ss_pred hhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCC
Confidence 3456666666666666666666 3334466667777777777777665555544 68888999999888 677766688
Q ss_pred ccceeeeecCcccccCCCcc-cccccccceecCCccccccccC
Q 037197 522 EKLVSLNLRNNRFSGEIPKA-VATMPTLAILDMSNNSLFGRIP 563 (1009)
Q Consensus 522 ~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p 563 (1009)
++|+.|+|++|+|+ .+|.. +..+++|+.|+|++|++++..|
T Consensus 473 ~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 473 QALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp CCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 89999999999998 56655 8888999999999999887665
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=402.17 Aligned_cols=263 Identities=22% Similarity=0.303 Sum_probs=203.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc------CCe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN------ETN 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~------~~~ 771 (1009)
++|+..+.||+|+||+||+|+++.+|+.||||++++........+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 46889999999999999999999999999999997766556666778899999999999999999998753 367
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
+|+|||||+ |+|.+++..... +++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~----l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQP----LTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999996 679999976532 88999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCC----CceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 852 RMMLHKN----ETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 852 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
+.+.... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||... +....+........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~-----~~~~~l~~I~~~~g 280 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK-----NYVHQLQLIMMVLG 280 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS-----SHHHHHHHHHHHHC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC-----CHHHHHHHHHHhcC
Confidence 8764322 234457899999999987765 5689999999999999999999999732 22222222221111
Q ss_pred ccccccCcc------------ccccCchHHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALDPS------------IAGQCKHVQE-----EMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~~~------------~~~~~~~~~~-----~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
......... +........+ ...++.+++.+||..||++|||+.|+++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111000000 0000000000 1134567899999999999999999875
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=399.20 Aligned_cols=295 Identities=30% Similarity=0.491 Sum_probs=230.9
Q ss_pred cChHHhHHHHHHHHhhccCCCCCCCCCCCCCccccCCcCCce--eeeEEeCCC---CceeEEecccccccc--ccccccc
Q 037197 15 SNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCN--WTGVWCNSR---GFVEKLDLSNMSLNG--SVSENIR 87 (1009)
Q Consensus 15 ~~~~~~~~~ll~~k~~~~d~~~~l~~W~~~~~~~~~~~~~C~--w~gv~C~~~---~~v~~l~l~~~~l~~--~~~~~l~ 87 (1009)
.|.++|++||++||+++.||. .+++|.. +.+||. |.||+|+.. ++|++|+|++++++| .+|+.+.
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~-------~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~ 73 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-------TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-------TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGG
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCC-------CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHh
Confidence 588999999999999999987 7999964 346888 999999864 799999999999998 8888899
Q ss_pred cCCCCCeEeccc-CcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCe
Q 037197 88 GLRSLSSLNICC-NEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLES 166 (1009)
Q Consensus 88 ~l~~L~~L~L~~-n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~ 166 (1009)
++++|++|+|++ |.+.+.+|..++++++|++|+|++|.+++.+|..++++++|++|+|++|.+++.+|..++.+++|++
T Consensus 74 ~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 153 (313)
T 1ogq_A 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153 (313)
T ss_dssp GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred CCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCe
Confidence 999999999984 8888888888888888999998888888888888888888888888888888888888888888888
Q ss_pred eeccCCccCCcCCccccCcc-ccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCc
Q 037197 167 LDFRGSFFEGSVPTSFRNLQ-KLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGS 245 (1009)
Q Consensus 167 L~L~~n~~~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 245 (1009)
|++++|.+++.+|..+.+++ +|++|+|++|++++.+|..++.++ |++|+|++|++++..|..|+++++|++|+|++|.
T Consensus 154 L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 232 (313)
T 1ogq_A 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232 (313)
T ss_dssp EECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSE
T ss_pred EECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCc
Confidence 88888888777787777776 778888888887777777777776 7777777777777777777777777777777777
Q ss_pred cccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccc-cCC
Q 037197 246 LSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQ-LTG 320 (1009)
Q Consensus 246 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~ 320 (1009)
+++.+|. +..+++|++|+|++|++++.+|..+..+++|++|+|++|++++.+|.. ..+++|+.|++++|+ +.|
T Consensus 233 l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 233 LAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp ECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred eeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 7655544 566666666666666666666666666666666666666666655554 556666666666665 443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=413.96 Aligned_cols=421 Identities=25% Similarity=0.339 Sum_probs=226.4
Q ss_pred cCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCee
Q 037197 88 GLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESL 167 (1009)
Q Consensus 88 ~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L 167 (1009)
..++|++|++++|.+ +.+|++++++++|++|++++|.+.|.+|..++++.+|+.++++.|.. .+|++|
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L 76 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL 76 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence 468899999999999 88999999999999999999999999999999998887777765542 457778
Q ss_pred eccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccc
Q 037197 168 DFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLS 247 (1009)
Q Consensus 168 ~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 247 (1009)
++++|.+++ +|.. .++|++|++++|.+++ +|.. +++|++|++++|++++ ++.. .++|++|++++|+++
T Consensus 77 ~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~ 144 (454)
T 1jl5_A 77 ELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLE 144 (454)
T ss_dssp ECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCS
T ss_pred EecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCC
Confidence 888887774 3332 3678888888888885 5643 3678888888888874 2221 167888888888888
Q ss_pred cccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCC
Q 037197 248 GQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLG 327 (1009)
Q Consensus 248 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~ 327 (1009)
+ +| .++++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .++.+++|++|++++|++++. |...
T Consensus 145 ~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l-~~~~- 214 (454)
T 1jl5_A 145 K-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL-PDLP- 214 (454)
T ss_dssp S-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CCCC-
T ss_pred C-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-CCCc-
Confidence 5 56 58888888888888888885 55433 478888888888875 45 577788888888888888763 3322
Q ss_pred CCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEE
Q 037197 328 ELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRV 407 (1009)
Q Consensus 328 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L 407 (1009)
++|+.|++++|.+. .+| .++.+++|+.|++++|.+++ +|.. +++|+.|++++|++++ +|.. .++|+.|
T Consensus 215 --~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L 282 (454)
T 1jl5_A 215 --LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFL 282 (454)
T ss_dssp --TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred --CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEE
Confidence 46777777777776 445 36677777777777777764 3332 2566777777776664 3332 2566666
Q ss_pred EcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCccc
Q 037197 408 RVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQ 487 (1009)
Q Consensus 408 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 487 (1009)
++++|++++ +|.. .++|+.|++++|++++ ++. ..++|+.|++++|++++ +|.. +++|+.|++++|+++
T Consensus 283 ~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~~---~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~ 350 (454)
T 1jl5_A 283 DVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LCD---LPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA 350 (454)
T ss_dssp ECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-ECC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS
T ss_pred ECcCCccCc-ccCc---CCcCCEEECcCCcCCc-ccC---CcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc
Confidence 666666664 1211 1456666666666653 221 11356666666666665 2322 345555555555555
Q ss_pred CCcccccccCCcCcEEEeecCCCCC--CCCccccccccceeeeecCcccccCCCcccccccccceecCCcccccc--ccC
Q 037197 488 AKIPNELQACPSLSVLDLSSNSLSG--EIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFG--RIP 563 (1009)
Q Consensus 488 ~~~p~~~~~l~~L~~LdLs~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p 563 (1009)
+ +|. .+++|+.|||++|++++ .+|.++.. |+.|++.|.+|.. +++|+.||+++|++++ .+|
T Consensus 351 ~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP 415 (454)
T 1jl5_A 351 E-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIP 415 (454)
T ss_dssp C-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC--------------------------------
T ss_pred c-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccch
Confidence 3 333 24555555555555554 44444332 2234444455442 3455566666666655 444
Q ss_pred cCcCCCCCCcEEecCCCccccCCC
Q 037197 564 ENFGASPALEMLNLSYNKLEGPVP 587 (1009)
Q Consensus 564 ~~~~~l~~L~~L~ls~N~l~g~ip 587 (1009)
.+ ++.|.+++|.+.+++|
T Consensus 416 ~s------l~~L~~~~~~~~~~~~ 433 (454)
T 1jl5_A 416 ES------VEDLRMNSERVVDPYE 433 (454)
T ss_dssp ------------------------
T ss_pred hh------HhheeCcCcccCCccc
Confidence 33 3334455555555544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=401.33 Aligned_cols=424 Identities=24% Similarity=0.294 Sum_probs=264.1
Q ss_pred CceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEec
Q 037197 66 GFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNA 145 (1009)
Q Consensus 66 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 145 (1009)
.+++.|+++++.+ |.+|+.++++++|++|++++|.+.+.+|..++++++|+++++++|.. .++++|++
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~l 78 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELEL 78 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEEC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEEe
Confidence 4688999999999 89999999999999999999999999999999999998888877753 46788888
Q ss_pred CCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhccccccccc
Q 037197 146 SSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGE 225 (1009)
Q Consensus 146 s~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 225 (1009)
++|++++ +|.. .++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++
T Consensus 79 ~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~- 145 (454)
T 1jl5_A 79 NNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK- 145 (454)
T ss_dssp TTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-
T ss_pred cCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-
Confidence 8888875 3432 3678888888888876 5543 3678888888888874 3321 1578888888888885
Q ss_pred CCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcc
Q 037197 226 IPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAEL 305 (1009)
Q Consensus 226 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l 305 (1009)
+| +|+++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .+..+++|++|++++|++++ +|...
T Consensus 146 lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~--- 214 (454)
T 1jl5_A 146 LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP--- 214 (454)
T ss_dssp CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---
T ss_pred Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---
Confidence 66 58888888888888888875 45433 478888888888886 55 57888888888888888875 44322
Q ss_pred cCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeec
Q 037197 306 KNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLIL 385 (1009)
Q Consensus 306 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l 385 (1009)
++|++|++++|+++. +| .++.+++|++|++++|++++ +|. ...+|+.|++++|.+++ +|.. .++|+.|++
T Consensus 215 ~~L~~L~l~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-l~~---~~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l 284 (454)
T 1jl5_A 215 LSLESIVAGNNILEE-LP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTD-LPEL---PQSLTFLDV 284 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred CcccEEECcCCcCCc-cc-ccCCCCCCCEEECCCCcCCc-ccc---cccccCEEECCCCcccc-cCcc---cCcCCEEEC
Confidence 478888888888884 45 37888888888888888875 333 23678888888888885 4443 367888999
Q ss_pred ccccccccCCcccccCccccEEEcccCccccccCCccCCC-CcccEEEeecccccccCCcCCcCCCCCcEEecccCcccc
Q 037197 386 FNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNL-PSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLES 464 (1009)
Q Consensus 386 ~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 464 (1009)
++|++++. |.. .++|+.|++++|++++ ++ .+ ++|++|++++|++++ +|.. +++|+.|++++|++++
T Consensus 285 s~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~ 351 (454)
T 1jl5_A 285 SENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE 351 (454)
T ss_dssp CSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC
T ss_pred cCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc
Confidence 99888862 211 2678899999998884 22 23 478999999999985 6654 5789999999999987
Q ss_pred cCCCcccCCcccchhccccCcccC--CcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCccccc--CCCc
Q 037197 465 YLPSSILSIPSLQTFMASHNNLQA--KIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSG--EIPK 540 (1009)
Q Consensus 465 ~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~ 540 (1009)
+ |. .+++|+.|++++|++++ .+|..++ +|+.|.+.+.+|.. +++|+.|+|++|++++ .+|.
T Consensus 352 l-p~---~l~~L~~L~L~~N~l~~l~~ip~~l~--------~L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~ 416 (454)
T 1jl5_A 352 V-PE---LPQNLKQLHVEYNPLREFPDIPESVE--------DLRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE 416 (454)
T ss_dssp C-CC---CCTTCCEEECCSSCCSSCCCCCTTCC--------EEECCC---------------------------------
T ss_pred c-cc---hhhhccEEECCCCCCCcCCCChHHHH--------hhhhcccccccccc---cCcCCEEECCCCcCCccccchh
Confidence 4 44 47889999999999988 6676655 34568888888874 5789999999999987 6665
Q ss_pred ccccccccceecCCccccccccCcCcCCC
Q 037197 541 AVATMPTLAILDMSNNSLFGRIPENFGAS 569 (1009)
Q Consensus 541 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 569 (1009)
+ |+.|.+.+|.+.+.+|......
T Consensus 417 s------l~~L~~~~~~~~~~~~~~~~~~ 439 (454)
T 1jl5_A 417 S------VEDLRMNSERVVDPYEFAHETT 439 (454)
T ss_dssp -----------------------------
T ss_pred h------HhheeCcCcccCCccccCHHHh
Confidence 4 5667889999988887665443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=408.73 Aligned_cols=394 Identities=19% Similarity=0.211 Sum_probs=273.1
Q ss_pred CeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccC-CccccCCCCccEEEecc
Q 037197 165 ESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEI-PAEFGNLTNLRYLDLAV 243 (1009)
Q Consensus 165 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~ 243 (1009)
+.++.+++.++ .+|. +. ++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ +..|+++++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 35666666666 4454 22 66777777777777766777777777777777777776444 45677777777777777
Q ss_pred CccccccCcccCCCCCCcEEEcccCCcCCCCCcc--cccccccccccccccccCCCcchh-hhcccCCCeEeccccccCC
Q 037197 244 GSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPE--LGSITSLAFLDLSDNQISGEIPVK-LAELKNLQLLNLMCNQLTG 320 (1009)
Q Consensus 244 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~-l~~l~~L~~L~L~~N~l~~ 320 (1009)
|++++..|..|+++++|++|+|++|.+++..+.. +..+++|++|+|++|++++..|.. +..+++|++|++++|++++
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 168 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence 7777777777777777777777777776544333 666777777777777777665554 6667777777777777776
Q ss_pred CCCcCCCCC--CcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCccc
Q 037197 321 LIPDKLGEL--TKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSL 398 (1009)
Q Consensus 321 ~~~~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l 398 (1009)
..+..+..+ .+|+.|++++|.+.+..+..++. .....+..+++|+.|++++|++++..|..+
T Consensus 169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~----------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~ 232 (455)
T 3v47_A 169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW----------------EKCGNPFKNTSITTLDLSGNGFKESMAKRF 232 (455)
T ss_dssp CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH----------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHH
T ss_pred cChhhhhccccccccccccccCcccccchhhccc----------------cccccccccceeeeEecCCCcccccchhhh
Confidence 666666554 45666666666655433322110 000112233445555555555555444444
Q ss_pred ccC---ccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcC--CCCCcEEecccCcccccCCCcccCC
Q 037197 399 STC---KSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISL--STSLSFVDISWNHLESYLPSSILSI 473 (1009)
Q Consensus 399 ~~~---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--l~~L~~L~Ls~N~l~~~~~~~~~~l 473 (1009)
... ++|+.|++++|.+.+... ..+.+.+..+..+.. .++|+.|++++|++++..|..|..+
T Consensus 233 ~~~~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 298 (455)
T 3v47_A 233 FDAIAGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHF 298 (455)
T ss_dssp HHHTTTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTC
T ss_pred hccccccceeeEeecccccccccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccC
Confidence 333 555666666555442211 111222222222222 2577888888888888778888888
Q ss_pred cccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecC
Q 037197 474 PSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDM 553 (1009)
Q Consensus 474 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 553 (1009)
++|++|++++|++++..|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|+|
T Consensus 299 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 378 (455)
T 3v47_A 299 TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELAL 378 (455)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEEC
Confidence 88888888888888777888888999999999999998888888999999999999999999888999999999999999
Q ss_pred CccccccccCcCcCCCCCCcEEecCCCccccCCCCCCcc
Q 037197 554 SNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGIL 592 (1009)
Q Consensus 554 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~ 592 (1009)
++|++++..+..|..+++|++|+|++|++++.+|....+
T Consensus 379 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~l 417 (455)
T 3v47_A 379 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 417 (455)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHH
T ss_pred CCCccccCCHhHhccCCcccEEEccCCCcccCCCcchHH
Confidence 999999888888899999999999999999999965444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=401.80 Aligned_cols=385 Identities=18% Similarity=0.186 Sum_probs=223.6
Q ss_pred cccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcC-CccccCccccceeeeccc
Q 037197 118 SMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSV-PTSFRNLQKLKFLGLSGN 196 (1009)
Q Consensus 118 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~-p~~~~~l~~L~~L~L~~n 196 (1009)
.++.+++.++ .+|. + .++|++|+|++|.+++..|..++++++|++|+|++|.+.+.+ +..|.++++|++|+|++|
T Consensus 14 ~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n 89 (455)
T 3v47_A 14 NAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89 (455)
T ss_dssp EEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred ccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence 3445555443 3333 2 145555555555555555555555555555555555554333 334555555555555555
Q ss_pred cccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCc
Q 037197 197 NLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPP 276 (1009)
Q Consensus 197 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 276 (1009)
++++..|..|+++++|++|+|++|++++..+.. ..++.+++|++|+|++|.+++..|.
T Consensus 90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~----------------------~~~~~l~~L~~L~L~~n~l~~~~~~ 147 (455)
T 3v47_A 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSG----------------------NFFKPLTSLEMLVLRDNNIKKIQPA 147 (455)
T ss_dssp TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHS----------------------STTTTCTTCCEEECCSSBCCSCCCC
T ss_pred ccCccChhhccCcccCCEEeCCCCCCCccccCc----------------------ccccCcccCCEEECCCCccCccCcc
Confidence 555444444554555555555554444433222 1244455555555555555544444
Q ss_pred c-cccccccccccccccccCCCcchhhhcc--cCCCeEeccccccCCCCCcC--------CCCCCcccEEEccCCccCcc
Q 037197 277 E-LGSITSLAFLDLSDNQISGEIPVKLAEL--KNLQLLNLMCNQLTGLIPDK--------LGELTKLEVLELWKNSLIGS 345 (1009)
Q Consensus 277 ~-~~~l~~L~~L~Ls~N~l~~~~~~~l~~l--~~L~~L~L~~N~l~~~~~~~--------l~~l~~L~~L~L~~N~l~~~ 345 (1009)
. +.++++|++|+|++|++++..+..+..+ .+|+.|++++|.+.+..+.. +..+++|+.|++++|.+++.
T Consensus 148 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~ 227 (455)
T 3v47_A 148 SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES 227 (455)
T ss_dssp GGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHH
T ss_pred cccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCccccc
Confidence 3 4455555555555555555555555444 45566666666665544333 23556777777777777766
Q ss_pred CCccccCC---CCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCcc
Q 037197 346 LPMRLGQS---SPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGL 422 (1009)
Q Consensus 346 ~~~~~~~~---~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~ 422 (1009)
.|..+... .+|+.|++++|.+.+.. +..+.+....+..+..+
T Consensus 228 ~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~--------------------- 272 (455)
T 3v47_A 228 MAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGL--------------------- 272 (455)
T ss_dssp HHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGG---------------------
T ss_pred chhhhhccccccceeeEeeccccccccc--------------cchhhhccCcccccccc---------------------
Confidence 66555433 55666666666554321 11111211111111111
Q ss_pred CCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcE
Q 037197 423 GNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSV 502 (1009)
Q Consensus 423 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 502 (1009)
..++|+.|++++|++++.+|..+..+++|+.|+|++|++++..|..|..+++|+.|++++|++++..|..|..+++|+.
T Consensus 273 -~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 351 (455)
T 3v47_A 273 -EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEV 351 (455)
T ss_dssp -TTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCE
T ss_pred -cccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCE
Confidence 1245556666666666555666666666666666666666666666666666777777777776666777778888888
Q ss_pred EEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCc
Q 037197 503 LDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPE 564 (1009)
Q Consensus 503 LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 564 (1009)
|||++|++++..|..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|++++.+|.
T Consensus 352 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 352 LDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred EECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 88888888877788888888888888888888876666778888888888888888887773
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=385.98 Aligned_cols=198 Identities=24% Similarity=0.375 Sum_probs=170.0
Q ss_pred HHHhcCCcCceeccCCceEEEEEEEC---CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCC
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFH---RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNET 770 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~ 770 (1009)
++.+.|+..+.||+|+||+||+|+++ .+++.||||++... ....++.+|+++++.+ +||||+++++++.+.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 45678999999999999999999875 45789999998543 2345677999999998 6999999999999999
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-CcEEEcccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN-LEARIADFG 849 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfG 849 (1009)
++|+||||+++|+|.++++. +++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 94 ~~~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EEEEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999999842 67888899999999999999999 99999999999999877 799999999
Q ss_pred cceecccCC----------------------------CceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhC
Q 037197 850 LARMMLHKN----------------------------ETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTG 900 (1009)
Q Consensus 850 ls~~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg 900 (1009)
+|+...... ......+||+.|+|||++.+. .++.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 998653321 112345799999999998765 489999999999999999999
Q ss_pred CCCCCC
Q 037197 901 KMPLDP 906 (1009)
Q Consensus 901 ~~Pf~~ 906 (1009)
+.||..
T Consensus 244 ~~Pf~~ 249 (361)
T 4f9c_A 244 RYPFYK 249 (361)
T ss_dssp CSSSSC
T ss_pred CCCCCC
Confidence 999964
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=404.29 Aligned_cols=254 Identities=20% Similarity=0.288 Sum_probs=208.5
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.++|+..+.||+|+||.||+|.++.+|+.||+|++... .....+.+.+|+++|+.++|||||+++++|.+...+|+|
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 457899999999999999999999999999999998654 234456677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC--CcEEEccccccee
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN--LEARIADFGLARM 853 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~--~~~kl~DfGls~~ 853 (1009)
||||+||+|.+++..... .+++.++..++.||+.||+|||++ +|+||||||+||+++.+ +.+||+|||+|+.
T Consensus 233 ~E~~~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EECCCCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EeecCCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 999999999999865432 288999999999999999999999 99999999999999854 8999999999998
Q ss_pred cccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
+.. .......+||+.|||||++.+..|+.++||||+||++|||++|+.||... +..+.+......... +.
T Consensus 307 ~~~-~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~-----~~~~~~~~i~~~~~~----~~ 376 (573)
T 3uto_A 307 LDP-KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDDETLRNVKSCDWN----MD 376 (573)
T ss_dssp CCT-TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHTTCCC----CC
T ss_pred ccC-CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHHHHhCCCC----CC
Confidence 743 34455678999999999999999999999999999999999999999732 222232222221111 11
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.......+ .++.+++.+||+.||++||++.|+++
T Consensus 377 ~~~~~~~s------~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 377 DSAFSGIS------EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp SGGGTTSC------HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccccCCC------HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111 23557888999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=402.69 Aligned_cols=250 Identities=24% Similarity=0.232 Sum_probs=198.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCC----CChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD----NDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
+.|+..++||+|+||.||+|+++.+|+.||||++.+.. ........+..++.+++.++|||||+++++|++.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56889999999999999999999999999999996432 11122223334567788889999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+|||||+||+|.+++..... +++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~~~~----l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999975432 78899999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
+... .....+||+.|||||++.. ..|+.++||||+||++|||++|+.||...... +..+.... +....
T Consensus 342 ~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--~~~~i~~~-i~~~~------ 410 (689)
T 3v5w_A 342 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRM-TLTMA------ 410 (689)
T ss_dssp CSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--CHHHHHHH-HHHCC------
T ss_pred cCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHh-hcCCC------
Confidence 6432 3345689999999999864 57999999999999999999999999743222 22222222 21111
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT-----MRDVI 972 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl 972 (1009)
..+....+ .++..++.+|++.||++|++ +.|+.
T Consensus 411 -~~~p~~~S------~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 411 -VELPDSFS------PELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp -CCCCTTSC------HHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred -CCCCccCC------HHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 11111111 23567889999999999998 56654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=368.66 Aligned_cols=278 Identities=32% Similarity=0.542 Sum_probs=227.2
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
....++|+..+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 345678999999999999999999976 48899999985542 334566779999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++|+|.+++.........+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999977654445589999999999999999999998 999999999999999999999999999986
Q ss_pred cccCC--CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC-CccHHHHHHHHHhhcccccc
Q 037197 854 MLHKN--ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG-SKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 930 (1009)
..... .......||+.|+|||+..+..++.++||||||+++|||++|+.||...... ......|.......+. ...
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 267 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ-LEQ 267 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC-CCS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc-HHH
Confidence 54322 2233456899999999988888999999999999999999999999754332 3345555544433322 334
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
..++.+.... ..+....+.+++.+|++.||++|||+.|+++.|+.+.+
T Consensus 268 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 268 IVDPNLADKI--RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSSCTTCS--CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcChhhcccc--CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 4444443322 23455678889999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=364.21 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=208.5
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
..++|+..+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 45679999999999999999999999999999999865432 2345677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++|+|.+++.... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 96 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EECCTTCBHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999996542 78889999999999999999999 99999999999999999999999999998776
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
..........||+.|+|||++.+..++.++||||||+++|||++|+.||... +.............. ....
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~~~~~~~~--~~~~-- 238 (297)
T 3fxz_A 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-----NPLRALYLIATNGTP--ELQN-- 238 (297)
T ss_dssp STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHHCSC--CCSC--
T ss_pred CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCC--CCCC--
Confidence 5555555678999999999999889999999999999999999999999632 222222222222211 1111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.... ...+.+++.+|++.||++|||+.|+++
T Consensus 239 -~~~~------~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 -PEKL------SAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -GGGS------CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cccc------CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111 124567889999999999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=371.16 Aligned_cols=286 Identities=37% Similarity=0.623 Sum_probs=230.0
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
....++|+..+.||+|+||.||+|.+.. ++.||||++..... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCSS-SCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHHhhccccceeEecCCCcEEEEEEecC-CCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 3346789999999999999999998654 88999999965432 222335779999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++|+|.++++........+++..++.++.|++.||+|||+.+.++|+||||||+||+++.++.+||+|||+++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 99999999999999988766666689999999999999999999998777999999999999999999999999999987
Q ss_pred cccCCC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC---CCCCCccHHHHHHHHHhhccccc
Q 037197 854 MLHKNE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP---AFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 854 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~---~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
...... ......||+.|+|||+..+..++.++||||||+++|||++|+.||+. ..........|+........ ..
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 262 (326)
T 3uim_A 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK-LE 262 (326)
T ss_dssp CCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC-ST
T ss_pred cCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh-hh
Confidence 654432 33445699999999998888899999999999999999999999962 12233445555544333222 23
Q ss_pred cccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCccc
Q 037197 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKS 984 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 984 (1009)
...+....... ..+....+.+++.+|++.||++|||+.|+++.|++....++.
T Consensus 263 ~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~ 315 (326)
T 3uim_A 263 ALVDVDLQGNY--KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW 315 (326)
T ss_dssp TSSCTTCTTSC--CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSC
T ss_pred hhcChhhcccc--CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhh
Confidence 33444433322 245566788999999999999999999999999986655543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=366.05 Aligned_cols=263 Identities=32% Similarity=0.459 Sum_probs=204.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|++. ++.||||++..........+.+.+|++++++++||||+++++++.+....++||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356888999999999999999874 788999999776655666677889999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP--VIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||+++|+|.++++.... ...+++..++.++.|+++||+|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 114 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp ECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred ecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999976542 22378999999999999999999998 8 999999999999999999999999999865
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
...........||+.|+|||++.+..++.++||||||+++|||++|+.||... ...+.......... ..
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~-----~~~~~~~~~~~~~~------~~ 258 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-----NPAQVVAAVGFKCK------RL 258 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS-----CHHHHHHHHHHSCC------CC
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCC------CC
Confidence 44434445567999999999999989999999999999999999999999732 12222222111111 11
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.+....+ ..+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 259 ~~~~~~~------~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 259 EIPRNLN------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 1111111 24667889999999999999999999999987543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=380.82 Aligned_cols=374 Identities=20% Similarity=0.207 Sum_probs=242.8
Q ss_pred cCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeecc
Q 037197 116 LKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSG 195 (1009)
Q Consensus 116 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~ 195 (1009)
++......+...+..+..++++++|++|++++|.+++. | .++.+++|++|++++|.+++. | ++.+++|++|++++
T Consensus 20 l~~~~~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~ 94 (457)
T 3bz5_A 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDS 94 (457)
T ss_dssp HHHHHHHHTTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCS
T ss_pred HHHHHHHhcCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcC
Confidence 44444444455555666777888888888888888864 4 678888888888888888764 3 77788888888888
Q ss_pred ccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCC
Q 037197 196 NNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIP 275 (1009)
Q Consensus 196 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 275 (1009)
|.+++. + ++++++|++|++++|++++. | ++++++|++|++++|++++. .++.+++|++|++++|...+.+
T Consensus 95 N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~- 164 (457)
T 3bz5_A 95 NKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL- 164 (457)
T ss_dssp SCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC-
T ss_pred CCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc-
Confidence 888753 3 77777888888888877753 3 77777777777777777763 2667777777777777554444
Q ss_pred cccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCC
Q 037197 276 PELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP 355 (1009)
Q Consensus 276 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 355 (1009)
.+..+++|++|++++|++++ +| +..+++|+.|++++|++++. .++.+++|+.|++++|++++ +| ++.+++
T Consensus 165 -~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~ 234 (457)
T 3bz5_A 165 -DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQ 234 (457)
T ss_dssp -CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTT
T ss_pred -ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCC
Confidence 35666777777777777764 33 56666677777777766654 25566666666666666655 23 445555
Q ss_pred CceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeec
Q 037197 356 LRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMAN 435 (1009)
Q Consensus 356 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 435 (1009)
|+.|++++|.+++.. + ..+++|+.|++++|+ |+.|++++
T Consensus 235 L~~L~l~~N~l~~~~---~------------------------~~l~~L~~L~l~~n~--------------L~~L~l~~ 273 (457)
T 3bz5_A 235 LTYFDCSVNPLTELD---V------------------------STLSKLTTLHCIQTD--------------LLEIDLTH 273 (457)
T ss_dssp CSEEECCSSCCSCCC---C------------------------TTCTTCCEEECTTCC--------------CSCCCCTT
T ss_pred CCEEEeeCCcCCCcC---H------------------------HHCCCCCEEeccCCC--------------CCEEECCC
Confidence 555555555555432 2 233344444444332 23344555
Q ss_pred ccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCC
Q 037197 436 NNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIP 515 (1009)
Q Consensus 436 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p 515 (1009)
|++.+.+| ++.+++|+.|++++|.+.+.+|. ..++|+.|++++| ++|+.|+|++|+|++. +
T Consensus 274 n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~ 334 (457)
T 3bz5_A 274 NTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D 334 (457)
T ss_dssp CTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C
T ss_pred CccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c
Confidence 55444444 23455555666666655444442 2344444444433 5777888888888764 2
Q ss_pred ccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCCC
Q 037197 516 ASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSN 589 (1009)
Q Consensus 516 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 589 (1009)
++.+++|+.|+|++|+|++ ++.|..|++++|.++|. ..+..|..+++++|+|+|.||..
T Consensus 335 --l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 335 --VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp --CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred --cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence 7778888888888888875 35667778888888876 24556777888888888888863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=367.15 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=207.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+..+|+.||||++..........+++.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35688999999999999999999999999999999766555566677889999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++|+|.+++..... +++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGR----MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999965432 78889999999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeeecccCcccCCcccCCCCCC-cccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVD-EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
. .......||+.|+|||++.+..++ .++||||+||++|||++|+.||... +........ ..+.. .
T Consensus 167 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i-~~~~~-------~ 232 (328)
T 3fe3_A 167 G-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-----NLKELRERV-LRGKY-------R 232 (328)
T ss_dssp S-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHH-HHCCC-------C
T ss_pred C-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-----CHHHHHHHH-HhCCC-------C
Confidence 3 334456799999999998877765 7999999999999999999999732 222222222 22211 0
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.... ...+..++.+|++.||++|||+.|+++
T Consensus 233 ~p~~~------s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 IPFYM------STDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CCTTS------CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCC------CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111 123567889999999999999999976
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=383.05 Aligned_cols=370 Identities=21% Similarity=0.237 Sum_probs=298.3
Q ss_pred cCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcC
Q 037197 99 CNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSV 178 (1009)
Q Consensus 99 ~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~ 178 (1009)
.....+..+..++++++|++|+|++|.+++. | .++.+++|++|+|++|++++. | ++.+++|++|++++|.+++.
T Consensus 27 ~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~- 100 (457)
T 3bz5_A 27 AFEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL- 100 (457)
T ss_dssp HTTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-
T ss_pred hcCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-
Confidence 3445556677899999999999999999874 5 799999999999999999974 4 89999999999999999975
Q ss_pred CccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCC
Q 037197 179 PTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLK 258 (1009)
Q Consensus 179 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 258 (1009)
+ ++++++|++|++++|++++ +| ++.+++|++|++++|++++. .++++++|++|++++|+..+.+ .++.++
T Consensus 101 ~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~ 170 (457)
T 3bz5_A 101 D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQT 170 (457)
T ss_dssp C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCT
T ss_pred e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCC
Confidence 3 8999999999999999996 44 89999999999999999974 3899999999999999766565 588999
Q ss_pred CCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEcc
Q 037197 259 KLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELW 338 (1009)
Q Consensus 259 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 338 (1009)
+|++|++++|++++ +| +..+++|+.|++++|++++. .+..+++|++|++++|++++. | ++.+++|+.|+++
T Consensus 171 ~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~ 241 (457)
T 3bz5_A 171 QLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCS 241 (457)
T ss_dssp TCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECC
T ss_pred cCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEee
Confidence 99999999999997 45 88899999999999999965 488999999999999999984 5 8899999999999
Q ss_pred CCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCcccccc
Q 037197 339 KNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTI 418 (1009)
Q Consensus 339 ~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~ 418 (1009)
+|++++.. ++.+++|+.|++++|. |+.|++++|.+.+.+| +..+++|+.|++++|.+.+.+
T Consensus 242 ~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l 302 (457)
T 3bz5_A 242 VNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLL 302 (457)
T ss_dssp SSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEE
T ss_pred CCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECCCCccccee
Confidence 99999864 4567788888887763 4566777777666554 344555555555555554444
Q ss_pred CCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCC
Q 037197 419 PVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACP 498 (1009)
Q Consensus 419 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 498 (1009)
|.. ..+|+.|++++| ++|+.|++++|++++. .+..++
T Consensus 303 ~~~---------------------------~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l---~l~~l~ 339 (457)
T 3bz5_A 303 DCQ---------------------------AAGITELDLSQN-------------PKLVYLYLNNTELTEL---DVSHNT 339 (457)
T ss_dssp ECT---------------------------TCCCSCCCCTTC-------------TTCCEEECTTCCCSCC---CCTTCT
T ss_pred ccC---------------------------CCcceEechhhc-------------ccCCEEECCCCccccc---ccccCC
Confidence 421 223333333333 4566666666666663 277788
Q ss_pred cCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCC
Q 037197 499 SLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGA 568 (1009)
Q Consensus 499 ~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 568 (1009)
+|+.||+++|+|++ ++.|..|++++|+++|. ..+..|..+|+++|+++|.||..+..
T Consensus 340 ~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~ 396 (457)
T 3bz5_A 340 KLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLD 396 (457)
T ss_dssp TCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred cCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHhc
Confidence 88899999998885 35677788999999876 46678889999999999999987644
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=360.39 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=209.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||+||+|.+..+++.||+|++... +....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 4578889999999999999999999999999988442 34556677799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.++++.... .+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999976432 378999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCce--------------eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh
Q 037197 858 NETV--------------SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 858 ~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
.... ....||+.|+|||++.+..++.++||||||+++|||++|..||...................
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2211 14578999999999999999999999999999999999999987533221111111111111
Q ss_pred hccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.. ..+ .++ ..+.+++.+|++.||++|||+.|+++.|+++..
T Consensus 242 ~~------~~~----~~~------~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 242 RY------CPP----NCP------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HT------CCT----TCC------TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc------CCC----CCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 10 011 111 135678899999999999999999999998864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=375.68 Aligned_cols=258 Identities=22% Similarity=0.243 Sum_probs=210.9
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
..+.++|+..+.||+|+||.||+|.+..+++.||+|++..........+.+.+|++++++++||||+++++++.+++..+
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 45778899999999999999999999999999999999766554555667779999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC---CCCcEEEccccc
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD---ANLEARIADFGL 850 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~DfGl 850 (1009)
+||||+++|+|.+++..... +++..+..++.||++||+|||+. +|+||||||+||+++ .++.+||+|||+
T Consensus 87 lv~E~~~gg~L~~~i~~~~~----~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999999875432 78999999999999999999999 999999999999998 467899999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
+..............||+.|+|||++.+..++.++||||+||++|+|++|+.||... +....... +..+.. .
T Consensus 160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~-----~~~~~~~~-i~~~~~--~ 231 (444)
T 3soa_A 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE-----DQHRLYQQ-IKAGAY--D 231 (444)
T ss_dssp CBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHH-HHHTCC--C
T ss_pred eEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc-----cHHHHHHH-HHhCCC--C
Confidence 987755544555678999999999999889999999999999999999999999632 22222222 222211 1
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+... ... .++.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~----~~s---~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 FPSPEWD----TVT---PEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCTTTTT----TSC---HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCccccc----cCC---HHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111111 111 24567889999999999999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=365.11 Aligned_cols=256 Identities=23% Similarity=0.303 Sum_probs=207.8
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh----hhHHHHHHHHHHHhccCCCceeeEEeEEEcCC
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI----ESGDDLFREVSLLGRLRHRNIVRLLGYLHNET 770 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~ 770 (1009)
.+.+.|+..+.||+|+||.||+|.+..+|+.||+|++.+..... ...+.+.+|++++++++||||+++++++.+..
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 34567899999999999999999999999999999997653221 13466779999999999999999999999999
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC----cEEEc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL----EARIA 846 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~ 846 (1009)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 9999999999999999996543 389999999999999999999999 999999999999998877 79999
Q ss_pred ccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 847 DFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 847 DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
|||++...... .......||+.|+|||++....++.++||||+||++|+|++|..||... +..+..........
T Consensus 162 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~-----~~~~~~~~i~~~~~ 235 (361)
T 2yab_A 162 DFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQETLANITAVSY 235 (361)
T ss_dssp CCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHTTCC
T ss_pred ecCCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCC
Confidence 99999876443 2334567999999999998889999999999999999999999999632 22222222221111
Q ss_pred ccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+++...... ...+.+++.+|+..||++|||+.|+++
T Consensus 236 ----~~~~~~~~~~------s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 ----DFDEEFFSQT------SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----CCCHHHHTTS------CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----CCCchhccCC------CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111111 124567889999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=356.30 Aligned_cols=267 Identities=25% Similarity=0.380 Sum_probs=210.2
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 4578899999999999999999999999999999865433 334456677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|.+++.... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999996543 278999999999999999999999 99999999999999999999999999998664
Q ss_pred cCC-CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 856 HKN-ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 856 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
... .......||+.|+|||...+..++.++||||+|+++|||++|+.||... ............... ....
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-----~~~~~~~~~~~~~~~---~~~~ 234 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE-----TAVSIAIKHIQDSVP---NVTT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS-----CHHHHHHHHHSSCCC---CHHH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHhhccCC---Ccch
Confidence 333 2233457899999999998888999999999999999999999999732 222222222221110 0000
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHhhcCCCccc
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-TMRDVITMLGEAKPRRKS 984 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~L~~~~~~~~~ 984 (1009)
..... .. ..+.+++.+|++.||++|| ++.++.+.|+.+....+.
T Consensus 235 ~~~~~---~~---~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 235 DVRKD---IP---QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp HSCTT---SC---HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred hcccC---CC---HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 11111 11 2456788999999999998 999999999998766543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=360.10 Aligned_cols=252 Identities=19% Similarity=0.261 Sum_probs=206.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 46788999999999999999999999999999998543 334456679999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC--CCcEEEcccccceec
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA--NLEARIADFGLARMM 854 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~DfGls~~~ 854 (1009)
||+++|+|.+++.... ..+++.+++.++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 81 EFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EeCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999999999996543 2378999999999999999999999 9999999999999987 789999999999876
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
.. ........||+.|+|||+..+..++.++||||+||++|+|++|+.||... ...+.+......... .+.
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~----~~~ 224 (321)
T 1tki_A 155 KP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-----TNQQIIENIMNAEYT----FDE 224 (321)
T ss_dssp CT-TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHTCCC----CCH
T ss_pred CC-CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC-----CHHHHHHHHHcCCCC----CCh
Confidence 43 33445567999999999998888899999999999999999999999732 222233222222111 111
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..... ...++.+++.+|++.||++|||+.|+++
T Consensus 225 ~~~~~------~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 225 EAFKE------ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTT------SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhcc------CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10001 1224667889999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=361.28 Aligned_cols=250 Identities=21% Similarity=0.257 Sum_probs=205.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|+..+.||+|+||.||+|+++.+++.||+|++.+... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 568889999999999999999999999999999864321 1223456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999986543 278889999999999999999999 999999999999999999999999999986544
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||... +............. .+
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~i~~~~~--------~~ 224 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHERLFELILMEEI--------RF 224 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC--------CC
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC-----CHHHHHHHHHcCCC--------CC
Confidence 444555678999999999999989999999999999999999999999632 22222222222111 11
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
..... .++..++.+|++.||++|| ++.|+++
T Consensus 225 p~~~s------~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 225 PRTLS------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CTTSC------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCC------HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11111 2456788899999999999 8988865
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=363.72 Aligned_cols=257 Identities=24% Similarity=0.310 Sum_probs=209.1
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
..+.+.|+..+.||+|+||.||+|.+..+++.||+|++..........+.+.+|++++++++||||+++++++.+++..+
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34567899999999999999999999999999999999766555555667779999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC---cEEEccccc
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL---EARIADFGL 850 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~DfGl 850 (1009)
+||||+++|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 105 lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 9999999999999987543 278999999999999999999999 999999999999998654 599999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||... +..+.... +..+.. .
T Consensus 178 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~-----~~~~~~~~-i~~~~~--~ 248 (362)
T 2bdw_A 178 AIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----DQHRLYAQ-IKAGAY--D 248 (362)
T ss_dssp CBCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH-HHHTCC--C
T ss_pred ceEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHH-HHhCCC--C
Confidence 9876432 2334567999999999999889999999999999999999999999632 22222222 222210 0
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+... .. ..++.+++.+|++.||++||++.|+++
T Consensus 249 ~~~~~~~----~~---~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 249 YPSPEWD----TV---TPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CCTTGGG----GS---CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCccccc----CC---CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111111 11 124567889999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=358.08 Aligned_cols=257 Identities=24% Similarity=0.306 Sum_probs=208.2
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh----hhHHHHHHHHHHHhccCCCceeeEEeEEEcC
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI----ESGDDLFREVSLLGRLRHRNIVRLLGYLHNE 769 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~ 769 (1009)
..+.+.|+..+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 345678999999999999999999999999999999987653221 2356677999999999999999999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC----cEEE
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL----EARI 845 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl 845 (1009)
...++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 99999999999999999996543 288999999999999999999999 999999999999999887 8999
Q ss_pred cccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc
Q 037197 846 ADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN 925 (1009)
Q Consensus 846 ~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 925 (1009)
+|||+++..... .......||+.|+|||+.....++.++|||||||++|+|++|+.||... ...+.........
T Consensus 160 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~~~~~~ 233 (326)
T 2y0a_A 160 IDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQETLANVSAVN 233 (326)
T ss_dssp CCCTTCEECCTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHHTC
T ss_pred EECCCCeECCCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-----CHHHHHHHHHhcC
Confidence 999999876433 2334467999999999998889999999999999999999999999632 2222222221111
Q ss_pred cccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 926 KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. .......... ...+.+++.+|++.||++|||+.|+++
T Consensus 234 ~----~~~~~~~~~~------~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 Y----EFEDEYFSNT------SALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C----CCCHHHHTTS------CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C----CcCccccccC------CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 0111111111 124567889999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=364.97 Aligned_cols=259 Identities=21% Similarity=0.279 Sum_probs=207.8
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCC---CChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD---NDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNV 772 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 772 (1009)
+.+.|+..+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|++++++++||||+++++++.+++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4567999999999999999999999999999999985321 1112346677999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc---EEEcccc
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE---ARIADFG 849 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~DfG 849 (1009)
++||||+++++|.+++.........+++..+..++.||++||+|||++ +|+||||||+||+++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999988865443344578999999999999999999999 9999999999999987654 9999999
Q ss_pred cceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 850 LARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 850 ls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
++..............||+.|+|||++.+..++.++|||||||++|||++|+.||... . ........ .+..
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~---~~~~~~i~-~~~~-- 249 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT---K---ERLFEGII-KGKY-- 249 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS---H---HHHHHHHH-HTCC--
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc---H---HHHHHHHH-cCCC--
Confidence 9988755444445567999999999999888999999999999999999999999742 1 11122211 1110
Q ss_pred cccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+...... ...+.+++.+|++.||++||++.|+++
T Consensus 250 -~~~~~~~~~~------s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 -KMNPRQWSHI------SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -CCCHHHHTTS------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCCccccccC------CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0111110111 124667889999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=355.20 Aligned_cols=266 Identities=23% Similarity=0.344 Sum_probs=202.8
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
+.+.++|+..+.||+|+||+||+|++.. ++.||+|++............+.+|++++++++||||+++++++.++...+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 3356789999999999999999999965 899999999765444444567779999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++ +|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 96 lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcCCCC-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCcee
Confidence 99999974 78888765432 378889999999999999999999 999999999999999999999999999988
Q ss_pred cccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccc--c
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD--E 930 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~ 930 (1009)
............+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... +....+........... .
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD--DQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT--THHHHHHHHHCCCCTTTSGG
T ss_pred cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHHCCCChHHhhh
Confidence 7555455556678999999998765 56899999999999999999999999743322 22333332221111000 0
Q ss_pred -------------ccC-ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 931 -------------ALD-PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 931 -------------~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
... ......... ...++.+++.+|++.||++|||++|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dP~~Rpt~~ell 299 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPG---FCQEGIDLLSNMLCFDPNKRISARDAM 299 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTT---CCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred hhccchhhhcccccccCCcHHHhCcc---cCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 000 000000000 113466889999999999999999987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=346.69 Aligned_cols=258 Identities=25% Similarity=0.429 Sum_probs=207.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||.||+|.+.. +..||+|++.... ...+++.+|++++++++||||+++++++.++...++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 568889999999999999998876 7789999996542 234567799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++.... ..+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999996542 2378999999999999999999999 9999999999999999999999999999876443
Q ss_pred CC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
.. ......+++.|+|||...+..++.++||||+|+++|||++ |+.||... .......... .+. ....+.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~~-~~~---~~~~~~ 228 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-----TNSEVVLKVS-QGH---RLYRPH 228 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHHHHH-TTC---CCCCCT
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc-----ChHHHHHHHH-cCC---CCCCCC
Confidence 32 2223345678999999988889999999999999999999 99999732 1222222221 111 111111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCcc
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRK 983 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 983 (1009)
. .+ ..+.+++.+|++.||++|||+.|+++.|+.+.++.+
T Consensus 229 ~---~~------~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k 267 (268)
T 3sxs_A 229 L---AS------DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267 (268)
T ss_dssp T---SC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred c---Ch------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence 1 11 246678899999999999999999999999987653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.93 Aligned_cols=265 Identities=25% Similarity=0.343 Sum_probs=204.0
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||+||+|.+..+++.||+|++............+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999999999999999997766555556777899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++ ++.+.+.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 5555554322 1278999999999999999999999 9999999999999999999999999999877555
Q ss_pred CCceeeecccCcccCCcccCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLK-VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
........+|+.|+|||+..+.. ++.++||||+||++|||++|..||.... +....................+..
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~----~~~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS----SHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC----CHHHHHHHHHHHhCCCChhhhhhh
Confidence 45555667899999999987665 7999999999999999999988864322 222222222211110000000000
Q ss_pred c---------------ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 937 A---------------GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 937 ~---------------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. ............+.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 000000011234567889999999999999999863
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=359.70 Aligned_cols=261 Identities=26% Similarity=0.408 Sum_probs=207.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCC---CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.++|+..+.||+|+||.||+|.+..+ +..||||++.... .....+.+.+|++++++++||||+++++++.+++..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 45688899999999999999999754 4569999996432 3444567779999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++|+|.++++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 127 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999965432 278999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCc---eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 854 MLHKNET---VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 854 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
....... .....+|+.|+|||++....++.++||||||+++|||++ |+.||... ........ +..+.
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-----~~~~~~~~-~~~~~--- 271 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM-----TNRDVISS-VEEGY--- 271 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS-----CHHHHHHH-HHTTC---
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC-----CHHHHHHH-HHcCC---
Confidence 6443321 222345778999999988889999999999999999999 99999632 11222222 22111
Q ss_pred cccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.......+. ..+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 272 ---~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 272 ---RLPAPMGCP------HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ---CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ---CCCCCCCcC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 111111111 24667889999999999999999999999986543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=354.65 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=204.4
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
.|+..+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 3666778999999999999999889999999986543 23356677999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 124 ~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 124 LQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp CCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence 9999999998653 278999999999999999999998 99999999999999999999999999998775544
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
.......||+.|+|||+..+..++.++||||||+++|||++|+.||... .....+... .... .+.+..
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~-----~~~~~~~~~-~~~~------~~~~~~ 263 (321)
T 2c30_A 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD-----SPVQAMKRL-RDSP------PPKLKN 263 (321)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHH-HHSS------CCCCTT
T ss_pred cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHH-hcCC------CCCcCc
Confidence 4445667999999999999889999999999999999999999999632 222222222 1111 111110
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.... ...+.+++.+|++.||++|||+.|+++
T Consensus 264 -~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 264 -SHKV---SPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -GGGS---CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -cccC---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011 124567888999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=360.33 Aligned_cols=267 Identities=26% Similarity=0.327 Sum_probs=206.2
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC----eEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET----NVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----~~~ 773 (1009)
++|+..+.||+|+||.||+|++. ++.||||++... ........+|+.++++++||||+++++++.+.. ..+
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 56889999999999999999886 689999998543 233444557899999999999999999998754 479
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhc-------CCCCeEEeccCCCcEEeCCCCcEEEc
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD-------CQPPVIHRDIKSNNILLDANLEARIA 846 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------~~~~ivH~dlk~~NIll~~~~~~kl~ 846 (1009)
+||||+++|+|.++++... +++..++.++.|+++||+|||+. +.++|+||||||+||+++.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 9999999999999996543 78999999999999999999975 23489999999999999999999999
Q ss_pred ccccceecccCCC--ceeeecccCcccCCcccCC-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCc-------
Q 037197 847 DFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYT-----LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSK------- 912 (1009)
Q Consensus 847 DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~------- 912 (1009)
|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999987654332 2233578999999998775 3566789999999999999999999975332211
Q ss_pred ----cHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 913 ----DIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 913 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
....+. ..... ....+.+..... ......++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 254 ~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 254 GQHPSLEDMQ-EVVVH-----KKKRPVLRDYWQ-KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CSSCCHHHHH-HHHTT-----SCCCCCCCGGGG-SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCchhhhh-hhhhc-----ccCCCCcccccc-ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111 11111 111222221111 112344578899999999999999999999999988643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=352.78 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=197.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh------------------------hhHHHHHHHHHHHh
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI------------------------ESGDDLFREVSLLG 752 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~ 752 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++....... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 356888999999999999999999999999999986543211 12356779999999
Q ss_pred ccCCCceeeEEeEEEc--CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEecc
Q 037197 753 RLRHRNIVRLLGYLHN--ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDI 830 (1009)
Q Consensus 753 ~l~Hpniv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl 830 (1009)
+++||||+++++++.+ ....++||||+++++|.+++... .+++.+++.++.|+++||+|||+. +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 56899999999999998876432 378999999999999999999999 9999999
Q ss_pred CCCcEEeCCCCcEEEcccccceecccCCCceeeecccCcccCCcccCCCC---CCcccchHhHHHHHHHHHhCCCCCCCC
Q 037197 831 KSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLK---VDEKSDIYSFGVVLLELLTGKMPLDPA 907 (1009)
Q Consensus 831 k~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlGvvl~elltg~~Pf~~~ 907 (1009)
||+||+++.++.+||+|||+++.............||+.|+|||...+.. ++.++||||||+++|||++|+.||...
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999999988755544455667999999999987654 378899999999999999999999732
Q ss_pred CCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 908 FGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
....... .+..... . .+.. ... . ..+.+++.+|++.||++||++.|+++
T Consensus 244 -----~~~~~~~-~~~~~~~--~--~~~~-~~~---~---~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 -----RIMCLHS-KIKSQAL--E--FPDQ-PDI---A---EDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -----SHHHHHH-HHHHCCC--C--CCSS-SCC---C---HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----cHHHHHH-HHhcccC--C--CCCc-ccc---C---HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2222222 2222110 0 0110 011 1 24567889999999999999999863
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=365.24 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=202.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l 774 (1009)
.+.|+..+.||+|+||.||+|+++.+++.||+|++++... .......+.+|..+++++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 3568899999999999999999999999999999976432 223344567899999887 89999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999875432 78999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC---CccHHHHHHHHHhhccccccc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG---SKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......+...+.....
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 279 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 279 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC----
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc----
Confidence 44455556678999999999999999999999999999999999999999643211 11122223333222211
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTM 968 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 968 (1009)
.+..... .++..++.+|++.||++||++
T Consensus 280 ---~~p~~~s------~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ---RIPRSLS------VKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---CCCTTSC------HHHHHHHHHHTCSCTTTSTTC
T ss_pred ---CCCCcCC------HHHHHHHHHHhcCCHhHcCCC
Confidence 1111111 245678899999999999996
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=364.75 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=209.6
Q ss_pred hcCCcCceeccCCceEEEEEEEC-------CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcC
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFH-------RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNE 769 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 769 (1009)
++|+..+.||+|+||.||+|.+. .++..||||+++.. ......+.+.+|+++++++ +||||+++++++.+.
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 56888999999999999999864 34678999999654 2344456778999999999 899999999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCccc------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAG------------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL 837 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 837 (1009)
+..++||||+++|+|.++++..... ...+++.+++.++.||++||+|||++ +|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 9999999999999999999764321 12378899999999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccH
Q 037197 838 DANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDI 914 (1009)
Q Consensus 838 ~~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~ 914 (1009)
+.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... ...+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~--~~~~ 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VEEL 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHH
Confidence 9999999999999987644332 2223456789999999988899999999999999999999 999997432 1222
Q ss_pred HHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 915 VEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.. .+..+. .+.....+. ..+.+++.+||+.||++||++.|+++.|+++..
T Consensus 315 ~~----~~~~~~------~~~~~~~~~------~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 315 FK----LLKEGH------RMDKPANCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp HH----HHHTTC------CCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH----HHhcCC------CCCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 22 122221 111111121 246678899999999999999999999998753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=370.69 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=208.6
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||+|.+..+++.||||+++.. ......+++.+|++++++++||||+++++++.+++..++|||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 4678889999999999999999988999999998643 233444566799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.++++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999997532 2378899999999999999999999 9999999999999999999999999999865332
Q ss_pred CCce--eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 858 NETV--SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 858 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
.... ....+++.|+|||.+....++.++|||||||++|||++ |+.||.... . ..+...+..+.. .
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~-----~-~~~~~~~~~~~~------~ 334 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-----N-QQTREFVEKGGR------L 334 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC-----H-HHHHHHHHTTCC------C
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----H-HHHHHHHHcCCC------C
Confidence 1111 11235678999999888889999999999999999998 999997421 1 112222222211 1
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.....++ ..+.+++.+||+.||++|||+.++++.|+++.++.
T Consensus 335 ~~~~~~~------~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 335 PCPELCP------DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp CCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCCC------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 1111121 24567889999999999999999999999986543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=350.00 Aligned_cols=276 Identities=34% Similarity=0.530 Sum_probs=215.8
Q ss_pred HHHHhcCCcC------ceeccCCceEEEEEEECCCCeEEEEEEcccCC--CChhhHHHHHHHHHHHhccCCCceeeEEeE
Q 037197 694 SEILACVKES------NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD--NDIESGDDLFREVSLLGRLRHRNIVRLLGY 765 (1009)
Q Consensus 694 ~~~~~~~~~~------~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~ 765 (1009)
..+++.|... +.||+|+||.||+|.+. ++.||||++.... ......+.+.+|++++++++||||++++++
T Consensus 21 ~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 98 (307)
T 2nru_A 21 KNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98 (307)
T ss_dssp HHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 4455556555 89999999999999873 6889999986542 223345667799999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEE
Q 037197 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARI 845 (1009)
Q Consensus 766 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 845 (1009)
+.+.+..++||||+++++|.+++..... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl 174 (307)
T 2nru_A 99 SSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKI 174 (307)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEE
Confidence 9999999999999999999999975432 23489999999999999999999999 9999999999999999999999
Q ss_pred cccccceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh
Q 037197 846 ADFGLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 846 ~DfGls~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
+|||++......... .....||+.|+|||...+ .++.++||||||+++|+|++|+.||...... .....+......
T Consensus 175 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~ 252 (307)
T 2nru_A 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIED 252 (307)
T ss_dssp CCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTTHHHHHHHT
T ss_pred eecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHHHHHHHhhh
Confidence 999999876443322 233568999999998764 5889999999999999999999999754322 222333333222
Q ss_pred hccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.........++.+.... ......+.+++.+|++.||++||++.|+++.|+++..
T Consensus 253 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 253 EEKTIEDYIDKKMNDAD---STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TSCCHHHHSCSSCSCCC---HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhhhhhhhccccccccc---hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 22223333444333222 2334567789999999999999999999999998763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=351.67 Aligned_cols=278 Identities=20% Similarity=0.289 Sum_probs=214.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC--eEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET--NVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~--~~~l 774 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|++++++++||||+++++++.... ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3568889999999999999999999999999999864322 233466679999999999999999999988665 7899
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe----CCCCcEEEccccc
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL----DANLEARIADFGL 850 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~DfGl 850 (1009)
||||+++++|.+++..... ...+++.+++.++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 87 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 9999999999999976543 22378999999999999999999999 99999999999999 7888899999999
Q ss_pred ceecccCCCceeeecccCcccCCcccC--------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGY--------TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ....+.+....
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~ 240 (319)
T 4euu_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP-RRNKEVMYKII 240 (319)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG-GGCHHHHHHHH
T ss_pred ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-chhHHHHHHHh
Confidence 98764433 333456999999999865 567899999999999999999999999754332 22233333333
Q ss_pred hhccccccc------------cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 923 KSNKAQDEA------------LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 923 ~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.... .... ..+.+...+.........+..++.+|++.||++|||++|+++...+....+
T Consensus 241 ~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~ 311 (319)
T 4euu_A 241 TGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG 311 (319)
T ss_dssp HHCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred cCCC-cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence 2211 0000 001111111222334455778999999999999999999999998876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=360.11 Aligned_cols=255 Identities=19% Similarity=0.284 Sum_probs=207.2
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
.+.+.|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+|++++++++||||+++++++.+....++
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 34678999999999999999999999999999999985432 3334567799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC--CCcEEEcccccce
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA--NLEARIADFGLAR 852 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~DfGls~ 852 (1009)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 126 v~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp EEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEcCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccce
Confidence 999999999999997543 2378999999999999999999999 9999999999999974 4689999999998
Q ss_pred ecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 853 MMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+.+......... .
T Consensus 200 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~~~~~~i~~~~~~----~ 269 (387)
T 1kob_A 200 KLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDLETLQNVKRCDWE----F 269 (387)
T ss_dssp ECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHHCCCC----C
T ss_pred ecCCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCC----C
Confidence 76433 3344567999999999999888999999999999999999999999732 222222222222111 1
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
++...... . .++.+++.+|++.||++|||+.|+++
T Consensus 270 ~~~~~~~~---s---~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 270 DEDAFSSV---S---PEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CSSTTTTS---C---HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CccccccC---C---HHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 11111111 1 24567889999999999999999987
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=369.80 Aligned_cols=345 Identities=28% Similarity=0.368 Sum_probs=180.6
Q ss_pred ccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEE
Q 037197 185 LQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVY 264 (1009)
Q Consensus 185 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 264 (1009)
+++|+.|++++|.++ .+| .+..+++|++|+|++|.+++..+ ++++++|++|++++|.+++..+ ++++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 344444444444444 222 24444444444444444443322 4455555555555555543332 45555555555
Q ss_pred cccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCc
Q 037197 265 LYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIG 344 (1009)
Q Consensus 265 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 344 (1009)
+++|.+++. +. +..+++|++|++++|.+++ ++ .+..+++|++|+++ |.+.+.. .+.++++|+.|++++|.+.+
T Consensus 119 L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 119 LFNNQITDI-DP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CCSSCCCCC-GG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCC-hH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCC
Confidence 555555532 21 4555555555555555553 22 25555555555554 3333321 24555555555555555443
Q ss_pred cCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCC
Q 037197 345 SLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGN 424 (1009)
Q Consensus 345 ~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~ 424 (1009)
. ..+..+++|+.|++++|.+++..| +..+++|+.|++++|++++. .. +..
T Consensus 192 ~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~------------------------l~~ 241 (466)
T 1o6v_A 192 I--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GT------------------------LAS 241 (466)
T ss_dssp C--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GG------------------------GGG
T ss_pred C--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hh------------------------hhc
Confidence 2 123344444444444444443322 33334444444444444321 12 334
Q ss_pred CCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEE
Q 037197 425 LPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLD 504 (1009)
Q Consensus 425 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~Ld 504 (1009)
+++|+.|++++|++++..| +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|+
T Consensus 242 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 315 (466)
T 1o6v_A 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLT 315 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEE
T ss_pred CCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEE
Confidence 4444444444444443322 4444455555555555544332 4455555555555555554333 56667777777
Q ss_pred eecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCcccc
Q 037197 505 LSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEG 584 (1009)
Q Consensus 505 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 584 (1009)
|++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++.+| +..++.|+.|++++|++++
T Consensus 316 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred CcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 77777776555 56777777777777777754 456777777777777777777766 6777777777777777776
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=356.92 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=202.9
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.|+..+.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 468889999999999999999999999999999976532 333455667899999988 899999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999996543 278899999999999999999999 99999999999999999999999999998654
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCC---ccHHHHHHHHHhhcccccccc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS---KDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+...+.....
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~----- 236 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----- 236 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-----
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-----
Confidence 44445556789999999999998899999999999999999999999997432111 1112222222222211
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTM 968 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 968 (1009)
.+..... ..+..++.+|++.||++||++
T Consensus 237 --~~p~~~s------~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 --RIPRSLS------VKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --CCCTTSC------HHHHHHHHHHTCSSTTTSTTC
T ss_pred --CCCCCCC------HHHHHHHHHHhcCCHhHCCCC
Confidence 1111111 245678899999999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=363.90 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=199.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l 774 (1009)
.++|+..+.||+|+||.||+|+++.+++.||||++.+... .........+|.++++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 4578899999999999999999999999999999864321 122345566899999988 79999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRR----FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999975432 78999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
...........||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+..........
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~~~~~~~i~~~~~-------- 241 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE-----NEDDLFEAILNDEV-------- 241 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC--------
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCC--------
Confidence 44444555678999999999998888999999999999999999999999732 22222222222111
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCH------HHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTM------RDVIT 973 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~------~evl~ 973 (1009)
.+..... ..+..++.+|++.||++||++ .|+++
T Consensus 242 ~~p~~~~------~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 VYPTWLH------EDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCTTSC------HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCC------HHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111111 235678899999999999998 66654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=364.07 Aligned_cols=261 Identities=25% Similarity=0.421 Sum_probs=198.6
Q ss_pred HhcCCcCceeccCCceEEEEEEEC---CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFH---RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
..+|+..+.||+|+||.||+|++. .++..||||+++... .....+.+.+|++++++++||||+++++++.+++..+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 357899999999999999999886 457789999996542 3445567789999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++|+|.++++.... .+++.+++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999976432 378999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCc---eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 854 MLHKNET---VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 854 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
....... .....+++.|+|||++....++.++||||||+++|||++ |+.||.... ..+.. ..+..+..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~-----~~~~~-~~i~~~~~-- 268 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-----NQDVI-KAVDEGYR-- 268 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC-----HHHHH-HHHHTTEE--
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC-----HHHHH-HHHHcCCC--
Confidence 6443221 122335678999999988899999999999999999998 999996321 11222 22222211
Q ss_pred cccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
......+ ...+.+++.+|++.||++||++.|+++.|+.+....
T Consensus 269 ----~~~~~~~------~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 ----LPPPMDC------PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ----CCCCTTC------BHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ----CCCCccc------cHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0001111 124667899999999999999999999999886543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.77 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=202.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 4678999999999999999999999999999999864422 222355679999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++|+|.+++..... +++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 85 e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp ECCTTEEGGGGSBTTTB----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EcCCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999975533 78999999999999999999998 999999999999999999999999999987643
Q ss_pred CC--CceeeecccCcccCCcccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 857 KN--ETVSMVAGSYGYIAPEYGYTLKV-DEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 857 ~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
.. .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||............+. .... ...
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~----~~~~----~~~ 229 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKKT----YLN 229 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH----TTCT----TST
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----cccc----cCC
Confidence 32 22345679999999999877665 7899999999999999999999975433322222221 1110 011
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
.. ... ...+.+++.+|++.||++|||+.|+++.
T Consensus 230 -~~----~~~---~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 -PW----KKI---DSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -TG----GGS---CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cc----ccC---CHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01 111 1235578899999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=349.60 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=197.0
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||.||+|.+ .+++.||+|++............+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 4688889999999999999998 458899999996654434445667799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++ +|.+++..... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCSE-EHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecCC-CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 9975 89998875432 278889999999999999999999 9999999999999999999999999999876444
Q ss_pred CCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc-------cc
Q 037197 858 NETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA-------QD 929 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------~~ 929 (1009)
........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+....+......... ..
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHHCCCChhhchhhhcc
Confidence 444445678999999998865 458999999999999999999999997421 11111111111110000 00
Q ss_pred cccCcccc--------ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 930 EALDPSIA--------GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 930 ~~~~~~~~--------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...++.+. ...... ..++.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGL---DESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSC---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhc---CHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00111110 000111 124567889999999999999999874
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=366.34 Aligned_cols=348 Identities=28% Similarity=0.394 Sum_probs=258.1
Q ss_pred ccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCe
Q 037197 87 RGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLES 166 (1009)
Q Consensus 87 ~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~ 166 (1009)
..+++|++|+++++.+.. +| .+..+++|++|+|++|.+.+..| ++++++|++|++++|.+++..+ ++++++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 346677888888887754 44 47778888888888888776543 7888888888888888875544 788888888
Q ss_pred eeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCcc
Q 037197 167 LDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSL 246 (1009)
Q Consensus 167 L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 246 (1009)
|++++|.+++..+ +.++++|++|++++|.+++ ++ .++.+++|++|+++ |.+.+.. .++++++|++|++++|.+
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l 189 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKV 189 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcC
Confidence 8888888875433 7788888888888888874 33 47778888888885 4554333 377888888888888887
Q ss_pred ccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCC
Q 037197 247 SGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKL 326 (1009)
Q Consensus 247 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l 326 (1009)
++. ..+..+++|++|++++|.+++..| ++.+++|++|++++|++++. ..+..+++|++|++++|++++..+ +
T Consensus 190 ~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~ 261 (466)
T 1o6v_A 190 SDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--L 261 (466)
T ss_dssp CCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred CCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--h
Confidence 654 347778888888888888876544 66778888888888888743 357778888888888888876644 7
Q ss_pred CCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccE
Q 037197 327 GELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVR 406 (1009)
Q Consensus 327 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~ 406 (1009)
..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..| +..+++|++
T Consensus 262 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 335 (466)
T 1o6v_A 262 SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQR 335 (466)
T ss_dssp TTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCE
T ss_pred hcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCE
Confidence 778888888888888776544 6777778888888888775443 6677778888888888776655 667778888
Q ss_pred EEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCccccc
Q 037197 407 VRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESY 465 (1009)
Q Consensus 407 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 465 (1009)
|++++|++++. ..+.++++|+.|++++|++++..| +..+++|+.|++++|.+++.
T Consensus 336 L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 336 LFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred eECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence 88888877754 357777788888888888876666 67777788888888877763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=356.16 Aligned_cols=262 Identities=16% Similarity=0.196 Sum_probs=210.6
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
++|+..+.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++++ +||||+++++++.+++..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 568889999999999999999999999999999865422 23467899999999 9999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc-----EEEcccccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE-----ARIADFGLA 851 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~-----~kl~DfGls 851 (1009)
||+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 999999997542 2389999999999999999999999 9999999999999999887 999999999
Q ss_pred eecccCCC-------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh
Q 037197 852 RMMLHKNE-------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS 924 (1009)
Q Consensus 852 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 924 (1009)
+.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..+.+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~--~~~~~~~~~i~~~ 235 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA--DTLKERYQKIGDT 235 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--SSHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc--ccHHHHHHHHHhh
Confidence 87644332 12456799999999999999999999999999999999999999975422 2333222222111
Q ss_pred ccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 925 NKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
... ... ...+...+ ++.+++.+|++.||++||++.++++.|+++..+.
T Consensus 236 ~~~----~~~--~~~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 236 KRA----TPI--EVLCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHH----SCH--HHHTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hcc----CCH--HHHhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 110 000 00011111 5678899999999999999999999999886554
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=348.29 Aligned_cols=261 Identities=26% Similarity=0.363 Sum_probs=201.5
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhc--cCCCceeeEEeEEEc----C
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGR--LRHRNIVRLLGYLHN----E 769 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~Hpniv~l~~~~~~----~ 769 (1009)
+.++|+..+.||+|+||.||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++.. .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 356789999999999999999988 4789999998432 33455567776666 799999999998654 3
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEeccCCCcEEeCCCC
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH--------HDCQPPVIHRDIKSNNILLDANL 841 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~dlk~~NIll~~~~ 841 (1009)
...++||||+++|+|.++++.. .+++..++.++.|+++||+||| +. +|+||||||+||+++.++
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTS
T ss_pred ceeEEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCC
Confidence 5589999999999999999643 2889999999999999999999 66 999999999999999999
Q ss_pred cEEEcccccceecccCCCc----eeeecccCcccCCcccCCC------CCCcccchHhHHHHHHHHHhC----------C
Q 037197 842 EARIADFGLARMMLHKNET----VSMVAGSYGYIAPEYGYTL------KVDEKSDIYSFGVVLLELLTG----------K 901 (1009)
Q Consensus 842 ~~kl~DfGls~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlGvvl~elltg----------~ 901 (1009)
.+||+|||+++........ .....||+.|+|||++.+. .++.++||||||+++|||++| +
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 9999999999876544332 2234789999999998766 456799999999999999999 8
Q ss_pred CCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 902 MPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 902 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
.||............. ........ ..+.+.... ........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 231 ~pf~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDM-RKVVCVDQ-----QRPNIPNRW-FSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CTTTTTSCSSCCHHHH-HHHHTTSC-----CCCCCCGGG-GGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccCCCCcchhhh-hHHHhccC-----CCCCCChhh-ccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 8886544433333222 22222111 111221110 0112345677899999999999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.21 Aligned_cols=256 Identities=23% Similarity=0.399 Sum_probs=207.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||.||+|.+.. ++.||+|++.... ...+++.+|++++++++||||+++++++.++...++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 467888999999999999999986 7789999996542 234567799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.++++.... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999975432 378899999999999999999999 9999999999999999999999999999765332
Q ss_pred C-CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 N-ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
. .......+++.|+|||......++.++||||+|+++|||++ |+.||... ......... ..+. .+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~-----~~~~~~~~~-~~~~------~~~ 227 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDI-STGF------RLY 227 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHH-HTTC------CCC
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH-hcCc------cCC
Confidence 2 12223446778999999988889999999999999999999 99999732 222222222 2111 111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
.....+ ..+.+++.+|++.||++||++.|+++.|+++.+.
T Consensus 228 ~~~~~~------~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 228 KPRLAS------THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCcCC------HHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111111 2466788999999999999999999999988654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=353.21 Aligned_cols=267 Identities=23% Similarity=0.350 Sum_probs=192.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|++.... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 356888999999999999999999999999999986543 2233456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCcc--ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 777 DYMPNDSLGEALHGKEA--GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||++ |+|.+++..... ....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 689998864321 122378889999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc-
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL- 932 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 932 (1009)
...........+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+...... ..+..
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~---~~~~~~ 233 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN--DEEQLKLIFDIMGT---PNESLW 233 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCS---CCTTTC
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCC---CChhHh
Confidence 544444455678999999999875 468999999999999999999999997321 11222222221110 00000
Q ss_pred ---------CccccccCc-hHH---------HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 933 ---------DPSIAGQCK-HVQ---------EEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 933 ---------~~~~~~~~~-~~~---------~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+.+..... ... .....+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000000 000 01125678999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=343.70 Aligned_cols=255 Identities=32% Similarity=0.562 Sum_probs=203.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhH-----HHHHHHHHHHhccCCCceeeEEeEEEcCCeE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESG-----DDLFREVSLLGRLRHRNIVRLLGYLHNETNV 772 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 772 (1009)
++|+..+.||+|+||.||+|.+..+++.||+|++.......... +.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 56888899999999999999999999999999986543322221 56779999999999999999999997665
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeccCCCcEEeCCCCc-----EEE
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP--VIHRDIKSNNILLDANLE-----ARI 845 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~NIll~~~~~-----~kl 845 (1009)
++||||+++|+|.+++..... .+++..++.++.|+++||+|||+. + |+||||||+||+++.++. +||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred eEEEEecCCCCHHHHHhcccC---CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 699999999999998865432 388999999999999999999998 8 999999999999988776 999
Q ss_pred cccccceecccCCCceeeecccCcccCCccc--CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh
Q 037197 846 ADFGLARMMLHKNETVSMVAGSYGYIAPEYG--YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 846 ~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
+|||+++... .......||+.|+|||++ ....++.++||||+|+++|||++|+.||....... .........
T Consensus 171 ~Dfg~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~ 244 (287)
T 4f0f_A 171 ADFGLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK---IKFINMIRE 244 (287)
T ss_dssp CCCTTCBCCS---SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH---HHHHHHHHH
T ss_pred CCCCcccccc---ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH---HHHHHHHhc
Confidence 9999997542 234456799999999997 45567899999999999999999999997543321 111222111
Q ss_pred hccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
.. ..+.+...++ ..+.+++.+|++.||++||++.|+++.|+++
T Consensus 245 ~~------~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 EG------LRPTIPEDCP------PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp SC------CCCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cC------CCCCCCcccC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 1122222222 2466788999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=352.81 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=200.5
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC----
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET---- 770 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~---- 770 (1009)
.+.++|+..+.||+|+||.||+|++..+++.||||++.... .....+.+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 35678999999999999999999999889999999996543 2344567789999999999999999999985543
Q ss_pred -----------------------------------------------------eEEEEEeccCCCChhhhhcCCcccccc
Q 037197 771 -----------------------------------------------------NVMMVYDYMPNDSLGEALHGKEAGKLL 797 (1009)
Q Consensus 771 -----------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~ 797 (1009)
+.++||||+++++|.+++...... ..
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~ 160 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL-ED 160 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG-GG
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc-cc
Confidence 389999999999999999876432 23
Q ss_pred ccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC------------ceeeec
Q 037197 798 VDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE------------TVSMVA 865 (1009)
Q Consensus 798 ~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~------------~~~~~~ 865 (1009)
.++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....... ......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 56777889999999999999999 999999999999999999999999999987654321 123356
Q ss_pred ccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHH
Q 037197 866 GSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQE 945 (1009)
Q Consensus 866 gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1009)
||+.|+|||++.+..++.++||||||+++|||++|..|+. ....... ...... .+ .....
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-------~~~~~~~-~~~~~~------~~------~~~~~ 297 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-------ERVRIIT-DVRNLK------FP------LLFTQ 297 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-------HHHHHHH-HHHTTC------CC------HHHHH
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-------HHHHHHH-HhhccC------CC------ccccc
Confidence 8999999999988899999999999999999999877643 1111111 111110 00 11122
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 946 EMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 946 ~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
....+.+++.+|++.||++||++.|+++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 2334577899999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=351.01 Aligned_cols=271 Identities=23% Similarity=0.319 Sum_probs=204.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCC-CChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|++.... .+......+.+|++++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 457899999999999999999999889999999996533 2344556677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|.+++.........+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999975433344488999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
..........+++.|+|||......++.++||||||+++|||++|+.||..... .............. .+.
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~------~~~ 258 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEQCDY------PPL 258 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C---CHHHHHHHHHTTCS------CCC
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---hHHHHHHHhhcccC------CCC
Confidence 444444456789999999999888899999999999999999999999964322 22222222211111 111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCcccc
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSI 985 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~ 985 (1009)
...... ..+.+++.+|++.||++||++.|+++.|+++.+.....
T Consensus 259 ~~~~~~------~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 259 PSDHYS------EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp CTTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred cccccC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 111111 24667889999999999999999999999998766543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=354.54 Aligned_cols=264 Identities=24% Similarity=0.359 Sum_probs=212.0
Q ss_pred HhcCCcCceeccCCceEEEEEEEC-----CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
.++|+..+.||+|+||.||+|.+. .+++.||||++... ......+.+.+|++++++++||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356888999999999999999873 45689999999643 234455677799999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCcc--------------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccC
Q 037197 772 VMMVYDYMPNDSLGEALHGKEA--------------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIK 831 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk 831 (1009)
.++||||+++++|.+++..... ....+++.+++.++.|+++||+|||++ +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999976432 123478999999999999999999999 99999999
Q ss_pred CCcEEeCCCCcEEEcccccceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 037197 832 SNNILLDANLEARIADFGLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAF 908 (1009)
Q Consensus 832 ~~NIll~~~~~~kl~DfGls~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~ 908 (1009)
|+||+++.++.+||+|||+++........ .....+++.|+|||...+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876443322 223456788999999888889999999999999999999 999997432
Q ss_pred CCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 909 GGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
. ...... +..+. .+....... ..+.+++.+|++.||++||++.|+++.|+++..++
T Consensus 258 ~--~~~~~~----~~~~~------~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 258 P--ERLFNL----LKTGH------RMERPDNCS------EEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp G--GGHHHH----HHTTC------CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred H--HHHHHH----hhcCC------cCCCCccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence 2 122222 22211 111111111 24667889999999999999999999999987655
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=351.62 Aligned_cols=264 Identities=28% Similarity=0.386 Sum_probs=203.4
Q ss_pred HhcCCcCceeccCCceEEEEEE----ECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc--CC
Q 037197 697 LACVKESNIIGMGGNGIVYKAE----FHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN--ET 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~ 770 (1009)
.++|+..+.||+|+||.||+|+ ...+++.||||++... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 3568889999999999999998 4567899999998543 34445677799999999999999999999854 35
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
..++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 68999999999999999976532 378899999999999999999998 999999999999999999999999999
Q ss_pred ceecccCCC---ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCC----------CCccHHHH
Q 037197 851 ARMMLHKNE---TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFG----------GSKDIVEW 917 (1009)
Q Consensus 851 s~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~----------~~~~~~~~ 917 (1009)
++....... ......+++.|+|||.+.+..++.++||||||+++|||++|..|+..... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987644332 22234467789999999888999999999999999999999999863210 00111111
Q ss_pred HHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 918 VLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
+........ .......++ .++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 241 ~~~~~~~~~------~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 241 LIELLKNNG------RLPRPDGCP------DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHTTC------CCCCCTTCC------HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccC------cCCCCcCcC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 222222111 111111111 246678899999999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=350.18 Aligned_cols=268 Identities=23% Similarity=0.312 Sum_probs=200.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 45788999999999999999999999999999999776555555667779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.++++.... +++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~----~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRG----VPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHHTSSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHhhhcC----CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999998865433 78899999999999999999999 999999999999999999999999999987755
Q ss_pred CCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh-----------
Q 037197 857 KNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS----------- 924 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~----------- 924 (1009)
.........+|+.|+|||+..+ ..++.++||||+|+++|+|++|+.||..... .+....+......
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD--VDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhccccccccccccc
Confidence 5444556678999999998765 6689999999999999999999999974211 1111111111100
Q ss_pred ccccccccCccccccCc---hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 925 NKAQDEALDPSIAGQCK---HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.........+....... ........+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000000000000 00011224667899999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=359.16 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=203.3
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l 774 (1009)
.+.|+..+.||+|+||.||+|+++.+++.||+|++.+... ..........|.++++.+ +||||+++++++.+.+..|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 4568889999999999999999999999999999965321 112345566899999877 99999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 96 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999997533 278899999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
...........||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+..... .... +
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~i-~~~~-------~ 235 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEEELFHSI-RMDN-------P 235 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHH-HHCC-------C
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHH-HhCC-------C
Confidence 44444455678999999999999889999999999999999999999999732 222222222 2221 1
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMR-DVI 972 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~-evl 972 (1009)
.+....+ ..+..++.+|++.||++||++. |++
T Consensus 236 ~~p~~~s------~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 FYPRWLE------KEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCCTTSC------HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCcccC------HHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1111111 2456788999999999999997 554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=371.95 Aligned_cols=348 Identities=20% Similarity=0.157 Sum_probs=217.0
Q ss_pred cEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEecccc
Q 037197 237 RYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCN 316 (1009)
Q Consensus 237 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 316 (1009)
+.++.++++++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 45666666665 4444432 45666666666666665666666666666666666666555666666666666666666
Q ss_pred ccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCc
Q 037197 317 QLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPV 396 (1009)
Q Consensus 317 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~ 396 (1009)
++++..+..|.++++|++|+|++|.+.+..+..+..+++|+.|++++|.+++..+..|..+++|+.|++++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 66665555566666666666666666555555555555555555555555544444555555555555555554444333
Q ss_pred ccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCccc
Q 037197 397 SLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSL 476 (1009)
Q Consensus 397 ~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 476 (1009)
.+.++++|+.|+|++|++++..+..+..+++|+.|++++|.+.+.+|..+....+|
T Consensus 171 ------------------------~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L 226 (477)
T 2id5_A 171 ------------------------ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226 (477)
T ss_dssp ------------------------HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCC
T ss_pred ------------------------HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccc
Confidence 44445555555555555554444445555555555555554444444444444466
Q ss_pred chhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCcc
Q 037197 477 QTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNN 556 (1009)
Q Consensus 477 ~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 556 (1009)
+.|++++|+++...+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|||++|
T Consensus 227 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 306 (477)
T 2id5_A 227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306 (477)
T ss_dssp SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence 66666666666544456777777888888888877777777777888888888888888777778888888888888888
Q ss_pred ccccccCcCcCCCCCCcEEecCCCccccCCCCCCcccccCCcccccCcCCCCCCC
Q 037197 557 SLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSVL 611 (1009)
Q Consensus 557 ~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lcg~~~ 611 (1009)
+|++..+..|..+++|++|+|++|++++..+....+.......+.++...|+.|.
T Consensus 307 ~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 307 QLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp CCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred cCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence 8887777777788888888888888877654322222233345566666776543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=343.13 Aligned_cols=255 Identities=23% Similarity=0.297 Sum_probs=207.4
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.++|+..+.||+|+||.||+|.+..+++.||+|++..........+.+.+|++++++++||||+++++++.++...++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 45678999999999999999999999999999999976655555566777999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc---EEEcccccce
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE---ARIADFGLAR 852 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~DfGls~ 852 (1009)
|||+++++|.+.+.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||.+.
T Consensus 84 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 99999999999886543 278899999999999999999999 9999999999999987655 9999999998
Q ss_pred ecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 853 MMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
..... .......||+.|+|||...+..++.++||||+|+++|+|++|+.||... +.............. ..
T Consensus 157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~---~~ 227 (284)
T 3kk8_A 157 EVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----DQHRLYAQIKAGAYD---YP 227 (284)
T ss_dssp ECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCC---CC
T ss_pred EcccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC-----chhHHHHHHHhcccc---CC
Confidence 76433 2334467899999999999989999999999999999999999999632 222222222211111 11
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+... . .. ..+.+++.+|++.||++|||+.|+++
T Consensus 228 ~~~~~-~---~~---~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SPEWD-T---VT---PEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTT-T---SC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhc-c---cC---HHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11111 1 11 24567889999999999999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=348.62 Aligned_cols=249 Identities=18% Similarity=0.214 Sum_probs=198.2
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l 774 (1009)
+.++|+..+.||+|+||+||+|.+..+++.||||++...........+...|+..+.++ +||||+++++++.+++..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 45789999999999999999999998899999999876655555566666777776666 89999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 778998886543 2389999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
... .......||+.|+|||++.+ .++.++|||||||++|||++|..|+.. . ... ..+..+ ...+
T Consensus 208 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~----~-~~~----~~~~~~-----~~~~ 271 (311)
T 3p1a_A 208 GTA-GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG----G-EGW----QQLRQG-----YLPP 271 (311)
T ss_dssp C-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS----H-HHH----HHHTTT-----CCCH
T ss_pred ccC-CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC----c-cHH----HHHhcc-----CCCc
Confidence 432 23344568999999998775 789999999999999999999766542 1 111 111111 1111
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+.... ...+.+++.+|++.||++|||+.|+++
T Consensus 272 ~~~~~~------~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 EFTAGL------SSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHTTS------CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccCC------CHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 121111 234678899999999999999999984
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.05 Aligned_cols=247 Identities=23% Similarity=0.301 Sum_probs=202.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|+..+.||+|+||.||+|++..+++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 568889999999999999999999999999999864321 1123455668999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999975432 78889999999999999999998 999999999999999999999999999987533
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
......||+.|+|||++.+..++.++|||||||++|||++|+.||... +............. .+
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~--------~~ 222 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----NTMKTYEKILNAEL--------RF 222 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHCCC--------CC
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCC--------CC
Confidence 233467999999999999889999999999999999999999999632 22222222222211 11
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
..... .++..++.+|++.||++|| ++.|+++
T Consensus 223 p~~~~------~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 PPFFN------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CTTSC------HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCC------HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11111 2456788899999999999 8888873
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=356.96 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=203.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCC-CChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.+.|+..+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|++++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356889999999999999999999999999999985432 1122345677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+.+|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVH----FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHTTCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999976432 78899999999999999999999 99999999999999999999999999998764
Q ss_pred cCCCceeeecccCcccCCcccCC---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYT---LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
. ........||+.|+|||++.. ..++.++|||||||++|||++|+.||...... .....+........
T Consensus 167 ~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~------ 237 (384)
T 4fr4_A 167 R-ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVHTFETTVV------ 237 (384)
T ss_dssp T-TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHHHHHHHHCCC------
T ss_pred C-CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhhccc------
Confidence 3 334455679999999999763 45889999999999999999999999743221 22222222211111
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT-MRDVIT 973 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~evl~ 973 (1009)
.+..... ..+..++.+|++.||++||+ +.++.+
T Consensus 238 --~~p~~~s------~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 --TYPSAWS------QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --CCCTTSC------HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --CCCCcCC------HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1111111 24567889999999999998 666654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=349.02 Aligned_cols=256 Identities=23% Similarity=0.305 Sum_probs=208.2
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh----hhHHHHHHHHHHHhccCCCceeeEEeEEEcCC
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI----ESGDDLFREVSLLGRLRHRNIVRLLGYLHNET 770 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~ 770 (1009)
.+.+.|+..+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|++++++++||||+++++++.++.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 45678999999999999999999999999999999997543222 13566779999999999999999999999999
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC----cEEEc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL----EARIA 846 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~ 846 (1009)
..++||||+++++|.+++.... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++ .+||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEc
Confidence 9999999999999999997543 278999999999999999999999 999999999999999887 79999
Q ss_pred ccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 847 DFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 847 DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
|||++...... .......||+.|+|||...+..++.++||||||+++|+|++|+.||... ...+.+........
T Consensus 162 Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~i~~~~~ 235 (321)
T 2a2a_A 162 DFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQETLANITSVSY 235 (321)
T ss_dssp CCTTCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHTTCC
T ss_pred cCccceecCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHhccc
Confidence 99999876443 2334456899999999998889999999999999999999999999632 22222222221111
Q ss_pred ccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..++...... ...+.+++.+|++.||++|||+.|+++
T Consensus 236 ----~~~~~~~~~~------~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 ----DFDEEFFSHT------SELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ----CCCHHHHTTC------CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ----ccChhhhccc------CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111111111 124567889999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=355.31 Aligned_cols=254 Identities=25% Similarity=0.303 Sum_probs=203.6
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEE
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~ 773 (1009)
.+.+.|+..+.||+|+||.||+|.++.+++.||||++.+... ...+|++++.++ +||||+++++++.+++..|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 467789999999999999999999999999999999965432 234688888888 7999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC----CcEEEcccc
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN----LEARIADFG 849 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~----~~~kl~DfG 849 (1009)
+||||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||++..+ +.+||+|||
T Consensus 93 lv~E~~~gg~L~~~i~~~~~----~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKF----FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTT----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 99999999999999976432 78999999999999999999999 99999999999998543 359999999
Q ss_pred cceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 850 LARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 850 ls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
+++.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.. ..+..+...
T Consensus 166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~-~~i~~~~~~- 241 (342)
T 2qr7_A 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEIL-ARIGSGKFS- 241 (342)
T ss_dssp TCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHH-HHHHHCCCC-
T ss_pred CcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHH-HHHccCCcc-
Confidence 998775555555567789999999998887789999999999999999999999974321 2222222 222222210
Q ss_pred cccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
........ .. ..+.+++.+|++.||++||++.|+++
T Consensus 242 --~~~~~~~~---~s---~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 --LSGGYWNS---VS---DTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --CCSTTTTT---SC---HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --cCcccccc---CC---HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11101011 11 24567888999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=356.61 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=200.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeE----EEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMV----VAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
++|+..+.||+|+||.||+|.+..+++. ||+|.+... ......+.+.+|++++++++||||+++++++.++. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 5688899999999999999998776654 578877543 22344567779999999999999999999998765 78
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+|+||+++|+|.+++..... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999976432 378899999999999999999999 999999999999999999999999999987
Q ss_pred cccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 854 MLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ...... +..+..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~----~~~~~~--- 237 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSI----LEKGER--- 237 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHH----HHTTCC---
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--HHHHHH----HHcCCC---
Confidence 644332 2233456789999999999999999999999999999999 9999974322 222222 221110
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
......+ ...+..++.+||+.||++||++.|+++.|+.+....
T Consensus 238 ---~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 238 ---LPQPPIC------TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ---CCCCTTB------CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred ---CCCCccC------CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 0111111 124667899999999999999999999999886643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=361.64 Aligned_cols=263 Identities=25% Similarity=0.338 Sum_probs=209.0
Q ss_pred HhcCCcCceeccCCceEEEEEE-----ECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCC
Q 037197 697 LACVKESNIIGMGGNGIVYKAE-----FHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNET 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~ 770 (1009)
.++|+..+.||+|+||.||+|. ...+++.||||++... ......+.+.+|+++++++ +||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 4678999999999999999998 4556799999999654 2334456677999999999 7999999999998754
Q ss_pred -eEEEEEeccCCCChhhhhcCCccc-------------------------------------------------------
Q 037197 771 -NVMMVYDYMPNDSLGEALHGKEAG------------------------------------------------------- 794 (1009)
Q Consensus 771 -~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------------------------- 794 (1009)
..++||||+++|+|.++++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 489999999999999999765421
Q ss_pred -------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC--ceeeec
Q 037197 795 -------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE--TVSMVA 865 (1009)
Q Consensus 795 -------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~--~~~~~~ 865 (1009)
+..+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....... ......
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 11278999999999999999999999 999999999999999999999999999987644332 233456
Q ss_pred ccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHH
Q 037197 866 GSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQ 944 (1009)
Q Consensus 866 gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1009)
+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ..+......+.. ........
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~~~~~~~~------~~~~~~~~--- 322 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCRRLKEGTR------MRAPDYTT--- 322 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-----HHHHHHHHHTCC------CCCCTTCC---
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-----HHHHHHHHcCCC------CCCCCCCC---
Confidence 8899999999988899999999999999999998 99999743222 122222222211 11111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 945 EEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 945 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.++.+++.+|++.||++|||+.|+++.|+.+.+
T Consensus 323 ---~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 323 ---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 246678899999999999999999999998763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=358.18 Aligned_cols=247 Identities=26% Similarity=0.333 Sum_probs=199.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++...... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35688899999999999999999999999999998543111 12234677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+ +|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 788998886543 278999999999999999999999 99999999999999999999999999998664
Q ss_pred cCCCceeeecccCcccCCcccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC-
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKV-DEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD- 933 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 933 (1009)
.. .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+....... ...+..
T Consensus 160 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~ 223 (336)
T 3h4j_B 160 DG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSC 223 (336)
T ss_dssp TS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSS
T ss_pred CC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcC
Confidence 33 33345679999999999887775 6899999999999999999999974322100 000000
Q ss_pred -ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 -PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 -~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+.... ...+.+++.+|++.||++|||+.|+++
T Consensus 224 ~~~~p~~~------s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 224 VYVMPDFL------SPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCCCTTS------CHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCCcccC------CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111111 124567889999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=353.21 Aligned_cols=262 Identities=24% Similarity=0.287 Sum_probs=204.3
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCC---CChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD---NDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET 770 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~ 770 (1009)
.++.++|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 677889999999999999999999999999999999985431 12344567779999999999999999999999999
Q ss_pred eEEEEEeccCCCChhhhhcCCcc------------------------------------ccccccHHHHHHHHHHHHHHH
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEA------------------------------------GKLLVDWVSRYNIAVGIAQGL 814 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~------------------------------------~~~~~~~~~~~~i~~~i~~~L 814 (1009)
..++||||+++|+|.+++..... ....+++..++.++.|+++||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999999853111 022356778889999999999
Q ss_pred HHHHhcCCCCeEEeccCCCcEEeCCCC--cEEEcccccceecccCCC----ceeeecccCcccCCcccCC--CCCCcccc
Q 037197 815 NYLHHDCQPPVIHRDIKSNNILLDANL--EARIADFGLARMMLHKNE----TVSMVAGSYGYIAPEYGYT--LKVDEKSD 886 (1009)
Q Consensus 815 ~~LH~~~~~~ivH~dlk~~NIll~~~~--~~kl~DfGls~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~sD 886 (1009)
+|||+. +|+||||||+||+++.++ .+||+|||+++.+..... ......||+.|+|||++.. ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998776 899999999987644321 2345678999999998764 67889999
Q ss_pred hHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCC
Q 037197 887 IYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP 966 (1009)
Q Consensus 887 v~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 966 (1009)
|||||+++|||++|+.||... .....+........ ....+... .. ...+.+++.+|++.||++||
T Consensus 259 iwslG~il~el~~g~~pf~~~-----~~~~~~~~~~~~~~---~~~~~~~~-~~------~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGV-----NDADTISQVLNKKL---CFENPNYN-VL------SPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC---CTTSGGGG-GS------CHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHCCCCCCCC-----ChHHHHHHHHhccc---ccCCcccc-cC------CHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999732 22222222222211 11111111 11 12456788999999999999
Q ss_pred CHHHHHH
Q 037197 967 TMRDVIT 973 (1009)
Q Consensus 967 s~~evl~ 973 (1009)
++.|+++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=352.53 Aligned_cols=248 Identities=23% Similarity=0.332 Sum_probs=179.8
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
.+.||+|+||.||+|.+..+++.||||++... ......+|+++++++. ||||+++++++.++...++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 47899999999999999999999999998432 3456668999999997 99999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC---cEEEcccccceecccCC
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL---EARIADFGLARMMLHKN 858 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~DfGls~~~~~~~ 858 (1009)
|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++......
T Consensus 91 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 91 GELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp CBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 99999997643 288999999999999999999999 999999999999998765 89999999998765555
Q ss_pred CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC--CccHHHHHHHHHhhccccccccCccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG--SKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.......+|+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+ +...+..+.. ....
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~---~~~~-- 237 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDF---SFEG-- 237 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCC---CCCS--
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCC---CCCc--
Confidence 5555667899999999999889999999999999999999999999743221 112222 2222222210 0010
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
........++.+++.+|++.||++|||++|++
T Consensus 238 ----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 238 ----EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp ----HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred ----ccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 00111123467889999999999999999886
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=355.95 Aligned_cols=251 Identities=24% Similarity=0.291 Sum_probs=203.7
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l 774 (1009)
.+.|+..+.||+|+||.||+|+++.+++.||+|++.+... .....+.+..|..+++.+ +||+|+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 3568889999999999999999999999999999865321 112345667899999988 89999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999975432 78899999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+..........
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~~~~~~~i~~~~~-------- 238 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-----DEDELFQSIMEHNV-------- 238 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC--------
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhCCC--------
Confidence 44444555678999999999999889999999999999999999999999732 22222222222111
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT-----MRDVIT 973 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 973 (1009)
.+....+ .++..++.+|++.||++||+ +.|+++
T Consensus 239 ~~p~~~s------~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 AYPKSMS------KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCCTTSC------HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCCC------HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111111 24567889999999999996 456553
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=356.41 Aligned_cols=264 Identities=27% Similarity=0.431 Sum_probs=210.3
Q ss_pred HhcCCcCceeccCCceEEEEEEEC-----CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
.++|+..+.||+|+||.||+|.+. .+++.||||+++... .....+.+.+|++++++++||||+++++++.+++.
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 457889999999999999999987 345899999996542 33445667799999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccc--------------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccC
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAG--------------------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIK 831 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~--------------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk 831 (1009)
.++||||+++|+|.++++..... ...+++.+++.++.||++||+|||++ +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 99999999999999999764211 13488999999999999999999999 99999999
Q ss_pred CCcEEeCCCCcEEEcccccceecccCC--CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 037197 832 SNNILLDANLEARIADFGLARMMLHKN--ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAF 908 (1009)
Q Consensus 832 ~~NIll~~~~~~kl~DfGls~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~ 908 (1009)
|+||+++.++.+||+|||+++...... .......+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~- 280 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM- 280 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC-
Confidence 999999999999999999998654332 22334567889999999888889999999999999999999 99999632
Q ss_pred CCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 909 GGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
...+.. ..+..+.. +.....++ ..+.+++.+||+.||++||++.|+++.|+++..+.
T Consensus 281 ----~~~~~~-~~~~~~~~------~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 281 ----AHEEVI-YYVRDGNI------LACPENCP------LELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp ----CHHHHH-HHHHTTCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred ----ChHHHH-HHHhCCCc------CCCCCCCC------HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 112222 22222211 11111111 24667889999999999999999999999998654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=352.87 Aligned_cols=262 Identities=26% Similarity=0.329 Sum_probs=198.2
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC----
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET---- 770 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~---- 770 (1009)
+.++|+..+.||+|+||.||+|.+..+++.||||++..... .......+.+|++++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 45678999999999999999999999999999999976433 2334456779999999999999999999987654
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
..++||||+++++|.++++... .+++.+++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred ccEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 3499999999999999997543 278999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCC---ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 851 ARMMLHKNE---TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 851 s~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...............
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-----~~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-----SPVSVAYQHVREDPI 237 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHCCCC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHhcCCCC
Confidence 987644322 223456899999999998889999999999999999999999999732 222222222222211
Q ss_pred cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHH-HHHHHhhcC
Q 037197 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRD-VITMLGEAK 979 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~e-vl~~L~~~~ 979 (1009)
..... .... ...+.+++.+|++.||++||++.+ +.+.+.+..
T Consensus 238 ~~~~~----~~~~------~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 238 PPSAR----HEGL------SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CHHHH----STTC------CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred Ccccc----cCCC------CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 00000 0011 124567889999999999996555 445665553
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=344.69 Aligned_cols=257 Identities=22% Similarity=0.328 Sum_probs=204.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+.. +..||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 3568888999999999999999885 7889999996542 23456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++..... .+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 99 EYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999976432 288999999999999999999999 999999999999999999999999999976533
Q ss_pred CC-CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 857 KN-ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 857 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
.. .......+|+.|+|||......++.++||||+|+++|||++ |+.||.... ....... +..+. ..
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~-~~~~~------~~ 240 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-----NSETAEH-IAQGL------RL 240 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHHH-HHTTC------CC
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC-----hhHHHHH-Hhccc------CC
Confidence 22 11223346778999999988889999999999999999998 999997421 1222222 22111 11
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
....... ..+.+++.+|++.||++|||+.|+++.|+++..+
T Consensus 241 ~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 YRPHLAS------EKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCC------HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1111111 2466788999999999999999999999988654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=344.47 Aligned_cols=264 Identities=15% Similarity=0.152 Sum_probs=210.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++.... ....+.+|+++++++ +|+|++++++++.++...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 456889999999999999999999999999999985442 223466899999999 799999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc-----EEEccccc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE-----ARIADFGL 850 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~-----~kl~DfGl 850 (1009)
|||+ +++|.+++..... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 9999999975432 378999999999999999999998 9999999999999988776 99999999
Q ss_pred ceecccCCC-------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh
Q 037197 851 ARMMLHKNE-------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 851 s~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
++....... ......||+.|+|||+..+..++.++||||||+++|||++|+.||...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~ 235 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--TNKQKYERIGE 235 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--CHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc--ccHHHHHHHHh
Confidence 987654332 234567999999999999889999999999999999999999999754322 11111111111
Q ss_pred hccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.... ...+.+...+ ...+.+++.+|++.||++||+++++++.|+++..+.
T Consensus 236 ~~~~---~~~~~~~~~~------~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 236 KKQS---TPLRELCAGF------PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHH---SCHHHHTTTS------CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hccC---ccHHHHHhhC------cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 1100 0000111111 124667889999999999999999999999987544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=357.75 Aligned_cols=265 Identities=23% Similarity=0.338 Sum_probs=208.1
Q ss_pred HhcCCcCceeccCCceEEEEEEE-----CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCC
Q 037197 697 LACVKESNIIGMGGNGIVYKAEF-----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNET 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~ 770 (1009)
.++|+..+.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 46788999999999999999997 3457789999996432 233456777999999999 8999999999999999
Q ss_pred eEEEEEeccCCCChhhhhcCCccc-------------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccC
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAG-------------------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIK 831 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk 831 (1009)
..++||||+++|+|.+++...... ...+++..++.++.||++||+|||+. +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 999999999999999999765321 12378899999999999999999999 99999999
Q ss_pred CCcEEeCCCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 037197 832 SNNILLDANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAF 908 (1009)
Q Consensus 832 ~~NIll~~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~ 908 (1009)
|+||+++.++.+||+|||++........ ......+|+.|+|||...+..++.++||||||+++|||+| |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654432 2233557889999999888889999999999999999998 999997432
Q ss_pred CCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 909 GGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.. ..+......+. .+......+ ..+..++.+||+.||++||++.|+++.|+.+....
T Consensus 280 ~~-----~~~~~~~~~~~------~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 VD-----ANFYKLIQNGF------KMDQPFYAT------EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CS-----HHHHHHHHTTC------CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cH-----HHHHHHHhcCC------CCCCCCCCC------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 21 11222222221 111111111 24667889999999999999999999999987654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=363.82 Aligned_cols=254 Identities=20% Similarity=0.270 Sum_probs=202.1
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.+.|+..+.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999999999999999854211 111223466899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++|+|.++++... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 148 ~E~~~gg~L~~~l~~~~-----~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp ECCCTTEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCCCcHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 99999999999996532 78888889999999999999999 99999999999999999999999999998764
Q ss_pred cCCC-ceeeecccCcccCCcccCCCC----CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 856 HKNE-TVSMVAGSYGYIAPEYGYTLK----VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 856 ~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
.... ......||+.|+|||++.... ++.++|||||||++|||++|+.||... +..............
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~~~~~~--- 291 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----SLVGTYSKIMNHKNS--- 291 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTHHHH---
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC-----ChhhHHHHHHhcccc---
Confidence 4332 233567999999999987654 789999999999999999999999732 222222222221110
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKG--RPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~ 973 (1009)
...+... .. . .++..++.+|++.+|++ ||++.|+++
T Consensus 292 ~~~p~~~-~~---s---~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 292 LTFPDDN-DI---S---KEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp CCCCTTC-CC---C---HHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ccCCCcc-cc---c---HHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0011100 11 1 24567888999999999 999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=361.10 Aligned_cols=264 Identities=25% Similarity=0.350 Sum_probs=208.5
Q ss_pred HhcCCcCceeccCCceEEEEEEE-----CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 697 LACVKESNIIGMGGNGIVYKAEF-----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
.++|+..+.||+|+||.||+|.+ ..+++.||||++... .......++.+|+.++++++||||+++++++.+...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 35688889999999999999994 446789999999543 234445567799999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCcc---ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC---cEEE
Q 037197 772 VMMVYDYMPNDSLGEALHGKEA---GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL---EARI 845 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl 845 (1009)
.++||||+++|+|.++++.... ....+++.+++.++.||++||+|||++ +|+||||||+||+++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999975432 223488999999999999999999999 999999999999999555 5999
Q ss_pred cccccceecccCC--CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHH
Q 037197 846 ADFGLARMMLHKN--ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 846 ~DfGls~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||... ...+.. ..+
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~-----~~~~~~-~~i 299 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-----SNQEVL-EFV 299 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHH-HHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----CHHHHH-HHH
Confidence 9999998653322 23334567899999999988899999999999999999998 99999732 222222 222
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
..+.. ......+. ..+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 300 ~~~~~------~~~~~~~~------~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 300 TSGGR------MDPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HTTCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HcCCC------CCCCccCC------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 22211 11111111 24567889999999999999999999999886544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=353.25 Aligned_cols=248 Identities=19% Similarity=0.234 Sum_probs=203.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.++|+..+.||+|+||.||+|++..+++.||+|++.+... .....+.+.+|++++++++||||+++++++.+....|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 3568889999999999999999999999999999854321 122345677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999975432 78899999999999999999999 99999999999999999999999999998763
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+....... +.. .
T Consensus 193 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~i~~-~~~-------~ 256 (350)
T 1rdq_E 193 GR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QPIQIYEKIVS-GKV-------R 256 (350)
T ss_dssp SC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHH-CCC-------C
T ss_pred CC---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC-----CHHHHHHHHHc-CCC-------C
Confidence 32 23457999999999999889999999999999999999999999732 22222222222 211 1
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT-----MRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 973 (1009)
+..... ..+..++.+|++.||++||+ +.|+++
T Consensus 257 ~p~~~~------~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 FPSHFS------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTTCC------HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCC------HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111111 24567889999999999998 777764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=353.37 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=189.0
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.+.|+..+.||+|+||.||+|++..+++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 3567888999999999999999999999999999996532 234566899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC---CCcEEEcccccce
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA---NLEARIADFGLAR 852 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~DfGls~ 852 (1009)
|||+++|+|.+++..... +++.+++.++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 127 ~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGY----YSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp ECCCCSCBHHHHHTTCSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEeCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 999999999999975432 78899999999999999999999 9999999999999975 8899999999998
Q ss_pred ecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 853 MMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+.... ....
T Consensus 200 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~i~~~~--~~~~ 271 (349)
T 2w4o_A 200 IVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----QFMFRRILNCE--YYFI 271 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----HHHHHHHHTTC--CCCC
T ss_pred ccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----HHHHHHHHhCC--CccC
Confidence 65332 2334567899999999999888999999999999999999999999643211 11112222111 0111
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+... .. ...+.+++.+|++.||++|||+.|+++
T Consensus 272 ~~~~~-~~------~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 SPWWD-EV------SLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTT-TS------CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Cchhh-hC------CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 11 124567889999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=357.94 Aligned_cols=251 Identities=25% Similarity=0.291 Sum_probs=196.0
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHH-HhccCCCceeeEEeEEEcCCeEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSL-LGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.|+..+.||+|+||.||+|+++.+++.||+|++.+.... ......+++|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 5688899999999999999999999999999999765322 2233455677776 5778999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999997543 278888889999999999999999 99999999999999999999999999998654
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+.......... .+.+.
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~~~~~~~i~~~~~----~~~~~ 261 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----NTAEMYDNILNKPL----QLKPN 261 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-----BHHHHHHHHHHSCC----CCCSS
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhccc----CCCCC
Confidence 4444555678999999999999989999999999999999999999999732 22233222222111 11111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
+ . ..+..++.+|++.||++||++.+.+++
T Consensus 262 ~----~------~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 262 I----T------NSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp S----C------HHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred C----C------HHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 1 1 235678899999999999998644433
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.55 Aligned_cols=265 Identities=23% Similarity=0.285 Sum_probs=201.7
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
..++|+..+.||+|+||.||+|.+..+++.||+|++..... +....+.+.+|++++++++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 45778999999999999999999998899999999865432 22334667799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++++|.+++.... .+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999999997543 278999999999999999999999 9999999999999999999999999999766
Q ss_pred ccCC-CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 855 LHKN-ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 855 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
.... .......+++.|+|||...+..++.++||||||+++|||++|+.||... . ...+...+...........
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~-~~~~~~~~~~~~~~~~~~~ 258 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-----Q-LSVMGAHINQAIPRPSTVR 258 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC-----H-HHHHHHHHHSCCCCGGGTS
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc-----h-HHHHHHHhccCCCCccccC
Confidence 4432 2233456899999999998888999999999999999999999999732 1 1222222222211111111
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHhhcCCCcc
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-TMRDVITMLGEAKPRRK 983 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~L~~~~~~~~ 983 (1009)
+.+ + ..+.+++.+|++.||++|| ++.++++.|+.+.....
T Consensus 259 ~~~----~------~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 259 PGI----P------VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp TTC----C------THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CCC----C------HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 111 1 1356788999999999999 99999999999876553
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=356.39 Aligned_cols=248 Identities=21% Similarity=0.282 Sum_probs=204.7
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChh------hHHHHHHHHHHHhccCCCceeeEEeEEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE------SGDDLFREVSLLGRLRHRNIVRLLGYLH 767 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~Hpniv~l~~~~~ 767 (1009)
.++.++|+..+.||+|+||.||+|.+..+++.||||++........ ....+.+|++++++++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4567889999999999999999999999999999999976532211 2334568999999999999999999999
Q ss_pred cCCeEEEEEeccCCC-ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEc
Q 037197 768 NETNVMMVYDYMPND-SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIA 846 (1009)
Q Consensus 768 ~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 846 (1009)
+.+..++||||+.+| +|.+++..... +++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~----l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEe
Confidence 999999999999777 99999976543 78999999999999999999999 99999999999999999999999
Q ss_pred ccccceecccCCCceeeecccCcccCCcccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc
Q 037197 847 DFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKV-DEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN 925 (1009)
Q Consensus 847 DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 925 (1009)
|||+++..... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 173 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 173 DFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp CCTTCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred ecccceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 99999876443 33345679999999999887776 78999999999999999999999631100
Q ss_pred cccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 926 KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
......+ .... ...+.+++.+|++.||++|||+.|+++-
T Consensus 237 --~~~~~~~--~~~~------~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 --VEAAIHP--PYLV------SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --TTTCCCC--SSCC------CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --HhhccCC--Cccc------CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000110 0011 1246678899999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=354.49 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=198.6
Q ss_pred cCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 702 ESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 702 ~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
..+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 356899999999999999999999999999653 234456677999999999999999999999999999999999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe--CCCCcEEEcccccceecccCCC
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL--DANLEARIADFGLARMMLHKNE 859 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll--~~~~~~kl~DfGls~~~~~~~~ 859 (1009)
++|.+++.... ..+++..++.++.||++||+|||+. +|+||||||+||++ +.++.+||+|||+++.+....
T Consensus 171 ~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 171 GELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp CEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 99999886542 2378899999999999999999999 99999999999999 567899999999998764332
Q ss_pred ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccccc
Q 037197 860 TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (1009)
......||+.|+|||++....++.++|||||||++|||++|+.||... +....+........... ..... .
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-----~~~~~~~~i~~~~~~~~---~~~~~-~ 314 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD-----NDAETLNNILACRWDLE---DEEFQ-D 314 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHTCCCSC---SGGGT-T
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhccCCCC---hhhhc-c
Confidence 334456999999999998888999999999999999999999999732 22233333332221111 11111 1
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhhc
Q 037197 940 CKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT--MLGEA 978 (1009)
Q Consensus 940 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~ 978 (1009)
. ..++.+++.+|++.||++||++.|+++ .+.+.
T Consensus 315 ---~---~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 315 ---I---SEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ---S---CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ---C---CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 1 124567889999999999999999987 55443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.93 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=182.2
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.++|+..+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35688899999999999999999888999999998543111 12235677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|.+++.... ..+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999997643 2378999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
..........|++.|+|||...+..++.++||||||+++|||++|+.||...... . .... .. ..+..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~---~~~~----~~----~~~~~ 230 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--N---TLNK----VV----LADYE 230 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------CC----SSCCC
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH--H---HHHH----Hh----hcccC
Confidence 4444444567899999999998888999999999999999999999999743221 0 0000 00 00111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.....+ .++.+++.+|++.||++||+++|+++
T Consensus 231 ~~~~~~------~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 MPSFLS------IEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCTTSC------HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CccccC------HHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 111111 24567899999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=341.49 Aligned_cols=257 Identities=24% Similarity=0.328 Sum_probs=200.3
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
.+.++|...+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 456789999999999999999999999999999999865432 2335677799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe---CCCCcEEEcccccc
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLA 851 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~DfGls 851 (1009)
||||+++|+|.+++.........+++..++.++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999999865433334488999999999999999999999 99999999999999 45678999999999
Q ss_pred eecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 852 RMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
...... .......||+.|+|||.+. ..++.++||||||+++|||++|+.||... ...... ........
T Consensus 175 ~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~-----~~~~~~-~~~~~~~~---- 242 (285)
T 3is5_A 175 ELFKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT-----SLEEVQ-QKATYKEP---- 242 (285)
T ss_dssp CC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHH-HHHHHCCC----
T ss_pred eecCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC-----CHHHHH-hhhccCCc----
Confidence 765432 2334567899999999875 56899999999999999999999999732 112221 11111111
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.......... .++.+++.+|++.||++|||+.|+++
T Consensus 243 ---~~~~~~~~~~---~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 ---NYAVECRPLT---PQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---CCCC--CCCC---HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---ccccccCcCC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0100101111 24567889999999999999999974
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=342.68 Aligned_cols=261 Identities=29% Similarity=0.452 Sum_probs=197.9
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|++.. .||+|++..........+.+.+|++++++++||||+++++++ .....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 4568899999999999999998754 599999976665566667788999999999999999999976 455689999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999965432 378899999999999999999999 999999999999999999999999999976543
Q ss_pred CC--CceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 857 KN--ETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 857 ~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
.. .......||+.|+|||.+. ...++.++||||||+++|||++|+.||..... ...+...+..+..
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~---- 243 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----RDQIIEMVGRGSL---- 243 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----HHHHHHHHHHTSC----
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-----HHHHHHHhccccc----
Confidence 22 2334457899999999876 56688899999999999999999999974321 1222222222221
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.+.+........ ..+.+++.+|++.||++||++.|+++.|+++.+
T Consensus 244 -~~~~~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 -SPDLSKVRSNCP---KRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -CCCTTSSCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -CcchhhccccCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111111111111 246678899999999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=352.27 Aligned_cols=265 Identities=21% Similarity=0.284 Sum_probs=194.5
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
..++|+..+.||+|+||.||+|.+..+++.||||++............+.+|++++++++||||+++++++.+++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 45679999999999999999999999999999999976554444456677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC-----CCCcEEEccccc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD-----ANLEARIADFGL 850 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-----~~~~~kl~DfGl 850 (1009)
|||++ |+|.+++..... +++..+..++.||++||+|||+. +|+||||||+||+++ +++.+||+|||+
T Consensus 112 ~e~~~-~~L~~~~~~~~~----~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNPD----VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCS-EEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCC-CCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 99997 599999876543 78899999999999999999999 999999999999994 455699999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc-ccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN-KAQ 928 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~ 928 (1009)
++.............+|+.|+|||++.+. .++.++|||||||++|||++|+.||... .....+....... ...
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD-----SEIDQLFKIFEVLGLPD 258 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHHHCCCC
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC-----CHHHHHHHHHHHhCCCc
Confidence 98765444455556789999999998764 4899999999999999999999999732 1122222222111 100
Q ss_pred cccc---------CccccccCc-hHHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 929 DEAL---------DPSIAGQCK-HVQE-----EMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 929 ~~~~---------~~~~~~~~~-~~~~-----~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.... ...+..... .... ...++.+++.+|++.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 000000000 0000 1134678999999999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.97 Aligned_cols=260 Identities=24% Similarity=0.302 Sum_probs=208.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEE--cCCeEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLH--NETNVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~--~~~~~~l 774 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|++..........+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 35788899999999999999999999999999999766555566677789999999999999999999874 4678999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCC-----eEEeccCCCcEEeCCCCcEEEcccc
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP-----VIHRDIKSNNILLDANLEARIADFG 849 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~dlk~~NIll~~~~~~kl~DfG 849 (1009)
||||+++++|.+++.........+++..++.++.|+++||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999976544444589999999999999999999998 7 9999999999999999999999999
Q ss_pred cceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 850 LARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 850 ls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
.++.............|++.|+|||...+..++.++||||||+++|+|++|+.||.... ... +...+..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~-~~~~i~~~~~-- 233 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----QKE-LAGKIREGKF-- 233 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHH-HHHHHHHTCC--
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-----HHH-HHHHHhhccc--
Confidence 99776443333334568999999999988889999999999999999999999997421 112 2222222221
Q ss_pred cccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
+.+...++ .++.+++.+|++.||++||++.|+++.+..
T Consensus 234 ----~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 ----RRIPYRYS------DELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ----CCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----ccCCcccC------HHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11111111 245678899999999999999999986543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=354.04 Aligned_cols=259 Identities=23% Similarity=0.334 Sum_probs=202.6
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeE----EEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMV----VAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
++|+..+.||+|+||.||+|.+..+++. ||+|.+.... .......+.+|+.++++++||||+++++++. +...+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 4578889999999999999999877665 7778774332 2233345668999999999999999999986 45689
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++|+|.+++..... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGG---GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHccc---cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999976532 378889999999999999999999 999999999999999999999999999987
Q ss_pred cccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 854 MLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
...... ......+++.|+|||++....++.++||||||+++|||++ |+.||...... .... .+..+.. .
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~----~~~~~~~--~ 236 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPD----LLEKGER--L 236 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHH----HHHTTCB--C
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHH----HHHcCCC--C
Confidence 644332 3344567889999999988889999999999999999999 99999743221 2222 2222210 0
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
....... ..+..++.+||+.||++||++.|+++.|+.+....
T Consensus 237 ~~~~~~~----------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 237 AQPQICT----------IDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp CCCTTBC----------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred CCCCcCc----------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1111111 12456888999999999999999999999987654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=340.04 Aligned_cols=254 Identities=21% Similarity=0.331 Sum_probs=206.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC--CeEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE--TNVMMV 775 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~lV 775 (1009)
++|+..+.||+|+||.||+|++. ++.||||++..........+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 56888899999999999999986 78899999977655566667788999999999999999999999877 788999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP--VIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
|||+++|+|.++++... ...+++..++.++.|+++||+|||+. + |+||||||+||+++.++.++++|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999997643 22479999999999999999999998 7 99999999999999999999999988754
Q ss_pred cccCCCceeeecccCcccCCcccCCCCCCc---ccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYTLKVDE---KSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
... ....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||... .............
T Consensus 163 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~~~~~~~~~~~----- 227 (271)
T 3kmu_A 163 FQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-----SNMEIGMKVALEG----- 227 (271)
T ss_dssp TSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS-----CHHHHHHHHHHSC-----
T ss_pred ecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc-----ChHHHHHHHHhcC-----
Confidence 322 2245789999999987665544 799999999999999999999732 2222222222221
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
..+.+....+ ..+.+++.+|++.||++|||+.|+++.|+++.+
T Consensus 228 -~~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 -LRPTIPPGIS------PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -CCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -CCCCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1122222222 246678899999999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=349.69 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=192.7
Q ss_pred HhcCCcCceeccCCceEEEEEEEC---CCCeEEEEEEcccCCC--ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFH---RPHMVVAVKKLWRSDN--DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
.++|+..+.||+|+||.||+|++. .+++.||+|++.+... .......+.+|++++++++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 356889999999999999999985 5789999999965432 12234456689999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++||||+++++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999996543 278888999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 852 RMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
+.............||+.|+|||++.+..++.++||||||+++|||++|+.||... +....+........
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~i~~~~~----- 238 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE-----NRKKTIDKILKCKL----- 238 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHTCC-----
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHhCCC-----
Confidence 76544444444567999999999998888999999999999999999999999732 22222222222211
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
.+..... ..+.+++.+|++.||++|| ++.|+++
T Consensus 239 ---~~p~~~~------~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ---NLPPYLT------QEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---CCCTTSC------HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---CCCCCCC------HHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1111111 2456788999999999999 6777765
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=360.06 Aligned_cols=278 Identities=20% Similarity=0.290 Sum_probs=215.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC--eEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET--NVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~--~~~l 774 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|++++++++||||+++++++.+.. ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 3568899999999999999999999999999999864321 233456679999999999999999999998755 7899
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe----CCCCcEEEccccc
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL----DANLEARIADFGL 850 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~DfGl 850 (1009)
||||+++|+|.++++..... ..+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 87 v~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999999765432 2378999999999999999999999 99999999999999 7788899999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCC--------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYT--------LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
++...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ...+.+....
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~-~~~~~~~~~~ 240 (396)
T 4eut_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-RNKEVMYKII 240 (396)
T ss_dssp CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT-TCHHHHHHHH
T ss_pred ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc-chHHHHHHHh
Confidence 98764332 3334569999999998654 567889999999999999999999997543322 2223333332
Q ss_pred hhccccccc------------cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 923 KSNKAQDEA------------LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 923 ~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
. +...... ....+...+.-.......+..++.+|++.||++||++.|+++.++++..++
T Consensus 241 ~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 241 T-GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp H-SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred c-CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 2 2111100 001111111212334455778999999999999999999999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=353.80 Aligned_cols=267 Identities=22% Similarity=0.310 Sum_probs=194.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCe---EEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeE-
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHM---VVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNV- 772 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~- 772 (1009)
.++|+..+.||+|+||.||+|.+..++. .||||++..........+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 3568899999999999999999887654 899999976544555667788999999999999999999999877655
Q ss_pred -----EEEEeccCCCChhhhhcCCcc--ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEE
Q 037197 773 -----MMVYDYMPNDSLGEALHGKEA--GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARI 845 (1009)
Q Consensus 773 -----~lV~E~~~~gsL~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 845 (1009)
++||||+++|+|.+++..... ....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence 999999999999999864432 222488999999999999999999999 9999999999999999999999
Q ss_pred cccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHH
Q 037197 846 ADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 846 ~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~---- 252 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEIYNYL---- 252 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHH----
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh--HHHHHHH----
Confidence 99999987644332 2233456789999999988889999999999999999999 9999974322 1222211
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCccc
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKS 984 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 984 (1009)
..+.. ....... ...+.+++.+|++.||++|||+.|+++.|+++......
T Consensus 253 ~~~~~------~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 253 IGGNR------LKQPPEC------MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp HTTCC------CCCCTTC------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred hcCCC------CCCCCcc------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 11110 0111111 12466789999999999999999999999998765543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.74 Aligned_cols=254 Identities=23% Similarity=0.253 Sum_probs=204.2
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.++.++|+..+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 4467789999999999999999999999999999999865432 33566779999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe---CCCCcEEEccccc
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGL 850 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~DfGl 850 (1009)
+||||+++++|.+++..... +++..++.++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~ 155 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRV----FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGL 155 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeccCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence 99999999999998865432 78999999999999999999999 99999999999999 7888999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
+...... .......+|+.|+|||...+ .++.++||||||+++|||++|+.||... ...............
T Consensus 156 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~--- 225 (277)
T 3f3z_A 156 AARFKPG-KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAP-----TDSEVMLKIREGTFT--- 225 (277)
T ss_dssp CEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCC---
T ss_pred ceeccCc-cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHhCCCC---
Confidence 9876433 33345579999999998765 4899999999999999999999999742 112222222111110
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
........ ....+.+++.+|++.||++||++.|+++
T Consensus 226 -~~~~~~~~------~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 -FPEKDWLN------VSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CCHHHHTT------SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCchhhhc------CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000001 1134667889999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=358.27 Aligned_cols=204 Identities=31% Similarity=0.508 Sum_probs=168.0
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCC--
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNET-- 770 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~-- 770 (1009)
..+.++|+..+.||+|+||.||+|.+..+++.||||++..............+|+.+++++. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 45678899999999999999999999999999999999766555666777889999999997 999999999997544
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
..|+||||++ ++|.++++.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 7899999997 6899988653 278888899999999999999999 999999999999999999999999999
Q ss_pred ceecccC---------------------CCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 851 ARMMLHK---------------------NETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 851 s~~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
++.+... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 9865321 112334579999999998876 6789999999999999999999999973
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=366.32 Aligned_cols=262 Identities=24% Similarity=0.323 Sum_probs=198.4
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC------
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE------ 769 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------ 769 (1009)
+.++|+..+.||+|+||.||+|.+..+++.||||++..........+++.+|+++++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 35679999999999999999999999999999999976544555667788999999999999999999999654
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFG 849 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 849 (1009)
...|+||||++++ +.+.+... +++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~~------l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeCCCCC-HHHHHhhc------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence 4579999999765 66666432 78888999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh-cccc
Q 037197 850 LARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS-NKAQ 928 (1009)
Q Consensus 850 ls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~ 928 (1009)
+++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||... +....+...+.. +...
T Consensus 210 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~-----~~~~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 210 LARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR-----DYIDQWNKVIEQLGTPC 283 (464)
T ss_dssp CC------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHHHCSCC
T ss_pred eeeecCC-CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHhcCCCC
Confidence 9987643 23344567999999999999999999999999999999999999999732 111122111111 1100
Q ss_pred ccc--------------------------cCccc-cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 929 DEA--------------------------LDPSI-AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 929 ~~~--------------------------~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+. +...+ ............++.+++.+|++.||++|||++|+++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00000 0000111112345788999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.43 Aligned_cols=264 Identities=23% Similarity=0.303 Sum_probs=207.3
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh----hhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI----ESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
+.++|+..+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|++++++++||||+++++++.+...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3467899999999999999999999989999999986543221 235667799999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC----cEEEcc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL----EARIAD 847 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~D 847 (1009)
.++||||+++++|.+++.... .+++.+++.++.|+++||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEe
Confidence 999999999999999996532 378999999999999999999999 999999999999998877 899999
Q ss_pred cccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 848 FGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 848 fGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
||.+....... ......+++.|+|||......++.++||||||+++|+|++|+.||... ..............
T Consensus 156 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~- 228 (283)
T 3bhy_A 156 FGIAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE-----TKQETLTNISAVNY- 228 (283)
T ss_dssp CTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTTCC-
T ss_pred cccceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc-----chHHHHHHhHhccc-
Confidence 99998764332 234456899999999998888999999999999999999999999732 11222222111111
Q ss_pred cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhhcCCCc
Q 037197 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT--MLGEAKPRR 982 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~~~~~ 982 (1009)
...+...... ...+.+++.+|++.||++||++.|+++ .++.+..+.
T Consensus 229 ---~~~~~~~~~~------~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 229 ---DFDEEYFSNT------SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp ---CCCHHHHTTC------CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred ---CCcchhcccC------CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 1111111111 124667889999999999999999997 556554443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.32 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=207.7
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4678899999999999999999999999999999865432 334456677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|.+++.... .+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999886533 278999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
..........|++.|+|||...+..++.++||||||+++|+|++|+.||... ...+.......... .
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~--------~ 233 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-----CLKETYLRIKKNEY--------S 233 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTTCC--------C
T ss_pred cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhhccC--------C
Confidence 4444445567899999999998888999999999999999999999999732 22222222211111 1
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+..... ..+.+++.+|++.||++||++.|+++
T Consensus 234 ~~~~~~------~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 234 IPKHIN------PVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCTTSC------HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CccccC------HHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111111 24567889999999999999999987
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=354.45 Aligned_cols=253 Identities=23% Similarity=0.299 Sum_probs=194.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 4578999999999999999999999999999999965432 2355679999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc--EEEcccccceec
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE--ARIADFGLARMM 854 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~--~kl~DfGls~~~ 854 (1009)
||+++|+|.+++..... +++..+..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||+++..
T Consensus 96 e~~~~~~L~~~l~~~~~----~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 96 EYASGGELYERICNAGR----FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp ECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EeCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999999865332 78999999999999999999999 9999999999999987765 999999999754
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcc-cchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEK-SDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
... .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||..... .......+..........
T Consensus 169 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~----- 241 (361)
T 3uc3_A 169 VLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PRDYRKTIQRILSVKYSI----- 241 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-----CCCHHHHHHHHHTTCCCC-----
T ss_pred ccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc-HHHHHHHHHHHhcCCCCC-----
Confidence 222 23344579999999999887777655 8999999999999999999974322 223333333332221110
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+... .. ...+.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~~-~~------s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 242 PDDI-RI------SPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CTTS-CC------CHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCcC-CC------CHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 0000 01 124567889999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=339.88 Aligned_cols=255 Identities=33% Similarity=0.489 Sum_probs=191.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC--hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND--IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
++|+..+.||+|+||.||+|.+. ++.||||++...... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46788899999999999999986 788999998654322 22345677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC--------CCcEEEcc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA--------NLEARIAD 847 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~--------~~~~kl~D 847 (1009)
|||+++++|.+++... .+++..++.++.|+++||+|||+....+|+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999999643 2788999999999999999999982122999999999999986 67899999
Q ss_pred cccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 848 FGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 848 fGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
||+++...... .....|++.|+|||...+..++.++||||||+++|||++|+.||.... ............
T Consensus 160 fg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~-- 230 (271)
T 3dtc_A 160 FGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-----GLAVAYGVAMNK-- 230 (271)
T ss_dssp CCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-----HHHHHHHHHTSC--
T ss_pred CCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHhhhcCC--
Confidence 99998654322 234568999999999888889999999999999999999999997321 111111111111
Q ss_pred cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
........++ ..+.+++.+|++.||++|||+.|+++.|+++
T Consensus 231 ----~~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 ----LALPIPSTCP------EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----CCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----CCCCCCcccC------HHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111111111 2466788999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=345.29 Aligned_cols=259 Identities=20% Similarity=0.285 Sum_probs=205.3
Q ss_pred HHHHhcCCcC-ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCe
Q 037197 694 SEILACVKES-NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 694 ~~~~~~~~~~-~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 771 (1009)
+.+.++|... +.||+|+||.||+|.+..+++.||+|++............+.+|+.+++++ +||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 5677778877 899999999999999999999999999976555455567788999999999 56999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC---CCcEEEccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA---NLEARIADF 848 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Df 848 (1009)
.++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999865422 2378999999999999999999999 9999999999999988 789999999
Q ss_pred ccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 849 GLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 849 Gls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
|+++...... ......||+.|+|||++....++.++||||||+++|||++|+.||... +..............
T Consensus 179 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~- 251 (327)
T 3lm5_A 179 GMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE-----DNQETYLNISQVNVD- 251 (327)
T ss_dssp GGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCC-
T ss_pred ccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CchHHHHHHHhcccc-
Confidence 9998764332 234467999999999999889999999999999999999999999632 122222222211111
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
......... ...+.+++.+|++.||++|||++|+++
T Consensus 252 ---~~~~~~~~~------~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 252 ---YSEETFSSV------SQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ---CCTTTTTTS------CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---cCchhhccc------CHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111111111 124567889999999999999999976
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=344.82 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=196.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECC---CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR---PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.++|+..+.||+|+||.||+|.+.. .+..||+|++... ......+.+.+|+.++++++||||+++++++. ++..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 4578889999999999999999865 3567999998653 23444566779999999999999999999985 45689
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++++|.+++.... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 9999999999999997543 2378999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 854 MLHKNE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 854 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
...... ......+++.|+|||......++.++||||||+++|||++ |..||..... .+....+ ..+..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--~~~~~~i----~~~~~---- 235 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRI----ENGER---- 235 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHH----HTTCC----
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH--HHHHHHH----HcCCC----
Confidence 644332 2233456789999999888889999999999999999997 9999974322 2222222 11110
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
..+...++ ..+.+++.+|++.||++||++.|+++.|+++.+++
T Consensus 236 --~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 236 --LPMPPNCP------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp --CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111111 24567889999999999999999999999987554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=356.59 Aligned_cols=264 Identities=25% Similarity=0.384 Sum_probs=211.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECC-------CCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEc
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR-------PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHN 768 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~ 768 (1009)
.++|...+.||+|+||.||+|.+.. .+..||||++... .......++.+|+++++++ +||||+++++++.+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3568888999999999999999643 3468999999654 3344456777999999999 99999999999999
Q ss_pred CCeEEEEEeccCCCChhhhhcCCccc------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEE
Q 037197 769 ETNVMMVYDYMPNDSLGEALHGKEAG------------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNIL 836 (1009)
Q Consensus 769 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIl 836 (1009)
++..++||||+++|+|.+++...... ...+++.+++.|+.||++||+|||+. +|+||||||+||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 99999999999999999999765321 23489999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceecccCC--CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 037197 837 LDANLEARIADFGLARMMLHKN--ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKD 913 (1009)
Q Consensus 837 l~~~~~~kl~DfGls~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~ 913 (1009)
++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||... .
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~-----~ 298 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-----P 298 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----C
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----C
Confidence 9999999999999998764433 22233456789999999988899999999999999999999 99999732 2
Q ss_pred HHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 914 IVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
..+. ...+..+. .......+. .++.+++.+||+.||++||++.|+++.|+++....
T Consensus 299 ~~~~-~~~~~~~~------~~~~~~~~~------~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 299 VEEL-FKLLKEGH------RMDKPSNCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHH-HHHHHTTC------CCCCCSSCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHH-HHHHHcCC------CCCCCccCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 2222 22222221 111111111 24667889999999999999999999999886433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=371.32 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=209.8
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
..|+..+.||+|+||.||+|.+..++..||||++.... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 45778889999999999999999889999999996542 345678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.++++.... ..+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 297 ~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999975432 2378899999999999999999999 9999999999999999999999999999876432
Q ss_pred CC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
.. ......+++.|+|||++....++.++|||||||++|||++ |+.||..... ..+.+. +..+. ...
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--~~~~~~----~~~~~------~~~ 439 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYEL----LEKDY------RME 439 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHH----HHTTC------CCC
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcCC------CCC
Confidence 21 1122345678999999988889999999999999999999 9999974321 122222 22211 111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
....++ ..+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 440 ~~~~~~------~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 440 RPEGCP------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp CCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred CCCCCC------HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 111121 24567889999999999999999999999986543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=340.37 Aligned_cols=249 Identities=29% Similarity=0.432 Sum_probs=199.3
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|++...... ......+.+|++++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 35688899999999999999999999999999998543211 12234566899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|.+++..... +++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999865432 78899999999999999999998 99999999999999999999999999986542
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
. .......|++.|+|||...+..++.++||||||+++|+|++|+.||... .............. .
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~--------~ 225 (279)
T 3fdn_A 161 S--SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEF--------T 225 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHTCC--------C
T ss_pred c--ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC-----cHHHHHHHHHhCCC--------C
Confidence 2 2234457899999999999888999999999999999999999999732 22222222211111 1
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+..... ..+.+++.+|++.||++||++.|+++
T Consensus 226 ~~~~~~------~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 226 FPDFVT------EGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CCTTSC------HHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcCC------HHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111 23567889999999999999999995
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=356.50 Aligned_cols=206 Identities=21% Similarity=0.289 Sum_probs=179.7
Q ss_pred HhcCCcCceeccC--CceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 697 LACVKESNIIGMG--GNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G--~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
.++|+..+.||+| +||.||+|++..+++.||||++..........+.+.+|++++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3568999999999 99999999999999999999997665555555667789999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++|+|.+++...... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999765322 278899999999999999999999 9999999999999999999999999998765
Q ss_pred ccCC-------CceeeecccCcccCCcccCC--CCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 037197 855 LHKN-------ETVSMVAGSYGYIAPEYGYT--LKVDEKSDIYSFGVVLLELLTGKMPLDPA 907 (1009)
Q Consensus 855 ~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~Pf~~~ 907 (1009)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 3322 11223468899999999877 67899999999999999999999999753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=367.24 Aligned_cols=251 Identities=20% Similarity=0.259 Sum_probs=196.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCC-CChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++.... ........+.+|++++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 356889999999999999999999999999999986431 1223345566899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH-DCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999986543 27899999999999999999998 7 9999999999999999999999999999865
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||... +.............
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~i~~~~~-------- 366 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILMEEI-------- 366 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC--------
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC-----CHHHHHHHHHhCCC--------
Confidence 44444555678999999999999899999999999999999999999999632 22222222222111
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
.+..... ..+.+++.+|++.||++|| ++.|+++
T Consensus 367 ~~p~~~~------~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 RFPRTLG------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCTTSC------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCccCC------HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1111111 2456788999999999999 9999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=342.05 Aligned_cols=257 Identities=27% Similarity=0.422 Sum_probs=197.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||.||+|++. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 45788899999999999999986 688999998532 345667799999999999999999998874 4789999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc-EEEcccccceeccc
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE-ARIADFGLARMMLH 856 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~-~kl~DfGls~~~~~ 856 (1009)
|+++|+|.++++.... ...+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred cCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999999976542 223678889999999999999999943239999999999999998886 79999999976532
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
. .....||+.|+|||+..+..++.++||||||+++|||++|+.||...... ........ ..+. .+..
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~-~~~~------~~~~ 225 (307)
T 2eva_A 159 H---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP---AFRIMWAV-HNGT------RPPL 225 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS---HHHHHHHH-HTTC------CCCC
T ss_pred c---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc---HHHHHHHH-hcCC------CCCc
Confidence 2 23346899999999999889999999999999999999999999743222 11111111 1111 1111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
....+ ..+.+++.+|++.||++|||+.|+++.|+.+...-
T Consensus 226 ~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 226 IKNLP------KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp BTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred ccccC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 11221 23567889999999999999999999999886543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.29 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=207.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.++|...+.||+|+||.||++.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4568889999999999999999999999999999865432 334456677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|.+++.... .+++.+++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999986533 278999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
..........|++.|+|||++.+..++.++||||||+++|||++|+.||... ...+.......... .
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~~--------~ 259 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-----CLKETYLRIKKNEY--------S 259 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHTCC--------C
T ss_pred cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC-----CHHHHHHHHhcCCC--------C
Confidence 4444455567999999999998888999999999999999999999999732 22222222221111 1
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+..... ..+.+++.+|++.||++||++.|+++
T Consensus 260 ~~~~~~------~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 IPKHIN------PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCTTSC------HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCccCC------HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 23567889999999999999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=346.35 Aligned_cols=263 Identities=25% Similarity=0.350 Sum_probs=204.4
Q ss_pred hcCCcCceeccCCceEEEEEE----ECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC--Ce
Q 037197 698 ACVKESNIIGMGGNGIVYKAE----FHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE--TN 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~ 771 (1009)
+.|+..+.||+|+||.||+|. ...+++.||+|++.... .....+.+.+|++++++++||||+++++++.+. ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 457888999999999999999 45678999999996543 233456777999999999999999999999876 66
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++||||+++++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 8999999999999999954332 278999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCC---ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC---------CCCccHHHHHH
Q 037197 852 RMMLHKNE---TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAF---------GGSKDIVEWVL 919 (1009)
Q Consensus 852 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~---------~~~~~~~~~~~ 919 (1009)
........ ......+|+.|+|||...+..++.++||||+|+++|||++|+.|+.... .........+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 87654432 2233457788999999988889999999999999999999999864210 01111111222
Q ss_pred HHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 920 SMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.....+. ........+ ..+.+++.+|++.||++|||+.|+++.|+++.
T Consensus 254 ~~~~~~~------~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLKEGK------RLPCPPNCP------DEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHTTC------CCCCCTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccC------CCCCCCCCC------HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2222211 111111111 24667899999999999999999999998864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=360.71 Aligned_cols=257 Identities=21% Similarity=0.233 Sum_probs=202.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.++|+..++||+|+||+||+|+++.+++.||+|++.+.... ......+.+|+.+++.++||||++++++|.+++..|+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 46799999999999999999999999999999998542111 11123366899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++|+|.++++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 153 ~Ey~~gg~L~~~l~~~~~---~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFED---RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp ECCCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHHccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 999999999999976322 278899999999999999999999 99999999999999999999999999998764
Q ss_pred cCCC-ceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 856 HKNE-TVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 856 ~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||... +..+..........
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~~--- 298 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHKE--- 298 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTHHH---
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC-----ChhHHHHhhhhccc---
Confidence 4433 233467999999999876 567899999999999999999999999732 22222222221110
Q ss_pred cccCccccccCchHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 037197 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKG--RPTMRDVIT 973 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~ 973 (1009)
....|...... . .++.+++.+|+..+|++ ||++.|+++
T Consensus 299 ~~~~p~~~~~~---s---~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 299 RFQFPTQVTDV---S---ENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HCCCCSSCCCS---C---HHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccCCcccccC---C---HHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 00111111111 1 23557888999988888 999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=347.74 Aligned_cols=268 Identities=24% Similarity=0.353 Sum_probs=202.3
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 46789999999999999999999999999999999766555555666779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.++...... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~~~~~----~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNG----LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHSTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999988754432 78999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH-----------Hhh
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSM-----------IKS 924 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~-----------~~~ 924 (1009)
.........+++.|+|||++.+. .++.++||||+|+++|||++|+.||..... .+....+... ...
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD--IDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCChhhhhHhhh
Confidence 54455556789999999988765 689999999999999999999999974211 1111111110 000
Q ss_pred ccccccccCccccccCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 925 NKAQDEALDPSIAGQCKH---VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.........+.+...... .......+.+++.+|++.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000111111111111000 0011235678899999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=365.26 Aligned_cols=257 Identities=25% Similarity=0.407 Sum_probs=205.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||+|.+.. +..||||+++.. ....+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTT---SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCC---CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 457788899999999999999976 788999999653 234567889999999999999999999986 567899999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.++++.... ..+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 263 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred ecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999975432 2368888999999999999999999 9999999999999999999999999999865332
Q ss_pred CC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
.. ......+++.|+|||++....++.++|||||||++|||++ |+.||... ...+... .+..+.. ..
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~-----~~~~~~~-~i~~~~~------~~ 405 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----SNPEVIR-ALERGYR------MP 405 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHHH-HHHHTCC------CC
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC-----CHHHHHH-HHHcCCC------CC
Confidence 21 1223345778999999988889999999999999999999 99999732 1222222 2222211 11
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
....++ ..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 406 ~~~~~~------~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 406 RPENCP------EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp CCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCCCC------HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 111111 24667889999999999999999999999987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=362.72 Aligned_cols=249 Identities=28% Similarity=0.394 Sum_probs=203.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|...+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5688899999999999999999999999999998543211 123456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 96 E~~~gg~L~~~l~~~~~----l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICKNGR----LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTSSSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999975432 78999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCceeeecccCcccCCcccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKV-DEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
. .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||+... ........ ..+.. ..+
T Consensus 169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~~~~~~~i-~~~~~----~~p- 236 (476)
T 2y94_A 169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----VPTLFKKI-CDGIF----YTP- 236 (476)
T ss_dssp T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----SHHHHHHH-HTTCC----CCC-
T ss_pred c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----HHHHHHHH-hcCCc----CCC-
Confidence 3 33445679999999999887765 689999999999999999999997421 22222222 21110 011
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.... ..+.+++.+|++.||++|||+.|+++
T Consensus 237 --~~~s------~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 237 --QYLN------PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --TTCC------HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --ccCC------HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1111 24567889999999999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=348.18 Aligned_cols=263 Identities=26% Similarity=0.355 Sum_probs=210.7
Q ss_pred HhcCCcCceeccCCceEEEEEEE-----CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCC
Q 037197 697 LACVKESNIIGMGGNGIVYKAEF-----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNET 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~ 770 (1009)
.++|+..+.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+++++++ +||||+++++++.+++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 35688899999999999999985 4567899999996543 334456777999999999 9999999999999999
Q ss_pred eEEEEEeccCCCChhhhhcCCccc--------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEE
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAG--------------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNIL 836 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIl 836 (1009)
..++||||+++|+|.+++...... ...+++.+++.++.|+++||+|||+. +|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 999999999999999999765321 22478999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceecccCCCc--eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 037197 837 LDANLEARIADFGLARMMLHKNET--VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKD 913 (1009)
Q Consensus 837 l~~~~~~kl~DfGls~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~ 913 (1009)
++.++.+||+|||++......... .....+++.|+|||...+..++.++||||||+++|||++ |+.||...... .
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~- 255 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-S- 255 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-H-
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-h-
Confidence 999999999999999876544321 223456789999999888889999999999999999999 99999743221 1
Q ss_pred HHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 914 IVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.+........ .+......+ ..+.+++.+|++.||++||++.|+++.|+++..
T Consensus 256 ---~~~~~~~~~~------~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 256 ---KFYKMIKEGF------RMLSPEHAP------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp ---HHHHHHHHTC------CCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHhccCC------CCCCcccCC------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1222222221 111111111 246678899999999999999999999998764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=365.58 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=204.8
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|+..+.||+|+||.||+|+++.+++.||+|++.+.... ......+.+|++++++++||||+++++++.+....|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 5688889999999999999999999999999999643211 122456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++|+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999976554344589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+...... .... .+
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~~i~-~~~~-------~~ 412 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVL-EQAV-------TY 412 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHHHHH-HCCC-------CC
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHHHHh-hccc-------CC
Confidence 444444568999999999999989999999999999999999999999753221 12222222222 1110 11
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTM 968 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 968 (1009)
....+ ..+..++.+|++.||++||++
T Consensus 413 p~~~s------~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 413 PDKFS------PASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CTTSC------HHHHHHHHHHSCSSGGGSCCC
T ss_pred CcccC------HHHHHHHHHhccCCHhHCCCC
Confidence 11111 245678889999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=354.03 Aligned_cols=264 Identities=25% Similarity=0.370 Sum_probs=209.7
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCC-----eEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCC
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPH-----MVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNET 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~ 770 (1009)
.+.|+..+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+++++++ +||||+++++++.+++
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 456888999999999999999987655 479999986542 334456677999999999 8999999999999999
Q ss_pred eEEEEEeccCCCChhhhhcCCcc----------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEA----------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN 840 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~ 840 (1009)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 99999999999999999975321 022368899999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHH
Q 037197 841 LEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEW 917 (1009)
Q Consensus 841 ~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 917 (1009)
+.+||+|||+++....... ......+|+.|+|||...+..++.++||||||+++|||++ |..||...... . .
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~----~ 275 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-S----K 275 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-H----H
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-H----H
Confidence 9999999999987644332 1223456789999999888889999999999999999999 99999743221 1 1
Q ss_pred HHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 918 VLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
+......+. ........+ ..+..++.+|++.||++||++.|+++.|+++...
T Consensus 276 ~~~~~~~~~------~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 FYKLVKDGY------QMAQPAFAP------KNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHHTC------CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCC------CCCCCCCCC------HHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 122222221 111111111 2456788999999999999999999999987653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=349.32 Aligned_cols=271 Identities=21% Similarity=0.315 Sum_probs=197.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||.||+|.+..+++.||+|++..... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 468888999999999999999999999999999854322 1112234479999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|++ |+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CCS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred ccc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 997 589888865432 378889999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+....+...... ...+......
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~--~~~~~~~~~~ 229 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST--VEEQLHFIFRILGT--PTEETWPGIL 229 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCC--CCTTTSTTGG
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCC--CChHhchhhh
Confidence 444555678999999998765 568999999999999999999999997421 11222222222111 1111111000
Q ss_pred cc-----------cCch----HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhhcCC
Q 037197 937 AG-----------QCKH----VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT--MLGEAKP 980 (1009)
Q Consensus 937 ~~-----------~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~~~ 980 (1009)
.. .... .......+.+++.+|++.||++|||++|+++ .+..+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 00 0000 0011234568899999999999999999987 4555443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=363.60 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=200.7
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
.+.+.|+..+.||+|+||.||+|.+..+++.||+|++.+..........+.+|++++++++||||+++++++.+....++
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 46678999999999999999999999999999999997665444455677899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC---CcEEEcccccc
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN---LEARIADFGLA 851 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~DfGls 851 (1009)
||||+++|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.. +.+||+|||++
T Consensus 114 v~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 999999999999886543 278899999999999999999999 99999999999999764 45999999999
Q ss_pred eecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 852 RMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
...... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||... ...+........... .
T Consensus 187 ~~~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~---~ 256 (494)
T 3lij_A 187 AVFENQ-KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ-----TDQEILRKVEKGKYT---F 256 (494)
T ss_dssp EECBTT-BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCC---C
T ss_pred eECCCC-ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCC---C
Confidence 876433 2334567999999999876 56899999999999999999999999732 222222222221111 1
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+... .. ...+.+++.+|++.||++|||+.|+++
T Consensus 257 ~~~~~~-~~------s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSPEWK-NV------SEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSGGGT-TS------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cchhcc-cC------CHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 111111 11 124567889999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=349.26 Aligned_cols=270 Identities=25% Similarity=0.333 Sum_probs=206.2
Q ss_pred hcCCcCceeccCCceEEEEEE----ECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEE--cCCe
Q 037197 698 ACVKESNIIGMGGNGIVYKAE----FHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLH--NETN 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~--~~~~ 771 (1009)
++|+..+.||+|+||.||+|+ ...+++.||||++... .....+.+.+|++++++++||||+++++++. +...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 568889999999999999999 4567899999998654 3444566779999999999999999999886 4567
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++||||+++++|.+++..... .+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 8999999999999999975332 378999999999999999999998 9999999999999999999999999999
Q ss_pred eecccCCC---ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCC---------CCccHHHHHH
Q 037197 852 RMMLHKNE---TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFG---------GSKDIVEWVL 919 (1009)
Q Consensus 852 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~---------~~~~~~~~~~ 919 (1009)
+....... ......+|+.|+|||+..+..++.++||||||+++|+|++|+.||..... ........+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 87644332 12234577889999998888899999999999999999999999863110 0001111112
Q ss_pred HHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCcccccc
Q 037197 920 SMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQ 987 (1009)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~ 987 (1009)
.....+. .......+ ...+.+++.+|++.||++|||+.|+++.|+.+.........
T Consensus 255 ~~~~~~~------~~~~~~~~------~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 255 ELLEEGQ------RLPAPPAC------PAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp HHHHTTC------CCCCCTTC------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred HHhhccc------CCCCCCcc------cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 2221111 11111111 12466788999999999999999999999999876655443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=347.04 Aligned_cols=251 Identities=29% Similarity=0.399 Sum_probs=201.1
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
..+.|+..+.||+|+||.||+|.+..+++.||||++...... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 456688899999999999999999989999999999655332 3334567799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+. |++.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 132 v~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EEECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 999997 67888875332 2378999999999999999999999 9999999999999999999999999999765
Q ss_pred ccCCCceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
... ....||+.|+|||++. ...++.++|||||||++|||++|+.||... .....+......... ..
T Consensus 205 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~-----~~~~~~~~~~~~~~~--~~ 273 (348)
T 1u5q_A 205 APA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSALYHIAQNESP--AL 273 (348)
T ss_dssp SSB----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHSCCC--CC
T ss_pred CCC----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcCCC--CC
Confidence 322 3456899999999873 567899999999999999999999999632 222222222222110 01
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
. ....+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 274 ~----~~~~~------~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 Q----SGHWS------EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp C----CTTSC------HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C----CCCCC------HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 11111 235678889999999999999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=333.03 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=204.9
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.++|+..+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 46789999999999999999999998899999999864432 23346677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|.+++.... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 84 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 99999999999997543 278899999999999999999999 99999999999999999999999999998764
Q ss_pred cCC--CceeeecccCcccCCcccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 856 HKN--ETVSMVAGSYGYIAPEYGYTLKV-DEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 856 ~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
... .......|++.|+|||...+..+ +.++||||||+++|||++|+.||............+. ... ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~---~~~ 228 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKK---TYL 228 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH-----TTC---TTS
T ss_pred CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh-----hcc---ccc
Confidence 332 22344578999999999887665 7899999999999999999999975433222222221 111 000
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. .. ... ...+.+++.+|++.||++|||+.|+++
T Consensus 229 ~-~~----~~~---~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 N-PW----KKI---DSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp T-TG----GGS---CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-ch----hhc---CHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1 00 111 124567889999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=346.62 Aligned_cols=263 Identities=25% Similarity=0.388 Sum_probs=208.9
Q ss_pred HhcCCcCceeccCCceEEEEEEEC-------CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEc
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFH-------RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHN 768 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~ 768 (1009)
.++|+..+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+++++++ +||||+++++++.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 356888999999999999999975 356789999996542 334456777999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCChhhhhcCCccc------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEE
Q 037197 769 ETNVMMVYDYMPNDSLGEALHGKEAG------------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNIL 836 (1009)
Q Consensus 769 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIl 836 (1009)
.+..++||||+++|+|.+++...... ...+++..++.++.||++||+|||+. +|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 99999999999999999999765421 12378899999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 037197 837 LDANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKD 913 (1009)
Q Consensus 837 l~~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~ 913 (1009)
++.++.+||+|||+++....... ......+++.|+|||+..+..++.++||||||+++|||++ |+.||... .
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-----~ 264 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----P 264 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-----C
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC-----C
Confidence 99999999999999987654332 1223456788999999888889999999999999999999 99999632 1
Q ss_pred HHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 914 IVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
..+.. ..+..+.. ......+. ..+.+++.+|++.||++||++.|+++.|+++...
T Consensus 265 ~~~~~-~~~~~~~~------~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 265 VEELF-KLLKEGHR------MDKPANCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHHHH-HHHHHTCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH-HHHhcCCC------CCCCccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 22222 22222211 11111111 2466788999999999999999999999998653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.82 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=203.6
Q ss_pred hcCCcCc-eeccCCceEEEEEEE--CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESN-IIGMGGNGIVYKAEF--HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~-~iG~G~~g~Vyk~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
++|+..+ .||+|+||.||+|.+ ..+++.||||++.....+....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4567777 899999999999954 56678999999976554445567778999999999999999999999 5567899
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++++|.+++..... +++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 95 v~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEECCTTEEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCcC----CCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999976432 78899999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCc---eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 855 LHKNET---VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 855 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
...... .....+++.|+|||......++.++||||||+++|||++ |+.||.... .. .+...+..+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~-~~~~~~~~~~---- 237 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GS-EVTAMLEKGE---- 237 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HH-HHHHHHHTTC----
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC-----HH-HHHHHHHcCC----
Confidence 444322 122345688999999888889999999999999999999 999997421 11 1222222221
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.+.....++ ..+.+++.+|++.||++||++.|+++.|+++....
T Consensus 238 --~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 238 --RMGCPAGCP------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp --CCCCCTTCC------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 111111111 24667889999999999999999999999886443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=347.01 Aligned_cols=262 Identities=28% Similarity=0.462 Sum_probs=202.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCC----CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRP----HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.+|+..+.||+|+||.||+|.+..+ +..||||++.... .......+.+|++++++++||||+++++++.+.+..+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4577788999999999999987654 3569999986432 3444566779999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++|+|.+++..... .+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999975422 378999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCC---ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 854 MLHKNE---TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 854 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
...... ......+++.|+|||......++.++||||||+++|||++ |+.||.... ..+. ...+..+..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-----~~~~-~~~~~~~~~-- 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----NHEV-MKAINDGFR-- 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHH-HHHHHTTCC--
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC-----HHHH-HHHHHCCCc--
Confidence 644322 1222345778999999988889999999999999999999 999996321 1122 222222211
Q ss_pred cccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCccc
Q 037197 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKS 984 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 984 (1009)
......+. ..+.+++.+||+.||++||++.|+++.|+++......
T Consensus 269 ----~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 269 ----LPTPMDCP------SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp ----CCCCTTCB------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred ----CCCcccCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 01111111 2456788999999999999999999999998765444
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=342.71 Aligned_cols=269 Identities=26% Similarity=0.381 Sum_probs=204.5
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc--CCCceeeEEeEEEcC---
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL--RHRNIVRLLGYLHNE--- 769 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~Hpniv~l~~~~~~~--- 769 (1009)
.+.++|+..+.||+|+||.||+|++. ++.||||++... ......+|.+++... +||||+++++++.+.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 45678999999999999999999986 789999998432 234445666666554 899999999999877
Q ss_pred -CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEeccCCCcEEeCCCCcE
Q 037197 770 -TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC-----QPPVIHRDIKSNNILLDANLEA 843 (1009)
Q Consensus 770 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~dlk~~NIll~~~~~~ 843 (1009)
...++||||+++|+|.++++... +++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCceEEEEeccCCCcHHHHhhccC-----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 78999999999999999996542 789999999999999999999752 3489999999999999999999
Q ss_pred EEcccccceecccCCCc----eeeecccCcccCCcccCCCCCCcc------cchHhHHHHHHHHHhC----------CCC
Q 037197 844 RIADFGLARMMLHKNET----VSMVAGSYGYIAPEYGYTLKVDEK------SDIYSFGVVLLELLTG----------KMP 903 (1009)
Q Consensus 844 kl~DfGls~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------sDv~SlGvvl~elltg----------~~P 903 (1009)
||+|||+++.+...... .....||+.|+|||++.+...+.+ +|||||||++|||++| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999999876443322 124578999999999877666554 9999999999999999 666
Q ss_pred CCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 904 LDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 904 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
|............. ....... ...+.+..... ......++.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 262 ~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 262 YHDLVPSDPSYEDM-REIVCIK-----KLRPSFPNRWS-SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTTSCSSCCHHHH-HHHHTTS-----CCCCCCCGGGG-GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HhhhcCCCCchhhh-HHHHhhh-----ccCccccccch-hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 65443333222222 2222111 11222221111 1133445778999999999999999999999999986543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.44 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=206.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||.||+|.+.. ++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTT---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEecC-CCeEEEEEccccC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 467888999999999999999975 7889999996543 234567799999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++++|.+++..... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999975432 378899999999999999999999 9999999999999999999999999999765332
Q ss_pred C-CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 N-ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
. .......+++.|+|||......++.++||||||+++|||++ |+.||... ...+.... +..+. ...
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~-i~~~~------~~~ 225 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVED-ISTGF------RLY 225 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHH-HHTTC------CCC
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC-----CHHHHHHH-HhcCC------cCC
Confidence 1 11223456778999999888889999999999999999999 89999732 22222222 22211 011
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
...... ..+.+++.+|++.||++||++.|+++.|+++.++
T Consensus 226 ~~~~~~------~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 226 KPRLAS------THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCccCc------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111 2456788999999999999999999999988653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=361.09 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=203.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC-eEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET-NVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-~~~lV~ 776 (1009)
+.|+..+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||+++++++.+.. ..++||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 56788899999999999999986 6799999996532 3466789999999999999999999987665 799999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++|+|.++++... ...+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 267 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp ECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999997543 22368889999999999999999999 999999999999999999999999999985432
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
. .....+++.|+|||.+....++.++||||||+++|||++ |+.||...... +.... +..+. ...
T Consensus 342 ~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~----i~~~~------~~~ 406 (450)
T 1k9a_A 342 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPR----VEKGY------KMD 406 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHH----HHTTC------CCC
T ss_pred c---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcCC------CCC
Confidence 2 222357889999999988899999999999999999998 99999743222 22222 22221 111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
....++ ..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 407 ~p~~~~------~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 407 APDGCP------PAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCcCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 111222 2456788999999999999999999999988643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=345.03 Aligned_cols=267 Identities=26% Similarity=0.344 Sum_probs=211.3
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhc--cCCCceeeEEeEEEcCC-
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGR--LRHRNIVRLLGYLHNET- 770 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~Hpniv~l~~~~~~~~- 770 (1009)
..+.++|+..+.||+|+||.||+|++. ++.||||++.. .....+.+|+++++. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 446678999999999999999999984 78999999843 234566788888887 78999999999998776
Q ss_pred ---eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEeccCCCcEEeCC
Q 037197 771 ---NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH--------HDCQPPVIHRDIKSNNILLDA 839 (1009)
Q Consensus 771 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~dlk~~NIll~~ 839 (1009)
..++||||+++|+|.++++.. .+++.+++.++.|+++||+||| +. +|+||||||+||+++.
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK 182 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred ccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence 789999999999999999653 2789999999999999999999 66 9999999999999999
Q ss_pred CCcEEEcccccceecccCCCc----eeeecccCcccCCcccCCC------CCCcccchHhHHHHHHHHHhC---------
Q 037197 840 NLEARIADFGLARMMLHKNET----VSMVAGSYGYIAPEYGYTL------KVDEKSDIYSFGVVLLELLTG--------- 900 (1009)
Q Consensus 840 ~~~~kl~DfGls~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlGvvl~elltg--------- 900 (1009)
++.+||+|||++......... .....||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999876544322 2345789999999987765 334789999999999999999
Q ss_pred -CCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 901 -KMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 901 -~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
..||............+.... .. ....+.+..... ..+....+.+++.+||+.||++||++.|+++.|+++.
T Consensus 263 ~~~p~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 263 YQLPYYDLVPSDPSVEEMRKVV-CE-----QKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHH-TT-----SCCCCCCCGGGG-TSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCccccCcCcccHHHHHHHH-HH-----HHhCCCCccccc-chhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 788875544433333333222 11 112222222111 1234456778999999999999999999999999987
Q ss_pred CCc
Q 037197 980 PRR 982 (1009)
Q Consensus 980 ~~~ 982 (1009)
++.
T Consensus 336 ~~~ 338 (342)
T 1b6c_B 336 QQE 338 (342)
T ss_dssp HTT
T ss_pred HHh
Confidence 654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=349.71 Aligned_cols=268 Identities=17% Similarity=0.205 Sum_probs=200.3
Q ss_pred HhcCCcCceeccCCceEEEEEEECC---CCeEEEEEEcccCCCChh---------hHHHHHHHHHHHhccCCCceeeEEe
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR---PHMVVAVKKLWRSDNDIE---------SGDDLFREVSLLGRLRHRNIVRLLG 764 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~---~~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~Hpniv~l~~ 764 (1009)
.++|+..+.||+|+||.||+|.+.. ++..||||++........ ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3568899999999999999999986 788999999865432111 1123557888899999999999999
Q ss_pred EEEc----CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC
Q 037197 765 YLHN----ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN 840 (1009)
Q Consensus 765 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~ 840 (1009)
++.. ....++||||+ +++|.+++.... .+++.+++.++.||++||+|||+. +|+||||||+||+++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9887 67899999999 999999997654 389999999999999999999999 99999999999999988
Q ss_pred C--cEEEcccccceecccCCC-------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCC
Q 037197 841 L--EARIADFGLARMMLHKNE-------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS 911 (1009)
Q Consensus 841 ~--~~kl~DfGls~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~ 911 (1009)
+ .+||+|||+++.+..... ......||+.|+|||+..+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999987643321 1234578999999999988889999999999999999999999996322221
Q ss_pred ccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 912 KDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.. ........... ....+..... ......++.+++.+|++.||++||++.++++.|+.+..
T Consensus 268 ~~-~~~~~~~~~~~------~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 VA-VQTAKTNLLDE------LPQSVLKWAP-SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HH-HHHHHHHHHHT------TTHHHHHHSC-TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HH-HHHHHHhhccc------ccHHHHhhcc-ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11 11111111111 1111100000 00011246778899999999999999999999998764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=336.16 Aligned_cols=250 Identities=25% Similarity=0.335 Sum_probs=200.6
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc----CCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN----ETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~----~~~~~ 773 (1009)
..|+..+.||+|+||.||+|.+..++..||+|++..........+.+.+|++++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34777888999999999999999999999999997665555666777899999999999999999999865 45689
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeccCCCcEEeC-CCCcEEEccccc
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP--VIHRDIKSNNILLD-ANLEARIADFGL 850 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~DfGl 850 (1009)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999996533 278899999999999999999998 7 99999999999997 789999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
+..... .......||+.|+|||+.. ..++.++||||+|+++|+|++|+.||.... ...... .....+.
T Consensus 179 ~~~~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~-~~~~~~~---- 246 (290)
T 1t4h_A 179 ATLKRA--SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIY-RRVTSGV---- 246 (290)
T ss_dssp GGGCCT--TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHH-HHHTTTC----
T ss_pred cccccc--cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC----cHHHHH-HHHhccC----
Confidence 965422 2334567999999999876 458999999999999999999999997422 222222 2222111
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.......... ..+.+++.+|++.||++|||+.|+++
T Consensus 247 -~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 -KPASFDKVAI------PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -CCGGGGGCCC------HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CccccCCCCC------HHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111111111 24667899999999999999999984
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.22 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=211.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 45688889999999999999999999999999999543 344567779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 89 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp ECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999975432 3378899999999999999999999 999999999999999999999999999987644
Q ss_pred CCC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 857 KNE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 857 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
... ......+++.|+|||......++.++||||||+++|+|++ |..||..... ....+.+ .... ..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--~~~~~~~----~~~~------~~ 231 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELL----EKDY------RM 231 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHH----HTTC------CC
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----hccC------CC
Confidence 332 2233456789999999988889999999999999999999 9999974321 1222221 1111 11
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
.....++ ..+.+++.+|++.||++||++.|+++.|+.+..+
T Consensus 232 ~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 232 ERPEGCP------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCC------HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111 2466788999999999999999999999987654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=342.41 Aligned_cols=267 Identities=22% Similarity=0.281 Sum_probs=197.7
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC---hhhHHHHHHHHHHHhcc---CCCceeeEEeEEEcC
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND---IESGDDLFREVSLLGRL---RHRNIVRLLGYLHNE 769 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~~ 769 (1009)
+.++|+..+.||+|+||+||+|++..+++.||||++...... ........+|+++++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999999999999999998643321 11223455677666665 599999999999775
Q ss_pred C-----eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEE
Q 037197 770 T-----NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEAR 844 (1009)
Q Consensus 770 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 844 (1009)
. ..++||||++ ++|.+++...... .+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP--GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 5 5899999996 6999999765432 278999999999999999999999 999999999999999999999
Q ss_pred EcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh
Q 037197 845 IADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS 924 (1009)
Q Consensus 845 l~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 924 (1009)
|+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+......
T Consensus 161 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--EADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS--HHHHHHHHHHHHCC
T ss_pred EeeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCC
Confidence 9999999765332 23345678999999999988899999999999999999999999997321 11222222221111
Q ss_pred ccccccccCc-------cccccCchH-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 925 NKAQDEALDP-------SIAGQCKHV-----QEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 925 ~~~~~~~~~~-------~~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. ....... .+....... .+....+.+++.+|++.||++|||+.|+++
T Consensus 238 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 P--PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp C--CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0 0000000 000000000 011234667899999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=363.61 Aligned_cols=256 Identities=24% Similarity=0.323 Sum_probs=204.2
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
..+.++|+..+.||+|+||+||+|.+..+++.||||++............+.+|++++++++||||+++++++.+....+
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 35678899999999999999999999999999999998654322334567789999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC---CCCcEEEccccc
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD---ANLEARIADFGL 850 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~DfGl 850 (1009)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++ .++.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp EEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred EEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 9999999999999886543 278999999999999999999999 999999999999995 456799999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
++.+... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||... .....+.... .+.. .
T Consensus 171 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~-~~~~--~ 240 (486)
T 3mwu_A 171 STCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK-----NEYDILKRVE-TGKY--A 240 (486)
T ss_dssp TTTBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHH-HTCC--C
T ss_pred CeECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHH-hCCC--C
Confidence 9865332 33345679999999999765 5899999999999999999999999632 2222222222 2211 0
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+... .. ...+.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~----~~---s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 241 FDLPQWR----TI---SDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp SCSGGGG----GS---CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCcccC----CC---CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0111111 11 124567889999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.89 Aligned_cols=268 Identities=25% Similarity=0.372 Sum_probs=209.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEE--EEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVV--AVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l 774 (1009)
++|+..+.||+|+||.||+|.+..++..+ |+|.+... ......+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 56888999999999999999998878755 99988643 2233456677999999999 89999999999999999999
Q ss_pred EEeccCCCChhhhhcCCc------------cccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc
Q 037197 775 VYDYMPNDSLGEALHGKE------------AGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE 842 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 842 (1009)
||||+++++|.+++.... .....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997654 1223488999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHH
Q 037197 843 ARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSM 921 (1009)
Q Consensus 843 ~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 921 (1009)
+||+|||+++..... .......+++.|+|||+.....++.++||||||+++|||++ |+.||... ...... ..
T Consensus 181 ~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~-----~~~~~~-~~ 253 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAELY-EK 253 (327)
T ss_dssp EEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHH-HH
T ss_pred EEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC-----cHHHHH-HH
Confidence 999999999743221 22233456889999999888888999999999999999998 99999632 112221 22
Q ss_pred HhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCccccccc
Q 037197 922 IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQN 988 (1009)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~ 988 (1009)
+..+. ........+ ..+.+++.+|++.||++||++.|+++.|+++..+++...+.
T Consensus 254 ~~~~~------~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 308 (327)
T 1fvr_A 254 LPQGY------RLEKPLNCD------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 308 (327)
T ss_dssp GGGTC------CCCCCTTBC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCC
T ss_pred hhcCC------CCCCCCCCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcccc
Confidence 21111 111111111 24667889999999999999999999999988776654443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.20 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=206.5
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc-----
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN----- 768 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~----- 768 (1009)
..+..+|+..+.||+|+||.||+|.+..+++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 446678999999999999999999999889999999995432 345689999999999999999998854
Q ss_pred -----------CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe
Q 037197 769 -----------ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL 837 (1009)
Q Consensus 769 -----------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 837 (1009)
....++||||+++++|.+++..... ..+++..++.++.|+++||+|||+. +|+||||||+||++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFL 155 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEE
Confidence 4458999999999999999975432 2378899999999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHH
Q 037197 838 DANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEW 917 (1009)
Q Consensus 838 ~~~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~ 917 (1009)
+.++.+||+|||++....... ......+++.|+|||...+..++.++||||||+++|||++|..|+.. ....
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-------~~~~ 227 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-------TSKF 227 (284)
T ss_dssp EETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-------HHHH
T ss_pred cCCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-------HHHH
Confidence 999999999999998764432 23345689999999999888899999999999999999999988641 1111
Q ss_pred HHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCccc
Q 037197 918 VLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKS 984 (1009)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 984 (1009)
.. ..... .+...++ ..+.+++.+|++.||++||++.|+++.|+.+......
T Consensus 228 ~~-~~~~~---------~~~~~~~------~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 228 FT-DLRDG---------IISDIFD------KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp HH-HHHTT---------CCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred HH-Hhhcc---------cccccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 11 11111 1111111 1356788999999999999999999999998765543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=349.48 Aligned_cols=261 Identities=23% Similarity=0.287 Sum_probs=195.1
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC------
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET------ 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------ 770 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46789999999999999999999999999999999765555556677789999999999999999999997654
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
..++||||++ ++|.+++... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhhc------cCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999997 5788887532 78888999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc-ccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK-AQD 929 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 929 (1009)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+........ ...
T Consensus 174 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 174 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-----HIDQWNKVIEQLGTPCP 247 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHC-CCCCCH
T ss_pred ccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCCH
Confidence 9865332 23344678999999999998889999999999999999999999997421 1111111111100 000
Q ss_pred c--------------------------ccCcc-ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 930 E--------------------------ALDPS-IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 930 ~--------------------------~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+ .+... ..............+.+++.+|++.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 00000 00001111122446788999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=355.37 Aligned_cols=256 Identities=20% Similarity=0.186 Sum_probs=200.7
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.+.|+..+.||+|+||.||+|+++.+++.||+|++.+... .......+.+|.+++..++||||+++++++.+.+..|+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 4678999999999999999999999999999999854311 112234466899999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++|+|.++++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 140 mE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 99999999999997532 1378889999999999999999998 99999999999999999999999999998765
Q ss_pred cCCCc-eeeecccCcccCCcccC-------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 856 HKNET-VSMVAGSYGYIAPEYGY-------TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 856 ~~~~~-~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||... +..+..........
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~~~~~- 287 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD-----STAETYGKIVHYKE- 287 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTHHH-
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC-----CHHHHHHHHHhccc-
Confidence 44332 23467999999999876 456899999999999999999999999732 22222222221110
Q ss_pred cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCC---CCHHHHHH
Q 037197 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGR---PTMRDVIT 973 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Ps~~evl~ 973 (1009)
....+......+ .++..++.+|+. +|++| |+++|+++
T Consensus 288 --~~~~p~~~~~~s------~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 288 --HLSLPLVDEGVP------EEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp --HCCCC----CCC------HHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred --CcCCCccccCCC------HHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 001111111111 245678889999 99998 58888875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=348.03 Aligned_cols=268 Identities=25% Similarity=0.312 Sum_probs=198.4
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh---hhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI---ESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
...++|+..+.||+|+||.||+|.+..+++.||||++....... .....+.+|++++++++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34577999999999999999999999989999999996532211 112456799999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++||||+++ +|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999975 8888886543 2377888899999999999999999 9999999999999999999999999999
Q ss_pred eecccCCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 852 RMMLHKNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
+.............+|+.|+|||++.+. .++.++|||||||++|||++|..||... .....+............
T Consensus 160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~-----~~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD-----SDLDQLTRIFETLGTPTE 234 (346)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHHHCCCCT
T ss_pred eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHHHcCCCCh
Confidence 8765544445556789999999988654 5889999999999999999999998632 112222222221110000
Q ss_pred ccCccccc--------cCc-hH-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 931 ALDPSIAG--------QCK-HV-----QEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 931 ~~~~~~~~--------~~~-~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
...+.... ... .. ......+.+++.+|++.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000 000 00 0111356789999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=351.35 Aligned_cols=271 Identities=16% Similarity=0.210 Sum_probs=203.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCC-----CeEEEEEEcccCCCChhh---------HHHHHHHHHHHhccCCCceeeE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRP-----HMVVAVKKLWRSDNDIES---------GDDLFREVSLLGRLRHRNIVRL 762 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~-----~~~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~Hpniv~l 762 (1009)
.++|+..+.||+|+||.||+|.+..+ ++.||||++......... .....+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45799999999999999999998764 578999998654211110 1123345566778889999999
Q ss_pred EeEEEcC----CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC
Q 037197 763 LGYLHNE----TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD 838 (1009)
Q Consensus 763 ~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~ 838 (1009)
++++... .+.++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+. +|+||||||+||+++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 9998764 4589999999 999999997642 2389999999999999999999999 999999999999999
Q ss_pred --CCCcEEEcccccceecccCCC-------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCC
Q 037197 839 --ANLEARIADFGLARMMLHKNE-------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFG 909 (1009)
Q Consensus 839 --~~~~~kl~DfGls~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~ 909 (1009)
.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 889999999999987644321 11334599999999999998999999999999999999999999974322
Q ss_pred CCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 910 GSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
. .............. .....++.+.. ... ..++.+++..|++.||++||++.++++.|+++..+.
T Consensus 267 ~-~~~~~~~~~~~~~~--~~~~~~~~~~~--~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 267 D-PKYVRDSKIRYREN--IASLMDKCFPA--ANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp C-HHHHHHHHHHHHHC--HHHHHHHHSCT--TCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred C-HHHHHHHHHHhhhh--HHHHHHHhccc--ccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 2 22222222211111 11112211110 011 124667889999999999999999999999886543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=343.59 Aligned_cols=265 Identities=21% Similarity=0.309 Sum_probs=202.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc--------
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN-------- 768 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-------- 768 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++............+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 467899999999999999999999999999999997665555555677799999999999999999999876
Q ss_pred CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 769 ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 769 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
.+..++||||+++ ++.+.+..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4468999999975 67777755432 278999999999999999999999 9999999999999999999999999
Q ss_pred ccceecccCC----CceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh
Q 037197 849 GLARMMLHKN----ETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 849 Gls~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
|+++.+.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+.....
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQLCG 246 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhC
Confidence 9998764322 22344568999999998765 458999999999999999999999997421 1122222221111
Q ss_pred hccccccccCccc------------cccCchHHHH------HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 924 SNKAQDEALDPSI------------AGQCKHVQEE------MLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 924 ~~~~~~~~~~~~~------------~~~~~~~~~~------~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. ......+.. ........+. ...+.+++.+|++.||++|||++|+++
T Consensus 247 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 247 S---ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp C---CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C---CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1 111111110 0001111111 123678999999999999999999886
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=338.82 Aligned_cols=253 Identities=19% Similarity=0.298 Sum_probs=200.9
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCC-------eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPH-------MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE 769 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~ 769 (1009)
.++|+..+.||+|+||.||+|.+..++ ..||+|++... .....+.+.+|++++++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 356888899999999999999988765 57999998543 234456777999999999999999999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc-------
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE------- 842 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~------- 842 (1009)
+..++||||+++|+|.+++..... .+++..++.++.|+++||+|||++ +|+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 999999999999999999976432 278889999999999999999999 9999999999999998887
Q ss_pred -EEEcccccceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHH
Q 037197 843 -ARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLS 920 (1009)
Q Consensus 843 -~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 920 (1009)
+||+|||.+...... ....+++.|+|||+..+ ..++.++||||||+++|||++|..|+.... +..... .
T Consensus 159 ~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~-~ 229 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL----DSQRKL-Q 229 (289)
T ss_dssp EEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS----CHHHHH-H
T ss_pred eeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc----chHHHH-H
Confidence 999999998654221 23457899999998876 678999999999999999999655443211 111111 1
Q ss_pred HHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 921 MIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
...... ....... .++.+++.+|++.||++|||+.|+++.|+++..
T Consensus 230 ~~~~~~----~~~~~~~----------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 230 FYEDRH----QLPAPKA----------AELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHTTC----CCCCCSS----------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HhhccC----CCCCCCC----------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111 1111111 134578889999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=348.18 Aligned_cols=259 Identities=24% Similarity=0.381 Sum_probs=199.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeE----EEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMV----VAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
++|+..+.||+|+||.||+|.+..+++. ||+|.+... ........+.+|++++++++||||+++++++..+. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 5688899999999999999999877654 477776433 23345567789999999999999999999998765 78
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+|+||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999976432 278899999999999999999999 999999999999999999999999999987
Q ss_pred cccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 854 MLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+ ..+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~----~~~~---- 236 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSIL----EKGE---- 236 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHH----HTTC----
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HcCC----
Confidence 644332 2233456778999999998899999999999999999999 9999974322 2222221 1111
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.......+. ..+.+++.+||+.||++||++.|+++.|+++....
T Consensus 237 --~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 237 --RLPQPPICT------IDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp --CCCCCTTBC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred --CCCCCccCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 001111111 24667889999999999999999999999887543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.51 Aligned_cols=251 Identities=26% Similarity=0.402 Sum_probs=207.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.+.|+..+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 4568889999999999999999999999999999965433 234567779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 100 EYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp ECCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 999999999999653 278999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.........|++.|+|||+..+..++.++||||||+++|||++|+.||.... ....... +.... .+.+
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~-~~~~~------~~~~ 239 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH-----PMKVLFL-IPKNN------PPTL 239 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHH-HHHSC------CCCC
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC-----HHHHHHH-hhcCC------CCCC
Confidence 4444455678999999999998899999999999999999999999997321 1111111 11111 1112
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
...++ ..+.+++.+|++.||++||++.|+++.
T Consensus 240 ~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYS------KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCC------HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccC------HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 22222 245678899999999999999999873
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=346.86 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=195.8
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCC--CceeeEEeEEEcCCeEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH--RNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H--pniv~l~~~~~~~~~~~lV 775 (1009)
+.|+..+.||+|+||.||+|.+.. ++.||||++..........+.+.+|++++++++| |||+++++++.++...++|
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 468889999999999999999865 8899999997665555666777899999999976 9999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|| +.+++|.+++..... +++.++..++.|+++||+|||+. +|+||||||+||+++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHHSCC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 568899999976432 78889999999999999999999 999999999999997 6789999999998764
Q ss_pred cCCC--ceeeecccCcccCCcccCC-----------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH
Q 037197 856 HKNE--TVSMVAGSYGYIAPEYGYT-----------LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 856 ~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
.... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ....+....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~~ 234 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QISKLHAII 234 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS----HHHHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh----HHHHHHHHh
Confidence 3332 2335679999999998754 6788999999999999999999999974321 222222222
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM 974 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 974 (1009)
.... ...+..... ..+.+++.+||+.||++|||+.|+++-
T Consensus 235 ~~~~------~~~~~~~~~------~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 DPNH------EIEFPDIPE------KDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CTTS------CCCCCCCSC------HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCc------ccCCcccCC------HHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111 111111111 245678899999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.22 Aligned_cols=264 Identities=20% Similarity=0.280 Sum_probs=205.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEE----cCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLH----NETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~----~~~~~~ 773 (1009)
++|+..+.||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++. .....+
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 5688999999999999999999988999999998543 3445567779999999999999999999986 345789
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++|+|.+++.........+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999999976433344589999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCC---------ceeeecccCcccCCcccCCCC---CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH
Q 037197 854 MLHKNE---------TVSMVAGSYGYIAPEYGYTLK---VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSM 921 (1009)
Q Consensus 854 ~~~~~~---------~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 921 (1009)
...... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||.............+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-- 261 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-- 261 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH--
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh--
Confidence 532111 112345689999999876543 688999999999999999999999632111112221111
Q ss_pred HhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 922 IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
... . .+. .... ...+.+++.+|++.||++||++.|+++.|+.+....
T Consensus 262 --~~~--~---~~~-~~~~------~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 262 --NQL--S---IPQ-SPRH------SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp --CC-------CCC-CTTS------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred --ccC--C---CCc-cccC------CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 110 0 000 0111 124667899999999999999999999999987543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=336.55 Aligned_cols=265 Identities=17% Similarity=0.187 Sum_probs=203.6
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEE-EcCCeEE
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYL-HNETNVM 773 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~-~~~~~~~ 773 (1009)
.+.++|+..+.||+|+||.||+|.+..+++.||||++..... ...+.+|++++++++|++++..+.++ .+++..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 355789999999999999999999999999999998754322 23466899999999988777666654 6778889
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe---CCCCcEEEccccc
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGL 850 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~DfGl 850 (1009)
+||||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+
T Consensus 82 lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEEcc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 999999 9999999974322 278999999999999999999999 99999999999999 7889999999999
Q ss_pred ceecccCCC-------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC-CccHHHHHHHHH
Q 037197 851 ARMMLHKNE-------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG-SKDIVEWVLSMI 922 (1009)
Q Consensus 851 s~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~-~~~~~~~~~~~~ 922 (1009)
++....... ......||+.|+|||...+..++.++|||||||++|||++|+.||...... .......+....
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence 987654332 223457899999999999989999999999999999999999999754322 112222221111
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.... . +.....+ ...+.+++.+|++.||++||++.++++.|+++..+.
T Consensus 235 ~~~~--~----~~~~~~~------~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 235 MSTP--I----EVLCKGY------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHSC--H----HHHTTTS------CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccch--h----hhhhccC------CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 1100 0 0000111 124667889999999999999999999999987544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=349.15 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=199.7
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC------C
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE------T 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------~ 770 (1009)
.++|+..+.||+|+||.||+|.+..+|+.||||++..........+++.+|+++++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4678899999999999999999999999999999976555555567788999999999999999999999765 3
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
.+|+||||+ +++|.++++.. .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 88999998653 278889999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc-ccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN-KAQ 928 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~ 928 (1009)
++.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||... +....+....... ...
T Consensus 175 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 175 ARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS-----DHLDQLKEIMKVTGTPP 246 (367)
T ss_dssp CEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHHHCCCC
T ss_pred cccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHhcCCCC
Confidence 987532 2344578999999998776 67899999999999999999999999732 1122222211111 000
Q ss_pred c-------------------cccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhhcC
Q 037197 929 D-------------------EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT--MLGEAK 979 (1009)
Q Consensus 929 ~-------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~~ 979 (1009)
. ......+....... ...+.+++.+|++.||++|||+.|+++ .+.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA---SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTC---CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCC---CHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 00011111111111 224667889999999999999999988 455443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.13 Aligned_cols=263 Identities=22% Similarity=0.344 Sum_probs=199.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECC---CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC---
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR---PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET--- 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~--- 770 (1009)
.++|+..+.||+|+||.||+|.+.. +++.||+|++..........+.+.+|++++++++||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 3568899999999999999998764 4668999999766555556677889999999999999999999987654
Q ss_pred --eEEEEEeccCCCChhhhhcCCc--cccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEc
Q 037197 771 --NVMMVYDYMPNDSLGEALHGKE--AGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIA 846 (1009)
Q Consensus 771 --~~~lV~E~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 846 (1009)
..++||||+++|+|.+++.... .....+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEe
Confidence 3599999999999999985332 2234489999999999999999999998 99999999999999999999999
Q ss_pred ccccceecccCC--CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHh
Q 037197 847 DFGLARMMLHKN--ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 847 DfGls~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
|||+++...... .......+++.|+|||...+..++.++||||||+++|||++ |..||..... ......+ .
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~----~ 263 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEMYDYL----L 263 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHH----H
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--HHHHHHH----H
Confidence 999998764433 22234457889999999988899999999999999999999 8899874321 1222211 1
Q ss_pred hccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.+. .+.....+. ..+.+++.+|++.||++||++.++++.|+++..
T Consensus 264 ~~~------~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 264 HGH------RLKQPEDCL------DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp TTC------CCCCBTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCC------CCCCCcccc------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 111111111 246678899999999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=360.42 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=200.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 457788899999999999999987 5679999996542 234677899999999999999999999876 67899999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.++++... ...+++.+++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 259 ~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 259 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999996432 12378889999999999999999999 9999999999999999999999999999876433
Q ss_pred CC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
.. ......+++.|+|||.+....++.++||||||+++|||++ |+.||... ...+. ...+..+. ...
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-----~~~~~-~~~i~~~~------~~~ 401 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREV-LDQVERGY------RMP 401 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHH-HHHHHTTC------CCC
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC-----CHHHH-HHHHHcCC------CCC
Confidence 21 2223456789999999888899999999999999999999 99999732 11222 22222221 111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
....++ ..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 402 ~~~~~~------~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 CPPECP------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 111121 2456788999999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=362.72 Aligned_cols=255 Identities=23% Similarity=0.278 Sum_probs=205.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|+..+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 568888999999999999999999999999999854321 1123455679999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 264 Ey~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp CCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999976432 2378899999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...+.... ..+
T Consensus 339 ~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~--~~~~~i~~~i~~~~-------~~~ 408 (576)
T 2acx_A 339 G-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--IKREEVERLVKEVP-------EEY 408 (576)
T ss_dssp T-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC--CCHHHHHHHHHHCC-------CCC
T ss_pred C-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc--hhHHHHHHHhhccc-------ccC
Confidence 3 3344568999999999999888999999999999999999999999753221 11122222222211 111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
..... ..+..++.+|++.||++|| ++.|+++
T Consensus 409 p~~~s------~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 409 SERFS------PQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CTTSC------HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CccCC------HHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11111 2456788999999999999 6777764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=357.48 Aligned_cols=257 Identities=21% Similarity=0.312 Sum_probs=194.0
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC------ChhhHHHHHHHHHHHhccCCCceeeEEeEEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN------DIESGDDLFREVSLLGRLRHRNIVRLLGYLH 767 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~ 767 (1009)
..+.++|...+.||+|+||.||+|.+..+++.||||++..... .......+.+|++++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 5567889999999999999999999999999999999865321 1112234668999999999999999999986
Q ss_pred cCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC---cEE
Q 037197 768 NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL---EAR 844 (1009)
Q Consensus 768 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~---~~k 844 (1009)
. +..++||||+++|+|.+++..... +++.++..++.|+++||+|||++ +|+||||||+||+++.++ .+|
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKR----LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEE
Confidence 5 457999999999999999875432 78999999999999999999999 999999999999997544 599
Q ss_pred EcccccceecccCCCceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH
Q 037197 845 IADFGLARMMLHKNETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSM 921 (1009)
Q Consensus 845 l~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 921 (1009)
|+|||+++.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..+...+
T Consensus 283 l~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~i--- 357 (419)
T 3i6u_A 283 ITDFGHSKILGE-TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQI--- 357 (419)
T ss_dssp ECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-CCHHHHH---
T ss_pred EeecccceecCC-CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-HHHHHHH---
Confidence 999999987643 23334567999999999875 356788999999999999999999999743222 2222222
Q ss_pred HhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 922 IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+.. ...+..... ....+.+++.+|++.||++||++.|+++
T Consensus 358 -~~~~~---~~~~~~~~~------~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 -TSGKY---NFIPEVWAE------VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -HTTCC---CCCHHHHTT------SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -hcCCC---CCCchhhcc------cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11110 011111111 1234667899999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=344.35 Aligned_cols=199 Identities=25% Similarity=0.317 Sum_probs=175.2
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-----CCceeeEEeEEEcCC
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-----HRNIVRLLGYLHNET 770 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----Hpniv~l~~~~~~~~ 770 (1009)
+.++|+..+.||+|+||.||+|++..+++.||||++... .........|+++++.+. ||||+++++++...+
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 456799999999999999999999999999999998532 344556668999999986 999999999999999
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC-----------
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA----------- 839 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~----------- 839 (1009)
..++||||+ +++|.+++...... .+++..+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYN--GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchh
Confidence 999999999 99999999765422 378889999999999999999999 9999999999999975
Q ss_pred --------------CCcEEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 037197 840 --------------NLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905 (1009)
Q Consensus 840 --------------~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~ 905 (1009)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 78999999999986433 2334578999999999999999999999999999999999999997
Q ss_pred C
Q 037197 906 P 906 (1009)
Q Consensus 906 ~ 906 (1009)
.
T Consensus 261 ~ 261 (360)
T 3llt_A 261 T 261 (360)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=338.08 Aligned_cols=251 Identities=18% Similarity=0.252 Sum_probs=202.9
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEE
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~ 773 (1009)
.+.++|+..+.||+|+||.||+|.+..+++.||+|++...........++.+|+..+.++ +||||+++++++.+++..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 456789999999999999999999998899999999977655555667788999999999 9999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-------------
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN------------- 840 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~------------- 840 (1009)
+||||+++++|.+++.........+++..++.++.||++||+|||++ +|+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999976543334478999999999999999999999 99999999999999844
Q ss_pred ------CcEEEcccccceecccCCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCcc
Q 037197 841 ------LEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKD 913 (1009)
Q Consensus 841 ------~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~ 913 (1009)
..+||+|||.+....... ...||+.|+|||...+. .++.++||||||+++|||++|..|+... +
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~ 235 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----D 235 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----H
T ss_pred cccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----h
Confidence 479999999998764332 23589999999998765 5668999999999999999999776421 1
Q ss_pred HHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 914 IVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
... .+..+. .+.+....+ ..+.+++.+|++.||++||++.|+++
T Consensus 236 ~~~----~~~~~~------~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 QWH----EIRQGR------LPRIPQVLS------QEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHH----HHHTTC------CCCCSSCCC------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH----HHHcCC------CCCCCcccC------HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111 111111 111221221 24567889999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=344.19 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=203.7
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC--h----hhHHHHHHHHHHHhcc-CCCceeeEEeEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND--I----ESGDDLFREVSLLGRL-RHRNIVRLLGYL 766 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~--~----~~~~~~~~E~~~l~~l-~Hpniv~l~~~~ 766 (1009)
..+.++|+..+.||+|+||.||+|.+..+|+.||||++...... . ...+.+.+|+++++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 44567899999999999999999999988999999998654321 1 1134556899999999 799999999999
Q ss_pred EcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEc
Q 037197 767 HNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIA 846 (1009)
Q Consensus 767 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 846 (1009)
......++||||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999996432 378999999999999999999999 99999999999999999999999
Q ss_pred ccccceecccCCCceeeecccCcccCCcccC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHH
Q 037197 847 DFGLARMMLHKNETVSMVAGSYGYIAPEYGY------TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLS 920 (1009)
Q Consensus 847 DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 920 (1009)
|||++...... .......||+.|+|||++. ...++.++|||||||++|||++|+.||... .......
T Consensus 243 DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~-----~~~~~~~- 315 (365)
T 2y7j_A 243 DFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR-----RQILMLR- 315 (365)
T ss_dssp CCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHH-
T ss_pred ecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC-----CHHHHHH-
Confidence 99999876433 2334567999999999865 335889999999999999999999999632 1111211
Q ss_pred HHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 921 MIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+..+.. ....+... . ....+.+++.+|++.||++||++.|+++
T Consensus 316 ~i~~~~~--~~~~~~~~-~------~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 MIMEGQY--QFSSPEWD-D------RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHTCC--CCCHHHHS-S------SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhCCC--CCCCcccc-c------CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111110 00001000 1 1124667899999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=350.24 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=190.4
Q ss_pred HhcCCcC-ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhc-cCCCceeeEEeEEEc----CC
Q 037197 697 LACVKES-NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGR-LRHRNIVRLLGYLHN----ET 770 (1009)
Q Consensus 697 ~~~~~~~-~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~Hpniv~l~~~~~~----~~ 770 (1009)
.+.|... +.||+|+||+||+|.+..+++.||||++.. .....+|++++.+ .+||||+++++++.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3455554 689999999999999999999999999843 2345688888744 589999999998865 56
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC---CCcEEEcc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA---NLEARIAD 847 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~D 847 (1009)
..|+||||+++|+|.+++..... ..+++.++..|+.||+.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 78999999999999999976432 2378999999999999999999998 9999999999999998 78999999
Q ss_pred cccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCC--ccHHHHHHHHHhhc
Q 037197 848 FGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS--KDIVEWVLSMIKSN 925 (1009)
Q Consensus 848 fGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~ 925 (1009)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+ ..+
T Consensus 208 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~ 282 (400)
T 1nxk_A 208 FGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMG 282 (400)
T ss_dssp CTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHT
T ss_pred cccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcC
Confidence 9999865432 23345678999999999998899999999999999999999999997543221 1122221 111
Q ss_pred cccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 926 KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.. ....+.. .... .++.+++.+||+.||++|||+.|+++
T Consensus 283 ~~--~~~~~~~----~~~s---~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 283 QY--EFPNPEW----SEVS---EEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CC--CCCTTTT----TTSC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cc--cCCCccc----ccCC---HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 0011111 1111 24567889999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=353.92 Aligned_cols=202 Identities=26% Similarity=0.372 Sum_probs=172.9
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-----C
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE-----T 770 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----~ 770 (1009)
+.++|+..+.||+|+||.||+|.+..+++.||||++..........+++.+|++++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 35679999999999999999999999999999999976655566677888999999999999999999998766 5
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
..|+||||++ ++|.++++... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 7899999996 69999997643 278999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCC----------------------ceeeecccCcccCCccc-CCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 037197 851 ARMMLHKNE----------------------TVSMVAGSYGYIAPEYG-YTLKVDEKSDIYSFGVVLLELLTGKMPLD 905 (1009)
Q Consensus 851 s~~~~~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlGvvl~elltg~~Pf~ 905 (1009)
++....... ......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 987643321 13556789999999985 56679999999999999999998666654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=336.80 Aligned_cols=253 Identities=22% Similarity=0.303 Sum_probs=202.3
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
.+.++|+..+.||+|+||.||+|++..+++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 456789999999999999999999998899999999965422 233456699999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe---CCCCcEEEcccccc
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLA 851 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~DfGls 851 (1009)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 84 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 84 VMQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp EECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEEcCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 999999999999986543 278899999999999999999999 99999999999999 77889999999999
Q ss_pred eecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 852 RMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
...... ......|++.|+|||...+..++.++||||+|+++|||++|+.||... ........ +..+.. .
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~-i~~~~~--~- 225 (304)
T 2jam_A 157 KMEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE-----TESKLFEK-IKEGYY--E- 225 (304)
T ss_dssp CCCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHH-HHHCCC--C-
T ss_pred eecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHH-HHcCCC--C-
Confidence 754322 223456899999999999889999999999999999999999999632 11222222 222211 0
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
......... ...+.+++.+|++.||++||++.|+++
T Consensus 226 ~~~~~~~~~------~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 FESPFWDDI------SESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCTTTTTTS------CHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCccccccC------CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111 124567889999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=346.25 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=196.3
Q ss_pred HhcCCcC-ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEE
Q 037197 697 LACVKES-NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 697 ~~~~~~~-~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l 774 (1009)
.+.|+.. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+++++++ +||||+++++++.+++..++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4567764 78999999999999999889999999996542 23456778999999985 79999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc---EEEcccccc
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE---ARIADFGLA 851 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~DfGls 851 (1009)
||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 999999999999997543 278899999999999999999999 9999999999999998776 999999998
Q ss_pred eecccCCC-------ceeeecccCcccCCcccCC-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCc-------
Q 037197 852 RMMLHKNE-------TVSMVAGSYGYIAPEYGYT-----LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSK------- 912 (1009)
Q Consensus 852 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~------- 912 (1009)
........ ......||+.|+|||++.. ..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 76532211 1223468999999998764 4578999999999999999999999975432210
Q ss_pred --cHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 913 --DIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 913 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.....+...+..+.. ......... ....+.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~i~~~~~---~~~~~~~~~------~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKY---EFPDKDWAH------ISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CHHHHHHHHHHHHHCCC---CCCHHHHTT------SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred chhHHHHHHHHHhccCc---ccCchhccc------CCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 001112222222210 000000000 1134668899999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=344.33 Aligned_cols=264 Identities=21% Similarity=0.357 Sum_probs=209.7
Q ss_pred HhcCCcCceeccCCceEEEEEEEC-----CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
.++|+..+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|++++++++||||+++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 467899999999999999999876 357889999996432 33445567799999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccc------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEE
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAG------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARI 845 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 845 (1009)
.++||||+++|+|.++++..... ...+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEE
Confidence 99999999999999999753211 12368899999999999999999999 9999999999999999999999
Q ss_pred cccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHH
Q 037197 846 ADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 846 ~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
+|||+++....... ......+|+.|+|||+..+..++.++||||||+++|||++ |+.||... ....... .+
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~~~-~~ 253 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVLR-FV 253 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHHH-HH
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC-----CHHHHHH-HH
Confidence 99999986543332 1223456889999999888889999999999999999999 89998632 1122222 22
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
..+.. +....... ..+.+++.+|++.||++||++.|+++.|+++....
T Consensus 254 ~~~~~------~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 254 MEGGL------LDKPDNCP------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp HTTCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred HcCCc------CCCCCCCC------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 21110 01111111 24567889999999999999999999999987643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=344.03 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=208.8
Q ss_pred HhcCCcCceeccCCceEEEEEEE-----CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCC
Q 037197 697 LACVKESNIIGMGGNGIVYKAEF-----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNET 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~ 770 (1009)
.++|+..+.||+|+||.||+|.+ ..+++.||||++.... .......+.+|+++++++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 46789999999999999999985 3567899999996542 334456677999999999 7999999999987654
Q ss_pred -eEEEEEeccCCCChhhhhcCCccc------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe
Q 037197 771 -NVMMVYDYMPNDSLGEALHGKEAG------------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL 837 (1009)
Q Consensus 771 -~~~lV~E~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 837 (1009)
..++||||+++++|.+++...... +..+++..++.++.|+++||+|||+. +|+||||||+||++
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~ 181 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 181 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEE
Confidence 589999999999999999765432 12278999999999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccH
Q 037197 838 DANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDI 914 (1009)
Q Consensus 838 ~~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~ 914 (1009)
+.++.+||+|||+++....... ......+|+.|+|||+..+..++.++||||||+++|||++ |+.||...... .
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~-- 258 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-E-- 258 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-H--
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh-H--
Confidence 9999999999999987644332 2233567889999999988889999999999999999998 99999743221 1
Q ss_pred HHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 915 VEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.+...+..+.. ........ ..+.+++.+|++.||++||++.|+++.|+.+..
T Consensus 259 --~~~~~~~~~~~------~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 259 --EFCRRLKEGTR------MRAPDYTT------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp --HHHHHHHHTCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHhccCcc------CCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 12222222211 11111111 245678899999999999999999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=335.44 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=202.2
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
++|+..+.||+|+||.||+|.+..+++.||+|++...... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5688899999999999999999999999999998543211 122355679999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++.... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999997543 278899999999999999999998 999999999999999999999999999976532
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
. ......|++.|+|||...+..++.++||||||+++|+|++|+.||... ............. ..+
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~--------~~~ 231 (284)
T 2vgo_A 167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-----SHTETHRRIVNVD--------LKF 231 (284)
T ss_dssp S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTTC--------CCC
T ss_pred c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC-----CHhHHHHHHhccc--------cCC
Confidence 2 233457899999999999888999999999999999999999999732 1122222221111 111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
....+ ..+.+++.+|++.||++||++.|+++
T Consensus 232 ~~~~~------~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 232 PPFLS------DGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CTTSC------HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcCC------HHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 11111 24567889999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=361.59 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=206.2
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.+.++|+..+.||+|+||.||+|.+..+++.||||++...... ......+.+|++++++++||||+++++++.+....+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3567899999999999999999999999999999998655432 334567779999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe---CCCCcEEEccccc
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGL 850 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~DfGl 850 (1009)
+||||+.+|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+||++ +.++.+||+|||+
T Consensus 103 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSC----CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 99999999999999876543 78999999999999999999999 99999999999999 5678999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
++.+.... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||... ...+.+... ..+.. .
T Consensus 176 a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i-~~~~~--~ 245 (484)
T 3nyv_A 176 STHFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA-----NEYDILKKV-EKGKY--T 245 (484)
T ss_dssp HHHBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHH-HHCCC--C
T ss_pred eEEccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHH-HcCCC--C
Confidence 98664332 3344579999999998765 6899999999999999999999999732 222222222 22211 0
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+... .. ...+.+++.+|++.||++|||+.|+++
T Consensus 246 ~~~~~~~----~~---s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 FELPQWK----KV---SESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCSGGGG----GS---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCcccc----cC---CHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1111111 11 124567889999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=360.87 Aligned_cols=255 Identities=26% Similarity=0.346 Sum_probs=201.6
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh-----------hhHHHHHHHHHHHhccCCCceeeEE
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI-----------ESGDDLFREVSLLGRLRHRNIVRLL 763 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~Hpniv~l~ 763 (1009)
.+.++|+..+.||+|+||+||+|.+..+++.||+|++....... ...+.+.+|++++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999999999999999997543221 2345677999999999999999999
Q ss_pred eEEEcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC--
Q 037197 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-- 841 (1009)
Q Consensus 764 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-- 841 (1009)
+++.++...++||||+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999999865432 88999999999999999999999 999999999999998776
Q ss_pred -cEEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHH
Q 037197 842 -EARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLS 920 (1009)
Q Consensus 842 -~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 920 (1009)
.+||+|||++...... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||... ...+.+..
T Consensus 186 ~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~ 258 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ-----NDQDIIKK 258 (504)
T ss_dssp SSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred ccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHH
Confidence 6999999999876433 3334567999999999876 46899999999999999999999999732 22222222
Q ss_pred HHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 921 MIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+..+.. ..+...... ...++.+++.+|++.||++|||+.|+++
T Consensus 259 -i~~~~~---~~~~~~~~~------~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 -VEKGKY---YFDFNDWKN------ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -HHHCCC---CCCHHHHTT------SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHcCCC---CCCccccCC------CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 222211 011000001 1124667889999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=338.42 Aligned_cols=257 Identities=23% Similarity=0.296 Sum_probs=189.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|++............+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 35688899999999999999999999999999999655433333333445666688899999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||++ |+|.+++.........+++..++.++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 5888887653333345899999999999999999999852 899999999999999999999999999987643
Q ss_pred CCCceeeecccCcccCCccc----CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 857 KNETVSMVAGSYGYIAPEYG----YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
. .......||+.|+|||++ ....++.++||||+|+++|||++|+.||..... ....+......... ...
T Consensus 163 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~--~~~ 235 (290)
T 3fme_A 163 D-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT----PFQQLKQVVEEPSP--QLP 235 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC----HHHHHHHHHHSCCC--CCC
T ss_pred c-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc----hHHHHHHHhccCCC--Ccc
Confidence 3 223344689999999985 566789999999999999999999999974222 22222222222211 000
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. ... ..++.+++.+|++.||++|||+.|+++
T Consensus 236 ~----~~~------~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 236 A----DKF------SAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp T----TTS------CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred c----ccC------CHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 111 124667889999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.35 Aligned_cols=263 Identities=17% Similarity=0.186 Sum_probs=206.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEE-EcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYL-HNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~-~~~~~~~lV 775 (1009)
.++|+..+.||+|+||.||+|++..+++.||||++..... ...+.+|++++++++|++++..+.++ .++...++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 4678899999999999999999998999999999855422 24577999999999988866666554 667788999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC---CCCcEEEcccccce
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD---ANLEARIADFGLAR 852 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~DfGls~ 852 (1009)
|||+ +++|.+++..... .+++.+++.++.|+++||+|||++ +|+||||||+||+++ .++.+||+|||++.
T Consensus 84 ~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 9999 9999999974322 388999999999999999999999 999999999999994 78899999999998
Q ss_pred ecccCCC-------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC-CccHHHHHHHHHhh
Q 037197 853 MMLHKNE-------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG-SKDIVEWVLSMIKS 924 (1009)
Q Consensus 853 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~ 924 (1009)
....... ......||+.|+|||...+..++.++||||||+++|||++|+.||...... .......+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 7654432 124567899999999999989999999999999999999999999754322 12222222221111
Q ss_pred ccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 925 NKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.. . +.+...++ ..+.+++.+|++.||++||++.|+++.|+++..+.
T Consensus 237 ~~--~----~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 237 TP--I----EVLCKGYP------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp SC--H----HHHTTTSC------HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred Cc--h----HHHHhhCC------HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 10 0 00111111 24667889999999999999999999999986544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=338.52 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=200.1
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
...+.|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+|++++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34567899999999999999999999999999999986532 24567799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 102 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp EEECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 999999999999986322 2378999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
...........|++.|+|||...+..++.++||||||+++|+|++|+.||.... ....+.... .... .....
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~-~~~~-~~~~~- 247 (314)
T 3com_A 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH-----PMRAIFMIP-TNPP-PTFRK- 247 (314)
T ss_dssp BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHH-HSCC-CCCSS-
T ss_pred hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHh-cCCC-cccCC-
Confidence 554444455678999999999988889999999999999999999999997321 111111111 1110 00000
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.... ...+.+++.+|++.||++||++.|+++
T Consensus 248 --~~~~------~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 --PELW------SDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --GGGS------CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --cccC------CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1111 124667889999999999999999975
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=358.18 Aligned_cols=321 Identities=21% Similarity=0.187 Sum_probs=207.4
Q ss_pred ceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccC
Q 037197 189 KFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKN 268 (1009)
Q Consensus 189 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 268 (1009)
+.++.++++++ .+|..+. +++++|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 56777777777 5666553 46777777777777766777777777777777777777766777777777777777777
Q ss_pred CcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCc
Q 037197 269 NFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPM 348 (1009)
Q Consensus 269 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 348 (1009)
.+++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|.+++..+..|.++++|+.|++++|.+++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 77755555566667777777777766665566666666666666666666666666666666666666666655544444
Q ss_pred cccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcc
Q 037197 349 RLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSL 428 (1009)
Q Consensus 349 ~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L 428 (1009)
.+.. +++|+.|++++|.+.+..+..+..+++|+.|++++|.+.+.+|..+....+|
T Consensus 171 ~l~~------------------------l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L 226 (477)
T 2id5_A 171 ALSH------------------------LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226 (477)
T ss_dssp HHTT------------------------CTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCC
T ss_pred Hhcc------------------------cCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccc
Confidence 4444 4455555555555554444455555556666666655555555555555566
Q ss_pred cEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecC
Q 037197 429 QRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSN 508 (1009)
Q Consensus 429 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N 508 (1009)
+.|+|++|++++..+..+..+++|+.|+|++|+++++.+..|..+++|+.|++++|++++..|..|..+++|+.|||++|
T Consensus 227 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 306 (477)
T 2id5_A 227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306 (477)
T ss_dssp SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence 66777776666433345666666666666666666666666666666666666666666666666666666777777777
Q ss_pred CCCCCCCccccccccceeeeecCccccc
Q 037197 509 SLSGEIPASIASCEKLVSLNLRNNRFSG 536 (1009)
Q Consensus 509 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 536 (1009)
+|++..+..|..+++|+.|+|++|.++.
T Consensus 307 ~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 307 QLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp CCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred cCceeCHhHcCCCcccCEEEccCCCccC
Confidence 7766555666666667777777766654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=351.11 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=196.8
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC--CCceeeEEeEEEcCCeEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR--HRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~~~~~lV 775 (1009)
..|+..+.||+|+||.||+|.+.. ++.||||++..........+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 458899999999999999999876 889999999766555566677889999999996 59999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|| +.+++|.+++.... .+++.++..++.||++||+|||+. +|+||||||+||+++ ++.+||+|||+++.+.
T Consensus 135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 56899999997653 378888999999999999999998 999999999999995 5899999999998764
Q ss_pred cCCC--ceeeecccCcccCCcccCC-----------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH
Q 037197 856 HKNE--TVSMVAGSYGYIAPEYGYT-----------LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 856 ~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
.... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.... .....+....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~----~~~~~~~~~~ 281 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII----NQISKLHAII 281 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC----CHHHHHHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh----HHHHHHHHHh
Confidence 3322 2334579999999998754 468899999999999999999999997422 1122222222
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.... ...+.... ...+.+++.+||+.||++||++.|+++
T Consensus 282 ~~~~------~~~~~~~~------~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 282 DPNH------EIEFPDIP------EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp CTTS------CCCCCCCS------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cccc------cCCCCccc------hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 1111 11111111 124567889999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=334.75 Aligned_cols=258 Identities=23% Similarity=0.362 Sum_probs=204.4
Q ss_pred cCCcCc-eeccCCceEEEEEEEC--CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 699 CVKESN-IIGMGGNGIVYKAEFH--RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 699 ~~~~~~-~iG~G~~g~Vyk~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+|...+ .||+|+||.||+|.+. .+++.||||++... ......+.+.+|++++++++||||+++++++. .+..++|
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv 87 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV 87 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence 445555 8999999999999864 45788999999654 23445667779999999999999999999994 5568999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|.+++.... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 99999999999996542 2378999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCCc---eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 856 HKNET---VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 856 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
..... .....+|+.|+|||+.....++.++||||||+++|||++ |+.||..... .+.. ..+..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~----~~i~~~~----- 230 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVM----AFIEQGK----- 230 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHH----HHHHTTC-----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHH----HHHhcCC-----
Confidence 43322 223346789999999888889999999999999999999 9999974321 1222 2222221
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.+.+...++ ..+.+++.+|++.||++||++.|+++.|+.+....
T Consensus 231 -~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 231 -RMECPPECP------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp -CCCCCTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -cCCCCCCcC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111111111 24667889999999999999999999999986543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=359.32 Aligned_cols=196 Identities=24% Similarity=0.383 Sum_probs=158.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc-----CCe
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN-----ETN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-----~~~ 771 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++.....+....+++.+|++++++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 467899999999999999999999999999999997665556667788899999999999999999999843 357
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.|+||||+ +++|.++++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 578999987543 288999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCC---------------------------CceeeecccCcccCCccc-CCCCCCcccchHhHHHHHHHHHhC
Q 037197 852 RMMLHKN---------------------------ETVSMVAGSYGYIAPEYG-YTLKVDEKSDIYSFGVVLLELLTG 900 (1009)
Q Consensus 852 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlGvvl~elltg 900 (1009)
+...... ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 8764221 123345789999999975 566799999999999999999993
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.25 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=204.3
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|++++++++||||+++++++.+ +..++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 3568889999999999999999875 7789999986542 234667799999999999999999999874 4589999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++.... ...+++.+++.++.|+++||+|||+. +|+||||||+||++++++.+||+|||.+.....
T Consensus 87 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp ECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999996542 12378899999999999999999999 999999999999999999999999999987644
Q ss_pred CCC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 857 KNE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 857 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
... ......+++.|+|||......++.++||||||+++|||++ |+.||... ...+.... +..+. ..
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~~~~-~~~~~------~~ 229 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQN-LERGY------RM 229 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHH-HHTTC------CC
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc-----CHHHHHHH-Hhccc------CC
Confidence 321 1223346778999999888889999999999999999999 99999732 11222222 22211 11
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
......+ ..+.+++.+|++.||++||++.++++.|+++..
T Consensus 230 ~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 230 VRPDNCP------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccccc------HHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 1111111 246678899999999999999999999998864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=347.79 Aligned_cols=266 Identities=24% Similarity=0.360 Sum_probs=196.9
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHH--HhccCCCceeeEEeEEEc-----CC
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSL--LGRLRHRNIVRLLGYLHN-----ET 770 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~Hpniv~l~~~~~~-----~~ 770 (1009)
++|+..+.||+|+||.||+|++ +++.||||++... ....+..|.++ ++.++||||+++++++.. ..
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 5688899999999999999987 4789999998532 22334444444 556899999999986532 23
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcC------CCCeEEeccCCCcEEeCCCCcEE
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC------QPPVIHRDIKSNNILLDANLEAR 844 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~dlk~~NIll~~~~~~k 844 (1009)
.+++||||+++|+|.+++.... .++..++.++.|+++||+|||+.+ .++|+||||||+||+++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 5789999999999999996543 478889999999999999999762 33899999999999999999999
Q ss_pred EcccccceecccCC--------CceeeecccCcccCCcccCC-------CCCCcccchHhHHHHHHHHHhCCCCCCCCCC
Q 037197 845 IADFGLARMMLHKN--------ETVSMVAGSYGYIAPEYGYT-------LKVDEKSDIYSFGVVLLELLTGKMPLDPAFG 909 (1009)
Q Consensus 845 l~DfGls~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~ 909 (1009)
|+|||+++.+.... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998764322 12224568999999998876 4567899999999999999999877643222
Q ss_pred CCc------------cHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhh
Q 037197 910 GSK------------DIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977 (1009)
Q Consensus 910 ~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 977 (1009)
... .....+...... ....+.+.............+.+++.+||+.||++|||++|+++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSR-----EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTT-----SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcc-----cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 111 001111111111 112233333222222344467889999999999999999999999998
Q ss_pred cCC
Q 037197 978 AKP 980 (1009)
Q Consensus 978 ~~~ 980 (1009)
+..
T Consensus 316 ll~ 318 (336)
T 3g2f_A 316 LMM 318 (336)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=335.76 Aligned_cols=260 Identities=22% Similarity=0.377 Sum_probs=203.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECC---CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR---PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.++|+..+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+.+|++++++++||||+++++++.++ ..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 3568888999999999999998653 34579999986542 344556777999999999999999999998754 568
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++++|.+++.... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999999999996532 2378899999999999999999999 999999999999999999999999999987
Q ss_pred cccCCC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 854 MLHKNE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 854 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
...... ......+++.|+|||......++.++||||||+++|||++ |+.||..... .+....+ ..+..
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--~~~~~~~----~~~~~---- 232 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDVIGVL----EKGDR---- 232 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--GGHHHHH----HHTCC----
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--HHHHHHH----hcCCC----
Confidence 644332 2234456789999999888889999999999999999998 9999964322 2222222 11110
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
......++ ..+.+++.+|++.||++||++.|+++.|+++....
T Consensus 233 --~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 233 --LPKPDLCP------PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp --CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCC------HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 01111111 24567889999999999999999999999886543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=349.38 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=194.3
Q ss_pred cCCcCceeccCCceEEEEEEECCC---CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc-CCeEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN-ETNVMM 774 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~~~~l 774 (1009)
.|+..+.||+|+||.||+|.+..+ +..||||.+... ......+++.+|+.++++++||||+++++++.+ ++..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 466778999999999999987532 356899998543 334456778899999999999999999998754 567899
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++|+|.++++.... .+++.+++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 169 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999975432 378889999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCC----ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 855 LHKNE----TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 855 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
..... ......+++.|+|||...+..++.++||||||+++|||++ |.+||..... .+....+ ..+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~--~~~~~~~----~~~~~-- 314 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL----LQGRR-- 314 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS--SCHHHHH----HTTCC--
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH--HHHHHHH----HcCCC--
Confidence 43321 1233456789999999988899999999999999999999 6777764322 2222221 11110
Q ss_pred cccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
...+ ..++ ..+.+++.+||+.||++||++.|+++.|+++...
T Consensus 315 -~~~p---~~~~------~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 315 -LLQP---EYCP------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp -CCCC---TTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCC---CCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111 1111 2466788999999999999999999999988643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.95 Aligned_cols=259 Identities=25% Similarity=0.413 Sum_probs=203.0
Q ss_pred cCCcCceeccCCceEEEEEEECCCC---eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeE-EE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPH---MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNV-MM 774 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~-~l 774 (1009)
.|+..+.||+|+||.||+|.+..++ ..||+|.+... ......+.+.+|++++++++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4566789999999999999975443 47999998543 3344556777999999999999999999999876655 99
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+.+|+|.+++..... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp EECCCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EEecccCCCHHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 9999999999999976432 378899999999999999999999 9999999999999999999999999999865
Q ss_pred ccCC----CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 855 LHKN----ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 855 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
.... .......+++.|+|||...+..++.++||||||+++|+|++|..|+..... ..+....+ .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~----~~~~~--- 246 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFL----AQGRR--- 246 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHH----HTTCC---
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHh----hcCCC---
Confidence 4322 222345678899999999998999999999999999999996665432211 12222221 11110
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
.......+ ..+.+++.+|++.||++|||+.|+++.|+++...
T Consensus 247 ---~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 247 ---LPQPEYCP------DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ---CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCccch------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01111111 2466788999999999999999999999998654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=350.41 Aligned_cols=264 Identities=18% Similarity=0.230 Sum_probs=205.5
Q ss_pred hcCCcCceeccCCceEEEEEEECC--------CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceee--------
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHR--------PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVR-------- 761 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~-------- 761 (1009)
++|+..+.||+|+||.||+|.+.. .++.||+|++... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 578999999999999999999987 4789999998543 35678999999999999988
Q ss_pred -------EEeEEEc-CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCC
Q 037197 762 -------LLGYLHN-ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSN 833 (1009)
Q Consensus 762 -------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~ 833 (1009)
+++++.. +...++||||+ +++|.+++.... ...+++.+++.++.||++||+|||++ +|+||||||+
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 6777765 77899999999 999999997652 23389999999999999999999999 9999999999
Q ss_pred cEEeCCCC--cEEEcccccceecccCCC-------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCC
Q 037197 834 NILLDANL--EARIADFGLARMMLHKNE-------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904 (1009)
Q Consensus 834 NIll~~~~--~~kl~DfGls~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf 904 (1009)
||+++.++ .+||+|||+++.+..... ......||+.|+|||+..+..++.++||||||+++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 999999999987643321 113347899999999999889999999999999999999999999
Q ss_pred CCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 905 DPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
..................... ....+.... ..... ..+.+++.+|++.||++||++.|+++.|+++..+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKP---GPFVGPCGH--WIRPS---ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSC---CCEECTTSC--EECCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccCCcCHHHHHHHHHhccCCh---hhhhhhccc--cCCCc---HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 754322222222222211111 111111100 00111 24667889999999999999999999999987554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.54 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=197.2
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEecc
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYM 779 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~ 779 (1009)
|....+||+|+||.||+|.+..+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 455668999999999999999999999999986542 334566779999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC-CCcEEEcccccceecccCC
Q 037197 780 PNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA-NLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 780 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGls~~~~~~~ 858 (1009)
++++|.+++..... ....++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999976432 23367888889999999999999999 9999999999999987 8999999999998765444
Q ss_pred CceeeecccCcccCCcccCCC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 859 ETVSMVAGSYGYIAPEYGYTL--KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.......|++.|+|||+.... .++.++||||||+++|||++|+.||...... ...+....... ..+.+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~------~~~~~ 247 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP----QAAMFKVGMFK------VHPEI 247 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH----HHHHHHHHHHC------CCCCC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch----hHHHHhhcccc------ccccc
Confidence 334456789999999987654 3789999999999999999999999632111 11111111111 11222
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..... ..+.+++.+|++.||++||++.|+++
T Consensus 248 ~~~~~------~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 PESMS------AEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CTTSC------HHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccCC------HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22221 24567889999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.61 Aligned_cols=262 Identities=26% Similarity=0.348 Sum_probs=204.3
Q ss_pred CCcCceeccCCceEEEEEEE----CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc--CCeEE
Q 037197 700 VKESNIIGMGGNGIVYKAEF----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN--ETNVM 773 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~~ 773 (1009)
|+..+.||+|+||.||++.. ..+++.||||++... ......+.+.+|++++++++||||+++++++.+ ....+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 48889999999999988764 346899999999654 334455677799999999999999999999987 46789
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++|+|.+++.... +++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 9999999999999996543 78899999999999999999999 999999999999999999999999999987
Q ss_pred cccCCC---ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC---------CccHHHHHHHH
Q 037197 854 MLHKNE---TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG---------SKDIVEWVLSM 921 (1009)
Q Consensus 854 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~---------~~~~~~~~~~~ 921 (1009)
...... ......+++.|+|||++.+..++.++||||||+++|||++|+.||...... .......+...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 754432 223345778899999998888999999999999999999999998632110 00000111111
Q ss_pred HhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 922 IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
...+. .......+. ..+.+++.+|++.||++|||+.|+++.|+.+.++.
T Consensus 264 ~~~~~------~~~~~~~~~------~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 264 LERGE------RLPRPDKCP------AEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHTTC------CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred Hhccc------CCCCCcccc------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11111 111111111 24667889999999999999999999999886543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=335.06 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=200.8
Q ss_pred hcCCcCceeccCCceEEEEEEECCC---CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEE-cCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLH-NETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~-~~~~~~ 773 (1009)
..|+..+.||+|+||.||+|.+..+ ...||+|.+... ......+.+.+|++++++++||||+++++++. .++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4578889999999999999997543 346899998643 33445567789999999999999999999864 556789
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++|+|.++++.... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999975432 378889999999999999999999 999999999999999999999999999986
Q ss_pred cccCC----CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 854 MLHKN----ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 854 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
..... .......+|+.|+|||...+..++.++||||+|+++|||++ |.+||...... +....+ . .+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~---~-~~~-- 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL---L-QGR-- 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHH---H-TTC--
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHH---h-cCC--
Confidence 64332 12334567789999999988889999999999999999999 55566532211 222111 1 111
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
. ... ....+ ..+.+++.+|++.||++||++.|+++.|+++...
T Consensus 250 ~-~~~---~~~~~------~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 250 R-LLQ---PEYCP------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp C-CCC---CTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred C-CCC---CccCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0 011 11111 2466788999999999999999999999988653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=339.23 Aligned_cols=254 Identities=23% Similarity=0.339 Sum_probs=198.4
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
..+.|+..+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 356789999999999999999999999999999998543 233456778999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|.+++..... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 95 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999865322 278899999999999999999999 99999999999999999999999999986543
Q ss_pred cCCCceeeecccCcccCCccc-----CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 856 HKNETVSMVAGSYGYIAPEYG-----YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
..........|++.|+|||+. ....++.++||||||+++|+|++|+.||... +............. ..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~--~~ 241 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIAKSDP--PT 241 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHSCC--CC
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC-----CHHHHHHHHhccCC--cc
Confidence 322233445789999999987 4667889999999999999999999999732 22222222222111 00
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
... ...+ ...+.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~---~~~~------~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 LLT---PSKW------SVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CSS---GGGS------CHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCC---cccc------CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000 1111 124667889999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=346.79 Aligned_cols=258 Identities=25% Similarity=0.347 Sum_probs=185.7
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC------
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE------ 769 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------ 769 (1009)
+.++|+..+.||+|+||.||+|.+..+++.||||++..........+.+.+|+++++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 34678999999999999999999999999999999976555556667788999999999999999999998654
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFG 849 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 849 (1009)
...++||||+ +++|.++++.. .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CeEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 78999988653 278899999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh-ccc
Q 037197 850 LARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS-NKA 927 (1009)
Q Consensus 850 ls~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~ 927 (1009)
+++.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||... +....+...... +..
T Consensus 178 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 178 LARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-----DHIDQLKLILRLVGTP 249 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHHHCSC
T ss_pred ccccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHhCCC
Confidence 9976532 2344678999999998776 67899999999999999999999999732 112222221111 110
Q ss_pred cccccC-------------------ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 928 QDEALD-------------------PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 928 ~~~~~~-------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+... ..+...+.. ....+.+++.+|++.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIG---ANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTT---CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCC---CCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000000 000000000 1134678899999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=331.98 Aligned_cols=249 Identities=29% Similarity=0.395 Sum_probs=193.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
++|+..+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 568889999999999999999998899999999854321 1123456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++.... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp ECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred eccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999996543 278889999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeecccCcccCCcccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKV-DEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
. .......+++.|+|||...+..+ +.++||||||+++|+|++|+.||... ...... ..+..+.. .
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~-~~~~~~~~-------~ 229 (276)
T 2h6d_A 164 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE-----HVPTLF-KKIRGGVF-------Y 229 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHH-HHHHHCCC-------C
T ss_pred C-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC-----cHHHHH-HHhhcCcc-------c
Confidence 2 22334568999999999887665 68999999999999999999999732 222222 22222210 0
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+..... ..+.+++.+|++.||++||++.|+++
T Consensus 230 ~~~~~~------~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 230 IPEYLN------RSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhcC------HHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111111 24567889999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=356.51 Aligned_cols=246 Identities=13% Similarity=0.149 Sum_probs=189.9
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHH---HHHhccCCCceeeEE-------eE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREV---SLLGRLRHRNIVRLL-------GY 765 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~---~~l~~l~Hpniv~l~-------~~ 765 (1009)
.+.|+..+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4568889999999999999999988899999999975432 333456677999 555666899999998 66
Q ss_pred EEcCCe-----------------EEEEEeccCCCChhhhhcCCcc---ccccccHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 037197 766 LHNETN-----------------VMMVYDYMPNDSLGEALHGKEA---GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825 (1009)
Q Consensus 766 ~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 825 (1009)
+.+.+. .++||||+ +|+|.+++..... ....+++..++.|+.||++||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 665532 79999999 6899999975321 112355788889999999999999999 99
Q ss_pred EEeccCCCcEEeCCCCcEEEcccccceecccCCCceeeecccCcccCCcccCCC-----------CCCcccchHhHHHHH
Q 037197 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL-----------KVDEKSDIYSFGVVL 894 (1009)
Q Consensus 826 vH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~SlGvvl 894 (1009)
+||||||+||+++.++.+||+|||+++.. ........| +.|+|||++... .++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~---~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRD---GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEET---TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheec---CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 99999999999999999999999999863 223445567 999999998877 799999999999999
Q ss_pred HHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 895 LELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 895 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
|||++|+.||....... ....... ...... ..+.+++.+||+.||++||++.|+++
T Consensus 304 ~elltg~~Pf~~~~~~~---------------~~~~~~~-----~~~~~~---~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 304 YWIWCADLPITKDAALG---------------GSEWIFR-----SCKNIP---QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHSSCCC------C---------------CSGGGGS-----SCCCCC---HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHCCCCCccccccc---------------chhhhhh-----hccCCC---HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999996322110 0001111 011111 24567889999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=345.48 Aligned_cols=254 Identities=13% Similarity=0.112 Sum_probs=201.1
Q ss_pred HhcCCcCceeccCCceEEEEEE-----ECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC---CCceeeEEeEEEc
Q 037197 697 LACVKESNIIGMGGNGIVYKAE-----FHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR---HRNIVRLLGYLHN 768 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---Hpniv~l~~~~~~ 768 (1009)
.+.|...+.||+|+||.||+|. ...+++.||||++... ...++.+|++++++++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 3568889999999999999994 5667899999998543 2345667777777776 9999999999999
Q ss_pred CCeEEEEEeccCCCChhhhhcCCcc-ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC--------
Q 037197 769 ETNVMMVYDYMPNDSLGEALHGKEA-GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA-------- 839 (1009)
Q Consensus 769 ~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-------- 839 (1009)
.+..++||||+++|+|.++++.... ....+++..++.|+.||++||+|||+. +|+||||||+||+++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999974321 223489999999999999999999998 9999999999999998
Q ss_pred ---CCcEEEcccccceecccC--CCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccH
Q 037197 840 ---NLEARIADFGLARMMLHK--NETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDI 914 (1009)
Q Consensus 840 ---~~~~kl~DfGls~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~ 914 (1009)
++.+||+|||+++.+... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....+.
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 899999999999865422 234455679999999999999899999999999999999999999996322210
Q ss_pred HHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCC-CCHHHHHHHHhhcCCC
Q 037197 915 VEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGR-PTMRDVITMLGEAKPR 981 (1009)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R-Ps~~evl~~L~~~~~~ 981 (1009)
......+.. .. ..+ .+.+++..|++.+|.+| |++.++.+.|++...+
T Consensus 293 ---------------~~~~~~~~~-~~-~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 ---------------CKPEGLFRR-LP-HLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ---------------EEECSCCTT-CS-SHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---------------eeechhccc-cC-cHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 001111111 11 122 34467789999999998 6888888888877654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.83 Aligned_cols=256 Identities=24% Similarity=0.323 Sum_probs=205.1
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
..+.++|+..+.||+|+||.||+|.+..+++.||+|++..........+.+.+|++++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 45678899999999999999999999988999999998665444445677889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC---CcEEEccccc
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN---LEARIADFGL 850 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~DfGl 850 (1009)
+||||+++++|.+++.... .+++.+++.++.|+++||+|||+. +|+||||||+||+++.+ +.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 9999999999999886533 278999999999999999999999 99999999999999764 4699999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
+....... ......+++.|+|||...+ .++.++||||||+++|+|++|+.||... ....... .+..+...
T Consensus 171 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~-~~~~~~~~-- 240 (287)
T 2wei_A 171 STCFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK-----NEYDILK-RVETGKYA-- 240 (287)
T ss_dssp GGTBCCCS-SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHH-HHHHCCCC--
T ss_pred ceeecCCC-ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC-----CHHHHHH-HHHcCCCC--
Confidence 97653322 2234468899999998765 4899999999999999999999999742 1222222 22222110
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...+... .. ..++.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~-~~------~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDLPQWR-TI------SDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCSGGGT-TS------CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhh-hc------CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0001111 11 124667889999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=366.54 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=198.3
Q ss_pred ceeccCCceEEEEEEE--CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEF--HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||.||+|.+ +..++.||||+++....+....+++.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999955 4557899999997654445556778899999999999999999999975 458899999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC--
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE-- 859 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~-- 859 (1009)
|+|.++++... .+++..++.|+.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999996543 278999999999999999999999 999999999999999999999999999987644332
Q ss_pred -ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 860 -TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 860 -~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
......+|+.|+|||++....++.++|||||||++|||++ |+.||.... .. .+...+..+. .....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-----~~-~~~~~i~~~~------~~~~p 594 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GS-EVTAMLEKGE------RMGCP 594 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HH-HHHHHHHTTC------CCCCC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----HH-HHHHHHHcCC------CCCCC
Confidence 2223456788999999988899999999999999999998 999997421 11 2222222222 11111
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
..++ .++.+++.+||+.||++||++.++++.|+++.
T Consensus 595 ~~~~------~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 595 AGCP------REMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp TTCC------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCC------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1222 24667889999999999999999999998763
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=339.63 Aligned_cols=257 Identities=22% Similarity=0.321 Sum_probs=199.2
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC------ChhhHHHHHHHHHHHhccCCCceeeEEeEEE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN------DIESGDDLFREVSLLGRLRHRNIVRLLGYLH 767 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~ 767 (1009)
..+.++|+..+.||+|+||.||+|.+..+++.||||++..... .......+.+|++++++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 4567889999999999999999999999999999999865421 1122334668999999999999999999997
Q ss_pred cCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc---EE
Q 037197 768 NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE---AR 844 (1009)
Q Consensus 768 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~---~k 844 (1009)
.+. .++||||+++++|.+++.... .+++..++.++.||++||+|||++ +|+||||||+||+++.++. +|
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEE
T ss_pred CCc-eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEE
Confidence 765 899999999999999987543 278899999999999999999999 9999999999999987664 99
Q ss_pred EcccccceecccCCCceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH
Q 037197 845 IADFGLARMMLHKNETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSM 921 (1009)
Q Consensus 845 l~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 921 (1009)
|+|||+++..... .......||+.|+|||++. ...++.++||||||+++|+|++|+.||...... ..+...+.
T Consensus 158 l~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~-- 233 (322)
T 2ycf_A 158 ITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQIT-- 233 (322)
T ss_dssp ECCCTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-SCHHHHHH--
T ss_pred EccCccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-HHHHHHHH--
Confidence 9999999876332 2223456899999999863 567889999999999999999999999743322 22222221
Q ss_pred HhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 922 IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+.. ...+...... ...+.+++.+|++.||++||++.|+++
T Consensus 234 --~~~~---~~~~~~~~~~------~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 --SGKY---NFIPEVWAEV------SEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HTCC---CCCHHHHTTS------CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --hCcc---ccCchhhhhc------CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1110 0111111111 234667899999999999999999984
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=343.40 Aligned_cols=201 Identities=23% Similarity=0.436 Sum_probs=176.3
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+..+++.||+|++... ......+.+.+|++++++++||||+++++++.+++..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 45688999999999999999999999999999998654 23445567779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.++++.... +++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++.....
T Consensus 111 e~~~~~~L~~~l~~~~~----~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999975432 788999999999999999999832 899999999999999999999999999976532
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2 23345789999999999998999999999999999999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=366.93 Aligned_cols=250 Identities=23% Similarity=0.380 Sum_probs=197.4
Q ss_pred eeccCCceEEEEEEEC--CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 705 IIGMGGNGIVYKAEFH--RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 705 ~iG~G~~g~Vyk~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
.||+|+||.||+|.+. .++..||||+++.. ......+.+.+|++++++++||||+++++++.+ +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 6999999999999875 34678999999654 233456778899999999999999999999986 5689999999999
Q ss_pred ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC---
Q 037197 783 SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE--- 859 (1009)
Q Consensus 783 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~--- 859 (1009)
+|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 421 ~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 421 PLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp BHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred cHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 9999996543 2378999999999999999999999 999999999999999999999999999987643322
Q ss_pred ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccc
Q 037197 860 TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938 (1009)
Q Consensus 860 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 938 (1009)
......+++.|+|||++....++.++|||||||++|||++ |+.||..... .++ ...+..+.. .....
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~----~~~i~~~~~------~~~p~ 562 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEV----MAFIEQGKR------MECPP 562 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHH----HHHHHTTCC------CCCCT
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHH----HHHHHcCCC------CCCCC
Confidence 1122345689999999988899999999999999999998 9999974322 122 222222221 11111
Q ss_pred cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 939 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.++ .++.+++.+||+.||++||++.++++.|+.+..
T Consensus 563 ~~~------~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 563 ECP------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp TCC------HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 121 246678899999999999999999999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=370.93 Aligned_cols=251 Identities=24% Similarity=0.293 Sum_probs=205.2
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l 774 (1009)
.+.|+..+.||+|+||.||+|++..+++.||||++.+... .....+.+..|.+++..+ +||+|+++++++++.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 3568889999999999999999999999999999864311 122345667899999988 79999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++|+|.++++.... +++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 420 V~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEeCcCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999975432 78899999999999999999999 9999999999999999999999999999875
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
...........||+.|+|||++....++.++|||||||++|||++|+.||... +..+..........
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~~~~~-------- 559 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-----DEDELFQSIMEHNV-------- 559 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHSSCC--------
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhCCC--------
Confidence 44455556678999999999999999999999999999999999999999732 22222222222111
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTM-----RDVIT 973 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~-----~evl~ 973 (1009)
.+..... .++..++.+|++.||++||++ .|+++
T Consensus 560 ~~p~~~s------~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 AYPKSMS------KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCCTTSC------HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCCccCC------HHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1111111 245678899999999999997 66653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=330.19 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=203.1
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-------hhhHHHHHHHHHHHhccC-CCceeeEEeEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-------IESGDDLFREVSLLGRLR-HRNIVRLLGYLH 767 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~ 767 (1009)
..++|+..+.||+|+||.||+|.+..+++.||||++...... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 456789999999999999999999999999999999654321 122345668999999995 999999999999
Q ss_pred cCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcc
Q 037197 768 NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIAD 847 (1009)
Q Consensus 768 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 847 (1009)
+....++||||+++++|.+++.... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999997532 378899999999999999999999 999999999999999999999999
Q ss_pred cccceecccCCCceeeecccCcccCCcccC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH
Q 037197 848 FGLARMMLHKNETVSMVAGSYGYIAPEYGY------TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSM 921 (1009)
Q Consensus 848 fGls~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 921 (1009)
||.+...... .......+++.|+|||+.. ...++.++||||||+++|||++|+.||... .........
T Consensus 168 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~ 241 (298)
T 1phk_A 168 FGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-----KQMLMLRMI 241 (298)
T ss_dssp CTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHH
T ss_pred ccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc-----cHHHHHHHH
Confidence 9999876433 2334457899999999864 456889999999999999999999999632 112222222
Q ss_pred HhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 922 IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..... ....+... .. ...+.+++.+|++.||++||++.|+++
T Consensus 242 ~~~~~---~~~~~~~~----~~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 MSGNY---QFGSPEWD----DY---SDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHTCC---CCCTTTGG----GS---CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hcCCc---ccCccccc----cc---CHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 21111 01111111 11 124667889999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=342.25 Aligned_cols=265 Identities=25% Similarity=0.346 Sum_probs=204.4
Q ss_pred HhcCCcCceeccCCceEEEEEE-----ECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 697 LACVKESNIIGMGGNGIVYKAE-----FHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
.++|+..+.||+|+||.||+|. ...+++.||||++... .......++.+|+.++++++||||+++++++.+...
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 4578899999999999999998 4456789999999643 233445667799999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccc---cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC---CCcEEE
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAG---KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA---NLEARI 845 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl 845 (1009)
.++||||+++++|.+++...... ...+++.+++.++.|+++||+|||+. +|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999765321 23478899999999999999999999 9999999999999984 446999
Q ss_pred cccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHH
Q 037197 846 ADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 846 ~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
+|||++........ ......+++.|+|||...+..++.++||||||+++|||++ |+.||... ...... ..+
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-----~~~~~~-~~~ 258 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-----SNQEVL-EFV 258 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHH-HHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc-----CHHHHH-HHH
Confidence 99999976533321 2234567889999999888889999999999999999998 99999632 112222 222
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCcc
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRK 983 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 983 (1009)
..+.. +.....+. ..+.+++.+||+.||++||++.|+++.|+.+.....
T Consensus 259 ~~~~~------~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 259 TSGGR------MDPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HTTCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred hcCCC------CCCCCCCC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 22211 11111111 245678899999999999999999999998865443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.94 Aligned_cols=263 Identities=28% Similarity=0.394 Sum_probs=205.0
Q ss_pred hcCCcCceeccCCceEEEEEEE----CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC--e
Q 037197 698 ACVKESNIIGMGGNGIVYKAEF----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET--N 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~--~ 771 (1009)
+.|+..+.||+|+||.||+|.. ..+++.||||++... .....+.+.+|++++++++||||+++++++...+ .
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 4588899999999999999984 567899999998653 3344567779999999999999999999986644 6
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++||||+++++|.+++..... .+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 8999999999999999976432 378899999999999999999998 9999999999999999999999999999
Q ss_pred eecccCCCc---eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC----------CCCccHHHHH
Q 037197 852 RMMLHKNET---VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAF----------GGSKDIVEWV 918 (1009)
Q Consensus 852 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~----------~~~~~~~~~~ 918 (1009)
......... .....++..|+|||...+..++.++||||||+++|||++|..||.... .........+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 876544322 122346778999999888889999999999999999999999886310 0000111111
Q ss_pred HHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 919 LSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
...+..+. .......++ .++.+++.+||+.||++||++.|+++.|+++..
T Consensus 273 ~~~~~~~~------~~~~~~~~~------~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 273 IELLKNNG------RLPRPDGCP------DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHTTC------CCCCCTTCC------HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhcCC------CCCCCCccc------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 12221111 011111111 246678899999999999999999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=345.17 Aligned_cols=262 Identities=20% Similarity=0.268 Sum_probs=194.0
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc-------
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN------- 768 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~------- 768 (1009)
..++|+..+.||+|+||.||+|.+..+++.||||++...... ..+|+++++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 346789999999999999999999999999999998543221 2279999999999999999999843
Q ss_pred -------------------------------CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHH
Q 037197 769 -------------------------------ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817 (1009)
Q Consensus 769 -------------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~L 817 (1009)
..+.++||||++ |+|.+.+.........+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345899999997 588877764333334488999999999999999999
Q ss_pred HhcCCCCeEEeccCCCcEEeC-CCCcEEEcccccceecccCCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHH
Q 037197 818 HHDCQPPVIHRDIKSNNILLD-ANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLL 895 (1009)
Q Consensus 818 H~~~~~~ivH~dlk~~NIll~-~~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~ 895 (1009)
|+. +|+||||||+||+++ .++.+||+|||+++..... .......+|+.|+|||.+.+. .++.++||||+||++|
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 998 999999999999997 6889999999999876433 333445689999999987764 4899999999999999
Q ss_pred HHHhCCCCCCCCCCCCccHHHHHHHHHhh-ccc-----------cccccCccccccC-ch--HHHHHHHHHHHHHHhccC
Q 037197 896 ELLTGKMPLDPAFGGSKDIVEWVLSMIKS-NKA-----------QDEALDPSIAGQC-KH--VQEEMLLVLRIAVLCTAK 960 (1009)
Q Consensus 896 elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~-----------~~~~~~~~~~~~~-~~--~~~~~~~l~~l~~~cl~~ 960 (1009)
||++|+.||.... ..+.+...+.. +.. ..+..-+.+.... .. .......+.+++.+|++.
T Consensus 234 ell~g~~pf~~~~-----~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 234 ELILGKPLFSGET-----SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHhCCCCCCCCC-----hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999997321 11111111111 000 0010011110000 00 000112467889999999
Q ss_pred CCCCCCCHHHHHH
Q 037197 961 LPKGRPTMRDVIT 973 (1009)
Q Consensus 961 dp~~RPs~~evl~ 973 (1009)
||++|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999984
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=342.17 Aligned_cols=257 Identities=23% Similarity=0.315 Sum_probs=198.5
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeE---
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNV--- 772 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~--- 772 (1009)
+.++|...+.||+|+||.||+|.+..+++.||||++............+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 34678889999999999999999999999999999976655555567778999999999999999999999877654
Q ss_pred ---EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccc
Q 037197 773 ---MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFG 849 (1009)
Q Consensus 773 ---~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 849 (1009)
++||||++ ++|.+++... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGME------FSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEEcccc-ccHHHHhhcC------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999997 6888887432 78899999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 850 LARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 850 ls~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||... +..+.+..........
T Consensus 190 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~i~~~~~~~ 261 (371)
T 4exu_A 190 LARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK-----DYLDQLTQILKVTGVP 261 (371)
T ss_dssp CC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHHHCCC
T ss_pred ccccccc---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCC
Confidence 9976532 2344578999999998876 67899999999999999999999999732 2222222222111100
Q ss_pred -cccc-------------------CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 929 -DEAL-------------------DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 929 -~~~~-------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+.. ...+..... .....+.+++.+|++.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFP---RASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHST---TSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhcc---ccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000 000000000 11235678999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=347.46 Aligned_cols=263 Identities=17% Similarity=0.215 Sum_probs=206.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCC-CceeeEEeEEEcCCeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH-RNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~l~~~~~~~~~~~lV 775 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++..... ..++.+|+++++.++| +++..+..++.+.+..++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 4678999999999999999999999899999998754432 2346789999999976 5666777777888899999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe---CCCCcEEEcccccce
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL---DANLEARIADFGLAR 852 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~DfGls~ 852 (1009)
|||+ +++|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 82 me~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 9999 9999999974322 289999999999999999999999 99999999999999 578999999999998
Q ss_pred ecccCCCc-------eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc
Q 037197 853 MMLHKNET-------VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN 925 (1009)
Q Consensus 853 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 925 (1009)
.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYEKISEKK 232 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS--SHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch--hHHHHHHHHhhcc
Confidence 76544321 22567999999999999999999999999999999999999999754332 1111111111110
Q ss_pred cccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 926 KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
. .... ..+...+ ..++.+++.+|++.+|++||++.++++.|+++..+
T Consensus 233 ~--~~~~-~~l~~~~------p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 233 V--ATSI-EALCRGY------PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp H--HSCH-HHHHTTS------CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred c--cccH-HHHhcCC------cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 0 0000 0011111 12467889999999999999999999999988543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=344.06 Aligned_cols=256 Identities=25% Similarity=0.300 Sum_probs=199.8
Q ss_pred hcCCcCceeccCCceEEEEEEEC---CCCeEEEEEEcccCCC--ChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFH---RPHMVVAVKKLWRSDN--DIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 771 (1009)
++|+..+.||+|+||.||+|++. .+++.||||+++.... .....+.+.+|+++++++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 56888999999999999999984 4689999999864321 112234455899999999 69999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++||||+++|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999997543 278899999999999999999999 9999999999999999999999999999
Q ss_pred eecccCC-CceeeecccCcccCCcccCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 852 RMMLHKN-ETVSMVAGSYGYIAPEYGYT--LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 852 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
+.+.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..............
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~--- 282 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSE--- 282 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHHHHHHHHHHCC---
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-chHHHHHHHHhccC---
Confidence 8764332 23334679999999999875 34789999999999999999999999743221 22222222222111
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHH
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVITML 975 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~L 975 (1009)
+.+..... ..+.+++.+|++.||++|| ++.|+++-.
T Consensus 283 -----~~~~~~~~------~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 -----PPYPQEMS------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----CCCCTTSC------HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----CCCCcccC------HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11111111 2356788999999999999 888887643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=334.51 Aligned_cols=260 Identities=20% Similarity=0.247 Sum_probs=198.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEc--CCeEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHN--ETNVM 773 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~--~~~~~ 773 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++... ..+.+.+|++++++++ ||||+++++++.+ ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 36789999999999999999999999999999998532 2456779999999997 9999999999987 66789
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC-cEEEcccccce
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-EARIADFGLAR 852 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGls~ 852 (1009)
+||||+++++|.++++. +++.++..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||+++
T Consensus 110 lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 99999999999999843 67888899999999999999999 999999999999999776 89999999998
Q ss_pred ecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc-----
Q 037197 853 MMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK----- 926 (1009)
Q Consensus 853 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~----- 926 (1009)
..... .......+++.|+|||+..+ ..++.++|||||||++|||++|+.||.........+...... .....
T Consensus 180 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~-~~~~~~~~~~ 257 (330)
T 3nsz_A 180 FYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV-LGTEDLYDYI 257 (330)
T ss_dssp ECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH-HCHHHHHHHH
T ss_pred EcCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHh-cCCchhhhHH
Confidence 76433 23344578999999999876 668999999999999999999999996432221111111110 00000
Q ss_pred -ccccccCccc------------cc--cCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 -AQDEALDPSI------------AG--QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 -~~~~~~~~~~------------~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
......++.+ .. ..........++.+++.+|++.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000 00 00000001235678899999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=334.87 Aligned_cols=263 Identities=29% Similarity=0.394 Sum_probs=196.0
Q ss_pred HhcCCcCceeccCCceEEEEEEECC-C--CeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR-P--HMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNV 772 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~-~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 772 (1009)
.++|+..+.||+|+||.||+|.+.. + +..||||++..... .....+.+.+|++++++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3568889999999999999998643 2 34699999865432 2344567779999999999999999999998765 8
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
++||||+++++|.+++.... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 89999999999999997542 2378899999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCCc---eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 853 MMLHKNET---VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 853 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
........ .....+++.|+|||+.....++.++||||||+++|||++ |+.||... ...+.+........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~~~~~~-- 242 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQILHKIDKEGE-- 242 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTSCC--
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC-----CHHHHHHHHHccCC--
Confidence 76443321 223456788999999888888999999999999999999 99999732 22222222222111
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCcc
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRK 983 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 983 (1009)
........+ ..+.+++.+|++.||++||++.++++.|+++.+...
T Consensus 243 ----~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 243 ----RLPRPEDCP------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp ----CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ----CCCCCcCcC------HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 111111111 246678899999999999999999999999886543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=334.90 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=194.8
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEc-----
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHN----- 768 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~----- 768 (1009)
...++|+..+.||+|+||.||+|.+..+++.||||++.... .....+.+|+++++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 34577999999999999999999999889999999986542 2345677999999999 89999999999876
Q ss_pred -CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcc
Q 037197 769 -ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIAD 847 (1009)
Q Consensus 769 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 847 (1009)
....++||||+++++|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 4678999999999999999976432 2378888999999999999999999 999999999999999999999999
Q ss_pred cccceecccCCCceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH
Q 037197 848 FGLARMMLHKNETVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 848 fGls~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
||++..............|++.|+|||++. ...++.++||||||+++|+|++|+.||.... .........
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~ 247 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-----PMRALFLIP 247 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHH
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHhh
Confidence 999987644333344567899999999876 5678899999999999999999999996321 111111111
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.... ...... ..+ ..+.+++.+|++.||++||++.|+++
T Consensus 248 ~~~~--~~~~~~----~~~------~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPA--PRLKSK----KWS------KKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCC--CCCSCS----CSC------HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCcc--ccCCcc----ccC------HHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111 111111 111 24567889999999999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=363.08 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=205.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 457788899999999999999987 5679999996542 234677899999999999999999999876 67899999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.++++.... ..+++.+++.|+.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 342 ~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999964321 2378889999999999999999999 9999999999999999999999999999865332
Q ss_pred CC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
.. ......++..|+|||++....++.++|||||||++|||++ |+.||... ...+. ...+..+.. ..
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~-----~~~~~-~~~i~~~~~------~~ 484 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREV-LDQVERGYR------MP 484 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC-----CHHHH-HHHHHTTCC------CC
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CHHHH-HHHHHcCCC------CC
Confidence 11 1223346778999999888889999999999999999999 99999732 11222 222222211 11
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
....+. ..+.+++.+||+.||++||++.++++.|+++....
T Consensus 485 ~~~~~~------~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 485 CPPECP------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCCCCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 111121 24567889999999999999999999999987543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=330.69 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=197.1
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC--ChhhHHHHHHHHHHHhccCCCceeeEEeEEE--cCCe
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN--DIESGDDLFREVSLLGRLRHRNIVRLLGYLH--NETN 771 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~--~~~~ 771 (1009)
+.++|+..+.||+|+||.||+|.+..+++.||+|++..... .......+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 45689999999999999999999999999999999864321 1233456779999999999999999999984 4567
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++||||++++ +.+++..... ..+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999877 7777754332 2378899999999999999999999 9999999999999999999999999999
Q ss_pred eecccCC--CceeeecccCcccCCcccCCCC--CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 852 RMMLHKN--ETVSMVAGSYGYIAPEYGYTLK--VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 852 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
....... .......|++.|+|||+..+.. .+.++||||||+++|||++|+.||... +..+..... ..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~i-~~~~~ 230 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-----NIYKLFENI-GKGSY 230 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHH-HHCCC
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc-----hHHHHHHHH-hcCCC
Confidence 8764322 2334566899999999877543 478999999999999999999999732 222222222 22110
Q ss_pred cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+...+. ..+.+++.+|++.||++||++.|+++
T Consensus 231 -------~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 231 -------AIPGDCG------PPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp -------CCCSSSC------HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------CCCCccC------HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111 24567889999999999999999996
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.17 Aligned_cols=262 Identities=22% Similarity=0.364 Sum_probs=198.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+.. .||+|++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 3568889999999999999999875 3899998765444444455668999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++++|.+++.... ..+++..++.++.|+++||+|||+. +|+||||||+||+++ ++.+||+|||+++....
T Consensus 109 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp BCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999997643 2378899999999999999999999 999999999999998 67999999999875432
Q ss_pred C-----CCceeeecccCcccCCcccCC---------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH
Q 037197 857 K-----NETVSMVAGSYGYIAPEYGYT---------LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 857 ~-----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
. ........|++.|+|||+... ..++.++||||||+++|||++|+.||... ........ +
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~~~~~~-~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-----PAEAIIWQ-M 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC-----CHHHHHHH-H
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHH-h
Confidence 1 122334568999999998764 45788999999999999999999999732 11222222 2
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCcccc
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSI 985 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~ 985 (1009)
..+.. ...... ... ..+.+++.+|++.||++||++.|++++|+++..+.+..
T Consensus 256 ~~~~~-~~~~~~----~~~------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 256 GTGMK-PNLSQI----GMG------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp HTTCC-CCCCCS----SCC------TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred ccCCC-CCCCcC----CCC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 22111 111111 111 13567889999999999999999999999998776543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=329.95 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=192.8
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc------
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN------ 768 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~------ 768 (1009)
++.++|+..+.||+|+||.||+|++..+++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 3567899999999999999999999988999999998542 3445667799999999999999999998754
Q ss_pred -------CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC
Q 037197 769 -------ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL 841 (1009)
Q Consensus 769 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~ 841 (1009)
....++||||+++|+|.++++... ..+++..++.++.|+++||+|||++ +|+||||||+||+++.++
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTS
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCC
Confidence 456899999999999999997543 2367888999999999999999999 999999999999999999
Q ss_pred cEEEcccccceecccCC--------------CceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 842 EARIADFGLARMMLHKN--------------ETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 842 ~~kl~DfGls~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
.+||+|||++....... .......|++.|+|||++.+. .++.++||||||+++|||++ ||..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 99999999997653221 122345689999999998754 68999999999999999998 5542
Q ss_pred CCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 907 AFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+....... +... .....+.+.... ...+.+++.+|++.||++|||+.|+++
T Consensus 231 ----~~~~~~~~~~-~~~~---~~~~~~~~~~~~------~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 231 ----GMERVNILKK-LRSV---SIEFPPDFDDNK------MKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ----HHHHHHHHHH-HHST---TCCCCTTCCTTT------SHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----chhHHHHHHh-cccc---ccccCccccccc------hHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111222222 1111 111112222111 123567889999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=329.49 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=196.2
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-CeEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE-TNVMMV 775 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-~~~~lV 775 (1009)
.++|+..+.||+|+||.||+|.+. ++.||||++... ...+.+.+|++++++++||||+++++++.+. +..++|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 356888999999999999999885 789999998543 2346677999999999999999999997554 578999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++++|.+++.... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999996542 22368888999999999999999999 99999999999999999999999999997653
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
.. .....+++.|+|||...+..++.++||||||+++|||++ |+.||..... .+.... +..+. .+
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~----~~~~~------~~ 233 (278)
T 1byg_A 169 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPR----VEKGY------KM 233 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHH----HTTTC------CC
T ss_pred cc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HhcCC------CC
Confidence 32 223457889999999888889999999999999999998 9999974321 122211 11111 11
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
.....++ ..+.+++.+|++.||++||++.|+++.|+++...
T Consensus 234 ~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 234 DAPDGCP------PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcccCC------HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1111111 2466788999999999999999999999988643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=340.45 Aligned_cols=257 Identities=21% Similarity=0.285 Sum_probs=187.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEE--------c
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLH--------N 768 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~--------~ 768 (1009)
.+|+..+.||+|+||.||+|++..+++.||||++... .......+.+|+.+++++. ||||+++++++. .
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 4688899999999999999999999999999998543 3444566779999999996 999999999984 3
Q ss_pred CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeccCCCcEEeCCCCcEEEc
Q 037197 769 ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP--VIHRDIKSNNILLDANLEARIA 846 (1009)
Q Consensus 769 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~ 846 (1009)
....++||||++ |+|.+++..... ...+++.+++.++.||+.||+|||+. + |+||||||+||+++.++.+||+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence 345899999995 789998865322 12389999999999999999999998 7 9999999999999999999999
Q ss_pred ccccceecccCCCc------------eeeecccCcccCCccc---CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCC
Q 037197 847 DFGLARMMLHKNET------------VSMVAGSYGYIAPEYG---YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS 911 (1009)
Q Consensus 847 DfGls~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~ 911 (1009)
|||+++........ .....+|+.|+|||++ ....++.++||||||+++|||++|+.||......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~- 259 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL- 259 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-
Confidence 99999876433211 1134589999999987 5667889999999999999999999999632111
Q ss_pred ccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 912 KDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
..+. .. .......... ..+.+++.+|++.||++||++.|+++.|+.+...+
T Consensus 260 ----~~~~----~~------~~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 260 ----RIVN----GK------YSIPPHDTQY------TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp --------------------CCCCTTCCSS------GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ----Hhhc----Cc------ccCCcccccc------hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 1110 00 0000001111 12456889999999999999999999999886543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=340.90 Aligned_cols=312 Identities=16% Similarity=0.136 Sum_probs=223.3
Q ss_pred ccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCe
Q 037197 87 RGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLES 166 (1009)
Q Consensus 87 ~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~ 166 (1009)
..++++++|++++|.++...+..+..+++|++|+|++|.+.+..+..++.+++|++|+|++|++++..|..++++++|++
T Consensus 42 ~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 42 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp GGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 35688999999999987665556889999999999999998777778899999999999999998887888888999999
Q ss_pred eeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCcc
Q 037197 167 LDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSL 246 (1009)
Q Consensus 167 L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 246 (1009)
|+|++|.++...+..|.++++|++|+|++|.+++..|..++.+++|++|++++|++++. .++.+++|++|++++|.+
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL 198 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCC
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccc
Confidence 99999988855555578888899999999888877777788888888888888888754 256677888888888877
Q ss_pred ccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCC
Q 037197 247 SGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKL 326 (1009)
Q Consensus 247 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l 326 (1009)
++. ...++|++|++++|.++.. |.. ..++|+.|++++|.+++. ..+..+++|++|++++|.+++..|..|
T Consensus 199 ~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~ 268 (390)
T 3o6n_A 199 STL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPF 268 (390)
T ss_dssp SEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGG
T ss_pred ccc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHc
Confidence 643 2335677777777777643 322 235667777777766643 356666666666666666666656666
Q ss_pred CCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccE
Q 037197 327 GELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVR 406 (1009)
Q Consensus 327 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~ 406 (1009)
..+++|+.|++++|++++ +|..+..+++|+.|++++|+++ .+|..+..+++|++
T Consensus 269 ~~l~~L~~L~L~~n~l~~-------------------------~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~ 322 (390)
T 3o6n_A 269 VKMQRLERLYISNNRLVA-------------------------LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 322 (390)
T ss_dssp TTCSSCCEEECCSSCCCE-------------------------EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSE
T ss_pred cccccCCEEECCCCcCcc-------------------------cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCE
Confidence 666666666666665543 2233334455555555555555 34445556666667
Q ss_pred EEcccCccccccCCccCCCCcccEEEeecccccc
Q 037197 407 VRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTG 440 (1009)
Q Consensus 407 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 440 (1009)
|++++|+++.. + +..+++|+.|++++|++++
T Consensus 323 L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 323 LYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp EECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred EECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence 77777766633 2 5566777777777777764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=347.28 Aligned_cols=253 Identities=9% Similarity=0.046 Sum_probs=179.2
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh-hhHHHHHHHH---HHHhccCCCceeeEE-------eEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI-ESGDDLFREV---SLLGRLRHRNIVRLL-------GYL 766 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~---~~l~~l~Hpniv~l~-------~~~ 766 (1009)
..|+..+.||+|+||.||+|.+..+++.||||++....... ...+.+.+|+ +.++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 34888899999999999999999999999999997764423 3344455775 45555 799988755 444
Q ss_pred EcC-----------------CeEEEEEeccCCCChhhhhcCCccccccccHHHH------HHHHHHHHHHHHHHHhcCCC
Q 037197 767 HNE-----------------TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSR------YNIAVGIAQGLNYLHHDCQP 823 (1009)
Q Consensus 767 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~------~~i~~~i~~~L~~LH~~~~~ 823 (1009)
... ...++||||++ |+|.++++.... .+++..+ +.++.||++||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 432 33799999998 899999975422 1344455 67889999999999999
Q ss_pred CeEEeccCCCcEEeCCCCcEEEcccccceecccCCCceeeecccCcccCCcccCC--CCCCcccchHhHHHHHHHHHhCC
Q 037197 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYT--LKVDEKSDIYSFGVVLLELLTGK 901 (1009)
Q Consensus 824 ~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~ 901 (1009)
+|+||||||+||+++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999986532 2224567799999999877 67899999999999999999999
Q ss_pred CCCCCCCCCCccHHHHHHHHHhhcccccccc--CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 902 MPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL--DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 902 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.||............ ........ ...+. ..... ...+.+++.+||+.||++|||+.|+++
T Consensus 291 ~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-~~~~~---~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFG-SCTPL---PDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCT-TSSCC---CHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccchh--------hhhhhhccccccchh-hccCC---CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999754322110000 00000000 00010 01111 124667889999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=347.39 Aligned_cols=199 Identities=27% Similarity=0.310 Sum_probs=172.8
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc------CCCceeeEEeEEEcC
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL------RHRNIVRLLGYLHNE 769 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~Hpniv~l~~~~~~~ 769 (1009)
+..+|+..+.||+|+||.||+|.+..+++.||||++... ......+.+|+++++.+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 456799999999999999999999999999999999543 33445566788887776 578999999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc--EEEcc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE--ARIAD 847 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~--~kl~D 847 (1009)
...++||||+. ++|.+++..... ..+++..+..++.||++||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred CeEEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence 99999999995 689999876532 2278889999999999999999999 9999999999999999987 99999
Q ss_pred cccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 848 FGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 848 fGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 246 FG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 246 FGSSCYEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp CTTCEETTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccceecCC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 999976432 23345789999999999988999999999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=345.48 Aligned_cols=204 Identities=26% Similarity=0.371 Sum_probs=156.2
Q ss_pred HHhcCCc-CceeccCCceEEEEEEEC--CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEE--cCC
Q 037197 696 ILACVKE-SNIIGMGGNGIVYKAEFH--RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLH--NET 770 (1009)
Q Consensus 696 ~~~~~~~-~~~iG~G~~g~Vyk~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~--~~~ 770 (1009)
+.+.|.. .++||+|+||.||+|+++ .+++.||||++.... ....+.+|++++++++||||+++++++. .+.
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 4455665 568999999999999976 457899999996432 2345779999999999999999999994 467
Q ss_pred eEEEEEeccCCCChhhhhcCCcc-----ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe----CCCC
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEA-----GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL----DANL 841 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll----~~~~ 841 (1009)
..++||||++ ++|.+++..... ....+++..++.|+.||+.||+|||+. +|+||||||+||++ +.++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence 8999999996 578877753221 122388999999999999999999999 99999999999999 6778
Q ss_pred cEEEcccccceecccCC---CceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 037197 842 EARIADFGLARMMLHKN---ETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPA 907 (1009)
Q Consensus 842 ~~kl~DfGls~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~ 907 (1009)
.+||+|||+++.+.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999999998764332 23344678999999998876 45899999999999999999999999643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=343.94 Aligned_cols=269 Identities=25% Similarity=0.343 Sum_probs=194.0
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC------Ce
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE------TN 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------~~ 771 (1009)
..|+..+.||+|+||.||+|++..+++.||||++..... ...+|++++++++||||+++++++... .+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 357888999999999999999999999999999854321 123799999999999999999988432 24
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-CcEEEccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN-LEARIADFGL 850 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfGl 850 (1009)
.++||||+++ ++.+.+.........+++..+..++.||++||+|||+. +|+||||||+||+++.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence 6799999975 56666643222233488999999999999999999998 99999999999999965 5789999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH-------H
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSM-------I 922 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~-------~ 922 (1009)
++...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.+.+... +
T Consensus 204 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 204 AKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp CEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHH
T ss_pred hhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence 98764332 33445789999999988654 789999999999999999999999974211 11122221110 0
Q ss_pred hh-ccccccccCccccccCch-H--HHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhhc
Q 037197 923 KS-NKAQDEALDPSIAGQCKH-V--QEEMLLVLRIAVLCTAKLPKGRPTMRDVIT--MLGEA 978 (1009)
Q Consensus 923 ~~-~~~~~~~~~~~~~~~~~~-~--~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~ 978 (1009)
.. .....+...+.+....-. . .....++.+++.+|++.||++||++.|+++ .+.++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 00 000011111111100000 0 001135678999999999999999999985 44444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=334.61 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=225.2
Q ss_pred CCCceeeccCccccc--cCCcCccCCCCCceeeccc-ccccccCCcccccCccccEEEcccCccccccCCccCCCCcccE
Q 037197 354 SPLRRLDASSNLLSG--EIPTGLCDSGNLTKLILFN-NSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQR 430 (1009)
Q Consensus 354 ~~L~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~l~~-N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 430 (1009)
..++.|++++|.+++ .+|..+..+++|++|++++ |.+.+.+|..+.++++|++|++++|++++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 356677777777776 6777777777777777774 7777777777888888888888888888778888888888888
Q ss_pred EEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCc-ccchhccccCcccCCcccccccCCcCcEEEeecCC
Q 037197 431 LEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIP-SLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNS 509 (1009)
Q Consensus 431 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~ 509 (1009)
|+|++|++++.+|..+..+++|++|++++|++++.+|..+..++ +|+.|++++|++++.+|..+..+. |+.|+|++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 88888888888888888888888888888888877888888887 888888888888888888888887 9999999999
Q ss_pred CCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCCC
Q 037197 510 LSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSN 589 (1009)
Q Consensus 510 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 589 (1009)
+++.+|..|..+++|+.|+|++|++++.+|. +..+++|+.|||++|++++.+|..|..++.|++|+|++|+++|.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 9999999999999999999999999977766 888999999999999999999999999999999999999999999999
Q ss_pred CcccccCCcccccCcCCCCCCCCCCC
Q 037197 590 GILMNINPNELIGNAGLCGSVLPPCS 615 (1009)
Q Consensus 590 ~~~~~~~~~~~~~n~~lcg~~~~~c~ 615 (1009)
+.+.++....+.+|+++||.|+++|+
T Consensus 288 ~~l~~L~~l~l~~N~~lc~~p~~~C~ 313 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp TTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred ccccccChHHhcCCCCccCCCCCCCC
Confidence 88999999999999999999998884
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.62 Aligned_cols=262 Identities=24% Similarity=0.349 Sum_probs=183.2
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3568889999999999999999988899999999854322 233456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCc----cccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 777 DYMPNDSLGEALHGKE----AGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
||+++++|.+++.... .....+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 9999999999986311 1123378999999999999999999999 99999999999999999999999999987
Q ss_pred ecccCC-----CceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 853 MMLHKN-----ETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 853 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
...... .......||+.|+|||.... ..++.++||||||+++|||++|+.||...... . ..........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~---~~~~~~~~~~ 244 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--K---VLMLTLQNDP 244 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--G---HHHHHHTSSC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--h---HHHHHhccCC
Confidence 654322 12234568999999998765 56899999999999999999999999743211 1 1111111111
Q ss_pred cc--ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQ--DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~--~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.. ....++....... ..+.+++.+|++.||++||++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYG------KSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCCCCC------HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cccccccccchhhhhhh------HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 0001111111111 24567889999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=338.84 Aligned_cols=260 Identities=24% Similarity=0.323 Sum_probs=200.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-----Ce
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE-----TN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----~~ 771 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++... ........+.+|++++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 45799999999999999999999999999999999643 2344456777999999999999999999999654 46
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++||||++ |+|.+++.... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~~-----~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQH-----LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999997 58999886532 78899999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCC---ceeeecccCcccCCcccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 852 RMMLHKNE---TVSMVAGSYGYIAPEYGY-TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 852 ~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
+....... ......||+.|+|||++. ...++.++||||+||++|||++|+.||.... ..+....+........
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~- 252 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH--YLDQLNHILGILGSPS- 252 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS--GGGHHHHHHHHHCSCC-
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC--hHHHHHHHHHHhCCCC-
Confidence 87643322 224457899999999764 4458999999999999999999999997432 1222222221111100
Q ss_pred ccccc----------------Cc---cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 928 QDEAL----------------DP---SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 928 ~~~~~----------------~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+.. .+ ........ ...++.+++.+|++.||++|||+.|+++
T Consensus 253 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 253 -QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN---ADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp -HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCC---CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00 00000000 1134678999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=336.91 Aligned_cols=256 Identities=23% Similarity=0.294 Sum_probs=196.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe-----
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN----- 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~----- 771 (1009)
.++|...+.||+|+||.||+|.+..+|+.||||++............+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 456888899999999999999999999999999997655555556677899999999999999999999987653
Q ss_pred -EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 772 -VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 772 -~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
.++||||++ ++|.+++... +++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGLK------FSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 6888887432 78899999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc-ccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN-KAQ 928 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~ 928 (1009)
++.... ......+|+.|+|||+..+ ..++.++||||||+++|||++|+.||.... ....+....... ...
T Consensus 173 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 173 ARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQLTQILKVTGVPG 244 (353)
T ss_dssp TTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC-----HHHHHHHHHHHHCBCC
T ss_pred ccCCCC---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCC
Confidence 976432 2334578999999998776 678999999999999999999999997421 112222111110 000
Q ss_pred c-------------------cccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 929 D-------------------EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 929 ~-------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. ....+.+...... ....+.+++.+|++.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR---ASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTT---SCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCC---cCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0000011111111 1234667889999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=340.30 Aligned_cols=267 Identities=19% Similarity=0.244 Sum_probs=186.5
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe--
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN-- 771 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-- 771 (1009)
....++|+..+.||+|+||.||+|.+..+++.||||++.... .....+.+|++.++.++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 445678999999999999999999999999999999985542 233456788888999999999999999865433
Q ss_pred -----EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHH--hcCCCCeEEeccCCCcEEeCC-CCcE
Q 037197 772 -----VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH--HDCQPPVIHRDIKSNNILLDA-NLEA 843 (1009)
Q Consensus 772 -----~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~dlk~~NIll~~-~~~~ 843 (1009)
.++||||+++ +|.+.+.........+++..+..++.|++.|++||| +. +|+||||||+||+++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 7899999976 455444322222334788889999999999999999 77 9999999999999997 8999
Q ss_pred EEcccccceecccCCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH
Q 037197 844 RIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 844 kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+....
T Consensus 172 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-----~~~~~~~~~ 245 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN-----SAGQLHEIV 245 (360)
T ss_dssp EECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHH
T ss_pred EEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC-----hHHHHHHHH
Confidence 999999998764332 33445689999999987654 48999999999999999999999997421 111111111
Q ss_pred hhc-ccccc--------ccCccccc--------cCc-hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 923 KSN-KAQDE--------ALDPSIAG--------QCK-HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 923 ~~~-~~~~~--------~~~~~~~~--------~~~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
... ....+ ..+..... ... ........+.+++.+|++.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 110 00000 00000000 000 00012345778999999999999999999986
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=358.45 Aligned_cols=336 Identities=18% Similarity=0.172 Sum_probs=251.5
Q ss_pred CCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEe
Q 037197 233 LTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLN 312 (1009)
Q Consensus 233 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 312 (1009)
+++++.|++++|.+....+..|+.+++|+.|+|++|.+++..|..|..+++|++|+|++|.+++..|..|+.+++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 56788899999888876666778888888888888888887777888888888888888888887777788888888888
Q ss_pred ccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccc
Q 037197 313 LMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSG 392 (1009)
Q Consensus 313 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~ 392 (1009)
|++|.+++.++..|+++++|++|+|++|.+++..|..+..+++|+.|++++|.+++.. +..+++|+.|++++|.+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc
Confidence 8888888777777788888888888888877777777777777777777777766432 3334455555555555442
Q ss_pred cCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccC
Q 037197 393 TFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILS 472 (1009)
Q Consensus 393 ~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 472 (1009)
+ ...++|+.|++++|.++...+. + .++|+.|+|++|.+++ +..+..
T Consensus 207 -----l------------------------~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~--~~~l~~ 252 (597)
T 3oja_B 207 -----L------------------------AIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD--TAWLLN 252 (597)
T ss_dssp -----E------------------------ECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC--CGGGGG
T ss_pred -----c------------------------cCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC--Chhhcc
Confidence 1 1223455556666555532221 1 2466677777777765 356677
Q ss_pred CcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceec
Q 037197 473 IPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILD 552 (1009)
Q Consensus 473 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 552 (1009)
+++|+.|++++|.+++.+|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+
T Consensus 253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~ 330 (597)
T 3oja_B 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330 (597)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEE
Confidence 7777777777777777777888888888888888888885 5666777888999999999888 6788888899999999
Q ss_pred CCccccccccCcCcCCCCCCcEEecCCCccccCCCCCCcccccCCcccccCcCCCCCCC
Q 037197 553 MSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSVL 611 (1009)
Q Consensus 553 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lcg~~~ 611 (1009)
|++|+|++.. +..++.|+.|+|++|++++..+ ...+..+....+.+++..|+.+.
T Consensus 331 L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~C~~~~ 385 (597)
T 3oja_B 331 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCKIDY 385 (597)
T ss_dssp CCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCCCCCTTC
T ss_pred CCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhH-HHHHHHHhhhccccccccCCcch
Confidence 9999988653 6677889999999999988643 23466777788899999998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=341.53 Aligned_cols=266 Identities=23% Similarity=0.277 Sum_probs=200.1
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC--------CCceeeEEeEEE-
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR--------HRNIVRLLGYLH- 767 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------Hpniv~l~~~~~- 767 (1009)
.++|+..+.||+|+||.||+|++..+++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 46799999999999999999999999999999999533 344566779999999985 788999999987
Q ss_pred ---cCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC---
Q 037197 768 ---NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL--- 841 (1009)
Q Consensus 768 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~--- 841 (1009)
++...++||||+ ++++.+++..... ..+++..++.++.||++||+|||+++ +|+||||||+||+++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence 566899999999 5566665543321 23788999999999999999999853 899999999999999875
Q ss_pred ----------------------------------------------cEEEcccccceecccCCCceeeecccCcccCCcc
Q 037197 842 ----------------------------------------------EARIADFGLARMMLHKNETVSMVAGSYGYIAPEY 875 (1009)
Q Consensus 842 ----------------------------------------------~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~ 875 (1009)
.+||+|||+++..... .....||+.|+|||+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence 7999999999876432 334578999999999
Q ss_pred cCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCcc-HHHHHHHHHhh-----------ccccccccCcc--------
Q 037197 876 GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKD-IVEWVLSMIKS-----------NKAQDEALDPS-------- 935 (1009)
Q Consensus 876 ~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~-----------~~~~~~~~~~~-------- 935 (1009)
+.+..++.++|||||||++|||++|+.||......... ....+...... +....+.+...
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 98888999999999999999999999999754332211 11111111110 00000000000
Q ss_pred ---------ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 ---------IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ---------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+........+....+.+++.+||+.||++|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00011112334456788999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=331.88 Aligned_cols=270 Identities=24% Similarity=0.314 Sum_probs=201.5
Q ss_pred HHhcCCcCceeccCCceEEEEEEEC-CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc---CCCceeeEEeEEE----
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFH-RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL---RHRNIVRLLGYLH---- 767 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~Hpniv~l~~~~~---- 767 (1009)
..++|+..+.||+|+||.||+|.+. .+++.||+|++............+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3467899999999999999999995 6689999999865433333334455677766665 8999999999987
Q ss_pred -cCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEc
Q 037197 768 -NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIA 846 (1009)
Q Consensus 768 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 846 (1009)
.....++||||++ |+|.+++..... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999997 699999875432 2378889999999999999999999 99999999999999999999999
Q ss_pred ccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 847 DFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 847 DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
|||+++..... .......+++.|+|||+..+..++.++||||||+++|||++|+.||.... ..+....+.......
T Consensus 163 Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~- 238 (326)
T 1blx_A 163 DFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIGLP- 238 (326)
T ss_dssp SCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCC-
T ss_pred cCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHHcCCC-
Confidence 99999865432 23344678999999999988889999999999999999999999997421 111122222111100
Q ss_pred ccccccC---------------ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhhcC
Q 037197 927 AQDEALD---------------PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT--MLGEAK 979 (1009)
Q Consensus 927 ~~~~~~~---------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~~ 979 (1009)
...... ..+........ ..+.+++.+|++.||++||++.|+++ .+.++.
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 239 -GEEDWPRDVALPRQAFHSKSAQPIEKFVTDID---ELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp -CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC---HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred -CcccCccccccchhhhcccCcchhhhccccCC---HHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 000000 00011111111 24567889999999999999999984 344443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=336.98 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=200.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChh---------------hHHHHHHHHHHHhccCCCceee
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE---------------SGDDLFREVSLLGRLRHRNIVR 761 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~E~~~l~~l~Hpniv~ 761 (1009)
.++|+..+.||+|+||.||+|.+ +++.||||++........ ..+.+.+|++++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 45788999999999999999999 689999999864321111 1167779999999999999999
Q ss_pred EEeEEEcCCeEEEEEeccCCCChhhh------hcCCccccccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeccCCCc
Q 037197 762 LLGYLHNETNVMMVYDYMPNDSLGEA------LHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH-DCQPPVIHRDIKSNN 834 (1009)
Q Consensus 762 l~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~dlk~~N 834 (1009)
+++++.+.+..++||||+++++|.++ +.... ...+++..++.++.|+++||+|||+ . +|+||||||+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSN 182 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHh
Confidence 99999999999999999999999999 54321 2348999999999999999999998 7 99999999999
Q ss_pred EEeCCCCcEEEcccccceecccCCCceeeecccCcccCCcccCCC-CCCc-ccchHhHHHHHHHHHhCCCCCCCCCCCCc
Q 037197 835 ILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL-KVDE-KSDIYSFGVVLLELLTGKMPLDPAFGGSK 912 (1009)
Q Consensus 835 Ill~~~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~SlGvvl~elltg~~Pf~~~~~~~~ 912 (1009)
|+++.++.+||+|||.+...... ......+++.|+|||...+. .++. ++||||||+++|||++|+.||......
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 99999999999999999875332 34456789999999998876 5666 999999999999999999999743221
Q ss_pred cHHHHHHHHHhhcccccccc-----CccccccCc-hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 913 DIVEWVLSMIKSNKAQDEAL-----DPSIAGQCK-HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+.... +..+....... .+....... ........+.+++.+|++.||++||++.|+++
T Consensus 259 --~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 --VELFNN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HHHHHH-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHHHH-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 122211 22111100000 000000000 00111234678899999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=331.10 Aligned_cols=259 Identities=25% Similarity=0.348 Sum_probs=191.2
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEE--------
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLH-------- 767 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~-------- 767 (1009)
+.++|+..+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 346788999999999999999999999999999998543 3455567779999999999999999999874
Q ss_pred ------cCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC-CC
Q 037197 768 ------NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD-AN 840 (1009)
Q Consensus 768 ------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~ 840 (1009)
+....++||||++ |+|.+++... .+++..++.++.|+++||+|||+. +|+||||||+||+++ ++
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED 157 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence 3467899999997 6999999643 278888999999999999999999 999999999999997 56
Q ss_pred CcEEEcccccceecccCC---CceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHH
Q 037197 841 LEARIADFGLARMMLHKN---ETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVE 916 (1009)
Q Consensus 841 ~~~kl~DfGls~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~ 916 (1009)
+.+||+|||+++...... .......+++.|+|||.... ..++.++||||||+++|||++|+.||.... ...
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~ 232 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH-----ELE 232 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC-----HHH
Confidence 799999999998654321 12233457889999998754 678999999999999999999999997422 112
Q ss_pred HHHHHHhhcccccc-----------------ccCc--cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 917 WVLSMIKSNKAQDE-----------------ALDP--SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 917 ~~~~~~~~~~~~~~-----------------~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.............. ...+ ........ ...++.+++.+|++.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 233 QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG---ISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTT---CCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcch---hhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 22211111100000 0000 00000001 1234678899999999999999999975
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=337.96 Aligned_cols=336 Identities=18% Similarity=0.176 Sum_probs=238.9
Q ss_pred CCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEe
Q 037197 233 LTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLN 312 (1009)
Q Consensus 233 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 312 (1009)
+++|++|++++|.++...+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..+..+++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 56788888888888765555577888888888888888877777788888888888888888877777778888888888
Q ss_pred ccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccc
Q 037197 313 LMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSG 392 (1009)
Q Consensus 313 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~ 392 (1009)
+++|+++...+..|.++++|++|++++|.+.+..+..+..+++|+.|++++|.+++. .+..+++|+.|++++|.+++
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~ 200 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST 200 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc
Confidence 888888866666677788888888887777776666677777777777777766643 13334455555555554442
Q ss_pred cCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccC
Q 037197 393 TFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILS 472 (1009)
Q Consensus 393 ~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 472 (1009)
+. ..++|+.|++++|+++.. |.. ..++|+.|++++|++++. ..+..
T Consensus 201 -----~~------------------------~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~ 246 (390)
T 3o6n_A 201 -----LA------------------------IPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLN 246 (390)
T ss_dssp -----EE------------------------CCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGG
T ss_pred -----cC------------------------CCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcC
Confidence 11 223455555555555532 222 135666666666666653 45666
Q ss_pred CcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceec
Q 037197 473 IPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILD 552 (1009)
Q Consensus 473 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 552 (1009)
+++|++|++++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+
T Consensus 247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~ 324 (390)
T 3o6n_A 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324 (390)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEE
Confidence 7777777777777777777777888888888888888874 5666677888888888888887 5777788888888888
Q ss_pred CCccccccccCcCcCCCCCCcEEecCCCccccCCCCCCcccccCCcccccCcCCCCCCC
Q 037197 553 MSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSVL 611 (1009)
Q Consensus 553 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lcg~~~ 611 (1009)
|++|++++.. +..++.|+.|++++|++++.-. ...+..+....+.+++..|+.+.
T Consensus 325 L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~c~~~~ 379 (390)
T 3o6n_A 325 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCKIDY 379 (390)
T ss_dssp CCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCSCCCTTC
T ss_pred CCCCccceeC---chhhccCCEEEcCCCCccchhH-HHHHHHHHhhcccccCceecccc
Confidence 8888887552 6677888999999999887432 22345566667788888887543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=355.42 Aligned_cols=350 Identities=15% Similarity=0.120 Sum_probs=241.6
Q ss_pred CCCCCCCCCCccccCCcCCce----eeeEEeCCCCceeEEeccccccccccccccccCCCCCeEecccCcccccCCcccc
Q 037197 36 NMLEDWKMPSNAAENGLLHCN----WTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLA 111 (1009)
Q Consensus 36 ~~l~~W~~~~~~~~~~~~~C~----w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~ 111 (1009)
..+++|.+. .+||. |.+|.|+. .++........ ...-..+++++.|++++|.++...+..+.
T Consensus 7 ~~l~~~~~~-------~~C~~~~~~~~c~~~~~-----~i~~~~~~~~~--~~~~l~l~~l~~l~l~~~~l~~lp~~~~~ 72 (597)
T 3oja_B 7 YNVKPRQPE-------YKCIDSNLQYDCVFYDV-----HIDMQTQDVYF--GFEDITLNNQKIVTFKNSTMRKLPAALLD 72 (597)
T ss_dssp ----CCCSE-------ECCCCC--CCSEEECSC-----EECSSCCCCEE--SCSSGGGCCCSEEEESSCEESEECTHHHH
T ss_pred ccccCCCCC-------CcCcccCcCceeEecCc-----eeccccccccc--CcccccCCCceEEEeeCCCCCCcCHHHHc
Confidence 357889743 34663 77777752 12222211111 11123467889999999998776666788
Q ss_pred ccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCcccccee
Q 037197 112 NLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFL 191 (1009)
Q Consensus 112 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L 191 (1009)
++++|++|+|++|.+.+..|..++.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|
T Consensus 73 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L 152 (597)
T 3oja_B 73 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTL 152 (597)
T ss_dssp HCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEE
Confidence 99999999999999988778889999999999999999998888888889999999999998886666667888889999
Q ss_pred eeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcC
Q 037197 192 GLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFT 271 (1009)
Q Consensus 192 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 271 (1009)
+|++|.+++..|..|+.+++|++|+|++|.+++.. ++.+++|++|++++|.+++. ....+|+.|++++|.++
T Consensus 153 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~ 224 (597)
T 3oja_B 153 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSIN 224 (597)
T ss_dssp ECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCC
T ss_pred EeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCccc
Confidence 99988888877778888888888888888887542 55677788888888877643 23456777777777776
Q ss_pred CCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCcccc
Q 037197 272 GKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLG 351 (1009)
Q Consensus 272 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 351 (1009)
...+ .+ .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|..|..+++|+.|+|++|.+++
T Consensus 225 ~~~~-~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~------- 292 (597)
T 3oja_B 225 VVRG-PV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA------- 292 (597)
T ss_dssp EEEC-SC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-------
T ss_pred cccc-cc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-------
Confidence 4322 22 2456666666666654 2455666666666666666666555556666666555555555543
Q ss_pred CCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEE
Q 037197 352 QSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRL 431 (1009)
Q Consensus 352 ~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 431 (1009)
+|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++. | +..+++|+.|
T Consensus 293 ------------------l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L 350 (597)
T 3oja_B 293 ------------------LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNL 350 (597)
T ss_dssp ------------------EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEE
T ss_pred ------------------CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEE
Confidence 2333444556666666666666 4555666777777777777777643 2 5667788888
Q ss_pred Eeeccccccc
Q 037197 432 EMANNNLTGQ 441 (1009)
Q Consensus 432 ~L~~N~l~~~ 441 (1009)
++++|.+++.
T Consensus 351 ~l~~N~~~~~ 360 (597)
T 3oja_B 351 TLSHNDWDCN 360 (597)
T ss_dssp ECCSSCEEHH
T ss_pred EeeCCCCCCh
Confidence 8888888754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=333.69 Aligned_cols=267 Identities=20% Similarity=0.295 Sum_probs=200.0
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-----C
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE-----T 770 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----~ 770 (1009)
+.++|+..+.||+|+||.||+|.+..+++.||||++... ........+.+|++++++++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 356788999999999999999999999999999999543 2344456677999999999999999999998654 6
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
..++||||++ ++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 7899999996 6899988653 278899999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCC----------ceeeecccCcccCCcccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHH
Q 037197 851 ARMMLHKNE----------TVSMVAGSYGYIAPEYGY-TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVL 919 (1009)
Q Consensus 851 s~~~~~~~~----------~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 919 (1009)
++....... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~ 236 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY--RHQLLLIF 236 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHH
Confidence 987643221 112346899999999765 46789999999999999999999999973211 11111111
Q ss_pred HHHhhcccccccc-------------------CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhhc
Q 037197 920 SMIKSNKAQDEAL-------------------DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT--MLGEA 978 (1009)
Q Consensus 920 ~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~ 978 (1009)
....... ..... ......... ....++.+++.+|++.||++|||+.|+++ .+...
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 237 GIIGTPH-SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFP---RVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HHHCCCC-STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHST---TSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHhCCCc-hhccccccccchhhHHhhcccCCCCcchhhhcc---cCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 1111000 00000 000000000 11234668899999999999999999987 44443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=334.93 Aligned_cols=201 Identities=24% Similarity=0.269 Sum_probs=171.2
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CC-----ceeeEEeEEEcC
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HR-----NIVRLLGYLHNE 769 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hp-----niv~l~~~~~~~ 769 (1009)
+.++|+..+.||+|+||+||+|.+..+++.||||++... .....++..|+++++.++ |+ +|+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 457899999999999999999999999999999999533 333455668888888874 55 499999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC--CCCcEEEcc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD--ANLEARIAD 847 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~D 847 (1009)
+..++||||++ ++|.+++...... .+++..+..++.|++.||+|||++ ..+|+||||||+||+++ .++.+||+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFR--GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CceEEEEecCC-CCHHHHHhhcCcC--CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999995 5999999765322 278889999999999999999953 23999999999999995 477899999
Q ss_pred cccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 037197 848 FGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDP 906 (1009)
Q Consensus 848 fGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~ 906 (1009)
||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 205 FG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 205 FGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CTTCEETTC---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCceeccc---ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999987633 23346789999999999998999999999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=338.57 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=188.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC------
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET------ 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------ 770 (1009)
..+|+..+.||+|+||.||+|++..+++ ||+|++...... ..+|+++++.++||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3568899999999999999999988665 888887543211 127999999999999999999985433
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC-CCCcEEEcccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD-ANLEARIADFG 849 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~DfG 849 (1009)
..++||||++++.+....+ .......+++..+..++.||++||+|||+. +|+||||||+||+++ .++.+||+|||
T Consensus 112 ~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRH-YAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEECCSEEHHHHHHH-HHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEeeccCccHHHHHHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 3789999998754433332 111223378889999999999999999999 999999999999999 78999999999
Q ss_pred cceecccCCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh-ccc
Q 037197 850 LARMMLHKNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS-NKA 927 (1009)
Q Consensus 850 ls~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~ 927 (1009)
+++..... .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.... ........... +..
T Consensus 188 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-----~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 188 SAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES-----GIDQLVEIIKVLGTP 261 (394)
T ss_dssp TCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCC
T ss_pred CcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCC
Confidence 99876433 233445789999999987654 58999999999999999999999997321 11111111111 000
Q ss_pred c--------ccccCccccccCch-HH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 928 Q--------DEALDPSIAGQCKH-VQ-----EEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 928 ~--------~~~~~~~~~~~~~~-~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. .......+...... .. ....++.+++.+|++.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0 00000001000000 00 01135678899999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=328.92 Aligned_cols=263 Identities=20% Similarity=0.244 Sum_probs=199.6
Q ss_pred HhcCCcCceeccCCceEEEEEEE-CCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCC------ceeeEEeEEEcC
Q 037197 697 LACVKESNIIGMGGNGIVYKAEF-HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHR------NIVRLLGYLHNE 769 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hp------niv~l~~~~~~~ 769 (1009)
.++|+..+.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|+++++.++|+ +++++++++.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 46789999999999999999998 557899999998543 34456677899999988665 499999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC----------
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA---------- 839 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---------- 839 (1009)
+..++||||+ +++|.+++..... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 9999999999 8999999975432 2378889999999999999999999 9999999999999987
Q ss_pred ---------CCcEEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC
Q 037197 840 ---------NLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG 910 (1009)
Q Consensus 840 ---------~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~ 910 (1009)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-- 238 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD-- 238 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC--
T ss_pred cccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--
Confidence 66899999999986432 2334578999999999998899999999999999999999999997421
Q ss_pred CccHHHHHHHHHhhcc-------cccccc-------C-------------ccccccCchHHHHHHHHHHHHHHhccCCCC
Q 037197 911 SKDIVEWVLSMIKSNK-------AQDEAL-------D-------------PSIAGQCKHVQEEMLLVLRIAVLCTAKLPK 963 (1009)
Q Consensus 911 ~~~~~~~~~~~~~~~~-------~~~~~~-------~-------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~ 963 (1009)
..+....+........ .....+ . ................+.+++.+|++.||+
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 1111111111110000 000000 0 000000000112234577899999999999
Q ss_pred CCCCHHHHHH
Q 037197 964 GRPTMRDVIT 973 (1009)
Q Consensus 964 ~RPs~~evl~ 973 (1009)
+|||+.|+++
T Consensus 319 ~Rpt~~ell~ 328 (339)
T 1z57_A 319 KRITLREALK 328 (339)
T ss_dssp TSCCHHHHTT
T ss_pred cccCHHHHhc
Confidence 9999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=337.00 Aligned_cols=266 Identities=21% Similarity=0.276 Sum_probs=192.2
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh---------hhHHHHHHHHHHHhccCCCceeeEEe
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI---------ESGDDLFREVSLLGRLRHRNIVRLLG 764 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~Hpniv~l~~ 764 (1009)
..+.++|+..+.||+|+||.||+|.+.. ++.||||++....... ...+.+.+|++++++++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 4556789999999999999999999876 8999999986543221 12366779999999999999999999
Q ss_pred EEEc-----CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC
Q 037197 765 YLHN-----ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA 839 (1009)
Q Consensus 765 ~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~ 839 (1009)
++.. ....++||||++ |+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLAD 169 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcC
Confidence 9843 346899999997 68888886543 2378999999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHH
Q 037197 840 NLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWV 918 (1009)
Q Consensus 840 ~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 918 (1009)
++.+||+|||+++..... .......+|+.|+|||+..+ ..++.++||||+||++|+|++|+.||... ......
T Consensus 170 ~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-----~~~~~~ 243 (362)
T 3pg1_A 170 NNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS-----TFYNQL 243 (362)
T ss_dssp TCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHH
T ss_pred CCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC-----CHHHHH
Confidence 999999999999754322 23344578999999998776 67899999999999999999999999742 111222
Q ss_pred HHHHhhcccc-------------ccccCccccccCch-----HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 919 LSMIKSNKAQ-------------DEALDPSIAGQCKH-----VQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 919 ~~~~~~~~~~-------------~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.......... .............. .......+.+++.+|++.||++|||+.|+++
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 2111110000 00000000000000 0011234678999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=360.46 Aligned_cols=259 Identities=23% Similarity=0.347 Sum_probs=202.9
Q ss_pred HhcCCcCceeccCCceEEEEEEECC---CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR---PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.++|+..+.||+|+||.||+|.+.. .+..||||++... ......+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 3568889999999999999999864 3578999998543 233445677799999999999999999999854 5689
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++|+|.++++... ..+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 467 lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999997543 2378999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 854 MLHKNE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 854 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
...... ......+++.|+|||++....++.++||||||+++|||++ |..||.... ..+.+.. +..+..
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-----~~~~~~~-i~~~~~---- 610 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGR-IENGER---- 610 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHH-HHHTCC----
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHH-HHcCCC----
Confidence 643332 2233456789999999988889999999999999999997 999997421 1222222 222211
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
..+...++ ..+.+++.+||+.||++||++.|+++.|+++.++
T Consensus 611 --~~~~~~~~------~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 611 --LPMPPNCP------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp --CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCcccc------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11111111 2456788999999999999999999999988644
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=326.58 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=195.2
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC--CCceeeEEeEEEcCCeEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR--HRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~~~~~l 774 (1009)
.++|+..+.||+|+||.||+|.+.. ++.||||++..........+.+.+|++++++++ ||||+++++++.++...++
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 3568999999999999999999875 889999999766555566677789999999997 5999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||| +.+++|.+++.... .+++.+++.++.|+++||+|||+. +|+||||||+||++++ +.+||+|||+++..
T Consensus 106 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 999 56899999997543 278889999999999999999999 9999999999999964 89999999999876
Q ss_pred ccCCC--ceeeecccCcccCCcccCC-----------CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH
Q 037197 855 LHKNE--TVSMVAGSYGYIAPEYGYT-----------LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSM 921 (1009)
Q Consensus 855 ~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 921 (1009)
..... ......|++.|+|||.... ..++.++||||||+++|||++|+.||..... ....+...
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~~~ 252 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QISKLHAI 252 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS----HHHHHHHH
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH----HHHHHHHH
Confidence 43322 2234568999999998764 4688899999999999999999999974321 12222222
Q ss_pred HhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 922 IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..... ...+..... ..+.+++.+|++.||++||++.|+++
T Consensus 253 ~~~~~------~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 253 IDPNH------EIEFPDIPE------KDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HCTTS------CCCCCCCSC------HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Hhccc------ccCCcccch------HHHHHHHHHHccCCcccCcCHHHHhc
Confidence 21111 111111111 24567889999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=329.69 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=172.0
Q ss_pred HHhcCCcC-ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHH-HHHhccCCCceeeEEeEEEc----C
Q 037197 696 ILACVKES-NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREV-SLLGRLRHRNIVRLLGYLHN----E 769 (1009)
Q Consensus 696 ~~~~~~~~-~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~Hpniv~l~~~~~~----~ 769 (1009)
+.++|... ++||+|+||.||+|.+..+++.||||++... ....+|+ ..++.++||||+++++++.. +
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 45678874 4699999999999999999999999998542 1222333 34666799999999999876 4
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC---CCcEEEc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA---NLEARIA 846 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~ 846 (1009)
...++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+. +|+||||||+||+++. ++.+||+
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence 558999999999999999976532 3488999999999999999999999 9999999999999976 4559999
Q ss_pred ccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 847 DFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 847 DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
|||+++.... .......+|+.|+|||++....++.++||||||+++|+|++|+.||...... .........+....
T Consensus 174 Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 174 DFGFAKETTQ--NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ--AISPGMKRRIRLGQ 249 (336)
T ss_dssp CCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred ccccceeccc--cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch--hhhhhHHHhhhccc
Confidence 9999986532 2233456899999999998888999999999999999999999999643221 11111111111100
Q ss_pred ccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.....+.. ... ...+.+++.+|++.||++|||+.|+++
T Consensus 250 --~~~~~~~~----~~~---~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 250 --YGFPNPEW----SEV---SEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---CCCTTTS----TTC---CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --cccCchhh----ccC---CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000100 111 124567889999999999999999997
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=326.07 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=180.2
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||.||+|.+..+++.||||++............+.++..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 35688889999999999999999988999999999765433333333335556788889999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH-DCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
||+ ++.+..+..... ..+++..++.++.|+++||+|||+ . +|+||||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 555555553221 237889999999999999999998 5 89999999999999999999999999997654
Q ss_pred cCCCceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
.. .......+++.|+|||+.. ...++.++||||||+++|||++|+.||.... .....+........
T Consensus 177 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~---- 247 (318)
T 2dyl_A 177 DD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK----TDFEVLTKVLQEEP---- 247 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC----SHHHHHHHHHHSCC----
T ss_pred CC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC----ccHHHHHHHhccCC----
Confidence 32 2233456899999999974 5568899999999999999999999997422 22222222222211
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.+... .... ..+..++.+|++.||++||++.|+++
T Consensus 248 ---~~~~~~-~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ---PLLPGH-MGFS---GDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ---CCCCSS-SCCC---HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCCCcc-CCCC---HHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111100 0011 24567889999999999999999876
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=333.73 Aligned_cols=275 Identities=18% Similarity=0.250 Sum_probs=196.6
Q ss_pred cChHHhHHHHHHHHhhc-cCCCCCCCCCCCCCccccCCcCCceeeeEEeCC---------CCceeEEecccccccccccc
Q 037197 15 SNADDELSTLLSIKAGL-IDPLNMLEDWKMPSNAAENGLLHCNWTGVWCNS---------RGFVEKLDLSNMSLNGSVSE 84 (1009)
Q Consensus 15 ~~~~~~~~~ll~~k~~~-~d~~~~l~~W~~~~~~~~~~~~~C~w~gv~C~~---------~~~v~~l~l~~~~l~~~~~~ 84 (1009)
++..+|++||++||+++ .||.+.+++|.... ..+.++|.|.||.|+. ..+|+.|+|+++.++ .+|+
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~---~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~ 98 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQAN---SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD 98 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHT---TTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccc---cccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh
Confidence 44578999999999999 58888889994211 1245789999999952 245555555555554 3444
Q ss_pred ccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCC
Q 037197 85 NIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSL 164 (1009)
Q Consensus 85 ~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L 164 (1009)
.+..+++|++|+|++|.++ .+|..++++++|++|+|++ |+++ .+|..++++++|
T Consensus 99 ~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~------------------------n~l~-~lp~~l~~l~~L 152 (328)
T 4fcg_A 99 QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR------------------------NPLR-ALPASIASLNRL 152 (328)
T ss_dssp CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEES------------------------CCCC-CCCGGGGGCTTC
T ss_pred hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCC------------------------Cccc-cCcHHHhcCcCC
Confidence 4444555555555555544 4444444455555555544 4444 444445555555
Q ss_pred CeeeccCCccCCcCCccc---------cCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCC
Q 037197 165 ESLDFRGSFFEGSVPTSF---------RNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTN 235 (1009)
Q Consensus 165 ~~L~L~~n~~~~~~p~~~---------~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 235 (1009)
++|+|++|.+.+.+|..+ .++++|++|+|++|+++ .+|..++.+++|++|+|++|++++ +|..++++++
T Consensus 153 ~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~ 230 (328)
T 4fcg_A 153 RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPK 230 (328)
T ss_dssp CEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTT
T ss_pred CEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCC
Confidence 555555544444444443 44888888888888888 778788888888888888888884 6667888888
Q ss_pred ccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccc
Q 037197 236 LRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMC 315 (1009)
Q Consensus 236 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 315 (1009)
|++|+|++|++.+.+|..++.+++|++|+|++|++.+.+|..+..+++|++|+|++|++.+.+|..+..+++|+.+++..
T Consensus 231 L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~ 310 (328)
T 4fcg_A 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310 (328)
T ss_dssp CCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCG
T ss_pred CCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCH
Confidence 88888888888888888888888888888888888888888888888899999999888888888899999999988888
Q ss_pred cccCCC
Q 037197 316 NQLTGL 321 (1009)
Q Consensus 316 N~l~~~ 321 (1009)
+.+...
T Consensus 311 ~~~~~l 316 (328)
T 4fcg_A 311 HLQAQL 316 (328)
T ss_dssp GGSCC-
T ss_pred HHHHHH
Confidence 776543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=329.33 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=176.8
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHH-HHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVS-LLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
++|+..+.||+|+||.||+|.+..+++.||||++..... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999999999999999965432 333445556665 777889999999999999999999999
Q ss_pred eccCCCChhhhhcCCc-cccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 777 DYMPNDSLGEALHGKE-AGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
||+++ +|.+++.... .....+++..+..++.|+++||+|||+. .+|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99975 7887775311 1123378899999999999999999985 289999999999999999999999999998764
Q ss_pred cCCCceeeecccCcccCCccc----CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 856 HKNETVSMVAGSYGYIAPEYG----YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
... ......||+.|+|||+. ....++.++||||||+++|||++|+.||...... ...+.. ....
T Consensus 178 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~-------~~~~ 245 (327)
T 3aln_A 178 DSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV----FDQLTQ-------VVKG 245 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CC-------CCCS
T ss_pred ccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH----HHHHHH-------HhcC
Confidence 322 22334689999999997 4567899999999999999999999999742211 011000 0000
Q ss_pred cCcccccc-CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 LDPSIAGQ-CKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+.+... .... ...+.+++.+|++.||++||++.|+++
T Consensus 246 ~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 DPPQLSNSEEREF---SPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCCSSCCC---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcccccC---CHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111110 0111 124667889999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.39 Aligned_cols=244 Identities=20% Similarity=0.364 Sum_probs=197.3
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh----hhHHHHHHHHHHHhccC--CCceeeEEeEEEcC
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI----ESGDDLFREVSLLGRLR--HRNIVRLLGYLHNE 769 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~ 769 (1009)
+.++|+..+.||+|+||.||+|.+..+++.||||++....... .....+.+|++++++++ ||||+++++++.++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 3567899999999999999999999999999999996543221 12234558999999996 59999999999999
Q ss_pred CeEEEEEeccCC-CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC-CCCcEEEcc
Q 037197 770 TNVMMVYDYMPN-DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD-ANLEARIAD 847 (1009)
Q Consensus 770 ~~~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~D 847 (1009)
+..++||||+.+ ++|.+++.... .+++..++.++.|+++||+|||+. +|+||||||+||+++ .++.+||+|
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred CcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence 999999999986 89999987533 278899999999999999999999 999999999999999 788999999
Q ss_pred cccceecccCCCceeeecccCcccCCcccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 848 FGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKV-DEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 848 fGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
||+++..... ......||+.|+|||++....+ +.++||||||+++|||++|+.||... .. ... ..
T Consensus 194 fg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-------~~----~~~-~~ 259 (320)
T 3a99_A 194 FGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EE----IIR-GQ 259 (320)
T ss_dssp CTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HH----HHH-CC
T ss_pred Cccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh-------hh----hhc-cc
Confidence 9999876432 2334568999999998876665 68899999999999999999999631 01 111 11
Q ss_pred ccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..... ... .++.+++.+|++.||++||++.|+++
T Consensus 260 ---~~~~~----~~~------~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 ---VFFRQ----RVS------SECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---CCCSS----CCC------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---ccccc----cCC------HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111 111 24567889999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=328.46 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=190.0
Q ss_pred HHHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh----hhHHHHHHHHHHHhcc----CCCceeeEEeE
Q 037197 694 SEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI----ESGDDLFREVSLLGRL----RHRNIVRLLGY 765 (1009)
Q Consensus 694 ~~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~Hpniv~l~~~ 765 (1009)
+.+.++|+..+.||+|+||.||+|.+..+++.||||++....... .....+.+|+++++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 445678999999999999999999999889999999996543221 1223344799999988 89999999999
Q ss_pred EEcCCeEEEEEec-cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC-CCCcE
Q 037197 766 LHNETNVMMVYDY-MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD-ANLEA 843 (1009)
Q Consensus 766 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~ 843 (1009)
+.+.+..++|||| +.+++|.+++.... .+++..++.++.|+++||+|||+. +|+||||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 78999999997543 278999999999999999999999 999999999999999 88999
Q ss_pred EEcccccceecccCCCceeeecccCcccCCcccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHH
Q 037197 844 RIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKV-DEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922 (1009)
Q Consensus 844 kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 922 (1009)
||+|||++...... ......|++.|+|||+..+..+ +.++||||||+++|||++|+.||... .. ..
T Consensus 180 kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~----~~ 246 (312)
T 2iwi_A 180 KLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-------QE----IL 246 (312)
T ss_dssp EECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HH----HH
T ss_pred EEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-------HH----Hh
Confidence 99999999876432 2344568999999998776665 45899999999999999999999631 11 11
Q ss_pred hhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.... .+..... ..+.+++.+|++.||++||++.|+++
T Consensus 247 ~~~~--------~~~~~~~------~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 EAEL--------HFPAHVS------PDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HTCC--------CCCTTSC------HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhcc--------CCcccCC------HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 1111111 24567889999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=327.16 Aligned_cols=263 Identities=17% Similarity=0.228 Sum_probs=197.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCC-eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCc------eeeEEeEEEcC
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPH-MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN------IVRLLGYLHNE 769 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn------iv~l~~~~~~~ 769 (1009)
.++|+..+.||+|+||.||+|.+..++ +.||+|++... ....+.+.+|++++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 467899999999999999999998766 79999999532 344556668999999997665 99999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe------------
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL------------ 837 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll------------ 837 (1009)
+..++||||+ ++++.+++..... ..+++.+++.++.||++||+|||+. +|+||||||+||++
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 9999999999 6667777654332 2378899999999999999999998 99999999999999
Q ss_pred -------CCCCcEEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC
Q 037197 838 -------DANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG 910 (1009)
Q Consensus 838 -------~~~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~ 910 (1009)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~- 244 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN- 244 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred ccccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-
Confidence 5678999999999986432 23345789999999999988999999999999999999999999974211
Q ss_pred CccHHHHHHHHHhh--------ccccccccCc-------------------cccccCchHHHHHHHHHHHHHHhccCCCC
Q 037197 911 SKDIVEWVLSMIKS--------NKAQDEALDP-------------------SIAGQCKHVQEEMLLVLRIAVLCTAKLPK 963 (1009)
Q Consensus 911 ~~~~~~~~~~~~~~--------~~~~~~~~~~-------------------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~ 963 (1009)
.+....+...... .......... .+............++.+++.+|++.||+
T Consensus 245 -~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 245 -REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp -HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred -HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 1111222111100 0000000000 00000000112234677899999999999
Q ss_pred CCCCHHHHHH
Q 037197 964 GRPTMRDVIT 973 (1009)
Q Consensus 964 ~RPs~~evl~ 973 (1009)
+|||+.|+++
T Consensus 324 ~Rpt~~e~l~ 333 (355)
T 2eu9_A 324 QRITLAEALL 333 (355)
T ss_dssp TSCCHHHHTT
T ss_pred hCcCHHHHhc
Confidence 9999999973
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=332.83 Aligned_cols=271 Identities=21% Similarity=0.286 Sum_probs=200.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-----------CCceeeEEeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-----------HRNIVRLLGYL 766 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------Hpniv~l~~~~ 766 (1009)
++|+..+.||+|+||.||+|++..+++.||||++... ......+.+|++++++++ ||||+++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 5688899999999999999999999999999998532 344556678999988886 89999999998
Q ss_pred EcCC----eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC----
Q 037197 767 HNET----NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD---- 838 (1009)
Q Consensus 767 ~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~---- 838 (1009)
...+ ..++||||+ +++|.+++...... .+++..+..++.||+.||+|||+++ +|+||||||+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhcc--CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 7654 789999999 99999999764322 2788899999999999999999853 899999999999994
Q ss_pred --CCCcEEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCC-ccHH
Q 037197 839 --ANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS-KDIV 915 (1009)
Q Consensus 839 --~~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~-~~~~ 915 (1009)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999876432 234578999999999988889999999999999999999999997533211 0111
Q ss_pred HHHHHHHhhcccc-----------ccccCc-----------------cccccCchHHHHHHHHHHHHHHhccCCCCCCCC
Q 037197 916 EWVLSMIKSNKAQ-----------DEALDP-----------------SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT 967 (1009)
Q Consensus 916 ~~~~~~~~~~~~~-----------~~~~~~-----------------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs 967 (1009)
..+.......... ...+.. .+............++.+++.+|++.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 1111111100000 000000 000011111234456788999999999999999
Q ss_pred HHHHHH--HHhhcC
Q 037197 968 MRDVIT--MLGEAK 979 (1009)
Q Consensus 968 ~~evl~--~L~~~~ 979 (1009)
+.|+++ .+.+..
T Consensus 328 ~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 328 AGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHTCGGGTTCT
T ss_pred HHHHhhChhhhccc
Confidence 999987 455443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=347.04 Aligned_cols=277 Identities=21% Similarity=0.253 Sum_probs=203.9
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc------C
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN------E 769 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~------~ 769 (1009)
..++|+..+.||+|+||.||+|.+..+++.||||++... ......+.+.+|++++++++||||+++++++.. +
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 347799999999999999999999988999999998653 334556677799999999999999999998765 6
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc---EEEc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE---ARIA 846 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~ 846 (1009)
+..++||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~-~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENC-CGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCT-TCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence 7789999999999999999865432 2378888999999999999999998 9999999999999997765 9999
Q ss_pred ccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc-
Q 037197 847 DFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN- 925 (1009)
Q Consensus 847 DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~- 925 (1009)
|||.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ....|........
T Consensus 167 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 167 DLGYAKELDQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSN 241 (676)
T ss_dssp SCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTTCC----
T ss_pred ccccccccccc-cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhhhhcccc
Confidence 99999876433 23345678999999999998999999999999999999999999996421 1111110000000
Q ss_pred --cccccccC------ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHH-----HHHHHhhcCCCc
Q 037197 926 --KAQDEALD------PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRD-----VITMLGEAKPRR 982 (1009)
Q Consensus 926 --~~~~~~~~------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~e-----vl~~L~~~~~~~ 982 (1009)
........ ................+.+++.+|++.||++|||+.| +.+.++++...+
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 00000000 0000000001112345678889999999999999988 667777666544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=318.02 Aligned_cols=308 Identities=23% Similarity=0.329 Sum_probs=204.4
Q ss_pred cccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCC
Q 037197 229 EFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNL 308 (1009)
Q Consensus 229 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 308 (1009)
.+..+++|++|++++|.+.. ++ .+..+++|++|++++|.+++. +. +..+++|++|++++|.+++ ++ .+..+++|
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L 112 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNL 112 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTC
T ss_pred cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcC
Confidence 35677888888888888874 33 377788888888888888753 33 7778888888888888774 33 57777788
Q ss_pred CeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccc
Q 037197 309 QLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNN 388 (1009)
Q Consensus 309 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N 388 (1009)
++|++++|++++..+ +..+++|+.|++++|......+. +..+++|+.|++++|.+.+..+ +.
T Consensus 113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~------------- 174 (347)
T 4fmz_A 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IA------------- 174 (347)
T ss_dssp SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GG-------------
T ss_pred CEEECcCCcccCchh--hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hc-------------
Confidence 888888888776533 67777777777777754443332 5555566666666665553322 44
Q ss_pred cccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCC
Q 037197 389 SFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPS 468 (1009)
Q Consensus 389 ~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 468 (1009)
.+++|++|++++|.+.+..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..+
T Consensus 175 -----------~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~- 238 (347)
T 4fmz_A 175 -----------NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP- 238 (347)
T ss_dssp -----------GCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-
T ss_pred -----------cCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-
Confidence 44444555555554443222 4455555555555555553322 4555556666666665555433
Q ss_pred cccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCccccccccc
Q 037197 469 SILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTL 548 (1009)
Q Consensus 469 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 548 (1009)
+..+++|++|++++|.+++. ..+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++..|..++.+++|
T Consensus 239 -~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 313 (347)
T 4fmz_A 239 -LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313 (347)
T ss_dssp -GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTC
T ss_pred -hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccC
Confidence 55666666666666666543 3567777888888888888754 357778888888888888887777888888888
Q ss_pred ceecCCccccccccCcCcCCCCCCcEEecCCCccc
Q 037197 549 AILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583 (1009)
Q Consensus 549 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 583 (1009)
+.|+|++|++++..| +..++.|++||+++|+++
T Consensus 314 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp SEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 888888888887766 777888888888888775
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=335.08 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=182.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|...+.||+|+||+||.+... +|+.||||++... ..+.+.+|+++++++ +||||+++++++.++...++||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~-~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES-SSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEE-CCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 34556788999999999876444 4899999998532 234567999999886 8999999999999999999999
Q ss_pred eccCCCChhhhhcCCcccccc---ccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-------------
Q 037197 777 DYMPNDSLGEALHGKEAGKLL---VDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN------------- 840 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~---~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~------------- 840 (1009)
||++ |+|.+++......... .++..++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence 9995 6999999765432211 13334577999999999999999 99999999999999754
Q ss_pred CcEEEcccccceecccCCC----ceeeecccCcccCCcccCC-------CCCCcccchHhHHHHHHHHHh-CCCCCCCCC
Q 037197 841 LEARIADFGLARMMLHKNE----TVSMVAGSYGYIAPEYGYT-------LKVDEKSDIYSFGVVLLELLT-GKMPLDPAF 908 (1009)
Q Consensus 841 ~~~kl~DfGls~~~~~~~~----~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~ 908 (1009)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 4899999999987654332 1234579999999998765 678999999999999999999 999997432
Q ss_pred CCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 909 GGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.. .. .......... .... ........++.+++.+|++.||++||++.|+++
T Consensus 245 ~~---~~----~i~~~~~~~~-----~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SR---ES----NIIRGIFSLD-----EMKC--LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TH---HH----HHHHTCCCCC-----CCTT--CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hh---HH----HHhcCCCCcc-----cccc--cccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 11 1111111100 1100 011122345678899999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=312.27 Aligned_cols=235 Identities=14% Similarity=0.085 Sum_probs=184.4
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
+.++|+..+.||+|+||.||+|.+..+++.||||++...... ....+.+.+|++++++++||||+++++++.+++..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 346789999999999999999999999999999999765433 3445677799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++++|.++++.. ....++.+|+.|+++||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 99999999999999543 23446778999999999999999 99999999999999999999998543
Q ss_pred ccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
|++ .++.++|||||||++|||++|+.||........ +. ........
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-~~-----------~~~~~~~~ 220 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-LA-----------PAERDTAG 220 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-SE-----------ECCBCTTS
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-hH-----------HHHHHhcc
Confidence 333 368899999999999999999999974322100 00 00000000
Q ss_pred cc---cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 935 SI---AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 935 ~~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.. ....... ...+.+++.+||+.||++| |+.|+++.|+++....
T Consensus 221 ~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 221 QPIEPADIDRDI---PFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CBCCHHHHCTTS---CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CCCChhhcccCC---CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00 0000111 1246678899999999999 9999999999987543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=317.36 Aligned_cols=308 Identities=25% Similarity=0.366 Sum_probs=231.6
Q ss_pred cCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCccccccccc
Q 037197 205 ELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSL 284 (1009)
Q Consensus 205 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 284 (1009)
.+..+++|++|++++|.++. ++ .+..+++|++|++++|.+++..+ +..+++|++|++++|.+++ + +.+..+++|
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L 112 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-I-SALQNLTNL 112 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTC
T ss_pred cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-c-hHHcCCCcC
Confidence 35678999999999999984 44 48999999999999999986544 9999999999999999996 3 468999999
Q ss_pred ccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCc
Q 037197 285 AFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSN 364 (1009)
Q Consensus 285 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N 364 (1009)
++|++++|.+++..+ +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|
T Consensus 113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 999999999995443 8899999999999997665544 48999999999999999987655 788999999999999
Q ss_pred cccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCc
Q 037197 365 LLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPD 444 (1009)
Q Consensus 365 ~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 444 (1009)
.+.+..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|++++..+ +..+++|++|++++|+++
T Consensus 188 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~----- 256 (347)
T 4fmz_A 188 QIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS----- 256 (347)
T ss_dssp CCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-----
T ss_pred ccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccC-----
Confidence 9875433 6666777777777777765433 5566666666666666654332 555555555555555554
Q ss_pred CCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccc
Q 037197 445 DISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKL 524 (1009)
Q Consensus 445 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L 524 (1009)
++ ..+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++..|..+..+++|
T Consensus 257 -------------------~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 313 (347)
T 4fmz_A 257 -------------------DI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313 (347)
T ss_dssp -------------------CC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTC
T ss_pred -------------------CC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccC
Confidence 32 2344455555555555555543 346677788888888888877777778888888
Q ss_pred eeeeecCcccccCCCcccccccccceecCCccccc
Q 037197 525 VSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLF 559 (1009)
Q Consensus 525 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 559 (1009)
+.|+|++|++++..| +..+++|+.||+++|+|+
T Consensus 314 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp SEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 888888888876555 777888888888888775
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=330.78 Aligned_cols=246 Identities=24% Similarity=0.318 Sum_probs=180.3
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEEe
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
.|+..++||+|+||+||.... .+++.||||++.... ...+.+|+++++++ +||||+++++++.+....++|||
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTT-----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 577888999999999664333 347899999985432 12345899999999 79999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-----CcEEEcccccce
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN-----LEARIADFGLAR 852 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-----~~~kl~DfGls~ 852 (1009)
|++ |+|.+++...... ..+..++.++.||++||+|||+. +|+||||||+||+++.+ ..+||+|||+++
T Consensus 99 ~~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 996 6999999765432 33445567999999999999999 99999999999999532 358899999998
Q ss_pred ecccCC---CceeeecccCcccCCcccC---CCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhc
Q 037197 853 MMLHKN---ETVSMVAGSYGYIAPEYGY---TLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSN 925 (1009)
Q Consensus 853 ~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 925 (1009)
...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||...... .... ....
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~------~~~~-~~~~ 244 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR------QANI-LLGA 244 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH------HHHH-HTTC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH------HHHH-Hhcc
Confidence 764332 2234467999999999987 4567889999999999999999 99998632111 1111 1111
Q ss_pred cccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 926 KAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. ......+ . ......+.+++.+|++.||++||++.|+++
T Consensus 245 ~-~~~~~~~-----~---~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 C-SLDCLHP-----E---KHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C-CCTTSCT-----T---CHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-CccccCc-----c---ccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1 0111110 0 112233567899999999999999999983
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=347.50 Aligned_cols=242 Identities=21% Similarity=0.244 Sum_probs=193.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECC-CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe----
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR-PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN---- 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~---- 771 (1009)
.++|+..+.||+|+||.||+|.+.. +++.||||++... ........+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3678999999999999999999975 6899999998653 234445667799999999999999999999987655
Q ss_pred -EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 772 -VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 772 -~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
.|+||||+++++|.+++.. .+++.+++.|+.||++||+|||++ +|+||||||+||+++.+ .+||+|||+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 7999999999999988754 288999999999999999999999 99999999999999986 999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
++..... ....||+.|+|||++.+. .+.++|||||||++|+|++|..||...... .
T Consensus 228 a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------------~ 283 (681)
T 2pzi_A 228 VSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-------------------G 283 (681)
T ss_dssp CEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-------------------S
T ss_pred chhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-------------------c
Confidence 9876432 345699999999987654 488999999999999999999887632111 0
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHhhcC
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-TMRDVITMLGEAK 979 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~L~~~~ 979 (1009)
. . ...........+.+++.+|++.||++|| ++.++.+.|..+.
T Consensus 284 ~-~-----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 L-P-----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp C-C-----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred c-c-----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0 0 0001111223567899999999999999 5666777776654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=305.76 Aligned_cols=233 Identities=23% Similarity=0.282 Sum_probs=178.3
Q ss_pred HHhcCCcC-ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHH-hccCCCceeeEEeEEEc----C
Q 037197 696 ILACVKES-NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLL-GRLRHRNIVRLLGYLHN----E 769 (1009)
Q Consensus 696 ~~~~~~~~-~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~Hpniv~l~~~~~~----~ 769 (1009)
+.+.|... +.||+|+||.||+|.+..+++.||+|++.. .....+|++++ +..+||||+++++++.. .
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 45567666 789999999999999999999999999843 23566888887 55699999999999876 6
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC---CCcEEEc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA---NLEARIA 846 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~ 846 (1009)
...++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred ceEEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence 778999999999999999976432 2378999999999999999999999 9999999999999998 7889999
Q ss_pred ccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 847 DFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 847 DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
|||++.... +..++.++|||||||++|||++|+.||....... . . ..
T Consensus 163 Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-----~-----~-~~ 209 (299)
T 3m2w_A 163 DFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----I-----S-PG 209 (299)
T ss_dssp CCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CC
T ss_pred ccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-----h-----h-HH
Confidence 999986542 2346789999999999999999999996422110 0 0 00
Q ss_pred ccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
......................++.+++.+|++.||++|||+.|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 210 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000000000000000011235678899999999999999999986
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=306.68 Aligned_cols=288 Identities=22% Similarity=0.304 Sum_probs=223.0
Q ss_pred ccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeecc
Q 037197 283 SLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDAS 362 (1009)
Q Consensus 283 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls 362 (1009)
+++.+++++|.++ .+|..+. ++|+.|++++|.+++..+..|.++++|++|++++|.+++..|..+..+++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4555566655555 4444332 456666666666666656666666666666666666666666666666666677777
Q ss_pred CccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccc--cccCCccCCCCcccEEEeecccccc
Q 037197 363 SNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLIS--GTIPVGLGNLPSLQRLEMANNNLTG 440 (1009)
Q Consensus 363 ~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~ 440 (1009)
+|.++ .+|..+. ++|++|++++|++++..+..+.++++|+.|++++|.++ +..|..+..+ +|+.|++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 77666 4444443 67888888888888766667888888888888888885 3667778777 89999999999984
Q ss_pred cCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccc
Q 037197 441 QIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIAS 520 (1009)
Q Consensus 441 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~ 520 (1009)
+|..+. ++|+.|++++|++++..+..|..+++|+.|++++|++++..+..+..+++|+.|+|++|+++ .+|..+..
T Consensus 187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 666554 78999999999999988889999999999999999999888888999999999999999998 78888999
Q ss_pred cccceeeeecCcccccCCCcccccc------cccceecCCccccc--cccCcCcCCCCCCcEEecCCCc
Q 037197 521 CEKLVSLNLRNNRFSGEIPKAVATM------PTLAILDMSNNSLF--GRIPENFGASPALEMLNLSYNK 581 (1009)
Q Consensus 521 l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~ls~N~ 581 (1009)
+++|+.|+|++|+|++..+..|..+ +.|+.|++++|++. +..|..|..++.|+.+++++|+
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 9999999999999997777777653 67899999999998 7788889999999999999885
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=321.29 Aligned_cols=244 Identities=14% Similarity=0.116 Sum_probs=178.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCC-Ccee---------------
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRH-RNIV--------------- 760 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H-pniv--------------- 760 (1009)
..|...+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++| +|..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 346778899999999999999999999999999864322 22334567799999999977 2211
Q ss_pred ------eEEeEEEc-----CCeEEEEEeccCCCChhhhhcCC---ccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 037197 761 ------RLLGYLHN-----ETNVMMVYDYMPNDSLGEALHGK---EAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVI 826 (1009)
Q Consensus 761 ------~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iv 826 (1009)
.+..++.. ...++++|+++ +++|.++++.. ......+++..++.++.||++||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 11111111 22457777765 78999988421 11233478899999999999999999999 999
Q ss_pred EeccCCCcEEeCCCCcEEEcccccceecccCCCceeeecccCcccCCccc----------CCCCCCcccchHhHHHHHHH
Q 037197 827 HRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYG----------YTLKVDEKSDIYSFGVVLLE 896 (1009)
Q Consensus 827 H~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~SlGvvl~e 896 (1009)
||||||+||+++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999999865332 344567 999999988 56668899999999999999
Q ss_pred HHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 897 LLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 897 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
|++|+.||...... +.....+. ...... ..+.+++.+||+.||++||++.|++
T Consensus 310 lltg~~Pf~~~~~~-------------------~~~~~~~~-~~~~~~---~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 310 IWCADLPNTDDAAL-------------------GGSEWIFR-SCKNIP---QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHSSCCCCTTGGG-------------------SCSGGGGS-SCCCCC---HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHCCCCCCCcchh-------------------hhHHHHHh-hcccCC---HHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999743211 00111111 111111 2466788899999999999976664
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-32 Score=304.97 Aligned_cols=294 Identities=23% Similarity=0.269 Sum_probs=189.2
Q ss_pred ccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeec
Q 037197 115 ALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLS 194 (1009)
Q Consensus 115 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~ 194 (1009)
+|++++++++.+. .+|..+. ++|++|+|++|++++..|..++++++|++|++++|.+++..|..|+++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 5677777777765 4565553 577777777777776666677777777777777777777777777777788888888
Q ss_pred cccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCcccc--ccCcccCCCCCCcEEEcccCCcCC
Q 037197 195 GNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSG--QIPPALGRLKKLTTVYLYKNNFTG 272 (1009)
Q Consensus 195 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~l~~L~~L~L~~n~l~~ 272 (1009)
+|.++ .+|..+. ++|++|++++|++++..+..|+++++|++|++++|.++. ..+..+..+ +|++|++++|.+++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 87777 5555544 677777777777776666667777777777777777753 556666666 67777777777764
Q ss_pred CCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccC
Q 037197 273 KIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQ 352 (1009)
Q Consensus 273 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 352 (1009)
+|..+. ++|++|+|++|.+++..+..+..+++|++|++++|++++..+..+..+++|+.|++++|+++ .+|..+..
T Consensus 187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 444433 56667777777766665566666666666666666666666656666666666666666665 44555555
Q ss_pred CCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccc--cccCCccCCCCcccE
Q 037197 353 SSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLIS--GTIPVGLGNLPSLQR 430 (1009)
Q Consensus 353 ~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~ 430 (1009)
+++|+.|++++|.+++..+..|+.... .....+|+.|++++|.+. +..|..|..+++|+.
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~ 324 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGF------------------GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA 324 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSC------------------CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTT
T ss_pred CccCCEEECCCCCCCccChhHcccccc------------------ccccccccceEeecCcccccccCcccccccchhhh
Confidence 555666666666555444444432200 001244566666666665 455566666777777
Q ss_pred EEeeccc
Q 037197 431 LEMANNN 437 (1009)
Q Consensus 431 L~L~~N~ 437 (1009)
|++++|+
T Consensus 325 l~l~~n~ 331 (332)
T 2ft3_A 325 IQFGNYK 331 (332)
T ss_dssp EEC----
T ss_pred hhccccc
Confidence 7776664
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-32 Score=302.63 Aligned_cols=289 Identities=23% Similarity=0.311 Sum_probs=189.5
Q ss_pred CCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEcc
Q 037197 259 KLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELW 338 (1009)
Q Consensus 259 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 338 (1009)
+++.++++++.++ .+|..+. ++|+.|+|++|++++..+..|..+++|++|++++|++++..|..|.++++|++|+++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4556666666655 3444332 455555555555554444455555555555555555555555555555555555555
Q ss_pred CCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCcccc--
Q 037197 339 KNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISG-- 416 (1009)
Q Consensus 339 ~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~-- 416 (1009)
+|.++ .+|..+. ++|++|++++|++++..+..+.++++|+.|++++|.+..
T Consensus 109 ~n~l~-------------------------~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 161 (330)
T 1xku_A 109 KNQLK-------------------------ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 161 (330)
T ss_dssp SSCCS-------------------------BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG
T ss_pred CCcCC-------------------------ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccC
Confidence 55544 2333322 456666666666665555556666666666666666642
Q ss_pred ccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCccccccc
Q 037197 417 TIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQA 496 (1009)
Q Consensus 417 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 496 (1009)
..+..+..+++|++|++++|+++ .+|..+. ++|+.|++++|++++..|..|..+++|+.|++++|++++..+..+..
T Consensus 162 ~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 238 (330)
T 1xku_A 162 IENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238 (330)
T ss_dssp BCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred cChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccC
Confidence 55566677777777777777776 3554443 67777777777777777777777777888888888777766677788
Q ss_pred CCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCccccc------ccccceecCCcccccc--ccCcCcCC
Q 037197 497 CPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVAT------MPTLAILDMSNNSLFG--RIPENFGA 568 (1009)
Q Consensus 497 l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~~--~~p~~~~~ 568 (1009)
+++|+.|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|.. .+.|+.|++++|++.. ..|..|..
T Consensus 239 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~ 317 (330)
T 1xku_A 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317 (330)
T ss_dssp STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred CCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccccc
Confidence 888888888888887 67777888888888888888888666666643 3678888888888863 56778888
Q ss_pred CCCCcEEecCCCc
Q 037197 569 SPALEMLNLSYNK 581 (1009)
Q Consensus 569 l~~L~~L~ls~N~ 581 (1009)
+..++.++|++|+
T Consensus 318 ~~~l~~l~L~~N~ 330 (330)
T 1xku_A 318 VYVRAAVQLGNYK 330 (330)
T ss_dssp CCCGGGEEC----
T ss_pred ccceeEEEecccC
Confidence 8888888888885
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-32 Score=301.02 Aligned_cols=295 Identities=22% Similarity=0.272 Sum_probs=172.4
Q ss_pred ccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeec
Q 037197 115 ALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLS 194 (1009)
Q Consensus 115 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~ 194 (1009)
+|++++++++.+. .+|..+. +.|++|+|++|++++..+..++++++|++|+|++|.+++..|..|+++++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4555555555544 3444332 456666666666665555566666666666666666666666666666677777777
Q ss_pred cccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCcccc--ccCcccCCCCCCcEEEcccCCcCC
Q 037197 195 GNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSG--QIPPALGRLKKLTTVYLYKNNFTG 272 (1009)
Q Consensus 195 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~l~~L~~L~L~~n~l~~ 272 (1009)
+|.++ .+|..+. ++|++|++++|++++..+..|+++++|++|++++|.+.. ..+..+..+++|++|++++|.++.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 66666 4454443 566667777777666656666777777777777776643 455666666677777777776663
Q ss_pred CCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccC
Q 037197 273 KIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQ 352 (1009)
Q Consensus 273 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 352 (1009)
+|..+. ++|++|++++|++++..|..+..+++|++|++++|++++..+..+..+++|+.|++++|.++ .+|..+..
T Consensus 186 -l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 186 -IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp -CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred -CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 444332 56666666666666555566666666666666666666655555666666666666666655 44445555
Q ss_pred CCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCcccc--ccCCccCCCCcccE
Q 037197 353 SSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISG--TIPVGLGNLPSLQR 430 (1009)
Q Consensus 353 ~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~ 430 (1009)
++.|++|++++|.+++..+..|+... ......+++.|++++|.+.. ..|..|..+.+++.
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~------------------~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~ 323 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPG------------------YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 323 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSS------------------CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGG
T ss_pred CCCcCEEECCCCcCCccChhhcCCcc------------------cccccccccceEeecCcccccccCccccccccceeE
Confidence 55555566666655544444443220 00112345555555555542 34455666666666
Q ss_pred EEeeccc
Q 037197 431 LEMANNN 437 (1009)
Q Consensus 431 L~L~~N~ 437 (1009)
++|++|+
T Consensus 324 l~L~~N~ 330 (330)
T 1xku_A 324 VQLGNYK 330 (330)
T ss_dssp EEC----
T ss_pred EEecccC
Confidence 6666663
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-36 Score=352.54 Aligned_cols=379 Identities=20% Similarity=0.130 Sum_probs=226.9
Q ss_pred cccceeeeccccccccCCcc-CCCCcchhhhhccccccccc----CCccccCCCCccEEEeccCccccccCcccC-CCC-
Q 037197 186 QKLKFLGLSGNNLTGKIPPE-LGQLSSLETIILGYNAFEGE----IPAEFGNLTNLRYLDLAVGSLSGQIPPALG-RLK- 258 (1009)
Q Consensus 186 ~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~-~l~- 258 (1009)
++|++|+|++|+++...... +..+++|++|+|++|++++. ++..+..+++|++|+|++|.+++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 56788888888887543333 66777888888888887743 456677778888888888887764443322 233
Q ss_pred ---CCcEEEcccCCcCC----CCCcccccccccccccccccccCCCcchhhhc-----ccCCCeEeccccccCCCC----
Q 037197 259 ---KLTTVYLYKNNFTG----KIPPELGSITSLAFLDLSDNQISGEIPVKLAE-----LKNLQLLNLMCNQLTGLI---- 322 (1009)
Q Consensus 259 ---~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~-----l~~L~~L~L~~N~l~~~~---- 322 (1009)
+|++|+|++|.++. .++..+..+++|++|+|++|.+++..+..+.. .++|++|++++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 57777777777774 34566667777777777777776544444332 345666666666666532
Q ss_pred CcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCcc-CCCCCceeeccccccccc----CCcc
Q 037197 323 PDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLC-DSGNLTKLILFNNSFSGT----FPVS 397 (1009)
Q Consensus 323 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~-~l~~L~~L~l~~N~l~~~----~p~~ 397 (1009)
+..+..+++|++|++++|.+.+..+..+.. .+. ..++|+.|++++|.+++. ++..
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~--------------------~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 222 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQ--------------------GLKDSPCQLEALKLESCGVTSDNCRDLCGI 222 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHH--------------------HHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHH--------------------HHhcCCCCceEEEccCCCCcHHHHHHHHHH
Confidence 333444555666666655554433222211 000 123444555555544432 3444
Q ss_pred cccCccccEEEcccCcccccc-----CCccCCCCcccEEEeeccccccc----CCcCCcCCCCCcEEecccCcccccCCC
Q 037197 398 LSTCKSLVRVRVQNNLISGTI-----PVGLGNLPSLQRLEMANNNLTGQ----IPDDISLSTSLSFVDISWNHLESYLPS 468 (1009)
Q Consensus 398 l~~~~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 468 (1009)
+..+++|++|++++|.+++.. +..+..+++|++|++++|++++. ++..+..+++|+.|++++|.+++..+.
T Consensus 223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 302 (461)
T 1z7x_W 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence 455555556666655555322 12223455666666666666542 444555566666666666666543332
Q ss_pred cccC-----CcccchhccccCcccCC----cccccccCCcCcEEEeecCCCCCCCCccccc-----cccceeeeecCccc
Q 037197 469 SILS-----IPSLQTFMASHNNLQAK----IPNELQACPSLSVLDLSSNSLSGEIPASIAS-----CEKLVSLNLRNNRF 534 (1009)
Q Consensus 469 ~~~~-----l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l 534 (1009)
.+.. .++|+.|++++|.+++. ++..+..+++|+.|||++|++++..+..+.. .++|+.|+|++|++
T Consensus 303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i 382 (461)
T 1z7x_W 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence 2222 24666777777766654 4566677788888888888887665555543 56888888888888
Q ss_pred cc----CCCcccccccccceecCCccccccccCcCcC-----CCCCCcEEecCCCcccc
Q 037197 535 SG----EIPKAVATMPTLAILDMSNNSLFGRIPENFG-----ASPALEMLNLSYNKLEG 584 (1009)
Q Consensus 535 ~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~ls~N~l~g 584 (1009)
++ .+|..+..+++|+.|||++|++++.-...+. ....|+.|++.+|.+..
T Consensus 383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred ChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence 76 6777888888888888888888764211111 12345666666555543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-33 Score=309.73 Aligned_cols=244 Identities=14% Similarity=0.120 Sum_probs=181.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC------ChhhHHHHHHHHHHHhccC---------CCceee
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN------DIESGDDLFREVSLLGRLR---------HRNIVR 761 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------Hpniv~ 761 (1009)
.++|+..+.||+|+||+||+|++ +++.||||++..... .....+.+.+|++++++++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45688999999999999999998 479999999976532 1223466778999988885 777777
Q ss_pred EEeEEE------------------------------cCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHH
Q 037197 762 LLGYLH------------------------------NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIA 811 (1009)
Q Consensus 762 l~~~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~ 811 (1009)
+.+.+. +....++||||+++|++.+.+... .+++..+..++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-----~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-----CCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-----CCCHHHHHHHHHHHH
Confidence 776542 267899999999999776666432 278899999999999
Q ss_pred HHHHHHH-hcCCCCeEEeccCCCcEEeCCCC--------------------cEEEcccccceecccCCCceeeecccCcc
Q 037197 812 QGLNYLH-HDCQPPVIHRDIKSNNILLDANL--------------------EARIADFGLARMMLHKNETVSMVAGSYGY 870 (1009)
Q Consensus 812 ~~L~~LH-~~~~~~ivH~dlk~~NIll~~~~--------------------~~kl~DfGls~~~~~~~~~~~~~~gt~~y 870 (1009)
.||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y 243 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCT
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecc
Confidence 9999999 88 999999999999999887 8999999999876432 34799999
Q ss_pred cCCcccCCCCCCcccchHhHHHH-HHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHH
Q 037197 871 IAPEYGYTLKVDEKSDIYSFGVV-LLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLL 949 (1009)
Q Consensus 871 ~aPE~~~~~~~~~~sDv~SlGvv-l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1009)
+|||++.+.. +.++||||+|++ .+++++|..||.. ..................... ..........+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~s~~ 311 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----VLWLHYLTDKMLKQMTFKTKC------NTPAMKQIKRK 311 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----HHHHHHHHHHHHHTCCCSSCC------CSHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----hhhhhHHHHhhhhhhccCccc------chhhhhhcCHH
Confidence 9999988666 899999998777 7888889999851 011011111111111001000 01112233456
Q ss_pred HHHHHHHhccCCCCCCCCHHHHH
Q 037197 950 VLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 950 l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
+.+++.+|++.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 788999999976 888877
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-36 Score=353.45 Aligned_cols=355 Identities=21% Similarity=0.256 Sum_probs=190.7
Q ss_pred CCCCeEecccCcccccCCcc-ccccCccCcccccccccCC----CCCCCCCCCcCCeEEecCCCCCCCCCCcccc-CCC-
Q 037197 90 RSLSSLNICCNEFASSLPKS-LANLTALKSMDVSQNNFIG----SFPTGLGKASGLTSVNASSNNFSGFLPEDLG-NAT- 162 (1009)
Q Consensus 90 ~~L~~L~L~~n~~~~~~~~~-l~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~- 162 (1009)
++|++|+|++|++++..... +..+++|++|+|++|.+++ .++..+..+++|++|+|++|.+++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 45788888888887654433 7778888888888888764 2455566667777777777777654343332 244
Q ss_pred ---CCCeeeccCCccCC----cCCccccCccccceeeeccccccccCCccCC-----CCcchhhhhcccccccccC----
Q 037197 163 ---SLESLDFRGSFFEG----SVPTSFRNLQKLKFLGLSGNNLTGKIPPELG-----QLSSLETIILGYNAFEGEI---- 226 (1009)
Q Consensus 163 ---~L~~L~L~~n~~~~----~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~-----~l~~L~~L~L~~n~l~~~~---- 226 (1009)
+|++|+|++|.++. .++..+..+++|++|+|++|.+++..+..+. ..++|++|+|++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 57777777776663 3355666666666666666666543332221 1234555555555554422
Q ss_pred CccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccc-cccccccccccccccCCC----cchh
Q 037197 227 PAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELG-SITSLAFLDLSDNQISGE----IPVK 301 (1009)
Q Consensus 227 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~----~~~~ 301 (1009)
+..+..+++|++|++++|.+++..+..+.. .+. ..++|++|+|++|.+++. ++..
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~--------------------~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 222 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQ--------------------GLKDSPCQLEALKLESCGVTSDNCRDLCGI 222 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHH--------------------HHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHH--------------------HHhcCCCCceEEEccCCCCcHHHHHHHHHH
Confidence 333344445555555555444332222211 000 123444555555544432 2344
Q ss_pred hhcccCCCeEeccccccCCCC-----CcCCCCCCcccEEEccCCccCcc----CCccccCCCCCceeeccCccccccCCc
Q 037197 302 LAELKNLQLLNLMCNQLTGLI-----PDKLGELTKLEVLELWKNSLIGS----LPMRLGQSSPLRRLDASSNLLSGEIPT 372 (1009)
Q Consensus 302 l~~l~~L~~L~L~~N~l~~~~-----~~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~~~~L~~L~Ls~N~l~~~~~~ 372 (1009)
+..+++|++|++++|++++.. +..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++..+.
T Consensus 223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 302 (461)
T 1z7x_W 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence 444555555555555544321 11222345555555555555543 334444455556666666655443333
Q ss_pred CccC-----CCCCceeeccccccccc----CCcccccCccccEEEcccCccccccCCccCC-----CCcccEEEeecccc
Q 037197 373 GLCD-----SGNLTKLILFNNSFSGT----FPVSLSTCKSLVRVRVQNNLISGTIPVGLGN-----LPSLQRLEMANNNL 438 (1009)
Q Consensus 373 ~l~~-----l~~L~~L~l~~N~l~~~----~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l 438 (1009)
.+.. .++|+.|++++|.+++. ++..+..+++|++|++++|.+++..+..+.. .++|++|+|++|++
T Consensus 303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i 382 (461)
T 1z7x_W 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence 2222 14566666666666543 3444555566666666666666544433322 45666666666666
Q ss_pred cc----cCCcCCcCCCCCcEEecccCcccc
Q 037197 439 TG----QIPDDISLSTSLSFVDISWNHLES 464 (1009)
Q Consensus 439 ~~----~~p~~~~~l~~L~~L~Ls~N~l~~ 464 (1009)
++ .+|..+..+++|+.|++++|++++
T Consensus 383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 383 SDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred ChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 64 455555556666666666666654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=299.43 Aligned_cols=281 Identities=20% Similarity=0.307 Sum_probs=233.5
Q ss_pred HHHhhccCCCCCCCCCCCCCccccCCcCCceeeeEEeCC---CCceeEEeccccccccccccccccCCCCCeEecccCcc
Q 037197 26 SIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWCNS---RGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEF 102 (1009)
Q Consensus 26 ~~k~~~~d~~~~l~~W~~~~~~~~~~~~~C~w~gv~C~~---~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~ 102 (1009)
+.|+++.|+..+|.+|+..- ..++|.|.+++|.. ...+. ...+....
T Consensus 20 ~~~~~~~~~~~aLl~~k~~~-----~~~~~~~~~~w~~~~~~~~~~~--~~~g~~~~----------------------- 69 (328)
T 4fcg_A 20 QGSTALRPYHDVLSQWQRHY-----NADRNRWHSAWRQANSNNPQIE--TRTGRALK----------------------- 69 (328)
T ss_dssp C--CCCCCHHHHHHHHHHHH-----HHCCTTHHHHHHHHTTTCTTSC--CSHHHHHH-----------------------
T ss_pred eccccCchHHHHHHHHHHhc-----cCCchhhhhhhccccccccccc--ccCCcchh-----------------------
Confidence 45566677767788897321 23679999999832 11111 11111000
Q ss_pred cccCCccc--cccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCc
Q 037197 103 ASSLPKSL--ANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPT 180 (1009)
Q Consensus 103 ~~~~~~~l--~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~ 180 (1009)
.++..+ ...+++++|+|++|.+. .+|..++++++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+|.
T Consensus 70 --~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~ 144 (328)
T 4fcg_A 70 --ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPA 144 (328)
T ss_dssp --HHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCG
T ss_pred --hhHHHHhcccccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcH
Confidence 011111 22366777777777776 67777888888888888888888 78889999999999999999999 8899
Q ss_pred cccCccccceeeeccccccccCCccCCC---------CcchhhhhcccccccccCCccccCCCCccEEEeccCccccccC
Q 037197 181 SFRNLQKLKFLGLSGNNLTGKIPPELGQ---------LSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIP 251 (1009)
Q Consensus 181 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~---------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 251 (1009)
.++++++|++|+|++|++.+.+|..++. +++|++|+|++|+++ .+|..++++++|++|+|++|.+++ +|
T Consensus 145 ~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~ 222 (328)
T 4fcg_A 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LG 222 (328)
T ss_dssp GGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CC
T ss_pred HHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cc
Confidence 9999999999999999999999988765 999999999999999 889999999999999999999995 67
Q ss_pred cccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCc
Q 037197 252 PALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTK 331 (1009)
Q Consensus 252 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 331 (1009)
..++.+++|++|+|++|++.+.+|..+..+++|++|+|++|.+.+.+|..+..+++|++|+|++|.+.+.+|..++++++
T Consensus 223 ~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~ 302 (328)
T 4fcg_A 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302 (328)
T ss_dssp GGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCT
T ss_pred hhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccC
Confidence 78999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccEEEccCCccC
Q 037197 332 LEVLELWKNSLI 343 (1009)
Q Consensus 332 L~~L~L~~N~l~ 343 (1009)
|+.+++..|.+.
T Consensus 303 L~~l~l~~~~~~ 314 (328)
T 4fcg_A 303 NCIILVPPHLQA 314 (328)
T ss_dssp TCEEECCGGGSC
T ss_pred ceEEeCCHHHHH
Confidence 999999887654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-33 Score=342.37 Aligned_cols=433 Identities=18% Similarity=0.136 Sum_probs=198.1
Q ss_pred CCceeeeEEeCCCCceeEEeccccccccccccccccCCCCCeEecccCccc---ccCCcccc------------ccCccC
Q 037197 53 LHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFA---SSLPKSLA------------NLTALK 117 (1009)
Q Consensus 53 ~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~---~~~~~~l~------------~l~~L~ 117 (1009)
.|++|.+|.+....++ .+.+ .....++..+..+++|++|+|+++... +.+|..++ .+++|+
T Consensus 40 vck~W~~~~~~~~~~l---~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~ 115 (592)
T 3ogk_B 40 VCRRWFKIDSETREHV---TMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115 (592)
T ss_dssp SCHHHHHHHHHHCCEE---EESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred HhHHHHHhhhccccEE---EEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence 4568999966433222 2222 223334445667788888888765321 22332222 556666
Q ss_pred cccccccccCCCCCCCCCCC--cCCeEEecCCCC-CCC-CCCccccCCCCCCeeeccCCccCCcC----CccccCccccc
Q 037197 118 SMDVSQNNFIGSFPTGLGKA--SGLTSVNASSNN-FSG-FLPEDLGNATSLESLDFRGSFFEGSV----PTSFRNLQKLK 189 (1009)
Q Consensus 118 ~L~Ls~n~l~~~~p~~l~~l--~~L~~L~Ls~n~-l~~-~~p~~l~~l~~L~~L~L~~n~~~~~~----p~~~~~l~~L~ 189 (1009)
+|+|++|.+++..+..++.. .+|++|+|++|. ++. .++....++++|++|+|++|.+++.. +..+.++++|+
T Consensus 116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~ 195 (592)
T 3ogk_B 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE 195 (592)
T ss_dssp EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence 66666665554444444442 236666666554 110 11122234556666666666554432 22234455555
Q ss_pred eeeecccccc----ccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEc
Q 037197 190 FLGLSGNNLT----GKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYL 265 (1009)
Q Consensus 190 ~L~L~~n~l~----~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 265 (1009)
+|++++|.++ +.++..+.++++|++|+|++|.+.+ ++..+.++++|++|+++........
T Consensus 196 ~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~--------------- 259 (592)
T 3ogk_B 196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGM--------------- 259 (592)
T ss_dssp EEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTC---------------
T ss_pred EEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccch---------------
Confidence 5555555554 1222233344555555555555443 3344555555555555432211000
Q ss_pred ccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCC-cCCCCCCcccEEEccCCccCc
Q 037197 266 YKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIP-DKLGELTKLEVLELWKNSLIG 344 (1009)
Q Consensus 266 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~ 344 (1009)
+..+..+..+++|+.|+++++... .+|..+..+++|++|++++|.+++... ..+..+++|+.|+++ +.+.+
T Consensus 260 ------~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~ 331 (592)
T 3ogk_B 260 ------PEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGD 331 (592)
T ss_dssp ------TTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHH
T ss_pred ------HHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCH
Confidence 112223334444444444443222 344444444555555555554432211 123445555555554 22221
Q ss_pred -cCCccccCCCCCceeecc-----------CccccccCCcC-ccCCCCCceeecccccccccCCccccc-CccccEEEcc
Q 037197 345 -SLPMRLGQSSPLRRLDAS-----------SNLLSGEIPTG-LCDSGNLTKLILFNNSFSGTFPVSLST-CKSLVRVRVQ 410 (1009)
Q Consensus 345 -~~~~~~~~~~~L~~L~Ls-----------~N~l~~~~~~~-l~~l~~L~~L~l~~N~l~~~~p~~l~~-~~~L~~L~L~ 410 (1009)
.++.....+++|+.|+++ .|.+++..... +..+++|++|+++.|.+++..+..+.. +++|+.|+++
T Consensus 332 ~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~ 411 (592)
T 3ogk_B 332 RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV 411 (592)
T ss_dssp HHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEE
T ss_pred HHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEe
Confidence 222222334445555555 23333221111 223455666666555555544444443 5566666664
Q ss_pred ----cCccccc-----cCCccCCCCcccEEEeecc--cccccCCcCCc-CCCCCcEEecccCccccc-CCCcccCCcccc
Q 037197 411 ----NNLISGT-----IPVGLGNLPSLQRLEMANN--NLTGQIPDDIS-LSTSLSFVDISWNHLESY-LPSSILSIPSLQ 477 (1009)
Q Consensus 411 ----~N~l~~~-----~p~~~~~l~~L~~L~L~~N--~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~ 477 (1009)
.|.+++. ++..+.++++|+.|++++| .+++..+..+. .+++|+.|+|++|++++. ++..+..+++|+
T Consensus 412 ~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~ 491 (592)
T 3ogk_B 412 LLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQ 491 (592)
T ss_dssp ECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCC
T ss_pred ecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccC
Confidence 4455532 2223444566666666532 24433332222 245566666666655431 222234445555
Q ss_pred hhccccCcccCC-cccccccCCcCcEEEeecCCCCCC
Q 037197 478 TFMASHNNLQAK-IPNELQACPSLSVLDLSSNSLSGE 513 (1009)
Q Consensus 478 ~L~l~~N~l~~~-~p~~~~~l~~L~~LdLs~N~l~~~ 513 (1009)
.|++++|.+++. ++..+..+++|+.|+|++|++++.
T Consensus 492 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 492 KLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp EEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred eeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 555555554322 222334455555555555555543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-31 Score=295.12 Aligned_cols=282 Identities=18% Similarity=0.227 Sum_probs=228.4
Q ss_pred CCceeeeEEeCCCCceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCC
Q 037197 53 LHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPT 132 (1009)
Q Consensus 53 ~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~ 132 (1009)
.+|.|.|+ |+ +++++++. +|..+. ++|++|+|++|.+++..+..+.++++|++|+|++|.+++..|.
T Consensus 28 ~~C~~~~~-c~---------~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 94 (353)
T 2z80_A 28 LSCDRNGI-CK---------GSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEED 94 (353)
T ss_dssp CEECTTSE-EE---------CCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT
T ss_pred CCCCCCeE-ee---------CCCCCccc-cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHh
Confidence 56899887 74 35556653 455443 5899999999999887777899999999999999999988888
Q ss_pred CCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCC-ccccCccccceeeeccc-cccccCCccCCCCc
Q 037197 133 GLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVP-TSFRNLQKLKFLGLSGN-NLTGKIPPELGQLS 210 (1009)
Q Consensus 133 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p-~~~~~l~~L~~L~L~~n-~l~~~~p~~l~~l~ 210 (1009)
.++++++|++|+|++|++++..+..++++++|++|++++|.+++..+ ..+.++++|++|++++| .+++..+..|+.++
T Consensus 95 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~ 174 (353)
T 2z80_A 95 SFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174 (353)
T ss_dssp TTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred hcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCC
Confidence 89999999999999999996555668999999999999999985444 47899999999999999 57766678899999
Q ss_pred chhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccc---cccccccc
Q 037197 211 SLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELG---SITSLAFL 287 (1009)
Q Consensus 211 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L 287 (1009)
+|++|++++|++++..|..|+++++|++|++++|.++...+..+..+++|+.|++++|.+++..+..+. ....++.+
T Consensus 175 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l 254 (353)
T 2z80_A 175 FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF 254 (353)
T ss_dssp EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEE
T ss_pred CCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhcc
Confidence 999999999999988899999999999999999998755444556689999999999999876555443 24566777
Q ss_pred cccccccCC----CcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCC
Q 037197 288 DLSDNQISG----EIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLP 347 (1009)
Q Consensus 288 ~Ls~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 347 (1009)
+|+++.+++ .+|..+..+++|++|++++|+++.+.+..|.++++|+.|++++|++.+..|
T Consensus 255 ~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 255 TFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp EEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 777777664 467778888889999999998886655556888888888888888775443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-32 Score=334.18 Aligned_cols=395 Identities=18% Similarity=0.139 Sum_probs=246.7
Q ss_pred CccccceeeeccccccccCCccCCCC--cchhhhhccccc-ccc-cCCccccCCCCccEEEeccCccccc----cCcccC
Q 037197 184 NLQKLKFLGLSGNNLTGKIPPELGQL--SSLETIILGYNA-FEG-EIPAEFGNLTNLRYLDLAVGSLSGQ----IPPALG 255 (1009)
Q Consensus 184 ~l~~L~~L~L~~n~l~~~~p~~l~~l--~~L~~L~L~~n~-l~~-~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~ 255 (1009)
.+++|++|+|++|.+++..+..++.. .+|++|+|++|. ++. .++....++++|++|+|++|.+++. ++..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 45566666666666555444444442 236666666554 211 1122233566777777777766544 223345
Q ss_pred CCCCCcEEEcccCCcCC----CCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccC---CCCCcCCCC
Q 037197 256 RLKKLTTVYLYKNNFTG----KIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLT---GLIPDKLGE 328 (1009)
Q Consensus 256 ~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~---~~~~~~l~~ 328 (1009)
.+++|++|++++|.+++ .++..+..+++|+.|+|++|.+.+ +|..+..+++|++|+++.+... +..+..+..
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~ 268 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF 268 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence 56777777777777762 223334566777788887777774 6677777788888887753322 223445667
Q ss_pred CCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCC-cCccCCCCCceeecccccccccCCcccccCccccEE
Q 037197 329 LTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIP-TGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRV 407 (1009)
Q Consensus 329 l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L 407 (1009)
+++|+.|+++++. .+.+|..+..+++|++|++++|.+++... ..+..+++|+.|+++++...+.++.....+++|++|
T Consensus 269 ~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L 347 (592)
T 3ogk_B 269 PRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRL 347 (592)
T ss_dssp CTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEE
T ss_pred cccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEE
Confidence 7788888887753 34556666777788888888887664433 334667788888887433333344444667888888
Q ss_pred Ecc-----------cCcccccc-CCccCCCCcccEEEeecccccccCCcCCcC-CCCCcEEecc----cCccccc-----
Q 037197 408 RVQ-----------NNLISGTI-PVGLGNLPSLQRLEMANNNLTGQIPDDISL-STSLSFVDIS----WNHLESY----- 465 (1009)
Q Consensus 408 ~L~-----------~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~----- 465 (1009)
+++ .|.+++.. +..+..+++|++|+++.|++++..+..+.. +++|+.|+++ .|++++.
T Consensus 348 ~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~ 427 (592)
T 3ogk_B 348 RIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNG 427 (592)
T ss_dssp EEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHH
T ss_pred EeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHH
Confidence 888 35665432 222345778888888888887766665554 7788888885 6677663
Q ss_pred CCCcccCCcccchhccccC--cccCCccccccc-CCcCcEEEeecCCCCC-CCCccccccccceeeeecCcccccC-CCc
Q 037197 466 LPSSILSIPSLQTFMASHN--NLQAKIPNELQA-CPSLSVLDLSSNSLSG-EIPASIASCEKLVSLNLRNNRFSGE-IPK 540 (1009)
Q Consensus 466 ~~~~~~~l~~L~~L~l~~N--~l~~~~p~~~~~-l~~L~~LdLs~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~ 540 (1009)
++..+.++++|+.|+++++ .+++..+..+.. +++|+.|+|++|++++ .++..+..+++|+.|+|++|.+++. ++.
T Consensus 428 ~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 507 (592)
T 3ogk_B 428 VRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAA 507 (592)
T ss_dssp HHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHH
T ss_pred HHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHH
Confidence 2223556777888887643 355544444433 7778888888888775 3344456678888888888887654 344
Q ss_pred ccccccccceecCCccccccccCcCcC-CCCCCcEEecCCC
Q 037197 541 AVATMPTLAILDMSNNSLFGRIPENFG-ASPALEMLNLSYN 580 (1009)
Q Consensus 541 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ls~N 580 (1009)
.+..+++|+.|+|++|+++..--..+. .+|.+....+..+
T Consensus 508 ~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 508 AVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp HHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred HHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 456678888888888887765433332 4566555544443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=285.41 Aligned_cols=280 Identities=20% Similarity=0.192 Sum_probs=183.9
Q ss_pred cccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeec
Q 037197 282 TSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDA 361 (1009)
Q Consensus 282 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L 361 (1009)
+.....++++|.++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|.+++..+..+..+++|++|++
T Consensus 31 ~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 31 DRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp CTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 33444566666665 4444433 35666666666666555555556666666655555555544444444444555554
Q ss_pred cCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccC-CccCCCCcccEEEeecc-ccc
Q 037197 362 SSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIP-VGLGNLPSLQRLEMANN-NLT 439 (1009)
Q Consensus 362 s~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~ 439 (1009)
++|++++..+..+.++++|++|++++|++++..+ ..+.++++|++|++++| .++
T Consensus 108 ------------------------s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~ 163 (353)
T 2z80_A 108 ------------------------SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT 163 (353)
T ss_dssp ------------------------CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC
T ss_pred ------------------------CCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccc
Confidence 4444443333335555556666666665553322 35666666666666666 355
Q ss_pred ccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCcccc
Q 037197 440 GQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIA 519 (1009)
Q Consensus 440 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~ 519 (1009)
+..+..+..+++|+.|++++|++++..|..+..+++|++|++++|++....+..+..+++|+.|+|++|++++..+..+.
T Consensus 164 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 243 (353)
T 2z80_A 164 KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243 (353)
T ss_dssp EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC---
T ss_pred ccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccc
Confidence 45556666667777777777777776677777777777777777777644444455688888899999988876665543
Q ss_pred ---ccccceeeeecCccccc----CCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCC
Q 037197 520 ---SCEKLVSLNLRNNRFSG----EIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPS 588 (1009)
Q Consensus 520 ---~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~ 588 (1009)
....++.++|++|.+++ .+|..+..+++|+.|||++|+++...+..|..+++|++|+|++|++++..|.
T Consensus 244 ~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 244 TGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp ---CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred cccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 35667888888888876 5788899999999999999999954444468999999999999999998874
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-30 Score=283.61 Aligned_cols=286 Identities=25% Similarity=0.287 Sum_probs=224.8
Q ss_pred CCceeeeEEeCCCCceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCC--C
Q 037197 53 LHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGS--F 130 (1009)
Q Consensus 53 ~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~--~ 130 (1009)
+.|.|++|.|+..+ ++ .+|..+ .++|++|+|++|.+++..+..++++++|++|+|++|.++.. .
T Consensus 5 C~C~~~~l~c~~~~-----------l~-~ip~~~--~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 70 (306)
T 2z66_A 5 CSCSGTEIRCNSKG-----------LT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70 (306)
T ss_dssp CEEETTEEECCSSC-----------CS-SCCSCC--CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEE
T ss_pred CeeCCCEEEcCCCC-----------cc-cCCCCC--CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCc
Confidence 35899999996532 22 233322 25788899999988755445578899999999999888632 3
Q ss_pred CCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCC-ccccCccccceeeeccccccccCCccCCCC
Q 037197 131 PTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVP-TSFRNLQKLKFLGLSGNNLTGKIPPELGQL 209 (1009)
Q Consensus 131 p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 209 (1009)
|..+..+++|++|+|++|.+. .+|..+..+++|++|++++|.+++..+ ..+.++++|++|++++|.+++..+..+..+
T Consensus 71 ~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 149 (306)
T 2z66_A 71 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 149 (306)
T ss_dssp EHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTC
T ss_pred ccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccC
Confidence 566667888999999999888 567778889999999999998886655 578888999999999999988888888889
Q ss_pred cchhhhhcccccccc-cCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCccccccccccccc
Q 037197 210 SSLETIILGYNAFEG-EIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLD 288 (1009)
Q Consensus 210 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 288 (1009)
++|++|++++|.+++ ..|..|..+++|++|++++|++++..|..+..+++|++|+|++|.+++..+..+..+++|++|+
T Consensus 150 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 229 (306)
T 2z66_A 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 229 (306)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEE
T ss_pred cCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeE
Confidence 999999999999886 5788889999999999999999888888899999999999999999877777788889999999
Q ss_pred ccccccCCCcchhhhccc-CCCeEeccccccCCCCC--cCCCCCCcccEEEccCCccCccCCccccCC
Q 037197 289 LSDNQISGEIPVKLAELK-NLQLLNLMCNQLTGLIP--DKLGELTKLEVLELWKNSLIGSLPMRLGQS 353 (1009)
Q Consensus 289 Ls~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~--~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~ 353 (1009)
|++|++++..|..+..++ +|++|++++|.+++... .....+...+.+.+..+.+....|..+.+.
T Consensus 230 L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g~ 297 (306)
T 2z66_A 230 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM 297 (306)
T ss_dssp CTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTTC
T ss_pred CCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCCc
Confidence 999999888888888874 89999999999876421 112223444555566677777777666553
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=276.68 Aligned_cols=280 Identities=21% Similarity=0.226 Sum_probs=169.5
Q ss_pred cccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCcc--CCccccCCCCCceeeccC
Q 037197 286 FLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGS--LPMRLGQSSPLRRLDASS 363 (1009)
Q Consensus 286 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~~~~~~~~~~L~~L~Ls~ 363 (1009)
.++++++.++ .+|..+. ++|++|++++|+++...+..|.++++|++|++++|.++.. .+..+..+++|++|++++
T Consensus 11 ~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred EEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 3444444444 3333222 3555555555555544444455555666666665555422 234444555666666666
Q ss_pred ccccccCCcCccCCCCCceeecccccccccCC-cccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccc-c
Q 037197 364 NLLSGEIPTGLCDSGNLTKLILFNNSFSGTFP-VSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTG-Q 441 (1009)
Q Consensus 364 N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p-~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~ 441 (1009)
|.+. .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+..+..+..+++|++|++++|++++ .
T Consensus 88 n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 166 (306)
T 2z66_A 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166 (306)
T ss_dssp CSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred Cccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccccc
Confidence 6665 344455566666666666666665443 456666677777777777766666666677777777777777765 4
Q ss_pred CCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCcccccc
Q 037197 442 IPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASC 521 (1009)
Q Consensus 442 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l 521 (1009)
+|..+..+++|+.|++++|++++..|..|..+++|+.|++++|++++..+..+..+++|+.|||++|++++..|..+..+
T Consensus 167 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 246 (306)
T 2z66_A 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246 (306)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCC
T ss_pred chhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhh
Confidence 66666677777777777777776666666666666666666666666555566667777777777777776666666666
Q ss_pred -ccceeeeecCcccccCCC--cccccccccceecCCccccccccCcCcCCC
Q 037197 522 -EKLVSLNLRNNRFSGEIP--KAVATMPTLAILDMSNNSLFGRIPENFGAS 569 (1009)
Q Consensus 522 -~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 569 (1009)
++|+.|+|++|.+++.-+ .....+..++.+.+..|.+....|..+...
T Consensus 247 ~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g~ 297 (306)
T 2z66_A 247 PSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM 297 (306)
T ss_dssp CTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTTC
T ss_pred hccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCCc
Confidence 367777777777765422 112334445555556666666666655443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=285.56 Aligned_cols=248 Identities=21% Similarity=0.248 Sum_probs=149.5
Q ss_pred cccCCCCCeEecccCcccccCCccccccCccCccccccccc-CCCCCCCCC-------CCcCCeEEecCCCCCCCCCCcc
Q 037197 86 IRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNF-IGSFPTGLG-------KASGLTSVNASSNNFSGFLPED 157 (1009)
Q Consensus 86 l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l-~~~~p~~l~-------~l~~L~~L~Ls~n~l~~~~p~~ 157 (1009)
+++.++|++|++++|.+ .+|..+... |++|+|++|.+ ...+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 44555666777777766 566655554 77777777766 334554444 5666666666666666666665
Q ss_pred c--cCCCCCCeeeccCCccCCcCCccccCc-----cccceeeeccccccccCCccCCCCcchhhhhccccccccc--CCc
Q 037197 158 L--GNATSLESLDFRGSFFEGSVPTSFRNL-----QKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGE--IPA 228 (1009)
Q Consensus 158 l--~~l~~L~~L~L~~n~~~~~~p~~~~~l-----~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~--~~~ 228 (1009)
+ +.+++|++|+|++|.+++. |..++.+ ++|++|+|++|++++..|..|+.+++|++|+|++|++.+. .+.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 4 6666666666666666655 5656555 6666666666666665556666666666666666665543 222
Q ss_pred cc--cCCCCccEEEeccCcccc---ccCcccCCCCCCcEEEcccCCcCCCCC-cccccccccccccccccccCCCcchhh
Q 037197 229 EF--GNLTNLRYLDLAVGSLSG---QIPPALGRLKKLTTVYLYKNNFTGKIP-PELGSITSLAFLDLSDNQISGEIPVKL 302 (1009)
Q Consensus 229 ~~--~~l~~L~~L~L~~n~l~~---~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~l 302 (1009)
.+ +++++|++|+|++|++++ .....+..+++|++|+|++|++++..| ..+..+++|++|+|++|+|+ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 33 566666666666666652 112233455666666666666665543 33444566666666666665 455444
Q ss_pred hcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccC
Q 037197 303 AELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLI 343 (1009)
Q Consensus 303 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 343 (1009)
. ++|++|++++|+|++. |. +..+++|++|++++|+++
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 4 5566666666666655 33 555666666666666554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-30 Score=283.29 Aligned_cols=259 Identities=20% Similarity=0.204 Sum_probs=223.7
Q ss_pred CCceeeeEEeCC-CCceeEEeccccccccccccccccCCCCCeEecccCcc-cccCCcccc-------ccCccCcccccc
Q 037197 53 LHCNWTGVWCNS-RGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEF-ASSLPKSLA-------NLTALKSMDVSQ 123 (1009)
Q Consensus 53 ~~C~w~gv~C~~-~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~-~~~~~~~l~-------~l~~L~~L~Ls~ 123 (1009)
.|+.|..+.... ...++.++++++.+ .+|..+... |++|+|++|.+ ...+|..+. ++++|++|+|++
T Consensus 29 ~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~ 104 (312)
T 1wwl_A 29 NCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104 (312)
T ss_dssp GSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEE
T ss_pred hhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccC
Confidence 466666654422 24688899999999 677766655 99999999999 456787776 899999999999
Q ss_pred cccCCCCCCCC--CCCcCCeEEecCCCCCCCCCCccccCC-----CCCCeeeccCCccCCcCCccccCccccceeeeccc
Q 037197 124 NNFIGSFPTGL--GKASGLTSVNASSNNFSGFLPEDLGNA-----TSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGN 196 (1009)
Q Consensus 124 n~l~~~~p~~l--~~l~~L~~L~Ls~n~l~~~~p~~l~~l-----~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n 196 (1009)
|++++.+|..+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|.+.+..|..|+++++|++|+|++|
T Consensus 105 n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 183 (312)
T 1wwl_A 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183 (312)
T ss_dssp EBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSC
T ss_pred CcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCC
Confidence 99999999987 9999999999999999987 8888887 99999999999999888899999999999999999
Q ss_pred ccccc--CCccC--CCCcchhhhhccccccccc--CC-ccccCCCCccEEEeccCccccccC-cccCCCCCCcEEEcccC
Q 037197 197 NLTGK--IPPEL--GQLSSLETIILGYNAFEGE--IP-AEFGNLTNLRYLDLAVGSLSGQIP-PALGRLKKLTTVYLYKN 268 (1009)
Q Consensus 197 ~l~~~--~p~~l--~~l~~L~~L~L~~n~l~~~--~~-~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n 268 (1009)
++.+. .|..+ +.+++|++|+|++|++++. ++ ..+.++++|++|+|++|++++..| ..+..+++|++|+|++|
T Consensus 184 ~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N 263 (312)
T 1wwl_A 184 PELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT 263 (312)
T ss_dssp TTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTS
T ss_pred CcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCC
Confidence 98765 34444 8999999999999999832 22 446789999999999999998775 56777899999999999
Q ss_pred CcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCC
Q 037197 269 NFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGL 321 (1009)
Q Consensus 269 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 321 (1009)
.++ .+|..+. ++|++|+|++|+|++. |. +..+++|++|++++|++++.
T Consensus 264 ~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 264 GLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp CCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred ccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 999 7888776 8999999999999966 65 89999999999999999864
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-28 Score=262.29 Aligned_cols=238 Identities=19% Similarity=0.157 Sum_probs=116.2
Q ss_pred cCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCcc-ccccCCcCccCCCCCceee
Q 037197 306 KNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNL-LSGEIPTGLCDSGNLTKLI 384 (1009)
Q Consensus 306 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~-l~~~~~~~l~~l~~L~~L~ 384 (1009)
++|++|++++|.+++..+..|..+++|++|++++|.+++..+..+..+++|++|++++|. +....|..+..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 345555555555554444445555555555555555544444444444444444444443 4433344444444445555
Q ss_pred cccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccc
Q 037197 385 LFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLES 464 (1009)
Q Consensus 385 l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 464 (1009)
+++|++++..|..+.++++|++|++++|++++..+..+..+++|++|+|++|++++..+..+..+++|+.|++++|
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n---- 187 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN---- 187 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS----
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCC----
Confidence 5444444444444444444444444444444333334444444444444444444333333444444444444444
Q ss_pred cCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCccccc
Q 037197 465 YLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVAT 544 (1009)
Q Consensus 465 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 544 (1009)
++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.++...+.. .-
T Consensus 188 --------------------~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~ 246 (285)
T 1ozn_A 188 --------------------RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PL 246 (285)
T ss_dssp --------------------CCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HH
T ss_pred --------------------cccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HH
Confidence 444444445555555555555555555544444555555555566655555433221 12
Q ss_pred ccccceecCCccccccccCcCcCC
Q 037197 545 MPTLAILDMSNNSLFGRIPENFGA 568 (1009)
Q Consensus 545 l~~L~~L~Ls~N~l~~~~p~~~~~ 568 (1009)
...++.++.+.|.+....|..+..
T Consensus 247 ~~~l~~~~~~~~~~~c~~p~~l~g 270 (285)
T 1ozn_A 247 WAWLQKFRGSSSEVPCSLPQRLAG 270 (285)
T ss_dssp HHHHHHCCSEECCCBEEESGGGTT
T ss_pred HHHHHhcccccCccccCCchHhCC
Confidence 233455555666666666665543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=278.23 Aligned_cols=250 Identities=19% Similarity=0.163 Sum_probs=154.9
Q ss_pred CCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeeccc
Q 037197 308 LQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFN 387 (1009)
Q Consensus 308 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~ 387 (1009)
...++.+++.++.+ |..+. ++++.|+|++|.+++..+..|..+++|+.|+|++|.+++..+..|..+++|++|+|++
T Consensus 56 ~~~v~c~~~~l~~i-P~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLSEV-PQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCSSC-CSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcCcc-CCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 45566666666643 33332 4555566655555555555555555555555555555544444444444555555555
Q ss_pred ccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEeccc-CcccccC
Q 037197 388 NSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISW-NHLESYL 466 (1009)
Q Consensus 388 N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~ 466 (1009)
|++++..+ ..|..+++|++|+|++|++++..+..+..+++|+.|++++ |.++.+.
T Consensus 133 n~l~~~~~------------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~ 188 (452)
T 3zyi_A 133 NWLTVIPS------------------------GAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYIS 188 (452)
T ss_dssp SCCSBCCT------------------------TTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC
T ss_pred CcCCccCh------------------------hhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccC
Confidence 44444444 4444555555555555555544444455555555555555 3344444
Q ss_pred CCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCccccccc
Q 037197 467 PSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMP 546 (1009)
Q Consensus 467 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 546 (1009)
+..|..+++|+.|++++|++++. | .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..++
T Consensus 189 ~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 266 (452)
T 3zyi_A 189 EGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLA 266 (452)
T ss_dssp TTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred hhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCC
Confidence 44555556666666666666543 2 366677788888888888877777788888888888888888877777788888
Q ss_pred ccceecCCccccccccCcCcCCCCCCcEEecCCCccccCC
Q 037197 547 TLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPV 586 (1009)
Q Consensus 547 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~i 586 (1009)
+|+.|||++|+|++..+..|..+++|+.|+|++|++....
T Consensus 267 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 267 SLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp TCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred CCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence 8888888888888777777788888888888888876543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-29 Score=278.64 Aligned_cols=267 Identities=23% Similarity=0.276 Sum_probs=143.9
Q ss_pred cccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccC
Q 037197 284 LAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASS 363 (1009)
Q Consensus 284 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~ 363 (1009)
++.++++.+.+.......+..+++|++|++++|++++..|..|.++++|++|++++|.+++..+ +..+++|++|++++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 3444555555543333334445556666666666665555555666666666666665554433 55555555555555
Q ss_pred ccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCC
Q 037197 364 NLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIP 443 (1009)
Q Consensus 364 N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 443 (1009)
|.+++.. ..++|+.|++++|++++..+.. +++|++|++++|++++..+..+..+++|++|+|++|++++..+
T Consensus 90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 161 (317)
T 3o53_A 90 NYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161 (317)
T ss_dssp SEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred Ccccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence 5555321 1245556666666555443322 3455666666666665555555556666666666666655444
Q ss_pred cCC-cCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccc
Q 037197 444 DDI-SLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCE 522 (1009)
Q Consensus 444 ~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~ 522 (1009)
..+ ..+++|++|+|++|+|++..+ ...+++|+.|+|++|++++ +|..+..++
T Consensus 162 ~~~~~~l~~L~~L~L~~N~l~~~~~--------------------------~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~ 214 (317)
T 3o53_A 162 AELAASSDTLEHLNLQYNFIYDVKG--------------------------QVVFAKLKTLDLSSNKLAF-MGPEFQSAA 214 (317)
T ss_dssp GGGGGGTTTCCEEECTTSCCCEEEC--------------------------CCCCTTCCEEECCSSCCCE-ECGGGGGGT
T ss_pred HHHhhccCcCCEEECCCCcCccccc--------------------------ccccccCCEEECCCCcCCc-chhhhcccC
Confidence 444 245555555555555554311 1124555555555555553 233355556
Q ss_pred cceeeeecCcccccCCCcccccccccceecCCccccc-cccCcCcCCCCCCcEEecC-CCccccCCCC
Q 037197 523 KLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLF-GRIPENFGASPALEMLNLS-YNKLEGPVPS 588 (1009)
Q Consensus 523 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls-~N~l~g~ip~ 588 (1009)
+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..+..++.|+.|+++ .+.++|..|.
T Consensus 215 ~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp TCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred cccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 6666666666665 35555555666666666666665 5555555666666666666 3445555553
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=275.49 Aligned_cols=249 Identities=20% Similarity=0.179 Sum_probs=159.5
Q ss_pred CCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeeccc
Q 037197 308 LQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFN 387 (1009)
Q Consensus 308 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~ 387 (1009)
...++.+++.++.+ |..+. ++++.|+|++|.+.+..+..|..+++|+.|+|++|.++
T Consensus 45 ~~~v~c~~~~l~~i-P~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-------------------- 101 (440)
T 3zyj_A 45 FSKVICVRKNLREV-PDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-------------------- 101 (440)
T ss_dssp SCEEECCSCCCSSC-CSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCC--------------------
T ss_pred CCEEEeCCCCcCcC-CCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCC--------------------
Confidence 45566666666643 33332 45555555555555554455555555555555555554
Q ss_pred ccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEeccc-CcccccC
Q 037197 388 NSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISW-NHLESYL 466 (1009)
Q Consensus 388 N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~ 466 (1009)
+..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++ |.+..+.
T Consensus 102 ----~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~ 177 (440)
T 3zyj_A 102 ----TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYIS 177 (440)
T ss_dssp ----EECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC
T ss_pred ----ccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeC
Confidence 44444445555555555555555544444455555555555555555544444555555555555555 3344444
Q ss_pred CCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCccccccc
Q 037197 467 PSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMP 546 (1009)
Q Consensus 467 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 546 (1009)
+..|.++++|+.|++++|+++. +| .+..+++|+.|||++|++++..|..|.++++|+.|+|++|+|++..|..|..++
T Consensus 178 ~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 255 (440)
T 3zyj_A 178 EGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ 255 (440)
T ss_dssp TTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCT
T ss_pred cchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCC
Confidence 4455666666666666666653 33 366778888888888888877788888888888888888888887788888888
Q ss_pred ccceecCCccccccccCcCcCCCCCCcEEecCCCccccC
Q 037197 547 TLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGP 585 (1009)
Q Consensus 547 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ 585 (1009)
+|+.|||++|+|++..+..|..+++|+.|+|++|++...
T Consensus 256 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 256 SLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp TCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred CCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 888888888888888888888888888888888887654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=260.60 Aligned_cols=234 Identities=18% Similarity=0.189 Sum_probs=174.2
Q ss_pred CCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCc-cccccCCccCCCCcccEEEe
Q 037197 355 PLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNL-ISGTIPVGLGNLPSLQRLEM 433 (1009)
Q Consensus 355 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L 433 (1009)
.|+.|++++|.+++..+..|..+++|++|++++|.+++..|..+..+++|++|++++|. ++...|..+..+++|++|++
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 34444444444444444445555555555555555555555566666666666666665 55555666777777777777
Q ss_pred ecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCC
Q 037197 434 ANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGE 513 (1009)
Q Consensus 434 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~ 513 (1009)
++|++++..|..+..+++|++|++++|++++..+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|++++.
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 77777766666777777777777777777777667777788888888888888776667789999999999999999999
Q ss_pred CCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCCC
Q 037197 514 IPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSN 589 (1009)
Q Consensus 514 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 589 (1009)
.|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++....+.. .....++.+..+.|.+.+..|..
T Consensus 193 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGG
T ss_pred CHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchH
Confidence 9999999999999999999999877788999999999999999998755432 11234566778899999998864
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=275.88 Aligned_cols=244 Identities=23% Similarity=0.204 Sum_probs=140.4
Q ss_pred cCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeecc
Q 037197 116 LKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSG 195 (1009)
Q Consensus 116 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~ 195 (1009)
...++.+++.++ .+|..+. ++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 345555555554 3454443 4666677777766666666666666677777766666666666666666777777777
Q ss_pred ccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccC-ccccccCcccCCCCCCcEEEcccCCcCCCC
Q 037197 196 NNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVG-SLSGQIPPALGRLKKLTTVYLYKNNFTGKI 274 (1009)
Q Consensus 196 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 274 (1009)
|++++..+..|..+++|++|+|++|+++...+..|.++++|++|++++| .+....+..|..+++|++|+|++|++++.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~- 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM- 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-
Confidence 7666555555666666666666666666555556666666666666663 33333334566666666666666666632
Q ss_pred CcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCC
Q 037197 275 PPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSS 354 (1009)
Q Consensus 275 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 354 (1009)
| .+..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+..|.++++|+.|+|++|++++..+..+..++
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 2 345555555555555555555555555555555555555555555555555555555555555544433333333333
Q ss_pred CCceeeccCc
Q 037197 355 PLRRLDASSN 364 (1009)
Q Consensus 355 ~L~~L~Ls~N 364 (1009)
+|+.|+|++|
T Consensus 291 ~L~~L~L~~N 300 (452)
T 3zyi_A 291 YLVELHLHHN 300 (452)
T ss_dssp TCCEEECCSS
T ss_pred CCCEEEccCC
Confidence 3333333333
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-27 Score=281.47 Aligned_cols=268 Identities=26% Similarity=0.375 Sum_probs=144.5
Q ss_pred CCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEec
Q 037197 234 TNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNL 313 (1009)
Q Consensus 234 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 313 (1009)
.+++.|++++|.++ .+|..+. ++|++|+|++|.++ .+|. .+++|++|+|++|+|+ .+|. .+++|++|++
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 35778888888887 5566554 67788888888777 3454 4567777777777776 3443 5567777777
Q ss_pred cccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeeccccccccc
Q 037197 314 MCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGT 393 (1009)
Q Consensus 314 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~ 393 (1009)
++|+++++.+ .+++|+.|++++|++++ +|.. +++|++|++++|.+++ +|.
T Consensus 109 s~N~l~~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~--------------------- 158 (622)
T 3g06_A 109 FSNPLTHLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA--------------------- 158 (622)
T ss_dssp CSCCCCCCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---------------------
T ss_pred cCCcCCCCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---------------------
Confidence 7777765432 34556666666666553 2221 2444444444444442 121
Q ss_pred CCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCC
Q 037197 394 FPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSI 473 (1009)
Q Consensus 394 ~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 473 (1009)
.+++|+.|++++|++++ +| ..+++|+.|++++|+|++ +|.. +++|+.|++++|.++.+ |. .+
T Consensus 159 ------~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l-~~---~~ 220 (622)
T 3g06_A 159 ------LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL-PA---LP 220 (622)
T ss_dssp ------CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSC-CC---CC
T ss_pred ------ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccccc-CC---CC
Confidence 12344444555555442 33 223455555555555552 3322 24555555555555542 21 12
Q ss_pred cccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecC
Q 037197 474 PSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDM 553 (1009)
Q Consensus 474 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 553 (1009)
++|+.|++++|++++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 344444444444443 22 23345555555555555 2333 3455555555555555 45555555555555555
Q ss_pred CccccccccCcCcCCC
Q 037197 554 SNNSLFGRIPENFGAS 569 (1009)
Q Consensus 554 s~N~l~~~~p~~~~~l 569 (1009)
++|++++.+|..+..+
T Consensus 292 ~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 292 EGNPLSERTLQALREI 307 (622)
T ss_dssp CSCCCCHHHHHHHHHH
T ss_pred cCCCCCCcCHHHHHhc
Confidence 5555555555544433
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-29 Score=278.72 Aligned_cols=270 Identities=20% Similarity=0.184 Sum_probs=185.4
Q ss_pred cEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccC
Q 037197 333 EVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNN 412 (1009)
Q Consensus 333 ~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N 412 (1009)
+..+++.+.+.......+..+++|++|++++|.+++..|..|..+++|++|++++|.+++..+ +..+++|++|++++|
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 333444444433333333344455555555555555444555555566666666666654443 566666666666666
Q ss_pred ccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCccc
Q 037197 413 LISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPN 492 (1009)
Q Consensus 413 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 492 (1009)
++++.. ..++|++|++++|++++..+.. +++|+.|++++|++++..+..+..+++|+.|++++|++++..+.
T Consensus 91 ~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 162 (317)
T 3o53_A 91 YVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162 (317)
T ss_dssp EEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG
T ss_pred cccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH
Confidence 666332 2367777777777777655443 46688888888888887777888888888888888888877777
Q ss_pred cc-ccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCC
Q 037197 493 EL-QACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPA 571 (1009)
Q Consensus 493 ~~-~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 571 (1009)
.+ ..+++|+.|+|++|++++. |. ...+++|++|+|++|+|++ +|..+..+++|+.|||++|+++ .+|..+..++.
T Consensus 163 ~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~ 238 (317)
T 3o53_A 163 ELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238 (317)
T ss_dssp GGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTT
T ss_pred HHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCC
Confidence 66 4789999999999999865 33 2358999999999999995 5666999999999999999999 57888999999
Q ss_pred CcEEecCCCccc-cCCCCC-CcccccCCcccccCcCCCCCCCCCCCC
Q 037197 572 LEMLNLSYNKLE-GPVPSN-GILMNINPNELIGNAGLCGSVLPPCSQ 616 (1009)
Q Consensus 572 L~~L~ls~N~l~-g~ip~~-~~~~~~~~~~~~~n~~lcg~~~~~c~~ 616 (1009)
|+.|+|++|+++ +.+|.. ..+..+......++..+.|.....|..
T Consensus 239 L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~~~~ 285 (317)
T 3o53_A 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285 (317)
T ss_dssp CCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCCCSS
T ss_pred CCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhccCC
Confidence 999999999998 555532 112222222334455555555445543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-27 Score=272.63 Aligned_cols=245 Identities=22% Similarity=0.250 Sum_probs=106.0
Q ss_pred CcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccc
Q 037197 117 KSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGN 196 (1009)
Q Consensus 117 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n 196 (1009)
+.++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+.+..+..|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 34455554443 3444333 34555555555555444444555555555555555554444444445555555555555
Q ss_pred cccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccC-ccccccCcccCCCCCCcEEEcccCCcCCCCC
Q 037197 197 NLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVG-SLSGQIPPALGRLKKLTTVYLYKNNFTGKIP 275 (1009)
Q Consensus 197 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 275 (1009)
+++...+..|..+++|++|+|++|+++...+..|.++++|++|+|++| .+....+..|.++
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l------------------ 184 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL------------------ 184 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTC------------------
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcc------------------
Confidence 544333334444444444444444444333334444444444444442 2222222233333
Q ss_pred cccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCC
Q 037197 276 PELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSP 355 (1009)
Q Consensus 276 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 355 (1009)
++|++|+|++|+++ .+| .+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++
T Consensus 185 ------~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 256 (440)
T 3zyj_A 185 ------SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQS 256 (440)
T ss_dssp ------SSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTT
T ss_pred ------cccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCC
Confidence 34444444444333 222 1333444444444444444444444444444444444444444433333333444
Q ss_pred CceeeccCccccccCCcCccCCCCCceeecccccc
Q 037197 356 LRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSF 390 (1009)
Q Consensus 356 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l 390 (1009)
|+.|+|++|.+++..+..|..+++|+.|++++|.+
T Consensus 257 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~ 291 (440)
T 3zyj_A 257 LVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291 (440)
T ss_dssp CCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCE
T ss_pred CCEEECCCCCCCccChhHhccccCCCEEEcCCCCc
Confidence 44444444444433333333333444444444433
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-28 Score=291.01 Aligned_cols=186 Identities=17% Similarity=0.092 Sum_probs=132.6
Q ss_pred eccCCceEEEEEEECCCCeEEEEEEcccCCCC--------hhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEEEE
Q 037197 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND--------IESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 706 iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.+.|++|.+.+++....|+.||+|++.+.... ....+++.+|+++|+++ .|+||++++++++++...|+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 56777787777777667889999999654211 12234567999999999 7999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||++|++|.+++..... ++.. +|+.||+.||+|+|++ |||||||||+|||++++|++||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~~~~----l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE----IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTTCC----CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhCCC----CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999976532 4443 4899999999999999 999999999999999999999999999987755
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCC
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKM 902 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~ 902 (1009)
........+||+.|+|||++.+ .+..++|+||+|++++++.++..
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 5555566789999999999765 46778999999999888766543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=274.56 Aligned_cols=269 Identities=24% Similarity=0.322 Sum_probs=197.2
Q ss_pred cchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccc
Q 037197 210 SSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDL 289 (1009)
Q Consensus 210 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 289 (1009)
.++++|++++|.++ .+|..+. ++|++|+|++|.++ .+|. .+++|++|+|++|++++ +|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence 35899999999999 7787765 79999999999998 4555 57899999999999994 665 6799999999
Q ss_pred cccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCcccccc
Q 037197 290 SDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGE 369 (1009)
Q Consensus 290 s~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 369 (1009)
++|++++ +|. .+++|+.|++++|+++++ |.. +++|++|++++|.+++. |. ...+|+.|++++|.+++
T Consensus 109 s~N~l~~-l~~---~l~~L~~L~L~~N~l~~l-p~~---l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~- 175 (622)
T 3g06_A 109 FSNPLTH-LPA---LPSGLCKLWIFGNQLTSL-PVL---PPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS- 175 (622)
T ss_dssp CSCCCCC-CCC---CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-
T ss_pred cCCcCCC-CCC---CCCCcCEEECCCCCCCcC-CCC---CCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC-
Confidence 9999995 444 578999999999999975 443 48999999999999864 32 34678889999998884
Q ss_pred CCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCC
Q 037197 370 IPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLS 449 (1009)
Q Consensus 370 ~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 449 (1009)
+| ..+++|+.|++++|++++ +|.. .++|+.|++++|.++ .+|.. +
T Consensus 176 l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-------------------------~l~~~---~ 220 (622)
T 3g06_A 176 LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-------------------------SLPAL---P 220 (622)
T ss_dssp CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-------------------------SCCCC---C
T ss_pred Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-------------------------ccCCC---C
Confidence 44 334566777777776663 2221 244555555555554 22221 2
Q ss_pred CCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeee
Q 037197 450 TSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNL 529 (1009)
Q Consensus 450 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~L 529 (1009)
++|+.|+|++|+|+++ | ..+++|+.|++++|+|+. +|. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|
T Consensus 221 ~~L~~L~Ls~N~L~~l-p---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 221 SGLKELIVSGNRLTSL-P---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred CCCCEEEccCCccCcC-C---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 4455555555555542 2 234556666666666653 343 4577888899999888 67888888999999999
Q ss_pred cCcccccCCCccccccc
Q 037197 530 RNNRFSGEIPKAVATMP 546 (1009)
Q Consensus 530 s~N~l~~~~p~~~~~l~ 546 (1009)
++|.+++.+|..+..++
T Consensus 292 ~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 292 EGNPLSERTLQALREIT 308 (622)
T ss_dssp CSCCCCHHHHHHHHHHH
T ss_pred cCCCCCCcCHHHHHhcc
Confidence 99999988888877766
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=250.57 Aligned_cols=216 Identities=22% Similarity=0.282 Sum_probs=132.5
Q ss_pred CCceeeeEEeCCCCceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCC
Q 037197 53 LHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPT 132 (1009)
Q Consensus 53 ~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~ 132 (1009)
++|.|.|+.|+-.+.++.+++++++++. +|..+. ++|++|+|++|.+++..+..+.++++|++|+|++|.++...+.
T Consensus 3 ~~C~~~~~~C~c~~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~ 79 (270)
T 2o6q_A 3 ALCKKDGGVCSCNNNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG 79 (270)
T ss_dssp CCBGGGTCSBEEETTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTT
T ss_pred ccCCCCCCCCEeCCCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChh
Confidence 6899999999766667789999988874 454443 4567777777777665555666677777777776666644444
Q ss_pred CCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcch
Q 037197 133 GLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSL 212 (1009)
Q Consensus 133 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 212 (1009)
.+..+++|++|+|++|++++..+..+.++++|++|++++|.+++..+..|.++++|++|+|++|.+++..+..|+.+++|
T Consensus 80 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 159 (270)
T 2o6q_A 80 IFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSL 159 (270)
T ss_dssp TTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred hhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCccc
Confidence 45666666666666666665545555666666666666666665555555566666666666666654444445555555
Q ss_pred hhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcC
Q 037197 213 ETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFT 271 (1009)
Q Consensus 213 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 271 (1009)
++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 160 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 160 KELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 55555555555444444555555555555555555444444555555555555555544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=279.94 Aligned_cols=236 Identities=24% Similarity=0.270 Sum_probs=137.7
Q ss_pred ccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceee
Q 037197 305 LKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLI 384 (1009)
Q Consensus 305 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 384 (1009)
+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|+.|+|++|.+++..+ .++|+.|+
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~ 105 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLH 105 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEE
Confidence 3478888888888887777777778888888777777766554 6666666666666666653221 24455555
Q ss_pred cccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccc
Q 037197 385 LFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLES 464 (1009)
Q Consensus 385 l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 464 (1009)
+++|.+++..+.. +++ |+.|+|++|++++..|..++.+++|+.|+|++|.+++
T Consensus 106 L~~N~l~~~~~~~---l~~------------------------L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 158 (487)
T 3oja_A 106 AANNNISRVSCSR---GQG------------------------KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158 (487)
T ss_dssp CCSSCCCCEEECC---CSS------------------------CEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCE
T ss_pred CcCCcCCCCCccc---cCC------------------------CCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCC
Confidence 5555554433321 233 4444444444444444444444444444444444444
Q ss_pred cCCCccc-CCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccc
Q 037197 465 YLPSSIL-SIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVA 543 (1009)
Q Consensus 465 ~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 543 (1009)
..|..+. .+++|+.|++++|.+++.. .+..+++|+.|||++|+|++.+ ..+..+++|+.|+|++|+|++ +|..+.
T Consensus 159 ~~~~~l~~~l~~L~~L~Ls~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~N~l~~-lp~~l~ 234 (487)
T 3oja_A 159 VNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLVL-IEKALR 234 (487)
T ss_dssp EEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCCE-ECTTCC
T ss_pred cChHHHhhhCCcccEEecCCCcccccc--ccccCCCCCEEECCCCCCCCCC-HhHcCCCCccEEEecCCcCcc-cchhhc
Confidence 4443333 3444444444444444331 1223566677777777776433 336667777777777777763 566667
Q ss_pred cccccceecCCccccc-cccCcCcCCCCCCcEEecC
Q 037197 544 TMPTLAILDMSNNSLF-GRIPENFGASPALEMLNLS 578 (1009)
Q Consensus 544 ~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls 578 (1009)
.+++|+.|++++|++. +.+|..+..++.|+.++++
T Consensus 235 ~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred cCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 7777777777777776 5666666666666666664
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-29 Score=306.96 Aligned_cols=390 Identities=17% Similarity=0.179 Sum_probs=178.2
Q ss_pred cccceeeeccccccccCCccCC-CCcchhhhhcccc-ccccc-CCccccCCCCccEEEeccCccccccCccc----CCCC
Q 037197 186 QKLKFLGLSGNNLTGKIPPELG-QLSSLETIILGYN-AFEGE-IPAEFGNLTNLRYLDLAVGSLSGQIPPAL----GRLK 258 (1009)
Q Consensus 186 ~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~l----~~l~ 258 (1009)
++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+ ..++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 3444444444444333333332 3344444444444 22221 12222344445555555444443322222 2344
Q ss_pred CCcEEEcccCC--cCCC-CCccccccccccccccccc-ccCCCcchhhhcccCCCeEeccc-------cccCCCCCcCCC
Q 037197 259 KLTTVYLYKNN--FTGK-IPPELGSITSLAFLDLSDN-QISGEIPVKLAELKNLQLLNLMC-------NQLTGLIPDKLG 327 (1009)
Q Consensus 259 ~L~~L~L~~n~--l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~~-------N~l~~~~~~~l~ 327 (1009)
+|++|++++|. ++.. ++..+..+++|++|+|++| .+.+ ++..+..+++|++|+++. |.+.+. +..+.
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l-~~~l~ 262 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGL-SVALS 262 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHH-HHHHH
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHH-HHHHh
Confidence 55555555554 1100 0011122355555555555 2332 444555555555555332 222322 22345
Q ss_pred CCCcccEE-EccCCccCccCCccccCCCCCceeeccCccccccCCc-CccCCCCCceeeccccccccc-CCcccccCccc
Q 037197 328 ELTKLEVL-ELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPT-GLCDSGNLTKLILFNNSFSGT-FPVSLSTCKSL 404 (1009)
Q Consensus 328 ~l~~L~~L-~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~l~~N~l~~~-~p~~l~~~~~L 404 (1009)
++++|+.| .+.+.. .+.++..+..+++|+.|++++|.+++.... .+..+++|+.|++++| ++.. ++.....+++|
T Consensus 263 ~~~~L~~Ls~~~~~~-~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L 340 (594)
T 2p1m_B 263 GCKELRCLSGFWDAV-PAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDL 340 (594)
T ss_dssp TCTTCCEEECCBTCC-GGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTC
T ss_pred cCCCcccccCCcccc-hhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCC
Confidence 55555555 222221 122333333455566666666655432221 2334566666666665 3221 22222346666
Q ss_pred cEEEcc---------cCccccccCCccC-CCCcccEEEeecccccccCCcCCc-CCCCCcEEecc--c----CcccccC-
Q 037197 405 VRVRVQ---------NNLISGTIPVGLG-NLPSLQRLEMANNNLTGQIPDDIS-LSTSLSFVDIS--W----NHLESYL- 466 (1009)
Q Consensus 405 ~~L~L~---------~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~~- 466 (1009)
++|++. .+.+++.....+. .+++|+.|.++.|++++..+..+. .+++|+.|+++ + |++++..
T Consensus 341 ~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~ 420 (594)
T 2p1m_B 341 RELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPL 420 (594)
T ss_dssp CEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCT
T ss_pred CEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCch
Confidence 666662 3444433222222 356677776666666654444443 35667777776 3 4444211
Q ss_pred ----CCcccCCcccchhccccCcccCCccccccc-CCcCcEEEeecCCCCCCCCccc-cccccceeeeecCcccccCCCc
Q 037197 467 ----PSSILSIPSLQTFMASHNNLQAKIPNELQA-CPSLSVLDLSSNSLSGEIPASI-ASCEKLVSLNLRNNRFSGEIPK 540 (1009)
Q Consensus 467 ----~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~LdLs~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~ 540 (1009)
+..+..+++|+.|++++ ++++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+.
T Consensus 421 ~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~ 499 (594)
T 2p1m_B 421 DIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALL 499 (594)
T ss_dssp HHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHH
T ss_pred hhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHH
Confidence 11133455566666654 444433333433 5666666666666654444333 4456666666666666443333
Q ss_pred -ccccccccceecCCccccccccCcCc-CCCCCCcEEecCCC
Q 037197 541 -AVATMPTLAILDMSNNSLFGRIPENF-GASPALEMLNLSYN 580 (1009)
Q Consensus 541 -~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N 580 (1009)
.+..+++|+.|++++|+++......+ ..++.|+...+..+
T Consensus 500 ~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~ 541 (594)
T 2p1m_B 500 ANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDER 541 (594)
T ss_dssp HTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSS
T ss_pred HHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCC
Confidence 23345666666666666643333333 33455544444443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-27 Score=276.89 Aligned_cols=239 Identities=22% Similarity=0.225 Sum_probs=193.5
Q ss_pred cccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCcee
Q 037197 280 SITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRL 359 (1009)
Q Consensus 280 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L 359 (1009)
.+++|+.|+|++|.+++..|..|..+++|++|+|++|.+++.+| +..+++|++|+|++|.+++..+ .++|+.|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 44589999999999999888999999999999999999998765 8999999999999999986543 3789999
Q ss_pred eccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccC-CCCcccEEEeecccc
Q 037197 360 DASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLG-NLPSLQRLEMANNNL 438 (1009)
Q Consensus 360 ~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l 438 (1009)
++++|.+++..+.. +++|+.|++++|.+++..|..+.++++|+.|+|++|.+++.+|..+. .+++|+.|+|++|.|
T Consensus 105 ~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 99999999776654 57899999999999988888888888888888888888877777765 677788888887777
Q ss_pred cccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccc
Q 037197 439 TGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASI 518 (1009)
Q Consensus 439 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~ 518 (1009)
++..+ ...+++|+.|+|++|+|++ . |..+..+++|+.|||++|.|++ +|..+
T Consensus 182 ~~~~~--~~~l~~L~~L~Ls~N~l~~------------------------~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l 233 (487)
T 3oja_A 182 YDVKG--QVVFAKLKTLDLSSNKLAF------------------------M-GPEFQSAAGVTWISLRNNKLVL-IEKAL 233 (487)
T ss_dssp CEEEC--CCCCTTCCEEECCSSCCCE------------------------E-CGGGGGGTTCSEEECTTSCCCE-ECTTC
T ss_pred ccccc--cccCCCCCEEECCCCCCCC------------------------C-CHhHcCCCCccEEEecCCcCcc-cchhh
Confidence 75422 2234555555555555544 2 2336677788888888888884 67778
Q ss_pred cccccceeeeecCcccc-cCCCcccccccccceecCCcc
Q 037197 519 ASCEKLVSLNLRNNRFS-GEIPKAVATMPTLAILDMSNN 556 (1009)
Q Consensus 519 ~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N 556 (1009)
..+++|+.|+|++|.+. +.+|..+..++.|+.|+++.+
T Consensus 234 ~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~~ 272 (487)
T 3oja_A 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272 (487)
T ss_dssp CCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHHH
T ss_pred ccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecccc
Confidence 88888899999999887 778888899999999988743
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=242.99 Aligned_cols=227 Identities=20% Similarity=0.139 Sum_probs=189.2
Q ss_pred eeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccc
Q 037197 359 LDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNL 438 (1009)
Q Consensus 359 L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 438 (1009)
++.++..+. .+|..+. ++|++|++++|++++..+..+.++++|++|++++|++++..+..|.++++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 444445554 4555443 4678888888888877777788888888888888888877777888888888888888888
Q ss_pred cccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCC-cccccccCCcCcEEEeecCCCCCCCCcc
Q 037197 439 TGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAK-IPNELQACPSLSVLDLSSNSLSGEIPAS 517 (1009)
Q Consensus 439 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~LdLs~N~l~~~~p~~ 517 (1009)
++..+..+..+++|+.|++++|++++..+..+..+++|++|++++|++++. +|..+..+++|+.|+|++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 168 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHH
Confidence 877778888888899999999988888777888899999999999998874 5889999999999999999999888888
Q ss_pred ccccccce----eeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCCC
Q 037197 518 IASCEKLV----SLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSN 589 (1009)
Q Consensus 518 ~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 589 (1009)
+..+.+|+ .|+|++|++++..+..+. ..+|+.|+|++|++++..+..|..+++|+.|+|++|++++..|.-
T Consensus 169 ~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp GHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred hhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 98888888 899999999965555554 458999999999999888888899999999999999999988753
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-29 Score=303.26 Aligned_cols=432 Identities=16% Similarity=0.147 Sum_probs=248.5
Q ss_pred ccccccCccCcccccccccCCC---CCCCC------------CCCcCCeEEecCCCCCCCCCCcccc-CCCCCCeeeccC
Q 037197 108 KSLANLTALKSMDVSQNNFIGS---FPTGL------------GKASGLTSVNASSNNFSGFLPEDLG-NATSLESLDFRG 171 (1009)
Q Consensus 108 ~~l~~l~~L~~L~Ls~n~l~~~---~p~~l------------~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~L~~ 171 (1009)
..+..+++|++|+|++|..... .|..+ ..+++|++|+|++|.+++..+..+. .+++|++|+|++
T Consensus 60 ~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~ 139 (594)
T 2p1m_B 60 TVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSS 139 (594)
T ss_dssp HHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEES
T ss_pred HHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCC
Confidence 3467889999999999764321 22221 2456778888887777766666665 577778888777
Q ss_pred C-ccCCc-CCccccCccccceeeeccccccccCCccCC----CCcchhhhhccccc--cccc-CCccccCCCCccEEEec
Q 037197 172 S-FFEGS-VPTSFRNLQKLKFLGLSGNNLTGKIPPELG----QLSSLETIILGYNA--FEGE-IPAEFGNLTNLRYLDLA 242 (1009)
Q Consensus 172 n-~~~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~----~l~~L~~L~L~~n~--l~~~-~~~~~~~l~~L~~L~L~ 242 (1009)
| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++|++|++++|. ++.. ++..+.++++|++|+++
T Consensus 140 ~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~ 219 (594)
T 2p1m_B 140 CEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLN 219 (594)
T ss_dssp CEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECC
T ss_pred cCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecC
Confidence 7 44432 333344677777777777776654443332 45577777777765 2211 11122345677777777
Q ss_pred cCccccccCcccCCCCCCcEEEcccCC-------cCCCCCcccccccccccc-cccccccCCCcchhhhcccCCCeEecc
Q 037197 243 VGSLSGQIPPALGRLKKLTTVYLYKNN-------FTGKIPPELGSITSLAFL-DLSDNQISGEIPVKLAELKNLQLLNLM 314 (1009)
Q Consensus 243 ~n~l~~~~~~~l~~l~~L~~L~L~~n~-------l~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 314 (1009)
+|.-.+.++..+..+++|++|+++.+. +.+ ++..+.++++|+.| .+.+... +.++..+..+++|++|+++
T Consensus 220 ~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~ 297 (594)
T 2p1m_B 220 RAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLS 297 (594)
T ss_dssp TTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECT
T ss_pred CCCcHHHHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEcc
Confidence 663222355566666777777654432 221 22234445555555 2322221 1233333445555555555
Q ss_pred ccccCCCCC-cCCCCCCcccEEEccCCccCcc-CCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccc
Q 037197 315 CNQLTGLIP-DKLGELTKLEVLELWKNSLIGS-LPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSG 392 (1009)
Q Consensus 315 ~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~ 392 (1009)
+|.+++... ..+..+++|+.|++++| +.+. ++.....+++|+.|+++++.-.| ....+.+++
T Consensus 298 ~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g---------------~~~~~~l~~ 361 (594)
T 2p1m_B 298 YATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFV---------------MEPNVALTE 361 (594)
T ss_dssp TCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTC---------------SSCSSCCCH
T ss_pred CCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccc---------------cccCCCCCH
Confidence 555442211 11334455555555544 2211 11111123344444442211000 002234443
Q ss_pred cCCcccc-cCccccEEEcccCccccccCCccC-CCCcccEEEee--c----cccccc-----CCcCCcCCCCCcEEeccc
Q 037197 393 TFPVSLS-TCKSLVRVRVQNNLISGTIPVGLG-NLPSLQRLEMA--N----NNLTGQ-----IPDDISLSTSLSFVDISW 459 (1009)
Q Consensus 393 ~~p~~l~-~~~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~--~----N~l~~~-----~p~~~~~l~~L~~L~Ls~ 459 (1009)
.....+. ++++|+.|.+..|.+++..+..+. .+++|+.|+++ + |++++. ++..+..+++|+.|+|++
T Consensus 362 ~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~ 441 (594)
T 2p1m_B 362 QGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG 441 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS
T ss_pred HHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC
Confidence 2222232 467788887777777765555554 47788888888 3 455421 112255677888888877
Q ss_pred CcccccCCCcccC-CcccchhccccCcccCCccccc-ccCCcCcEEEeecCCCCCCCCc-cccccccceeeeecCccccc
Q 037197 460 NHLESYLPSSILS-IPSLQTFMASHNNLQAKIPNEL-QACPSLSVLDLSSNSLSGEIPA-SIASCEKLVSLNLRNNRFSG 536 (1009)
Q Consensus 460 N~l~~~~~~~~~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~LdLs~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~ 536 (1009)
.+++..+..+.. +++|+.|++++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.|+|++|+++.
T Consensus 442 -~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 442 -LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp -SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred -cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 666554444544 7888999999998876555555 6789999999999999755444 34568999999999999975
Q ss_pred CCCccc-ccccccceecCCcccc
Q 037197 537 EIPKAV-ATMPTLAILDMSNNSL 558 (1009)
Q Consensus 537 ~~p~~~-~~l~~L~~L~Ls~N~l 558 (1009)
.....+ ..++.|+...+..+.-
T Consensus 521 ~~~~~l~~~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 521 GACKLLGQKMPKLNVEVIDERGA 543 (594)
T ss_dssp HHHHHHHHHCTTEEEEEECSSSC
T ss_pred HHHHHHHHhCCCCEEEEecCCCc
Confidence 544555 5678887777766643
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-24 Score=233.73 Aligned_cols=203 Identities=24% Similarity=0.252 Sum_probs=99.1
Q ss_pred CCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEecc
Q 037197 164 LESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAV 243 (1009)
Q Consensus 164 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 243 (1009)
|++|++++|.+++..+..|.++++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..|+++++|++|++++
T Consensus 30 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 109 (276)
T 2z62_A 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109 (276)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCC
Confidence 34444444444333333344444444444444444433333444444444444444444444444444555555555555
Q ss_pred CccccccCcccCCCCCCcEEEcccCCcCCC-CCcccccccccccccccccccCCCcchhhhcccCCC----eEecccccc
Q 037197 244 GSLSGQIPPALGRLKKLTTVYLYKNNFTGK-IPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQ----LLNLMCNQL 318 (1009)
Q Consensus 244 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~----~L~L~~N~l 318 (1009)
|.+++..+..++.+++|++|++++|.+++. +|..+..+++|++|+|++|++++..+..+..+.+|+ .|++++|++
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l 189 (276)
T 2z62_A 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189 (276)
T ss_dssp SCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCC
T ss_pred CCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcc
Confidence 555444444455555555555555555442 355555555555555555555544444555555554 556666666
Q ss_pred CCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCcccc
Q 037197 319 TGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLS 367 (1009)
Q Consensus 319 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~ 367 (1009)
++..+..+.. .+|+.|++++|.+++..+..+..+++|+.|++++|.+.
T Consensus 190 ~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 190 NFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp CEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred cccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 5554444332 25555555555555444444444555555555555444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-24 Score=230.07 Aligned_cols=185 Identities=20% Similarity=0.199 Sum_probs=136.5
Q ss_pred cccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccc
Q 037197 403 SLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMAS 482 (1009)
Q Consensus 403 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 482 (1009)
++++|++++|++++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|+++++.+..|..+++|+.|+++
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 45555555555554444556666666666666666664444445666666666666666666666666677777777777
Q ss_pred cCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCcccccccc
Q 037197 483 HNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRI 562 (1009)
Q Consensus 483 ~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 562 (1009)
+|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence 77777666677788888888888888888777777888888888888888888776777888889999999999998877
Q ss_pred CcCcCCCCCCcEEecCCCccccCCC
Q 037197 563 PENFGASPALEMLNLSYNKLEGPVP 587 (1009)
Q Consensus 563 p~~~~~l~~L~~L~ls~N~l~g~ip 587 (1009)
+..|..++.|+.|+|++|++.+..+
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 198 EGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred HHHhccccCCCEEEecCCCeeCCCc
Confidence 7788888999999999988876543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=233.90 Aligned_cols=207 Identities=19% Similarity=0.257 Sum_probs=102.8
Q ss_pred cccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCC
Q 037197 86 IRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLE 165 (1009)
Q Consensus 86 l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~ 165 (1009)
+..+++|++|++++|.++. .+.+..+++|++|+|++|.+.+. ..++.+++|++|+|++|++++..+..++++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 4455555555555555532 12355555555555555555431 2455555555555555555544444455555555
Q ss_pred eeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCc
Q 037197 166 SLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGS 245 (1009)
Q Consensus 166 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 245 (1009)
+|++++|.+++..+..|+++++|++|+|++|++++..+..++.+++|++|++++|++++..+..|+++++|++|++++|+
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 55555555554444445555555555555555554444444455555555555555554444444455555555555555
Q ss_pred cccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhh
Q 037197 246 LSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLA 303 (1009)
Q Consensus 246 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 303 (1009)
+++..+..++.+++|+.|+|++|.+.+. +++|+.|+++.|.++|.+|.+++
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~ 243 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAG 243 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTS
T ss_pred CCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccc
Confidence 5544444444455555555555544422 22344444444444444444443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.8e-25 Score=235.86 Aligned_cols=180 Identities=20% Similarity=0.186 Sum_probs=99.2
Q ss_pred cCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchh
Q 037197 400 TCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTF 479 (1009)
Q Consensus 400 ~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 479 (1009)
.+++|++|++++|.+++. ..+..+++|++|+|++|++++..+..+..+++|+.|++++|++++..+..|..+++|+.|
T Consensus 61 ~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 138 (272)
T 3rfs_A 61 YLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL 138 (272)
T ss_dssp GCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEE
Confidence 333444444444444321 134444444444444444444444444444555555555555554444445555555555
Q ss_pred ccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccc
Q 037197 480 MASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLF 559 (1009)
Q Consensus 480 ~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 559 (1009)
++++|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|++.
T Consensus 139 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (272)
T 3rfs_A 139 NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 218 (272)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcc
Confidence 55555555444445556666666666666666555555666666666666666666655555666666666666666665
Q ss_pred cccCcCcCCCCCCcEEecCCCccccCCCC
Q 037197 560 GRIPENFGASPALEMLNLSYNKLEGPVPS 588 (1009)
Q Consensus 560 ~~~p~~~~~l~~L~~L~ls~N~l~g~ip~ 588 (1009)
+.. +.|+.|+++.|+++|.||.
T Consensus 219 ~~~-------~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 219 CTC-------PGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp CCT-------TTTHHHHHHHHHTGGGBBC
T ss_pred ccC-------cHHHHHHHHHHhCCCcccC
Confidence 443 3466666666777776665
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-26 Score=258.43 Aligned_cols=266 Identities=19% Similarity=0.242 Sum_probs=174.7
Q ss_pred CCceeeeEEeCCCCceeEEeccccccccccccccccC--CCCCeEecccCcccccCCccccccCccCcccccccccCCC-
Q 037197 53 LHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGL--RSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGS- 129 (1009)
Q Consensus 53 ~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l--~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~- 129 (1009)
.|.+|.++.|+ ...++.+|++++.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+.+.
T Consensus 35 vc~~W~~~~~~-~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~ 109 (336)
T 2ast_B 35 VCKRWYRLASD-ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST 109 (336)
T ss_dssp SCHHHHHHHTC-STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred HHHHHHHHhcC-chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence 46689999986 345788899888776 3455666 7788888888887766554 55677788888887777655
Q ss_pred CCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCC-ccCCc-CCccccCccccceeeeccc-ccccc-CCcc
Q 037197 130 FPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGS-FFEGS-VPTSFRNLQKLKFLGLSGN-NLTGK-IPPE 205 (1009)
Q Consensus 130 ~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n-~~~~~-~p~~~~~l~~L~~L~L~~n-~l~~~-~p~~ 205 (1009)
+|..+..+++|++|+|++|.+++..|..++.+++|++|++++| .+++. ++..+.++++|++|++++| .+++. ++..
T Consensus 110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~ 189 (336)
T 2ast_B 110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 189 (336)
T ss_dssp HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHH
T ss_pred HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHH
Confidence 6666777777777777777777667777777777777777777 56542 4555667777777777777 77643 4555
Q ss_pred CCCCc-chhhhhcccc--ccc-ccCCccccCCCCccEEEeccCc-cccccCcccCCCCCCcEEEcccCC-cCCCCCcccc
Q 037197 206 LGQLS-SLETIILGYN--AFE-GEIPAEFGNLTNLRYLDLAVGS-LSGQIPPALGRLKKLTTVYLYKNN-FTGKIPPELG 279 (1009)
Q Consensus 206 l~~l~-~L~~L~L~~n--~l~-~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~ 279 (1009)
+..++ +|++|+|++| .++ +.++..+.++++|++|++++|. +++..+..++++++|++|++++|. ++......+.
T Consensus 190 ~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~ 269 (336)
T 2ast_B 190 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 269 (336)
T ss_dssp HHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGG
T ss_pred HHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHh
Confidence 66666 7777777777 344 3455566667777777777776 555566666666777777777664 2222222455
Q ss_pred cccccccccccccccCCCcchhhhcc-cCCCeEeccccccCCCCCcCCC
Q 037197 280 SITSLAFLDLSDNQISGEIPVKLAEL-KNLQLLNLMCNQLTGLIPDKLG 327 (1009)
Q Consensus 280 ~l~~L~~L~Ls~N~l~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~l~ 327 (1009)
.+++|+.|++++| ++.. .+..+ .+|+.|++++|++++..|..++
T Consensus 270 ~~~~L~~L~l~~~-i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 270 EIPTLKTLQVFGI-VPDG---TLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp GCTTCCEEECTTS-SCTT---CHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred cCCCCCEEeccCc-cCHH---HHHHHHhhCcceEEecccCccccCCccc
Confidence 6666666666666 3321 22333 2355555666666666555544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=227.35 Aligned_cols=203 Identities=24% Similarity=0.270 Sum_probs=110.6
Q ss_pred cCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccE
Q 037197 351 GQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQR 430 (1009)
Q Consensus 351 ~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 430 (1009)
..+++++.+++++|.++ .+|..+. ++++.|++++|.+++..+..+..+++|+.|++++|.+++..+. +.+++|++
T Consensus 7 ~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~ 81 (290)
T 1p9a_G 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGT 81 (290)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCE
T ss_pred cccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCE
Confidence 34445555555555555 3343332 3555666666666555555555556666666666655533221 45555555
Q ss_pred EEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCC
Q 037197 431 LEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSL 510 (1009)
Q Consensus 431 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l 510 (1009)
|+|++|+|+ .+|..+..+++|+.|++++|+|+++ .|..|..+++|+.|+|++|+|
T Consensus 82 L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l------------------------~~~~~~~l~~L~~L~L~~N~l 136 (290)
T 1p9a_G 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSL------------------------PLGALRGLGELQELYLKGNEL 136 (290)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCC------------------------CSSTTTTCTTCCEEECTTSCC
T ss_pred EECCCCcCC-cCchhhccCCCCCEEECCCCcCccc------------------------CHHHHcCCCCCCEEECCCCCC
Confidence 555555555 4444444455555555555555444 344455555555555555555
Q ss_pred CCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCcccc
Q 037197 511 SGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEG 584 (1009)
Q Consensus 511 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 584 (1009)
++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+...+.|+.|+|++|++..
T Consensus 137 ~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 5555555555556666666666665444444555666666666666665 455555555666666666666654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=227.41 Aligned_cols=205 Identities=25% Similarity=0.266 Sum_probs=161.4
Q ss_pred cccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccc
Q 037197 398 LSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQ 477 (1009)
Q Consensus 398 l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 477 (1009)
+.++++++++++++|.++ .+|..+. ++++.|+|++|++++..|..+..+++|+.|+|++|+|+++.+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 345556666666666666 4444443 4667777777777766666677777777777777777765443 5677888
Q ss_pred hhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccc
Q 037197 478 TFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNS 557 (1009)
Q Consensus 478 ~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 557 (1009)
.|++++|+++ .+|..+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 8888888887 567788899999999999999998888999999999999999999998878889999999999999999
Q ss_pred cccccCcCcCCCCCCcEEecCCCccccCCCCC-CcccccCCcccccCcCCCCC
Q 037197 558 LFGRIPENFGASPALEMLNLSYNKLEGPVPSN-GILMNINPNELIGNAGLCGS 609 (1009)
Q Consensus 558 l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~lcg~ 609 (1009)
|++..+..|..+++|+.|+|++|+|+. +|.+ .....+....+.+||+.|.+
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~~-ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCCc-cChhhcccccCCeEEeCCCCccCcC
Confidence 998888888999999999999999994 5543 33344555567899999974
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-25 Score=254.47 Aligned_cols=255 Identities=18% Similarity=0.201 Sum_probs=125.6
Q ss_pred EecccCcccccCCccccccCccCcccccccccCCCCC----CCCCCCc-CCeEEecCCCCCCCCCCccccCC-----CCC
Q 037197 95 LNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFP----TGLGKAS-GLTSVNASSNNFSGFLPEDLGNA-----TSL 164 (1009)
Q Consensus 95 L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p----~~l~~l~-~L~~L~Ls~n~l~~~~p~~l~~l-----~~L 164 (1009)
++|+.|.+++.+|..+...++|++|||++|.+++..+ ..+..++ +|++|+|++|++++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4566677766666666666667777777776665544 4455555 56666666666665555555543 566
Q ss_pred CeeeccCCccCCcCCccccC----c-cccceeeeccccccccCCccCC----C-CcchhhhhcccccccccCCccccCCC
Q 037197 165 ESLDFRGSFFEGSVPTSFRN----L-QKLKFLGLSGNNLTGKIPPELG----Q-LSSLETIILGYNAFEGEIPAEFGNLT 234 (1009)
Q Consensus 165 ~~L~L~~n~~~~~~p~~~~~----l-~~L~~L~L~~n~l~~~~p~~l~----~-l~~L~~L~L~~n~l~~~~~~~~~~l~ 234 (1009)
++|+|++|.+++..+..+.. + ++|++|+|++|.+++..+..++ . .++|++|+|++|++++..+..
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~----- 157 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDE----- 157 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHH-----
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHH-----
Confidence 66666666665544443322 2 5566666666655544333222 1 134444444444444322221
Q ss_pred CccEEEeccCccccccCcccCCCC-CCcEEEcccCCcCCCCCcccccc-----cccccccccccccCCC----cchhhhc
Q 037197 235 NLRYLDLAVGSLSGQIPPALGRLK-KLTTVYLYKNNFTGKIPPELGSI-----TSLAFLDLSDNQISGE----IPVKLAE 304 (1009)
Q Consensus 235 ~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~----~~~~l~~ 304 (1009)
++..+..++ +|++|+|++|++++..+..+... ++|++|+|++|.|++. ++..+..
T Consensus 158 ---------------l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~ 222 (362)
T 3goz_A 158 ---------------LIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS 222 (362)
T ss_dssp ---------------HHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred ---------------HHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence 112222232 45555555555544433322222 3555555555555432 2223333
Q ss_pred -ccCCCeEeccccccCCCCC----cCCCCCCcccEEEccCCccCccC-------CccccCCCCCceeeccCcccccc
Q 037197 305 -LKNLQLLNLMCNQLTGLIP----DKLGELTKLEVLELWKNSLIGSL-------PMRLGQSSPLRRLDASSNLLSGE 369 (1009)
Q Consensus 305 -l~~L~~L~L~~N~l~~~~~----~~l~~l~~L~~L~L~~N~l~~~~-------~~~~~~~~~L~~L~Ls~N~l~~~ 369 (1009)
.++|++|+|++|++++..+ ..+..+++|+.|++++|.+.+.. +..+..++.|+.||+++|.+.+.
T Consensus 223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 2355555555555554332 22344555555555555533221 22334444455555555555433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=256.58 Aligned_cols=186 Identities=17% Similarity=0.212 Sum_probs=144.3
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChh------hHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIE------SGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
...+.||+|+||.||+|... ++.+++|+......... ..+++.+|++++++++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44678999999999999544 57788887644322111 13446799999999999999966666667777899
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++++|.++++. +..++.|+++||+|||++ +|+||||||+||+++. .+||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999965 346899999999999999 9999999999999998 9999999999987
Q ss_pred ccCCCc-------eeeecccCcccCCcccCC--CCCCcccchHhHHHHHHHHHhCCCCCC
Q 037197 855 LHKNET-------VSMVAGSYGYIAPEYGYT--LKVDEKSDIYSFGVVLLELLTGKMPLD 905 (1009)
Q Consensus 855 ~~~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvvl~elltg~~Pf~ 905 (1009)
...... .....||+.|+|||++.. ..|+.++|+|+..+-..+-+.++.+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 443221 235679999999999876 567888999999998888888776663
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.1e-24 Score=233.03 Aligned_cols=223 Identities=19% Similarity=0.218 Sum_probs=146.3
Q ss_pred CCCeEecccCcccccCCc---cccccCccCcccccccccCCCCCCCC--CCCcCCeEEecCCCCCCCCCC----ccccCC
Q 037197 91 SLSSLNICCNEFASSLPK---SLANLTALKSMDVSQNNFIGSFPTGL--GKASGLTSVNASSNNFSGFLP----EDLGNA 161 (1009)
Q Consensus 91 ~L~~L~L~~n~~~~~~~~---~l~~l~~L~~L~Ls~n~l~~~~p~~l--~~l~~L~~L~Ls~n~l~~~~p----~~l~~l 161 (1009)
.++.|.+..+.++..... .+..+++|++|+|++|.+.+.+|..+ +.+++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 467777777766542111 22345668888888888888888777 778888888888888876555 334567
Q ss_pred CCCCeeeccCCccCCcCCccccCccccceeeecccccccc--C--CccCCCCcchhhhhcccccccccCCc----cccCC
Q 037197 162 TSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGK--I--PPELGQLSSLETIILGYNAFEGEIPA----EFGNL 233 (1009)
Q Consensus 162 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~--~--p~~l~~l~~L~~L~L~~n~l~~~~~~----~~~~l 233 (1009)
++|++|+|++|.+.+..|..|+++++|++|+|++|++.+. + +..++.+++|++|+|++|+++. ++. .++++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 7888888888888777777778888888888888876542 2 2234677777777777777762 222 24666
Q ss_pred CCccEEEeccCccccccCcccCCC---CCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCe
Q 037197 234 TNLRYLDLAVGSLSGQIPPALGRL---KKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQL 310 (1009)
Q Consensus 234 ~~L~~L~L~~n~l~~~~~~~l~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 310 (1009)
++|++|+|++|++++..|..+..+ ++|++|+|++|+++ .+|..+. ++|++|+|++|+|++. |. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 777777777777776666666555 46666666666666 4455443 5566666666666532 22 344555555
Q ss_pred EeccccccC
Q 037197 311 LNLMCNQLT 319 (1009)
Q Consensus 311 L~L~~N~l~ 319 (1009)
|++++|+++
T Consensus 299 L~L~~N~l~ 307 (310)
T 4glp_A 299 LTLDGNPFL 307 (310)
T ss_dssp EECSSTTTS
T ss_pred EECcCCCCC
Confidence 555555554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.6e-24 Score=234.72 Aligned_cols=200 Identities=24% Similarity=0.276 Sum_probs=148.1
Q ss_pred CCceeecccccccccCCccc--ccCccccEEEcccCccccccC----CccCCCCcccEEEeecccccccCCcCCcCCCCC
Q 037197 379 NLTKLILFNNSFSGTFPVSL--STCKSLVRVRVQNNLISGTIP----VGLGNLPSLQRLEMANNNLTGQIPDDISLSTSL 452 (1009)
Q Consensus 379 ~L~~L~l~~N~l~~~~p~~l--~~~~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 452 (1009)
+|++|++++|.+++..|..+ ..+++|++|++++|++++..+ ..+..+++|++|+|++|++++..|..+..+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 45555555555555555555 555566666666666654333 234467777777777777777677777777778
Q ss_pred cEEecccCcccc---cC-CCcccCCcccchhccccCcccCCccc----ccccCCcCcEEEeecCCCCCCCCcccccc---
Q 037197 453 SFVDISWNHLES---YL-PSSILSIPSLQTFMASHNNLQAKIPN----ELQACPSLSVLDLSSNSLSGEIPASIASC--- 521 (1009)
Q Consensus 453 ~~L~Ls~N~l~~---~~-~~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~LdLs~N~l~~~~p~~~~~l--- 521 (1009)
++|+|++|++.+ .. +..+..+++|++|++++|+++. ++. .+..+++|+.|||++|++++..|..+..+
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 888888877654 22 2334678888888888888863 233 35788999999999999998888888776
Q ss_pred ccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCcccc
Q 037197 522 EKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEG 584 (1009)
Q Consensus 522 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 584 (1009)
++|++|+|++|+|+ .+|..+. ++|+.|||++|+|++. |. +..++.|+.|+|++|+++.
T Consensus 251 ~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 251 SALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp TTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 69999999999999 7788775 7999999999999975 33 6778999999999999975
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=222.71 Aligned_cols=192 Identities=24% Similarity=0.295 Sum_probs=128.4
Q ss_pred CCceeeeEEeCCCCceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCC
Q 037197 53 LHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPT 132 (1009)
Q Consensus 53 ~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~ 132 (1009)
.||.|.|++|.. ..+.+++++++++. +|..+ . ++|++|+|++|.+.+..+.
T Consensus 3 ~Cp~~~gC~C~~--~~~~l~~~~~~l~~-~p~~~------------------------~--~~l~~L~L~~n~l~~~~~~ 53 (251)
T 3m19_A 3 TCETVTGCTCNE--GKKEVDCQGKSLDS-VPSGI------------------------P--ADTEKLDLQSTGLATLSDA 53 (251)
T ss_dssp -CHHHHSSEEEG--GGTEEECTTCCCSS-CCSCC------------------------C--TTCCEEECTTSCCCCCCTT
T ss_pred cCCCCCceEcCC--CCeEEecCCCCccc-cCCCC------------------------C--CCCCEEEccCCCcCccCHh
Confidence 488999999953 23457777777763 33222 2 3455555555555555555
Q ss_pred CCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcch
Q 037197 133 GLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSL 212 (1009)
Q Consensus 133 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 212 (1009)
.++++++|++|+|++|++++..|..+.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|
T Consensus 54 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 133 (251)
T 3m19_A 54 TFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKL 133 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred HhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcc
Confidence 55555666666666666665555556666666666666666665555666667777777777777765555556677777
Q ss_pred hhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCC
Q 037197 213 ETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGK 273 (1009)
Q Consensus 213 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 273 (1009)
++|+|++|++++..+..|+++++|++|+|++|++++..+..|..+++|+.|+|++|.+++.
T Consensus 134 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 134 KELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 7777777777766666777778888888888888877777788888888888888888754
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.3e-25 Score=248.59 Aligned_cols=259 Identities=20% Similarity=0.225 Sum_probs=181.5
Q ss_pred EEeccccccccccccccccCCCCCeEecccCcccccCC----ccccccC-ccCcccccccccCCCCCCCCCCC-----cC
Q 037197 70 KLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLP----KSLANLT-ALKSMDVSQNNFIGSFPTGLGKA-----SG 139 (1009)
Q Consensus 70 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~----~~l~~l~-~L~~L~Ls~n~l~~~~p~~l~~l-----~~ 139 (1009)
..+|+.++++|.++..+...++|++|+|++|.+++..+ ..+.+++ +|++|+|++|.+++..+..++.+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35789999999998888888889999999999988877 7888899 99999999999998878777765 99
Q ss_pred CeEEecCCCCCCCCCCccccC----C-CCCCeeeccCCccCCcCCcccc----C-ccccceeeeccccccccCCcc----
Q 037197 140 LTSVNASSNNFSGFLPEDLGN----A-TSLESLDFRGSFFEGSVPTSFR----N-LQKLKFLGLSGNNLTGKIPPE---- 205 (1009)
Q Consensus 140 L~~L~Ls~n~l~~~~p~~l~~----l-~~L~~L~L~~n~~~~~~p~~~~----~-l~~L~~L~L~~n~l~~~~p~~---- 205 (1009)
|++|+|++|++++..+..++. + ++|++|+|++|.+++..+..+. . .++|++|+|++|.+++..+..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999999887775554 4 8999999999999977766554 3 369999999999999644333
Q ss_pred CCCCc-chhhhhcccccccccCCccccC----C-CCccEEEeccCccccc----cCcccCC-CCCCcEEEcccCCcCCCC
Q 037197 206 LGQLS-SLETIILGYNAFEGEIPAEFGN----L-TNLRYLDLAVGSLSGQ----IPPALGR-LKKLTTVYLYKNNFTGKI 274 (1009)
Q Consensus 206 l~~l~-~L~~L~L~~n~l~~~~~~~~~~----l-~~L~~L~L~~n~l~~~----~~~~l~~-l~~L~~L~L~~n~l~~~~ 274 (1009)
+..++ +|++|+|++|++++..+..++. + ++|++|+|++|.+++. ++..+.. .++|++|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 34444 7777777777777666544433 3 4677777777766642 2333333 235555555555555432
Q ss_pred CcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCC-------CcCCCCCCcccEEEccCCccCccCC
Q 037197 275 PPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLI-------PDKLGELTKLEVLELWKNSLIGSLP 347 (1009)
Q Consensus 275 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-------~~~l~~l~~L~~L~L~~N~l~~~~~ 347 (1009)
+..+. ..+..+++|+.|++++|.+.+.. +..+..+++|+.||+++|.+.+..+
T Consensus 242 ~~~l~--------------------~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 242 LENLK--------------------LLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHHHH--------------------HTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHHHH--------------------HHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 21111 11233344555555555533222 2356677778888888888766544
Q ss_pred c
Q 037197 348 M 348 (1009)
Q Consensus 348 ~ 348 (1009)
.
T Consensus 302 ~ 302 (362)
T 3goz_A 302 I 302 (362)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-24 Score=243.36 Aligned_cols=222 Identities=16% Similarity=0.213 Sum_probs=158.1
Q ss_pred CCCeEecccCcccccCCcccccc--CccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCC-CCccccCCCCCCee
Q 037197 91 SLSSLNICCNEFASSLPKSLANL--TALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGF-LPEDLGNATSLESL 167 (1009)
Q Consensus 91 ~L~~L~L~~n~~~~~~~~~l~~l--~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L 167 (1009)
.++.|+++++.+. +..+..+ +++++|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4788999988876 5667777 8899999999988876655 56788888888888888765 77778888888888
Q ss_pred eccCCccCCcCCccccCccccceeeeccc-ccccc-CCccCCCCcchhhhhcccc-ccccc-CCccccCCC-CccEEEec
Q 037197 168 DFRGSFFEGSVPTSFRNLQKLKFLGLSGN-NLTGK-IPPELGQLSSLETIILGYN-AFEGE-IPAEFGNLT-NLRYLDLA 242 (1009)
Q Consensus 168 ~L~~n~~~~~~p~~~~~l~~L~~L~L~~n-~l~~~-~p~~l~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~-~L~~L~L~ 242 (1009)
+|++|.+++..+..++.+++|++|+|++| .+++. ++..+..+++|++|++++| .+++. ++..+..++ +|++|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 88888888777778888888888888888 56652 5555667777777777777 77654 456667777 77777777
Q ss_pred cC--ccc-cccCcccCCCCCCcEEEcccCC-cCCCCCcccccccccccccccccc-cCCCcchhhhcccCCCeEecccc
Q 037197 243 VG--SLS-GQIPPALGRLKKLTTVYLYKNN-FTGKIPPELGSITSLAFLDLSDNQ-ISGEIPVKLAELKNLQLLNLMCN 316 (1009)
Q Consensus 243 ~n--~l~-~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~l~~l~~L~~L~L~~N 316 (1009)
+| .++ +.++..+..+++|++|++++|. +++..+..+..+++|++|+|++|. +.......+..+++|+.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 77 344 3445555666777777777776 555555566666666666666663 22221224555666666666665
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=215.42 Aligned_cols=183 Identities=19% Similarity=0.238 Sum_probs=145.1
Q ss_pred cccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccc
Q 037197 403 SLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMAS 482 (1009)
Q Consensus 403 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 482 (1009)
+.++++++++.++ .+|..+. ++|+.|+|++|++++..+..+..+++|++|+|++|+|+++.+..|..+++|+.|+++
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4556666666666 4555444 467777777777776666677777777777777777777777777777888888888
Q ss_pred cCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCcccccccc
Q 037197 483 HNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRI 562 (1009)
Q Consensus 483 ~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 562 (1009)
+|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|+.+++|+.|||++|+|++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 88887777777888888888888888888777777888889999999999998777778888999999999999999888
Q ss_pred CcCcCCCCCCcEEecCCCccccCCCC
Q 037197 563 PENFGASPALEMLNLSYNKLEGPVPS 588 (1009)
Q Consensus 563 p~~~~~l~~L~~L~ls~N~l~g~ip~ 588 (1009)
|..|..++.|+.|+|++|++++..+.
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~~~~ 197 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCSRCE 197 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTTSTT
T ss_pred HHHHhCCCCCCEEEeeCCceeCCccc
Confidence 88888899999999999999887443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.9e-25 Score=252.25 Aligned_cols=240 Identities=19% Similarity=0.209 Sum_probs=139.6
Q ss_pred cccccccCCCCCeEecccCcccccCC----ccccccCccCccccccc---ccCCCCCCCC-------CCCcCCeEEecCC
Q 037197 82 VSENIRGLRSLSSLNICCNEFASSLP----KSLANLTALKSMDVSQN---NFIGSFPTGL-------GKASGLTSVNASS 147 (1009)
Q Consensus 82 ~~~~l~~l~~L~~L~L~~n~~~~~~~----~~l~~l~~L~~L~Ls~n---~l~~~~p~~l-------~~l~~L~~L~Ls~ 147 (1009)
++..+..+++|++|+|++|.+++..+ ..+..+++|++|+|++| ++.+.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 44566677777777777777766533 33557777777777775 3344455444 5667777777777
Q ss_pred CCCCC----CCCccccCCCCCCeeeccCCccCCcCCcccc----Cc---------cccceeeecccccc-ccCC---ccC
Q 037197 148 NNFSG----FLPEDLGNATSLESLDFRGSFFEGSVPTSFR----NL---------QKLKFLGLSGNNLT-GKIP---PEL 206 (1009)
Q Consensus 148 n~l~~----~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~----~l---------~~L~~L~L~~n~l~-~~~p---~~l 206 (1009)
|.+++ .+|..+..+++|++|+|++|.++...+..+. .+ ++|++|+|++|+++ +.+| ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 77765 3556666777777777777776543333332 22 56666666666665 2233 244
Q ss_pred CCCcchhhhhcccccccc-----cCCccccCCCCccEEEeccCccc----cccCcccCCCCCCcEEEcccCCcCCC----
Q 037197 207 GQLSSLETIILGYNAFEG-----EIPAEFGNLTNLRYLDLAVGSLS----GQIPPALGRLKKLTTVYLYKNNFTGK---- 273 (1009)
Q Consensus 207 ~~l~~L~~L~L~~n~l~~-----~~~~~~~~l~~L~~L~L~~n~l~----~~~~~~l~~l~~L~~L~L~~n~l~~~---- 273 (1009)
..+++|++|+|++|+++. ..+..+..+++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++.
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 263 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence 455566666666666552 22335556666666666666664 34555555566666666666665543
Q ss_pred CCcccc--cccccccccccccccCC----Ccchhh-hcccCCCeEeccccccCCC
Q 037197 274 IPPELG--SITSLAFLDLSDNQISG----EIPVKL-AELKNLQLLNLMCNQLTGL 321 (1009)
Q Consensus 274 ~~~~~~--~l~~L~~L~Ls~N~l~~----~~~~~l-~~l~~L~~L~L~~N~l~~~ 321 (1009)
++..+. .+++|+.|+|++|.+++ .+|..+ .++++|++|++++|++++.
T Consensus 264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~ 318 (386)
T 2ca6_A 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318 (386)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence 233332 25556666666665554 244444 3355555555555555544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=214.76 Aligned_cols=196 Identities=19% Similarity=0.197 Sum_probs=122.4
Q ss_pred CCceeecccccccccCCcccccCccccEEEcccCc-cccccCCccCCCCcccEEEeec-ccccccCCcCCcCCCCCcEEe
Q 037197 379 NLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNL-ISGTIPVGLGNLPSLQRLEMAN-NNLTGQIPDDISLSTSLSFVD 456 (1009)
Q Consensus 379 ~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ 456 (1009)
+|+.|++++|++++..+..+.++++|++|++++|+ +++..+..|.++++|++|++++ |++++..+..|..+++|+.|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 56666666666665555566666666666666665 5544445666666666666666 666655555666666666666
Q ss_pred cccCcccccCCCcccCCcccc---hhccccC-cccCCcccccccCCcCc-EEEeecCCCCCCCCccccccccceeeeecC
Q 037197 457 ISWNHLESYLPSSILSIPSLQ---TFMASHN-NLQAKIPNELQACPSLS-VLDLSSNSLSGEIPASIASCEKLVSLNLRN 531 (1009)
Q Consensus 457 Ls~N~l~~~~~~~~~~l~~L~---~L~l~~N-~l~~~~p~~~~~l~~L~-~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~ 531 (1009)
+++|++++ +|. |..+++|+ .|++++| ++++..+..|..+++|+ .|+|++|+++...+..|.. ++|+.|+|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 66666666 333 55555555 6666666 66655555666667777 7777777776333333333 6677777777
Q ss_pred cc-cccCCCcccccc-cccceecCCccccccccCcCcCCCCCCcEEecCCC
Q 037197 532 NR-FSGEIPKAVATM-PTLAILDMSNNSLFGRIPENFGASPALEMLNLSYN 580 (1009)
Q Consensus 532 N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 580 (1009)
|+ +++..+..|..+ ++|+.|||++|++++..+. .++.|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 74 765555666777 7777777777777644333 4556666666654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=214.60 Aligned_cols=196 Identities=18% Similarity=0.182 Sum_probs=118.4
Q ss_pred CCeEEecCCCCCCCCCCccccCCCCCCeeeccCCc-cCCcCCccccCccccceeeecc-ccccccCCccCCCCcchhhhh
Q 037197 139 GLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSF-FEGSVPTSFRNLQKLKFLGLSG-NNLTGKIPPELGQLSSLETII 216 (1009)
Q Consensus 139 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~-~~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~ 216 (1009)
+|++|++++|++++..+..++++++|++|++++|. ++...+..|.++++|++|+|++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 56666666666665545556666666666666664 5544445566666666666666 666655455566666666666
Q ss_pred cccccccccCCccccCCCCcc---EEEeccC-ccccccCcccCCCCCCc-EEEcccCCcCCCCCcccccccccccccccc
Q 037197 217 LGYNAFEGEIPAEFGNLTNLR---YLDLAVG-SLSGQIPPALGRLKKLT-TVYLYKNNFTGKIPPELGSITSLAFLDLSD 291 (1009)
Q Consensus 217 L~~n~l~~~~~~~~~~l~~L~---~L~L~~n-~l~~~~~~~l~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 291 (1009)
+++|++++ +|. |+.+++|+ +|++++| .+++..+..|..+++|+ +|++++|.++. +|......++|+.|+|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~-i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCE-ECTTTTTTCEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcc-cCHhhcCCCCCCEEEcCC
Confidence 66666664 443 55666665 6777776 66655555666667777 77777776663 333322226666777777
Q ss_pred cc-cCCCcchhhhcc-cCCCeEeccccccCCCCCcCCCCCCcccEEEccCC
Q 037197 292 NQ-ISGEIPVKLAEL-KNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKN 340 (1009)
Q Consensus 292 N~-l~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 340 (1009)
|+ +++..+..|..+ ++|+.|++++|++++..+. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 63 664445556666 6677777777766654333 3455566665544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=8.3e-25 Score=249.53 Aligned_cols=247 Identities=19% Similarity=0.248 Sum_probs=128.5
Q ss_pred CcchhhhcccCCCeEeccccccCCCCC----cCCCCCCcccEEEccCCc---cCccCCccc-------cCCCCCceeecc
Q 037197 297 EIPVKLAELKNLQLLNLMCNQLTGLIP----DKLGELTKLEVLELWKNS---LIGSLPMRL-------GQSSPLRRLDAS 362 (1009)
Q Consensus 297 ~~~~~l~~l~~L~~L~L~~N~l~~~~~----~~l~~l~~L~~L~L~~N~---l~~~~~~~~-------~~~~~L~~L~Ls 362 (1009)
.++..+..+++|++|+|++|.+++..+ ..+..+++|++|+|++|. +++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 344455555666666666666654322 235556666666666543 223333222 344444444444
Q ss_pred Cccccc----cCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCC---------Cccc
Q 037197 363 SNLLSG----EIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNL---------PSLQ 429 (1009)
Q Consensus 363 ~N~l~~----~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l---------~~L~ 429 (1009)
+|.+++ .+|..+..+++|+.|+|++|.++...+..+.. .+..+ ++|+
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~--------------------~l~~l~~~~~~~~~~~L~ 162 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--------------------ALQELAVNKKAKNAPPLR 162 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--------------------HHHHHHHHHHHHTCCCCC
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHH--------------------HHHHHhhhhhcccCCCCc
Confidence 444443 23333333444444444444443222211111 11111 4444
Q ss_pred EEEeeccccc-ccCC---cCCcCCCCCcEEecccCcccc-----cCCCcccCCcccchhccccCccc----CCccccccc
Q 037197 430 RLEMANNNLT-GQIP---DDISLSTSLSFVDISWNHLES-----YLPSSILSIPSLQTFMASHNNLQ----AKIPNELQA 496 (1009)
Q Consensus 430 ~L~L~~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~l~~N~l~----~~~p~~~~~ 496 (1009)
+|+|++|+++ +.+| ..+..+++|+.|+|++|+|+. ..+..+..+++|+.|++++|.++ ..+|..+..
T Consensus 163 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~ 242 (386)
T 2ca6_A 163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242 (386)
T ss_dssp EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred EEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHcc
Confidence 4444444443 2222 233344455555555555441 22334455555555555555554 345666777
Q ss_pred CCcCcEEEeecCCCCCC----CCcccc--ccccceeeeecCccccc----CCCccc-ccccccceecCCccccccccC
Q 037197 497 CPSLSVLDLSSNSLSGE----IPASIA--SCEKLVSLNLRNNRFSG----EIPKAV-ATMPTLAILDMSNNSLFGRIP 563 (1009)
Q Consensus 497 l~~L~~LdLs~N~l~~~----~p~~~~--~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~p 563 (1009)
+++|+.|+|++|++++. +|..+. .+++|+.|+|++|++++ .+|..+ .++++|+.|+|++|++++..|
T Consensus 243 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred CCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 77777777777777654 445542 36777777777777776 466666 557778888888887776664
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=7.9e-22 Score=216.95 Aligned_cols=192 Identities=21% Similarity=0.374 Sum_probs=133.9
Q ss_pred CCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEe
Q 037197 377 SGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVD 456 (1009)
Q Consensus 377 l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 456 (1009)
+++|+.|++++|.++. ++ .+..+++|++|++++|++++..+ +..+++|++|+|++|++++. + .+..+++|+.|+
T Consensus 40 l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~ 113 (308)
T 1h6u_A 40 LDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLD 113 (308)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEE
T ss_pred cCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEE
Confidence 4445555555555542 22 35556666666666666654333 66666666666666666642 2 466666777777
Q ss_pred cccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCccccc
Q 037197 457 ISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSG 536 (1009)
Q Consensus 457 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 536 (1009)
+++|+++++. .+..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++
T Consensus 114 l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 187 (308)
T 1h6u_A 114 LTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD 187 (308)
T ss_dssp CTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCc
Confidence 7777776643 26677777777777777775443 7788888888888888886444 7788888888888888885
Q ss_pred CCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCcccc
Q 037197 537 EIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEG 584 (1009)
Q Consensus 537 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 584 (1009)
..+ +..+++|+.|+|++|++++..| +..+++|+.|+|++|++++
T Consensus 188 ~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 188 ISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred Chh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 443 7888888888888888887664 7888888999999998876
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=7.2e-22 Score=217.25 Aligned_cols=194 Identities=28% Similarity=0.432 Sum_probs=95.6
Q ss_pred cccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccce
Q 037197 111 ANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKF 190 (1009)
Q Consensus 111 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~ 190 (1009)
..+++|++|++++|.+.. +| .+..+++|++|+|++|++++..+ +..+++|++|+|++|.+++. ..+..+++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~ 111 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT 111 (308)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred HHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCE
Confidence 344444555555444432 22 34444455555555555443222 44555555555555554432 23455555555
Q ss_pred eeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCc
Q 037197 191 LGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNF 270 (1009)
Q Consensus 191 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 270 (1009)
|+|++|++++ ++ .+..+++|++|++++|++++..+ ++++++|++|++++|.+++..+ +..+++|+.|++++|.+
T Consensus 112 L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l 185 (308)
T 1h6u_A 112 LDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185 (308)
T ss_dssp EECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCcc
Confidence 5555555553 22 14455555555555555543322 5555555555555555553322 55555555555555555
Q ss_pred CCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCC
Q 037197 271 TGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG 320 (1009)
Q Consensus 271 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 320 (1009)
++..+ +..+++|++|+|++|++++.. .+..+++|+.|++++|++++
T Consensus 186 ~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 186 SDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred CcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 53322 455555555555555555332 24555555555555555553
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-21 Score=200.45 Aligned_cols=186 Identities=24% Similarity=0.278 Sum_probs=130.0
Q ss_pred CCceeeeEEeCCCCceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCC
Q 037197 53 LHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPT 132 (1009)
Q Consensus 53 ~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~ 132 (1009)
+.|+|++|.|+..+. + .+|..+ .++|++|+|++|.+++..+..++++++|++|+|++|++++..+.
T Consensus 5 C~C~~~~v~c~~~~l-----------~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (208)
T 2o6s_A 5 CSCSGTTVECYSQGR-----------T-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG 70 (208)
T ss_dssp CEEETTEEECCSSCC-----------S-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred CEECCCEEEecCCCc-----------c-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChh
Confidence 458999999975431 1 122222 34677777777777766666677777777777777777765555
Q ss_pred CCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcch
Q 037197 133 GLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSL 212 (1009)
Q Consensus 133 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 212 (1009)
.++.+++|++|+|++|++++..+..++++++|++|++++|.+++..+..|.++++|++|+|++|++++..+..+..+++|
T Consensus 71 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 150 (208)
T 2o6s_A 71 VFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSL 150 (208)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred hcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCc
Confidence 56777777777777777776555667777777777777777776666667777777777777777776555557777777
Q ss_pred hhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCC
Q 037197 213 ETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKK 259 (1009)
Q Consensus 213 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~ 259 (1009)
++|++++|.+.+ .+++|++|+++.|+++|.+|..++.++.
T Consensus 151 ~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 151 QYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp CEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred cEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 777777776653 3456777777777777777777776654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=219.53 Aligned_cols=246 Identities=17% Similarity=0.168 Sum_probs=124.2
Q ss_pred CCceeeeEEeCCCCceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCC
Q 037197 53 LHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPT 132 (1009)
Q Consensus 53 ~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~ 132 (1009)
+.|+|+.|.|+. ++++ .+|..+ .+++++|+|++|+++...+.+|+++++|++|+|++|++.+.+|.
T Consensus 7 C~C~~~~v~C~~-----------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~ 72 (350)
T 4ay9_X 7 CHCSNRVFLCQE-----------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 72 (350)
T ss_dssp SEEETTEEEEES-----------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECT
T ss_pred cEeeCCEEEecC-----------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccCh
Confidence 448888888853 3343 244433 24567777777777654445566677777777776666554443
Q ss_pred -CCCCCcCCeE-EecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCc
Q 037197 133 -GLGKASGLTS-VNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLS 210 (1009)
Q Consensus 133 -~l~~l~~L~~-L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 210 (1009)
.+.++++|++ +.+++|+++...|..|..+++|++|++++|.+....+..+....++..|++.++
T Consensus 73 ~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~-------------- 138 (350)
T 4ay9_X 73 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN-------------- 138 (350)
T ss_dssp TSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESC--------------
T ss_pred hHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccc--------------
Confidence 3455555443 444455555444555555555555555555555444444444444555555332
Q ss_pred chhhhhcccccccccCCccccCCC-CccEEEeccCccccccCcccCCCCCCcEEEccc-CCcCCCCCccccccccccccc
Q 037197 211 SLETIILGYNAFEGEIPAEFGNLT-NLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYK-NNFTGKIPPELGSITSLAFLD 288 (1009)
Q Consensus 211 ~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~ 288 (1009)
|+++...+..|..+. .|++|+|++|+|+.. +.......+|++|++++ |.++...+..|..+++|++||
T Consensus 139 ---------~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~Ld 208 (350)
T 4ay9_X 139 ---------INIHTIERNSFVGLSFESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD 208 (350)
T ss_dssp ---------TTCCEECTTSSTTSBSSCEEEECCSSCCCEE-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEE
T ss_pred ---------cccccccccchhhcchhhhhhccccccccCC-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhh
Confidence 333333333344432 355555555555532 22222334555555543 333322223455556666666
Q ss_pred ccccccCCCcchhhhcccCCCeEecccc-ccCCCCCcCCCCCCcccEEEccCCc
Q 037197 289 LSDNQISGEIPVKLAELKNLQLLNLMCN-QLTGLIPDKLGELTKLEVLELWKNS 341 (1009)
Q Consensus 289 Ls~N~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~~~~l~~l~~L~~L~L~~N~ 341 (1009)
|++|+|+...+..+. +|+.|.+.++ .++ .+| .+.++++|+.+++.++.
T Consensus 209 Ls~N~l~~lp~~~~~---~L~~L~~l~~~~l~-~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 209 ISRTRIHSLPSYGLE---NLKKLRARSTYNLK-KLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp CTTSCCCCCCSSSCT---TCCEEECTTCTTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred cCCCCcCccChhhhc---cchHhhhccCCCcC-cCC-CchhCcChhhCcCCCCc
Confidence 666666533232333 3333333222 233 233 25666666666665443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=1e-20 Score=212.24 Aligned_cols=220 Identities=18% Similarity=0.147 Sum_probs=105.8
Q ss_pred ceeeccCccccccCCcCccCCCCCceeecccccccccCC-cccccCccccE-EEcccCccccccCCccCCCCcccEEEee
Q 037197 357 RRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFP-VSLSTCKSLVR-VRVQNNLISGTIPVGLGNLPSLQRLEMA 434 (1009)
Q Consensus 357 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p-~~l~~~~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 434 (1009)
++|+|++|+|+...+..|..+++|++|+|++|++.+.+| ..|.+++++.+ +.+..|+++...|..|..+++|++|+++
T Consensus 33 ~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~ 112 (350)
T 4ay9_X 33 IELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 112 (350)
T ss_dssp SEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEE
T ss_pred CEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccccc
Confidence 333333333332222334444444444444444433222 23444444433 3344455554445555555555555555
Q ss_pred cccccccCCcCCcCCCCCcEEeccc-CcccccCCCcccCCc-ccchhccccCcccCCcccccccCCcCcEEEeec-CCCC
Q 037197 435 NNNLTGQIPDDISLSTSLSFVDISW-NHLESYLPSSILSIP-SLQTFMASHNNLQAKIPNELQACPSLSVLDLSS-NSLS 511 (1009)
Q Consensus 435 ~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~-N~l~ 511 (1009)
+|++++..+..+....++..|++++ |++..+.+..|..+. .++.|++++|+|+.. |.......+|+.|++++ |.++
T Consensus 113 ~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i-~~~~f~~~~L~~l~l~~~n~l~ 191 (350)
T 4ay9_X 113 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNLE 191 (350)
T ss_dssp EECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE-CTTSSTTEEEEEEECTTCTTCC
T ss_pred ccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCC-ChhhccccchhHHhhccCCccc
Confidence 5555544444444444555555533 345554444454443 355555555555532 22323344566666653 4454
Q ss_pred CCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCc
Q 037197 512 GEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNK 581 (1009)
Q Consensus 512 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 581 (1009)
...+..|..+++|+.|+|++|+|+...+..|.++++|+.+++. ++ ..+| .+.++++|+.++++++.
T Consensus 192 ~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~--~l-~~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 192 ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY--NL-KKLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp CCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCT--TC-CCCC-CTTTCCSCCEEECSCHH
T ss_pred CCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCC--Cc-CcCC-CchhCcChhhCcCCCCc
Confidence 3333455666666666666666663333344444444444432 22 2444 35566666666666543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1e-21 Score=231.69 Aligned_cols=199 Identities=23% Similarity=0.330 Sum_probs=120.6
Q ss_pred eeeeE-EeCCCCceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCCCCC
Q 037197 56 NWTGV-WCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGL 134 (1009)
Q Consensus 56 ~w~gv-~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l 134 (1009)
.|.|+ .|.. ++++.|+|+++++++ +|..+ +++|++|+|++|.++ .+| ..+++|++|+|++|++++ +|. +
T Consensus 49 ~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l 118 (571)
T 3cvr_A 49 AVSLLKECLI-NQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-L 118 (571)
T ss_dssp HHHHHHHHHH-TTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-C
T ss_pred hhhhcccccc-CCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-h
Confidence 69999 7853 467888888888876 55544 256666666666665 444 345566666666666654 444 4
Q ss_pred CCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhh
Q 037197 135 GKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLET 214 (1009)
Q Consensus 135 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 214 (1009)
+. +|++|+|++|++++ +|. .+++|+.|+|++|.+++ +|. .++ +|++
T Consensus 119 ~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~------------------------~L~~ 164 (571)
T 3cvr_A 119 PA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPT------------------------SLEV 164 (571)
T ss_dssp CT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCT------------------------TCCE
T ss_pred hc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCC------------------------CcCE
Confidence 43 55555555555554 333 34555555555555543 332 234 4455
Q ss_pred hhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCC-------cEEEcccCCcCCCCCcccccccccccc
Q 037197 215 IILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKL-------TTVYLYKNNFTGKIPPELGSITSLAFL 287 (1009)
Q Consensus 215 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L-------~~L~L~~n~l~~~~~~~~~~l~~L~~L 287 (1009)
|+|++|+|++ +|. |. ++|++|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|
T Consensus 165 L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L 235 (571)
T 3cvr_A 165 LSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTI 235 (571)
T ss_dssp EECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEE
T ss_pred EECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEE
Confidence 5555555443 333 33 55666666666655 3444 333 44 88888888888 577777778888888
Q ss_pred cccccccCCCcchhhhcccC
Q 037197 288 DLSDNQISGEIPVKLAELKN 307 (1009)
Q Consensus 288 ~Ls~N~l~~~~~~~l~~l~~ 307 (1009)
+|++|.+++.+|..+..+..
T Consensus 236 ~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 236 ILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp ECCSSSCCHHHHHHHHHHHH
T ss_pred EeeCCcCCCcCHHHHHHhhc
Confidence 88888888888887777654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=8.2e-21 Score=196.25 Aligned_cols=160 Identities=20% Similarity=0.203 Sum_probs=75.5
Q ss_pred cccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccc
Q 037197 403 SLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMAS 482 (1009)
Q Consensus 403 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 482 (1009)
+|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++|++|+|++|+++++.+..|..+++|+.|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 34444444444443333334444444444444444443333334444444444444444444444444444444444444
Q ss_pred cCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCcccccccc
Q 037197 483 HNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRI 562 (1009)
Q Consensus 483 ~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 562 (1009)
+|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.+ .++.|++|+++.|+++|.+
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~i 181 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVV 181 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTB
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCcee
Confidence 444444334444455555555555555554444445555555555555554442 2234555555555555555
Q ss_pred CcCcCCC
Q 037197 563 PENFGAS 569 (1009)
Q Consensus 563 p~~~~~l 569 (1009)
|..++.+
T Consensus 182 p~~~~~l 188 (208)
T 2o6s_A 182 RNSAGSV 188 (208)
T ss_dssp BCTTSSB
T ss_pred eccCccc
Confidence 5554443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=4.9e-21 Score=225.81 Aligned_cols=167 Identities=29% Similarity=0.478 Sum_probs=95.4
Q ss_pred CCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecc
Q 037197 379 NLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDIS 458 (1009)
Q Consensus 379 ~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 458 (1009)
+|+.|++++|+|+ .+| ..+++|+.|++++|+|++ +|. +.. +|+.|+|++|+|++ +|. .+++|+.|+|+
T Consensus 81 ~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 148 (571)
T 3cvr_A 81 QITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINAD 148 (571)
T ss_dssp TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCC
Confidence 3444444444444 233 223455555555555553 443 333 55555555555554 443 34556666666
Q ss_pred cCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccc-------eeeeecC
Q 037197 459 WNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKL-------VSLNLRN 531 (1009)
Q Consensus 459 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L-------~~L~Ls~ 531 (1009)
+|+|++ +|. .+++|+.|++++|++++ +|. |. ++|+.|||++|+|+ .+|. |.. +| +.|+|++
T Consensus 149 ~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~ 216 (571)
T 3cvr_A 149 NNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRE 216 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCS
T ss_pred CCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCC
Confidence 666655 232 34556666666666654 444 44 66777777777776 4454 443 55 7777777
Q ss_pred cccccCCCcccccccccceecCCccccccccCcCcCCCC
Q 037197 532 NRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASP 570 (1009)
Q Consensus 532 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 570 (1009)
|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..++
T Consensus 217 N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp SCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred Ccce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 7777 5677777777777777777777777777665543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.7e-21 Score=209.08 Aligned_cols=145 Identities=13% Similarity=0.068 Sum_probs=114.6
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh----------------hhHHHHHHHHHHHhccCCCceeeEE
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI----------------ESGDDLFREVSLLGRLRHRNIVRLL 763 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~ 763 (1009)
|+..+.||+|+||.||+|.+ .+|+.||+|.++...... .....+.+|++++++++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 55668999999999999999 679999999986432111 13456779999999998 4 5666
Q ss_pred eEEEcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcE
Q 037197 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEA 843 (1009)
Q Consensus 764 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 843 (1009)
+++.. +..++||||+++++|.+ +... ....++.|+++||+|||+. +|+||||||+||+++ ++.+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~~----------~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRVE----------NPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCCS----------CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEE
T ss_pred eEEec-cceEEEEEecCCCcHHH-cchh----------hHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcE
Confidence 65544 45699999999999998 4221 1235899999999999998 999999999999999 9999
Q ss_pred EEcccccceecccCCCceeeecccCcccCCcccC
Q 037197 844 RIADFGLARMMLHKNETVSMVAGSYGYIAPEYGY 877 (1009)
Q Consensus 844 kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~ 877 (1009)
||+|||+++.. ..|.|||++.
T Consensus 232 kl~DFG~a~~~-------------~~~~a~e~l~ 252 (282)
T 1zar_A 232 WIIDFPQSVEV-------------GEEGWREILE 252 (282)
T ss_dssp EECCCTTCEET-------------TSTTHHHHHH
T ss_pred EEEECCCCeEC-------------CCCCHHHHHH
Confidence 99999999643 3567888643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=8.1e-21 Score=197.77 Aligned_cols=156 Identities=19% Similarity=0.261 Sum_probs=117.2
Q ss_pred EEEeecccccccCCcCCcCCCCCcEEecccCcccccCC-CcccCCcccchhccccCcccCCcccccccCCcCcEEEeecC
Q 037197 430 RLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLP-SSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSN 508 (1009)
Q Consensus 430 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N 508 (1009)
.+++++|.++ .+|..+. ..++.|+|++|+|+++.+ ..|..+++|+.|++++|++++..+..|..+++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4555555554 3444332 234566666666666533 34566667777777777776666667788888888888888
Q ss_pred CCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCC
Q 037197 509 SLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPS 588 (1009)
Q Consensus 509 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~ 588 (1009)
+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.+|..|..+++|++|+|++|++++..+-
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 88877777888888888888888888888888888888899999999999888888898899999999999999887663
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.2e-21 Score=239.98 Aligned_cols=268 Identities=18% Similarity=0.177 Sum_probs=81.0
Q ss_pred cChHHhHHHHHHHHhhccCC-CCCCCCCCCCCccccCCcCCceeeeEEeCCCCceeEEeccccccccccccccccCCCCC
Q 037197 15 SNADDELSTLLSIKAGLIDP-LNMLEDWKMPSNAAENGLLHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLS 93 (1009)
Q Consensus 15 ~~~~~~~~~ll~~k~~~~d~-~~~l~~W~~~~~~~~~~~~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~ 93 (1009)
+..+.++++|+++...+..+ ...-..|.... +..+.|.+++++. .+++.|+|.++++... +. ..|+
T Consensus 128 s~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~-~~-----~~l~ 194 (727)
T 4b8c_D 128 SLVDCTKQALMEMADTLTDSKTAKKQQPTGDS------TPSGTATNSAVST-PLTPKIELFANGKDEA-NQ-----ALLQ 194 (727)
T ss_dssp ----CCCHHHHHHHHHHHHHHTTC--------------------------------------------------------
T ss_pred hccccchhhhhhhhhhcccccCcccCCCcCCC------CccccCCCceecC-CccceEEeeCCCCCcc-hh-----hHhh
Confidence 45578899999999888432 22345665332 3467899998865 6788999988877652 21 1233
Q ss_pred eEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCc
Q 037197 94 SLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSF 173 (1009)
Q Consensus 94 ~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~ 173 (1009)
.++|+.|.+. .++++.|.+. ..|..+..+..|+.|+|++|.+. .+|..+.++++|++|+|++|.
T Consensus 195 ~l~Ls~~~i~--------------~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~ 258 (727)
T 4b8c_D 195 HKKLSQYSID--------------EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNS 258 (727)
T ss_dssp ------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSC
T ss_pred cCccCccccc--------------Ccccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCc
Confidence 3444444332 2233334333 33444444555555555555554 344444444444444444444
Q ss_pred cCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcc
Q 037197 174 FEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPA 253 (1009)
Q Consensus 174 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 253 (1009)
++ .+|..|++|++|++|+|++|.|+ .+| ..|++|++|++|+|++|.|+ .+|..
T Consensus 259 l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp------------------------~~~~~l~~L~~L~L~~N~l~-~lp~~ 311 (727)
T 4b8c_D 259 LT-ELPAEIKNLSNLRVLDLSHNRLT-SLP------------------------AELGSCFQLKYFYFFDNMVT-TLPWE 311 (727)
T ss_dssp CS-CCCGGGGGGTTCCEEECTTSCCS-SCC------------------------SSGGGGTTCSEEECCSSCCC-CCCSS
T ss_pred Cc-ccChhhhCCCCCCEEeCcCCcCC-ccC------------------------hhhcCCCCCCEEECCCCCCC-ccChh
Confidence 44 44444444444444444444444 334 44444444444444444443 33444
Q ss_pred cCCCCCCcEEEcccCCcCCCCCccccccc-ccccccccccccCCCcchhhhcccCCCeEecccc--------ccCCCCCc
Q 037197 254 LGRLKKLTTVYLYKNNFTGKIPPELGSIT-SLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCN--------QLTGLIPD 324 (1009)
Q Consensus 254 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N--------~l~~~~~~ 324 (1009)
|+.+++|++|+|++|.|++.+|..+..+. .+..|+|++|.+++.+|.. |+.|+++.| .+.+..+.
T Consensus 312 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~ 385 (727)
T 4b8c_D 312 FGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEH 385 (727)
T ss_dssp TTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-------------------------------
T ss_pred hhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccc
Confidence 45555555555555555544444443321 1223555555555555432 333444444 33333444
Q ss_pred CCCCCCcccEEEccCCccCc
Q 037197 325 KLGELTKLEVLELWKNSLIG 344 (1009)
Q Consensus 325 ~l~~l~~L~~L~L~~N~l~~ 344 (1009)
.+.++..+....++.|-+.+
T Consensus 386 ~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 386 LATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp ----------------CCCG
T ss_pred hhhcccccceeeeecccccc
Confidence 45555666666677776543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=3.2e-20 Score=193.25 Aligned_cols=154 Identities=19% Similarity=0.249 Sum_probs=111.3
Q ss_pred EEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCC
Q 037197 430 RLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNS 509 (1009)
Q Consensus 430 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~ 509 (1009)
.+++++|+++ .+|..+. .+|+.|+|++|+|+++.+..|..+++|+.|++++|++++..|..|..+++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 4555555554 3444332 456666666666666666666666666666666666666667777777788888888888
Q ss_pred CCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCC
Q 037197 510 LSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPV 586 (1009)
Q Consensus 510 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~i 586 (1009)
|+...+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 87666666777888888888888888777788888888888888888888887778888888888888888887643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=5.8e-20 Score=219.28 Aligned_cols=193 Identities=23% Similarity=0.296 Sum_probs=99.3
Q ss_pred CCeEecccCcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccC
Q 037197 92 LSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRG 171 (1009)
Q Consensus 92 L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~ 171 (1009)
+..++++.+.+.+.++ +..|++|++|+|++|.+.. +| .++.+++|+.|+|++|++++..| +..+++|+.|+|++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 3444455555443322 4555666666666655542 22 34455555555555555543322 44444444444444
Q ss_pred CccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccC
Q 037197 172 SFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIP 251 (1009)
Q Consensus 172 n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 251 (1009)
|.+.+ +| .++.+++|++|+|++|++++. ..+..+++|+.|+|++|.+++.
T Consensus 97 N~l~~-------------------------l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l-- 146 (605)
T 1m9s_A 97 NKIKD-------------------------LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-- 146 (605)
T ss_dssp SCCCC-------------------------CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--
T ss_pred CCCCC-------------------------Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--
Confidence 44442 11 344444444444444444431 2355555555555555555543
Q ss_pred cccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCc
Q 037197 252 PALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPD 324 (1009)
Q Consensus 252 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 324 (1009)
..++.+++|+.|+|++|.+++..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++....
T Consensus 147 ~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~ 215 (605)
T 1m9s_A 147 TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPIN 215 (605)
T ss_dssp GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCC
T ss_pred hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCccc
Confidence 445555666666666666654433 55566666666666666532 2456666666666666666654333
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.8e-19 Score=186.39 Aligned_cols=155 Identities=20% Similarity=0.245 Sum_probs=117.9
Q ss_pred cEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecC
Q 037197 429 QRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSN 508 (1009)
Q Consensus 429 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N 508 (1009)
+.+++++++++ .+|..+. ++|+.|+|++|+|+++.|..|..+++|+.|++++|+++...+..|..+++|+.|||++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 34555555554 4444332 56666666666666666666666777777777777776555566778888888888888
Q ss_pred CCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCCC
Q 037197 509 SLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVP 587 (1009)
Q Consensus 509 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip 587 (1009)
+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..+
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 888777777888888888888888888 788888888889999999999888877888888899999999998887665
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=7.2e-20 Score=199.43 Aligned_cols=171 Identities=26% Similarity=0.384 Sum_probs=86.7
Q ss_pred CCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhh
Q 037197 136 KASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETI 215 (1009)
Q Consensus 136 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 215 (1009)
.+++|++|++++|.+.+. + .++.+++|++|++++|.+++..+ +.++++|++|+|++|.+++ +| .++.+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence 344555555555555422 2 24555555555555555553322 5555555555555555553 22 24555555555
Q ss_pred hcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccC
Q 037197 216 ILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQIS 295 (1009)
Q Consensus 216 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 295 (1009)
+|++|++++. ..+..+++|++|++++|++++. ..++.+++|++|++++|.+++..+ +..+++|+.|+|++|.++
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 5555555432 3355555555555555555533 345555555555555555554322 455555555555555555
Q ss_pred CCcchhhhcccCCCeEeccccccCC
Q 037197 296 GEIPVKLAELKNLQLLNLMCNQLTG 320 (1009)
Q Consensus 296 ~~~~~~l~~l~~L~~L~L~~N~l~~ 320 (1009)
+ ++ .+..+++|+.|++++|+++.
T Consensus 192 ~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 192 D-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp B-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred C-Ch-hhccCCCCCEEECcCCcccC
Confidence 3 22 25555555555555555554
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.5e-19 Score=185.83 Aligned_cols=158 Identities=21% Similarity=0.225 Sum_probs=81.2
Q ss_pred CcCCceeeeEEeCCCCceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCC
Q 037197 51 GLLHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSF 130 (1009)
Q Consensus 51 ~~~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~ 130 (1009)
+.+.|+|++|.|+..+ ++ .+|..+. ++|++|+|++|.+++..|..+.++++|++|+|++|++....
T Consensus 15 ~~~~Cs~~~v~c~~~~-----------l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~ 80 (229)
T 3e6j_A 15 SQCSCSGTTVDCRSKR-----------HA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALP 80 (229)
T ss_dssp TTCEEETTEEECTTSC-----------CS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCCEEeCCEeEccCCC-----------cC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcC
Confidence 4568999999996432 21 2332221 55566666666665555555555555555555555554333
Q ss_pred CCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCc
Q 037197 131 PTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLS 210 (1009)
Q Consensus 131 p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 210 (1009)
+..+..+++|++|+|++|++++..+..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|++++..+..|..++
T Consensus 81 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 159 (229)
T 3e6j_A 81 VGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159 (229)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCC
Confidence 344455555555555555555444444444555555555555544 3444444444444444444444433333344444
Q ss_pred chhhhhccccccc
Q 037197 211 SLETIILGYNAFE 223 (1009)
Q Consensus 211 ~L~~L~L~~n~l~ 223 (1009)
+|++|+|++|.+.
T Consensus 160 ~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 160 SLTHAYLFGNPWD 172 (229)
T ss_dssp TCCEEECTTSCBC
T ss_pred CCCEEEeeCCCcc
Confidence 4444444444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=9.8e-20 Score=217.31 Aligned_cols=174 Identities=32% Similarity=0.425 Sum_probs=118.4
Q ss_pred ccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCcc
Q 037197 158 LGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLR 237 (1009)
Q Consensus 158 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 237 (1009)
+..+++|+.|++++|.+.. +| .+..+++|+.|+|++|++++..| +..+++|+.|+|++|++++ + ..++.+++|+
T Consensus 39 ~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~ 112 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-L-SSLKDLKKLK 112 (605)
T ss_dssp HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-TTSTTCTTCC
T ss_pred hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-C-hhhccCCCCC
Confidence 3456666666666666653 23 46677777777777777775433 6777777777777777774 2 2577777788
Q ss_pred EEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccc
Q 037197 238 YLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQ 317 (1009)
Q Consensus 238 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 317 (1009)
+|+|++|.+++. ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+
T Consensus 113 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 113 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 186 (605)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence 888877777753 4567777777777777777754 456677777777777777775555 6677777777777777
Q ss_pred cCCCCCcCCCCCCcccEEEccCCccCcc
Q 037197 318 LTGLIPDKLGELTKLEVLELWKNSLIGS 345 (1009)
Q Consensus 318 l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 345 (1009)
|++. ..+..+++|+.|+|++|++.+.
T Consensus 187 i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 187 ISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred CCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 7654 3466677777777777766543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=204.29 Aligned_cols=176 Identities=21% Similarity=0.210 Sum_probs=90.5
Q ss_pred ceeecccccccccCCcccccCccccEEEcccCccccccCCccC-CCCcccEEEeecccccccCCcCCcCCCCCcEEeccc
Q 037197 381 TKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLG-NLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISW 459 (1009)
Q Consensus 381 ~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 459 (1009)
+.+++++|.++. +|..+. ..++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 456666666653 343332 2355566666666655555554 555666666666666555555555555555555555
Q ss_pred CcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccc---cccccceeeeecCccccc
Q 037197 460 NHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASI---ASCEKLVSLNLRNNRFSG 536 (1009)
Q Consensus 460 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~ 536 (1009)
|+|+++.+..|..+++|+.|++++|++++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 55555555555555555555555555555445555555555555555555553333333 334555555555555543
Q ss_pred CCCcccccccc--cceecCCccccc
Q 037197 537 EIPKAVATMPT--LAILDMSNNSLF 559 (1009)
Q Consensus 537 ~~p~~~~~l~~--L~~L~Ls~N~l~ 559 (1009)
..+..+..++. |+.|+|++|++.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 33344444443 244444444443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.3e-19 Score=195.42 Aligned_cols=173 Identities=25% Similarity=0.388 Sum_probs=106.3
Q ss_pred cccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccce
Q 037197 111 ANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKF 190 (1009)
Q Consensus 111 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~ 190 (1009)
..+++|++|++++|.+... + .++.+++|++|+|++|++++..+ ++++++|++|++++|.+++ + ..+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-L-SSLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-G-GGGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-C-hhhccCCCCCE
Confidence 4455555555555555432 2 35555555555555555554332 5566666666666666553 2 23566666666
Q ss_pred eeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCc
Q 037197 191 LGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNF 270 (1009)
Q Consensus 191 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 270 (1009)
|+|++|++++. +.+..+++|++|++++|++++. ..++.+++|++|++++|++++..+ +..+++|+.|+|++|.+
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 66666666642 3456666666666666666643 456677777777777777765544 67777777777777777
Q ss_pred CCCCCcccccccccccccccccccCCC
Q 037197 271 TGKIPPELGSITSLAFLDLSDNQISGE 297 (1009)
Q Consensus 271 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 297 (1009)
++ ++ .+..+++|+.|++++|+++..
T Consensus 191 ~~-l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 191 SD-LR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred CC-Ch-hhccCCCCCEEECcCCcccCC
Confidence 74 33 367777777788877777643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.1e-19 Score=184.09 Aligned_cols=156 Identities=19% Similarity=0.193 Sum_probs=118.0
Q ss_pred cEEEcccCccccccCCccCCCCcccEEEeecccccccCC-cCCcCCCCCcEEecccCcccccCCCcccCCcccchhcccc
Q 037197 405 VRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIP-DDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASH 483 (1009)
Q Consensus 405 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 483 (1009)
+.+++++|.++ .+|..+. +.+++|+|++|+|++..| ..|..+++|+.|+|++|+|+++.+..|..+++|++|++++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 35666666665 3454443 245677777777776544 3466777777777777777777777777778888888888
Q ss_pred CcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccC
Q 037197 484 NNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIP 563 (1009)
Q Consensus 484 N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 563 (1009)
|++++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 88877777778888888888888888888888888888888888888888888778888888888888888888876544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7.4e-19 Score=182.92 Aligned_cols=152 Identities=16% Similarity=0.252 Sum_probs=95.1
Q ss_pred EEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCc
Q 037197 406 RVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNN 485 (1009)
Q Consensus 406 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 485 (1009)
.+++++|.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+++.|..|.++++|+.|++++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 3444444444 3343332 455556666666555445555555666666666666666556666666666666666666
Q ss_pred ccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCcccccc
Q 037197 486 LQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFG 560 (1009)
Q Consensus 486 l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 560 (1009)
++...+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 665555556667777777777777776666777777777777777777776666667777777777777777653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.1e-21 Score=230.35 Aligned_cols=188 Identities=21% Similarity=0.229 Sum_probs=91.3
Q ss_pred CCCCceeeccCccccccCCcCccCCCCCceeeccccc-------------ccccCCcccccCccccEEE-cccCcccccc
Q 037197 353 SSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNS-------------FSGTFPVSLSTCKSLVRVR-VQNNLISGTI 418 (1009)
Q Consensus 353 ~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~-------------l~~~~p~~l~~~~~L~~L~-L~~N~l~~~~ 418 (1009)
.++|+.|+|++|.++ .+|..+..+++|+.|++++|. +.+..|..+..+++|+.|+ ++.|.+
T Consensus 348 ~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~---- 422 (567)
T 1dce_A 348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL---- 422 (567)
T ss_dssp TTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH----
T ss_pred CccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc----
Confidence 444555555555554 445555555555555554443 2233344444444444444 333322
Q ss_pred CCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCC
Q 037197 419 PVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACP 498 (1009)
Q Consensus 419 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 498 (1009)
..|..+.+++|.+++..+ ..|+.|+|++|+|++ +|. |..+++|+.|++++|+|+ .+|..|+.++
T Consensus 423 -------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 486 (567)
T 1dce_A 423 -------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALR 486 (567)
T ss_dssp -------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCT
T ss_pred -------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCC
Confidence 123333344444442211 125555555555555 233 555555555555555555 4455555555
Q ss_pred cCcEEEeecCCCCCCCCccccccccceeeeecCcccccCC-CcccccccccceecCCccccccccC
Q 037197 499 SLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEI-PKAVATMPTLAILDMSNNSLFGRIP 563 (1009)
Q Consensus 499 ~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p 563 (1009)
+|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ |..++.+++|+.|+|++|+|++.+|
T Consensus 487 ~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 487 CLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp TCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 55555555555553 34 4555555555555555555444 5555555555555555555554443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=6.1e-19 Score=198.61 Aligned_cols=176 Identities=21% Similarity=0.176 Sum_probs=120.2
Q ss_pred ceeeccCccccccCCcCccCCCCCceeecccccccccCCcccc-cCccccEEEcccCccccccCCccCCCCcccEEEeec
Q 037197 357 RRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLS-TCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMAN 435 (1009)
Q Consensus 357 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~-~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 435 (1009)
+.+++++|.++ .+|..+. ..++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 46677777776 4555443 3467777777777766666666 777777777777777766666677777777777777
Q ss_pred ccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCccccc---ccCCcCcEEEeecCCCCC
Q 037197 436 NNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNEL---QACPSLSVLDLSSNSLSG 512 (1009)
Q Consensus 436 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~---~~l~~L~~LdLs~N~l~~ 512 (1009)
|+|++..+..|..+++|+.|+|++|+|+++.|..|..+++|+.|++++|++++..+..| ..+++|+.|||++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 77776666667777777777777777777767777777777777777777776444444 456777777777777776
Q ss_pred CCCcccccccc--ceeeeecCcccc
Q 037197 513 EIPASIASCEK--LVSLNLRNNRFS 535 (1009)
Q Consensus 513 ~~p~~~~~l~~--L~~L~Ls~N~l~ 535 (1009)
..+..+..++. |+.|+|++|.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 55566666665 366777777765
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=8.6e-21 Score=225.13 Aligned_cols=104 Identities=32% Similarity=0.375 Sum_probs=50.2
Q ss_pred ccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccc
Q 037197 236 LRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMC 315 (1009)
Q Consensus 236 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 315 (1009)
|++|+|++|.+++ +|. ++.+++|+.|+|++|.|+ .+|..++.+++|+.|+|++|+|++ +| .++.+++|++|+|++
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 4555555555543 333 445555555555555554 444445555555555555555543 33 444444455555555
Q ss_pred cccCCCC-CcCCCCCCcccEEEccCCccCc
Q 037197 316 NQLTGLI-PDKLGELTKLEVLELWKNSLIG 344 (1009)
Q Consensus 316 N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~ 344 (1009)
|+|++.+ |..++.+++|+.|+|++|.+++
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~ 547 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCC
Confidence 5444443 4444444444444444444443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.5e-19 Score=219.40 Aligned_cols=181 Identities=23% Similarity=0.238 Sum_probs=74.6
Q ss_pred CCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCC
Q 037197 394 FPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSI 473 (1009)
Q Consensus 394 ~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 473 (1009)
.+..+..++.|+.|+|++|.+. .+|..+.++++|++|+|++|+|+ .+|..|+.+++|+.|+|++|+|+. +|..|..+
T Consensus 216 ~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~l 292 (727)
T 4b8c_D 216 PKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTS-LPAELGSC 292 (727)
T ss_dssp ------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSS-CCSSGGGG
T ss_pred ChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCc-cChhhcCC
Confidence 3444444455555555555554 44444445555555555555555 455555555555555555555552 35555555
Q ss_pred cccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCcccccccc-ceeeeecCcccccCCCcccccccccceec
Q 037197 474 PSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEK-LVSLNLRNNRFSGEIPKAVATMPTLAILD 552 (1009)
Q Consensus 474 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 552 (1009)
++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.++|.+|.. |+.|+
T Consensus 293 ~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~ 365 (727)
T 4b8c_D 293 FQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIE 365 (727)
T ss_dssp TTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----------
T ss_pred CCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeE
Confidence 55555555555554 34555555566666666666666555555544322 223556666666655543 33444
Q ss_pred CCcc--------ccccccCcCcCCCCCCcEEecCCCcccc
Q 037197 553 MSNN--------SLFGRIPENFGASPALEMLNLSYNKLEG 584 (1009)
Q Consensus 553 Ls~N--------~l~~~~p~~~~~l~~L~~L~ls~N~l~g 584 (1009)
+++| .|.+.++..+.++..+....+++|-+.+
T Consensus 366 l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 366 INTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp ------------------------------------CCCG
T ss_pred eecccccccccCCccccccchhhcccccceeeeecccccc
Confidence 5544 3333334444444555555555555543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=1.8e-18 Score=175.84 Aligned_cols=136 Identities=21% Similarity=0.293 Sum_probs=96.5
Q ss_pred ccchhccccCcccCCccc-ccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecC
Q 037197 475 SLQTFMASHNNLQAKIPN-ELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDM 553 (1009)
Q Consensus 475 ~L~~L~l~~N~l~~~~p~-~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 553 (1009)
++++|++++|++++..+. .|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|||
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 445555555555544443 3677778888888888888777888888888888888888888777777888888888888
Q ss_pred CccccccccCcCcCCCCCCcEEecCCCccccCCCCCCcccccCCcccccCcCCCCCC
Q 037197 554 SNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSV 610 (1009)
Q Consensus 554 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lcg~~ 610 (1009)
++|+|++.+|..|..+++|++|+|++|++++..|.......+....+.++...|+.|
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 888888888888888888888888888888877642211112223444555566654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.9e-18 Score=175.28 Aligned_cols=154 Identities=20% Similarity=0.245 Sum_probs=81.3
Q ss_pred ccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccch
Q 037197 399 STCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQT 478 (1009)
Q Consensus 399 ~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 478 (1009)
..+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|+++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~--------------- 101 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVT--------------- 101 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCB---------------
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccC---------------
Confidence 44555555666655555 333 4555555555555555443 1223444445555555555444
Q ss_pred hccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCcccc
Q 037197 479 FMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSL 558 (1009)
Q Consensus 479 L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 558 (1009)
+..+..+..+++|+.|+|++|++++..|..+..+++|++|+|++|++.+.+| .+..+++|+.|++++|++
T Consensus 102 ---------~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i 171 (197)
T 4ezg_A 102 ---------SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGV 171 (197)
T ss_dssp ---------GGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCC
T ss_pred ---------cccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCC
Confidence 4444455555555555555555555555555555556666666655222344 455666666666666666
Q ss_pred ccccCcCcCCCCCCcEEecCCCccc
Q 037197 559 FGRIPENFGASPALEMLNLSYNKLE 583 (1009)
Q Consensus 559 ~~~~p~~~~~l~~L~~L~ls~N~l~ 583 (1009)
++. + .+..+++|++|++++|++.
T Consensus 172 ~~~-~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 172 HDY-R-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCC-T-TGGGCSSCCEEEECBC---
T ss_pred cCh-H-HhccCCCCCEEEeeCcccC
Confidence 542 2 4556666666666666654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-18 Score=185.53 Aligned_cols=127 Identities=23% Similarity=0.337 Sum_probs=55.0
Q ss_pred ccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCcc
Q 037197 158 LGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLR 237 (1009)
Q Consensus 158 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 237 (1009)
++.+++|++|+|++|.+++..+ +.++++|++|+|++|++++ +|. +.. ++|++|+|++|++++. ..++++++|+
T Consensus 59 l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~ 131 (263)
T 1xeu_A 59 MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLE 131 (263)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCC
T ss_pred HhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCccccc
Confidence 3344444444444444432222 4444444444444444442 221 111 4444444444444432 1344444455
Q ss_pred EEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccC
Q 037197 238 YLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQIS 295 (1009)
Q Consensus 238 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 295 (1009)
+|++++|++++. ..++.+++|+.|+|++|.+++. ..+..+++|+.|++++|.++
T Consensus 132 ~L~Ls~N~i~~~--~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 132 ILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp EEECTTSCCCBC--GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEE
T ss_pred EEECCCCcCCCC--hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCccc
Confidence 555555544432 1344445555555555555433 33444555555555555554
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=9.7e-18 Score=178.98 Aligned_cols=139 Identities=16% Similarity=0.173 Sum_probs=105.5
Q ss_pred CCcCceeccCCceEEEEEEECCCCeE--EEEEEcccCCCCh----------------------hhHHHHHHHHHHHhccC
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMV--VAVKKLWRSDNDI----------------------ESGDDLFREVSLLGRLR 755 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 755 (1009)
|+..+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+++++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678999999999999999666888 9999875432110 01124568999999998
Q ss_pred CCce--eeEEeEEEcCCeEEEEEeccCC-C----ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHH-hcCCCCeEE
Q 037197 756 HRNI--VRLLGYLHNETNVMMVYDYMPN-D----SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH-HDCQPPVIH 827 (1009)
Q Consensus 756 Hpni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH 827 (1009)
|+++ +.++++ ...++||||+.+ | +|.++... .++..+..++.|++.|++||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8754 444443 246899999942 4 66665432 223455678999999999999 87 9999
Q ss_pred eccCCCcEEeCCCCcEEEcccccceec
Q 037197 828 RDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 828 ~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
|||||+||+++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-17 Score=169.77 Aligned_cols=154 Identities=19% Similarity=0.261 Sum_probs=104.4
Q ss_pred ccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCc
Q 037197 374 LCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLS 453 (1009)
Q Consensus 374 l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 453 (1009)
...+++|+.|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..|..+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 356789999999999999 555 69999999999999997763 34788999999999999999988888888888999
Q ss_pred EEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcc
Q 037197 454 FVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNR 533 (1009)
Q Consensus 454 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 533 (1009)
+|++++|++++..+..+..+++|+.|++++|++.+.+| .+..+++|+.|++++|++++. + .+..+++|+.|++++|+
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC-
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcc
Confidence 99888888877555555555555555555554212222 344444444444444444421 1 33334444444444444
Q ss_pred c
Q 037197 534 F 534 (1009)
Q Consensus 534 l 534 (1009)
+
T Consensus 193 i 193 (197)
T 4ezg_A 193 I 193 (197)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.4e-17 Score=178.42 Aligned_cols=171 Identities=22% Similarity=0.278 Sum_probs=100.5
Q ss_pred cccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCcee
Q 037197 280 SITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRL 359 (1009)
Q Consensus 280 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L 359 (1009)
.+.++..+++++|.+++ ++ .+..+++|++|++++|.++.. + .+..+++|+.|++++|++++..+ +..+++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 44556666666666663 33 466666677777777766643 2 45666666666666666665444 5666666666
Q ss_pred eccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeeccccc
Q 037197 360 DASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLT 439 (1009)
Q Consensus 360 ~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 439 (1009)
++++|.+++. |. +.. .+|+.|++++|++++. ..+..+++|+.|++++|++++. + .+..+++|+.|+|++|+++
T Consensus 91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 6666666542 22 112 5666666666666542 2355666666666666666543 2 4555666666666666665
Q ss_pred ccCCcCCcCCCCCcEEecccCccccc
Q 037197 440 GQIPDDISLSTSLSFVDISWNHLESY 465 (1009)
Q Consensus 440 ~~~p~~~~~l~~L~~L~Ls~N~l~~~ 465 (1009)
+. ..+..+++|+.|++++|.++..
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 44 4455556666666666665543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=1.7e-17 Score=168.55 Aligned_cols=130 Identities=21% Similarity=0.261 Sum_probs=69.0
Q ss_pred cEEEcccCccccccCCccCCCCcccEEEeecccccccCCc-CCcCCCCCcEEecccCcccccCCCcccCCcccchhcccc
Q 037197 405 VRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPD-DISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASH 483 (1009)
Q Consensus 405 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 483 (1009)
+.+++++|+++ .+|..+.. +|++|++++|+|++..+. .+..+++|+.|+|++|+|+++.|..|..+++|++|++++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45666666664 45544432 566666666666544443 255555555555555555555555555555555555555
Q ss_pred CcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccC
Q 037197 484 NNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGE 537 (1009)
Q Consensus 484 N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 537 (1009)
|++++..+..|..+++|+.|||++|+|++..|..|..+++|+.|+|++|.+++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 555544444455555555555555555544444454555555555555555443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.7e-17 Score=184.35 Aligned_cols=265 Identities=11% Similarity=0.088 Sum_probs=139.7
Q ss_pred CCCccEEEeccCccc--cccCcccCCCCCCcEEEcccCCcCCCCCccccc--------ccccccccccccccCCCcchhh
Q 037197 233 LTNLRYLDLAVGSLS--GQIPPALGRLKKLTTVYLYKNNFTGKIPPELGS--------ITSLAFLDLSDNQISGEIPVKL 302 (1009)
Q Consensus 233 l~~L~~L~L~~n~l~--~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~--------l~~L~~L~Ls~N~l~~~~~~~l 302 (1009)
+++|++|||++|++. ......+ +.+..+.+..|.| .+..|.+ +++|+.|+|++ .++...+.+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 555666666666655 2221111 1133344444422 2234445 67777777766 6664555567
Q ss_pred hcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCcc----CccCCccccCCCCCc-eeeccCccccccCCcCccCC
Q 037197 303 AELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSL----IGSLPMRLGQSSPLR-RLDASSNLLSGEIPTGLCDS 377 (1009)
Q Consensus 303 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l----~~~~~~~~~~~~~L~-~L~Ls~N~l~~~~~~~l~~l 377 (1009)
.++++|+.|++++|.+..+.+.+|.++.++..+.+..+.. .......|..+..|+ .+++.... .++..
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~---- 193 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDE---- 193 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHH----
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC---cHHHH----
Confidence 7777777777777776666666676666666555544221 111222233333333 22222110 00000
Q ss_pred CCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEec
Q 037197 378 GNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDI 457 (1009)
Q Consensus 378 ~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 457 (1009)
....-....++..+.+.++-...........+++|+.|+|++|+++...+..|..+++|+.|+|
T Consensus 194 ----------------~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l 257 (329)
T 3sb4_A 194 ----------------IMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL 257 (329)
T ss_dssp ----------------HHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred ----------------HhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence 0000011233344444433211111100112456666666666666444555666666666666
Q ss_pred ccCcccccCCCcccCCcccc-hhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeee
Q 037197 458 SWNHLESYLPSSILSIPSLQ-TFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNL 529 (1009)
Q Consensus 458 s~N~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~L 529 (1009)
.+| ++.+.+.+|.++++|+ .+++.+ +++.+.+.+|.++++|+.|+++.|+++.+.+..|.++++|+.|+.
T Consensus 258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 666 6666666677777776 777766 565555677777777777777777777666677777777777653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.8e-17 Score=184.18 Aligned_cols=101 Identities=13% Similarity=0.077 Sum_probs=56.7
Q ss_pred CCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCccc-EEEeecccccccCCcCCcCCCCCcEEe
Q 037197 378 GNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQ-RLEMANNNLTGQIPDDISLSTSLSFVD 456 (1009)
Q Consensus 378 ~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~ 456 (1009)
++|+.|++++|+++...+.+|.+|++|+.|++.+| +....+.+|.++++|+ .+++.+ +++..-+..|..+++|+.|+
T Consensus 226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 44555555555555444455555555555555555 4434444555555565 566655 45544445566666666666
Q ss_pred cccCcccccCCCcccCCcccchhc
Q 037197 457 ISWNHLESYLPSSILSIPSLQTFM 480 (1009)
Q Consensus 457 Ls~N~l~~~~~~~~~~l~~L~~L~ 480 (1009)
++.|+++.+.+.+|.++++|+.++
T Consensus 304 l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 304 ATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp ECSSCCCEECTTTTCTTCCCCEEE
T ss_pred eCCCccCccchhhhcCCcchhhhc
Confidence 666666666666666666666554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.2e-16 Score=155.59 Aligned_cols=133 Identities=22% Similarity=0.239 Sum_probs=78.0
Q ss_pred CcccEEEeeccccc-ccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEE
Q 037197 426 PSLQRLEMANNNLT-GQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLD 504 (1009)
Q Consensus 426 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~Ld 504 (1009)
++|+.|++++|+++ +.+|..+..+++|+.|++++|.+++. ..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--------------------------~~~~~l~~L~~L~ 77 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--------------------------SNLPKLPKLKKLE 77 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--------------------------SSCCCCSSCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--------------------------hhhccCCCCCEEE
Confidence 45555555555555 44555455555555555555555443 4455556666666
Q ss_pred eecCCCCCCCCccccccccceeeeecCcccccCC-CcccccccccceecCCccccccccC---cCcCCCCCCcEEecCCC
Q 037197 505 LSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEI-PKAVATMPTLAILDMSNNSLFGRIP---ENFGASPALEMLNLSYN 580 (1009)
Q Consensus 505 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~ls~N 580 (1009)
|++|++++.+|..+..+++|+.|+|++|++++.. +..+..+++|+.|++++|++++..+ ..+..+++|++||+++|
T Consensus 78 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n 157 (168)
T 2ell_A 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDR 157 (168)
T ss_dssp EESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEET
T ss_pred CcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCC
Confidence 6666666555555555666666666666666422 2556666666666666666665544 45666666666666666
Q ss_pred cccc
Q 037197 581 KLEG 584 (1009)
Q Consensus 581 ~l~g 584 (1009)
.++.
T Consensus 158 ~~~~ 161 (168)
T 2ell_A 158 EDQE 161 (168)
T ss_dssp TSCB
T ss_pred Chhh
Confidence 6653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.7e-16 Score=155.10 Aligned_cols=133 Identities=21% Similarity=0.185 Sum_probs=100.9
Q ss_pred CccccEEEcccCccc-cccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchh
Q 037197 401 CKSLVRVRVQNNLIS-GTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTF 479 (1009)
Q Consensus 401 ~~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 479 (1009)
.++|++|++++|+++ +.+|..+..+++|++|+|++|++++. ..+..+++|++|++++|++++.+|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~------------ 88 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLD------------ 88 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCC------------
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHH------------
Confidence 478999999999998 78898899999999999999999965 778888888888888888876444
Q ss_pred ccccCcccCCcccccccCCcCcEEEeecCCCCCCCC-ccccccccceeeeecCcccccCCC---cccccccccceecCCc
Q 037197 480 MASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIP-ASIASCEKLVSLNLRNNRFSGEIP---KAVATMPTLAILDMSN 555 (1009)
Q Consensus 480 ~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~ 555 (1009)
..+..+++|+.|+|++|++++..+ ..+..+++|+.|+|++|.+++..+ ..+..+++|+.||+++
T Consensus 89 ------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~ 156 (168)
T 2ell_A 89 ------------MLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYD 156 (168)
T ss_dssp ------------HHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEE
T ss_pred ------------HHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCC
Confidence 344455666666666666664322 566667777777777777775444 4677777777777777
Q ss_pred cccc
Q 037197 556 NSLF 559 (1009)
Q Consensus 556 N~l~ 559 (1009)
|.+.
T Consensus 157 n~~~ 160 (168)
T 2ell_A 157 REDQ 160 (168)
T ss_dssp TTSC
T ss_pred CChh
Confidence 7765
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1e-15 Score=155.35 Aligned_cols=129 Identities=24% Similarity=0.310 Sum_probs=101.7
Q ss_pred EEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcc
Q 037197 454 FVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNR 533 (1009)
Q Consensus 454 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 533 (1009)
.+++++|+++.+ |..+. ++|++|++++|+++ .+|..|..+++|+.|||++|+|++..+..|.++++|++|+|++|+
T Consensus 14 ~l~~~~~~l~~i-p~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLKVL-PKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCSSC-CSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCCcC-CCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 455555555542 22221 35666666666666 456778888889999999999988888888899999999999999
Q ss_pred cccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCC
Q 037197 534 FSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPV 586 (1009)
Q Consensus 534 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~i 586 (1009)
|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 99888888999999999999999999887778999999999999999987643
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=7.9e-16 Score=154.18 Aligned_cols=115 Identities=20% Similarity=0.193 Sum_probs=87.2
Q ss_pred cccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecC
Q 037197 474 PSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDM 553 (1009)
Q Consensus 474 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 553 (1009)
++|+.|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 35555555555555555556677777888888888887666666778888888888888888766677788888888888
Q ss_pred CccccccccCcCcCCCCCCcEEecCCCccccCCCC
Q 037197 554 SNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPS 588 (1009)
Q Consensus 554 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~ 588 (1009)
++|++++..+..|..+++|++|+|++|++++.+|.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 88888877776778888888888888888887763
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=5e-16 Score=150.81 Aligned_cols=127 Identities=21% Similarity=0.282 Sum_probs=65.4
Q ss_pred CcccEEEeeccccc-ccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEE
Q 037197 426 PSLQRLEMANNNLT-GQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLD 504 (1009)
Q Consensus 426 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~Ld 504 (1009)
++|+.|++++|+++ +.+|..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45555666666655 45555555555666666666655553 3444444455555555554444444444555555555
Q ss_pred eecCCCCCC-CCccccccccceeeeecCcccccCCC---cccccccccceecCC
Q 037197 505 LSSNSLSGE-IPASIASCEKLVSLNLRNNRFSGEIP---KAVATMPTLAILDMS 554 (1009)
Q Consensus 505 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls 554 (1009)
+++|++++. .|..+..+++|+.|+|++|++++..+ ..+..+++|+.||++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555555532 22444555555555555555554333 344455555555544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.9e-16 Score=152.51 Aligned_cols=129 Identities=19% Similarity=0.217 Sum_probs=117.0
Q ss_pred CCCCcEEecccCccc-ccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceee
Q 037197 449 STSLSFVDISWNHLE-SYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSL 527 (1009)
Q Consensus 449 l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L 527 (1009)
.++|+.|++++|.++ +.+|..+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++.+|..+..+++|+.|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 478999999999998 67888899999999999999999876 789999999999999999998889988889999999
Q ss_pred eecCcccccC-CCcccccccccceecCCccccccccC---cCcCCCCCCcEEecCC
Q 037197 528 NLRNNRFSGE-IPKAVATMPTLAILDMSNNSLFGRIP---ENFGASPALEMLNLSY 579 (1009)
Q Consensus 528 ~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~ls~ 579 (1009)
+|++|++++. .|..++.+++|+.|++++|++++..+ ..+..+++|+.||+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999863 45889999999999999999998877 6789999999999874
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.9e-15 Score=151.39 Aligned_cols=132 Identities=18% Similarity=0.227 Sum_probs=83.4
Q ss_pred cEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecC
Q 037197 429 QRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSN 508 (1009)
Q Consensus 429 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N 508 (1009)
+.+++++|+++ .+|..+ .++|+.|++++|+++++.+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 34444444444 233222 245555555555555555555555666666666666666555555667777777777777
Q ss_pred CCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccC
Q 037197 509 SLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIP 563 (1009)
Q Consensus 509 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 563 (1009)
+|++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 7776666667777777777777777775555556777777777777777776555
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.3e-15 Score=152.73 Aligned_cols=109 Identities=20% Similarity=0.217 Sum_probs=66.3
Q ss_pred CCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeec
Q 037197 451 SLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLR 530 (1009)
Q Consensus 451 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls 530 (1009)
+|+.|+|++|+|+. +|..|..+++|+.|++++|++++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|+
T Consensus 32 ~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 44445555555543 33445555555555555555555555556666666666666666666666666666777777777
Q ss_pred CcccccCCCcccccccccceecCCcccccc
Q 037197 531 NNRFSGEIPKAVATMPTLAILDMSNNSLFG 560 (1009)
Q Consensus 531 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 560 (1009)
+|+|++..+..|..+++|+.|+|++|++..
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 777765555556667777777777776653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3.7e-14 Score=160.77 Aligned_cols=270 Identities=11% Similarity=0.089 Sum_probs=138.9
Q ss_pred CCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEe
Q 037197 162 TSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDL 241 (1009)
Q Consensus 162 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 241 (1009)
..++.+.+.++ ++.+...+|.+. +|+.+.+.++ ++......|.++ +|+.+.+.. .++.....+|.++++|+.+++
T Consensus 113 ~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 44445554432 332334445543 4555655544 443334445442 455555543 444444455666666666666
Q ss_pred ccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCC
Q 037197 242 AVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGL 321 (1009)
Q Consensus 242 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 321 (1009)
++|+++.....+|. ..+|+.+.|..+ ++.....+|.++++|+.+++..| ++.....+|.+ .+|+.+.+ .+.++.+
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I 262 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNI 262 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEE
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEE
Confidence 66655544444444 355666666532 44444555555566666665543 33233344444 45555555 3344444
Q ss_pred CCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccC
Q 037197 322 IPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTC 401 (1009)
Q Consensus 322 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~ 401 (1009)
...+|.++++|+.+++.+|.+.. +.+....+..|..+.+|+.+++. +.++.....+|.+|
T Consensus 263 ~~~aF~~c~~L~~l~l~~~~~~~-------------------~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c 322 (401)
T 4fdw_A 263 ASRAFYYCPELAEVTTYGSTFND-------------------DPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGN 322 (401)
T ss_dssp CTTTTTTCTTCCEEEEESSCCCC-------------------CTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTC
T ss_pred ChhHhhCCCCCCEEEeCCccccC-------------------CcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCC
Confidence 55555666666666555554330 00012333445555555555555 23444455556666
Q ss_pred ccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCC-CCCcEEecccCccc
Q 037197 402 KSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLS-TSLSFVDISWNHLE 463 (1009)
Q Consensus 402 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~ 463 (1009)
.+|+.+.+.+| ++.....+|.++ +|+.+++.+|.+....+..|..+ ..+..|++..+.+.
T Consensus 323 ~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 323 RKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred CCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 66666666443 443445556666 66666666666654444555555 35666666666554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.7e-14 Score=161.83 Aligned_cols=269 Identities=11% Similarity=0.101 Sum_probs=125.3
Q ss_pred CCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEc
Q 037197 258 KKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLEL 337 (1009)
Q Consensus 258 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 337 (1009)
..++.+.+.+ .++.+...+|.++ +|+.+.+.+| ++.....+|.+. +|+.+.+.. .++.+...+|.++++|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4445555533 3443444555553 5666666554 443444455552 466666654 444444555555555555555
Q ss_pred cCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccc
Q 037197 338 WKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGT 417 (1009)
Q Consensus 338 ~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~ 417 (1009)
.+|.++......|. ..+|+.+.+..+ +......+|.+|++|+.+++.+| ++..
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-------------------------l~~I~~~aF~~~~~L~~l~l~~~-l~~I 240 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-------------------------LKEIGSQAFLKTSQLKTIEIPEN-VSTI 240 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-------------------------CCEECTTTTTTCTTCCCEECCTT-CCEE
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-------------------------hheehhhHhhCCCCCCEEecCCC-ccCc
Confidence 55555443333333 234444444322 33333444444555555554443 2323
Q ss_pred cCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccC
Q 037197 418 IPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQAC 497 (1009)
Q Consensus 418 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 497 (1009)
...+|.+ .+|+.+.+ .|.++..-...|..+++|+.+++.+|.+.. +.+....+..|.++
T Consensus 241 ~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~-------------------~~~~~I~~~aF~~c 299 (401)
T 4fdw_A 241 GQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFND-------------------DPEAMIHPYCLEGC 299 (401)
T ss_dssp CTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCC-------------------CTTCEECTTTTTTC
T ss_pred ccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccC-------------------CcccEECHHHhhCC
Confidence 3333444 44555555 233443334445555555555555544430 00001223344444
Q ss_pred CcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCC-CCcEEe
Q 037197 498 PSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASP-ALEMLN 576 (1009)
Q Consensus 498 ~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~ 576 (1009)
++|+.++|. |.++.+....|.++.+|+.++|.+| ++..-+..|.++ +|+.+++++|.+....+..|..++ .++.|+
T Consensus 300 ~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~ 376 (401)
T 4fdw_A 300 PKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIR 376 (401)
T ss_dssp TTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEE
T ss_pred ccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEE
Confidence 444444444 2244333444555555555555333 333334445555 555555555555544455555553 455555
Q ss_pred cCCCcc
Q 037197 577 LSYNKL 582 (1009)
Q Consensus 577 ls~N~l 582 (1009)
+..|.+
T Consensus 377 vp~~~~ 382 (401)
T 4fdw_A 377 VPAESV 382 (401)
T ss_dssp ECGGGH
T ss_pred eCHHHH
Confidence 555443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.56 E-value=5e-14 Score=160.48 Aligned_cols=158 Identities=11% Similarity=0.006 Sum_probs=83.4
Q ss_pred CCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccc
Q 037197 151 SGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEF 230 (1009)
Q Consensus 151 ~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~ 230 (1009)
+.....+|.++++|+++.+..+ ++.+...+|.++++|+.++|.++ ++......|.++++|+.+.+..+ +......+|
T Consensus 60 tsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF 136 (394)
T 4fs7_A 60 VSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAF 136 (394)
T ss_dssp EEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTT
T ss_pred eEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceee
Confidence 3334456777777777777643 55455567777777777777654 44344456667777776666543 333444555
Q ss_pred cCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCe
Q 037197 231 GNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQL 310 (1009)
Q Consensus 231 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 310 (1009)
.+...++...... +......+|.++++|+.+.+.++. .......|.++.+|+.+++..| ++......|.++..|+.
T Consensus 137 ~~~~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~ 212 (394)
T 4fs7_A 137 KGCDFKEITIPEG--VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLEN 212 (394)
T ss_dssp TTCCCSEEECCTT--CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCB
T ss_pred ecccccccccCcc--ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccce
Confidence 5554333322221 222334456666666666665432 2233445555555555555544 22223334444444444
Q ss_pred Eeccc
Q 037197 311 LNLMC 315 (1009)
Q Consensus 311 L~L~~ 315 (1009)
+.+..
T Consensus 213 i~~~~ 217 (394)
T 4fs7_A 213 MEFPN 217 (394)
T ss_dssp CCCCT
T ss_pred eecCC
Confidence 44443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-15 Score=168.67 Aligned_cols=141 Identities=13% Similarity=0.081 Sum_probs=100.1
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC------------hhhHH--------HHHHHHHHHhccCCCce
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND------------IESGD--------DLFREVSLLGRLRHRNI 759 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~------------~~~~~--------~~~~E~~~l~~l~Hpni 759 (1009)
|+..+.||+|+||.||+|.... |+.||||+++..... ..... ...+|...+.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~-G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEK-GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTT-CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECCC-CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 7889999999999999999865 899999987532100 00011 11256677777754443
Q ss_pred eeEEeEEEcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC
Q 037197 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA 839 (1009)
Q Consensus 760 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~ 839 (1009)
.-..-+.... .++||||++|++|.++.... ....++.|++.++.|||+. |||||||||.|||+++
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~~~----------~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSSVP----------DPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCCCS----------CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcccH----------HHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 2221121222 37999999999887664321 1234789999999999998 9999999999999988
Q ss_pred CC----------cEEEcccccceeccc
Q 037197 840 NL----------EARIADFGLARMMLH 856 (1009)
Q Consensus 840 ~~----------~~kl~DfGls~~~~~ 856 (1009)
++ .+.|+||+-+....+
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred CCCcccccccccceEEEEeCCcccCCC
Confidence 76 389999998865433
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=5.9e-17 Score=165.63 Aligned_cols=151 Identities=23% Similarity=0.296 Sum_probs=94.2
Q ss_pred CcccEEEeecccccccCCc------CCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCc
Q 037197 426 PSLQRLEMANNNLTGQIPD------DISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPS 499 (1009)
Q Consensus 426 ~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 499 (1009)
..++.++++.|.++|.+|. .+..+++|+.|++++|++++ +| .+..+++|+.|++++|+++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3444444444444444443 45555555555555555555 33 5555566666666666665 34555666677
Q ss_pred CcEEEeecCCCCCCCCccccccccceeeeecCcccccCCC-cccccccccceecCCccccccccCcC----------cCC
Q 037197 500 LSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIP-KAVATMPTLAILDMSNNSLFGRIPEN----------FGA 568 (1009)
Q Consensus 500 L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~ 568 (1009)
|+.|+|++|++++ +| .+..+++|+.|+|++|++++..+ ..+..+++|+.|++++|++++.+|.. +..
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~ 172 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR 172 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHh
Confidence 7777777777775 34 56677777777777777764222 46777777777777777777776653 667
Q ss_pred CCCCcEEecCCCccc
Q 037197 569 SPALEMLNLSYNKLE 583 (1009)
Q Consensus 569 l~~L~~L~ls~N~l~ 583 (1009)
++.|+.|| +|.++
T Consensus 173 l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 173 LPNLKKLD--GMPVD 185 (198)
T ss_dssp CSSCSEEC--CGGGT
T ss_pred CCCcEEEC--CcccC
Confidence 77777776 55554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.8e-13 Score=155.82 Aligned_cols=160 Identities=10% Similarity=-0.008 Sum_probs=74.6
Q ss_pred ccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcc
Q 037197 198 LTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPE 277 (1009)
Q Consensus 198 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 277 (1009)
++.....+|.++++|+.+.|.. .++.+...+|.++++|+.+++..+ ++.....+|.++.+|+.+.+..+ +......+
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence 3333344566666666666643 344444555666666666666543 44344455555666655554432 23233334
Q ss_pred cccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCc
Q 037197 278 LGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLR 357 (1009)
Q Consensus 278 ~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~ 357 (1009)
|.++..+.......... ....+|.++++|+.+.+.++. ..+....|.++.+|+.+++..| ++......|..+..|+
T Consensus 136 F~~~~~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~ 211 (394)
T 4fs7_A 136 FKGCDFKEITIPEGVTV--IGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLE 211 (394)
T ss_dssp TTTCCCSEEECCTTCCE--ECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCC
T ss_pred eecccccccccCccccc--cchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccc
Confidence 44433222222221111 222345555555555554332 2233445555555555555443 3333344444445555
Q ss_pred eeeccCc
Q 037197 358 RLDASSN 364 (1009)
Q Consensus 358 ~L~Ls~N 364 (1009)
.+.+..+
T Consensus 212 ~i~~~~~ 218 (394)
T 4fs7_A 212 NMEFPNS 218 (394)
T ss_dssp BCCCCTT
T ss_pred eeecCCC
Confidence 5444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=4.7e-15 Score=148.28 Aligned_cols=133 Identities=17% Similarity=0.173 Sum_probs=68.9
Q ss_pred cCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCc
Q 037197 422 LGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLS 501 (1009)
Q Consensus 422 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 501 (1009)
+.+.++|+.|++++|+++ .+|......++|+.|++++|+|+++ ..|.. +++|+
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~------------------------l~~L~ 67 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPL------------------------LRRLK 67 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCC------------------------CSSCC
T ss_pred cCCcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc--ccccc------------------------CCCCC
Confidence 445566777777777766 3343222223666666666666653 34444 44555
Q ss_pred EEEeecCCCCCCCCccccccccceeeeecCcccccCCCc--ccccccccceecCCccccccccCcC----cCCCCCCcEE
Q 037197 502 VLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPK--AVATMPTLAILDMSNNSLFGRIPEN----FGASPALEML 575 (1009)
Q Consensus 502 ~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L 575 (1009)
.|+|++|+|++..|..+..+++|+.|+|++|+|+ .+|. .+..+++|+.|++++|+++ .+|.. +..++.|+.|
T Consensus 68 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~L 145 (176)
T 1a9n_A 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVL 145 (176)
T ss_dssp EEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEE
T ss_pred EEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcccee
Confidence 5555555555333333345555555555555553 3343 4555555555555555554 23332 4555555555
Q ss_pred ecCCCccc
Q 037197 576 NLSYNKLE 583 (1009)
Q Consensus 576 ~ls~N~l~ 583 (1009)
|+++|.++
T Consensus 146 d~~~n~~~ 153 (176)
T 1a9n_A 146 DFQKVKLK 153 (176)
T ss_dssp TTEECCHH
T ss_pred CCCcCCHH
Confidence 55555544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=8.7e-15 Score=146.36 Aligned_cols=135 Identities=21% Similarity=0.242 Sum_probs=97.0
Q ss_pred cccccCccccEEEcccCccccccCCccCCCC-cccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCc
Q 037197 396 VSLSTCKSLVRVRVQNNLISGTIPVGLGNLP-SLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIP 474 (1009)
Q Consensus 396 ~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 474 (1009)
..+.++.+|+.|++++|+++. +|. +..+. +|+.|++++|+|++. ..+..+++|+.|++++|+|+++.+..|
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~---- 84 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLD---- 84 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHH----
T ss_pred HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchh----
Confidence 356778999999999999994 454 55554 999999999999965 678999999999999999987544433
Q ss_pred ccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCc--cccccccceeeeecCcccccCCCcc----ccccccc
Q 037197 475 SLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPA--SIASCEKLVSLNLRNNRFSGEIPKA----VATMPTL 548 (1009)
Q Consensus 475 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L 548 (1009)
..+++|+.|+|++|+++ .+|. .+..+++|+.|+|++|.++ .+|.. +..+++|
T Consensus 85 --------------------~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L 142 (176)
T 1a9n_A 85 --------------------QALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQV 142 (176)
T ss_dssp --------------------HHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTC
T ss_pred --------------------hcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcc
Confidence 44555555555555554 3333 5556666666666666666 44543 6677777
Q ss_pred ceecCCcccccc
Q 037197 549 AILDMSNNSLFG 560 (1009)
Q Consensus 549 ~~L~Ls~N~l~~ 560 (1009)
+.||+++|.+..
T Consensus 143 ~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 143 RVLDFQKVKLKE 154 (176)
T ss_dssp SEETTEECCHHH
T ss_pred ceeCCCcCCHHH
Confidence 777777776643
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.3e-16 Score=163.18 Aligned_cols=137 Identities=16% Similarity=0.212 Sum_probs=73.0
Q ss_pred ccccCccCcccccccccCCCCCC------CCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCcccc
Q 037197 110 LANLTALKSMDVSQNNFIGSFPT------GLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFR 183 (1009)
Q Consensus 110 l~~l~~L~~L~Ls~n~l~~~~p~------~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~ 183 (1009)
+.....++.++++.+.+.+.+|. .++.+++|++|+|++|++++ +| .+.++++|++|++++|.++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 45556666667776666666554 44445555555555555543 34 5555555555555555555 3444455
Q ss_pred CccccceeeeccccccccCCccCCCCcchhhhhcccccccccCC-ccccCCCCccEEEeccCccccccC
Q 037197 184 NLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIP-AEFGNLTNLRYLDLAVGSLSGQIP 251 (1009)
Q Consensus 184 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~ 251 (1009)
.+++|++|+|++|++++ +| .++.+++|++|++++|++++..+ ..+..+++|++|++++|.+++..|
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence 55555555555555553 23 34555555555555555553221 345555555555555555554433
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=7.1e-14 Score=138.64 Aligned_cols=107 Identities=21% Similarity=0.250 Sum_probs=78.8
Q ss_pred hhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccc
Q 037197 478 TFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNS 557 (1009)
Q Consensus 478 ~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 557 (1009)
.+++++|+++. +|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+
T Consensus 13 ~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 34444444442 333332 567778888888887777778888888888888888886666677888888888888888
Q ss_pred cccccCcCcCCCCCCcEEecCCCccccCCC
Q 037197 558 LFGRIPENFGASPALEMLNLSYNKLEGPVP 587 (1009)
Q Consensus 558 l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip 587 (1009)
|++..|..|..+++|++|+|++|++++..+
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 887777778888888888888888877655
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.9e-13 Score=135.98 Aligned_cols=106 Identities=17% Similarity=0.202 Sum_probs=75.4
Q ss_pred hccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCcccc
Q 037197 479 FMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSL 558 (1009)
Q Consensus 479 L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 558 (1009)
+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|||++|+|
T Consensus 17 l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l 93 (174)
T 2r9u_A 17 VNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHL 93 (174)
T ss_dssp EECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCcc
Confidence 444444443 2333332 5677777777777777777777788888888888888765555677788888888888888
Q ss_pred ccccCcCcCCCCCCcEEecCCCccccCCC
Q 037197 559 FGRIPENFGASPALEMLNLSYNKLEGPVP 587 (1009)
Q Consensus 559 ~~~~p~~~~~l~~L~~L~ls~N~l~g~ip 587 (1009)
++..+..|..+++|++|+|++|++++..+
T Consensus 94 ~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 94 KSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 87766678888888888888888876543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.42 E-value=2.7e-13 Score=134.48 Aligned_cols=88 Identities=19% Similarity=0.205 Sum_probs=49.1
Q ss_pred cccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecC
Q 037197 474 PSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDM 553 (1009)
Q Consensus 474 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 553 (1009)
++|+.|++++|+|++..|..|..+++|+.|||++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 33444444444444444455555555556666666665555555555666666666666666544455666666666666
Q ss_pred Cccccccc
Q 037197 554 SNNSLFGR 561 (1009)
Q Consensus 554 s~N~l~~~ 561 (1009)
++|+++..
T Consensus 110 ~~N~~~c~ 117 (170)
T 3g39_A 110 LNNPWDCA 117 (170)
T ss_dssp CSSCBCTT
T ss_pred CCCCCCCC
Confidence 66666544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.38 E-value=7.9e-13 Score=131.51 Aligned_cols=103 Identities=21% Similarity=0.261 Sum_probs=44.6
Q ss_pred EEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCC
Q 037197 430 RLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNS 509 (1009)
Q Consensus 430 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~ 509 (1009)
.+++++|+++ .+|..+. ++|+.|+|++|+|+++.|..|..+++|+.|++++|+|++..+..|..+++|+.|||++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 4444444443 3343332 444445555554444444444444444444444444443333333444444444444444
Q ss_pred CCCCCCccccccccceeeeecCcccc
Q 037197 510 LSGEIPASIASCEKLVSLNLRNNRFS 535 (1009)
Q Consensus 510 l~~~~p~~~~~l~~L~~L~Ls~N~l~ 535 (1009)
|++..+..|..+++|+.|+|++|.+.
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred cceeCHHHhccccCCCEEEeCCCCcc
Confidence 44333333444444444444444443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.32 E-value=9.4e-11 Score=133.30 Aligned_cols=329 Identities=12% Similarity=0.104 Sum_probs=131.6
Q ss_pred ccccCCC-CccEEEeccCccccccCcccCCCCCCcEEEcccCC---cCCCCCcccccccccccccccccccCCCcchhhh
Q 037197 228 AEFGNLT-NLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNN---FTGKIPPELGSITSLAFLDLSDNQISGEIPVKLA 303 (1009)
Q Consensus 228 ~~~~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 303 (1009)
.+|.+.. .|+.+.+..+ ++.....+|.++++|+.+.+..|. ++.....+|..+.+|+.+.+..+ ++......|.
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~ 134 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH 134 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence 3444442 3555555432 443444455555555555554432 33333444555555555555433 2223334455
Q ss_pred cccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCcee
Q 037197 304 ELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKL 383 (1009)
Q Consensus 304 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 383 (1009)
.+.+|+.+.+..+ +..+....|..+.+|+.+.+..+ ++......|. ...|+.+.+..+... .....|..+..++..
T Consensus 135 ~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~~i~ip~~~~~-i~~~af~~c~~l~~~ 210 (394)
T 4gt6_A 135 HCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALTQIHIPAKVTR-IGTNAFSECFALSTI 210 (394)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCSEEEECTTCCE-ECTTTTTTCTTCCEE
T ss_pred hhcccccccccce-eeeecccceecccccccccccce-eeEecccccc-ccceeEEEECCcccc-cccchhhhcccccee
Confidence 5555555555432 22233445555555555555433 2222222332 234555544433221 333344444444444
Q ss_pred ecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCccc
Q 037197 384 ILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLE 463 (1009)
Q Consensus 384 ~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 463 (1009)
....+......-..+.......... ..+.....+..+.+. +.++..-...|..+..|+.+.+..+. .
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~-~ 277 (394)
T 4gt6_A 211 TSDSESYPAIDNVLYEKSANGDYAL-----------IRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSV-V 277 (394)
T ss_dssp EECCSSSCBSSSCEEEECTTSCEEE-----------EECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTC-C
T ss_pred cccccccccccceeecccccccccc-----------cccccccccceEEcC-CcceEcccceeeecccccEEeccccc-c
Confidence 4333322211000000000000000 000001111122221 11221222334444444444443322 2
Q ss_pred ccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccc
Q 037197 464 SYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVA 543 (1009)
Q Consensus 464 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 543 (1009)
.+...+|.++++|+.+.+. +.++.....+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.|..+ ++..-..+|.
T Consensus 278 ~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~ 354 (394)
T 4gt6_A 278 SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFS 354 (394)
T ss_dssp EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGT
T ss_pred eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhh
Confidence 2333444455555555443 2333333445555555555555543 44344455555556666655433 4423344555
Q ss_pred cccccceecCCccccccccCcCcCCCCCCcEEecCCCc
Q 037197 544 TMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNK 581 (1009)
Q Consensus 544 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 581 (1009)
++++|+.+++++|.... ..+.....|+.+.+..|.
T Consensus 355 ~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 355 NCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp TCTTCCEEEESSCHHHH---HTCBCCCCC---------
T ss_pred CCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCC
Confidence 56666666665554321 234445555555555443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.30 E-value=5.4e-11 Score=135.30 Aligned_cols=132 Identities=16% Similarity=0.097 Sum_probs=80.4
Q ss_pred CCccccCCC-CCCeeeccCCccCCcCCccccCccccceeeecccc---ccccCCccCCCCcchhhhhcccccccccCCcc
Q 037197 154 LPEDLGNAT-SLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNN---LTGKIPPELGQLSSLETIILGYNAFEGEIPAE 229 (1009)
Q Consensus 154 ~p~~l~~l~-~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~---l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~ 229 (1009)
...+|.+.. .|+.+.+..+ ++.+...+|.++.+|+.+.+..|. ++......|..+.+|+.+.+..+ ++......
T Consensus 55 g~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~a 132 (394)
T 4gt6_A 55 GDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEA 132 (394)
T ss_dssp CTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTT
T ss_pred CHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhh
Confidence 345666664 5888888754 555667788888888888887764 55444566777777777776544 44355556
Q ss_pred ccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCccccccccccccccc
Q 037197 230 FGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLS 290 (1009)
Q Consensus 230 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 290 (1009)
|.++.+|+.+.+..+ +......+|..+.+|+.+.+..+ ++.....+|.. .+|+.+.+.
T Consensus 133 F~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip 190 (394)
T 4gt6_A 133 FHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIP 190 (394)
T ss_dssp TTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEEC
T ss_pred hhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEEC
Confidence 777777777777543 33344556666666666666543 33233333322 345554443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=3.3e-14 Score=159.62 Aligned_cols=158 Identities=16% Similarity=0.182 Sum_probs=73.0
Q ss_pred CCeEEecCCCCCCCCCCccccCC-----CCCCeeeccCCccCCcCCccc-cCccccceeeeccccccccCCccC-----C
Q 037197 139 GLTSVNASSNNFSGFLPEDLGNA-----TSLESLDFRGSFFEGSVPTSF-RNLQKLKFLGLSGNNLTGKIPPEL-----G 207 (1009)
Q Consensus 139 ~L~~L~Ls~n~l~~~~p~~l~~l-----~~L~~L~L~~n~~~~~~p~~~-~~l~~L~~L~L~~n~l~~~~p~~l-----~ 207 (1009)
.|++|+|++|.++......+... ++|++|+|++|.++......+ ..+++|++|+|++|.++......+ .
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 45555555555543322222221 456666666665543322222 234556666666666653322222 1
Q ss_pred CCcchhhhhccccccccc----CCccccCCCCccEEEeccCcccccc----CcccCCCCCCcEEEcccCCcCCCCC----
Q 037197 208 QLSSLETIILGYNAFEGE----IPAEFGNLTNLRYLDLAVGSLSGQI----PPALGRLKKLTTVYLYKNNFTGKIP---- 275 (1009)
Q Consensus 208 ~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~~~---- 275 (1009)
..++|++|+|++|.|+.. ++..+..+++|++|+|++|.+++.. +..+...++|++|+|++|.|++...
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~ 232 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALA 232 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHH
T ss_pred cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHH
Confidence 234455555555555432 2223344555666666666555321 3334444555555555555543211
Q ss_pred cccccccccccccccccccCC
Q 037197 276 PELGSITSLAFLDLSDNQISG 296 (1009)
Q Consensus 276 ~~~~~l~~L~~L~Ls~N~l~~ 296 (1009)
..+...++|++|+|++|.|++
T Consensus 233 ~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 233 RAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHhCCCCCEEeccCCCCCH
Confidence 122233445555555554443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=3.9e-14 Score=159.03 Aligned_cols=164 Identities=15% Similarity=0.135 Sum_probs=77.4
Q ss_pred CCCCeEecccCcccccCCcccccc-----CccCcccccccccCCCCCCCCC-CCcCCeEEecCCCCCCCCCCcccc----
Q 037197 90 RSLSSLNICCNEFASSLPKSLANL-----TALKSMDVSQNNFIGSFPTGLG-KASGLTSVNASSNNFSGFLPEDLG---- 159 (1009)
Q Consensus 90 ~~L~~L~L~~n~~~~~~~~~l~~l-----~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~l~---- 159 (1009)
++|++|+|++|.++......+..+ ++|++|+|++|.++......+. .+.+|++|+|++|+++......++
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 456666666666655443344333 4566666666665433222222 234556666666655533333321
Q ss_pred -CCCCCCeeeccCCccCCc----CCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCC
Q 037197 160 -NATSLESLDFRGSFFEGS----VPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLT 234 (1009)
Q Consensus 160 -~l~~L~~L~L~~n~~~~~----~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 234 (1009)
..++|++|+|++|.++.. ++..+..+++|++|+|++|.|+..... .++..+...+
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~--------------------~L~~~L~~~~ 211 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE--------------------LLAAQLDRNR 211 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH--------------------HHHHHGGGCS
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH--------------------HHHHHHhcCC
Confidence 234555555555555432 222234445555555555554421100 1123344444
Q ss_pred CccEEEeccCccccc----cCcccCCCCCCcEEEcccCCcCCC
Q 037197 235 NLRYLDLAVGSLSGQ----IPPALGRLKKLTTVYLYKNNFTGK 273 (1009)
Q Consensus 235 ~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~ 273 (1009)
+|++|+|++|.+++. ++..+...++|++|+|++|.|++.
T Consensus 212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 555555555555432 222333345555555555555543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=8e-12 Score=139.66 Aligned_cols=103 Identities=20% Similarity=0.197 Sum_probs=64.6
Q ss_pred ccccC-cccCCcccccccCCcCcEEEeec-CCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccc
Q 037197 480 MASHN-NLQAKIPNELQACPSLSVLDLSS-NSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNS 557 (1009)
Q Consensus 480 ~l~~N-~l~~~~p~~~~~l~~L~~LdLs~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 557 (1009)
+++++ +|+. +|. +..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|||++|+
T Consensus 14 ~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 91 (347)
T 2ifg_A 14 RCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (347)
T ss_dssp ECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence 44444 4443 444 55666666666664 66666555666666666666666666666666666666666666666666
Q ss_pred cccccCcCcCCCCCCcEEecCCCccccC
Q 037197 558 LFGRIPENFGASPALEMLNLSYNKLEGP 585 (1009)
Q Consensus 558 l~~~~p~~~~~l~~L~~L~ls~N~l~g~ 585 (1009)
|++.+|..|..++ |+.|+|++|+|...
T Consensus 92 l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 92 LESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp CSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred cceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 6665555555554 67777777776653
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.20 E-value=1.9e-11 Score=136.58 Aligned_cols=102 Identities=21% Similarity=0.264 Sum_probs=58.3
Q ss_pred EEeecc-cccccCCcCCcCCCCCcEEeccc-CcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecC
Q 037197 431 LEMANN-NLTGQIPDDISLSTSLSFVDISW-NHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSN 508 (1009)
Q Consensus 431 L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N 508 (1009)
++++++ +|+ .+|. +..+++|+.|+|++ |+|+++.+..|..+++|+.|+|++|+|++..|..|..+++|+.|||++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455554 454 3444 55555555555553 5555555555555555555555555555555555666666666666666
Q ss_pred CCCCCCCccccccccceeeeecCcccc
Q 037197 509 SLSGEIPASIASCEKLVSLNLRNNRFS 535 (1009)
Q Consensus 509 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 535 (1009)
+|++..+..|..+. |+.|+|++|.|.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 66655444454444 666666666665
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=1.8e-10 Score=123.09 Aligned_cols=144 Identities=14% Similarity=0.070 Sum_probs=110.3
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~l 774 (1009)
....|+....++.|+.+.||++... +..+++|....... .....+.+|+++++.+. +..+.++++++.+.+..|+
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 4456777777888888999999754 57899999854211 11234668999998884 6788899999998889999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD---------------------------------- 820 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~---------------------------------- 820 (1009)
||||++|.++.+..... .....++.+++++++.||+.
T Consensus 88 v~e~i~G~~l~~~~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCCTT---------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccCCc---------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999999998764211 12235788999999999981
Q ss_pred ----------------------CCCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 821 ----------------------CQPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 821 ----------------------~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
..+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01368999999999999876666799999774
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.4e-08 Score=114.73 Aligned_cols=144 Identities=13% Similarity=0.148 Sum_probs=75.0
Q ss_pred ccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCccc
Q 037197 397 SLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSL 476 (1009)
Q Consensus 397 ~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 476 (1009)
.+..+.+|+.+.+..+ +.......+.+...|+.+.+..+ ++..-...+..+.+|+.+.+..+ ++.+...+|.++.+|
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence 3444444444444333 22233334444555555555443 33233344555555555555432 444444555666666
Q ss_pred chhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccc
Q 037197 477 QTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATM 545 (1009)
Q Consensus 477 ~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 545 (1009)
+.+.+.++.++.....+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++..-..+|.+.
T Consensus 289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred ccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 66666655555445556666666666666544 55444566667777777776544 442334455544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.97 E-value=5.7e-11 Score=131.94 Aligned_cols=202 Identities=17% Similarity=0.222 Sum_probs=100.3
Q ss_pred CceeEEecccccccc-c-------cccccccCCCCCeEecccCccc---------ccCCccccccCccCcccccccccCC
Q 037197 66 GFVEKLDLSNMSLNG-S-------VSENIRGLRSLSSLNICCNEFA---------SSLPKSLANLTALKSMDVSQNNFIG 128 (1009)
Q Consensus 66 ~~v~~l~l~~~~l~~-~-------~~~~l~~l~~L~~L~L~~n~~~---------~~~~~~l~~l~~L~~L~Ls~n~l~~ 128 (1009)
.+|+.|.+...+..| . +.+++..+++|+.|.+..+... +.+...+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 467777777655542 2 1334556778888887654321 123445566677777777766211
Q ss_pred CCCCCCCCCcCCeEEecCCCCCCCCCCcccc--CCCCCCeeeccC--CccCCc-----CCccccCccccceeeecccccc
Q 037197 129 SFPTGLGKASGLTSVNASSNNFSGFLPEDLG--NATSLESLDFRG--SFFEGS-----VPTSFRNLQKLKFLGLSGNNLT 199 (1009)
Q Consensus 129 ~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~--~l~~L~~L~L~~--n~~~~~-----~p~~~~~l~~L~~L~L~~n~l~ 199 (1009)
.++. + .+++|++|+|..|.+.......++ .+++|++|+|+. |...+. +...+.
T Consensus 186 ~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~---------------- 247 (362)
T 2ra8_A 186 SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS---------------- 247 (362)
T ss_dssp BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC----------------
T ss_pred eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh----------------
Confidence 1222 2 256666666666665433333333 456666666542 111111 000111
Q ss_pred ccCCccCCCCcchhhhhcccccccccCCcccc---CCCCccEEEeccCccccc----cCcccCCCCCCcEEEcccCCcCC
Q 037197 200 GKIPPELGQLSSLETIILGYNAFEGEIPAEFG---NLTNLRYLDLAVGSLSGQ----IPPALGRLKKLTTVYLYKNNFTG 272 (1009)
Q Consensus 200 ~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~ 272 (1009)
...+++|++|+|.+|.+.+..+..+. .+++|++|+|+.|.+++. ++..+..+++|+.|+|++|.++.
T Consensus 248 ------~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 248 ------KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp ------TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred ------cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 01234555555555554433222222 355666666666666553 22333445667777777776654
Q ss_pred CCCcccccccccccccccccc
Q 037197 273 KIPPELGSITSLAFLDLSDNQ 293 (1009)
Q Consensus 273 ~~~~~~~~l~~L~~L~Ls~N~ 293 (1009)
.....+...- ...+++++++
T Consensus 322 ~~~~~l~~al-g~~~~~~~~~ 341 (362)
T 2ra8_A 322 EMKKELQKSL-PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHHHC-CSEEECCSBC
T ss_pred HHHHHHHHHc-CCEEEecCCc
Confidence 3322222200 2446666665
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.96 E-value=2e-08 Score=113.43 Aligned_cols=166 Identities=13% Similarity=0.134 Sum_probs=103.2
Q ss_pred cccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccc
Q 037197 398 LSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQ 477 (1009)
Q Consensus 398 l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 477 (1009)
+..+..+..+.+..+... .....+....+|+.+.+..+ ++......+..+..|+.+.+..+ ++.+...+|.+..+|+
T Consensus 190 ~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~ 266 (379)
T 4h09_A 190 YPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALK 266 (379)
T ss_dssp CCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred ccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhc
Confidence 334445555555443322 44455666777888877654 34344556777788888887665 6666666777777777
Q ss_pred hhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccc
Q 037197 478 TFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNS 557 (1009)
Q Consensus 478 ~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 557 (1009)
.+.+..+ +.......|.++.+|+.+++.++.++.+....|.++.+|+.++|..+ ++..-..+|.++.+|+.+.+..+
T Consensus 267 ~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~- 343 (379)
T 4h09_A 267 TLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS- 343 (379)
T ss_dssp EEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-
T ss_pred ccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-
Confidence 7776543 44444556777777777777777777555667777777777777644 54333456777777777776544
Q ss_pred cccccCcCcCCC
Q 037197 558 LFGRIPENFGAS 569 (1009)
Q Consensus 558 l~~~~p~~~~~l 569 (1009)
++..-..+|.+.
T Consensus 344 v~~I~~~aF~~c 355 (379)
T 4h09_A 344 ITLIESGAFEGS 355 (379)
T ss_dssp CCEECTTTTTTS
T ss_pred cCEEchhHhhCC
Confidence 443334445443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.92 E-value=1.7e-10 Score=128.07 Aligned_cols=137 Identities=18% Similarity=0.231 Sum_probs=64.0
Q ss_pred ccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCcccc--CCCCccEEEeccC--ccccc-----c
Q 037197 180 TSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFG--NLTNLRYLDLAVG--SLSGQ-----I 250 (1009)
Q Consensus 180 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n--~l~~~-----~ 250 (1009)
..+..+++|+.|+|++|.-. .++. +. +++|++|+|..|.++......++ .+++|++|+|+.+ ...+. +
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l 242 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred HHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence 44455666777777665211 1222 22 56666666666665543333343 5667777776431 11111 0
Q ss_pred Cccc--CCCCCCcEEEcccCCcCCCCCcccc---cccccccccccccccCCCc----chhhhcccCCCeEeccccccC
Q 037197 251 PPAL--GRLKKLTTVYLYKNNFTGKIPPELG---SITSLAFLDLSDNQISGEI----PVKLAELKNLQLLNLMCNQLT 319 (1009)
Q Consensus 251 ~~~l--~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~ 319 (1009)
...+ ..+++|+.|+|++|.+.+..+..+. .+++|++|+|+.|.+++.. +..+..+++|+.|+|++|.|+
T Consensus 243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 0111 1345566666665555432222221 2445555555555554322 122233445555555555444
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.90 E-value=2.1e-09 Score=114.55 Aligned_cols=129 Identities=16% Similarity=0.121 Sum_probs=94.7
Q ss_pred ccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCc--eeeEEeEEEcCCeEEEEEeccCCCCh
Q 037197 707 GMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN--IVRLLGYLHNETNVMMVYDYMPNDSL 784 (1009)
Q Consensus 707 G~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn--iv~l~~~~~~~~~~~lV~E~~~~gsL 784 (1009)
+.|..+.||++... +|..+++|..... ....+.+|+++++.+.+.+ +.+++++...++..++||||++|.++
T Consensus 29 ~gg~~~~v~~~~~~-~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQ-GRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp CTTSSCEEEEEECT-TSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCCCceEEEEecC-CCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 45666999999754 4678999987432 1234568899988885434 56689998888889999999999988
Q ss_pred hhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 037197 785 GEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC------------------------------------------- 821 (1009)
Q Consensus 785 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------------------------------------------- 821 (1009)
. ... .+ ...++.++++.++.||+..
T Consensus 103 ~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 103 L--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp T--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred C--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 4 211 11 1246777888888888641
Q ss_pred ------------CCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 822 ------------QPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 822 ------------~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
...++|+|++|.||++++++.+.|+|||.+..
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.85 E-value=7.3e-09 Score=116.04 Aligned_cols=142 Identities=12% Similarity=0.174 Sum_probs=104.5
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcc--cCCCChhhHHHHHHHHHHHhccC--CCceeeEEeEEEcC---CeEEEE
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLW--RSDNDIESGDDLFREVSLLGRLR--HRNIVRLLGYLHNE---TNVMMV 775 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~---~~~~lV 775 (1009)
.+.++.|.++.||++...+ ..+++|+.. ... .......+.+|+++++.+. +..+++++.++.+. +..++|
T Consensus 43 ~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEECCC-CCSCEEEEECSS--CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred EEEcCCcccceEEEEEECC--ceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4568999999999988654 578888874 221 1112345668999999886 45688999998776 447999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC---------------------------------- 821 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~---------------------------------- 821 (1009)
|||++|..+.+.... .++..++..++.++++.|+.||+..
T Consensus 120 me~v~G~~l~~~~~~------~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQSLP------GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTTCT------TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCccc------cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999999887542211 1566777889999999999999731
Q ss_pred ---------------------CCCeEEeccCCCcEEeCCCCc--EEEccccccee
Q 037197 822 ---------------------QPPVIHRDIKSNNILLDANLE--ARIADFGLARM 853 (1009)
Q Consensus 822 ---------------------~~~ivH~dlk~~NIll~~~~~--~kl~DfGls~~ 853 (1009)
.+.++|+|+++.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.82 E-value=4.4e-11 Score=125.82 Aligned_cols=143 Identities=18% Similarity=0.168 Sum_probs=62.5
Q ss_pred CceeeeEEeCCCC-ceeEEeccc---cccccccc-cccccCCCCCeEecccCcccccCC-ccccccCccCc--ccccccc
Q 037197 54 HCNWTGVWCNSRG-FVEKLDLSN---MSLNGSVS-ENIRGLRSLSSLNICCNEFASSLP-KSLANLTALKS--MDVSQNN 125 (1009)
Q Consensus 54 ~C~w~gv~C~~~~-~v~~l~l~~---~~l~~~~~-~~l~~l~~L~~L~L~~n~~~~~~~-~~l~~l~~L~~--L~Ls~n~ 125 (1009)
-|+|.|+.|+..+ +|..+-..+ ..+.+.+. +.+..++. .|..++|.-++.+. ..+...+.|+. ++++.|.
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 4889999998653 565554433 23333332 22222222 22222333222221 12444444554 4555552
Q ss_pred cC---CCCCCCCCCCcCCeEEecCCCCCCC--CCCccccCCCCCCeeeccCCccCCcCCccccCcc--ccceeeeccccc
Q 037197 126 FI---GSFPTGLGKASGLTSVNASSNNFSG--FLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQ--KLKFLGLSGNNL 198 (1009)
Q Consensus 126 l~---~~~p~~l~~l~~L~~L~Ls~n~l~~--~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~--~L~~L~L~~n~l 198 (1009)
.. +.++....++++|++|+|++|+|++ .+|..+..+++|+.|+|++|.+.+. ..+..+. +|++|+|++|.+
T Consensus 155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl 232 (267)
T 3rw6_A 155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSL 232 (267)
T ss_dssp HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTT
T ss_pred HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcC
Confidence 21 1111111234455555555555554 3334444555555555555555432 1122222 444444444444
Q ss_pred cc
Q 037197 199 TG 200 (1009)
Q Consensus 199 ~~ 200 (1009)
.+
T Consensus 233 ~~ 234 (267)
T 3rw6_A 233 CD 234 (267)
T ss_dssp GG
T ss_pred cc
Confidence 43
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.71 E-value=5.5e-09 Score=114.07 Aligned_cols=184 Identities=23% Similarity=0.237 Sum_probs=119.5
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCc--eeeEEeEEEcCC---eEEEEE
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRN--IVRLLGYLHNET---NVMMVY 776 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpn--iv~l~~~~~~~~---~~~lV~ 776 (1009)
.+.++.|....||++. ..+++|+... ......+.+|+++++.+. +.. +.+++.+....+ ..|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4568999999999873 3588888632 233456668999998883 332 445555544333 348899
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhc------------------------------------
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD------------------------------------ 820 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------------------------------------ 820 (1009)
||++|.++.+.... .++..++..++.++++.++.||+.
T Consensus 96 ~~i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp ECCCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred cccCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 99999888754321 145666677888888888888861
Q ss_pred -------------------CCCCeEEeccCCCcEEeCC--CCcEEEcccccceecccCCCceeeec--------------
Q 037197 821 -------------------CQPPVIHRDIKSNNILLDA--NLEARIADFGLARMMLHKNETVSMVA-------------- 865 (1009)
Q Consensus 821 -------------------~~~~ivH~dlk~~NIll~~--~~~~kl~DfGls~~~~~~~~~~~~~~-------------- 865 (1009)
..+.++|+|++|.||++++ +..+.|+||+.+..- +.........
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~-~~~~Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS-DPDNDFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE-CTTHHHHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC-ChHHHHHHHHhhccccCHHHHHHH
Confidence 1246899999999999998 456789999988653 2211100000
Q ss_pred -ccCcccC-CcccCCCCCCcccchHhHHHHHHHHHhCCCCC
Q 037197 866 -GSYGYIA-PEYGYTLKVDEKSDIYSFGVVLLELLTGKMPL 904 (1009)
Q Consensus 866 -gt~~y~a-PE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf 904 (1009)
...++.. |+... ......+.|++|.++|++.+|+.+|
T Consensus 249 l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0001111 22111 1122368999999999999999765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.57 E-value=1.1e-08 Score=107.42 Aligned_cols=105 Identities=25% Similarity=0.277 Sum_probs=69.8
Q ss_pred ccCCcccch--hccccCccc---CCcccccccCCcCcEEEeecCCCCC--CCCccccccccceeeeecCcccccCCCccc
Q 037197 470 ILSIPSLQT--FMASHNNLQ---AKIPNELQACPSLSVLDLSSNSLSG--EIPASIASCEKLVSLNLRNNRFSGEIPKAV 542 (1009)
Q Consensus 470 ~~~l~~L~~--L~l~~N~l~---~~~p~~~~~l~~L~~LdLs~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 542 (1009)
|...+.|.. ++++.|+.. +.++....++++|+.|+||+|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 334455554 556666432 2222233567888888888888887 4456677888888888888888754 334
Q ss_pred cccc--ccceecCCccccccccCc-------CcCCCCCCcEEe
Q 037197 543 ATMP--TLAILDMSNNSLFGRIPE-------NFGASPALEMLN 576 (1009)
Q Consensus 543 ~~l~--~L~~L~Ls~N~l~~~~p~-------~~~~l~~L~~L~ 576 (1009)
..+. +|+.|+|++|++++.+|+ .+..+|+|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 4444 788888888888876663 356677777775
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.40 E-value=8.6e-09 Score=103.23 Aligned_cols=118 Identities=19% Similarity=0.147 Sum_probs=67.8
Q ss_pred cccccccCCCCCeEecccC-ccccc----CCccccccCccCcccccccccCCCC----CCCCCCCcCCeEEecCCCCCCC
Q 037197 82 VSENIRGLRSLSSLNICCN-EFASS----LPKSLANLTALKSMDVSQNNFIGSF----PTGLGKASGLTSVNASSNNFSG 152 (1009)
Q Consensus 82 ~~~~l~~l~~L~~L~L~~n-~~~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~----p~~l~~l~~L~~L~Ls~n~l~~ 152 (1009)
+...+...++|++|+|++| .+... +...+...++|++|+|++|.+.... ...+...++|++|+|++|.|++
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 4455666777888888877 77653 3344555667777777777765432 2233344566666666666654
Q ss_pred C----CCccccCCCCCCeeec--cCCccCCcCC----ccccCccccceeeecccccc
Q 037197 153 F----LPEDLGNATSLESLDF--RGSFFEGSVP----TSFRNLQKLKFLGLSGNNLT 199 (1009)
Q Consensus 153 ~----~p~~l~~l~~L~~L~L--~~n~~~~~~p----~~~~~l~~L~~L~L~~n~l~ 199 (1009)
. +...+...++|++|+| ++|.++.... ..+...++|++|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3 2344555566666666 5566654322 22333355666666666554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.34 E-value=3.6e-08 Score=98.71 Aligned_cols=91 Identities=15% Similarity=0.230 Sum_probs=53.4
Q ss_pred ccccCCcCcEEEeecCCCCCCC----CccccccccceeeeecCcccccC----CCcccccccccceecC--Cccccccc-
Q 037197 493 ELQACPSLSVLDLSSNSLSGEI----PASIASCEKLVSLNLRNNRFSGE----IPKAVATMPTLAILDM--SNNSLFGR- 561 (1009)
Q Consensus 493 ~~~~l~~L~~LdLs~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~- 561 (1009)
.+...++|++|||++|+|+..- ...+...+.|++|+|++|.|+.. +...+...++|+.|+| ++|.+...
T Consensus 60 ~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g 139 (185)
T 1io0_A 60 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNV 139 (185)
T ss_dssp HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHH
T ss_pred HHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHH
Confidence 3444556666666666665322 22233345666777777766642 3455555666777777 66777653
Q ss_pred ---cCcCcCCCCCCcEEecCCCccc
Q 037197 562 ---IPENFGASPALEMLNLSYNKLE 583 (1009)
Q Consensus 562 ---~p~~~~~l~~L~~L~ls~N~l~ 583 (1009)
+.+.+...+.|++|+|++|.+.
T Consensus 140 ~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 140 EMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2334444567777777777764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=3.5e-06 Score=89.96 Aligned_cols=136 Identities=18% Similarity=0.175 Sum_probs=98.6
Q ss_pred eeccCCce-EEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 705 IIGMGGNG-IVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 705 ~iG~G~~g-~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
.+..|..| .||+......+..+++|+-.. .....+.+|+..++.+. +--+.++++++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34556555 699988877677899998632 23445668999988884 444778999999999999999999998
Q ss_pred ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 037197 783 SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC----------------------------------------- 821 (1009)
Q Consensus 783 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------- 821 (1009)
++.+...... .....++.++++.++.||+..
T Consensus 106 ~~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 106 TAFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp EHHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred cccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 8877653221 112235566667777776421
Q ss_pred --------------CCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 822 --------------QPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 822 --------------~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
.+.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12478999999999999877778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=1.4e-05 Score=86.86 Aligned_cols=136 Identities=21% Similarity=0.218 Sum_probs=91.7
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCC---ceeeEEeEEE-cCCeEEEEEec
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHR---NIVRLLGYLH-NETNVMMVYDY 778 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hp---niv~l~~~~~-~~~~~~lV~E~ 778 (1009)
.+.++.|....||+. +..+++|+-. .......+.+|+++++.+.+. .+.+++.++. ..+..++||||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456788999999998 3457888742 123345667999999999642 3667777774 44567899999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD-------------------------------------- 820 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------------------------------------- 820 (1009)
++|.++.+..... ++..++..++.++++.|+.||+.
T Consensus 95 i~G~~l~~~~~~~------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 95 VQGQILGEDGMAV------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CCSEECHHHHHTT------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred cCCeECchhhhhh------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9998887632111 22333334444444444444432
Q ss_pred -------------------CCCCeEEeccCCCcEEeCC---CCc-EEEccccccee
Q 037197 821 -------------------CQPPVIHRDIKSNNILLDA---NLE-ARIADFGLARM 853 (1009)
Q Consensus 821 -------------------~~~~ivH~dlk~~NIll~~---~~~-~kl~DfGls~~ 853 (1009)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2346799999999999987 455 48999998754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.81 E-value=3.2e-06 Score=82.13 Aligned_cols=34 Identities=6% Similarity=0.135 Sum_probs=15.0
Q ss_pred CCeEEecCCCCCCCCCCccccCCCCCCeeeccCC
Q 037197 139 GLTSVNASSNNFSGFLPEDLGNATSLESLDFRGS 172 (1009)
Q Consensus 139 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n 172 (1009)
.|++|||+++.++...-..+.++++|++|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 4555555555544333333334444444444443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.77 E-value=6.2e-06 Score=80.17 Aligned_cols=82 Identities=13% Similarity=0.153 Sum_probs=39.7
Q ss_pred CccEEEeccCccccccCcccCCCCCCcEEEcccCC-cCCCCCcccccc----ccccccccccc-ccCCCcchhhhcccCC
Q 037197 235 NLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNN-FTGKIPPELGSI----TSLAFLDLSDN-QISGEIPVKLAELKNL 308 (1009)
Q Consensus 235 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l----~~L~~L~Ls~N-~l~~~~~~~l~~l~~L 308 (1009)
+|++||++++.++...-..+.++++|++|+|++|. +++..-..+..+ ++|++|+|++| +|++..-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555554444444555555555555553 443322233332 24555555554 2544333444455555
Q ss_pred CeEecccc
Q 037197 309 QLLNLMCN 316 (1009)
Q Consensus 309 ~~L~L~~N 316 (1009)
++|+++++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555554
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=6.8e-05 Score=84.79 Aligned_cols=78 Identities=15% Similarity=0.053 Sum_probs=49.3
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcccCCC--C---hhhHHHHHHHHHHHhccCC--C-ceeeEEeEEEcCCeEEE
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN--D---IESGDDLFREVSLLGRLRH--R-NIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~--~---~~~~~~~~~E~~~l~~l~H--p-niv~l~~~~~~~~~~~l 774 (1009)
.+.+|.|..+.||++....+++.|+||....... . .....+...|.++++.+.. | .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4568999999999997765567899998643211 0 1123455678888887732 3 34566654 3345689
Q ss_pred EEeccCCC
Q 037197 775 VYDYMPND 782 (1009)
Q Consensus 775 V~E~~~~g 782 (1009)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00023 Score=79.04 Aligned_cols=84 Identities=6% Similarity=-0.013 Sum_probs=55.3
Q ss_pred Ccee-ccCCceEEEEEEEC---C---CCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccC-C--CceeeEEeEEEcC--
Q 037197 703 SNII-GMGGNGIVYKAEFH---R---PHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLR-H--RNIVRLLGYLHNE-- 769 (1009)
Q Consensus 703 ~~~i-G~G~~g~Vyk~~~~---~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-H--pniv~l~~~~~~~-- 769 (1009)
.+.| +.|....+|+.... + ++..+++|+...... .......+.+|+++++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3457 88889999998754 1 156788887643210 0001234557888888774 2 3577888887665
Q ss_pred -CeEEEEEeccCCCChhh
Q 037197 770 -TNVMMVYDYMPNDSLGE 786 (1009)
Q Consensus 770 -~~~~lV~E~~~~gsL~~ 786 (1009)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00028 Score=77.78 Aligned_cols=141 Identities=19% Similarity=0.307 Sum_probs=78.2
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC--CCceeeEEe------EEEcCCeEEEE
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR--HRNIVRLLG------YLHNETNVMMV 775 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--Hpniv~l~~------~~~~~~~~~lV 775 (1009)
+.|+.|..+.||++...+ + .+++|+.... . .....|+++++.+. .-.+++++. +....+..++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~-~-~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDS-G-AVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EECC----CEEEEEEETT-E-EEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeccccccCcEEEEEeCC-C-CEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 346667788999998754 3 5889988542 1 22234455544442 112334443 22346678999
Q ss_pred EeccCCCChh--------------hhhcCCc-----c-c----cccccHHHHH---------------------------
Q 037197 776 YDYMPNDSLG--------------EALHGKE-----A-G----KLLVDWVSRY--------------------------- 804 (1009)
Q Consensus 776 ~E~~~~gsL~--------------~~l~~~~-----~-~----~~~~~~~~~~--------------------------- 804 (1009)
|||++|..+. ..+|... . . .....|...+
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999987542 1111110 0 0 0001221110
Q ss_pred ----HHHHHHHHHHHHHHh----------cCCCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 805 ----NIAVGIAQGLNYLHH----------DCQPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 805 ----~i~~~i~~~L~~LH~----------~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
.+...+.+++++|+. .....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666653 124589999999999999888899999999774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00075 Score=72.84 Aligned_cols=140 Identities=16% Similarity=0.160 Sum_probs=91.3
Q ss_pred cCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC---CCceeeEEeEEEcCCeEEEEEec
Q 037197 702 ESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR---HRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 702 ~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
..+.|+.|....+|+.... +..+++|+.... ....+..|++.++.+. ...++++++++...+..++||||
T Consensus 40 ~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE--VQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEEECCSSSSEEEEEESS--SCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeCCccceeeeEEEEC--CCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 3456899999999999753 567888987422 2445568988888883 36788999998888889999999
Q ss_pred cCCCChhh-----------hhcCCcc-cc-----------------ccccHHHHH---HHHH----------------HH
Q 037197 779 MPNDSLGE-----------ALHGKEA-GK-----------------LLVDWVSRY---NIAV----------------GI 810 (1009)
Q Consensus 779 ~~~gsL~~-----------~l~~~~~-~~-----------------~~~~~~~~~---~i~~----------------~i 810 (1009)
+++..+.. .+|.... .. ..-+|...+ ++.. .+
T Consensus 113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l 192 (312)
T 3jr1_A 113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI 192 (312)
T ss_dssp CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence 99886521 1222211 00 012454322 1111 11
Q ss_pred HHH-HHHHHh-cCCCCeEEeccCCCcEEeCCCCcEEEcccc
Q 037197 811 AQG-LNYLHH-DCQPPVIHRDIKSNNILLDANLEARIADFG 849 (1009)
Q Consensus 811 ~~~-L~~LH~-~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 849 (1009)
++. ...|.. ...+.++|+|+.+.||+++.++ +.|+|++
T Consensus 193 ~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 193 VQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 223321 2256899999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0012 Score=75.13 Aligned_cols=78 Identities=13% Similarity=0.142 Sum_probs=47.8
Q ss_pred CCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCceeeecc--cCcccCCcccCCC---CCCcccchHhHHHHHHH
Q 037197 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG--SYGYIAPEYGYTL---KVDEKSDIYSFGVVLLE 896 (1009)
Q Consensus 822 ~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~sDv~SlGvvl~e 896 (1009)
.+.++|+|+++.||+++.++ ++++||+.+..-. .......... ...|.+|+..... ......++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~-p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP-MGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC-HHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc-hHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34899999999999998876 9999999886532 1111111111 1245666543211 11223455677888888
Q ss_pred HHhCC
Q 037197 897 LLTGK 901 (1009)
Q Consensus 897 lltg~ 901 (1009)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0014 Score=70.11 Aligned_cols=78 Identities=14% Similarity=0.099 Sum_probs=53.3
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-C--CceeeEEeEEEcCCeEEEEE
Q 037197 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-H--RNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 700 ~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H--pniv~l~~~~~~~~~~~lV~ 776 (1009)
....+.+|.|..+.||+....+ |+.|++|+..... ......+..|++.|+.+. . --+++++++. .-++||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred eEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 3445678999999999999876 7889999864332 122234558998888874 2 2355566542 237899
Q ss_pred eccCCCCh
Q 037197 777 DYMPNDSL 784 (1009)
Q Consensus 777 E~~~~gsL 784 (1009)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0014 Score=72.67 Aligned_cols=143 Identities=18% Similarity=0.197 Sum_probs=81.7
Q ss_pred ceeccCCceEEEEEEECC-------CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEEE
Q 037197 704 NIIGMGGNGIVYKAEFHR-------PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.+..|-...+|++.... ++..|++|+... .........+|.++++.+. +.-..++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~---~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA---ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC---ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 456668888899998742 346888988622 1123445558988888873 3334677777654 399
Q ss_pred EeccCCCChhhh-----------------hcCCc--cccccc-cHHHHHHHHHHHH-------------------HHHHH
Q 037197 776 YDYMPNDSLGEA-----------------LHGKE--AGKLLV-DWVSRYNIAVGIA-------------------QGLNY 816 (1009)
Q Consensus 776 ~E~~~~gsL~~~-----------------l~~~~--~~~~~~-~~~~~~~i~~~i~-------------------~~L~~ 816 (1009)
|||++|.++..- +|... .++... -|.+..++..++. +.++.
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998655311 11111 011111 2333333333321 12222
Q ss_pred H----Hhc-CCCCeEEeccCCCcEEeCCC----CcEEEccccccee
Q 037197 817 L----HHD-CQPPVIHRDIKSNNILLDAN----LEARIADFGLARM 853 (1009)
Q Consensus 817 L----H~~-~~~~ivH~dlk~~NIll~~~----~~~kl~DfGls~~ 853 (1009)
| ... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 221 23478899999999999876 7899999998854
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.96 E-value=7.7e-05 Score=73.90 Aligned_cols=115 Identities=14% Similarity=0.135 Sum_probs=62.8
Q ss_pred cccccCCCCCeEecccC-ccccc----CCccccccCccCcccccccccCCCCCCC----CCCCcCCeEEecCCCCCCCCC
Q 037197 84 ENIRGLRSLSSLNICCN-EFASS----LPKSLANLTALKSMDVSQNNFIGSFPTG----LGKASGLTSVNASSNNFSGFL 154 (1009)
Q Consensus 84 ~~l~~l~~L~~L~L~~n-~~~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~p~~----l~~l~~L~~L~Ls~n~l~~~~ 154 (1009)
..+.+-+.|++|+|++| ++.+. +.+.+..-+.|++|+|++|.+....... +..-+.|++|+|++|.|+...
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 34455667777888774 66542 3455566667777777777765433222 223456677777777666432
Q ss_pred ----CccccCCCCCCeeeccCC---ccCCc----CCccccCccccceeeeccccc
Q 037197 155 ----PEDLGNATSLESLDFRGS---FFEGS----VPTSFRNLQKLKFLGLSGNNL 198 (1009)
Q Consensus 155 ----p~~l~~l~~L~~L~L~~n---~~~~~----~p~~~~~l~~L~~L~L~~n~l 198 (1009)
...+..-+.|++|+|++| .+... +...+..-+.|+.|+++.|.+
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 233444455666666644 22221 222333335566666655543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00012 Score=72.50 Aligned_cols=15 Identities=20% Similarity=0.266 Sum_probs=7.9
Q ss_pred ccccCccCccccccc
Q 037197 110 LANLTALKSMDVSQN 124 (1009)
Q Consensus 110 l~~l~~L~~L~Ls~n 124 (1009)
+.+-+.|++|+|++|
T Consensus 37 l~~n~~L~~L~L~~n 51 (197)
T 1pgv_A 37 REDDTDLKEVNINNM 51 (197)
T ss_dssp HTTCSSCCEEECTTC
T ss_pred HhcCCCccEEECCCC
Confidence 344455666666553
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0033 Score=67.71 Aligned_cols=71 Identities=13% Similarity=0.051 Sum_probs=42.6
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCce-eeEEeEEEcCCeEEEEEecc-C
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI-VRLLGYLHNETNVMMVYDYM-P 780 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpni-v~l~~~~~~~~~~~lV~E~~-~ 780 (1009)
.+.|+.|....+|+. ..+++|+..... .......+|+.+++.+....+ .+++++. .+.-++|+||+ +
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 677888999999999 347888874321 111112357776666632222 4666543 33347899999 6
Q ss_pred CCCh
Q 037197 781 NDSL 784 (1009)
Q Consensus 781 ~gsL 784 (1009)
+.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0029 Score=71.85 Aligned_cols=73 Identities=15% Similarity=0.254 Sum_probs=49.1
Q ss_pred ceeccCCceEEEEEEECC-------CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEEE
Q 037197 704 NIIGMGGNGIVYKAEFHR-------PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.|+.|....||++...+ .+..|++|+.... .. ...+.+|..+++.+. +.-.+++++.+.+ .+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 457888889999998753 2467889987321 11 134557888888874 3334677776643 389
Q ss_pred EeccCCCCh
Q 037197 776 YDYMPNDSL 784 (1009)
Q Consensus 776 ~E~~~~gsL 784 (1009)
|||++|.++
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999987544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0044 Score=70.64 Aligned_cols=75 Identities=19% Similarity=0.192 Sum_probs=47.8
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCce-eeEEeEEEcCCeEEEEEeccCC
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI-VRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpni-v~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
.+.|+.|-...+|++...+.+..+++|+........ -+-.+|..+++.+...++ .++++++.. ..||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 346788888999999886545788899874321111 111378888888854444 577777632 359999988
Q ss_pred CCh
Q 037197 782 DSL 784 (1009)
Q Consensus 782 gsL 784 (1009)
.++
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0053 Score=67.20 Aligned_cols=32 Identities=25% Similarity=0.428 Sum_probs=27.7
Q ss_pred CCCeEEeccCCCcEEeCCC----CcEEEccccccee
Q 037197 822 QPPVIHRDIKSNNILLDAN----LEARIADFGLARM 853 (1009)
Q Consensus 822 ~~~ivH~dlk~~NIll~~~----~~~kl~DfGls~~ 853 (1009)
...++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3489999999999999875 6899999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0024 Score=59.02 Aligned_cols=37 Identities=27% Similarity=0.269 Sum_probs=21.2
Q ss_pred ccceecCCccccccccCcCcCCCCCCcEEecCCCccc
Q 037197 547 TLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583 (1009)
Q Consensus 547 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 583 (1009)
+|+.|||++|+|+...+..|..+++|+.|+|++|++.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555566666665555555555666666666555443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0027 Score=58.59 Aligned_cols=56 Identities=18% Similarity=0.341 Sum_probs=31.7
Q ss_pred EEEeecCCCC-CCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccc
Q 037197 502 VLDLSSNSLS-GEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLF 559 (1009)
Q Consensus 502 ~LdLs~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 559 (1009)
.+|.+++.|+ ..+|..+. .+|+.|+|++|+|+...+..|..+++|+.|+|++|++.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555556554 23443322 24666666666666444555666666666666666653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.31 E-value=0.014 Score=63.37 Aligned_cols=144 Identities=16% Similarity=0.157 Sum_probs=78.4
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCc--eeeEEeE------EEcCCeEEEE
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN--IVRLLGY------LHNETNVMMV 775 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn--iv~l~~~------~~~~~~~~lV 775 (1009)
+.|+.|....+|+....+ + .+++|+.... .....+..|+++++.+.... +.+++.. ....+..++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTK-D-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEECC---EEEEEEEESS-C-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eccCCCcccceEEEEeCC-c-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 456778889999998754 3 5888987542 11223445777666653111 3333321 1234567899
Q ss_pred EeccCCCChhh--------------hhcCC----ccc----cccccHHHHHH------------HHHHHHHHHHHHHhc-
Q 037197 776 YDYMPNDSLGE--------------ALHGK----EAG----KLLVDWVSRYN------------IAVGIAQGLNYLHHD- 820 (1009)
Q Consensus 776 ~E~~~~gsL~~--------------~l~~~----~~~----~~~~~~~~~~~------------i~~~i~~~L~~LH~~- 820 (1009)
|+|++|..+.. .+|.. ... .....|...+. +...+.+.+++++..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 99999865421 01110 000 00112322111 011234445555432
Q ss_pred ---CCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 821 ---CQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 821 ---~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
...+++|+|+.+.||++++++.+.|+||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234799999999999999876668999997753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.02 E-value=0.019 Score=63.75 Aligned_cols=74 Identities=11% Similarity=0.132 Sum_probs=42.7
Q ss_pred ceeccCCceEEEEEEECC--------CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCc-eeeEEeEEEcCCeEEE
Q 037197 704 NIIGMGGNGIVYKAEFHR--------PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN-IVRLLGYLHNETNVMM 774 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn-iv~l~~~~~~~~~~~l 774 (1009)
+.++.|....+|++...+ .+..+++|+.... .....+...|.++++.+...+ +.++++.. . -++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 356778888999998754 1257888886432 111112246777777774223 45666554 2 268
Q ss_pred EEeccCCCCh
Q 037197 775 VYDYMPNDSL 784 (1009)
Q Consensus 775 V~E~~~~gsL 784 (1009)
||||++|.++
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999988544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.97 E-value=0.051 Score=59.01 Aligned_cols=143 Identities=13% Similarity=0.120 Sum_probs=78.5
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCC--CceeeEEeE-----EEcCCeEEEEE
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH--RNIVRLLGY-----LHNETNVMMVY 776 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H--pniv~l~~~-----~~~~~~~~lV~ 776 (1009)
..++ |....||++...+ |+.+++|...... .....+..|..+++.+.. -.+++++.. ...++..++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~-g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDED-RRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCTT-CCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcCC-CCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 3566 8888999886544 5678999984221 123445567777777632 124444443 22345668899
Q ss_pred eccCCCChhh-----h---------hcC----Ccc-ccccccHHHH----HH---------------HHHHHHHHHHHHH
Q 037197 777 DYMPNDSLGE-----A---------LHG----KEA-GKLLVDWVSR----YN---------------IAVGIAQGLNYLH 818 (1009)
Q Consensus 777 E~~~~gsL~~-----~---------l~~----~~~-~~~~~~~~~~----~~---------------i~~~i~~~L~~LH 818 (1009)
||++|..+.. + +|. ... .....++... .. +...+.+.++.+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 9998854321 0 111 000 0011111110 00 0111112233332
Q ss_pred hc----CCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 819 HD----CQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 819 ~~----~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
.. ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 21 234678999999999999 4 899999987753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.82 E-value=0.033 Score=60.92 Aligned_cols=31 Identities=23% Similarity=0.333 Sum_probs=27.6
Q ss_pred CCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 823 PPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 823 ~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4789999999999999888899999987754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.46 E-value=0.21 Score=49.58 Aligned_cols=103 Identities=20% Similarity=0.178 Sum_probs=65.9
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCCce
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV 861 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~~~ 861 (1009)
-||.+.+.... .++++.++|.++.|.+.+|.-+-.... . ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence 37889987654 349999999999999999877722101 1 1233456899999999888874 2111
Q ss_pred eeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCC
Q 037197 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903 (1009)
Q Consensus 862 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~P 903 (1009)
.....+.|||... ...+.+.=|||+|+++|.-+-=..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122466888753 3456788999999999998874444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.08 E-value=0.18 Score=56.56 Aligned_cols=74 Identities=9% Similarity=0.049 Sum_probs=46.2
Q ss_pred ceeccCCceEEEEEEECCC-------CeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEEE
Q 037197 704 NIIGMGGNGIVYKAEFHRP-------HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.+..|-...+|+...... +..|++|+..... ...-+-.+|.++++.+. +.-..++++.+. + +.|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEE
Confidence 4566788889999987631 4678888863321 11112236777777763 333456665442 2 789
Q ss_pred EeccCCCCh
Q 037197 776 YDYMPNDSL 784 (1009)
Q Consensus 776 ~E~~~~gsL 784 (1009)
|||++|.++
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.95 E-value=1.1 Score=49.88 Aligned_cols=30 Identities=27% Similarity=0.408 Sum_probs=25.2
Q ss_pred CeEEeccCCCcEEe------CCCCcEEEccccccee
Q 037197 824 PVIHRDIKSNNILL------DANLEARIADFGLARM 853 (1009)
Q Consensus 824 ~ivH~dlk~~NIll------~~~~~~kl~DfGls~~ 853 (1009)
.++|+|+.+.||++ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35699999999999 4567799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.47 E-value=1.8 Score=42.96 Aligned_cols=115 Identities=10% Similarity=0.121 Sum_probs=80.2
Q ss_pred CCCceeeEEeEEEcCCeEEEEEeccCCC-ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCC
Q 037197 755 RHRNIVRLLGYLHNETNVMMVYDYMPND-SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSN 833 (1009)
Q Consensus 755 ~Hpniv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~ 833 (1009)
.||++++. .+-.+++.+.+.|+.-+.+ ++.. ++. .+...+++++.+|+....++++. +|--+.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~-------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS-------FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG-------SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh-------cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence 68988877 5666667666666654322 3333 322 57788999999999988777744 78899999
Q ss_pred cEEeCCCCcEEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCC
Q 037197 834 NILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLD 905 (1009)
Q Consensus 834 NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~ 905 (1009)
|++++.++.+++.=.|+...+ +|. ..++..=.-.+=+++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l-----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV-----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB-----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCC-----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877754322 222 11222223347788899999998886
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.49 E-value=0.13 Score=58.66 Aligned_cols=62 Identities=11% Similarity=0.076 Sum_probs=17.1
Q ss_pred CceeccCCceEEEEEEECCCCeEEEE------EEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEE
Q 037197 703 SNIIGMGGNGIVYKAEFHRPHMVVAV------KKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLH 767 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~ 767 (1009)
.+.+| ||.||+|.+.....+||| |..+......+....+.+|..+++..+|||+++.+++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 34565 999999999875578888 766443333344456778999999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1009 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 8e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 6e-65
Identities = 80/277 (28%), Positives = 128/277 (46%), Gaps = 28/277 (10%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G VYK ++H VAVK L + + EV +L + RH NI+ +
Sbjct: 14 QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
GY + +V + SL LH E K + + +IA AQG++YLH
Sbjct: 71 GY-STAPQLAIVTQWCEGSSLYHHLHIIE-TKF--EMIKLIDIARQTAQGMDYLHA---K 123
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM--VAGSYGYIAPEY---GYT 878
+IHRD+KSNNI L +L +I DFGLA + + + ++GS ++APE
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 879 LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938
+SD+Y+FG+VL EL+TG++P + + + ++ M+ L P ++
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYS-----NINNRDQIIFMVGRGY-----LSPDLSK 233
Query: 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
+ + M R+ C K RP ++ +
Sbjct: 234 VRSNCPKAM---KRLMAECLKKKRDERPLFPQILASI 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-57
Identities = 49/206 (23%), Positives = 103/206 (50%), Gaps = 9/206 (4%)
Query: 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
++ + +G G G+V+K +V+A K + + + + RE+ +L IV
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
G +++ + + ++M SL + L +AG++ +++ + +GL YL
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRI--PEQILGKVSIAVIKGLTYLREK 123
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLK 880
++HRD+K +NIL+++ E ++ DFG++ + + + G+ Y++PE
Sbjct: 124 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTH 179
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLDP 906
+SDI+S G+ L+E+ G+ P+ P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPP 205
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-57
Identities = 72/273 (26%), Positives = 122/273 (44%), Gaps = 28/273 (10%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V+ + H VAVK L S D E +L+ +L+H+ +VRL
Sbjct: 19 ERLGAGQFGEVWMGY-YNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
+ E + ++ +YM N SL + L KL ++A IA+G+ ++
Sbjct: 75 AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKL--TINKLLDMAAQIAEGMAFIEERN-- 129
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMM-LHKNETVSMVAGSYGYIAPEYGYTLKVD 882
IHRD+++ NIL+ L +IADFGLAR++ ++ + APE
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 883 EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942
KSD++SFG++L E++T P V+ ++ + P +
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMT-----NPEVIQNLERGY---RMVRPD------N 234
Query: 943 VQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
EE+ ++ LC + P+ RPT + ++L
Sbjct: 235 CPEEL---YQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-57
Identities = 63/273 (23%), Positives = 106/273 (38%), Gaps = 22/273 (8%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G K ++ K+L L EV+LL L+H NIVR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 764 GYLHNETN--VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH--H 819
+ + TN + +V +Y L + + +D + + L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL 879
D V+HRD+K N+ LD ++ DFGLAR++ H G+ Y++PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM 189
Query: 880 KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939
+EKSDI+S G +L EL P F + + I+ K + + + +
Sbjct: 190 SYNEKSDIWSLGCLLYELCALMPP----FTAFSQ--KELAGKIREGKFRR--IPYRYSDE 241
Query: 940 CKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
++ R RP++ +++
Sbjct: 242 LNE------IITR----MLNLKDYHRPSVEEIL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-55
Identities = 64/291 (21%), Positives = 114/291 (39%), Gaps = 33/291 (11%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G G VYKA+ ++ A K + E +D E+ +L H NIV+LL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+ E N+ ++ ++ ++ + E + + LNYLH +
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY-----GYTLK 880
IHRD+K+ NIL + + ++ADFG++ + G+ ++APE
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQC 940
D K+D++S G+ L+E+ + P VL I ++ A +
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPP----HHELNP--MRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITM----LGEAKPRRKSICQ 987
K ++ L K R T ++ + KP R+ I +
Sbjct: 246 KDFLKKCL----------EKNVDARWTTSQLLQHPFVTVDSNKPIRELIAE 286
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 4e-55
Identities = 70/297 (23%), Positives = 117/297 (39%), Gaps = 38/297 (12%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR--EVSLLGRLRHRNIVRLL 763
IG G G V++ ++ VAVK FR E+ LRH NI+ +
Sbjct: 11 IGKGRFGEVWRGKWR--GEEVAVKIF-----SSREERSWFREAEIYQTVMLRHENILGFI 63
Query: 764 GYLHNE----TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
+ + T + +V DY + SL + L+ V +A+ A GL +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 118
Query: 820 DC-----QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM----VAGSYGY 870
+ +P + HRD+KS NIL+ N IAD GLA +T+ + G+ Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 871 IAPEY------GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS 924
+APE + +++DIY+ G+V E+ + V S
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 925 NKAQ----DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977
+ + ++ L P+I + E + ++ +I C R T + L +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 8e-55
Identities = 64/278 (23%), Positives = 113/278 (40%), Gaps = 29/278 (10%)
Query: 700 VKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI 759
+K IG G VYK + VA +L E +L L+H NI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 760 VRLLGY----LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
VR + + +++V + M + +L L + + + I +GL
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQ 126
Query: 816 YLHHDCQPPVIHRDIKSNNILLDA-NLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE 874
+LH PP+IHRD+K +NI + +I D GLA + + V G+ ++APE
Sbjct: 127 FLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPE 183
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934
Y K DE D+Y+FG+ +LE+ T + P S+ + ++ + + D
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRVTSGVKPASFDK 236
Query: 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
+ K ++ C + R +++D++
Sbjct: 237 VAIPEVKE------IIEG----CIRQNKDERYSIKDLL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (483), Expect = 1e-54
Identities = 70/295 (23%), Positives = 125/295 (42%), Gaps = 34/295 (11%)
Query: 690 NFTSSEILACVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFR 746
F ++CVK +IG G G V P + VA+K L + + D
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-RDFLS 76
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNI 806
E S++G+ H N++ L G + T VM++ ++M N SL L + + +
Sbjct: 77 EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF---TVIQLVGM 133
Query: 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVA- 865
GIA G+ YL +HRD+ + NIL+++NL +++DFGL+R + + +
Sbjct: 134 LRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 190
Query: 866 ----GSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS-KDIVEWVLS 920
+ APE K SD++S+G+V+ E+++ P + + +D++ +
Sbjct: 191 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMTNQDVINAIE- 247
Query: 921 MIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
QD L P + ++ + C K RP ++ L
Sbjct: 248 -------QDYRLPPP-----MDCPSAL---HQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 3e-54
Identities = 73/270 (27%), Positives = 116/270 (42%), Gaps = 29/270 (10%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-REVSLLGRLRHRNIVRL 762
+G G G VY A + ++A+K L+++ + + REV + LRH NI+RL
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
GY H+ T V ++ +Y P ++ L + K D +A L+Y H
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQ--KLSKF--DEQRTATYITELANALSYCH---S 124
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD 882
VIHRDIK N+LL + E +IADFG + + + + G+ Y+ PE D
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 883 EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942
EK D++S GV+ E L GK P + + + I + + +
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRISRVEFT---FPDFVTEGARD 233
Query: 943 VQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
L+ R P RP +R+V+
Sbjct: 234 ------LISR----LLKHNPSQRPMLREVL 253
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-54
Identities = 61/287 (21%), Positives = 118/287 (41%), Gaps = 35/287 (12%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G+V+ VA+K + S +D E ++ +L H +V+L
Sbjct: 11 QEIGSGQFGLVHLGY-WLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
G + + +V+++M + L + L + L + + + + +G + + +
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEG---MAYLEEA 120
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM-VAGSYGYIAPEYGYTLKVD 882
VIHRD+ + N L+ N +++DFG+ R +L T S + +PE +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 883 EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942
KSD++SFGV++ E+ + S ++VE + + + P +A
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRL-------YKPRLASTH-- 230
Query: 943 VQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSICQNG 989
V +I C + P+ RP ++ L I ++G
Sbjct: 231 -------VYQIMNHCWKERPEDRPAFSRLLRQL-------AEIAESG 263
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-53
Identities = 73/291 (25%), Positives = 130/291 (44%), Gaps = 32/291 (10%)
Query: 693 SSEI-LACVKESNIIGMGGNGIVYKAEFH----RPHMVVAVKKLWRSDNDIESGDDLFRE 747
++EI +CV +IG G G VYK + + VA+K L + + D E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGE 59
Query: 748 VSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIA 807
++G+ H NI+RL G + +M++ +YM N +L + L K+ + +
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGML 116
Query: 808 VGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE---TVSMV 864
GIA G+ + +HRD+ + NIL+++NL +++DFGL+R++ E T S
Sbjct: 117 RGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 865 AGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS 924
+ APE K SD++SFG+V+ E++T W LS +
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY-----------WELSNHEV 222
Query: 925 NKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
KA ++ + + ++ + C + RP D++++L
Sbjct: 223 MKAINDGFRLPT------PMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-53
Identities = 60/276 (21%), Positives = 108/276 (39%), Gaps = 30/276 (10%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G+V + R VA+K + S D+ E ++ L H +V+L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
G + + ++ +YM N L L + + + + YL
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES---K 119
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM-VAGSYGYIAPEYGYTLKVD 882
+HRD+ + N L++ +++DFGL+R +L T S+ + PE K
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 883 EKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941
KSDI++FGV++ E+ + GKMP + + I P +A +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMP----YERFTN--SETAEHIAQGL---RLYRPHLASEK- 229
Query: 942 HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977
V I C + RPT + +++ + +
Sbjct: 230 --------VYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-53
Identities = 68/273 (24%), Positives = 110/273 (40%), Gaps = 28/273 (10%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V+ VA+K L S + +E ++ +LRH +V+L
Sbjct: 23 VKLGQGCFGEVWMGT-WNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 78
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
+ E + +V +YM SL + L G+ + ++A IA G+ Y+
Sbjct: 79 AVVSEE-PIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERMN-- 133
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV-SMVAGSYGYIAPEYGYTLKVD 882
+HRD+++ NIL+ NL ++ADFGLAR++ T + APE +
Sbjct: 134 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 883 EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942
KSD++SFG++L EL T P + VL ++ P
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPG-----MVNREVLDQVERGY--RMPCPPECPESLHD 245
Query: 943 VQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
+ C K P+ RPT + L
Sbjct: 246 ----------LMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-53
Identities = 68/280 (24%), Positives = 114/280 (40%), Gaps = 32/280 (11%)
Query: 702 ESNIIGMGGNGIVYKAEFH--RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNI 759
E +G G G V K + + VAVK L ND D+L E +++ +L + I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
VR++G E + M+V + L + L V + + ++ G+ YL
Sbjct: 71 VRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEE 125
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMM---LHKNETVSMVAGSYGYIAPEYG 876
+HRD+ + N+LL A+I+DFGL++ + + + + + APE
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 877 YTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935
K KSD++SFGV++ E + G+ P + G K V +M++ +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKP----YRGMKG--SEVTAMLEKGERMG------ 230
Query: 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
EM + LC + RP V L
Sbjct: 231 ---CPAGCPREM---YDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (470), Expect = 4e-53
Identities = 64/275 (23%), Positives = 119/275 (43%), Gaps = 30/275 (10%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+ +G G G VY+ + + + VAVK L ++E + +E +++ ++H N+V+LL
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 79
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
G E ++ ++M +L + L ++ V +A I+ + YL +
Sbjct: 80 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--SAVVLLYMATQISSAMEYLE---KK 134
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV-SMVAGSYGYIAPEYGYTLKVD 882
IHRD+ + N L+ N ++ADFGL+R+M T + + APE K
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 883 EKSDIYSFGVVLLELLTGKMPLDPAFGGSK--DIVEWVLSMIKSNKAQDEALDPSIAGQC 940
KSD+++FGV+L E+ T M P S+ +++E M + ++ +
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE------- 247
Query: 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
+ C P RP+ ++
Sbjct: 248 ------------LMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 7e-53
Identities = 67/304 (22%), Positives = 120/304 (39%), Gaps = 34/304 (11%)
Query: 680 PWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDN 736
P + A Q + S ++ V + +IG G G VY + AVK L R
Sbjct: 11 PELVQAVQHVVIGPSSLI--VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-IT 67
Query: 737 DIESGDDLFREVSLLGRLRHRNIVRLLGY-LHNETNVMMVYDYMPNDSLGEALHGKEAGK 795
DI E ++ H N++ LLG L +E + ++V YM + L E
Sbjct: 68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHN 126
Query: 796 LLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855
V + + + V + +HRD+ + N +LD ++ADFGLAR M
Sbjct: 127 PTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181
Query: 856 HKNE----TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS 911
K + ++A E T K KSD++SFGV+L EL+T P
Sbjct: 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPD 237
Query: 912 KDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
+ + + +++ + ++ + + + + C + RP+ ++
Sbjct: 238 VNTFDITVYLLQGRRLLQP----------EYCPDPL---YEVMLKCWHPKAEMRPSFSEL 284
Query: 972 ITML 975
++ +
Sbjct: 285 VSRI 288
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-52
Identities = 57/267 (21%), Positives = 111/267 (41%), Gaps = 26/267 (9%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G +G VY A VA++++ + + + E+ ++ ++ NIV L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+ +V +Y+ SL + + +D + Q L +LH V
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLH---SNQV 137
Query: 826 IHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKS 885
IHRDIKS+NILL + ++ DFG + + S + G+ ++APE K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 886 DIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQE 945
DI+S G++ +E++ G+ P + + L +I +N + ++ +
Sbjct: 198 DIWSLGIMAIEMIEGEPP----YLNENPL--RALYLIATNGTPELQNPEKLSAIFRD--- 248
Query: 946 EMLLVLRIAVLCTAKLPKGRPTMRDVI 972
+ R C + R + ++++
Sbjct: 249 ---FLNR----CLDMDVEKRGSAKELL 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (468), Expect = 2e-52
Identities = 78/276 (28%), Positives = 115/276 (41%), Gaps = 32/276 (11%)
Query: 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNI 759
+ IG G G VY A R VVA+KK+ S E D+ +EV L +LRH N
Sbjct: 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
++ G E +V +Y + K+ + V + G QGL YLH
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLH- 132
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY---G 876
+IHRD+K+ NILL ++ DFG A +M N V G+ ++APE
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV----GTPYWMAPEVILAM 186
Query: 877 YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936
+ D K D++S G+ +EL K P + L I N+ P++
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP----LFNMNAMS--ALYHIAQNE------SPAL 234
Query: 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
Q H E + C K+P+ RPT ++
Sbjct: 235 --QSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLL 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-52
Identities = 60/276 (21%), Positives = 112/276 (40%), Gaps = 32/276 (11%)
Query: 706 IGMGGNGIVYKAEFHRP--HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V + + + VA+K L + + +++ RE ++ +L + IVRL+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
G +M+V + L + L GK + + + ++ G+ YL
Sbjct: 76 GVCQ-AEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEE---K 128
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV---SMVAGSYGYIAPEYGYTLK 880
+HRD+ + N+LL A+I+DFGL++ + + S + APE K
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 881 VDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939
+SD++S+GV + E L+ G+ P + K V++ I+ K + P +
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKP----YKKMKG--PEVMAFIEQGKRME--CPPECPPE 240
Query: 940 CKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
+ C + RP V +
Sbjct: 241 LYA----------LMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-52
Identities = 58/273 (21%), Positives = 111/273 (40%), Gaps = 32/273 (11%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G V ++ VAVK + + + E S++ +LRH N+V+LL
Sbjct: 13 QTIGKGEFGDVMLGDYR--GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLL 66
Query: 764 GY-LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
G + + + +V +YM SL + L + G+ ++ ++ + + + YL
Sbjct: 67 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG--- 121
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD 882
+HRD+ + N+L+ + A+++DFGL + + T + APE K
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKKFS 178
Query: 883 EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942
KSD++SFG++L E+ + P + ++ V+ ++ D
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYP-----RIPLKDVVPRVEKGYKMD---------APDG 224
Query: 943 VQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
+ + C RP+ + L
Sbjct: 225 CPPAV---YEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (463), Expect = 5e-52
Identities = 69/299 (23%), Positives = 124/299 (41%), Gaps = 48/299 (16%)
Query: 704 NIIGMGGNGIVYKAEF-----HRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
IG G G V++A + P +VAVK L + + + D RE +L+ + N
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPN 77
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGK--------------------EAGKLLV 798
IV+LLG + ++++YM L E L G +
Sbjct: 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137
Query: 799 DWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858
+ IA +A G+ YL +HRD+ + N L+ N+ +IADFGL+R + +
Sbjct: 138 SCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 859 ETVSM--VAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVE 916
+ A ++ PE + + +SD++++GVVL E+ + + P +G + E
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMA---HE 249
Query: 917 WVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
V+ ++ + + + + LC +KLP RP+ + +L
Sbjct: 250 EVIYYVRDGNILA--CPENCPLELYN----------LMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-51
Identities = 61/271 (22%), Positives = 106/271 (39%), Gaps = 27/271 (9%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V A VAVK + ++ +++ +E+ + L H N+V+
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
G+ + +Y L + + + + G+ YLH
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM--VAGSYGYIAPEYGYTLKV 881
+ HRDIK N+LLD +I+DFGLA + + N + + G+ Y+APE +
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 882 D-EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQC 940
E D++S G+VL +L G+ + D + K + L+P
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGE----LPWDQPSDSCQ----EYSDWKEKKTYLNPW----- 229
Query: 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
K + L +L + P R T+ D+
Sbjct: 230 KKIDSAPLALLH---KILVENPSARITIPDI 257
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-51
Identities = 65/299 (21%), Positives = 122/299 (40%), Gaps = 47/299 (15%)
Query: 705 IIGMGGNGIVYKAEFHRPH-----MVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRN 758
++G G G V A + + VAVK L + E + L E+ ++ +L H N
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER-EALMSELKMMTQLGSHEN 102
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGK-------------------EAGKLLVD 799
IV LLG + ++++Y L L K E ++
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 800 WVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE 859
+ A +A+G+ +L +HRD+ + N+L+ +I DFGLAR ++ +
Sbjct: 163 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 860 TVSM--VAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEW 917
V ++APE + KSD++S+G++L E+ + + P +
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI----PVDAN 275
Query: 918 VLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976
+I++ D Q + EE+ ++++ C A + RP+ ++ + LG
Sbjct: 276 FYKLIQNGFKMD---------QPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 6e-51
Identities = 67/296 (22%), Positives = 120/296 (40%), Gaps = 37/296 (12%)
Query: 704 NIIGMGGNGIVYKAEFHRP--HMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIV 760
++IG G G V KA + M A+K++ + + D E+ +L +L H NI+
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGK------------EAGKLLVDWVSRYNIAV 808
LLG + + + +Y P+ +L + L + + + A
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 809 GIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSY 868
+A+G++YL Q IHRD+ + NIL+ N A+IADFGL+R +M
Sbjct: 135 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVKKTMGRLPV 190
Query: 869 GYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928
++A E SD++S+GV+L E+++ P G + + +
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMT---CAELYEKLPQGYRL 245
Query: 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKS 984
++ L+ V + C + P RP+ ++ L RK+
Sbjct: 246 EKPLNCDDE------------VYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-50
Identities = 71/294 (24%), Positives = 114/294 (38%), Gaps = 42/294 (14%)
Query: 704 NIIGMGGNGIVYKAEFHRPH-----MVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHR 757
+G G G V +A + M VAVK L + + + L E+ +L L H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHM 87
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGK--------------EAGKLLVDWVSR 803
NIV LLG +++ +Y L L K E +L +D
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 804 YNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV-- 861
+ + +A+G+ +L IHRD+ + NILL +I DFGLAR + + + V
Sbjct: 148 LSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 862 SMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSM 921
++APE + +SD++S+G+ L EL + P + +
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI--- 261
Query: 922 IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
K L P +H EM I C P RPT + ++ ++
Sbjct: 262 ----KEGFRMLSP------EHAPAEM---YDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (453), Expect = 4e-50
Identities = 67/312 (21%), Positives = 126/312 (40%), Gaps = 37/312 (11%)
Query: 664 YNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPH 723
Y+++ D++K+ + P + L+ +I +G G G+V++
Sbjct: 1 YDNYVFDIWKQYYPQ-PVEIKHDHVLD--HYDIH------EELGTGAFGVVHRVTERATG 51
Query: 724 MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDS 783
A K + + + +E+ + LRH +V L ++ ++M+Y++M
Sbjct: 52 NNFAAKFV--MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109
Query: 784 LGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL--DANL 841
L E + E K+ + +GL ++H + +H D+K NI+ +
Sbjct: 110 LFEKVA-DEHNKM--SEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSN 163
Query: 842 EARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGK 901
E ++ DFGL L ++V + G+ + APE V +D++S GV+ LL+G
Sbjct: 164 ELKLIDFGLTA-HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222
Query: 902 MPLDPAFGGSKDIVEWVLSMIKSNKAQ-DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAK 960
P FGG D L +KS D++ I+ K ++L
Sbjct: 223 SP----FGGENDDE--TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL----------LA 266
Query: 961 LPKGRPTMRDVI 972
P R T+ +
Sbjct: 267 DPNTRMTIHQAL 278
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 6e-50
Identities = 80/281 (28%), Positives = 121/281 (43%), Gaps = 30/281 (10%)
Query: 706 IGMGGNGIVYKAEFHRPH---MVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVR 761
+G G G+V + E+ P + VAVK L + E+ DD REV+ + L HRN++R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
L G + + MV + P SL + K G L+ +SRY AV +A+G+ YL
Sbjct: 76 LYGVVLTP-PMKMVTELAPLGSLLD-RLRKHQGHFLLGTLSRY--AVQVAEGMGYLES-- 129
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM---VAGSYGYIAPEYGYT 878
IHRD+ + N+LL +I DFGL R + ++ M + + APE T
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 879 LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938
SD + FGV L E+ T G +L I + +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILHKIDKEGERLPRPE----- 238
Query: 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979
+++ + V C A P+ RPT + L EA+
Sbjct: 239 ---DCPQDI---YNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 5e-49
Identities = 52/271 (19%), Positives = 103/271 (38%), Gaps = 29/271 (10%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF-REVSLLGRLRHRNIVRL 762
I+G G V A A+K L + E+ RE ++ RL H V+L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
++ + Y N L + + + G Y A+ ++ L +
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFY-----TAEIVSALEYLHG 126
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM--VAGSYGYIAPEYGYTLK 880
+IHRD+K NILL+ ++ +I DFG A+++ +++ G+ Y++PE
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQC 940
+ SD+++ G ++ +L+ G P F + + + I + +
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPP----FRAGNEYL--IFQKIIKLEYD---FPEKFFPKA 237
Query: 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
+ + E++L R ++
Sbjct: 238 RDLVEKLL----------VLDATKRLGCEEM 258
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (439), Expect = 3e-48
Identities = 61/311 (19%), Positives = 134/311 (43%), Gaps = 35/311 (11%)
Query: 664 YNSFFDDLFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPH 723
Y+ F++D++KK + P + ++ +IL +G G G+V++
Sbjct: 4 YDKFYEDIWKKYVPQ-PVEVKQGSVYDYY--DIL------EELGSGAFGVVHRCVEKATG 54
Query: 724 MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDS 783
V K + + + E+S++ +L H ++ L ++ ++++ +++
Sbjct: 55 RVFVAKFI--NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112
Query: 784 LGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEA 843
L + + ++ + N +GL ++H + ++H DIK NI+ + +
Sbjct: 113 LFDRIAAEDYK---MSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKAS 166
Query: 844 RI--ADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGK 901
+ DFGLA L+ +E V + + + APE V +D+++ GV+ LL+G
Sbjct: 167 SVKIIDFGLAT-KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225
Query: 902 MPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKL 961
P +D +E + ++ + + DE S++ + K + +L K
Sbjct: 226 SPFA-----GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL----------QKE 270
Query: 962 PKGRPTMRDVI 972
P+ R T+ D +
Sbjct: 271 PRKRLTVHDAL 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-47
Identities = 62/281 (22%), Positives = 112/281 (39%), Gaps = 31/281 (11%)
Query: 701 KESNIIGMGGNGIVYKAEFHRPH----MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH 756
K+ ++G G G VYK + + VA+K+L R ++ ++ E ++ + +
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDN 70
Query: 757 RNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNY 816
++ RLLG V ++ MP L L K + N V IA+G+NY
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 817 LHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM--VAGSYGYIAPE 874
L ++HRD+ + N+L+ +I DFGLA+++ + + ++A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934
+SD++S+GV + EL+T + G + S+++ + P
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGS---KPYDGIPA--SEISSILEKGERLP--QPP 236
Query: 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
I V C RP R++I
Sbjct: 237 ICTIDVYM----------IMVKCWMIDADSRPKFRELIIEF 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-46
Identities = 63/284 (22%), Positives = 109/284 (38%), Gaps = 29/284 (10%)
Query: 705 IIGMGGNGIVYKAEFHRPH---MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVR 761
IG G G V++ + P + VA+K +D + +E + + H +IV+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVK 72
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
L+G + E V ++ + L + L D S A ++ L YL
Sbjct: 73 LIGVIT-ENPVWIIMELCTLGEL-RSFLQVRKYSL--DLASLILYAYQLSTALAYLE--- 125
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETV-SMVAGSYGYIAPEYGYTLK 880
+HRDI + N+L+ +N ++ DFGL+R M S ++APE +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 881 VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQC 940
SD++ FGV + E+L + P G V+ I+ + + P+
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVK--PFQGVK---NNDVIGRIE--NGERLPMPPNCPPTL 238
Query: 941 KHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKS 984
L+ + C A P RP ++ L K+
Sbjct: 239 YS------LMTK----CWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (417), Expect = 9e-46
Identities = 55/269 (20%), Positives = 102/269 (37%), Gaps = 21/269 (7%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+++G G V AE R +VA+K + + E+++L +++H NIV L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCI-AKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
+ ++ ++ + L + + K G SR + + + YLH
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASR--LIFQVLDAVKYLHDLGIV 129
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
+ LD + + I+DFGL++ M +S G+ GY+APE +
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188
Query: 884 KSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHV 943
D +S GV+ LL G P ++ + ++K+ D I+ K
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFY-----DENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 944 QEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
++ K P+ R T +
Sbjct: 244 IRHLM----------EKDPEKRFTCEQAL 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 163 bits (413), Expect = 2e-45
Identities = 74/280 (26%), Positives = 112/280 (40%), Gaps = 31/280 (11%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLL 763
I+G GG V+ A R H VAVK L D RE L H IV +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 764 GYLHNETN----VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
ET +V +Y+ +L + +H G + IA L+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEV-----IADACQALNF 126
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM---VAGSYGYIAPEYG 876
Q +IHRD+K NI++ A ++ DFG+AR + +V+ V G+ Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 877 YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936
VD +SD+YS G VL E+LTG+ P V ++ + A +
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFT-----GDSPVSVAYQHVREDPIPPSARHEGL 241
Query: 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-TMRDVITML 975
+ +VL+ AK P+ R T ++ L
Sbjct: 242 SADLDA------VVLK----ALAKNPENRYQTAAEMRADL 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-44
Identities = 60/296 (20%), Positives = 114/296 (38%), Gaps = 35/296 (11%)
Query: 704 NIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
+G G G+VY+ P VA+K + + + E + E S++ +
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASVMKEFNCHH 84
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLV------DWVSRYNIAVGIAQ 812
+VRLLG + +++ + M L L +A IA
Sbjct: 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144
Query: 813 GLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM--VAGSYGY 870
G+ YL+ +HRD+ + N ++ + +I DFG+ R + + +
Sbjct: 145 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201
Query: 871 IAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930
++PE SD++SFGVVL E+ T + + G + E VL + D+
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLA---EQPYQGLSN--EQVLRFVMEGGLLDK 256
Query: 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML-GEAKPRRKSI 985
+ + + + +C PK RP+ ++I+ + E +P + +
Sbjct: 257 P---------DNCPDML---FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 3e-44
Identities = 51/268 (19%), Positives = 106/268 (39%), Gaps = 27/268 (10%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G GIV++ K + D + +E+S+L RHRNI+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIARHRNILHLHES 69
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
+ ++M+++++ + E ++ ++ + + + L +LH +
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLH---SHNI 123
Query: 826 IHRDIKSNNILLDANLEAR--IADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
H DI+ NI+ + I +FG AR + + ++ + Y APE V
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 884 KSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHV 943
+D++S G ++ LL+G P ++ + + +++ + DE I+ +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFL-----AETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 944 QEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
+ +L K K R T +
Sbjct: 238 VDRLL----------VKERKSRMTASEA 255
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 161 bits (408), Expect = 5e-44
Identities = 62/271 (22%), Positives = 99/271 (36%), Gaps = 30/271 (11%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLF----REVSLLGRLRHRNI 759
IIG GG G VY + A+K L + ++ G+ L +SL+ I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 760 VRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
V + H + + D M L L + A I GL ++H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMH- 124
Query: 820 DCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYT- 878
V++RD+K NILLD + RI+D GLA + G++GY+APE
Sbjct: 125 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHASVGTHGYMAPEVLQKG 180
Query: 879 LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAG 938
+ D +D +S G +L +LL G P + + + L S +
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQ------HKTKDKHEIDRMTLTMAVELPDSFSP 234
Query: 939 QCKHVQEEMLLVLRIAVLCTAKLPKGRPTMR 969
+ + + E +L + R
Sbjct: 235 ELRSLLEGLL----------QRDVNRRLGCL 255
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (403), Expect = 9e-44
Identities = 59/269 (21%), Positives = 101/269 (37%), Gaps = 25/269 (9%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRL 762
+G G G V+ A+K L + ++ + E +L + H I+R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
G + + M+ DY+ L L A+ L +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHS 122
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD 882
+I+RD+K NILLD N +I DFG A+ + T + G+ YIAPE T +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT---LCGTPDYIAPEVVSTKPYN 179
Query: 883 EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942
+ D +SFG+++ E+L G P F S + I + + + P K
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP----FYDSNTMK--TYEKILNAELR---FPPFFNEDVKD 230
Query: 943 VQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
+ ++ + +L + DV
Sbjct: 231 LLSRLI-----TRDLSQRLGNLQNGTEDV 254
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 72/294 (24%), Positives = 123/294 (41%), Gaps = 43/294 (14%)
Query: 704 NIIGMGGNGIVYKAEFHRPH-------MVVAVKKLWRSDNDIESGDDLFREVSLLGRL-R 755
+G G G V AE VAVK L +SD + DL E+ ++ + +
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGK 77
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLL------------VDWVSR 803
H+NI+ LLG + + ++ +Y +L E L + L +
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 804 YNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM 863
+ A +A+G+ YL IHRD+ + N+L+ + +IADFGLAR + H +
Sbjct: 138 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 864 VA--GSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSM 921
++APE + +SD++SFGV+L E+ T P VE + +
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-----VPVEELFKL 249
Query: 922 IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
+K D + + E+ +++R C +P RPT + ++ L
Sbjct: 250 LKEGHRMD---------KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 291
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (398), Expect = 1e-43
Identities = 66/284 (23%), Positives = 112/284 (39%), Gaps = 39/284 (13%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDD-------LFREVSLLGRLR- 755
I+G G + +V + AVK + + S ++ +EV +L ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
H NI++L T +V+D M L + L K L I + + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTL--SEKETRKIMRALLEVIC 124
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY 875
LH + ++HRD+K NILLD ++ ++ DFG + L E + V G+ Y+APE
Sbjct: 125 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLREVCGTPSYLAPEI 180
Query: 876 ------GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQ- 928
++ D++S GV++ LL G P F K ++ +L MI S Q
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQML--MLRMIMSGNYQF 234
Query: 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
+ K + L P+ R T + +
Sbjct: 235 GSPEWDDYSDTVKDLVSRFL----------VVQPQKRYTAEEAL 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 5e-43
Identities = 62/275 (22%), Positives = 117/275 (42%), Gaps = 31/275 (11%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWR----SDNDIESGDDLFREVSLLGRLRHRNIVR 761
+G G +V K + A K + + S S +D+ REVS+L ++H N++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
L N+T+V+++ + + L + E L + + + + Q LN +++
Sbjct: 78 LHEVYENKTDVILILELVAGGELFD--FLAEKESLTEEEATEF-----LKQILNGVYYLH 130
Query: 822 QPPVIHRDIKSNNILLD----ANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGY 877
+ H D+K NI+L +I DFGLA + NE ++ G+ ++APE
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVN 189
Query: 878 TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937
+ ++D++S GV+ LL+G P E + ++ N ++ + +
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFL-----GDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
K +L K PK R T++D +
Sbjct: 245 ALAKDFIRRLL----------VKDPKKRMTIQDSL 269
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-42
Identities = 66/287 (22%), Positives = 116/287 (40%), Gaps = 30/287 (10%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKL---WRSDNDIESGDDLFREVSLLGRLRHRNIV 760
+ +G G VYKA + +VA+KK+ RS+ RE+ LL L H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 761 RLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
LL +++N+ +V+D+M D + + L + Y + L L +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAY-----MLMTLQGLEYL 116
Query: 821 CQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLK 880
Q ++HRD+K NN+LLD N ++ADFGLA+ N + + Y APE + +
Sbjct: 117 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 881 V-DEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQ 939
+ D+++ G +L ELL L ++ + + ++ E P +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLP-----GDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
Query: 940 CKHVQEEMLLVLRIAVL--------------CTAKLPKGRPTMRDVI 972
+V + + + + P R T +
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-42
Identities = 59/271 (21%), Positives = 111/271 (40%), Gaps = 28/271 (10%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESG-DDLFREVSLLGR-LRHRNIVR 761
++G G G V+ AEF + + A+K L + ++ + E +L H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 762 LLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC 821
+ + N+ V +Y+ L + K + + Y A+ + L
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFY-----AAEIILGLQFLH 120
Query: 822 QPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKV 881
+++RD+K +NILLD + +IADFG+ + + + + G+ YIAPE K
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 882 DEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCK 941
+ D +SFGV+L E+L G+ P F G + + S + + + + K
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSP----FHG-----QDEEELFHSIRMDNPFYPRWLEKEAK 231
Query: 942 HVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
+ ++ + P+ R +R I
Sbjct: 232 DLLVKLF----------VREPEKRLGVRGDI 252
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-42
Identities = 66/294 (22%), Positives = 106/294 (36%), Gaps = 39/294 (13%)
Query: 704 NIIGMGGNGIVYKAEFHRPHM-----VVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN 758
+G G G V +A+ VAVK L E + L+ H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 759 IVRLLGYLHNETN-VMMVYDYMPNDSLGEALHGK------------EAGKLLVDWVSRYN 805
+V LLG +M++ ++ +L L K + K +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 806 IAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM-- 863
+ +A+G+ +L IHRD+ + NILL +I DFGLAR + + V
Sbjct: 139 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 864 VAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923
++APE + +SD++SFGV+L E+ + P I E +K
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCRRLK 251
Query: 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGE 977
+ EM + + C P RPT +++ LG
Sbjct: 252 EGTRMRAP---------DYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 9e-42
Identities = 66/290 (22%), Positives = 113/290 (38%), Gaps = 37/290 (12%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G+VYKA VVA+KK+ RE+SLL L H NIV+LL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
+H E + +V++++ + L + + + + + Y + Q L L
Sbjct: 68 DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGLAFCHSH 121
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE-YGYTLKVD 882
V+HRD+K N+L++ ++ADFGLAR T + + Y APE
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 883 EKSDIYSFGVVLLELLTGKMPL--------------------DPAFGGSKDIVEWVLSMI 922
DI+S G + E++T + + + G + ++ S
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 923 KSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
K + + P + + + +ML P R + + +
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQML----------HYDPNKRISAKAAL 281
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (380), Expect = 4e-41
Identities = 64/283 (22%), Positives = 110/283 (38%), Gaps = 25/283 (8%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G+VYKA+ + A+KK+ D RE+S+L L+H NIV+L
Sbjct: 8 EKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
+H + +++V++++ D + + + Q LN + +
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEG-------GLESVTAKSFLLQLLNGIAYCHDR 119
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGY-TLKVD 882
V+HRD+K N+L++ E +IADFGLAR + + Y AP+ + K
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 883 EKSDIYSFGVVLLELLTGKMPLDP-----------AFGGSKDIVEW--VLSMIKSNKAQD 929
DI+S G + E++ G G+ + W V + K +
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
K + E + +L P R T + +
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQAL 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-41
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIV 760
++ +IG G G+VY+A+ +VA+KK+ + RE+ ++ +L H NIV
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIV 76
Query: 761 RLLGYLH------NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
RL + + +E + +V DY+P A H A + L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-PVIYVKLYMYQLFRSL 135
Query: 815 NYLHHDCQPPVIHRDIKSNNILLDAN-LEARIADFGLARMMLHKNETVSMVAGSYGYIAP 873
Y+H + HRDIK N+LLD + ++ DFG A+ ++ VS + Y
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 874 EYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
D++S G VL ELL G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 66/284 (23%), Positives = 110/284 (38%), Gaps = 27/284 (9%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G V+KA+ H +VA+K++ D+D RE+ LL L+H+NIVRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
LH++ + +V+++ D + + + Q L L
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKV-D 882
V+HRD+K N+L++ N E ++A+FGLAR S + Y P+ + K+
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 883 EKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKH 942
D++S G + EL PL P D+ + + + + E PS+ +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPG----NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 943 VQEEMLLVLRIAVL---------------CTAKLPKGRPTMRDV 971
M V P R + +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-39
Identities = 67/288 (23%), Positives = 118/288 (40%), Gaps = 28/288 (9%)
Query: 704 NIIGMGGNGIVYKAEFHRP-HMVVAVKKLWRSDNDIESGDDLFREVSLLGRL---RHRNI 759
IG G G V+KA + VA+K++ + REV++L L H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 760 VRLLGYLH-----NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGL 814
VRL ET + +V++++ D E G V + ++ + +GL
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDMMFQLLRGL 129
Query: 815 NYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPE 874
++LH V+HRD+K NIL+ ++ + ++ADFGLAR+ + S+V + Y APE
Sbjct: 130 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-VTLWYRAPE 185
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934
D++S G + E+ K + D + +L +I +D D
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS--SDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 935 SIAGQCKHVQEEMLLVLRIAVL----------CTAKLPKGRPTMRDVI 972
++ Q H + + + + C P R + +
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-39
Identities = 44/201 (21%), Positives = 76/201 (37%), Gaps = 8/201 (3%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRL 762
++G G G V A+K L + + E +L RH + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 763 LGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQ 822
+ V +Y L L + + A+ ++ L +
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHS 123
Query: 823 PPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVD 882
V++RDIK N++LD + +I DFGL + + T+ G+ Y+APE
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 883 EKSDIYSFGVVLLELLTGKMP 903
D + GVV+ E++ G++P
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLP 204
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-39
Identities = 58/292 (19%), Positives = 115/292 (39%), Gaps = 25/292 (8%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
IG G G V+KA + VA+KK+ + RE+ +L L+H N+V L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 764 G--------YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
Y + ++ +V+D+ +D G + K + + R + LN
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRV-----MQMLLN 128
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET----VSMVAGSYGYI 871
L++ + ++HRD+K+ N+L+ + ++ADFGLAR + + + Y
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 872 APEYGYTLK-VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930
PE + D++ G ++ E+ T + + + + +
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ-----GNTEQHQLALISQLCGSITP 243
Query: 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982
+ P++ + + E++ + V K P D+I L P +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 295
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-39
Identities = 60/276 (21%), Positives = 114/276 (41%), Gaps = 41/276 (14%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRS----DNDIESGDDLFREVSLLGRLR--HRN 758
++G GG G VY ++ VA+K + + ++ +G + EV LL ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 759 IVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
++RLL + + +++ + E G L + + Q L +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF-----FWQVLEAVR 124
Query: 819 HDCQPPVIHRDIKSNNILLDAN-LEARIADFGLARMMLHKNETVSMVAGSYGYIAPEY-G 876
H V+HRDIK NIL+D N E ++ DFG ++ K+ + G+ Y PE+
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIR 182
Query: 877 YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936
Y + ++S G++L +++ G +P F ++I+ + +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVF-----------FRQRV 227
Query: 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
+ +C+H L+ C A P RPT ++
Sbjct: 228 SSECQH------LIRW----CLALRPSDRPTFEEIQ 253
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 8e-39
Identities = 60/276 (21%), Positives = 111/276 (40%), Gaps = 32/276 (11%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLL 763
++G+G NG V + R A+K ++ REV L R + +IVR++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKM-------LQDCPKARREVELHWRASQCPHIVRIV 71
Query: 764 GYLHN----ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH 819
N +++V + + L + + S I I + + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE--IMKSIGEAIQYLH- 128
Query: 820 DCQPPVIHRDIKSNNILLDANLE---ARIADFGLARMMLHKNETVSMVAGSYGYIAPEYG 876
+ HRD+K N+L + ++ DFG A+ + +++ + Y+APE
Sbjct: 129 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPYYVAPEVL 185
Query: 877 YTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936
K D+ D++S GV++ LL G P G I + + I+ + + + S
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKTRIRMGQYEFPNPEWS- 242
Query: 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
V EE+ +++R P R T+ + +
Sbjct: 243 -----EVSEEVKMLIR---NLLKTEPTQRMTITEFM 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 8e-39
Identities = 67/295 (22%), Positives = 112/295 (37%), Gaps = 41/295 (13%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLL 763
+ IG G G+V A + + VA+KK+ RE+ +L R RH NI+ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
+ T M Y+ +G L+ + L I +GL Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHL-SNDHICYFLYQILRGLKYIH---SA 128
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSM---VAGSYGYIAPEYGYTLK 880
V+HRD+K +N+LL+ + +I DFGLAR+ ++ + Y APE K
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 881 VD-EKSDIYSFGVVLLELLTGKMPL----------------------DPAFGGSKDIVEW 917
+ DI+S G +L E+L+ + D + +
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 248
Query: 918 VLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972
+LS+ NK L P+ + + ++ML P R + +
Sbjct: 249 LLSLPHKNKVPWNRLFPNADSKALDLLDKML----------TFNPHKRIEVEQAL 293
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (355), Expect = 1e-37
Identities = 50/280 (17%), Positives = 89/280 (31%), Gaps = 31/280 (11%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
IG G G +Y VA+K L E + ++ + + +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRW 70
Query: 766 LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPV 825
E + ++ + SL E L + K + +A + + Y+H
Sbjct: 71 CGAEGDYNVMVMELLGPSL-EDLFNFCSRKF--SLKTVLLLADQMISRIEYIH---SKNF 124
Query: 826 IHRDIKSNNIL---LDANLEARIADFGLARMMLHKNETV-------SMVAGSYGYIAPEY 875
IHRD+K +N L I DFGLA+ + G+ Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 876 GYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935
++ + D+ S G VL+ G +P +K K + ++ +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--------RQKYERISEKKMSTP 236
Query: 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITML 975
I CK E L C + +P + +
Sbjct: 237 IEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLF 273
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 138 bits (347), Expect = 1e-36
Identities = 42/291 (14%), Positives = 85/291 (29%), Gaps = 35/291 (12%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN-IVRLLG 764
IG G G++++ + VA+K R + L E L I +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPP 824
+ + ++V D + G+ A + + +H +
Sbjct: 69 FGQEGLHNVLVIDLLGPSLED---LLDLCGRKFSVKTVAM-AAKQMLARVQSIH---EKS 121
Query: 825 VIHRDIKSNNILLDANLE-----ARIADFGLARM-------MLHKNETVSMVAGSYGYIA 872
+++RDIK +N L+ + DFG+ + ++G+ Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 873 PEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932
+ + D+ + G V + L G +P G + I K
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ---GLKAATNKQKYERIGEKK-----Q 233
Query: 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRK 983
+ C EE + P + + + R
Sbjct: 234 STPLRELCAGFPEEF---YKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-35
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 17/223 (7%)
Query: 687 QRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR 746
Q + T+ E+ A ++ +G G G V A R VA+KKL+R +R
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66
Query: 747 EVSLLGRLRHRNIVRLLGY------LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDW 800
E+ LL +RH N++ LL L + T+ +V +M D H K +
Sbjct: 67 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK------LGE 120
Query: 801 VSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNET 860
+ + +GL Y+H HRD+K N+ ++ + E +I DFGLAR +E
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA--DSEM 175
Query: 861 VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
V + ++ + DI+S G ++ E++TGK
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (336), Expect = 1e-34
Identities = 51/268 (19%), Positives = 101/268 (37%), Gaps = 25/268 (9%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLL 763
+G G G V + A+K L + ++ + E +L + +V+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 764 GYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQP 823
+ +N+ MV +Y+ + L G+ A I YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRF--SEPHARFYAAQIVLTFEYLH---SL 160
Query: 824 PVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDE 883
+I+RD+K N+L+D ++ DFG A+ + + T+ G+ +APE + ++
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---GTPEALAPEIILSKGYNK 217
Query: 884 KSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHV 943
D ++ GV++ E+ G P F + I + + + + K +
Sbjct: 218 AVDWWALGVLIYEMAAGYPP----FFADQPI-----QIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 944 QEEMLLVLRIAVLCTAKLPKGRPTMRDV 971
+L V T + + + D+
Sbjct: 269 LRNLL-----QVDLTKRFGNLKNGVNDI 291
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 31/275 (11%)
Query: 704 NIIGMGGNGIVYKAE---FHRPHMVVAVKKLWRSD--NDIESGDDLFREVSLLGRLRHR- 757
++G G G V+ H + A+K L ++ ++ + E +L +R
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 758 NIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYL 817
+V L ET + ++ DY+ L L +E + V Y + + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIY-----VGEIVLAL 142
Query: 818 HHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML-HKNETVSMVAGSYGYIAPE-- 874
H + +I+RDIK NILLD+N + DFGL++ + + E G+ Y+AP+
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 875 YGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934
G D+ D +S GV++ ELLTG P F + + + +
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEK-NSQAEISRRILKSEPPYPQ 257
Query: 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMR 969
++ K + + +L K PK R
Sbjct: 258 EMSALAKDLIQRLL----------MKDPKKRLGCG 282
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-32
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 5/217 (2%)
Query: 687 QRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR 746
Q LN T E+ + + +G G G V A + + VAVKKL R I +R
Sbjct: 7 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 66
Query: 747 EVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNI 806
E+ LL ++H N++ LL ++ D L A + +
Sbjct: 67 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 807 AVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAG 866
I +GL Y+H HRD+K +N+ ++ + E +I DFGLAR +
Sbjct: 127 IYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA--T 181
Query: 867 SYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMP 903
+ + ++ DI+S G ++ ELLTG+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-32
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 705 IIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLG 764
IG G GIV A VA+KKL R + +RE+ L+ + H+NI+ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 765 Y------LHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLH 818
L +V +V + M + + ++ +D + + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLC-------QVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 819 HDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYT 878
IHRD+K +NI++ ++ +I DFGLAR + ++ + Y APE
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 192
Query: 879 LKVDEKSDIYSFGVVLLELLTGKMP 903
+ E DI+S G ++ E++ K+
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 3e-31
Identities = 44/208 (21%), Positives = 85/208 (40%), Gaps = 21/208 (10%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRL 762
+G G V++A + V VK L + RE+ +L LR NI+ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITL 95
Query: 763 LGYLHNETN--VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD 820
+ + + +V++++ N + + I + L+Y H
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM 148
Query: 821 CQPPVIHRDIKSNNILLDA-NLEARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTL 879
++HRD+K +N+++D + + R+ D+GLA H + ++ S + PE
Sbjct: 149 G---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 204
Query: 880 K-VDEKSDIYSFGVVLLELLTGKMPLDP 906
+ D D++S G +L ++ K P
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFH 232
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (284), Expect = 8e-28
Identities = 47/235 (20%), Positives = 94/235 (40%), Gaps = 26/235 (11%)
Query: 706 IGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGY 765
+G G V+ A+ + VA+K + D + E+ LL R+ + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 766 LH-NETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYN-----------IAVGIAQG 813
+ ++ +++ + + + + G+ L+ + +Y I+ + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 814 LNYLHHDCQPPVIHRDIKSNNILLDAN------LEARIADFGLARMMLHKNETVSMVAGS 867
L+Y+H C +IH DIK N+L++ ++ +IAD G A +
Sbjct: 138 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT---NSIQT 192
Query: 868 YGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMI 922
Y +PE +DI+S ++ EL+TG +P G S + ++ I
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 103 bits (256), Expect = 5e-24
Identities = 73/388 (18%), Positives = 138/388 (35%), Gaps = 39/388 (10%)
Query: 184 NLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAV 243
L + L N+T + L + T+ + I L NL ++ +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 244 GSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLA 303
L+ P L L KL + + N P + + L + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 304 ELKNLQLLNL---------------MCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPM 348
+ N + L LT LE L++ N +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--IS 191
Query: 349 RLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVR 408
L + + L L A++N +S P G+ NL +L L N +L++ +L +
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 409 VQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPS 468
+ NN IS P L L L L++ N ++ P L+ + ++ N + S
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISP----LAGLTALTNLELNENQLEDIS 301
Query: 469 SILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLN 528
I ++ +L NN+ P + + L L ++N +S +S+A+ + L+
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357
Query: 529 LRNNRFSGEIPKAVATMPTLAILDMSNN 556
+N+ S P +A + + L +++
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 97.4 bits (241), Expect = 4e-22
Identities = 79/388 (20%), Positives = 142/388 (36%), Gaps = 41/388 (10%)
Query: 209 LSSLETIILGYNAFEGEIP-AEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYK 267
L+ +LG + + +T L+ L + S+ G + L LT +
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 268 NNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIP---- 323
N T P L ++T L + +++NQI+ P+ L +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 324 -----------DKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPT 372
+ L+ L L+ + L + L RLD SSN +S
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 373 GLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLE 432
NL LI NN S P+ + +L + + N + L +L +L L+
Sbjct: 194 AKLT--NLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 433 MANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPN 492
+ANN ++ P +S T L+ + + N + + P + L+ + + + I N
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 493 ELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILD 552
+L+ L L N++S P ++S KL L NN+ S ++A + + L
Sbjct: 306 ----LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357
Query: 553 MSNNSLFGRIPENFGASPALEMLNLSYN 580
+N + P + L L+
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.9 bits (232), Expect = 5e-21
Identities = 84/380 (22%), Positives = 135/380 (35%), Gaps = 35/380 (9%)
Query: 70 KLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGS 129
K L ++ +VS+ L +++L S + L L ++ S N
Sbjct: 26 KTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDI 81
Query: 130 FPTGLGKASGLTSVNASSN------------NFSGFLPEDLGNATSLESLDFRGSFFEGS 177
P L + L + ++N N +G + +
Sbjct: 82 TP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 139
Query: 178 VPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAF-EGEIPAEFGNLTNL 236
+ ++ L L G +L L++L T+ + + + LTNL
Sbjct: 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL 199
Query: 237 RYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISG 296
L +S P + L + L N L S+T+L LDL++NQIS
Sbjct: 200 ESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 255
Query: 297 EIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPL 356
P L+ L L L L NQ++ + P L LT L LEL +N L P+ L
Sbjct: 256 LAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLKNL 309
Query: 357 RRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISG 416
L N +S P L +L NN S SL+ ++ + +N IS
Sbjct: 310 TYLTLYFNNISDISPVSSL--TKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365
Query: 417 TIPVGLGNLPSLQRLEMANN 436
P L NL + +L + +
Sbjct: 366 LTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 92.4 bits (228), Expect = 2e-20
Identities = 71/365 (19%), Positives = 127/365 (34%), Gaps = 51/365 (13%)
Query: 257 LKKLTTVYLYKNNFTGKIPP-ELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMC 315
L + L K N T + +L +T+L L I G + L NL +N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 316 NQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLC 375
NQLT + P L LTKL + + N + P+ + L + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 376 DSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGT-------------IPVGL 422
+ ++ + + SL +V L + T L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 423 GNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMAS 482
L +L+ L NN ++ P I T+L + ++ N L+ ++ S+ +L +
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 483 HNNLQAKIPNELQACPSLSVLDLSSNSLSGEIP--------------------ASIASCE 522
+N + P L L+ L L +N +S P + I++ +
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 523 KLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKL 582
L L L N S P V+++ L L +NN + + + L+ +N++
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363
Query: 583 EGPVP 587
P
Sbjct: 364 SDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.9 bits (219), Expect = 3e-19
Identities = 78/365 (21%), Positives = 141/365 (38%), Gaps = 33/365 (9%)
Query: 109 SLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLD 168
S +L + ++ + I S G+ + LT +N S+N + P L N T L +
Sbjct: 39 SQTDLDQVTTLQADRLG-IKSI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 94
Query: 169 FRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPP------------ELGQLSSLETII 216
+ P + L + + + +S+L +
Sbjct: 95 MNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLT 154
Query: 217 LGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPAL-GRLKKLTTVYLYKNNFTGKIP 275
G + L NL L+ S + ++ +L L ++ N + P
Sbjct: 155 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP 214
Query: 276 PELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVL 335
+ +T+L L L+ NQ+ LA L NL L+L NQ++ L P L LTKL L
Sbjct: 215 LGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 268
Query: 336 ELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFP 395
+L N + P+ + L+ + E + + + NLT L L+ N+ S P
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQL----EDISPISNLKNLTYLTLYFNNISDISP 324
Query: 396 VSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFV 455
+S+ L R+ NN +S L NL ++ L +N ++ P ++ T ++ +
Sbjct: 325 --VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 378
Query: 456 DISWN 460
++
Sbjct: 379 GLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.4 bits (210), Expect = 3e-18
Identities = 80/388 (20%), Positives = 137/388 (35%), Gaps = 35/388 (9%)
Query: 146 SSNNFSGFLP-EDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPP 204
N + + DL T+L++ +G L L + S N LT P
Sbjct: 30 GKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP- 83
Query: 205 ELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVY 264
L L+ L I++ N P
Sbjct: 84 -LKNLTKLVDILMNNNQIADITPLANLTNLTGLT---------LFNNQITDIDPLKNLTN 133
Query: 265 LYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPD 324
L + + ++ +++ L L LA L L+ L++ N+++
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS--DIS 191
Query: 325 KLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLI 384
L +LT LE L N + P+ + + L L + N L L NLT L
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILTN--LDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 385 LFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPD 444
L NN S P LS L +++ N IS P L L +L LE+ N L P
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPI 303
Query: 445 DISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLD 504
+L+++ + +N++ P + S+ LQ ++N + + L +++ L
Sbjct: 304 SN--LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS--DVSSLANLTNINWLS 357
Query: 505 LSSNSLSGEIPASIASCEKLVSLNLRNN 532
N +S P +A+ ++ L L +
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 69.6 bits (169), Expect = 5e-13
Identities = 42/188 (22%), Positives = 77/188 (40%), Gaps = 13/188 (6%)
Query: 35 LNMLEDWKMPSNAAENGLLHCNWTGV-WCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLS 93
++ + + +N E L + S + LDL+N ++ + GL L+
Sbjct: 209 ISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNL--APLSGLTKLT 266
Query: 94 SLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGF 153
L + N+ ++ P LA LTAL ++++++N P LT + NN S
Sbjct: 267 ELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDI 322
Query: 154 LPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLE 213
P + + T L+ L F + +S NL + +L N ++ P L L+ +
Sbjct: 323 SP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRIT 376
Query: 214 TIILGYNA 221
+ L A
Sbjct: 377 QLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 4e-07
Identities = 23/145 (15%), Positives = 44/145 (30%), Gaps = 6/145 (4%)
Query: 4 HLLFLYCYIVESNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWCN 63
L I L+ L +K G N+ + + + +
Sbjct: 245 DLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS 304
Query: 64 SRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQ 123
+ + L L +++ + L L L N+ + SLANLT + +
Sbjct: 305 NLKNLTYLTLYFNNISDI--SPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 124 NNFIGSFPTGLGKASGLTSVNASSN 148
N P L + +T + +
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 2e-06
Identities = 45/290 (15%), Positives = 90/290 (31%), Gaps = 25/290 (8%)
Query: 321 LIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNL 380
+ D L + L K ++ ++ + L A + G+ NL
Sbjct: 15 IFTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNL 68
Query: 381 TKLILFNNSFSGTFPVS----LSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANN 436
T++ NN + P+ L ++ + L + Q ++
Sbjct: 69 TQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 128
Query: 437 NLTGQIPDDISLSTSLSFVDI--------SWNHLESYLPSSILSIPSLQTFMASHNNLQA 488
+ S ++S + + L+ + + +N +
Sbjct: 129 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188
Query: 489 KIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTL 548
I + +L L ++N +S P I L L+L N+ +A++ L
Sbjct: 189 DISVLAK-LTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNL 243
Query: 549 AILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPN 598
LD++NN + P L L L N++ P G+ N
Sbjct: 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (249), Expect = 1e-23
Identities = 69/295 (23%), Positives = 114/295 (38%), Gaps = 20/295 (6%)
Query: 194 SGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPA 253
S L K+P +L + L N +F NL NL L L +S P A
Sbjct: 18 SDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74
Query: 254 LGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNL 313
L KL +YL KN +P ++ L + +N+I+ L + ++ L
Sbjct: 75 FAPLVKLERLYLSKNQLKE-LPEKMPKTLQE--LRVHENEITKVRKSVFNGLNQMIVVEL 131
Query: 314 MCNQL--TGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIP 371
N L +G+ + KL + + ++ ++P L S L L N ++
Sbjct: 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGLPPS--LTELHLDGNKITKVDA 188
Query: 372 TGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRL 431
L NL KL L NS S SL+ L + + NN + +P GL + +Q +
Sbjct: 189 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 247
Query: 432 EMANNNLTG------QIPDDISLSTSLSFVDISWNHLESY--LPSSILSIPSLQT 478
+ NNN++ P + S S V + N ++ + PS+ +
Sbjct: 248 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 302
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (249), Expect = 1e-23
Identities = 59/302 (19%), Positives = 105/302 (34%), Gaps = 23/302 (7%)
Query: 54 HCNWTGVWCNSRGF----------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFA 103
C+ V C+ G LDL N + + + L++L +L + N+ +
Sbjct: 9 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 104 SSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATS 163
P + A L L+ + +S+N L + L
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 164 LESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFE 223
+E L G +F+ ++KL ++ ++ N+T IP G SL + L N
Sbjct: 129 VE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT 184
Query: 224 GEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITS 283
A L NL L L+ S+S +L L ++L N K+P L
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243
Query: 284 LAFLDLSDNQISG------EIPVKLAELKNLQLLNLMCNQLT--GLIPDKLGELTKLEVL 335
+ + L +N IS P + + ++L N + + P + +
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303
Query: 336 EL 337
+L
Sbjct: 304 QL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 99.7 bits (247), Expect = 2e-23
Identities = 58/278 (20%), Positives = 102/278 (36%), Gaps = 13/278 (4%)
Query: 260 LTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLT 319
+ L N T + ++ +L L L +N+IS P A L L+ L L NQL
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 320 GLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGN 379
L L +L V E + S+ L Q + L + SG
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKK 151
Query: 380 LTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLT 439
L+ + + + + + + SL + + N I+ L L +L +L ++ N+++
Sbjct: 152 LSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 440 GQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQA------KIPNE 493
++ + L + ++ N L P + +Q +NN+ A P
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267
Query: 494 LQACPSLSVLDLSSNSLS-GEIPASIASC-EKLVSLNL 529
S S + L SN + EI S C ++ L
Sbjct: 268 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 97.4 bits (241), Expect = 1e-22
Identities = 71/326 (21%), Positives = 123/326 (37%), Gaps = 54/326 (16%)
Query: 260 LTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLT 319
L V K+P +L A LDL +N+I+ LKNL L L+ N+++
Sbjct: 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 320 GLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGN 379
+ P L KLE L L KN L LP ++ + L+ L N ++ +
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQL-KELPEKMPK--TLQELRVHENEITKVRKSVFNGLNQ 125
Query: 380 LTKLILFN--NSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNN 437
+ + L SG + K L +R+ + I+ TIP GL PSL L + N
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 182
Query: 438 LTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQAC 497
+T + +L+ + +S+N + + S+ + P L+ ++N L K+P L
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 241
Query: 498 PSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNS 557
+ V+ L +N++S + +N F
Sbjct: 242 KYIQVVYLHNNNIS----------------AIGSNDFCP--------------------- 264
Query: 558 LFGRIPENFGASPALEMLNLSYNKLE 583
P + ++L N ++
Sbjct: 265 -----PGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 93.6 bits (231), Expect = 2e-21
Identities = 65/290 (22%), Positives = 111/290 (38%), Gaps = 18/290 (6%)
Query: 123 QNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSF 182
+ + P L ++ +N + D N +L +L + P +F
Sbjct: 18 SDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75
Query: 183 RNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLA 242
L KL+ L LS N L +P ++ + +L+ + + N + F L + ++L
Sbjct: 76 APLVKLERLYLSKNQLKE-LPEKMPK--TLQELRVHENEITKVRKSVFNGLNQMIVVELG 132
Query: 243 VGSL--SGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPV 300
L SG A +KKL+ + + N T IP L SL L L N+I+
Sbjct: 133 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAA 189
Query: 301 KLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLD 360
L L NL L L N ++ + L L L L N L+ P L ++ +
Sbjct: 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVY 248
Query: 361 ASSNLLSGEIPTGLCDSG------NLTKLILFNNSFSGTFPVSLSTCKSL 404
+N +S C G + + + LF+N + + ST + +
Sbjct: 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ-YWEIQPSTFRCV 297
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.2 bits (217), Expect = 2e-19
Identities = 53/282 (18%), Positives = 94/282 (33%), Gaps = 14/282 (4%)
Query: 345 SLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSL 404
+P L LD +N ++ + NL LIL NN S P + + L
Sbjct: 24 KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 405 VRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLES 464
R+ + N + L L+ E + + + ++ +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS-G 140
Query: 465 YLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKL 524
+ + L + N+ IP L PSL+ L L N ++ AS+ L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 525 VSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEG 584
L L N S ++A P L L ++NN L ++P ++++ L N +
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
Query: 585 -------PVPSNGILMNINPNELIGNAGLCGSVLPPCSQNLT 619
P N + + L N + P + +
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.6 bits (135), Expect = 4e-09
Identities = 34/247 (13%), Positives = 68/247 (27%), Gaps = 4/247 (1%)
Query: 451 SLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSL 510
L V S LE +P + P +N + + + +L L L +N +
Sbjct: 11 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 511 SGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASP 570
S P + A KL L L N+ K T+ L + + + +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 571 ALEMLNLSYNKLEGPVPSNGILMNINPNELIGNA-GLCGSVLPPCSQNLTAKPGQTRKMH 629
+E+ + + ++ + LPP L + K+
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVD 187
Query: 630 INHIIFGFIIGTLVIVSLGIVFFAGKWAYRRWYLYNSFFDDLFKKSCKEWPWRLIAFQRL 689
+ + L + I +L ++ Q +
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVV 247
Query: 690 NFTSSEI 696
++ I
Sbjct: 248 YLHNNNI 254
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 100 bits (248), Expect = 2e-23
Identities = 68/312 (21%), Positives = 116/312 (37%), Gaps = 14/312 (4%)
Query: 18 DDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHCNWTGVWCNSRGF---VEKLDLS 74
+ LL IK L +P L W ++ + W GV C++ V LDLS
Sbjct: 5 PQDKQALLQIKKDLGNP-TTLSSWLPTTDCC-----NRTWLGVLCDTDTQTYRVNNLDLS 58
Query: 75 NMSLNG--SVSENIRGLRSLSSLNI-CCNEFASSLPKSLANLTALKSMDVSQNNFIGSFP 131
++L + ++ L L+ L I N +P ++A LT L + ++ N G+ P
Sbjct: 59 GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118
Query: 132 TGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFL 191
L + L +++ S N SG LP + + +L + F G+ G++P S+ + KL
Sbjct: 119 DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178
Query: 192 GLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIP 251
N P + + + +
Sbjct: 179 MTISRNRLTGKIPPTFA-NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237
Query: 252 PALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLL 311
+G K L + L N G +P L + L L++S N + GEIP + L+ +
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVS 296
Query: 312 NLMCNQLTGLIP 323
N+ P
Sbjct: 297 AYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 96.4 bits (238), Expect = 3e-22
Identities = 63/268 (23%), Positives = 103/268 (38%), Gaps = 4/268 (1%)
Query: 351 GQSSPLRRLDASSNLLSG--EIPTGLCDSGNLTKLILFNN-SFSGTFPVSLSTCKSLVRV 407
Q+ + LD S L IP+ L + L L + + G P +++ L +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 408 RVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLP 467
+ + +SG IP L + +L L+ + N L+G +P IS +L + N + +P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 468 SSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSL 527
S S L T M N + S ++ + + +K
Sbjct: 167 DSYGSFSKLFTSMTISRN-RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225
Query: 528 NLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVP 587
V L LD+ NN ++G +P+ L LN+S+N L G +P
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 588 SNGILMNINPNELIGNAGLCGSVLPPCS 615
G L + + N LCGS LP C+
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 79.0 bits (193), Expect = 2e-16
Identities = 83/308 (26%), Positives = 129/308 (41%), Gaps = 29/308 (9%)
Query: 158 LGNATSLESLDFRGSF----FEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLE 213
LGN T+L S + G + + ++ L LSG NL P
Sbjct: 18 LGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP---------- 67
Query: 214 TIILGYNAFEGEIPAEFGNLTNLRYLDLA-VGSLSGQIPPALGRLKKLTTVYLYKNNFTG 272
IP+ NL L +L + + +L G IPPA+ +L +L +Y+ N +G
Sbjct: 68 ------------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG 115
Query: 273 KIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKL 332
IP L I +L LD S N +SG +P ++ L NL + N+++G IPD G +KL
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175
Query: 333 EVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSG 392
+ + + L +D S N + + L S T+ I +
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLNLAFVDLSRN-MLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 393 TFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSL 452
+ K+L + ++NN I GT+P GL L L L ++ NNL G+IP +L
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL-QRF 293
Query: 453 SFVDISWN 460
+ N
Sbjct: 294 DVSAYANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.0 bits (128), Expect = 4e-08
Identities = 17/65 (26%), Positives = 26/65 (40%), Gaps = 2/65 (3%)
Query: 141 TSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNN-LT 199
++ +N G LP+ L L SL+ + G +P NLQ+ + N L
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLC 305
Query: 200 GKIPP 204
G P
Sbjct: 306 GSPLP 310
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.1 bits (207), Expect = 4e-19
Identities = 38/204 (18%), Positives = 66/204 (32%), Gaps = 29/204 (14%)
Query: 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI-------ESGDDLF-REVSLLGRLR 755
++G G V+ VK + GD F R
Sbjct: 6 KLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 756 HRNIVRLLGYLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLN 815
R + +L G V VY + N L E + KE ++ V+ + I + +
Sbjct: 65 FRALQKLQGL-----AVPKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVA 117
Query: 816 YLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN--ETVSM-VAGSYGYIA 872
+H ++H D+ N+L+ I DF + + + E + V Y +
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173
Query: 873 PEYGYTLKVDEKSDIYSFGVVLLE 896
Y + DI S +L+
Sbjct: 174 RTYRT------EKDINSAIDRILQ 191
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (205), Expect = 4e-18
Identities = 53/277 (19%), Positives = 87/277 (31%), Gaps = 8/277 (2%)
Query: 261 TTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG 320
T + +P + + + L N+IS +NL +L L N L
Sbjct: 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70
Query: 321 LIPDKLGELTKLEVLELWKNSLIGSL-PMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGN 379
+ L LE L+L N+ + S+ P L L L P
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130
Query: 380 LTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLT 439
L L L +N+ + +L + + N IS L SL RL + N +
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 440 GQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPS 499
P L + + N+L + ++ + +LQ + N
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW-AW 249
Query: 500 LSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSG 536
L SS+ + +P +A L N G
Sbjct: 250 LQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (198), Expect = 3e-17
Identities = 56/263 (21%), Positives = 87/263 (33%), Gaps = 5/263 (1%)
Query: 138 SGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNN 197
+ + +P + + + + G+ SFR + L L L N
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 198 LTGKIPPELGQLSSLETIILGYNAFEGEI-PAEFGNLTNLRYLDLAVGSLSGQIPPALGR 256
L L+ LE + L NA + PA F L L L L L P
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 257 LKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCN 316
L L +YL N + +L L L N+IS L +L L L N
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 317 QLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCD 376
++ + P +L +L L L+ N+L L L+ L + N +
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPL 246
Query: 377 SGNLTKLILFNNSFSGTFPVSLS 399
L K ++ + P L+
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (193), Expect = 1e-16
Identities = 56/276 (20%), Positives = 96/276 (34%), Gaps = 15/276 (5%)
Query: 56 NWTGVWCNSRGF----------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASS 105
C +G +++ L ++ + + R R+L+ L + N A
Sbjct: 12 PKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 106 LPKSLANLTALKSMDVSQNNFIGS-FPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSL 164
+ L L+ +D+S N + S P L +++ P +L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 165 ESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEG 224
+ L + + + +FR+L L L L GN ++ L SL+ ++L N
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 225 EIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSL 284
P F +L L L L +LS AL L+ L + L N + L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWL 250
Query: 285 AFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG 320
S +++ +P L L L N L G
Sbjct: 251 QKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (189), Expect = 5e-16
Identities = 51/299 (17%), Positives = 91/299 (30%), Gaps = 32/299 (10%)
Query: 287 LDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSL 346
+ +PV + Q + L N+++ + L +L L N L
Sbjct: 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 347 PMRLGQSSPLRRLDASSNLLSGEI-PTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLV 405
+ L +LD S N + P G L L L P +L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 406 RVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESY 465
+ +Q+N + +L +L L + N ++ SL + + N +
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 466 LPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLV 525
P + + L T NNL A L +L L L+ N +
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR---------- 242
Query: 526 SLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEG 584
+ L L S++ + +P+ ++ L+ N L+G
Sbjct: 243 ARPLWAW---------------LQKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (188), Expect = 7e-16
Identities = 57/289 (19%), Positives = 92/289 (31%), Gaps = 31/289 (10%)
Query: 225 EIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSL 284
+P + + L +S + + LT ++L+ N + L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 285 AFLDLSDNQISGEI-PVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLI 343
LDLSDN + P L L L+L L L P L L+ L L N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 344 GSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKS 403
L L N +S +L +L+L N + P +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 404 LVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLE 463
L+ + + N +S L L +LQ L + +N D ++
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC----DCRARPLWAW--------- 249
Query: 464 SYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSG 512
LQ F S + + +P L + L++N L G
Sbjct: 250 ------------LQKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (176), Expect = 2e-14
Identities = 48/259 (18%), Positives = 89/259 (34%), Gaps = 4/259 (1%)
Query: 352 QSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQN 411
+ P L +P G+ ++ L N S S C++L + + +
Sbjct: 9 YNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 412 NLISGTIPVGLGNLPSLQRLEMANNNLTGQI-PDDISLSTSLSFVDISWNHLESYLPSSI 470
N+++ L L++L++++N + P L + + L+ P
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF 125
Query: 471 LSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLR 530
+ +LQ N LQA + + +L+ L L N +S + L L L
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 531 NNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNG 590
NR + P A + L L + N+L E AL+ L L+ N +
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP 245
Query: 591 ILMNINPNELIGNAGLCGS 609
+ + + C
Sbjct: 246 LWAWLQKFRGSSSEVPCSL 264
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (125), Expect = 6e-08
Identities = 31/176 (17%), Positives = 57/176 (32%), Gaps = 7/176 (3%)
Query: 52 LLHCNWTGVWCNSRGFVEKL---DLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPK 108
L C + + L L + +L + R L +L+ L + N +S +
Sbjct: 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171
Query: 109 SLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLD 168
+ L +L + + QN P L ++ +NN S E L +L+ L
Sbjct: 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231
Query: 169 FRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEG 224
+ + L+ S + + +P L L N +G
Sbjct: 232 LNDNPWVCDCRARP-LWAWLQKFRGSSSEVPCSLPQRLAGRDLKR---LAANDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (152), Expect = 3e-11
Identities = 54/210 (25%), Positives = 71/210 (33%), Gaps = 7/210 (3%)
Query: 181 SFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLD 240
+ + NLT +PP+L + L N A T L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 241 LAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPV 300
L G L L T+ L N ++ +L LD+S N+++
Sbjct: 62 L--DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLG 118
Query: 301 KLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLD 360
L L LQ L L N+L L P L KLE L L N+L L L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 361 ASSNLLSGEIPTGLCDSGNLTKLILFNNSF 390
N L IP G S L L N +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 2e-09
Identities = 44/208 (21%), Positives = 74/208 (35%), Gaps = 7/208 (3%)
Query: 327 GELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILF 386
++ + K +L +LP L + L S NLL L LT+L L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 387 NNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDI 446
+ ++ ++ ++P+ LP+L L+++ N LT +
Sbjct: 64 RAELTKLQVD---GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 447 SLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLS 506
L + + N L++ P + P L+ ++NNL L +L L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 507 SNSLSGEIPASIASCEKLVSLNLRNNRF 534
NSL IP L L N +
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.6 bits (135), Expect = 3e-09
Identities = 42/211 (19%), Positives = 78/211 (36%), Gaps = 7/211 (3%)
Query: 277 ELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLE 336
E+ + S ++ ++ +P L K+ +L+L N L L T+L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 337 LWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPV 396
L + L +++ + P+ S+ +P LT L + N +
Sbjct: 62 LDRAELT---KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 397 SLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVD 456
+L L + ++ N + P L P L++L +ANNNLT ++ +L +
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 457 ISWNHLESYLPSSILSIPSLQTFMASHNNLQ 487
+ N L + +P L N
Sbjct: 179 LQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.8 bits (125), Expect = 6e-08
Identities = 45/211 (21%), Positives = 71/211 (33%), Gaps = 6/211 (2%)
Query: 397 SLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVD 456
+S S + V ++ +P L L ++ N L + T L+ ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 457 ISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPA 516
+ L L P L T SHN LQ+ + D+S N L+
Sbjct: 62 LDRAELTKLQVDGTL--PVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLG 118
Query: 517 SIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLN 576
++ +L L L+ N P + P L L ++NN+L L+ L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 577 LSYNKLEGPVPSNGILMNINPNELIGNAGLC 607
L N L + L GN LC
Sbjct: 179 LQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.2 bits (108), Expect = 8e-06
Identities = 45/192 (23%), Positives = 67/192 (34%), Gaps = 14/192 (7%)
Query: 60 VWCNSRGF----------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKS 109
V C+ R L LS L + L+ LN+ E
Sbjct: 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG 74
Query: 110 LANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDF 169
L L ++D+S N G LT ++ S N + L L+ L
Sbjct: 75 --TLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131
Query: 170 RGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAE 229
+G+ + P KL+ L L+ NNLT L L +L+T++L N+ IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 230 FGNLTNLRYLDL 241
F L + L
Sbjct: 191 FFGSHLLPFAFL 202
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 46/266 (17%), Positives = 94/266 (35%), Gaps = 16/266 (6%)
Query: 117 KSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRG-SFFE 175
+++D++ N L + G+ + + L E ++ +D
Sbjct: 3 QTLDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEV 60
Query: 176 GSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGY--NAFEGEIPAEFGNL 233
++ KL+ L L G L+ I L + S+L + L E + +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 234 TNLRYLDLAVGSLSG------QIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFL 287
+ L L+L+ + + +L KN + + +L L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 288 DLSDN-QISGEIPVKLAELKNLQLLNLM-CNQLTGLIPDKLGELTKLEVLELWKNSLIGS 345
DLSD+ + + + +L LQ L+L C + +LGE+ L+ L+++ G+
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 346 LPMRLGQSSPLRRLDASSNLLSGEIP 371
L + L L + + +
Sbjct: 241 LQLLKEA---LPHLQINCSHFTTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 1e-09
Identities = 41/272 (15%), Positives = 84/272 (30%), Gaps = 13/272 (4%)
Query: 335 LELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSG-T 393
L+L +L + RL S + + + + + + L N+ T
Sbjct: 5 LDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVST 62
Query: 394 FPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLS 453
LS C L + ++ +S I L +L RL ++ + + LS+
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 454 FVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQA---------CPSLSVLD 504
+++ + + + + + + NL N ++ + +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 505 LSSNSLSGEIPASIASCEKLVSLNLRN-NRFSGEIPKAVATMPTLAILDMSNNSLFGRIP 563
S L + L L+L E + +PTL L + G +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 564 ENFGASPALEMLNLSYNKLEGPVPSNGILMNI 595
A P L++ + + P N I
Sbjct: 243 LLKEALPHLQINCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 1e-09
Identities = 47/271 (17%), Positives = 99/271 (36%), Gaps = 20/271 (7%)
Query: 70 KLDLSNMSLNGSVSENI--RGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNF- 126
LDL+ +L+ V+ + +G+ + C F + ++ MD+S +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVIAFR----CPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 127 IGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFR--GSFFEGSVPTSFRN 184
+ + L + S L +++ S + L ++L L+ F E ++ T +
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 185 LQKLKFL------GLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRY 238
+L L + ++ + ++ L N + ++ NL +
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179
Query: 239 LDLAV-GSLSGQIPPALGRLKKLTTVYLYK-NNFTGKIPPELGSITSLAFLDLSDNQISG 296
LDL+ L +L L + L + + + ELG I +L L + G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 297 EIPVKLAELKNLQLLNLMCNQLTGLIPDKLG 327
+ + L +LQ+ C+ T + +G
Sbjct: 240 TLQLLKEALPHLQIN---CSHFTTIARPTIG 267
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.3 bits (130), Expect = 2e-09
Identities = 25/125 (20%), Positives = 44/125 (35%), Gaps = 6/125 (4%)
Query: 189 KFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSG 248
+ L L+ +LT + L QL + + L +N P L L L +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNAL 55
Query: 249 QIPPALGRLKKLTTVYLYKNNFTG-KIPPELGSITSLAFLDLSDNQISGEIPVKLAELKN 307
+ + L +L + L N L S L L+L N + E ++ +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 308 LQLLN 312
L ++
Sbjct: 116 LPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.9 bits (116), Expect = 2e-07
Identities = 28/118 (23%), Positives = 44/118 (37%), Gaps = 6/118 (5%)
Query: 482 SHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKA 541
+H +L + L+ ++ LDLS N L P ++A+ L L +N A
Sbjct: 6 AHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVA 62
Query: 542 VATMPTLAILDMSNNSLFG-RIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPN 598
L + NN L + + P L +LNL N L L + P+
Sbjct: 63 NLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 7e-07
Identities = 25/104 (24%), Positives = 44/104 (42%), Gaps = 7/104 (6%)
Query: 411 NNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSI 470
+L T+ L L + L++++N L P +L+ + + +
Sbjct: 8 KDL---TVLCHLEQLLLVTHLDLSHNRLRALPP---ALAALRCLEVLQASDNALENVDGV 61
Query: 471 LSIPSLQTFMASHNNLQA-KIPNELQACPSLSVLDLSSNSLSGE 513
++P LQ + +N LQ L +CP L +L+L NSL E
Sbjct: 62 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 2e-05
Identities = 28/107 (26%), Positives = 41/107 (38%), Gaps = 6/107 (5%)
Query: 287 LDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSL 346
L L+ ++ + L +L + L+L N+L L P L L LEVL+ N+L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 347 PMRLGQSSPLRRLDASSNLL-SGEIPTGLCDSGNLTKLILFNNSFSG 392
+ L+ L +N L L L L L NS
Sbjct: 60 GVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.1 bits (93), Expect = 2e-04
Identities = 25/107 (23%), Positives = 36/107 (33%), Gaps = 4/107 (3%)
Query: 334 VLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGT 393
VL L L ++ L Q + LD S N L P L L L +N+
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 394 FPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTG 440
V+ + + N L L + P L L + N+L
Sbjct: 59 DGVANLPRLQELLLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 4e-04
Identities = 20/118 (16%), Positives = 40/118 (33%), Gaps = 5/118 (4%)
Query: 95 LNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFL 154
L++ + ++ L L + +D+S +N + + P L L + AS N
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLS-HNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 155 PEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSL 212
L + + + +L L L GN+L +L+ +
Sbjct: 60 GVANLPRLQELLLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 55.4 bits (132), Expect = 5e-09
Identities = 33/227 (14%), Positives = 71/227 (31%), Gaps = 18/227 (7%)
Query: 305 LKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSN 364
L N + + +T + +L + L + + ++ + + L L+ N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTG-VTTIE-GVQYLNNLIGLELKDN 73
Query: 365 LLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGN 424
++ P +L S + ++ L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 425 LPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHN 484
L QI + L+ + +S + + + + ++ L T A N
Sbjct: 134 L----------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 485 NLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRN 531
+ P L + P+L + L +N +S P +A+ L + L N
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 7e-07
Identities = 35/216 (16%), Positives = 71/216 (32%), Gaps = 22/216 (10%)
Query: 257 LKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCN 316
L + K+N T + + + L ++ I + L NL L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDN 73
Query: 317 QLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCD 376
Q+T L P K L + ++ + +++ + L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 377 SGNLTKLILFNNSF--------------SGTFPVSLSTCKSLVRVRVQNNLISGTIPVGL 422
I + + L+ L ++ +N IS P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 423 GNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDIS 458
+LP+L + + NN ++ P ++ +++L V ++
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 1e-06
Identities = 34/215 (15%), Positives = 67/215 (31%), Gaps = 46/215 (21%)
Query: 379 NLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNL 438
N K+ ++ + V+ + + + ++ TI G+ L +L LE+ +N +
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQI 75
Query: 439 TGQIPDDISLSTSLSFVDISW--------------------------------------N 460
T P + + +
Sbjct: 76 TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135
Query: 461 HLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIAS 520
+ + + S N Q L L+ L N +S P +AS
Sbjct: 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LAS 193
Query: 521 CEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSN 555
L+ ++L+NN+ S P +A L I+ ++N
Sbjct: 194 LPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 28/220 (12%), Positives = 67/220 (30%), Gaps = 18/220 (8%)
Query: 287 LDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSL 346
+ + ++ + A+L + L+ +T + + + L L LEL N +
Sbjct: 24 IAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA 79
Query: 347 PMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVR 406
P++ L + + L + ++ T + +
Sbjct: 80 PLKNLTKITELE----------LSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 407 VRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYL 466
L I ++ N ++ + L+ + N +
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-- 187
Query: 467 PSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLS 506
S + S+P+L +N + P L +L ++ L+
Sbjct: 188 ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 3e-06
Identities = 38/227 (16%), Positives = 68/227 (29%), Gaps = 18/227 (7%)
Query: 111 ANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFR 170
L + ++N + G+T+++A + E + +L L+ +
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 171 GSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEF 230
+ P L + I + T + +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 231 GNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLS 290
L QI YL N L +++ L L
Sbjct: 132 QVLYLDLN----------QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181
Query: 291 DNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLEL 337
DN+IS P LA L NL ++L NQ++ + P L + L ++ L
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 3e-06
Identities = 38/230 (16%), Positives = 72/230 (31%), Gaps = 19/230 (8%)
Query: 88 GLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASS 147
L + + + ++ + A+L + ++ + + G+ + L +
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTG-VTTIE-GVQYLNNLIGLELKD 72
Query: 148 NNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELG 207
N + P + L ++ + L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 208 QLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYK 267
L I + G ++ ++ N + D L L KLTT+
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD----------LTPLANLSKLTTLKADD 182
Query: 268 NNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQ 317
N + P L S+ +L + L +NQIS P LA NL ++ L NQ
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 29/210 (13%), Positives = 61/210 (29%), Gaps = 22/210 (10%)
Query: 70 KLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGS 129
K+ ++ +V++ L +++L+ +++ + L L +++ N
Sbjct: 23 KIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGV-TTIE-GVQYLNNLIGLELKDNQITDL 78
Query: 130 FPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLK 189
P ++ + + T + + ++ + L
Sbjct: 79 APLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138
Query: 190 FLGLSGNNLTGKI--------------PPELGQLSSLETIILGYNAFEGEIPAEFGNLTN 235
+ + L G L LS L T+ N P +L N
Sbjct: 139 NQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPN 196
Query: 236 LRYLDLAVGSLSGQIPPALGRLKKLTTVYL 265
L + L +S P L L V L
Sbjct: 197 LIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 7e-08
Identities = 18/106 (16%), Positives = 34/106 (32%), Gaps = 13/106 (12%)
Query: 459 WNHLESYLPSSILSIPSLQTFMASHNNLQAK----IPNELQACPSLSVLDLSSNSLSGEI 514
+ L+ + ++ + L A SL LDLS+N L
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413
Query: 515 PASIAS-----CEKLVSLNLRNNRFSGEIPKAVATM----PTLAIL 551
+ L L L + +S E+ + + P+L ++
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 1e-07
Identities = 19/93 (20%), Positives = 34/93 (36%), Gaps = 10/93 (10%)
Query: 235 NLRYLDLAVGSLS-GQIPPALGRLKKLTTVYLYKNNFTGK----IPPELGSITSLAFLDL 289
+++ LD+ LS + L L++ V L T I L +LA L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 290 SDNQISGEIPVKLAEL-----KNLQLLNLMCNQ 317
N++ + + +Q L+L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 28/203 (13%), Positives = 51/203 (25%), Gaps = 10/203 (4%)
Query: 499 SLSVLDLSSNSLSGEIPASIASC-EKLVSLNLRNNRFSGE----IPKAVATMPTLAILDM 553
+ LD+ LS A + ++ + L + + I A+ P LA L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 554 SNNSLFGRIPENFGA-----SPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCG 608
+N L S ++ L+L L G L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 609 SVLPPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVFFAGKWAYRRWYLYNSFF 668
+ Q L + + + L V A N
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 182
Query: 669 DDLFKKSCKEWPWRLIAFQRLNF 691
+ + C+ + L
Sbjct: 183 EAGVRVLCQGLKDSPCQLEALKL 205
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 16/93 (17%), Positives = 31/93 (33%), Gaps = 5/93 (5%)
Query: 449 STSLSFVDISWNHL-ESYLPSSILSIPSLQTFMASHNNLQAK----IPNELQACPSLSVL 503
S + +DI L ++ + + Q L I + L+ P+L+ L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 504 DLSSNSLSGEIPASIASCEKLVSLNLRNNRFSG 536
+L SN L + + S ++
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 8e-07
Identities = 19/89 (21%), Positives = 27/89 (30%), Gaps = 9/89 (10%)
Query: 227 PAEFGNLTNLRYLDLAVGSLSGQ----IPPALGRLKKLTTVYLYKNNFTGKIPPELGSI- 281
+ LR L LA +S + L L + L N +L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 282 ----TSLAFLDLSDNQISGEIPVKLAELK 306
L L L D S E+ +L L+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 20/92 (21%), Positives = 35/92 (38%), Gaps = 10/92 (10%)
Query: 307 NLQLLNLMCNQLTGL-IPDKLGELTKLEVLELWKNSL----IGSLPMRLGQSSPLRRLDA 361
++Q L++ C +L+ + L L + +V+ L L + L + L L+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 362 SSNLLSGEIPTGLCD-----SGNLTKLILFNN 388
SN L + S + KL L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 17/92 (18%), Positives = 27/92 (29%), Gaps = 10/92 (10%)
Query: 475 SLQTFMASHNNLQAKIPNEL-QACPSLSVLDLSSNSLSGE----IPASIASCEKLVSLNL 529
+Q+ L EL V+ L L+ I +++ L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 530 RNNRFSGEIPKAVATM-----PTLAILDMSNN 556
R+N V + L + N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 19/83 (22%), Positives = 33/83 (39%), Gaps = 9/83 (10%)
Query: 258 KKLTTVYLYKNNFTGK----IPPELGSITSLAFLDLSDNQISGEIPVKLAE-----LKNL 308
L ++L + + + L + SL LDLS+N + ++L E L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 309 QLLNLMCNQLTGLIPDKLGELTK 331
+ L L + + D+L L K
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 8e-06
Identities = 15/87 (17%), Positives = 27/87 (31%), Gaps = 9/87 (10%)
Query: 182 FRNLQKLKFLGLSGNNLTGK----IPPELGQLSSLETIILGYNAFEGEIPAEFG-----N 232
+ L+ L L+ +++ + L SL + L N +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 233 LTNLRYLDLAVGSLSGQIPPALGRLKK 259
L L L S ++ L L+K
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 2e-05
Identities = 10/91 (10%), Positives = 28/91 (30%), Gaps = 5/91 (5%)
Query: 68 VEKLDLSNMSLNGS-VSENIRGLRSLSSLNICCNEF----ASSLPKSLANLTALKSMDVS 122
++ LD+ L+ + +E + L+ + + + +L AL +++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 123 QNNFIGSFPTGLGKASGLTSVNASSNNFSGF 153
N + + S +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 13/89 (14%), Positives = 30/89 (33%), Gaps = 10/89 (11%)
Query: 260 LTTVYLYKNNFTGKIPPEL-GSITSLAFLDLSDNQISGEIPVKLAE----LKNLQLLNLM 314
+ ++ + + EL + + L D ++ ++ L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 315 CNQLTGLIPDKLGEL-----TKLEVLELW 338
N+L + + + K++ L L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 12/90 (13%), Positives = 26/90 (28%), Gaps = 5/90 (5%)
Query: 188 LKFLGLSGNNLTGKIPPEL-GQLSSLETIILGYNAFEGE----IPAEFGNLTNLRYLDLA 242
++ L + L+ EL L + + L I + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 243 VGSLSGQIPPALGRLKKLTTVYLYKNNFTG 272
L + + + + + K +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 17/124 (13%), Positives = 37/124 (29%), Gaps = 6/124 (4%)
Query: 41 WKMPSNAAENGLLHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLS-SLNICC 99
+ + + + D L + + LR L +
Sbjct: 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 382
Query: 100 NEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKA-----SGLTSVNASSNNFSGFL 154
+ SSL +L +L+ +D+S N + L ++ L + +S +
Sbjct: 383 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM 442
Query: 155 PEDL 158
+ L
Sbjct: 443 EDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 6e-04
Identities = 21/80 (26%), Positives = 31/80 (38%), Gaps = 9/80 (11%)
Query: 330 TKLEVLELWKNSL----IGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDS-----GNL 380
+ L VL L + SL L + LR LD S+N L L +S L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 381 TKLILFNNSFSGTFPVSLST 400
+L+L++ +S L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 16/83 (19%), Positives = 22/83 (26%), Gaps = 9/83 (10%)
Query: 515 PASIASCEKLVSLNLRNNRFSGE----IPKAVATMPTLAILDMSNNSLFGRIPENFGAS- 569
L L L + S + + +L LD+SNN L S
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 570 ----PALEMLNLSYNKLEGPVPS 588
LE L L +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 9e-04
Identities = 16/78 (20%), Positives = 28/78 (35%), Gaps = 9/78 (11%)
Query: 306 KNLQLLNLMCNQLTGL----IPDKLGELTKLEVLELWKNSLIGSLPMRLGQS-----SPL 356
L++L L ++ + L L L+L N L + ++L +S L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 357 RRLDASSNLLSGEIPTGL 374
+L S E+ L
Sbjct: 429 EQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 14/81 (17%), Positives = 24/81 (29%), Gaps = 9/81 (11%)
Query: 138 SGLTSVNASSNNFSG----FLPEDLGNATSLESLDFRGSFFEGSVPTSF-----RNLQKL 188
S L + + + S L L SL LD + + + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 189 KFLGLSGNNLTGKIPPELGQL 209
+ L L + ++ L L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 13/95 (13%), Positives = 29/95 (30%), Gaps = 10/95 (10%)
Query: 353 SSPLRRLDASSNLLSGEIPTGLCDS-GNLTKLILFNNSFSG----TFPVSLSTCKSLVRV 407
S ++ LD LS L + L + + +L +L +
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 408 RVQNNLISGTIPVGLG-----NLPSLQRLEMANNN 437
+++N + + +Q+L + N
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 13/77 (16%), Positives = 28/77 (36%), Gaps = 9/77 (11%)
Query: 379 NLTKLILFNNSFSGT----FPVSLSTCKSLVRVRVQNNLISGTIPVGLG-----NLPSLQ 429
L L L + S + +L SL + + NN + + L L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 430 RLEMANNNLTGQIPDDI 446
+L + + + ++ D +
Sbjct: 430 QLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 15/83 (18%), Positives = 25/83 (30%), Gaps = 9/83 (10%)
Query: 160 NATSLESLDFRGSFFEG----SVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQ-----LS 210
+ L L S+ + L+ L LS N L +L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 211 SLETIILGYNAFEGEIPAEFGNL 233
LE ++L + E+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 53.0 bits (125), Expect = 8e-08
Identities = 46/295 (15%), Positives = 84/295 (28%), Gaps = 31/295 (10%)
Query: 274 IPPELGSITSLAFLDLSDNQISGE----IPVKLAELKNLQLLNLMCNQLTGL-------- 321
+ L S+ + LS N I E + +A K+L++ +
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 322 --IPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGN 379
+ L + KL + L N+ + L L + +
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 380 LTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSL------QRLEM 433
L N + P S R+ + L ++ R E
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 434 ANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNE 493
+ L + L + + S L ++ S P+L+ + L A+
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262
Query: 494 LQAC------PSLSVLDLSSNSLSGEIPASIAS-----CEKLVSLNLRNNRFSGE 537
+ L L L N + + ++ + L+ L L NRFS E
Sbjct: 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 38/307 (12%), Positives = 83/307 (27%), Gaps = 32/307 (10%)
Query: 283 SLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTG----LIPDKLGELTKLEVLELW 338
SL ++ + L E +++ + L N + + + + LE+ E
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 339 KNSLIGSLPMRLGQSSPLRRLDASSNLLS---GEIPTGLCDSGNLTKLILFNNSFSGTFP 395
L + L + L ++
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 396 VSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIP------------ 443
+ + ++ L + N P L+ + N L
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 444 -DDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSV 502
+ + + + + L L + + + L++ P+L
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 503 LDLSSNSLSGEIPASIASC------EKLVSLNLRNNRFSGEIPKAVAT-----MPTLAIL 551
L L+ LS A++ L +L L+ N + + + T MP L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 552 DMSNNSL 558
+++ N
Sbjct: 308 ELNGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 2e-04
Identities = 27/272 (9%), Positives = 71/272 (26%), Gaps = 10/272 (3%)
Query: 499 SLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGE----IPKAVATMPTLAILDMS 554
SL + +++ + A + + + + L N E + + +A+ L I + S
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 555 NNSLF---GRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSVL 611
+ IPE + + + + G + + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 612 PPCSQNLTAKPGQTRKMHINHIIFGFIIGTLVIVSLGIVFFA-GKWAYRRWYLYNSFFDD 670
+ + + + + S+ + + W
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 671 LFKKSCKEWPWRLIAFQRLNFTSSEILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKK 730
L + R + L +K ++ + A +++
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 731 LWRSDNDIESGDDLFREVSLLGRLRHRNIVRL 762
L +D + S V +L + + L
Sbjct: 248 LGLNDCLL-SARGAAAVVDAFSKLENIGLQTL 278
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 13/80 (16%), Positives = 26/80 (32%), Gaps = 12/80 (15%)
Query: 264 YLYKNNFTGKIPPELGSI------TSLAFLDLSDNQISGEIPVKLAE-----LKNLQLLN 312
L + + + L L L N+I + L + +L L
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 313 LMCNQLTGLIPDKLGELTKL 332
L N+ + D + E+ ++
Sbjct: 309 LNGNRFSEE-DDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 4e-04
Identities = 12/82 (14%), Positives = 28/82 (34%), Gaps = 5/82 (6%)
Query: 482 SHNNLQAKIPNELQACPSLSVLDLSSNSLSGE----IPASIASCEKLVSLNLRNNRFSGE 537
+ + ++ + L S+ + LS N++ E + +IAS + L +
Sbjct: 16 TTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRV 74
Query: 538 IPKAVATMPTLAILDMSNNSLF 559
+ + L + L
Sbjct: 75 KDEIPEALRLLLQALLKCPKLH 96
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 1e-07
Identities = 19/89 (21%), Positives = 33/89 (37%), Gaps = 9/89 (10%)
Query: 246 LSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAEL 305
S +I L + + N ++P L L S N ++ E+P
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVP---ELP 323
Query: 306 KNLQLLNLMCNQLTGLIPDKLGELTKLEV 334
+NL+ L++ N L PD + L +
Sbjct: 324 QNLKQLHVEYNPLREF-PDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 2e-07
Identities = 57/309 (18%), Positives = 94/309 (30%), Gaps = 24/309 (7%)
Query: 287 LDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIG-- 344
L+L++ +S +P +L+ L CN LT L P+ L L V +L
Sbjct: 43 LELNNLGLS-SLP---ELPPHLESLVASCNSLTEL-PELPQSLKSLLVDNNNLKALSDLP 97
Query: 345 -SLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKS 403
L ++ L +L N +I +S + + F L
Sbjct: 98 PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPE 157
Query: 404 LVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLE 463
L + + + + L + N + ++ L+ + N L+
Sbjct: 158 LQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK 217
Query: 464 SYLPSSILSIPSLQTFMA--------SHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIP 515
+ N L N+ S EI
Sbjct: 218 TLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR 277
Query: 516 ASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEML 575
+ L LN+ NN+ E+P A P L L S N L +PE L+ L
Sbjct: 278 SLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHL-AEVPELPQN---LKQL 329
Query: 576 NLSYNKLEG 584
++ YN L
Sbjct: 330 HVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 1e-06
Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 435 NNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNEL 494
N + +I L SL +++S N L LP+ P L+ +AS N+L ++P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-EVPELP 323
Query: 495 QACPSLSVLDLSSNSLSGEIPASIASCEKL 524
Q +L L + N L E P S E L
Sbjct: 324 Q---NLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 23/91 (25%), Positives = 36/91 (39%), Gaps = 9/91 (9%)
Query: 458 SWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPAS 517
N + + S PSL+ S+N L ++P P L L S N L+ E+P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPEL 322
Query: 518 IASCEKLVSLNLRNNRFSGEIPKAVATMPTL 548
+ L L++ N E P ++ L
Sbjct: 323 PQN---LKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 7e-06
Identities = 25/91 (27%), Positives = 38/91 (41%), Gaps = 10/91 (10%)
Query: 479 FMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEI 538
+ N +I + PSL L++S+N L E+PA +L L N + E+
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EV 319
Query: 539 PKAVATMPTLAILDMSNNSL--FGRIPENFG 567
P+ L L + N L F IPE+
Sbjct: 320 PE---LPQNLKQLHVEYNPLREFPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 1e-05
Identities = 21/93 (22%), Positives = 38/93 (40%), Gaps = 9/93 (9%)
Query: 385 LFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPD 444
+ N+ S SL + V NN + +P P L+RL + N+L ++P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPE 321
Query: 445 DISLSTSLSFVDISWNHLESYLPSSILSIPSLQ 477
+L + + +N L P S+ L+
Sbjct: 322 LPQ---NLKQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 3e-05
Identities = 20/92 (21%), Positives = 34/92 (36%), Gaps = 9/92 (9%)
Query: 193 LSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPP 252
N + +I SLE + + N E+PA L L + L+ ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321
Query: 253 ALGRLKKLTTVYLYKNNFTGKIPPELGSITSL 284
LK+L ++ N + P S+ L
Sbjct: 322 LPQNLKQL---HVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 3e-05
Identities = 20/90 (22%), Positives = 34/90 (37%), Gaps = 10/90 (11%)
Query: 264 YLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIP 323
Y N + +I SL L++S+N++ E+P A L+ L N L +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLAEVPE 321
Query: 324 DKLGELTKLEVLELWKNSL--IGSLPMRLG 351
L+ L + N L +P +
Sbjct: 322 ----LPQNLKQLHVEYNPLREFPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 3e-04
Identities = 19/93 (20%), Positives = 32/93 (34%), Gaps = 9/93 (9%)
Query: 337 LWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPV 396
+ N+ + L L+ S+N L E+P L +LI N + P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPE 321
Query: 397 SLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQ 429
K L V+ N + P ++ L+
Sbjct: 322 LPQNLKQL---HVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 4e-04
Identities = 23/92 (25%), Positives = 32/92 (34%), Gaps = 9/92 (9%)
Query: 289 LSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPM 348
N S EI +L+ LN+ N+L L +LE L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHL-AEVPE 321
Query: 349 RLGQSSPLRRLDASSNLLSGEIPTGLCDSGNL 380
L++L N L E P +L
Sbjct: 322 LPQN---LKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 6e-04
Identities = 19/94 (20%), Positives = 29/94 (30%), Gaps = 9/94 (9%)
Query: 119 MDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSV 178
N + L +N S+N LP LE L + V
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EV 319
Query: 179 PTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSL 212
P +NL++L + N L + P + L
Sbjct: 320 PELPQNLKQLH---VEYNPLR-EFPDIPESVEDL 349
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 50.2 bits (118), Expect = 2e-07
Identities = 38/180 (21%), Positives = 65/180 (36%), Gaps = 8/180 (4%)
Query: 141 TSVNASSNNFSGFLPEDLGNATSLESLDFRG-SFFEGSVPTSFRNLQKLKFLGLSGNNLT 199
T+V+ + +P D+ L S F L L L L N LT
Sbjct: 11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 200 GKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKK 259
G P S ++ + LG N + F L L+ L+L +S +P + L
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 260 LTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLT 319
LT++ L N F L L+ P ++++++Q+ +L ++
Sbjct: 128 LTSLNLASNPFNC-NCHLAWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.9 bits (99), Expect = 5e-05
Identities = 31/171 (18%), Positives = 61/171 (35%), Gaps = 12/171 (7%)
Query: 54 HCNWTGVWCNSRGF----------VEKLDLSNMSLNGSVSENIRGLRS-LSSLNICCNEF 102
HC T V C RG +L L++ L S+ + G L L + N+
Sbjct: 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL 66
Query: 103 ASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNAT 162
P + + ++ + + +N L ++N N S +P +
Sbjct: 67 TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
Query: 163 SLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLE 213
SL SL+ + F + ++ + L+ L+G P ++ + +
Sbjct: 127 SLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSKVRDVQIKD 176
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 1e-05
Identities = 26/135 (19%), Positives = 45/135 (33%), Gaps = 2/135 (1%)
Query: 497 CPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAV-ATMPTLAILDMSN 555
S L + + + + E L L + N + + + L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 556 NSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNGILMNINPNELIGNAGLCGSVLPPCS 615
+ L P+ F +P L LNLS+N LE +++ L GN C L
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125
Query: 616 QNLTAKPGQTRKMHI 630
+ G + +
Sbjct: 126 RWEEEGLGGVPEQKL 140
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 5e-04
Identities = 23/141 (16%), Positives = 41/141 (29%), Gaps = 4/141 (2%)
Query: 188 LKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAE-FGNLTNLRYLDLAVGSL 246
L + + L +L + + + L LR L + L
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 247 SGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVK-LAEL 305
P A +L+ + L N + + SL L LS N + ++ L
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127
Query: 306 KNLQLLNLMCNQLTGLIPDKL 326
+ L + +L L
Sbjct: 128 EEEGLGGVPEQKLQCHGQGPL 148
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 5e-04
Identities = 20/153 (13%), Positives = 44/153 (28%), Gaps = 13/153 (8%)
Query: 55 CNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPK-SLANL 113
+G+ C G + ++ G +L+ L I + L L L
Sbjct: 8 HGSSGLRCTRDGAL------------DSLHHLPGAENLTELYIENQQHLQHLELRDLRGL 55
Query: 114 TALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSF 173
L+++ + ++ P L+ +N S N + + + E +
Sbjct: 56 GELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
Query: 174 FEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPEL 206
+ ++ G+ L L
Sbjct: 116 HCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPL 148
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 28/203 (13%), Positives = 58/203 (28%), Gaps = 16/203 (7%)
Query: 305 LKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSN 364
NL +T + EL ++ + + + + + +L + N
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 365 LLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGN 424
L T + NL L + +S ++ + I +
Sbjct: 79 KL-----TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 425 LPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHN 484
N + ++ +LS D + + + + LQ S N
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-----LAGLTKLQNLYLSKN 188
Query: 485 NLQAKIPNELQACPSLSVLDLSS 507
++ L +L VL+L S
Sbjct: 189 HISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 8e-05
Identities = 35/192 (18%), Positives = 64/192 (33%), Gaps = 19/192 (9%)
Query: 379 NLTKLILFN-NSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNN 437
+ I N S T V+ + S+ ++ N+ I G+ LP++ +L + N
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNK 79
Query: 438 LTG------------QIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNN 485
LT D+ + S D+ S + I I L +
Sbjct: 80 LTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESL 139
Query: 486 LQAKIPNELQACPSLSVLDLSSNSLSGEI--PASIASCEKLVSLNLRNNRFSGEIPKAVA 543
S + + +I +A KL +L L N S +A+A
Sbjct: 140 YLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRALA 197
Query: 544 TMPTLAILDMSN 555
+ L +L++ +
Sbjct: 198 GLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 32/202 (15%), Positives = 72/202 (35%), Gaps = 16/202 (7%)
Query: 257 LKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCN 316
+ L K + T + + S+ + +++ I + L N+ L L N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 317 QLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCD 376
+LT + P L L+ L + + + + + +I +
Sbjct: 79 KLTDIKP-----LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 377 SGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANN 436
+ + N T L+ + + +++N IS +P L L LQ L ++ N
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDT---LSLEDNQISDIVP--LAGLTKLQNLYLSKN 188
Query: 437 NLTGQIPDDISLSTSLSFVDIS 458
+++ + L +L +++
Sbjct: 189 HISD-LRALAGL-KNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 7e-04
Identities = 33/195 (16%), Positives = 63/195 (32%), Gaps = 16/195 (8%)
Query: 144 NASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIP 203
N + + + ++ S++ + S + + L + L L+GN LT
Sbjct: 30 NLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIK- 84
Query: 204 PELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTV 263
L++L+ + + + I + + +
Sbjct: 85 ----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLY 140
Query: 264 YLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIP 323
+ L + +L+ D + I LA L LQ L L N ++ L
Sbjct: 141 LGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-----LAGLTKLQNLYLSKNHISDLRA 195
Query: 324 DKLGELTKLEVLELW 338
L L L+VLEL+
Sbjct: 196 --LAGLKNLDVLELF 208
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (100), Expect = 4e-05
Identities = 23/136 (16%), Positives = 41/136 (30%), Gaps = 7/136 (5%)
Query: 181 SFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLD 240
+ N + + L L G + I L + I N F L L+ L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLL 69
Query: 241 LAVGSLSGQIPPALGRLKKLTTVYLYKNNFTG----KIPPELGSITSLAFLDLSDNQISG 296
+ + L LT + L N+ L S+T L L
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 297 EIPVKLAELKNLQLLN 312
+ ++ +++L+
Sbjct: 130 YRLYVIYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.003
Identities = 29/136 (21%), Positives = 45/136 (33%), Gaps = 7/136 (5%)
Query: 160 NATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGY 219
NA LD RG + L + + S N + + L L+T+++
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNN 72
Query: 220 NAFEGEIPAEFGNLTNLRYLDLAVGSLSG-QIPPALGRLKKLTTVYLYKNNFTGKI---P 275
N L +L L L SL L LK LT + + +N T K
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 276 PELGSITSLAFLDLSD 291
+ + + LD
Sbjct: 133 YVIYKVPQVRVLDFQK 148
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 9/58 (15%), Positives = 24/58 (41%)
Query: 476 LQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNR 533
+ ++ +NNL+ + +LD+S + + + +KL + + N +
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 9e-04
Identities = 7/45 (15%), Positives = 15/45 (33%)
Query: 302 LAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSL 346
+L++ ++ L L L KL + + +L
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 33/237 (13%), Positives = 58/237 (24%), Gaps = 17/237 (7%)
Query: 54 HCNWTGVWCNSRGF----------VEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFA 103
HC+ C +L L G L + I N+
Sbjct: 7 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 66
Query: 104 SSLPKSLANLTALKSMDVSQ--NNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNA 161
+ + + + NN + P L + S+ ++
Sbjct: 67 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 126
Query: 162 TSLESLDFRG--SFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGY 219
LD + + + + L L+ N + E +
Sbjct: 127 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDN 186
Query: 220 NAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPP 276
N E F + LD++ + L LKKL Y K+P
Sbjct: 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 25/227 (11%), Positives = 61/227 (26%), Gaps = 7/227 (3%)
Query: 287 LDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSL 346
+++++ EIP L +N L + +L + LE +E+ +N ++ +
Sbjct: 13 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 347 PMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLS----TCK 402
+ + P + L ++ + K
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 403 SLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHL 462
L+ ++ N+ + +G L + N + + + N+L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 463 ESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNS 509
E S + + L+ L +
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 13/57 (22%), Positives = 21/57 (36%), Gaps = 3/57 (5%)
Query: 266 YKNNFTGKIPPE-LGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGL 321
NN ++P + + LD+S +I L LK L+ + L L
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKL 238
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 30/229 (13%), Positives = 60/229 (26%), Gaps = 7/229 (3%)
Query: 357 RRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISG 416
R + ++ EIP+ L N +L + S L ++ + N +
Sbjct: 11 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 417 TIPVGLGNLPSLQR--LEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIP 474
I + + NNL P+ +L ++ IS ++ +
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 475 SLQTFMASH--NNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNN 532
N + + + +L L+ N + + + NN
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 533 RFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNK 581
ILD+S + L + K
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 5e-04
Identities = 18/134 (13%), Positives = 45/134 (33%), Gaps = 5/134 (3%)
Query: 201 KIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKL 260
++ + + L + L+ S++ + + +L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPEL 67
Query: 261 TTVYLYKNNFTGK--IPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQL 318
++ L N + + +L L+LS N++ E + + L+ L L N L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 319 TGLIPDKLGELTKL 332
+ D+ ++ +
Sbjct: 128 SDTFRDQSTYISAI 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 5e-04
Identities = 22/107 (20%), Positives = 37/107 (34%), Gaps = 7/107 (6%)
Query: 468 SSILSIPSLQTF-----MASHNNLQAKIPNELQACPSLSVLDLSSNSLSG--EIPASIAS 520
+ S P L + +++ A + + P L L+LS+N L ++ + +
Sbjct: 30 KGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQK 89
Query: 521 CEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFG 567
L LNL N E L L + NSL +
Sbjct: 90 APNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQST 136
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.003
Identities = 29/164 (17%), Positives = 56/164 (34%), Gaps = 15/164 (9%)
Query: 288 DLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLP 347
+L Q+ ++ + +++ + L L L VL ++S+ +L
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLR 58
Query: 348 MRLGQSSPLRRLDASSNLLSG--EIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLV 405
+ L L+ S+N L ++ + + + NL L L N + L
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 406 RVRVQNNLISGTIPVG-------LGNLPSLQRLEMANNNLTGQI 442
+ + N +S T P L RL+ + L I
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHELPPPI 160
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.003
Identities = 28/126 (22%), Positives = 49/126 (38%), Gaps = 9/126 (7%)
Query: 473 IPSLQTFMASHNNLQAKI--PNELQACPSLSVLDL-----SSNSLSGEIPASIASCEKLV 525
+ L+ M+ + + L++ P L ++ +S++ + + +L+
Sbjct: 9 VEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELL 68
Query: 526 SLNLRNNRFSG--EIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLE 583
SLNL NNR ++ V P L IL++S N L + LE L L N L
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 584 GPVPSN 589
Sbjct: 129 DTFRDQ 134
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 39/185 (21%), Positives = 74/185 (40%), Gaps = 16/185 (8%)
Query: 257 LKKLTTVYLYKNNFTGKIPP-ELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMC 315
L + L K N T + +L +T+L I I + L NL +N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQTDLDQVTTL---QADRLGIK-SID-GVEYLNNLTQINFSN 71
Query: 316 NQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLC 375
NQLT + P K ++ + + I L + + +++ + T L
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 376 DSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMAN 435
L +S + + +LS SL ++ +N ++ P L NL +L+RL++++
Sbjct: 132 --------RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 436 NNLTG 440
N ++
Sbjct: 182 NKVSD 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1009 | |||
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.52 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.48 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.47 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.3 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.21 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.58 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.4 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.78 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.45 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.41 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.3 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.64 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.48 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.13 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.62 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.11 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=411.62 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=197.8
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc--CCeEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN--ETNVMMV 775 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~~lV 775 (1009)
+.|+..+.||+|+||+||+|+++.+|+.||||++..........+.+.+|++++++++||||+++++++.+ ...+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 45888999999999999999999999999999997766555666777799999999999999999999865 4568999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcC--CCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC--QPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
||||++|+|.+++.........+++..++.++.||+.||+|||++. ..+|+||||||+||+++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999754433445899999999999999999999871 12499999999999999999999999999988
Q ss_pred cccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
............||+.|+|||++.+..++.++|||||||++|||+||+.||... +..+ +...+..+..
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~-----~~~~-~~~~i~~~~~------ 231 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-----SQKE-LAGKIREGKF------ 231 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHH-HHHHHHHTCC------
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC-----CHHH-HHHHHHcCCC------
Confidence 755555556678999999999999999999999999999999999999999732 1222 2222222221
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.+...++ .++.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~s------~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 RRIPYRYS------DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCcccC------HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11111222 24567889999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=413.04 Aligned_cols=250 Identities=21% Similarity=0.315 Sum_probs=208.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.++|+..+.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 4579999999999999999999999999999999865432 23466779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
|||++|+|.+++.... +++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+.+..
T Consensus 97 Ey~~gg~L~~~~~~~~-----l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 97 EYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp ECCTTCBHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCcHHHHhhccC-----CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999999886532 78899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+.+......... ....
T Consensus 169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~~~~~~~~-----~~~~ 238 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-----NPLRALYLIATNGTP-----ELQN 238 (293)
T ss_dssp TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHHCSC-----CCSS
T ss_pred ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC-----CHHHHHHHHHhCCCC-----CCCC
Confidence 555556678999999999999999999999999999999999999999632 222333333322211 1111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
....+ ..+.+++.+||+.||++|||+.|++
T Consensus 239 ~~~~s------~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 239 PEKLS------AIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp GGGSC------HHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred cccCC------HHHHHHHHHHccCChhHCcCHHHHh
Confidence 11111 2456788999999999999999985
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=406.40 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=201.5
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.+.|+..+.||+|+||+||+|+++.+++.||||++..... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 3568889999999999999999999999999999965432 233456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++|+|.++++... .+++.++..++.||++||+|||++ +|+||||||+||++++++.+||+|||+|+....
T Consensus 83 Ey~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp ECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred eccCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 9999999999997543 288999999999999999999999 999999999999999999999999999987654
Q ss_pred CC--CceeeecccCcccCCcccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 857 KN--ETVSMVAGSYGYIAPEYGYTLKV-DEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 857 ~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
.. .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||............ . ..... ..
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~----~-~~~~~----~~ 226 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----W-KEKKT----YL 226 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH----H-HTTCT----TS
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH----H-hcCCC----CC
Confidence 33 23445689999999999887776 57899999999999999999999753322211111 1 11110 00
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
+.. .... .++.+++.+|++.||++|||++|++
T Consensus 227 ~~~----~~~s---~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 227 NPW----KKID---SAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp TTG----GGSC---HHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred Ccc----ccCC---HHHHHHHHHHcCCChhHCcCHHHHh
Confidence 000 1111 2355788899999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=407.24 Aligned_cols=259 Identities=30% Similarity=0.461 Sum_probs=203.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||+||+|+++. .||||+++.........+.+.+|++++++++|||||++++++.+ +..++|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467889999999999999998654 59999997665556667778899999999999999999998765 56899999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
||++|+|.++++.... .+++..+..|+.||++||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999975432 389999999999999999999998 9999999999999999999999999999876433
Q ss_pred C--CceeeecccCcccCCcccCC---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 858 N--ETVSMVAGSYGYIAPEYGYT---LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 858 ~--~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
. .......||+.|+|||++.. ..++.++|||||||++|||+||+.||..... ...+...+..+. .
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~~-----~ 227 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----RDQIIFMVGRGY-----L 227 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHHTS-----C
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-----HHHHHHHHhcCC-----C
Confidence 2 23345679999999998753 3578999999999999999999999974321 222223333222 1
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.+.......... .++.+++.+||+.||++|||++|+++.|+.++
T Consensus 228 ~p~~~~~~~~~~---~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 228 SPDLSKVRSNCP---KAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp CCCGGGSCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcchhccccch---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 122211111112 24567889999999999999999999998775
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=405.22 Aligned_cols=248 Identities=29% Similarity=0.428 Sum_probs=204.6
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|+..+.||+|+||+||+|+++.+++.||+|++.+... +....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 458888999999999999999999999999999864321 1223456679999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
|||++|+|.+++..... +++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~~----l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999975432 88999999999999999999999 999999999999999999999999999976533
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+.... +.... ..+
T Consensus 159 --~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~-i~~~~-------~~~ 223 (263)
T d2j4za1 159 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKR-ISRVE-------FTF 223 (263)
T ss_dssp --CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHH-HHTTC-------CCC
T ss_pred --CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC-----CHHHHHHH-HHcCC-------CCC
Confidence 2344567999999999999999999999999999999999999999632 22222222 22211 111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
....+ .++.+++.+|++.||++|||++|+++
T Consensus 224 p~~~s------~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 PDFVT------EGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCC------HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11111 24567888999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=401.80 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=196.9
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
.|+..+.||+|+||+||+|.+.+ ++.||||++... ....+++.+|++++++++||||++++|+|.+++..++||||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 47778899999999999999876 678999999653 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
+++|+|.+++..... .+++..++.|+.|||+||+|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~~~~---~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999875432 378999999999999999999999 99999999999999999999999999998765443
Q ss_pred C-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhC-CCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 859 E-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTG-KMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 859 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
. ......||+.|+|||++.+..++.++|||||||++|||+|+ ++||.. ....+.+. .+..+. ....|
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-----~~~~~~~~-~i~~~~---~~~~p-- 224 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-----RSNSEVVE-DISTGF---RLYKP-- 224 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-----CCHHHHHH-HHHHTC---CCCCC--
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC-----CCHHHHHH-HHHhcC---CCCCc--
Confidence 2 23345789999999999999999999999999999999995 555442 12222222 222221 11111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
..++ .++.+++.+||+.||++|||++|+++.|+++++
T Consensus 225 -~~~~------~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 -RLAS------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -TTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cccC------HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1121 246678999999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.2e-47 Score=410.70 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=198.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCC---eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPH---MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
+.|+..+.||+|+||+||+|.++.++ ..||||++.... .....+.+.+|++++++++|||||+++|++.+++..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 55778889999999999999987655 368999885433 34455678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
|||||++|+|.+++..... .+++.+++.|+.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 105 v~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999998876432 389999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCCc-----eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 855 LHKNET-----VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 855 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
...... .....+|+.|+|||+..+..++.++|||||||++|||+| |+.||... ...+.+ ..+..+..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~-----~~~~~~-~~i~~~~~- 251 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----TNQDVI-NAIEQDYR- 251 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHH-HHHHTTCC-
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC-----CHHHHH-HHHHcCCC-
Confidence 443321 122457899999999998999999999999999999998 89999742 112222 22222211
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
+.....++ .++.+++.+||+.||++|||++|+++.|+++..
T Consensus 252 -----~~~~~~~~------~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 -----LPPPMDCP------SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -----CCCCTTCC------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCCccch------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11111111 246678999999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=407.72 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=203.6
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 45788899999999999999999999999999986542 3445677899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
||++|+|.+++.... ..+++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 90 y~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 90 FCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp CCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred cCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 999999999976432 2388999999999999999999999 9999999999999999999999999999876444
Q ss_pred CCceeeecccCcccCCcccC-----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 858 NETVSMVAGSYGYIAPEYGY-----TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
........||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+ .+........ ....
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--~~---~~~~i~~~~~--~~~~ 236 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MR---VLLKIAKSEP--PTLA 236 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--GG---HHHHHHHSCC--CCCS
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--HH---HHHHHHcCCC--CCCC
Confidence 33444567999999999863 55688999999999999999999999974321 11 2222222111 0010
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. ... .. .++.+++.+||+.||++|||++|+++
T Consensus 237 ~---~~~---~s---~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 Q---PSR---WS---SNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp S---GGG---SC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c---ccc---CC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 111 11 24567889999999999999999854
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-47 Score=408.52 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=212.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||+||+|.+..+++.||||+++.. ....+++.+|++++++++|||||+++++|.+++..++|||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 4578888999999999999999999999999998654 2345678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... ..+++..+..|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 94 ~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 94 FMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp CCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred cccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999965432 3478999999999999999999998 9999999999999999999999999999876443
Q ss_pred CC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 858 NE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 858 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.. ......|++.|+|||++.+..++.++|||||||++|||++|..||.... +.. .+...+..+. .+..
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----~~~-~~~~~i~~~~------~~~~ 237 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLS-QVYELLEKDY------RMER 237 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----CHH-HHHHHHHTTC------CCCC
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----hHH-HHHHHHhcCC------CCCC
Confidence 32 2233458899999999998999999999999999999999877764221 111 2222232221 1122
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
...++ .++.+++.+||+.||++|||++|+++.|+.+..+.
T Consensus 238 ~~~~~------~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 238 PEGCP------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp CTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred Cccch------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 22222 24667899999999999999999999999886543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=397.32 Aligned_cols=249 Identities=26% Similarity=0.364 Sum_probs=198.5
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc----CCeEEEEE
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN----ETNVMMVY 776 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~----~~~~~lV~ 776 (1009)
+..+.||+|+||+||+|.+..+++.||+|++..........+.+.+|++++++++|||||++++++.+ +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45567999999999999999999999999997665555556677899999999999999999999865 34689999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC-CCCcEEEcccccceecc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD-ANLEARIADFGLARMML 855 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~DfGls~~~~ 855 (1009)
||+++|+|.++++... .+++..+..++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999997543 278899999999999999999998 12399999999999996 57899999999997542
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
........||+.|+|||++.+ +++.++|||||||++|||++|+.||.... +. ..+...+..+.. .+.
T Consensus 167 --~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~----~~-~~~~~~i~~~~~-----~~~ 233 (270)
T d1t4ha_ 167 --ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NA-AQIYRRVTSGVK-----PAS 233 (270)
T ss_dssp --TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SH-HHHHHHHTTTCC-----CGG
T ss_pred --CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc----cH-HHHHHHHHcCCC-----Ccc
Confidence 233456789999999998765 69999999999999999999999996321 11 222223322211 111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+..... .++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~------~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 FDKVAI------PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGCCC------HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCccCC------HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 211111 23567889999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-47 Score=408.02 Aligned_cols=250 Identities=20% Similarity=0.255 Sum_probs=202.2
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|+..+.||+|+||+||+|+++.+++.||||++.+... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 458889999999999999999999999999999864321 1233456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccCC----CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999875432 88999999999999999999999 999999999999999999999999999987754
Q ss_pred CC--CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 857 KN--ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 857 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+.... +.... .
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~~~~~-i~~~~-------~ 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEYLIFQK-IIKLE-------Y 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH-HHTTC-------C
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc-----CHHHHHHH-HHcCC-------C
Confidence 33 2334567999999999999999999999999999999999999999732 22222222 22221 1
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
.+..... .++.+++.+||+.||++|||++|+++
T Consensus 228 ~~p~~~s------~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPEKFF------PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCTTCC------HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCccCC------HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1111111 23567889999999999999998743
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-46 Score=406.54 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=191.5
Q ss_pred HHHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 695 EILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 695 ~~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
++.+.|+..+.||+|+||+||+|+++.+++.||||++.+.... .....+.+|++++++++||||+++++++.+++..|+
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3556799999999999999999999999999999999655332 223455699999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC---CCCcEEEcccccc
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD---ANLEARIADFGLA 851 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~DfGls 851 (1009)
|||||++|+|.+++..... +++.++..++.||+.||+|||++ +|+||||||+||++. +++.+||+|||++
T Consensus 85 vmE~~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EECCCCSCBHHHHHHTCSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEeccCCCcHHHhhhcccC----CCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEecccee
Confidence 9999999999999976433 89999999999999999999999 999999999999994 5789999999999
Q ss_pred eecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 852 RMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+...........
T Consensus 158 ~~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~~~~~i~~~~~~---- 227 (307)
T d1a06a_ 158 KMEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE-----NDAKLFEQILKAEYE---- 227 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHTTCCC----
T ss_pred EEccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC-----CHHHHHHHHhccCCC----
Confidence 865332 3334567999999999999999999999999999999999999999732 222222222222111
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
......... . .++.+++.+|++.||++|||++|+++
T Consensus 228 ~~~~~~~~~---s---~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 FDSPYWDDI---S---DSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCTTTTTTS---C---HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCccccCC---C---HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111111111 1 24567889999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=399.44 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=203.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||+||+|.+++ ++.||||++.... ...+.+.+|++++++++|||||++++++.+ +..++|||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 467888999999999999999875 7889999996542 334668899999999999999999998865 46789999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++.... ...+++.++++|+.||++||+|||++ +|+||||||+||++++++.+||+|||+|+.....
T Consensus 88 y~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp CCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred eCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC
Confidence 999999999886543 23379999999999999999999998 9999999999999999999999999999877543
Q ss_pred CC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 858 NE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 858 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
.. ......||+.|+|||++....++.++|||||||++|||+||..|+.... ...+.+ ..+..+. .+..
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~----~~~~~~-~~i~~~~------~~~~ 231 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----TNPEVI-QNLERGY------RMVR 231 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHH-HHHHTTC------CCCC
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC----CHHHHH-HHHHhcC------CCCC
Confidence 32 2334568899999999988899999999999999999999666554221 122222 2222221 1112
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
...++ .++.+++.+||+.||++|||++||++.|++.
T Consensus 232 p~~~~------~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 232 PDNCP------EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCh------HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 22222 2456788999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=390.34 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=208.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||+||+|+++ +++.||||++++.. ...+++.+|++++++++||||++++|+|.+++..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 45788899999999999999986 48899999997643 334678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... .+++..+++++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 y~~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp CCTTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred ccCCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 9999999999765433 378889999999999999999998 9999999999999999999999999999876444
Q ss_pred CC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 858 NE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 858 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
.. ......+|+.|+|||.+....++.++|||||||++|||+| |+.||... ...+ +...+..+. ....|
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-----~~~~-~~~~i~~~~---~~~~p- 223 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-----TNSE-TAEHIAQGL---RLYRP- 223 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-----CHHH-HHHHHHTTC---CCCCC-
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC-----CHHH-HHHHHHhCC---CCCCc-
Confidence 32 3334668999999999998999999999999999999998 89999732 2222 223333221 11111
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
..++ .++.+++.+||+.||++|||+.|+++.|.++
T Consensus 224 --~~~~------~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 --HLAS------EKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --TTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --cccc------HHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1222 2467889999999999999999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=395.55 Aligned_cols=249 Identities=26% Similarity=0.362 Sum_probs=198.7
Q ss_pred ceeccCCceEEEEEEECC--CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEeccCC
Q 037197 704 NIIGMGGNGIVYKAEFHR--PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDYMPN 781 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~ 781 (1009)
+.||+|+||+||+|.++. +++.||||+++....+....+++.+|++++++++|||||+++++|.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 469999999999998653 457899999976555555567788999999999999999999999754 57899999999
Q ss_pred CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCCC--
Q 037197 782 DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKNE-- 859 (1009)
Q Consensus 782 gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~~-- 859 (1009)
|+|.++++.... +++..++.|+.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 92 g~L~~~l~~~~~----l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhccC----CCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999975443 89999999999999999999998 999999999999999999999999999987644432
Q ss_pred -ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcccc
Q 037197 860 -TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSIA 937 (1009)
Q Consensus 860 -~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 937 (1009)
......||+.|+|||.+....++.++|||||||++|||+| |+.||.... .. .+...+..+. .+...
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-----~~-~~~~~i~~~~------~~~~p 232 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GS-EVTAMLEKGE------RMGCP 232 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HH-HHHHHHHTTC------CCCCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-----HH-HHHHHHHcCC------CCCCC
Confidence 2234568999999999998899999999999999999998 899997421 11 2223333322 11122
Q ss_pred ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhc
Q 037197 938 GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEA 978 (1009)
Q Consensus 938 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 978 (1009)
..++ .++.+++.+||+.||++|||++||++.|+..
T Consensus 233 ~~~~------~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 233 AGCP------REMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TTCC------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cccC------HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 2222 2456788999999999999999999988765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=411.45 Aligned_cols=201 Identities=23% Similarity=0.437 Sum_probs=178.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
.+.|+..+.||+|+||+||+|++..+|+.||+|+++... ......++.+|++++++++|||||+++++|.+++..++||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356889999999999999999999999999999996543 3344567789999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH-DCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
||+++|+|.+++++... +++..+..++.|+++||+|||+ + +|+||||||+|||++.++++||+|||+|+.+.
T Consensus 84 Ey~~gg~L~~~l~~~~~----l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999975432 7899999999999999999996 5 89999999999999999999999999998764
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPA 907 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~ 907 (1009)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 157 ~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 157 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp HH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred CC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 32 234568999999999999999999999999999999999999999743
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=400.10 Aligned_cols=255 Identities=24% Similarity=0.303 Sum_probs=207.5
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC----hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND----IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
+.++|+..+.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|++++++++|||||++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 456799999999999999999999999999999998654322 2235677799999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC----cEEEcc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL----EARIAD 847 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~D 847 (1009)
.|+|||||++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+|++|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecc
Confidence 999999999999999997543 289999999999999999999999 999999999999998876 599999
Q ss_pred cccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 848 FGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 848 fGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+...........
T Consensus 161 fG~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 161 FGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQETLANVSAVNYE 234 (293)
T ss_dssp CTTCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHTTCCC
T ss_pred hhhhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC-----CHHHHHHHHHhcCCC
Confidence 9999876433 3334567899999999999889999999999999999999999999732 222222222221110
Q ss_pred cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+...... ...+.+++.+||+.||++|||++|+++
T Consensus 235 ----~~~~~~~~~------s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 ----FEDEYFSNT------SALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----CCHHHHTTS------CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCchhcCCC------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111111 124567889999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-46 Score=398.25 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=204.0
Q ss_pred cCCcCce-eccCCceEEEEEEECC--CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 699 CVKESNI-IGMGGNGIVYKAEFHR--PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 699 ~~~~~~~-iG~G~~g~Vyk~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
.|...+. ||+|+||+||+|.++. ++..||||+++.. ......+++.+|++++++++|||||+++|++.++ ..|+|
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv 86 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV 86 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence 3445554 9999999999998753 4568999999654 3345567788999999999999999999999754 58999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++|+|.+++..... .+++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 87 mE~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999865432 389999999999999999999998 99999999999999999999999999998775
Q ss_pred cCCC---ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 856 HKNE---TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 856 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
.... ......||+.|+|||++....++.++|||||||++|||+| |+.||.... ..++ ...+..+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~----~~~i~~~~~---- 230 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEV----MAFIEQGKR---- 230 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHH----HHHHHTTCC----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC--HHHH----HHHHHcCCC----
Confidence 4432 2234568899999999988899999999999999999998 999997432 1122 223333321
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
+.....++ .++.+++.+||+.||++|||+.+|++.|+...
T Consensus 231 --~~~p~~~~------~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 231 --MECPPECP------PELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp --CCCCTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCcCC------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 12222222 24567899999999999999999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-45 Score=401.86 Aligned_cols=250 Identities=28% Similarity=0.378 Sum_probs=203.4
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC-hhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND-IESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
..+.|+..+.||+|+||+||+|++..+++.||||++...... ....+.+.+|++++++++|||||++++++.+++..|+
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 456689999999999999999999999999999999765433 3344567799999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
|||||++|++..++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 93 v~E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccccccc
Confidence 999999999987765433 289999999999999999999999 9999999999999999999999999999765
Q ss_pred ccCCCceeeecccCcccCCcccCC---CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 855 LHKNETVSMVAGSYGYIAPEYGYT---LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 855 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...+.+........ ...
T Consensus 166 ~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-----~~~~~~~~i~~~~~--~~~ 234 (309)
T d1u5ra_ 166 AP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSALYHIAQNES--PAL 234 (309)
T ss_dssp SS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHSCC--CCC
T ss_pred CC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHhCCC--CCC
Confidence 32 234579999999998753 45899999999999999999999999632 22222322222221 111
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
... .++ ..+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~----~~s------~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 QSG----HWS------EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCT----TSC------HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC----CCC------HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111 111 24567889999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.3e-45 Score=405.29 Aligned_cols=254 Identities=20% Similarity=0.288 Sum_probs=208.4
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.++|+..+.||+|+||.||+|+++.+|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467899999999999999999999999999999999654 234456677999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC--CCcEEEccccccee
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA--NLEARIADFGLARM 853 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~DfGls~~ 853 (1009)
||||++|+|.+++..... .+++..+..|+.||+.||+|||++ +||||||||+||+++. ++.+||+|||+++.
T Consensus 102 mE~~~gg~L~~~l~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp ECCCCSCBHHHHHTCTTS---CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEcCCCCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 999999999999865432 289999999999999999999999 9999999999999964 57899999999987
Q ss_pred cccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
... ........||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+.+......... ..
T Consensus 176 ~~~-~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~~~~~~----~~ 245 (350)
T d1koaa2 176 LDP-KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDDETLRNVKSCDWN----MD 245 (350)
T ss_dssp CCT-TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCC----SC
T ss_pred ccc-ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCC----CC
Confidence 643 34445678999999999999999999999999999999999999999632 223333333222211 11
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
....... . .++.+++.+|++.||++|||++|+++
T Consensus 246 ~~~~~~~---s---~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 246 DSAFSGI---S---EDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CGGGGGC---C---HHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCC---C---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111 1 24567889999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-46 Score=400.01 Aligned_cols=259 Identities=28% Similarity=0.448 Sum_probs=200.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCC----eEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPH----MVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
.+|+..++||+|+||+||+|.++.++ ..||||++.... ......++.+|++++++++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 45778899999999999999987644 579999986543 3344556779999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+.++++.+++..... .+++.++.+++.||+.|++|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999998765432 389999999999999999999998 999999999999999999999999999987
Q ss_pred cccCCC---ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccc
Q 037197 854 MLHKNE---TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDE 930 (1009)
Q Consensus 854 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (1009)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..|+.... ...+ +...+..+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~----~~~~-~~~~i~~~~---- 230 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHE-VMKAINDGF---- 230 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHH-HHHHHHTTC----
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC----CHHH-HHHHHhccC----
Confidence 644322 2233567899999999999999999999999999999999766654221 1122 222222222
Q ss_pred ccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 931 ALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
.+.....++ .++.+++.+||+.||++|||+.||++.|+.+..
T Consensus 231 --~~~~~~~~~------~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 231 --RLPTPMDCP------SAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp --CCCCCTTCB------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCchhhH------HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 112222222 246678999999999999999999999988754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.2e-45 Score=403.46 Aligned_cols=254 Identities=20% Similarity=0.287 Sum_probs=208.1
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.+.|+..+.||+|+||.||+|.+..+|+.||||++.... ......+.+|++++++++|||||++++++.+++..|+|
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4567999999999999999999999999999999986542 33445667999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC--CCCcEEEccccccee
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD--ANLEARIADFGLARM 853 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~DfGls~~ 853 (1009)
||||++|+|.+++.... ..+++.++..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.
T Consensus 105 mE~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 105 LEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEcCCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccccee
Confidence 99999999999876543 2389999999999999999999998 999999999999998 578999999999988
Q ss_pred cccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
+.. ........||+.|+|||++.+..++.++||||+||++|||+||+.||... +..+.................
T Consensus 179 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~ 252 (352)
T d1koba_ 179 LNP-DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDLETLQNVKRCDWEFDEDAF 252 (352)
T ss_dssp CCT-TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHHCCCCCCSSTT
T ss_pred cCC-CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCCcccc
Confidence 743 34455678999999999999999999999999999999999999999632 222333332222211111111
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
+.+ . .++.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~-------s---~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 253 SSV-------S---PEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTS-------C---HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCC-------C---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1 24567889999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=404.80 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=204.9
Q ss_pred hcCCcCceeccCCceEEEEEEECCCC-----eEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPH-----MVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 771 (1009)
+.|+..+.||+|+||+||+|++...+ ..||||++.... .......+.+|+.+++++ +|||||++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 46888999999999999999986543 479999986543 233455677999999998 89999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccc-------------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCC
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAG-------------------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKS 832 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~ 832 (1009)
.++|||||++|+|.++++..... ...+++..++.++.||++||+|||++ +||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 99999999999999999765321 12478999999999999999999999 999999999
Q ss_pred CcEEeCCCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCC
Q 037197 833 NNILLDANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFG 909 (1009)
Q Consensus 833 ~NIll~~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~ 909 (1009)
+||+++.++.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654443 2234568999999999999999999999999999999998 8999974322
Q ss_pred CCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 037197 910 GSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLG 976 (1009)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 976 (1009)
. .. +...+..+. .+.....++ .++.+++.+||+.||++|||++||++.|.
T Consensus 273 ~-~~----~~~~~~~~~------~~~~p~~~~------~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 D-AN----FYKLIQNGF------KMDQPFYAT------EEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp S-HH----HHHHHHTTC------CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H-HH----HHHHHhcCC------CCCCCCcCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 12 222222221 111222222 24667899999999999999999999985
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.9e-45 Score=392.65 Aligned_cols=262 Identities=27% Similarity=0.349 Sum_probs=206.3
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC----
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET---- 770 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~---- 770 (1009)
+.++|+..+.||+|+||+||+|++..+++.||||+++.... +....+.+.+|++++++++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 34678999999999999999999999999999999976543 3444566779999999999999999999987653
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
..|+||||+++++|.+++..... +++.++..++.||++||+|||++ +|+||||||+||+++.++.++++|||.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~----l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred eEEEEEECCCCCEehhhhcccCC----CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhh
Confidence 37999999999999998865432 88999999999999999999998 999999999999999999999999999
Q ss_pred ceecccCC---CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc
Q 037197 851 ARMMLHKN---ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA 927 (1009)
Q Consensus 851 s~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 927 (1009)
+....... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.. .+..+.....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-----~~~~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-----DSPVSVAYQHVREDPI 232 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-----SSHHHHHHHHHHCCCC
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC-----cCHHHHHHHHHhcCCC
Confidence 87653332 234456799999999999988999999999999999999999999973 2333344444433322
Q ss_pred cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHhhcC
Q 037197 928 QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-TMRDVITMLGEAK 979 (1009)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~L~~~~ 979 (1009)
......+.++ .++.+++.+|++.||++|| |++++.+.|.++.
T Consensus 233 ~~~~~~~~~s----------~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 PPSARHEGLS----------ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CGGGTSSSCC----------HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCchhccCCC----------HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111111121 2456788899999999999 8999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=398.27 Aligned_cols=250 Identities=21% Similarity=0.254 Sum_probs=207.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|+..+.||+|+||.||+|+++.+++.||||++.+... .....+.+.+|++++++++||||+++++++.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 468899999999999999999999999999999965421 1233566779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
|||++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+||+++++|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhcccC----CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999876443 78888889999999999999999 999999999999999999999999999987655
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....... +. ..+
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~-----~~~~~~~~i~~-~~-------~~~ 224 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHERLFELILM-EE-------IRF 224 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHH-CC-------CCC
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc-----CHHHHHHHHhc-CC-------CCC
Confidence 555566678999999999999999999999999999999999999999732 22222222222 21 111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT-----MRDVIT 973 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 973 (1009)
....+ .++..++.+|++.||++||+ +.|+++
T Consensus 225 p~~~s------~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 PRTLS------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CTTSC------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccCC------HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11111 23567889999999999995 777765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=388.24 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=199.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||+||+|++++ ++.||||++.... ...+.+.+|+.++++++|||||++++++.+ +..++|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 458889999999999999999987 4679999996442 334678899999999999999999999965 45789999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+++|+|.+++..... ..++|.+++.|+.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 92 y~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 92 YMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 9999999999865432 2389999999999999999999999 9999999999999999999999999999876433
Q ss_pred C-CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 858 N-ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 858 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
. .......||+.|+|||++....++.++|||||||++|||++|..|+.... ...+.+ ..+..+. .+..
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~----~~~~~~-~~i~~~~------~~~~ 235 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVL-DQVERGY------RMPC 235 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHH-HHHHTTC------CCCC
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC----CHHHHH-HHHHhcC------CCCC
Confidence 3 23344678999999999999999999999999999999999776654321 222222 2222221 1112
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
...++ .++.+++.+||+.||++||++++|+++|++...
T Consensus 236 ~~~~~------~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 PPECP------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CcccC------HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 22222 245678999999999999999999999998663
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=392.54 Aligned_cols=253 Identities=19% Similarity=0.259 Sum_probs=206.3
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.++|+..+.||+|+||+||+|.++.+++.||||+++.. ......+.+|++++++++||||+++++++.+++.+|+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 356789999999999999999999999999999999654 23344566999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC--CcEEEccccccee
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN--LEARIADFGLARM 853 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~--~~~kl~DfGls~~ 853 (1009)
||||++|+|.+++..... .+++.++..++.||++||+|||++ +|+||||||+||+++.+ ..+||+|||+++.
T Consensus 80 mE~~~gg~L~~~i~~~~~---~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp ECCCCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhc
Confidence 999999999999975432 378999999999999999999998 99999999999999854 4899999999987
Q ss_pred cccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD 933 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1009)
... ........+|+.|+|||...+..++.++||||+||++|+|++|+.||... +..+.+......... ++
T Consensus 154 ~~~-~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~-----~~~~~~~~i~~~~~~----~~ 223 (321)
T d1tkia_ 154 LKP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-----TNQQIIENIMNAEYT----FD 223 (321)
T ss_dssp CCT-TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHTCCC----CC
T ss_pred ccc-CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCC----CC
Confidence 633 33445567899999999999999999999999999999999999999732 222222222222111 11
Q ss_pred ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
....... ..++.+++.+|++.||++|||+.|+++
T Consensus 224 ~~~~~~~------s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 EEAFKEI------SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTS------CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCC------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1110011 124567889999999999999999987
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-44 Score=390.64 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=203.2
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
+.|+..+.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 458889999999999999999999999999999864321 1233466779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
|||+||++.+++..... +++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999876543 67778888999999999999998 999999999999999999999999999987643
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+.......... ...+.+
T Consensus 157 ~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~i~~~~~----~~p~~~ 224 (316)
T d1fota_ 157 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----NTMKTYEKILNAEL----RFPPFF 224 (316)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHCCC----CCCTTS
T ss_pred c---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc-----CHHHHHHHHHcCCC----CCCCCC
Confidence 2 33467999999999999999999999999999999999999999732 22233222222111 111111
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
+ .++.+++.+|++.||++|+ |++|+++
T Consensus 225 ----s------~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 225 ----N------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----C------HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----C------HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1 2356788899999999996 8888875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-43 Score=380.39 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=202.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh-------hhHHHHHHHHHHHhccC-CCceeeEEeEEEcC
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI-------ESGDDLFREVSLLGRLR-HRNIVRLLGYLHNE 769 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~ 769 (1009)
++|+..+.||+|+||+||+|++..+++.||||++.+..... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 56888999999999999999999999999999997654322 12345679999999997 99999999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFG 849 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 849 (1009)
+..|+|||||++|+|.++++... .+++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999997543 389999999999999999999998 99999999999999999999999999
Q ss_pred cceecccCCCceeeecccCcccCCcccC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh
Q 037197 850 LARMMLHKNETVSMVAGSYGYIAPEYGY------TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 850 ls~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
+++..... .......||+.|+|||++. ...++.++||||+||++|||++|+.||... +... +...+.
T Consensus 156 ~a~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~-----~~~~-~~~~i~ 228 (277)
T d1phka_ 156 FSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-----KQML-MLRMIM 228 (277)
T ss_dssp TCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHH-HHHHHH
T ss_pred heeEccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC-----CHHH-HHHHHH
Confidence 99876443 3345567999999999764 345788999999999999999999999732 1122 222222
Q ss_pred hccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 037197 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDV 971 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ev 971 (1009)
.+.. ....+... .. . .++.+++.+|++.||++|||+.|+
T Consensus 229 ~~~~--~~~~~~~~-~~---s---~~~~~li~~~L~~~p~~R~s~~ei 267 (277)
T d1phka_ 229 SGNY--QFGSPEWD-DY---S---DTVKDLVSRFLVVQPQKRYTAEEA 267 (277)
T ss_dssp HTCC--CCCTTTGG-GS---C---HHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred hCCC--CCCCcccc-cC---C---HHHHHHHHHHccCChhHCcCHHHH
Confidence 2221 11111111 11 1 245678899999999999999997
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-44 Score=390.98 Aligned_cols=262 Identities=26% Similarity=0.427 Sum_probs=209.2
Q ss_pred HhcCCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCe
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 771 (1009)
.++|+..+.||+|+||+||+|+++. +++.||||++... ......+++.+|++++++++||||++++++|.+.+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3568999999999999999999753 4689999998643 334445678899999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCcc--------------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccC
Q 037197 772 VMMVYDYMPNDSLGEALHGKEA--------------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIK 831 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk 831 (1009)
.++||||+++|+|.++++.... ....+++.+++.|+.|++.||+|||++ +|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence 9999999999999999864321 122478999999999999999999998 99999999
Q ss_pred CCcEEeCCCCcEEEcccccceecccCC--CceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCC-CCCCCCC
Q 037197 832 SNNILLDANLEARIADFGLARMMLHKN--ETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGK-MPLDPAF 908 (1009)
Q Consensus 832 ~~NIll~~~~~~kl~DfGls~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~-~Pf~~~~ 908 (1009)
|+||+++.++.+||+|||+|+...... .......+++.|+|||++....++.++|||||||++|||++|. .||...
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~- 246 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM- 246 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC-
Confidence 999999999999999999998664433 2334567889999999999999999999999999999999986 566532
Q ss_pred CCCccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 909 GGSKDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
+..+... .+..+.. +.+....+ .++.+++.+||+.||++||||.||+++|+++.+
T Consensus 247 ----~~~e~~~-~v~~~~~------~~~p~~~~------~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 247 ----AHEEVIY-YVRDGNI------LACPENCP------LELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp ----CHHHHHH-HHHTTCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ----CHHHHHH-HHHcCCC------CCCCccch------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2222222 2222221 11111121 246678999999999999999999999998864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=387.82 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=198.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCC---CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
++|+..+.||+|+||.||+|++..+ +..||||+++.. ......+.+.+|++++++++||||+++++++.+ +..++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 4688889999999999999998643 467999998543 334445677899999999999999999999964 57899
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
||||+++|++.+++..... .+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998765432 378999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCC-ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 855 LHKNE-TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 855 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
..... ......||+.|+|||++....++.++|||||||++|||++ |.+||..... .++...+ ..+..
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~i----~~~~~----- 227 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRI----ENGER----- 227 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHH----HTTCC-----
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--HHHHHHH----HcCCC-----
Confidence 44332 3344568899999999999999999999999999999998 8999874322 2222222 22211
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCcc
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRK 983 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 983 (1009)
+.+...++ .++.+++.+||+.||++|||+.||++.|+.+.++++
T Consensus 228 -~~~~~~~~------~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 228 -LPMPPNCP------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp -CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCC------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 11222222 246678899999999999999999999998865543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=394.65 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=200.1
Q ss_pred cCCcCceeccCCceEEEEEEECCCCe----EEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHM----VVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l 774 (1009)
.|+..+.||+|+||+||+|.+..+|+ .||+|++... ......+++.+|++++++++|||||+++|+|.++ ..++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 48888999999999999999987665 5888888543 2334456788999999999999999999999875 5678
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceec
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMM 854 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~ 854 (1009)
|+||+.+|+|.+++..... .+++..+++++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8999999999998865432 388999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccc
Q 037197 855 LHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEA 931 (1009)
Q Consensus 855 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (1009)
..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||+... ...+... +..+..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~--~~~~~~~----i~~~~~---- 231 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSI----LEKGER---- 231 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--GGGHHHH----HHHTCC----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC--HHHHHHH----HHcCCC----
Confidence 54332 2334568999999999999999999999999999999999 888887432 1222222 222211
Q ss_pred cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 932 LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
+.....++ .++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 232 --~~~p~~~~------~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 232 --LPQPPICT------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp --CCCCTTBC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCcccC------HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 11111121 245678999999999999999999999987753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-44 Score=379.30 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=196.2
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc-CCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN-ETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~~~~lV~ 776 (1009)
++|+..+.||+|+||.||+|+++ |+.||||+++.+ ...+.+.+|++++++++||||++++|++.+ .+.+++||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 34677889999999999999985 678999999543 234667899999999999999999999854 45689999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+++|+|.++++... ...+++..+++|+.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++....
T Consensus 81 ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999996542 23479999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
......+++.|+|||++.+..++.++|||||||++|||+| |+.||... ...++..++ ..+. .+.
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i----~~~~------~~~ 220 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRV----EKGY------KMD 220 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHH----TTTC------CCC
T ss_pred ---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHH----HcCC------CCC
Confidence 2334567899999999988899999999999999999998 68777632 222333333 2221 222
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
+....+ .++.+++.+||+.||++|||+.|++++|++++.
T Consensus 221 ~~~~~~------~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 APDGCP------PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCC------HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 222222 245678899999999999999999999998753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=382.55 Aligned_cols=258 Identities=29% Similarity=0.412 Sum_probs=195.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCC---CeEEEEEEcccCCC-ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDN-DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~---~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
++|+..+.||+|+||+||+|++... ...||||++.+... .....+++.+|++++++++||||++++|++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 4578888999999999999986532 35799999865433 233456778999999999999999999999764 678
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++|++.+++..+.. .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999998865432 388999999999999999999998 999999999999999999999999999997
Q ss_pred cccCCCc---eeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 854 MLHKNET---VSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 854 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
....... .....+++.|+|||.+.+..++.++|||||||++|||+| |+.||... +..+.+......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-----~~~~~~~~i~~~~~--- 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQILHKIDKEGE--- 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTSCC---
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-----CHHHHHHHHHhCCC---
Confidence 6444322 223457789999999999899999999999999999998 89999632 22333333322221
Q ss_pred cccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 930 EALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
.+......+ ..+.+++.+||+.||++|||+.||++.|++++
T Consensus 233 ---~~~~~~~~~------~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 233 ---RLPRPEDCP------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp ---CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---CCCCccccc------HHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 111111222 24667899999999999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-43 Score=391.41 Aligned_cols=247 Identities=19% Similarity=0.233 Sum_probs=204.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCC-CChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSD-NDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 776 (1009)
++|+..+.||+|+||.||+|+++.+|+.||||++.+.. ......+.+.+|++++++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57899999999999999999999999999999985432 12233456779999999999999999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceeccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLH 856 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~ 856 (1009)
||+.+|+|.+++..... +++.++..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~~----l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999865432 78999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 857 KNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 857 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||... +......... .+.. .+
T Consensus 194 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~i~-~~~~-------~~ 257 (350)
T d1rdqe_ 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QPIQIYEKIV-SGKV-------RF 257 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHH-HCCC-------CC
T ss_pred c---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-----CHHHHHHHHh-cCCC-------CC
Confidence 2 33467999999999999999999999999999999999999999632 2222222222 2211 11
Q ss_pred cccCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 037197 937 AGQCKHVQEEMLLVLRIAVLCTAKLPKGRP-----TMRDVIT 973 (1009)
Q Consensus 937 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 973 (1009)
....+ .++.+++.+|++.||++|+ |++|+++
T Consensus 258 p~~~s------~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 PSHFS------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTCC------HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CccCC------HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11111 2456788899999999994 8999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=387.50 Aligned_cols=265 Identities=25% Similarity=0.358 Sum_probs=206.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCe--EEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHM--VVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l 774 (1009)
++|+..+.||+|+||+||+|+++.++. .||||++.... .....+.+.+|+++++++ +|||||++++++.+++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 456778899999999999999988775 47788875332 233456788999999998 79999999999999999999
Q ss_pred EEeccCCCChhhhhcCCc------------cccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCc
Q 037197 775 VYDYMPNDSLGEALHGKE------------AGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLE 842 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~ 842 (1009)
||||+++|+|.++++... .....+++.+++.++.||++||.|+|+. +|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 999999999999997652 1234489999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCC-CCCCCCCCCccHHHHHHHH
Q 037197 843 ARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKM-PLDPAFGGSKDIVEWVLSM 921 (1009)
Q Consensus 843 ~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~-Pf~~~~~~~~~~~~~~~~~ 921 (1009)
+||+|||+++...... ......||+.|+|||.+....++.++|||||||++|||++|.. ||... +..+ +...
T Consensus 166 ~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-----~~~~-~~~~ 238 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAE-LYEK 238 (309)
T ss_dssp EEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHH-HHHH
T ss_pred eEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-----CHHH-HHHH
Confidence 9999999997653322 2234568999999999999999999999999999999999764 56521 2222 2222
Q ss_pred HhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCcccc
Q 037197 922 IKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRRKSI 985 (1009)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~ 985 (1009)
+..+. .+......+ .++.+++.+||+.||++||||+||++.|+++.++++..
T Consensus 239 i~~~~------~~~~~~~~~------~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~ 290 (309)
T d1fvra_ 239 LPQGY------RLEKPLNCD------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 290 (309)
T ss_dssp GGGTC------CCCCCTTBC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred HHhcC------CCCCCccCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCC
Confidence 22221 122222221 24667889999999999999999999999987655543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=383.94 Aligned_cols=265 Identities=24% Similarity=0.320 Sum_probs=200.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
+.|+..+.||+|+||+||+|++..+++.||||+++.........+.+.+|++++++++||||+++++++.++...|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 46888999999999999999999999999999996554434445678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+.++.+........ ..+++..+..++.||+.||+|||++ +||||||||+||+++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 997654443333222 2378999999999999999999999 9999999999999999999999999999877655
Q ss_pred CCceeeecccCcccCCcccCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCccc
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLK-VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPSI 936 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (1009)
........||+.|+|||...... ++.++||||+||++|+|++|+.||... +................+...+..
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD-----SEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC-----CHHHHHHHHHHhcCCCchhhcccc
Confidence 55555678999999999866555 578999999999999999999999732 111222222211111111111110
Q ss_pred ----------cccCch-HH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 937 ----------AGQCKH-VQ----EEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 937 ----------~~~~~~-~~----~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
...... .. ....++.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000 00 11134677899999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-44 Score=389.12 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=203.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC-ChhhHHHHHHHHHHHh-ccCCCceeeEEeEEEcCCeEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN-DIESGDDLFREVSLLG-RLRHRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.|...+.||+|+||+||+|+++.+++.||||++++... .....+.++.|+.++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 458888999999999999999999999999999964321 1223455667777665 68999999999999999999999
Q ss_pred EeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecc
Q 037197 776 YDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMML 855 (1009)
Q Consensus 776 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~ 855 (1009)
|||+++|+|.++++.... +++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999975433 78888999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCcc
Q 037197 856 HKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDPS 935 (1009)
Q Consensus 856 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (1009)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+ +...+..+. +.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~-----~~~~-~~~~i~~~~-------~~ 221 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEEE-LFHSIRMDN-------PF 221 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHH-HHHHHHHCC-------CC
T ss_pred cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-----CHHH-HHHHHHcCC-------CC
Confidence 5555556678999999999999999999999999999999999999999732 2222 222222221 11
Q ss_pred ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 037197 936 IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMR-DVI 972 (1009)
Q Consensus 936 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~-evl 972 (1009)
+....+ .++..++.+|++.||++||++. |++
T Consensus 222 ~p~~~s------~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 222 YPRWLE------KEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CCTTSC------HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCccCC------HHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 111111 2356788999999999999996 665
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.3e-43 Score=389.48 Aligned_cols=251 Identities=24% Similarity=0.244 Sum_probs=197.5
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCC----ChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDN----DIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVM 773 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 773 (1009)
+.|+..+.||+|+||.||+|++..+|+.||||++.+... .......+.+|+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 458889999999999999999999999999999854321 1111222334577788889999999999999999999
Q ss_pred EEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 774 MVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 774 lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
+||||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhccc----ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999975432 78889999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccccccc
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEAL 932 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 932 (1009)
+... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||...... +..... .. ... .
T Consensus 157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~-~~---~~~----~ 224 (364)
T d1omwa3 157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEID-RM---TLT----M 224 (364)
T ss_dssp CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHH-HH---SSS----C
T ss_pred cCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHH-Hh---ccc----C
Confidence 6433 3345679999999999864 56899999999999999999999999753222 222111 11 110 1
Q ss_pred CccccccCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 037197 933 DPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT-----MRDVIT 973 (1009)
Q Consensus 933 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 973 (1009)
...+....+ .++.+++.+||+.||++||| ++|+++
T Consensus 225 ~~~~~~~~s------~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 AVELPDSFS------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCCSSSC------HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCCC------HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111111111 23567889999999999999 577764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=384.87 Aligned_cols=261 Identities=25% Similarity=0.287 Sum_probs=195.9
Q ss_pred cCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh---hhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEec
Q 037197 702 ESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI---ESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYDY 778 (1009)
Q Consensus 702 ~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 778 (1009)
..++||+|+||+||+|+++.+|+.||||+++...... ...+.+.+|++++++++|||||++++++.++++.|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999999999999999996543221 1234677999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
++++++..+..... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 99988777765432 277788889999999999999999 99999999999999999999999999998775555
Q ss_pred CceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC----
Q 037197 859 ETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD---- 933 (1009)
Q Consensus 859 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 933 (1009)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||.... ..+....+..... ....+...
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~~~~l~~i~~~~~--~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLG--TPTEEQWPDMCS 230 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHC--CCCTTTSSSTTS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC--HHHHHHHHHHhcC--CCChhhccchhc
Confidence 55556679999999998764 457999999999999999999999996321 1111222221111 00000000
Q ss_pred ----ccccccCchHH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 934 ----PSIAGQCKHVQ-----EEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 934 ----~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
........... ....++.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000000000 11234678899999999999999999874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=385.45 Aligned_cols=254 Identities=24% Similarity=0.305 Sum_probs=197.9
Q ss_pred HHhcCCcC-ceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEc----C
Q 037197 696 ILACVKES-NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHN----E 769 (1009)
Q Consensus 696 ~~~~~~~~-~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~----~ 769 (1009)
+.+.|+.. ++||+|+||+||+|++..+++.||||++.. ...+.+|++++.++ +|||||+++++|++ +
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 45678776 469999999999999999999999999843 24566899987655 89999999999865 4
Q ss_pred CeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC---CCcEEEc
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA---NLEARIA 846 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~ 846 (1009)
..+|+|||||+||+|.+++..+.. ..+++.++..|+.||+.||+|||+. +|+||||||+||+++. ++.+||+
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 668999999999999999976432 3489999999999999999999999 9999999999999986 4679999
Q ss_pred ccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 847 DFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 847 DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .....+...+...
T Consensus 157 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~--~~~~~~~~~i~~~- 232 (335)
T d2ozaa1 157 DFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKTRIRMG- 232 (335)
T ss_dssp CCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSC-
T ss_pred ccceeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH--HHHHHHHHHHhcC-
Confidence 99999876443 3345567999999999999999999999999999999999999999643221 1111111111000
Q ss_pred ccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
. . .+. .........++.+++.+|++.||++|||+.|+++
T Consensus 233 ---~-~--~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 ---Q-Y--EFP--NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---S-S--SCC--TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---C-C--CCC--CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0 000 0111112235678899999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=382.28 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=202.3
Q ss_pred CceeccCCceEEEEEEECCC---CeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc-CCeEEEEEec
Q 037197 703 SNIIGMGGNGIVYKAEFHRP---HMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN-ETNVMMVYDY 778 (1009)
Q Consensus 703 ~~~iG~G~~g~Vyk~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~~~~lV~E~ 778 (1009)
.++||+|+||+||+|.+..+ ...||||++... .+....+++.+|++++++++||||++++|++.+ +...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 56899999999999998653 346999998643 345556778899999999999999999999865 5689999999
Q ss_pred cCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccCC
Q 037197 779 MPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHKN 858 (1009)
Q Consensus 779 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~~ 858 (1009)
|++|+|.++++.... ..++..+++++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999999876543 367888899999999999999998 99999999999999999999999999998764433
Q ss_pred C----ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccCc
Q 037197 859 E----TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALDP 934 (1009)
Q Consensus 859 ~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1009)
. ......||+.|+|||......++.++||||||+++|||+||+.||...... .++..++ ..+.. +
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i----~~g~~------~ 253 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYL----LQGRR------L 253 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH----HTTCC------C
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHH----HcCCC------C
Confidence 2 223356899999999999999999999999999999999988887643211 1222222 22221 1
Q ss_pred cccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 935 SIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 935 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
.....++ .++.+++.+||+.||++||++.||++.|+.+...
T Consensus 254 ~~p~~~~------~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 LQPEYCP------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCcccCc------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1111111 2456788999999999999999999999998643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=385.30 Aligned_cols=266 Identities=26% Similarity=0.313 Sum_probs=201.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHH--HHHHHhccCCCceeeEEeEEEcCC----e
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFR--EVSLLGRLRHRNIVRLLGYLHNET----N 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~--E~~~l~~l~Hpniv~l~~~~~~~~----~ 771 (1009)
+.|...+.||+|+||.||+|++. |+.||||++... ....+.+ |+..+++++||||+++++++.+.+ .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 44667788999999999999974 789999998432 2233444 455566789999999999987653 5
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEeccCCCcEEeCCCCcEEEc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHD-----CQPPVIHRDIKSNNILLDANLEARIA 846 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~ 846 (1009)
+++|||||++|+|.+++++.. ++|..+++++.|+|.||+|+|+. +.++|+||||||+||+++.++.+||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~-----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecccCCCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 899999999999999997542 89999999999999999999973 13599999999999999999999999
Q ss_pred ccccceecccCCC----ceeeecccCcccCCcccCCC------CCCcccchHhHHHHHHHHHhCCCCCCCCCCCC-----
Q 037197 847 DFGLARMMLHKNE----TVSMVAGSYGYIAPEYGYTL------KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGS----- 911 (1009)
Q Consensus 847 DfGls~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~----- 911 (1009)
|||+++....... ......||+.|+|||++... .++.++|||||||++|||+||..||.......
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 9999988754432 23346799999999987654 36779999999999999999998875321110
Q ss_pred ----ccHHHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCC
Q 037197 912 ----KDIVEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPR 981 (1009)
Q Consensus 912 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 981 (1009)
......+..... ....+|.+..... ..+....+.+++.+||+.||++|||+.||++.|+++..+
T Consensus 231 ~~~~~~~~~~~~~~~~-----~~~~~p~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVC-----EQKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TSCSSCCHHHHHHHHT-----TSCCCCCCCGGGG-GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHh-----ccccCCCCCcccC-ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 111222222222 2223333332221 223445678899999999999999999999999988643
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.7e-43 Score=386.81 Aligned_cols=292 Identities=30% Similarity=0.477 Sum_probs=201.9
Q ss_pred cChHHhHHHHHHHHhhccCCCCCCCCCCCCCccccCCcCCc--eeeeEEeCCC---CceeEEeccccccccc--cccccc
Q 037197 15 SNADDELSTLLSIKAGLIDPLNMLEDWKMPSNAAENGLLHC--NWTGVWCNSR---GFVEKLDLSNMSLNGS--VSENIR 87 (1009)
Q Consensus 15 ~~~~~~~~~ll~~k~~~~d~~~~l~~W~~~~~~~~~~~~~C--~w~gv~C~~~---~~v~~l~l~~~~l~~~--~~~~l~ 87 (1009)
=|.++||+|||+||+++.||. .+++|.. ++||| .|+||+|+.. +||++|||++++++|. +|+.++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~-------~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~ 73 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-------TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-------TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGG
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCC-------CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHh
Confidence 388999999999999999986 6999973 35789 4999999864 4899999999999884 667777
Q ss_pred cCCCCCeEeccc-CcccccCCccccccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCe
Q 037197 88 GLRSLSSLNICC-NEFASSLPKSLANLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLES 166 (1009)
Q Consensus 88 ~l~~L~~L~L~~-n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~ 166 (1009)
+|++|++|+|++ |+++|.+|++|++|++|++|+|++|++.+..|..+..+..|+++++++|.+.+.+|..+++++.|+.
T Consensus 74 ~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~ 153 (313)
T d1ogqa_ 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153 (313)
T ss_dssp GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred cCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccce
Confidence 777777777765 6777777777777777777777777777766666677777777777777777677777777777777
Q ss_pred eeccCCccCCcCCccccCcccc-ceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCc
Q 037197 167 LDFRGSFFEGSVPTSFRNLQKL-KFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGS 245 (1009)
Q Consensus 167 L~L~~n~~~~~~p~~~~~l~~L-~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 245 (1009)
+++++|.+.+.+|..+..+.++ +.+++++|++++..|..++.+..+ .++++++.+.+.+|..++.+++|+.|++++|.
T Consensus 154 l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~ 232 (313)
T d1ogqa_ 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232 (313)
T ss_dssp EECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSE
T ss_pred eeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccc
Confidence 7777777766666666666554 666666666666666665555433 46666666666666666666666666666666
Q ss_pred cccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccc
Q 037197 246 LSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQ 317 (1009)
Q Consensus 246 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 317 (1009)
+.+.++ .++.+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|. ++.+++|+.+++++|+
T Consensus 233 l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 233 LAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp ECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred cccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 654433 355555566666666666555555555555555555555555555552 3455555555555554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=380.09 Aligned_cols=262 Identities=25% Similarity=0.345 Sum_probs=208.7
Q ss_pred hcCCcCceeccCCceEEEEEEEC-----CCCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcCCe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFH-----RPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNETN 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 771 (1009)
++|+..+.||+|+||.||+|++. .+++.||||+++... .......+.+|+.+++++ +|||||++++++.++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46788899999999999999863 457899999996543 345556777999999999 69999999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCcc--------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe
Q 037197 772 VMMVYDYMPNDSLGEALHGKEA--------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL 837 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 837 (1009)
.++|||||++|+|.++++.... ....+++..+..++.||++|++|||++ +||||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 9999999999999999975432 223488999999999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHH
Q 037197 838 DANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIV 915 (1009)
Q Consensus 838 ~~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~ 915 (1009)
+.++.+|++|||.++....... ......||+.|+|||++....++.++|||||||++|||+|+..|+.........+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987654432 22346789999999999999999999999999999999995544433222222222
Q ss_pred HHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 916 EWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
+.+ ..+. .+......+ ..+.+++.+||+.||++|||+.|++++|+++.
T Consensus 259 ~~i----~~~~------~~~~~~~~~------~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 259 KMI----KEGF------RMLSPEHAP------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHH----HHTC------CCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH----hcCC------CCCCccccc------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 322 2221 111111111 24667899999999999999999999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-43 Score=380.39 Aligned_cols=260 Identities=26% Similarity=0.385 Sum_probs=205.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCC-------CeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcC
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRP-------HMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNE 769 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 769 (1009)
++|+..+.||+|+||.||+|+.... +..||||+++... ......++.+|+..+.++ +|||||+++++|.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4678889999999999999987543 3579999996543 344456777899999888 899999999999999
Q ss_pred CeEEEEEeccCCCChhhhhcCCccc------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEe
Q 037197 770 TNVMMVYDYMPNDSLGEALHGKEAG------------KLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILL 837 (1009)
Q Consensus 770 ~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll 837 (1009)
+..++||||+++|+|.++++.+... ...+++.+++.++.||+.||+|||++ +||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 9999999999999999999765421 23479999999999999999999999 99999999999999
Q ss_pred CCCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCCCCccH
Q 037197 838 DANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLT-GKMPLDPAFGGSKDI 914 (1009)
Q Consensus 838 ~~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~ellt-g~~Pf~~~~~~~~~~ 914 (1009)
+.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.... .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-----~ 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----V 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----H
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-----H
Confidence 9999999999999987654432 2334568899999999999999999999999999999998 788886321 1
Q ss_pred HHHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 915 VEWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
..+...+..+. .+.....+. .++.+++.+||+.||++|||+.||+++|+++.
T Consensus 244 -~~~~~~i~~~~------~~~~p~~~~------~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 244 -EELFKLLKEGH------RMDKPSNCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -HHHHHHHHTTC------CCCCCSSCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHHcCC------CCCCCccch------HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 22223333322 112222222 24668999999999999999999999998874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=379.21 Aligned_cols=261 Identities=25% Similarity=0.327 Sum_probs=197.2
Q ss_pred hcCCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhcc-CCCceeeEEeEEEcC-C
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRL-RHRNIVRLLGYLHNE-T 770 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~-~ 770 (1009)
++|+..+.||+|+||.||+|.+.. +++.||||+++... .....+.+.+|+.++.++ +|+||+++++++.+. .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 568889999999999999999753 35789999986433 334456677888888777 689999999998654 5
Q ss_pred eEEEEEeccCCCChhhhhcCCcc------------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeC
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEA------------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLD 838 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~ 838 (1009)
..++|||||++|+|.++++.... .+..+++.++..++.||++||+|||++ +||||||||+||+++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 68999999999999999975432 123478999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCC-CCCCCCCCCCccHH
Q 037197 839 ANLEARIADFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGK-MPLDPAFGGSKDIV 915 (1009)
Q Consensus 839 ~~~~~kl~DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~-~Pf~~~~~~~~~~~ 915 (1009)
+++.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+||. .||..... .
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-~---- 243 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-D---- 243 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-S----
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-H----
Confidence 999999999999987644332 233467999999999999999999999999999999999964 56753221 1
Q ss_pred HHHHHHHhhccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcC
Q 037197 916 EWVLSMIKSNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAK 979 (1009)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 979 (1009)
+.+...+..+.. +.....+. .++.+++.+||+.||++|||++|+++.|+++.
T Consensus 244 ~~~~~~~~~~~~------~~~~~~~~------~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 244 EEFCRRLKEGTR------MRAPDYTT------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHHHTCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCC------CCCCccCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 222223332221 11211111 24667899999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-43 Score=380.44 Aligned_cols=263 Identities=21% Similarity=0.343 Sum_probs=210.4
Q ss_pred hcCCcCceeccCCceEEEEEEECC-----CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHR-----PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNV 772 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 772 (1009)
++|+..+.||+|+||+||+|.++. +++.||||+++... .......+.+|++++++++||||+++++++..++..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 567888999999999999998752 35789999996543 344455677999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhcCCcc------ccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEc
Q 037197 773 MMVYDYMPNDSLGEALHGKEA------GKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIA 846 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 846 (1009)
++||||+++|+|.++++.... ....+++..+.+++.|+++||.|||++ +|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 999999999999999864321 123368899999999999999999998 99999999999999999999999
Q ss_pred ccccceecccCCC--ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCC-CCCCCCCCCCccHHHHHHHHHh
Q 037197 847 DFGLARMMLHKNE--TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGK-MPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 847 DfGls~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~-~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
|||+++....... ......+|+.|+|||.+.+..++.++||||||+++|||+||. .||.. ....+......
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-----~~~~~~~~~i~- 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-----LSNEQVLRFVM- 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-----SCHHHHHHHHH-
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-----CCHHHHHHHHH-
Confidence 9999987644432 223346899999999999999999999999999999999985 66652 23333333222
Q ss_pred hccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.+.. +.....++ ..+.+++.+||+.+|++|||+.||++.|++..+..
T Consensus 250 ~~~~------~~~p~~~~------~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 250 EGGL------LDKPDNCP------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp TTCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred hCCC------CCCcccch------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 2221 11111222 24678899999999999999999999999886543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5e-42 Score=371.85 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=197.9
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||+||+|+++ +++.||||++..........+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 57889999999999999999997 48999999997655444456778899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
|+.++.+..+.+.... +++..+..++.||+.||+|||+. +||||||||+||+++.++.+|++|||.+......
T Consensus 81 ~~~~~~~~~~~~~~~~----l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHTSTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHhhcCC----cchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9988877777654432 89999999999999999999998 9999999999999999999999999999877555
Q ss_pred CCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh-ccccccc----
Q 037197 858 NETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS-NKAQDEA---- 931 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~---- 931 (1009)
........+++.|+|||.... ..++.++||||+||++|||++|+.||.... ..+........ +......
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-----EADQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC-----HHHHHHHHHHhhCCCChhhccch
Confidence 555555678999999998765 456899999999999999999999997421 11111111110 0000000
Q ss_pred -----cCccccc----cCch-HHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 932 -----LDPSIAG----QCKH-VQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 932 -----~~~~~~~----~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
....... .... .......+.+++.+|++.||++|||++|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0000000 0000 000112456789999999999999999997
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=371.85 Aligned_cols=242 Identities=21% Similarity=0.361 Sum_probs=194.8
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCCh----hhHHHHHHHHHHHhccC--CCceeeEEeEEEcCCe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDI----ESGDDLFREVSLLGRLR--HRNIVRLLGYLHNETN 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~~~ 771 (1009)
++|+..+.||+|+||+||+|++..+++.||||++.+..... ....++.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 56889999999999999999999999999999986542211 11233558999999986 8999999999999999
Q ss_pred EEEEEeccCC-CChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCC-CcEEEcccc
Q 037197 772 VMMVYDYMPN-DSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDAN-LEARIADFG 849 (1009)
Q Consensus 772 ~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfG 849 (1009)
.++||||+.+ +++.+++.... .+++.++..++.||++||+|||++ +|+||||||+||+++.+ +.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 57888876443 288999999999999999999999 99999999999999854 799999999
Q ss_pred cceecccCCCceeeecccCcccCCcccCCCCC-CcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 850 LARMMLHKNETVSMVAGSYGYIAPEYGYTLKV-DEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 850 ls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
+|+.... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||... . . +..+.
T Consensus 157 ~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~-------~-i~~~~-- 220 (273)
T d1xwsa_ 157 SGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E-------E-IIRGQ-- 220 (273)
T ss_dssp TCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H-------H-HHHCC--
T ss_pred cceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----h-------H-Hhhcc--
Confidence 9986533 23345679999999999876665 57799999999999999999999731 0 1 11111
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
..+.+.+ + .++.+++.+|++.||++|||++|+++
T Consensus 221 -~~~~~~~----s------~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 -VFFRQRV----S------SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CCCSSCC----C------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cCCCCCC----C------HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1112222 1 24567889999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-41 Score=371.17 Aligned_cols=265 Identities=21% Similarity=0.292 Sum_probs=196.8
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc--------
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN-------- 768 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-------- 768 (1009)
.++|+..+.||+|+||+||+|++..+|+.||||++...........++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999999999999999997665555556778899999999999999999998855
Q ss_pred CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccc
Q 037197 769 ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADF 848 (1009)
Q Consensus 769 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 848 (1009)
....++||||++++.+......... +++..+..++.|+++||.|||++ +|+||||||+||+++.++.+|++||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~----~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhcccc----cccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 3458999999988877665543332 67788889999999999999999 9999999999999999999999999
Q ss_pred ccceecccCC----CceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHh
Q 037197 849 GLARMMLHKN----ETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIK 923 (1009)
Q Consensus 849 Gls~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 923 (1009)
|+++...... .......||+.|+|||++... .++.++||||+||++|||++|+.||.... .......+.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~--~~~~~~~i~~~~~ 239 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQLCG 239 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--HHHHHHHHHHhcC
Confidence 9998764332 122335689999999987654 68999999999999999999999997321 1111111211111
Q ss_pred hccccccccCc-----------cccccCchHHHH------HHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 924 SNKAQDEALDP-----------SIAGQCKHVQEE------MLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 924 ~~~~~~~~~~~-----------~~~~~~~~~~~~------~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
....+.... ..........+. ...+.+++.+|++.||++|||++|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 240 --SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp --CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred --CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 100110000 000011111111 22456789999999999999999997
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=369.11 Aligned_cols=262 Identities=24% Similarity=0.305 Sum_probs=195.4
Q ss_pred HhcCCcCceeccCCceEEEEEEECCC-CeEEEEEEcccCCCChhhHHHHHHHHHHHhcc---CCCceeeEEeEEEc----
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRP-HMVVAVKKLWRSDNDIESGDDLFREVSLLGRL---RHRNIVRLLGYLHN---- 768 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~---- 768 (1009)
.++|+..+.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36789999999999999999999654 67899999865443333344555777766655 89999999999853
Q ss_pred -CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcc
Q 037197 769 -ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIAD 847 (1009)
Q Consensus 769 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 847 (1009)
....++||||++++++......... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~---~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 3468999999998877655443322 278888889999999999999999 999999999999999999999999
Q ss_pred cccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh-cc
Q 037197 848 FGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS-NK 926 (1009)
Q Consensus 848 fGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~ 926 (1009)
||+++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+........ +.
T Consensus 160 fg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 160 FGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-----SDVDQLGKILDVIGL 233 (305)
T ss_dssp CCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHHHCC
T ss_pred hhhhhhhcc-cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC-----CHHHHHHHHHHhhCC
Confidence 999876533 23445677999999999999999999999999999999999999999732 112222221111 00
Q ss_pred ccccccC---------------ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 927 AQDEALD---------------PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 927 ~~~~~~~---------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
....... ........... ..+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID---ELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CchhcccccccchhhhhccccccchhhccccCC---HHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 00000011111 23557888999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=362.26 Aligned_cols=264 Identities=25% Similarity=0.335 Sum_probs=207.7
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCCeEEEEEe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNETNVMMVYD 777 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 777 (1009)
++|+..+.||+|+||+||+|++..+++.||||+++..........++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47889999999999999999999999999999997665555667788899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccceecccC
Q 037197 778 YMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLARMMLHK 857 (1009)
Q Consensus 778 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~~~~~ 857 (1009)
++.++++..+++.... +++..+..++.|+++||+|||++ +|+||||||+||+++.++.+|++|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTTC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccccccc----cchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999999888765533 68888899999999999999999 9999999999999999999999999999987655
Q ss_pred CCceeeecccCcccCCcccCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccccccC---
Q 037197 858 NETVSMVAGSYGYIAPEYGYTLK-VDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQDEALD--- 933 (1009)
Q Consensus 858 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 933 (1009)
........+++.|+|||.+.... ++.++||||+||++|||++|+.||... .+..+.+...........+...
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG----NDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC----SSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC----CCHHHHHHHHHhhcCCCChhhhhhh
Confidence 55555566788999999876554 689999999999999999999997532 2222333222221111110000
Q ss_pred ------------ccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 037197 934 ------------PSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVI 972 (1009)
Q Consensus 934 ------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 972 (1009)
+...............+.+++.+|++.||++|||++|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 000000000011122456788899999999999999885
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=371.74 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=198.6
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC-----
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET----- 770 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----- 770 (1009)
+.++|+..+.||+|+||+||+|.+..+|+.||||++.+........+.+.+|+++|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 456799999999999999999999999999999999766555566677889999999999999999999997654
Q ss_pred -eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccc
Q 037197 771 -NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFG 849 (1009)
Q Consensus 771 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 849 (1009)
++++||||+ +.+|..+.+... +++..+..++.||+.||+|||++ +|+||||||+||+++.++.+|++|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecc-cccHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence 579999999 677888775432 88999999999999999999999 99999999999999999999999999
Q ss_pred cceecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhc-cc
Q 037197 850 LARMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSN-KA 927 (1009)
Q Consensus 850 ls~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~ 927 (1009)
+|+.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.... ............ ..
T Consensus 167 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~-----~~~~~~~~~~~~~~~ 238 (346)
T d1cm8a_ 167 LARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-----HLDQLKEIMKVTGTP 238 (346)
T ss_dssp TCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCC
T ss_pred ceeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC-----hHHHHHHHHhccCCC
Confidence 9987533 3345679999999998765 456899999999999999999999997431 111111111100 00
Q ss_pred -------------------cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhhcC
Q 037197 928 -------------------QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT--MLGEAK 979 (1009)
Q Consensus 928 -------------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~~ 979 (1009)
..+.....+....... ...+.+++.+|+..||++|||+.|+++ .++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA---SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTC---CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cHHHHhhhcchhhhhhhccCCcccccchHHhccCC---CHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0001111111111111 123567889999999999999999987 355543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-40 Score=365.03 Aligned_cols=264 Identities=26% Similarity=0.336 Sum_probs=194.6
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc------CCeE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN------ETNV 772 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~------~~~~ 772 (1009)
.|+..++||+|+||+||+|++..+++.||||++..... ...+|++++++++||||++++++|.. ..+.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 57888999999999999999999999999999965422 12379999999999999999999853 3457
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC-cEEEcccccc
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-EARIADFGLA 851 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGls 851 (1009)
++|||||+++.+..+.+ .......+++.++..++.||++||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 95 ~lv~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 99999998764444332 222233489999999999999999999998 999999999999999875 8999999999
Q ss_pred eecccCCCceeeecccCcccCCcccCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhh-cc---
Q 037197 852 RMMLHKNETVSMVAGSYGYIAPEYGYT-LKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKS-NK--- 926 (1009)
Q Consensus 852 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~--- 926 (1009)
+..... .......||+.|+|||...+ ..++.++||||+||++|||++|+.||.... ........... +.
T Consensus 171 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~-----~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 171 KQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-----GVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp EECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS-----HHHHHHHHHHHHCCCCH
T ss_pred hhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC-----HHHHHHHHHHHhCCChH
Confidence 876433 33344679999999998664 568999999999999999999999996321 11111111110 00
Q ss_pred --------ccccccCcccc------ccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhhcCCC
Q 037197 927 --------AQDEALDPSIA------GQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT--MLGEAKPR 981 (1009)
Q Consensus 927 --------~~~~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~~~~ 981 (1009)
......-+... ..... ...++.+++.+|++.||++|||+.|+++ .++++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPR---TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTT---SCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred HhhhhhccchhhccccccccCchhhhcccC---CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 00000000000 00011 1124567889999999999999999996 46665443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=366.25 Aligned_cols=263 Identities=22% Similarity=0.279 Sum_probs=194.6
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcCC----eE
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNET----NV 772 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----~~ 772 (1009)
..+|+..+.||+|+||+||+|.+..+|+.||||++.+.. .....+++.+|++++++++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 456899999999999999999999999999999996543 3445567889999999999999999999987543 23
Q ss_pred EEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 773 MMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 773 ~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
+++++|+.+|+|.+++.... +++..+..++.|+++||+|||++ +||||||||+||+++.++.+||+|||+++
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~-----l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeecCCchhhhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 45556677999999996542 78999999999999999999999 99999999999999999999999999998
Q ss_pred ecccCCC---ceeeecccCcccCCcccC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccc-
Q 037197 853 MMLHKNE---TVSMVAGSYGYIAPEYGY-TLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKA- 927 (1009)
Q Consensus 853 ~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 927 (1009)
....... ......||+.|+|||++. ...++.++||||+||++|||++|+.||..... .+..............
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~--~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHILGILGSPSQE 235 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH--HHHHHHHhhhccCCChh
Confidence 7644322 234567899999999874 45678999999999999999999999974221 1111111100000000
Q ss_pred ----------------cccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 928 ----------------QDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 928 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
................ ..++..++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNA---DSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCC---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000000 124667899999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-39 Score=352.11 Aligned_cols=262 Identities=16% Similarity=0.176 Sum_probs=205.4
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCC-CceeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRH-RNIVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~l~~~~~~~~~~~lV~ 776 (1009)
++|+..+.||+|+||+||+|++..+++.||||++..... ...+.+|++.++.++| +|++.+++++.++...++||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 568899999999999999999999999999998854422 2345678888888865 89999999999999999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC-----CCcEEEcccccc
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA-----NLEARIADFGLA 851 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~DfGls 851 (1009)
||+ +++|.++++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+|
T Consensus 81 e~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 999 7899998865432 378889999999999999999999 9999999999999975 578999999999
Q ss_pred eecccCCC-------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCc-cHHHHHHHHHh
Q 037197 852 RMMLHKNE-------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSK-DIVEWVLSMIK 923 (1009)
Q Consensus 852 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~-~~~~~~~~~~~ 923 (1009)
+.+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ .....+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 88654321 23346799999999999999999999999999999999999999975432211 11111111111
Q ss_pred hccccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCCCc
Q 037197 924 SNKAQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKPRR 982 (1009)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~ 982 (1009)
.. . .+.+. ...+ .++.+++..|++.+|++||+++.+.+.|+++.++.
T Consensus 234 ~~-~-----~~~l~---~~~p---~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 234 ST-P-----LRELC---AGFP---EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HS-C-----HHHHT---TTSC---HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CC-C-----hHHhc---CCCC---HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 00 0 00111 1112 24567888999999999999999999998886544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-39 Score=352.78 Aligned_cols=261 Identities=16% Similarity=0.170 Sum_probs=197.1
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCc-eeeEEeEEEcCCeEEEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN-IVRLLGYLHNETNVMMVY 776 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn-iv~l~~~~~~~~~~~lV~ 776 (1009)
++|+..+.||+|+||.||+|++..+++.||||++..... ..++.+|++++++++|++ |+.+.+++.+++..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 468899999999999999999999999999999865432 234678999999998766 455566677888999999
Q ss_pred eccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCC---CCcEEEccccccee
Q 037197 777 DYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDA---NLEARIADFGLARM 853 (1009)
Q Consensus 777 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~DfGls~~ 853 (1009)
||+ ++++.+.+..... .+++..+..++.|++.||+|||++ +|+||||||+||+++. +..+|++|||+|+.
T Consensus 83 e~~-~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEc-CCchhhhhhhccC---CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 999 5666666543322 278899999999999999999999 9999999999999864 45799999999998
Q ss_pred cccCCC-------ceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcc
Q 037197 854 MLHKNE-------TVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNK 926 (1009)
Q Consensus 854 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 926 (1009)
+..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~--~~~~~~~~~~~~ 233 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERISEKKM 233 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------HHHHHHHHH
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH--HHHHHHhhcccC
Confidence 754331 23346799999999999999999999999999999999999999975432211 111111100000
Q ss_pred ccccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhhcCC
Q 037197 927 AQDEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVITMLGEAKP 980 (1009)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 980 (1009)
....+.....++ .++.+++.+|++.+|++||+++++.+.|+.+..
T Consensus 234 ---~~~~~~~~~~~p------~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 234 ---STPIEVLCKGYP------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ---HSCHHHHTTTSC------HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ---CCChhHhccCCC------HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 000011111111 245678889999999999999999999988754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=361.16 Aligned_cols=264 Identities=23% Similarity=0.285 Sum_probs=193.1
Q ss_pred HhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEc------CC
Q 037197 697 LACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHN------ET 770 (1009)
Q Consensus 697 ~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~------~~ 770 (1009)
.++|+..+.||+|+||+||+|.+..+|+.||||++...........++.+|+.++++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 467999999999999999999999999999999997766656666778899999999999999999999853 46
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
+.|+||||+.++.+. .+... +++..+..++.||+.||+|||+. ||+||||||+||+++.++.+|++|||+
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~~~------~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEEHHH-HHTSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchHHHH-hhhcC------CCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 789999999766554 44322 68888999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHH----------
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLS---------- 920 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~---------- 920 (1009)
++.... ........+|+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+..
T Consensus 166 ~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~--~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--YIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCHHHH
T ss_pred hhcccc-ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC--HHHHHHHHHHhccCCCHHHH
Confidence 876533 234445678999999999999999999999999999999999999996321 1111111110
Q ss_pred ---------HHhhccccc-----cccCcc-ccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 037197 921 ---------MIKSNKAQD-----EALDPS-IAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT 973 (1009)
Q Consensus 921 ---------~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 973 (1009)
......... ...... ..............+.+++.+|++.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 001100000 000000 11111122233456788999999999999999999973
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.2e-39 Score=354.16 Aligned_cols=194 Identities=22% Similarity=0.308 Sum_probs=168.3
Q ss_pred hcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEc--CCeEEE
Q 037197 698 ACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHN--ETNVMM 774 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~--~~~~~l 774 (1009)
++|+..+.||+|+||+||+|++..+++.||||+++.. ..+++.+|++++++++ ||||+++++++.. ....++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 5799999999999999999999999999999998542 2456779999999995 9999999999874 456899
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCC-cEEEccccccee
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANL-EARIADFGLARM 853 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGls~~ 853 (1009)
||||+.+++|.++.+ .+++.++..++.||++||+|||++ +|+||||||+|||++.++ .+||+|||+|+.
T Consensus 110 v~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 110 VFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence 999999999987642 278888999999999999999999 999999999999998655 699999999987
Q ss_pred cccCCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCC
Q 037197 854 MLHKNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPA 907 (1009)
Q Consensus 854 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~ 907 (1009)
.... .......+|+.|+|||...+. .++.++||||+||++|||++|+.||...
T Consensus 180 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 180 YHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp CCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 6433 334456789999999987765 4799999999999999999999999743
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=355.94 Aligned_cols=254 Identities=24% Similarity=0.298 Sum_probs=198.2
Q ss_pred hcCCcCceeccCCceEEEEEEE---CCCCeEEEEEEcccCCC--ChhhHHHHHHHHHHHhccCC-CceeeEEeEEEcCCe
Q 037197 698 ACVKESNIIGMGGNGIVYKAEF---HRPHMVVAVKKLWRSDN--DIESGDDLFREVSLLGRLRH-RNIVRLLGYLHNETN 771 (1009)
Q Consensus 698 ~~~~~~~~iG~G~~g~Vyk~~~---~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~H-pniv~l~~~~~~~~~ 771 (1009)
++|+..+.||+|+||+||+|++ +.+|+.||||++.+... +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5689999999999999999987 44689999999865421 12234556699999999976 899999999999999
Q ss_pred EEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEcccccc
Q 037197 772 VMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGLA 851 (1009)
Q Consensus 772 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGls 851 (1009)
.++||||+.+|+|.+++..... ..+.....++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999975543 56778888999999999999999 9999999999999999999999999999
Q ss_pred eecccCC-CceeeecccCcccCCcccCCC--CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhcccc
Q 037197 852 RMMLHKN-ETVSMVAGSYGYIAPEYGYTL--KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQ 928 (1009)
Q Consensus 852 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1009)
+.+.... .......|++.|+|||..... .++.++||||+||++|||++|+.||...... +....+........
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~--~~~~~i~~~~~~~~-- 252 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE-- 252 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--CCHHHHHHHHHHCC--
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcccCC--
Confidence 8764433 334456789999999987644 4678999999999999999999999754322 22222222221111
Q ss_pred ccccCccccccCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 037197 929 DEALDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPT-----MRDVIT 973 (1009)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 973 (1009)
+.+....+ .++.+++.+|+++||++||| ++|+++
T Consensus 253 -----~~~~~~~s------~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -----PPYPQEMS------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----CCCCTTSC------HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CCCcccCC------HHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11111111 24567888999999999994 778764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-39 Score=359.46 Aligned_cols=265 Identities=23% Similarity=0.314 Sum_probs=199.4
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCceeeEEeEEEcC-----C
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRNIVRLLGYLHNE-----T 770 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----~ 770 (1009)
+.++|+..+.||+|+||+||+|++..+|+.||||++.+...+....+++.+|++++++++||||+++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 35679999999999999999999999999999999987666666667788999999999999999999998633 3
Q ss_pred eEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEEEccccc
Q 037197 771 NVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEARIADFGL 850 (1009)
Q Consensus 771 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 850 (1009)
..++||||+.+|+|.++++.+. +++.++..++.||+.||+|||++ +|+||||||+||+++.++.+|++|||.
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~-----l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQK-----LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred ceEEEEEeecCCchhhhccccc-----ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence 4466777888999999996542 78999999999999999999999 999999999999999999999999999
Q ss_pred ceecccCCCceeeecccCcccCCcccCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHHhhccccc
Q 037197 851 ARMMLHKNETVSMVAGSYGYIAPEYGYTL-KVDEKSDIYSFGVVLLELLTGKMPLDPAFGGSKDIVEWVLSMIKSNKAQD 929 (1009)
Q Consensus 851 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1009)
+.... .......|++.|+|||...+. .++.++||||+||++|+|++|+.||.... .......+.... +....
T Consensus 168 a~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~--~~~~~~~i~~~~--~~~~~ 240 (348)
T d2gfsa1 168 ARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRLV--GTPGA 240 (348)
T ss_dssp --CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHH--CCCCH
T ss_pred hcccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHHhc--CCCCh
Confidence 97643 233446789999999986654 46899999999999999999999997321 111111111110 00000
Q ss_pred cc-------------------cCccccccCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhhc
Q 037197 930 EA-------------------LDPSIAGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMRDVIT--MLGEA 978 (1009)
Q Consensus 930 ~~-------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~ 978 (1009)
+. ....+...... ....+.+++.+|++.||++|||++|+++ .+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIG---ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTT---CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCC---CCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00 00000000001 1124567899999999999999999987 45543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-34 Score=322.33 Aligned_cols=265 Identities=20% Similarity=0.219 Sum_probs=187.2
Q ss_pred cCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-----------CCceeeEEeEEE
Q 037197 699 CVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-----------HRNIVRLLGYLH 767 (1009)
Q Consensus 699 ~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------Hpniv~l~~~~~ 767 (1009)
+|+..+.||+|+||+||+|++..+|+.||||++++. ....+...+|+++++.++ |+||+++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 589999999999999999999999999999999543 334456668998888775 578999999875
Q ss_pred c--CCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeccCCCcEEeCCCC---
Q 037197 768 N--ETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH-DCQPPVIHRDIKSNNILLDANL--- 841 (1009)
Q Consensus 768 ~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~dlk~~NIll~~~~--- 841 (1009)
. ....++||+++..+.......... ....+++..+..++.||++|++|||+ . +|+||||||+||+++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred eccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 4 356677777765553332221111 12236788889999999999999998 5 999999999999998665
Q ss_pred ---cEEEcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCCC-CccHHHH
Q 037197 842 ---EARIADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVLLELLTGKMPLDPAFGG-SKDIVEW 917 (1009)
Q Consensus 842 ---~~kl~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl~elltg~~Pf~~~~~~-~~~~~~~ 917 (1009)
.++++|||.+..... ......||+.|+|||+.....++.++||||+||+++||++|+.||...... .......
T Consensus 167 ~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ccceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 499999999986533 234467999999999998889999999999999999999999999753221 1111111
Q ss_pred HHHHHh-hcc----------ccccccC-----ccc------------cccCchHHHHHHHHHHHHHHhccCCCCCCCCHH
Q 037197 918 VLSMIK-SNK----------AQDEALD-----PSI------------AGQCKHVQEEMLLVLRIAVLCTAKLPKGRPTMR 969 (1009)
Q Consensus 918 ~~~~~~-~~~----------~~~~~~~-----~~~------------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 969 (1009)
....+. .+. ......+ ..+ .............+.+++.+|++.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 111100 000 0000000 000 001111233455678899999999999999999
Q ss_pred HHHH
Q 037197 970 DVIT 973 (1009)
Q Consensus 970 evl~ 973 (1009)
|+++
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=5.6e-34 Score=313.03 Aligned_cols=259 Identities=28% Similarity=0.437 Sum_probs=216.3
Q ss_pred CCceeeccCccccc--cCCcCccCCCCCceeeccc-ccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEE
Q 037197 355 PLRRLDASSNLLSG--EIPTGLCDSGNLTKLILFN-NSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRL 431 (1009)
Q Consensus 355 ~L~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~l~~-N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 431 (1009)
.++.|+|++|.+.+ .+|..++.+++|++|+|++ |+++|.+|..+.++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 45566666666665 4667777777777777775 67777777777777777777777777777777777777778888
Q ss_pred EeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCccc-chhccccCcccCCcccccccCCcCcEEEeecCCC
Q 037197 432 EMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSL-QTFMASHNNLQAKIPNELQACPSLSVLDLSSNSL 510 (1009)
Q Consensus 432 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l 510 (1009)
++++|++.+.+|..+..++.++.+++++|.+++.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 888888777777778888888888888888887777777777765 667888888888888888777655 699999999
Q ss_pred CCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCCCC
Q 037197 511 SGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSNG 590 (1009)
Q Consensus 511 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~ 590 (1009)
.+.+|..+..+++|+.|++++|.+++.+| .++.+++|+.|||++|+|+|.+|+.|+++++|++|||++|+|+|.||..+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 99999999999999999999999997665 68889999999999999999999999999999999999999999999988
Q ss_pred cccccCCcccccCcCCCCCCCCCCC
Q 037197 591 ILMNINPNELIGNAGLCGSVLPPCS 615 (1009)
Q Consensus 591 ~~~~~~~~~~~~n~~lcg~~~~~c~ 615 (1009)
.+.++....+.+|+.+||.|+|+|+
T Consensus 289 ~L~~L~~l~l~~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred cCCCCCHHHhCCCccccCCCCCCCC
Confidence 8999999999999999999999995
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=5.8e-29 Score=281.24 Aligned_cols=357 Identities=24% Similarity=0.299 Sum_probs=218.9
Q ss_pred eccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccc
Q 037197 168 DFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLS 247 (1009)
Q Consensus 168 ~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 247 (1009)
.+..+.+++.+. ...+.+|++|++++|.++. + +.++.+++|++|+|++|+|++.. .|+++++|++|++++|++.
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccc
Confidence 445555554433 2456667777777777763 2 34666666777777777666432 2666666666666666665
Q ss_pred cccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCC
Q 037197 248 GQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLG 327 (1009)
Q Consensus 248 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~ 327 (1009)
+.. .++.+++|+.|++++|.+++..+ ......+..+....|.+....+.................. ...+.
T Consensus 102 ~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 172 (384)
T d2omza2 102 DIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLA 172 (384)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----CGGGT
T ss_pred ccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccch-----hhhhc
Confidence 432 25566666666666666554322 2233444555555555543222111111111111111111 11122
Q ss_pred CCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEE
Q 037197 328 ELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRV 407 (1009)
Q Consensus 328 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L 407 (1009)
.... ........|... ....+..+++++.+++++|.+++..| +..+++|++|
T Consensus 173 ~~~~------------------------~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L 224 (384)
T d2omza2 173 NLTT------------------------LERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL 224 (384)
T ss_dssp TCTT------------------------CCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred cccc------------------------cccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEE
Confidence 2222 223333333322 23334445566666666666665433 3455667777
Q ss_pred EcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCccc
Q 037197 408 RVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQ 487 (1009)
Q Consensus 408 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 487 (1009)
++++|++++ + ..+..+++|+.|++++|++++..+ +..+++|+.|++++|++++.. .+..++.++.+.++.|+++
T Consensus 225 ~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~ 298 (384)
T d2omza2 225 SLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLE 298 (384)
T ss_dssp ECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCS
T ss_pred ECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccccccccccc
Confidence 777777663 2 246667777777777777765432 566777777777777777643 3667777788888888877
Q ss_pred CCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcC
Q 037197 488 AKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFG 567 (1009)
Q Consensus 488 ~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 567 (1009)
+. ..+..+++++.|+|++|++++..| +..+++|++|+|++|+|++ ++ .++++++|++|||++|+|++.+| +.
T Consensus 299 ~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~ 370 (384)
T d2omza2 299 DI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LA 370 (384)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GT
T ss_pred cc--cccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hc
Confidence 53 357788889999999999986543 7788999999999999984 44 68889999999999999998766 88
Q ss_pred CCCCCcEEecCCCc
Q 037197 568 ASPALEMLNLSYNK 581 (1009)
Q Consensus 568 ~l~~L~~L~ls~N~ 581 (1009)
++++|++|+|++|.
T Consensus 371 ~l~~L~~L~L~~Na 384 (384)
T d2omza2 371 NLTRITQLGLNDQA 384 (384)
T ss_dssp TCTTCSEEECCCEE
T ss_pred cCCCCCEeeCCCCc
Confidence 89999999999883
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.5e-28 Score=277.83 Aligned_cols=357 Identities=23% Similarity=0.270 Sum_probs=237.2
Q ss_pred EecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccc
Q 037197 143 VNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAF 222 (1009)
Q Consensus 143 L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 222 (1009)
..++.+.+++.+. ...+.+|++|+++++.++. + +.++.+++|++|+|++|+|++. | .++++++|++|++++|++
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccc
Confidence 4567777776554 3578899999999999984 3 4688999999999999999954 4 399999999999999999
Q ss_pred cccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhh
Q 037197 223 EGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKL 302 (1009)
Q Consensus 223 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 302 (1009)
++.. .++++++|+.|++++|.+++..+ ......+..+....|.+....+............... ......+
T Consensus 101 ~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 171 (384)
T d2omza2 101 ADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQ-----VTDLKPL 171 (384)
T ss_dssp CCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEES-----CCCCGGG
T ss_pred cccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc-----cchhhhh
Confidence 8654 38999999999999999986543 4455678888888888765433222222222211111 1222345
Q ss_pred hcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCce
Q 037197 303 AELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTK 382 (1009)
Q Consensus 303 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 382 (1009)
.............|.... ...+..+++++.+++++|.+++..| +....+|+.|++++|.+++. ..+..+++|+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~ 245 (384)
T d2omza2 172 ANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTD 245 (384)
T ss_dssp TTCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred cccccccccccccccccc--ccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccch
Confidence 555666666666666543 3456677788888888887776543 34455666666666665531 23344444444
Q ss_pred eecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcc
Q 037197 383 LILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHL 462 (1009)
Q Consensus 383 L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 462 (1009)
|+ +++|.+++..+ ++.+++|++|++++|++++.. .+..+..++.++++.|++
T Consensus 246 L~------------------------l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l 297 (384)
T d2omza2 246 LD------------------------LANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQL 297 (384)
T ss_dssp EE------------------------CCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCC
T ss_pred hc------------------------cccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccc
Confidence 44 44444443222 444555555555555555322 244455566666666666
Q ss_pred cccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCccc
Q 037197 463 ESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAV 542 (1009)
Q Consensus 463 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 542 (1009)
++. ..+..+++++.|++++|++++.. .+..+++|+.|+|++|+|++ ++ .+.++++|++|+|++|+|++..| +
T Consensus 298 ~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l 369 (384)
T d2omza2 298 EDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--L 369 (384)
T ss_dssp SCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--G
T ss_pred ccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--h
Confidence 542 23555666666677777666543 36777888888888888874 33 57788888888888888886554 7
Q ss_pred ccccccceecCCcc
Q 037197 543 ATMPTLAILDMSNN 556 (1009)
Q Consensus 543 ~~l~~L~~L~Ls~N 556 (1009)
+++++|+.|+|++|
T Consensus 370 ~~l~~L~~L~L~~N 383 (384)
T d2omza2 370 ANLTRITQLGLNDQ 383 (384)
T ss_dssp TTCTTCSEEECCCE
T ss_pred ccCCCCCEeeCCCC
Confidence 88888888888887
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=7.8e-26 Score=246.59 Aligned_cols=270 Identities=19% Similarity=0.275 Sum_probs=180.3
Q ss_pred cCCceeeeEEeCCCCceeEEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCCCC
Q 037197 52 LLHCNWTGVWCNSRGFVEKLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGSFP 131 (1009)
Q Consensus 52 ~~~C~w~gv~C~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p 131 (1009)
.+.|.|++|.|+. .+++ .+|..+. +++++|+|++|+++...+.+|.++++|++|++++|.+....|
T Consensus 7 ~c~c~~~~~~C~~-----------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~ 72 (305)
T d1xkua_ 7 RCQCHLRVVQCSD-----------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP 72 (305)
T ss_dssp TCEEETTEEECTT-----------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCT
T ss_pred CCEecCCEEEecC-----------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccch
Confidence 3458999999964 2333 3454442 568888888888876555678888888888888888887667
Q ss_pred CCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeecccccc--ccCCccCCCC
Q 037197 132 TGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLT--GKIPPELGQL 209 (1009)
Q Consensus 132 ~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~--~~~p~~l~~l 209 (1009)
..+.++++|++|++++|+++ .+|..+ ...|+.|++++|.+.+..+..+.....++.++...|... ...+..+..+
T Consensus 73 ~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l 149 (305)
T d1xkua_ 73 GAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149 (305)
T ss_dssp TTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGC
T ss_pred hhhhCCCccCEecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccc
Confidence 77888888888888888887 345432 357778888888877666666666777777777766433 2334456666
Q ss_pred cchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccc
Q 037197 210 SSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDL 289 (1009)
Q Consensus 210 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 289 (1009)
++|+.+++++|.++ .+|..+ +++|++|++++|..++..+..|.+++.++.|++++|.+++..+..+.++++|++|+|
T Consensus 150 ~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred cccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 67777777777666 334332 456777777777776666666777777777777777777666666666677777777
Q ss_pred cccccCCCcchhhhcccCCCeEeccccccCCCCCcCCC------CCCcccEEEccCCcc
Q 037197 290 SDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLG------ELTKLEVLELWKNSL 342 (1009)
Q Consensus 290 s~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~------~l~~L~~L~L~~N~l 342 (1009)
++|+|+ .+|.++..+++|++|+|++|+|+.+....|. .+.+|+.|+|++|.+
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~ 284 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred cccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcC
Confidence 777766 4566666667777777777766655433332 234444444444443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.5e-25 Score=244.39 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=122.5
Q ss_pred CCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecc
Q 037197 307 NLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILF 386 (1009)
Q Consensus 307 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~ 386 (1009)
++++|+|++|+|+.+.+..|.++++|++|++++|.+....|..|..++.|+.|++++|+++ .+|..+ ...+..|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~ 108 (305)
T d1xkua_ 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVH 108 (305)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECC
T ss_pred CCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccch--hhhhhhhhcc
Confidence 3444444444444433334444444444444444444444444444444444444444444 222222 1244555555
Q ss_pred cccccccCCcccccCccccEEEcccCccc--cccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccc
Q 037197 387 NNSFSGTFPVSLSTCKSLVRVRVQNNLIS--GTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLES 464 (1009)
Q Consensus 387 ~N~l~~~~p~~l~~~~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 464 (1009)
+|.+.+..+..+.....+..+....|... ...+..+..+++|+.+++++|+++ .+|..+ .++|+.|++++|.++
T Consensus 109 ~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~- 184 (305)
T d1xkua_ 109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT- 184 (305)
T ss_dssp SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCC-
T ss_pred ccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCC-
Confidence 55555444444444445555555554332 222334444555555555555554 233221 234444444444444
Q ss_pred cCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCccccc
Q 037197 465 YLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVAT 544 (1009)
Q Consensus 465 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 544 (1009)
...+..|..++.+++|++++|++++..+..+.++++|++|+|++|+|+ .+|..|..
T Consensus 185 -----------------------~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~ 240 (305)
T d1xkua_ 185 -----------------------KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 240 (305)
T ss_dssp -----------------------EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred -----------------------CCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccc
Confidence 444444555555555555555555555555555555666666666555 44555556
Q ss_pred ccccceecCCccccccccCcCc------CCCCCCcEEecCCCccc-cCCCC
Q 037197 545 MPTLAILDMSNNSLFGRIPENF------GASPALEMLNLSYNKLE-GPVPS 588 (1009)
Q Consensus 545 l~~L~~L~Ls~N~l~~~~p~~~------~~l~~L~~L~ls~N~l~-g~ip~ 588 (1009)
+++|+.|+|++|+|+......| ..++.|+.|+|++|+++ +++|.
T Consensus 241 l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~ 291 (305)
T d1xkua_ 241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291 (305)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCG
T ss_pred ccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCH
Confidence 6666666666666654333222 34566777777777764 44543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=6.3e-25 Score=236.46 Aligned_cols=250 Identities=19% Similarity=0.190 Sum_probs=131.7
Q ss_pred CCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeecc-CccccccCCcCccCCCCCceeec
Q 037197 307 NLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDAS-SNLLSGEIPTGLCDSGNLTKLIL 385 (1009)
Q Consensus 307 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls-~N~l~~~~~~~l~~l~~L~~L~l 385 (1009)
++++|+|++|+|+.+.+..|.++++|++|++++|.+....+..+.....++.++.. .|.++...+.
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~------------- 99 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPA------------- 99 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTT-------------
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccch-------------
Confidence 44555555555554444455555555555555555544444444444444444332 2333333333
Q ss_pred ccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCccccc
Q 037197 386 FNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESY 465 (1009)
Q Consensus 386 ~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 465 (1009)
.+.++++|++|++++|.+....+..+...++|+.+++++|+|++..+..|..+++|+.|++++|+|+++
T Consensus 100 -----------~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l 168 (284)
T d1ozna_ 100 -----------TFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168 (284)
T ss_dssp -----------TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred -----------hhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccccc
Confidence 344444444444444444433344444445555555555555544444455555555555555555555
Q ss_pred CCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccc
Q 037197 466 LPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATM 545 (1009)
Q Consensus 466 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 545 (1009)
.+..|.++++|+.+++++|++++..|..|..+++|+.||+++|++++..|..|.++.+|+.|+|++|.+...-+. ..-.
T Consensus 169 ~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~ 247 (284)
T d1ozna_ 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLW 247 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHH
T ss_pred chhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHH
Confidence 555555555555566666655555566666666666666666666666666666666666666666666643321 1112
Q ss_pred cccceecCCccccccccCcCcCCCCCCcEEecCCCcccc
Q 037197 546 PTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEG 584 (1009)
Q Consensus 546 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 584 (1009)
..++.+....+++....|..+.. ....+++.++|+|
T Consensus 248 ~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 248 AWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp HHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred HHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 24555666666666666666543 3444566666665
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5.8e-25 Score=236.79 Aligned_cols=234 Identities=18% Similarity=0.185 Sum_probs=197.4
Q ss_pred CCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcc-cCccccccCCccCCCCcccEEEe
Q 037197 355 PLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQ-NNLISGTIPVGLGNLPSLQRLEM 433 (1009)
Q Consensus 355 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~L 433 (1009)
.+++|+|++|.|++..+..|..+++|++|++++|++....+..+..+..+..+... .|.++...+..|.++++|++|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 45666666666665555567777777777777777777777777777788887654 66677677888999999999999
Q ss_pred ecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCC
Q 037197 434 ANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGE 513 (1009)
Q Consensus 434 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~ 513 (1009)
++|.+.+..+..+....+|+.+++++|+|+++.+..|..+++|+.|++++|+++...+..|.++++|+.+++++|++++.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 99999877788889999999999999999998889999999999999999999998899999999999999999999999
Q ss_pred CCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCccccCCCCC
Q 037197 514 IPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEGPVPSN 589 (1009)
Q Consensus 514 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~ 589 (1009)
.|..|..+++|++|++++|++++..|..|+.+++|+.|+|++|++.+.-+.. .-...++.+....+++.+..|..
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~-~l~~~l~~~~~~~~~~~C~~p~~ 267 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQR 267 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGG
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccch-HHHHHHHhCcCCCCceEeCCchH
Confidence 9999999999999999999999988899999999999999999998654321 11234667777888888777753
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=6.5e-23 Score=218.05 Aligned_cols=201 Identities=23% Similarity=0.278 Sum_probs=113.7
Q ss_pred CCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEE
Q 037197 353 SSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLE 432 (1009)
Q Consensus 353 ~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 432 (1009)
...+.+++.+++.|+ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+
T Consensus 9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~ 83 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLD 83 (266)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEE
T ss_pred cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccc
Confidence 344555666666666 4555543 45677777777776655566666677777777777666 333 245566666666
Q ss_pred eecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCC
Q 037197 433 MANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSG 512 (1009)
Q Consensus 433 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~ 512 (1009)
|++|+++ ..+..+..+++|+.|++++|.+.++.+..+..+ .+++.|++++|.++.
T Consensus 84 Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l------------------------~~l~~L~l~~n~l~~ 138 (266)
T d1p9ag_ 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL------------------------GELQELYLKGNELKT 138 (266)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTC------------------------TTCCEEECTTSCCCC
T ss_pred ccccccc-ccccccccccccccccccccccceeeccccccc------------------------cccccccccccccce
Confidence 6666665 334455555666666666665555444444444 444455555555544
Q ss_pred CCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCCCcccc
Q 037197 513 EIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSYNKLEG 584 (1009)
Q Consensus 513 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g 584 (1009)
..+..+..++.|+.|++++|+|++..+..|..+++|+.|||++|+|+ .+|+.+..+++|+.|+|++|++..
T Consensus 139 l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred eccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 44444445555555555555555444445555555555555555555 455555555555555555555543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=8.8e-23 Score=217.02 Aligned_cols=201 Identities=25% Similarity=0.263 Sum_probs=157.4
Q ss_pred ccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhcc
Q 037197 402 KSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMA 481 (1009)
Q Consensus 402 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 481 (1009)
.++.+++.+++.++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|+.+. .+..+++|+.|++
T Consensus 10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~L 84 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLDL 84 (266)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEEC
T ss_pred CCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccccccc
Confidence 34445566666665 3454443 35666677777666555556666777777777777776543 2456777777778
Q ss_pred ccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccc
Q 037197 482 SHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGR 561 (1009)
Q Consensus 482 ~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 561 (1009)
++|+++. .+..+..+++|+.|++++|.+....+..+..+.+++.|++++|.+++..+..+..++.|+.|++++|+|++.
T Consensus 85 s~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 85 SHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp CSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred ccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccccc
Confidence 8777764 466788899999999999999988889999999999999999999987788889999999999999999999
Q ss_pred cCcCcCCCCCCcEEecCCCccccCCCCC-CcccccCCcccccCcCCCCC
Q 037197 562 IPENFGASPALEMLNLSYNKLEGPVPSN-GILMNINPNELIGNAGLCGS 609 (1009)
Q Consensus 562 ~p~~~~~l~~L~~L~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~lcg~ 609 (1009)
.+..|..+++|++|||++|+|+ .||.+ ..+..+....+.|||+.|++
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 9999999999999999999999 67753 33445566678899999985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=2.6e-21 Score=194.19 Aligned_cols=171 Identities=12% Similarity=0.103 Sum_probs=119.0
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCC----------------hhhHHHHHHHHHHHhccCCCceeeEEe
Q 037197 701 KESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDND----------------IESGDDLFREVSLLGRLRHRNIVRLLG 764 (1009)
Q Consensus 701 ~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~Hpniv~l~~ 764 (1009)
...+.||+|+||+||+|.+.+ |+.||||+++..... ........+|...+.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~-g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETT-TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECCC-CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356789999999999999865 889999987532110 011223346888999999999999887
Q ss_pred EEEcCCeEEEEEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcCCCCeEEeccCCCcEEeCCCCcEE
Q 037197 765 YLHNETNVMMVYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDCQPPVIHRDIKSNNILLDANLEAR 844 (1009)
Q Consensus 765 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 844 (1009)
+.. .++||||++++.+.++ +......++.|++++++|||++ +|+||||||+||+++++ .++
T Consensus 82 ~~~----~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EET----TEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred ecC----CEEEEEeeccccccch-----------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEE
Confidence 642 2799999987655432 2223346899999999999998 99999999999999865 589
Q ss_pred EcccccceecccCCCceeeecccCcccCCcccCCCCCCcccchHhHHHHH
Q 037197 845 IADFGLARMMLHKNETVSMVAGSYGYIAPEYGYTLKVDEKSDIYSFGVVL 894 (1009)
Q Consensus 845 l~DfGls~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvvl 894 (1009)
++|||.|.....+.... ........ ..| ...+.|..++|+||..--+
T Consensus 143 liDFG~a~~~~~~~~~~-~l~rd~~~-~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWRE-ILERDVRN-IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHHH-HHHHHHHH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcHH-HHHHHHHH-HHH-HHcCCCCCcccHHHHHHHH
Confidence 99999997764332110 00000000 001 1245678899999975433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=3.9e-19 Score=196.98 Aligned_cols=303 Identities=27% Similarity=0.346 Sum_probs=142.2
Q ss_pred ccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcc
Q 037197 187 KLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLY 266 (1009)
Q Consensus 187 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 266 (1009)
+|++|+|++|.++ .+|+. .++|++|+|++|+|+ .+|..+ .+|+.|++++|+++. ++.. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---cccccccccc
Confidence 5777777777776 45643 345666777777776 455443 356666666666652 2211 1245566666
Q ss_pred cCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccC
Q 037197 267 KNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSL 346 (1009)
Q Consensus 267 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 346 (1009)
+|.++ .+|. ++.+++|+.|++++|.+... +. ....+..+.+.++.... ...+..++.++.+++++|......
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~~ 178 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKLP 178 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSCC
T ss_pred ccccc-cccc-hhhhccceeecccccccccc-cc---ccccccchhhccccccc--cccccccccceecccccccccccc
Confidence 66655 2332 34555556666555555422 21 12334444444443332 223444445555555444433211
Q ss_pred CccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCC
Q 037197 347 PMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLP 426 (1009)
Q Consensus 347 ~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~ 426 (1009)
.. ....+.+...++.+. .++ .+..++.|+.+++++|... .++. ...
T Consensus 179 -------------------------~~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~---~~~ 224 (353)
T d1jl5a_ 179 -------------------------DL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPD---LPP 224 (353)
T ss_dssp -------------------------CC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCCS---CCT
T ss_pred -------------------------cc---ccccccccccccccc-ccc-ccccccccccccccccccc-cccc---ccc
Confidence 10 111222333333222 111 2334455555555555544 2222 123
Q ss_pred cccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEee
Q 037197 427 SLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLS 506 (1009)
Q Consensus 427 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs 506 (1009)
++..+.+.+|++.. .+. ....+...++..|.+.+... . .......++..|.+.+ ....+++|++|+|+
T Consensus 225 ~l~~~~~~~~~~~~-~~~---~~~~l~~~~~~~~~~~~l~~-l---~~~~~~~~~~~~~~~~----~~~~~~~L~~L~Ls 292 (353)
T d1jl5a_ 225 SLEALNVRDNYLTD-LPE---LPQSLTFLDVSENIFSGLSE-L---PPNLYYLNASSNEIRS----LCDLPPSLEELNVS 292 (353)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSEESC-C---CTTCCEEECCSSCCSE----ECCCCTTCCEEECC
T ss_pred cccccccccccccc-ccc---cccccccccccccccccccc-c---cchhcccccccCcccc----ccccCCCCCEEECC
Confidence 45555555555542 221 12344455555544433210 0 0112223333333332 12334566666666
Q ss_pred cCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCc
Q 037197 507 SNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPE 564 (1009)
Q Consensus 507 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 564 (1009)
+|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|+
T Consensus 293 ~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 293 NNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp SSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence 66666 44443 345666666666665 45542 345666666666665 3444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=1.2e-18 Score=192.94 Aligned_cols=307 Identities=26% Similarity=0.303 Sum_probs=192.3
Q ss_pred CCCCeeeccCCccCCcCCccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEe
Q 037197 162 TSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDL 241 (1009)
Q Consensus 162 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 241 (1009)
.+|++|||++|.++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 47999999999998 57764 468999999999999 778765 46888899999887 33321 146999999
Q ss_pred ccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCC
Q 037197 242 AVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGL 321 (1009)
Q Consensus 242 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 321 (1009)
++|.+. .+|. ++.+++|++|++++|.+... +.. ...+..+.+.++... ....+..++.++.|++++|.+...
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC
T ss_pred cccccc-cccc-hhhhccceeecccccccccc-ccc---cccccchhhcccccc--ccccccccccceeccccccccccc
Confidence 999998 4554 68899999999999998843 333 356677777766654 345677889999999999998754
Q ss_pred CCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcccccC
Q 037197 322 IPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTC 401 (1009)
Q Consensus 322 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~ 401 (1009)
.. . ....+.+....+.+. .. ..+..++.|+.+++++|.... .+. ...++..+.+.+|.+...
T Consensus 178 ~~-~---~~~~~~l~~~~~~~~-~~-~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~-------- 239 (353)
T d1jl5a_ 178 PD-L---PLSLESIVAGNNILE-EL-PELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDL-------- 239 (353)
T ss_dssp CC-C---CTTCCEEECCSSCCS-SC-CCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCC--------
T ss_pred cc-c---ccccccccccccccc-cc-ccccccccccccccccccccc-ccc---cccccccccccccccccc--------
Confidence 22 2 223445555554443 22 224455666666666665542 222 123444555555544321
Q ss_pred ccccEEEcccCccccccCCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhcc
Q 037197 402 KSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMA 481 (1009)
Q Consensus 402 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 481 (1009)
+. ....+...++..|.+.+. +. ........++..|.+.+. ...+++|++|++
T Consensus 240 -----------------~~---~~~~l~~~~~~~~~~~~l-~~---l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~L 291 (353)
T d1jl5a_ 240 -----------------PE---LPQSLTFLDVSENIFSGL-SE---LPPNLYYLNASSNEIRSL----CDLPPSLEELNV 291 (353)
T ss_dssp -----------------CC---CCTTCCEEECCSSCCSEE-SC---CCTTCCEEECCSSCCSEE----CCCCTTCCEEEC
T ss_pred -----------------cc---cccccccccccccccccc-cc---ccchhcccccccCccccc----cccCCCCCEEEC
Confidence 11 112333444444433321 10 012333445555555442 122456666666
Q ss_pred ccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccc
Q 037197 482 SHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVA 543 (1009)
Q Consensus 482 ~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 543 (1009)
++|+++ .+|.. +++|+.|+|++|+|+ .+|.. +.+|++|+|++|+|+ .+|....
T Consensus 292 s~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~ 344 (353)
T d1jl5a_ 292 SNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPE 344 (353)
T ss_dssp CSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCT
T ss_pred CCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcccc
Confidence 666665 34432 467777888888877 45543 456788888888887 5665433
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=9e-22 Score=226.92 Aligned_cols=380 Identities=19% Similarity=0.126 Sum_probs=204.4
Q ss_pred cccceeeeccccccccC-CccCCCCcchhhhhccccccccc----CCccccCCCCccEEEeccCccccc----cCcccCC
Q 037197 186 QKLKFLGLSGNNLTGKI-PPELGQLSSLETIILGYNAFEGE----IPAEFGNLTNLRYLDLAVGSLSGQ----IPPALGR 256 (1009)
Q Consensus 186 ~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~ 256 (1009)
.+|++||+++|++++.. .+.+..+++|++|+|++|.++.. ++..+..+++|++|||++|.|+.. +...+..
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 46889999999988532 23456678888899999988743 345567788899999988888642 2223332
Q ss_pred -CCCCcEEEcccCCcCCC----CCcccccccccccccccccccCCCcchhhhc-c----cCCCeEeccccccCCCC----
Q 037197 257 -LKKLTTVYLYKNNFTGK----IPPELGSITSLAFLDLSDNQISGEIPVKLAE-L----KNLQLLNLMCNQLTGLI---- 322 (1009)
Q Consensus 257 -l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~-l----~~L~~L~L~~N~l~~~~---- 322 (1009)
..+|++|+|++|.+++. ++..+..+++|++|+|++|.++......+.. + .....+......+....
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 34788888888888754 2344566778888888888876433222221 1 11222222222221110
Q ss_pred CcCCCCCCcccEEEccCCccCccCCc----cc-cCCCCCceeeccCccccccCCcCccCCCCCceeecccccccccCCcc
Q 037197 323 PDKLGELTKLEVLELWKNSLIGSLPM----RL-GQSSPLRRLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVS 397 (1009)
Q Consensus 323 ~~~l~~l~~L~~L~L~~N~l~~~~~~----~~-~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~ 397 (1009)
...+.....++.++++.+........ .+ ........+++..+.+...... .....
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~--------------------~~~~~ 221 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR--------------------DLCGI 221 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH--------------------HHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhh--------------------ccccc
Confidence 00112234455555555443211000 00 1111233344444333211000 01112
Q ss_pred cccCccccEEEcccCcccc-----ccCCccCCCCcccEEEeeccccccc----CCcCCcCCCCCcEEecccCcccccCCC
Q 037197 398 LSTCKSLVRVRVQNNLISG-----TIPVGLGNLPSLQRLEMANNNLTGQ----IPDDISLSTSLSFVDISWNHLESYLPS 468 (1009)
Q Consensus 398 l~~~~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 468 (1009)
+...+.++.+++.+|++.. ..+........++.+++++|.+... ....+...+.++.+++++|.++.....
T Consensus 222 l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~ 301 (460)
T d1z7xw1 222 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 301 (460)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred ccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2334455555555555431 1122233344566666666655421 112233455566666666665432111
Q ss_pred cc-----cCCcccchhccccCcccCCcc----cccccCCcCcEEEeecCCCCCCC----Ccccc-ccccceeeeecCccc
Q 037197 469 SI-----LSIPSLQTFMASHNNLQAKIP----NELQACPSLSVLDLSSNSLSGEI----PASIA-SCEKLVSLNLRNNRF 534 (1009)
Q Consensus 469 ~~-----~~l~~L~~L~l~~N~l~~~~p----~~~~~l~~L~~LdLs~N~l~~~~----p~~~~-~l~~L~~L~Ls~N~l 534 (1009)
.+ .....|+.+++++|.++.... ..+...++|+.|||++|++++.. +..+. ..+.|++|+|++|+|
T Consensus 302 ~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i 381 (460)
T d1z7xw1 302 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 381 (460)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred hhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCC
Confidence 11 123456666666666654322 23345567888888888876432 22222 345688888888888
Q ss_pred ccC----CCcccccccccceecCCccccccccCcCc----C-CCCCCcEEecCCCccccC
Q 037197 535 SGE----IPKAVATMPTLAILDMSNNSLFGRIPENF----G-ASPALEMLNLSYNKLEGP 585 (1009)
Q Consensus 535 ~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~ls~N~l~g~ 585 (1009)
+.. +++.+...++|++|||++|+|+......| . +...|+.|++++|.+...
T Consensus 382 ~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 382 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred ChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 742 44556667888888888888875433332 2 334688888888887654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.2e-18 Score=180.00 Aligned_cols=219 Identities=16% Similarity=0.122 Sum_probs=138.1
Q ss_pred eeeccCccccccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccC-CccCCCCcccEEEeec-
Q 037197 358 RLDASSNLLSGEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIP-VGLGNLPSLQRLEMAN- 435 (1009)
Q Consensus 358 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~- 435 (1009)
.++.+++.++ .+|..+. .++++|++++|+++...+.+|.++++|++|++++|.+...++ ..|.+++.++++.+..
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 4455555554 4444432 356666666666665555566666777777777766654433 3456666777666653
Q ss_pred ccccccCCcCCcCCCCCcEEecccCcccccCCC-cccCCcccchhccccCcccCCcccccccCC-cCcEEEeecCCCCCC
Q 037197 436 NNLTGQIPDDISLSTSLSFVDISWNHLESYLPS-SILSIPSLQTFMASHNNLQAKIPNELQACP-SLSVLDLSSNSLSGE 513 (1009)
Q Consensus 436 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~LdLs~N~l~~~ 513 (1009)
|++....+..|..+++|+.+++++|++....+. .+..+..+..+..+++++....+..|..++ .++.|++++|+++..
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i 168 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 168 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc
Confidence 556655566666777777777777776654332 233455555556666666655556666654 677888888888754
Q ss_pred CCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccCcCcCCCCCCcEEecCC
Q 037197 514 IPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIPENFGASPALEMLNLSY 579 (1009)
Q Consensus 514 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 579 (1009)
.+..+.....++.+++++|+|+...+..|.++++|+.|||++|+|+...+..|.+++.|+++++++
T Consensus 169 ~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 169 HNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred ccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 444443333334446777888744445678888888888888888866666788888887777644
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=7.4e-22 Score=227.67 Aligned_cols=385 Identities=19% Similarity=0.136 Sum_probs=222.0
Q ss_pred CCCCeeeccCCccCCcC-CccccCccccceeeeccccccc----cCCccCCCCcchhhhhcccccccccCCccc----c-
Q 037197 162 TSLESLDFRGSFFEGSV-PTSFRNLQKLKFLGLSGNNLTG----KIPPELGQLSSLETIILGYNAFEGEIPAEF----G- 231 (1009)
Q Consensus 162 ~~L~~L~L~~n~~~~~~-p~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~----~- 231 (1009)
.+|++||+++|++++.. ...+..+++|+.|+|++|.++. .+...+..+++|++|+|++|+|+......+ .
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36899999999998643 3346778999999999999884 334556788999999999999975332233 2
Q ss_pred CCCCccEEEeccCccccc----cCcccCCCCCCcEEEcccCCcCCCCCccccc-----ccccccccccccccCCCc----
Q 037197 232 NLTNLRYLDLAVGSLSGQ----IPPALGRLKKLTTVYLYKNNFTGKIPPELGS-----ITSLAFLDLSDNQISGEI---- 298 (1009)
Q Consensus 232 ~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~~---- 298 (1009)
...+|++|+|++|++++. ++..+..+++|++|+|++|.++......+.. ......+......+....
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 235799999999999864 4567888999999999999987532222211 111222333333222111
Q ss_pred chhhhcccCCCeEeccccccCCCCCc----CC-CCCCcccEEEccCCccCccC----CccccCCCCCceeeccCcccccc
Q 037197 299 PVKLAELKNLQLLNLMCNQLTGLIPD----KL-GELTKLEVLELWKNSLIGSL----PMRLGQSSPLRRLDASSNLLSGE 369 (1009)
Q Consensus 299 ~~~l~~l~~L~~L~L~~N~l~~~~~~----~l-~~l~~L~~L~L~~N~l~~~~----~~~~~~~~~L~~L~Ls~N~l~~~ 369 (1009)
...+.....++.++++++.+...... .+ ........+++..+.+.... ...+.....++.+++++|.+...
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 12244567899999998876532100 01 11234567788777654321 12334566788888888876421
Q ss_pred -----CCcCccCCCCCceeeccccccccc----CCcccccCccccEEEcccCccccccCCcc-----CCCCcccEEEeec
Q 037197 370 -----IPTGLCDSGNLTKLILFNNSFSGT----FPVSLSTCKSLVRVRVQNNLISGTIPVGL-----GNLPSLQRLEMAN 435 (1009)
Q Consensus 370 -----~~~~l~~l~~L~~L~l~~N~l~~~----~p~~l~~~~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~ 435 (1009)
..........++.+++++|.+... ....+...+.++.+++++|.++......+ .....|+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~ 321 (460)
T d1z7xw1 242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 321 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence 122233355677777777766532 22234455666667777766653222111 1223455555555
Q ss_pred ccccccCCc----CCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccc-cCCcCcEEEeecCCC
Q 037197 436 NNLTGQIPD----DISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQ-ACPSLSVLDLSSNSL 510 (1009)
Q Consensus 436 N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~LdLs~N~l 510 (1009)
|.++..... .+....+|++|+|++|+|++.... .++..+. ..+.|++|+|++|.|
T Consensus 322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~--------------------~l~~~l~~~~~~L~~L~Ls~n~i 381 (460)
T d1z7xw1 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR--------------------ELCQGLGQPGSVLRVLWLADCDV 381 (460)
T ss_dssp SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH--------------------HHHHHHTSTTCCCCEEECTTSCC
T ss_pred cchhhhhhhhcccccccccchhhhheeeecccCcccc--------------------hhhhhhhcccCCCCEEECCCCCC
Confidence 555432111 112233444555554444321000 1222222 244567777777776
Q ss_pred CCC----CCccccccccceeeeecCcccccCCCcccc-----cccccceecCCccccccccCcCc
Q 037197 511 SGE----IPASIASCEKLVSLNLRNNRFSGEIPKAVA-----TMPTLAILDMSNNSLFGRIPENF 566 (1009)
Q Consensus 511 ~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~~~ 566 (1009)
+.. ++..+..+++|++|+|++|+|+......+. +...|+.|++++|.+....+..+
T Consensus 382 ~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l 446 (460)
T d1z7xw1 382 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446 (460)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred ChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHH
Confidence 532 233344556777777777777643333322 22357777777777765544433
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1.1e-18 Score=180.30 Aligned_cols=205 Identities=23% Similarity=0.351 Sum_probs=101.0
Q ss_pred cCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeecc
Q 037197 116 LKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSG 195 (1009)
Q Consensus 116 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~ 195 (1009)
+..++++.+.+++.+ .++.+.+|++|++++|+++. + +.+..+++|++|++++|.+.+..| +..+++|++|++++
T Consensus 21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (227)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence 334444444444321 23344455555555555542 2 235555555555555555543322 45555555555555
Q ss_pred ccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCC
Q 037197 196 NNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIP 275 (1009)
Q Consensus 196 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 275 (1009)
|.++ .++ .+..+++|+.++++++...+. ..+...+.++.++++.+.+... ..+...++|++|++++|.+++.
T Consensus 95 n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~-- 166 (227)
T d1h6ua2 95 NPLK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL-- 166 (227)
T ss_dssp CCCS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--
T ss_pred cccc-ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--
Confidence 5554 222 344455555555555544322 2234445555555555554422 1244455555555555555432
Q ss_pred cccccccccccccccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEcc
Q 037197 276 PELGSITSLAFLDLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELW 338 (1009)
Q Consensus 276 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 338 (1009)
..+.++++|+.|+|++|++++ ++ .++.+++|++|+|++|+++++. .++++++|+.|+++
T Consensus 167 ~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 167 TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred hhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 124555556666666665553 22 2555566666666666665442 25555566665554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=7.9e-18 Score=173.73 Aligned_cols=209 Identities=25% Similarity=0.320 Sum_probs=123.2
Q ss_pred CCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCCCCcccccccccccc
Q 037197 208 QLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGKIPPELGSITSLAFL 287 (1009)
Q Consensus 208 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 287 (1009)
.+.++..++++.+++++.. .++.+.+|++|++.+|+++.. +.+..+++|++|++++|.+++..| +..+++|+++
T Consensus 17 ~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l 90 (227)
T d1h6ua2 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90 (227)
T ss_dssp HHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred HHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccc
Confidence 3444555667777776543 456667777888887777643 346777777777777777775432 6677777777
Q ss_pred cccccccCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEccCCccCccCCccccCCCCCceeeccCcccc
Q 037197 288 DLSDNQISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLELWKNSLIGSLPMRLGQSSPLRRLDASSNLLS 367 (1009)
Q Consensus 288 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~ 367 (1009)
++++|.++. ++ .+..+++|+.++++++...+. ..+...+.++.+.++.+.+.... .+..+.+|+.|++++|.+.
T Consensus 91 ~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~ 164 (227)
T d1h6ua2 91 ELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVS 164 (227)
T ss_dssp ECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCC
T ss_pred ccccccccc-cc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccc
Confidence 777777763 32 466777777777777776644 23555666777777666654332 2445555666666666554
Q ss_pred ccCCcCccCCCCCceeecccccccccCCcccccCccccEEEcccCccccccCCccCCCCcccEEEee
Q 037197 368 GEIPTGLCDSGNLTKLILFNNSFSGTFPVSLSTCKSLVRVRVQNNLISGTIPVGLGNLPSLQRLEMA 434 (1009)
Q Consensus 368 ~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 434 (1009)
+. ..+..+++|+.|++++|++++. + .+.++++|++|++++|++++..| +.++++|+.|+++
T Consensus 165 ~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 165 DL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp CC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred cc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 22 1244455555555555555432 1 24455555555555555543221 4455555555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=6.1e-18 Score=176.59 Aligned_cols=198 Identities=14% Similarity=0.095 Sum_probs=97.7
Q ss_pred CCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcC-CccccCccccceeeecc-ccccccCCccCCCCcchhhhh
Q 037197 139 GLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSV-PTSFRNLQKLKFLGLSG-NNLTGKIPPELGQLSSLETII 216 (1009)
Q Consensus 139 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~-p~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~ 216 (1009)
++++|+|++|+|+...+..|.++++|++|++++|.+...+ +.+|.+++++++|.+.. |++....+..|.++++|++|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 3444444444444322334444555555555555444322 23344555555554432 344444444455555555555
Q ss_pred cccccccccCCc-cccCCCCccEEEeccCccccccCcccCCCC-CCcEEEcccCCcCCCCCcccccccccc-cccccccc
Q 037197 217 LGYNAFEGEIPA-EFGNLTNLRYLDLAVGSLSGQIPPALGRLK-KLTTVYLYKNNFTGKIPPELGSITSLA-FLDLSDNQ 293 (1009)
Q Consensus 217 L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~-~L~Ls~N~ 293 (1009)
+++|++....+. .+..+..|..+...++.+....+..|..++ .++.|++++|+++...+..+ ...+++ .+++++|+
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~ 188 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNN 188 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTT
T ss_pred cchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccc-cchhhhccccccccc
Confidence 555554422211 233344444555555555544444554443 56666666666664333333 233333 33455566
Q ss_pred cCCCcchhhhcccCCCeEeccccccCCCCCcCCCCCCcccEEEc
Q 037197 294 ISGEIPVKLAELKNLQLLNLMCNQLTGLIPDKLGELTKLEVLEL 337 (1009)
Q Consensus 294 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 337 (1009)
++...+..|.++++|++|+|++|+|+.+.+..|.++++|+.+++
T Consensus 189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 66433445666666666666666666555555666666655544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=2.8e-18 Score=171.90 Aligned_cols=174 Identities=17% Similarity=0.189 Sum_probs=111.3
Q ss_pred cEEEcccCccccccCCccCCCCcccEEEeecccccccC-CcCCcCCCCCcEEecccCcccccCCCcccCCcccchhcccc
Q 037197 405 VRVRVQNNLISGTIPVGLGNLPSLQRLEMANNNLTGQI-PDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASH 483 (1009)
Q Consensus 405 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 483 (1009)
++++.++|+++ .+|..+. +++++|+|++|+|++.+ +..|..+++|+.|+|++|++..+.+..|..+++|++|++++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 34555555555 4454442 45666666666665433 34456666666666666666666666666666777777777
Q ss_pred CcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCccccccccC
Q 037197 484 NNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFGRIP 563 (1009)
Q Consensus 484 N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 563 (1009)
|+|+...|..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|.+....+. ..-...++.+.++.|.++...|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCC
Confidence 777666666677777777777777777766677777777777777777777643322 1122346667777777777667
Q ss_pred cCcCCCCCCcEEecCCCccccC
Q 037197 564 ENFGASPALEMLNLSYNKLEGP 585 (1009)
Q Consensus 564 ~~~~~l~~L~~L~ls~N~l~g~ 585 (1009)
..+. .++.+||+.|+|...
T Consensus 167 ~~l~---~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 167 SKVR---DVQIKDLPHSEFKCS 185 (192)
T ss_dssp TTTT---TSBGGGSCTTTCCCC
T ss_pred hhhc---CCEeeecCHhhCcCC
Confidence 6543 455667777777643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=9.6e-18 Score=167.99 Aligned_cols=158 Identities=20% Similarity=0.256 Sum_probs=109.4
Q ss_pred ccccEEEcccCcccccc-CCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhc
Q 037197 402 KSLVRVRVQNNLISGTI-PVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFM 480 (1009)
Q Consensus 402 ~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 480 (1009)
+++++|+|++|+|++.+ +..|.++++|+.|+|++|++++..+..+..+++|++|+|++|+|+.+.+.+|.++++|++|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 34555556666665433 34556667777777777777766666777777777777777777777777777777777777
Q ss_pred cccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCcccccc
Q 037197 481 ASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNNSLFG 560 (1009)
Q Consensus 481 l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 560 (1009)
|++|+|++..+..|..+++|++|+|++|.+....+.. .-...++.+.+..|.++...|..+ ..++.+||+.|.|.-
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKC 184 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCC
T ss_pred cCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcC
Confidence 7777777777777888888888888888887443322 223457778888888887777654 557788999998864
Q ss_pred ccC
Q 037197 561 RIP 563 (1009)
Q Consensus 561 ~~p 563 (1009)
..+
T Consensus 185 ~~~ 187 (192)
T d1w8aa_ 185 SSE 187 (192)
T ss_dssp CCC
T ss_pred CCC
Confidence 433
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=9.2e-18 Score=170.69 Aligned_cols=119 Identities=15% Similarity=0.251 Sum_probs=51.5
Q ss_pred cccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeeecccc
Q 037197 118 SMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGNN 197 (1009)
Q Consensus 118 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~ 197 (1009)
..++..+.+++.++. ..+.+|++|++++|.+.+. + .+..+++|++|+|++|.+++.. .++++++|++|++++|+
T Consensus 28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENK 101 (210)
T ss_dssp HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred HHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccc
Confidence 344444444433221 2244555555555555432 1 2444555555555555554322 23445555555555555
Q ss_pred ccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCcc
Q 037197 198 LTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSL 246 (1009)
Q Consensus 198 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 246 (1009)
+++ +| .+..+++|+.|++++|.+.. ...+..+++|+.++++.|.+
T Consensus 102 i~~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l 146 (210)
T d1h6ta2 102 VKD-LS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKI 146 (210)
T ss_dssp CCC-GG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCC
T ss_pred ccc-cc-cccccccccccccccccccc--cccccccccccccccccccc
Confidence 542 22 23444444444444444331 12233444444444444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=3.4e-17 Score=166.38 Aligned_cols=166 Identities=25% Similarity=0.385 Sum_probs=92.3
Q ss_pred ccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCcccccee
Q 037197 112 NLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFL 191 (1009)
Q Consensus 112 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L 191 (1009)
.+.+|++|++++|.+... .++..+++|++|+|++|++++. + .++.+++|++|++++|.+++ +| .+.++++|+.|
T Consensus 44 ~L~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (210)
T ss_dssp HHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred HhcCccEEECcCCCCCCc--hhHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-ccccccccccc
Confidence 344555555555555431 1345555555555555555532 2 24555566666666665553 22 35556666666
Q ss_pred eeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcC
Q 037197 192 GLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFT 271 (1009)
Q Consensus 192 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 271 (1009)
++++|.+.. + ..+..+++|+.+++++|.+++ +..+..+++|+++++++|++++.. .++++++|++|+|++|+++
T Consensus 118 ~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 118 SLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp ECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred ccccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCC
Confidence 666665542 2 245555666666666666553 234555666666666666666432 2666666777777777666
Q ss_pred CCCCcccccccccccccccc
Q 037197 272 GKIPPELGSITSLAFLDLSD 291 (1009)
Q Consensus 272 ~~~~~~~~~l~~L~~L~Ls~ 291 (1009)
+ ++ .+.++++|++|+|++
T Consensus 192 ~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 192 D-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp B-CG-GGTTCTTCSEEEEEE
T ss_pred C-Ch-hhcCCCCCCEEEccC
Confidence 3 33 466666777776653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=2.5e-17 Score=165.88 Aligned_cols=181 Identities=25% Similarity=0.355 Sum_probs=84.2
Q ss_pred CccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCccccceeee
Q 037197 114 TALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFLGL 193 (1009)
Q Consensus 114 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L 193 (1009)
.++..++++.+.+++.++ ...+.+|++|++++|++.. + +.++.+++|++|++++|.+++..| ++++++|++|++
T Consensus 18 ~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l 91 (199)
T d2omxa2 18 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM 91 (199)
T ss_dssp HHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred HHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccc
Confidence 333444555555443222 1234455555555555542 2 234455555555555555553322 555555555555
Q ss_pred ccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcCCC
Q 037197 194 SGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFTGK 273 (1009)
Q Consensus 194 ~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 273 (1009)
++|.+.. ++ .++++++|+.|++++|.+... ..+..+++|++|++++|++... +.+..+++|+.|++.+|++++.
T Consensus 92 ~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l 165 (199)
T d2omxa2 92 NNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL 165 (199)
T ss_dssp CSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC
T ss_pred ccccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCC
Confidence 5555542 22 244455555555555544421 2244455555555555554421 2344455555555555555432
Q ss_pred CCcccccccccccccccccccCCCcchhhhcccCCCe
Q 037197 274 IPPELGSITSLAFLDLSDNQISGEIPVKLAELKNLQL 310 (1009)
Q Consensus 274 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 310 (1009)
+ .+.++++|++|++++|++++ ++ .++.+++|++
T Consensus 166 -~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~ 198 (199)
T d2omxa2 166 -K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLES 198 (199)
T ss_dssp -G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSE
T ss_pred -c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCc
Confidence 1 24444555555555555442 22 2444444443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=3.1e-17 Score=165.27 Aligned_cols=162 Identities=23% Similarity=0.354 Sum_probs=89.1
Q ss_pred ccCccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCCCCccccCCCCCCeeeccCCccCCcCCccccCcccccee
Q 037197 112 NLTALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGFLPEDLGNATSLESLDFRGSFFEGSVPTSFRNLQKLKFL 191 (1009)
Q Consensus 112 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L 191 (1009)
.+.+|++|++++|.+.. + +++..+++|++|+|++|++++..| ++++++|++|++++|.+.. ++ .+.++++|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence 44455555555555442 1 234455555555555555553322 5555566666666555542 22 25556666666
Q ss_pred eeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCccccccCcccCCCCCCcEEEcccCCcC
Q 037197 192 GLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQIPPALGRLKKLTTVYLYKNNFT 271 (1009)
Q Consensus 192 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 271 (1009)
++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|++|++.+|++++.. .++++++|++|++++|+++
T Consensus 112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred cccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence 6666655532 235556666666666666652 2 24566666666666666665432 3666667777777777666
Q ss_pred CCCCcccccccccccc
Q 037197 272 GKIPPELGSITSLAFL 287 (1009)
Q Consensus 272 ~~~~~~~~~l~~L~~L 287 (1009)
+ ++ .++++++|+.|
T Consensus 186 ~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 186 D-IS-VLAKLTNLESL 199 (199)
T ss_dssp C-CG-GGGGCTTCSEE
T ss_pred C-Cc-cccCCCCCCcC
Confidence 4 22 35566666654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=3.4e-16 Score=166.85 Aligned_cols=221 Identities=19% Similarity=0.197 Sum_probs=102.8
Q ss_pred EEeccccccccccccccccCCCCCeEecccCcccccCCccccccCccCcccccccccCCC-CCCCCCCCcCCeEEecCCC
Q 037197 70 KLDLSNMSLNGSVSENIRGLRSLSSLNICCNEFASSLPKSLANLTALKSMDVSQNNFIGS-FPTGLGKASGLTSVNASSN 148 (1009)
Q Consensus 70 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~Ls~n 148 (1009)
.+||+++.+.+.....+.. ..+..+.++...+...+. ......+|++|||++|.+... ++..+.++++|++|+|++|
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 5677766654333222221 123444444443332222 223344566666666655433 2233455666666666666
Q ss_pred CCCCCCCccccCCCCCCeeeccCC-ccCCcC-CccccCccccceeeeccc-ccccc-CCccCCC-Ccchhhhhcccc--c
Q 037197 149 NFSGFLPEDLGNATSLESLDFRGS-FFEGSV-PTSFRNLQKLKFLGLSGN-NLTGK-IPPELGQ-LSSLETIILGYN--A 221 (1009)
Q Consensus 149 ~l~~~~p~~l~~l~~L~~L~L~~n-~~~~~~-p~~~~~l~~L~~L~L~~n-~l~~~-~p~~l~~-l~~L~~L~L~~n--~ 221 (1009)
.+++..+..++.+++|++|++++| .++... ...+.++++|++|++++| .++.. +...+.. .++|+.|+++++ .
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~ 161 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 161 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGG
T ss_pred CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccc
Confidence 665555555666666666666663 333211 111234566666666654 23211 1111211 234555555432 2
Q ss_pred cccc-CCccccCCCCccEEEeccC-ccccccCcccCCCCCCcEEEcccC-CcCCCCCccccccccccccccccc
Q 037197 222 FEGE-IPAEFGNLTNLRYLDLAVG-SLSGQIPPALGRLKKLTTVYLYKN-NFTGKIPPELGSITSLAFLDLSDN 292 (1009)
Q Consensus 222 l~~~-~~~~~~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~N 292 (1009)
++.. +...+.++++|++|++++| .+++.....+.++++|++|+|++| .+++.....++++++|+.|+++++
T Consensus 162 i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp SCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 2221 1112234455555555553 344444445555555555555553 344443444445555555555544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=5.7e-16 Score=165.15 Aligned_cols=220 Identities=16% Similarity=0.192 Sum_probs=113.1
Q ss_pred CeEecccCcccccCCccccccC--ccCcccccccccCCCCCCCCCCCcCCeEEecCCCCCCCC-CCccccCCCCCCeeec
Q 037197 93 SSLNICCNEFASSLPKSLANLT--ALKSMDVSQNNFIGSFPTGLGKASGLTSVNASSNNFSGF-LPEDLGNATSLESLDF 169 (1009)
Q Consensus 93 ~~L~L~~n~~~~~~~~~l~~l~--~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~L 169 (1009)
++|||+++.+.. +.++.+. .+..+.++...+...+ .......+|++|||++|.+++. ++..+..+++|++|+|
T Consensus 3 ~~lDLs~~~l~~---~~l~~l~~~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L 78 (284)
T d2astb2 3 QTLDLTGKNLHP---DVTGRLLSQGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78 (284)
T ss_dssp SEEECTTCBCCH---HHHHHHHHTTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred CEEECCCCCCCc---hHHHHHHhccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccc
Confidence 578998887753 3333332 2445555555443322 2334556788888888877643 3344667788888888
Q ss_pred cCCccCCcCCccccCccccceeeeccc-cccccC-CccCCCCcchhhhhcccc-ccccc-CCccccC-CCCccEEEeccC
Q 037197 170 RGSFFEGSVPTSFRNLQKLKFLGLSGN-NLTGKI-PPELGQLSSLETIILGYN-AFEGE-IPAEFGN-LTNLRYLDLAVG 244 (1009)
Q Consensus 170 ~~n~~~~~~p~~~~~l~~L~~L~L~~n-~l~~~~-p~~l~~l~~L~~L~L~~n-~l~~~-~~~~~~~-l~~L~~L~L~~n 244 (1009)
++|.+++..+..++.+++|++|+|++| .++... ...+..+++|++|+++++ .+++. +...+.. .++|+.|+++++
T Consensus 79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~ 158 (284)
T d2astb2 79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158 (284)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred cccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccc
Confidence 888777666777777778888888774 444211 111234555666666553 23221 1112222 245555555543
Q ss_pred --ccccc-cCcccCCCCCCcEEEcccC-CcCCCCCccccccccccccccccc-ccCCCcchhhhcccCCCeEecccc
Q 037197 245 --SLSGQ-IPPALGRLKKLTTVYLYKN-NFTGKIPPELGSITSLAFLDLSDN-QISGEIPVKLAELKNLQLLNLMCN 316 (1009)
Q Consensus 245 --~l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~~N 316 (1009)
.++.. +...+.++++|++|++++| .+++.....+..+++|++|+|++| .+++.....++++++|+.|+++++
T Consensus 159 ~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 22211 1112233445555555443 244333444444444444444442 343333333444444444444443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.51 E-value=3e-16 Score=172.90 Aligned_cols=241 Identities=20% Similarity=0.175 Sum_probs=116.4
Q ss_pred ccccccCCCCCeEecccCccccc----CCccccccCccCcccccccccCCC----------CCCCCCCCcCCeEEecCCC
Q 037197 83 SENIRGLRSLSSLNICCNEFASS----LPKSLANLTALKSMDVSQNNFIGS----------FPTGLGKASGLTSVNASSN 148 (1009)
Q Consensus 83 ~~~l~~l~~L~~L~L~~n~~~~~----~~~~l~~l~~L~~L~Ls~n~l~~~----------~p~~l~~l~~L~~L~Ls~n 148 (1009)
...+...+.|++|+|++|.+... +...+...++|+.|+++++..... +...+..+++|++|+|++|
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n 103 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 103 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence 34566677777777777777543 233455667777777776643211 1122344566666666666
Q ss_pred CCCCC----CCccccCCCCCCeeeccCCccCCcCCccc-------------cCccccceeeeccccccccCCccCCCCcc
Q 037197 149 NFSGF----LPEDLGNATSLESLDFRGSFFEGSVPTSF-------------RNLQKLKFLGLSGNNLTGKIPPELGQLSS 211 (1009)
Q Consensus 149 ~l~~~----~p~~l~~l~~L~~L~L~~n~~~~~~p~~~-------------~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 211 (1009)
.++.. +...+...++|++|++++|.+.......+ ...+.|+.|++++|.++.....
T Consensus 104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~------- 176 (344)
T d2ca6a1 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK------- 176 (344)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHH-------
T ss_pred ccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccc-------
Confidence 66543 22334455666666666665542111111 1223444555555444321110
Q ss_pred hhhhhcccccccccCCccccCCCCccEEEeccCccccc-----cCcccCCCCCCcEEEcccCCcCCC----CCccccccc
Q 037197 212 LETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSLSGQ-----IPPALGRLKKLTTVYLYKNNFTGK----IPPELGSIT 282 (1009)
Q Consensus 212 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-----~~~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~ 282 (1009)
.+...+...+.|++|+|++|.++.. +...+..+++|+.|+|++|.++.. +...+..++
T Consensus 177 -------------~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~ 243 (344)
T d2ca6a1 177 -------------EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243 (344)
T ss_dssp -------------HHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred -------------cccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccc
Confidence 1112233344555555555554421 223344455555555555554322 122334445
Q ss_pred ccccccccccccCCCcchhhh----c--ccCCCeEeccccccCCCC----CcCC-CCCCcccEEEccCCccC
Q 037197 283 SLAFLDLSDNQISGEIPVKLA----E--LKNLQLLNLMCNQLTGLI----PDKL-GELTKLEVLELWKNSLI 343 (1009)
Q Consensus 283 ~L~~L~Ls~N~l~~~~~~~l~----~--l~~L~~L~L~~N~l~~~~----~~~l-~~l~~L~~L~L~~N~l~ 343 (1009)
+|++|+|++|.|++.....++ . .+.|++|++++|+|+... ...+ .++++|+.|+|++|++.
T Consensus 244 ~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred cchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 555555555555533222221 1 234666666666654321 1112 13455666666666654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=1.9e-14 Score=138.59 Aligned_cols=126 Identities=21% Similarity=0.210 Sum_probs=60.4
Q ss_pred CCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcE
Q 037197 423 GNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSV 502 (1009)
Q Consensus 423 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 502 (1009)
.+..+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+.+ ..|..+++|++|++++|+++...+..+..+++|+.
T Consensus 15 ~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp ECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred cCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccccc
Confidence 34445555555555555 3344344455555555555555543 12444444444445554444333333444555555
Q ss_pred EEeecCCCCCCCC-ccccccccceeeeecCcccccCCC----cccccccccceec
Q 037197 503 LDLSSNSLSGEIP-ASIASCEKLVSLNLRNNRFSGEIP----KAVATMPTLAILD 552 (1009)
Q Consensus 503 LdLs~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~ 552 (1009)
|+|++|+++.... ..+..+++|++|++++|.++. .| ..+..+|+|++||
T Consensus 92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred ceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 5555555543211 234455555555555555542 22 1344455555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.47 E-value=5e-16 Score=171.06 Aligned_cols=253 Identities=19% Similarity=0.169 Sum_probs=174.9
Q ss_pred cCCccccccCccCcccccccccCCC----CCCCCCCCcCCeEEecCCCCCCCC----------CCccccCCCCCCeeecc
Q 037197 105 SLPKSLANLTALKSMDVSQNNFIGS----FPTGLGKASGLTSVNASSNNFSGF----------LPEDLGNATSLESLDFR 170 (1009)
Q Consensus 105 ~~~~~l~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~Ls~n~l~~~----------~p~~l~~l~~L~~L~L~ 170 (1009)
.+...+.+.+.|++|+|++|.+... +...+...++|+.|+++++..... +...+...++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 4567788899999999999987543 334567788999999988765421 12334556788888888
Q ss_pred CCccCCcCC----ccccCccccceeeeccccccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEeccCcc
Q 037197 171 GSFFEGSVP----TSFRNLQKLKFLGLSGNNLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLAVGSL 246 (1009)
Q Consensus 171 ~n~~~~~~p----~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 246 (1009)
+|.++.... ..+...++|++|++++|.+.......++ ..|..+... ......+.|+.|++++|.+
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~--~~l~~~~~~---------~~~~~~~~L~~l~l~~n~i 170 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA--RALQELAVN---------KKAKNAPPLRSIICGRNRL 170 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHH--HHHHHHHHH---------HHHHTCCCCCEEECCSSCC
T ss_pred ccccccccccchhhhhcccccchheeccccccccccccccc--ccccccccc---------cccccCcccceeecccccc
Confidence 888775432 3344567788888888876532111111 112222211 1123456899999999988
Q ss_pred ccc----cCcccCCCCCCcEEEcccCCcCCC-----CCcccccccccccccccccccCCC----cchhhhcccCCCeEec
Q 037197 247 SGQ----IPPALGRLKKLTTVYLYKNNFTGK-----IPPELGSITSLAFLDLSDNQISGE----IPVKLAELKNLQLLNL 313 (1009)
Q Consensus 247 ~~~----~~~~l~~l~~L~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L 313 (1009)
+.. +...+...+.|++|+|++|.++.. +...+..+++|+.|+|++|.++.. +...+..+++|++|+|
T Consensus 171 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~L 250 (344)
T d2ca6a1 171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 250 (344)
T ss_dssp TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred cccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhh
Confidence 743 334456778999999999998743 234567788999999999998743 3345678899999999
Q ss_pred cccccCCCCCcCC----C--CCCcccEEEccCCccCccCC----ccc-cCCCCCceeeccCccccc
Q 037197 314 MCNQLTGLIPDKL----G--ELTKLEVLELWKNSLIGSLP----MRL-GQSSPLRRLDASSNLLSG 368 (1009)
Q Consensus 314 ~~N~l~~~~~~~l----~--~l~~L~~L~L~~N~l~~~~~----~~~-~~~~~L~~L~Ls~N~l~~ 368 (1009)
++|.|++.....+ . ..+.|++|++++|.+..... ..+ .+.+.|+.|+|++|.+..
T Consensus 251 s~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 251 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred hcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 9999986432222 2 24679999999999875332 223 256789999999999974
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=1.6e-14 Score=139.09 Aligned_cols=128 Identities=13% Similarity=0.120 Sum_probs=105.8
Q ss_pred CcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccce
Q 037197 446 ISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLV 525 (1009)
Q Consensus 446 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~ 525 (1009)
+.++..+++|+|++|+|+.+ +..+..+++|+.|++++|+|+.. +.|..+++|+.|+|++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 55677899999999999985 66678899999999999999854 3588899999999999999976666677899999
Q ss_pred eeeecCcccccCCC--cccccccccceecCCcccccccc---CcCcCCCCCCcEEec
Q 037197 526 SLNLRNNRFSGEIP--KAVATMPTLAILDMSNNSLFGRI---PENFGASPALEMLNL 577 (1009)
Q Consensus 526 ~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~l 577 (1009)
.|+|++|+|+. ++ ..+..+++|+.|++++|+++... +..+..+|+|++||-
T Consensus 91 ~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 91 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred cceeccccccc-cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 99999999984 33 46888999999999999987543 235677889998873
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=5.6e-14 Score=128.50 Aligned_cols=101 Identities=28% Similarity=0.395 Sum_probs=46.2
Q ss_pred EEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcc
Q 037197 454 FVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNR 533 (1009)
Q Consensus 454 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 533 (1009)
+|+|++|+|+.+ + .+..+++|++|++++|+++. +|..+..+++|+.|++++|+|++. | .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 445555555432 1 23444444444444444442 333444455555555555555422 2 24445555555555555
Q ss_pred cccCC-CcccccccccceecCCccccc
Q 037197 534 FSGEI-PKAVATMPTLAILDMSNNSLF 559 (1009)
Q Consensus 534 l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 559 (1009)
|++.. ...++.+++|+.||+++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 54221 133444555555555555544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.42 E-value=1.2e-13 Score=126.26 Aligned_cols=104 Identities=28% Similarity=0.375 Sum_probs=91.8
Q ss_pred chhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCcccccccccceecCCcc
Q 037197 477 QTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAILDMSNN 556 (1009)
Q Consensus 477 ~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 556 (1009)
+.|++++|+++. ++ .+..+++|++||+++|+|+ .+|..++.+++|+.|++++|+|++ +| .++.+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 468999999984 44 5899999999999999998 577889999999999999999984 55 5899999999999999
Q ss_pred cccccc-CcCcCCCCCCcEEecCCCccccC
Q 037197 557 SLFGRI-PENFGASPALEMLNLSYNKLEGP 585 (1009)
Q Consensus 557 ~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~ 585 (1009)
+++... +..+..+++|++|++++|+++..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 998654 36789999999999999999864
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.30 E-value=3.2e-14 Score=142.01 Aligned_cols=125 Identities=22% Similarity=0.263 Sum_probs=63.6
Q ss_pred cCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCCCcccccccccee
Q 037197 447 SLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVS 526 (1009)
Q Consensus 447 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~ 526 (1009)
..+++|+.|+|++|+|+.+ + .+..+++|+.|++++|+++. +|..+..+++|+.|++++|+++.. ..+..+++|+.
T Consensus 45 ~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~~ 119 (198)
T d1m9la_ 45 STLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLVNLRV 119 (198)
T ss_dssp HHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSSE
T ss_pred hcccccceeECcccCCCCc-c-cccCCccccChhhccccccc-cccccccccccccccccccccccc--ccccccccccc
Confidence 3334444444444444432 1 23344444444444444432 233333344566666666666532 23556666666
Q ss_pred eeecCcccccCCC-cccccccccceecCCccccccccCcC----------cCCCCCCcEEe
Q 037197 527 LNLRNNRFSGEIP-KAVATMPTLAILDMSNNSLFGRIPEN----------FGASPALEMLN 576 (1009)
Q Consensus 527 L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~ 576 (1009)
|+|++|+|+.... ..+..+++|+.|+|++|++....+.. +..+|+|+.||
T Consensus 120 L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp EEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 6666666653211 34666666666666666665544433 34566666665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.28 E-value=4.7e-14 Score=140.84 Aligned_cols=129 Identities=22% Similarity=0.297 Sum_probs=85.0
Q ss_pred CCccCCCCcccEEEeecccccccCCcCCcCCCCCcEEecccCcccccCCCcccCCcccchhccccCcccCCcccccccCC
Q 037197 419 PVGLGNLPSLQRLEMANNNLTGQIPDDISLSTSLSFVDISWNHLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACP 498 (1009)
Q Consensus 419 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 498 (1009)
+..+..+++|++|+|++|+|+ .++ .+..+++|+.|+|++|+|+.+ |..+..+++|+.|++++|+++.. ..+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i-~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKI-ENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSC-SSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred hhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccccc-ccccccccccccccccccccccc--ccccccc
Confidence 344555566666666666665 233 355666666666666666542 33444455677777777777642 3477788
Q ss_pred cCcEEEeecCCCCCCCC-ccccccccceeeeecCcccccCCCcc----------cccccccceec
Q 037197 499 SLSVLDLSSNSLSGEIP-ASIASCEKLVSLNLRNNRFSGEIPKA----------VATMPTLAILD 552 (1009)
Q Consensus 499 ~L~~LdLs~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~ 552 (1009)
+|+.|||++|+++.... ..+..+++|+.|+|++|.+....+.. +..+|+|+.||
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 88888888888874332 45778888888888888887544432 56788999988
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=6.6e-12 Score=119.60 Aligned_cols=105 Identities=19% Similarity=0.216 Sum_probs=58.1
Q ss_pred cEEEeecccccccCCcCCcCCCCCcEEecccC-cccccCCCcccCCcccchhccccCcccCCcccccccCCcCcEEEeec
Q 037197 429 QRLEMANNNLTGQIPDDISLSTSLSFVDISWN-HLESYLPSSILSIPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSS 507 (1009)
Q Consensus 429 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~ 507 (1009)
+.+++++++++ ..|..+..+++|+.|++++| .|+.+.+.+|.++++|+.|++++|+|+...|.+|..+++|+.|||++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34555555554 34455555555666666444 35555555555566666666666666555555566666666666666
Q ss_pred CCCCCCCCccccccccceeeeecCcccc
Q 037197 508 NSLSGEIPASIASCEKLVSLNLRNNRFS 535 (1009)
Q Consensus 508 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 535 (1009)
|+|+...+..|.. ..|+.|+|++|.+.
T Consensus 90 N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp SCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred CCCcccChhhhcc-ccccccccCCCccc
Confidence 6666333333433 24666666666553
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.21 E-value=1.5e-11 Score=117.04 Aligned_cols=83 Identities=16% Similarity=0.113 Sum_probs=38.0
Q ss_pred CCeeeccCCccCCcCCccccCccccceeeeccc-cccccCCccCCCCcchhhhhcccccccccCCccccCCCCccEEEec
Q 037197 164 LESLDFRGSFFEGSVPTSFRNLQKLKFLGLSGN-NLTGKIPPELGQLSSLETIILGYNAFEGEIPAEFGNLTNLRYLDLA 242 (1009)
Q Consensus 164 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n-~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 242 (1009)
.+.++.+++.+. ..|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+...+.+|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 344555554444 33444444555555555433 2443333344444444444444444444444444444444444444
Q ss_pred cCccc
Q 037197 243 VGSLS 247 (1009)
Q Consensus 243 ~n~l~ 247 (1009)
+|+|+
T Consensus 89 ~N~l~ 93 (156)
T d2ifga3 89 FNALE 93 (156)
T ss_dssp SSCCS
T ss_pred CCCCc
Confidence 44444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=4e-09 Score=100.68 Aligned_cols=103 Identities=20% Similarity=0.109 Sum_probs=71.9
Q ss_pred CcccchhccccCcccCCcccccccCCcCcEEEeecCCCCCCC--CccccccccceeeeecCcccccCCCcccccccccce
Q 037197 473 IPSLQTFMASHNNLQAKIPNELQACPSLSVLDLSSNSLSGEI--PASIASCEKLVSLNLRNNRFSGEIPKAVATMPTLAI 550 (1009)
Q Consensus 473 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 550 (1009)
+..+..++..+|... .++..+..+++|++||||+|+|+... +..+..+++|+.|+|++|+|+...+-.+.....|+.
T Consensus 41 ~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~ 119 (162)
T d1koha1 41 QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119 (162)
T ss_dssp TTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSS
T ss_pred ccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccce
Confidence 333444444444332 34555567888999999999998653 355677899999999999998544434445567899
Q ss_pred ecCCccccccccCcC-------cCCCCCCcEEe
Q 037197 551 LDMSNNSLFGRIPEN-------FGASPALEMLN 576 (1009)
Q Consensus 551 L~Ls~N~l~~~~p~~-------~~~l~~L~~L~ 576 (1009)
|++++|++++..... +..+|+|+.||
T Consensus 120 L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred eecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 999999998765533 56788888886
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=8.3e-09 Score=98.41 Aligned_cols=88 Identities=30% Similarity=0.341 Sum_probs=64.1
Q ss_pred cccCCcccchhccccCcccCC--cccccccCCcCcEEEeecCCCCCCCCccccccccceeeeecCcccccCCCc------
Q 037197 469 SILSIPSLQTFMASHNNLQAK--IPNELQACPSLSVLDLSSNSLSGEIPASIASCEKLVSLNLRNNRFSGEIPK------ 540 (1009)
Q Consensus 469 ~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~------ 540 (1009)
.+..+++|++|++++|+|+.. ++..+..+++|+.|||++|+++...+..+.....|+.|+|++|.++.....
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~ 139 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS 139 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence 344567777777777777754 345677889999999999999865544444556789999999999865543
Q ss_pred -ccccccccceecCCcccc
Q 037197 541 -AVATMPTLAILDMSNNSL 558 (1009)
Q Consensus 541 -~~~~l~~L~~L~Ls~N~l 558 (1009)
.+..+|+|+.|| ++++
T Consensus 140 ~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 140 AIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHTTSTTCCEET--TEEC
T ss_pred HHHHHCCCCCEEC--cCCC
Confidence 356789999988 5544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.19 E-value=2.3e-06 Score=88.24 Aligned_cols=145 Identities=14% Similarity=0.072 Sum_probs=95.7
Q ss_pred HHhcCCcCceeccCCceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEE
Q 037197 696 ILACVKESNIIGMGGNGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMM 774 (1009)
Q Consensus 696 ~~~~~~~~~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~l 774 (1009)
..+.|+..+..+-++.+.||+.... +..+++|+...... .....+.+|...++.+. +--+.+++.+..+++..++
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~~~--~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEECS--SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEEeC--CCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 3445554444444455789988643 45677887743321 12234557888877663 4446788888888889999
Q ss_pred EEeccCCCChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 037197 775 VYDYMPNDSLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHHDC--------------------------------- 821 (1009)
Q Consensus 775 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--------------------------------- 821 (1009)
||++++|.++.+...... ....++.++++.++.||+..
T Consensus 88 v~~~l~G~~~~~~~~~~~---------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDEQ---------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHTTTCS---------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEecccccccccccccc---------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999988866542211 11224555666666666421
Q ss_pred -----------------------CCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 822 -----------------------QPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 822 -----------------------~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12478999999999999876677999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.78 E-value=2.1e-05 Score=80.32 Aligned_cols=129 Identities=17% Similarity=0.140 Sum_probs=82.7
Q ss_pred eccCCc-eEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC--CCceeeEEeEEEcCCeEEEEEeccCCC
Q 037197 706 IGMGGN-GIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR--HRNIVRLLGYLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 706 iG~G~~-g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~~~~~lV~E~~~~g 782 (1009)
+..|.. +.||+..... +..+++|...... ...+.+|++.++.+. .-.+.+++++..+++..++||||++|.
T Consensus 18 ~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp CSCTTSSCEEEEEECTT-SCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred cCCcccCCeEEEEEeCC-CCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 444543 6789988765 6668888764321 223456777777663 334678888888888899999999987
Q ss_pred ChhhhhcCCccccccccHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 037197 783 SLGEALHGKEAGKLLVDWVSRYNIAVGIAQGLNYLHH------------------------------------------- 819 (1009)
Q Consensus 783 sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~------------------------------------------- 819 (1009)
++.+... ... .++.++.+.++-||+
T Consensus 92 ~~~~~~~---------~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 92 DLLSSHL---------APA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp ETTTSCC---------CHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred ccccccc---------cHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 6543210 000 012223333333332
Q ss_pred --------c----CCCCeEEeccCCCcEEeCCCCcEEEcccccce
Q 037197 820 --------D----CQPPVIHRDIKSNNILLDANLEARIADFGLAR 852 (1009)
Q Consensus 820 --------~----~~~~ivH~dlk~~NIll~~~~~~kl~DfGls~ 852 (1009)
. ..+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12347999999999999987777899999774
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.45 E-value=8.5e-06 Score=77.31 Aligned_cols=89 Identities=12% Similarity=0.161 Sum_probs=49.1
Q ss_pred cccCCcCcEEEeecCCCCCCC----CccccccccceeeeecCcccccCC----CcccccccccceecCCccccccc----
Q 037197 494 LQACPSLSVLDLSSNSLSGEI----PASIASCEKLVSLNLRNNRFSGEI----PKAVATMPTLAILDMSNNSLFGR---- 561 (1009)
Q Consensus 494 ~~~l~~L~~LdLs~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~---- 561 (1009)
+...+.|+.|+|++|.++... ...+...+.|++|+|++|.++..- -..+..-++|+.|+|++|.+...
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~ 119 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV 119 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHH
Confidence 444455666666666665322 222333456666777777665422 22344456677777777654321
Q ss_pred ---cCcCcCCCCCCcEEecCCCcc
Q 037197 562 ---IPENFGASPALEMLNLSYNKL 582 (1009)
Q Consensus 562 ---~p~~~~~l~~L~~L~ls~N~l 582 (1009)
+.+.+..-+.|+.|+++++..
T Consensus 120 ~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 120 EMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHHhCCCccEeeCcCCCc
Confidence 334444456777777776644
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.41 E-value=0.00016 Score=78.51 Aligned_cols=78 Identities=17% Similarity=0.053 Sum_probs=49.7
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEEcccC-----CCChhhHHHHHHHHHHHhcc-CC--CceeeEEeEEEcCCeEEEE
Q 037197 704 NIIGMGGNGIVYKAEFHRPHMVVAVKKLWRS-----DNDIESGDDLFREVSLLGRL-RH--RNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~E~~~l~~l-~H--pniv~l~~~~~~~~~~~lV 775 (1009)
+.||.|....||++....+++.|+||.-... ...+....+...|++.++.+ .+ ..+++++.+. ++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 4589999999999998777888999975321 11122334556788888766 22 3466666653 4455889
Q ss_pred EeccCCCC
Q 037197 776 YDYMPNDS 783 (1009)
Q Consensus 776 ~E~~~~gs 783 (1009)
|||+++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.30 E-value=3.1e-05 Score=73.25 Aligned_cols=111 Identities=14% Similarity=0.082 Sum_probs=63.3
Q ss_pred cCCCCCeEecccC-ccccc----CCccccccCccCcccccccccCCCCC----CCCCCCcCCeEEecCCCCCCCCC----
Q 037197 88 GLRSLSSLNICCN-EFASS----LPKSLANLTALKSMDVSQNNFIGSFP----TGLGKASGLTSVNASSNNFSGFL---- 154 (1009)
Q Consensus 88 ~l~~L~~L~L~~n-~~~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~p----~~l~~l~~L~~L~Ls~n~l~~~~---- 154 (1009)
+.++|++|+|+++ .++.. +...+...+.|++|+|++|.+..... ..+...+.|++|+|++|.++...
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3456666666653 34432 23345555667777777766653222 22334566777777777776432
Q ss_pred CccccCCCCCCeeeccCCccCCc-------CCccccCccccceeeeccccc
Q 037197 155 PEDLGNATSLESLDFRGSFFEGS-------VPTSFRNLQKLKFLGLSGNNL 198 (1009)
Q Consensus 155 p~~l~~l~~L~~L~L~~n~~~~~-------~p~~~~~l~~L~~L~L~~n~l 198 (1009)
-..+...++|++|++++|.+... +...+..-+.|+.|+++.+..
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 23455667788888877755422 223344457788888766543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.64 E-value=0.00011 Score=69.40 Aligned_cols=91 Identities=15% Similarity=0.219 Sum_probs=52.6
Q ss_pred ccccCCcCcEEEeecCCCCCCCCc----cccccccceeeeecCcccccC----CCcccccccccce--ecCCcccccc--
Q 037197 493 ELQACPSLSVLDLSSNSLSGEIPA----SIASCEKLVSLNLRNNRFSGE----IPKAVATMPTLAI--LDMSNNSLFG-- 560 (1009)
Q Consensus 493 ~~~~l~~L~~LdLs~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~--L~Ls~N~l~~-- 560 (1009)
.+...++|+.|+|++|.++...-. .+...+.++.|++++|.++.. +-..+...++|+. |++++|.+..
T Consensus 41 al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~ 120 (166)
T d1io0a_ 41 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNV 120 (166)
T ss_dssp HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHH
T ss_pred HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHH
Confidence 344556666667776666533222 233456677777777776532 2244555666665 4455666643
Q ss_pred --ccCcCcCCCCCCcEEecCCCccc
Q 037197 561 --RIPENFGASPALEMLNLSYNKLE 583 (1009)
Q Consensus 561 --~~p~~~~~l~~L~~L~ls~N~l~ 583 (1009)
.+.+.+...+.|+.|++++|+..
T Consensus 121 ~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 121 EMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 34444556677888888776543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.48 E-value=0.00015 Score=68.38 Aligned_cols=12 Identities=25% Similarity=0.249 Sum_probs=6.6
Q ss_pred Cccccceeeecc
Q 037197 184 NLQKLKFLGLSG 195 (1009)
Q Consensus 184 ~l~~L~~L~L~~ 195 (1009)
+.++|++|+|++
T Consensus 15 ~~~~L~~L~L~~ 26 (166)
T d1io0a_ 15 NDPDLEEVNLNN 26 (166)
T ss_dssp TCTTCCEEECTT
T ss_pred cCCCCcEEEcCC
Confidence 445555565554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.13 E-value=0.0059 Score=65.87 Aligned_cols=73 Identities=16% Similarity=0.268 Sum_probs=48.8
Q ss_pred ceeccCCceEEEEEEECC-------CCeEEEEEEcccCCCChhhHHHHHHHHHHHhccC-CCceeeEEeEEEcCCeEEEE
Q 037197 704 NIIGMGGNGIVYKAEFHR-------PHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLR-HRNIVRLLGYLHNETNVMMV 775 (1009)
Q Consensus 704 ~~iG~G~~g~Vyk~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lV 775 (1009)
+.|+.|-.-.+|++.... ....|.+++.-.. .......+|..+++.+. +.-..++++++.+ ++|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 457778888999998754 2356777776322 12233447888888874 4445578887754 689
Q ss_pred EeccCCCCh
Q 037197 776 YDYMPNDSL 784 (1009)
Q Consensus 776 ~E~~~~gsL 784 (1009)
|||++|.++
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.62 E-value=0.024 Score=58.92 Aligned_cols=68 Identities=13% Similarity=0.133 Sum_probs=43.3
Q ss_pred ceEEEEEEECCCCeEEEEEEcccCCCChhhHHHHHHHHHHHhccCCCc--eeeEEe-----EEEcCCeEEEEEeccCCC
Q 037197 711 NGIVYKAEFHRPHMVVAVKKLWRSDNDIESGDDLFREVSLLGRLRHRN--IVRLLG-----YLHNETNVMMVYDYMPND 782 (1009)
Q Consensus 711 ~g~Vyk~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn--iv~l~~-----~~~~~~~~~lV~E~~~~g 782 (1009)
--.||++...+ |+.|++|+.+.. ....+++..|.+.+..+.... ++..+. .+..++..+.|++|++|.
T Consensus 35 EN~vy~v~~~d-g~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDED-RRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTT-CCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCC-CCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 45899998865 788999997432 223455667888777763221 111111 234566789999999874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.11 E-value=0.13 Score=52.74 Aligned_cols=32 Identities=25% Similarity=0.332 Sum_probs=28.3
Q ss_pred CCCeEEeccCCCcEEeCCCCcEEEccccccee
Q 037197 822 QPPVIHRDIKSNNILLDANLEARIADFGLARM 853 (1009)
Q Consensus 822 ~~~ivH~dlk~~NIll~~~~~~kl~DfGls~~ 853 (1009)
..++||+|+.++||+++.+...-|+||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 45899999999999999987778999998853
|